PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Biggs, MB; Papin, JA				Biggs, Matthew B.; Papin, Jason A.			Novel Multiscale Modeling Tool Applied to Pseudomonas aeruginosa Biofilm Formation	PLOS ONE			English	Article							METABOLIC NETWORK ANALYSIS; FLUX BALANCE ANALYSIS; ADAPTATION; GROWTH	Multiscale modeling is used to represent biological systems with increasing frequency and success. Multiscale models are often hybrids of different modeling frameworks and programming languages. We present the MATLAB-NetLogo extension (MatNet) as a novel tool for multiscale modeling. We demonstrate the utility of the tool with a multiscale model of Pseudomonas aeruginosa biofilm formation that incorporates both an agent-based model (ABM) and constraint-based metabolic modeling. The hybrid model correctly recapitulates oxygen-limited biofilm metabolic activity and predicts increased growth rate via anaerobic respiration with the addition of nitrate to the growth media. In addition, a genome-wide survey of metabolic mutants and biofilm formation exemplifies the powerful analyses that are enabled by this computational modeling tool.	[Biggs, Matthew B.; Papin, Jason A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA	University of Virginia	Papin, JA (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.	papin@virginia.edu		Biggs, Matthew/0000-0001-6492-8180; Papin, Jason/0000-0002-2769-5805	University of Virginia; National Institutes of Health [RO1 GM088244]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088244] Funding Source: NIH RePORTER	University of Virginia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge funding by a Commonwealth Fellowship in Engineering from the University of Virginia [http://bme.virginia.edu/] to MBB, and from the National Institutes of Health (RO1 GM088244)[http://www.nih.gov/] to JAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, R LANG ENV STAT COMP; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bengtsson H, 2005, SWEDEN MATH STATICS; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Chave Jerome, 2013, Ecology Letters, V16, P4, DOI 10.1111/ele.12048; de Werra P, 2009, APPL ENVIRON MICROB, V75, P4162, DOI 10.1128/AEM.00295-09; Gianchandani EP, 2010, WIRES SYST BIOL MED, V2, P372, DOI 10.1002/wsbm.60; Hayenga HN, 2011, ANN BIOMED ENG, V39, P2669, DOI 10.1007/s10439-011-0363-9; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Mabrouk N, 2011, UNDERST COMPLEX SYST, P131, DOI 10.1007/978-3-642-20423-4_6; Mabrouk N, 2010, THEOR BIOSCI, V129, P1, DOI 10.1007/s12064-009-0078-8; Magliocca NR, 2013, T GIS, V17, P883, DOI 10.1111/tgis.12012; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Manos J, 2009, FEMS MICROBIOL LETT, V292, P107, DOI 10.1111/j.1574-6968.2008.01472.x; Merkey BV, 2011, ENVIRON MICROBIOL, V13, P2435, DOI 10.1111/j.1462-2920.2011.02535.x; Neidig A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-77; Noguera DR, 2004, MICROBIAL BIOFILMS, P222; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Pizarro G, 2001, J ENVIRON ENG-ASCE, V127, P782, DOI 10.1061/(ASCE)0733-9372(2001)127:9(782); Railsback S., 2012, AGENT BASED INDIVIDU; Robertson SH, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-46; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; The MathWorks Inc, 2012, MATLAB STAT TOOLB; Thiele JC, 2010, ENVIRON MODELL SOFTW, V25, P972, DOI 10.1016/j.envsoft.2010.02.008; Thorne BC, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00020; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Walpole J, 2013, ANNU REV BIOMED ENG, V15, P137, DOI 10.1146/annurev-bioeng-071811-150104; Wilensky U., 1999, NETLOGO; Xu KD, 1998, APPL ENVIRON MICROB, V64, P4035	32	43	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78011	10.1371/journal.pone.0078011	http://dx.doi.org/10.1371/journal.pone.0078011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147108	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200093
J	Jiang, YH; Peng, CH; Liu, HT; Kuo, HC				Jiang, Yuan-Hong; Peng, Chung-Hsin; Liu, Hsin-Tzu; Kuo, Hann-Chorng			Increased Pro-Inflammatory Cytokines, C-Reactive Protein and Nerve Growth Factor Expressions in Serum of Patients with Interstitial Cystitis/Bladder Pain Syndrome	PLOS ONE			English	Article							NATIONAL INSTITUTE; BLADDER; CELL; PATHOGENESIS; FEATURES; MARKERS; URINE; RAT	Objective: The etiology and pathogenesis of interstitial cystitis/bladder pain syndrome (IC/BPS) are unclear. Chronic inflammation is considered the main pathology of IC/BPS. This study measured the serum c-reactive protein (CRP), nerve growth factor (NGF) and pro-inflammatory cytokine/chemokine interleukin (IL)-1 beta, IL-6, tumor necrosis factor (TNF)-alpha, and IL-8 expression in patients with IC/BPS to elucidate the involvement of systemic inflammation in IC/BPS. Methods: Serum samples were collected from 30 IC/BPS patients and 26 control subjects. The concentrations of serum nerve growth factor (NGF), IL-1 beta, IL-6, TNF-alpha, and IL-8 were quantified using a bead-based, human serum adipokine panel kit. Serum C-reactive protein (CRP) was also assessed. Differences of serum CRP, NGF, IL-1 beta, IL-6, TNF-alpha, and IL-8 levels between the IC/BPS patients and controls were compared, and correlations between CRP and pro-inflammatory cytokines and chemokine were also evaluated. Results: The results showed that CRP level (p = 0.031), NGF (p = 0.015) and pro-inflammatory cytokines/chemokine IL-1 beta, IL-6, TNF-alpha, and IL-8 levels were significantly higher in the patients with IC/BPS than among controls (all p<0.001). Significant associations were observed between IL-1 beta and IL-8 (p<0.001), IL-6 and CRP (p = 0.01), IL-6 and IL-8 (p = 0.02), and IL-6 and TNF-alpha (p = 0.03). Conclusion: Increased pro-inflammatory cytokines/chemokine (IL-1 beta, IL-6, TNF-alpha, and IL-8) expression in the sera of IC/BPS patients implies not only mast cell activation, but also that other inflammatory mediators play important roles in the pathogenesis of IC/BPS. Thus, for some patients, IC/BPS is considered a chronic inflammatory disease.	[Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Jiang, Yuan-Hong; Peng, Chung-Hsin; Kuo, Hann-Chorng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Peng, Chung-Hsin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Urol, New Taipei City, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Sch Med, Dept Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw						Bhangoo S, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-38; Bouchelouche K, 2003, CURR OPIN UROL, V13, P309, DOI 10.1097/00042307-200307000-00007; Bouchelouche K, 2001, J UROLOGY, V166, P2121, DOI 10.1016/S0022-5347(05)65518-8; Chancellor MB, 2004, UROLOGY, V63, P85, DOI 10.1016/j.urology.2003.10.034; Chung SD, 2011, NEUROUROL URODYNAM, V30, P417, DOI 10.1002/nau.20938; Dodd LG, 1998, ACTA CYTOL, V42, P923, DOI 10.1159/000331969; Dupont MC, 2001, J UROLOGY, V166, P1111, DOI 10.1016/S0022-5347(05)65931-9; Erickson DR, 2008, J UROLOGY, V179, P1850, DOI 10.1016/j.juro.2008.01.047; Erickson DR, 2005, J UROLOGY, V173, P93, DOI 10.1097/01.ju.0000146466.71311.ab; Erickson DR, 1997, J UROLOGY, V158, P790, DOI 10.1016/S0022-5347(01)64317-9; Hanno PM, 2001, UROLOGY, V57, P2, DOI 10.1016/S0090-4295(01)01112-8; Lamale LM, 2006, UROLOGY, V68, P702, DOI 10.1016/j.urology.2006.04.033; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044687; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Lowe EM, 1997, BRIT J UROL, V79, P572, DOI 10.1046/j.1464-410X.1997.00097.x; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MARTINS SM, 1994, J UROLOGY, V151, P1198, DOI 10.1016/S0022-5347(17)35212-6; Nickel JC, 2010, J UROLOGY, V184, P1358, DOI 10.1016/j.juro.2010.06.005; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Peters EMJ, 2011, J INVEST DERMATOL, V131, P735, DOI 10.1038/jid.2010.317; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Smaldone MC, 2009, UROLOGY, V73, P421, DOI 10.1016/j.urology.2008.07.031; Tseng-Rogenski S, 2009, AM J PHYSIOL-RENAL, V297, pF816, DOI 10.1152/ajprenal.90733.2008; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Tyagi P, 2010, INT UROL NEPHROL, V42, P629, DOI 10.1007/s11255-009-9647-5; Van De Merwe JP, 2000, BJU INT, V85, P995, DOI 10.1046/j.1464-410x.2000.00646.x; Wilkinson David R, 2006, Curr Urol Rep, V7, P414, DOI 10.1007/s11934-006-0013-1	27	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76779	10.1371/journal.pone.0076779	http://dx.doi.org/10.1371/journal.pone.0076779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146927	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200020
J	De Jong, HJI; Damoiseaux, JGMC; Vandebriel, RJ; Souverein, PC; Gremmer, ER; Wolfs, M; Klungel, OH; Van Loveren, H; Tervaert, JWC; Verschuren, WMM				De Jong, Hilda J. I.; Damoiseaux, Jan G. M. C.; Vandebriel, Rob J.; Souverein, Patrick C.; Gremmer, Eric R.; Wolfs, Mia; Klungel, Olaf H.; Van Loveren, Henk; Tervaert, Jan Willem Cohen; Verschuren, W. M. Monique			Statin Use and Markers of Immunity in the Doetinchem Cohort Study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; C-REACTIVE PROTEIN; COA REDUCTASE INHIBITOR; ENDOTHELIAL-DEPENDENT VASODILATION; NECROSIS-FACTOR-ALPHA; T-CELLS; ANTINUCLEAR ANTIBODIES; ATORVASTATIN; SIMVASTATIN; THERAPY	It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases. Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serological levels of C-reactive protein (CRP), neopterin, immunoglobulin E (IgE) antibodies and the presence of autoantibodies (antinuclear antibodies (ANA) and IgM rheumatoid factor (RF)) in the general population. We conducted a nested case-control study within the population-based Doetinchem cohort. Data from health questionnaires, serological measurements and information on medication from linkage to pharmacy-dispensing records were available. We selected 332 statin users (cases) and 331 non-users (controls), matched by age, sex, date of serum collection, history of cardiovascular diseases, diabetes mellitus type II and stroke. Multivariate regression analyses were performed to estimate effect of statins on the immune system. The median level of CRP in statin users (1.28 mg/L, interquartile range (IQR): 0.59-2.79) was lower than in non-users (1.62 mg/L, IQR: 0.79-3.35), which after adjustment was estimated to be a 28% lower level. We observed an inverse association between duration of statin use and CRP levels. Elevated levels of IgE (> 100 IU/mL) were more prevalent in statin users compared to non-users. A trend towards increased levels of IgE antibodies in statin users was observed, whereas no associations were found between statin use and levels of neopterin or the presence of autoantibodies. In this general population sub-sample, we observed an anti-inflammatory effect of statin use and a trend towards an increase of IgE levels, an surrogate marker for Th (helper) 2 responses without a decrease in neopterin levels, a surrogate marker for Th1 response and/or self-tolerance. We postulate that the observed decreased inflammatory response during statin therapy may be important but is insufficient to induce loss of self-tolerance.	[De Jong, Hilda J. I.; Vandebriel, Rob J.; Gremmer, Eric R.; Van Loveren, Henk] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [De Jong, Hilda J. I.; Van Loveren, Henk] Maastricht Univ, Dept Toxicogen, Med Ctr, Maastricht, Netherlands; [De Jong, Hilda J. I.; Souverein, Patrick C.; Klungel, Olaf H.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Dept Pharmaceut Sci, Fac Sci,Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Damoiseaux, Jan G. M. C.; Wolfs, Mia; Tervaert, Jan Willem Cohen] Maastricht Univ, Cent Diagnost Lab, Med Ctr, Maastricht, Netherlands; [Tervaert, Jan Willem Cohen] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Verschuren, W. M. Monique] Natl Inst Publ Hlth & Environm, Ctr Nutr Prevent & Hlth Serv, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Maastricht University; Utrecht University; Maastricht University; Maastricht University; Netherlands National Institute for Public Health & the Environment	Damoiseaux, JGMC (corresponding author), Maastricht Univ, Cent Diagnost Lab, Med Ctr, Maastricht, Netherlands.	jan.damoiseaux@mumc.nl	Vandebriel, Rob/P-6769-2019; Damoiseaux, Jan/B-8993-2009; tervaert, jan willem cohen/AAB-1111-2019	Vandebriel, Rob/0000-0001-9140-952X; Damoiseaux, Jan/0000-0003-4007-6985; de Jong, Hilda/0000-0002-4112-7572; Souverein, Patrick/0000-0002-7452-0477	National Institute for Public Health and the Environment [S/340040]	National Institute for Public Health and the Environment	Funding for this study was obtained from the National Institute for Public Health and the Environment (project S/340040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abud-Mendoza C, 2003, LUPUS, V12, P607, DOI 10.1191/0961203303lu429oa; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; [Anonymous], 2012, LANCET, V379, P93, DOI 10.1016/S0140-6736(12)60041-5; Arnaud C, 2005, TRENDS CARDIOVAS MED, V15, P202, DOI 10.1016/j.tcm.2005.07.002; Arora M, 2006, P NATL ACAD SCI USA, V103, P7777, DOI 10.1073/pnas.0508492103; Aziz N, 1999, CLIN DIAGN LAB IMMUN, V6, P89, DOI 10.1128/CDLI.6.1.89-95.1999; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barsante MM, 2005, EUR J PHARMACOL, V516, P282, DOI 10.1016/j.ejphar.2005.05.005; Bellosta S, 2004, CIRCULATION, V109, P50, DOI 10.1161/01.CIR.0000131519.15067.1f; BRUMMER E, 1993, CELL IMMUNOL, V149, P258, DOI 10.1006/cimm.1993.1153; Buurma H, 2008, J CLIN PHARM THER, V33, P17, DOI 10.1111/j.1365-2710.2008.00878.x; Chapman-Shimshoni D, 2003, EXP HEMATOL, V31, P779, DOI 10.1016/S0301-472X(03)00192-9; Cherfan P, 2007, ATHEROSCLEROSIS, V193, P186, DOI 10.1016/j.atherosclerosis.2006.06.022; Chodick G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000336; Cole TJ, 2000, STAT MED, V19, P3109, DOI 10.1002/1097-0258(20001130)19:22<3109::AID-SIM558>3.0.CO;2-F; Coward WR, 2006, J IMMUNOL, V176, P5284, DOI 10.4049/jimmunol.176.9.5284; Dalakas MC, 2012, AUTOIMMUN REV, V11, P203, DOI 10.1016/j.autrev.2011.05.013; Damoiseaux JGMC, 2006, AUTOIMMUN REV, V5, P10, DOI 10.1016/j.autrev.2005.05.007; de Jong HJI, 2012, ANN RHEUM DIS, V71, P648, DOI 10.1136/ard.2011.155622; de Jong HJI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041289; de Jong HJI, 2011, SEMIN ARTHRITIS RHEU, V41, P373, DOI 10.1016/j.semarthrit.2011.06.002; Dedeoglu F, 2009, CURR OPIN RHEUMATOL, V21, P547, DOI 10.1097/BOR.0b013e32832f13db; Dieker JWC, 2004, NEPHROL DIAL TRANSPL, V19, P282, DOI 10.1093/ndt/gfg485; FAIRWEATHER D, 2007, ENCY LIFE SCI, P1; Fauchais AL, 2004, REV MED INTERNE, V25, P294, DOI 10.1016/j.revmed.2003.10.013; Fehr T, 2004, ATHEROSCLEROSIS, V175, P83, DOI 10.1016/j.atherosclerosis.2004.02.016; Ferreira GA, 2007, RHEUMATOLOGY, V46, P1560, DOI 10.1093/rheumatology/kem186; FOSSO CK, 1995, J ALLERGY CLIN IMMUN, V95, P1053, DOI 10.1016/S0091-6749(95)70109-5; Funk JL, 2008, J RHEUMATOL, V35, P1083; GREENLAND S, 1989, AM J EPIDEMIOL, V130, P1066, DOI 10.1093/oxfordjournals.aje.a115409; Gurevich VS, 2005, AUTOIMMUN REV, V4, P123, DOI 10.1016/j.autrev.2004.08.037; Haas D, 2007, NEW ENGL J MED, V356, P2671, DOI 10.1056/NEJMp078083; Henderson CE, 1998, J IMMUNOL METHODS, V213, P99, DOI 10.1016/S0022-1759(98)00014-3; Henneman L, 2010, J INHERIT METAB DIS, V33, P625, DOI 10.1007/s10545-010-9173-8; HERINGS RMC, 1992, J EPIDEMIOL COMMUN H, V46, P136, DOI 10.1136/jech.46.2.136; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hodes RJ, 1997, IMMUNOL REV, V160, P5, DOI 10.1111/j.1600-065X.1997.tb01022.x; Jick SS, 2009, ANN RHEUM DIS, V68, P546, DOI 10.1136/ard.2008.091967; Kagami S, 2008, INT ARCH ALLERGY IMM, V146, P61, DOI 10.1159/000126063; Kagami S, 2009, INT IMMUNOL, V21, P679, DOI 10.1093/intimm/dxp037; Kay Jonathan, 2006, N Engl J Med, V354, P623; Khattri S, 2013, IMMUNOL RES, V56, P348, DOI 10.1007/s12026-013-8409-8; Korpilahde T, 2003, ANN RHEUM DIS, V62, P353, DOI 10.1136/ard.62.4.353; Kotyla PJ, 2008, RHEUMATOLOGY, V47, P381, DOI 10.1093/rheumatology/kem381; Kotyla PJ, 2006, J RHEUMATOL, V33, P2361; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Kwak BR, 2003, AUTOIMMUN REV, V2, P332, DOI 10.1016/S1568-9972(03)00049-1; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lawman S, 2004, J IMMUNOL, V173, P7641, DOI 10.4049/jimmunol.173.12.7641; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Lyngdoh T, 2011, ATHEROSCLEROSIS, V219, P253, DOI 10.1016/j.atherosclerosis.2011.07.117; Mammen AL, 2012, ARTHRIT CARE RES, V64, P269, DOI 10.1002/acr.20662; Mammen AL, 2011, ARTHRITIS RHEUM-US, V63, P713, DOI 10.1002/art.30156; Matta GME, 2007, CLIN CANCER RES, V13, P5348, DOI 10.1158/1078-0432.CCR-06-2819; Mausner-Fainberg K, 2008, ATHEROSCLEROSIS, V197, P829, DOI 10.1016/j.atherosclerosis.2007.07.031; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; Meng X, 2012, MOL MED, V18, P598, DOI 10.2119/molmed.2011.00471; Mevorach D, 2003, CLIN REV ALLERG IMMU, V25, P49, DOI 10.1385/CRIAI:25:1:49; Mulder DJ, 2007, CARDIOVASC DRUG THER, V21, P91, DOI 10.1007/s10557-007-6010-x; Nilsson TK, 2005, THROMB RES, V116, P249, DOI 10.1016/j.thromres.2004.12.005; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Noel B, 2007, J EUR ACAD DERMATOL, V21, P17, DOI 10.1111/j.1468-3083.2006.01838.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peters SAE, 2010, J INTERN MED, V268, P155, DOI 10.1111/j.1365-2796.2010.02230.x; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Scoble T, 2011, AUTOIMMUN REV, V10, P669, DOI 10.1016/j.autrev.2011.04.030; Sen D, 2010, INT J RHEUM DIS, V13, pe29, DOI 10.1111/j.1756-185X.2010.01481.x; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shimazu H, 2010, CLIN IMMUNOL, V136, P188, DOI 10.1016/j.clim.2010.03.008; Smeenk RJT, 2000, RHEUMATOLOGY, V39, P581, DOI 10.1093/rheumatology/39.6.581; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Steffens S, 2006, NAT CLIN PRACT NEPHR, V2, P378, DOI 10.1038/ncpneph0217; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tervaert JWC, 2007, ANN NY ACAD SCI, V1107, P251, DOI 10.1196/annals.1381.027; Thewissen MM, 2011, OBESITY, V19, P1690, DOI 10.1038/oby.2010.337; van Haelst P L, 2001, Eur J Intern Med, V12, P503, DOI 10.1016/S0953-6205(01)00172-8; Vandebriel RJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3814; Verschuren WMM, 2008, INT J EPIDEMIOL, V37, P1236, DOI 10.1093/ije/dym292; Walter RB, 2003, CLIN CHEM LAB MED, V41, P1314, DOI 10.1515/CCLM.2003.200; Yamagata T, 2007, RHEUMATOL INT, V27, P631, DOI 10.1007/s00296-006-0270-9; Yokota K, 2006, J RHEUMATOL, V33, P463; Yoon SS, 2010, J ATHEROSCLER THROMB, V17, P1176, DOI 10.5551/jat.5652; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	89	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77587	10.1371/journal.pone.0077587	http://dx.doi.org/10.1371/journal.pone.0077587			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147031	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400122
J	Klampfl, T; Milosevic, JD; Puda, A; Schonegger, A; Bagienski, K; Berg, T; Harutyunyan, AS; Gisslinger, B; Rumi, E; Malcovati, L; Pietra, D; Elena, C; Della Porta, MG; Pieri, L; Guglielmelli, P; Bock, C; Doubek, M; Dvorakova, D; Suvajdzic, N; Tomin, D; Tosic, N; Racil, Z; Steurer, M; Pavlovic, S; Vannucchi, AM; Cazzola, M; Gisslinger, H; Kralovics, R				Klampfl, Thorsten; Milosevic, Jelena D.; Puda, Ana; Schoenegger, Andreas; Bagienski, Klaudia; Berg, Tiina; Harutyunyan, Ashot S.; Gisslinger, Bettina; Rumi, Elisa; Malcovati, Luca; Pietra, Daniela; Elena, Chiara; Della Porta, Matteo Giovanni; Pieri, Lisa; Guglielmelli, Paola; Bock, Christoph; Doubek, Michael; Dvorakova, Dana; Suvajdzic, Nada; Tomin, Dragica; Tosic, Natasa; Racil, Zdenek; Steurer, Michael; Pavlovic, Sonja; Vannucchi, Alessandro M.; Cazzola, Mario; Gisslinger, Heinz; Kralovics, Robert			Complex Patterns of Chromosome 11 Aberrations in Myeloid Malignancies Target CBL, MLL, DDB1 and LMO2	PLOS ONE			English	Article							ACQUIRED UNIPARENTAL DISOMY; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE JAK2; DNA-SEQUENCING DATA; GAIN-OF-FUNCTION; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; GENOMIC ABERRATIONS; TANDEM DUPLICATION	Exome sequencing of primary tumors identifies complex somatic mutation patterns. Assignment of relevance of individual somatic mutations is difficult and poses the next challenge for interpretation of next generation sequencing data. Here we present an approach how exome sequencing in combination with SNP microarray data may identify targets of chromosomal aberrations in myeloid malignancies. The rationale of this approach is that hotspots of chromosomal aberrations might also harbor point mutations in the target genes of deletions, gains or uniparental disomies (UPDs). Chromosome 11 is a frequent target of lesions in myeloid malignancies. Therefore, we studied chromosome 11 in a total of 813 samples from 773 individual patients with different myeloid malignancies by SNP microarrays and complemented the data with exome sequencing in selected cases exhibiting chromosome 11 defects. We found gains, losses and UPDs of chromosome 11 in 52 of the 813 samples (6.4%). Chromosome 11q UPDs frequently associated with mutations of CBL. In one patient the 11qUPD amplified somatic mutations in both CBL and the DNA repair gene DDB1. A duplication within MLL exon 3 was detected in another patient with 11qUPD. We identified several common deleted regions (CDR) on chromosome 11. One of the CDRs associated with de novo acute myeloid leukemia (P=0.013). One patient with a deletion at the LMO2 locus harbored an additional point mutation on the other allele indicating that LMO2 might be a tumor suppressor frequently targeted by 11p deletions. Our chromosome-centered analysis indicates that chromosome 11 contains a number of tumor suppressor genes and that the role of this chromosome in myeloid malignancies is more complex than previously recognized.	[Klampfl, Thorsten; Milosevic, Jelena D.; Puda, Ana; Schoenegger, Andreas; Bagienski, Klaudia; Berg, Tiina; Harutyunyan, Ashot S.; Bock, Christoph; Kralovics, Robert] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Gisslinger, Bettina; Gisslinger, Heinz; Kralovics, Robert] Med Univ Vienna, Div Hematol & Blood Coagulat, Dept Internal Med 1, Vienna, Austria; [Rumi, Elisa; Malcovati, Luca; Pietra, Daniela; Elena, Chiara; Della Porta, Matteo Giovanni; Cazzola, Mario] Fdn IRCCS Policlin San Matteo, Dept Hematol Oncol, Pavia, Italy; [Della Porta, Matteo Giovanni; Cazzola, Mario] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [Pieri, Lisa; Guglielmelli, Paola; Vannucchi, Alessandro M.] Univ Florence, Sect Hematol, Florence, Italy; [Doubek, Michael; Dvorakova, Dana; Racil, Zdenek] Masaryk Univ, Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic; [Doubek, Michael; Dvorakova, Dana; Racil, Zdenek] Masaryk Univ, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Suvajdzic, Nada; Tomin, Dragica] Univ Belgrade, Sch Med, Clin Hematol, Clin Ctr Serbia, Belgrade, Serbia; [Tosic, Natasa; Pavlovic, Sonja] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Steurer, Michael] Univ Innsbruck Hosp, Div Hematol & Oncol, A-6020 Innsbruck, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; IRCCS Fondazione San Matteo; University of Pavia; University of Florence; Masaryk University Brno; University Hospital Brno; Masaryk University Brno; Clinical Centre of Serbia; University of Belgrade; University of Belgrade; Medical University of Innsbruck	Kralovics, R (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	robert.kralovics@cemm.oeaw.ac.at	Tosic, Natasa/AAV-1507-2020; Feenstra, Jelena D Milosevic/K-2114-2012; Rumi, Elisa/J-7424-2016; Cazzola, Mario/AAQ-8854-2021; Guglielmelli, Paola/K-7509-2016; Malcovati, Luca/CAJ-1695-2022; Pieri, Lisa/K-1762-2016; Bock, Christoph/AAE-7618-2019; Dvorakova, Dana/E-1105-2012; Vannucchi, Alessandro M./K-7499-2016; Harutyunyan, Ashot S/M-3528-2014; Doubek, Michael/E-1504-2012; Racil, Zdenek/I-2387-2014; Pietra, Daniela/F-3931-2016; Doubek, Michael/J-7011-2018	Feenstra, Jelena D Milosevic/0000-0001-7420-3298; Rumi, Elisa/0000-0002-7572-9504; Cazzola, Mario/0000-0001-6984-8817; Guglielmelli, Paola/0000-0003-1809-284X; Malcovati, Luca/0000-0002-1460-1611; Pieri, Lisa/0000-0003-1812-8072; Bock, Christoph/0000-0001-6091-3088; Vannucchi, Alessandro M./0000-0001-5755-0730; Harutyunyan, Ashot S/0000-0002-9050-9315; Pietra, Daniela/0000-0002-6575-8766; ELENA, CHIARA/0000-0002-0058-7142; Kralovics, Robert/0000-0002-6997-8539; Klampfl, Thorsten/0000-0002-6666-9773; Della Porta, Matteo Giovanni/0000-0002-6915-5970; Tosic, Natasa/0000-0002-1293-6215	Austrian Science Fund (FWF) [P23257-B12]; MPN Research Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano); Fondazione Berlucchi, Brescia, Italy; Dana Dvorakova's laboratory [MSM0021622430]; Italian Society of Experimental Hematology (SIES); Italian Ministry of Health for young Investigators; Austrian Science Fund (FWF) [P 23257] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); MPN Research Foundation; Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro); Fondazione Berlucchi, Brescia, Italy; Dana Dvorakova's laboratory; Italian Society of Experimental Hematology (SIES); Italian Ministry of Health for young Investigators; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF, P23257-B12) (www.fwf.ac.at) and the MPN Research Foundation (www.mpnresearchfoundation.org) (RK). Studies on myeloproliferative neoplasms conducted at the Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, and the Hematology Section, University of Florence, were supported by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5x1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative) (www.progettoagimm.it). Studies on myelodysplastic syndromes conducted in Pavia were supported by a grant from Fondazione Cariplo (www.fondazionecariplo.it) to Mario Cazzola, while those on secondary acute myeloid leukemia were supported by a grant from Fondazione Berlucchi, Brescia, Italy (www.fondazioneberlucchi.com) to Matteo Giovanni Della Porta. The work performed at the Masaryk University Brno was supported by MSMT CR CZ.1.05/1.1.00/02.0068 (CEITEC) (www.ceitec.eu), whereas studies in Serbia were supported by III41004 MESTD RSerbia (www.mpn.gov.rs). Studies in Dana Dvorakova's laboratory were supported by MSM0021622430 (www.msmt.cz). Work performed by Elisa Rumi was supported by a grant awarded from the Italian Society of Experimental Hematology (SIES) (www.siesonline.it), and a grant awarded from the Italian Ministry of Health for young Investigators (www.salute.gov.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Buxhofer-Ausch V, 2009, EUR J HAEMATOL, V82, P161, DOI 10.1111/j.1600-0609.2008.01183.x; Caligiuri MA, 1996, CANCER RES, V56, P1418; CHEN CS, 1993, BLOOD, V81, P2386; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dohner H, 1997, BLOOD, V89, P2516, DOI 10.1182/blood.V89.7.2516; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; Gupta M, 2008, GENE CHROMOSOME CANC, V47, P729, DOI 10.1002/gcc.20573; Iovine B, 2011, INT J BIOCHEM CELL B, V43, P1664, DOI 10.1016/j.biocel.2011.09.001; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Klampfl T, 2011, BLOOD, V118, P167, DOI 10.1182/blood-2011-01-331678; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kotake Y, 2009, CANCER RES, V69, P1809, DOI 10.1158/0008-5472.CAN-08-2739; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Luttikhuis MEMO, 2001, BRIT J CANCER, V85, P531, DOI 10.1054/bjoc.2001.1960; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Monni O, 2001, LEUKEMIA LYMPHOMA, V40, P259, DOI 10.3109/10428190109057924; OSHIMURA M, 1977, CANCER, V40, P1161, DOI 10.1002/1097-0142(197709)40:3<1161::AID-CNCR2820400327>3.0.CO;2-2; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; R Development Core Team, 2008, R LANG ENV STAT COMP; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Rumi E, 2011, AM J HEMATOL, V86, P974, DOI 10.1002/ajh.22166; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; SCHICHMAN SA, 1994, P NATL ACAD SCI USA, V91, P6236, DOI 10.1073/pnas.91.13.6236; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Schnittger S, 2000, LEUKEMIA, V14, P796, DOI 10.1038/sj.leu.2401773; Score J, 2012, BLOOD, V119, P1208, DOI 10.1182/blood-2011-07-367243; Stegelmann F, 2010, HAEMATOL-HEMATOL J, V95, P666, DOI 10.3324/haematol.2009.013623; Sverdlow SH, 2008, WHO CLASSIFICATION T; Szpurka H, 2009, LEUKEMIA, V23, P610, DOI 10.1038/leu.2008.249; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thoennissen NH, 2010, BLOOD, V115, P2882, DOI 10.1182/blood-2009-07-235119; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	49	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77819	10.1371/journal.pone.0077819	http://dx.doi.org/10.1371/journal.pone.0077819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147083	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400137
J	Schag, K; Teufel, M; Junne, F; Preissl, H; Hautzinger, M; Zipfel, S; Giel, KE				Schag, Kathrin; Teufel, Martin; Junne, Florian; Preissl, Hubert; Hautzinger, Martin; Zipfel, Stephan; Giel, Katrin Elisabeth			Impulsivity in Binge Eating Disorder: Food Cues Elicit Increased Reward Responses and Disinhibition	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; INHIBITORY CONTROL; ATTENTION BIAS; OBESITY; PREVALENCE; ACTIVATION; OVERWEIGHT; PICTURES; IMAGES; WOMEN	Background: Binge eating disorder (BED) represents a distinct eating disorder diagnosis. Current approaches assume increased impulsivity to be one factor leading to binge eating and weight gain. We used eye tracking to investigate both components of impulsivity, namely reward sensitivity and rash-spontaneous behaviour towards food in BED for the first time. Methods: Overweight and obese people with BED (BED+; n = 25), without BED (BED-; n = 26) and healthy normal-weight controls (NWC; n = 25) performed a free exploration paradigm measuring reward sensitivity (experiment 1) and a modified antisaccade paradigm measuring disinhibited, rash-spontaneous behaviour (experiment 2) using food and nonfood stimuli. Additionally, trait impulsivity was assessed. Results: In experiment 1, all participants located their initial fixations more often on food stimuli and BED+ participants gazed longer on food stimuli in comparison with BED- and NWC participants. In experiment 2, BED+ participants had more difficulties inhibiting saccades towards food and nonfood stimuli compared with both other groups in first saccades, and especially towards food stimuli in second saccades and concerning sequences of first and second saccades. BED- participants did not differ significantly from NWC participants in both experiments. Additionally, eye tracking performance was associated with self-reported reward responsiveness and self-control. Conclusions: According to these results, food-related reward sensitivity and rash-spontaneous behaviour, as the two components of impulsivity, are increased in BED in comparison with weight-matched and normal-weight controls. This indicates that BED represents a neurobehavioural phenotype of obesity that is characterised by increased impulsivity. Interventions for BED should target these special needs of affected patients.	[Schag, Kathrin; Teufel, Martin; Junne, Florian; Zipfel, Stephan; Giel, Katrin Elisabeth] Univ Tubingen, Univ Hosp Tubingen, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Preissl, Hubert] Univ Tubingen, Univ Hosp Tubingen, FMEG Ctr, Tubingen, Germany; [Preissl, Hubert] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Hautzinger, Martin] Univ Tubingen, Dept Psychol Clin & Dev Psychol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Schag, K (corresponding author), Univ Tubingen, Univ Hosp Tubingen, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany.	kathrin.schag@med.uni-tuebingen.de	Preißl, Hubert/E-9070-2012; Junne, Florian/ABI-7343-2020	Preißl, Hubert/0000-0002-8859-4661; Zipfel, Stephan/0000-0003-1659-4440	fortune programme of the Medical Faculty Tubingen [F1292005]; Deutsche Forschungsgemeinschaft; Tubingen University	fortune programme of the Medical Faculty Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tubingen University	The authors are grateful for funding support from a grant of the fortune programme of the Medical Faculty Tubingen (project number F1292005) (URL: http://www.med.uni-tuebingen.de/Forschung/Forschung+_+F%C3%B6rderung+an+der+Medizinischen+Fakult%C3%A4t/fort%C3%BCne.html). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tubingen University, (URL: http://www.uni-tuebingen.de/einrichtungen/universitaetsbibliothek/lernen-lehren-forschen/open-access-publikationsfonds.html.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichert DS, 2012, J CLIN EXP NEUROPSYC, V34, P1016, DOI 10.1080/13803395.2012.706261; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2013, BING EAT DIS; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Carnell S, 2012, OBES REV, V13, P43, DOI 10.1111/j.1467-789X.2011.00927.x; Castellanos EH, 2009, INT J OBESITY, V33, P1063, DOI 10.1038/ijo.2009.138; Crawford TJ, 2005, BIOL PSYCHIAT, V57, P1052, DOI 10.1016/j.biopsych.2005.01.017; Dawe S, 2004, NEUROSCI BIOBEHAV R, V28, P343, DOI 10.1016/j.neubiorev.2004.03.007; de Zwaan M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-220; Fielding J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030475; Fischer B, 1997, BRAIN RES PROTOC, V2, P47, DOI 10.1016/S1385-299X(97)00027-5; Frank S, 2010, BRAIN RES, V1350, P159, DOI 10.1016/j.brainres.2010.04.030; Giel KE, 2011, BIOL PSYCHIAT, V69, P661, DOI 10.1016/j.biopsych.2010.09.047; Giel KE, EUROPEAN EA IN PRESS, V21; Graham R, 2011, APPETITE, V56, P577, DOI 10.1016/j.appet.2011.01.029; Guerrieri R., 2008, PSIHOLOGIJSKE TEME, V17, P265; Hautzinger M., 2006, BECK DEPRESSIONS INV; Hilbert A., 2006, EATING DISORDER EXAM; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Jones A, 2012, EXPT CLIN PSYCHOPHAR; Manwaring JL, 2011, PSYCHOL REC, V61, P561, DOI 10.1007/BF03395777; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Mitchell KS, 2010, PSYCHOL MED, V40, P1899, DOI 10.1017/S0033291710000139; Mobbs O, 2011, APPETITE, V57, P263, DOI 10.1016/j.appet.2011.04.023; Mosconi MW, 2009, PSYCHOL MED, V39, P1559, DOI 10.1017/S0033291708004984; Mueller SC, 2012, J CHILD PSYCHOL PSYC, V53, P856, DOI 10.1111/j.1469-7610.2012.02541.x; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nijs IMT, 2010, APPETITE, V54, P243, DOI 10.1016/j.appet.2009.11.004; Nummenmaa L, 2011, PLOS ONE, V6; Preuss UW, 2008, NERVENARZT, V79, P305, DOI 10.1007/s00115-007-2360-7; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Schag K, 2013, OBES REV, V14, P477, DOI 10.1111/obr.12017; Schienle A, 2009, BIOL PSYCHIAT, V65, P654, DOI 10.1016/j.biopsych.2008.09.028; SensoMotoricInstruments, 2010, BEGAZE; SensoMotoricInstruments, 2010, IVIEWX; Smink FRE, 2012, CURR PSYCHIAT REP, V14, P406, DOI 10.1007/s11920-012-0282-y; Smith DG, 2013, BIOL PSYCHIAT, V73, P804, DOI 10.1016/j.biopsych.2012.08.026; Smyrnis N, 2008, BRAIN COGNITION, V68, P341, DOI 10.1016/j.bandc.2008.08.022; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Striegel-Moore RH, 2008, ANNU REV CLIN PSYCHO, V4, P305, DOI 10.1146/annurev.clinpsy.4.022007.141149; Strobel A., 2001, DIFFER DIAGNOST PSYC, V22, P216, DOI [10.1024//0170-1789.22.3.216, DOI 10.1024//0170-1789.22.3.216]; Svaldi J, 2010, APPETITE, V55, P685, DOI 10.1016/j.appet.2010.10.002; Tammela LI, 2010, CLIN PHYSIOL FUNCT I, V30, P135, DOI 10.1111/j.1475-097X.2009.00916.x; Waxman SE, 2009, EUR EAT DISORD REV, V17, P408, DOI 10.1002/erv.952; Werthmann J, 2011, HEALTH PSYCHOL, V30, P561, DOI 10.1037/a0024291; Wittchen H-U, 1997, SKID 1 STRUKTURIERTE; Wonderlich SA, 2009, INT J EAT DISORDER, V42, P687, DOI 10.1002/eat.20719	48	128	128	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76542	10.1371/journal.pone.0076542	http://dx.doi.org/10.1371/journal.pone.0076542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146885	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400070
J	Schel, AM; Townsend, SW; Machanda, Z; Zuberbuhler, K; Slocombe, KE				Schel, Anne Marijke; Townsend, Simon W.; Machanda, Zarin; Zuberbuehler, Klaus; Slocombe, Katie E.			Chimpanzee Alarm Call Production Meets Key Criteria for Intentionality	PLOS ONE			English	Article							GESTURAL COMMUNICATION; SEMANTIC COMMUNICATION; ATTENTIONAL STATUS; DIFFERENTIAL USE; GROUP MEMBERS; LANGUAGE; ELABORATION; PERSISTENCE; PRIMATES; ANIMALS	Determining the intentionality of primate communication is critical to understanding the evolution of human language. Although intentional signalling has been claimed for some great ape gestural signals, comparable evidence is currently lacking for their vocal signals. We presented wild chimpanzees with a python model and found that two of three alarm call types exhibited characteristics previously used to argue for intentionality in gestural communication. These alarm calls were: (i) socially directed and given to the arrival of friends, (ii) associated with visual monitoring of the audience and gaze alternations, and (iii) goal directed, as calling only stopped when recipients were safe from the predator. Our results demonstrate that certain vocalisations of our closest living relatives qualify as intentional signals, in a directly comparable way to many great ape gestures. We conclude that our results undermine a central argument of gestural theories of language evolution and instead support a multimodal origin of human language.	[Schel, Anne Marijke; Slocombe, Katie E.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Schel, Anne Marijke; Zuberbuehler, Klaus] Budongo Conservat Field Stn, Masindi, Uganda; [Townsend, Simon W.] Univ Zurich, Anim Behav Grp, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Machanda, Zarin] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Zuberbuehler, Klaus] Univ Neuchatel, Dept Comparat Cognit, CH-2000 Neuchatel, Switzerland; [Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of York - UK; University of Zurich; Harvard University; University of Neuchatel; University of St Andrews	Slocombe, KE (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	katie.slocombe@york.ac.uk	Slocombe, Katie E/B-8788-2016; Zuberbühler, Klaus/A-9053-2011	Slocombe, Katie E/0000-0002-7310-1887; Zuberbühler, Klaus/0000-0001-8378-088X	BBSRC; Wenner-Gren Hunt Fellowship; University of Zurich; Leverhulme Trust [F/00 268/AP]; Biotechnology and Biological Sciences Research Council [BB/G00613X/1] Funding Source: researchfish; BBSRC [BB/G00613X/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wenner-Gren Hunt Fellowship; University of Zurich; Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by a BBSRC project grant to KS. ZM was supported by a Wenner-Gren Hunt Fellowship, ST was supported by the University of Zurich, and KZ was supported by the Leverhulme Trust (F/00 268/AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arbib MA., 2012, BRAIN GOT LANGUAGE; Bates D., 2009, LME4 LINEAR MIXED EF; BATES E, 1975, MERRILL PALMER QUART, V21, P205; Bullinger AF, 2011, DEVELOPMENTAL SCI, V14, P58, DOI 10.1111/j.1467-7687.2010.00952.x; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Byrne RW, 2006, CURR BIOL, V16, pR445, DOI 10.1016/j.cub.2006.05.040; Casar C, 2012, ANIM BEHAV, V84, P405, DOI 10.1016/j.anbehav.2012.05.010; Call J., 2007, GESTURAL COMMUNICATI; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; Cartmill EA, 2010, ANIM COGN, V13, P793, DOI 10.1007/s10071-010-0328-7; CHENEY D, 1990, ANIM BEHAV, V40, P742, DOI 10.1016/S0003-3472(05)80703-1; Cheney D.L., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Cheney DL, 2005, LINGUIST REV, V22, P135, DOI 10.1515/tlir.2005.22.2-4.135; CHENEY DL, 1985, BEHAVIOUR, V94, P150, DOI 10.1163/156853985X00316; Cheney Dorothy L., 2007, BABOON METAPHYSICS; Corballis MC, 1999, AM SCI, V87, P138, DOI 10.1511/1999.2.138; Crawley M. J, 2002, STAT COMPUTING INTRO; Crockford C, 2012, CURR BIOL, V22, P142, DOI 10.1016/j.cub.2011.11.053; Dennett Daniel C., 1987, INTENTIONAL STANCE; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Faraway J. J., 2006, LINEAR MODELS R; GEMBA H, 1995, BRAIN RES, V697, P143, DOI 10.1016/0006-8993(95)00797-T; Genty E, 2010, ANIM COGN, V13, P287, DOI 10.1007/s10071-009-0266-4; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Golabek KA, 2012, ANIM BEHAV, V83, P613, DOI 10.1016/j.anbehav.2011.11.034; Goodall J., 1986, CHIMPANZEES GOMBE PA; GRICE HP, 1957, PHILOS REV, V66, P377, DOI 10.2307/2182440; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; Hooff JARAM van, 2013, DEV PRIMATE GESTURE; Hopkins WD, 1998, J COMP PSYCHOL, V112, P95, DOI 10.1037/0735-7036.112.1.95; Hopkins WD, 2007, ANIM BEHAV, V73, P281, DOI 10.1016/j.anbehav.2006.08.004; Hostetter AB, 2001, J COMP PSYCHOL, V115, P337, DOI 10.1037//0735-7036.115.4.337; Kaminski J, 2008, COGNITION, V109, P224, DOI 10.1016/j.cognition.2008.08.010; Leavens DA, 1996, J COMP PSYCHOL, V110, P346, DOI 10.1037/0735-7036.110.4.346; Leavens DA, 2005, CHILD DEV, V76, P291, DOI 10.1111/j.1467-8624.2005.00845.x; Leavens DA, 2004, ANIM BEHAV, V67, P467, DOI 10.1016/j.anbehav.2003.04.007; Leavens DA, 1998, DEV PSYCHOL, V34, P813, DOI 10.1037/0012-1649.34.5.813; Leavens DA, 2010, ANIM COGN, V13, P33, DOI 10.1007/s10071-009-0242-z; Liebal K, 2004, AM J PRIMATOL, V64, P377, DOI 10.1002/ajp.20087; Liebal K, PRIMATE COMMUNICATIO; Liebal K, 2004, INTERACT STUD, V5, P199, DOI 10.1075/is.5.2.03lie; Liebal Katja, 2006, GESTURE, V6, P1, DOI [10.1075/gest.6.1.02lie, DOI 10.1075/GEST.6.1.02LIE]; McFarland D., 1995, COMP APPROACHES COGN, P415; Meguerditchian A, 2010, CORTEX, V46, P40, DOI 10.1016/j.cortex.2009.02.013; OHMAN A, 1994, J ABNORM PSYCHOL, V103, P231, DOI 10.1037/0021-843X.103.2.231; Penkunas MJ, 2013, J EXP CHILD PSYCHOL, V114, P522, DOI 10.1016/j.jecp.2012.10.001; PIERCE J D JR, 1985, Primates, V26, P202, DOI 10.1007/BF02382019; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Poss SR, 2006, AM J PRIMATOL, V68, P978, DOI 10.1002/ajp.20304; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; Reynolds V., 2005, CHIMPANZEES BUDONGO; Ristau C.A., 1991, P91; Roberts AI, 2013, ANIM COGN, V16, P187, DOI 10.1007/s10071-012-0563-1; Schel AM, ANIM BEHAV IN PRESS; SEYFARTH RM, 1980, ANIM BEHAV, V28, P1070, DOI 10.1016/S0003-3472(80)80097-2; Slocombe Katie, 2010, P192; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Slocombe KE, 2011, ANIM BEHAV, V81, P919, DOI 10.1016/j.anbehav.2011.02.002; Slocombe KE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1959, DOI 10.1007/s00265-010-1006-0; Taglialatela JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018852; Tomasello M, 2008, JEAN NICOD LECT, P1; Townsend SW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002431; Vauclair Jacques, 2004, Interaction Studies, V5, P365, DOI 10.1075/is.5.3.04vau; Wich SA, 2006, P ROY SOC B-BIOL SCI, V273, P735, DOI 10.1098/rspb.2005.3320; Wich SA, 2003, AM J PRIMATOL, V60, P155, DOI 10.1002/ajp.10102; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706; Zuberbuhler K, 2003, ADV STUD BEHAV, V33, P265, DOI 10.1016/S0065-3454(03)33006-2	71	179	180	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76674	10.1371/journal.pone.0076674	http://dx.doi.org/10.1371/journal.pone.0076674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146908	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400080
J	Sorberg, A; Lundin, A; Allebeck, P; Melin, B; Falkstedt, D; Hemmingsson, T				Sorberg, Alma; Lundin, Andreas; Allebeck, Peter; Melin, Bo; Falkstedt, Daniel; Hemmingsson, Tomas			Cognitive Ability in Late Adolescence and Disability Pension in Middle Age: Follow-Up of a National Cohort of Swedish Males	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; SOCIAL-CLASS; MORTALITY; IQ; INTELLIGENCE; CHILDHOOD; MEN; LIFE; CONSCRIPTION	Low cognitive ability in late adolescence has previously been shown to be associated with disability pension (DP) in young adulthood. However, most DP's are granted later in working life, and the mechanisms of the association are not fully understood. We aimed to investigate the association between cognitive ability in late adolescence and DP at ages 40-59, and investigate the role of individual and socioeconomic factors. Information on cognitive ability, health status, personality aspects and health behaviours at age 18-20 was obtained from the 1969-70 conscription cohort, comprising 49 321 Swedish men. Data on DP's 1991-2008 was obtained from the Longitudinal Database of Education, Income and Employment. Information on socioeconomic and work-related factors in childhood and adulthood was obtained from national sociodemographic databases. Hazard ratios for DP during follow-up were estimated by Cox proportional hazards models. We found a graded relationship between cognitive ability in late adolescence and DP in middle age. One step decrease on the nine-point stanine scale of cognitive ability was associated with a crude hazard ratio of 1.26 (95 % CI 1.24-1.27). Socioeconomic and work-related circumstances in adulthood explained much of the association, but factors measured already in late adolescence also showed importance. The findings suggest an accumulation of risks over the life course. Although attenuated, the graded relationship remained after adjusting for all factors.	[Sorberg, Alma; Lundin, Andreas; Hemmingsson, Tomas] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Allebeck, Peter; Falkstedt, Daniel] Karolinska Inst, Dept Publ Hlth Sci, S-10401 Stockholm, Sweden; [Melin, Bo; Falkstedt, Daniel] Karolinska Inst, Div Psychol, Dept Clin Neurosci, S-10401 Stockholm, Sweden; [Hemmingsson, Tomas] Stockholm Univ, Ctr Social Res Alcohol & Drugs, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University	Sorberg, A (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	alma.sorberg@ki.se		Hemmingsson, Tomas/0000-0001-6156-3964; Melin, Bo Arthur/0000-0002-8008-2215; Falkstedt, Daniel/0000-0003-4441-7003; Sorberg Wallin, Alma/0000-0002-8804-095X	Swedish Council for Working Life and Social Research [2008-0907]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was funded by research grants from the Swedish Council for Working Life and Social Research (Project No. 2008-0907; http://www.fas.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEBECK P, 1990, BRIT J PSYCHIAT, V157, P339, DOI 10.1192/bjp.157.3.339; [Anonymous], 2009, ONG INT SJUKF OCH AR, P1; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2009, EUR HEART J, V30, P1903, DOI 10.1093/eurheartj/ehp254; Bratko D, 2012, INTELLIGENCE, V40, P91, DOI 10.1016/j.intell.2012.02.001; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Carlstedt B, 2000, COGNITIVE ABILITIES; Chamorro-Premuzic T, 2004, BRIT J PSYCHOL, V95, P249, DOI 10.1348/000712604773952458; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P850, DOI 10.1111/j.1469-7610.2005.01472.x; Gjesdal S, 2003, THESIS U BERGEN BERG; Gravseth HM, 2008, EUR J PUBLIC HEALTH, V18, P650, DOI 10.1093/eurpub/ckn055; Harkonmaki K, 2007, J EPIDEMIOL COMMUN H, V61, P479, DOI 10.1136/jech.2006.052670; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Hemmingsson T, 2005, INT J EPIDEMIOL, V34, P260, DOI 10.1093/ije/dyh314; Hemmingsson T, 2008, PSYCHOSOM MED, V70, P805, DOI 10.1097/PSY.0b013e31817b955f; Hemmingsson T, 2007, SOC SCI MED, V65, P1410, DOI 10.1016/j.socscimed.2007.05.006; Henderson M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000777; Johansson E, 2012, J EPIDEMIOL COMMUN H, V66, P901, DOI 10.1136/jech-2011-200317; Karlsson H, 2010, BRAIN BEHAV IMMUN, V24, P868, DOI 10.1016/j.bbi.2010.02.009; Karlsson NE, 2008, EUR J PUBLIC HEALTH, V18, P224, DOI 10.1093/eurpub/ckm128; Khandaker GM, 2011, SCHIZOPHR RES, V132, P220, DOI 10.1016/j.schres.2011.06.017; Koenen KC, 2003, DEV PSYCHOPATHOL, V15, P297, DOI 10.1017/S0954579403000166; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; Labriola M, 2009, SCAND J PUBLIC HEALT, V37, P778, DOI 10.1177/1403494809344103; Larsson D, 2002, SCAND J PUBLIC HEALT, V30, P259, DOI 10.1080/14034940210133997; Lilieblad B, 1977, RELIABILITET HOS PSY; Lounsbury JW, 2004, PERS INDIV DIFFER, V37, P181, DOI 10.1016/j.paid.2003.08.010; Lundin A, 2010, J EPIDEMIOL COMMUN H, V64, P22, DOI 10.1136/jech.2008.079269; Mansson NO, 1998, INT J EPIDEMIOL, V27, P1019, DOI 10.1093/ije/27.6.1019; Mulder M, 2011, SOCIAL INSURANCE FIG; OECD, 2009, SICKN DIS WORK BREAK; Roivainen E, 2011, LEARN INDIVID DIFFER, V21, P145, DOI 10.1016/j.lindif.2010.11.021; Ropponen A, 2012, J PSYCHOSOM RES, V73, P289, DOI 10.1016/j.jpsychores.2012.07.003; Sidorchuk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042083; Sorberg A, 2013, PSYCHOL MED, V43, P49, DOI 10.1017/S0033291712001043; Statistics Sweden, 2001, LONG DAT KRING UTB I; Stenbacka M, 2011, ACCIDENT ANAL PREV, V43, P228, DOI 10.1016/j.aap.2010.08.014; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Upmark M, 2001, SCAND J PUBLIC HEALT, V29, P96, DOI 10.1177/14034948010290020601; Wallman T, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-103; Warren JR, 2004, SOC SCI MED, V59, P1367, DOI 10.1016/j.socscimed.2004.01.035; Wulff C, 2009, J APPL DEV PSYCHOL, V30, P398, DOI 10.1016/j.appdev.2008.12.015; Zammit S, 2004, ARCH GEN PSYCHIAT, V61, P354, DOI 10.1001/archpsyc.61.4.354	46	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78268	10.1371/journal.pone.0078268	http://dx.doi.org/10.1371/journal.pone.0078268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24147128	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400154
J	Yang, CX; Jurczyk, A; Diiorio, P; Norowski, E; Brehm, MA; Grant, CW; Guberski, DL; Greiner, DL; Bortell, R				Yang, Chaoxing; Jurczyk, Agata; Diiorio, Philip; Norowski, Elaine; Brehm, Michael A.; Grant, Christian W.; Guberski, Dennis L.; Greiner, Dale L.; Bortell, Rita			Salicylate Prevents Virus-Induced Type 1 Diabetes in the BBDR Rat	PLOS ONE			English	Article							ENTEROVIRUS INFECTION; SERUM; EXPRESSION; IDENTIFICATION; SIGNATURE; SALSALATE; RESISTANT; CHILDREN; TARGET	Epidemiologic and clinical evidence suggests that virus infection plays an important role in human type 1 diabetes pathogenesis. We used the virus-inducible BioBreeding Diabetes Resistant (BBDR) rat to investigate the ability of sodium salicylate, a non-steroidal anti-inflammatory drug (NSAID), to modulate development of type 1 diabetes. BBDR rats treated with Kilham rat virus (KRV) and polyinosinic: polycytidylic acid (pIC, a TLR3 agonist) develop diabetes at nearly 100% incidence by similar to 2 weeks. We found distinct temporal profiles of the proinflammatory serum cytokines, IL-1 beta, IL-6, IFN-gamma, IL-12, and haptoglobin (an acute phase protein) in KRV+pIC treated rats. Significant elevations of IL-1 beta and IL-12, coupled with sustained elevations of haptoglobin, were specific to KRV+ pIC and not found in rats co-treated with pIC and H1, a non-diabetogenic virus. Salicylate administered concurrently with KRV +pIC inhibited the elevations in IL-1 beta, IL-6, IFN-Upsilon and haptoglobin almost completely, and reduced IL-12 levels significantly. Salicylate prevented diabetes in a dose-dependent manner, and diabetes-free animals had no evidence of insulitis. Our data support an important role for innate immunity in virus-induced type 1 diabetes pathogenesis. The ability of salicylate to prevent diabetes in this robust animal model demonstrates its potential use to prevent or attenuate human autoimmune diabetes.	[Yang, Chaoxing; Jurczyk, Agata; Diiorio, Philip; Norowski, Elaine; Brehm, Michael A.; Greiner, Dale L.; Bortell, Rita] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Grant, Christian W.; Guberski, Dennis L.] Biomed Res Models, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester	Bortell, R (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	rita.bortell@umassmed.edu		Brehm, Michael/0000-0001-6813-3262	National Institutes of Health [AI46629, AI073871]; Juvenile Diabetes Research Foundation; NIH Diabetes Endocrinology Research Center [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629, U01AI073871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH Diabetes Endocrinology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AI46629, AI073871, and grants from the Juvenile Diabetes Research Foundation. Core resources supported by the NIH Diabetes Endocrinology Research Center grant (DK32520) were used. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortell Rita, 2012, Methods Mol Biol, V933, P31, DOI 10.1007/978-1-62703-068-7_3; BROWN DW, 1993, J VIROL, V67, P5873, DOI 10.1128/JVI.67.10.5873-5878.1993; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; GUBERSKI DL, 1991, SCIENCE, V254, P1010, DOI 10.1126/science.1658938; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Kaldunski M, 2010, DIABETES, V59, P2375, DOI 10.2337/db10-0372; Kruger AJ, 2010, EXP BIOL MED, V235, P1328, DOI 10.1258/ebm.2010.010150; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Meyers AJ, 2010, J MOL MED, V88, P1221, DOI 10.1007/s00109-010-0666-6; Mordes JP, 2004, ILAR J, V45, P278, DOI 10.1093/ilar.45.3.278; Nairn C, 1999, DIABETIC MED, V16, P509, DOI 10.1046/j.1464-5491.1999.00098.x; Redondo MJ, 2001, DIABETOLOGIA, V44, P354, DOI 10.1007/s001250051626; Ruan H, 2009, CURR OPIN INVEST DR, V10, P346; Rumore MM, 2010, ANN PHARMACOTHER, V44, P1207, DOI 10.1345/aph.1M483; Schalkwijk CG, 1999, DIABETOLOGIA, V42, P351, DOI 10.1007/s001250051162; Wang XJ, 2008, J IMMUNOL, V180, P1929, DOI 10.4049/jimmunol.180.3.1929; Wolter TR, 2009, CLIN IMMUNOL, V132, P103, DOI 10.1016/j.clim.2009.02.007; Yeung WCG, 2012, DIABETES, V61, P1500, DOI 10.2337/db11-0264; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35; Zipris D, 2003, J IMMUNOL, V170, P3592, DOI 10.4049/jimmunol.170.7.3592	24	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78050	10.1371/journal.pone.0078050	http://dx.doi.org/10.1371/journal.pone.0078050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147110	Green Published, gold			2022-12-27	WOS:000326019400146
J	Demmer, RT; Trinquart, L; Zuk, A; Fu, BC; Blomkvist, J; Michalowicz, BS; Ravaud, P; Desvarieux, M				Demmer, Ryan T.; Trinquart, Ludovic; Zuk, Aleksandra; Fu, Benjamin C.; Blomkvist, Josefin; Michalowicz, Bryan S.; Ravaud, Philippe; Desvarieux, Moise			The Influence of Anti-Infective Periodontal Treatment on C-Reactive Protein: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; 1ST NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; INFLAMMATORY MARKERS; VASCULAR-DISEASE; INSULIN-RESISTANCE; METABOLIC-CONTROL; DOSE DOXYCYCLINE	Background: Periodontal infections are hypothesized to increase the risk of adverse systemic outcomes through inflammatory mechanisms. The magnitude of effect, if any, of anti-infective periodontal treatment on systemic inflammation is unknown, as are the patient populations most likely to benefit. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to test the hypothesis that anti-infective periodontal treatment reduces systemic c-reactive protein (CRP). Methods and Findings: MEDLINE, EMBASE, CENTRAL and CINAHL databases were searched using sensitivity-enhancing search terms. Eligible RCTs enrolled patients with periodontal infection, compared a clearly defined anti-infective periodontal intervention (experimental group) to an "inactive control" (no periodontal intervention) or to an "active control" (lower treatment intensity than the experimental group). Mean differences in final CRP values at the earliest post-treatment time point (typically 1-3 months) between experimental and control groups were analyzed using random-effects regression. Among 2,753 possible studies 20 were selected, which included 2,561 randomized patients(median=57). Baseline CRP values were >3.0 mg/L in 40% of trials. Among studies with a control group receiving no treatment, the mean difference in CRP final values among experimental treatment vs. control groups was -0.37 mg/L [95% CI=-0.64, -0.11], (P=0.005), favoring experimental treatment. Trials for which the experimental group received antibiotics had stronger effects (P for interaction=0.03) and the mean difference in CRP final values among experimental treatment vs. control was -0.75 mg/L [95% CI=-1.17,-0.33]. No treatment effect was observed among studies using an active treatment comparator. Treatment effects were stronger for studies that included patients with co-morbidities vs. studies that included "systemically healthy" patients, although the interaction was not significant (P=0.48). Conclusions: Anti-infective periodontal treatment results in short-term modest reductions in systemic CRP.	[Demmer, Ryan T.; Zuk, Aleksandra; Fu, Benjamin C.; Ravaud, Philippe; Desvarieux, Moise] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Trinquart, Ludovic; Blomkvist, Josefin; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Trinquart, Ludovic; Blomkvist, Josefin; Ravaud, Philippe; Desvarieux, Moise] INSERM, U738, Paris, France; [Trinquart, Ludovic; Blomkvist, Josefin; Ravaud, Philippe] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Trinquart, Ludovic; Blomkvist, Josefin; Ravaud, Philippe] French Cochrane Ctr, Paris, France; [Michalowicz, Bryan S.] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN USA; [Ravaud, Philippe; Desvarieux, Moise] EHESP Sch Publ Hlth, Rennes, France	Columbia University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Minnesota System; University of Minnesota Twin Cities	Demmer, RT (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	rtd2106@columbia.edu	Trinquart, Ludovic/H-4961-2019; ravaud, philippe/C-1694-2009; Desvarieux, Moise/C-4991-2019	Trinquart, Ludovic/0000-0002-3028-4900; Demmer, Ryan/0000-0003-3429-0379; Ravaud, Philippe/0000-0001-8264-9206	NIH [R00 DE-018739, R01 DE-13094]; Mailman School of Public Health, Columbia University; Diabetes and Endocrinology Research Center, College of Physicians and Surgeons, Columbia University; Chair in Chronic Disease, Ecole des Hautes Etudes en Sante Publique, France; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE018739, R01DE013094] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mailman School of Public Health, Columbia University; Diabetes and Endocrinology Research Center, College of Physicians and Surgeons, Columbia University; Chair in Chronic Disease, Ecole des Hautes Etudes en Sante Publique, France; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by NIH grants R00 DE-018739 (Dr. Demmer) and R01 DE-13094 (Dr. Desvarieux). Additional funding support was provided by a Calderone Research Award from the Mailman School of Public Health, Columbia University (Dr. Demmer); a Pilot & Feasibility Award from the Diabetes and Endocrinology Research Center, College of Physicians and Surgeons, Columbia University (Dr. Demmer); a Chair in Chronic Disease, Ecole des Hautes Etudes en Sante Publique, France (Dr. Desvarieux). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Katma MK, 2007, JCR-J CLIN RHEUMATOL, V13, P134, DOI 10.1097/RHU.0b013e3180690616; Beck JD, 2008, J PERIODONTOL, V79, P90, DOI 10.1902/jop.2008.070223 ; Bokhari SAH, 2012, J CLIN PERIODONTOL, V39, P1065, DOI 10.1111/j.1600-051X.2012.01942.x; Chen L, 2012, J PERIODONTOL, V83, P435, DOI 10.1902/jop.2011.110327; Choi YH, 2011, DIABETES CARE, V34, P381, DOI 10.2337/dc10-1354; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; D'Aiuto F, 2005, INFLAMM RES, V54, P412, DOI 10.1007/s00011-005-1375-4; D'Aiuto F, 2005, J DENT RES, V84, P269, DOI 10.1177/154405910508400312; D'Aiuto F, 2006, AM HEART J, V151, P977, DOI 10.1016/j.ahj.2005.06.018; de Pablo P, 2008, J RHEUMATOL, V35, P70; Demmer RT, 2008, DIABETES CARE, V31, P1373, DOI 10.2337/dc08-0026; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Demmer RT, 2012, DIABETES CARE, V35, P2235, DOI 10.2337/dc12-0072; Demmer RT, 2011, J CLIN PERIODONTOL, V38, P998, DOI 10.1111/j.1600-051X.2011.01776.x; Demmer RT, 2010, DIABETES CARE, V33, P1037, DOI 10.2337/dc09-1778; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Desvarieux M, 2010, J HYPERTENS, V28, P1413, DOI 10.1097/HJH.0b013e328338cd36; Gonzales JR, 2011, J PERIODONTOL, V82, P1131, DOI 10.1902/jop.2011.100287; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Ide M, 2003, J CLIN PERIODONTOL, V30, P334, DOI 10.1034/j.1600-051X.2003.00282.x; Ide M, 2004, J PERIODONTOL, V75, P420, DOI 10.1902/jop.2004.75.3.420; Ioannidou E, 2006, J PERIODONTOL, V77, P1635, DOI 10.1902/jop.2006.050443; Janket SJ, 2005, J DENT RES, V84, P1154, DOI 10.1177/154405910508401212; Janket SJ, 2003, ORAL SURG ORAL MED O, V95, P559, DOI 10.1067/moe.2003.107; Joseph R, 2011, J PERIODONTOL, V82, P201, DOI 10.1902/jop.2010.100258; Kamil W, 2011, J PERIODONTAL RES, V46, P616, DOI 10.1111/j.1600-0765.2011.01380.x; Katagiri S, 2009, DIABETES RES CLIN PR, V83, P308, DOI 10.1016/j.diabres.2008.10.016; Kebschull M, 2010, J DENT RES, V89, P879, DOI 10.1177/0022034510375281; Koromantzos PA, 2012, J PERIODONTOL, V83, P3, DOI 10.1902/jop.2011.110148; Li XA, 2011, J CLIN PERIODONTOL, V38, P148, DOI 10.1111/j.1600-051X.2010.01651.x; Lin SJ, 2012, CLIN ORAL INVEST, V16, P599, DOI 10.1007/s00784-011-0535-x; Llambes F, 2012, MED ORAL PATOL ORAL, V17, pE562, DOI 10.4317/medoral.17793; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Lopez NJ, 2012, J PERIODONTOL, V83, P267, DOI 10.1902/jop.2011.110227; Mealey BL, 2006, J AM DENT ASSOC, V137, p26S, DOI 10.14219/jada.archive.2006.0404; Michalowicz BS, 2006, NEW ENGL J MED, V355, P1885, DOI 10.1056/NEJMoa062249; Michalowicz BS, 2009, J PERIODONTOL, V80, P1731, DOI 10.1902/jop.2009.090236; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Offenbacher S, 2006, J PERIODONTOL, V77, P2011, DOI 10.1902/jop.2006.060047; Offenbacher S, 2009, J PERIODONTOL, V80, P190, DOI [10.1902/jop.2009.080007, 10.1902/jop.2009.080007 ]; Ortiz P, 2009, J PERIODONTOL, V80, P535, DOI 10.1902/jop.2009.080447; Paraskevas S, 2008, J CLIN PERIODONTOL, V35, P277, DOI 10.1111/j.1600-051X.2007.01173.x; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pinho Márcia de Noronha, 2009, Braz. Dent. J., V20, P355, DOI 10.1590/S0103-64402009000500001; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Saito T, 2004, J DENT RES, V83, P485, DOI 10.1177/154405910408300610; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Seinost G, 2005, AM HEART J, V149, P1050, DOI 10.1016/j.ahj.2004.09.059; Sun WL, 2011, INTERNAL MED, V50, P1569, DOI 10.2169/internalmedicine.50.5166; Sun WL, 2010, ARCH ORAL BIOL, V55, P970, DOI 10.1016/j.archoralbio.2010.08.001; Taylor B, 2010, EUR J ORAL SCI, V118, P350, DOI 10.1111/j.1600-0722.2010.00748.x; Taylor G W, 1998, Ann Periodontol, V3, P30, DOI 10.1902/annals.1998.3.1.30; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; Tuter G, 2007, J CLIN PERIODONTOL, V34, P673, DOI 10.1111/j.1600-051X.2007.01104.x; Tuter G, 2010, J PERIODONTOL, V81, P1132, DOI 10.1902/jop.2010.090694; Vergnes Jean-Noel, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.028; Vidal F, 2009, J PERIODONTOL, V80, P786, DOI 10.1902/jop.2009.080471; Wang X, 2013, DIABETES CARE, V36, P166, DOI 10.2337/dc12-0702; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749	67	72	75	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77441	10.1371/journal.pone.0077441	http://dx.doi.org/10.1371/journal.pone.0077441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155956	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300090
J	Llusia, D; Gomez, M; Penna, M; Marquez, R				Llusia, Diego; Gomez, Miguel; Penna, Mario; Marquez, Rafael			Call Transmission Efficiency in Native and Invasive Anurans: Competing Hypotheses of Divergence in Acoustic Signals	PLOS ONE			English	Article							BULLFROGS RANA-CATESBEIANA; RUFOUS-COLLARED SPARROW; EVOKED VOCAL RESPONSES; RED-LEGGED FROGS; BIOLOGICAL INVASIONS; INTRODUCED BULLFROGS; ADVERTISEMENT CALLS; MIDWIFE TOADS; BATRACHOCHYTRIUM-DENDROBATIDIS; GEOGRAPHICAL VARIATION	Invasive species are a leading cause of the current biodiversity decline, and hence examining the major traits favouring invasion is a key and long-standing goal of invasion biology. Despite the prominent role of the advertisement calls in sexual selection and reproduction, very little attention has been paid to the features of acoustic communication of invasive species in nonindigenous habitats and their potential impacts on native species. Here we compare for the first time the transmission efficiency of the advertisement calls of native and invasive species, searching for competitive advantages for acoustic communication and reproduction of introduced taxa, and providing insights into competing hypotheses in evolutionary divergence of acoustic signals: acoustic adaptation vs. morphological constraints. Using sound propagation experiments, we measured the attenuation rates of pure tones (0.2-5 kHz) and playback calls (Lithobates catesbeianus and Pelophylax perezi) across four distances (1, 2, 4, and 8 m) and over two substrates (water and soil) in seven Iberian localities. All factors considered (signal type, distance, substrate, and locality) affected transmission efficiency of acoustic signals, which was maximized with lower frequency sounds, shorter distances, and over water surface. Despite being broadcast in nonindigenous habitats, the advertisement calls of invasive L. catesbeianus were propagated more efficiently than those of the native species, in both aquatic and terrestrial substrates, and in most of the study sites. This implies absence of optimal relationship between native environments and propagation of acoustic signals in anurans, in contrast to what predicted by the acoustic adaptation hypothesis, and it might render these vertebrates particularly vulnerable to intrusion of invasive species producing low frequency signals, such as L. catesbeianus. Our findings suggest that mechanisms optimizing sound transmission in native habitat can play a less significant role than other selective forces or biological constraints in evolutionary design of anuran acoustic signals.	[Llusia, Diego; Gomez, Miguel; Marquez, Rafael] Museo Nacl Ciencias Nat CSIC, Dept Biodiversidad & Biol Evolut, Fonoteca Zool, Madrid, Spain; [Penna, Mario] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago 7, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad de Chile	Llusia, D (corresponding author), Museo Nacl Ciencias Nat CSIC, Dept Biodiversidad & Biol Evolut, Fonoteca Zool, Madrid, Spain.	diego_llusia@mncn.csic.es	Llusia, Diego/AAB-2576-2020	Llusia, Diego/0000-0001-5432-2716; Gomez, Miguel/0000-0003-2714-2925; Marquez, Rafael/0000-0002-2070-860X	project TEMPURA [CGL2005-00092/BOS]; project ACOURA [CGL2008-04814-C02]; project TATANKA [CGL2011-25062]; Ministerio de Ciencia e Innovacion; FCW, Ministerio de Economia y Competitividad, Spain [CGL2011-16159-E]; Ministerio de Ciencia e Innovacion, Spain [BES-2006-13104]	project TEMPURA; project ACOURA; project TATANKA; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FCW, Ministerio de Economia y Competitividad, Spain; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Research funded by projects TEMPURA (CGL2005-00092/BOS), ACOURA (CGL2008-04814-C02), and TATANKA (CGL2011-25062), Ministerio de Ciencia e Innovacion, and FCW (CGL2011-16159-E), Ministerio de Economia y Competitividad, Spain (PI. R. Marquez). The first author was supported by an FPI predoctoral grant from Ministerio de Ciencia e Innovacion (BES-2006-13104, Spain) (http://www.mineco.gob.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RICHARD D., 1961, BEHAVIOUR, V17, P130, DOI 10.1163/156853961X00042; ANDERSON ME, 1985, WILSON BULL, V97, P436; Ayllon E, 2001, SEGUIMIENTO EVOLUCIO; Badyaev AV, 1997, AUK, V114, P40, DOI 10.2307/4089063; Baker H. G., 1965, The genetics of colonizing species., P147; Bee MA, 2004, J ACOUST SOC AM, V116, P3770, DOI 10.1121/1.1784445; Bee MA, 2001, ANIM BEHAV, V62, P1129, DOI 10.1006/anbe.2001.1851; Blackburn TM, 2001, NATURE, V414, P195, DOI 10.1038/35102557; Boatright-Horowitz SL, 2000, ETHOLOGY, V106, P701, DOI 10.1046/j.1439-0310.2000.00580.x; Bosch J, 2004, CAN J ZOOL, V82, P880, DOI 10.1139/Z04-060; Bosch J, 2001, COPEIA, P169, DOI 10.1643/0045-8511(2001)001[0169:CTIMMA]2.0.CO;2; Both C, 2012, BIOL LETTERS, V8, P714, DOI 10.1098/rsbl.2012.0412; BOWMAN R I, 1979, Journal fuer Ornithologie, V120, P353, DOI 10.1007/BF01642911; Bradbury Jack W., 1998, pi; Brooks DR, 1991, PHYLOGENY ECOLOGY BE; BROWN CH, 1984, Z TIERPSYCHOL, V65, P273; Buddenhagen CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005261; Cabana Martino, 2010, Boletin de la Asociacion Herpetologica Espanola, V21, P101; Capranica R.R., 1965, EVOKED VOCAL RESPONS; Castellano S, 2002, ETHOLOGY, V108, P75, DOI 10.1046/j.1439-0310.2002.00761.x; CHAPUIS C, 1971, Terre et la Vie, V118, P183; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Cook DG, 2007, HERPETOLOGICA, V63, P430, DOI 10.1655/0018-0831(2007)63[430:MUOTCR]2.0.CO;2; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; De la Torre S, 2002, ANIM BEHAV, V63, P847, DOI 10.1006/anbe.2001.1978; Drake JA, 1989, BIOL INVASIONS GLOBA; Elton C., 1958; EMLEN ST, 1976, BEHAV ECOL SOCIOBIOL, V1, P283, DOI 10.1007/BF00300069; Ey E, 2009, BIOACOUSTICS, V19, P21, DOI 10.1080/09524622.2009.9753613; Farina A, 2013, BIOACOUSTICS, V22, P175, DOI 10.1080/09524622.2012.761571; Fay RR, 1999, COMP HEARING FISH AM; FENG AS, 1975, J COMP PHYSIOL, V100, P221, DOI 10.1007/BF00614532; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Garcia-Paris M., 2004, FAUNA IBERICA, V24; Garcia-Paris M, 1991, REV ESPANOLA HERPETO, V5, P89; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; GERHARDT HC, 1980, BEHAV PROCESS, V5, P143, DOI 10.1016/0376-6357(80)90061-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GISH SL, 1981, Z TIERPSYCHOL, V56, P74; Goicoechea N, 2010, ZOOL SCR, V39, P141, DOI 10.1111/j.1463-6409.2009.00413.x; Gomez M, 2012, THESIS U AUTONOMA MA; Goodwin BJ, 1999, CONSERV BIOL, V13, P422, DOI 10.1046/j.1523-1739.1999.013002422.x; Grafe TU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037965; Greenspan SE, 2012, J WILDLIFE DIS, V48, P575, DOI 10.7589/0090-3558-48.3.575; Gridi-Papp M., 2007, SOUNDRULER ACOUSTIC; HANDFORD P, 1991, CONDOR, V93, P644, DOI 10.2307/1368196; HANDFORD P, 1988, CAN J ZOOL, V66, P2658, DOI 10.1139/z88-391; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; HARRIS CM, 1966, J ACOUST SOC AM, V40, P148, DOI 10.1121/1.1910031; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Heger Tina, 2003, Biological Invasions, V5, P313; HOWARD RD, 1978, EVOLUTION, V32, P850, DOI 10.1111/j.1558-5646.1978.tb04639.x; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Jehle Robert, 1998, Bioacoustics, V9, P35; JILKA A, 1974, Journal fuer Ornithologie, V115, P192, DOI 10.1007/BF01643290; Kaiser K, 2009, BEHAVIOUR, V146, P1053, DOI 10.1163/156853909X404457; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; Kiesecker JM, 1998, CONSERV BIOL, V12, P776, DOI 10.1046/j.1523-1739.1998.97125.x; Kiesecker JM, 2001, ECOLOGY, V82, P1964, DOI 10.1890/0012-9658(2001)082[1964:PMUTDO]2.0.CO;2; Kime NM, 2000, BEHAV ECOL, V11, P71, DOI 10.1093/beheco/11.1.71; Kirschel ANG, 2009, BEHAV ECOL, V20, P1089, DOI 10.1093/beheco/arp101; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kraus Fred, 2009, V4, P1; Lever C, 2003, NATURALIZED REPTILES; LEWIS ER, 1982, J COMP PHYSIOL, V145, P437, DOI 10.1007/BF00612809; Llorente G.A., 2002, ATLAS LIBRO ROJO ANF, P126; LOPEZ PT, 1988, ANIM BEHAV, V36, P1295, DOI 10.1016/S0003-3472(88)80198-2; Lowe S., 2000, ENCY BIOL INVASIONS; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MARQUEZ R, 1995, BEHAVIOUR, V132, P151, DOI 10.1163/156853995X00342; Marquez R, 1995, J ZOOL SYST EVOL RES, V33, P185, DOI 10.1111/j.1439-0469.1995.tb00971.x; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P291, DOI 10.1007/BF00299741; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; MEGELASIMMONS A, 1984, J ACOUST SOC AM, V76, P676, DOI 10.1121/1.391254; MEGELASIMMONS A, 1985, J ACOUST SOC AM, V78, P1236, DOI 10.1121/1.392892; Mockford EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028242; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; Narins PM, 2007, HEARING SOUND COMMUN; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; OCONNOR RJ, 1986, PHILOS T R SOC B, V314, P583, DOI 10.1098/rstb.1986.0074; PAILLETT.M, 1969, CR SOC BIOL, V163, P74; Parris KM, 2009, ECOL SOC, V14; Parris KM, 2009, ECOL SOC, V14; Pearl CA, 2004, COPEIA, P11, DOI 10.1643/CE-03-010R2; Penna M, 1998, BEHAV ECOL SOCIOBIOL, V42, P371, DOI 10.1007/s002650050452; Penna M, 2006, J ACOUST SOC AM, V119, P1227, DOI 10.1121/1.2149769; Penna M, 2005, ANIM BEHAV, V70, P639, DOI 10.1016/j.anbehav.2004.11.022; Penna M, 2007, ANIM BEHAV, V74, P45, DOI 10.1016/j.anbehav.2006.11.010; Penna M, 2012, J ACOUST SOC AM, V132, P4025, DOI 10.1121/1.4763982; Perla BS, 2002, BEHAV ECOL, V13, P844, DOI 10.1093/beheco/13.6.844; Piercy JE, 1991, HDB ACOUSTICAL MEASU, P31; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Pleguezuelos J.M., 2002, ATLAS LIBRO ROJO ANF; R Development Core Team, 2012, R LANG ENV STAT COMP; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; Ryan M.J., 1988, P637; RYAN MJ, 1980, COPEIA, P108; RYAN MJ, 1990, EVOLUTION, V44, P1869, DOI 10.1111/j.1558-5646.1990.tb05256.x; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; RYAN MJ, 1986, BRAIN BEHAV EVOLUT, V28, P70, DOI 10.1159/000118693; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Santos-Barrera G, 2009, IUCN 2013 IUCN RED L; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; SCHNEIDER H, 1982, ZOOL ANZ, V208, P161; SCHNEIDER H, 1990, ZOOL ANZ, V225, P265; Sequeira F, 2008, ATLAS ANFIBIOS REPTE, P92; Shirley SM, 2009, GLOBAL ECOL BIOGEOGR, V18, P450, DOI 10.1111/j.1466-8238.2009.00452.x; SHIROSE LJ, 1993, CAN J ZOOL, V71, P2363, DOI 10.1139/z93-332; SHY E, 1983, BEHAV ECOL SOCIOBIOL, V12, P71, DOI 10.1007/BF00296935; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; SORJONEN J, 1986, BEHAVIOUR, V98, P286, DOI 10.1163/156853986X01017; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; TUBARO PL, 1995, CONDOR, V97, P792, DOI 10.2307/1369187; Veltman CJ, 1996, AM NAT, V147, P542, DOI 10.1086/285865; Vermeij GJ, 1996, BIOL CONSERV, V78, P3, DOI 10.1016/0006-3207(96)00013-4; Vitousek PM, 1996, AM SCI, V84, P468; WAAS JR, 1988, CAN J ZOOL, V66, P2578, DOI 10.1139/z88-379; WALLSCHLAGER D, 1980, EXPERIENTIA, V36, P412, DOI 10.1007/BF01975119; WASER PM, 1977, Z TIERPSYCHOL, V43, P239; WEARY DM, 1991, ANIM BEHAV, V41, P540, DOI 10.1016/S0003-3472(05)80860-7; Werner EE, 1995, J HERPETOL, V29, P600, DOI 10.2307/1564744; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; WILEY RH, 1991, AM NAT, V138, P973, DOI 10.1086/285263; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; WILSON E O, 1992; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235	137	13	13	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77312	10.1371/journal.pone.0077312	http://dx.doi.org/10.1371/journal.pone.0077312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155940	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300074
J	Diepstraten, SCE; van de Ven, SMWY; Pijnappel, RM; Peeters, PHM; van den Bosch, MAAJ; Verkooijen, HM; Elias, SG				Diepstraten, Suzanne C. E.; van de Ven, Stephanie M. W. Y.; Pijnappel, Ruud M.; Peeters, Petra H. M.; van den Bosch, Maurice A. A. J.; Verkooijen, Helena M.; Elias, Sjoerd G.			Development and Evaluation of a Prediction Model for Underestimated Invasive Breast Cancer in Women with Ductal Carcinoma In Situ at Stereotactic Large Core Needle Biopsy	PLOS ONE			English	Article							LYMPH-NODE BIOPSY; DIAGNOSIS; DISEASE; RISK; MICROCALCIFICATION; RECOMMENDATIONS; MANAGEMENT; IMPUTATION; SPECIMENS; LESIONS	Background: We aimed to develop a multivariable model for prediction of underestimated invasiveness in women with ductal carcinoma in situ at stereotactic large core needle biopsy, that can be used to select patients for sentinel node biopsy at primary surgery. Methods: From the literature, we selected potential preoperative predictors of underestimated invasive breast cancer. Data of patients with nonpalpable breast lesions who were diagnosed with ductal carcinoma in situ at stereotactic large core needle biopsy, drawn from the prospective COBRA (Core Biopsy after RAdiological localization) and COBRA2000 cohort studies, were used to fit the multivariable model and assess its overall performance, discrimination, and calibration. Results: 348 women with large core needle biopsy-proven ductal carcinoma in situ were available for analysis. In 100 (28.7%) patients invasive carcinoma was found at subsequent surgery. Nine predictors were included in the model. In the multivariable analysis, the predictors with the strongest association were lesion size (OR 1.12 per cm, 95% CI 0.98-1.28), number of cores retrieved at biopsy (OR per core 0.87, 95% CI 0.75-1.01), presence of lobular cancerization (OR 5.29, 95% CI 1.25-26.77), and microinvasion (OR 3.75, 95% CI 1.42-9.87). The overall performance of the multivariable model was poor with an explained variation of 9% (Nagelkerke's R-2), mediocre discrimination with area under the receiver operating characteristic curve of 0.66 (95% confidence interval 0.58-0.73), and fairly good calibration. Conclusion: The evaluation of our multivariable prediction model in a large, clinically representative study population proves that routine clinical and pathological variables are not suitable to select patients with large core needle biopsy-proven ductal carcinoma in situ for sentinel node biopsy during primary surgery.	[Diepstraten, Suzanne C. E.; Pijnappel, Ruud M.; van den Bosch, Maurice A. A. J.; Verkooijen, Helena M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [van de Ven, Stephanie M. W. Y.] Stanford Univ, Med Ctr, Dept Radiol, Stanford, CA 94305 USA; [Peeters, Petra H. M.; Elias, Sjoerd G.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Stanford University; Utrecht University; Utrecht University Medical Center	Diepstraten, SCE (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	s.c.e.diepstraten@umcutrecht.nl	Elias, Sjoerd G/E-6057-2011	Elias, Sjoerd G/0000-0003-3903-4024; van de Ven, Stephanie/0000-0003-0861-0471; Pijnappel, Ruud/0000-0002-6912-9414	Dutch Cancer Society;  [UU 2010-4893]	Dutch Cancer Society(KWF Kankerbestrijding); 	This research project was supported financially in the form of a grant from the Dutch Cancer Society to Sjoerd G. Elias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant number: UU 2010-4893. URL of funder's website: http://dcs.kwfkankerbestrijding.nl/Pages/Home.aspx	Bagnall MJC, 2001, CLIN RADIOL, V56, P828, DOI 10.1053/crad.2001.0779; Bonnett M, 2002, MODERN PATHOL, V15, P95, DOI 10.1038/modpathol.3880497; Brem RF, 2001, RADIOLOGY, V219, P793, DOI 10.1148/radiology.219.3.r01jn34793; Brennan ME, 2011, RADIOLOGY, V260, P119, DOI 10.1148/radiol.11102368; Bruening W, 2010, ANN INTERN MED, V152, P238, DOI 10.7326/0003-4819-152-1-201001050-00190; Chan MYP, 2010, ASIAN J SURG, V33, P76, DOI 10.1016/S1015-9584(10)60013-9; Cox D, 2006, BREAST, V15, P210, DOI 10.1016/j.breast.2005.06.001; Dillon MF, 2006, J SURG ONCOL, V93, P559, DOI 10.1002/jso.20445; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Doyle B, 2009, J CLIN PATHOL, V62, P534, DOI 10.1136/jcp.2008.061457; Go EML, 2010, MODERN PATHOL, V23, P737, DOI 10.1038/modpathol.2009.187; Goyal A, 2006, BREAST CANCER RES TR, V98, P311, DOI 10.1007/s10549-006-9167-2; Hoorntje LE, 2003, ANN SURG ONCOL, V10, P748, DOI 10.1245/ASO.2003.11.011; Houssami N, 2007, CANCER, V109, P487, DOI 10.1002/cncr.22435; Houssami N, 2011, ANN SURG ONCOL, V18, P1364, DOI 10.1245/s10434-010-1438-9; Huo L, 2006, CANCER-AM CANCER SOC, V107, P1760, DOI 10.1002/cncr.22216; Jackman RJ, 2001, RADIOLOGY, V218, P497, DOI 10.1148/radiology.218.2.r01fe35497; Jang MH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3239; Kerlikowske Karla, 2010, Journal of the National Cancer Institute Monographs, P139, DOI 10.1093/jncimonographs/lgq027; King TA, 2001, AM SURGEON, V67, P907; Kurniawan ED, 2010, ARCH SURG-CHICAGO, V145, P1098, DOI 10.1001/archsurg.2010.243; Lee CH, 2000, RADIOLOGY, V217, P466, DOI 10.1148/radiology.217.2.r00nv08466; Lee JW, 2008, J SURG ONCOL, V98, P15, DOI 10.1002/jso.21077; Leikola J, 2007, ACTA ONCOL, V46, P798, DOI 10.1080/02841860601128941; Londero V, 2007, RADIOL MED, V112, P863, DOI 10.1007/s11547-007-0183-z; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Meijnen P, 2007, BRIT J SURG, V94, P952, DOI 10.1002/bjs.5735; Mittendorf Elizabeth A, 2005, Curr Surg, V62, P253; Miyake T, 2011, AM J SURG, V202, P59, DOI 10.1016/j.amjsurg.2010.09.032; Nakajo M, 2010, EUR J NUCL MED MOL I, V37, P2011, DOI 10.1007/s00259-010-1529-7; O'Flynn EAM, 2009, CLIN RADIOL, V64, P178, DOI 10.1016/j.crad.2008.08.007; Pandelidis S, 2003, ANN SURG ONCOL, V10, P43, DOI 10.1245/ASO.2003.05.004; Park HS, 2013, BREAST, V22, P869, DOI 10.1016/j.breast.2013.03.009; Park HS, 2013, J SURG ONCOL, V107, P388, DOI 10.1002/jso.23273; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Peters N, 2008, INT J CANCER, V122, P468, DOI 10.1002/ijc.23078; Renshaw AA, 2002, ARCH PATHOL LAB MED, V126, P39; Rubin D. B., 2004, MULTIPLE IMPUTATION; Rutstein LA, 2007, BREAST J, V13, P251, DOI 10.1111/j.1524-4741.2007.00418.x; Schulz S, 2013, BREAST, V22, P537, DOI 10.1016/j.breast.2012.11.002; Sie A, 2006, CANCER, V107, P945, DOI 10.1002/cncr.22090; Son BK, 2011, J BREAST CANCER, V14, P301, DOI 10.4048/jbc.2011.14.4.301; Steyerberg E., 2009, CLIN PREDICTION MODE; Tan JCC, 2007, ANN SURG ONCOL, V14, P638, DOI 10.1245/s10434-006-9211-9; Trentin C, 2012, BREAST, V21, P635, DOI 10.1016/j.breast.2012.06.009; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; van Esser S, 2009, ANN SURG ONCOL, V16, P2252, DOI 10.1245/s10434-009-0513-6; Verkooijen HM, 2002, INT J CANCER, V99, P853, DOI 10.1002/ijc.10419; Wahedna Y, 2001, EUR J CANCER, V37, P459, DOI 10.1016/S0959-8049(00)00397-X; WEINBERG CR, 1994, AM J EPIDEMIOL, V140, P565, DOI 10.1093/oxfordjournals.aje.a117283; Wilkie C, 2005, AM J SURG, V190, P563, DOI 10.1016/j.amjsurg.2005.06.011; Won B, 1999, AM J ROENTGENOL, V173, P227, DOI 10.2214/ajr.173.1.10397131; Yen TWF, 2005, J AM COLL SURGEONS, V200, P516, DOI 10.1016/j.jamcollsurg.2004.11.012; Yi M, 2008, AM J SURG, V196, P81, DOI 10.1016/j.amjsurg.2007.08.057	54	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77826	10.1371/journal.pone.0077826	http://dx.doi.org/10.1371/journal.pone.0077826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147085	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400140
J	Hillemann, D; Hoffner, S; Cirillo, D; Drobniewski, F; Richter, E; Rusch-Gerdes, S				Hillemann, Doris; Hoffner, Sven; Cirillo, Daniela; Drobniewski, Francis; Richter, Elvira; Ruesch-Gerdes, Sabine		Baltic-Nordic TB-Lab Network; TB PAN-Net; ECDC ERLN-TB Networks	First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries	PLOS ONE			English	Article							MULTICENTER LABORATORY VALIDATION; ANTIMICROBIAL DRUGS; CLASSICAL 2ND-LINE; PYRAZINAMIDE; 1ST-LINE	Three networks/projects involving 27 European countries were established to investigate the quality of second-line drug (SLD) susceptibility testing with conventional and molecular methods. 1. The "Baltic-Nordic TB-Laboratory Network" comprised 11 reference laboratories in the Baltic-Nordic States. They performed SLD testing in the first phase with a panel of 20 Mycobacterium tuberculosis strains. After several laboratories made technical changes a second panel of 10 strains with a higher proportion of resistant strains were tested. Although the concordance for Ofloxacin, Kanamycin, and Capreomycin was consistently high, the largest improvements in performance were achieved for the analysis of Ofloxacin resistant (from 88.9 to 95.0%), and Capreomycin resistant (from 71.0 to 88.9%) strains. 2. Within the FP7 TB PAN-NET project (EU Grant agreement 223681) a quality control panel to standardize the EQA (External Quality Assurance) for first-line drugs (FLD) and SLD testing for phenotypic and molecular methods was established. The strains were characterized by their robustness, unambiguous results when tested, and low proportion of secondary drug resistances. 3. The (European Reference Laboratory Network-TB) ERLN-TB network analyzed four different panels for drug resistance testing using phenotypic and molecular methods; in two rounds in 2010 the 31 participating laboratories began with 5 strains, followed by 10 strains and 6 additional crude DNA extracts in 2011 and 2012 were examined by conventional DST and molecular methods. Overall, we demonstrated the importance of developing inter-laboratory networks to establish quality assurance and improvement of SLD testing of M. tuberculosis.	[Hillemann, Doris; Richter, Elvira; Ruesch-Gerdes, Sabine] Forschungszentrum Borstel, Natl Reference Lab Mycobacteria, Borstel, Germany; [Hoffner, Sven] Swedish Inst Communicable Dis Control, Supranat Reference TB Lab, Solna, Sweden; [Cirillo, Daniela] Ist Sci San Raffaele, I-20132 Milan, Italy; [Drobniewski, Francis] Publ Hlth England, Natl Mycobacterial Reference Lab, London, England	Forschungszentrum Borstel; Swedish Institute for Infectious Disease Control; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Public Health England	Hillemann, D (corresponding author), Forschungszentrum Borstel, Natl Reference Lab Mycobacteria, Borstel, Germany.	dhillemann@fz-borstel.de	Cirillo, Daniela Maria/AAB-3646-2019; Bang, Didi/GXV-1668-2022	Cirillo, Daniela Maria/0000-0001-6415-1535; Bang, Didi/0000-0002-7490-5369	EU [223681]; ECDC [2009/004]	EU(European Commission); ECDC	The study has been supported by the EU FP7 (Grant agreement 223681; TB PAN-NET project), and ECDC Grant/2009/004; the ERLN-TB network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angr PK, 2012, J CLIN MICROBIOL, V50, P1233, DOI 10.1128/JCM.06479-11; Bai GH, 2007, J CLIN MICROBIOL, V45, P3626, DOI 10.1128/JCM.00784-07; Barrera L, 2008, WHOHTMTB2008392; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Fattorini L, 2008, INT J TUBERC LUNG D, V12, P214; Fattorini L, 2012, EUR RESPIR J, V39, P1263, DOI 10.1183/09031936.00129011; Garrigo M, 2007, J CLIN MICROBIOL, V45, P1766, DOI 10.1128/JCM.02162-06; Johansen IS, 2003, INT J TUBERC LUNG D, V7, P899; Kent PT, 1985, PUBLIC HLTH MYCOBACT, P159; Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304; Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006; Laslo A, 2002, INT J TUBERC LUNG D, V6, P748; Laszlo A, 1997, INT J TUBERC LUNG D, V1, P231; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P3179, DOI 10.1128/JCM.37.10.3179-3186.1999; Pfyffer GE, 2002, J CLIN MICROBIOL, V40, P1670, DOI 10.1128/JCM.40.5.1670-1674.2002; Rusch-Gerdes S, 2006, J CLIN MICROBIOL, V44, P688, DOI 10.1128/JCM.44.3.688-692.2006; Rusch-Gerdes S, 1999, J CLIN MICROBIOL, V37, P45; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Shulgina MV, 2009, INT J TUBERC LUNG D, V13, P1294; SIDDIQI SH, 1995, BACTEC 460 TB SYSTEM; Woods GL, 2003, NCCLS, V23	22	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76765	10.1371/journal.pone.0076765	http://dx.doi.org/10.1371/journal.pone.0076765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146924	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400080
J	Zhang, HL; Zhang, YZ; Yang, WH; Feng, Y; Nasci, RS; Yang, J; Liu, YH; Dong, CL; Li, S; Zhang, BS; Yin, ZL; Wang, PY; Fu, SH; Li, MH; Liu, F; Zhang, J; Sun, J; Li, CW; Gao, XY; Liu, H; Wang, HY; Petersen, LR; Liang, GD				Zhang, Hai-Lin; Zhang, Yu-Zhen; Yang, Wei-Hong; Feng, Yun; Nasci, Roger S.; Yang, Jie; Liu, Yong-Hua; Dong, Chao-Liang; Li, Shi; Zhang, Bao-Sen; Yin, Zheng-Liu; Wang, Pi-Yu; Fu, Shi-Hong; Li, Ming-Hua; Liu, Fen; Zhang, Juan; Sun, Jie; Li, Can-Wei; Gao, Xiao-Yan; Liu, Hong; Wang, Huan-Yu; Petersen, Lyle R.; Liang, Guo-Dong			Mosquitoes of Western Yunnan Province, China: Seasonal Abundance, Diversity, and Arbovirus Associations	PLOS ONE			English	Article							JAPANESE-ENCEPHALITIS-VIRUS; SOUTH-EASTERN; GENOTYPE-I; INFECTION; SEQUENCE; IDENTIFICATION; DENSOVIRUS; GRADIENT	Objective: The western borderland between Yunnan Province, China, and Myanmar is characterized by a climate that facilitates year-round production of mosquitoes. Numerous mosquito-transmitted viruses, including Japanese encephalitis virus circulate in this area. This project was to describe seasonal patterns in mosquito species abundance and arbovirus activity in the mosquito populations. Methods: Mosquitoes were collected in Mangshi and Ruili cities of Dehong Prefecture near the border of China and Burma in Yunnan Province, the Peoples Republic of China in 2010. We monitored mosquito species abundance for a 12-month period using ultraviolet light, carbon dioxide baited CDC light and gravid traps; and tested the captured mosquitoes for the presence of virus to evaluate mosquito-virus associations in rural/agricultural settings in the area. Results: A total of 43 species of mosquitoes from seven genera were collected, including 15 Culex species, 15 Anopheles spp., four Aedes spp., three Armigeres spp., one Mimomyia spp., two Uranotaenia spp. and three Mansonia spp.. Species richness and diversity varied between Mangshi and Ruili. Culex tritaeniorhynchus, Culex quinquefasciatus, Anopheles sinensis and Anopheles peditaeniatus were the most abundant species in both sampling sites. Ultraviolet light traps collected more specimens than CDC light traps baited with dry ice, though both collected the same variety of mosquito species. The CDC gravid trap was the most effective trap for capture of Culex quinquefasciatus, a species underrepresented in light trap collections. A total of 26 virus strains were isolated, which included 13 strains of Japanese encephalitis virus, four strains of Getah virus, one strain of Oya virus, one strain from the orbivirus genus, and seven strains of Culex pipien pallens densovirus. Conclusions: The present study illustrates the value of monitoring mosquito populations and mosquito-transmitted viruses year-round in areas where the climate supports year-round adult mosquito activity.	[Zhang, Hai-Lin; Zhang, Yu-Zhen; Yang, Wei-Hong; Feng, Yun; Liu, Fen; Zhang, Juan; Sun, Jie; Li, Can-Wei] Yunnan Prov Ctr Virus & Rickettsia Res, Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan, Peoples R China; [Nasci, Roger S.; Petersen, Lyle R.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Yang, Jie; Dong, Chao-Liang; Zhang, Bao-Sen] Dehong Prefecture Ctr Dis Control & Prevent, Mangshi, Yunnan, Peoples R China; [Liu, Yong-Hua; Li, Shi; Yin, Zheng-Liu] Ruili City Ctr Dis Control & Prevent, Ruili, Yunnan, Peoples R China; [Wang, Pi-Yu] Yunnan Inst Parasit Dis, Simao, Yunnan, Peoples R China; [Fu, Shi-Hong; Li, Ming-Hua; Gao, Xiao-Yan; Liu, Hong; Wang, Huan-Yu; Liang, Guo-Dong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Yunnan Institute for Endemic Disease Control & Prevention; Centers for Disease Control & Prevention - USA; Chinese Center for Disease Control & Prevention	Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	Yang, Wei/HIA-0360-2022; Li, Minghua/M-8776-2016; Yang, Wei/GWV-4107-2022		China Centers for Disease Control and Prevention - U.S. Centers for Disease Control and Prevention [U-19-GH000004]; Ministry of Science and Technology, China [2011CB504702]; State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	China Centers for Disease Control and Prevention - U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Ministry of Science and Technology, China(Ministry of Science and Technology, China); State Key Laboratory for Infectious Disease Prevention and Control	This study was supported by from China Centers for Disease Control and Prevention - U.S. Centers for Disease Control and Prevention Cooperative Agreement U-19-GH000004; The Ministry of Science and Technology, China (2011CB504702); and Development grant of the State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2005, J GEN VIROL, V86, P1, DOI [10.1099/vir.0.80466-0, DOI 10.1099/VIR.0.80466-0.PUBMED:15604425]; Berge T, 1975, GETAH, P278; Brown CM, 1998, TROP ANIM HEALTH PRO, V30, P241, DOI 10.1023/A:1005079229232; Bryant JE, 2005, AM J TROP MED HYG, V73, P470, DOI 10.4269/ajtmh.2005.73.470; CARESTIA RALPH R., 1967, MOSQUITONEWS, V27, P90; [邓淑珍 DENG Shu-zhen], 2009, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V20, P344; Deng SZ, 2009, ENDEM DIS B, V24, P1; Devi N. Pemola, 2004, Journal of Vector Borne Diseases, V41, P17; Feng Y, 2013, EMERG INFECT DIS, V19, P672, DOI 10.3201/eid1904.120137; Feng Y, 2012, JPN J INFECT DIS, V65, P215, DOI 10.7883/yoken.65.215; Feng Yun, 2011, Jishengchong Yu Yixue Kunchong Xuebao, V18, P15, DOI 10.3969/j.issn.1005-0507.2011.01.004; Fu ShiHong, 2012, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V23, P432; Heino J, 2008, ECOL ENTOMOL, V33, P614, DOI 10.1111/j.1365-2311.2008.01012.x; KAMADA M, 1980, AM J TROP MED HYG, V29, P984, DOI 10.4269/ajtmh.1980.29.984; Kavazos CRJ, 2012, LANDSCAPE URBAN PLAN, V106, P183, DOI 10.1016/j.landurbplan.2012.03.002; Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671; Kono Y, 2002, ARCH VIROL, V147, P1623, DOI 10.1007/s00705-002-0838-y; Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2; Kuwata R, 2013, AM J TROP MED HYG, V88, P681, DOI 10.4269/ajtmh.12-0407; Liu H, 2013, VECTOR-BORNE ZOONOT, V13, P41, DOI 10.1089/vbz.2012.1016; Liu H, 2010, EMERG INFECT DIS, V16, P514, DOI 10.3201/eid1603.091160; Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x; Mi ZQ, 2002, CHIN J PESTS CONTROL, V18, P367; Molaei G, 2007, AM J TROP MED HYG, V77, P73; Nitatpattana N, 2008, EMERG INFECT DIS, V14, P1762, DOI 10.3201/eid1411.080542; Nitatpattana Narong, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P875; Pan XL, 2011, J VIROL, V85, P9847, DOI 10.1128/JVI.00825-11; Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709; REITER P, 1983, MOSQ NEWS, V43, P496; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Spitzer K, 1999, J INSECT CONSERV, V3, P97, DOI 10.1023/A:1009634611130; Sun J, 2011, GUOJI BINGDUXUE ZAZH, V18, P125; Sun XH, 2009, VECTOR-BORNE ZOONOT, V9, P623, DOI 10.1089/vbz.2008.0145; Sun YuJie, 2012, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V23, P436; Tao San-ju, 2003, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V17, P322; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Wang Jing-jing, 2008, Virologica Sinica, V23, P31, DOI 10.1007/s12250-008-2891-5; Wang Jing-lin, 2008, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V22, P87; Wang Jing-lin, 2008, Chinese Journal of Zoonoses, V24, P636; Wang Jing-lin, 2008, Chinese Journal of Zoonoses, V24, P1; Wang JL, 2011, AM J TROP MED HYG, V84, P738, DOI 10.4269/ajtmh.2011.10-0294; Wang LH, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-345; XU P, 1988, Chinese Journal of Virology, V4, P218; Xu PuTing, 1990, Chinese Journal of Virology, V6, P27; Yang Du-juan, 2011, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V22, P304; Zhai YG, 2008, J GEN VIROL, V89, P1446, DOI 10.1099/vir.0.83607-0; Zhai YG, 2008, J GEN VIROL, V89, P195, DOI 10.1099/vir.0.83221-0; ZHANG H, 1989, Chinese Journal of Virology, V5, P31; Zhang Hai-lin, 2002, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V13, P101; Zhang Hai-lin, 2005, Chinese Journal of Zoonoses, V21, P548; Zhang Hailin, 1999, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V10, P192; Zhang Hailin, 1998, Difangbing Tongbao, V13, P78; Zhang Hailin, 1999, Difangbing Tongbao, V14, P50; Zhang HL, 1990, CHIN J PREV MED, V24, P265; Zhang HL, 2000, CHINESE J PREVENTIVE, V22, P81; Zhang HL, 2000, CHIN J PESTS CONTROL, V16, P113; Zhang HL, 1999, CHIN J PESTS CONTROL, V15, P23; Zhang HL, 1999, CHIN J PESTS CONTROL, V15, P59; Zhang YZ, 2001, CHIN J VECTOR BIOL C, V12, P28	61	20	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77017	10.1371/journal.pone.0077017	http://dx.doi.org/10.1371/journal.pone.0077017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146951	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400094
J	Huang, L				Huang, Lin			What Happened if Various Kinds of Postconditioning Working on the Preconditioned Ischemic Skin Flaps	PLOS ONE			English	Article							REPERFUSION INJURY; DELAY; DEFICIENT; SURVIVAL; IMPACT	Objective: Ischemic pre-conditioning and post-conditioning are useful manipulations to reduce the undesirable effects of ischemia-reperfusion skin flap each. But the impact of post-conditioning on the pre-conditioning skin flap is not manifested. Here we investigated the influence of ischemic post-conditioning in a preconditioned axial pattern skin flap model. Method: We used the skin flap in 40 rabbits and divided them into 5 groups randomly. At first we induced the ischemic pre-conditioning of the flap which was applied by 2 periods of 15 minutes of ischemia/15 minutes of reperfusion cycle. Next post-conditioning was performed by 6 cycles of 10 seconds of repeated ischemia/reperfusion periods at different times of just after the reperfusion, 5 minutes after the reperfusion, 10 minutes after the reperfusion. The animals were allocated into 5 groups: group 1 (Ischemia Group); group 2: (Pre-conditioning Group); group 3: (Pre-conditioning+ Post-conditioning Group); group 4 (Pre-conditioning+ Post-conditioning 5 minutes later Group); group5 (Pre-conditioning+ Post-conditioning 10 minutes later). The neutrophil count was assessed with histologic analysis before the dissection of the skin flap. Flap viability was assessed 1 week after the operation, and surviving flap area was recorded as a percentage of the whole flap area. LSD test was used for statistical analysis among different groups to evaluate the effects of ischemic pre-conditioning against ischemia. Result: Among the varying groups, the neutrophil count varied: Group 1 was50.12 +/- 5.91; Group 2, 30.00 +/- 2.00, and Group 3, 18.87 +/- 3; Group 4, 22.50 +/- 1.92; Group 5, 30.12 +/- 1.88. The mean +/- SD surviving areas of the flaps for groups 1, 2, 3, 4 and 5 were 31.76 +/- 4.59, 51.26 +/- 3.24,82.18 +/- 5.28,66.85 +/- 3.87 and 51.13 +/- 2.90 respectively. Spearman correlation analysis shows an increase relation between neutrophil count and flap survival rate in the different groups (P < 0.05). Conclusion: Ischemic post-conditioning has protective effect on ischemic preconditioned skin flaps, but the post-conditioning should be performed within 5 minutes after the end of ischemia.	Capital Univ Med Sci, Anzheng Hosp, Beijing, Peoples R China	Capital Medical University	Huang, L (corresponding author), Capital Univ Med Sci, Anzheng Hosp, Beijing, Peoples R China.	cc.ll.80811@163.com			National Natural Science Foundation of China [81272130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No 81272130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benacquista T, 1996, PLAST RECONSTR SURG, V98, P834, DOI 10.1097/00006534-199610000-00013; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Cederna PS, 1997, PLAST RECONSTR SURG, V99, P183, DOI 10.1097/00006534-199701000-00027; Eppihimer MJ, 1997, SHOCK, V8, P16, DOI 10.1097/00024382-199707000-00004; Fan LK, 2000, ANN PLAS SURG, V44, P65, DOI 10.1097/00000637-200044010-00011; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Hosnuter M, 2003, ANN PLAS SURG, V50, P398, DOI 10.1097/01.SAP.0000037261.84618.7F; Huang L, 2011, TRANSPL P, V43, P2550, DOI 10.1016/j.transproceed.2011.04.018; Huang L, 2011, WOUNDS, V23, P328; ISSEKUTZ TB, 1990, J IMMUNOL, V144, P2140; Jassem W, 1998, TRANSPLANT REV, V12, P14, DOI DOI 10.1016/S0955-470X(98)80037-2; KOENIG WJ, 1992, PLAST RECONSTR SURG, V90, P659, DOI 10.1097/00006534-199210000-00016; Kunkel EJ, 1996, J EXP MED, V183, P57, DOI 10.1084/jem.183.1.57; Matsumura H, 2001, BRIT J PLAST SURG, V54, P58, DOI 10.1054/bjps.2000.3470; Meldrum DR, 1997, J MOL CELL CARDIOL, V29, P2849, DOI 10.1006/jmcc.1997.0506; Menger MD, 1996, BRIT J SURG, V83, P588, DOI 10.1002/bjs.1800830506; Moon JG, 2008, MICROSURG, V28, P531, DOI 10.1002/micr.20530; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pradillo JM, 2009, J NEUROCHEM, V109, P287, DOI 10.1111/j.1471-4159.2009.05972.x; Salmi AM, 1999, SCAND J PLAST RECONS, V33, P163; Thuny F, 2012, J AM COLL CARDIOL, V59, P2175, DOI 10.1016/j.jacc.2012.03.026; URKEN ML, 1994, ARCH OTOLARYNGOL, V120, P633	22	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2013	8	9							e72818	10.1371/journal.pone.0072818	http://dx.doi.org/10.1371/journal.pone.0072818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	242KO	24147150	Green Submitted, gold, Green Published			2022-12-27	WOS:000326240100019
J	Adgent, MA; Flake, GP; Umbach, DM; Stallings, VA; Bernbaum, JC; Rogan, WJ				Adgent, Margaret A.; Flake, Gordon P.; Umbach, David M.; Stallings, Virginia A.; Bernbaum, Judy C.; Rogan, Walter J.			Urogenital Epithelial Cells as Simple Markers of Estrogen Response in Infants: Methods and Applications	PLOS ONE			English	Article							URINARY SEDIMENT; CHILDHOOD; CYTOLOGY; SMEARS	Exposure to estrogen-mimicking chemicals during critical periods of development, such as infancy, may have adverse effects. However, these effects can be difficult to characterize in most epidemiologic studies. For example, growth of reproductive organs may be susceptible to estrogenic chemicals, but measuring it requires skilled ultrasound examination; timing of pubertal onset may be altered, but observing it requires long-term follow up. To address the need for a simple marker of response to estrogenic exposures in infants, we propose a novel application of a classic marker of estrogen response in adult women: cytological evaluation of urogenital epithelial cells. In this cross-sectional study of 34 female and 41 male infants, we demonstrate that epithelial cells can be obtained from swabs of the vaginal introitus (females) and urethral meatus (males), as well as from spun urine, and that these cells respond to differential estrogenic conditions, as indicated by the relative abundance of the superficial epithelial cell type. To model varying estrogen exposure, we sampled from infants who were either newborn (highly exposed to maternal estrogens), or 12 weeks old (12W) (negligibly exposed to estrogen). Newborns had a higher percentage of superficial cells (%S), as compared to 12W (mean +/- standard error: 8.3 +/- 1.8 vs. 0.9 +/- 0.2) (p < 0.01), consistent with an estrogen response. This difference in %S from newborn to 12W was observed similarly for swab (-7.6 +/- 1.7) and urine (-7.3 +/- 2.6) specimens and for males (-9.6 +/- 2.9) and females (-5.2 +/- 2.1). Examination of urogenital epithelial cells can successfully demonstrate estrogen response in both sexes, using cell specimens collected from either swab or urine sampling. In future studies, this simple, non-invasive method may be applied to assess whether estrogen-mimicking chemicals produce an estrogenic response in infants.	[Adgent, Margaret A.; Rogan, Walter J.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Flake, Gordon P.] NIEHS, Cellular & Mol Pathol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Umbach, David M.] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Stallings, Virginia A.; Bernbaum, Judy C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Stallings, Virginia A.; Bernbaum, Judy C.] Univ Penn, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Rogan, WJ (corresponding author), NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA.	rogan@niehs.nih.gov	Rogan, Walter/I-6034-2012	Rogan, Walter/0000-0002-9302-0160	NIH, National Institute of Environmental Health Sciences; National Institutes of Health [ES044006]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044006, ZIAES049004] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported (in part) by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. The funding for this study was provided by the intramural research program of the National Institutes of Health (Intramural Project ES044006), where Drs. Rogan, Adgent, Umbach and Flake work. Drs. Stallings and Bernbaum and the data collection activities were supported by a contract between Children's Hospital of Philadelphia and NIH. The work was carried out collaboratively.	Arbuckle TE, 2008, ENVIRON HEALTH PERSP, V116, P948, DOI 10.1289/ehp.11226; Bernbaum JC, 2008, ENVIRON HEALTH PERSP, V116, P416, DOI 10.1289/ehp.10409; Cibas ES, 1996, CYTOLOGY DIAGNOSTIC, P1; COLLETTSOLBERG PR, 1965, J PEDIATR-US, V66, P883, DOI 10.1016/S0022-3476(65)80063-4; Currie AW, 1988, BASIC HISTOLOGY CYTO; DELCASTILLO EB, 1948, J CLIN ENDOCRINOL, V8, P76; DeMay RM, 1999, PRACTICAL PRINCIPLES, P1; ELSTEIN M, 1963, J OBSTET GYN BR COMM, V70, P1050; Farage Miranda, 2006, Archives of Gynecology and Obstetrics, V273, P195, DOI 10.1007/s00404-005-0079-x; FOREST MG, 1976, CLIN ENDOCRINOL, V5, P551, DOI 10.1111/j.1365-2265.1976.tb01985.x; Fraenkel L, 1938, AM J ANAT, V62, P427, DOI 10.1002/aja.1000620402; Hedberg GT, 1950, BR J UROL, V22, P26, DOI [DOI 10.1111/J.1464-410X.1950.TB09223.X, 10.1111/j.1464-410X.1950.tb09223.x]; HOLSTEIN AF, 1991, CELL TISSUE RES, V264, P23, DOI 10.1007/BF00305719; McEndree B., 1999, NURSE PRACT, V24, P51; Moore KL, 2003, DEV HUMAN CLIN ORIEN, P287; Naib ZM, 1976, EXFOLIATIVE CYTOPATH; Nguyen RHN, 2011, PEDIATR RADIOL, V41, P633, DOI 10.1007/s00247-010-1895-0; Papanicolaou GN, 1933, AM J ANAT, V52, P519, DOI 10.1002/aja.1000520402; ROBINE N, 1988, BIOL NEONATE, V54, P93; SILVER HK, 1960, PEDIATRICS, V26, P255; SILVER HK, 1966, PEDIATRICS, V38, P886; VINCZE LO, 1959, J CLIN ENDOCR METAB, V19, P281, DOI 10.1210/jcem-19-3-281; WIED GL, 1991, COMPREHENSIVE CYTOPA, P85	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77061	10.1371/journal.pone.0077061	http://dx.doi.org/10.1371/journal.pone.0077061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146956	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400092
J	Engineer, CT; Perez, CA; Carraway, RS; Chang, KQ; Roland, JL; Sloan, AM; Kilgard, MP				Engineer, Crystal T.; Perez, Claudia A.; Carraway, Ryan S.; Chang, Kevin Q.; Roland, Jarod L.; Sloan, Andrew M.; Kilgard, Michael P.			Similarity of Cortical Activity Patterns Predicts generalization Behavior	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; SPEECH-PERCEPTION; NEURAL RESPONSES; FACE RECOGNITION; MAP PLASTICITY; ACOUSTIC CUES; TEMPORAL CUES; DISCRIMINATION; REPRESENTATION; FEATURES	Humans and animals readily generalize previously learned knowledge to new situations. Determining similarity is critical for assigning category membership to a novel stimulus. We tested the hypothesis that category membership is initially encoded by the similarity of the activity pattern evoked by a novel stimulus to the patterns from known categories. We provide behavioral and neurophysiological evidence that activity patterns in primary auditory cortex contain sufficient information to explain behavioral categorization of novel speech sounds by rats. Our results suggest that category membership might be encoded by the similarity of the activity pattern evoked by a novel speech sound to the patterns evoked by known sounds. Categorization based on featureless pattern matching may represent a general neural mechanism for ensuring accurate generalization across sensory and cognitive systems.	[Engineer, Crystal T.; Perez, Claudia A.; Carraway, Ryan S.; Chang, Kevin Q.; Roland, Jarod L.; Sloan, Andrew M.; Kilgard, Michael P.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Engineer, CT (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	novitski@utdallas.edu	Roland, Jarod L/J-1433-2019	Roland, Jarod L/0000-0002-1312-8826; Kilgard, Michael/0000-0002-6699-1818; Engineer, Crystal/0000-0002-2188-2335	National Institute on Deafness and other Communicative Disorders [R01DC010433, R15DC006624]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010433, R15DC006624] Funding Source: NIH RePORTER	National Institute on Deafness and other Communicative Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The project described was supported by Grant Numbers R01DC010433 and R15DC006624 from the National Institute on Deafness and other Communicative Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; BERTONCINI J, 1987, J ACOUST SOC AM, V82, P31, DOI 10.1121/1.395570; Bidelman GM, 2013, NEUROIMAGE, V79, P201, DOI 10.1016/j.neuroimage.2013.04.093; Bizley JK, 2013, CURR BIOL, V23, P620, DOI 10.1016/j.cub.2013.03.003; BLUMSTEIN SE, 1980, J ACOUST SOC AM, V67, P648, DOI 10.1121/1.383890; Boersma Paul, 2002, GLOT INT, V5, P341; Brown M, 2004, CEREB CORTEX, V14, P952, DOI 10.1093/cercor/bhh056; BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042, DOI 10.1109/34.254061; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Cano P, 2005, J VLSI SIG PROC SYST, V41, P271, DOI 10.1007/s11265-005-4151-3; Centanni TM, 2013, J NEUROPHYSIOL, V110, P177, DOI 10.1152/jn.00092.2013; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Cohen YE, 2006, BIOL LETTERS, V2, P261, DOI 10.1098/rsbl.2005.0436; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; DEMANY L, 1985, J ACOUST SOC AM, V78, P1118, DOI 10.1121/1.393034; DORMAN MF, 1980, J PHONETICS, V8, P397, DOI 10.1016/S0095-4470(19)31496-2; EGGERMONT JJ, 1995, J ACOUST SOC AM, V98, P911, DOI 10.1121/1.413517; EIMAS PD, 1974, PERCEPT PSYCHOPHYS, V16, P513, DOI 10.3758/BF03198580; ELLIS HD, 1979, PERCEPTION, V8, P431, DOI 10.1068/p080431; Engineer CT, 2008, NAT NEUROSCI, V11, P603, DOI 10.1038/nn.2109; Engineer ND, 2012, NEUROSCIENCE, V205, P81, DOI 10.1016/j.neuroscience.2011.12.056; Fishman YI, 1998, BRAIN RES, V786, P18, DOI 10.1016/S0006-8993(97)01423-6; Floody OR, 2010, PHYSIOL BEHAV, V101, P260, DOI 10.1016/j.physbeh.2010.05.009; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Francis AL, 2008, J ACOUST SOC AM, V124, P1234, DOI 10.1121/1.2945161; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gifford GW, 2005, J COGNITIVE NEUROSCI, V17, P1471, DOI 10.1162/0898929054985464; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; GUTTMAN N, 1956, J EXP PSYCHOL, V51, P79, DOI 10.1037/h0046219; Haitsma J., 2002, P INT S MUS INF RETR, P1; Hampton James A, 1998, COGNITION, V65, P137, DOI 10.1016/S0010-0277(97)00042-5; Hernandez A, 2010, NEURON, V66, P300, DOI 10.1016/j.neuron.2010.03.031; HOFFMAN HS, 1958, J ACOUST SOC AM, V30, P1035, DOI 10.1121/1.1909448; Kawahara H, 1997, INT CONF ACOUST SPEE, P1303, DOI 10.1109/ICASSP.1997.596185; KLATT DH, 1990, J ACOUST SOC AM, V87, P820, DOI 10.1121/1.398894; KLUENDER KR, 1987, SCIENCE, V237, P1195, DOI 10.1126/science.3629235; KUHL PK, 1975, SCIENCE, V190, P69, DOI 10.1126/science.1166301; LISKER L, 1986, LANG SPEECH, V29, P3, DOI 10.1177/002383098602900102; LOGAN B, 2001, P IEEE INT C MULT EX, P745; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Mesgarani N, 2008, J ACOUST SOC AM, V123, P899, DOI 10.1121/1.2816572; MILLER GA, 1955, J ACOUST SOC AM, V27, P338, DOI 10.1121/1.1907526; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Niwa M, 2013, J NEUROSCI, V33, P8378, DOI 10.1523/JNEUROSCI.2672-12.2013; Niwa M, 2012, J NEUROSCI, V32, P3193, DOI 10.1523/JNEUROSCI.0767-11.2012; Pasley BN, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001251; Pavlov I.P., 1927, CONDITIONED REFLEXES; Perez CA, 2013, CEREB CORTEX, V23, P670, DOI 10.1093/cercor/bhs045; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Porter BA, 2011, BEHAV BRAIN RES, V219, P68, DOI 10.1016/j.bbr.2010.12.015; Ranasinghe KG, 2013, NEUROSCIENCE, V252, P80, DOI 10.1016/j.neuroscience.2013.08.005; RANASINGHE KG, 2012, JARO; RAPHAEL LJ, 2005, HDB SPEECH PERCEPTIO; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Reed P, 2003, J EXP ANAL BEHAV, V80, P205, DOI 10.1901/jeab.2003.80-205; Rennaker RL, 2005, J NEUROSCI METH, V142, P169, DOI 10.1016/j.jneumeth.2004.08.009; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Russ BE, 2008, CURR BIOL, V18, P1483, DOI 10.1016/j.cub.2008.08.054; Russ BE, 2008, J NEUROPHYSIOL, V99, P87, DOI 10.1152/jn.01069.2007; SANDELL JH, 1979, J COMP PHYSIOL PSYCH, V93, P626, DOI 10.1037/h0077594; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Schvartz KC, 2012, EAR HEARING, V33, P411, DOI 10.1097/AUD.0b013e31823d78dc; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; Selezneva E, 2006, CURR BIOL, V16, P2428, DOI 10.1016/j.cub.2006.10.027; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sharma A, 2000, J ACOUST SOC AM, V108, P3030, DOI 10.1121/1.1320474; Shepard RN, 2004, PSYCHON B REV, V11, P1, DOI 10.3758/BF03206455; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Shetake JA, 2011, EUR J NEUROSCI, V34, P1823, DOI 10.1111/j.1460-9568.2011.07887.x; Sinnott JM, 1997, PERCEPT PSYCHOPHYS, V59, P1214, DOI 10.3758/BF03214209; SJOLANDER K, 2000, ICSLP 2000 BEIJ CHIN; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Steinschneider M, 2005, CEREB CORTEX, V15, P170, DOI 10.1093/cercor/bhh120; Steinschneider M, 2003, J ACOUST SOC AM, V114, P307, DOI 10.1121/1.1582449; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; Thompson JV, 2010, J NEUROPHYSIOL, V103, P1785, DOI 10.1152/jn.00885.2009; Tsunada J, 2011, J NEUROPHYSIOL, V105, P2634, DOI 10.1152/jn.00037.2011; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Walker KMM, 2011, J NEUROSCI, V31, P14565, DOI 10.1523/JNEUROSCI.2074-11.2011; Walker KMM, 2009, J ACOUST SOC AM, V126, P1321, DOI 10.1121/1.3179676; Weinberger NM, 1998, AUDIOL NEURO-OTOL, V3, P145, DOI 10.1159/000013787; Wong SW, 2003, SPEECH COMMUN, V41, P93, DOI 10.1016/S0167-6393(02)00096-1; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wright R, 2004, PHONETICALLY BASED P; Wyttenbach RA, 1996, SCIENCE, V273, P1542, DOI 10.1126/science.273.5281.1542; Xu L, 2005, J ACOUST SOC AM, V117, P3255, DOI 10.1121/1.1886405	96	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78607	10.1371/journal.pone.0078607	http://dx.doi.org/10.1371/journal.pone.0078607			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147140	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400159
J	Wu, Y; Liu, YF; Hou, PP; Yan, ZH; Kong, WJ; Liu, BY; Li, X; Yao, J; Zhang, YX; Qin, F; Ding, JP				Wu, Ying; Liu, Yongfeng; Hou, Panpan; Yan, Zonghe; Kong, Wenjuan; Liu, Beiying; Li, Xia; Yao, Jing; Zhang, Yuexuan; Qin, Feng; Ding, Jiuping			TRPV1 Channels Are Functionally Coupled with BK(mSlo1) Channels in Rat Dorsal Root Ganglion (DRG) Neurons	PLOS ONE			English	Article							INFLAMMATORY PAIN; CAPSAICIN RECEPTOR; BK CHANNELS; CALCIUM; CELLS; CONDUCTANCE; ACTIVATION; CURRENTS; COMPLEX	The transient receptor potential vanilloid receptor 1 (TRPV1) channel is a nonselective cation channel activated by a variety of exogenous and endogenous physical and chemical stimuli, such as temperature (>= 42 degrees C), capsaicin, a pungent compound in hot chili peppers, and allyl isothiocyanate. Large-conductance calcium-and voltage-activated potassium (BK) channels regulate the electric activities and neurotransmitter releases in excitable cells, responding to changes in membrane potentials and elevation of cytosolic calcium ions (Ca2+). However, it is unknown whether the TRPV1 channels are coupled with the BK channels. Using patch-clamp recording combined with an infrared laser device, we found that BK channels could be activated at 0 mV by a Ca2+ influx through TRPV1 channels not the intracellular calcium stores in submilliseconds. The local calcium concentration around BK is estimated over 10 mu M. The crosstalk could be affected by 10 mM BAPTA, whereas 5 mM EGTA was ineffectual. Fluorescence and co-immunoprecipitation experiments also showed that BK and TRPV1 were able to form a TRPV1-BK complex. Furthermore, we demonstrated that the TRPV1-BK coupling also occurs in dosal root ganglion (DRG) cells, which plays a critical physiological role in regulating the "pain" signal transduction pathway in the peripheral nervous system.	[Wu, Ying; Liu, Yongfeng; Hou, Panpan; Kong, Wenjuan; Li, Xia; Yao, Jing; Zhang, Yuexuan; Ding, Jiuping] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Yan, Zonghe; Liu, Beiying; Qin, Feng] SUNY Buffalo, Dept Physiol & Biophys Sci, Buffalo, NY 14260 USA; [Liu, Yongfeng] Xinxiang Med Univ, Sch Publ Hlth, Xinxiang, Henan, Peoples R China	Huazhong University of Science & Technology; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Xinxiang Medical University	Qin, F (corresponding author), SUNY Buffalo, Dept Physiol & Biophys Sci, Buffalo, NY 14260 USA.	qin@buffalo.edu; jpding@mail.hust.edu.cn	Liu, Yongfeng/ABG-1361-2020; Hou, Panpan/Q-2941-2019	Liu, Yongfeng/0000-0002-8649-7892; Hou, Panpan/0000-0001-7694-2262	Autonomous innovation funds for international scientific cooperation [2013ZZGH017]; National Basic Research Program of China [2010CB529804]; National Science Foundation of China [30971179, 31170814, 31028006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104521] Funding Source: NIH RePORTER	Autonomous innovation funds for international scientific cooperation; National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Autonomous innovation funds for international scientific cooperation (2013ZZGH017), National Basic Research Program of China (2010CB529804), the National Science Foundation of China (30971179, 31170814, 31028006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsalem M, 2013, BRIT J PHARMACOL, V168, P1961, DOI 10.1111/bph.12092; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; GORMAN ALF, 1980, J PHYSIOL-LONDON, V308, P287, DOI 10.1113/jphysiol.1980.sp013472; HEYER CB, 1976, J PHYSIOL-LONDON, V262, P349, DOI 10.1113/jphysiol.1976.sp011599; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; KOSTYUK P, 1993, J PHYSIOL-LONDON, V461, P467, DOI 10.1113/jphysiol.1993.sp019523; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Li W, 2007, J CELL PHYSIOL, V212, P348, DOI 10.1002/jcp.21007; Liu BY, 2005, J NEUROSCI, V25, P4835, DOI 10.1523/JNEUROSCI.1296-05.2005; Mergler S, 2012, CELL SIGNAL, V24, P233, DOI 10.1016/j.cellsig.2011.09.005; Nakanishi M, 2010, MOL BIOL CELL, V21, P2568, DOI 10.1091/mbc.E10-01-0049; Negri L, 2006, J NEUROSCI, V26, P6716, DOI 10.1523/JNEUROSCI.5403-05.2006; Prakriya M, 2000, J NEUROPHYSIOL, V84, P1123, DOI 10.1152/jn.2000.84.3.1123; Schwartz ES, 2011, GASTROENTEROLOGY, V140, P1283, DOI 10.1053/j.gastro.2010.12.033; Staaf S, 2009, PAIN, V144, P187, DOI 10.1016/j.pain.2009.04.013; Szolcsanyi J., 1993, CAPSAICIN STUDY PAIN, P1; Toth A, 2005, LIFE SCI, V76, P2921, DOI 10.1016/j.lfs.2004.10.056; Wu Y, 2009, J BIOL CHEM, V284, P23353, DOI 10.1074/jbc.M109.027789; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yao J, 2010, BIOPHYS J, V99, P1743, DOI 10.1016/j.bpj.2010.07.022; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; ZHANG X, 1995, J COMP NEUROL, V352, P481, DOI 10.1002/cne.903520402; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zong XG, 1996, FEBS LETT, V378, P121, DOI 10.1016/0014-5793(95)01434-9	27	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78203	10.1371/journal.pone.0078203	http://dx.doi.org/10.1371/journal.pone.0078203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147119	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400152
J	Cheng, CKY; Channarith, H; Cowling, BJ				Cheng, Calvin K. Y.; Channarith, Hing; Cowling, Benjamin J.			Potential Use of School Absenteeism Record for Disease Surveillance in Developing Countries, Case Study in Rural Cambodia	PLOS ONE			English	Article							INTERVENTION	Background: Disease surveillance allows prospective monitoring of patterns in disease incidence in the general community, specific institutions (e. g. hospitals, elderly care homes), and other important population subgroups. Surveillance activities are now routinely conducted in many developed countries and in certain easy-to-reach areas of the developing ones. However due to limited health resources, population in rural area that consisted of the most the vulnerable groups are not under surveillance. Cheaper alternative ways for disease surveillance were needed in resource-limited settings. Methods and Findings: In this study, a syndromic surveillance system using disease specific absenteeism rates was established in 47 pre-schools with 1,417 students 3-6 y of age in a rural area of Kampot province, Cambodia. School absenteeism data were collected via short message service. Data collected between 1st January and 31st December 2012 was used for system evaluation for future potential use in larger scale. The system appeared to be feasible and acceptable in the rural study setting. Moderate correlation was found between rates of school absenteeism due to illness and the reference data on rates of attendance at health centers in persons <16 y (maximum cross-correlation coefficient =0.231 at lag = 21 week). Conclusions: School absenteeism data is pre-existing, easily accessible and requires minimum time and resources after initial development, and our results suggest that this system may be able to provide complementary data for disease surveillance, especially in resource limited settings where there is very little information on illnesses in the community and traditional surveillance systems are difficult to implement. An important next step is to validate the syndromic data with other forms of surveillance including laboratory data.	[Cheng, Calvin K. Y.; Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China; [Channarith, Hing] Cambodian Childrens Advocacy Fdn, Phnom Penh, Cambodia	University of Hong Kong	Cowling, BJ (corresponding author), Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154	Center of Development and Resources for Students, The University of Hong Kong; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]	Center of Development and Resources for Students, The University of Hong Kong; Area of Excellence Scheme of the Hong Kong University Grants Committee	This work has received financial support from the Service 100 Fund of the Center of Development and Resources for Students, The University of Hong Kong, and from the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar M, PUBLIC HLTH, V126, P507; Besculides M, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-105; Buehler James W, 2004, MMWR Recomm Rep, V53, P1; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Cheng CK, EMERG INFECT DIS, V18, P885; Corley CD, 2010, ADV EXP MED BIOL, V680, P559, DOI 10.1007/978-1-4419-5913-3_61; Duerr HP, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-76; Egger JR, 2012, EMERG INFECT DIS, V18, P1375, DOI 10.3201/eid1808.111538; Espino Jeremy U, 2003, AMIA Annu Symp Proc, P215; German R R, 2001, MMWR Recomm Rep, V50, P1; Hasler B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-225; Jackson C, 2011, EMERG INFECT DIS, V17, P245, DOI 10.3201/eid1702.100458; John TJ, 1998, LANCET, V352, P58, DOI 10.1016/S0140-6736(97)10494-9; Kasper MR, 2012, AM J TROP MED HYG, V86, P246, DOI 10.4269/ajtmh.2012.11-0409; Mogto CAK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034084; Mook P, 2007, Euro Surveill, V12, pE11; Needle RH, 2003, AM J PUBLIC HEALTH, V93, P970, DOI 10.2105/AJPH.93.6.970; Nsubuga P, 2006, PUBLIC HLTH SURVEILL, V2nd; Oshitani Hitoshi, 2006, Journal of Infection and Chemotherapy, V12, P167, DOI 10.1007/s10156-006-0453-z; Rahman SA, J HLTH POPUL NUTR, V30, P353; Ruijs WL, BMC INFECT DIS, V11, P227; Seiff A, LANCET, V380, P206; SHI LY, 1993, B WORLD HEALTH ORGAN, V71, P723; Suzue T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030639; Vergu E, 2006, EMERG INFECT DIS, V12, P416, DOI 10.3201/eid1203.050573; Yan WR, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-4	26	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76859	10.1371/journal.pone.0076859	http://dx.doi.org/10.1371/journal.pone.0076859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155907	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300041
J	El Andalousi, J; Li, Y; Anand-Srivastava, MB				El Andalousi, Jasmine; Li, Yuan; Anand-Srivastava, Madhu B.			Natriuretic Peptide Receptor-C Agonist Attenuates the Expression of Cell Cycle Proteins and Proliferation of Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats: Role of Gi Proteins and MAPkinase/PI3kinase Signaling	PLOS ONE			English	Article							ADENYLATE-CYCLASE; ENHANCED EXPRESSION; CLEARANCE RECEPTOR; CYTOPLASMIC DOMAIN; ATRIAL; GROWTH; INHIBITION; MECHANISMS; 3-KINASE; KINASE	Vascular smooth muscle cells (VSMC) from spontaneously hypertensive rats (SHR) exhibit hyperproliferation and overexpression of cell cycle proteins. We earlier showed that small peptide fragments of cytoplasmic domain of natriuretic receptor-C (NPR-C) attenuate vasoactive peptide-induced hyperproliferation of VSMC. The present study investigated if C-ANP(4-23), a specific agonist of NPR-C, could attanuate the hyperproliferation of VSMC from SHR by inhibiting the overexpression of cell cycle proteins and examine the underlying signaling pathways contributing to this inhibition. The proliferation of VSMC was determined by [H-3] thymidine incorporation and the expression of proteins was determined by Western blotting. The hyperproliferation of VSMC from SHR and overexpression of cyclin D1, cyclin A, cyclin E, cyclin-dependent kinase 2 (cdk2), phosphorylated retinoblastoma protein (pRb), Gi alpha proteins and enhanced phosphorylation of ERK1/2 and AKT exhibited by VSMC from SHR were attenuated by C-ANP(4-23) to control levels. In addition, in vivo treatment of SHR with C-ANP(4-23) also attenuated the enhanced proliferation of VSMC. Furthemore, PD98059, wortmannin and pertussis toxin, the inhibitors of MAP kinase, PI3kinase and Gi alpha proteins respectively, also attenuated the hyperproliferation of VSMC from SHR and overexpression of cell cycle proteins to control levels. These results indicate that NPR-C activation by C-ANP(4-23) attenuates the enhanced levels of cell cycle proteins through the inhibition of enhanced expression of Gi alpha proteins and enhanced activation of MAPkinase/PI3kinase and results in the attenuation of hyperproliferation of VSMC from SHR. It may be suggested that C-ANP(4-23) could be used as a therapeutic agent in the treatment of vascular complications associated with hypertension, atherosclerosis and restenosis.	[El Andalousi, Jasmine; Li, Yuan; Anand-Srivastava, Madhu B.] Univ Montreal, Dept Physiol, Quebec City, PQ, Canada	Universite de Montreal	Anand-Srivastava, MB (corresponding author), Univ Montreal, Dept Physiol, Quebec City, PQ, Canada.	madhu.anand-srivastava@umontreal.ca			Canadian Institutes of Health Research [MOP 86569]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by a grant from Canadian Institutes of Health Research (MOP 86569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANANDSRIVASTAVA MB, 1986, AM J PHYSIOL, V251, pF417, DOI 10.1152/ajprenal.1986.251.3.F417; ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566; ANANDSRIVASTAVA MB, 1986, BIOCHEM BIOPH RES CO, V138, P427, DOI 10.1016/0006-291X(86)90299-8; ANANDSRIVASTAVA MB, 1984, BIOCHEM BIOPH RES CO, V121, P855, DOI 10.1016/0006-291X(84)90756-3; ANANDSRIVASTAVA MB, 1985, LIFE SCI, V36, P1873, DOI 10.1016/0024-3205(85)90161-4; ANANDSRIVASTAVA MB, 1987, J BIOL CHEM, V262, P4931; ANANDSRIVASTAVA MB, 1985, FEBS LETT, V181, P199, DOI 10.1016/0014-5793(85)80259-3; ANANDSRIVASTAVA MB, 1982, BIOCHEM BIOPH RES CO, V108, P213, DOI 10.1016/0006-291X(82)91853-8; ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; FULLER F, 1988, J BIOL CHEM, V263, P9395; HAMET P, 1984, BIOCHEM BIOPH RES CO, V123, P515, DOI 10.1016/0006-291X(84)90260-2; Hashim S, 2006, AM J PHYSIOL-HEART C, V291, pH3144, DOI 10.1152/ajpheart.00327.2006; Hayashi S, 2000, HYPERTENSION, V35, P237, DOI 10.1161/01.HYP.35.1.237; HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8; Kubo A, 2000, AM J HYPERTENS, V13, P1117, DOI 10.1016/S0895-7061(00)00298-3; Kubo A, 1996, J CARDIOVASC PHARM, V27, P58, DOI 10.1097/00005344-199601000-00010; Lappas G, 2005, J HYPERTENS, V23, P2251, DOI 10.1097/01.hjh.0000191905.26853.f1; Lee SJ, 2009, INT IMMUNOPHARMACOL, V9, P837, DOI 10.1016/j.intimp.2009.03.010; Levin ER, 1998, NEW ENGL J MED, V339, P321; Li Y, 2005, CAN J CARDIOL, V21, p155C; Li Y, 2013, HYPERTENSION; LIAU G, 1989, J BIOL CHEM, V264, P10315; MOLLOY CJ, 1993, J BIOL CHEM, V268, P7338; Mouawad R, 2004, MOL PHARMACOL, V65, P917, DOI 10.1124/mol.65.4.917; Pagano M, 2001, J BIOL CHEM, V276, P22064, DOI 10.1074/jbc.M101587200; Pedram A, 1998, J BIOL CHEM, V273, P13966, DOI 10.1074/jbc.273.22.13966; Prins BA, 1996, J BIOL CHEM, V271, P14156, DOI 10.1074/jbc.271.24.14156; Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005; Sandoval YHG, 2009, CAN J PHYSIOL PHARM, V87, P1037, DOI 10.1139/Y09-089; Saward L, 1997, CIRC RES, V81, P249, DOI 10.1161/01.RES.81.2.249; Schmidt CM, 1999, EUR J GASTROEN HEPAT, V11, P1393, DOI 10.1097/00042737-199912000-00009; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Tanner FC, 2003, HYPERTENSION, V42, P184, DOI 10.1161/01.HYP.0000082360.65547.7C; Touyz RM, 2005, EXP PHYSIOL, V90, P449, DOI 10.1113/expphysiol.2005.030080; VARTICOVSKI L, 1994, BBA-MOL BASIS DIS, V1226, P1, DOI 10.1016/0925-4439(94)90051-5; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661	41	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76183	10.1371/journal.pone.0076183	http://dx.doi.org/10.1371/journal.pone.0076183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155894	gold, Green Submitted, Green Published			2022-12-27	WOS:000325887300028
J	Rubin, AN; Kessaris, N				Rubin, Anna Noren; Kessaris, Nicoletta			PROX1: A Lineage Tracer for Cortical Interneurons Originating in the Lateral/Caudal Ganglionic Eminence and Preoptic Area	PLOS ONE			English	Article							CAUDAL MIGRATORY STREAM; FATE MAPPING REVEALS; NEURAL STEM-CELLS; GABAERGIC INTERNEURONS; NEOCORTICAL INTERNEURONS; COUP-TFII; TERMINAL DIFFERENTIATION; CEREBRAL-CORTEX; DIVERSITY; IDENTITY	The homeobox-encoding gene Prox1 and its Drosophila homologue prospero are key regulators of cell fate-specification. In the developing rodent cortex a sparse population of cells thought to correspond to late-generated cortical pyramidal neuron precursors expresses PROX1. Using a series of transgenic mice that mark cell lineages in the subcortical telencephalon and, more specifically, different populations of cortical interneurons, we demonstrate that neurons expressing PROX1 do not represent pyramidal neurons or their precursors but are instead subsets of cortical interneurons. These correspond to interneurons originating in the lateral/caudal ganglionic eminence (LGE/CGE) and a small number of preoptic area (POA)-derived neurons. Expression within the cortex can be detected from late embryonic stages onwards when cortical interneurons are still migrating. There is persistent expression in postmitotic cells in the mature brain mainly in the outer cortical layers. PROX1(+ve) interneurons express neurochemical markers such as calretinin, neuropeptide Y, reelin and vasoactive intestinal peptide, all of which are enriched in LGE/CGE- and some POA-derived cells. Unlike in the cortex, in the striatum PROX1 marks nearly all interneurons regardless of their origin. Weak expression of PROX1 can also be detected in oligodendrocyte lineage cells throughout the forebrain. Our data show that PROX1 can be used as a genetic lineage tracer of nearly all LGE/CGE- and subsets POA-derived cortical interneurons at all developmental and postnatal stages in vivo.	[Kessaris, Nicoletta] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Cell & Dev Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Kessaris, N (corresponding author), UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England.	n.tekki-kessaris@ucl.ac.uk	Kessaris, Nicoletta/AAD-6774-2019	Kessaris, Nicoletta/0000-0003-1191-6009; Rubin, Anna/0000-0001-6190-2882	Wellcome Trust; European Research Council (ERC) under the European Community [207807]; MRC [G0501173] Funding Source: UKRI; Medical Research Council [G0501173] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC) under the European Community(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A.N.R. was supported by a PhD studentship from the Wellcome Trust (http://www.wellcome.ac.uk/). Financial support for the work was provided to N.K. by a European Research Council (ERC) Starting Grant under the European Community's Seventh Framework Programme (Grant agreement no. 207807) (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiades PG, 2011, EUR J NEUROSCI, V34, P1542, DOI 10.1111/j.1460-9568.2011.07904.x; Anderson SA., 2012, JASPERS BASIC MECH E, V4th ed.; Aranguren XL, 2013, J CELL SCI, V126, P1164, DOI 10.1242/jcs.116293; Arber C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00010; Azim E, 2009, NAT NEUROSCI, V12, P1238, DOI 10.1038/nn.2387; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; Cai YQ, 2013, J COMP NEUROL, V521, P479, DOI 10.1002/cne.23186; Cambray S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1817; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Close J, 2012, J NEUROSCI, V32, P17690, DOI 10.1523/JNEUROSCI.3583-12.2012; Denaxa M, 2012, CELL REP, V2, P1351, DOI 10.1016/j.celrep.2012.10.003; Elkouris M, 2011, STEM CELLS, V29, P89, DOI 10.1002/stem.554; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Fragkouli A, 2009, DEVELOPMENT, V136, P3841, DOI 10.1242/dev.038083; Francois M, 2011, PHYSIOLOGY, V26, P146, DOI 10.1152/physiol.00053.2010; Fuerstenberg S, 1998, INT J DEV BIOL, V42, P379; Galeeva A, 2007, NEUROSCIENCE, V146, P604, DOI 10.1016/j.neuroscience.2007.02.002; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Johnson NC, 2008, GENE DEV, V22, P3282, DOI 10.1101/gad.1727208; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kanatani S, 2008, J NEUROSCI, V28, P13582, DOI 10.1523/JNEUROSCI.2132-08.2008; Karalay O, 2011, P NATL ACAD SCI USA, V108, P5807, DOI 10.1073/pnas.1013456108; Lavado A, 2007, DEV DYNAM, V236, P518, DOI 10.1002/dvdy.21024; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Li L, 2000, GENE DEV, V14, P147; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Long JE, 2009, CEREB CORTEX S1, V19, P196; Ma T, 2012, CEREB CORTEX, V22, P2120, DOI 10.1093/cercor/bhr296; Magno L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00065; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; Maroof AM, 2010, J NEUROSCI, V30, P4667, DOI 10.1523/JNEUROSCI.4255-09.2010; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; Rubin AN, 2010, J NEUROSCI, V30, P12050, DOI 10.1523/JNEUROSCI.6178-09.2010; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Torii MA, 1999, DEVELOPMENT, V126, P443; Vucurovic K, 2010, CEREB CORTEX, V20, P2333, DOI 10.1093/cercor/bhp310; Welagen J, 2011, DEV NEUROBIOL, V71, P10, DOI 10.1002/dneu.20857; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yozu M, 2005, J NEUROSCI, V25, P7268, DOI 10.1523/JNEUROSCI.2072-05.2005	53	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77339	10.1371/journal.pone.0077339	http://dx.doi.org/10.1371/journal.pone.0077339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155945	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300079
J	Yan, S; Song, H; Pang, DX; Zou, QJ; Li, L; Yan, QM; Fan, NN; Zhao, XJ; Yu, H; Li, ZJ; Wang, HJ; Gao, F; Ouyang, HS; Lai, LX				Yan, Sen; Song, Hong; Pang, Daxin; Zou, Qingjian; Li, Li; Yan, Quanmei; Fan, Nana; Zhao, Xiangjie; Yu, Hao; Li, Zhanjun; Wang, Haijun; Gao, Fei; Ouyang, Hongsheng; Lai, Liangxue			Expression of Plant Sweet Protein Brazzein in the Milk of Transgenic Mice	PLOS ONE			English	Article							RECOMBINANT BRAZZEIN; GENE; SEQUENCES; PROMOTER; EXCISION; GENOME	Sugar, the most popular sweetener, is essential in daily food. However, excessive sugar intake has been associated with several lifestyle-related diseases. Finding healthier and more economical alternatives to sugars and artificial sweeteners has received increasing attention to fulfill the growing demand. Brazzein, which comes from the pulp of the edible fruit of the African plant Pentadiplandra brazzeana Baill, is a protein that is 2,000 times sweeter than sucrose by weight. Here we report the production of transgenic mice that carry the optimized brazzein gene driven by the goat Beta-casein promoter, which specifically directs gene expression in the mammary glands. Using western blot analysis and immunohistochemistry, we confirmed that brazzein could be efficiently expressed in mammalian milk, while retaining its sweetness. This study presents the possibility of producing plant protein-sweetened milk from large animals such as cattle and goats.	[Yan, Sen; Pang, Daxin; Li, Li; Yan, Quanmei; Yu, Hao; Li, Zhanjun; Wang, Haijun; Gao, Fei; Ouyang, Hongsheng; Lai, Liangxue] Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China; [Song, Hong; Zou, Qingjian; Fan, Nana; Zhao, Xiangjie; Lai, Liangxue] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China	Jilin University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Lai, LX (corresponding author), Jilin Univ, Coll Anim Sci, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Peoples R China.	lai_liangxue@gibh.ac.cn			National Natural Science Foundation of China [31071293]; National Science and Technology Major Project [2009ZX10004-405]; Science and Technology Planning Project of Guangdong Province, China [2011A060901019]; Innovative Research Team in University [IRT1248]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Science and Technology Planning Project of Guangdong Province, China; Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by grants from the National Natural Science Foundation of China (Grant no. 31071293), National Science and Technology Major Project (Grant no. 2009ZX10004-405), Science and Technology Planning Project of Guangdong Province, China (Grant no. 2011A060901019), and Innovative Research Team in University (Grant no IRT1248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi-Porter FM, 2000, ARCH BIOCHEM BIOPHYS, V376, P252, DOI 10.1006/abbi.2000.1725; Berlec A, 2006, APPL MICROBIOL BIOT, V73, P158, DOI 10.1007/s00253-006-0438-y; Conner DA, 2001, CURR PROTOC MOL BIOL; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; DePeters EJ, 2009, J MAMMARY GLAND BIOL, V14, P397, DOI 10.1007/s10911-009-9158-0; Faus I, 2000, APPL MICROBIOL BIOT, V53, P145, DOI 10.1007/s002530050001; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Guan ZY, 1995, CHEM SENSES, V20, P99; Hare PD, 2002, NAT BIOTECHNOL, V20, P575, DOI 10.1038/nbt0602-575; Haruyama N, 2009, CURR PROTOC CELL BIO; Hellekant G, 2005, CHEM SENSES, V30, pI88, DOI 10.1093/chemse/bjh127; Izawa H, 1996, BIOPOLYMERS, V39, P95, DOI 10.1002/(SICI)1097-0282(199607)39:1<95::AID-BIP10>3.0.CO;2-B; Jin ZY, 2003, FEBS LETT, V544, P33, DOI 10.1016/S0014-5793(03)00383-1; Karatzas CN, 1997, J DAIRY SCI, V80, P2225, DOI 10.3168/jds.S0022-0302(97)76171-X; KEREN DF, 1979, INFECT IMMUN, V24, P441, DOI 10.1128/IAI.24.2.441-448.1979; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lamphear BJ, 2005, PLANT BIOTECHNOL J, V3, P103, DOI 10.1111/j.1467-7652.2004.00105.x; Lee KK, 1999, J BIOCH, V126, P320; Liu S, 2011, TRANSGENIC RES; MING D, 1994, FEBS LETT, V355, P106, DOI 10.1016/0014-5793(94)01184-2; OSTERUD B, 1978, J BIOL CHEM, V253, P5946; PERSUY MA, 1995, GENE, V165, P291, DOI 10.1016/0378-1119(95)00405-U; PITTIUS CW, 1988, P NATL ACAD SCI USA, V85, P5874, DOI 10.1073/pnas.85.16.5874; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Rachid A, 2009, CHEM SENSES, V34, pA80; ROBERTS B, 1992, GENE, V121, P255, DOI 10.1016/0378-1119(92)90129-D; RUSSELL SH, 1992, MOL GEN GENET, V234, P49, DOI 10.1007/BF00272344; Saeki K, 2004, P NATL ACAD SCI USA, V101, P6361, DOI 10.1073/pnas.0308111101; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049697	31	15	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76769	10.1371/journal.pone.0076769	http://dx.doi.org/10.1371/journal.pone.0076769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155905	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300039
J	Cai, XT; Lu, WG; Yang, Y; Yang, J; Ye, J; Gu, ZH; Hu, CP; Wang, XN; Cao, P				Cai, Xueting; Lu, Wuguang; Yang, Yang; Yang, Jie; Ye, Juan; Gu, Zhenhua; Hu, Chunping; Wang, Xiaoning; Cao, Peng			Digitoflavone Inhibits I kappa B alpha Kinase and Enhances Apoptosis Induced by TNF alpha through Downregulation of Expression of Nuclear Factor kappa B-Regulated Gene Products in Human Pancreatic Cancer Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BLOCKS INTERLEUKIN-1-BETA-INDUCED ACTIVATION; MULTIPLE-MYELOMA CELLS; CURCUMIN DIFERULOYLMETHANE; CARCINOMA-CELLS; CONSTITUTIVE ACTIVATION; LEUKEMIA-CELLS; ONCOGENIC RAS; CYCLE ARREST; LUTEOLIN	Tumor necrosis factor-alpha (TNF alpha) activates both cell death and cell survival pathways. The activation of survival pathway renders most cancer cells resistant to TNF-induced cytotoxicity. We found that pretreatment with digitoflavone, a plant flavonoid, greatly sensitized TNF alpha-induced apoptotic cell death in several human pancreatic cancer cells. In search of the molecular basis of the sensitization effect of digitoflavone, digitoflavone was found to inhibit TNF alpha-induced activation of nuclear transcription factor-kappa B (NF-kappa B) which is the main survival factor in TNF alpha signaling. NF-kappa B suppression occurred through inhibition of I kappa B alpha kinase activation, I kappa B alpha phosphorylation, I kappa B alpha degradation, and NF-kappa B nuclear translocation. This inhibition correlated with suppression of NF-kappa B-dependent genes involved in antiapoptosis (mcl-1, bcl-2, bcl-xl, c-iap1, c-iap2, flip, and survivin), proliferation (c-myc, cyclin d1), and angiogenesis (vegf, cox-2, and mmp-9). In addition, digitoflavone can activate JNK through inhibition of NF-kappa B signaling, provide a continuous blockade of the feed-back inhibitory mechanism by JNK-induced NF-kappa B activation. This study found a novel function of digitoflavone and enhanced the value of digitoflavone as an anticancer agent.	[Cai, Xueting; Lu, Wuguang; Yang, Yang; Yang, Jie; Ye, Juan; Gu, Zhenhua; Hu, Chunping; Wang, Xiaoning; Cao, Peng] China Acad Chinese Med Sci, Jiangsu Branch, Nanjing, Jiangsu, Peoples R China; [Cai, Xueting; Lu, Wuguang; Yang, Yang; Yang, Jie; Ye, Juan; Gu, Zhenhua; Hu, Chunping; Wang, Xiaoning; Cao, Peng] Jiangsu Prov Acad Tradit Chinese Med, Lab Cellular & Mol Biol, Nanjing, Jiangsu, Peoples R China	China Academy of Chinese Medical Sciences; Nanjing University of Chinese Medicine	Cao, P (corresponding author), China Acad Chinese Med Sci, Jiangsu Branch, Nanjing, Jiangsu, Peoples R China.	pcao79@yahoo.com	Sheng, Lei/HDO-1972-2022	, Peng/0000-0002-2044-3074	National Natural Science Foundation of China [30701098, 30873410, 81073101]; Natural Science Foundation of Zhejiang Province [Y2090676]; Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine	This work was supported by the National Natural Science Foundation of China (Nos. 30701098, 30873410 and 81073101), Natural Science Foundation of Zhejiang Province (No. Y2090676) and Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal Bharat B., 2004, Indian Journal of Experimental Biology, V42, P341; Ashokkumar P, 2008, BIOMED PHARMACOTHER, V62, P590, DOI 10.1016/j.biopha.2008.06.031; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Blaszkowsky Lawrence, 1998, Frontiers in Bioscience, V3, pE214; Bonizzi G, 1997, J IMMUNOL, V159, P5264; Brown JE, 1998, BIOCHEM J, V330, P1173; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cai XT, 2011, TOXICOL IN VITRO, V25, P1385, DOI 10.1016/j.tiv.2011.05.009; Chang JS, 2005, LIFE SCI, V76, P1883, DOI 10.1016/j.lfs.2004.11.003; Chen S, 2002, J DENT RES, V81, P98, DOI 10.1177/154405910208100203; Estrov Z, 1999, BLOOD, V94, P2844, DOI 10.1182/blood.V94.8.2844.420k43_2844_2853; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Galati G, 2001, FREE RADICAL BIO MED, V30, P370, DOI 10.1016/S0891-5849(00)00481-0; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Giri DK, 1998, J BIOL CHEM, V273, P14008, DOI 10.1074/jbc.273.22.14008; Gold E B, 1998, Surg Oncol Clin N Am, V7, P67; Hu LP, 2003, BLOOD, V101, P3126, DOI 10.1182/blood-2002-08-2640; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Lee HJ, 2005, TOXICOL APPL PHARM, V203, P124, DOI 10.1016/j.taap.2004.08.004; Lee WJ, 2006, CHEM-BIOL INTERACT, V160, P123, DOI 10.1016/j.cbi.2006.01.002; Li L, 2004, CANCER-AM CANCER SOC, V101, P2351, DOI 10.1002/cncr.20605; Lim DY, 2007, AM J PHYSIOL-GASTR L, V292, pG66, DOI 10.1152/ajpgi.00248.2006; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; Plaumann B, 1996, ONCOGENE, V13, P1605; Sasaki N, 2003, CHEM-BIOL INTERACT, V145, P101, DOI 10.1016/S0009-2797(02)00248-X; Schutte ME, 2008, FOOD CHEM TOXICOL, V46, P557, DOI 10.1016/j.fct.2007.08.038; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Watanabe N, 1996, PANCREAS, V13, P395, DOI 10.1097/00006676-199611000-00009; WATANABE N, 1994, ONCOLOGY, V51, P360; Xavier CPR, 2009, CANCER LETT, V281, P162, DOI 10.1016/j.canlet.2009.02.041; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Yamamoto Yumi, 2001, Current Molecular Medicine (Hilversum), V1, P287; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Yee SB, 2003, ARCH PHARM RES, V26, P151, DOI 10.1007/BF02976662; Zhang Q, 2008, FOOD CHEM TOXICOL, V46, P2042, DOI 10.1016/j.fct.2008.01.049	47	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77126	10.1371/journal.pone.0077126	http://dx.doi.org/10.1371/journal.pone.0077126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146961	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400099
J	Deepa, D; Achanta, S; Jaju, J; Rao, K; Samyukta, R; Claassens, M; Kumar, AMV; Vishnu, PH				Deepa, Dorai; Achanta, Shanta; Jaju, Jyoti; Rao, Koteswara; Samyukta, Rani; Claassens, Mareli; Kumar, Ajay M. V.; Vishnu, P. H.			The Impact of Isoniazid Resistance on the Treatment Outcomes of Smear Positive Re-Treatment Tuberculosis Patients in the State of Andhra Pradesh, India	PLOS ONE			English	Article								Background: Multi drug resistant and rifampicin resistant TB patients in India are treated with the World Health Organization (WHO) recommended standardized treatment regimens but no guidelines are available for the management of isoniazid (INH) resistant TB patients. There have been concerns that the standard eight-month retreatment regimen being used in India (2H(3)R(3)Z(3)E(3)S(3)/1H(3)R(3)Z(3)E(3)/5H(3)R(3)E(3); H-Isoniazid; R-Rifampicin; Z-Pyrazinamide; E-Ethambutol; S-Streptomycin) may be inadequate to treat INH resistant TB cases and leads to poor treatment outcomes. We aimed to assess if INH resistance is associated with unfavorable treatment outcomes (death, default, failure and transferred out) among a cohort of smear positive retreatment TB patients registered in three districts of Andhra Pradesh, India. Methods: We conducted a retrospective record review of all smear positive retreatment TB patients without rifampicin resistance registered during April-December 2011. Results: Of 1,947 TB patients, 1,127 (58%) were tested with LPA-50 (4%) were rifampicin resistant, 933 (84%) were sensitive to INH and rifampicin and 144 (12%) were INH resistant. Of 144 INH resistant cases, 64 (44%) had poor treatment outcomes (25 (17%) default, 22 (15%) death, 12 (8%) failure and 5 (3%) transfer out) as compared to 287 (31%) among INH sensitive cases [aRR 1.46; 95% CI (1.19-1.78)]. Conclusion: Our study confirms that INH resistance is independently associated with unfavorable treatment outcomes among smear positive retreatment TB patients, indicating that the current treatment regimen may be inadequate. These findings call for an urgent need for randomized controlled trials to discover the most effective treatment regimen for managing INH resistant TB.	[Deepa, Dorai; Rao, Koteswara; Vishnu, P. H.] Govt Andhra Pradesh, Directorate Gen Hlth Serv, State TB Training & Demonstrat Ctr, Hyderabad, Andhra Pradesh, India; [Achanta, Shanta; Jaju, Jyoti] World Hlth Org WHO Country Off India, New Delhi, India; [Samyukta, Rani] Govt Andhra Pradesh, Minist Hlth & Family Welf, State TB Cell Directorate Gen Hlth Serv, Hyderabad, Andhra Pradesh, India; [Claassens, Mareli] Univ Stellenbosch, Dept Pediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa; [Kumar, Ajay M. V.] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India	World Health Organization; Stellenbosch University	Deepa, D (corresponding author), Govt Andhra Pradesh, Directorate Gen Hlth Serv, State TB Training & Demonstrat Ctr, Hyderabad, Andhra Pradesh, India.	dr.ddeepa@gmail.com	Claassens, Mareli/Y-3544-2019	Claassens, Mareli/0000-0002-5927-284X; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	Revised National Tuberculosis Control Programme(RNTCP) of India	Revised National Tuberculosis Control Programme(RNTCP) of India	Funding for the research was by Revised National Tuberculosis Control Programme(RNTCP) of India. Funders had no role in study design, data collection, analysis decision to publish, or preparation of the manuscript.	Central TBDivision, 2011, TB IND 2011 REV NAT; Central TBDivision, 2011, MAN RNTCP YOUR AR TR; Central TBDivision, 2012, REV NAT TUB CONTR PR; Chadha SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026659; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Gegia M, 2012, INT J TUBERC LUNG D, V16, P812, DOI 10.5588/ijtld.11.0637; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Swaminathan S, 2010, AM J RESP CRIT CARE, V181, P743, DOI 10.1164/rccm.200903-0439OC; Vijay S., 2002, Indian Journal of Tuberculosis, V49, P195; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2008, WORLD HLTH REPORT 20; World Health Organization, 2008, WHOHTMTB2008402, P1	14	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76189	10.1371/journal.pone.0076189	http://dx.doi.org/10.1371/journal.pone.0076189			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146839	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400046
J	Gasca-Pineda, J; Cassaigne, I; Alonso, RA; Eguiarte, LE				Gasca-Pineda, Jaime; Cassaigne, Ivonne; Alonso, Rogelio A.; Eguiarte, Luis E.			Effective Population Size, Genetic Variation, and Their Relevance for Conservation: The Bighorn Sheep in Tiburon Island and Comparisons with Managed Artiodactyls	PLOS ONE			English	Article							OVIS-CANADENSIS; NORTH-AMERICA; F-STATISTICS; SOFTWARE; DNA; DIVERSITY; DROUGHT; DECLINE; VARIABILITY; INFERENCE	The amount of genetic diversity in a finite biological population mostly depends on the interactions among evolutionary forces and the effective population size (N-e) as well as the time since population establishment. Because the N-e estimation helps to explore population demographic history, and allows one to predict the behavior of genetic diversity through time, N-e is a key parameter for the genetic management of small and isolated populations. Here, we explored an N-e-based approach using a bighorn sheep population on Tiburon Island, Mexico (TI) as a model. We estimated the current (N-crnt) and ancestral stable (N-stbl) inbreeding effective population sizes as well as summary statistics to assess genetic diversity and the demographic scenarios that could explain such diversity. Then, we evaluated the feasibility of using TI as a source population for reintroduction programs. We also included data from other bighorn sheep and artiodactyl populations in the analysis to compare their inbreeding effective size estimates. The TI population showed high levels of genetic diversity with respect to other managed populations. However, our analysis suggested that TI has been under a genetic bottleneck, indicating that using individuals from this population as the only source for reintroduction could lead to a severe genetic diversity reduction. Analyses of the published data did not show a strict correlation between H-E and N-crnt estimates. Moreover, we detected that ancient anthropogenic and climatic pressures affected all studied populations. We conclude that the estimation of N-crnt and N-stbl are informative genetic diversity estimators and should be used in addition to summary statistics for conservation and population management planning.	[Gasca-Pineda, Jaime; Cassaigne, Ivonne; Eguiarte, Luis E.] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico; [Alonso, Rogelio A.] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Eguiarte, LE (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico.	fruns@servidor.unam.mx			Consejo Nacional de Ciencia y Tecnologia (CONACyT) [199870]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by a scholarship of the Consejo Nacional de Ciencia y Tecnologia (CONACyT) to JGP (number 199870). The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; Arif IA, 2010, GENES GENET SYST, V85, P141, DOI 10.1266/ggs.85.141; Ballou Jonathan D., 1996, P263; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2003, GENETICS, V164, P1139; BERGER WH, 1990, GLOBAL PLANET CHANGE, V89, P219, DOI 10.1016/0921-8181(90)90018-8; Booth RK, 2005, HOLOCENE, V15, P321, DOI 10.1191/0959683605hl825ft; Boyce MS, 2002, POPULATION VIABILITY ANALYSIS, P41; Boyce WM, 1999, MOL ECOL, V8, P99, DOI 10.1046/j.1365-294X.1999.00536.x; BRITON J, 1994, BIOL CONSERV, V69, P267, DOI 10.1016/0006-3207(94)90426-X; Buechner H. K., 1960, Wildlife Monographs.; Byers DA, 2004, AM ANTIQUITY, V69, P235, DOI 10.2307/4128418; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Cannon Kenneth P., 2001, Great Plains Research, V11, P145; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Colchero F, 2009, J ANIM ECOL, V78, P666, DOI 10.1111/j.1365-2656.2009.01528.x; Coltman DW, 2005, MOL ECOL, V14, P2593, DOI 10.1111/j.1365-294X.2005.02600.x; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Corti P, 2011, CONSERV GENET, V12, P119, DOI 10.1007/s10592-009-9997-7; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EWENS WJ, 1990, CONVERGENT ISSUES GE, P307; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; EZCURRA E, 1987, VEGETATIO, V71, P49, DOI 10.1007/BF00048511; Falush D, 2003, GENETICS, V164, P1567; Fisher RA, 1930, GENETICAL THEORY NAT; FLORES D, 1991, J AM HIST, V78, P465, DOI 10.2307/2079530; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frantz AC, 2004, J APPL ECOL, V41, P985, DOI 10.1111/j.0021-8901.2004.00951.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray ST, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016154; Grayson DK, 2001, SCIENCE, V294, P1459; GRAYSON DK, 1991, J WORLD PREHIST, V5, P193, DOI 10.1007/BF00974990; Gutierrez-Espeleta GA, 2001, HEREDITY, V86, P439, DOI 10.1046/j.1365-2540.2001.00853.x; Gutierrez-Espeleta Gustavo A., 2000, Conservation Genetics, V1, P3, DOI 10.1023/A:1010125519304; Halbert ND, 2008, MOL ECOL, V17, P4963, DOI 10.1111/j.1365-294X.2008.03973.x; Hedrick P.W., 2011, GENETICS POPULATIONS, V4th ed.; HEDRICK PW, 1992, ECOL APPL, V2, P30, DOI 10.2307/1941887; Hedrick PW, 2001, MOL ECOL, V10, P851, DOI 10.1046/j.1365-294X.2001.01243.x; Janetski JC, 1997, J ARCHAEOL SCI, V24, P1075, DOI 10.1006/jasc.1996.0187; KACHITVICHYANUKUL V, 1988, COMMUN ACM, V31, P216, DOI 10.1145/42372.42381; Kaeuffer R, 2007, P ROY SOC B-BIOL SCI, V274, P527, DOI 10.1098/rspb.2006.3743; KRAUSMAN PR, 2000, ECOLOGY MANAGEMENT L, P517; Kruschke JK, 2013, J EXP PSYCHOL GEN, V142, P573, DOI 10.1037/a0029146; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leberg P, 2005, J WILDLIFE MANAGE, V69, P1385, DOI 10.2193/0022-541X(2005)69[1385:GAFETE]2.0.CO;2; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Lyman RL, 2009, HOLOCENE, V19, P143, DOI 10.1177/0959683608098958; McNeely J. A., 1990, CONSERVING WORLDS BI; Montoya B., 1975, DESERT BIGHORN COUNC, V19, P28; Mooring MS, 2003, BEHAVIOUR, V140, P183, DOI 10.1163/156853903321671497; Ni XW, 2009, ANIM BIOL, V59, P273, DOI 10.1163/157075609X454908; Nichols RA, 2001, MOL ECOL, V10, P593, DOI 10.1046/j.1365-294x.2001.01204.x; Olivieri GL, 2008, BIOL CONSERV, V141, P1257, DOI 10.1016/j.biocon.2008.02.025; Ortego J, 2011, MOL ECOL, V20, P1601, DOI 10.1111/j.1365-294X.2011.05022.x; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2012, R LANG ENV STAT COMP; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwartz M, 1999, J ADV MATER, V31, P2; Storz JF, 2002, EVOLUTION, V56, P154; Storz JF, 2001, EVOLUTION, V55, P1224; Tallmon DA, 2004, GENETICS, V167, P977, DOI 10.1534/genetics.103.026146; Tucker JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052803; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wand M., 2010, HDRCDE HIGHEST DENSI; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Waples RS, 2002, POPULATION VIABILITY ANALYSIS, P147; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whittaker DG, 2004, J WILDLIFE MANAGE, V68, P850, DOI 10.2193/0022-541X(2004)068[0850:GVORCB]2.0.CO;2; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1931, GENETICS, V16, P0097; ZONTAK K, 1995, GREAT PLAINS QUART, V15, P133; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1007/S10021-010-9402-X	92	20	20	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78120	10.1371/journal.pone.0078120	http://dx.doi.org/10.1371/journal.pone.0078120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147115	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400144
J	Wagner, LM; DeLuca, NA				Wagner, Lauren M.; DeLuca, Neal A.			Temporal Association of Herpes Simplex Virus ICP4 with Cellular Complexes Functioning at Multiple Steps in PolII Transcription	PLOS ONE			English	Article							RNA-POLYMERASE-II; CARBOXYL-TERMINAL-DOMAIN; REGULATORY PROTEIN; MACROMOLECULAR-SYNTHESIS; ALPHA-GENES; TYPE-1; MEDIATOR; BINDING; DNA; IDENTIFICATION	The herpes simplex virus type 1 (HSV-1) immediate early protein, ICP4, participates in the regulation of viral gene expression by both activating and repressing RNA polII transcription. We used affinity purification of ICP4 expressed in infected cells followed by mass spectrometry and western blot analysis to determine the composition of cellular complexes associated with ICP4 throughout infection. ICP4 was associated with TFIID complexes containing a distinct set of TAFs. These complexes were most abundant early, but were detected throughout infection, whereas Mediator was found in ICP4 containing complexes later in infection, indicating a temporal pattern for the utilization of these complexes for the transcription of the viral genome. The form of Mediator copurifying with ICP4 was enriched for the kinase domain and also lacked the activator-specific component, Med26, suggesting that Mediator-ICP4 interactions may be involved in repression of viral transcription. The N-terminal 774 amino acids of ICP4, which retains partial function, were sufficient to form complexes with TFIID and Mediator, although these interactions were not as strong as with full-length ICP4. Additionally, components involved in transcription elongation, chromatin remodeling, and mRNA processing were isolated with ICP4. Together our data indicate that ICP4 plays a more integrated role in mediating HSV transcription, possibly affecting multiple steps in transcription and gene expression.	[Wagner, Lauren M.; DeLuca, Neal A.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	DeLuca, NA (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15213 USA.	ndeluca@pitt.edu			NIH [R01 AI030612, T32 AI049820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant R01 AI030612 to NAD. LMW was supported by the NIH training grant T32 AI049820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; ALWINE JC, 1974, VIROLOGY, V60, P302, DOI 10.1016/0042-6822(74)90390-0; BATTERSON W, 1983, J VIROL, V46, P371, DOI 10.1128/JVI.46.2.371-377.1983; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; CAMPBELL MEM, 1984, J MOL BIOL, V180, P1, DOI 10.1016/0022-2836(84)90427-3; Carrozza MJ, 1996, MOL CELL BIOL, V16, P3085; Chan S, 2011, WIRES RNA, V2, P321, DOI 10.1002/wrna.54; Conesa C, 2010, RNA BIOL, V7, P287, DOI 10.4161/rna.7.3.11491; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DELUCA NA, 1988, J VIROL, V62, P732, DOI 10.1128/JVI.62.3.732-743.1988; DELUCA NA, 1987, NUCLEIC ACIDS RES, V15, P4491, DOI 10.1093/nar/15.11.4491; DIXON RAF, 1980, J VIROL, V36, P189, DOI 10.1128/JVI.36.1.189-203.1980; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; FABER SW, 1986, NUCLEIC ACIDS RES, V14, P6067, DOI 10.1093/nar/14.15.6067; FLORES O, 1992, J BIOL CHEM, V267, P2786; Fraser KA, 2005, J VIROL, V79, P11323, DOI 10.1128/JVI.79.17.11323-11334.2005; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Gazit K, 2009, J BIOL CHEM, V284, P26286, DOI 10.1074/jbc.M109.011486; GERARD M, 1991, J BIOL CHEM, V266, P20940; Grondin B, 2000, J VIROL, V74, P11504, DOI 10.1128/JVI.74.24.11504-11510.2000; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; HONESS RW, 1975, P NATL ACAD SCI USA, V72, P1276, DOI 10.1073/pnas.72.4.1276; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; KRISTIE TM, 1986, P NATL ACAD SCI USA, V83, P3218, DOI 10.1073/pnas.83.10.3218; Kuddus RH, 2007, J VIROL, V81, P9230, DOI 10.1128/JVI.01054-07; Lester JT, 2011, J VIROL, V85, P5733, DOI 10.1128/JVI.00385-11; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; METZLER DW, 1985, J VIROL, V55, P329, DOI 10.1128/JVI.55.2.329-337.1985; MULLER MT, 1987, J VIROL, V61, P858, DOI 10.1128/JVI.61.3.858-865.1987; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Papamichos-Chronakis M, 2008, NAT STRUCT MOL BIOL, V15, P338, DOI 10.1038/nsmb.1413; PATERSON T, 1988, NUCLEIC ACIDS RES, V16, P11005, DOI 10.1093/nar/16.23.11005; POST LE, 1981, CELL, V24, P555, DOI 10.1016/0092-8674(81)90346-9; PRESTON CM, 1979, J VIROL, V29, P275, DOI 10.1128/JVI.29.1.275-284.1979; Sampath P, 2008, J VIROL, V82, P2339, DOI 10.1128/JVI.02459-07; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; SHEPARD AA, 1989, J VIROL, V63, P3714, DOI 10.1128/JVI.63.9.3714-3728.1989; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Tsai KL, 2013, NAT STRUCT MOL BIOL; Wagner LM, 2013, J VIROL, V87, P1010, DOI 10.1128/JVI.02844-12; Wagner LM, 2012, J VIROL; WATSON RJ, 1980, NATURE, V285, P329, DOI 10.1038/285329a0; Weller SK, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P1; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	59	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78242	10.1371/journal.pone.0078242	http://dx.doi.org/10.1371/journal.pone.0078242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147125	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400149
J	Banh, A; Chavez, V; Doi, J; Nguyen, A; Hernandez, S; Ha, V; Jimenez, P; Espinoza, F; Johnson, HA				Banh, Andy; Chavez, Valarie; Doi, Julia; Allison Nguyen; Hernandez, Sophia; Vu Ha; Jimenez, Peter; Espinoza, Fernanda; Johnson, Hope A.			Manganese (Mn) Oxidation Increases Intracellular Mn in Pseudomonas putida GB-1	PLOS ONE			English	Article							AFFINITY IRON UPTAKE; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; BRADYRHIZOBIUM-JAPONICUM; MULTICOPPER OXIDASE; STRESS RESISTANCE; MN(II) OXIDATION; OXIDIZING FACTOR; IDENTIFICATION; MECHANISMS	Bacterial manganese (Mn) oxidation plays an important role in the global biogeochemical cycling of Mn and other compounds, and the diversity and prevalence of Mn oxidizers have been well established. Despite many hypotheses of why these bacteria may oxidize Mn, the physiological reasons remain elusive. Intracellular Mn levels were determined for Pseudomonas putida GB-1 grown in the presence or absence of Mn by inductively coupled plasma mass spectrometry (ICP-MS). Mn oxidizing wild type P. putida GB-1 had higher intracellular Mn than non Mn oxidizing mutants grown under the same conditions. P. putida GB-1 had a 5 fold increase in intracellular Mn compared to the non Mn oxidizing mutant P. putida GB-1-007 and a 59 fold increase in intracellular Mn compared to P. putida GB-1 Delta 2665.2447. The intracellular Mn is primarily associated with the less than 3 kDa fraction, suggesting it is not bound to protein. Protein oxidation levels in Mn oxidizing and non oxidizing cultures were relatively similar, yet Mn oxidation did increase survival of P. putida GB-1 when oxidatively stressed. This study is the first to link Mn oxidation to Mn homeostasis and oxidative stress protection.	[Banh, Andy; Chavez, Valarie; Doi, Julia; Allison Nguyen; Hernandez, Sophia; Vu Ha; Jimenez, Peter; Espinoza, Fernanda; Johnson, Hope A.] Calif State Univ Fullerton, Dept Biol Sci, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA	California State University System; California State University Fullerton	Johnson, HA (corresponding author), Calif State Univ Fullerton, Dept Biol Sci, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA.	hajohnson@fullerton.edu		Banh, Andy/0000-0001-7333-8254; Hernandez, Sophia/0000-0001-5763-2672	Research Corporation; National Science Foundation [MCB-1021187]; California State University Fullerton Associated Students, Inc	Research Corporation(Research Corporation for Science Advancement); National Science Foundation(National Science Foundation (NSF)); California State University Fullerton Associated Students, Inc	Funding for this project was provided by Research Corporation (http://www.rescorp.org), the National Science Foundation (MCB-1021187), California State University Fullerton Associated Students, Inc research grants to JD, AB, VC, AN, SH, VH, FE, and PJ; and a State Mini Grant to HAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; ARCHIBALD FS, 1981, J BACTERIOL, V145, P442, DOI 10.1128/JB.145.1.442-451.1981; ARCHIBALD FS, 1982, ARCH BIOCHEM BIOPHYS, V214, P452, DOI 10.1016/0003-9861(82)90049-2; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Barnese K, 2012, P NATL ACAD SCI USA, V109, P6892, DOI 10.1073/pnas.1203051109; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; BOOGERD FC, 1987, J BACTERIOL, V169, P489, DOI 10.1128/jb.169.2.489-494.1987; Brouwers GJ, 1998, AM MINERAL, V83, P1573, DOI 10.2138/am-1998-11-1245; Brouwers GJ, 2000, GEOMICROBIOL J, V17, P1, DOI 10.1080/014904500270459; Brouwers GJ, 1999, APPL ENVIRON MICROB, V65, P1762; Carmichael MJ, 2013, GEOMICROBIOL J, V30, P779, DOI 10.1080/01490451.2013.769651; CARR RJG, 1986, APPL ENVIRON MICROB, V52, P1112, DOI 10.1128/AEM.52.5.1112-1116.1986; Caspi R, 1998, APPL ENVIRON MICROB, V64, P3549; Cellier MFM, 2012, CURR TOP MEMBR, V69, P249, DOI 10.1016/B978-0-12-394390-3.00010-0; Champion OL, 2011, MICROBIOL-SGM, V157, P1115, DOI 10.1099/mic.0.045807-0; Culotta VC, 2013, ANTIOXID REDOX SIGN, V19, P933, DOI 10.1089/ars.2012.5093; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; de Vrind J, 2003, MOL MICROBIOL, V47, P993, DOI 10.1046/j.1365-2958.2003.03339.x; de Vrind JPM, 1998, APPL ENVIRON MICROB, V64, P3556; Do SH, 2009, CHEMOSPHERE, V75, P8, DOI 10.1016/j.chemosphere.2008.11.075; EHRLICH HL, 1990, ARCH MICROBIOL, V154, P12; Galiazzo F, 1989, Biol Met, V2, P6, DOI 10.1007/BF01116194; Geszvain K, 2013, APPL ENVIRON MICROB, V79, P357, DOI 10.1128/AEM.01850-12; Geszvain K, 2012, BIOCHEM SOC T, V40, P1244, DOI 10.1042/BST20120229; Geszvain K, 2011, ARCH MICROBIOL, V193, P605, DOI 10.1007/s00203-011-0702-0; Geszvain K, 2010, APPL ENVIRON MICROB, V76, P1224, DOI 10.1128/AEM.02473-09; GHIORSE WC, 1984, ANNU REV MICROBIOL, V38, P515, DOI 10.1146/annurev.mi.38.100184.002503; Granger AC, 2011, APPL ENVIRON MICROB, V77, P32, DOI 10.1128/AEM.01965-10; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Green RT, 2013, ISME J, V7, P581, DOI 10.1038/ismej.2012.140; Hohle TH, 2012, MOL MICROBIOL, V84, P766, DOI 10.1111/j.1365-2958.2012.08057.x; Hohle TH, 2009, MOL MICROBIOL, V72, P399, DOI 10.1111/j.1365-2958.2009.06650.x; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Jakubovics NS, 2009, MOL MICROBIOL, V72, P1, DOI 10.1111/j.1365-2958.2009.06637.x; Johnson HA, 2008, ARCH MICROBIOL, V189, P59, DOI 10.1007/s00203-007-0293-y; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kopytko M, 2002, ELECTRON J BIOTECHNO, V5, P182, DOI 10.2225/vol5-issue2-fulltext-1; Kwok EY, 2006, BIOCHEMISTRY-US, V45, P6317, DOI 10.1021/bi052173c; LAHA S, 1990, ENVIRON SCI TECHNOL, V24, P363, DOI 10.1021/es00073a012; Learman DR, 2011, NAT GEOSCI, V4, P95, DOI [10.1038/ngeo1055, 10.1038/NGEO1055]; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021983; MACARA IG, 1973, BIOCHEM J, V135, P785, DOI 10.1042/bj1350785; Makui H, 2000, MOL MICROBIOL, V35, P1065, DOI 10.1046/j.1365-2958.2000.01774.x; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; Miyata N, 2007, J BIOSCI BIOENG, V104, P1, DOI 10.1263/jbb.104.1; NEALSON KH, 1988, ADV APPL MICROBIOL, V33, P279, DOI 10.1016/S0065-2164(08)70209-0; Okazaki M, 1997, APPL ENVIRON MICROB, V63, P4793, DOI 10.1128/AEM.63.12.4793-4799.1997; Parikh SJ, 2005, GEOMICROBIOL J, V22, P207, DOI 10.1080/01490450590947724; Santelli CM, 2010, APPL ENVIRON MICROB, V76, P4871, DOI 10.1128/AEM.03029-09; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Spiro TG, 2010, ACCOUNTS CHEM RES, V43, P2, DOI 10.1021/ar800232a; STADTMAN ER, 1990, P NATL ACAD SCI USA, V87, P384, DOI 10.1073/pnas.87.1.384; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Sun HX, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-319; SUNDA WG, 1994, NATURE, V367, P62, DOI 10.1038/367062a0; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Tebo BM, 2004, ANNU REV EARTH PL SC, V32, P287, DOI 10.1146/annurev.earth.32.101802.120213; Tebo BM, 1997, REV MINERAL, V35, P225; Tebo BM, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P1223; van der Werf MJ, 2008, MOL BIOSYST, V4, P315, DOI 10.1039/b717340g; Veyrier FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002261; Waters LS, 2011, J BACTERIOL, V193, P5887, DOI 10.1128/JB.05872-11; Yamamoto K, 2011, J BACTERIOL, V193, P1477, DOI 10.1128/JB.01230-10; YIM MB, 1990, P NATL ACAD SCI USA, V87, P394, DOI 10.1073/pnas.87.1.394	67	44	46	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77835	10.1371/journal.pone.0077835	http://dx.doi.org/10.1371/journal.pone.0077835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147089	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200081
J	Lin, FM; Chen, Y; Levine, R; Lee, K; Yuan, YJ; Lin, XN				Lin, Fengming; Chen, Yu; Levine, Robert; Lee, Kilho; Yuan, Yingjin; Lin, Xiaoxia Nina			Improving Fatty Acid Availability for Bio-Hydrocarbon Production in Escherichia coli by Metabolic Engineering	PLOS ONE			English	Article							BIODIESEL PRODUCTION; OVERPRODUCTION; BIOSYNTHESIS; CHEMICALS; FUELS; GENE; IDENTIFICATION; STRAINS; BIOMASS; ALKANES	Previous studies have demonstrated the feasibility of producing fatty-acid-derived hydrocarbons in Escherichia coli. However, product titers and yields remain low. In this work, we demonstrate new methods for improving fatty acid production by modifying central carbon metabolism and storing fatty acids in triacylglycerol. Based on suggestions from a computational model, we deleted seven genes involved in aerobic respiration, mixed-acid fermentation, and glyoxylate bypass (in the order of cyoA, nuoA, ndh, adhE, dld, pta, and iclR) to modify the central carbon metabolic/regulatory networks. These gene deletions led to increased total fatty acids, which were the highest in the mutants containing five or six gene knockouts. Additionally, when two key enzymes in the fatty acid biosynthesis pathway were over-expressed, we observed further increase in strain Delta cyoA Delta adhE Delta nuoA Delta ndh Delta pta Delta dld, leading to 202 mg/g dry cell weight of total fatty acids, similar to 250% of that in the wild-type strain. Meanwhile, we successfully introduced a triacylglycerol biosynthesis pathway into E. coli through heterologous expression of wax ester synthase/acylcoenzyme: diacylglycerol acyltransferase (WS/DGAT) enzymes. The added pathway improved both the amount and fuel quality of the fatty acids. These new metabolic engineering strategies are providing promising directions for future investigation.	[Lin, Fengming; Chen, Yu; Levine, Robert; Lee, Kilho; Lin, Xiaoxia Nina] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Lin, Fengming; Yuan, Yingjin] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China; [Lin, Xiaoxia Nina] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Lin, Xiaoxia Nina] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Tianjin University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lin, XN (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	ninalin@umich.edu			NSF [EFRI 0937992]	NSF(National Science Foundation (NSF))	NSF (EFRI 0937992) http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AF, 2008, MICROBIOL-SGM, V154, P2327, DOI 10.1099/mic.0.2008/016568-0; Alvarez HM, 1996, ARCH MICROBIOL, V165, P377, DOI 10.1007/s002030050341; Arabolaza A, 2008, APPL ENVIRON MICROB, V74, P2573, DOI 10.1128/AEM.02638-07; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Cao YJ, 2010, APPL MICROBIOL BIOT, V87, P271, DOI 10.1007/s00253-009-2377-x; Chen Y, 2012, THESIS U MICHIGAN AN; Covert MW, 2002, J BIOL CHEM, V277, P28058, DOI 10.1074/jbc.M201691200; Davis MS, 2000, J BIOL CHEM, V275, P28593, DOI 10.1074/jbc.M004756200; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; Dellomonaco C, 2010, APPL ENVIRON MICROB, V76, P5067, DOI 10.1128/AEM.00046-10; Duan YK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020265; GROGAN DW, 1984, J BACTERIOL, V158, P286, DOI 10.1128/JB.158.1.286-295.1984; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Gui LZ, 1996, J BACTERIOL, V178, P321, DOI 10.1128/jb.178.1.321-324.1996; Holtzapple E, 2007, J BACTERIOL, V189, P3804, DOI 10.1128/JB.01932-06; JIANG P, 1994, J BACTERIOL, V176, P2814, DOI 10.1128/JB.176.10.2814-2821.1994; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Kim J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-53; KORNBERG HL, 1966, BIOCHEM J, V99, P1; Lee EG, 2009, BIOTECHNOL BIOENG, V102, P200, DOI 10.1002/bit.22040; Lennen RM, 2012, TRENDS BIOTECHNOL, V30, P659, DOI 10.1016/j.tibtech.2012.09.006; Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660; Levine RB, 2010, ENERG FUEL, V24, P5235, DOI 10.1021/ef1008314; Liu H, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-41; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; MALOY SR, 1980, J BACTERIOL, V143, P720, DOI 10.1128/JB.143.2.720-725.1980; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Park JY, 2008, BIORESOURCE TECHNOL, V99, P1196, DOI 10.1016/j.biortech.2007.02.017; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Ranganathan S, 2012, METAB ENG, V14, P687, DOI 10.1016/j.ymben.2012.08.008; Ranganathan S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000744; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Santala S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-36; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Subrahmanyam S, 1998, J BACTERIOL, V180, P4596, DOI 10.1128/JB.180.17.4596-4602.1998; Timmis KN, 2010, GENETICS WAX ESTER T, P527; Xu P, 2011, METAB ENG, V13, P578, DOI 10.1016/j.ymben.2011.06.008; Youngquist JT, 2012, BIOTECHNOL BIOENG, V109, P1518, DOI 10.1002/bit.24420; Yun NR, 2005, J APPL MICROBIOL, V99, P1404, DOI 10.1111/j.1365-2672.2005.02724.x; Zha WJ, 2009, METAB ENG, V11, P192, DOI 10.1016/j.ymben.2009.01.005; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149	44	21	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78595	10.1371/journal.pone.0078595	http://dx.doi.org/10.1371/journal.pone.0078595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147139	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200100
J	Marrero, I; Hamm, DE; Davies, JD				Marrero, Idania; Hamm, David E.; Davies, Joanna D.			High-Throughput Sequencing of Islet-Infiltrating Memory CD4(+) T Cells Reveals a Similar Pattern of TCR V beta Usage in Prediabetic and Diabetic NOD Mice	PLOS ONE			English	Article							PANCREATIC-ISLETS; PERIPHERAL-BLOOD; ANTIBODY THERAPY; AUTOIMMUNE; DIVERSITY; CLONES; TRANSPLANTATION; REPERTOIRE; LYMPHOCYTE; RECURRENCE	Autoreactive memory CD4(+) T cells play a critical role in the development of type 1 diabetes, but it is not yet known how the clonotypic composition and TCR beta repertoire of the memory CD4(+) T cell compartment changes during the transition from prediabetes to diabetes. In this study, we used high-throughput sequencing to analyze the TCR beta repertoire of sorted islet-infiltrating memory CD4(+)CD44(high) T cells in 10-week-old prediabetic and recently diabetic NOD mice. We show that most clonotypes of islet-infiltrating CD4(+)CD44(high) T cells were rare, but high-frequency clonotypes were significantly more common in diabetic than in prediabetic mice. Moreover, although the CD4(+)CD44(high) TCR beta repertoires were highly diverse at both stages of disease development, dominant use of TRBV1 (V beta 2), TRBV13-3 (V beta 8.1), and TRBV19 (V beta 6) was evident in both prediabetic and diabetic mice. Our findings strongly suggest that therapeutic targeting of cells specifically expressing the dominant TCR beta might reduce pancreatic infiltration in prediabetic mice and attenuate the progression to diabetes.	[Marrero, Idania; Davies, Joanna D.] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Hamm, David E.] Adapt Biotechnol Corp, Seattle, WA USA	Torrey Pines Institute for Molecular Studies, California	Marrero, I (corresponding author), Torrey Pines Inst Mol Studies, San Diego, CA USA.	imarrero@tpims.org			American Diabetes Association Junior Faculty Award Grant [1-11-JF-29]; National Institutes of Health [R01AI065937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065937] Funding Source: NIH RePORTER	American Diabetes Association Junior Faculty Award Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an American Diabetes Association Junior Faculty Award Grant (1-11-JF-29) and by the National Institutes of Health Grant (R01AI065937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Axelsson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029008; BACELJ A, 1989, DIABETES, V38, P1492, DOI 10.2337/diabetes.38.11.1492; BACELJ A, 1992, TRANSPLANT P, V24, P220; Baker FJ, 2002, P NATL ACAD SCI USA, V99, P9374, DOI 10.1073/pnas.142284899; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; BERSCHICK P, 1993, J AUTOIMMUN, V6, P405, DOI 10.1006/jaut.1993.1034; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Burton AR, 2008, DIABETES, V57, P1321, DOI 10.2337/db07-1129; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1561, DOI 10.1073/pnas.1018973108; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1567, DOI 10.1073/pnas.1018975108; CANDEIAS S, 1991, P NATL ACAD SCI USA, V88, P6167, DOI 10.1073/pnas.88.14.6167; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Cohen J., 2003, APPL MULTIPLE REGRES; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Diz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052054; DREXLER K, 1993, IMMUNOL LETT, V37, P187, DOI 10.1016/0165-2478(93)90030-6; EDOUARD P, 1993, EUR J IMMUNOL, V23, P727, DOI 10.1002/eji.1830230324; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Fohse L, 2011, EUR J IMMUNOL, V41, P3101, DOI 10.1002/eji.201141986; Fousteri G, 2010, DIABETOLOGIA, V53, P1958, DOI 10.1007/s00125-010-1777-x; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; GALLEY KA, 1995, J IMMUNOL, V154, P2969; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; HEROLD KC, 1995, DIABETES, V44, P354, DOI 10.2337/diabetes.44.3.354; Huurman VAL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002435; Jasinski JM, 2006, DIABETES, V55, P1978, DOI 10.2337/db06-0058; Klarenbeek PL, 2010, IMMUNOL LETT, V133, P42, DOI 10.1016/j.imlet.2010.06.011; Laughlin E, 2008, CLIN IMMUNOL, V128, P23, DOI 10.1016/j.clim.2008.03.459; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Leiter Edward H, 2005, Curr Diab Rep, V5, P141, DOI 10.1007/s11892-005-0042-z; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Li L, 2009, J IMMUNOL, V183, P7585, DOI 10.4049/jimmunol.0901587; Liu ZJ, 2012, DIABETES, V61, P1160, DOI 10.2337/db11-0867; Marrero I, 2012, MOL IMMUNOL, V52, P9, DOI 10.1016/j.molimm.2012.04.004; MILLER BJ, 1988, J IMMUNOL, V140, P52; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Monti P, 2007, J IMMUNOL, V179, P5785, DOI 10.4049/jimmunol.179.9.5785; NAKANO N, 1991, J EXP MED, V173, P1091, DOI 10.1084/jem.173.5.1091; Oling V, 2012, CELL IMMUNOL, V273, P133, DOI 10.1016/j.cellimm.2011.12.008; QIAN T, 1993, DIABETES, V42, P1544, DOI 10.2337/diabetes.42.10.1544; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sarukhan A., 1994, INT IMMUNOL, V17, P139; Siebert JC, 2008, CYTOM PART A, V73A, P289, DOI 10.1002/cyto.a.20509; Simone E, 1997, P NATL ACAD SCI USA, V94, P2518, DOI 10.1073/pnas.94.6.2518; Tikochinski Y, 1999, INT IMMUNOL, V11, P951, DOI 10.1093/intimm/11.6.951; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Wong CP, 2007, J IMMUNOL, V178, P1388, DOI 10.4049/jimmunol.178.3.1388; Yang Y, 1996, IMMUNITY, V4, P189, DOI 10.1016/S1074-7613(00)80683-4; Zhang L, 2009, J AUTOIMMUN, V33, P42, DOI 10.1016/j.jaut.2009.02.003	57	20	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76546	10.1371/journal.pone.0076546	http://dx.doi.org/10.1371/journal.pone.0076546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146886	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200015
J	Sterling, M; Elliott, JM; Cabot, PJ				Sterling, Michele; Elliott, James M.; Cabot, Peter J.			The Course of Serum Inflammatory Biomarkers Following Whiplash Injury and Their Relationship to Sensory and Muscle Measures: a Longitudinal Cohort Study	PLOS ONE			English	Article							LOW-BACK-PAIN; C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; THERAPEUTIC INTERVENTIONS; DISORDER WAD; HYPERSENSITIVITY; HYPERALGESIA; METAANALYSIS; RECOVERY	Tissue damage or pathological alterations are not detectable in the majority of people with whiplash associated disorders (WAD). Widespread hyperalgisa, morphological muscle changes and psychological distress are common features of WAD. However little is known about the presence of inflammation and its association with symptom persistence or the clinical presentation of WAD. This study aimed to prospectively investigate changes in serum inflammatory biomarker levels from the acute (<3 weeks) to chronic (>3 months) stages of whiplash injury. It also aimed to determine relationships between biomarker levels and hyperalgesia, fatty muscle infiltrates of the cervical extensors identified on MRI and psychological factors. 40 volunteers with acute WAD and 18 healthy controls participated. Participants with WAD were classified at 3 months as recovered/mild disability or having moderate/severe disability using the Neck Disability Index. At baseline both WAD groups showed elevated serum levels of CRP but by 3 months levels remained elevated only in the moderate/severe group. The recovered/mild disability WAD group had higher levels of TNF-alpha at both time points than both the moderate/severe WAD group and healthy controls. There were no differences found in serum IL-1 beta. Moderate relationships were found between hyperalgesia and CRP at both time points and between hyperalgesia and IL-1 beta 3 months post injury. There was a moderate negative correlation between TNF-alpha and amount of fatty muscle infiltrate and pain intensity at 3 months. Only a weak relationship was found between CRP and pain catastrophising and no relationship between biomarker levels and posttraumatic stress symptoms. The results of the study indicate that inflammatory biomarkers may play a role in outcomes following whiplash injury as well as being associated with hyperalgesia and fatty muscle infiltrate in the cervical extensors.	[Sterling, Michele] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med CONROD, Brisbane, Qld, Australia; [Elliott, James M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Cabot, Peter J.] Univ Brisbane, Pharm Australia Ctr Excellence, Sch Pharm, Queensland, Qld, Australia	University of Queensland; Northwestern University; Feinberg School of Medicine	Sterling, M (corresponding author), Univ Queensland, Ctr Natl Res Disabil & Rehabil Med CONROD, Brisbane, Qld, Australia.	m.sterling@uq.edu.au	Cabot, Peter John/B-2424-2013; Sterling, Michele/F-1679-2010	Cabot, Peter John/0000-0003-1778-3753; Sterling, Michele/0000-0003-1772-2248; Sterling, Michele/0000-0001-8242-2685	Physiotherapy Research Foundation of Australia; National Health and Medical Research Council of Australia (NHMRC)	Physiotherapy Research Foundation of Australia; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Funding was received from the Physiotherapy Research Foundation of Australia to conduct this study. MS receives a fellowship from the National Health and Medical Research Council of Australia (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Afari N, 2011, ANN BEHAV MED, V42, P277, DOI 10.1007/s12160-011-9297-6; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; Barreiro E, 2008, THORAX, V63, P100, DOI 10.1136/thx.2007.078030; Carp S, 2007, CLIN SCI, V112; Carp S, 2008, BIOMARK MED, V2, P67, DOI 10.2217/17520363.2.1.67; Curatolo M, 2001, CLIN J PAIN, V17, P306, DOI 10.1097/00002508-200112000-00004; Curatolo M, 2011, SPINE, V36, pS309, DOI 10.1097/BRS.0b013e318238842a; Edwards RR, 2008, PAIN, V140, P135, DOI 10.1016/j.pain.2008.07.024; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Elliott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021194; Elliott JM, 2010, SPINE, V35, P948, DOI 10.1097/BRS.0b013e3181bb0e55; Ferroni P, 2003, CIRCULATION, V108, P1673, DOI 10.1161/01.CIR.0000094732.02060.27; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; Freeland AE, 2002, MICROSURG, V22, P378, DOI 10.1002/micr.10065; Goldsmith R, 2012, MANUAL THER, V17, P402, DOI 10.1016/j.math.2012.02.014; Haheim LL, 2009, SCAND J PUBLIC HEALT, V37, P640, DOI 10.1177/1403494809104358; Haldeman S, 2008, SPINE, V33, pS5; Kamper SJ, 2008, PAIN, V138, P617, DOI 10.1016/j.pain.2008.02.019; Kivioja J, 2001, CLIN IMMUNOL, V101, P106, DOI 10.1006/clim.2001.5086; Kraychete DC, 2010, SAO PAULO MED J, V128, P259, DOI 10.1590/S1516-31802010000500003; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Lord SM, 1996, NEW ENGL J MED, V335, P1721, DOI 10.1056/NEJM199612053352302; Macintyre PE, 2009, ACUTE PAIN MANAGEMENT, P204, DOI 10.1017/CBO9780511576706.016; Namas R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008406; Pedersen M, 2003, MECH AGEING DEV, V124, P495, DOI 10.1016/S0047-6374(03)00027-7; Reid MB, 2001, RESP RES, V2, P269, DOI 10.1186/rr67; Rivest K, 2010, MANUAL THER, V15, P154, DOI 10.1016/j.math.2009.10.001; ROSENSTIEL AK, 1983, PAIN, V17, P33, DOI 10.1016/0304-3959(83)90125-2; Sin DD, 2008, THORAX, V63, P95, DOI 10.1136/thx.2007.088575; Spitzer WO, 1995, SPINE S8, V20, P1, DOI DOI 10.1097/00007632-199504151-00001; Statistics ABo, 1995, NAT LONG SURV CHILDR, P1; Sterling M, 2003, PAIN, V106, P481, DOI 10.1016/j.pain.2003.09.013; Sterling M, 2004, SPINE, V29, P182, DOI 10.1097/01.BRS.0000105535.12598.AE; Sterling M, 2005, PAIN, V114, P141, DOI 10.1016/j.pain.2004.12.005; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Sterling M, 2012, PAIN, V153, P1727, DOI 10.1016/j.pain.2012.05.004; Sterling M, 2010, PAIN, V150, P501, DOI 10.1016/j.pain.2010.06.003; Sterling M, 2010, PAIN, V150, P22, DOI 10.1016/j.pain.2010.02.013; Stone A, 2012, MAN THER, V18, P111; Sturmer T, 2005, ANN RHEUM DIS, V64, P921, DOI 10.1136/ard.2004.027045; Taylor J R, 1993, Ann Acad Med Singap, V22, P187; Teasell RW, 2010, PAIN RES MANAG, V15, P313, DOI 10.1155/2010/487279; Teasell RW, 2010, PAIN RES MANAG, V15, P295, DOI 10.1155/2010/640164; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Vernon H., 1996, J MUSCULOSKELET PAIN, V4, P95, DOI [10.1300/J094v04n04_09, DOI 10.1300/J094V04N04_09, DOI 10.1300/J094V04N04_]; Walton DM, 2009, J ORTHOP SPORT PHYS, V39, P334, DOI 10.2519/jospt.2009.2765; Wang H, 2008, CLIN J PAIN, V24, P273, DOI 10.1097/AJP.0b013e31816111d3; Ware J., 1993, SF 36 HLTH SURVEY MA; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; WATKINS LR, 1994, BRAIN RES, V654, P15, DOI 10.1016/0006-8993(94)91566-0	50	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77903	10.1371/journal.pone.0077903	http://dx.doi.org/10.1371/journal.pone.0077903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147095	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200084
J	Yu, ZS; Kong, JJ; Pan, B; Sun, HC; Lv, TW; Zhu, J; Huang, GY; Tian, J				Yu, Zhongsu; Kong, Juanjuan; Pan, Bo; Sun, Huichao; Lv, Tiewei; Zhu, Jing; Huang, Guoying; Tian, Jie			Islet-1 May Function as an Assistant Factor for Histone Acetylation and Regulation of Cardiac Development-Related Transcription Factor Mef2c Expression	PLOS ONE			English	Article							2ND HEART FIELD; ARTERIAL POLE; CELLS; ISL1; CONTRIBUTES; LINEAGES; P300	Objective: Islet-1 is an important transcription factor for cardiac development through mediating extensive interactions between DNA and proteins. The present study was to investigate the role of Islet-1 in regulating the expression of cardiac development-related transcription factors and mechanism. Methods and Results: The expression of Islet-1 and histone acetylases (HATs) subtype p300 was determined in newborn mouse hearts and mouse embryonic hearts at different development stages using Western blot. The expression of Islet-1 and cardiac development-related transcription factors Mef2c, GATA4 and Tbx5 as well as histone H3 acetylation level were determined in cardiac progenitor cells with and without transfection of Islet-1 interference RNA (RNAi) in lentivirus using PCR and Western blot. Islet-1 peak expression occurred on day E14.5 in mouse embryonic heart, and was present in the promoter regions of Mef2c, GATA4 and Tbx5 that were precipitated with p300 antibody. When Islet-1 was inhibited with specific RNAi in cardiac progenitor cells, the expression of Mef2c and Tbx5, but not GATA4, was significantly suppressed along with selective reduction in histone H3 acetylation in the promoter region of Mef2c, but not GATA4 and Tbx5. The level of Mef2c DNA, not GATA4 and Tbx5, in the complex associated with p300 was significantly decreased in the cells with Islet-1 knockdown. Conclusions: These data suggested that Islet-1 might function as an assistant factor that was involved in the regulation of histone acetylation and Mef2c expression via assisting p300 on specifically targeting the promoter of Mef2c.	[Yu, Zhongsu; Kong, Juanjuan; Pan, Bo; Sun, Huichao; Lv, Tiewei; Tian, Jie] Chongqing Med Univ, Childrens Hosp, Ctr Heart, Chongqing, Peoples R China; [Yu, Zhongsu; Kong, Juanjuan; Zhu, Jing] Chongqing Med Univ, Minist Educ, Key Lab Dev Dis Childhood, Chongqing, Peoples R China; [Huang, Guoying] Fudan Univ, Childrens Hosp, Pediat Heart Ctr, Shanghai 200433, Peoples R China	Chongqing Medical University; Chongqing Medical University; Fudan University	Tian, J (corresponding author), Chongqing Med Univ, Childrens Hosp, Ctr Heart, Chongqing, Peoples R China.	jietian@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2010CB529505]; Natural Science Foundation of Chongqing, China [2009BA5084]; Research Foundation of Chongqing Medical University, China [XBZD201014]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing); Research Foundation of Chongqing Medical University, China	This study was supported by research grants from the National Basic Research Program of China (973 Program, grant number: 2010CB529505), the Natural Science Foundation of Chongqing, China (grant number: CSTC,2009BA5084), and the Research Foundation of Chongqing Medical University, China (grant number: XBZD201014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cecchetto A, 2010, FUTUR CARDIOL, V6, P373, DOI [10.2217/fca.10.10, 10.2217/FCA.10.10]; Chen GZ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-24; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Dodou E, 2004, DEVELOPMENT, V131, P3931, DOI 10.1242/dev.01256; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Fonoudi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055577; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Genead R, 2010, STEM CELL RES, V4, P69, DOI 10.1016/j.scr.2009.10.001; Haycock PC, 2009, BIOL REPROD, V81, P607, DOI 10.1095/biolreprod.108.074690; Herrmann F, 2011, DEV DYNAM, V240, P2634, DOI 10.1002/dvdy.22776; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; Kelly RG, 2002, TRENDS GENET, V18, P210, DOI 10.1016/S0168-9525(02)02642-2; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Snarr BS, 2007, CIRC RES, V101, P971, DOI 10.1161/CIRCRESAHA.107.162206; Stevens KN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010855; Sun HC, 2010, LIFE SCI, V87, P707, DOI 10.1016/j.lfs.2010.10.009; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Waldo KL, 2005, DEV BIOL, V281, P78, DOI 10.1016/j.ydbio.2005.02.012; Yang XF, 2010, J CHONGQING MED U, V35, P961; Yuan SP, 2000, ANAT REC, V260, P204, DOI 10.1002/1097-0185(20001001)260:2<204::AID-AR90>3.0.CO;2-5; [智深深 Zhi Shenshen], 2011, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V36, P170; Zhong LL, 2010, CARDIOVASC TOXICOL, V10, P268, DOI 10.1007/s12012-010-9081-z; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	33	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77690	10.1371/journal.pone.0077690	http://dx.doi.org/10.1371/journal.pone.0077690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147056	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200066
J	Carmichael, SN; Bekaert, M; Taggart, JB; Christie, HRL; Bassett, DI; Bron, JE; Skuce, PJ; Gharbi, K; Skern-Mauritzen, R; Sturm, A				Carmichael, Stephen N.; Bekaert, Michael; Taggart, John B.; Christie, Hayden R. L.; Bassett, David I.; Bron, James E.; Skuce, Philip J.; Gharbi, Karim; Skern-Mauritzen, Rasmus; Sturm, Armin			Identification of a Sex-Linked SNP Marker in the Salmon Louse (Lepeophtheirus salmonis) Using RAD Sequencing	PLOS ONE			English	Article							SHRIMP PENAEUS-MONODON; MACROBRACHIUM-ROSENBERGII; DE-NOVO; CRUSTACEA; GENES; LICE; CALIGIDAE; EVOLUTION; COPEPODA; DNA	The salmon louse (Lepeophtheirus salmonis (Kroyer, 1837)) is a parasitic copepod that can, if untreated, cause considerable damage to Atlantic salmon (Salmo salar Linnaeus, 1758) and incurs significant costs to the Atlantic salmon mariculture industry. Salmon lice are gonochoristic and normally show sex ratios close to 1:1. While this observation suggests that sex determination in salmon lice is genetic, with only minor environmental influences, the mechanism of sex determination in the salmon louse is unknown. This paper describes the identification of a sex-linked Single Nucleotide Polymorphism (SNP) marker, providing the first evidence for a genetic mechanism of sex determination in the salmon louse. Restriction site-associated DNA sequencing (RAD-seq) was used to isolate SNP markers in a laboratory-maintained salmon louse strain. A total of 85 million raw Illumina 100 base paired-end reads produced 281,838 unique RAD-tags across 24 unrelated individuals. RAD marker Lsa101901 showed complete association with phenotypic sex for all individuals analysed, being heterozygous in females and homozygous in males. Using an allele-specific PCR assay for genotyping, this SNP association pattern was further confirmed for three unrelated salmon louse strains, displaying complete association with phenotypic sex in a total of 96 genotyped individuals. The marker Lsa101901 was located in the coding region of the prohibitin-2 gene, which showed a sex-dependent differential expression, with mRNA levels determined by RT-qPCR about 1.8-fold higher in adult female than adult male salmon lice. This study's observations of a novel sex-linked SNP marker are consistent with sex determination in the salmon louse being genetic and following a female heterozygous system. Marker Lsa101901 provides a tool to determine the genetic sex of salmon lice, and could be useful in the development of control strategies.	[Carmichael, Stephen N.; Bekaert, Michael; Taggart, John B.; Christie, Hayden R. L.; Bron, James E.; Sturm, Armin] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Skuce, Philip J.] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Gharbi, Karim] Univ Edinburgh, Sch Biol Sci, GenePool, Edinburgh, Midlothian, Scotland; [Bassett, David I.] Univ Stirling, Marine Environm Res Lab, Machrihanish, Argyll, Scotland; [Skern-Mauritzen, Rasmus] Inst Marine Res, N-5024 Bergen, Norway	University of Stirling; Moredun Research Institute; University of Edinburgh; University of Stirling; Institute of Marine Research - Norway	Carmichael, SN (corresponding author), Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland.	snc2@stir.ac.uk	Bron, James E/B-6231-2018; Gharbi, Karim/C-5771-2012	Bron, James E/0000-0003-3544-0519; Gharbi, Karim/0000-0003-1092-4488; Sturm, Armin/0000-0003-2632-1999; Bekaert, Michael/0000-0002-1206-7654; Taggart, John/0000-0002-3843-9663; Bassett, David/0000-0002-7529-0829	Scottish Salmon Producers Organisation (SSPO); University of Stirling; Moredun Foundation; Medical Research Council [MR/K001744/1] Funding Source: researchfish; MRC [MR/K001744/1] Funding Source: UKRI	Scottish Salmon Producers Organisation (SSPO); University of Stirling; Moredun Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was financed by the Scottish Salmon Producers Organisation (SSPO) (http://www.scottishsalmon.co.uk), the University of Stirling (http://www.stir.ac.uk) and the Moredun Foundation (http://www.moredun.org.uk/charitable-work/the-moredun-foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Bron J. E., 1993, Pathogens of wild and farmed fish: sea lice., P263; Campos-Ramos R, 2006, AQUAC RES, V37, P1583, DOI 10.1111/j.1365-2109.2006.01604.x; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Charlesworth D, 2010, GENETICS, V186, P9, DOI 10.1534/genetics.110.117697; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Criscione CD, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r71; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; FAO, 2012, FAO YB FISH AQ STAT; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; Gusmao LFM, 2009, J PLANKTON RES, V31, P1101, DOI 10.1093/plankt/fbp059; Hanfling B, 2011, BIOCONTROL, V56, P573, DOI 10.1007/s10526-011-9380-8; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Heumann J, 2012, COMP BIOCHEM PHYS C, V155, P198, DOI 10.1016/j.cbpc.2011.08.004; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Horsberg TE, 2012, CURR PHARM BIOTECHNO, V13, P1095; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Hutchinson TH, 1999, ENVIRON TOXICOL CHEM, V18, P2914, DOI [10.1002/etc.5620181237, 10.1897/1551-5028(1999)018&lt;2914:LCSWMC&gt;2.3.CO;2]; JOHNSON SC, 1991, J MAR BIOL ASSOC UK, V71, P425, DOI 10.1017/S0025315400051687; Juchault P, 1999, CR ACAD SCI III-VIE, V322, P423, DOI 10.1016/S0764-4469(99)80078-X; JUCHAULT P, 1972, CR ACAD SCI D NAT, V274, P1387; Kato Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001345; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Laufer H, 1998, GEN COMP ENDOCR, V111, P113, DOI 10.1006/gcen.1998.7109; LECHER P, 1995, INVERTEBR REPROD DEV, V27, P85, DOI 10.1080/07924259.1995.9672440; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; LEGRAND JJ, 1987, BIOL REV, V62, P439, DOI 10.1111/j.1469-185X.1987.tb01637.x; Li YT, 2003, AQUACULTURE, V219, P143, DOI 10.1016/S0044-8486(02)00355-1; MALECHA SR, 1992, AQUACULTURE, V105, P201, DOI 10.1016/0044-8486(92)90087-2; Mao H, 2012, MOL BIOL REP, V39, P7031, DOI 10.1007/s11033-012-1534-y; Mazurova E, 2008, BIOLOGIA, V63, P139, DOI 10.2478/s11756-008-0027-x; Michaud M, 2004, MAR ECOL PROG SER, V269, P163, DOI 10.3354/meps269163; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Nakamura M, 2010, J EXP ZOOL PART A, V313A, P381, DOI 10.1002/jez.616; Ohbayashi F, 2002, CURR SCI INDIA, V83, P466; Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Peterson JK, 2001, ENVIRON TOXICOL CHEM, V20, P582, DOI [10.1897/1551-5028(2001)020&lt;0582:MAOEAM&gt;2.0.CO;2, 10.1002/etc.5620200318]; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao H, 2012, COMP BIOCHEM PHYS D, V7, P268, DOI 10.1016/j.cbd.2012.04.003; Ritchie G, 1996, J EXP MAR BIOL ECOL, V201, P285, DOI 10.1016/0022-0981(96)00008-1; Rodriguez EM, 2007, COMP BIOCHEM PHYS A, V146, P661, DOI 10.1016/j.cbpa.2006.04.030; Sevatdal S, 2003, AQUACULTURE, V218, P21, DOI 10.1016/S0044-8486(02)00339-3; Staelens J, 2008, GENETICS, V179, P917, DOI 10.1534/genetics.107.080150; Torrissen O, 2013, J FISH DIS, V36, P171, DOI 10.1111/jfd.12061; Ventura T, 2011, HEREDITY, V107, P456, DOI 10.1038/hdy.2011.32; Voordouw MJ, 2008, EVOL ECOL RES, V10, P1007; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	57	55	57	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77832	10.1371/journal.pone.0077832	http://dx.doi.org/10.1371/journal.pone.0077832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147087	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400138
J	Cattoni, DI; Fiche, JB; Valeri, A; Mignot, T; Nollmann, M				Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Mignot, Tam; Noellmann, Marcelo			Super-Resolution Imaging of Bacteria in a Microfluidics Device	PLOS ONE			English	Article							GENE-EXPRESSION; LOCALIZATION MICROSCOPY; BACILLUS-SUBTILIS; CELL; DNA; SPOIIIE; MOLECULES; QUANTIFICATION; SPORULATION; PROTEINS	Bacteria have evolved complex, highly-coordinated, multi-component cellular engines to achieve high degrees of efficiency, accuracy, adaptability, and redundancy. Super-resolution fluorescence microscopy methods are ideally suited to investigate the internal composition, architecture, and dynamics of molecular machines and large cellular complexes. These techniques require the long-term stability of samples, high signal-to-noise-ratios, low chromatic aberrations and surface flatness, conditions difficult to meet with traditional immobilization methods. We present a method in which cells are functionalized to a microfluidics device and fluorophores are injected and imaged sequentially. This method has several advantages, as it permits the long-term immobilization of cells and proper correction of drift, avoids chromatic aberrations caused by the use of different filter sets, and allows for the flat immobilization of cells on the surface. In addition, we show that different surface chemistries can be used to image bacteria at different time-scales, and we introduce an automated cell detection and image analysis procedure that can be used to obtain cell-to-cell, single-molecule localization and dynamic heterogeneity as well as average properties at the super-resolution level.	[Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Noellmann, Marcelo] Ctr Natl Rech Sci, Ctr Biochim Struct, Unite Mixte Rech 5048, Montpellier, France; [Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Noellmann, Marcelo] Inst Natl Sante & Rech Med, U1054, Montpellier, France; [Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Noellmann, Marcelo] Univ Montpellier I, Montpellier, France; [Cattoni, Diego I.; Fiche, Jean-Bernard; Valeri, Alessandro; Noellmann, Marcelo] Univ Montpellier 2, Montpellier, France; [Mignot, Tam] Aix Marseille Univ, Lab Chim Bacterienne, Ctr Natl Rech Sci, Unite Mixte Rech 7283, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier	Nollmann, M (corresponding author), Ctr Natl Rech Sci, Ctr Biochim Struct, Unite Mixte Rech 5048, Montpellier, France.	marcelo.nollmann@cbs.cnrs.fr		Nollmann, Marcelo/0000-0003-3339-2349; Cattoni, Diego I./0000-0002-0048-8531; Mignot, Tam/0000-0003-4338-9063	Human Frontiers Science Program [00017/2009]; Institut National de la Sante et la Recherche Medicale; European Research Council [260787]	Human Frontiers Science Program(Human Frontier Science Program); Institut National de la Sante et la Recherche Medicale; European Research Council(European Research Council (ERC)European Commission)	Financial support was provided by the Human Frontiers Science Program (Career Development Award 00017/2009 to M.N.), the Institut National de la Sante et la Recherche Medicale (Avenir programme to M.N.) and the European Research Council (Starting Grant 260787 to M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Badrinarayanan A, 2012, SCIENCE, V338, P528, DOI 10.1126/science.1227126; Becker EC, 2007, MOL MICROBIOL, V66, P1066, DOI 10.1111/j.1365-2958.2007.05992.x; Bergmiller T, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-118; Beta C, 2011, EUR J CELL BIOL, V90, P811, DOI 10.1016/j.ejcb.2011.05.006; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Biteen JS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000448; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g; Cattoni DI, 2012, CURR OPIN MICROBIOL, V15, P758, DOI 10.1016/j.mib.2012.10.007; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Chung BG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-60; Churchman L Stirling, 2012, Cold Spring Harb Protoc, V2012, P141, DOI 10.1101/pdb.top067918; Churchman L Stirling, 2012, Cold Spring Harb Protoc, V2012, P242, DOI 10.1101/pdb.prot067926; Cozzarelli NR, 2006, NAT REV MOL CELL BIO, V7, P580, DOI 10.1038/nrm1982; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Ducret Adrien, 2013, Methods Mol Biol, V966, P97, DOI 10.1007/978-1-62703-245-2_6; Ducret A, 2012, P NATL ACAD SCI USA, V109, P10036, DOI 10.1073/pnas.1120979109; Ducret A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007282; English BP, 2011, P NATL ACAD SCI USA, V108, pE365, DOI 10.1073/pnas.1102255108; Eswaramoorthy P, 2011, MBIO, V2, DOI 10.1128/mBio.00257-11; Ferguson ML, 2011, ANAL BIOCHEM, V419, P250, DOI 10.1016/j.ab.2011.08.017; Fiche JB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001557; Fleming TC, 2010, GENE DEV, V24, P1160, DOI 10.1101/gad.1925210; FOULGER D, 1989, MOL MICROBIOL, V3, P1247, DOI 10.1111/j.1365-2958.1989.tb00275.x; Gahlmann A, 2013, NANO LETT, V13, P987, DOI 10.1021/nl304071h; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Jeon H, 2009, BIOMED MICRODEVICES, V11, P1135, DOI 10.1007/s10544-009-9330-8; Joyce Graham, 2011, BMC Res Notes, V4, P73, DOI 10.1186/1756-0500-4-73; Lee SH, 2012, P NATL ACAD SCI USA, V109, P17436, DOI 10.1073/pnas.1215175109; Lew MD, 2011, P NATL ACAD SCI USA, V108, pE1102, DOI 10.1073/pnas.1114444108; Marquis KA, 2008, GENE DEV, V22, P1786, DOI 10.1101/gad.1684008; Mattheyses AL, 2010, J CELL SCI, V123, P3621, DOI 10.1242/jcs.056218; McEvoy AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051314; Pandey R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058972; Pelletier J, 2012, P NATL ACAD SCI USA, V109, pE2649, DOI 10.1073/pnas.1208689109; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schoen I, 2011, NANO LETT, V11, P4008, DOI 10.1021/nl2025954; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; Strauss MP, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001389; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Uphoff S, 2013, P NATL ACAD SCI USA, V110, P8063, DOI 10.1073/pnas.1301804110; Walden M, 2011, CURR OPIN BIOTECH, V22, P81, DOI 10.1016/j.copbio.2010.10.004; Wong I, 2010, LAB CHIP, V10, P2710, DOI 10.1039/c004719h; Young JW, 2012, NAT PROTOC, V7, P80, DOI 10.1038/nprot.2011.432	57	26	27	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76268	10.1371/journal.pone.0076268	http://dx.doi.org/10.1371/journal.pone.0076268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146850	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400050
J	Gunnell, AS; Einarsdottir, K; Galvao, DA; Joyce, S; Tomlin, S; Graham, V; McIntyre, C; Newton, RU; Briffa, T				Gunnell, Anthony S.; Einarsdottir, Kristjana; Galvao, Daniel A.; Joyce, Sarah; Tomlin, Stephania; Graham, Vicki; McIntyre, Caroline; Newton, Robert U.; Briffa, Tom			Lifestyle Factors, Medication Use and Risk for Ischaemic Heart Disease Hospitalisation: A Longitudinal Population-Based Study	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; BRITISH VEGETARIANS; PHYSICAL-ACTIVITY; 52 COUNTRIES; EPIC-OXFORD; ALL-CAUSE; MORTALITY; COHORT	Background: Lifestyle factors have been implicated in ischaemic heart disease (IHD) development however a limited number of longitudinal studies report results stratified by cardio-protective medication use. Purpose: This study investigated the influence of self-reported lifestyle factors on hospitalisation for IHD, stratified by blood pressure and/or lipid-lowering therapy. Methods: A population-based cohort of 14,890 participants aged 45+ years and IHD-free was identified from the Western Australian Health and wellbeing Surveillance System (2004 to 2010 inclusive), and linked with hospital administrative data. Adjusted hazard ratios for future IHD-hospitalisation were estimated using Cox regression. Results: Current smokers remained at higher risk for IHD-hospitalisation (adjusted HR=1.57; 95% CI: 1.22-2.03) after adjustment for medication use, as did those considered overweight (BMI=25-29 kg/m(2); adjusted HR=1.28; 95% CI: 1.04-1.57) or obese (BMI of >= 30kg/m(2); adjusted HR=1.31; 95% CI: 1.03-1.66). Weekly leisure-time physical activity (LTPA) of 150 minutes or more and daily intake of 3 or more fruit/vegetable servings reduced risk by 21% (95% CI: 0.64-0.97) and 26% (95% CI: 0.58-0.96) respectively. Benefits of LTPA appeared greatest in those on blood pressure lowering medication (adjusted HR=0.50; 95% CI: 0.31-0.82 [ for LTPA<150 mins], adjusted HR=0.64; 95% CI: 0.42-0.96 [ for LTPA>=150 mins]). IHD risk in smokers was most pronounced in those taking neither medication (adjusted HR=2.00; 95% CI: 1.41-2.83). Conclusion: This study confirms the contribution of previously reported lifestyle factors towards IHD hospitalisation, even after adjustment for antihypertensive and lipid-lowering medication use. Medication stratified results suggest that IHD risks related to LTPA and smoking may differ according to medication use.	[Gunnell, Anthony S.; Galvao, Daniel A.; McIntyre, Caroline; Newton, Robert U.] Edith Cowan Univ, Hlth & Wellness Inst, Joondalup, WA, Australia; [Gunnell, Anthony S.; Graham, Vicki] Edith Cowan Univ, Survey Res Ctr, Joondalup, WA, Australia; [Einarsdottir, Kristjana] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Subiaco, WA, Australia; [Joyce, Sarah; Tomlin, Stephania] Western Australian Dept Hlth, Epidemiol Branch, Perth, WA, Australia; [Briffa, Tom] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia	Edith Cowan University; Edith Cowan University; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia	Gunnell, AS (corresponding author), Edith Cowan Univ, Hlth & Wellness Inst, Joondalup, WA, Australia.	a.gunnell@ecu.edu.au	Newton, Robert Usher/A-3466-2009; Galvao, Daniel A/A-2744-2010; Einarsdóttir, Kristjana/E-8337-2011	Newton, Robert Usher/0000-0003-0302-6129; Galvao, Daniel A/0000-0002-8209-2281; Einarsdóttir, Kristjana/0000-0003-4931-7650; Gunnell, Anthony/0000-0002-5432-6685	Edith Cowan University Health and Wellness Institute	Edith Cowan University Health and Wellness Institute	Financial salary support was received from Edith Cowan University Health and Wellness Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS (Australian Bureau of Statistics), 2012, 303 0 CAUS DEATH ALL; AIHW, 2003, ACT AUSTR SURV GUID, P22; Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Australian Institute of Health andWelfare (AIHW), 2011, CARD DIS AUSTR FACTS; Briffa T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b36; Britt H, 2010, GEN PRACTICE SERIES, V27; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; Crowe FL, 2013, AM J CLIN NUTR, V97, P597, DOI 10.3945/ajcn.112.044073; Crowe FL, 2011, EUR HEART J, V32, P1235, DOI 10.1093/eurheartj/ehq465; Davies AR, 2007, EUR HEART J, V28, P2142, DOI 10.1093/eurheartj/ehm272; Davis P, 2011, HLTH WELLBEING ADULT; DTF Department of Treasury and Finance Western Australia, 2006, 200602 W AUSTR DTF D; Ge Z, 2012, J HYPERTENS, V30, P2307, DOI 10.1097/HJH.0b013e328359aa1f; He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Key TJ, 2009, AM J CLIN NUTR, V89, pS1613, DOI 10.3945/ajcn.2009.26736L; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Milionis HJ, 2001, ANGIOLOGY, V52, P575, DOI 10.1177/000331970105200901; Nelson MR, 2006, MED J AUSTRALIA, V185, P487, DOI 10.5694/j.1326-5377.2006.tb00662.x; NHF, 2008, GUID MAN HYPERTENSIO; Nordestgaard BG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001212; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Ruff CT, 2011, NAT REV CARDIOL, V8, P140, DOI 10.1038/nrcardio.2010.199; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Swift DL, 2013, CIRC J, V77, P281, DOI 10.1253/circj.CJ-13-0007; Turnbull F, 2003, LANCET, V362, P1527; WHO, 2004, GLOB DAT BOD MASS IN; WHO (World Health Organization), 2007, REV CARD DIS GUID AS; Wilt TJ, 2004, ARCH INTERN MED, V164, P1427, DOI 10.1001/archinte.164.13.1427; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77833	10.1371/journal.pone.0077833	http://dx.doi.org/10.1371/journal.pone.0077833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147088	Green Published, gold			2022-12-27	WOS:000326019400139
J	Jenabian, MA; Patel, M; Kema, I; Kanagaratham, C; Radzioch, D; Thebault, P; Lapointe, R; Tremblay, C; Gilmore, N; Ancuta, P; Routy, JP				Jenabian, Mohammad-Ali; Patel, Mital; Kema, Ido; Kanagaratham, Cynthia; Radzioch, Danuta; Thebault, Pamela; Lapointe, Rejean; Tremblay, Cecile; Gilmore, Norbert; Ancuta, Petronela; Routy, Jean-Pierre			Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers	PLOS ONE			English	Article							REGULATORY T-CELLS; SIMIAN IMMUNODEFICIENCY VIRUS; THERAPY REDUCES DEGRADATION; DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; IMMUNE DYSFUNCTION; IDO EXPRESSION; TGF-BETA	Tryptophan (Trp) catabolism into immunosuppressive kynurenine (Kyn) by indoleamine 2,3-dioxygenase (IDO) was previously linked to Th17/Treg differentiation and immune activation. Here we examined Trp catabolism and its impact on Th17/Treg balance in uninfected healthy subjects (HS) and a large cohort of HIV-infected patients with different clinical outcomes: ART-naive, Successfully Treated (ST), and elite controllers (EC). In ART-naive patients, increased IDO activity/expression, together with elevated levels of TNF-alpha and sCD40L, were associated with Treg expansion and an altered Th17/Treg balance. These alterations were normalized under ART. In contrast, Trp 2,3-dioxegenase (TDO) expression was dramatically lower in EC when compared to all other groups. Interestingly, EC displayed a distinctive Trp metabolism characterized by low Trp plasma levels similar to ART-na ve patients without accumulating immunosuppressive Kyn levels which was accompanied by a preserved Th17/Treg balance. These results suggest a distinctive Trp catabolism and Th17/Treg balance in HIV progressors and EC. Thus, IDO-induced immune-metabolism may be considered as a new inflammation-related marker for HIV-1 disease progression.	[Jenabian, Mohammad-Ali; Patel, Mital; Gilmore, Norbert; Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada; [Jenabian, Mohammad-Ali; Kanagaratham, Cynthia; Radzioch, Danuta; Gilmore, Norbert; Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; [Kema, Ido] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [Thebault, Pamela; Lapointe, Rejean] CHUM Res Ctr CRCHUM, Montreal, PQ, Canada; [Thebault, Pamela; Lapointe, Rejean; Tremblay, Cecile; Ancuta, Petronela] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Tremblay, Cecile; Ancuta, Petronela] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Routy, Jean-Pierre] McGill Univ, Ctr Hlth, Div Hematol, Montreal, PQ, Canada	McGill University; McGill University; University of Groningen; Universite de Montreal; Universite de Montreal; McGill University	Routy, JP (corresponding author), McGill Univ, Ctr Hlth, Chron Viral Illness Serv, Montreal, PQ, Canada.	jean-pierre.routy@mcgill.ca		Radzioch, Danuta/0000-0002-1601-2757	Canadian Institutes of Health Research [103230]; CANFAR; Fonds de la Recherche Quebec-Sante (FRQ-S): Therapie cellulaire and Reseau SIDA/Maladies infectieuses, Quebec, Canada; CIHR Canadian HIV Trials Network [CTN 247]; CANFAR/CTN Postdoctoral Fellowship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CANFAR; Fonds de la Recherche Quebec-Sante (FRQ-S): Therapie cellulaire and Reseau SIDA/Maladies infectieuses, Quebec, Canada; CIHR Canadian HIV Trials Network(Canadian Institutes of Health Research (CIHR)); CANFAR/CTN Postdoctoral Fellowship Award	This work was supported by Canadian Institutes of Health Research (grant# 103230), CANFAR and Fonds de la Recherche Quebec-Sante (FRQ-S): Therapie cellulaire and Reseau SIDA/Maladies infectieuses, Quebec, Canada. This study was also supported by the CIHR Canadian HIV Trials Network (CTN 247). Dr. M. A. Jenabian is supported by a CANFAR/CTN Postdoctoral Fellowship Award. Dr. J.P. Routy is a holder of Louis Lowenstein Chair in Hematology & Oncology, McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree MH, 2012, J REPROD IMMUNOL, V94, P131, DOI 10.1016/j.jri.2012.03.488; Ancuta P, 2010, CURR OPIN HIV AIDS, V5, P158, DOI 10.1097/COH.0b013e3283364733; Autran B, 2011, CURR OPIN HIV AIDS, V6, P181, DOI 10.1097/COH.0b013e328345a328; Baban B, 2009, J IMMUNOL, V183, P2475, DOI 10.4049/jimmunol.0900986; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bronte V, 2011, J CLIN INVEST, V121, P1247, DOI 10.1172/JCI57190; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Cumont MC, 2007, CELL DEATH DIFFER, V14, P1747, DOI 10.1038/sj.cdd.4402192; de Jong WHA, 2009, J CHROMATOGR B, V877, P603, DOI 10.1016/j.jchromb.2009.01.015; Doherty LF, 2011, AM J PHYSIOL-ENDOC M, V300, pE86, DOI 10.1152/ajpendo.00439.2010; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Godin-Ethier J, 2011, MOL IMMUNOL, V49, P253, DOI 10.1016/j.molimm.2011.08.017; Higashitani K, 2013, J GASTROENTEROL, V48, P660, DOI 10.1007/s00535-012-0667-z; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Huengsberg M, 1998, CLIN CHEM, V44, P858; Hunt P, 2012, CROI 2012; Hunt P, 2011, IMPACT TRYPTOPHAN CA; Jenabian MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003319; Jenabian MA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/908314; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kurtz J, 2009, BLOOD, V113, P3475, DOI 10.1182/blood-2008-01-133736; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042166; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Neurauter G, 2003, ADV EXP MED BIOL, V527, P317; Nixon DE, 2010, CURR OPIN HIV AIDS, V5, P498, DOI 10.1097/COH.0b013e32833ed6f4; Okulicz JF, 2011, CURR OPIN HIV AIDS, V6, P163, DOI 10.1097/COH.0b013e328344f35e; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Presicce P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042802; Puccetti P, 2008, BLOOD CELL MOL DIS, V40, P101, DOI 10.1016/j.bcmd.2007.06.026; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Smith DG, 2001, J NEUROVIROL, V7, P56; Soichot M, 2013, ALCOHOL ALCOHOLISM, V48, P415, DOI 10.1093/alcalc/agt028; Soliman H, 2010, CANCER J, V16, P354, DOI 10.1097/PPO.0b013e3181eb3343; TEFF KL, 1989, PHARMACOL BIOCHEM BE, V34, P829, DOI 10.1016/0091-3057(89)90282-7; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Thackray SJ, 2008, BIOCHEM SOC T, V36, P1120, DOI 10.1042/BST0361120; Theze J, 2011, CLIN IMMUNOL, V141, P15, DOI 10.1016/j.clim.2011.07.007; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; van Grevenynghe J, 2012, CYTOKINE GROWTH F R, V23, P215, DOI 10.1016/j.cytogfr.2012.05.008; Von Bubnoff D, 2011, J IMMUNOL, V186, P6701, DOI 10.4049/jimmunol.1003151; Wu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059749; Zangerle R, 2002, CLIN IMMUNOL, V104, P242, DOI 10.1006/clim.2002.5231; Zhu XF, 2010, J BIOL CHEM, V285, P21126, DOI 10.1074/jbc.M110.120485; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	56	73	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78146	10.1371/journal.pone.0078146	http://dx.doi.org/10.1371/journal.pone.0078146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147117	Green Published, gold			2022-12-27	WOS:000326019400150
J	Kimura, Y; Jacobs, LL; Flynn, LJ				Kimura, Yuri; Jacobs, Louis L.; Flynn, Lawrence J.			Lineage-Specific Responses of Tooth Shape in Murine Rodents (Murinae, Rodentia) to Late Miocene Dietary Change in the Siwaliks of Pakistan	PLOS ONE			English	Article							NEOGENE MAMMALIAN FAUNAS; CLIMATE-CHANGE; BODY-SIZE; COMPARATIVE PALEOECOLOGY; EVOLUTION; HYPSODONTY; MURIDAE; RECONSTRUCTION; SPECIATION; PALEOGENE	Past ecological responses of mammals to climate change are recognized in the fossil record by adaptive significance of morphological variations. To understand the role of dietary behavior on functional adaptations of dental morphology in rodent evolution, we examine evolutionary change of tooth shape in late Miocene Siwalik murine rodents, which experienced a dietary shift toward C-4 diets during late Miocene ecological change indicated by carbon isotopic evidence. Geometric morphometric analysis in the outline of upper first molars captures dichotomous lineages of Siwalik murines, in agreement with phylogenetic hypotheses of previous studies (two distinct clades: the Karnimata and Progonomys clades), and indicates lineage-specific functional responses to mechanical properties of their diets. Tooth shapes of the two clades are similar at their sympatric origin but deviate from each other with decreasing overlap through time. Shape change in the Karnimata clade is associated with greater efficiency of propalinal chewing for tough diets than in the Progonomys clade. Larger body mass in Karnimata may be related to exploitation of lower-quality food items, such as grasses, than in smaller-bodied Progonomys. The functional and ecophysiological aspects of Karnimata exploiting C-4 grasses are concordant with their isotopic dietary preference relative to Progonomys. Lineage-specific selection was differentially greater in Karnimata, and a faster rate of shape change toward derived Karnimata facilitated inclusion of C-4 grasses in the diet. Sympatric speciation in these clades is most plausibly explained by interspecific competition on resource utilization between the two, based on comparisons of our results with the carbon isotope data. Interspecific competition with Karnimata may have suppressed morphological innovation of the Progonomys clade. Pairwise analyses of morphological and carbon isotope data can uncover ecological causes of sympatric speciation and define functional adaptations of teeth to resources.	[Kimura, Yuri; Jacobs, Louis L.] So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA; [Kimura, Yuri; Flynn, Lawrence J.] Harvard Univ, Peabody Museum, Cambridge, MA 02138 USA; [Kimura, Yuri; Flynn, Lawrence J.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA	Southern Methodist University; Harvard University; Harvard University	Kimura, Y (corresponding author), So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA.	ykimura@mail.smu.edu		Kimura, Yuri/0000-0002-7621-9901; Jacobs, Louis/0000-0002-7735-3678	Society of Vertebrate Paleontology; Geological Society of America; ISEM at Southern Methodist University	Society of Vertebrate Paleontology; Geological Society of America; ISEM at Southern Methodist University	This work was supported by the Society of Vertebrate Paleontology (Mary R. Dawson Grant to Y.K.), the Geological Society of America (Graduate Student Research Grant to Y.K.), and ISEM (travel grants to Y.K.) at Southern Methodist University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2008, P NATL ACAD SCI USA, V105, P12382, DOI 10.1073/pnas.0805039105; Alroy J, 2000, PALEOBIOLOGY, V26, P259, DOI 10.1666/0094-8373(2000)26[259:GCCANA]2.0.CO;2; Badgley C, 2008, P NATL ACAD SCI USA, V105, P12145, DOI 10.1073/pnas.0805592105; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Behrensmeyer AK, 2007, GEOL SOC AM BULL, V119, P1486, DOI 10.1130/B26064.1; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BUTLER PM, 1980, FUNCTIONAL ASPECTS E, P249; Canty A, 2012, BOOT BOOTSTRAP R S P; Clauss M, 2003, OECOLOGIA, V136, P14, DOI 10.1007/s00442-003-1254-z; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Damuth J, 2011, BIOL REV, V86, P733, DOI 10.1111/j.1469-185X.2011.00176.x; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Figueirido B, 2012, P NATL ACAD SCI USA, V109, P722, DOI 10.1073/pnas.1110246108; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; Goswami A., 2010, PALEONTOL SOC PAP, V16, P213, DOI [10.1017/S1089332600001881, DOI 10.1017/S1089332600001881, 10.1017/s1089332600001881]; GUNNELL GF, 1995, PALAEOGEOGR PALAEOCL, V115, P265, DOI 10.1016/0031-0182(94)00115-O; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; JACOBS L L, 1989, Natural History Museum of Los Angeles County Science Series, P157; Jacobs L. L., 1977, PaleoBios, VNo. 25, P1; Jacobs L.L., 1978, MUS NO ARIZONA PRESS, V52, P1; Jacobs LL, 1990, NATO ASI SER, P573; Jacobs Louis L., 2005, P63; Jacobs Louis L., 1994, National Science Museum Monographs, V8, P149; Janis C.M., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P367; Janis Christine, 2008, V195, P21, DOI 10.1007/978-3-540-72422-3_2; Janis CM, 2002, PALAEOGEOGR PALAEOCL, V177, P183, DOI 10.1016/S0031-0182(01)00359-5; Jernvall J, 2002, NATURE, V417, P538, DOI 10.1038/417538a; JUSTICE KE, 1992, AM NAT, V139, P398, DOI 10.1086/285333; Kimura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069308; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Koch PL, 1998, ANNU REV EARTH PL SC, V26, P573, DOI 10.1146/annurev.earth.26.1.573; Lazzari V, 2008, PALEOBIOLOGY, V34, P46, DOI 10.1666/06052.1; Lazzari V, 2011, ARCH ORAL BIOL, V56, P194, DOI 10.1016/j.archoralbio.2010.09.011; Lazzari V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003607; Legendre P., 2012, NUMERICAL ECOLOGY; Lindsay E.H., 1988, Palaeovertebrata (Montpellier), V18, P95; Lucas PW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0923; Macholan M, 2006, J ZOOL, V270, P672, DOI 10.1111/j.1469-7998.2006.00156.x; Martin Suarez E., 1993, Scripta Geologica, V103, P65; Mendoza M, 2008, J ZOOL, V274, P134, DOI 10.1111/j.1469-7998.2007.00365.x; Mihlbachler Matthew C., 2006, Journal of Mammalian Evolution, V13, P11, DOI 10.1007/s10914-005-9001-3; Misonne X., 1969, Annales du Musee R de l'Afrique Central, VNo. 172, P1; Monteiro LR, 2003, J ZOOL, V261, P47, DOI 10.1017/S0952836903003893; MORGAN ME, 1995, PALAEOGEOGR PALAEOCL, V115, P287, DOI 10.1016/0031-0182(94)00116-P; Nowak R.M, 1999, WALKERS MAMMALS WORL, V6th; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Patnaik R, 2003, PALAEOGEOGR PALAEOCL, V197, P133, DOI 10.1016/S0031-0182(03)00390-0; R Development Core Team, 2012, LANG ENV STAT COMP; Renaud S, 2005, P ROY SOC B-BIOL SCI, V272, P609, DOI 10.1098/rspb.2004.2992; Renaud S, 2002, PALAEOGEOGR PALAEOCL, V184, P163, DOI 10.1016/S0031-0182(02)00255-9; Renaud S, 1996, PALEOBIOLOGY, V22, P255, DOI 10.1017/S0094837300016201; Renaud S, 1999, LETHAIA, V32, P61; Rohlf F. James, 1993, Monografias del Museo Nacional de Ciencias Naturales, V1993, P131; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Rohlf FJ, 2011, TPSREGR VERSION 1 38; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Taylor PJ, 2009, BIOL J LINN SOC, V96, P913, DOI 10.1111/j.1095-8312.2008.01153.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Van Dam Jan A., 1997, Geologica Ultraiectina, V156, P1; van de Weerd A, 1976, UTRECHT MICROPALEONT, V2; vanDam J, 1996, NATO ADV SCI INST SE, V284, P449; VANDERMEULEN AJ, 1992, PALAEOGEOGR PALAEOCL, V93, P227, DOI 10.1016/0031-0182(92)90099-Q; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Wessels W., 2009, GEOL ULTRAIECTINA, V307; Williams Susan H., 2001, Journal of Mammalian Evolution, V8, P207, DOI 10.1023/A:1012231829141; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X	75	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76070	10.1371/journal.pone.0076070	http://dx.doi.org/10.1371/journal.pone.0076070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155885	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300019
J	Short, MD; Abell, GCJ; Bodrossy, L; van den Akker, B				Short, Michael D.; Abell, Guy C. J.; Bodrossy, Levente; van den Akker, Ben			Application of a Novel Functional Gene Microarray to Probe the Functional Ecology of Ammonia Oxidation in Nitrifying Activated Sludge	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; 16S RIBOSOMAL-RNA; OXIDIZING ARCHAEA; DIVERSITY; BACTERIA; ABUNDANCE; NICHE; INDUSTRIAL; DYNAMICS; POPULATIONS	We report on the first study trialling a newly-developed, functional gene microarray (FGA) for characterising bacterial and archaeal ammonia oxidisers in activated sludge. Mixed liquor (ML) and media biofilm samples from a full-scale integrated fixed-film activated sludge (IFAS) plant were analysed with the FGA to profile the diversity and relative abundance of ammonia-oxidising archaea and bacteria (AOA and AOB respectively). FGA analyses of AOA and AOB communities revealed ubiquitous distribution of AOA across all samples - an important finding for these newly-discovered and poorly characterised organisms. Results also revealed striking differences in the functional ecology of attached versus suspended communities within the IFAS reactor. Quantitative assessment of AOB and AOA functional gene abundance revealed a dominance of AOB in the ML and approximately equal distribution of AOA and AOB in the media-attached biofilm. Subsequent correlations of functional gene abundance data with key water quality parameters suggested an important functional role for media-attached AOB in particular for IFAS reactor nitrification performance and indicate possible functional redundancy in some IFAS ammonia oxidiser communities. Results from this investigation demonstrate the capacity of the FGA to resolve subtle ecological shifts in key microbial communities in nitrifying activated sludge and indicate its value as a tool for better understanding the linkages between the ecology and performance of these engineered systems.	[Short, Michael D.; van den Akker, Ben] Univ New S Wales, Sch Civil & Environm Engn, UNSW Water Res Ctr, Kensington, NSW 2033, Australia; [Short, Michael D.] Univ S Australia, Sch Nat & Built Environm, SA Water Ctr Water Management & Reuse, Adelaide, SA 5001, Australia; [Abell, Guy C. J.; Bodrossy, Levente] CSIRO Marine & Atmospher Res & Wealth Oceans Natl, Hobart, Tas, Australia	University of New South Wales Sydney; University of South Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Abell, GCJ (corresponding author), CSIRO Marine & Atmospher Res & Wealth Oceans Natl, Hobart, Tas, Australia.	guy.abell@csiro.au	Abell, Guy C J/A-1767-2010; Bodrossy, Levente/B-8054-2009	Bodrossy, Levente/0000-0001-6940-452X; van den Akker, Ben/0000-0002-1937-6097; Short, Michael/0000-0003-2086-1855	University of New South Wales Faculty of Engineering Early Career Researcher Grant [PS24573]; Australian Research Council Discovery Project [DP1095722]	University of New South Wales Faculty of Engineering Early Career Researcher Grant; Australian Research Council Discovery Project(Australian Research Council)	This work was funded in part by a University of New South Wales Faculty of Engineering Early Career Researcher Grant PS24573 and Australian Research Council Discovery Project DP1095722. The authors thank Bret Robinson from the Australian Water Quality Centre for sampling support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051542; Abell GCJ, 2011, FEMS MICROBIOL ECOL, V75, P111, DOI 10.1111/j.1574-6941.2010.00988.x; Abell GCJ, 2010, ISME J, V4, P286, DOI 10.1038/ismej.2009.105; Adamczyk J, 2003, APPL ENVIRON MICROB, V69, P6875, DOI 10.1128/AEM.69.11.6875-6887.2003; [Anonymous], 2010, R LANG ENV STAT COMP; Bai YH, 2012, FEMS MICROBIOL ECOL, V80, P323, DOI 10.1111/j.1574-6941.2012.01296.x; Biller SJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00252; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; Fernandez-Guerra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047330; French E, 2012, APPL ENVIRON MICROB, V78, P5773, DOI 10.1128/AEM.00432-12; Gapes DJ, 2009, PROCESS BIOCHEM, V44, P43, DOI 10.1016/j.procbio.2008.09.004; Hatzenpichler R, 2012, APPL ENVIRON MICROB, V78, P7501, DOI 10.1128/AEM.01960-12; Jin T, 2010, APPL MICROBIOL BIOT, V87, P1167, DOI 10.1007/s00253-010-2595-2; Kelly JJ, 2005, WATER RES, V39, P3229, DOI 10.1016/j.watres.2005.05.044; Kim HS, 2011, WATER ENVIRON RES, V83, P627, DOI 10.2175/106143010X12851009156448; Li C, 2012, WATER SCI TECHNOL, V66, P2785, DOI 10.2166/wst.2012.421; Limpiyakorn T, 2013, APPL MICROBIOL BIOT, V97, P1425, DOI 10.1007/s00253-012-4650-7; Limpiyakorn T, 2011, BIORESOURCE TECHNOL, V102, P3694, DOI 10.1016/j.biortech.2010.11.085; Mahendran B, 2012, WATER RES, V46, P5085, DOI 10.1016/j.watres.2012.05.058; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Nicol GW, 2011, NITRIFICATION, P157; Oerther Daniel B., 2003, Reviews in Environmental Science and Bio/Technology, V2, P1, DOI 10.1023/B:RESB.0000022932.74077.5e; Ofiteru ID, 2010, P NATL ACAD SCI USA, V107, P15345, DOI 10.1073/pnas.1000604107; Okabe S, 2011, NITRIFICATION, P405; Onnis-Hayden A, 2011, WATER RES, V45, P3845, DOI 10.1016/j.watres.2011.04.039; Park HD, 2006, APPL ENVIRON MICROB, V72, P5643, DOI 10.1128/AEM.00402-06; Regmi P, 2011, WATER RES, V45, P6699, DOI 10.1016/j.watres.2011.10.009; Roh SW, 2010, TRENDS BIOTECHNOL, V28, P291, DOI 10.1016/j.tibtech.2010.03.001; Santoro AE, 2010, ENVIRON MICROBIOL, V12, P1989, DOI 10.1111/j.1462-2920.2010.02205.x; Satoh H, 2006, BIOTECHNOL BIOENG, V94, P762, DOI 10.1002/bit.20894; Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seviour R, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P1; Siripong S, 2006, ENVIRON MICROBIOL, V8, P1564, DOI 10.1111/j.1462-2920.2006.01047.x; Stralis-Pavese N, 2011, NAT PROTOC, V6, P609, DOI 10.1038/nprot.2010.191; Valentin-Vargas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042524; van den Akker B, 2010, WATER RES, V44, P2919, DOI 10.1016/j.watres.2010.02.016; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Winkler MKH, 2013, APPL MICROBIOL BIOT, V97, P7459, DOI 10.1007/s00253-012-4459-4; Xia S, 2008, ECOL ENG, V32, P256, DOI 10.1016/j.ecoleng.2007.11.013; Zhang T, 2009, J APPL MICROBIOL, V107, P970, DOI 10.1111/j.1365-2672.2009.04283.x; [No title captured]; [No title captured]	48	9	9	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77139	10.1371/journal.pone.0077139	http://dx.doi.org/10.1371/journal.pone.0077139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155925	gold, Green Published, Green Accepted			2022-12-27	WOS:000325887300059
J	Trinschek, B; Lussi, F; Haas, J; Wildemann, B; Zipp, F; Wiendl, H; Becker, C; Jonuleit, H				Trinschek, Bettina; Luessi, Felix; Haas, Juergen; Wildemann, Brigitte; Zipp, Frauke; Wiendl, Heinz; Becker, Christian; Jonuleit, Helmut			Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis	PLOS ONE			English	Article							AUTOIMMUNE ENCEPHALOMYELITIS; INTERLEUKIN-6 IL-6; CYTOKINE MILIEU; TGF-BETA; DISEASE; DIFFERENTIATION; INFLAMMATION; ACTIVATION; GENERATION; T(H)17	In multiple sclerosis (MS) autoaggressive T effector cells (Teff) are not efficiently controlled by regulatory T cells (Treg) but the underlying mechanisms are incompletely understood. Proinflammatory cytokines are key factors facilitating Teff activity in chronic inflammation. Here we investigated the influence of IL-6 on Treg sensitivity of Teff from therapy-naive MS patients with or without active disease. Compared to healthy volunteers and independent of disease course CD4(+) and especially CD8(+) MS-Teff were insensitive against functional active Treg from healthy controls. This unresponsiveness was caused by accelerated production of IL-6, elevated IL-6 receptor expression and phosphorylation of protein kinase B (PKB)/c-Akt in MS-Teff. In a positive feedback loop, IL-6 itself induced its accelerated synthesis and enhanced phosphorylation of PKB/c-Akt that finally mediated Treg resistance. Furthermore, accelerated IL-6 release especially by CD8+ Teff prevented control of surrounding Teff, described here as "bystander resistance". Blockade of IL-6 receptor signaling or direct inhibition of PKB/c-Akt phosphorylation restored Treg responsiveness of Teff and prevented bystander resistance. In Teff of healthy controls (HC) exogenous IL-6 also changed the kinetics of IL-6 production and induced Treg unresponsiveness. This modulation was only transient in Teff from healthy volunteers, whereas accelerated IL-6 production in MS-Teff maintained also in absence of IL-6. Hence, we showed that the kinetics of IL-6 production instead of elevated IL-6 levels defines the Teff responsiveness in early Treg-T cell communication in MS independent of their disease course and propose IL-6 and associated PKB/c-Akt activation as effective therapeutic targets for modulation of Teff activity in MS.	[Trinschek, Bettina; Becker, Christian; Jonuleit, Helmut] Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr, D-55122 Mainz, Germany; [Luessi, Felix; Zipp, Frauke] Johannes Gutenberg Univ Mainz, Dept Neurol, Univ Med Ctr, D-55122 Mainz, Germany; [Haas, Juergen; Wildemann, Brigitte] Heidelberg Univ, Div Mol Neuroimmunol, Dept Neurol, Heidelberg, Germany; [Wiendl, Heinz] Univ Munster, Dept Neurol Inflammatory Disorders Nervous Syst N, Munster, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; University of Munster	Jonuleit, H (corresponding author), Johannes Gutenberg Univ Mainz, Dept Dermatol, Univ Med Ctr, D-55122 Mainz, Germany.	helmut.jonuleit@unimedizin-mainz.de	Becker, Christian/GLS-0862-2022; Zipp, Frauke/C-9968-2015; Wiendl, Heinz/AAX-6041-2021; Jonuleit, Helmut/D-8059-2011	Becker, Christian/0000-0002-1716-7208; Zipp, Frauke/0000-0002-1231-1928; Jonuleit, Helmut/0000-0002-5672-9365; Wiendl, Heinz/0000-0003-4310-3432; Haas, Juergen/0000-0002-2314-7465	Transregio 128; Competence Network for Multiple Sclerosis; Federal Ministry of Education and Research (BMBF) [FKZ 01GI0917]	Transregio 128; Competence Network for Multiple Sclerosis; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Financial support was provided by the Transregio 128 (project A9 and B4) and by the Competence Network for Multiple Sclerosis, funded by the Federal Ministry of Education and Research (BMBF), FKZ 01GI0917 to H.J. and H. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; BARR TA, 2012, J EXP MED, P1465; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cobbold S, 1998, CURR OPIN IMMUNOL, V10, P518, DOI 10.1016/S0952-7915(98)80217-3; de Andres C, 2007, J NEUROIMMUNOL, V182, P204, DOI 10.1016/j.jneuroim.2006.09.012; Fujimoto M, 2011, J IMMUNOL, V186, P32, DOI 10.4049/jimmunol.0903314; Galassetti PR, 2006, AM J PHYSIOL-ENDOC M, V290, pE833, DOI 10.1152/ajpendo.00445.2005; Goodman WA, 2012, CRIT REV IMMUNOL, V32, P65, DOI 10.1615/CritRevImmunol.v32.i1.40; Haas J, 2005, EUR J IMMUNOL, V35, P3343, DOI 10.1002/eji.200526065; Hirano T, 1998, Int Rev Immunol, V16, P249; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Ifergan I, 2008, BRAIN, V131, P785, DOI 10.1093/brain/awm295; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Jin Y, 2009, CLIN IMMUNOL, V130, P272, DOI 10.1016/j.clim.2008.10.005; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; KIESEIER BC, 2012, ARCH NEUROL-CHICAGO, P1; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Korporal M, 2008, ARCH NEUROL-CHICAGO, V65, P1434, DOI 10.1001/archneur.65.11.1434; Kubach J, 2007, BLOOD, V110, P1550, DOI 10.1182/blood-2007-01-069229; Leech MD, 2013, J IMMUNOL, V190, P881, DOI 10.4049/jimmunol.1202925; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Linker RA, 2008, J NEUROIMMUNOL, V205, P64, DOI 10.1016/j.jneuroim.2008.09.007; Maimone D, 1997, J NEUROL SCI, V146, P59, DOI 10.1016/S0022-510X(96)00283-3; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mendel I, 1998, EUR J IMMUNOL, V28, P1727, DOI 10.1002/(SICI)1521-4141(199805)28:05<1727::AID-IMMU1727>3.0.CO;2-#; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Murakami M, 2011, J EXP MED, V208, P103, DOI 10.1084/jem.20100900; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Pierau M, 2009, J IMMUNOL, V183, P6124, DOI 10.4049/jimmunol.0900246; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Schneider A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004970; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; SWAAK AJ, 1988, SCAND J RHEUMATOL, V17, P469, DOI 10.3109/03009748809098809; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vladic A, 2002, CYTOKINE, V20, P86, DOI 10.1006/cyto.2002.1984; Wehrens EJ, 2011, BLOOD, V118, P3538, DOI 10.1182/blood-2010-12-328187; Wohlfert EA, 2004, J IMMUNOL, V173, P1059, DOI 10.4049/jimmunol.173.2.1059; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	50	36	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77634	10.1371/journal.pone.0077634	http://dx.doi.org/10.1371/journal.pone.0077634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155968	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300102
J	Wang, Y; Zhang, D; Shen, ZY; Feng, CH; Chen, J				Wang, Ying; Zhang, Di; Shen, Zhenyao; Feng, Chenghong; Chen, Jing			Revealing Sources and Distribution Changes of Dissolved Organic Matter (DOM) in Pore Water of Sediment from the Yangtze Estuary	PLOS ONE			English	Article							PARALLEL FACTOR-ANALYSIS; MOLECULAR CHARACTERIZATION; FLUORESCENCE; MARINE; RIVER; SEA; ENVIRONMENTS; TERRESTRIAL; POREWATER; SHELF	Dissolved organic matter (DOM) in sediment pore waters from Yangtze estuary of China based on abundance, UV absorbance, molecular weight distribution and fluorescence were investigated using a combination of various parameters of DOM as well as 3D fluorescence excitation emission matrix spectra (F-EEMS) with the parallel factor and principal component analysis (PARAFAC-PCA). The results indicated that DOM in pore water of Yangtze estuary was very variable which mainly composed of low aromaticity and molecular weight materials. Three humic-like substances (C1, C2, C4) and one protein-like substance (C3) were identified by PARAFAC model. C1, C2 and C4 exhibited same trends and were very similar. The separation of samples on both axes of the PCA showed the difference in DOM properties. C1, C2 and C4 concurrently showed higher positive factor 1 loadings, while C3 showed highly positive factor 2 loadings. The PCA analysis showed a combination contribution of microbial DOM signal and terrestrial DOM signal in the Yangtze estuary. Higher and more variable DOM abundance, aromaticity and molecular weight of surface sediment pore water DOM can be found in the southern nearshore than the other regions primarily due to the influence of frequent and intensive human activities and tributaries inflow in this area. The DOM abundance, aromaticity, molecular weight and fluorescence intensity in core of different depth were relative constant and increased gradually with depth. DOM in core was mainly composed of humic-like material, which was due to higher release of the sedimentary organic material into the porewater during early diagenesis.	[Wang, Ying; Zhang, Di; Shen, Zhenyao; Feng, Chenghong] Beijing Normal Univ, Sch Environm, Minist Educ, Key Lab Water & Sediment Sci, Beijing 100875, Peoples R China; [Wang, Ying; Shen, Zhenyao; Chen, Jing] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Wang, Y (corresponding author), Beijing Normal Univ, Sch Environm, Minist Educ, Key Lab Water & Sediment Sci, Beijing 100875, Peoples R China.	yingwang@bnu.edu.cn	Chen, Lei/AAD-3766-2019	Chen, Lei/0000-0001-8415-3896; Feng, Chenghong/0000-0002-2130-8851; Shen, Zhenyao/0000-0002-6620-1943	National Basic Research Program of China (973 Project) [2010CB429003]; National Natural Science Foundation of China [21177013]	National Basic Research Program of China (973 Project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Project, Grant No. 2010CB429003) and National Natural Science Foundation of China (Grant No. 21177013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baghoth SA, 2011, WATER RES, V45, P797, DOI 10.1016/j.watres.2010.09.005; Bai JH, 2011, ECOL MODEL, V222, P301, DOI 10.1016/j.ecolmodel.2009.12.002; Berto D, 2010, MAR ENVIRON RES, V70, P73, DOI 10.1016/j.marenvres.2010.03.005; Burdige DJ, 2004, MAR CHEM, V89, P289, DOI 10.1016/j.marchem.2004.02.015; CHIN YP, 1994, ENVIRON SCI TECHNOL, V28, P1853, DOI 10.1021/es00060a015; Coble PG, 1996, MAR CHEM, V51, P325, DOI 10.1016/0304-4203(95)00062-3; Coble PG, 1998, DEEP-SEA RES PT II, V45, P2195, DOI 10.1016/S0967-0645(98)00068-X; Fu PQ, 2007, APPL GEOCHEM, V22, P1668, DOI 10.1016/j.apgeochem.2007.03.041; Gao L, 2011, ENVIRON EARTH SCI, V64, P643, DOI 10.1007/s12665-010-0885-8; Jaffe R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000683; Kawasaki N, 2011, WATER RES, V45, P6240, DOI 10.1016/j.watres.2011.09.021; Lepane V, 2010, PROCEDIA CHEM, V2, P101, DOI 10.1016/j.proche.2009.12.016; Li BH, 2012, MAR POLLUT BULL, V64, P636, DOI 10.1016/j.marpolbul.2011.12.005; Li X, 2013, ENVIRON EARTH SCI, V69, P1537, DOI 10.1007/s12665-012-1988-1; Murphy KR, 2008, MAR CHEM, V108, P40, DOI 10.1016/j.marchem.2007.10.003; O'Loughlin EJ, 2004, BIOGEOCHEMISTRY, V71, P371, DOI 10.1007/s10533-004-0373-x; Para J, 2013, BIOGEOSCIENCES, V10, P2761, DOI 10.5194/bg-10-2761-2013; Qiong L, 2011, PROC SPIE, V8175, DOI 10.1117/12.897865; Rosario-Ortiz FL, 2007, WATER RES, V41, P4115, DOI 10.1016/j.watres.2007.05.045; Sadro S, 2012, ECOSYSTEMS, V15, P363, DOI 10.1007/s10021-011-9515-x; Schmidt F, 2009, GEOCHIM COSMOCHIM AC, V73, P3337, DOI 10.1016/j.gca.2009.03.008; Smith EM, 2005, AQUAT MICROB ECOL, V40, P37, DOI 10.3354/ame040037; Stedmon CA, 2008, LIMNOL OCEANOGR-METH, V6, P572, DOI 10.4319/lom.2008.6.572; Syvitski JPM, 2011, PHILOS T R SOC A, V369, P957, DOI 10.1098/rsta.2010.0329; Tremblay LB, 2007, MAR CHEM, V105, P15, DOI 10.1016/j.marchem.2006.12.015; Wang K, 2013, INT BIODETER BIODEGR, V85, P617, DOI 10.1016/j.ibiod.2013.03.033; Wang Y, 2012, ENVIRON SCI POLLUT R, V19, P4148, DOI 10.1007/s11356-012-0952-7; Williams CJ, 2010, LIMNOL OCEANOGR, V55, P1159, DOI 10.4319/lo.2010.55.3.1159; Xue S, 2012, FRONT ENV SCI ENG, V6, P784, DOI 10.1007/s11783-012-0436-5; Yamashita Y, 2008, LIMNOL OCEANOGR, V53, P1900, DOI 10.4319/lo.2008.53.5.1900; Yamashita Y, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000987; Yang F., 2007, J ENV SCI SUSTAINABL, V1, P55; Yang Z, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR003970; Yao X, 2011, CHEMOSPHERE, V82, P145, DOI 10.1016/j.chemosphere.2010.10.049; Zeng H, 2006, SCI TOTAL ENVIRON, V367, P999, DOI 10.1016/j.scitotenv.2006.03.001; Zhang E.F., 2012, HYDROL EARTH SYST SC, V9, P2213, DOI [10.5194/hessd-9-2213-2012, DOI 10.5194/HESSD-9-2213-2012]; Zhang YL, 2009, WATER RES, V43, P4685, DOI 10.1016/j.watres.2009.07.024; Ziegelgruber KL, 2013, LIMNOL OCEANOGR, V58, P1136, DOI 10.4319/lo.2013.58.3.1136	38	37	37	8	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76633	10.1371/journal.pone.0076633	http://dx.doi.org/10.1371/journal.pone.0076633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155904	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300038
J	Zheng, YD; Blair, D; Bradley, JE				Zheng, Yadong; Blair, David; Bradley, Janette E.			Phyletic Distribution of Fatty Acid-Binding Protein Genes	PLOS ONE			English	Article							SPLICEOSOMAL INTRONS; ALLERGEN; EVOLUTION; EXPRESSION; GENOME	Fatty acid-binding proteins (FABPs) are a family of fatty acid-binding small proteins essential for lipid trafficking, energy storage and gene regulation. Although they have 20 to 70% amino acid sequence identity, these proteins share a conserved tertiary structure comprised of ten beta sheets and two alpha helixes. Availability of the complete genomes of 34 invertebrates, together with transcriptomes and ESTs, allowed us to systematically investigate the gene structure and alternative splicing of FABP genes over a wide range of phyla. Only in genomes of two cnidarian species could FABP genes not be identified. The genomic loci for FABP genes were diverse and their genomic structure varied. In particular, the intronless FABP genes, in most of which the key residues involved in fatty acid binding varied, were common in five phyla. Interestingly, several species including one trematode, one nematode and four arthropods generated FABP mRNA variants via alternative splicing. These results demonstrate that both gene duplication and post-transcriptional modifications are used to generate diverse FABPs in species studied.	[Zheng, Yadong; Bradley, Janette E.] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Zheng, Yadong] CAAS, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Blair, David] James Cook Univ, Townsville, Qld 4811, Australia	University of Nottingham; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; James Cook University	Bradley, JE (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	jan.bradley@nottingham.ac.uk	YD, Zh/HGA-5541-2022; Blair, David/O-2786-2019	YD, Zh/0000-0001-6795-9978; Blair, David/0000-0002-4658-3251; Bradley, Janette/0000-0003-3973-7977	University of Nottingham Scholarship (UK); Lanzhou Veterinary Research Institute, China	University of Nottingham Scholarship (UK); Lanzhou Veterinary Research Institute, China	Y.Z. is an awardee of an Overseas Research Students Awards (ORS), the University of Nottingham Scholarship (UK) and of Stipend from Lanzhou Veterinary Research Institute, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulleiro MJ, 2007, BIOL REPROD, V77, P504, DOI 10.1095/biolreprod.107.061598; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; Bonne A, 2003, MOL BIOL REP, V30, P173, DOI 10.1023/A:1024968606162; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; Esteves A, 2003, BBA-MOL CELL BIOL L, V1631, P26, DOI 10.1016/S1388-1981(02)00321-9; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Huang LS, 2012, MOL CELL BIOCHEM, V363, P367, DOI 10.1007/s11010-011-1189-3; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Jakobsson E, 2003, BBA-PROTEINS PROTEOM, V1649, P40, DOI 10.1016/S1570-9639(03)00151-1; Jeong KY, 2005, CLIN DIAGN LAB IMMUN, V12, P581, DOI 10.1128/CDLI.12.5.581-585.2005; Kennedy MW, 2000, BBA-PROTEIN STRUCT M, V1476, P149, DOI 10.1016/S0167-4838(99)00249-6; Kim SH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001868; Lek M, 2010, MOL BIOL EVOL, V27, P773, DOI 10.1093/molbev/msp268; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Orton SM, 2007, J PARASITOL, V93, P1378, DOI 10.1645/GE-1217.1; Pettitt J, 2010, BIOCHEM SOC T, V38, P1125, DOI 10.1042/BST0381125; Prinsen CFM, 1997, GENE, V193, P245, DOI 10.1016/S0378-1119(97)00129-7; Puerta L, 1999, INT ARCH ALLERGY IMM, V119, P181, DOI 10.1159/000024193; Rogozin IB, 2003, CURR BIOL, V13, P1512, DOI 10.1016/S0960-9822(03)00558-X; ROSS LH, 1995, J BIOL CHEM, V270, P22066, DOI 10.1074/jbc.270.37.22066; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; SPENCE HJ, 1993, MOL BIOCHEM PARASIT, V57, P339, DOI 10.1016/0166-6851(93)90210-O; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TREUNER M, 1994, GENE, V147, P237, DOI 10.1016/0378-1119(94)90073-6; Venkatachalam AB, 2009, FEBS J, V276, P6787, DOI 10.1111/j.1742-4658.2009.07393.x	34	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77636	10.1371/journal.pone.0077636	http://dx.doi.org/10.1371/journal.pone.0077636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155969	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000325887300103
J	Dragowska, WH; Weppler, SA; Wang, JC; Wong, LY; Kapanen, AI; Rawji, JS; Warburton, C; Qadir, MA; Donohue, E; Roberge, M; Gorski, SM; Gelmon, KA; Bally, MB				Dragowska, Wieslawa H.; Weppler, Sherry A.; Wang, Jun Chih; Wong, Ling Yan; Kapanen, Anita I.; Rawji, Jenna S.; Warburton, Corinna; Qadir, Mohammed A.; Donohue, Elizabeth; Roberge, Michel; Gorski, Sharon M.; Gelmon, Karen A.; Bally, Marcel B.			Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; LAPATINIB RESISTANCE; INDUCED CYTOTOXICITY; CELLS; TRASTUZUMAB; ZD1839; EXPRESSION; APOPTOSIS; IRESSA	Gefitinib (Iressa (R), ZD1839) is a small molecule inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. We report on an early cellular response to gefitinib that involves induction of functional autophagic flux in phenotypically diverse breast cancer cells that were sensitive (BT474 and SKBR3) or insensitive (MCF7-GFPLC3 and JIMT-1) to gefitinib. Our data show that elevation of autophagy in gefitinib-treated breast cancer cells correlated with downregulation of AKT and ERK1/2 signaling early in the course of treatment. Inhibition of autophagosome formation by BECLIN-1 or ATG7 siRNA in combination with gefitinib reduced the abundance of autophagic organelles and sensitized SKBR3 but not MCF7-GFPLC3 cells to cell death. However, inhibition of the late stage of gefitinib-induced autophagy with hydroxychloroquine (HCQ) or bafilomycin A1 significantly increased (p<0.05) cell death in gefitinib-sensitive SKBR3 and BT474 cells, as well as in gefitinib-insensitive JIMT-1 and MCF7-GFPLC3 cells, relative to the effects observed with the respective single agents. Treatment with the combination of gefitinib and HCQ was more effective (p<0.05) in delaying tumor growth than either monotherapy (p>0.05), when compared to vehicle-treated controls. Our results also show that elevated autophagosome content following short-term treatment with gefitinib is a reversible response that ceases upon removal of the drug. In aggregate, these data demonstrate that elevated autophagic flux is an early response to gefitinib and that targeting EGFR and autophagy should be considered when developing new therapeutic strategies for EGFR expressing breast cancers.	[Dragowska, Wieslawa H.; Weppler, Sherry A.; Wang, Jun Chih; Wong, Ling Yan; Kapanen, Anita I.; Rawji, Jenna S.; Warburton, Corinna; Qadir, Mohammed A.; Bally, Marcel B.] British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada; [Donohue, Elizabeth; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada; [Roberge, Michel; Bally, Marcel B.] Ctr Drug Res & Dev, Vancouver, BC, Canada; [Gorski, Sharon M.] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Gorski, Sharon M.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Gelmon, Karen A.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Gelmon, Karen A.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Bally, Marcel B.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Bally, Marcel B.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	British Columbia Cancer Agency; University of British Columbia; British Columbia Cancer Agency; Simon Fraser University; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Dragowska, WH (corresponding author), British Columbia Canc Agcy, Dept Expt Therapeut, Vancouver, BC V5Z 4E6, Canada.	vdragows@bccrc.ca	Gorski, Sharon M/E-9375-2012	Gorski, Sharon M/0000-0002-3821-8289; Bally, Marcel/0000-0002-1994-4787	Canadian Institutes of Health Research [MOP 106638, MOP 78882, GPG 102167]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research grant# MOP 106638, MOP 78882 and GPG 102167. High content screening equipment was obtained with the support of an equipment grant from the Canadian Institutes of Health Research. TEM imaging was performed with equipment obtained through the Canadian Foundation for Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Anido J, 2003, CLIN CANCER RES, V9, P1274; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bernardini M, 2005, NEOPLASIA, V7, P603, DOI 10.1593/neo.04760; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Brehmer D, 2005, CANCER RES, V65, P379; Bristol ML, 2013, J PHARMACOL EXP THER, V344, P544, DOI 10.1124/jpet.112.199802; Chen SN, 2011, MED HYPOTHESES, V77, P206, DOI 10.1016/j.mehy.2011.04.013; Cohen MH, 2004, CLIN CANCER RES, V10, P1212, DOI 10.1158/1078-0432.CCR-03-0564; Cooper RG, 2008, INDIAN J MED RES, V127, P305; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055; Dragowska WH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-420; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Gelmon Karen A, 2004, Clin Breast Cancer, V5, P52, DOI 10.3816/CBC.2004.n.010; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; Harhaji-Trajkovic L, 2009, J CELL MOL MED, V13, P3644, DOI 10.1111/j.1582-4934.2009.00663.x; Hu YL, 2012, CANCER RES, V72, P4294, DOI 10.1158/0008-5472.CAN-12-1076; Jahanzeb M, 2008, CLIN BREAST CANCER, V8, P324, DOI 10.3816/CBC.2008.n.037; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kaiser SE, 2012, NAT STRUCT MOL BIOL, V19, P1242, DOI 10.1038/nsmb.2415; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koninki K, 2010, CANCER LETT, V294, P211, DOI 10.1016/j.canlet.2010.02.002; Lamoureux F, 2013, CLIN CANCER RES, V19, P833, DOI 10.1158/1078-0432.CCR-12-3114; Li XQ, 2010, AUTOPHAGY, V6, P1066, DOI 10.4161/auto.6.8.13366; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Ma XH, 2011, CLIN CANCER RES, V17, P3478, DOI 10.1158/1078-0432.CCR-10-2372; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Maycotte P, 2011, CANCER BIOL THER, V11, P127, DOI 10.4161/cbt.11.2.14627; McKillop D, 2005, MOL CANCER THER, V4, P641, DOI 10.1158/1535-7163.MCT-04-0329; Mirzoeva OK, 2011, J MOL MED, V89, P877, DOI 10.1007/s00109-011-0774-y; Moasser MM, 2001, CANCER RES, V61, P7184; Moulder SL, 2001, CANCER RES, V61, P8887; Nahta R, 2007, ONCOGENE, V26, P3637, DOI 10.1038/sj.onc.1210379; Prasad M, 2008, GENE CHROMOSOME CANC, V47, P427, DOI 10.1002/gcc.20547; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Rimawi MF, 2010, CANCER-AM CANCER SOC, V116, P1234, DOI 10.1002/cncr.24816; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; SAITO H, 1993, CANCER RES, V53, P3382; Saxena R, 2012, MED RES REV, V32, P166, DOI 10.1002/med.20209; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Sun WL, 2011, AUTOPHAGY, V7, P1035, DOI 10.4161/auto.7.9.16521; Swaisland HC, 2005, CLIN PHARMACOKINET, V44, P1165, DOI 10.2165/00003088-200544110-00004; Swampillai AL, 2012, CLIN ONCOL-UK, V24, P387, DOI 10.1016/j.clon.2011.09.010; Takeuchi H, 2004, BRIT J CANCER, V90, P1069, DOI 10.1038/sj.bjc.6601605; Tanner M, 2004, MOL CANCER THER, V3, P1585; Tevaarwerk AJ, 2009, CLIN THER, V31, P2332, DOI 10.1016/j.clinthera.2009.11.029; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Warburton C, 2004, CLIN CANCER RES, V10, P2512, DOI 10.1158/1078-0432.CCR-03-0244; Weigelt B, 2011, ONCOGENE; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wirawan E, 2012, AUTOPHAGY, V8, P6, DOI 10.4161/auto.8.1.16645; Wiseman SM, 2005, CANCER-AM CANCER SOC, V103, P1770, DOI 10.1002/cncr.20970; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhang L, 2004, P NATL ACAD SCI USA, V101, P10296, DOI 10.1073/pnas.0403175101; Zou YY, 2013, J THORAC ONCOL, V8, P693, DOI 10.1097/JTO.0b013e31828c7210	65	74	80	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76503	10.1371/journal.pone.0076503	http://dx.doi.org/10.1371/journal.pone.0076503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146879	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400062
J	Nordberg, V; Peralta, AQ; Galindo, T; Turlej-Rogacka, A; Iversen, A; Giske, CG; Naver, L				Nordberg, Viveka; Peralta, Arturo Quizhpe; Galindo, Telmo; Turlej-Rogacka, Agata; Iversen, Aina; Giske, Christian G.; Naver, Lars			High Proportion of Intestinal Colonization with Successful Epidemic Clones of ESBL-Producing Enterobacteriaceae in a Neonatal Intensive Care Unit in Ecuador	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE ACQUISITION; RISK-FACTORS; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; OUTBREAK; NEWBORNS; INFANTS	Background and Aims: Neonatal infections caused by Extended-spectrum beta-lactamase (ESBL)-producing bacteria are associated with increased morbidity and mortality. No data are available on neonatal colonization with ESBL-producing bacteria in Ecuador. The aim of this study was to determine the proportion of intestinal colonization with ESBL-producing Enterobacteriaceae, their resistance pattern and risk factors of colonization in a neonatal intensive care unit in Ecuador. Methods: During a three month period, stool specimens were collected every two weeks from hospitalized neonates. Species identification and susceptibility testing were performed with Vitek2, epidemiologic typing with automated repetitive PCR. Associations between groups were analyzed using the Pearson chi(2) test and Fisher exact test. A forward step logistic regression model identified significant predictors for colonization. Results: Fifty-six percent of the neonates were colonized with ESBL-producing Enterobacteriaceae. Length of stay longer than 20 days and enteral feeding with a combination of breastfeeding and formula feeding were significantly associated with ESBL-colonization. The strains found were E. coli (EC, 89%) and K. pneumoniae (KP, 11%) and epidemiological typing divided these isolates in two major clusters. All EC and KP had bla(CTX-M) group 1 except for a unique EC isolate that had bla(CTX-M) group 9. Multi-locus sequence typing performed on the K. pneumoniae strains showed that the strains belonged to ST855 and ST897. The two detected STs belong to two different epidemic clonal complexes (CC), CC11 and CC14, which previously have been associated with dissemination of carbapenemases. None of the E. coli strains belonged to the epidemic ST 131 clone. Conclusions: More than half of the neonates were colonized with ESBL-producing Enterobacteriaceae where the main risk factor for colonization was length of hospital stay. Two of the isolated clones were epidemic and known to disseminate carbapenemases. The results underline the necessity for improved surveillance and infection control in this context.	[Nordberg, Viveka; Naver, Lars] Karolinska Univ Hosp, Dept Neonatol, Stockholm, Sweden; [Nordberg, Viveka; Naver, Lars] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Peralta, Arturo Quizhpe; Galindo, Telmo] Univ Cuenca, Fac Med Sci, Dept Microbiol, Cuenca, Ecuador; [Peralta, Arturo Quizhpe] Radboud Univ Nijmegen, Med Ctr, Nijmegen Int Ctr Hlth Syst Res & Educ, NL-6525 ED Nijmegen, Netherlands; [Turlej-Rogacka, Agata; Iversen, Aina; Giske, Christian G.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Turlej-Rogacka, Agata; Iversen, Aina; Giske, Christian G.] Karolinska Inst, Dept Clin Microbiol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Universidad de Cuenca; Radboud University Nijmegen; Karolinska Institutet; Karolinska Institutet	Nordberg, V (corresponding author), Karolinska Univ Hosp, Dept Neonatol, Stockholm, Sweden.	Viveka.yao-nordberg@karolinska.se	Navér, Lars/E-5085-2013	Naver, Lars/0000-0001-6027-0211	ReAct, Uppsala; research foundation Allmanna BB, Sweden	ReAct, Uppsala; research foundation Allmanna BB, Sweden	This work was supported in part by a grant from ReAct, Uppsala, http://www.reactgroup.org/ and research foundation Allmanna BB, Sweden, www.allmannabb.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya E, 2010, J CHEMOTHERAPY, V22, P25; Bagattini M, 2006, J ANTIMICROB CHEMOTH, V57, P979, DOI 10.1093/jac/dkl077; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Boo NY, 2005, J HOSP INFECT, V61, P68, DOI 10.1016/j.jhin.2005.01.025; Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004; Cassettari VC, 2009, J HOSP INFECT, V71, P340, DOI 10.1016/j.jhin.2008.11.019; Crivaro V, 2007, J HOSP INFECT, V67, P135, DOI 10.1016/j.jhin.2007.07.026; Desimoni MC, 2004, ENFERM INFEC MICR CL, V22, P507, DOI 10.1157/13067617; Duman M, 2005, PEDIATR INT, V47, P267, DOI 10.1111/j.1442-200x.2005.02064.x; Perez JAE, 2013, ANTIMICROB AGENTS CH, V57, P1957, DOI 10.1128/AAC.01447-12; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; Harbarth S, 1999, INFECT CONT HOSP EP, V20, P598, DOI 10.1086/501677; Kaufman D, 2004, CLIN MICROBIOL REV, V17, P638, DOI 10.1128/CMR.17.3.638-680.2004; Lautenbach E, 2005, ANTIMICROB AGENTS CH, V49, P798, DOI 10.1128/AAC.49.2.798-800.2005; Mammina C, 2007, AM J INFECT CONTROL, V35, P222, DOI 10.1016/j.ajic.2006.04.210; Murki S, 2010, INDIAN PEDIAT; Nair V, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/874726; Pessoa-Silva CL, 2003, J HOSP INFECT, V53, P198, DOI 10.1053/jhin.2002.1373; Rettedal S, 2013, SCAND J INFECT DIS, V45, P54, DOI 10.3109/00365548.2012.713116; Shakil S, 2010, J TROP PEDIATRICS, V56, P90, DOI 10.1093/tropej/fmp060; Valverde A, 2004, J CLIN MICROBIOL, V42, P4769, DOI 10.1128/JCM.42.10.4769-4775.2004; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; World Health Organisation, 2002, PREV NOS INF PRACT G; Zingg W, 2008, CURR OPIN INFECT DIS, V21, P228, DOI 10.1097/QCO.0b013e3282fcec5f	24	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76597	10.1371/journal.pone.0076597	http://dx.doi.org/10.1371/journal.pone.0076597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146896	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400066
J	Shan, Z; Deng, GY; Li, JP; Li, YY; Zhang, YX; Zhao, QH				Shan, Zhi; Deng, Guoying; Li, Jipeng; Li, Yangyang; Zhang, Yongxing; Zhao, Qinghua			Correlational Analysis of neck/shoulder Pain and Low Back Pain with the Use of Digital Products, Physical Activity and Psychological Status among Adolescents in Shanghai	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COMPUTER OFFICE WORKERS; RISK-FACTORS; SHOULDER PAIN; NECK PAIN; MUSCULOSKELETAL PAIN; CHINESE ADOLESCENTS; YOUNG-ADULTS; PREVALENCE; SYMPTOMS	Purpose: This study investigates the neck/shoulder pain (NSP) and low back pain (LBP) among current high school students in Shanghai and explores the relationship between these pains and their possible influences, including digital products, physical activity, and psychological status. Methods: An anonymous self-assessment was administered to 3,600 students across 30 high schools in Shanghai. This questionnaire examined the prevalence of NSP and LBP and the level of physical activity as well as the use of mobile phones, personal computers (PC) and tablet computers (Tablet). The CES-D (Center for Epidemiological Studies Depression) scale was also included in the survey. The survey data were analyzed using the chi-square test, univariate logistic analyses and a multivariate logistic regression model. Results: Three thousand sixteen valid questionnaires were received including 1,460 (48.41%) from male respondents and 1,556 (51.59%) from female respondents. The high school students in this study showed NSP and LBP rates of 40.8% and 33.1%, respectively, and the prevalence of both influenced by the student's grade, use of digital products, and mental status; these factors affected the rates of NSP and LBP to varying degrees. The multivariate logistic regression analysis revealed that Gender, grade, soreness after exercise, PC using habits, tablet use, sitting time after school and academic stress entered the final model of NSP, while the final model of LBP consisted of gender, grade, soreness after exercise, PC using habits, mobile phone use, sitting time after school, academic stress and CES-D score. Conclusions: High school students in Shanghai showed high prevalence of NSP and LBP that were closely related to multiple factors. Appropriate interventions should be implemented to reduce the occurrences of NSP and LBP.	[Shan, Zhi; Deng, Guoying; Li, Jipeng; Li, Yangyang; Zhang, Yongxing; Zhao, Qinghua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthopaed Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhao, QH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	sawboneszhao2012@163.com	Deng, Guoying/L-4150-2019	Deng, Guoying/0000-0002-1693-8453	Class Tutor Program of Shanghai Jiao Tong University, School of Medicine [2012006]	Class Tutor Program of Shanghai Jiao Tong University, School of Medicine	This work was financially supported by the Class Tutor Program of Shanghai Jiao Tong University, School of Medicine in contract of 2012006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alricsson M, 2006, THESCIENTIFICWORLDJO, V6, P816, DOI 10.1100/tsw.2006.164; Astfalck RG, 2010, MANUAL THER, V15, P240, DOI 10.1016/j.math.2009.12.007; Auvinen JP, 2010, EUR SPINE J, V19, P641, DOI 10.1007/s00586-009-1215-2; Cagnie B, 2007, EUR SPINE J, V16, P679, DOI 10.1007/s00586-006-0269-7; Chiu TTW, 2002, CLIN REHABIL, V16, P772, DOI 10.1191/0269215502cr552oa; Cho CY, 2008, J MANIP PHYSIOL THER, V31, P224, DOI 10.1016/j.jmpt.2008.02.003; Diepenmaat ACM, 2006, PEDIATRICS, V117, P412, DOI 10.1542/peds.2004-2766; Eccleston C, 2003, ARCH DIS CHILD, V88, P881, DOI 10.1136/adc.88.10.881; El-Metwally A, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-46; Eltayeb S, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-68; Eltayeb SM, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-33; Faucett J, 1996, AAOHN J, V44, P33; Fejer R, 2006, RHEUMATOLOGY, V45, P589, DOI 10.1093/rheumatology/kei224; Fritz JM, 2010, J ATHL TRAINING, V45, P61, DOI 10.4085/1062-6050-45.1.61; Hakala P, 2002, BRIT MED J, V325, P743, DOI 10.1136/bmj.325.7367.743; Hakala PT, 2006, EUR J PUBLIC HEALTH, V16, P536, DOI 10.1093/eurpub/ckl025; Harma AM, 2002, SCAND J PRIM HEALTH, V20, P92, DOI 10.1080/713796398; Harreby M, 1999, EUR SPINE J, V8, P444, DOI 10.1007/s005860050203; Jacobs Karen, 2002, Work, V18, P221; Kwon S, 2013, ETHNIC DIS, V23, P129; Mikkelsson M, 1997, PEDIATRICS, V100, P220, DOI 10.1542/peds.100.2.220; Miranda H, 2001, OCCUP ENVIRON MED, V58, P528, DOI 10.1136/oem.58.8.528; Nakamura M, 2011, J ORTHOP SCI, V16, P424, DOI 10.1007/s00776-011-0102-y; Palmer KT, 2000, BRIT MED J, V320, P1577, DOI 10.1136/bmj.320.7249.1577; Pollock CM, 2011, MANUAL THER, V16, P246, DOI 10.1016/j.math.2010.10.010; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Rempel DM, 2006, OCCUP ENVIRON MED, V63, P300, DOI 10.1136/oem.2005.022285; Roh YH, 2012, CLIN ORTHOP RELAT R, V470, P3470, DOI 10.1007/s11999-012-2503-4; Roh YH, 2012, ARCH ORTHOP TRAUM SU, V132, P1251, DOI 10.1007/s00402-012-1545-0; Siivola SM, 2004, SPINE, V29, P1662, DOI 10.1097/01.BRS.0000133644.29390.43; Smith L, 2009, CEPHALALGIA, V29, P250, DOI 10.1111/j.1468-2982.2008.01714.x; SPECKENS AEM, 1995, BRIT MED J, V311, P1328, DOI 10.1136/bmj.311.7016.1328; Torgen M, 2002, EUR J APPL PHYSIOL, V86, P418, DOI 10.1007/s00421-001-0567-z; Wedderkopp N, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-52; Williams C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052735; Yao WG, 2012, PAIN MED, V13, P658, DOI 10.1111/j.1526-4637.2012.01369.x; Yue PY, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-789	38	120	129	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78109	10.1371/journal.pone.0078109	http://dx.doi.org/10.1371/journal.pone.0078109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147114	gold, Green Published			2022-12-27	WOS:000325819400143
J	Kim, SH; Shim, SH; Sung, SR; Lee, KA; Shim, JY; Cha, DH; Lee, KJ				Kim, Soo Hyun; Shim, Sung Han; Sung, Se Ra; Lee, Kyung A.; Shim, Jung Yun; Cha, Dong Hyun; Lee, Kyoung Jin			Gene Expression Analysis of the Microdissected Trophoblast Layer of Human Placenta after the Spontaneous Onset of Labor	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; HUMAN GESTATIONAL TISSUES; FETAL MEMBRANES; MESSENGER-RNA; KAPPA-B; TERM; INFLAMMATION; PROTEIN; SIRT1; DEHYDROGENASE	Background: Despite increasing evidence that human parturition is associated with alteration in gene expression in the uteroplacental unit, the precise mechanisms that elicit spontaneous term labor in humans remain unknown. Our goal in this study was to compare the mRNA expression pattern of the trophoblast layer of normal term placenta between women who had given natural birth (labor group) and those who had undergone an elective cesarean section without labor (non-labor group). Methods: We collected placental tissue samples from six pregnant women after term vaginal deliveries (labor group) and from six pregnant women after scheduled Cesarean sections (non-labor group). Frozen sections were made immediately after placental delivery. Because the placenta is a heterogeneous tissue composed of several cell types, we used laser capture microdissection to separate the trophoblast layer from the rest of the placental tissues. Results: A number of genes were differentially expressed in the trophoblast layer when the labor and non-labor groups were compared. The expression of SIRT1, KAP1, and CRH was significantly lower in the trophoblast layer of the labor group than of the non-labor group. The expression of IL-1b, NF-kB1 and TLR 8 in the labor group was significantly higher than that in the non-labor group. Conclusions: Human term labor may be closely associated with inflammatory response. We suggest that downregulation of SIRT1, KAP1, and CRH gene expression in the trophoblast may play a key role in parturition and initiation of labor in pregnant human females.	[Kim, Soo Hyun; Cha, Dong Hyun; Lee, Kyoung Jin] CHA Univ, Dept Obstet & Gynecol, CHA Gangnam Med Ctr, Seoul, South Korea; [Shim, Sung Han; Sung, Se Ra] CHA Gangnam Med Ctr, Genet Lab, Fertil Ctr, Seoul, South Korea; [Lee, Kyung A.] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul, South Korea; [Shim, Jung Yun] CHA Univ, Dept Pathol, CHA Gangnam Med Ctr, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Cha, DH (corresponding author), CHA Univ, Dept Obstet & Gynecol, CHA Gangnam Med Ctr, Seoul, South Korea.	chadh001@chamc.co.kr; jlee3575@chamc.co.kr		Cha, Dong Hyun/0000-0003-0722-1714				Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Bollapragada S, 2009, AM J OBSTET GYNECOL, V200, pe101, DOI DOI 10.1016/J.AJ0G.2008.08.032); Bowen JM, 2002, PLACENTA, V23, P239, DOI 10.1053/plac.2001.0781; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chan S, 2004, PLACENTA, V25, P758, DOI 10.1016/j.placenta.2004.02.007; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Cong BH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-43; Curran S, 2000, J CLIN PATHOL-MOL PA, V53, P64, DOI 10.1136/mp.53.2.64; Dudley DJ, 1996, J SOC GYNECOL INVEST, V3, P328, DOI 10.1016/S1071-5576(96)00042-1; Erkhembaatar LO, 2013, PLACENTA, V34, P353, DOI 10.1016/j.placenta.2013.01.014; FRIM DM, 1988, J CLIN INVEST, V82, P287, DOI 10.1172/JCI113585; GOLAND RS, 1986, J CLIN ENDOCR METAB, V63, P1199, DOI 10.1210/jcem-63-5-1199; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Hauguel-de Mouzon S, 2006, PLACENTA, V27, P794, DOI 10.1016/j.placenta.2005.08.009; HIRST JJ, 1995, REPROD FERT DEVELOP, V7, P633, DOI 10.1071/RD9950633; Hobel CJ, 1999, AM J OBSTET GYNECOL, V180, pS257, DOI 10.1016/S0002-9378(99)70712-X; Jabbour HN, 2009, REPRODUCTION, V138, P903, DOI 10.1530/REP-09-0247; Lappas M, 2011, BIOL REPROD, V84, P167, DOI 10.1095/biolreprod.110.086983; Lee KJ, 2010, PLACENTA, V31, P698, DOI 10.1016/j.placenta.2010.05.006; McKeown KJ, 2003, J CLIN ENDOCR METAB, V88, P1737, DOI 10.1210/jc.2002-021369; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; MITCHELL MD, 1984, J DEV PHYSIOL, V6, P107; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; NAKLA S, 1986, AM J OBSTET GYNECOL, V155, P1337, DOI 10.1016/0002-9378(86)90170-5; Norman Jane E, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS7, DOI 10.1186/1471-2393-7-S1-S7; NOVY MJ, 1980, SEMIN PERINATOL, V4, P45; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; SANGHA RK, 1994, J CLIN ENDOCR METAB, V78, P982, DOI 10.1210/jc.78.4.982; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Sullivan MHF, 1991, ACTA OBSTET GYN SCAN, V70, P425, DOI 10.3109/00016349109007154; Weetman AP, 1999, THYROID, V9, P643, DOI 10.1089/thy.1999.9.643; WOLFE C, 1987, LANCET, V1, P335; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006	35	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77648	10.1371/journal.pone.0077648	http://dx.doi.org/10.1371/journal.pone.0077648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147045	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200057
J	Hedger, SC; Nusbaum, HC; Hoeckner, B				Hedger, Stephen C.; Nusbaum, Howard C.; Hoeckner, Berthold			Conveying Movement in Music and Prosody	PLOS ONE			English	Article							ACOUSTIC PROPERTIES; SOUND SYMBOLISM; LANGUAGE; ATTENTION; MOTION; PERCEPTION	We investigated whether acoustic variation of musical properties can analogically convey descriptive information about an object. Specifically, we tested whether information from the temporal structure in music interacts with perception of a visual image to form an analog perceptual representation as a natural part of music perception. In Experiment 1, listeners heard music with an accelerating or decelerating temporal pattern, and then saw a picture of a still or moving object and decided whether it was animate or inanimate - a task unrelated to the patterning of the music. Object classification was faster when musical motion matched visually depicted motion. In Experiment 2, participants heard spoken sentences that were accompanied by accelerating or decelerating music, and then were presented with a picture of a still or moving object. When motion information in the music matched motion information in the picture, participants were similarly faster to respond. Fast and slow temporal patterns without acceleration and deceleration, however, did not make participants faster when they saw a picture depicting congruent motion information (Experiment 3), suggesting that understanding temporal structure information in music may depend on specific metaphors about motion in music. Taken together, these results suggest that visuo-spatial referential information can be analogically conveyed and represented by music and can be integrated with speech or influence the understanding of speech.	[Hedger, Stephen C.; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Hoeckner, Berthold] Univ Chicago, Dept Mus, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Hedger, SC (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	shedger@uchicago.edu	Van Hedger, Stephen Charles/V-3248-2019	Van Hedger, Stephen Charles/0000-0002-2448-9088	Andrew W. Mellon Foundation; Social Sciences Division of the University of Chicago	Andrew W. Mellon Foundation; Social Sciences Division of the University of Chicago	This research was supported by a New Directions Fellowship from the Andrew W. Mellon Foundation (to author BH) and the Social Sciences Division of the University of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aveyard ME, 2012, MEM COGNITION, V40, P83, DOI 10.3758/s13421-011-0139-3; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bartolomeo P, 2002, CORTEX, V38, P357, DOI 10.1016/S0010-9452(08)70665-8; Beilock SL, 2008, P NATL ACAD SCI USA, V105, P13269, DOI 10.1073/pnas.0803424105; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Eitan Z, 2006, MUSIC PERCEPT, V23, P221, DOI 10.1525/mp.2006.23.3.221; FREYD JJ, 1983, PERCEPT PSYCHOPHYS, V33, P575, DOI 10.3758/BF03202940; Gentner D, 2006, CURR DIR PSYCHOL SCI, V15, P297, DOI 10.1111/j.1467-8721.2006.00456.x; GOLDSTEIN AG, 1957, J EXP PSYCHOL, V54, P457, DOI 10.1037/h0044965; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Kourtzi Z, 2000, TRENDS COGN SCI, V4, P295, DOI 10.1016/S1364-6613(00)01512-6; Lakoff George, 2003, METAPHOR WE LIVE BY; Levitin DJ, 1996, PERCEPT PSYCHOPHYS, V58, P927, DOI 10.3758/BF03205494; MARKS LE, 1987, J EXP PSYCHOL HUMAN, V13, P384, DOI 10.1037/0096-1523.13.3.384; McNeill D., 1992, HAND MIND WHAT GESTU; MELARA RD, 1990, MEM COGNITION, V18, P477, DOI 10.3758/BF03198481; Meyer L., 1956, EMOTION MEANING MUSI; MORAY N, 1959, Q J EXP PSYCHOL, V11, P56, DOI 10.1080/17470215908416289; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Nygaard LC, 2009, COGNITION, V112, P181, DOI 10.1016/j.cognition.2009.04.001; Painter JG, 2011, PSYCHOPHYSIOLOGY, V48, P645, DOI 10.1111/j.1469-8986.2010.01134.x; Parise CV, 2011, EXP BRAIN RES, V214, P373, DOI 10.1007/s00221-011-2836-3; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Shintel H, 2008, COGNITIVE SCI, V32, P1063, DOI 10.1080/03640210801897831; Shintel H, 2007, COGNITION, V105, P681, DOI 10.1016/j.cognition.2006.11.005; Shintel H, 2006, J MEM LANG, V55, P167, DOI 10.1016/j.jml.2006.03.002; Slevc LR, 2012, WIRES COGN SCI, V3, P483, DOI 10.1002/wcs.1186; Slevc LR, 2009, PSYCHON B REV, V16, P374, DOI 10.3758/16.2.374; TREISMAN AM, 1969, J EXP PSYCHOL, V79, P27, DOI 10.1037/h0026890; Tubul ZEN, 2010, MUSIC SCI, P89; Winawer J, 2008, PSYCHOL SCI, V19, P276, DOI 10.1111/j.1467-9280.2008.02080.x; WOOD N, 1995, J EXP PSYCHOL LEARN, V21, P255, DOI 10.1037/0278-7393.21.1.255; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430	36	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76744	10.1371/journal.pone.0076744	http://dx.doi.org/10.1371/journal.pone.0076744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	239JR	24146920	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400085
J	Jiang, L; Lin, M; Zhang, Y; Li, YP; Xu, X; Li, S; Huang, H				Jiang, Ling; Lin, Ming; Zhang, Yang; Li, Yanping; Xu, Xian; Li, Shuang; Huang, He			Identification and Characterization of a Novel Trehalose Synthase Gene Derived from Saline-Alkali Soil Metagenomes	PLOS ONE			English	Article							ESCHERICHIA-COLI; CORD FACTOR; CLONING; EXPRESSION; YEAST; INSIGHTS; GROWTH; PATHOGENESIS; RESOLUTION; EVOLUTION	A novel trehalose synthase (TreS) gene was identified from a metagenomic library of saline-alkali soil by a simple activity-based screening system. Sequence analysis revealed that TreS encodes a protein of 552 amino acids, with a deduced molecular weight of 63.3 kDa. After being overexpressed in Escherichia coli and purified, the enzymatic properties of TreS were investigated. The recombinant TreS displayed its optimal activity at pH 9.0 and 45 degrees C, and the addition of most common metal ions (1 or 30 mM) had no inhibition effect on the enzymatic activity evidently, except for the divalent metal ions Zn2+ and Hg2+. Kinetic analysis showed that the recombinant TreS had a 4.1-fold higher catalytic efficientcy (Kcat/K-m) for maltose than for trehalose. The maximum conversion rate of maltose into trehalose by the TreS was reached more than 78% at a relatively high maltose concentration (30%), making it a good candidate in the large-scale production of trehalsoe after further study. In addition, five amino acid residues, His172, Asp201, Glu251, His318 and Asp319, were shown to be conserved in the TreS, which were also important for glycosyl hydrolase family 13 enzyme catalysis.	[Jiang, Ling] Nanjing Univ Technol, Coll Food Sci & Light Ind, Nanjing, Jiangsu, Peoples R China; [Lin, Ming; Xu, Xian; Li, Shuang; Huang, He] Nanjing Univ Technol, Coll Biotechnol & Pharmaceut Engn, State Key Lab Mat Oriented Chem Engn, Nanjing, Jiangsu, Peoples R China; [Zhang, Yang; Li, Yanping] Nanjing Univ Technol, Coll Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Tech University; Nanjing Tech University; Nanjing Tech University	Huang, H (corresponding author), Nanjing Univ Technol, Coll Biotechnol & Pharmaceut Engn, State Key Lab Mat Oriented Chem Engn, Nanjing, Jiangsu, Peoples R China.	biotech@njut.edu.cn			National Science Foundation for Distinguished Young Scholars of China [21225626]; National Basic Research Program of China [2012CB725204]; National Natural Science Foundation of China for Young Scholars [21106064]; Natural Science Foundation of Jiangsu Province [BK20131406, BK20130917]; National High Technology Research and Development Program of China [2012AA022101, 2012AA021700]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China for Young Scholars(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The experiments were conceived and designed with the support of the National Science Foundation for Distinguished Young Scholars of China (No. 21225626). The experiment materials were bought mainly with the support of the National Basic Research Program of China (No. 2012CB725204), as well as the National Natural Science Foundation of China for Young Scholars (No. 21106064). The data collection and analysis, together with the preparation of the manuscript were mainly supported by the Natural Science Foundation of Jiangsu Province (No. BK20131406, BK20130917). The isolation of DNA from environmental sample and construction of a metagenomic library in this study were mainly supported by the National High Technology Research and Development Program of China (No. 2012AA022101, 2012AA021700).	Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Benoliel B, 2010, APPL BIOCHEM BIOTECH, V160, P2036, DOI 10.1007/s12010-009-8732-7; BUISSON G, 1987, EMBO J, V6, P3909, DOI 10.1002/j.1460-2075.1987.tb02731.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang SW, 2012, FOOD CHEM, V134, P1745, DOI 10.1016/j.foodchem.2012.03.065; Chen YS, 2006, J AGR FOOD CHEM, V54, P7098, DOI 10.1021/jf060828q; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Filipkowski P, 2012, ACTA BIOCHIM POL, V59, P425; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; GELINAS P, 1989, APPL ENVIRON MICROB, V55, P2453; GRBA S, 1976, EUR J APPL MICROBIOL, V2, P29, DOI 10.1007/BF01385443; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Han SE, 2003, PROTEIN EXPRES PURIF, V30, P194, DOI 10.1016/S1046-5928(03)00104-9; HOTTIGER T, 1994, EUR J BIOCHEM, V219, P187, DOI 10.1111/j.1432-1033.1994.tb19929.x; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Hunter RL, 2009, TUBERCULOSIS, V89, pS18, DOI 10.1016/S1472-9792(09)70007-1; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jiang L, 2012, BIOTECHNOL BIOENG, V109, P708, DOI 10.1002/bit.23346; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Kim YH, 2000, APPL ENVIRON MICROB, V66, P4620, DOI 10.1128/AEM.66.11.4620-4624.2000; Lee JH, 2005, APPL MICROBIOL BIOT, V68, P213, DOI 10.1007/s00253-004-1862-5; Liang JY, 2013, J MOL CATAL B-ENZYM, V90, P26, DOI 10.1016/j.molcatb.2013.01.014; MARUTA K, 1995, BIOSCI BIOTECH BIOCH, V59, P1829, DOI 10.1271/bbb.59.1829; Mirza O, 2001, BIOCHEMISTRY-US, V40, P9032, DOI 10.1021/bi010706l; NISHIMOTO T, 1995, BIOSCI BIOTECH BIOCH, V59, P2189, DOI 10.1271/bbb.59.2189; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Paiva C L, 1996, Biotechnol Annu Rev, V2, P293, DOI 10.1016/S1387-2656(08)70015-2; Purvis JE, 2005, APPL ENVIRON MICROB, V71, P3761, DOI 10.1128/AEM.71.7.3761-3769.2005; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P420, DOI 10.1016/S0167-7799(02)02041-3; Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; TEWARI YB, 1991, BIOPHYS CHEM, V40, P59, DOI 10.1016/0301-4622(91)85029-P; Van Vaeck C, 2001, BIOCHEM J, V353, P157; Wang JH, 2007, J AGR FOOD CHEM, V55, P3435, DOI 10.1021/jf070181p; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Wei YT, 2004, ACTA BIOCH BIOPH SIN, V36, P477, DOI 10.1093/abbs/36.7.477; Woo EJ, 2010, J MOL BIOL, V404, P247, DOI 10.1016/j.jmb.2010.09.056; Wu XL, 2009, APPL MICROBIOL BIOT, V83, P477, DOI 10.1007/s00253-009-1863-5; Yao J, 2011, J AGR FOOD CHEM, V59, P3812, DOI 10.1021/jf104394m; Yue M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-34; Zhang R, 2011, J BIOL CHEM, V286, P35601, DOI 10.1074/jbc.M111.280362; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	46	29	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77437	10.1371/journal.pone.0077437	http://dx.doi.org/10.1371/journal.pone.0077437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146994	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400106
J	Jiang, XP; Zhang, DX; Teng, M; Zhang, Q; Zhang, JP; Huang, YS				Jiang, Xu-pin; Zhang, Dong-xia; Teng, Miao; Zhang, Qiong; Zhang, Jia-ping; Huang, Yue-sheng			Downregulation of CD9 in Keratinocyte Contributes to Cell Migration via Upregulation of Matrix Metalloproteinase-9	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE (MMP)-2; HUMAN EPIDERMAL-KERATINOCYTES; TETRASPANIN CD9; WOUND REPAIR; IN-VITRO; MMP-9 EXPRESSION; MELANOMA-CELLS; MOTILITY; PATHWAY; SKIN	Tetraspanin CD9 has been implicated in various cellular and physiological processes, including cell migration. In our previous study, we found that wound repair is delayed in CD9-null mice, suggesting that CD9 is critical for cutaneous wound healing. However, many cell types, including immune cells, endothelial cells, keratinocytes and fibroblasts undergo marked changes in gene expression and phenotype, leading to cell proliferation, migration and differentiation during wound repair, whether CD9 regulates kerationcytes migration directly remains unclear. In this study, we showed that the expression of CD9 was downregulated in migrating keratinocytes during wound repair in vivo and in vitro. Recombinant adenovirus vector for CD9 silencing or overexpressing was constructed and used to infect HaCaT cells. Using cell scratch wound assay and cell migration assay, we have also demonstrated that downregulation of CD9 promoted keratinocyte migration in vitro, whereas CD9 overexpression inhibited cell migration. Moreover, CD9 inversely regulated the activity and expression of MMP-9 in keratinocytes, which was involved in CD9-regulated keratinocyte migration. Importantly, CD9 silencing-activated JNK signaling was accompanied by the upregulation of MMP-9 activity and expression. Coincidentally, we found that SP600125, a JNK pathway inhibitor, decreased the activity and expression of MMP-9 of CD9-silenced HaCaT cells. Thus, our results suggest that CD9 is downregulated in migrating keratinocytes in vivo and in vitro, and a low level of CD9 promotes keratinocyte migration in vitro, in which the regulation of MMP-9 through the JNK pathway plays an important role.	[Jiang, Xu-pin; Zhang, Dong-xia; Zhang, Qiong; Zhang, Jia-ping; Huang, Yue-sheng] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China; [Teng, Miao] Chongqing Med Univ, Dept Burn & Plast Surg, Affiliated Hosp 1, Chongqing, Peoples R China	Army Medical University; Chongqing Medical University	Zhang, JP (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	japzhang@yahoo.com.cn; yshuang.tmmu@gmail.com			National Natural Science Foundation of China [30973125]; State Key Development Program for Basic Research of China (973 Program) [2012CB518101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development Program for Basic Research of China (973 Program)(National Basic Research Program of ChinaState Key Development Program for Basic Research of China)	This work was supported by the National Natural Science Foundation of China (30973125), and the State Key Development Program for Basic Research of China (973 Program) (No. 2012CB518101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; ANTON ES, 1995, J NEUROSCI, V15, P584; Bassani S, 2012, INT J BIOCHEM CELL B, V44, P703, DOI 10.1016/j.biocel.2012.01.020; Baudoux B, 2000, EUR J CELL BIOL, V79, P41, DOI 10.1078/S0171-9335(04)70006-0; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Chen JS, 2013, CARCINOGENESIS, V34, P10, DOI 10.1093/carcin/bgs274; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Deissler H, 2007, INT J MOL MED, V20, P643; Gutierrez-Lopez MD, 2011, CELL MOL LIFE SCI, V68, P3275, DOI 10.1007/s00018-011-0639-0; Ekekezie II, 2004, PEDIATRICS, V113, P1709, DOI 10.1542/peds.113.6.1709; Fan J, 2010, MOL CARCINOGEN, V49, P85, DOI 10.1002/mc.20580; Garcia-Lopez MA, 2005, J INVEST DERMATOL, V125, P1001, DOI 10.1111/j.0022-202X.2005.23882.x; GERMAIN L, 1993, BURNS, V19, P99, DOI 10.1016/0305-4179(93)90028-7; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hong IK, 2005, EXP MOL MED, V37, P230, DOI 10.1038/emm.2005.31; Hsu JYC, 2008, J NEUROSCI, V28, P13467, DOI 10.1523/JNEUROSCI.2287-08.2008; Kahari VM, 1997, EXP DERMATOL, V6, P199, DOI 10.1111/j.1600-0625.1997.tb00164.x; Karroum A, 2010, CANCER LETT, V295, P242, DOI 10.1016/j.canlet.2010.03.007; Kim S, 2007, FEBS LETT, V581, P3869, DOI 10.1016/j.febslet.2007.06.074; Kirfel G, 2004, PROTOPLASMA, V223, P67, DOI 10.1007/s00709-003-0031-5; Klein-Soyer C, 2000, ARTERIOSCL THROM VAS, V20, P360, DOI 10.1161/01.ATV.20.2.360; Kotha J, 2010, ARTERIOSCL THROM VAS, V30, pE263; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lu CY, 2013, ACTA TROP, V125, P320, DOI 10.1016/j.actatropica.2012.11.002; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MASELLISSMITH A, 1994, J IMMUNOL, V152, P2768; Miyake M, 2000, ONCOGENE, V19, P5221, DOI 10.1038/sj.onc.1203919; O'Toole EA, 2008, J CELL PHYSIOL, V214, P47, DOI 10.1002/jcp.21160; Orlando S, 1997, J BIOL CHEM, V272, P31764, DOI 10.1074/jbc.272.50.31764; Penas PF, 2005, ACTAS DERMO-SIFILOGR, V96, P30, DOI 10.1016/S0001-7310(05)73029-5; Penas PF, 2000, J INVEST DERMATOL, V114, P1126, DOI 10.1046/j.1523-1747.2000.00998.x; Powner D, 2011, BIOCHEM SOC T, V39, P563, DOI 10.1042/BST0390563; RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277; Ravanti L, 2000, INT J MOL MED, V6, P391; Rayment EA, 2008, BRIT J DERMATOL, V158, P951, DOI 10.1111/j.1365-2133.2008.08462.x; Reiss MJ, 2010, SURGERY, V147, P295, DOI 10.1016/j.surg.2009.10.016; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Thomas GJ, 2001, J INVEST DERMATOL, V116, P898, DOI 10.1046/j.1523-1747.2001.01352.x; Xue ML, 2008, J INVEST DERMATOL, V128, P2676, DOI 10.1038/jid.2008.136; Zhang JP, 2012, J INVEST DERMATOL, V132, P226, DOI 10.1038/jid.2011.268; Zhang Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038487, DOI 10.1371/J0URNAL.P0NE.0038487.PUBMED:22679510]; Zheng M, 2011, MOL BIOL REP, V38, P2099, DOI [10.1007/ s11033-010-0336-3, DOI 10.1007/S11033-010-0336-3.PUBMED:20857208]	50	25	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77806	10.1371/journal.pone.0077806	http://dx.doi.org/10.1371/journal.pone.0077806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147081	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400135
J	Liu, W; Zhang, ZJ; Zhao, YJ; Liu, ZF; Li, BC				Liu, Wei; Zhang, Zhi-Jun; Zhao, Ya-Jun; Liu, Zhi-Fang; Li, Bing-Chen			Effects of Awareness on Numerosity Adaptation	PLOS ONE			English	Article							NUMBER; REPRESENTATION; PERCEPTION; SUPPRESSION; ANIMALS; REVEALS; DEPENDS; SCALE; SETS	Numerosity perception is a process involving several stages of visual processing. This study investigated whether distinct mechanisms exist in numerosity adaptation under different awareness conditions to characterize how numerosity perception occurs at each stage. The status of awareness was controlled by masking conditions, in which monoptic and dichoptic masking were proposed to influence different levels of processing. Numerosity adaptation showed significant aftereffects when the participants were aware (monoptic masking) and unaware (dichoptic masking) of adaptors. The interocular transfer for numerosity adaptation was distinct under the different awareness conditions. Adaptation was primarily binocular when participants were aware of stimuli and was purely monocular when participants were unaware of adaptors. Moreover, numerosity adaptation was significantly reduced when the adaptor dots were clustered into chunks with awareness, whereas clustering had no effect on unaware adaptation. These results show that distinct mechanisms exist in numerosity processing under different awareness conditions. It is suggested that awareness is crucial to numerosity cognition. With awareness, grouping (by clustering) influences numerosity coding through altered object representations, which involves higher-level cognitive processing.	[Liu, Wei; Zhang, Zhi-Jun; Li, Bing-Chen] Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Ya-Jun] Southwest Univ Nationalities, Coll Sociol & Psychol, Chengdu, Peoples R China; [Liu, Zhi-Fang] Ningbo Univ, Coll Teacher Educ, Ningbo 315211, Zhejiang, Peoples R China	Zhejiang University; Southwest Minzu University; Ningbo University	Zhang, ZJ (corresponding author), Zhejiang Univ, Dept Psychol & Behav Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zjzhang@zju.edu.cn			National Natural Science Foundation of China [31271101, 31371039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Funds of the National Natural Science Foundation of China (Grant No. 31271101, 2012; Grant No. 31371039, 2013). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIK J, 1991, PSYCHOL RES-PSYCH FO, V53, P290, DOI 10.1007/BF00920482; ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Amihai I, 2011, CONSCIOUS COGN, V20, P269, DOI 10.1016/j.concog.2010.08.004; Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Blake R, 2006, P NATL ACAD SCI USA, V103, P4783, DOI 10.1073/pnas.0509634103; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Burr DC, 2011, SEEING PERCEIVING, V24, P141, DOI 10.1163/187847511X570097; Burr DC, 2011, PHILOS T R SOC B, V366, P504, DOI 10.1098/rstb.2010.0244; Castelli F, 2006, P NATL ACAD SCI USA, V103, P4693, DOI 10.1073/pnas.0600444103; Chen L, 2005, VIS COGN, V12, P553, DOI 10.1080/13506280444000256; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; de Hevia MD, 2011, COGNITION, V121, P253, DOI 10.1016/j.cognition.2011.04.002; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Durgin FH, 2001, VISION RES, V41, P2619, DOI 10.1016/S0042-6989(01)00121-3; Durgin FH, 1996, SPATIAL VISION, V9, P423, DOI 10.1163/156856896X00204; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Franconeri SL, 2009, COGNITION, V113, P1, DOI 10.1016/j.cognition.2009.07.002; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Gazzaniga M. S., 2008, COGNITIVE NEUROSCIEN; Halberda J, 2006, PSYCHOL SCI, V17, P572, DOI 10.1111/j.1467-9280.2006.01746.x; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; He LX, 2009, PSYCHON B REV, V16, P509, DOI 10.3758/PBR.16.3.509; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kramer P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017378; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LIU W, 2012, ACTA PSYCHOL SINICA, V44, P1; Macknik SL, 2004, J COGNITIVE NEUROSCI, V16, P1049, DOI 10.1162/0898929041502788; Moradi F, 2005, NEURON, V45, P169, DOI 10.1016/j.neuron.2004.12.018; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Palmer SE, 2003, ACTA PSYCHOL, V114, P311, DOI 10.1016/j.actpsy.2003.06.003; Roitman JD, 2007, PLOS BIOL, V5, P1672, DOI 10.1371/journal.pbio.0050208; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; Roth HL, 2002, BRAIN, V125, P2023, DOI 10.1093/brain/awf210; SANG CC, 2010, WIRES COGN SCI, V10, P1002; Sophian C, 2008, COGNITION, V107, P460, DOI 10.1016/j.cognition.2007.10.009; Sweeny TD, 2011, PSYCHOL SCI, V22, P943, DOI 10.1177/0956797611413292; Sweeny TD, 2011, J NEUROPHYSIOL, V105, P1236, DOI 10.1152/jn.00061.2010; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; WALK RD, 1966, MONOGR SOC RES CHILD, V31, P82, DOI 10.2307/1165648; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; YANG E, 2010, J VIS, V10, P13, DOI DOI 10.1167/10.12.1.PUBMED:21047733	48	8	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77556	10.1371/journal.pone.0077556	http://dx.doi.org/10.1371/journal.pone.0077556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24147023	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400120
J	McCarthy, MK; Levine, RE; Procario, MC; McDonnell, PJ; Zhu, LQ; Mancuso, P; Crofford, LJ; Aronoff, DM; Weinberg, JB				McCarthy, Mary K.; Levine, Rachael E.; Procario, Megan C.; McDonnell, Peter J.; Zhu, Lingqiao; Mancuso, Peter; Crofford, Leslie J.; Aronoff, David M.; Weinberg, Jason B.			Prostaglandin E-2 Induction during Mouse Adenovirus Type 1 Respiratory Infection Regulates Inflammatory Mediator Generation but Does Not Affect Viral Pathogenesis	PLOS ONE			English	Article							SYNCYTIAL VIRUS; CYCLOOXYGENASE-1 COX-1; B-LYMPHOCYTES; NITRIC-OXIDE; MICE LACKING; T-CELLS; EXPRESSION; SYNTHASE; IDENTIFICATION; ACTIVATION	Respiratory viruses cause substantial disease and are a significant healthcare burden. Virus-induced inflammation can be detrimental to the host, causing symptoms during acute infection and leading to damage that contributes to long-term residual lung disease. Prostaglandin E-2 (PGE(2)) is a lipid mediator that is increased in response to many viral infections, and inhibition of PGE(2) production during respiratory viral infection often leads to a decreased inflammatory response. We tested the hypothesis that PGE(2) promotes inflammatory responses to mouse adenovirus type 1 (MAV-1) respiratory infection. Acute MAV-1 infection increased COX-2 expression and PGE(2) production in wild type mice. Deficiency of the E prostanoid 2 receptor had no apparent effect on MAV-1 pathogenesis. Virus-induced induction of PGE(2), IFN-gamma, CXCL1, and CCL5 was reduced in mice deficient in microsomal PGE synthase-1 (mPGES-1(-/-) mice). However, there were no differences between mPGES-1(+/+) and mPGES-1(-/-) mice in viral replication, recruitment of leukocytes to airways or lung inflammation. Infection of both mPGES-1(+/+) and mPGES-1(-/-) mice led to protection against reinfection. Thus, while PGE(2) promotes the expression of a variety of cytokines in response to acute MAV-1 infection, PGE(2) synthesis does not appear to be essential for generating pulmonary immunity.	[Levine, Rachael E.; Procario, Megan C.; McDonnell, Peter J.; Weinberg, Jason B.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [McCarthy, Mary K.; Zhu, Lingqiao; Aronoff, David M.; Weinberg, Jason B.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Aronoff, David M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Mancuso, Peter] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA; [Crofford, Leslie J.] Vanderbilt Univ, Dept Internal Med, Nashville, TN 37235 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University	Weinberg, JB (corresponding author), Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA.	jbwein@umich.edu	Mancuso, Peter/AGZ-3550-2022	Aronoff, David/0000-0003-4587-6121; Mancuso, Peter/0000-0002-2559-7320; Weinberg, Jason/0000-0002-4768-4361	NIH [R01 AI083334, R01 AR049010]; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases award; Nancy Newton Loeb Award from the University of Michigan Department of Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases award; Nancy Newton Loeb Award from the University of Michigan Department of Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by NIH grants R01 AI083334 (JBW and DMA) and R01 AR049010 (LJC), a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Diseases award (DMA), and a Nancy Newton Loeb Award from the University of Michigan Department of Pediatrics (JBW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VE, 2009, VIROLOGY, V391, P25, DOI 10.1016/j.virol.2009.06.009; Aronoff DM, 2012, PROSTAG OTH LIPID M, V98, P23, DOI 10.1016/j.prostaglandins.2012.03.002; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bancos S, 2009, CELL IMMUNOL, V258, P18, DOI 10.1016/j.cellimm.2009.03.007; BETZ M, 1991, J IMMUNOL, V146, P108; Bloom D, 1999, CELL IMMUNOL, V194, P21, DOI 10.1006/cimm.1999.1479; Boulet L, 2004, J BIOL CHEM, V279, P23229, DOI 10.1074/jbc.M400443200; Carey MA, 2005, J IMMUNOL, V175, P6878, DOI 10.4049/jimmunol.175.10.6878; Carey MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011610; Cauthen Angela N, 2007, Methods Mol Med, V130, P41; Coomes SM, 2010, J IMMUNOL, V184, P5130, DOI 10.4049/jimmunol.0901871; Crofford LJ, 2005, J GENE MED, V7, P288, DOI 10.1002/jgm.661; Culver CA, 2007, J IMMUNOL, V179, P4170, DOI 10.4049/jimmunol.179.6.4170; Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/eri.11.56, 10.1586/ERI.11.56]; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Jania LA, 2009, PROSTAG OTH LIPID M, V88, P73, DOI 10.1016/j.prostaglandins.2008.10.003; Kapoor M, 2006, FASEB J, V20, P2387, DOI 10.1096/fj.06-6366fje; KNIPE DM, 2007, FIELDS VIROLOGY, P2355; Lauder SN, 2011, THORAX, V66, P368, DOI 10.1136/thx.2010.150318; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Liu TS, 2005, VIROLOGY, V343, P12, DOI 10.1016/j.virol.2005.08.012; Lovgren AK, 2007, MOL CELL BIOL, V27, P4416, DOI 10.1128/MCB.02314-06; MCCARTHY MK, 2012, MEDIAT INFLAMM, V2012, P1; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Monrad SU, 2011, PROSTAG LEUKOTR ESS, V84, P113, DOI 10.1016/j.plefa.2010.10.003; Moore ML, 2004, J VIROL, V78, P5584, DOI 10.1128/JVI.78.11.5584-5590.2004; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Natarajan G, 2007, ANN CLIN LAB SCI, V37, P170; Nguyen Y, 2011, VIRUS RES, V160, P351, DOI 10.1016/j.virusres.2011.07.012; Nguyen YN, 2008, VIROLOGY, V380, P182, DOI 10.1016/j.virol.2008.07.031; Procario MC, 2012, J VIROL, V86, P4194, DOI 10.1128/JVI.06967-11; Radi ZA, 2010, VIRAL IMMUNOL, V23, P43, DOI 10.1089/vim.2009.0042; Richardson JY, 2005, J IMMUNOL, V174, P4356, DOI 10.4049/jimmunol.174.7.4356; Roper RL, 2002, IMMUNOL LETT, V84, P191, DOI 10.1016/S0165-2478(02)00185-2; ROPER RL, 1995, J IMMUNOL, V154, P162; Ryan EP, 2005, J IMMUNOL, V174, P2619, DOI 10.4049/jimmunol.174.5.2619; Sadikot RT, 2007, EUR J IMMUNOL, V37, P1001, DOI 10.1002/eji.200636636; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Seymour ML, 2002, J INFECT DIS, V185, P540, DOI 10.1086/338570; SNIJDEWINT FGM, 1993, J IMMUNOL, V150, P5321; Steer SA, 2003, VIRAL IMMUNOL, V16, P447, DOI 10.1089/088282403771926283; Sznajer Y, 2004, J PEDIATR-US, V145, P115, DOI 10.1016/j.jpeds.2004.03.049; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tavakoli S, 2001, AM J PHYSIOL-LUNG C, V280, pL127, DOI 10.1152/ajplung.2001.280.1.L127; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; Weinberg JB, 2007, VIROLOGY, V357, P54, DOI 10.1016/j.virol.2006.08.013; Weinberg JB, 2005, VIROLOGY, V340, P245, DOI 10.1016/j.virol.2005.06.021; Weinberg JB, 2002, J VIROL, V76, P10518, DOI 10.1128/JVI.76.20.10518-10523.2002; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785; Xu F, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-16; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799	58	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77628	10.1371/journal.pone.0077628	http://dx.doi.org/10.1371/journal.pone.0077628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147040	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400124
J	Wang, WJ; Lu, JJ; Wang, CX; Wang, YL; Li, H; Zhao, XQ				Wang, Wenjuan; Lu, Jingjing; Wang, Chunxue; Wang, Yilong; Li, Hao; Zhao, Xingquan		Investigators China Natl Stroke	Prognostic Value of ICH Score and ICH-GS Score in Chinese Intracerebral Hemorrhage Patients: Analysis From the China National Stroke Registry (CNSR)	PLOS ONE			English	Article							BLOOD-PRESSURE; GRADING SCALE; CASE-FATALITY; MORTALITY; SUBTYPES; TRENDS	Purpose: No strong evidence of efficacy currently exists for different intracerebral hemorrhage (ICH) scoring system in predicting the prognosis of ICH in the Chinese population. This study aimed to test the accuracy of the ICH score and the ICH grading scale (ICH-GS) score in predicting the favorable prognosis in a large cohort of ICH patients in China. Methods: This study was a multicenter, prospective cohort study. Patients diagnosed with ICH between September 2007 and August 2008 from the nationwide China National Stroke Registry (CNSR) database were screened and enrolled in this study. Demographics of the patients, treatments, mortality as well as the clinic and radiologic findings of ICH were collected. AnICH score and an ICH-GS score were evaluated for all the patients at admission. Follow-ups were conducted by phone at 3, 6 and 12 months after ICH onset. The modified Rankin scale (mRS) score was used to evaluate favorable functional outcome and was obtained at hospital discharge and during the 3-, 6- and 12-month follow-up visits. Results: There were 410 (12.6%) in-hospital mortality out of a total of 3,255 ICH patients. The values of the Area Under Curve (AUC) at discharge, 3-, 6- and 12-month follow-up for ICH score were 0.72, 0.76, 0.76 and 0.75, respectively; while the numbers for the ICH-GS score were 0.71, 0.77, 0.78 and 0.78, respectively. At 6-month and 12-month follow-up, the ICH-GS score presented a significant better value in predicting favorable prognosis than did the ICH score (P=0.0003 and <0.0001, respectively). Conclusion: Both the ICH and ICH-GS scores were effective inaccurately predicting the favorable functional outcome of ICH in the Chinese population. For mid-term and long-term prediction, the ICH-GS score was superior over the ICH score.	[Wang, Wenjuan; Lu, Jingjing; Wang, Chunxue; Wang, Yilong; Li, Hao; Zhao, Xingquan; Investigators China Natl Stroke] Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing, Peoples R China	Capital Medical University	Zhao, XQ (corresponding author), Capital Med Univ, Dept Neurol, Beijing Tiantan Hosp, Beijing, Peoples R China.	zxq@vip.163.com	Li, Hao/GPS-9834-2022; LU, JINGJING/AFJ-9406-2022; LU, JINGJING/AAF-6443-2022	LU, JINGJING/0000-0002-1128-020X; LU, JINGJING/0000-0002-1128-020X	capital health research and development of special [capital 2011-2004-03]; National Science and technology major special project [2011ZX09307-001-06]	capital health research and development of special; National Science and technology major special project	This study was sponsored by The capital health research and development of special (number capital 2011-2004-03) and the National Science and technology major special project (number 2011ZX09307-001-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, STROKE, V20, P1407; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; Clarke JL, 2004, NEUROCRIT CARE, V1, P53, DOI 10.1385/NCC:1:1:53; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Fernandes H, 2002, STROKE, V33, P1455, DOI 10.1161/01.STR.0000018666.74574.9B; Ferro JM, 2006, J NEUROL, V253, P985, DOI 10.1007/s00415-006-0201-4; Godoy DA, 2003, STROKE, V34, DOI 10.1161/01.STR.0000089493.23505.CA; Hemphill JC, 2009, NEUROLOGY, V73, P1088, DOI 10.1212/WNL.0b013e3181b8b332; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hwang BY, 2010, NEUROCRIT CARE, V13, P141, DOI 10.1007/s12028-010-9382-x; Jamora RDG, 2003, STROKE, V34, P6, DOI 10.1161/01.STR.0000047847.18178.D3; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Patriota GC, 2009, ARQ NEURO-PSIQUIAT, V67, P605, DOI 10.1590/S0004-282X2009000400006; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Ruiz-Sandoval JL, 2007, STROKE, V38, P1641, DOI 10.1161/STROKEAHA.106.478222; Song YM, 2004, BMJ-BRIT MED J, V328, P324, DOI 10.1136/bmj.328.7435.324; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; Tolonen H, 2002, STROKE, V33, P2367, DOI 10.1161/01.STR.0000033131.27936.7F; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Yang QD, 2004, CEREBROVASC DIS, V17, P303, DOI 10.1159/000077341; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807	25	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77421	10.1371/journal.pone.0077421	http://dx.doi.org/10.1371/journal.pone.0077421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146993	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400105
J	Bettencourt, LMA; Trancik, JE; Kaur, J				Bettencourt, Luis M. A.; Trancik, Jessika E.; Kaur, Jasleen			Determinants of the Pace of Global Innovation in Energy Technologies	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; CLIMATE-CHANGE-MITIGATION; PATENTS; ELECTRICITY; INVESTMENT; KNOWLEDGE; INVENTION; PROGRESS; FUTURE; POLICY	Understanding the factors driving innovation in energy technologies is of critical importance to mitigating climate change and addressing other energy-related global challenges. Low levels of innovation, measured in terms of energy patent filings, were noted in the 1980s and 90s as an issue of concern and were attributed to limited investment in public and private research and development (R&D). Here we build a comprehensive global database of energy patents covering the period 1970-2009, which is unique in its temporal and geographical scope. Analysis of the data reveals a recent, marked departure from historical trends. A sharp increase in rates of patenting has occurred over the last decade, particularly in renewable technologies, despite continued low levels of R&D funding. To solve the puzzle of fast innovation despite modest R&D increases, we develop a model that explains the nonlinear response observed in the empirical data of technological innovation to various types of investment. The model reveals a regular relationship between patents, R&D funding, and growing markets across technologies, and accurately predicts patenting rates at different stages of technological maturity and market development. We show quantitatively how growing markets have formed a vital complement to public R&D in driving innovative activity. These two forms of investment have each leveraged the effect of the other in driving patenting trends over long periods of time.	[Bettencourt, Luis M. A.; Trancik, Jessika E.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Bettencourt, Luis M. A.] Los Alamos Natl Lab, Theoret Div T5, Los Alamos, NM USA; [Trancik, Jessika E.] MIT, Engn Syst Div, Cambridge, MA 02139 USA; [Kaur, Jasleen] Indiana Univ, Sch Informat & Comp, Ctr Complex Networks & Syst Res, Bloomington, IN USA	The Santa Fe Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; Massachusetts Institute of Technology (MIT); Indiana University System; Indiana University Bloomington	Trancik, JE (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.	trancik@mit.edu	Bettencourt, Luis/R-9861-2019		Army Research Office [W911NF-12-1-0097]; Los Alamos National Laboratory LDRD program [SGER-0742161]; National Science Foundation [SBE-0738187]; Solomon Buchsbaum Research Fund	Army Research Office; Los Alamos National Laboratory LDRD program(United States Department of Energy (DOE)Los Alamos National Laboratory); National Science Foundation(National Science Foundation (NSF)); Solomon Buchsbaum Research Fund	This work was supported by: the Army Research Office under grant W911NF-12-1-0097 (to LB); the Los Alamos National Laboratory LDRD program under grant SGER-0742161 (to LB); the National Science Foundation under grant SBE-0738187 (to JET); and the Solomon Buchsbaum Research Fund (to JET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs ZJ, 2002, RES POLICY, V31, P1069, DOI 10.1016/S0048-7333(01)00184-6; [Anonymous], 2001, 8498 NBER; Barro R., 2004, EC GROWTH, VSecond; Caldeira K, 2003, SCIENCE, V299, P2052, DOI 10.1126/science.1078938; Core Writing Team, 2007, SYNTH REP CONTR WORK; Damodaran A., 2011, APPL CORPORATE FINAN; Dechezlepretre A, 2011, REV ENV ECON POLICY, V5, P109, DOI 10.1093/reep/req023; Economics and Statistics Division of the World Intellectual Property Organization, 2010, TECHNICAL REPORT; EurObserv'ER and The European Commission, 2011, TECHNICAL REPORT; Fri RW, 2003, ENERGY J, V24, P51; Gallagher KS, 2006, ANNU REV ENV RESOUR, V31, P193, DOI 10.1146/annurev.energy.30.050504.144321; Gallagher KS, 2011, WIRES CLIM CHANGE, V2, P373, DOI 10.1002/wcc.112; Gompers P, 2001, J ECON PERSPECT, V15, P145, DOI 10.1257/jep.15.2.145; GRILICHES Z, 1990, J ECON LIT, V28, P1661, DOI 10.3386/w3301; Hall BH, 2002, OXFORD REV ECON POL, V18, P35, DOI 10.1093/oxrep/18.1.35; Henderson R., 2011, ACCELERATING ENERGY; Hoffert MI, 1998, NATURE, V395, P881, DOI 10.1038/27638; JAFFE AB, 1986, AM ECON REV, V76, P984; Jamasb T, 2007, ENERG J, V28, P51; Johnstone N, 2010, ENVIRON RESOUR ECON, V45, P133, DOI 10.1007/s10640-009-9309-1; Koh H, 2008, TECHNOL FORECAST SOC, V75, P735, DOI 10.1016/j.techfore.2007.05.007; Kortum S, 2000, RAND J ECON, V31, P674, DOI 10.2307/2696354; Margolis RM, 1999, SCIENCE, V285, P690, DOI 10.1126/science.285.5428.690; Margolis RM, 1999, ENERG POLICY, V27, P575, DOI 10.1016/S0301-4215(99)00053-1; McNerney J, 2011, ENERG POLICY, V39, P3042, DOI 10.1016/j.enpol.2011.01.037; National Academy of Engineering: Committee on America's Energy Future, 2009, TECHNICAL REPORT; Nemet GF, 2007, ENERG POLICY, V35, P746, DOI 10.1016/j.enpol.2005.12.012; Nemet GF, 2010, ENERG POLICY, V38, P7216, DOI 10.1016/j.enpol.2010.07.052; Newell RG, 2011, ENERGY INNOVATION SY; Newell RG, 2010, OXFORD REV ECON POL, V26, P253, DOI 10.1093/oxrep/grq009; Nuvolari A, 2011, EXPLOR ECON HIST, V48, P97, DOI 10.1016/j.eeh.2010.09.005; Popp D, 2010, HBK ECON, V2, P873, DOI 10.1016/S0169-7218(10)02005-8; Programme UNE, 2010, TECHNICAL REPORT; RUTTAN VW, 1959, Q J ECON, V73, P596, DOI 10.2307/1884305; Schmookler J., 1966, INVENTION EC GROWTH; Strumsky D, 2010, SYST RES BEHAV SCI, V27, P496, DOI 10.1002/sres.1057; The Pew Charitable Trust, 2010, TECHNICAL REPORT; Trajtenberg, 2002, PATENTS CITATIONS IN, DOI 10.7551/mitpress/5263.001.0001; Trancik JE, 2006, ENVIRON RES LETT, V1, DOI 10.1088/1748-9326/1/1/014009; World Intellectual Property Organization, 2008, TECHNICAL REPORT	40	46	46	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e67864	10.1371/journal.pone.0067864	http://dx.doi.org/10.1371/journal.pone.0067864			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155867	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300001
J	Bik, HM; Fournier, D; Sung, W; Bergeron, RD; Thomas, WK				Bik, Holly M.; Fournier, David; Sung, Way; Bergeron, R. Daniel; Thomas, W. Kelley			Intra-Genomic Variation in the Ribosomal Repeats of Nematodes	PLOS ONE			English	Article							RDNA COPY NUMBER; RNA GENE; CONCERTED EVOLUTION; SEQUENCE VARIATION; SACCHAROMYCES-CEREVISIAE; INTRAGENOMIC VARIATION; MUTATION-RATE; DNA REPEATS; SIZE; RECOMBINATION	Ribosomal loci represent a major tool for investigating environmental diversity and community structure via high-throughput marker gene studies of eukaryotes (e. g. 18S rRNA). Since the estimation of species' abundance is a major goal of environmental studies (by counting numbers of sequences), understanding the patterns of rRNA copy number across species will be critical for informing such high-throughput approaches. Such knowledge is critical, given that ribosomal RNA genes exist within multi-copy repeated arrays in a genome. Here we measured the repeat copy number for six nematode species by mapping the sequences from whole genome shotgun libraries against reference sequences for their rRNA repeat. This revealed a 6-fold variation in repeat copy number amongst taxa investigated, with levels of intragenomic variation ranging from 56 to 323 copies of the rRNA array. By applying the same approach to four C. elegans mutation accumulation lines propagated by repeated bottlenecking for an average of similar to 400 generations, we find on average a 2-fold increase in repeat copy number (rate of increase in rRNA estimated at 0.0285-0.3414 copies per generation), suggesting that rRNA repeat copy number is subject to selection. Within each Caenorhabditis species, the majority of intragenomic variation found across the rRNA repeat was observed within gene regions (18S, 28S, 5.8S), suggesting that such intragenomic variation is not a product of selection for rRNA coding function. We find that the dramatic variation in repeat copy number among these six nematode genomes would limit the use of rRNA in estimates of organismal abundance. In addition, the unique pattern of variation within a single genome was uncorrelated with patterns of divergence between species, reflecting a strong signature of natural selection for rRNA function. A better understanding of the factors that control or affect copy number in these arrays, as well as their rates and patterns of evolution, will be critical for informing estimates of global biodiversity.	[Bik, Holly M.] Univ Calif Davis, Union Council Davis Genome Ctr, Davis, CA 95616 USA; [Bik, Holly M.; Sung, Way; Thomas, W. Kelley] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA; [Fournier, David; Bergeron, R. Daniel] Univ New Hampshire, Dept Comp Sci, Durham, NH 03824 USA; [Sung, Way] Indiana Univ, Dept Biol, Bloomington, IN USA	University of California System; University of California Davis; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Indiana University System; Indiana University Bloomington	Bik, HM (corresponding author), Univ Calif Davis, Union Council Davis Genome Ctr, Davis, CA 95616 USA.	holly.bik@gmail.com		Bik, Holly/0000-0002-4356-3837	NSF RAPID award [DEB-1058458]; New Hampshire INBRE [NIH-1P20RR030360-01]; New England Cyberinfrastructure Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR030360] Funding Source: NIH RePORTER	NSF RAPID award; New Hampshire INBRE; New England Cyberinfrastructure Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NSF RAPID award DEB-1058458, New Hampshire INBRE (NIH-1P20RR030360-01), and a Regional Award for Cyber-enabled Research (RACER) awarded by the New England Cyberinfrastructure Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Averbeck KT, 2005, GENETICS, V171, P1837, DOI 10.1534/genetics.105.047670; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Birnstiel M L, 1971, Prog Nucleic Acid Res Mol Biol, V11, P351, DOI 10.1016/S0079-6603(08)60332-3; Bosco G, 2007, GENETICS, V177, P1277, DOI 10.1534/genetics.107.075069; Carranza S, 1999, J MOL EVOL, V49, P250, DOI 10.1007/PL00006547; Cavalier-Smith T., 1985, P69; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Fenton B, 1998, GENOME, V41, P337, DOI 10.1139/gen-41-3-337; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; GALL JG, 1981, J CELL BIOL, V91, pS3, DOI 10.1083/jcb.91.3.3s; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; Ganley ARD, 2011, MOL BIOL EVOL, V28, P2883, DOI 10.1093/molbev/msr117; Glass SK, 2008, GENOME, V51, P988, DOI 10.1139/G08-092; Grishkevich V, 2011, GENOME RES, V21, P707, DOI 10.1101/gr.113381.110; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Houseley J, 2011, NUCLEIC ACIDS RES, V39, P8778, DOI 10.1093/nar/gkr589; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; Keller I, 2008, EVOLUTION, V62, P833, DOI 10.1111/j.1558-5646.2008.00320.x; Keller I, 2006, GENETICS, V174, P863, DOI 10.1534/genetics.106.061341; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kobayashi T, 2011, CELL MOL LIFE SCI, V68, P1395, DOI 10.1007/s00018-010-0613-2; Leroy S, 2003, MOL BIOCHEM PARASIT, V128, P91, DOI 10.1016/S0166-6851(03)00023-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim KY, 2000, CHROMOSOMA, V109, P161; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; LONG EO, 1979, CELL, V18, P1185, DOI 10.1016/0092-8674(79)90231-9; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; MALESZKA R, 1990, MOL GEN GENET, V223, P342, DOI 10.1007/BF00265074; McTaggart S, 2007, GENETICS, V175, P311, DOI 10.1534/genetics.105.050229; Michel AH, 2005, GENE DEV, V19, P1199, DOI 10.1101/gad.340205; Paredes S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001376; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Reeder RH, 1999, PROG NUCLEIC ACID RE, V62, P293; RITOSSA FM, 1968, P NATL ACAD SCI USA, V60, P509, DOI 10.1073/pnas.60.2.509; Rooney AP, 2004, MOL BIOL EVOL, V21, P1704, DOI 10.1093/molbev/msh178; Simon UK, 2008, MOL BIOL EVOL, V25, P2251, DOI 10.1093/molbev/msn188; Stage DE, 2007, GENOME RES, V17, P1888, DOI 10.1101/gr.6376807; Sung W, 2012, P NATL ACAD SCI USA, V109, P18488, DOI 10.1073/pnas.1216223109; TARTOF KD, 1973, GENETICS, V73, P57; TERRACOL R, 1981, BIOCHIMIE, V63, P451, DOI 10.1016/S0300-9084(81)80020-X; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; VanKuren NW, 2013, EVOLUTION, V67, P207, DOI 10.1111/j.1558-5646.2012.01747.x; Veltsos P, 2009, HEREDITY, V103, P54, DOI 10.1038/hdy.2009.32; Weider LJ, 2005, ANNU REV ECOL EVOL S, V36, P219, DOI 10.1146/annurev.ecolsys.36.102003.152620; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	66	67	69	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78230	10.1371/journal.pone.0078230	http://dx.doi.org/10.1371/journal.pone.0078230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147124	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400148
J	Gaudin, A; Farnoux, C; Bonnard, A; Alison, M; Maury, L; Biran, V; Baud, O				Gaudin, Aurelie; Farnoux, Caroline; Bonnard, Arnaud; Alison, Marianne; Maury, Laure; Biran, Valerie; Baud, Olivier			Necrotizing Enterocolitis (NEC) and the Risk of Intestinal Stricture: The Value of C-Reactive Protein	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; SURGICAL-MANAGEMENT; UNITED-STATES; EPIDEMIOLOGY; PERFORATION; MORTALITY; OUTCOMES; NEWBORN; TRENDS	Necrotizing enterocolitis (NEC) is a severe complication frequently seen during the neonatal period associated with high mortality rate and severe and prolonged morbidity including Post-NEC intestinal stricture. The aim of this study is to define the incidence and risk factors of these post-NEC strictures, in order to better orient their medicosurgical care. Sixty cases of NEC were retrospectively reviewed from a single tertiary center with identical treatment protocols throughout the period under study, including systematic X-ray contrast study. This study reports a high rate of post-NEC intestinal stricture (n = 27/48; 57% of survivors), either in cases treated surgically (91%) and after the medical treatment of NEC (47%). A colonic localization of the strictures was more frequent in medically-treated patients than in those with NEC treated surgically (87% vs. 50%). The length of the strictures was significantly shorter in case of NEC treated medically. No deaths were attributable to the presence of post-NEC stricture. The mean hospitalization time in NICU and the median age at discontinuation of parenteral nutrition were longer in the group with stricture, but this difference was not significant. The median age at discharge was significantly higher in the group with stricture (p = 0.02). The occurrence of post-NEC stricture was significantly associated with the presence of parietal signs of inflammation and thrombopenia (<100 000 platelets/mm(3)). The mean maximum CRP concentration during acute phase was significantly higher in infants who developed stricture (p<0.001), as was the mean duration of the elevation of CRP levels (p<0.001). The negative predictive value of CRP levels continually <10 mg/dL for the appearance of stricture was 100% in our study. In conclusion, this retrospective and monocentric study demonstrates the correlation between the intensity of the inflammatory syndrome and the risk of secondary intestinal stricture, when systematic contrast study is performed following NEC.	[Gaudin, Aurelie; Farnoux, Caroline; Maury, Laure; Biran, Valerie; Baud, Olivier] Robert Debre Children Univ Hosp, Neonatal Intens Care Unit, Paris, France; [Gaudin, Aurelie; Farnoux, Caroline; Bonnard, Arnaud; Alison, Marianne; Maury, Laure; Biran, Valerie; Baud, Olivier] Denis Diderot Paris Univ, APHP, Paris, France; [Bonnard, Arnaud] Robert Debre Children Univ Hosp, Dept Gen Pediat Surg, Paris, France; [Alison, Marianne] Robert Debre Children Univ Hosp, Dept Pediat Radiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Baud, O (corresponding author), Robert Debre Children Univ Hosp, Neonatal Intens Care Unit, Paris, France.	olivier.baud@rdb.aphp.fr	Biran, Valerie/GQY-8192-2022; Alison, Marianne/A-2253-2016	Alison, Marianne/0000-0002-9245-9390				Baudon JJ, 1997, ARCH PEDIATRIE, V4, P305, DOI 10.1016/S0929-693X(97)86445-7; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; BELL MJ, 1976, J PEDIATR SURG, V11, P319, DOI 10.1016/S0022-3468(76)80185-6; Bisquera JA, 2002, PEDIATRICS, V109, P423, DOI 10.1542/peds.109.3.423; Blakely ML, 2005, ANN SURG, V241, P984, DOI 10.1097/01.sla.0000164181.67862.7f; Bohnhorst B, 2003, J PEDIATR-US, V143, P484, DOI 10.1067/S0022-3476(03)00443-8; BORN M, 1985, J PEDIATR SURG, V20, P461, DOI 10.1016/S0022-3468(85)80242-6; EVRARD J, 1991, EUR J PEDIATR, V150, P757, DOI 10.1007/BF02026705; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Guthrie Scott O, 2003, J Perinatol, V23, P278, DOI 10.1038/sj.jp.7210892; HARTMAN GE, 1988, J PEDIATR SURG, V23, P562, DOI 10.1016/S0022-3468(88)80369-5; HELOURY Y, 1987, CHIR PEDIATR, V28, P209; Henry MCW, 2009, ANNU REV MED, V60, P111, DOI 10.1146/annurev.med.60.050207.092824; Holman RC, 1997, AM J PUBLIC HEALTH, V87, P2026, DOI 10.2105/AJPH.87.12.2026; Holman RC, 2006, PAEDIATR PERINAT EP, V20, P498, DOI 10.1111/j.1365-3016.2006.00756.x; Horbar JD, 2002, PEDIATRICS, V110, P143, DOI 10.1542/peds.110.1.143; HORWITZ JR, 1995, J PEDIATR SURG, V30, P994, DOI 10.1016/0022-3468(95)90328-3; Hunter CJ, 2008, J PERINATOL, V28, pS14, DOI 10.1038/jp.2008.44; JANIK JS, 1981, J PEDIATR SURG, V16, P438, DOI 10.1016/S0022-3468(81)80002-4; Kafetzis DA, 2003, CURR OPIN INFECT DIS, V16, P349, DOI 10.1097/00001432-200308000-00007; KOSLOSKE AM, 1980, ANN SURG, V192, P202, DOI 10.1097/00000658-198008000-00013; KRASNA IH, 1970, J PEDIATR SURG, V5, P200, DOI 10.1016/0022-3468(70)90276-9; Lamireau T, 1996, ARCH PEDIATRIE, V3, P9, DOI 10.1016/S0929-693X(96)80002-9; Lapillonne A, 1997, ARCH PEDIATRIE, V4, P1150, DOI 10.1016/S0929-693X(97)88994-4; LEMELLE JL, 1994, ACTA PAEDIATR, V83, P70, DOI 10.1111/j.1651-2227.1994.tb13248.x; Llanos AR, 2002, PAEDIATR PERINAT EP, V16, P342, DOI 10.1046/j.1365-3016.2002.00445.x; Luig M, 2005, J PAEDIATR CHILD H, V41, P174, DOI 10.1111/j.1440-1754.2005.00583.x; Luzzatto C, 1996, EUR J PEDIATR SURG, V6, P92, DOI 10.1055/s-2008-1066479; Moss RL, 2008, J PERINATOL, V28, P665, DOI 10.1038/jp.2008.119; Moss RL, 2006, NEW ENGL J MED, V354, P2225, DOI 10.1056/NEJMoa054605; Petty John K, 2005, Semin Pediatr Surg, V14, P191, DOI 10.1053/j.sempedsurg.2005.05.009; Pierro A, 2005, EARLY HUM DEV, V81, P79, DOI 10.1016/j.earlhumdev.2004.10.018; Pourcyrous M, 2005, PEDIATRICS, V116, P1064, DOI 10.1542/peds.2004-1806; RABINOWITZ JG, 1968, AMER J ROENTGENOL RA, V103, P359, DOI 10.2214/ajr.103.2.359; Rees CM, 2008, ARCH DIS CHILD-FETAL, V93, pF395, DOI 10.1136/adc.2007.136994; Rees CM, 2007, ARCH DIS CHILD-FETAL, V92, pF193, DOI 10.1136/adc.2006.099929; Rees CM, 2005, ARCH DIS CHILD-FETAL, V90, P152, DOI 10.1136/adc.2004.051862; RYDER RW, 1980, AM J EPIDEMIOL, V112, P113, DOI 10.1093/oxfordjournals.aje.a112960; SANTULLI TV, 1975, PEDIATRICS, V55, P376; SCHIMPL G, 1994, ACTA PAEDIATR, V83, P80, DOI 10.1111/j.1651-2227.1994.tb13251.x; SCHWARTZ MA, 1980, J AM CHEM SOC, V102, P890, DOI 10.1021/ja00522a603; SCHWARTZ MZ, 1982, J PEDIATR SURG, V17, P764, DOI 10.1016/S0022-3468(82)80443-0; STOLL BJ, 1980, J PEDIATR-US, V96, P447; Thyoka M, 2011, J PEDIATR SURG, V46, P1041, DOI 10.1016/j.jpedsurg.2011.03.024; Walsh M, 2006, FANAROFF MARTINS NEO, P1403; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6	46	19	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76858	10.1371/journal.pone.0076858	http://dx.doi.org/10.1371/journal.pone.0076858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146936	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400087
J	Harris, JBC; Haskell, DG				Harris, J. Berton C.; Haskell, David G.			Simulated Birdwatchers' Playback Affects the Behavior of Two Tropical Birds	PLOS ONE			English	Article							MALE SONG; PLASMA-LEVELS; TESTOSTERONE; GRALLARIA; STRESS; COSTS	Although recreational birdwatchers may benefit conservation by generating interest in birds, they may also have negative effects. One such potentially negative impact is the widespread use of recorded vocalizations, or "playback," to attract birds of interest, including range-restricted and threatened species. Although playback has been widely used to test hypotheses about the evolution of behavior, no peer-reviewed study has examined the impacts of playback in a birdwatching context on avian behavior. We studied the effects of simulated birdwatchers' playback on the vocal behavior of Plain-tailed Wrens Thryothorus euophrys and Rufous Antpittas Grallaria rufula in Ecuador. Study species' vocal behavior was monitored for an hour after playing either a single bout of five minutes of song or a control treatment of background noise. We also studied the effects of daily five minute playback on five groups of wrens over 20 days. In single bout experiments, antpittas made more vocalizations of all types, except for trills, after playback compared to controls. Wrens sang more duets after playback, but did not produce more contact calls. In repeated playback experiments, wren responses were strong at first, but hardly detectable by day 12. During the study, one study group built a nest, apparently unperturbed, near a playback site. The playback-induced habituation and changes in vocal behavior we observed suggest that scientists should consider birdwatching activity when selecting research sites so that results are not biased by birdwatchers' playback. Increased vocalizations after playback could be interpreted as a negative effect of playback if birds expend energy, become stressed, or divert time from other activities. In contrast, the habituation we documented suggests that frequent, regular birdwatchers' playback may have minor effects on wren behavior.	[Harris, J. Berton C.] Fdn Conservac, Jocotoco, Quito, Ecuador; [Harris, J. Berton C.] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Haskell, David G.] Univ South, Dept Biol, Sewanee, TN 37375 USA	Princeton University; Sewanee: University of the South	Harris, JBC (corresponding author), Fdn Conservac, Jocotoco, Quito, Ecuador.	johnbh@princeton.edu			Jocotoco Foundation	Jocotoco Foundation	This research was funded by the Jocotoco Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Birding Association, 2012, COD ETH; Bates D., 2010, LME4 LINEAR MIXED EF; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Bradshaw CJA, 2010, CONSERVATION BIOLOGY FOR ALL, P313; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Crawley M.J., 2007, R BOOK; Deeble B, 1999, ROSE THROATED BECARD, P6; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Emanuel Victor Nature Tours, 2012, VENT BIRD TOURS; Game Arizona and Fish Department, 2001, PACHYRAMPHUS A UNPUB; Greeney Harold F., 2010, Bulletin of the British Ornithologists' Club, V130, P61; Harris J.B.C., 2012, RAFFLES B ZOOL, V25, P189; Jepson P, 2011, B AFRICAN BIRD CLUB; Juina ME, 2009, ORNITOL NEOTROP, V20, P305; Krabbe N, 1999, AUK, V116, P882, DOI 10.2307/4089669; Krabbe N.K., 2003, P682; KROODSMA D. E., 2005, HDB BIRDS WORLD, V10, P356; Langham GM, 2006, ECOSCIENCE, V13, P485, DOI 10.2980/1195-6860(2006)13[485:WPWTPS]2.0.CO;2; Mann NI, 2006, BIOL LETTERS, V2, P1, DOI 10.1098/rsbl.2005.0373; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Michigan Department of Natural Resources, 2003, KIRTL WARBL DENDR KI; Mota PG, 2004, ETHOLOGY, V110, P841, DOI 10.1111/j.1439-0310.2004.01032.x; Mullner A, 2004, BIOL CONSERV, V118, P549, DOI 10.1016/j.biocon.2003.10.003; NORRIS K, 1993, J ANIM ECOL, V62, P287, DOI 10.2307/5360; Pinheiro J, 2010, PACKAGE NLME LINEAR; Quantrill B, 1998, B AFRICAN BIRD CLUB, P137; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ralph CJ, 1995, PSWGTR149 US FOR SER; Ridgely RS, 2001, THE BIRDS OF ECUADOR; Royal Society for the Protection of Birds, 2006, BIRDS HAB LAW; Scheipl F, 2010, PACKAGE RLRSIM EXACT; Sekercioglu C.H., 2003, BIRDING, V35, P394; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Sen SK, 2009, ETHICS SCI BIRD CALL; Sibley David, 2011, PROPER USE PLAYBACK; Thomas RJ, 2002, ANIM BEHAV, V63, P959, DOI 10.1006/anbe.2001.1969; Thomas RJ, 2003, BEHAVIOUR, V140, P387, DOI 10.1163/156853903321826693; Ward MP, 2004, CONSERV BIOL, V18, P519, DOI 10.1111/j.1523-1739.2004.00494.x; Water Melbourne, 2012, BIRD WATCH PERM; WINGFIELD JC, 1995, ZOOL SCI, V12, P615, DOI 10.2108/zsj.12.615; WINGFIELD JC, 1985, HORM BEHAV, V19, P174, DOI 10.1016/0018-506X(85)90017-0; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WINGFIELD JC, 1989, J COMP PHYSIOL A, V166, P189; Wingfield JC, 2001, BRAIN BEHAV EVOLUT, V57, P239, DOI 10.1159/000047243; de Lima AMX, 2009, REV BRAS ORNITOL, V17, P37; Zuur Alain F., 2009, P1	46	22	23	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77902	10.1371/journal.pone.0077902	http://dx.doi.org/10.1371/journal.pone.0077902			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147094	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400141
J	Kutscher, S; Dembek, CJ; Deckert, S; Russo, C; Korber, N; Bogner, JR; Geisler, F; Umgelter, A; Neuenhahn, M; Albrecht, J; Cosma, A; Protzer, U; Bauer, T				Kutscher, Sarah; Dembek, Claudia J.; Deckert, Simone; Russo, Carolina; Koerber, Nina; Bogner, Johannes R.; Geisler, Fabian; Umgelter, Andreas; Neuenhahn, Michael; Albrecht, Julia; Cosma, Antonio; Protzer, Ulrike; Bauer, Tanja			Overnight Resting of PBMC Changes Functional Signatures of Antigen Specific T-Cell Responses: Impact for Immune Monitoring within Clinical Trials	PLOS ONE			English	Article							OPTIMIZATION; SENSITIVITY; VACCINE	Polyfunctional CD4 or CD8 T cells are proposed to represent a correlate of immune control for persistent viruses as well as for vaccine mediated protection against infection. A well-suited methodology to study complex functional phenotypes of antiviral T cells is the combined staining of intracellular cytokines and phenotypic marker expression using polychromatic flow cytometry. In this study we analyzed the effect of an overnight resting period at 37 degrees C on the quantity and functionality of HIV-1, EBV, CMV, HBV and HCV specific CD4 and CD8 T-cell responses in a cohort of 21 individuals. We quantified total antigen specific T cells by multimer staining and used 10-color intracellular cytokine staining (ICS) to determine IFN gamma, TNF alpha, IL2 and MIP1 beta production. After an overnight resting significantly higher numbers of functionally active T cells were detectable by ICS for all tested antigen specificities, whereas the total number of antigen specific T cells determined by multimer staining remained unchanged. Overnight resting shifted the quality of T-cell responses towards polyfunctionality and increased antigen sensitivity of T cells. Our data suggest that the observed effect is mediated by T cells rather than by antigen presenting cells. We conclude that overnight resting of PBMC prior to ex vivo analysis of antiviral T-cell responses represents an efficient method to increase sensitivity of ICS-based methods and has a prominent impact on the functional phenotype of T cells.	[Kutscher, Sarah; Dembek, Claudia J.; Deckert, Simone; Russo, Carolina; Koerber, Nina; Protzer, Ulrike; Bauer, Tanja] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany; [Kutscher, Sarah; Dembek, Claudia J.; Deckert, Simone; Neuenhahn, Michael; Albrecht, Julia; Protzer, Ulrike; Bauer, Tanja] Helmholtz Zentrum Munchen, Cooperat Grp Immune Monitoring, Munich, Germany; [Bogner, Johannes R.] Univ Munich, Dept Infect Dis, Med Klin & Poliklin, Univ Hosp Munich, Munich, Germany; [Geisler, Fabian; Umgelter, Andreas] Tech Univ Munich, Klinikum Rechts Isar, Dept Internal Med 2, D-80290 Munich, Germany; [Neuenhahn, Michael; Albrecht, Julia] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Cosma, Antonio] CEA, Div Immunovirol, Paris, France; [Dembek, Claudia J.] German Ctr Infect Res DZIF, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Technical University of Munich; CEA; German Center for Infection Research	Bauer, T (corresponding author), Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munchen, D-80290 Munich, Germany.	tanja.bauer@helmholtz-muenchen.de	Protzer, Ulrike/D-5915-2015	Protzer, Ulrike/0000-0002-9421-1911; Cosma, Antonio/0000-0002-3686-8034				Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Britten CM, 2011, CANCER IMMUNOL IMMUN, V60, P15, DOI 10.1007/s00262-010-0940-z; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; Gascoigne NRJ, 2008, NAT REV IMMUNOL, V8, P895, DOI 10.1038/nri2431; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Kutscher S, 2010, GENE THER, V17, P1372, DOI 10.1038/gt.2010.90; Lamoreaux L, 2006, NAT PROTOC, V1, P1507, DOI 10.1038/nprot.2006.268; Maecker HT, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-13; Malnati MS, 2012, J IMMUNOL METHODS, V375, P46, DOI 10.1016/j.jim.2011.09.005; Morgan C, 2008, PLOS MED, V5, P1200, DOI 10.1371/journal.pmed.0050173; Owen RE, 2007, J IMMUNOL METHODS, V326, P93, DOI 10.1016/j.jim.2007.07.012; Pantaleo G, 2006, NAT REV IMMUNOL, V6, P417, DOI 10.1038/nri1840; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Suni Maria A, 2003, BMC Immunol, V4, P9, DOI 10.1186/1471-2172-4-9; van der Burg SH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002785; Vigano S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/153863; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741	23	39	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76215	10.1371/journal.pone.0076215	http://dx.doi.org/10.1371/journal.pone.0076215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146841	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400048
J	Soyiri, IN; Reidpath, DD				Soyiri, Ireneous N.; Reidpath, Daniel D.			The Use of Quantile Regression to Forecast Higher Than Expected Respiratory Deaths in a Daily Time Series: A Study of New York City Data 1987-2000	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; AIR-POLLUTION; DAILY MORTALITY; HEALTH; PREDICTION; MODELS; OZONE; CARE	Forecasting higher than expected numbers of health events provides potentially valuable insights in its own right, and may contribute to health services management and syndromic surveillance. This study investigates the use of quantile regression to predict higher than expected respiratory deaths. Data taken from 70,830 deaths occurring in New York were used. Temporal, weather and air quality measures were fitted using quantile regression at the 90th-percentile with half the data (in-sample). Four QR models were fitted: an unconditional model predicting the 90th-percentile of deaths (Model 1), a seasonal / temporal (Model 2), a seasonal, temporal plus lags of weather and air quality (Model 3), and a seasonal, temporal model with 7-day moving averages of weather and air quality. Models were cross-validated with the out of sample data. Performance was measured as proportionate reduction in weighted sum of absolute deviations by a conditional, over unconditional models; i.e., the coefficient of determination (R1). The coefficient of determination showed an improvement over the unconditional model between 0.16 and 0.19. The greatest improvement in predictive and forecasting accuracy of daily mortality was associated with the inclusion of seasonal and temporal predictors (Model 2). No gains were made in the predictive models with the addition of weather and air quality predictors (Models 3 and 4). However, forecasting models that included weather and air quality predictors performed slightly better than the seasonal and temporal model alone (i.e., Model 3 > Model 4 > Model 2) This study provided a new approach to predict higher than expected numbers of respiratory related-deaths. The approach, while promising, has limitations and should be treated at this stage as a proof of concept.	[Soyiri, Ireneous N.; Reidpath, Daniel D.] Monash Univ, Sch Med & Hlth Sci, SEACO, Kuala Lumpur, Malaysia; [Soyiri, Ireneous N.; Reidpath, Daniel D.] Monash Univ, Sch Med & Hlth Sci, Kuala Lumpur, Malaysia	Monash University; Monash University Sunway; Monash University; Monash University Sunway	Reidpath, DD (corresponding author), Monash Univ, Sch Med & Hlth Sci, SEACO, Kuala Lumpur, Malaysia.	daniel.reidpath@monash.edu	Soyiri, Ireneous N./H-4594-2011; Soyiri, Ireneous/AAE-7617-2019	Soyiri, Ireneous N./0000-0003-4697-5156; Soyiri, Ireneous/0000-0003-4697-5156; Reidpath, Daniel/0000-0002-8796-0420				BARNETT AG, 2010, ANAL SEASONAL HLTH D, P168; Beyerlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033205; Beyerlein A, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-59; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Burgette LF, 2011, EPIDEMIOLOGY, V22, P859, DOI 10.1097/EDE.0b013e31822908b3; Chatterjee C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004726; Cheng YX, 2012, J EPIDEMIOL, V22, P28, DOI 10.2188/jea.JE20110049; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Dominici F, 2005, J TOXICOL ENV HEAL A, V68, P1071, DOI 10.1080/15287390590935932; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; HAO L, 2007, QUANTILE REGRESSION, P139; Kam HJ, 2010, HEALTHC INFORM RES, V16, P158, DOI 10.4258/hir.2010.16.3.158; Koenker R, 2006, J AM STAT ASSOC, V101, P980, DOI 10.1198/016214506000000672; Machado JAF, 2005, J AM STAT ASSOC, V100, P1226, DOI 10.1198/016214505000000330; Metzger KB, 2010, ENVIRON HEALTH PERSP, V118, P80, DOI 10.1289/ehp.0900906; Peng RD, 2005, AM J EPIDEMIOL, V161, P585, DOI 10.1093/aje/kwi075; PENG RD, 2004, R NEWS, V4, P10; Rajarathnam Uma, 2011, Res Rep Health Eff Inst, P47; SOYIRI IN, 2012, INT J BIOMETEOROL, V57, P1; Soyiri IN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047823; Soyiri IN, 2012, INT J GEN MED, V5, P693, DOI 10.2147/IJGM.S34647; Stieb DM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-25; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Sun Y, 2012, ANN EMERG MED, V60, P299, DOI 10.1016/j.annemergmed.2012.03.011; Tao YB, 2012, ENVIRON HEALTH PERSP, V120, P393, DOI 10.1289/ehp.1103715; Wehby GL, 2009, HEALTH POLICY PLANN, V24, P175, DOI 10.1093/heapol/czp005; Winkelmann R, 2006, J HEALTH ECON, V25, P131, DOI 10.1016/j.jhealeco.2005.03.005; Yang CX, 2012, SCI TOTAL ENVIRON, V426, P83, DOI 10.1016/j.scitotenv.2012.03.036; Zeger SL, 2006, ANNU REV PUBL HEALTH, V27, P57, DOI 10.1146/annurev.publhealth.26.021304.144517; Zibners LM, 2006, PEDIATR EMERG CARE, V22, P104, DOI 10.1097/01.pec.0000199561.34475.29	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78215	10.1371/journal.pone.0078215	http://dx.doi.org/10.1371/journal.pone.0078215			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147122	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400147
J	Quintavalle, C; Mangani, D; Roscigno, G; Romano, G; Diaz-Lagares, A; Iaboni, M; Donnarumma, E; Fiore, D; De Marinis, P; Soini, Y; Esteller, M; Condorelli, G				Quintavalle, Cristina; Mangani, Davide; Roscigno, Giuseppina; Romano, Giulia; Diaz-Lagares, Angel; Iaboni, Margherita; Donnarumma, Elvira; Fiore, Danilo; De Marinis, Pasqualino; Soini, Ylermi; Esteller, Manel; Condorelli, Gerolama			miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells	PLOS ONE			English	Article							PROMOTER METHYLATION; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMAS; GLIOBLASTOMA; CANCER; MICRORNAS; MICE; OVEREXPRESSION; TUMORIGENESIS	Glioblastoma multiforme (GBM) is one of the most deadly types of cancer. To date, the best clinical approach for treatment is based on administration of temozolomide (TMZ) in combination with radiotherapy. Much evidence suggests that the intracellular level of the alkylating enzyme O-6-methylguanine-DNA methyltransferase (MGMT) impacts response to TMZ in GBM patients. MGMT expression is regulated by the methylation of its promoter. However, evidence indicates that this is not the only regulatory mechanism present. Here, we describe a hitherto unknown microRNA-mediated mechanism of MGMT expression regulation. We show that miR-221 and miR-222 are upregulated in GMB patients and that these paralogues target MGMT mRNA, inducing greater TMZ-mediated cell death. However, miR-221/miR-222 also increase DNA damage and, thus, chromosomal rearrangements. Indeed, miR-221 overexpression in glioma cells led to an increase in markers of DNA damage, an effect rescued by reexpression of MGMT. Thus, chronic miR-221/222-mediated MGMT downregulation may render cells unable to repair genetic damage. This, associated also to miR-221/222 oncogenic potential, may poor GBM prognosis.	[Quintavalle, Cristina; Mangani, Davide; Roscigno, Giuseppina; Iaboni, Margherita; Fiore, Danilo; Condorelli, Gerolama] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Quintavalle, Cristina; Roscigno, Giuseppina; Condorelli, Gerolama] CNR, IEOS, I-80125 Naples, Italy; [Romano, Giulia; Donnarumma, Elvira] Fdn IRCCS SDN, Naples, Italy; [Diaz-Lagares, Angel; Esteller, Manel] Hosp Duran & Reynals, Epigenet & Canc Biol Program PEBC IDIBELL, Barcelona, Spain; [De Marinis, Pasqualino] Osped Cardarelli, Naples, Italy; [Soini, Ylermi] Univ Eastern Finland, Canc Ctr Eastern Finland, Inst Clin Med Pathol & Forens Med, Dept Pathol & Forens Med,Sch Med, Kuopio, Finland	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Antonio Cardarelli Hospital; University of Eastern Finland	Condorelli, G (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.	gecondor@unina.it	Fiore, Danilo/A-6002-2019; Quintavalle, Cristina/AHH-9379-2022; Esteller, Manel/L-5956-2014; Condorelli, Gerolama/AAC-3472-2022; Mangani, Davide/A-3383-2017	Fiore, Danilo/0000-0003-3004-6862; Esteller, Manel/0000-0003-4490-6093; Condorelli, Gerolama/0000-0003-0177-8829; Mangani, Davide/0000-0001-5297-0234; Roscigno, Giuseppina/0000-0002-5359-6376	Associazione Italiana Ricerca sul Cancro [10620]; MERIT [RBNE08E8CZ_002]; POR Campania; Project CREME; "Federazione Italiana Ricerca sul Cancro" Post-Doctoral Research Fellowship; Xunta de Galicia and European Social Fund; Sara Borrell postdoctoral contract from the Instituto de Salud Carlos III at the Spanish Ministry of Economy and Competitiveness [CD12/00738]	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MERIT; POR Campania(Regione Campania); Project CREME; "Federazione Italiana Ricerca sul Cancro" Post-Doctoral Research Fellowship(Fondazione AIRC per la ricerca sul cancro); Xunta de Galicia and European Social Fund; Sara Borrell postdoctoral contract from the Instituto de Salud Carlos III at the Spanish Ministry of Economy and Competitiveness	This work was partially supported by funds from Associazione Italiana Ricerca sul Cancro, to GC (grant n.ro 10620), MERIT (RBNE08E8CZ_002) to GC, POR Campania FSE 2007-2013, Project CREME to GC. CQ and MI was supported by the "Federazione Italiana Ricerca sul Cancro" Post-Doctoral Research Fellowship. GR was supported by a MERIT project Fellowship. ADL was supported by the Angeles Alvarino-2009 postdoctoral fellowship from the Xunta de Galicia and European Social Fund and at present is the recipient of a Sara Borrell postdoctoral contract (CD12/00738) from the Instituto de Salud Carlos III at the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allay E, 1999, ONCOGENE, V18, P3783, DOI 10.1038/sj.onc.1202697; Bignami M, 2000, MUTAT RES-REV MUTAT, V462, P71, DOI 10.1016/S1383-5742(00)00016-8; Blough MD, 2007, CANCER RES, V67, P580, DOI 10.1158/0008-5472.CAN-06-2782; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Dunn J, 2009, BRIT J CANCER, V101, P124, DOI 10.1038/sj.bjc.6605127; Esteller M, 1999, CANCER RES, V59, P793; Garofalo M, 2012, CURR MOL MED, V12, P27, DOI 10.2174/156652412798376170; Garofalo M, 2010, CELL DEATH DIFFER, V17, P200, DOI 10.1038/cdd.2009.105; Garofalo M, 2012, NAT MED, V18, P74, DOI 10.1038/nm.2577; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Garofalo M, 2008, CURR OPIN PHARMACOL, V8, P661, DOI 10.1016/j.coph.2008.06.005; Gerson SL, 2002, J CLIN ONCOL, V20, P2388, DOI 10.1200/JCO.2002.06.110; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Quintavalle C, 2012, ONCOGENE, V31, P858, DOI 10.1038/onc.2011.280; Reese JS, 2001, ONCOGENE, V20, P5258, DOI 10.1038/sj.onc.1204700; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Sakumi K, 1997, CANCER RES, V57, P2415; Sandercock LE, 2008, CARCINOGENESIS, V29, P866, DOI 10.1093/carcin/bgn030; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2013, NAT REV CLIN ONCOL, V10, P69, DOI 10.1038/nrclinonc.2012.240; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takagi Y, 2003, DNA REPAIR, V2, P1135, DOI 10.1016/S1568-7864(03)00134-4; WALTER CA, 1993, CARCINOGENESIS, V14, P1537, DOI 10.1093/carcin/14.8.1537; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang W, 2012, NEURO-ONCOLOGY, V14, P712, DOI 10.1093/neuonc/nos089	37	69	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e74466	10.1371/journal.pone.0074466	http://dx.doi.org/10.1371/journal.pone.0074466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24147153	Green Submitted, gold, Green Published			2022-12-27	WOS:000324777300035
J	Toyama, T; Furuichi, K; Ninomiya, T; Shimizu, M; Hara, A; Iwata, Y; Kaneko, S; Wada, T				Toyama, Tadashi; Furuichi, Kengo; Ninomiya, Toshiharu; Shimizu, Miho; Hara, Akinori; Iwata, Yasunori; Kaneko, Shuichi; Wada, Takashi			The Impacts of Albuminuria and Low eGFR on the Risk of Cardiovascular Death, All-Cause Mortality, and Renal Events in Diabetic Patients: Meta-Analysis	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; URINARY ALBUMIN; PREDICT MORTALITY; END-POINTS; FOLLOW-UP; MICROALBUMINURIA; MELLITUS; NEPHROPATHY; PROGRESSION	Background: Precise effects of albuminuria and low estimated glomerular filtration rate (eGFR) on cardiovascular mortality, all-cause mortality, and renal events in diabetic patients are uncertain. Materials and Methods: A systematic review was conducted of the literature through MEDLINE, EMBASE, and CINHAL from 1950 to December 2010. Cohort studies of diabetic patients providing adjusted relative risk (RR) of albuminuria and eGFR for risks of cardiovascular mortality, all-cause mortality, and renal events were selected. Two reviewers screened abstracts and full papers of each study using standardized protocol. Results: We identified 31 studies fulfilling the criteria from 6546 abstracts. With regard to the risk of cardiovascular mortality, microalbuminuria (RR 1.76, 95% CI 1.38-2.25) and macroalbuminuria (RR 2.96 95% CI 2.44-3.60) were significant risk factors compared to normoalbuminuria. The same trends were seen in microalbuminuria (RR 1.60, 95% CI 1.42-1.81), and macroalbuminuria (RR 2.64, 95% CI 2.13-3.27) for the risk of all-cause mortality, and also in microalbuminuria (RR 3.21, 95% CI 2.05-5.02) and macroalbuminuria (RR 11.63, 95% CI 5.68-23.83) for the risk of renal events. The magnitudes of relative risks associated with low eGFR along with albuminuria were almost equal to multiplying each risk rate of low eGFR and albuminuria. No significant factors were found by investigating potential sources of heterogeneity using subgroup analysis. Conclusions: High albuminuria and low eGFR are relevant risk factors in diabetic patients. Albuminuria and low eGFR may be independent of each other. To evaluate the effects of low eGFR, intervention, or race, appropriately designed studies are needed.	[Toyama, Tadashi; Furuichi, Kengo; Shimizu, Miho; Hara, Akinori; Iwata, Yasunori; Wada, Takashi] Kanazawa Univ, Div Nephrol, Kanazawa, Ishikawa, Japan; [Ninomiya, Toshiharu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan; [Kaneko, Shuichi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa, Japan; [Wada, Takashi] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Dept Lab Med, Kanazawa, Ishikawa, Japan	Kanazawa University; Kyushu University; Kanazawa University; Kanazawa University	Wada, T (corresponding author), Kanazawa Univ, Div Nephrol, Kanazawa, Ishikawa, Japan.	twada@m-kanazawa.jp	Hara, Akinori/W-8522-2019		Ministry of Health, Labor and Welfare of Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a Grant-in-Aid for Diabetic Nephropathy Research, from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beilin J, 1996, AUST NZ J MED, V26, P519, DOI 10.1111/j.1445-5994.1996.tb00598.x; Brinkman JW, 2004, KIDNEY INT, V66, pS69, DOI 10.1111/j.1523-1755.2004.09219.x; Bruno G, 2007, DIABETOLOGIA, V50, P941, DOI 10.1007/s00125-007-0616-1; Bruno G, 2003, DIABETES CARE, V26, P2353, DOI 10.2337/diacare.26.8.2353; Casiglia E, 2000, EUR J EPIDEMIOL, V16, P677, DOI 10.1023/A:1007673123716; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Boer IH, 2009, DIABETES CARE, V32, P1833, DOI 10.2337/dc09-0191; de Grauw WJC, 2001, DIABETIC MED, V18, P139, DOI 10.1046/j.1464-5491.2001.00423.x; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Florkowski CM, 2001, DIABETES RES CLIN PR, V53, P113, DOI 10.1016/S0168-8227(01)00246-7; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; GALL MA, 1995, DIABETES, V44, P1303, DOI 10.2337/diabetes.44.11.1303; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Grauslund J, 2010, J DIABETES COMPLICAT, V24, P223, DOI 10.1016/j.jdiacomp.2009.05.003; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Gross JL, 2005, DIABETES CARE, V28, P164, DOI 10.2337/diacare.28.1.164; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hanninen J, 1999, DIABETES RES CLIN PR, V43, P121, DOI 10.1016/S0168-8227(98)00131-4; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P617, DOI 10.1161/01.ATV.19.3.617; Jude EB, 2002, QJM-INT J MED, V95, P371, DOI 10.1093/qjmed/95.6.371; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; Mattock MB, 1998, DIABETES, V47, P1786, DOI 10.2337/diabetes.47.11.1786; Miller WG, 2009, CLIN CHEM, V55, P24, DOI 10.1373/clinchem.2008.106567; Molitch ME, 2010, DIABETES CARE, V33, P1536, DOI 10.2337/dc09-1098; NEIL A, 1993, DIABETES CARE, V16, P996, DOI 10.2337/diacare.16.7.996; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; O'Hare AM, 2010, ARCH INTERN MED, V170, P930, DOI 10.1001/archinternmed.2010.129; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Ostgren CJ, 2002, DIABETES CARE, V25, P1297, DOI 10.2337/diacare.25.8.1297; Pohl MA, 2005, J AM SOC NEPHROL, V16, P3027, DOI 10.1681/ASN.2004110919; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Rossing P, 1996, BRIT MED J, V313, P779; Roy M, 2006, DIABETIC MED, V23, P698, DOI 10.1111/j.1464-5491.2006.01901.x; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; So WY, 2006, DIABETES CARE, V29, P2046, DOI 10.2337/dc06-0248; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Sviridov D, 2006, CLIN CHEM, V52, P389, DOI 10.1373/clinchem.2005.057323; Tong PCY, 2007, DIABETIC MED, V24, P741, DOI 10.1111/j.1464-5491.2007.02145.x; Valmadrid CT, 2000, ARCH INTERN MED, V160, P1093, DOI 10.1001/archinte.160.8.1093; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Vlek ALM, 2008, J INTERN MED, V264, P351, DOI 10.1111/j.1365-2796.2008.01970.x; Wada T, 2012, CLIN EXP NEPHROL, V16, P96, DOI 10.1007/s10157-011-0508-z; Witte EC, 2009, J AM SOC NEPHROL, V20, P436, DOI 10.1681/ASN.2008030292; XU J, 2005, BR J DIABETES VASC D, V5, P334; Yang SH, 2010, NEW ENGL J MED, V362, P2425; Yokoyama H, 2008, DIABETIC MED, V25, P1426, DOI 10.1111/j.1464-5491.2008.02592.x; Yuyun MF, 2003, DIABETIC MED, V20, P277, DOI 10.1046/j.1464-5491.2003.00940.x	59	53	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e71810	10.1371/journal.pone.0071810	http://dx.doi.org/10.1371/journal.pone.0071810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	24147148	Green Published, gold, Green Submitted			2022-12-27	WOS:000323880200006
J	Tola-Arribas, MA; Yugueros, MI; Garea, MJ; Ortega-Valin, F; Ceron-Fernandez, A; Fernandez-Malvido, B; San Jose-Gallegos, A; Gonzalez-Touya, M; Botran-Velicia, A; Iglesias-Rodriguez, V; Diaz-Gomez, B				Angel Tola-Arribas, Miguel; Isabel Yugueros, Maria; Jose Garea, Maria; Ortega-Valin, Fernando; Ceron-Fernandez, Ana; Fernandez-Malvido, Beatriz; San Jose-Gallegos, Antonio; Gonzalez-Touya, Marta; Botran-Velicia, Ana; Iglesias-Rodriguez, Vanessa; Diaz-Gomez, Barbara			Prevalence of Dementia and Subtypes in Valladolid, Northwestern Spain: The DEMINVALL Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; COGNITIVE IMPAIRMENT; MEDITERRANEAN DIET; GLOBAL PREVALENCE; MAJOR SUBTYPES; DIAGNOSIS; RISK; VALIDATION; EDUCATION	Objective: To describe the prevalence of dementia and subtypes in a general elderly population in northwestern Spain and to analyze the influence of socio-demographic factors. Methods: Cross-sectional, two-phase, door-to-door, population-based study. A total of 870 individuals from a rural region and 2,119 individuals from an urban region of Valladolid, Spain, were involved. The seven-minute screen neurocognitive battery was used in the screening phase. A control group was included. Results: A total of 2,170 individuals aged 65 to 104 years (57% women) were assessed. There were 184 subjects diagnosed with dementia. The crude prevalence was 8.5% (95% CI: 7.3-9.7). Age-and sex-adjusted prevalence was 5.5 (95% CI: 4.5-6.5). Main subtypes of dementia were: Alzheimer's disease (AD) 77.7%, Lewy Body disease, 7.6% and vascular dementia (VD) 5.9%. Crude prevalences were 6.6% (AD), 0.6% (Lewy Body disease), and 0.5% (VD). Dementia was associated with age (OR 1.14 for 1-year increase in age), female sex (OR 1.79) and the absence of formal education (OR 2.53 compared to subjects with primary education or more). Conclusion: The prevalence of dementia in the study population was lower than the most recent estimates for Western Europe. There was a high proportion of AD among all dementia cases and very low prevalence of VD. Old age, female sex, and low education level were independent risk factors for dementia and AD.	[Angel Tola-Arribas, Miguel; Isabel Yugueros, Maria; Jose Garea, Maria; Ortega-Valin, Fernando] Hosp Univ Rio Hortega, Dept Neurol, Valladolid, Spain; [Ceron-Fernandez, Ana] Hosp Univ Rio Hortega, Dept Geriatr, Valladolid, Spain; [Fernandez-Malvido, Beatriz] Hosp Univ Rio Hortega, Dept Psychol, Valladolid, Spain; [San Jose-Gallegos, Antonio; Gonzalez-Touya, Marta] Hosp Medina del Campo, Emergency Dept, Valladolid, Spain; [Botran-Velicia, Ana; Iglesias-Rodriguez, Vanessa] Atenc Primaria Area Oeste, Valladolid, Spain; [Diaz-Gomez, Barbara] Ctr Salud Arroyo de la Vega, Madrid, Spain	Hospital del Rio Hortega; Hospital del Rio Hortega; Hospital del Rio Hortega	Tola-Arribas, MA (corresponding author), Hosp Univ Rio Hortega, Dept Neurol, Valladolid, Spain.	mtola.nrl@gmail.com	Arribas, Miguel Angel Tola/D-6936-2016	Arribas, Miguel Angel Tola/0000-0003-4105-0998; Gonzalez-Touya, Marta/0000-0003-4523-1905	Gerencia Regional de Salud de Castilla y Leon [GRS/340/09]; Fundacion General de la Universidad de Valladolid	Gerencia Regional de Salud de Castilla y Leon; Fundacion General de la Universidad de Valladolid	The survey was funded (Grant GRS/340/09) by the Gerencia Regional de Salud de Castilla y Leon (http://www.saludcastillayleon.es) and by the Fundacion General de la Universidad de Valladolid (http://www.funge.uva.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2010, J NEUROL SCI, V289, P18, DOI 10.1016/j.jns.2009.08.034; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P133; Tola-Arribas MA, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-86; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Benedetti MD, 2002, NEUROEPIDEMIOLOGY, V21, P74, DOI 10.1159/000048620; Caamano-Isorna F, 2006, NEUROEPIDEMIOLOGY, V26, P226, DOI 10.1159/000093378; CORRADA M, 1995, INT J EPIDEMIOL, V24, P1000, DOI 10.1093/ije/24.5.1000; de Pedro-Cuesta J, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-55; Del Ser T, 2006, DEMENT GERIATR COGN, V22, P454, DOI 10.1159/000095858; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; European Heart Network, 2012, EUROPEAN CARDIOVASCU; Fernandez M, 2008, REV NEUROLOGIA, V46, P89, DOI 10.33588/rn.4602.2007530; Martinez MF, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-39; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Gascon-Bayarri J, 2007, NEUROEPIDEMIOLOGY, V28, P224, DOI 10.1159/000108597; Gavrila D, 2009, ACTA NEUROL SCAND, V120, P300, DOI 10.1111/j.1600-0404.2009.01283.x; Helmer C, 2001, AM J EPIDEMIOL, V154, P642, DOI 10.1093/aje/154.7.642; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; JORM AF, 1988, BRIT J PSYCHIAT, V152, P209, DOI 10.1192/bjp.152.2.209; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Knopman DS, 2003, ARCH NEUROL-CHICAGO, V60, P569, DOI 10.1001/archneur.60.4.569; LINN MW, 1982, J AM GERIATR SOC, V30, P378, DOI 10.1111/j.1532-5415.1982.tb02835.x; Lobo A, 2000, NEUROLOGY, V54, pS4; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meulen EFJ, 2004, J NEUROL NEUROSUR PS, V75, P700, DOI 10.1136/jnnp.2003.021055; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Norton S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1; *OFF OFF PUBL EUR, 2012, 2012 AG REP EC BUDG; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Quijano TDS, 2004, NEUROLOGIA, V19, P344; Ravaglia G, 2002, DEMENT GERIATR COGN, V14, P90, DOI 10.1159/000064930; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; REYNISH E, 2006, EUROCODE REPORT WP7; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Russ TC, 2012, INT J EPIDEMIOL, V41, P1012, DOI 10.1093/ije/dys103; Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349; Spada RS, 2009, J NEUROL SCI, V283, P62, DOI 10.1016/j.jns.2009.02.311; Tognoni G, 2005, ACTA NEUROL SCAND, V112, P65, DOI 10.1111/j.1600-0404.2005.00444.x; Tsivgoulis G, 2013, NEUROLOGY, V80, P1684, DOI 10.1212/WNL.0b013e3182904f69; Virues-Ortega J, 2011, ACTA NEUROL SCAND, V123, P316, DOI 10.1111/j.1600-0404.2010.01398.x; Wimo A, 2013, ALZHEIMERS DEMENT, V9, P1, DOI 10.1016/j.jalz.2012.11.006; World Health Organization, 2013, EUR HLTH REP 2012 CH; Zaccai J, 2005, AGE AGEING, V34, P561, DOI 10.1093/ageing/afi190	47	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77688	10.1371/journal.pone.0077688	http://dx.doi.org/10.1371/journal.pone.0077688			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147055	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200065
J	Li, ZW; Huang, JQ; Zeng, GM; Nie, XD; Ma, WM; Yu, W; Guo, W; Zhang, JC				Li, Zhongwu; Huang, Jinquan; Zeng, Guangming; Nie, Xiaodong; Ma, Wenming; Yu, Wei; Guo, Wang; Zhang, Jiachao			Effect of Erosion on Productivity in Subtropical Red Soil Hilly Region: A Multi-Scale Spatio-Temporal Study by Simulated Rainfall	PLOS ONE			English	Article							ORGANIC-MATTER; CLIMATE-CHANGE; CROP YIELD; CARBON; IMPACTS; WHEAT; REDISTRIBUTION; DEGRADATION; RUNOFF	The effects of water erosion (including long-term historical erosion and single erosion event) on soil properties and productivity in different farming systems were investigated. A typical sloping cropland with homogeneous soil properties was designed in 2009 and then protected from other external disturbances except natural water erosion. In 2012, this cropland was divided in three equally sized blocks. Three treatments were performed on these blocks with different simulated rainfall intensities and farming methods: (1) high rainfall intensity (1.5 - 1.7 mm min(-1)), no-tillage operation; (2) low rainfall intensity (0.5 - 0.7 mm min(-1)), no-tillage operation; and (3) low rainfall intensity, tillage operation. All of the blocks were divided in five equally sized subplots along the slope to characterize the three-year effects of historical erosion quantitatively. Redundancy analysis showed that the effects of long-term historical erosion significantly caused most of the variations in soil productivity in no-tillage and low rainfall erosion intensity systems. The intensities of the simulated rainfall did not exhibit significant effects on soil productivity in no-tillage systems. By contrast, different farming operations induced a statistical difference in soil productivity at the same single erosion intensity. Soil organic carbon (SOC) was the major limiting variable that influenced soil productivity. Most explanations of long-term historical erosion for the variation in soil productivity arose from its sharing with SOC. SOC, total nitrogen, and total phosphorus were found as the regressors of soil productivity because of tillage operation. In general, this study provided strong evidence that single erosion event could also impose significant constraints on soil productivity by integrating with tillage operation, although single erosion is not the dominant effect relative to the long-term historical erosion. Our study demonstrated that an effective management of organic carbon pool should be the preferred option to maintain soil productivity in subtropical red soil hilly region.	[Li, Zhongwu; Huang, Jinquan; Zeng, Guangming; Nie, Xiaodong; Ma, Wenming; Yu, Wei; Guo, Wang] Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China; [Li, Zhongwu; Huang, Jinquan; Zeng, Guangming; Nie, Xiaodong; Ma, Wenming; Yu, Wei; Guo, Wang] Hunan Univ, Minist Educ, Key Lab Environm Biol & Pollut Control, Changsha 410082, Hunan, Peoples R China; [Zhang, Jiachao] Hunan Agr Univ, Coll Resources & Environm, Changsha, Hunan, Peoples R China	Hunan University; Hunan University; Hunan Agricultural University	Li, ZW (corresponding author), Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Hunan, Peoples R China.	lizw@hnu.edu.cn	Nie, xiaodong/A-1729-2016; Li, Zhongwu/AAF-9530-2020		National Natural Science Foundation of China [40971179]; Program for New Century Excellent Talents in University [NCET-09-330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was jointly supported by the National Natural Science Foundation of China (40971179) and the Program for New Century Excellent Talents in University (NCET-09-330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker MM, 2004, CATENA, V57, P55, DOI 10.1016/j.catena.2003.07.002; Bertol Ildegardis, 2003, Sci. agric. (Piracicaba, Braz.), V60, P581, DOI 10.1590/S0103-90162003000300025; Deluca TH, 1998, ENVIRON MANAGE, V22, P255, DOI 10.1007/s002679900101; Duan XW, 2011, CATENA, V87, P268, DOI 10.1016/j.catena.2011.06.012; EHLERS W, 1975, SOIL SCI, V119, P242, DOI 10.1097/00010694-197503000-00010; Fenton TE, 2005, SOIL TILL RES, V81, P163, DOI 10.1016/j.still.2004.09.005; Fu GB, 2006, SOIL TILL RES, V85, P38, DOI 10.1016/j.still.2004.11.009; Gao Y, 2011, J APPL ECOL, V48, P1145, DOI 10.1111/j.1365-2664.2011.02011.x; Garcia-Ruiz JM, 2010, CATENA, V81, P1, DOI 10.1016/j.catena.2010.01.001; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Gregg JS, 2010, BIOFUELS-UK, V1, P69, DOI 10.4155/BFS.09.8; Huang JQ, 2013, ECOL ENG, V60, P67, DOI 10.1016/j.ecoleng.2013.07.040; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Jacinthe PA, 2004, SOIL TILL RES, V77, P111, DOI 10.1016/j.still.2003.11.004; Kara D, 1997, TALANTA, V44, P2027, DOI 10.1016/S0039-9140(97)00014-3; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Kosmas C, 2001, SOIL TILL RES, V58, P31, DOI 10.1016/S0167-1987(00)00175-6; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Lal R, 2001, LAND DEGRAD DEV, V12, P519, DOI 10.1002/ldr.472; Lal R, 2008, SCIENCE, V319, P1040, DOI 10.1126/science.319.5866.1040; Larney F.J., 2012, PRAIRIE SOILS CROPS, V5, P139; Larney FJ, 2009, SOIL TILL RES, V103, P73, DOI 10.1016/j.still.2008.09.008; Li XJ, 2008, GEOMORPHOLOGY, V96, P221, DOI 10.1016/j.geomorph.2007.08.006; Liu YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056443; Liu ZF, 2010, SOIL BIOL BIOCHEM, V42, P445, DOI 10.1016/j.soilbio.2009.11.027; Majumder B, 2008, SOIL SCI SOC AM J, V72, P775, DOI 10.2136/sssaj2006.0378; Morgan, 1996, SOIL EROSION CONSERV, P320; Nearing MA, 2004, J SOIL WATER CONSERV, V59, P43; OLDEMAN LR, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P99; Osunbitan JA, 2005, SOIL TILL RES, V82, P57, DOI 10.1016/j.still.2004.05.007; PHILLIPS RE, 1980, SCIENCE, V208, P1108, DOI 10.1126/science.208.4448.1108; PIERCE FJ, 1983, J SOIL WATER CONSERV, V38, P39; Pimentel D, 2000, ECOSYST HEALTH, V6, P221, DOI 10.1046/j.1526-0992.2000.006004221.x; Quinton JN, 2010, NAT GEOSCI, V3, P311, DOI [10.1038/NGEO838, 10.1038/ngeo838]; Turner B.L., 1990, CUP ARCH; Van Hemelryck H, 2011, EARTH SURF PROC LAND, V36, P427, DOI 10.1002/esp.2055; Van Oost K, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P301; VERITY GE, 1990, CAN J SOIL SCI, V70, P471, DOI 10.4141/cjss90-046; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; WEESIES GA, 1994, J SOIL WATER CONSERV, V49, P597; XIAOJUN N, 2013, PLOS ONE, V0008; Yang F, 1989, HUNAN SOILS; Zhang JC, 2011, BIORESOURCE TECHNOL, V102, P2950, DOI 10.1016/j.biortech.2010.11.089; Zhao L, 2012, J MT SCI-ENGL, V9, P96, DOI 10.1007/s11629-012-2241-9	46	14	14	9	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77838	10.1371/journal.pone.0077838	http://dx.doi.org/10.1371/journal.pone.0077838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147090	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200082
J	Zheng, DP; Rodrigues, M; Bile, E; Nguyen, DB; Diallo, K; DeVos, JR; Nkengasong, JN; Yang, CF				Zheng, Du-Ping; Rodrigues, Margarida; Bile, Ebi; Nguyen, Duc B.; Diallo, Karidia; DeVos, Joshua R.; Nkengasong, John N.; Yang, Chunfu			Molecular Characterization of Ambiguous Mutations in HIV-1 Polymerase Gene: Implications for Monitoring HIV Infection Status and Drug Resistance	PLOS ONE			English	Article							BLOOD SPOT SPECIMENS; TRANSMITTED HIV; GENOTYPING ASSAY; TESTING SITES; SURVEILLANCE; DIVERSITY; ACCURACY; HIV/AIDS; PROTEASE; VIETNAM	Detection of recent HIV infections is a prerequisite for reliable estimations of transmitted HIV drug resistance (t-HIVDR) and incidence. However, accurately identifying recent HIV infection is challenging due partially to the limitations of current serological tests. Ambiguous nucleotides are newly emerged mutations in quasispecies, and accumulate by time of viral infection. We utilized ambiguous mutations to establish a measurement for detecting recent HIV infection and monitoring early HIVDR development. Ambiguous nucleotides were extracted from HIV-1 pol-gene sequences in the datasets of recent (HIVDR threshold surveys [HIVDR-TS] in 7 countries; n=416) and established infections (1 HIVDR monitoring survey at baseline; n=271). An ambiguous mutation index of 2.04x10(-3) nts/site was detected in HIV-1 recent infections which is equivalent to the HIV-1 substitution rate (2x10(-3) nts/site/year) reported before. However, significantly higher index (14.41x10(-3) nts/site) was revealed with established infections. Using this substitution rate, 75.2% subjects in HIVDR-TS with the exception of the Vietnam dataset and 3.3% those in HIVDR-baseline were classified as recent infection within one year. We also calculated mutation scores at amino acid level at HIVDR sites based on ambiguous or fitted mutations. The overall mutation scores caused by ambiguous mutations increased (0.54x10(-2)3.48x10(-2)/DR-site) whereas those caused by fitted mutations remained stable (7.50-7.89x10(-2)/DR-site) in both recent and established infections, indicating that t-HIVDR exists in drug-naive populations regardless of infection status in which new HIVDR continues to emerge. Our findings suggest that characterization of ambiguous mutations in HIV may serve as an additional tool to differentiate recent from established infections and to monitor HIVDR emergence.	[Zheng, Du-Ping; Diallo, Karidia; DeVos, Joshua R.; Nkengasong, John N.; Yang, Chunfu] Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30329 USA; [Rodrigues, Margarida] CDC GAP Angola, Luanda, Angola; [Bile, Ebi] CDC GAP Botswana, Gaborone, Botswana; [Nguyen, Duc B.] US CDC, Dept Hlth & Human Serv, Hanoi, Vietnam	Centers for Disease Control & Prevention - USA	Yang, CF (corresponding author), Ctr Dis Control & Prevent CDC, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30329 USA.	CYang1@cdc.gov	Yang, Chunfu/G-6890-2013	Bile, Ebi Celestin/0000-0003-1930-7443	Centers for Disease Control and Prevention; FOGARTY INTERNATIONAL CENTER [D43TW001042] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2013, INFECT GENET EVOL, V18, P125, DOI 10.1016/j.meegid.2013.03.050; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Bussmann H, 2011, AIDS RES HUM RETROV, V27, P365, DOI [10.1089/aid.2009.0299, 10.1089/aid.2010.0273]; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Dean J, 2011, AIDS RES HUM RETROV, V27, P797, DOI 10.1089/aid.2011.0013; Duc NB, 2012, CLIN INFECT DIS, V54, pS343, DOI 10.1093/cid/cir1049; Ekstrand ML, 2011, INT HEALTH, V3, P27, DOI 10.1016/j.inhe.2010.11.003; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; Gojobori T, 2000, AIDS REV, V2, P39; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Inzaule S, 2013, J CLIN MICROBIOL, V51, P529, DOI 10.1128/JCM.02347-12; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kamoto K, 2008, ANTIVIR THER, V13, P83; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; Lemey P, 2006, AIDS REV, V8, P125; Lisovsky I, 2010, ANTIMICROB AGENTS CH, V54, P2878, DOI 10.1128/AAC.01828-09; Myatt M, 2008, ANTIVIR THER, V13, P37; National AIDS/STDs Control Program FMoH Abuja Nigeria, 2007, NAT GUID HIV AIDS TR; Nguyen HT, 2008, ANTIVIR THER, V13, P115; Oette M, 2012, INTERVIROLOGY, V55, P160, DOI 10.1159/000332018; Parekh BS, 2005, INDIAN J MED RES, V121, P510; Park SY, 2011, AIDS, V25, pF13, DOI 10.1097/QAD.0b013e328349f089; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Somi GR, 2008, ANTIVIR THER, V13, P77; Sungkanuparph S, 2011, CLIN INFECT DIS, V52, P1053, DOI 10.1093/cid/cir107; Thanh DC, 2009, AIDS BEHAV, V13, P1151, DOI 10.1007/s10461-008-9451-8; Ugbena R, 2012, CLIN INFECT DIS, V54, pS375, DOI 10.1093/cid/cir1064; Wensing Annemarie M. J., 2003, AIDS Reviews, V5, P140; WHO, 2012, WHO HIV DRUG RES REP; Who U UNICEF, 2011, GLOB HIV AIDS RESP E; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10; Zhang J, 2010, AIDS RES HUM RETROV, V26, P99, DOI 10.1089/aid.2009.0184; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77649	10.1371/journal.pone.0077649	http://dx.doi.org/10.1371/journal.pone.0077649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147046	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200058
J	Bin Raies, A; Mansour, H; Incitti, R; Bajic, VB				Bin Raies, Arwa; Mansour, Hicham; Incitti, Roberto; Bajic, Vladimir B.			Combining Position Weight Matrices and Document-Term Matrix for Efficient Extraction of Associations of Methylated Genes and Diseases from Free Text	PLOS ONE			English	Article							DNA METHYLATION; DATABASE; EPIGENETICS; MEINFOTEXT	Background: In a number of diseases, certain genes are reported to be strongly methylated and thus can serve as diagnostic markers in many cases. Scientific literature in digital form is an important source of information about methylated genes implicated in particular diseases. The large volume of the electronic text makes it difficult and impractical to search for this information manually. Methodology: We developed a novel text mining methodology based on a new concept of position weight matrices (PWMs) for text representation and feature generation. We applied PWMs in conjunction with the document-term matrix to extract with high accuracy associations between methylated genes and diseases from free text. The performance results are based on large manually-classified data. Additionally, we developed a web-tool, DEMGD, which automates extraction of these associations from free text. DEMGD presents the extracted associations in summary tables and full reports in addition to evidence tagging of text with respect to genes, diseases and methylation words. The methodology we developed in this study can be applied to similar association extraction problems from free text. Conclusion: The new methodology developed in this study allows for efficient identification of associations between concepts. Our method applied to methylated genes in different diseases is implemented as a Web-tool, DEMGD, which is freely available at http://www.cbrc.kaust.edu.sa/demgd/. The data is available for online browsing and download.	[Bin Raies, Arwa; Bajic, Vladimir B.] KAUST, CBRC, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia; [Mansour, Hicham; Incitti, Roberto] KAUST, Biosci Core Labs, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Bajic, VB (corresponding author), KAUST, CBRC, Comp Elect & Math Sci & Engn Div CEMSE, Thuwal, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Incitti, Roberto/AAD-1672-2019; Bajic, Vladimir/D-2810-2009; Raies, Arwa/D-8079-2018	Bajic, Vladimir/0000-0001-5435-4750; Raies, Arwa/0000-0003-3952-7363	KAUST Base Research Funds	KAUST Base Research Funds	This project was funded by the KAUST Base Research Funds to VBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, 2012, CH CRC DATA MIN KNOW, P3; ALDOUS D, 1991, ANN PROBAB, V19, P1, DOI 10.1214/aop/1176990534; Amoreira C, 2003, NUCLEIC ACIDS RES, V31, P75, DOI 10.1093/nar/gkg093; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brower V, 2011, NATURE, V471, pS12, DOI 10.1038/471S12a; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chun HW, 2006, P PAC S BIOC PSB 11; CLAVERIE JM, 1994, COMPUT CHEM, V18, P287, DOI 10.1016/0097-8485(94)85024-0; Coenen F, 2005, ADV KNOWLEDGE DISCOV; Coulet A, 2010, J BIOMED INFORM, V43, P1009, DOI 10.1016/j.jbi.2010.08.005; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fang YC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-471; Fang YC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-22; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Grunau C, 2001, NUCLEIC ACIDS RES, V29, P270, DOI 10.1093/nar/29.1.270; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pD75, DOI 10.1093/nar/gkq942; Hakenberg J, 2012, J BIOMED INFORM, V45, P842, DOI 10.1016/j.jbi.2012.04.006; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Han J, 2012, MOR KAUF D, P1; He XM, 2008, NUCLEIC ACIDS RES, V36, pD836, DOI 10.1093/nar/gkm730; Li W, 2001, 2001 IEEE INT C DAT; Liu B, 1998, 4 INT C KNOWL DISC D; Luehr S, 2012, NUCLEIC ACIDS RES, V40, pW104, DOI 10.1093/nar/gks602; Lv J, 2012, NUCLEIC ACIDS RES, V40, pD1030, DOI 10.1093/nar/gkr1169; Miner G, 2012, PRACTICAL TEXT MINING AND STATISTICAL ANALYSIS FOR NON-STRUCTURED TEXT DATA APPLICATIONS, P1; Nandi S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-416; Ongenaert M, 2008, NUCLEIC ACIDS RES, V36, pD842, DOI 10.1093/nar/gkm788; Porter MF, 2006, PROGRAM-ELECTRON LIB, V40, P211, DOI 10.1108/eb046814; Quinlan J, 1993, P EUR C MACH LEARN E; Quinlan J.R., 1993, CONSTRUCTING DECISIO, P17; SALTON G, 1988, INFORM PROCESS MANAG, V24, P513, DOI 10.1016/0306-4573(88)90021-0; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Scholkopf B., 2005, LEARNING KERNELS SUP, DOI [10.1109/tnn.2005.848998, DOI 10.1109/TNN.2005.848998]; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Stormo GD, 2000, GENOME RES, V10, P394, DOI 10.1101/gr.10.4.394; Summers T, 2013, J CANCER, V4, P210, DOI 10.7150/jca.5839; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Wallach HM, 2006, ICML 06 P 23 INT C M; Wang S, 2008, DNA METHYLATION MICR, P17; Weinberger KQ, 2009, J MACH LEARN RES, V10, P207; Weiss SM, 2010, TEXTS COMPUT SCI, P1, DOI 10.1007/978-1-84996-226-1; Xin YR, 2012, NUCLEIC ACIDS RES, V40, pD1245, DOI 10.1093/nar/gkr1193; Yang Y, 1997, P 4 INT C MACH LEARN; Yin XX, 2003, SIAM PROC S, P331; Zheng JH, 2013, CLIN CANCER RES, V19, P1400, DOI 10.1158/1078-0432.CCR-12-2888	47	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77848	10.1371/journal.pone.0077848	http://dx.doi.org/10.1371/journal.pone.0077848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147091	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400140
J	Gakamsky, A; Oron, E; Valente, D; Mitra, PP; Segal, D; Benjamini, Y; Golani, I				Gakamsky, Anna; Oron, Efrat; Valente, Dan; Mitra, Partha P.; Segal, Daniel; Benjamini, Yoav; Golani, Ilan			The Angular Interval between the Direction of Progression and Body Orientation in Normal, Alcohol- and Cocaine Treated Fruit Flies	PLOS ONE			English	Article							LOCOMOTOR-ACTIVITY; FREE EXPLORATION; DROSOPHILA; BEHAVIOR; ETHANOL; COMPLEX; SENSITIZATION; COORDINATION; RESPONSES; MOVEMENT	In this study we characterize the coordination between the direction a fruit-fly walks and the direction it faces, as well as offer a methodology for isolating and validating key variables with which we phenotype fly locomotor behavior. Our fundamental finding is that the angular interval between the direction a fly walks and the direction it faces is actively managed in intact animals and modulated in a patterned way with drugs. This interval is small in intact flies, larger with alcohol and much larger with cocaine. The dynamics of this interval generates six coordinative modes that flow smoothly into each other. Under alcohol and much more so under cocaine, straight path modes dwindle and modes involving rotation proliferate. To obtain these results we perform high content analysis of video-tracked open field locomotor behavior. Presently there is a gap between the quality of descriptions of insect behaviors that unfold in circumscribed situations, and descriptions that unfold in extended time and space. While the first describe the coordination between low-level kinematic variables, the second quantify cumulative measures and subjectively defined behavior patterns. Here we reduce this gap by phenotyping extended locomotor behavior in terms of the coordination between low-level kinematic variables, which we quantify, combining into a single field two disparate fields, that of high content phenotyping and that of locomotor coordination. This will allow the study of the genes/brain/locomotor coordination interface in genetically engineered and pharmacologically manipulated animal models of human diseases.	[Gakamsky, Anna; Oron, Efrat; Golani, Ilan] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Valente, Dan; Mitra, Partha P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Segal, Daniel] Tel Aviv Univ, IL-69978 Tel Aviv, Israel; [Benjamini, Yoav] Tel Aviv Univ, Dept Stat & OR, IL-69978 Tel Aviv, Israel; [Gakamsky, Anna; Oron, Efrat; Segal, Daniel; Benjamini, Yoav; Golani, Ilan] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Cold Spring Harbor Laboratory; Tel Aviv University; Tel Aviv University; Tel Aviv University	Golani, I (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	ilan99@post.tau.ac.il		Mitra, Partha/0000-0001-8818-6804; Segal, Daniel/0000-0002-6777-505X	Israel Science Foundation [760/08]	Israel Science Foundation(Israel Science Foundation)	This study was funded by the Israel Science Foundation (grant No 760/08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADANI N, 1991, NEUROSCI BIOBEHAV R, V15, P455, DOI 10.1016/S0149-7634(05)80131-9; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Beer CG, 1980, COMP METHODS PSYCHOL, P17; BELL WJ, 1985, J INSECT PHYSIOL, V31, P837, DOI 10.1016/0022-1910(85)90101-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2011, P NATL ACAD SCI USA, V108, P15580, DOI 10.1073/pnas.1014837108; Benjamini Y, 2010, NEUROSCI BIOBEHAV R, V34, P1351, DOI 10.1016/j.neubiorev.2010.04.004; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; BURNET B, 1988, HEREDITY, V61, P111, DOI 10.1038/hdy.1988.96; CONNOLLY K, 1967, ANIM BEHAV, V15, P149, DOI 10.1016/S0003-3472(67)80026-5; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; EILAM D, 1988, DEV PSYCHOBIOL, V21, P679, DOI 10.1002/dev.420210707; EWING ARTHUR W., 1963, ANIMAL BEHAVIOUR, V11, P369, DOI 10.1016/S0003-3472(63)80128-1; Fonio E, 2009, P NATL ACAD SCI USA, V106, P21335, DOI 10.1073/pnas.0812513106; Gomez-Marin A, 2012, CURR OPIN NEUROBIOL, V22, P208, DOI 10.1016/j.conb.2011.11.008; Gomez-Marin A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00006; Gruntman E, 2007, J COMP PHYSIOL A, V193, P331, DOI 10.1007/s00359-006-0187-5; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Horev G, 2007, GENES BRAIN BEHAV, V6, P30, DOI 10.1111/j.1601-183X.2006.00216.x; Kafkafi N, 2005, GENES BRAIN BEHAV, V4, P431, DOI 10.1111/j.1601-183X.2005.00126.x; Kafkafi N, 1998, BIOL CYBERN, V78, P441, DOI 10.1007/s004220050448; Lebreton S, 2009, J NEUROGENET, V23, P225, DOI 10.1080/01677060802509160; Likitlersuang J, 2012, JOVE-J VIS EXP, V2012, P17; Lipkind D, 2004, J APPL PHYSIOL, V97, P347, DOI 10.1152/japplphysiol.00148.2004; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Martin JR, 2003, BEHAV PROCESS, V64, P145, DOI 10.1016/S0376-6357(03)00132-3; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Mittelstaedt H., 1957, P51; Olberg RM, 2012, CURR OPIN NEUROBIOL, V22, P267, DOI 10.1016/j.conb.2011.11.015; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Powell SB, 2004, BEHAV BRAIN RES, V152, P341, DOI 10.1016/j.bbr.2003.10.020; Reiser MB, 2010, J EXP BIOL, V213, P1771, DOI 10.1242/jeb.035147; Ritzmann RE, 2007, COLD SPRING HARB MON, V49, P229; Rothenfluh A, 2002, CURR OPIN NEUROBIOL, V12, P639, DOI 10.1016/S0959-4388(02)00380-X; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; Soibam B, 2012, BRAIN BEHAV, V2, P97, DOI 10.1002/brb3.36; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Stephens GJ, 2010, PLOS ONE, V16, P5, DOI DOI 10.1371/J0URNAL.P0NE.0013914; Stephens GJ, 2011, P NATL ACAD SCI USA, V108, P7286, DOI 10.1073/pnas.1007868108; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Wilson E.O., 1975, P1; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wolf FW, 2002, J NEUROSCI, V22, P11035; Yang P, 2000, GENETICS, V155, P1161; Youn J, 2012, BEHAV BRAIN RES, V226, P397, DOI 10.1016/j.bbr.2011.09.034	49	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76257	10.1371/journal.pone.0076257	http://dx.doi.org/10.1371/journal.pone.0076257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146845	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400047
J	Ge, FM; Yuan, SZ; Su, LD; Shen, ZH; He, AB; Huang, T; Gong, WH				Ge, Fangmin; Yuan, Shunzong; Su, Lida; Shen, Zhonghua; He, Aibin; Huang, Tao; Gong, Weihua			Alteration of Innate Immunity by Donor IL-6 Deficiency in a Presensitized Heart Transplant Model	PLOS ONE			English	Article							ALLOGRAFT-REJECTION; KIDNEY-TRANSPLANT; GRAFT-REJECTION; CELLS	Engraftment of IL-6 deficient donor into wild-type recipient could significantly improve allograft survival through T cell lineage particularly regulatory T cells (Tregs) in non-sensitized transplant host. However, its effect on innate immune responses remains uncertain. Our data revealed that donor IL-6 deficiency significantly increased infiltration of two subsets of MDSCs (CD11b+Gr1+myeloid-derived suppressor cells), CD11b+Gr1(-low) and CD11b+Gr1(-int) with strong immunosuppression activity in the transplanted graft. It resulted in a dramatic increase of CD11b+Gr1(-low) frequency and a significant decrease of the frequency of CD11b+Gr1(-high) and CD4-CD8-NK1.1+ cells in the recipient's spleen. Unexpectedly, donor IL-6 deficiency could not significantly reduce macrophage frequency irrespective of in the host's spleen or graft. Taken together, suppression of innate immune effector cells and enhanced activity of regulatory MDSCs contributed to tolerance induction by blockade of IL-6 signaling pathway. The unveiled novel mechanism of targeting IL-6 might shed light on clinical therapeutic application in preventing accelerated allograft rejection for those pre-sensitized transplant recipients.	[Ge, Fangmin; Su, Lida; Shen, Zhonghua; Gong, Weihua] Zhejiang Univ, Sch Med, Dept Surg & Med, TIRC,Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Yuan, Shunzong] Acad Mil Med Sci, Dept Lymphoma, Affiliated Hosp, Beijing, Peoples R China; [Yuan, Shunzong; Huang, Tao] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA; [He, Aibin] Harvard Univ, Sch Med, Dept Cardiol, Childrens Hosp Boston, Boston, MA USA	Zhejiang University; Academy of Military Medical Sciences - China; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Gong, WH (corresponding author), Zhejiang Univ, Sch Med, Dept Surg & Med, TIRC,Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	weihua.gong@gmail.com	he, aibin/ABA-2759-2021; Yuan, Shunzong/AAO-3551-2020		Department of Education of Zhejiang Province [Y201226017]; National Natural Science Foundation of China [81270323]; National Foundation of Natural Science of China [31100780]; Qianjiang Talents Project of Zhejiang Province [2012R10022]; Zhejiang Provincial Outstanding Youth Foundation [LR13H020001]	Department of Education of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Qianjiang Talents Project of Zhejiang Province; Zhejiang Provincial Outstanding Youth Foundation	The work was supported by the Department of Education of Zhejiang Province (Grant No. Y201226017), the National Natural Science Foundation of China (No. 81270323), the National Foundation of Natural Science of China (No. 31100780), the Qianjiang Talents Project of Zhejiang Province (Grant No. 2012R10022), and Zhejiang Provincial Outstanding Youth Foundation (Grant No. LR13H020001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth AJ, 2011, J IMMUNOL, V187, P5764, DOI 10.4049/jimmunol.1100766; Diaz JA, 2009, AM J TRANSPLANT, V9, P1773, DOI 10.1111/j.1600-6143.2009.02706.x; Fairchild RL, 2013, AM J TRANSPLANT, V13, P2235; Fogal B, 2011, J IMMUNOL, V187, P6268, DOI 10.4049/jimmunol.1003774; Ge FM, 2011, EXP CLIN TRANSPLANT, V9, P287; Gelman AE, 2010, AM J TRANSPLANT, V10, P1189, DOI 10.1111/j.1600-6143.2010.03101.x; Gong W, 2009, AM J TRANSPLANT, V9, P1742, DOI 10.1111/j.1600-6143.2009.02725.x; Gong W, 2013, TRANSPLANTATION; Gong W, 2012, EXP CLIN TRANSPLANT, V10, P158, DOI 10.6002/ect.2011.0123; HEIDECKE CD, 1985, TRANSPLANTATION, V40, P441; Lee J, 2012, J IMMUNOL, V189, P1928, DOI 10.4049/jimmunol.1103613; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Liang Y, 2007, TRANSPLANTATION, V84, P771, DOI 10.1097/01.tp.0000281384.24333.0b; Murphy SP, 2011, IMMUNOL REV, V241, P39, DOI 10.1111/j.1600-065X.2011.01009.x; Oberbarnscheidt MH, 2011, SEMIN IMMUNOL, V23, P264, DOI 10.1016/j.smim.2011.06.006; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Reinhold SW, 2012, CYTOKINE, V57, P379, DOI 10.1016/j.cyto.2011.12.006; Shen H, 2009, J AM SOC NEPHROL, V20, P1032, DOI 10.1681/ASN.2008070778; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Xiao X, 2012, J IMMUNOL, V188, P892, DOI 10.4049/jimmunol.1101373; Xu H., 2012, CELL TRANSPLANT; YANKELEVICH B, 1989, J IMMUNOL, V142, P3423; Zecher D, 2010, J IMMUNOL, V184, P6649, DOI 10.4049/jimmunol.0903729; Zecher D, 2009, J IMMUNOL, V183, P7810, DOI 10.4049/jimmunol.0902194	25	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77559	10.1371/journal.pone.0077559	http://dx.doi.org/10.1371/journal.pone.0077559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147024	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400121
J	Huang, B; Huang, SG; Chen, Y; Zheng, HQ; Shen, JL; Lun, ZR; Wang, Y; Kasper, LH; Lu, FL				Huang, Bo; Huang, Shiguang; Chen, Ying; Zheng, Huanqin; Shen, Jilong; Lun, Zhao-Rong; Wang, Yong; Kasper, Lloyd H.; Lu, Fangli			Mast Cells Modulate Acute Toxoplasmosis in Murine Models	PLOS ONE			English	Article							CALOMYS-CALLOSUS RODENTIA; T-LYMPHOCYTES; HOST-DEFENSE; GONDII; GAMMA; INTERLEUKIN-10; LOCALIZATION; ENCEPHALITIS; PATHOGENESIS; INFLAMMATION	The role of mast cells (MCs) in Toxoplasma gondii infection is poorly known. Kunming outbred mice were infected intraperitoneally with RH strain T. gondii, either treated with compound 48/80 (C48/80, MC activator) or disodium cromoglycate (DSCG, MC inhibitor). Compared with infected controls, infected mice treated with C48/80 exhibited significantly increased inflammation in the liver (P < 0.01), spleen (P < 0.05), and mesentery (P < 0.05) tissues, higher parasite burden in the peritoneal lavage fluids (P < 0.01), and increased levels of mRNA transcripts of T. gondii tachyzoite surface antigen 1 (SAG1) gene in the spleen and liver tissues (P < 0.01), accompanied with significantly increased Th1 cytokine (IFN-gamma, IL-12p40, and TNF-alpha) (P < 0.01) and decreased IL-10 (P < 0.01) mRNA expressions in the liver, and increased IFN-gamma (P < 0.01) and IL-12p40 (P < 0.01) but decreased TNF-alpha (P < 0.01) and IL-4 (P < 0.01) in the spleens of infected mice treated with C48/80 at day 9-10 p.i. Whereas mice treated with DSCG had significantly decreased tissue lesions (P < 0.01), lower parasite burden in the peritoneal lavage fluids (P < 0.01) and decreased SAG1 expressions in the spleen and liver tissues (P < 0.01), accompanied with significantly increased IFN-gamma (P < 0.01) and IL-12p40 (P < 0.05) in the liver, and decreased IFN-gamma (P < 0.05) and TNF-alpha (P < 0.01) in the spleens; IL-4 and IL-10 expressions in both the spleen and liver were significantly increased (P < 0.01) in the infected mice treated with DSCG. These findings suggest that mediators associated with the MC activation may play an important role in modulating acute inflammatory pathogenesis and parasite clearance during T. gondii infection in this strain of mice. Thus, MC activation/inhibition mechanisms are potential novel targets for the prevention and control of T. gondii infection.	[Huang, Bo; Chen, Ying; Zheng, Huanqin; Lu, Fangli] Sun Yat Sen Univ, Dept Parasitol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Bo; Chen, Ying; Zheng, Huanqin; Lun, Zhao-Rong; Lu, Fangli] Sun Yat Sen Univ, Key Lab Trop Dis Control, Minist Educ, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Shiguang] Jinan Univ, Dept Periodontol, Sch Med, Guangzhou, Guangdong, Peoples R China; [Shen, Jilong] Anhui Med Univ, Anhui Prov Lab Pathogen Biol, Hefei, Anhui, Peoples R China; [Lun, Zhao-Rong] Sun Yat Sen Univ, Ctr Parasit Organisms, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Yong] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Kasper, Lloyd H.] Dartmouth Med Sch, Dept Microbiol, Lebanon, NH USA	Sun Yat Sen University; Sun Yat Sen University; Jinan University; Anhui Medical University; Sun Yat Sen University; Nanjing Medical University; Dartmouth College	Lu, FL (corresponding author), Sun Yat Sen Univ, Dept Parasitol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	fanglilu@yahoo.com			National Basic Research Program of China (973 Program) [2010CB530001]; Natural Science Foundation of China [81071387, 81271854]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the National Basic Research Program of China (973 Program) [grant number 2010CB530001] and the Natural Science Foundation of China to F. L. [grant numbers 81071387 and 81271854]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischoff SC, 1999, GUT, V44, P643, DOI 10.1136/gut.44.5.643; Carlos D, 2007, J INFECT DIS, V196, P1361, DOI 10.1086/521830; Cavalcanti MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025259; Collington SJ, 2011, TRENDS IMMUNOL, V32, P478, DOI 10.1016/j.it.2011.08.002; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Ferreira GLS, 2004, MICROBES INFECT, V6, P172, DOI 10.1016/j.micinf.2003.11.007; GATTI S, 1993, INT J IMMUNOPHARMACO, V15, P551, DOI 10.1016/0192-0561(93)90071-6; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; Gersch C, 2002, HISTOCHEM CELL BIOL, V118, P41, DOI 10.1007/s00418-002-0425-z; Gil CD, 2002, PARASITOL RES, V88, P557, DOI 10.1007/s00436-002-0593-8; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Gupta S, 2013, INDIAN J PHARMACOL, V45, P83, DOI 10.4103/0253-7613.106442; Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017; Henderson WR, 1998, J INFECT DIS, V177, P1437, DOI 10.1086/517833; Hepworth MR, 2012, P NATL ACAD SCI USA, V109, P6644, DOI 10.1073/pnas.1112268109; Huang SG, 2013, J PERIODONTOL, V84, P248, DOI 10.1902/jop.2012.120066; Im SJ, 2011, PARASITE, V18, P49, DOI 10.1051/parasite/2011181049; Jash A, 2011, J ETHNOPHARMACOL, V133, P654, DOI 10.1016/j.jep.2010.10.054; Jones LA, 2010, EUR J IMMUNOL, V40, P426, DOI 10.1002/eji.200939705; Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171; Lu FL, 2003, INFECT IMMUN, V71, P7159, DOI 10.1128/IAI.71.12.7159-7163.2003; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Matowicka-Karna J, 2009, CLIN DEV IMMUNOL, DOI 10.1155/2009/374696; Matsuguchi T, 2012, CURR MED CHEM, V19, P1432, DOI 10.2174/092986712799828319; Maurer M, 2006, FASEB J, V20, P2460, DOI 10.1096/fj.06-5860com; Messina A, 2000, LAB INVEST, V80, P423, DOI 10.1038/labinvest.3780047; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Miyatake Akihiko, 2007, Allergol Int, V56, P231, DOI 10.2332/allergolint.O-06-444; Nickdel MB, 2004, PARASITE IMMUNOL, V26, P75, DOI 10.1111/j.0141-9838.2004.00686.x; Norose K, 2003, INVEST OPHTH VIS SCI, V44, P4375, DOI 10.1167/iovs.03-0156; OKAYAMA Y, 1995, INT ARCH ALLERGY IMM, V107, P158, DOI 10.1159/000236963; Oldenburg PJ, 2005, J PHARMACOL EXP THER, V313, P319, DOI 10.1124/jpet.104.071720; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; Roffe E, 2012, J IMMUNOL, V188, P649, DOI 10.4049/jimmunol.1003845; SUBAUSTE CS, 1991, J IMMUNOL, V147, P3955; Sun J, 2007, J CLIN INVEST, V117, P3359, DOI 10.1172/JCI31311; Suzuki Y, 1996, J IMMUNOL, V157, P2564; Suzuki Y, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002018; Swedenborg J, 2011, ARTERIOSCL THROM VAS, V31, P734, DOI 10.1161/ATVBAHA.110.213157; Theoharides TC, 2000, J PHARMACOL EXP THER, V294, P810; Woolley DE, 2003, NEW ENGL J MED, V348, P1709, DOI 10.1056/NEJMcibr023206; Wu B, 2013, PARASITOL RES, V112, P2511, DOI 10.1007/s00436-013-3416-1; Yamamoto YI, 1998, ANN TROP MED PARASIT, V92, P23, DOI 10.1080/00034989860139; Zhao J, 2011, ANTIOXID REDOX SIGN, V14, P1589, DOI 10.1089/ars.2010.3583	44	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77327	10.1371/journal.pone.0077327	http://dx.doi.org/10.1371/journal.pone.0077327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146978	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400102
J	Kamiya, K; Shimizu, K; Igarashi, A; Kobashi, H				Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito; Kobashi, Hidenaga			Time Course of Optical Quality and Intraocular Scattering after Refractive Lenticule Extraction	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; FEMTOSECOND LASER; CLINICAL-EVALUATION; MYOPIC ASTIGMATISM; PUPIL SIZE; SURGERY; ZONE; INSTRUMENT; MICROSCOPY; EFFICACY	Purpose: To assess the time course of optical quality and intraocular scattering in relation to visual acuity after femtosecond lenticule extraction (FLEx) for the correction of myopia. Methods: This study evaluated 36 eyes of 36 patients with spherical equivalents of -4.38 +/- 1.53 D [mean +/- standard deviation] who underwent FLEx. Before surgery, and 1 week and 1, 3 and 6 months after surgery, we assessed the modulation transfer function (MTF) cutoff frequency, Strehl ratio, objective scattering index (OSI), and OQAS values (OVs), using a double-pass instrument. We also investigated the relationship of the OSI with corrected distance visual acuity (CDVA) preoperatively and postoperatively. Results: The mean changes in MTF cutoff frequency, Strehl ratio, OSI, OV100%, OV20%, and OV9% preoperatively and 6 months postoperatively were -5.51 +/- 15.01, -0.03 +/- 0.07, 0.35 +/- 0.83, -0.17 +/- 0.48, -0.14 +/- 0.38, and -0.09 +/- 0.22, respectively. We found no significant preoperative correlation between the OSI and logMAR CDVA (Spearman rank correlation coefficient r = 0.068, p = 0.69), and modest, but significant correlations 1 week and 1, 3, and 6 months postoperatively (r = 0.572, r = 0.562, r = 0.542, r = 0.540, p < 0.001, respectively). Conclusions: FLEx induced a transient decrease in optical quality in association with an increase in intraocular scattering in the early postoperative period, possibly due to mild interface haze formation, but gradually recovered with time. It is suggested that this transient degradation in optical quality related to an increase in the intraocular scattering may result in a slight delay of CDVA recovery in the early postoperative period.	[Kamiya, Kazutaka; Shimizu, Kimiya; Igarashi, Akihito; Kobashi, Hidenaga] Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan	Kitasato University	Kamiya, K (corresponding author), Kitasato Univ, Sch Med, Dept Ophthalmol, Kanagawa, Japan.	kamiyak-tky@umin.ac.jp						Ang M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-75; Artal P, 2000, J REFRACT SURG, V16, pS560; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Blum M, 2010, KLIN MONATSBL AUGENH, V227, P961, DOI 10.1055/s-0029-1245894; Blum M, 2013, GRAEF ARCH CLIN EXP, V251, P349, DOI 10.1007/s00417-012-2064-y; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Diaz-Douton F, 2006, INVEST OPHTH VIS SCI, V47, P1710, DOI 10.1167/iovs.05-1049; Fang LH, 2013, OPT EXPRESS, V21, P1404, DOI 10.1364/OE.21.001404; Fankhauser Franz, 2004, Technol Health Care, V12, P443; Freedman KA, 2003, J CATARACT REFR SURG, V29, P1924, DOI 10.1016/S0886-3350(03)00214-1; Gertnere J, 2012, GRAEFES ARCH CLIN EX; Guell JL, 2004, J CATARACT REFR SURG, V30, P1598, DOI 10.1016/j.jcrs.2004.04.031; Guirao A, 1999, INVEST OPHTH VIS SCI, V40, P203; Heichel J, 2011, OPHTHALMIC RES, V46, P107, DOI 10.1159/000323814; Kamiya K, 2012, J CATARACT REFR SURG, V38, P1996, DOI 10.1016/j.jcrs.2012.06.052; Kamiya K, 2012, INVEST OPHTH VIS SCI, V53, P3161, DOI 10.1167/iovs.12-9650; Krueger RR, 1998, J REFRACT SURG, V14, P467; Kunert KS, 2011, GRAEF ARCH CLIN EXP, V249, P1417, DOI 10.1007/s00417-010-1578-4; Ratkay-Traub I, 2003, J REFRACT SURG, V19, P94; ROBERTS CW, 1993, INVEST OPHTH VIS SCI, V34, P2275; Saad A, 2010, J CATARACT REFR SURG, V36, P28, DOI 10.1016/j.jcrs.2009.07.033; SANTAMARIA J, 1987, J OPT SOC AM A, V4, P1109, DOI 10.1364/JOSAA.4.001109; Sekundo W, 2008, J CATARACT REFR SURG, V34, P1513, DOI 10.1016/j.jcrs.2008.05.033; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P1636, DOI 10.1016/j.jcrs.2011.03.056; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Vestergaard A, 2012, ACTA OPHTHALMOL; Vestergaard A, 2012, J CATARACT REFR SURG, V38, P2003, DOI 10.1016/j.jcrs.2012.07.021; Wang BG, 2008, LASER SURG MED, V40, P247, DOI 10.1002/lsm.20628; Wang BG, 2006, ANN ANAT, V188, P395, DOI 10.1016/j.aanat.2006.02.006	30	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76738	10.1371/journal.pone.0076738	http://dx.doi.org/10.1371/journal.pone.0076738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146917	gold, Green Submitted, Green Published			2022-12-27	WOS:000326019400083
J	Fang, IM; Yang, CH; Yang, CM; Chen, MS				Fang, I-Mo; Yang, Chang-Hao; Yang, Chung-May; Chen, Muh-Shy			Chitosan Oligosaccharides Attenuates Oxidative-Stress Related Retinal Degeneration in Rats	PLOS ONE			English	Article							NF-KAPPA-B; WATER-SOLUBLE CHITOSAN; TRANSCRIPTION FACTOR; IN-VITRO; CELLS; BCL-2; GLUTATHIONE; APOPTOSIS; PROTEINS; EFFICACY	This study investigated the therapeutic potential and mechanisms of chitosan oligosaccharides (COS) for oxidative stress-induced retinal diseases. Retinal oxidative damage was induced in Sprague-Dawley rats by intravitreal injection of paraquat (PQ). Low-dose (5 mg/kg) or high-dose (10 mg/kg) COS or PBS was intragastrically given for 14 days after PQ injection. Electroretinograms were performed to determine the functionality of the retinas. The surviving neurons in the retinal ganglion cell layer and retinal apoptosis were determined by counting Neu N-positive cells in whole-mounted retinas and TUNEL staining, respectively. The generation of reactive oxygen species (ROS) was determined by lucigenin- and luminol-enhanced chemiluminescence. Retinal oxidative damages were assessed by staining with nitrotyrosine, acrolein, and 8-hydroxy-2'-deoxyguanosine (8-OHdG). Immunohistochemical studies were used to demonstrate the expression of nuclear factor-kappa B (NF-kappa B) p65 in retinas. An in vitro study using RGC-5 cells was performed to verify the results. We demonstrated COS significantly enhanced the recovery of retinal function, preserved inner retinal thickness, and decreased retinal neurons loss in a dose-dependent manner. COS administration demonstrated anti-oxidative effects by reducing luminol-and lucigenin-dependent chemiluminenscense levels and activating superoxide dismutase and catalase, leading to decreased retinal apoptosis. COS markedly reduced retinal NF-kappa B p65. An in vitro study demonstrated COS increased I kappa B expression, attenuated the increase of p65 and thus decreased NF-kappa B/DNA binding activity in PQ-stimulated RGC-5 cells. In conclusion, COS attenuates oxidative stress-induced retinal damages, probably by decreasing free radicals, maintaining the activities of anti-oxidative enzymes, and inhibiting the activation of NF-kappa B.	[Fang, I-Mo] Taipei City Hosp, Zhongxiao Branch, Dept Ophthalmol, Taipei, Taiwan; [Yang, Chang-Hao; Yang, Chung-May; Chen, Muh-Shy] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan	Taipei City Hospital; National Taiwan University; National Taiwan University Hospital	Yang, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	chyangoph@ntu.edu.tw	Yang, Chang-Hao/AAR-3759-2021; Yang, Chung-May/AAV-3737-2020	YANG, CHANG-HAO/0000-0002-4328-8716; YANG, CHUNG-MAY/0000-0003-4082-420X	Department of Health, Taipei City Government [101-43]	Department of Health, Taipei City Government	This study was supported by a research grant from the Department of Health, Taipei City Government (101-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2000, BIOCHEM PHARMACOL, V60, P1033, DOI 10.1016/S0006-2952(00)00393-2; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Chen F, 1999, CLIN CHEM, V45, P7; Chen Q, 2006, EUR J PHARMACOL, V541, P1, DOI 10.1016/j.ejphar.2006.03.044; Cho YS, 2011, BIOORG MED CHEM LETT, V21, P3070, DOI 10.1016/j.bmcl.2011.03.033; Cingolani C, 2006, FREE RADICAL BIO MED, V40, P660, DOI 10.1016/j.freeradbiomed.2005.09.032; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Gracy RW, 1999, MUTAT RES-FUND MOL M, V428, P17, DOI 10.1016/S1383-5742(99)00027-7; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Je JY, 2004, FOOD CHEM TOXICOL, V42, P381, DOI 10.1016/j.fct.2003.10.001; Joodi G, 2011, INT J BIOL MACROMOL, V48, P726, DOI 10.1016/j.ijbiomac.2011.02.011; Khodagholi F, 2010, MOL CELL BIOCHEM, V337, P39, DOI 10.1007/s11010-009-0284-1; Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b; Liu HT, 2009, PHARMACOL RES, V59, P167, DOI 10.1016/j.phrs.2008.12.001; Luo T, 2006, ANESTH ANALG, V103, P110, DOI 10.1213/01.ane.0000221183.02244.80; Mendis E, 2007, LIFE SCI, V80, P2118, DOI 10.1016/j.lfs.2007.03.016; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Ozkan E, 2010, J SURG RES, V159, P588, DOI 10.1016/j.jss.2008.08.006; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pae HO, 2001, LEUKEMIA RES, V25, P339, DOI 10.1016/S0145-2126(00)00138-7; Pangestuti R, 2010, MAR DRUGS, V8, P2117, DOI 10.3390/md8072117; PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T; Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016; Qin CQ, 2002, INT J BIOL MACROMOL, V31, P111, DOI 10.1016/S0141-8130(02)00064-8; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Ryu B, 2012, CARBOHYD RES, V350, P55, DOI 10.1016/j.carres.2011.12.028; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; Tanito M, 2002, INVEST OPHTH VIS SCI, V43, P2392; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wei P, 2012, GLYCOCONJUGATE J, V29, P285, DOI 10.1007/s10719-012-9392-3; WIEGAND RD, 1983, INVEST OPHTH VIS SCI, V24, P1433; Winkler BS, 1999, MOL VIS, V5; Xie WM, 2001, BIOORG MED CHEM LETT, V11, P1699, DOI 10.1016/S0960-894X(01)00285-2; Yoon HJ, 2008, FOOD CHEM TOXICOL, V46, P710, DOI 10.1016/j.fct.2007.09.111; Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013; Yu ZJ, 2004, INT IMMUNOPHARMACOL, V4, P193, DOI 10.1016/j.intimp.2003.12.001	40	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77323	10.1371/journal.pone.0077323	http://dx.doi.org/10.1371/journal.pone.0077323			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155943	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300077
J	Gmyrek, GB; Akilesh, HM; Graham, DB; Fuchs, A; Yang, LH; Miller, MJ; Sandoval, GJ; Sheehan, KCF; Schreiber, RD; Diamond, MS; Swat, W				Gmyrek, Grzegorz B.; Akilesh, Holly M.; Graham, Daniel B.; Fuchs, Anja; Yang, Lihua; Miller, Mark J.; Sandoval, Gabriel J.; Sheehan, Kathleen C. F.; Schreiber, Robert D.; Diamond, Michael S.; Swat, Wojciech			Loss of DAP12 and FcR gamma Drives Exaggerated IL-12 Production and CD8(+) T Cell Response by CCR2(+) Mo-DCs	PLOS ONE			English	Article							TRANSCRIPTION FACTOR IRF8; DENDRITIC CELLS; IFN-GAMMA; MONOCYTE MIGRATION; SIGNALING PATHWAYS; GM-CSF; RECEPTOR; INFECTION; MACROPHAGES; ADAPTERS	Dap12 and FcR gamma, the two transmembrane ITAM-containing signaling adaptors expressed in dendritic cells (DC), are implicated in the regulation of DC function. Several activating and adhesion receptors including integrins require these chains for their function in triggering downstream signaling and effector pathways, however the exact role(s) for Dap12 and FcR gamma remains elusive as their loss can lead to both attenuating and enhancing effects. Here, we report that mice congenitally lacking both Dap12 and FcR gamma chains (DF) show a massively enhanced effector CD8(+) T cell response to protein antigen immunization or West Nile Virus (WNV) infection. Thus, immunization of DF mice with MHCI-restricted OVA peptide leads to accumulation of IL-12-producing monocyte-derived dendritic cells (Mo-DC) in draining lymph nodes, followed by vastly enhanced generation of antigen-specific IFN gamma-producing CD8(+) T cells. Moreover, DF mice show increased viral clearance in the WNV infection model. Depletion of CCR2+ monocytes/macrophages in vivo by administration anti-CCR2 antibodies or clodronate liposomes completely prevents the exaggerated CD8+ T cell response in DF mice. Mechanistically, we show that the loss of Dap12 and FcR gamma-mediated signals in Mo-DC leads to a disruption of GM-CSF receptor-induced STAT5 activation resulting in upregulation of expression of IRF8, a transcription factor. Consequently, Dap12- and FcR gamma-deficiency exacerbates GM-CSF-driven monocyte differentiation and production of inflammatory Mo-DC. Our data suggest a novel cross-talk between DC-ITAM and GM-CSF signaling pathways, which controls Mo-DC differentiation, IL-12 production, and CD8(+) T cell responses.	[Gmyrek, Grzegorz B.; Akilesh, Holly M.; Graham, Daniel B.; Fuchs, Anja; Miller, Mark J.; Sandoval, Gabriel J.; Sheehan, Kathleen C. F.; Schreiber, Robert D.; Diamond, Michael S.; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Yang, Lihua; Miller, Mark J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Swat, W (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	swat@wustl.edu	Schreiber, Robert/Q-7550-2019; Diamond, Michael/AAH-1733-2019; Gmyrek, Grzegorz/C-3175-2011	Diamond, Michael/0000-0002-8791-3165; Schreiber, Robert/0000-0003-1590-2341; Miller, Mark/0000-0001-5676-389X	National Institutes of Health [R01AI061077, R01AI073718]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073718, R01AI061077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant nos. R01AI061077 (to W.S.), R01AI073718 (to W.S.), and Leukemia and Lymphoma Society Scholar (W.S.) and Special Fellow (D.B.G.) awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Chu CL, 2008, EUR J IMMUNOL, V38, P166, DOI 10.1002/eji.200737600; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Divangahi M, 2007, J IMMUNOL, V179, P4015, DOI 10.4049/jimmunol.179.6.4015; Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Finberg RW, 2009, IMMUNITY, V30, P173, DOI 10.1016/j.immuni.2009.02.001; Gmyrek GB, 2013, EUR J IMMUNOL, V43, P1185, DOI 10.1002/eji.201142362; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Graham DB, 2010, BLOOD, V116, P3208, DOI 10.1182/blood-2009-10-250415; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Hida S, 2009, NAT IMMUNOL, V10, P214, DOI 10.1038/ni.1686; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu XY, 2005, J IMMUNOL, V175, P3637, DOI 10.4049/jimmunol.175.6.3637; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Huynh L, 2012, J IMMUNOL, V188, P3447, DOI 10.4049/jimmunol.1102211; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Li P, 2011, BLOOD, V117, P2847, DOI 10.1182/blood-2010-07-294272; Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003; McCormick S, 2011, J IMMUNOL, V187, P4280, DOI 10.4049/jimmunol.1101050; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Minten C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049851; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Pinto AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002407; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Town T, 2009, IMMUNITY, V30, P242, DOI 10.1016/j.immuni.2008.11.012; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang BM, 2012, CELL IMMUNOL, V278, P103, DOI 10.1016/j.cellimm.2012.07.005; Ward NL, 2011, BRIT J DERMATOL, V164, P750, DOI 10.1111/j.1365-2133.2010.10129.x; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Zhan YF, 2012, EUR J IMMUNOL, V42, P2889, DOI 10.1002/eji.201242477; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhan YF, 2010, J IMMUNOL, V185, P2125, DOI 10.4049/jimmunol.0903793; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76145	10.1371/journal.pone.0076145	http://dx.doi.org/10.1371/journal.pone.0076145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155889	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300023
J	Ortolan, TG; Menck, CFM				Ortolan, Tatiana Grohmann; Menck, Carlos Frederico M.			UVB-Induced Cell Death Signaling Is Associated with G1-S Progression and Transcription Inhibition in Primary Human Fibroblasts	PLOS ONE			English	Article							LIGHT-INDUCED APOPTOSIS; ULTRAVIOLET-INDUCED APOPTOSIS; DNA-DAMAGE; COUPLED REPAIR; PYRIMIDINE DIMERS; HAMSTER-CELLS; P53 RESPONSE; S-PHASE; GENES; RADIATION	DNA damage induced by ultraviolet (UV) radiation can be removed by nucleotide excision repair through two sub-pathways, one general (GGR) and the other specific for transcribed DNA (TCR), and the processing of unrepaired lesions trigger signals that may lead to cell death. These signals involve the tumor suppressor p53 protein, a central regulator of cell responses to DNA damage, and the E3 ubiquitin ligase Mdm2, that forms a feedback regulatory loop with p53. The involvement of cell cycle and transcription on the signaling to apoptosis was investigated in UVB-irradiated synchronized, DNA repair proficient, CS-B (TCR-deficient) and XP-C (GGR-deficient) primary human fibroblasts. Cells were irradiated in the G1 phase of the cell cycle, with two doses with equivalent levels of apoptosis (low and high), defined for each cell line. In the three cell lines, the low doses of UVB caused only a transient delay in progression to the S phase, whereas the high doses induced permanent cell cycle arrest. However, while accumulation of Mdm2 correlated well with the recovery from transcription inhibition at the low doses for normal and CS-B fibroblasts, for XP-C cells this protein was shown to be accumulated even at UVB doses that induced high levels of apoptosis. Thus, UVB-induced accumulation of Mdm2 is critical for counteracting p53 activation and apoptosis avoidance, but its effect is limited due to transcription inhibition. However, in the case of XP-C cells, an excess of unrepaired DNA damage would be sufficient to block S phase progression, which would signal to apoptosis, independent of Mdm2 accumulation. The data clearly discriminate DNA damage signals that lead to cell death, depending on the presence of UVB-induced DNA damage in replicating or transcribing regions.	[Ortolan, Tatiana Grohmann; Menck, Carlos Frederico M.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Menck, CFM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.	cfmmenck@usp.br	Menck, Carlos FM/G-6321-2011	Menck, Carlos FM/0000-0003-1941-0694	FAPESP, Sao Paulo, Brazil; CNPq, Brasilia, Brazil	FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq, Brasilia, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by FAPESP, Sao Paulo, Brazil, and CNPq, Brasilia, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; Batista LFZ, 2006, APOPTOSIS, V11, P1139, DOI 10.1007/s10495-006-7109-4; Cadet J, 2012, PHOTOCHEM PHOTOBIOL, V88, P1048, DOI 10.1111/j.1751-1097.2012.01200.x; Carvalho H, 2008, DNA REPAIR, V7, P922, DOI 10.1016/j.dnarep.2008.03.003; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Conforti G, 2000, ONCOGENE, V19, P2714, DOI 10.1038/sj.onc.1203583; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; Courdavault S, 2004, PHOTOCHEM PHOTOBIOL, V79, P145, DOI 10.1562/0031-8655(2004)079<0145:UCPDDN>2.0.CO;2; D'Errico M, 2005, CANCER RES, V65, P432; De Santis LP, 2002, DNA REPAIR, V1, P209, DOI 10.1016/S1568-7864(01)00017-9; De Santis LP, 2001, MUTAT RES-DNA REPAIR, V485, P121, DOI 10.1016/S0921-8777(00)00065-3; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Dumaz N, 1997, MOL CARCINOGEN, V20, P340, DOI 10.1002/(SICI)1098-2744(199712)20:4<340::AID-MC3>3.0.CO;2-N; Dunkern TR, 2002, MOL BIOL CELL, V13, P348, DOI 10.1091/mbc.01-05-0225; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Kaufmann WK, 2007, CELL CYCLE, V6, P1460; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Leite RA, 2009, J INVEST DERMATOL, V129, P502, DOI 10.1038/jid.2008.239; Li G, 1998, BRIT J DERMATOL, V139, P3; Ljungman M, 1996, ONCOGENE, V13, P823; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; McKay BC, 2002, DNA REPAIR, V1, P811, DOI 10.1016/S1568-7864(02)00109-X; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Orren DK, 1997, MOL BIOL CELL, V8, P1129, DOI 10.1091/mbc.8.6.1129; ORREN DK, 1995, MOL CELL BIOL, V15, P3722; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Rechkunova NI, 2011, BIOCHEMISTRY-MOSCOW+, V76, P24, DOI 10.1134/S0006297911010056; Sertic S, 2012, CELL CYCLE, V11, P668, DOI 10.4161/cc.11.4.19117; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Moraes MCS, 2012, FRONT BIOSCI-LANDMRK, V17, P1362, DOI 10.2741/3992; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; YAMAIZUMI M, 1994, ONCOGENE, V9, P2775	41	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76936	10.1371/journal.pone.0076936	http://dx.doi.org/10.1371/journal.pone.0076936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155908	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300042
J	Richardson, A; Gardner, RG; Prelich, G				Richardson, Aaron; Gardner, Richard G.; Prelich, Gregory			Physical and Genetic Associations of the Irc20 Ubiquitin Ligase with Cdc48 and SUMO	PLOS ONE			English	Article							RNA-POLYMERASE-II; AAA ATPASE CDC48/P97; SACCHAROMYCES-CEREVISIAE; HISTONE H2B; PROTEIN UBIQUITINATION; TRANSCRIPTION FACTOR; GENOME STABILITY; DNA-REPAIR; YEAST; DOMAIN	A considerable percentage of the genome is dedicated to the ubiquitin-proteasome system, with the yeast genome predicted to encode approximately 100 ubiquitin ligases (or E3s), and the human genome predicted to encode more than 600 E3s. The most abundant class of E3s consists of RING finger-containing proteins. Although many insights have been obtained regarding the structure and catalytic mechanism of the E3s, much remains to be learned about the function of the individual E3s. Here we characterize IRC20, which encodes a dual RING- and Snf/Swi family ATPase domain-containing protein in yeast that has been implicated in DNA repair. We found that overexpression of IRC20 causes two transcription-associated phenotypes and demonstrate that the Irc20 RING domain possesses ubiquitin E3 activity in vitro. Two mass spectrometry approaches were undertaken to identify Irc20-associated proteins. Wild-type Irc20 associated with Cdc48, a AAA-ATPase that serves as an intermediary in the ubiquitin-proteasome system. A second approach using a RING mutant derivative of Irc20 detected increased association of the Irc20 mutant with SUMO. These findings provide a foundation for understanding the roles of Irc20 in transcription and DNA repair.	[Richardson, Aaron; Prelich, Gregory] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Yeshiva University; Albert Einstein College of Medicine; University of Washington; University of Washington Seattle	Prelich, G (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	gregory.prelich@EINSTEIN.YU.EDU		Gardner, Richard/0000-0003-2162-6275	Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; National Institutes of Health (NIH) [DA028786]; NIH/NCRR [R21 RR025787]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028786] Funding Source: NIH RePORTER	Training Program in Cellular and Molecular Biology and Genetics; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the Training Program in Cellular and Molecular Biology and Genetics, T32 GM007491 and by National Institutes of Health (NIH) grant DA028786 to GP and NIH/NCRR R21 RR025787 to RG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; AUBLE DT, 1994, GENE DEV, V8, P1920, DOI 10.1101/gad.8.16.1920; Bergink S, 2013, NAT CELL BIOL; Bohm S, 2011, MOL CELL BIOL, V31, P1528, DOI 10.1128/MCB.00962-10; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buchberger A, 2010, SUBCELL BIOCHEM, V54, P17, DOI 10.1007/978-1-4419-6676-6_2; Cal-Bakowska M, 2011, NUCLEIC ACIDS RES, V39, P8765, DOI 10.1093/nar/gkr587; Collins GA, 2009, NATURE, V461, pE7, DOI 10.1038/nature08406; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Flaus A, 2011, FEBS J, V278, P3579, DOI 10.1111/j.1742-4658.2011.08281.x; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gangavarapu V, 2006, MOL CELL BIOL, V26, P7783, DOI 10.1128/MCB.01260-06; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Jones GM, 2008, NAT METHODS, V5, P239, DOI 10.1038/NMETH.1181; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Miura T, 2012, GENETICS, V191, P65, DOI 10.1534/genetics.112.139105; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Murray S, 2001, MOL CELL BIOL, V21, P4089, DOI 10.1128/MCB.21.13.4089-4096.2001; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PRELICH G, 1993, GENETICS, V135, P665; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Ramsey KL, 2004, MOL CELL BIOL, V24, P6362, DOI 10.1128/MCB.24.14.6362-6378.2004; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Richmond E, 1996, NUCLEIC ACIDS RES, V24, P3685, DOI 10.1093/nar/24.19.3685; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rose MD., 1990, METHODS YEAST GENETI; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Wang Q, 2005, J BIOL CHEM, V280, P40515, DOI 10.1074/jbc.M509636200; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Winston F, 1998, COLD SPRING HARB SYM, V63, P553, DOI 10.1101/sqb.1998.63.553; WINSTON F, 1984, GENETICS, V107, P179; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	63	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76424	10.1371/journal.pone.0076424	http://dx.doi.org/10.1371/journal.pone.0076424			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155900	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300034
J	Hughes, PW; Ellefson, MR				Hughes, P. William; Ellefson, Michelle R.			Inquiry-based training improves teaching effectiveness of biology teaching assistants	PLOS ONE			English	Article							STUDENTS EVALUATIONS; GRADUATE; FACULTY	Graduate teaching assistants (GTAs) are used extensively as undergraduate science lab instructors at universities, yet they often have having minimal instructional training and little is known about effective training methods. This blind randomized control trial study assessed the impact of two training regimens on GTA teaching effectiveness. GTAs teaching undergraduate biology labs (n = 52) completed five hours of training in either inquiry-based learning pedagogy or general instructional "best practices". GTA teaching effectiveness was evaluated using: (1) a nine-factor student evaluation of educational quality; (2) a six-factor questionnaire for student learning; and (3) course grades. Ratings from both GTAs and undergraduates indicated that indicated that the inquiry-based learning pedagogy training has a positive effect on GTA teaching effectiveness.	[Hughes, P. William] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Hughes, P. William; Ellefson, Michelle R.] Univ Cambridge, Fac Educ, Cambridge, England	Carleton University; University of Cambridge	Hughes, PW (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada.	william_hughes@carleton.ca	Hughes, P. William/G-9119-2018; Ellefson, Michelle/U-3602-2018	Hughes, P. William/0000-0003-4142-2579; Ellefson, Michelle/0000-0003-0407-9767	Opportunities for Innovation Fund; Higher Education Quality Council of Ontario (HEQCO) [OIFM-004-12-13]	Opportunities for Innovation Fund; Higher Education Quality Council of Ontario (HEQCO)	This project was supported by a grant from the Opportunities for Innovation Fund, awarded by the Higher Education Quality Council of Ontario (HEQCO grant OIFM-004-12-13; Funding Body URL: www.heqco.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, APPL MULTIVARIATE RE; Apedoe X. S., 2006, J GEOSCIENCE ED, V54, P414; Banchi H., 2008, SCI CHILDREN, V46, P26; BOHRER K, 2007, P 28 WORKSH C ASS BI, V28, P335; Camodeca M, 2005, EDUC RES-UK, V47, P93, DOI 10.1080/0013188042000337587; COFFEY M, 2001, ASSESS EVAL HIGH EDU, V26, P37, DOI DOI 10.1080/02602930020022318.ACCESSED; Edelson DC, 1999, J LEARN SCI, V8, P391, DOI 10.1207/s15327809jls0803&4_3; Farrell JJ, 1999, J CHEM EDUC, V76, P570, DOI 10.1021/ed076p570; French D, 2002, BIOSCIENCE, V52, P1036, DOI 10.1641/0006-3568(2002)052[1036:DGTABF]2.0.CO;2; Gaddis BA, 2007, J CHEM EDUC, V84, P848; Goldey ES, 2012, CBE-LIFE SCI EDUC, V11, P353, DOI 10.1187/cbe.11-02-0017; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Hardre PL, 2012, INSTR SCI, V40, P93, DOI 10.1007/s11251-010-9163-0; Henige K, 2011, ADV PHYSIOL EDUC, V35, P197, DOI 10.1152/advan.00086.2010; Iler HD, 2012, J CHEM EDUC, V89, P1178, DOI 10.1021/ed2005664; Kendall KD, 2012, CBE-LIFE SCI EDUC, V11, P187, DOI 10.1187/cbe.11-10-0091; Koenig KM, 2007, PHYS REV SPEC TOP-PH, V3, DOI 10.1103/PhysRevSTPER.3.010104; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; LOWMAN J, 1993, TEACH PSYCHOL, V20, P84, DOI 10.1207/s15328023top2002_4; Luckie DB, 2004, ADV PHYSIOL EDUC, V28, P199, DOI 10.1152/advan.00025.2004; Luft JA, 2004, J RES SCI TEACH, V41, P211, DOI 10.1002/tea.20004; Marbach-Ad G, 2012, J CHEM EDUC, V89, P865, DOI 10.1021/ed200563b; MARSH HW, 1982, BRIT J EDUC PSYCHOL, V52, P77, DOI 10.1111/j.2044-8279.1982.tb02505.x; MARSH HW, 1993, J HIGH EDUC, V64, P1, DOI 10.2307/2959975; Meyers SA, 2000, TEACH PSYCHOL, V27, P258, DOI 10.1207/S15328023TOP2704_03; OLSON CL, 1976, PSYCHOL BULL, V83, P579, DOI 10.1037/0033-2909.83.4.579; Park C, 2004, TEACH HIGH EDUC, V9, P349, DOI 10.1080/1356251042000216660; PICKERING M, 1980, CHRONLICLE HIGHER ED, V45, P80; PRIETO LR, 1994, RES HIGH EDUC, V35, P481, DOI 10.1007/BF02496384; Rissing SW, 2009, CBE-LIFE SCI EDUC, V8, P55, DOI 10.1187/cbe.08-05-0023; Rodriques RAB, 2006, J CHEM EDUC, V83, P305, DOI 10.1021/ed083p305; Roehrig GH, 2003, J CHEM EDUC, V80, P1206; Rushin JW, 1997, AM BIOL TEACH, V59, P86; Shannon DM, 1998, J HIGH EDUC, V69, P440, DOI 10.2307/2649274; Vale RD, 2012, SCIENCE, V338, P1542, DOI 10.1126/science.1216570; Weaver GC, 2008, NAT CHEM BIOL, V4, P577, DOI 10.1038/nchembio1008-577; Wilke RR, 2005, AM BIOL TEACH, V67, P534, DOI 10.1662/0002-7685(2005)067[0534:PAFTIS]2.0.CO;2; Windschitl M, 2003, SCI EDUC, V87, P112, DOI 10.1002/sce.10044; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306	40	13	13	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78540	10.1371/journal.pone.0078540	http://dx.doi.org/10.1371/journal.pone.0078540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147138	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400153
J	Xu, JL; Yin, ZQ; Gao, W; Liu, LX; Yin, YM; Liu, P; Shu, YQ				Xu, Jiali; Yin, Zhiqiang; Gao, Wen; Liu, Lingxiang; Yin, Yongmei; Liu, Ping; Shu, Yongqian			Genetic Variation in a MicroRNA-502 Minding Site in SET8 Gene Confers Clinical Outcome of Non-Small Cell Lung Cancer in a Chinese Population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; HISTONE METHYLTRANSFERASE SET8; 3' UNTRANSLATED REGION; MIR-502 BINDING-SITE; 3'-UNTRANSLATED REGION; S-PHASE; EXPRESSION; H4; SURVIVAL; PR-SET7	Background: Genetic variants may influence microRNA-target interaction through modulate their binding affinity, creating or destroying miRNA-binding sites. SET8, a member of the SET domain-containing methyltransferase, has been implicated in a variety array of biological processes. Methods: Using Taqman assay, we genotyped a polymorphism rs16917496 T>C within the miR-502 binding site in the 3'-untranslated region of the SET8 gene in 576 non-small cell lung cancer (NSCLC) patients. Functions of rs16917496 were investigated using luciferase activity assay and validated by immunostaining. Results: Log-rank test and cox regression indicated that the CC genotype was associated with a longer survival and a reduced risk of death for NSCLC [58.0 vs. 41.0 months, P = 0.031; hazard ratio = 0.44, 95% confidential interval: 0.26-0.74]. Further stepwise regression analysis suggested rs16917496 was an independently favorable factor for prognosis and the protective effect more prominent in never smokers, patients without diabetes and patients who received chemotherapy. A significant interaction was observed between rs16917496 and smoking status in relation to NSCLC survival (P<0.001). Luciferase activity assay showed a lower expression level for C allele as compared with T allele, and the miR-502 had an effect on modulation of SET8 gene in vitro. The CC genotype was associated with reduced SET8 protein expression based on immunostaining of 192 NSCLC tissue sample (P = 0.007). Lower levels of SET8 were associated with a non-significantly longer survival (55.0 vs. 43.1 months). Conclusion: Our data suggested that the rs16917496 T>C located at miR-502 binding site contributes to NSCLC survival by altering SET8 expression through modulating miRNA-target interaction.	[Xu, Jiali; Gao, Wen; Liu, Lingxiang; Yin, Yongmei; Liu, Ping; Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Yin, Zhiqiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Dermatol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Shu, YQ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	shuyongqian@csco.org.cn	Liu, Lingxiang/I-7538-2016; Shu, Yongqian/ABD-5698-2021	Liu, Lingxiang/0000-0001-8689-1788; 	National Natural Science Foundation of China [81172140, 81272532]; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]; Jiangsu Province Clinical science and technology projects (Clinical Research Center) [BL2012008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Province Clinical science and technology projects (Clinical Research Center)	This work was supported by National Natural Science Foundation of China (81172140, 81272532), the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801) and Jiangsu Province Clinical science and technology projects (Clinical Research Center, BL2012008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Ding CM, 2012, EXP THER MED, V3, P689, DOI 10.3892/etm.2012.469; Duan RH, 2007, HUM MOL GENET, V16, P1124, DOI 10.1093/hmg/ddm062; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Guo ZJ, 2012, INT J CANCER, V131, P1318, DOI 10.1002/ijc.27352; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Lu Y, 2012, CARCINOGENESIS, V33, P1046, DOI 10.1093/carcin/bgs100; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skrzypski M, 2011, MUTAT RES-FUND MOL M, V717, P25, DOI 10.1016/j.mrfmmm.2011.04.002; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Sweeney C, 2003, CANCER EPIDEM BIOMAR, V12, P527; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Teo MTW, 2012, CARCINOGENESIS, V33, P581, DOI 10.1093/carcin/bgr300; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang CJ, 2012, CANCER GENET-NY, V205, P373, DOI 10.1016/j.cancergen.2012.04.010; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang K, 2012, CARCINOGENESIS, V33, P2147, DOI 10.1093/carcin/bgs259; WESTRA WH, 1993, AM J SURG PATHOL, V17, P213, DOI 10.1097/00000478-199303000-00001; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Wu XF, 2002, JNCI-J NATL CANCER I, V94, P681; Xing JL, 2012, CANCER EPIDEM BIOMAR, V21, P217, DOI 10.1158/1055-9965.EPI-11-0624; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; Xu JL, 2012, ASIAN PAC J CANCER P, V13, P851, DOI 10.7314/APJCP.2012.13.3.851; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Yin YL, 2005, J BIOL CHEM, V280, P30025, DOI 10.1074/jbc.M501691200; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhai H, 2013, ONCOGENE, V32, P1570, DOI 10.1038/onc.2012.167	50	27	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77024	10.1371/journal.pone.0077024	http://dx.doi.org/10.1371/journal.pone.0077024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146953	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400096
J	Goswami, N; Gorur, P; Pilsl, U; Anyaehie, B; Green, DA; Bondarenko, AI; Roessler, A; Hinghofer-Szalkay, HG				Goswami, Nandu; Gorur, Paavan; Pilsl, Ulrike; Anyaehie, Bond; Green, David A.; Bondarenko, Alexander I.; Roessler, Andreas; Hinghofer-Szalkay, Helmut G.			Effect of Orthostasis on Endothelial Function: A Gender Comparative Study	PLOS ONE			English	Article							FLOW-MEDIATED DILATATION; BRACHIAL-ARTERY; ULTRASOUND ASSESSMENT; SMOOTH-MUSCLE; VASODILATION; REACTIVITY; ASTRONAUTS; MODULATION; STRESS	As the vascular endothelium has multiple functions, including regulation of vascular tone, it may play a role in the pathophysiology of orthostatic intolerance. We investigated the effect of orthostasis on endothelial function using EndoPAT (R), a non-invasive and user-independent method, and across gender. As sex steroid hormones are known to affect endothelial function, this study examined the potential effect of these hormones on the endothelial response to orthostasis by including females at different phases of the menstrual cycle (follicular and luteal-where the hormone balance differs), and females taking an oral contraceptive. A total of 31 subjects took part in this study (11 males, 11 females having normal menstrual cycles and 9 females taking oral contraceptive). Each subject made two visits for testing; in the case of females having normal menstrual cycles the first session was conducted either 1-7 (follicular) or 14-21 days (luteal) after the start of menstruation, and the second session two weeks later, i.e., during the other phase, respectively. Endothelial function was assessed at baseline and following a 20-min orthostatic challenge (active standing). The EndoPAT (R) index increased from 1.71 +/- 0.09 (mean +/- SEM) at baseline to 2.07 +/- 0.09 following orthostasis in females (p<0.001). In males, the index increased from 1.60 +/- 0.08 to 1.94 +/- 0.13 following orthostasis (p<0.001). There were no significant differences, however, in the endothelial response to orthostasis between females and males, menstrual cycle phases and the usage of oral contraceptive. Our results suggest an increased vasodilatatory endothelial response following orthostasis in both females and males. The effect of gender and sex hormones on the endothelial response to orthostasis appears limited. Further studies are needed to determine the potential role of this post orthostasis endothelial response in the pathophysiology of orthostatic intolerance.	[Goswami, Nandu; Roessler, Andreas; Hinghofer-Szalkay, Helmut G.] Med Univ Graz, Inst Physiol, Ctr Physiol Med, Graz, Austria; [Gorur, Paavan; Green, David A.] Kings Coll London, Ctr Human & Aerosp Physiol Sci, London, England; [Pilsl, Ulrike] Med Univ Graz, Dept Anat, Graz, Austria; [Anyaehie, Bond] Univ Nigeria, Dept Physiol, Coll Med, Enugu, Nigeria; [Bondarenko, Alexander I.] AA Bogomoletz Inst Physiol, Circulatory Physiol Dept, Kiev, Ukrainian State, Ukraine	Medical University of Graz; University of London; King's College London; Medical University of Graz; University of Nigeria; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Goswami, N (corresponding author), Med Univ Graz, Inst Physiol, Ctr Physiol Med, Graz, Austria.	nandu.goswami@medunigraz.at	Bondarenko, Alexander I/B-3080-2013; Goswami, Nandu/B-4021-2011; Roessler, Andreas/A-5751-2008	Roessler, Andreas/0000-0001-9543-8870; Bondarenko, Oleksandr/0000-0003-2629-5962	Land Steiermark, Graz, Austria; King's College London, UK	Land Steiermark, Graz, Austria; King's College London, UK	Dr. Goswami received financial support from the Land Steiermark, Graz, Austria for the purchase of the EndoPAT probes and Dr. Gorur was supported by King's College London, UK as the project formed part of his Space Physiology & Health MSc. The funders had no role in the study design, data colletion and analysis, decision to publish, or preparation of the mansucript.	Agewall S, 2001, CLIN PHYSIOL, V21, P9, DOI 10.1046/j.1365-2281.2001.00302.x; Blaber AP, 2011, STROKE, V42, P1844, DOI 10.1161/STROKEAHA.110.610576; Bonetti PO, 2004, J AM COLL CARDIOL, V44, P2137, DOI 10.1016/j.jacc.2004.08.062; Buckey JC, 2006, SPACE PHYSL; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; FritschYelle JM, 1996, J APPL PHYSIOL, V81, P2134, DOI 10.1152/jappl.1996.81.5.2134; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GOSWAMI N, 2012, EUR J APPL PHYSL, P20239; Guazzi M, 2005, AM J HYPERTENS, V18, P986, DOI 10.1016/j.amjhyper.2005.02.018; Guazzi M, 2004, ACTA PHYSIOL SCAND, V182, P353, DOI 10.1111/j.1365-201X.2004.01365.x; HASHIMOTO M, 1995, CIRCULATION, V92, P3431, DOI 10.1161/01.CIR.92.12.3431; Hinghofer-Szalkay HG, 2006, J APPL PHYSIOL, V100, P844, DOI 10.1152/japplphysiol.01039.2005; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Lepori M, 2001, CARDIOVASC RES, V51, P767, DOI 10.1016/S0008-6363(01)00325-X; Levick J.R, 2012, INTRO CARDIOVASCULAR, V5th; Meendering JR, 2010, CONTRACEPTION, V82, P366, DOI 10.1016/j.contraception.2010.03.009; Meendering JR, 2009, CONTRACEPTION, V79, P41, DOI 10.1016/j.contraception.2008.07.025; Munzel T, 2008, ANN MED, V40, P180, DOI 10.1080/07853890701854702; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4; Sartori C, 2005, PHARMACOL THERAPEUT, V106, P209, DOI 10.1016/j.pharmthera.2004.11.009; Shoemaker JK, 2001, AM J PHYSIOL-HEART C, V281, pH2028, DOI 10.1152/ajpheart.2001.281.5.H2028; Torgrimson BN, 2007, AM J PHYSIOL-HEART C, V292, pH2874, DOI 10.1152/ajpheart.00762.2006; VANHOUTTE PM, 1986, ANNU REV PHYSIOL, V48, P307; Williams MRI, 2001, J CLIN ENDOCR METAB, V86, P5389, DOI 10.1210/jc.86.11.5389	25	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 2	2013	8	8							e71655	10.1371/journal.pone.0071655	http://dx.doi.org/10.1371/journal.pone.0071655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219XU	24147147	Green Published, gold, Green Submitted			2022-12-27	WOS:000324545800066
J	Diekhoff, T; Schlattmann, P; Dewey, M				Diekhoff, Torsten; Schlattmann, Peter; Dewey, Marc			Impact of Article Language in Multi-Language Medical Journals - a Bibliometric Analysis of Self-Citations and Impact Factor	PLOS ONE			English	Article								Background: In times of globalization there is an increasing use of English in the medical literature. The aim of this study was to analyze the influence of English-language articles in multi-language medical journals on their international recognition - as measured by a lower rate of self-citations and higher impact factor (IF). Methods and Findings: We analyzed publications in multi-language journals in 2008 and 2009 using the Web of Science (WoS) of Thomson Reuters (former Institute of Scientific Information) and PubMed as sources of information. The proportion of English-language articles during the period was compared with both the share of self-citations in the year 2010 and the IF with and without self-citations. Multivariable linear regression analysis was performed to analyze these factors as well as the influence of the journals' countries of origin and of the other language(s) used in publications besides English. We identified 168 multi-language journals that were listed in WoS as well as in PubMed and met our criteria. We found a significant positive correlation of the share of English articles in 2008 and 2009 with the IF calculated without self-citations (Pearson r=0.56, p = <0.0001), a correlation with the overall IF (Pearson r = 0.47, p = <0.0001) and with the cites to years of IF calculation (Pearson r = 0.34, p = <0.0001), and a weak negative correlation with the share of self-citations (Pearson r = -0.2, p = 0.009). The IF without self-citations also correlated with the journal's country of origin - North American journals had a higher IF compared to Middle and South American or European journals. Conclusion: Our findings suggest that a larger share of English articles in multi-language medical journals is associated with greater international recognition. Fewer self-citations were found in multi-language journals with a greater share of original articles in English.	[Diekhoff, Torsten; Dewey, Marc] Free Univ Berlin, Humboldt Univ, Charite Univ Med Berlin Campus Mitte, Dept Radiol, Berlin, Germany; [Schlattmann, Peter] Free Univ Berlin, Humboldt Univ, Charite Univ Med Berlin Campus Mitte, Dept Biometry & Clin Epidemiol, Berlin, Germany; [Schlattmann, Peter] Univ Jena, Dept Med Stat Comp Sci & Documentat, Jena, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena	Dewey, M (corresponding author), Free Univ Berlin, Humboldt Univ, Charite Univ Med Berlin Campus Mitte, Dept Radiol, Berlin, Germany.	dewey@charite.de	Diekhoff, Torsten/K-5182-2019	Diekhoff, Torsten/0000-0003-3593-1449; Dewey, Marc/0000-0002-4402-2733	Heisenberg Professorship of the German Research Foundation (DFG)	Heisenberg Professorship of the German Research Foundation (DFG)(German Research Foundation (DFG))	No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Marc Dewey is supported by a Heisenberg Professorship of the German Research Foundation (DFG).	Foo JYA, 2011, SCI ENG ETHICS, V17, P65, DOI 10.1007/s11948-009-9177-7; Foo JYA, 2009, ACCOUNT RES, V16, P127, DOI 10.1080/08989620902984080; Garfield E, 1999, CAN MED ASSOC J, V161, P979; Gargouri Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013636; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Habibzadeh F, 2010, CROAT MED J, V51, P165, DOI 10.3325/cmj.2010.51.165; Hasse W, 2010, CHIRURG, V81, P361, DOI 10.1007/s00104-009-1786-9; Karageorgopoulos DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016300; Kurmis AP, 2003, J BONE JOINT SURG AM, V85A, P2449, DOI 10.2106/00004623-200312000-00028; Lundh A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000354; Marcovitch H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000355; Mueller PS, 2006, SWISS MED WKLY, V136, P441; Mueller PS, 2006, NETH J MED, V64, P39; Poomkottayil D, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13148; Rieder S, 2010, LANGENBECK ARCH SURG, V395, pS57, DOI 10.1007/s00423-010-0623-4; Rizkallah J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010204; Ruano-Ravina A, 2012, ANN EPIDEMIOL; Satya-Murti S, 2006, JAMA-J AM MED ASSOC, V296, P1410; Seglen PO, 1997, BRIT MED J, V314, P498; Tighe P, 2011, ANESTH ANALG, V113, P378, DOI 10.1213/ANE.0b013e31821d72e5; Wang J, 2013, SCIENTOMETRICS, V94, P851, DOI 10.1007/s11192-012-0775-9; Winkmann G, 2002, KLIN MONATSBL AUGENH, V219, P72, DOI 10.1055/s-2002-23505	22	24	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76816	10.1371/journal.pone.0076816	http://dx.doi.org/10.1371/journal.pone.0076816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146929	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200021
J	Khajehkazemi, R; Sadeghirad, B; Karamouzian, M; Fallah, MS; Mehrolhassani, MH; Dehnavieh, R; Haghdoost, A				Khajehkazemi, Razieh; Sadeghirad, Behnam; Karamouzian, Mohammad; Fallah, Mohammad-Sadegh; Mehrolhassani, Mohammad-Hossien; Dehnavieh, Reza; Haghdoost, AliAkbar			The Projection of Burden of Disease in Islamic Republic of Iran to 2025	PLOS ONE			English	Article								Objective: Iran as a developing country is in the transition phase, which might have a big impact on the Burden of Disease and Injury (BOD). This study aims to estimate Burden of Disease and Injury (BOD) in Iran up to 2025 due to four broad cause groups using Disability-Adjusted Life Year (DALY). Methods: The impacts of demographic and epidemiological changes on BOD (DemBOD and EpiBOD) were assessed separately. We estimated DemBOD in nine scenarios, using different projections for life expectancy and total fertility rate. EpiBOD was modeled in two scenarios as a proportion of DemBOD, based on the extracted parameters from an international study. Findings: The BOD is projected to increase from 14.3 million in 2003 to 19.4 million in 2025 (95% uncertainty interval: 16.8, 21.9), which shows an overall increase of 35.3%. Non-communicable diseases (12.7 million DALY, 66.0%), injuries (4.6 million DALY, 24.0%), and communicable diseases, except HIV/AIDS (1.8 million DALY, 9%) will be the leading causes of losing healthy life. Under the most likely scenario, the maximum increase in disease burden due to DemBOD is projected to be observed in HIV/AIDS and Non-communicable diseases (63.9 and 62.4%, respectively) and due to EpiBOD in HIV/AIDS (319.5%). Conclusion: It seems that in the following decades, BOD will have a sharp increase in Iran, mainly due to DemBOD. It seems that communicable diseases (except HIV/AIDS) will have less contribution, and especially non-communicable diseases will play a more significant role.	[Khajehkazemi, Razieh; Karamouzian, Mohammad] Kerman Univ Med Sci, Inst Futures Studies Hlth, Reg Knowledge Hub & WHO Collaborating Ctr HIV Sur, Kerman, Iran; [Sadeghirad, Behnam] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran; [Fallah, Mohammad-Sadegh] Kawsar Human Genet Res Ctr, Tehran, Iran; [Mehrolhassani, Mohammad-Hossien; Dehnavieh, Reza] Kerman Univ Med Sci, Inst Futures Studies Hlth, Res Ctr Hlth Serv Management, Dept Hlth Serv Management, Kerman, Iran; [Haghdoost, AliAkbar] Kerman Univ Med Sci, Inst Futures Studies Hlth, Res Ctr Modeling Hlth, Kerman, Iran	Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences; Kerman University of Medical Sciences	Haghdoost, A (corresponding author), Kerman Univ Med Sci, Inst Futures Studies Hlth, Res Ctr Modeling Hlth, Kerman, Iran.	ahaghdoost@kmu.ac.ir	Dehnavieh, Reza/AAZ-9792-2020; Sadeghirad, Behnam/A-1772-2009; Mehrolhassani, Mohammad Hossein/ABD-6252-2020; Haghdoost, Ali Akbar/C-2823-2009; Karamouzian, Mohammad/C-9277-2018	Dehnavieh, Reza/0000-0002-6456-1355; Sadeghirad, Behnam/0000-0001-9422-5232; Mehrolhassani, Mohammad Hossein/0000-0002-2412-9277; Haghdoost, Ali Akbar/0000-0003-4628-4849; Karamouzian, Mohammad/0000-0002-5631-4469	I.R.Iran's National Institute of Health Research, Tehran University of Medical Sciences [241-M-486]	I.R.Iran's National Institute of Health Research, Tehran University of Medical Sciences	This study was supported by a grant from I.R.Iran's National Institute of Health Research, Tehran University of Medical Sciences, contract No: 241-M-486. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2009, INT HEALTH, V1, P3, DOI 10.1016/j.inhe.2009.02.003; [Anonymous], WORLD BANK LIST EC; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], 2009, WORLD BANK LIST EC; Begg S., 2007, BURDEN DIS INJURY AU; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; Chappell NL, 2012, INT ENCY REHABILITAT; Haghdoost AA, 2011, J AIDS HIV RES, V3, P231, DOI [https://doi.org/10.5897/JAHR11.030, DOI 10.5897/JAHR11.030]; Hyder AA, 2000, AM J PUBLIC HEALTH, V90, P1235, DOI 10.2105/AJPH.90.8.1235; Lapostolle A, 2009, HLTH FRANCE 2025 PRO; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michaud CM, 2001, JAMA-J AM MED ASSOC, V285, P535, DOI 10.1001/jama.285.5.535; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P481; Murray CJL, 1996, REPORT AD HOC COMMIT; Naghavi Mohsen, 2009, Popul Health Metr, V7, P9, DOI 10.1186/1478-7954-7-9; Somerford P, 2004, W AUSTR BURDEN DIS S; World Health Organization (WHO), 2009, WORLD HLTH STAT	17	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76881	10.1371/journal.pone.0076881	http://dx.doi.org/10.1371/journal.pone.0076881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146941	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200024
J	Lai, CH; Chang, LL; Lin, JN; Chen, WF; Kuo, LL; Lin, HH; Chen, YH				Lai, Chung-Hsu; Chang, Lin-Li; Lin, Jiun-Nong; Chen, Wei-Fang; Kuo, Li-Li; Lin, Hsi-Hsun; Chen, Yen-Hsu			High Seroprevalence of Mycoplasma pneumoniae IgM in Acute Q Fever by Enzyme-Linked Immunosorbent Assay (ELISA)	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; SEROLOGICAL CROSS-REACTIONS; COXIELLA-BURNETII; CHLAMYDIA-PNEUMONIAE; COMMERCIAL TESTS; IMMUNOGLOBULIN-G; SOUTHERN TAIWAN; INFECTION; DIAGNOSIS; ANTIBODIES	Q fever is serologically cross-reactive with other intracellular microorganisms. However, studies of the serological status of Mycoplasma pneumoniae and Chlamydophila pneumoniae during Q fever are rare. We conducted a retrospective serological study of M. pneumoniae and C. pneumoniae by enzyme-linked immunosorbent assay (ELISA), a method widely used in clinical practice, in 102 cases of acute Q fever, 39 cases of scrub typhus, and 14 cases of murine typhus. The seropositive (57.8%, 7.7%, and 0%, p<0.001) and seroconversion rates (50.6%, 8.8%, and 0%, p<0.001) of M. pneumoniae IgM, but not M. pneumoniae IgG and C. pneumoniae IgG/IgM, in acute Q fever were significantly higher than in scrub typhus and murine typhus. Another ELISA kit also revealed a high seropositivity (49.5%) and seroconversion rate (33.3%) of M. pneumoniae IgM in acute Q fever. The temporal and age distributions of patients with positive M. pneumoniae IgM were not typical of M. pneumoniae pneumonia. Comparing acute Q fever patients who were positive for M. pneumoniae IgM (59 cases) with those who were negative (43 cases), the demographic characteristics and underlying diseases were not different. In addition, the clinical manifestations associated with atypical pneumonia, including headache (71.2% vs. 81.4%, p=0.255), sore throat (8.5% vs. 16.3%, p=0.351), cough (35.6% vs. 23.3%, p=0.199), and chest x-ray suggesting pneumonia (19.3% vs. 9.5%, p=0.258), were unchanged between the two groups. Clinicians should be aware of the high seroprevalence of M. pneumoniae IgM in acute Q fever, particularly with ELISA kits, which can lead to misdiagnosis, overestimations of the prevalence of M. pneumoniae pneumonia, and underestimations of the true prevalence of Q fever pneumonia.	[Lai, Chung-Hsu; Chang, Lin-Li; Lin, Jiun-Nong; Kuo, Li-Li; Chen, Yen-Hsu] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Lai, Chung-Hsu; Lin, Jiun-Nong; Lin, Hsi-Hsun] I Shou Univ, E Da Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lai, Chung-Hsu; Chen, Wei-Fang] I Shou Univ, E Da Hosp, Div Infect Control Lab, Kaohsiung, Taiwan; [Chang, Lin-Li] Kaohsiung Med Univ, Dept Microbiol, Coll Med, Fac Med, Kaohsiung, Taiwan; [Kuo, Li-Li] Ctr Dis Control, Dept Hlth, Res & Diagnost Ctr, Taipei, Taiwan; [Lin, Hsi-Hsun] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Chen, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.	infchen@gmail.com	Teixeira, JJ/H-6495-2016	Chen, Yen-hsu/0000-0002-8667-4844	National Science Council [NSC 99-2745-B-650-001]; E-Da Hospital [EDAHP100001]	National Science Council(Ministry of Science and Technology, Taiwan); E-Da Hospital	This work was supported by research grants from the National Science Council [NSC 99-2745-B-650-001] and E-Da Hospital [EDAHP100001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RF, 2007, EUR J CLIN MICROBIOL, V26, P495, DOI 10.1007/s10096-007-0323-3; Arnold FW, 2007, AM J RESP CRIT CARE, V175, P1086, DOI 10.1164/rccm.200603-350OC; Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Beersma MFC, 2005, J CLIN MICROBIOL, V43, P2277, DOI 10.1128/JCM.43.5.2277-2285.2005; Camacho M T, 2005, J Autoimmune Dis, V2, P10, DOI 10.1186/1740-2557-2-10; Cunha BA, 2006, CLIN MICROBIOL INFEC, V12, P12, DOI 10.1111/j.1469-0691.2006.01393.x; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Graham JV, 2000, CLIN INFECT DIS, V30, P609, DOI 10.1086/313701; Hermann C, 2002, J CLIN MICROBIOL, V40, P1603, DOI 10.1128/JCM.40.5.1603-1609.2002; Hou MY, 2011, JPN J INFECT DIS, V64, P161; Kumar S, 2007, CLIN INFECT DIS, V44, P568, DOI 10.1086/511076; Kung CM, 2007, JPN J INFECT DIS, V60, P352; Lai CH, 2008, SCAND J INFECT DIS, V40, P105, DOI 10.1080/00365540701558722; Lai CH, 2007, CLIN INFECT DIS, V45, pE52, DOI 10.1086/520680; Lai CH, 2009, EMERG INFECT DIS, V15, P1659, DOI 10.3201/eid1510.090007; Lai CH, 2009, J FORMOS MED ASSOC, V108, P367, DOI 10.1016/S0929-6646(09)60080-2; LaScola B, 1996, J CLIN MICROBIOL, V34, P2270, DOI 10.1128/JCM.34.9.2270-2274.1996; Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026; Lee CH, 2011, JPN J INFECT DIS, V64, P525; LEVY P, 1989, EUR J EPIDEMIOL, V5, P447, DOI 10.1007/BF00140139; Liu FC, 2008, JPN J INFECT DIS, V61, P397; Lukacova M, 1999, FOLIA MICROBIOL, V44, P579, DOI 10.1007/BF02816263; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Musso D, 1997, CLIN DIAGN LAB IMMUN, V4, P208, DOI 10.1128/CDLI.4.2.208-212.1997; Nir-Paz R, 2006, CLIN MICROBIOL INFEC, V12, P685, DOI 10.1111/j.1469-0691.2006.01469.x; Persson K, 2000, CLIN DIAGN LAB IMMUN, V7, P739, DOI 10.1128/CDLI.7.5.739-744.2000; Petitjean J, 2002, J CLIN MICROBIOL, V40, P165, DOI 10.1128/JCM.40.1.165-171.2002; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Rolain JM, 2005, CLIN INFECT DIS, V40, P82, DOI 10.1086/426440; Shibli F, 2010, ISR MED ASSOC J, V12, P477; Talkington DF, 2004, CLIN DIAGN LAB IMMUN, V11, P862, DOI 10.1128/CDLI.11.5.862-867.2004; Vardi M, 2011, EUR J CLIN MICROBIOL, V30, P1527, DOI 10.1007/s10096-011-1255-5; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Yen MY, 2005, J FORMOS MED ASSOC, V104, P724	34	12	13	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77640	10.1371/journal.pone.0077640	http://dx.doi.org/10.1371/journal.pone.0077640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147043	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200056
J	Livingston, G; Jha, S; Vega, A; Gilbert, L				Livingston, George; Jha, Shalene; Vega, Andres; Gilbert, Lawrence			Conservation Value and Permeability of Neotropical Oil Palm Landscapes for Orchid Bees	PLOS ONE			English	Article							MALE EUGLOSSINE BEES; ELAEIS-GUINEENSIS; BIODIVERSITY; PLANTATIONS; FOREST; HYMENOPTERA; DIVERSITY; PHYLOGENIES; BEHAVIOR; BIOLOGY	The proliferation of oil palm plantations has led to dramatic changes in tropical landscapes across the globe. However, relatively little is known about the effects of oil palm expansion on biodiversity, especially in key ecosystem-service providing organisms like pollinators. Rapid land use change is exacerbated by limited knowledge of the mechanisms causing biodiversity decline in the tropics, particularly those involving landscape features. We examined these mechanisms by undertaking a survey of orchid bees, a well-known group of Neotropical pollinators, across forest and oil palm plantations in Costa Rica. We used chemical baits to survey the community in four regions: continuous forest sites, oil palm sites immediately adjacent to forest, oil palm sites 2km from forest, and oil palm sites greater than 5km from forest. We found that although orchid bees are present in all environments, orchid bee communities diverged across the gradient, and community richness, abundance, and similarity to forest declined as distance from forest increased. In addition, mean phylogenetic distance of the orchid bee community declined and was more clustered in oil palm. Community traits also differed with individuals in oil palm having shorter average tongue length and larger average geographic range size than those in the forest. Our results indicate two key features about Neotropical landscapes that contain oil palm: 1) oil palm is selectively permeable to orchid bees and 2) orchid bee communities in oil palm have distinct phylogenetic and trait structure compared to communities in forest. These results suggest that conservation and management efforts in oil palm-cultivating regions should focus on landscape features.	[Livingston, George; Jha, Shalene; Gilbert, Lawrence] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Vega, Andres] AMBICOR, Tibas, Costa Rica	University of Texas System; University of Texas Austin	Livingston, G (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	glivingston@utexas.edu			Hosteling International-Austin Travel Fellowship; Graduate Program in Ecology, Evolution and Behavior at the University of Texas; US National Science Foundation	Hosteling International-Austin Travel Fellowship; Graduate Program in Ecology, Evolution and Behavior at the University of Texas; US National Science Foundation(National Science Foundation (NSF))	This work was supported by a Hosteling International-Austin Travel Fellowship (http://www.hiusa.org/austin) and a grant from the Graduate Program in Ecology, Evolution and Behavior at the University of Texas (http://www.biosci.utexas.edu/graduate/eeb/default.aspx) to GL. GL was supported by a US National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JD, 1982, BIOTROPICA, V14, P241, DOI 10.2307/2388080; ARMBRUSTER WS, 1994, BIOTROPICA, V26, P50, DOI 10.2307/2389110; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Brosi BJ, 2009, BIOL CONSERV, V142, P414, DOI 10.1016/j.biocon.2008.11.003; Cameron SA, 2004, ANNU REV ENTOMOL, V49, P377, DOI 10.1146/annurev.ento.49.072103.115855; Cao Y, 1997, WATER ENVIRON RES, V69, P95, DOI 10.2175/106143097X125227; Castiblanco C, 2013, ENVIRON SCI POLICY, V27, P172, DOI 10.1016/j.envsci.2013.01.003; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foster WA, 2011, PHILOS T R SOC B, V366, P3277, DOI 10.1098/rstb.2011.0041; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Godfree R, 2004, J VEG SCI, V15, P227, DOI 10.1111/j.1654-1103.2004.tb02257.x; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; JANZEN DH, 1982, ECOLOGY, V63, P66, DOI 10.2307/1937032; Kehlenbeck K, 2004, AGROFOREST SYST, V63, P53, DOI 10.1023/B:AGFO.0000049433.95038.25; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; KIMSEY LS, 1980, ANIM BEHAV, V28, P996, DOI 10.1016/S0003-3472(80)80088-1; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2008, J APPL ECOL, V45, P1002, DOI 10.1111/j.1365-2664.2008.01491.x; Koh LP, 2008, ECOL APPL, V18, P821, DOI 10.1890/07-1650.1; Landolt PJ, 1998, ENVIRON ENTOMOL, V27, P1229, DOI 10.1093/ee/27.5.1229; Liow LH, 2001, J APPL ECOL, V38, P180, DOI 10.1046/j.1365-2664.2001.00582.x; Livingston G, 2013, BIOTROPICA, V45, P10, DOI 10.1111/j.1744-7429.2012.00894.x; Lucey JM, 2012, BIOTROPICA, V44, P368, DOI 10.1111/j.1744-7429.2011.00824.x; Mayfield MM, 2005, ECON BOT, V59, P190, DOI 10.1663/0013-0001(2005)059[0190:TIONFT]2.0.CO;2; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; Nemesio A, 2006, J BIOGEOGR, V33, P91, DOI 10.1111/j.1365-2699.2005.01370.x; Nemesio A, 2012, BIOSCI J, V28, P118; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pfeiffer M, 2008, ECOGRAPHY, V31, P21, DOI 10.1111/j.2007.0906-7590.05172.x; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; POWELL AH, 1987, BIOTROPICA, V19, P176, DOI 10.2307/2388742; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Rappole JH, 2003, CONSERV BIOL, V17, P334, DOI 10.1046/j.1523-1739.2003.01548.x; Roubik D.W., 1990, ECOLOGY NATURAL HIST, V1st ed., P526, DOI [10.1126/science.248.4958.1026, DOI 10.1126/SCIENCE.248.4958.1026]; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Thiele R, 2005, STUD NEOTROP FAUNA E, V40, P39, DOI 10.1080/01650520400025712; Tonhasca A, 2002, BIOTROPICA, V34, P416, DOI 10.1111/j.1744-7429.2002.tb00555.x; Turner EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001572; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Wang JP, 2010, BIOMETRIKA, V97, P727, DOI 10.1093/biomet/asq026; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wikelski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010738; Zimmermann Y, 2009, ECOLOGY, V90, P2994, DOI 10.1890/08-1858.1	47	17	17	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78523	10.1371/journal.pone.0078523	http://dx.doi.org/10.1371/journal.pone.0078523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147137	gold, Green Published			2022-12-27	WOS:000326022200099
J	Petersen, L; Sorensen, TIA; Andersen, PK; Mortensen, PB; Hawton, K				Petersen, Liselotte; Sorensen, Thorkild I. A.; Andersen, Per Kragh; Mortensen, Preben Bo; Hawton, Keith			Genetic and Familial Environmental Effects on Suicide - An Adoption Study of Siblings	PLOS ONE			English	Article							NESTED CASE-CONTROL; AFTER-DISCHARGE; PREMATURE DEATH; ADULT ADOPTEES; RISK; BEHAVIOR; COHORT	Background: While there is clear evidence of familial influences on suicide, the origin of these is less certain. We have investigated genetic and familial environmental factors by studying the occurrence of suicide in biological and adoptive siblings of adoptees who died by suicide compared to siblings of surviving adoptees. Method: We used the Danish Adoption Register and Danish population registers to compare 221 siblings of adoptees who died by suicide with the siblings of 1,903 adoptees who did not die by suicide. All adoptions in the Danish Adoption Register are non-familial, i.e. the adoptive parents are biologically unrelated to the adoptee. Analyses were conducted on incidence rates of suicide in biological and adoptive siblings given occurrence of suicide in the adoptees while also taking into account psychiatric disorders. Results: The risk of suicide in full siblings of adoptees who died by suicide before age 60 years was significantly higher than in full siblings of adoptees who had not died by suicide (incidence rate ratios (IRR) = 5.01; 95% confidence interval [CI] = 1.28 - 19.6). This increase persisted after adjustment for history of psychiatric admission of siblings (IRR = 4.19; 95% CI = 1.00 - 17.5). Conclusions: Genetic factors influence risk of suicide, probably independently of psychiatric disorder. This is relevant in provision of advice to families, including possible prevention of suicide.	[Petersen, Liselotte; Sorensen, Thorkild I. A.; Mortensen, Preben Bo] Univ Aarhus, Natl Ctr Register Based Res, iPSYCH, Aarhus V, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Andersen, Per Kragh] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; [Hawton, Keith] Univ Oxford, Warneford Hosp, Univ Dept Psychiat, Ctr Suicide Res, Oxford, England	Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Oxford	Petersen, L (corresponding author), Univ Aarhus, Natl Ctr Register Based Res, iPSYCH, Aarhus V, Denmark.	LLP@ncrr.dk	Mortensen, Preben B/D-2358-2015	Mortensen, Preben B/0000-0002-5230-9865; Petersen, Liselotte Vogdrup/0000-0002-0479-5379	Danish National Research Foundation; Lundbeck Foundation; Velux Fonden; Aarhus University Research Foundation; England National Institute for Health Research Senior Investigator; National Institute for Health Research [NF-SI-0508-10053] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Velux Fonden(Velux Fonden); Aarhus University Research Foundation; England National Institute for Health Research Senior Investigator; National Institute for Health Research(National Institute for Health Research (NIHR))	The Danish National Research Foundation supported the adoption study, and this work was also supported by grants from The Lundbeck Foundation and from Velux Fonden. Professor Keith Hawton was supported by a visiting researcher grant from Aarhus University Research Foundation and is an England National Institute for Health Research Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbo E, 2002, BMJ-BRIT MED J, V325, P74, DOI 10.1136/bmj.325.7355.74; Asberg M, 1981, Adv Exp Med Biol, V133, P739; Brent DA, 2005, AM J MED GENET C, V133C, P13, DOI 10.1002/ajmg.c.30042; BROWN GL, 1982, AM J PSYCHIAT, V139, P741; Folstein Marshal F., J PSYCHIATR RES, V12, P189, DOI [10.1016/0022-3956(75)90026-6, DOI 10.1016/0022-3956(75)90026-6, DOI 10.1016/0022-3956(68)90026-5]; GOLDACRE M, 1993, LANCET, V342, P283, DOI 10.1016/0140-6736(93)91822-4; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; Mann JJ, 2009, BIOL PSYCHIAT, V65, P556, DOI 10.1016/j.biopsych.2008.11.021; McGirr A, 2009, AM J PSYCHIAT, V166, P1124, DOI 10.1176/appi.ajp.2009.08111744; Neale MC, 1992, METHODOLOGY GENETIC; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersen L, 2005, GENET EPIDEMIOL, V28, P376, DOI 10.1002/gepi.20071; Petersen L, 2008, EPIDEMIOLOGY, V19, P472, DOI 10.1097/EDE.0b013e3181692769; Petersen L, 2011, SCAND J PUBLIC HEALT, V39, P83, DOI 10.1177/1403494810394714; Petersen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014365; Petersen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010603; Qin P, 2002, LANCET, V360, P1126, DOI 10.1016/S0140-6736(02)11197-4; Schulsinger F., 1979, ORIGIN PREVENTION TR, P277; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; TEASDALE TW, 1979, BEHAV GENET, V9, P103, DOI 10.1007/BF01074329; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; Tomassini C, 2003, BRIT MED J, V327, P373, DOI 10.1136/bmj.327.7411.373; Turecki G, 2001, BIPOLAR DISORD, V3, P335, DOI 10.1034/j.1399-5618.2001.30608.x; von Borczyskowski A, 2011, PSYCHOL MED, V41, P749, DOI 10.1017/S0033291710001315; Voracek M, 2007, WIEN KLIN WOCHENSCHR, V119, P463, DOI 10.1007/s00508-007-0823-2	27	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77973	10.1371/journal.pone.0077973	http://dx.doi.org/10.1371/journal.pone.0077973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147105	Green Published, gold			2022-12-27	WOS:000326022200090
J	Scopinho, AA; Lisboa, SFS; Guimaraes, FS; Correa, FMA; Resstel, LBM; Joca, SRL				Scopinho, America A.; Lisboa, Sabrina F. S.; Guimaraes, Francisco S.; Correa, Fernando M. A.; Resstel, Leonardo B. M.; Joca, Samia R. L.			Dorsal and Ventral Hippocampus Modulate Autonomic Responses but Not Behavioral Consequences Associated to Acute Restraint Stress in Rats	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; VENTROLATERAL PERIAQUEDUCTAL GRAY; NITRIC-OXIDE SYNTHASE; LATERAL SEPTAL AREA; ELEVATED PLUS-MAZE; CARDIOVASCULAR-RESPONSES; STRIA TERMINALIS; BED NUCLEUS; NEUROENDOCRINE RESPONSES; ANXIETY-LIKE	Recent evidence has suggested that the dorsal (DH) and the ventral (VH) poles of the hippocampus are structurally, molecularly and functionally different regions. While the DH is preferentially involved in the modulation of spatial learning and memory, the VH modulates defensive behaviors related to anxiety. Acute restraint is an unavoidable stress situation that evokes marked and sustained autonomic changes, which are characterized by elevated blood pressure (BP), intense heart rate (HR) increases, skeletal muscle vasodilatation and cutaneous vasoconstriction, which are accompanied by a rapid skin temperature drop followed by body temperature increases. In addition to those autonomic responses, animals submitted to restraint also present behavioral changes, such as reduced exploration of the open arms of an elevated plus-maze (EPM), an anxiogenic-like effect. In the present work, we report a comparison between the effects of pharmacological inhibition of DH and VH neurotransmission on autonomic and behavioral responses evoked by acute restraint stress in rats. Bilateral microinjection of the unspecific synaptic blocker cobalt chloride (CoCl2, 1mM) into the DH or VH attenuated BP and HR responses, as well as the decrease in the skin temperature, elicited by restraint stress exposure. Moreover, DH or VH inhibition before restraint did not change the delayed increased anxiety behavior observed 24 h later in the EPM. The present results demonstrate for the first time that both DH and VH mediate stress-induced autonomic responses to restraint but they are not involved in the modulation of the delayed emotional consequences elicited by such stress.	[Scopinho, America A.; Lisboa, Sabrina F. S.; Guimaraes, Francisco S.; Correa, Fernando M. A.; Resstel, Leonardo B. M.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil; [Joca, Samia R. L.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Pharmacol Lab, Sao Paulo, Brazil; [Guimaraes, Francisco S.; Resstel, Leonardo B. M.; Joca, Samia R. L.] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Resstel, LBM (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil.	leoresstel@yahoo.com.br; samia@usp.br	Lisboa, Sabrina F/G-2672-2012; Joca, Samia/F-8698-2012; Lisboa, Sabrina/N-5710-2019; Correa, Fernando/D-1614-2012; Resstel, Leonardo/C-6100-2012; Guimaraes, Francisco Silveira/C-1059-2012	Lisboa, Sabrina F/0000-0002-2069-3524; Joca, Samia/0000-0003-0255-5889; Lisboa, Sabrina/0000-0002-2069-3524; Correa, Fernando/0000-0003-4067-9524; Guimaraes, Francisco Silveira/0000-0003-4092-7778	FAPESP [2011/06615-1, 2011/17281-7, 2012/09300-4]; FAEPA; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAEPA; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present research was supported by grants from FAPESP (2011/06615-1; 2011/17281-7; 2012/09300-4), FAEPA and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FHF, 2010, BRAIN RES, V1333, P57, DOI 10.1016/j.brainres.2010.03.077; Antoniadis EA, 2001, EXP BRAIN RES, V138, P200, DOI 10.1007/s002210000645; Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; BAO JX, 1990, ACTA PHARM SINIC, V11, P130; Benes FM, 1997, J PSYCHIATR RES, V31, P257, DOI 10.1016/S0022-3956(96)00044-1; Bertoglio LJ, 2006, BEHAV BRAIN RES, V175, P183, DOI 10.1016/j.bbr.2006.08.021; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; BLANCHAR.RJ, 1970, J COMP PHYSIOL PSYCH, V71, P92, DOI 10.1037/h0028958; BLANCHARD RJ, 1972, J COMP PHYSIOL PSYCH, V78, P77, DOI 10.1037/h0032176; Blessing WW, 2003, NEUROSCIENCE, V117, P939, DOI 10.1016/S0306-4522(02)00810-2; Blessing WW, 2003, CELL MOL NEUROBIOL, V23, P527, DOI 10.1023/A:1025020029037; BORRELL J, 1980, NEUROENDOCRINOLOGY, V31, P53, DOI 10.1159/000123050; Boscan P, 2001, AUTON NEUROSCI-BASIC, V86, P170, DOI 10.1016/S1566-0702(00)00255-1; BRITTON KT, 1992, BRAIN RES, V574, P125, DOI 10.1016/0006-8993(92)90808-M; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Busnardo C, 2010, AUTON NEUROSCI-BASIC, V158, P51, DOI 10.1016/j.autneu.2010.06.003; Campeau S, 1997, J NEUROENDOCRINOL, V9, P577; Campos AC, 2010, NEUROSCIENCE, V167, P238, DOI 10.1016/j.neuroscience.2010.01.062; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Cavun S, 2001, AM J PHYSIOL-REG I, V281, pR747, DOI 10.1152/ajpregu.2001.281.3.R747; Cenquizca LA, 2007, BRAIN RES REV, V56, P1, DOI 10.1016/j.brainresrev.2007.05.002; Chiba T, 2000, NEUROSCI RES, V38, P373, DOI 10.1016/S0168-0102(00)00183-8; Choi DC, 2008, ENDOCRINOLOGY, V149, P818, DOI 10.1210/en.2007-0883; Chowdhury GMI, 2000, BRAIN RES BULL, V52, P171; Ciriello J, 2008, AM J PHYSIOL-REG I, V294, pR1276, DOI 10.1152/ajpregu.00437.2007; Clark RE, 2000, J NEUROSCI, V20, P8853; Conti LH, 2001, NEUROPEPTIDES, V35, P71, DOI 10.1054/npep.2001.0847; Crestani CC, 2007, J NEUROSCI RES, V85, P1592, DOI 10.1002/jnr.21250; Crestani CC, 2009, STRESS, V12, P268, DOI 10.1080/10253890802331477; CULLINAN WE, 1993, J COMP NEUROL, V332, P1, DOI 10.1002/cne.903320102; Deolindo M, 2008, NEUROSCI LETT, V430, P124, DOI 10.1016/j.neulet.2007.10.028; Dong HW, 2006, J COMP NEUROL, V494, P142, DOI 10.1002/cne.20788; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Ferbinteanu J, 2003, NEUROSCI LETT, V345, P131, DOI 10.1016/S0304-3940(03)00473-7; Ferbinteanu J, 2001, HIPPOCAMPUS, V11, P187, DOI 10.1002/hipo.1036; Fortaleza EAT, 2009, NEUROSCIENCE, V159, P717, DOI 10.1016/j.neuroscience.2009.01.003; Fouquet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067232; GAMALLO A, 1992, PHYSIOL BEHAV, V51, P1201, DOI 10.1016/0031-9384(92)90309-P; Gold PW, 1996, MOL PSYCHIATR, V1, P257; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; GUIMARAES FS, 1993, BEHAV BRAIN RES, V58, P133, DOI 10.1016/0166-4328(93)90098-B; HAGIWARA S, 1981, ANNU REV NEUROSCI, V4, P69, DOI 10.1146/annurev.ne.04.030181.000441; Heim C, 2004, NEUROPSYCHOPHARMACOL, V29, P641, DOI 10.1038/sj.npp.1300397; HENKE PG, 1990, BEHAV BRAIN RES, V36, P97, DOI 10.1016/0166-4328(90)90164-A; HENKIN RI, 1963, AM J PHYSIOL, V204, P710, DOI 10.1152/ajplegacy.1963.204.4.710; Holland PC, 1999, CURR OPIN NEUROBIOL, V9, P195, DOI 10.1016/S0959-4388(99)80027-0; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; IRWIN MR, 1989, PHARMACOL BIOCHEM BE, V32, P913, DOI 10.1016/0091-3057(89)90058-0; Joca SRL, 2006, PSYCHOPHARMACOLOGY, V185, P298, DOI 10.1007/s00213-006-0326-2; Joca SRL, 2003, BRAIN RES, V978, P177, DOI 10.1016/S0006-8993(03)02943-3; Jones BF, 2005, NEUROSCIENCE, V133, P193, DOI 10.1016/j.neuroscience.2005.01.063; Kaplan Z, 2001, PSYCHIATR SERV, V52, P824, DOI 10.1176/appi.ps.52.6.824; KENNETT GA, 1985, BRAIN RES, V330, P253, DOI 10.1016/0006-8993(85)90684-5; KENNETT GA, 1987, EUR J PHARMACOL, V134, P265, DOI 10.1016/0014-2999(87)90357-8; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Kubo T, 2002, NEUROSCI LETT, V318, P25, DOI 10.1016/S0304-3940(01)02463-6; Kurumaji A, 2011, NEUROSCI RES, V71, P161, DOI 10.1016/j.neures.2011.06.006; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Masini CV, 2008, BEHAV NEUROSCI, V122, P210, DOI 10.1037/0735-7044.122.1.210; Mattson MP, 2001, BIOCHEM SOC SYMP, V67, P151, DOI 10.1042/bss0670151; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; McNaughton N, 1997, PHARMACOL BIOCHEM BE, V56, P603, DOI 10.1016/S0091-3057(96)00419-4; Mendonca FH, 1998, BEHAV BRAIN RES, V91, P207, DOI 10.1016/S0166-4328(97)00129-0; Meyer C, 1998, UNFALLCHIRURG, V101, P878, DOI 10.1007/s001130050354; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; OVERTON JM, 1991, PHYSIOL BEHAV, V49, P93, DOI 10.1016/0031-9384(91)90237-I; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; PADOVAN CM, 1993, BRAZ J MED BIOL RES, V26, P1085; Padovan CM, 2000, PHARMACOL BIOCHEM BE, V67, P325, DOI 10.1016/S0091-3057(00)00361-0; Pelosi GG, 2007, AUTON NEUROSCI-BASIC, V131, P70, DOI 10.1016/j.autneu.2006.07.002; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Reis DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023171; Resstel LBM, 2008, NEUROSCIENCE, V154, P869, DOI 10.1016/j.neuroscience.2008.04.007; Resstel LBM, 2004, BRAIN RES, V1015, P136, DOI 10.1016/j.brainres.2004.04.065; Resstel LBM, 2008, BEHAV PHARMACOL, V19, P137, DOI 10.1097/FBP.0b013e3282f62c9e; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; Roberts AC, 2007, J COMP NEUROL, V502, P86, DOI 10.1002/cne.21300; RUIT KG, 1988, BRAIN RES, V457, P310, DOI 10.1016/0006-8993(88)90701-9; Saha S., 1996, Indian Journal of Physiology and Pharmacology, V40, P35; Salchner P, 2004, CELL MOL LIFE SCI, V61, P1498, DOI 10.1007/s00018-004-4140-x; Sanchez RM, 2001, J NEUROSCI, V21, P8154, DOI 10.1523/JNEUROSCI.21-20-08154.2001; Scopinho AA, 2007, AUTON NEUROSCI-BASIC, V137, P77, DOI 10.1016/j.autneu.2007.08.003; Sevgi S, 2006, METHOD FIND EXP CLIN, V28, P95, DOI 10.1358/mf.2006.28.2.977840; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Tavares RF, 2006, NEUROSCIENCE, V143, P231, DOI 10.1016/j.neuroscience.2006.07.030; Tavares RF, 2009, J NEUROSCI RES, V87, P2601, DOI 10.1002/jnr.22070; Vianna DML, 2005, EUR J NEUROSCI, V21, P2505, DOI 10.1111/j.1460-9568.2005.04073.x; Walker DL, 2009, PROG NEURO-PSYCHOPH, V33, P1291, DOI 10.1016/j.pnpbp.2009.06.022; Welberg LAM, 2001, NEUROSCIENCE, V104, P71, DOI 10.1016/S0306-4522(01)00065-3; Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006; Yoshino K, 2005, AUTON NEUROSCI-BASIC, V119, P61, DOI 10.1016/j.autneu.2005.02.004	94	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77750	10.1371/journal.pone.0077750	http://dx.doi.org/10.1371/journal.pone.0077750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147071	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200071
J	Varghese, B; Supply, P; Shoukri, M; Allix-Beguec, C; Memish, Z; Abuljadayel, N; Al-Hakeem, R; AlRabiah, F; Al-Hajoj, S				Varghese, Bright; Supply, Philip; Shoukri, Mohammed; Allix-Beguec, Caroline; Memish, Ziad; Abuljadayel, Naila; Al-Hakeem, Raafat; AlRabiah, Fahad; Al-Hajoj, Sahal			Tuberculosis Transmission among Immigrants and Autochthonous Populations of the Eastern Province of Saudi Arabia	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; PATTERNS; DATABASE; STRAINS; IMPACT; BORN	Background: Eastern province of Saudi Arabia is an industrial zone with large immigrant population and high level of tuberculosis case notification among immigrants. The impact of immigration and current trends of tuberculosis transmission among immigrants and autochthonous population in the region had not been investigated so far using molecular tools. Methodology: During 2009-2011, a total of 524 Mycobacterium tuberculosis isolates were collected from the central tuberculosis reference laboratory, representing an estimated 79.2% of the culture-positive tuberculosis cases over the study period in the province. These isolates were genotyped by using 24 locus-based MIRU-VNTR typing and spoligotyping followed by first line drug susceptibility testing. The molecular clustering profiles and phylogenetic diversity of isolates were determined and compared to the geographical origins of the patients. Principle Findings: Genotyping showed an overall predominance of Delhi/CAS (29.4%), EAI (23.8%) and Ghana (13.3%) lineages, with slightly higher proportions of Delhi/CAS among autochthonous population (33.3 %) and EAI (30.9%) among immigrants. Rate of any drug resistance was 20.2% with 2.5% of multi-drug resistance. Strain cluster analysis indicated 42 clusters comprising 210 isolates, resulting in a calculated recent transmission index of 32.1%. Overall shared cluster ratio was 78.6% while 75.8% were shared between autochthonous population and immigrant population with a predominance of immigrants from South east Asia (40.7%). In contrast, cross national transmission within the immigrant population was limited (24.2%). Younger age (15-30- p value-0.043, 16-45, p value 0.030), Saudi nationality (p value-0.004) and South East Asian origin (p value-0.011) were identified as significant predisposing factors for molecular strain clustering. Conclusions: The high proportion of molecular clusters shared among the autochthonous and immigrant populations suggests a high permeability of tuberculosis transmission between both populations in the province. These results prompt for the need to strengthen the current tuberculosis control strategies and surveillance programs.	[Varghese, Bright; Al-Hajoj, Sahal] King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia; [Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Supply, Philip] INSERM, U1019, F-59045 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Supply, Philip] Univ Lille Nord France, Lille, France; [Shoukri, Mohammed] King Faisal Specialist Hosp & Res Ctr, Ctr Biotechnol, Riyadh 11211, Saudi Arabia; [Allix-Beguec, Caroline] Genoscreen, Lille, France; [Memish, Ziad; Abuljadayel, Naila; Al-Hakeem, Raafat] Minist Hlth, Publ Hlth Directorate, Riyadh, Saudi Arabia; [AlRabiah, Fahad] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; King Faisal Specialist Hospital & Research Center; Ministry of Health - Saudi Arabia; King Faisal Specialist Hospital & Research Center	Al-Hajoj, S (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Infect & Immun, Riyadh 11211, Saudi Arabia.	hajoj@kfshrc.edu.sa	Allix-Béguec, Caroline/AAI-4645-2021; Memish, Ziad Ahmed/AEJ-9424-2022; Supply, Philip/A-9580-2019	Allix-Béguec, Caroline/0000-0001-7642-4844; Memish, Ziad Ahmed/0000-0002-5099-0714; Supply, Philip/0000-0003-3690-3853	King Abdul-Aziz City for Science and Technology [AT-26/110]	King Abdul-Aziz City for Science and Technology	This study was financially supported by King Abdul-Aziz City for Science and Technology under the Grant AT-26/110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzeid MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039478; Al-Hajoj S, 2013, ANTIMICROB AGENTS CH, V57, P2161, DOI 10.1128/AAC.02403-12; Al-Hajoj SAM, 2007, J CLIN MICROBIOL, V45, P2467, DOI 10.1128/JCM.02293-06; Al-Jasser FS, 2012, SAUDI MED J, V33, P879; Al-Tawfiq JA, 2012, EUROSURVEILLANCE, V17, P6; Allix-Beguec C, 2008, EUR RESPIR J, V31, P1077, DOI 10.1183/09031936.00053307; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Alzeer AH, 2009, ANN THORAC MED, V4, P50, DOI 10.4103/1817-1737.49412; Barniol J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-197; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Blackwood KS, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-18; Borrell S, 2010, CLIN MICROBIOL INFEC, V16, P568, DOI 10.1111/j.1469-0691.2009.02886.x; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Central Department of Statistics and Information, 2012, STAT YB 2011; Central Department of Statistics and Information, 2002, STAT YB, P1999; Central Department of Statistics and Information, 2011, STAT YB 2010; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; Dahle UR, 2007, AM J RESP CRIT CARE, V176, P930, DOI 10.1164/rccm.200702-187OC; Dale JW, 2005, J MED MICROBIOL, V54, P575, DOI 10.1099/jmm.0.45959-0; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Diel R, 2004, J CLIN MICROBIOL, V42, P2952, DOI 10.1128/JCM.42.7.2952-2960.2004; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garcia-Garcia JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016272; Garzelli C, 2010, CLIN MICROBIOL INFEC, V16, P1691, DOI [10.1111/j.1469-0691.2009.03149.x, 10.1111/j.1469-0691.2010.03149.x]; Gleason JA, 2012, ANN EPIDEMIOL, V22, P264, DOI 10.1016/j.annepidem.2012.01.007; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Ho MJ, 2003, MED ANTHROPOL Q, V17, P442, DOI 10.1525/maq.2003.17.4.442; Inigo J, 2007, J CLIN MICROBIOL, V45, P63, DOI 10.1128/JCM.01644-06; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Martinez-Lirola M, 2008, CLIN INFECT DIS, V47, P8, DOI 10.1086/588785; Ministry of Health, 2009, STAT BOOK YEAR 2009, P52; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rodriguez NA, 2009, CLIN MICROBIOL INFEC, V15, P435, DOI 10.1111/j.1469-0691.2008.02670.x; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Varghese B, 2013, TUBERCULOSIS, V93, P246, DOI 10.1016/j.tube.2012.12.001; Varghese B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055598; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	41	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77635	10.1371/journal.pone.0077635	http://dx.doi.org/10.1371/journal.pone.0077635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147042	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200055
J	Yamada, T; Shigemura, H; Ishiguro, N; Inoshima, Y				Yamada, Tetsuya; Shigemura, Hiroaki; Ishiguro, Naotaka; Inoshima, Yasuo			Cell Infectivity in Relation to Bovine Leukemia Virus gp51 and p24 in Bovine Milk Exosomes	PLOS ONE			English	Article							STRUCTURES L-PARTICLES; RNA; TRANSMISSION; CATTLE; IDENTIFICATION; ASSOCIATION; MICRORNAS; TEGUMENT; PLASMA; BLOOD	Exosomes are small membranous microvesicles (40-100 nm in diameter) and are extracellularly released from a wide variety of cells. Exosomes contain microRNA, mRNA, and cellular proteins, which are delivered into recipient cells via these exosomes, and play a role in intercellular communication. In bovine leukemia virus (BLV) infection of cattle, although it is thought to be a minor route of infection, BLV can be transmitted to calves via milk. Here, we investigated the association between exosomes and BLV in bovine milk. BLV structural proteins, gp51 (Env) and p24 (Gag), were detected in bovine milk exosomes from BLV-infected cattle by Western blot analysis. In cells inoculated with these milk exosomes, BLV DNA was not detected during three serial passages by nested PCR. Purification of exosomes from persistently BLV-infected cells was achieved by immuno-magnetic separation using an antibody against exosomes coupled to magnetic beads. Consistently, BLV gp51 and p24 proteins were detected in purified exosomes. Moreover, reverse transcriptase activity was observed in purified exosomes, meaning that exosomes also contain viral enzyme. However, BLV DNA was not detected in serially passaged cells after inoculation of purified exosomes, indicating that exosomes carrying BLV proteins appeared to be not infectious. These results suggest that BLV proteins are released with milk exosomes and could be transferred into recipient cells of calves via milk exosomes as an alternative route not requiring virus infection. Moreover it is also possible that bovine milk exosomes play a role in clearance of BLV proteins from infected cells.	[Yamada, Tetsuya; Shigemura, Hiroaki; Ishiguro, Naotaka; Inoshima, Yasuo] Gifu Univ, Dept Vet Med, Gifu, Japan	Gifu University	Inoshima, Y (corresponding author), Gifu Univ, Dept Vet Med, Gifu, Japan.	inoshima@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23380178]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-Aid for Scientific Research (B) ( No. 23380178) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; AOKI N, 1994, BBA-GEN SUBJECTS, V1199, P87, DOI 10.1016/0304-4165(94)90101-5; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; BURNY A, 1988, VET MICROBIOL, V17, P197, DOI 10.1016/0378-1135(88)90066-1; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Campbell TD, 2008, ETHN DIS, V18; Dukers DF, 2000, J IMMUNOL, V165, P663, DOI 10.4049/jimmunol.165.2.663; Eldh M, 2012, MOL IMMUNOL, V50, P278, DOI 10.1016/j.molimm.2012.02.001; FERRER JF, 1981, CANCER RES, V41, P4906; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; ITOHARA S, 1984, MICROBIOL IMMUNOL, V28, P251, DOI 10.1111/j.1348-0421.1984.tb00677.x; JOHNSON R, 1991, COMP CONT EDUC PRACT, V13, P315; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; KETTMANN R, 1976, P NATL ACAD SCI USA, V73, P1014, DOI 10.1073/pnas.73.4.1014; Kohara J, 2006, JPN J VET RES, V54, P25; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kuckleburg CJ, 2003, J VET DIAGN INVEST, V15, P72, DOI 10.1177/104063870301500117; LASSAUZET MLG, 1990, CAN J VET RES, V54, P184; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; MCLAUCHLAN J, 1992, J GEN VIROL, V73, P269, DOI 10.1099/0022-1317-73-2-269; Meas S, 2002, VET MICROBIOL, V84, P275, DOI 10.1016/S0378-1135(01)00458-8; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Michishita K., 2011, Journal of Veterinary Medicine, Japan, V64, P815; Mohan M, 2001, MOL REPROD DEV, V60, P289, DOI 10.1002/mrd.1090; MURAKAMI K, 1994, VIROLOGY, V202, P458, DOI 10.1006/viro.1994.1362; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Reinhardt TA, 2012, J PROTEOMICS, V75, P1486, DOI 10.1016/j.jprot.2011.11.017; RIXON FJ, 1992, J GEN VIROL, V73, P277, DOI 10.1099/0022-1317-73-2-277; SHIMIZU M, 1987, JPN J VET SCI, V49, P1045; Tamai K, 2012, VIROLOGY, V422, P377, DOI 10.1016/j.virol.2011.11.009; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Der Maaten M J, 1975, Bibl Haematol, P360; Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Wurdinger T, 2012, ADV VIROL, V2012, DOI 10.1155/2012/767694; Yamada T, 2012, J VET MED SCI, V74, P1523, DOI 10.1292/jvms.12-0032; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118	54	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77359	10.1371/journal.pone.0077359	http://dx.doi.org/10.1371/journal.pone.0077359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146982	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200033
J	Graciani, FS; Ximenes, VF				Graciani, Fernanda S.; Ximenes, Valdecir F.			Investigation of Human Albumin-Induced Circular Dichroism in Dansylglycine	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; DRUG BINDING-SITES; FLUORESCENCE; WARFARIN; OXIDATION	Induced circular dichroism (ICD), or induced chirality, is a phenomenon caused by the fixation of an achiral substance inside a chiral microenvironment, such as the hydrophobic cavities in proteins. Dansylglycine belongs to a class of dansylated amino acids, which are largely used as fluorescent probes for the characterization of the binding sites in albumin. Here, we investigated the ICD in dansylglycine provoked by its binding to human serum albumin (HSA). We found that the complexation of HSA with dansylglycine resulted in the appearance of an ICD band centred at 346 nm. Using this ICD signal and site-specific ligands of HSA, we confirmed that dansylglycine is a site II ligand. The intensity of the ICD signal was dependent on the temperature and revealed that the complexation between the protein and the ligand was reversible. The induced chirality of dansylglycine was susceptive to the alteration caused by the oxidation of the protein. A comparison was made between hypochlorous acid (HOCl) and hypobromous acid (HOBr), and revealed that site II in the protein is more susceptible to alteration provoked by the latter oxidant. These findings suggest the relevance of the aromatic amino acids in the site II, since HOBr is a more efficient oxidant of these residues in proteins than HOCl. The three-dimensional structure of HSA is pH-dependent, and different conformations have been characterised. We found that HSA in its basic form at pH 9.0, which causes the protein to be less rigid, lost the capacity to bind dansylglycine. At pH 3.5, HSA retained almost all of its capacity for binding to dansylglycine. Since the structure of HSA at pH 3.5 is expanded, separating the domain IIIA from the rest of the molecule, we concluded that this separation did not alter its binding capacity to dansylglycine.	[Graciani, Fernanda S.; Ximenes, Valdecir F.] Univ Estadual Paulista, Dept Quim, Fac Ciencias, Bauru, SP, Brazil; [Graciani, Fernanda S.; Ximenes, Valdecir F.] Univ Estadual Paulista, Fac Ciencias Farmaceut, Dept Anal Clin, Araraquara, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Ximenes, VF (corresponding author), Univ Estadual Paulista, Dept Quim, Fac Ciencias, Bauru, SP, Brazil.	vfximenes@fc.unesp.br	Ximenes, Valdecir/A-5323-2008	Ximenes, Valdecir/0000-0003-2636-3080	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp) [2011/50652-9]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (Capes)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp), process 2011/50652-9 and Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (Capes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOS OJM, 1988, BIOCHEM PHARMACOL, V37, P3905, DOI 10.1016/0006-2952(88)90072-X; BREE F, 1990, EUR J DRUG METAB PH, V15, P303, DOI 10.1007/BF03190219; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Di Bari L, 2010, CHIRALITY, V22, P593, DOI 10.1002/chir.20794; Dockal M, 2000, J BIOL CHEM, V275, P3042, DOI 10.1074/jbc.275.5.3042; Domotor O, 2013, J BIOL INORG CHEM, V18, P9, DOI 10.1007/s00775-012-0944-6; Faizul FM, 2008, J PHOTOCH PHOTOBIO B, V90, P1, DOI 10.1016/j.jphotobiol.2007.10.002; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; FEHSKE KJ, 1982, MOL PHARMACOL, V21, P387; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Liu XP, 2010, EUR J MED CHEM, V45, P4043, DOI 10.1016/j.ejmech.2010.05.063; Maciazek-Jurczyk M, 2011, SPECTROCHIM ACTA A, V82, P181, DOI 10.1016/j.saa.2011.07.030; Marin M, 2011, J PHYS CHEM B, V115, P2910, DOI 10.1021/jp2009463; MULLER N, 1994, J PHARM PHARMACOL, V46, P300, DOI 10.1111/j.2042-7158.1994.tb03798.x; Nozaki A, 2009, CHEM PHARM BULL, V57, P224, DOI 10.1248/cpb.57.224; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Petronio MS, 2012, BBA-PROTEINS PROTEOM, V1824, P1090, DOI 10.1016/j.bbapap.2012.06.013; Petronio MS, 2013, BR J PHARM RES, V3, P147; Petronio MS, 2012, LUMINESCENCE, DOI [10.1002/bio.2445, DOI 10.1002/BI0.2445.[]; Petronio MS, 2013, PROTEIN PEPT LETT; Pistolozzi M, 2008, CHIRALITY, V20, P552, DOI 10.1002/chir.20521; Qi Z, 2008, J PHARMACEUT BIOMED, V46, P699, DOI 10.1016/j.jpba.2007.10.016; Rosenbaum S., 2011, BASIC PHARMACOKINETI, V1st ed.; Roy S, 2004, METHOD ENZYMOL, V379, P175; Ryan AJ, 2011, J STRUCT BIOL, V174, P84, DOI 10.1016/j.jsb.2010.10.004; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; Sun CX, 2005, BIOPHYS J, V88, P3518, DOI 10.1529/biophysj.104.051516; Thumser AEA, 1998, J LIPID RES, V39, P1033; van de Weert M, 2011, J MOL STRUCT, V998, P144, DOI 10.1016/j.molstruc.2011.05.023; WARE WR, 1962, J PHYS CHEM-US, V66, P455, DOI 10.1021/j100809a020; Wu XH, 2011, SPECTROCHIM ACTA A, V79, P1202, DOI 10.1016/j.saa.2011.04.043; Ximenes VF, 2011, ARCH BIOCHEM BIOPHYS, V507, P315, DOI 10.1016/j.abb.2010.12.026; Ximenes VF, 2005, BRAZ J MED BIOL RES, V38, P1575, DOI 10.1590/S0100-879X2005001100003; Zhang XY, 2013, PLOS ONE, V8	36	41	41	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76849	10.1371/journal.pone.0076849	http://dx.doi.org/10.1371/journal.pone.0076849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146932	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400088
J	Liew, LC; Singh, MB; Bhalla, PL				Liew, Lim Chee; Singh, Mohan B.; Bhalla, Prem L.			An RNA-Seq Transcriptome Analysis of Histone Modifiers and RNA Silencing Genes in Soybean during Floral Initiation Process	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; FLOWERING-LOCUS-T; DNA METHYLATION; DEACETYLASE FAMILIES; DOMAIN PROTEINS; MOLECULAR-BASIS; NONCODING RNAS; LEAF POLARITY; LYSINE 4; ARABIDOPSIS	Epigenetics has been recognised to play vital roles in many plant developmental processes, including floral initiation through the epigenetic regulation of gene expression. The histone modifying proteins that mediate these modifications involve the SET domain-containing histone methyltransferases, JmjC domain-containing demethylase, acetylases and deacetylases. In addition, RNA interference (RNAi)-associated genes are also involved in epigenetic regulation via RNA-directed DNA methylation and post-transcriptional gene silencing. Soybean, a major crop legume, requires a short day to induce flowering. How histone modifications regulate the plant response to external cues that initiate flowering is still largely unknown. Here, we used RNA-seq to address the dynamics of transcripts that are potentially involved in the epigenetic programming and RNAi mediated gene silencing during the floral initiation of soybean. Soybean is a paleopolyploid that has been subjected to at least two rounds of whole genome duplication events. We report that the expanded genomic repertoire of histone modifiers and RNA silencing genes in soybean includes 14 histone acetyltransferases, 24 histone deacetylases, 47 histone methyltransferases, 15 protein arginine methyltransferases, 24 JmjC domain-containing demethylases and 47 RNAi-associated genes. To investigate the role of these histone modifiers and RNA silencing genes during floral initiation, we compared the transcriptional dynamics of the leaf and shoot apical meristem at different time points after a short-day treatment. Our data reveal that the extensive activation of genes that are usually involved in the epigenetic programming and RNAi gene silencing in the soybean shoot apical meristem are reprogrammed for floral development following an exposure to inductive conditions.	[Liew, Lim Chee; Singh, Mohan B.; Bhalla, Prem L.] Univ Melbourne, Plant Mol Biol & Biotechnol Lab, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia	University of Melbourne	Bhalla, PL (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Lab, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia.	premlb@unimelb.edu.au	Liew, Lim Chee/Y-6050-2019	Singh, Mohan/0000-0001-9427-8975; Liew, Lim Chee/0000-0001-8243-8521; Bhalla, Prem/0000-0002-2910-0393	Australian Research Council [CE0348212, DP0988972]; McKenzie Postdoctoral Fellowship scheme, University of Melbourne	Australian Research Council(Australian Research Council); McKenzie Postdoctoral Fellowship scheme, University of Melbourne	This work was supported by the Australian Research Council (CE0348212 and DP0988972). L.C. Liew gratefully acknowledges financial support by McKenzie Postdoctoral Fellowship scheme, University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD A, 2012, J GENET GENOMICS, P24881; Ahmad A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022664; Aquea F, 2010, PLANT PHYSIOL BIOCH, V48, P194, DOI 10.1016/j.plaphy.2009.12.009; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Avramova Z, 2009, INT J DEV BIOL, V53, P371, DOI 10.1387/ijdb.082664za; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Benhamed M, 2006, PLANT CELL, V18, P2893, DOI 10.1105/tpc.106.043489; Bond DM, 2009, MOL PLANT, V2, P724, DOI 10.1093/mp/ssp021; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Chen XS, 2011, BBA-GENE REGUL MECH, V1809, P421, DOI 10.1016/j.bbagrm.2011.03.004; Chen XM, 2002, DEVELOPMENT, V129, P1085; Colville A, 2011, PLANT CELL REP, V30, P1969, DOI 10.1007/s00299-011-1105-z; Demetriou K, 2009, PHYSIOL PLANTARUM, V136, P358, DOI 10.1111/j.1399-3054.2009.01236.x; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Farinas B, 2011, PLANT J, V66, P318, DOI 10.1111/j.1365-313X.2011.04484.x; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grini PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007817; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Guo L, 2010, P NATL ACAD SCI USA, V107, P18557, DOI 10.1073/pnas.1010478107; Haerizadeh F, 2009, PLANT MOL BIOL, V69, P711, DOI 10.1007/s11103-008-9450-1; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; Hemmes H, 2012, PLANT CELL PHYSIOL, V53, P2016, DOI 10.1093/pcp/pcs148; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hollender C, 2008, J INTEGR PLANT BIOL, V50, P875, DOI 10.1111/j.1744-7909.2008.00704.x; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jeong JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008033; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Jones MA, 2010, P NATL ACAD SCI USA, V107, P21623, DOI 10.1073/pnas.1014204108; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038250; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kanno T, 2011, BBA-GENE REGUL MECH, V1809, P444, DOI 10.1016/j.bbagrm.2011.05.002; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kraft E, 2008, PLANT J, V56, P704, DOI 10.1111/j.1365-313X.2008.03631.x; Krogan NT, 2012, DEVELOPMENT, V139, P4180, DOI 10.1242/dev.085407; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu QL, 2009, PLANT J, V58, P27, DOI 10.1111/j.1365-313X.2008.03757.x; Lu FL, 2008, J INTEGR PLANT BIOL, V50, P886, DOI 10.1111/j.1744-7909.2008.00692.x; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Lu FL, 2010, CELL RES, V20, P387, DOI 10.1038/cr.2010.27; Lu SX, 2011, PLANT SIGNAL BEHAV, V6, P810, DOI 10.4161/psb.6.6.15171; Lu SX, 2011, PLANT PHYSIOL, V155, P906, DOI 10.1104/pp.110.167015; Luo M, 2012, J EXP BOT, V63, P3297, DOI 10.1093/jxb/ers059; MA X, 2013, PLANT CELL REP, V32, P1, DOI DOI 10.1007/S00299-012-1342-9.PUBMED:23007688; Malapeira J, 2012, P NATL ACAD SCI USA, V109, P21540, DOI 10.1073/pnas.1217022110; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; McManus KJ, 2001, BIOCHEM CELL BIOL, V79, P253, DOI 10.1139/bcb-79-3-253; Millar CB, 2006, NAT REV MOL CELL BIO, V7, P657, DOI 10.1038/nrm1986; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Nakazawa Y, 2007, PLANT MOL BIOL, V63, P777, DOI 10.1007/s11103-006-9125-8; Niu LF, 2007, EMBO REP, V8, P1190, DOI 10.1038/sj.embor.7401111; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontvianne F, 2010, ADV BOT RES, V53, P1, DOI 10.1016/S0065-2296(10)53001-5; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saleh A, 2008, PLANT CELL, V20, P568, DOI 10.1105/tpc.107.056614; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Simpson GG, 2004, CURR OPIN PLANT BIOL, V7, P570, DOI 10.1016/j.pbi.2004.07.002; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Tamada Y, 2009, PLANT CELL, V21, P3257, DOI 10.1105/tpc.109.070060; Thorstensen T, 2011, BBA-GENE REGUL MECH, V1809, P407, DOI 10.1016/j.bbagrm.2011.05.008; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; van Wolfswinkel JC, 2010, J CELL SCI, V123, P1825, DOI 10.1242/jcs.061713; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Veiseth SV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001325; Weller JL, 2012, P NATL ACAD SCI USA, V109, P21158, DOI 10.1073/pnas.1207943110; Weller JL, 2009, J EXP BOT, V60, P2493, DOI 10.1093/jxb/erp120; WESLEY SV, 2004, RNA INTERFERENCE EDI, V265, P117; Wong CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065319; Wong CE, 2011, J EXP BOT, V62, P2495, DOI 10.1093/jxb/erq437; Wong CE, 2009, PLANT SIGNAL BEHAV, V4, P648, DOI [10.1111/j.1365-313X.2008.03730.x, 10.4161/psb.4.7.8978]; Wong CE, 2009, PLANT J, V57, P832, DOI 10.1111/j.1365-313X.2008.03730.x; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zeevaart JAD, 2006, PLANT CELL, V18, P1783, DOI 10.1105/tpc.106.043513; Zhang HM, 2011, CURR OPIN PLANT BIOL, V14, P142, DOI 10.1016/j.pbi.2011.02.003; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514; Zhou CH, 2004, PLANT J, V38, P715, DOI 10.1111/j.1365-313X.2004.02083.x; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	98	18	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77502	10.1371/journal.pone.0077502	http://dx.doi.org/10.1371/journal.pone.0077502			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147010	Green Published, gold			2022-12-27	WOS:000326019400115
J	Wardill, TJ; Chen, TW; Schreiter, ER; Hasseman, JP; Tsegaye, G; Fosque, BF; Behnam, R; Shields, BC; Ramirez, M; Kimmel, BE; Kerr, RA; Jayaraman, V; Looger, LL; Svoboda, K; Kim, DS				Wardill, Trevor J.; Chen, Tsai-Wen; Schreiter, Eric R.; Hasseman, Jeremy P.; Tsegaye, Getahun; Fosque, Benjamin F.; Behnam, Reza; Shields, Brenda C.; Ramirez, Melissa; Kimmel, Bruce E.; Kerr, Rex A.; Jayaraman, Vivek; Looger, Loren L.; Svoboda, Karel; Kim, Douglas S.			A Neuron-Based Screening Platform for Optimizing Genetically-Encoded Calcium Indicators	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; IN-VIVO; CA2+ INDICATORS; ACTION-POTENTIALS; CELLS; PROBE; ACTIVATION; EXPRESSION; REPORTER; MOUSE	Fluorescent protein-based sensors for detecting neuronal activity have been developed largely based on non-neuronal screening systems. However, the dynamics of neuronal state variables (e. g., voltage, calcium, etc.) are typically very rapid compared to those of non-excitable cells. We developed an electrical stimulation and fluorescence imaging platform based on dissociated rat primary neuronal cultures. We describe its use in testing genetically-encoded calcium indicators (GECIs). Efficient neuronal GECI expression was achieved using lentiviruses containing a neuronal-selective gene promoter. Action potentials (APs) and thus neuronal calcium levels were quantitatively controlled by electrical field stimulation, and fluorescence images were recorded. Images were segmented to extract fluorescence signals corresponding to individual GECI-expressing neurons, which improved sensitivity over full-field measurements. We demonstrate the superiority of screening GECIs in neurons compared with solution measurements. Neuronal screening was useful for efficient identification of variants with both improved response kinetics and high signal amplitudes. This platform can be used to screen many types of sensors with cellular resolution under realistic conditions where neuronal state variables are in relevant ranges with respect to timing and amplitude.	[Wardill, Trevor J.; Chen, Tsai-Wen; Schreiter, Eric R.; Hasseman, Jeremy P.; Tsegaye, Getahun; Fosque, Benjamin F.; Kimmel, Bruce E.; Kerr, Rex A.; Jayaraman, Vivek; Looger, Loren L.; Svoboda, Karel; Kim, Douglas S.] Howard Hughes Med Inst, Genetically Encoded Neuronal Indicator & Effector, Ashburn, VA USA; [Behnam, Reza; Shields, Brenda C.; Ramirez, Melissa] Howard Hughes Med Inst, Ashburn, VA USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute	Kim, DS (corresponding author), Howard Hughes Med Inst, Genetically Encoded Neuronal Indicator & Effector, Janelia Farm Res Campus, Ashburn, VA USA.	kimd@janelia.hhmi.org	; Fosque, Benjamin/I-1036-2014	Wardill, Trevor/0000-0002-2049-113X; Fosque, Benjamin/0000-0002-8862-2204; Chen, Tsai-Wen/0000-0001-6782-3819; Schreiter, Eric/0000-0002-2864-7469; Kim, Douglas/0000-0001-9029-314X	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by funding from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; BASARSKY TA, 1994, J NEUROSCI, V14, P6402; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BRENNER JF, 1976, J HISTOCHEM CYTOCHEM, V24, P100, DOI 10.1177/24.1.1254907; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Dreosti E, 2009, NAT METHODS, V6, P883, DOI 10.1038/nmeth.1399; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hempel CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025999; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Looger LL, 2012, CURR OPIN NEUROBIOL, V22, P18, DOI 10.1016/j.conb.2011.10.024; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mao T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001796; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Marvin JS, 2013, NAT METHODS, V10, P162, DOI [10.1038/NMETH.2333, 10.1038/nmeth.2333]; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Muto A, 2011, P NATL ACAD SCI USA, V108, P5425, DOI 10.1073/pnas.1000887108; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039933; Petreanu L, 2012, NATURE, V489, P299, DOI 10.1038/nature11321; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suter BA, 2010, FRONT NEURAL CIRCUIT, V4, P100, DOI DOI 10.3389/FNCIR.2010.00100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	44	36	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77728	10.1371/journal.pone.0077728	http://dx.doi.org/10.1371/journal.pone.0077728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155972	Green Published, gold			2022-12-27	WOS:000325887300106
J	Fang, NF; Shi, ZH; Yue, BJ; Wang, L				Fang, Nu-Fang; Shi, Zhi-Hua; Yue, Ben-Jiang; Wang, Ling			The Characteristics of Extreme Erosion Events in a Small Mountainous Watershed	PLOS ONE			English	Article							SUSPENDED SEDIMENT TRANSPORT; LAND-USE CHANGE; ABANDONED FARMLAND CATCHMENT; CENTRAL SPANISH PYRENEES; SOIL-EROSION; AGRICULTURAL CATCHMENT; EPHEMERAL CHANNELS; RAINFALL EVENTS; SE SPAIN; RUNOFF	A large amount of soil loss is caused by a small number of extreme events that are mainly responsible for the time compression of geomorphic processes. The aim of this study was to analyze suspended sediment transport during extreme erosion events in a mountainous watershed. Field measurements were conducted in Wangjiaqiao, a small agricultural watershed (16.7 km(2)) in the Three Gorges Area (TGA) of China. Continuous records were used to analyze suspended sediment transport regimes and assess the sediment loads of 205 rainfall-runoff events during a period of 16 hydrological years (1989-2004). Extreme events were defined as the largest events, ranked in order of their absolute magnitude (representing the 95th percentile). Ten extreme erosion events from 205 erosion events, representing 83.8% of the total suspended sediment load, were selected for study. The results of canonical discriminant analysis indicated that extreme erosion events are characterized by high maximum flood-suspended sediment concentrations, high runoff coefficients, and high flood peak discharge, which could possibly be explained by the transport of deposited sediment within the stream bed during previous events or bank collapses.	[Fang, Nu-Fang; Shi, Zhi-Hua] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China; [Fang, Nu-Fang; Shi, Zhi-Hua; Yue, Ben-Jiang; Wang, Ling] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Peoples R China; [Fang, Nu-Fang; Shi, Zhi-Hua; Yue, Ben-Jiang; Wang, Ling] Minist Water Resources, Yangling, Peoples R China; [Shi, Zhi-Hua] Huazhong Agr Univ, Coll Resources & Environm, Wuhan, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Huazhong Agricultural University	Shi, ZH (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling, Peoples R China.	pengshi@mail.hzau.edu.cn	Shi, ZH/F-7342-2012; Wang, Lingqing/AAF-7692-2020; Shi, Zhiahua/S-9311-2019	Shi, ZH/0000-0002-6961-1518; 	National Natural Science Foundation of China [41071190]; Program for New Century Excellent Talents in University [NCET-10-0423]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	Financial support for this research was provided by the National Natural Science Foundation of China (41071190) and the Program for New Century Excellent Talents in University (NCET-10-0423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, STUDY SOIL EROSION 3; Bakker MM, 2008, GEOMORPHOLOGY, V98, P213, DOI 10.1016/j.geomorph.2006.12.027; Bathurst JC, 2010, WATER INT, V35, P114, DOI 10.1080/02508061003660714; Belmonte AMC, 2001, CATENA, V45, P229; Bull LJ, 2000, CATENA, V38, P191, DOI 10.1016/S0341-8162(99)00071-5; Gonzalez-Hidalgo JC, 2012, CATENA, V95, P85, DOI 10.1016/j.catena.2012.03.006; Chen LD, 2001, AGR ECOSYST ENVIRON, V86, P163, DOI 10.1016/S0167-8809(00)00271-1; Chu ZX, 2008, J COASTAL RES, V24, P30, DOI 10.2112/05-0547.1; Coppus R, 2002, EARTH SURF PROC LAND, V27, P1365, DOI 10.1002/esp.435; Dai ZJ, 2011, AMBIO, V40, P496, DOI 10.1007/s13280-011-0148-2; Estrany J, 2010, J HYDROL, V380, P180, DOI 10.1016/j.jhydrol.2009.10.035; Fang NF, 2011, GEOMORPHOLOGY, V135, P158, DOI 10.1016/j.geomorph.2011.08.013; Fu ZY, 2011, GEODERMA, V167-68, P41, DOI 10.1016/j.geoderma.2011.08.013; Garcia-Ruiz JM, 2005, CATENA, V59, P79, DOI 10.1016/j.catena.2004.05.006; Gonzalez-Hidalgo JC, 2007, CATENA, V71, P193, DOI 10.1016/j.catena.2007.03.005; Hewlett J.D., 1967, FOREST HYDROLOGY, V1, P275; Hooke JM, 2000, GEOMORPHOLOGY, V34, P163, DOI 10.1016/S0169-555X(00)00005-2; Kirkby MJ, 2005, CATENA, V62, P136, DOI 10.1016/j.catena.2005.05.002; KLEIN M, 1984, CATENA, V11, P251, DOI 10.1016/S0341-8162(84)80024-7; Lana-Renault N, 2007, NORD HYDROL, V38, P139, DOI 10.2166/nh.2007.003; Lana-Renault N, 2009, EARTH SURF PROC LAND, V34, P1291, DOI 10.1002/esp.1825; Larson WE, 1997, J SOIL WATER CONSERV, V52, P90; Lenzi MA, 2003, HYDROLOG SCI J, V48, P899, DOI 10.1623/hysj.48.6.899.51425; Lu XX, 2001, GEOMORPHOLOGY, V41, P157, DOI 10.1016/S0169-555X(01)00113-1; Mano V, 2009, HYDROL PROCESS, V23, P777, DOI 10.1002/hyp.7178; McBroom MW, 2008, J ENVIRON QUAL, V37, P114, DOI 10.2134/jeq2006.0552; Ministry of Water Resources of the People's Republic of China (MWRPRC), 2002, TECHN COD PRACT WAT; Nadal-Romero E, 2008, CATENA, V74, P127, DOI 10.1016/j.catena.2008.03.014; Nearing MA, 2005, CATENA, V61, P131, DOI 10.1016/j.catena.2005.03.007; Ng SL, 2008, AGROFOREST SYST, V74, P279, DOI 10.1007/s10457-008-9158-x; Nunes JP, 2005, CATENA, V61, P210, DOI 10.1016/j.catena.2005.03.005; Oeurng C, 2010, EARTH SURF PROC LAND, V35, P1289, DOI 10.1002/esp.1971; Old GH, 2003, SCI TOTAL ENVIRON, V314, P495, DOI 10.1016/S0048-9697(03)00070-6; Osterkamp WR, 2000, HYDROL PROCESS, V14, P2817, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2817::AID-HYP121&gt;3.0.CO;2-B; Poesen JWA, 1997, PROG PHYS GEOG, V21, P157, DOI 10.1177/030913339702100201; Seeger M, 2004, J HYDROL, V288, P299, DOI 10.1016/j.jhydrol.2003.10.012; Shi DM, 1992, RESOURCES ENV YANGTZ, V1, P62; Shi ZH, 2004, CATENA, V55, P33, DOI 10.1016/S0341-8162(03)00088-2; Shi ZH, 2009, CATENA, V77, P1, DOI 10.1016/j.catena.2008.11.006; Si JJ, 2009, CHINA ACAD J; Siriwardena L, 2006, J HYDROL, V326, P199, DOI 10.1016/j.jhydrol.2005.10.030; Soler M, 2007, CATENA, V71, P164, DOI 10.1016/j.catena.2006.06.009; Stroosnijder L, 2005, CATENA, V64, P162, DOI 10.1016/j.catena.2005.08.004; [涂恩强 Tu Enqiang], 2010, [水土保持通报, Bulletin of Soil and Water Conservation], V30, P7; White S, 1998, AMBIO, V27, P300; WILLIAMS GP, 1989, J HYDROL, V111, P89, DOI 10.1016/0022-1694(89)90254-0; WOLMAN MG, 1960, J GEOL, V68, P54, DOI 10.1086/626637; [吴从林 Wu Conglin], 2002, [长江流域资源与环境, Resources and Environment in the Yangtze Valley], V11, P165; Zabaleta A, 2007, CATENA, V71, P179, DOI 10.1016/j.catena.2006.06.007; Zhang XinBao, 2006, Journal of Soil and Water Conservation (China), V20, P1	50	10	11	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76610	10.1371/journal.pone.0076610	http://dx.doi.org/10.1371/journal.pone.0076610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146898	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400067
J	Wang, Q; Jia, PL; Cuenco, KT; Feingold, E; Marazita, ML; Wang, LL; Zhao, ZM				Wang, Quan; Jia, Peilin; Cuenco, Karen T.; Feingold, Eleanor; Marazita, Mary L.; Wang, Lily; Zhao, Zhongming			Multi-Dimensional Prioritization of Dental Caries Candidate Genes and Its Enriched Dense Network Modules	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MATRIX METALLOPROTEINASES; HUMAN ODONTOBLASTS; PULP COMPLEX; TOOTH-PULP; EXPRESSION; DISEASE; CYTOKINES; HEALTHY; AMELX	A number of genetic studies have suggested numerous susceptibility genes for dental caries over the past decade with few definite conclusions. The rapid accumulation of relevant information, along with the complex architecture of the disease, provides a challenging but also unique opportunity to review and integrate the heterogeneous data for follow-up validation and exploration. In this study, we collected and curated candidate genes from four major categories: association studies, linkage scans, gene expression analyses, and literature mining. Candidate genes were prioritized according to the magnitude of evidence related to dental caries. We then searched for dense modules enriched with the prioritized candidate genes through their protein-protein interactions (PPIs). We identified 23 modules comprising of 53 genes. Functional analyses of these 53 genes revealed three major clusters: cytokine network relevant genes, matrix metalloproteinases (MMPs) family, and transforming growth factor-beta (TGF-beta) family, all of which have been previously implicated to play important roles in tooth development and carious lesions. Through our extensive data collection and an integrative application of gene prioritization and PPI network analyses, we built a dental caries-specific sub-network for the first time. Our study provided insights into the molecular mechanisms underlying dental caries. The framework we proposed in this work can be applied to other complex diseases.	[Wang, Quan; Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Cuenco, Karen T.; Feingold, Eleanor; Marazita, Mary L.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Cuenco, Karen T.; Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Dept Oral Biol, Pittsburgh, PA USA; [Feingold, Eleanor] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Wang, Lily] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Wang, Lily; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Ctr Quantitat Sci, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zhao, ZM (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Wang, Quan/K-4540-2017	Wang, Quan/0000-0002-7056-0519; Feingold, Eleanor/0000-0003-2898-6484	National Institutes of Health [R03DE022093, R01LM011177, R21HG006037]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014899, R03DE022093] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grants from National Institutes of Health (R03DE022093, R01LM011177, and R21HG006037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2007, J DENT RES, V86, P1217, DOI 10.1177/154405910708601215; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azevedo LF, 2010, J APPL ORAL SCI, V18, P166, DOI 10.1590/S1678-77572010000200011; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BEGUEKIRN C, 1994, INT J DEV BIOL, V38, P405; BORAAS JC, 1988, J DENT RES, V67, P1150, DOI 10.1177/00220345880670090201; Brancher JA, 2011, INT J DENT, V2011, DOI 10.1155/2011/571726; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Caron C, 2001, J DENT RES, V80, P1660, DOI 10.1177/00220345010800071201; Chang SK, 2011, P NATL ACAD SCI USA, V108, P8402, DOI 10.1073/pnas.1019437108; Chaussain-Miller C, 2006, J DENT RES, V85, P22, DOI 10.1177/154405910608500104; Culp DJ, 2005, CARIES RES, V39, P448, DOI 10.1159/000088179; Doncheva NT, 2012, WIRES SYST BIOL MED, V4, P429, DOI 10.1002/wsbm.1177; Featherstone J D B, 2004, J Dent Res, V83 Spec No C, pC39; Fischer CL, 2012, ANTIMICROB AGENTS CH, V56, P1157, DOI 10.1128/AAC.05151-11; Garcia-Alonso L, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks699; Gasse B, 2013, J DENT RES, V92, P418, DOI 10.1177/0022034513482941; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Gornowicz A, 2012, ANN AGR ENV MED, V19, P711; GRAHN E, 1988, ACTA ODONTOL SCAND, V46, P67, DOI 10.3109/00016358809004749; Hannas AR, 2007, ACTA ODONTOL SCAND, V65, P1, DOI 10.1080/00016350600963640; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Horst OV, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-9; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jia PL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002587; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang SW, 2011, ORAL DIS, V17, P399, DOI 10.1111/j.1601-0825.2010.01766.x; Kao CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018696; Kulkarni GV, 2013, CARIES RES, V47, P219, DOI 10.1159/000345652; Liekens AML, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r57; McLachlan JL, 2003, ARCH ORAL BIOL, V48, P273, DOI 10.1016/S0003-9969(03)00003-7; McLachlan JL, 2005, BBA-MOL BASIS DIS, V1741, P271, DOI 10.1016/j.bbadis.2005.03.007; Menezes-Silva R, 2012, J ENDODONT, V38, P604, DOI 10.1016/j.joen.2012.02.009; Moreau Y, 2012, NAT REV GENET, V13, P523, DOI 10.1038/nrg3253; Morgan CR, 2005, J OROFAC PAIN, V19, P248; Nakahara Y, 2012, TOXICOL PATHOL; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Olszowski T, 2012, ORAL DIS, V18, P389, DOI 10.1111/j.1601-0825.2011.01887.x; Ozturk A, 2010, J DENT RES, V89, P631, DOI 10.1177/0022034510364491; Paakkonen V, 2005, EUR J ORAL SCI, V113, P369, DOI 10.1111/j.1600-0722.2005.00237.x; Palosaari H, 2000, J DENT RES, V79, P77, DOI 10.1177/00220345000790011401; Peyyala R, 2012, CYTOKINE, V58, P65, DOI 10.1016/j.cyto.2011.12.016; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Schork NJ, 1997, AM J RESP CRIT CARE, V156, pS103, DOI 10.1164/ajrccm.156.4.12-tac-5; Shaffer JR, 2013, J DENT RES, V92, P38, DOI 10.1177/0022034512463579; Shaffer JR, 2011, J DENT RES, V90, P1457, DOI 10.1177/0022034511422910; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shapiro H, 2011, THESCIENTIFICWORLDJO, V11, P2509, DOI 10.1100/2011/397971; Shimada Y, 2009, AUST DENT J, V54, P347, DOI 10.1111/j.1834-7819.2009.01161.x; Sloan AJ, 1999, HISTOCHEM J, V31, P565, DOI 10.1023/A:1003852409574; Sloan AJ, 2000, HISTOCHEM J, V32, P247, DOI 10.1023/A:1004007202404; Sloan AJ, 1999, ARCH ORAL BIOL, V44, P149, DOI 10.1016/S0003-9969(98)00106-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002488; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Tannure PN, 2012, CARIES RES, V46, P401, DOI 10.1159/000339379; Tannure PN, 2012, J DENT, V40, P381, DOI 10.1016/j.jdent.2012.01.015; Tjaderhane L, 1998, J DENT RES, V77, P1486, DOI 10.1177/00220345980770070301; Tjaderhane L, 1998, J DENT RES, V77, P1622, DOI 10.1177/00220345980770081001; Toledano M, 2010, J DENT, V38, P635, DOI 10.1016/j.jdent.2010.05.001; Townsend GC, 1998, AUST DENT J, V43, P269, DOI 10.1111/j.1834-7819.1998.tb00176.x; Valarini N, 2012, CARIES RES, V46, P530, DOI 10.1159/000341188; Vieira AR, 2008, J DENT RES, V87, P435, DOI 10.1177/154405910808700506; WALLENGREN ML, 1991, ORAL MICROBIOL IMMUN, V6, P292, DOI 10.1111/j.1399-302X.1991.tb00495.x; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072653; Wang X, 2012, CARIES RES, V46, P177, DOI 10.1159/000337282; Wang X, 2010, CARIES RES, V44, P277, DOI 10.1159/000314676; Wang XJ, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-57; Wendell S, 2010, J DENT RES, V89, P1198, DOI 10.1177/0022034510381502; Werneck RI, 2010, ORAL DIS, V16, P613, DOI 10.1111/j.1601-0825.2010.01675.x; Wilson M, 1998, INFECT IMMUN, V66, P2401, DOI 10.1128/IAI.66.6.2401-2409.1998; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zhao ZM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S16	81	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76666	10.1371/journal.pone.0076666	http://dx.doi.org/10.1371/journal.pone.0076666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146904	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400070
J	Fenner, L; Ballif, M; Graber, C; Nhandu, V; Dusingize, JC; Cortes, CP; Carriquiry, G; Anastos, K; Garone, D; Jong, E; Gnokoro, JC; Sued, O; Ajayi, S; Diero, L; Wools-Kaloustian, K; Kiertiburanakul, S; Castelnuovo, B; Lewden, C; Durier, N; Sterling, TR; Egger, M				Fenner, Lukas; Ballif, Marie; Graber, Claire; Nhandu, Venerandah; Dusingize, Jean Claude; Cortes, Claudia P.; Carriquiry, Gabriela; Anastos, Kathryn; Garone, Daniela; Jong, Eefje; Gnokoro, Joachim Charles; Sued, Omar; Ajayi, Samuel; Diero, Lameck; Wools-Kaloustian, Kara; Kiertiburanakul, Sasisopin; Castelnuovo, Barbara; Lewden, Charlotte; Durier, Nicolas; Sterling, Timothy R.; Egger, Matthias		IeDEA	Tuberculosis in Antiretroviral Treatment Programs in Lower Income Countries: Availability and Use of Diagnostics and Screening	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; INTERNATIONAL EPIDEMIOLOGIC DATABASES; HIV-INFECTED ADULTS; EVALUATE AIDS IEDEA; XPERT MTB/RIF TEST; IMMUNE RECONSTITUTION; COHORT PROFILE; SOUTH-AFRICA; THERAPY; MORTALITY	Objectives: In resource-constrained settings, tuberculosis (TB) is a common opportunistic infection and cause of death in HIV-infected persons. TB may be present at the start of antiretroviral therapy (ART), but it is often under-diagnosed. We describe approaches to TB diagnosis and screening of TB in ART programs in low-and middle-income countries. Methods and findings: We surveyed ART programs treating HIV-infected adults in sub-Saharan Africa, Asia and Latin America in 2012 using online questionnaires to collect program-level and patient-level data. Forty-seven sites from 26 countries participated. Patient-level data were collected on 987 adult TB patients from 40 sites (median age 34.7 years; 54% female). Sputum smear microscopy and chest radiograph were available in 47 (100%) sites, TB culture in 44 (94%), and Xpert MTB/RIF in 23 (49%). Xpert MTB/RIF was rarely available in Central Africa and South America. In sites with access to these diagnostics, microscopy was used in 745 (76%) patients diagnosed with TB, culture in 220 (24%), and chest X-ray in 688 (70%) patients. When free of charge culture was done in 27% of patients, compared to 21% when there was a fee (p = 0.033). Corresponding percentages for Xpert MTB/RIF were 26% and 15% of patients (p = 0.001). Screening practices for active disease before starting ART included symptom screening (46 sites, 98%), chest X-ray (38, 81%), sputum microscopy (37, 79%), culture (16, 34%), and Xpert MTB/RIF (5, 11%). Conclusions: Mycobacterial culture was infrequently used despite its availability at most sites, while Xpert MTB/RIF was not generally available. Use of available diagnostics was higher when offered free of charge.	[Fenner, Lukas; Ballif, Marie; Graber, Claire; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Fenner, Lukas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Fenner, Lukas] Univ Basel, Basel, Switzerland; [Nhandu, Venerandah] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Dusingize, Jean Claude] Womens Equ Access Care & Treatment, Kigali, Rwanda; [Cortes, Claudia P.] Univ Chile Sch Med, Santiago, Chile; [Carriquiry, Gabriela] Inst Med Trop Alexander von Humboldt, Lima, Peru; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA; [Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Garone, Daniela] Med Sans Frontieres, Khayelitsha ART Programme, Cape Town, South Africa; [Jong, Eefje] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Gnokoro, Joachim Charles] CEPREF ART Program, Abidjan, Cote Ivoire; [Sued, Omar] Fdn Huesped, Buenos Aires, DF, Argentina; [Ajayi, Samuel] Univ Abuja Teaching Hosp, Abuja, Nigeria; [Diero, Lameck; Wools-Kaloustian, Kara] USAID AMPATH, Eldoret, Kenya; [Wools-Kaloustian, Kara] Indiana Univ, Indianapolis, IN 46204 USA; [Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok 10400, Thailand; [Castelnuovo, Barbara] Infect Dis Inst, Res Dept, Kampala, Uganda; [Lewden, Charlotte] Univ Bordeaux Segalen, ISPED, Bordeaux, France; [Durier, Nicolas] TREAT Asia, AmfAR Fdn AIDS Res, Bangkok, Thailand; [Sterling, Timothy R.] Vanderbilt Univ Sch Med, Nashville, TN USA	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Universidad Peruana Cayetano Heredia; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Witwatersrand; United States Agency for International Development (USAID); Indiana University System; Indiana University-Purdue University Indianapolis; Mahidol University; UDICE-French Research Universities; Universite de Bordeaux; Vanderbilt University	Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	lukas.fenner@unibas.ch	Cortes, Claudia P/AAF-7326-2020; Sued, Omar/H-3325-2019	Cortes, Claudia P/0000-0001-9101-9783; Sued, Omar/0000-0001-5818-770X; Egger, Matthias/0000-0001-7462-5132; Dusingize, Jean Claude/0000-0001-5721-100X; Fenner, Lukas/0000-0003-3309-4835	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U01AI069924, U01AI069907, U01A096299, U01AI069911, U01AI069923, U01AI069919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907, K24AI065298, U01AI096299, U01AI069924, U01AI069911, U01AI069923, U01AI069919] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number Southern Africa: U01AI069924, Asia: U01AI069907, Central Africa: U01A096299, East Africa: U01AI069911, Caribbean, Central and South America: U01AI069923 and West Africa: U01AI069919. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, INT J TUBERC LUNG D, V13, P927; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Davies MA, 2009, CLIN INFECT DIS, V49, P973, DOI 10.1086/605501; Edmonds A, 2009, INT J EPIDEMIOL; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Fenner L, 2011, INT J TUBERC LUNG D, V15, P620, DOI 10.5588/ijtld.10.0249; Gange SJ, 2007, INT J EPIDEMIOL, V36, P294, DOI 10.1093/ije/dyl286; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lin HH, 2012, B WORLD HEALTH ORGAN, V90, P739, DOI 10.2471/BLT.11.101436; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; McGowan CC, 2007, INT J EPIDEMIOL, V36, P969, DOI 10.1093/ije/dym073; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Nicol MP, 2011, LANCET INFECT DIS, V11, P819, DOI 10.1016/S1473-3099(11)70167-0; Saito S, 2012, JAIDS-J ACQ IMM DEF, V61, P216, DOI 10.1097/QAI.0b013e3182638ec7; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	29	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77697	10.1371/journal.pone.0077697	http://dx.doi.org/10.1371/journal.pone.0077697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147059	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000326022200067
J	Okamoto, K; Miyoshi, K; Murawaki, Y				Okamoto, Kinya; Miyoshi, Kenichi; Murawaki, Yoshikazu			miR-29b, miR-205 and miR-221 Enhance Chemosensitivity to Gemcitabine in HuH28 Human Cholangiocarcinoma Cells	PLOS ONE			English	Article							MICRORNA; CANCER; EXPRESSION; GROWTH; INVASION; GENES; TUMORIGENICITY; BIOGENESIS; RESISTANCE; PTEN	Background and Aims: Cholangiocarcinoma (CCA) is highly resistant to chemotherapy, including gemcitabine (Gem) treatment. MicroRNAs (miRNAs) are endogenous, non-coding, short RNAs that can regulate multiple genes expression. Some miRNAs play important roles in the chemosensitivity of tumors. Here, we examined the relationship between miRNA expression and the sensitivity of CCA cells to Gem. Methods: Microarray analysis was used to determine the miRNA expression profiles of two CCA cell lines, HuH28 and HuCCT1. To determine the effect of candidate miRNAs on Gem sensitivity, expression of each candidate miRNA was modified via either transfection of a miRNA mimic or transfection of an anti-oligonucleotide. Ontology-based programs were used to identify potential target genes of candidate miRNAs that were confirmed to affect the Gem sensitivity of CCA cells. Results: HuCCT1 cells were more sensitive to Gem than were HuH28 cells, and 18 miRNAs were differentially expressed whose ratios over +/- 2log2 between HuH28 and HuCCT1. Among these 18 miRNAs, ectopic overexpression of each of three downregulated miRNAs in HuH28 (miR-29b, miR-205, miR-221) restored Gem sensitivity to HuH28. Suppression of one upregulated miRNA in HuH28, miR-125a-5p, inhibited HuH28 cell proliferation independently to Gem treatment. Selective siRNA-mediated downregulation of either of two software-predicted targets, PIK3R1 (target of miR-29b and miR-221) or MMP-2 (target of miR-29b), also conferred Gem sensitivity to HuH28. Conclusions: miRNA expression profiling was used to identify key miRNAs that regulate Gem sensitivity in CCA cells, and software that predicts miRNA targets was used to identify promising target genes for anti-tumor therapies.	[Okamoto, Kinya; Miyoshi, Kenichi; Murawaki, Yoshikazu] Tottori Univ, Sch Med, Dept Internal Med 2, Yonago, Tottori 683, Japan	Tottori University	Okamoto, K (corresponding author), Tottori Univ, Sch Med, Dept Internal Med 2, Yonago, Tottori 683, Japan.	okamotka@grape.med.tottori-u.ac.jp		Okamoto, Kinya/0000-0001-9087-8965				Adachi R, 2011, BIOCHEM BIOPH RES CO, V411, P804, DOI 10.1016/j.bbrc.2011.07.033; Amodio N, 2012, ONCOTARGET, V3, P1246; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu Aruna, 2011, Genes Cancer, V2, P108, DOI 10.1177/1947601911409212; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chetty C, 2007, ONCOGENE, V26, P7675, DOI 10.1038/sj.onc.1210584; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gesto DS, 2012, CURR MED CHEM, V19, P1076; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guduric-Fuchs J, 2012, J CELL BIOCHEM, V113, P2098, DOI 10.1002/jcb.24084; He Q, 2011, MOL CARCINOG; Jiang LL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-318; Kawahigashi Yutaka, 2009, Journal of Nippon Medical School, V76, P188; Kesanakurti D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019341; Kim J. K., 2012, HEPATOLOGY; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lazaridis KN, 2005, GASTROENTEROLOGY, V128, P1655, DOI 10.1053/j.gastro.2005.03.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu K, 2012, J INT MED RES, V40, P467, DOI 10.1177/147323001204000208; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Okano J, 2006, J GASTROENTEROL, V41, P166, DOI 10.1007/s00535-005-1736-3; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Papaconstantinou I, 2011, MOL CARCINOG; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Qin AY, 2012, EUR J CELL BIOL; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Skipworth JRA, 2011, ALIMENT PHARM THER, V34, P1063, DOI 10.1111/j.1365-2036.2011.04851.x; Steele Robert, 2010, Genes Cancer, V1, P381; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; Veltkamp SA, 2008, ONCOLOGIST, V13, P261, DOI 10.1634/theoncologist.2007-0215; Vihinen P, 2002, INT J CANCER, V99, P157, DOI 10.1002/ijc.10329; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yang Y, 2010, CANCER GENET CYTOGEN, V200, P127, DOI 10.1016/j.cancergencyto.2010.03.014; Yu ZW, 2010, ORAL ONCOL, V46, P317, DOI 10.1016/j.oraloncology.2010.02.002	51	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77623	10.1371/journal.pone.0077623	http://dx.doi.org/10.1371/journal.pone.0077623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147037	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200052
J	Walenda, G; Abnaof, K; Joussen, S; Meurer, S; Smeets, H; Rath, B; Hoffmann, K; Frohlich, H; Zenke, M; Weiskirchen, R; Wagner, W				Walenda, Gudrun; Abnaof, Khalid; Joussen, Sylvia; Meurer, Steffen; Smeets, Hubert; Rath, Bjoern; Hoffmann, Kurt; Froehlich, Holger; Zenke, Martin; Weiskirchen, Ralf; Wagner, Wolfgang			TGF-beta1 Does Not Induce Senescence of Multipotent Mesenchymal Stromal Cells and Has Similar Effects in Early and Late Passages	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; FALSE DISCOVERY RATE; TGF-BETA; STEM-CELLS; GENE-EXPRESSION; DNA-METHYLATION; CELLULAR SENESCENCE; OSTEOGENIC DIFFERENTIATION; REPLICATIVE SENESCENCE; PROLIFERATION	Transforming growth factor-beta 1 (TGF-beta 1) stimulates a broad range of effects which are cell type dependent, and it has been suggested to induce cellular senescence. On the other hand, long-term culture of multipotent mesenchymal stromal cells (MSCs) has a major impact on their cellular physiology and therefore it is well conceivable that the molecular events triggered by TGF-beta 1 differ considerably in cells of early and late passages. In this study, we analyzed the effect of TGF-beta 1 on and during replicative senescence of MSCs. Stimulation with TGF-beta 1 enhanced proliferation, induced a network like growth pattern and impaired adipogenic and osteogenic differentiation. TGF-beta 1 did not induce premature senescence. However, due to increased proliferation rates the cells reached replicative senescence earlier than untreated controls. This was also evident, when we analyzed senescence-associated DNA-methylation changes. Gene expression profiles of MSCs differed considerably at relatively early (P 3 - 5) and later passages (P 10). Nonetheless, relative gene expression differences provoked by TGF-beta 1 at individual time points or in a time course dependent manner (stimulation for 0, 1, 4 and 12 h) were very similar in MSCs of early and late passage. These results support the notion that TGF-beta 1 has major impact on MSC function, but it does not induce senescence and has similar molecular effects during culture expansion.	[Walenda, Gudrun; Joussen, Sylvia; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn Stem Cell Biol & Cellu, Aachen, Germany; [Abnaof, Khalid; Froehlich, Holger] Univ Bonn, Bonn Aachen Int Ctr Informat Technol, Bonn, Germany; [Abnaof, Khalid; Hoffmann, Kurt] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Bioanalyt Resource Ctr Aachen, Aachen, Germany; [Meurer, Steffen; Weiskirchen, Ralf] Rhein Westfal TH Aachen, Sch Med, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Smeets, Hubert] Univ Maastricht, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Rath, Bjoern] Rhein Westfal TH Aachen, Sch Med, Dept Orthoped, Aachen, Germany; [Zenke, Martin] Rhein Westfal TH Aachen, Sch Med, Dept Cell Biol, Inst Biomed Technol, Aachen, Germany	RWTH Aachen University; University of Bonn; RWTH Aachen University; RWTH Aachen University; Maastricht University; RWTH Aachen University; RWTH Aachen University	Wagner, W (corresponding author), Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn Stem Cell Biol & Cellu, Aachen, Germany.	wwagner@ukaachen.de	Rath, Björn/AAF-3938-2022; Rath, Björn/AFI-8239-2022; Hoffmann, Kurt/P-2539-2014; Weiskirchen, Ralf/O-1734-2018; Fröhlich, Holger/H-1976-2017	Hoffmann, Kurt/0000-0002-7991-423X; Weiskirchen, Ralf/0000-0003-3888-0931; Fröhlich, Holger/0000-0002-5328-1243; Wagner, Wolfgang/0000-0002-1971-3217	Stem Cell Network North Rhine Westphalia; Else-Kroner-Fresenius Stiftung; Interregional Program Alma in Silico	Stem Cell Network North Rhine Westphalia; Else-Kroner-Fresenius Stiftung; Interregional Program Alma in Silico	This work was supported by the Stem Cell Network North Rhine Westphalia (to WW), by the Else-Kroner-Fresenius Stiftung (to WW), and particularly by Interregional Program Alma in Silico (http://www.alma-in-silico.com; to HS, KH, MZ, RW, and WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryee MJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-409; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; Chase LG, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt8; Chieregato K, 2011, CYTOTHERAPY, V13, P933, DOI 10.3109/14653249.2011.583232; Cholewa D, 2011, CELL TRANSPLANT, V20, P1409, DOI 10.3727/096368910X557218; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gharibi B, 2012, STEM CELL TRANSL MED, V1, P771, DOI 10.5966/sctm.2010-0031; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Iqbal J, 2000, BIOCHEM BIOPH RES CO, V274, P467, DOI 10.1006/bbrc.2000.3167; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Kloth JN, 2005, CARCINOGENESIS, V26, P1493, DOI 10.1093/carcin/bgi110; Koch CM, 2013, GENOME RES, V23, P248, DOI 10.1101/gr.141945.112; Koch CM, 2012, AGING CELL, V11, P366, DOI 10.1111/j.1474-9726.2011.00784.x; Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679; KOCH CM, 2013, METHODS MOL IN PRESS; Koli K, 2008, BONE, V43, P679, DOI 10.1016/j.bone.2008.06.016; Kumar A, 2012, ENDOCRINOLOGY, V153, P254, DOI 10.1210/en.2011-1169; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Liang YY, 2009, CELL RES, V19, P140, DOI 10.1038/cr.2008.321; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCCAFFREY TA, 1993, MOL BIOL CELL, V4, P315, DOI 10.1091/mbc.4.3.315; Mizutani A, 2011, J BIOL CHEM, V286, P29848, DOI 10.1074/jbc.M110.217745; Montaner D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010348; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Muller J, 2010, CELL CYCLE, V9, P4622, DOI 10.4161/cc.9.23.14211; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Oida T, 2010, J IMMUNOL METHODS, V362, P195, DOI 10.1016/j.jim.2010.09.008; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schallmoser K, 2010, HAEMATOL-HEMATOL J, V95, P867, DOI 10.3324/haematol.2009.011692; Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669; Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STOUFFER GA, 1994, J CLIN INVEST, V93, P2048, DOI 10.1172/JCI117199; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; VANBEUNINGEN HM, 1994, ANN RHEUM DIS, V53, P593, DOI 10.1136/ard.53.9.593; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wagner W, 2010, TISSUE ENG PART B-RE, V16, P445, DOI [10.1089/ten.teb.2009.0825, 10.1089/ten.TEB.2009.0825]; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Xie L, 2003, BREAST CANCER RES, V5, pR187, DOI 10.1186/bcr640; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]	66	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77656	10.1371/journal.pone.0077656	http://dx.doi.org/10.1371/journal.pone.0077656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147049	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200061
J	Dodero, L; Damiano, M; Galbusera, A; Bifone, A; Tsaftsaris, SA; Scattoni, ML; Gozzi, A				Dodero, Luca; Damiano, Mario; Galbusera, Alberto; Bifone, Angelo; Tsaftsaris, Sotirios A.; Scattoni, Maria Luisa; Gozzi, Alessandro			Neuroimaging Evidence of Major Morpho-Anatomical and Functional Abnormalities in the BTBR T plus TF/J Mouse Model of Autism	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; CEREBRAL BLOOD-VOLUME; CORTICAL THICKNESS; CORPUS-CALLOSUM; SPECTRUM DISORDERS; PROBST BUNDLE; IN-VIVO; BRAIN; AGENESIS; CONNECTIVITY	BTBR T+tf/J (BTBR) mice display prominent behavioural deficits analogous to the defining symptoms of autism, a feature that has prompted a widespread use of the model in preclinical autism research. Because neuro-behavioural traits are described with respect to reference populations, multiple investigators have examined and described the behaviour of BTBR mice against that exhibited by C57BL/6J (B6), a mouse line characterised by high sociability and low self-grooming. In an attempt to probe the translational relevance of this comparison for autism research, we used Magnetic Resonance Imaging (MRI) to map in both strain multiple morpho-anatomical and functional neuroimaging readouts that have been extensively used in patient populations. Diffusion tensor tractography confirmed previous reports of callosal agenesis and lack of hippocampal commissure in BTBR mice, and revealed a concomitant rostro-caudal reorganisation of major cortical white matter bundles. Intact inter-hemispheric tracts were found in the anterior commissure, ventro-medial thalamus, and in a strain-specific white matter formation located above the third ventricle. BTBR also exhibited decreased fronto-cortical, occipital and thalamic gray matter volume and widespread reductions in cortical thickness with respect to control B6 mice. Foci of increased gray matter volume and thickness were observed in the medial prefrontal and insular cortex. Mapping of resting-state brain activity using cerebral blood volume weighted fMRI revealed reduced cortico-thalamic function together with foci of increased activity in the hypothalamus and dorsal hippocampus of BTBR mice. Collectively, our results show pronounced functional and structural abnormalities in the brain of BTBR mice with respect to control B6 mice. The large and widespread white and gray matter abnormalities observed do not appear to be representative of the neuroanatomical alterations typically observed in autistic patients. The presence of reduced fronto-cortical metabolism is of potential translational relevance, as this feature recapitulates previously-reported clinical observations.	[Dodero, Luca; Damiano, Mario; Galbusera, Alberto; Bifone, Angelo; Gozzi, Alessandro] Ctr Neurosci & Cognit Syst UniTn, Ist Italiano Tecnol, Rovereto, Italy; [Tsaftsaris, Sotirios A.] Northwestern Univ, Dept Elect Engn & Comp Sci, Evanston, IL USA; [Scattoni, Maria Luisa] Ist Super Sanita, Neurotoxicol & Neuroendocrinol Sect, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Italiano di Tecnologia - IIT; Northwestern University; Istituto Superiore di Sanita (ISS)	Gozzi, A (corresponding author), Ctr Neurosci & Cognit Syst UniTn, Ist Italiano Tecnol, Rovereto, Italy.	alessandro.gozzi@iit.it	Scattoni, Maria Luisa/K-4116-2016; Gozzi, Alessandro/K-6342-2016; Galbusera, Alberto/N-5531-2016	Scattoni, Maria Luisa/0000-0002-6659-0280; Gozzi, Alessandro/0000-0002-5731-4137; Galbusera, Alberto/0000-0001-7213-0013	Istituto Italiano di Tecnologia	Istituto Italiano di Tecnologia(Istituto Italiano di Tecnologia - IIT)	The study was funded by the Istituto Italiano di Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anagnostou E, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-4; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Babineau BA, 2013, PHYSIOL BEHAV, V114, P49, DOI 10.1016/j.physbeh.2013.03.006; Badaruddin DH, 2007, CHILD PSYCHIAT HUM D, V38, P287, DOI 10.1007/s10578-007-0065-6; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Brown WS, 2005, NEUROPSYCHOLOGIA, V43, P906, DOI 10.1016/j.neuropsychologia.2004.09.008; Damiano M, 2013, VOXEL BASED MO UNPUB; Das SR, 2009, NEUROIMAGE, V45, P867, DOI 10.1016/j.neuroimage.2008.12.016; Devinsky O, 2003, EPILEPSY BEHAV, V4, P607, DOI 10.1016/j.yebeh.2003.08.029; Dorr AE, 2008, NEUROIMAGE, V42, P60, DOI 10.1016/j.neuroimage.2008.03.037; Ellegood J, 2013, NEUROIMAGE, V70, P288, DOI 10.1016/j.neuroimage.2012.12.029; Ferrari L, 2012, J NEUROSCI METH, V204, P9, DOI 10.1016/j.jneumeth.2011.10.020; Ferrari L, 2010, J NEUROSCI METH, V186, P143, DOI 10.1016/j.jneumeth.2009.11.005; Frazier TW, 2009, BIOL PSYCHIAT, V66, P935, DOI 10.1016/j.biopsych.2009.07.022; GEORGE MS, 1992, J NERV MENT DIS, V180, P413, DOI 10.1097/00005053-199207000-00002; GONZALEZ RG, 1995, AM J NEURORADIOL, V16, P1763; Gozzi A, 2007, MAGN RESON IMAGING, V25, P826, DOI 10.1016/j.mri.2007.03.003; Gozzi A, 2013, NEUROIMAGE, V69, P112, DOI 10.1016/j.neuroimage.2012.12.015; Gozzi A, 2011, NEUROPSYCHOPHARMACOL, V36, P2431, DOI 10.1038/npp.2011.129; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hardan AY, 2009, BIOL PSYCHIAT, V66, P320, DOI 10.1016/j.biopsych.2009.04.024; Haznedar MM, 2006, AM J PSYCHIAT, V163, P1252, DOI 10.1176/appi.ajp.163.7.1252; Haznedar MM, 1997, AM J PSYCHIAT, V154, P1047; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Ito H, 2005, J MED INVESTIG, V52, P49, DOI 10.2152/jmi.52.49; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Lau YC, 2012, J AUTISM DEV DISORD; Lerch JP, 2008, NEUROIMAGE, V41, P243, DOI 10.1016/j.neuroimage.2008.02.019; Lerch JP, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00006; Magnuson M, 2010, J MAGN RESON IMAGING, V32, P584, DOI 10.1002/jmri.22295; Meyer BU, 1998, J NEUROL NEUROSUR PS, V64, P138, DOI 10.1136/jnnp.64.1.138; Miller VM, 2013, BRAIN RES, V1513, P26, DOI 10.1016/j.brainres.2013.04.001; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; MOUNTZ JM, 1995, J NUCL MED, V36, P1156; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; Paul LK, 2003, BRAIN LANG, V85, P313, DOI 10.1016/S0093-934X(03)00062-2; Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107; Ren T, 2007, J NEUROSCI, V27, P10345, DOI 10.1523/JNEUROSCI.2787-07.2007; Sasaki M, 2010, BRAIN DEV-JPN, V32, P776, DOI 10.1016/j.braindev.2010.06.003; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schobel SA, 2013, NEURON, V78, P81, DOI 10.1016/j.neuron.2013.02.011; Senjem ML, 2005, NEUROIMAGE, V26, P600, DOI 10.1016/j.neuroimage.2005.02.005; Sforazzini F, 2013, NEUROIMAGE UNPUB; Shen S, 2007, MAGN RESON IMAGING, V25, P1385, DOI 10.1016/j.mri.2007.03.025; Silverman JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003501; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Silverman JL, 2010, NEUROPSYCHOPHARMACOL, V35, P976, DOI 10.1038/npp.2009.201; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Tovar-Moll F, 2007, CEREB CORTEX, V17, P531, DOI 10.1093/cercor/bhj178; Turk AA, 2010, NEUROPSYCHOLOGIA, V48, P43, DOI 10.1016/j.neuropsychologia.2009.08.009; Utsunomiya H, 2006, ACTA RADIOL, V47, P1063, DOI 10.1080/02841850600930025; Via E, 2011, ARCH GEN PSYCHIAT, V68, P409, DOI 10.1001/archgenpsychiatry.2011.27; Vissers ME, 2012, NEUROSCI BIOBEHAV R, V36, P604, DOI 10.1016/j.neubiorev.2011.09.003; Wahlsten D, 2003, BRAIN RES, V971, P47, DOI 10.1016/S0006-8993(03)02354-0; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Yang M, 2012, PHYSIOL BEHAV, V107, P649, DOI 10.1016/j.physbeh.2011.12.025; Yang M, 2009, EUR J NEUROSCI, V29, P1663, DOI 10.1111/j.1460-9568.2009.06714.x; Zaharchuk G, 1999, STROKE, V30, P2197, DOI 10.1161/01.STR.30.10.2197; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zilbovicius M, 2000, AM J PSYCHIAT, V157, P1988, DOI 10.1176/appi.ajp.157.12.1988	76	79	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76655	10.1371/journal.pone.0076655	http://dx.doi.org/10.1371/journal.pone.0076655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146902	Green Accepted, Green Published, gold			2022-12-27	WOS:000326019400078
J	Fleming, A; Diekmann, H; Goldsmith, P				Fleming, Angeleen; Diekmann, Heike; Goldsmith, Paul			Functional Characterisation of the Maturation of the Blood-Brain Barrier in Larval Zebrafish	PLOS ONE			English	Article							P-GLYCOPROTEIN; TRANSGENIC ZEBRAFISH; VASCULAR DEVELOPMENT; IN-VIVO; GENE; DRUGS; PERMEABILITY; PENETRATION; SEIZURES; MODELS	Zebrafish are becoming increasingly popular as an organism in which to model human disease and to study the effects of small molecules on complex physiological and pathological processes. Since larvae are no more than a few millimetres in length, and can live in volumes as small as 100 microliters, they are particularly amenable to high-throughput and high content compound screening in 96 well plate format. There is a growing literature providing evidence that many compounds show similar pharmacological effects in zebrafish as they do in mammals, and in particular humans. However, a major question regarding their utility for small molecule screening for neurological conditions is whether a molecule will reach its target site within the central nervous system. Studies have shown that Claudin-5 and ZO-1, tight-junction proteins which are essential for blood-brain barrier (BBB) integrity in mammals, can be detected in some cerebral vessels in zebrafish from 3 days post-fertilisation (d.p.f.) onwards and this timing coincides with the retention of dyes, immunoreactive tracers and fluorescent markers within some but not all cerebral vessels. Whilst these findings demonstrate that features of a BBB are first present at 3 d.p.f., it is not clear how quickly the zebrafish BBB matures or how closely the barrier resembles that of mammals. Here, we have combined anatomical analysis by transmission electron microscopy, functional investigation using fluorescent markers and compound uptake using liquid chromatography/tandem mass spectrometry to demonstrate that maturation of the zebrafish BBB occurs between 3 d.p.f. and 10 d.p.f. and that this barrier shares both structural and functional similarities with that of mammals.	[Fleming, Angeleen; Diekmann, Heike; Goldsmith, Paul] DanioLabs Ltd, Cambridge, England		Fleming, A (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Cambridge, England.	af425@cam.ac.uk		Fleming, Angeleen/0000-0003-3721-7126	DanioLabs Ltd; MRC Skills Gap Award	DanioLabs Ltd; MRC Skills Gap Award	The authors are all former employees of DanioLabs Ltd (a biotechnology company) and a large part of this work was carried out during this period of employment. Work performed at DanioLabs Ltd was financed by DanioLabs Ltd and not by grant funding. The company no longer exists and there are no restrictions on publishing this data. Dr A Fleming continued working on this project after leaving the company to work at the University of Cambridge and this part of the work was funded by an MRC Skills Gap Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton W, 2010, XENOBIOTICA, V40, P547, DOI 10.3109/00498254.2010.493960; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Berghmans Stephane, 2008, Journal of Pharmacological and Toxicological Methods, V58, P59, DOI 10.1016/j.vascn.2008.05.130; Chen CP, 2003, DRUG METAB DISPOS, V31, P312, DOI 10.1124/dmd.31.3.312; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Delvecchio C, 2011, ASSAY DRUG DEV TECHN, V9, P354, DOI 10.1089/adt.2010.0346; Fukunaga-Kalabis M, 2010, ONCOGENE, V29, P6115, DOI 10.1038/onc.2010.350; GEORGES E, 1990, P NATL ACAD SCI USA, V87, P152, DOI 10.1073/pnas.87.1.152; Hawkins BT, 2006, J NEUROSCI METH, V151, P262, DOI 10.1016/j.jneumeth.2005.08.006; Hung CC, 2008, PHARMACOGENET GENOM, V18, P390, DOI 10.1097/FPC.0b013e3282f85e36; Jeong JY, 2008, BRAIN RES BULL, V75, P619, DOI 10.1016/j.brainresbull.2007.10.043; JOHANSSON BB, 1978, ACTA PHYSIOL SCAND, V104, P281, DOI 10.1111/j.1748-1716.1978.tb06280.x; Kalvass JC, 2007, DRUG METAB DISPOS; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kokel D, 2012, TRENDS BIOTECHNOL, V30, P421, DOI 10.1016/j.tibtech.2012.05.001; Kozler P, 2003, PHYSIOL RES, V52, P607; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LEVIN VA, 1980, J MED CHEM, V23, P682, DOI 10.1021/jm00180a022; MacRae CA, DRUG DISCOVERY TODAY; Moitra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016318; Morita S, 2013, J LIPID RES, V54, P1221, DOI 10.1194/jlr.M032425; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; PETITO CK, 1977, BRAIN RES, V127, P251, DOI 10.1016/0006-8993(77)90539-X; Sager JJ, 2010, BRAIN STRUCT FUNCT, V214, P285, DOI 10.1007/s00429-009-0237-1; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; Stewart AM, 2012, BRAIN RES BULL, V87, P135, DOI 10.1016/j.brainresbull.2011.11.020; STEWART PA, 1987, DEV BRAIN RES, V32, P271, DOI 10.1016/0165-3806(87)90107-6; Tam SJ, 2012, DEV CELL, V22, P403, DOI 10.1016/j.devcel.2011.11.018; Terasaki T, 2003, DRUG DISCOV TODAY, V8, P944, DOI 10.1016/S1359-6446(03)02858-7; Westerfield M, 1997, SEMIN CELL DEV BIOL, V8, P477, DOI 10.1006/scdb.1997.0173; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Xi YW, 2011, CURR NEUROL NEUROSCI, V11, P274, DOI 10.1007/s11910-011-0182-2; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Zheng PP, 2010, ANN NEUROL, V68, P835, DOI 10.1002/ana.22318	36	152	153	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77548	10.1371/journal.pone.0077548	http://dx.doi.org/10.1371/journal.pone.0077548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147021	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400119
J	Goswami, ND; Pfeiffer, CD; Horton, JR; Chiswell, K; Tasneem, A; Tsalik, EL				Goswami, Neela D.; Pfeiffer, Christopher D.; Horton, John R.; Chiswell, Karen; Tasneem, Asba; Tsalik, Ephraim L.			The State of Infectious Diseases Clinical Trials: A Systematic Review of ClinicalTrials.gov	PLOS ONE			English	Article							REGISTRATION; SOCIETY	Background: There is a paucity of clinical trials informing specific questions faced by infectious diseases (ID) specialists. The ClinicalTrials.gov registry offers an opportunity to evaluate the ID clinical trials portfolio. Methods: We examined 40,970 interventional trials registered with ClinicalTrials.gov from 2007-2010, focusing on study conditions and interventions to identify ID-related trials. Relevance to ID was manually confirmed for each programmatically identified trial, yielding 3570 ID trials and 37,400 non-ID trials for analysis. Results: The number of ID trials was similar to the number of trials identified as belonging to cardiovascular medicine (n = 3437) or mental health (n = 3695) specialties. Slightly over half of ID trials were treatment-oriented trials (53%, vs. 77% for non-ID trials) followed by prevention (38%, vs. 8% in non-ID trials). ID trials tended to be larger than those of other specialties, with a median enrollment of 125 subjects (interquartile range [IQR], 45-400) vs. 60 (IQR, 30-160) for non-ID trials. Most ID studies are randomized (73%) but nonblinded (56%). Industry was the funding source in 51% of ID trials vs. 10% that were primarily NIH-funded. HIV-AIDS trials constitute the largest subset of ID trials (n = 815 [23%]), followed by influenza vaccine (n = 375 [11%]), and hepatitis C (n = 339 [9%]) trials. Relative to U. S. and global mortality rates, HIV-AIDS and hepatitis C virus trials are over-represented, whereas lower respiratory tract infection trials are under-represented in this large sample of ID clinical trials. Conclusions: This work is the first to characterize ID clinical trials registered in ClinicalTrials.gov, providing a framework to discuss prioritization, methodology, and policy.	[Goswami, Neela D.; Tsalik, Ephraim L.] Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27706 USA; [Pfeiffer, Christopher D.] Portland VA Med Ctr, Dept Hosp & Specialty Med, Portland, OR USA; [Pfeiffer, Christopher D.] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA; [Horton, John R.; Chiswell, Karen; Tasneem, Asba] Duke Clin Res Inst, Durham, NC USA; [Tsalik, Ephraim L.] Durham VA Med Ctr, Emergency Med Serv, Durham, NC USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center	Tsalik, EL (corresponding author), Duke Univ, Sch Med, Dept Med, Div Infect Dis & Int Hlth, Durham, NC 27706 USA.	e.t@duke.edu		Tsalik, Ephraim/0000-0002-6417-2042	US Food and Drug Administration [U19FD003800]; Clinical Science Research and Development Service of the Veterans Health Administration Office of Research and Development [1IK2CX000530]; FOOD AND DRUG ADMINISTRATION [U19FD003800] Funding Source: NIH RePORTER	US Food and Drug Administration; Clinical Science Research and Development Service of the Veterans Health Administration Office of Research and Development; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	This work was supported by grant U19FD003800 from the US Food and Drug Administration awarded to Duke University for the Clinical Trials Transformation Initiative. Dr. Tsalik's efforts were also supported by Award Number 1IK2CX000530 from the Clinical Science Research and Development Service of the Veterans Health Administration Office of Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Clinical Trials Transformation Initiative website, 2012, AACT DAT AGGR AN CLI; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; English R., 2010, FORUM DRUG DISCOVERY; Gill CJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001186; Gillen JE, 2004, STUD HEALTH TECHNOL, V107, P1466; Johnson Lorraine, 2010, Philos Ethics Humanit Med, V5, P9, DOI 10.1186/1747-5341-5-9; Khan AR, 2010, CLIN INFECT DIS, V51, P1147, DOI 10.1086/656735; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Lee DH, 2011, ARCH INTERN MED, V171, P18, DOI 10.1001/archinternmed.2010.482; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Tasneem A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033677; The International Committee of Medical Journal Editors, BIOMEDICAL J O UNPUB; Wazny K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001446; Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863; World Health Organization, 2011, WHO HLTH STAT HLTH I; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	19	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77086	10.1371/journal.pone.0077086	http://dx.doi.org/10.1371/journal.pone.0077086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146958	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400093
J	Hennessy, RC; Doohan, F; Mullins, E				Hennessy, Rosanna C.; Doohan, Fiona; Mullins, Ewen			Generating Phenotypic Diversity in a Fungal Biocatalyst to Investigate Alcohol Stress Tolerance Encountered during Microbial Cellulosic Biofuel Production	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; FUSARIUM-OXYSPORUM; ETHANOL-PRODUCTION; SACCHAROMYCES-CEREVISIAE; INSERTIONAL MUTAGENESIS; GENE-EXPRESSION; IDENTIFICATION; DNA; FERMENTATION; GENOMICS	Consolidated bioprocessing (CBP) of lignocellulosic biomass offers an alternative route to renewable energy. The crop pathogen Fusarium oxysporum is a promising fungal biocatalyst because of its broad host range and innate ability to co-saccharify and ferment lignocellulose to bioethanol. A major challenge for cellulolytic CBP-enabling microbes is alcohol inhibition. This research tested the hypothesis that Agrobacterium tumefaciens - mediated transformation (ATMT) could be exploited as a tool to generate phenotypic diversity in F. oxysporum to investigate alcohol stress tolerance encountered during CBP. A random mutagenesis library of gene disruption transformants (n=1,563) was constructed and screened for alcohol tolerance in order to isolate alcohol sensitive or tolerant phenotypes. Following three rounds of screening, exposure of select transformants to 6% ethanol and 0.75% n-butanol resulted respectively in increased (>= 11.74%) and decreased (<= 43.01%) growth compared to the wild - type (WT). Principal component analysis (PCA) quantified the level of phenotypic diversity across the population of genetically transformed individuals and isolated candidate strains for analysis. Characterisation of one strain, Tr. 259, ascertained a reduced growth phenotype under alcohol stress relative to WT and indicated the disruption of a coding region homologous to a putative sugar transporter (FOXG_09625). Quantitative PCR (RT-PCR) showed FOXG_09625 was differentially expressed in Tr. 259 compared to WT during alcohol-induced stress (P<0.05). Phylogenetic analysis of putative sugar transporters suggests diverse functional roles in F. oxysporum and other filamentous fungi compared to yeast for which sugar transporters form part of a relatively conserved family. This study has confirmed the potential of ATMT coupled with a phenotypic screening program to select for genetic variation induced in response to alcohol stress. This research represents a first step in the investigation of alcohol tolerance in F. oxysporum and has resulted in the identification of several novel strains, which will be of benefit to future biofuel research.	[Hennessy, Rosanna C.; Mullins, Ewen] Teagasc Res Ctr, Dept Crop Sci, Oak Pk, Carlow, Ireland; [Hennessy, Rosanna C.; Doohan, Fiona] Univ Coll Dublin, Mol Plant Microbe Interact Lab, Sch Biol & Environm Sci, Dublin 2, Ireland	Teagasc; University College Dublin	Mullins, E (corresponding author), Teagasc Res Ctr, Dept Crop Sci, Oak Pk, Carlow, Ireland.	ewen.mullins@teagasc.ie	Mullins, Ewen/AAN-2907-2021	Mullins, Ewen/0000-0003-3005-4264; Hennessy, Rosanna C./0000-0002-2359-8565; Doohan, Fiona/0000-0002-1953-6070	Irish Department of Agriculture and Food's Research Stimulus Fund [RSF 07 513]	Irish Department of Agriculture and Food's Research Stimulus Fund	Funding provided through the Irish Department of Agriculture and Food's Research Stimulus Fund (Project Code RSF 07 513; see, http://www.agriculture.gov.ie/research/researchstimulusfundrsf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre H, 2001, FEBS LETT, V498, P98, DOI 10.1016/S0014-5793(01)02503-0; Ali SAM, 2012, STUD DEV ACCOUNT THO, V14D, P1, DOI 10.1108/S1479-3504(2012)000014D004; Ali SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054701; Ali SS, 2013, BIOENERGY RES; Amore A, 2012, RENEW SUST ENERG REV, V16, P3286, DOI 10.1016/j.rser.2012.02.050; Anderson MJ, 2012, FEMS YEAST RES, V12, P48, DOI 10.1111/j.1567-1364.2011.00762.x; Asiimwe T, 2012, MYCORRHIZA, V22, P471, DOI 10.1007/s00572-011-0424-9; Atsumi S, 2008, METAB ENG, V10, P305, DOI 10.1016/j.ymben.2007.08.003; Betts MF, 2007, FUNGAL GENET BIOL, V44, P1035, DOI 10.1016/j.fgb.2007.05.001; Bhatia L, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-65; Bills GF, 2008, J APPL MICROBIOL, V104, P1644, DOI 10.1111/j.1365-2672.2008.03735.x; Brennan JM, 2005, PLANT PATHOL, V54, P156, DOI 10.1111/j.1365-3059.2005.01157.x; Brodeur G., 2011, ENZYME RES, V2011, DOI [https://doi.org/10.4061/2011/787532, DOI 10.4061/2011/787532]; Brown SD, 2011, P NATL ACAD SCI USA, V108, P2011; Chandler M, 2004, ANN MICROBIOL, V54, P427; CHRISTAKOPOULOS P, 1991, ENZYME MICROB TECH, V13, P272, DOI 10.1016/0141-0229(91)90141-V; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21; Eckardt NA, 2011, PLANT CELL, V23, P3561, DOI 10.1105/tpc.111.231010; Edel V, 2000, MYCOL RES, V104, P518, DOI 10.1017/S0953756299001896; Elkins JG, 2010, CURR OPIN BIOTECH, V21, P657, DOI 10.1016/j.copbio.2010.05.008; Favaro L, 2013, BIOENGINEERED, V4, P97, DOI 10.4161/bioe.22268; Fernandes Sara, 2010, Bioeng Bugs, V1, P424, DOI 10.4161/bbug.1.6.12724; Greatrix BW, 2006, CURR GENET, V49, P205, DOI 10.1007/s00294-005-0046-x; Helber N, 2011, PLANT CELL, V23, P3812, DOI 10.1105/tpc.111.089813; Horak J, 2013, CURR GENET, V59, P1, DOI 10.1007/s00294-013-0388-8; Hossain SM, 2012, INDIAN J CHEM TECHN, V19, P63; Hu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035542; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Jia KZ, 2010, ENG LIFE SCI, V10, P422, DOI 10.1002/elsc.201000076; Kataoka N, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-10; Knoshaug EP, 2009, APPL BIOCHEM BIOTECH, V153, P13, DOI 10.1007/s12010-008-8460-4; la Grange DC, 2010, APPL MICROBIOL BIOT, V87, P1195, DOI 10.1007/s00253-010-2660-x; Lakshman DK, 2012, EUR J PLANT PATHOL, V133, P729, DOI 10.1007/s10658-012-9953-0; Liu D, 2000, J CLIN MICROBIOL, V38, P471; Liu SQ, 2009, NEW BIOTECHNOL, V26, P117, DOI 10.1016/j.nbt.2009.06.984; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MF, 2008, NEW PHYTOL, V180, P365, DOI 10.1111/j.1469-8137.2008.02539.x; Lubbehusen TL, 2004, APPL MICROBIOL BIOT, V63, P543, DOI 10.1007/s00253-003-1394-4; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Maruthachalam K, 2011, MOL BIOTECHNOL, V49, P209, DOI 10.1007/s12033-011-9392-8; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; MISHRA C, 1984, APPL ENVIRON MICROB, V48, P224, DOI 10.1128/AEM.48.1.224-228.1984; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-7; Olson DG, 2012, ECENT PROGR CONSOLID, V12, P396; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Panagiotou G, 2008, BIORESOURCE TECHNOL, V99, P7397, DOI 10.1016/j.biortech.2008.01.017; Patrascu E, 2009, FOOD BIOTECHNOL, V4; Pfromm PH, 2010, BIOMASS BIOENERG, V34, P515, DOI 10.1016/j.biombioe.2009.12.017; Reyes LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017678; Ruhl J, 2009, APPL ENVIRON MICROB, V75, P4653, DOI 10.1128/AEM.00225-09; Sakuragi H, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/416931; Sambrook J., 2011, MOL CLONING LAB MANU, V3rd; SINGH A, 1991, CRIT REV BIOTECHNOL, V11, P129, DOI 10.3109/07388559109040619; Snowdon C, 2009, FEMS YEAST RES, V9, P372, DOI 10.1111/j.1567-1364.2009.00497.x; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Tako M, 2010, ACTA BIOL HUNG, V61, P101, DOI 10.1556/ABiol.61.2010.1.10; Talbot NJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000308; Vinche HM, 2012, J CHEM TECHNOL BIOT, V87, P1222, DOI [10.1002/jctb.3822, DOI 10.1002/JCTB.3822.PUBMED:23329859]; Wahl R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000303; Wei HJ, 2004, FUNGAL GENET BIOL, V41, P148, DOI 10.1016/j.fgb.2003.10.006; Xiros C, 2011, J CHEM TECHNOL BIOT, V86, P223, DOI 10.1002/jctb.2499; Xiros C, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-4; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006; ZEUTHEN ML, 1988, J GEN MICROBIOL, V134, P1375; Zingaro KA, 2012, MBIO, V3, DOI 10.1128/mBio.00308-12	68	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77501	10.1371/journal.pone.0077501	http://dx.doi.org/10.1371/journal.pone.0077501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147009	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400114
J	Kraemer, A; Barjaktarovic, Z; Sarioglu, H; Winkler, K; Eckardt-Schupp, F; Tapio, S; Atkinson, MJ; Moertl, S				Kraemer, Anne; Barjaktarovic, Zarko; Sarioglu, Hakan; Winkler, Klaudia; Eckardt-Schupp, Friederike; Tapio, Soile; Atkinson, Michael J.; Moertl, Simone			Cell Survival Following Radiation Exposure Requires miR-525-3p Mediated Suppression of ARRB1 and TXN1	PLOS ONE			English	Article							IONIZING-RADIATION; INDUCED APOPTOSIS; ENDOTHELIAL-CELLS; LUNG-CANCER; DNA-DAMAGE; MICRORNA EXPRESSION; TARGET RECOGNITION; ANIMAL MICRORNAS; GROWTH-FACTOR; THIOREDOXIN	Background: microRNAs (miRNAs) are non-coding RNAs that alter the stability and translation efficiency of messenger RNAs. Ionizing radiation (IR) induces rapid and selective changes in miRNA expression. Depletion of the miRNA processing enzymes Dicer or Ago2 reduces the capacity of cells to survive radiation exposure. Elucidation of critical radiation-regulated miRNAs and their target proteins offers a promising approach to identify new targets to increase the therapeutic effectiveness of the radiation treatment of cancer. Principal Findings: Expression of miR-525-3p is rapidly up-regulated in response to radiation. Manipulation of miR-525-3p expression in irradiated cells confirmed that this miRNA mediates the radiosensitivity of a variety of non-transformed (RPE, HUVEC) and tumor-derived cell lines (HeLa, U2-Os, EA. hy926) cell lines. Thus, anti-miR-525-3p mediated inhibition of the increase in miR-525-3p elevated radiosensitivity, while overexpression of precursor miR-525-3p conferred radioresistance. Using a proteomic approach we identified 21 radiation-regulated proteins, of which 14 were found to be candidate targets for miR-525-3p-mediated repression. Luciferase reporter assays confirmed that nine of these were indeed direct targets of miR-525-3p repression. Individual analysis of these direct targets by RNAi-mediated knockdown established that ARRB1, TXN1 and HSPA9 are essential miR-525-3p-dependent regulators of radiation sensitivity. Conclusion: The transient up-regulation of miR-525-3p, and the resultant repression of its direct targets ARRB1, TXN1 and HSPA9, is required for cell survival following irradiation. The conserved function of miR-525-3p across several cell types makes this microRNA pathway a promising target for modifying the efficacy of radiotherapy.	[Kraemer, Anne; Barjaktarovic, Zarko; Winkler, Klaudia; Eckardt-Schupp, Friederike; Tapio, Soile; Atkinson, Michael J.; Moertl, Simone] Helmholtz Ctr Munich, Inst Radiat Biol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Sarioglu, Hakan] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Dept Prot Sci, Prote Core Facil, Neuherberg, Germany; [Atkinson, Michael J.] Tech Univ Munich, Chair Radiat Biol, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Moertl, S (corresponding author), Helmholtz Ctr Munich, Inst Radiat Biol, German Res Ctr Environm Hlth, Neuherberg, Germany.	moertl@helmholtz-muenchen.de	Tapio, Soile/CAJ-5871-2022; Atkinson, Michael J/E-5537-2011; Atkinson, Michael/AAU-5127-2020; Moertl, Simone/M-7353-2014; Tapio, Soile/M-7358-2014	Atkinson, Michael J/0000-0003-3358-2089; Atkinson, Michael/0000-0003-3358-2089; Moertl, Simone/0000-0003-0644-0878; Tapio, Soile/0000-0001-9860-3683	Kompetenzerhalt Strahlenforschung (Germany) [03NUK007C/E]	Kompetenzerhalt Strahlenforschung (Germany)	This work was supported by the grant Kompetenzerhalt Strahlenforschung 03NUK007C/E (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2003, CANCER RES, V63, P3755; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angermeier M, 2010, CELL SIGNAL, V22, P1388, DOI 10.1016/j.cellsig.2010.05.009; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Byun HS, 2005, FEBS LETT, V579, P4055, DOI 10.1016/j.febslet.2005.06.023; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; Didier C, 2001, FREE RADICAL BIO MED, V31, P585, DOI 10.1016/S0891-5849(01)00617-7; Du LQ, 2012, EXPERT OPIN BIOL TH, V12, P1221, DOI 10.1517/14712598.2012.697149; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Ezekwudo D, 2008, CANCER LETT, V270, P277, DOI 10.1016/j.canlet.2008.05.022; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Guo WW, 2012, MOL MED REP, V6, P1423, DOI 10.3892/mmr.2012.1070; Gwak HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047449; Haley B, 2009, INT J RADIAT BIOL, V85, P643, DOI 10.1080/09553000903009548; Hara MR, 2011, NATURE, V477, P349, DOI 10.1038/nature10368; He M, 2012, NEURON, V73, P35, DOI 10.1016/j.neuron.2011.11.010; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Huang TC, 2013, PROTEOMICS, V13, P558, DOI 10.1002/pmic.201200339; Josson S, 2008, PROSTATE, V68, P1599, DOI 10.1002/pros.20827; Koturbash I, 2011, MUTAT RES-GEN TOX EN, V722, P114, DOI 10.1016/j.mrgentox.2010.05.007; Kraemer A, 2011, RADIAT RES, V176, P575, DOI 10.1667/RR2638.1; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2012, ANAL CHEM, V84, P5097, DOI 10.1021/ac300839d; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; LUNN CA, 1987, INT J RADIAT BIOL, V51, P29, DOI 10.1080/09553008714550461; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Maes OC, 2008, J CELL BIOCHEM, V105, P824, DOI 10.1002/jcb.21878; Magne N, 2006, CANCER LETT, V231, P158, DOI 10.1016/j.canlet.2005.01.022; Maher B, 2012, NATURE, V489, P46, DOI 10.1038/489046a; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Martin G, 2007, J BIOSCIENCES, V32, P1049, DOI 10.1007/s12038-007-0106-0; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Mukherjee A, 2008, BRIT J RADIOL, V81, pS57, DOI 10.1259/bjr/34180435; Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pena LA, 2000, CANCER RES, V60, P321; Piccirillo S, 2009, J BIOL CHEM, V284, P27721, DOI 10.1074/jbc.M109.014837; Pluder F, 2011, RADIAT ENVIRON BIOPH, V50, P155, DOI 10.1007/s00411-010-0342-9; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Sagan D, 2009, CARCINOGENESIS, V30, P408, DOI 10.1093/carcin/bgp004; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Shonai T, 2002, CELL DEATH DIFFER, V9, P963, DOI 10.1038/sj.cdd.4401050; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Sriharshan A, 2012, J PROTEOMICS, V75, P2319, DOI 10.1016/j.jprot.2012.02.009; Supino R, 2001, EUR J CANCER, V37, P2247, DOI 10.1016/S0959-8049(01)00268-4; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wang XC, 2011, LUNG CANCER, V72, P92, DOI 10.1016/j.lungcan.2010.07.014; Witherow DS, 2004, P NATL ACAD SCI USA, V101, P8603, DOI 10.1073/pnas.0402851101; Witkos TM, 2011, CURR MOL MED, V11, P93; Wu Y, 2012, J RADIAT RES, V53, P516, DOI 10.1093/jrr/rrs002; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu J, 2012, RNA BIOL, V9, P1031, DOI [10.4161/ma.21729, DOI 10.4161/RNA.21729]; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	65	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77484	10.1371/journal.pone.0077484	http://dx.doi.org/10.1371/journal.pone.0077484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147004	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400111
J	Kurapati, KRV; Atluri, VSR; Samikkannu, T; Nair, MPN				Kurapati, Kesava Rao Venkata; Atluri, Venkata Subba Rao; Samikkannu, Thangavel; Nair, Madhavan P. N.			Ashwagandha (Withania somnifera) Reverses beta-Amyloid(1-42) Induced Toxicity in Human Neuronal Cells: Implications in HIV-Associated Neurocognitive Disorders (HAND)	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; NATURAL-PRODUCTS; IN-VITRO; A-BETA; HYDROGEN-PEROXIDE; MALACHITE GREEN; ROOT EXTRACT; PEPTIDE	Alzheimer's disease (AD) is characterized by progressive dysfunction of memory and higher cognitive functions with abnormal accumulation of extracellular amyloid plaques and intracellular neurofibrillary tangles throughout cortical and limbic brain regions. At present no curative treatment is available, and research focuses on drugs for slowing disease progression or providing prophylaxis. Withania somnifera (WS) also known as 'ashwagandha' is used widely in Ayurvedic medicine as a nerve tonic and memory enhancer. However, there is a paucity of data on the potential neuroprotective effects of W. somnifera against beta-Amyloid (1-42)-induced neuropathogenesis. In the present study, we have tested the neuroprotective effects of methanol: Chloroform (3:1) extract of ashwagandha against beta-amyloid induced toxicity and HIV-1(Ba-L) (clade B) infection using a human neuronal SK-N-MC cell line. Our results showed that beta-amyloid induced cytotoxic effects in SK-N-MC cells as shown by decreased cell growth when tested individually. Also, confocal microscopic analysis showed decreased spine density, loss of spines and decreased dendrite diameter, total dendrite and spine area in clade B infected SK-N-MC cells compared to uninfected cells. However, when ashwagandha was added to beta-amyloid treated and HIV-1 infected samples, the toxic effects were neutralized. Further, the MTT cell viability assays and the peroxisome proliferator-activated receptor-gamma (PPAR gamma) levels supported these observations indicating the neuroprotective effect of WS root extract against beta-amyloid and HIV-1(Ba-L) (clade B) induced neuro-pathogenesis.	[Kurapati, Kesava Rao Venkata; Atluri, Venkata Subba Rao; Samikkannu, Thangavel; Nair, Madhavan P. N.] Florida Int Univ, Dept Immunol, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Miami, FL 33199 USA	State University System of Florida; Florida International University	Nair, MPN (corresponding author), Florida Int Univ, Dept Immunol, Inst NeuroImmune Pharmacol, Herbert Wertheim Coll Med, Modesto A Maidique Campus, Miami, FL 33199 USA.	nairm@fiu.edu	Atluri, Venkata/G-3277-2014	Atluri, Venkata/0000-0002-8070-6745	National Institutes Health [1R01MH085259, 1R37DA025576, 5RO1DA021537, 1RO1DA027049]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA025576, R01DA021537, R01DA027049] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institutes Health: 1R01MH085259, 1R37DA025576, 5RO1DA021537, and 1RO1DA027049 to Prof. Madhavan Nair. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2005, HUM EXP TOXICOL, V24, P137, DOI 10.1191/0906327105ht209oa; Archana R, 1999, J ETHNOPHARMACOL, V64, P91, DOI 10.1016/S0378-8741(98)00107-X; Atluri VSR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061399; Bailey JA, 2011, GENE, V488, P13, DOI 10.1016/j.gene.2011.06.017; BEHL C, 1992, BIOCHEM BIOPH RES CO, V186, P944, DOI 10.1016/0006-291X(92)90837-B; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Behl C, 1997, CELL TISSUE RES, V290, P471, DOI 10.1007/s004410050955; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bhatnagar M, 2009, NEUROCHEM RES, V34, P1975, DOI 10.1007/s11064-009-9987-7; Bhattacharya A, 2001, J ETHNOPHARMACOL, V74, P1, DOI 10.1016/S0378-8741(00)00309-3; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chinetti-Gbaguidi G, 2011, CIRC RES, V108, P985, DOI 10.1161/CIRCRESAHA.110.233775; Citron M, 2004, NAT REV NEUROSCI, V5, P677, DOI 10.1038/nrn1495; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Giunta B, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-23; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; GRANDHI A, 1994, J ETHNOPHARMACOL, V44, P131, DOI 10.1016/0378-8741(94)01119-2; Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c; GREENLUND LJS, 1995, NEURON, V14, P303, DOI 10.1016/0896-6273(95)90287-2; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Houghton PJ, 2005, NEUROSIGNALS, V14, P6, DOI 10.1159/000085382; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; IVERSEN LL, 1995, BIOCHEM J, V311, P1; Jain S, 2001, PHYTOTHER RES, V15, P544, DOI 10.1002/ptr.802; Ji HF, 2008, ACTA PHARMACOL SIN, V29, P143, DOI 10.1111/j.1745-7254.2008.00752.x; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Kulkarni SK, 2008, PROG NEURO-PSYCHOPH, V32, P1093, DOI 10.1016/j.pnpbp.2007.09.011; Kumar S, 2010, PHYTOTHER RES, V24, P1567, DOI 10.1002/ptr.3261; Kurapati Kesava Rao V., 2012, Journal of Basic and Clinical Physiology and Pharmacology, V23, P139, DOI 10.1515/jbcpp-2012-0021; London JA, 1996, P NATL ACAD SCI USA, V93, P4147, DOI 10.1073/pnas.93.9.4147; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; Lyketsos CG, 2006, AM J GERIAT PSYCHIAT, V14, P561, DOI 10.1097/01.JGP.0000221334.65330.55; Mandrekar-Colucci S, 2012, J NEUROSCI, V32, P10117, DOI 10.1523/JNEUROSCI.5268-11.2012; Mandrekar-Colucci S, 2010, CNS NEUROL DISORD-DR, V9, P156, DOI 10.2174/187152710791012071; Michaelis ML, 2005, J PHARMACOL EXP THER, V312, P659, DOI 10.1124/jpet.104.074450; Mishra L C, 2000, Altern Med Rev, V5, P334; Mohamed A, 2011, INT J ALZHEIMERS DIS, V12, P79; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Ohyagi Y, 2008, CURR ALZHEIMER RES, V5, P555, DOI 10.2174/156720508786898514; Ohyagi Y, 2006, MINI-REV MED CHEM, V6, P1075, DOI 10.2174/138955706778560175; PANANDIKER A, 1992, CANCER LETT, V67, P93, DOI 10.1016/0304-3835(92)90131-E; PANANDIKER A, 1994, CARCINOGENESIS, V15, P2445, DOI 10.1093/carcin/15.11.2445; Rao KVK, 2012, ASIAN PAC J CANCER P, V13, P1031, DOI 10.7314/APJCP.2012.13.3.1031; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sankar SR, 2007, CELL MOL BIOL LETT, V12, P473, DOI 10.2478/s11658-007-0015-0; Scartezzini P, 2000, J ETHNOPHARMACOL, V71, P23, DOI 10.1016/S0378-8741(00)00213-0; Schliebs R, 1997, NEUROCHEM INT, V30, P181, DOI 10.1016/S0197-0186(96)00025-3; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; SHEARMAN MS, 1994, P NATL ACAD SCI USA, V91, P1470, DOI 10.1073/pnas.91.4.1470; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Smith DL, 2009, P NATL ACAD SCI USA, V106, P16877, DOI 10.1073/pnas.0908706106; Soontornniyomkij V, 2012, AIDS, V26, P2327, DOI 10.1097/QAD.0b013e32835a117c; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tohda C, 2000, NEUROREPORT, V11, P1981, DOI 10.1097/00001756-200006260-00035; van Marum RJ, 2008, FUND CLIN PHARMACOL, V22, P265, DOI 10.1111/j.1472-8206.2008.00578.x; Van Nostrand WE, 1999, BIOCHEMISTRY-US, V38, P11570, DOI 10.1021/bi990610f; Vinutha B, 2007, J ETHNOPHARMACOL, V109, P359, DOI 10.1016/j.jep.2006.06.014; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Zhang C, 2012, Curr Alzheimer Res; Zhao J, 2002, CHEM PHARM BULL, V50, P760, DOI 10.1248/cpb.50.760	74	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77624	10.1371/journal.pone.0077624	http://dx.doi.org/10.1371/journal.pone.0077624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147038	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400123
J	von Wyl, V; Klimkait, T; Yerly, S; Nicca, D; Furrer, H; Cavassini, M; Calmy, A; Bernasconi, E; Boni, J; Aubert, V; Gunthard, HF; Bucher, HC; Glass, TR				von Wyl, Viktor; Klimkait, Thomas; Yerly, Sabine; Nicca, Dunja; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Bernasconi, Enos; Boeni, Juerg; Aubert, Vincent; Guenthard, Huldrych F.; Bucher, Heiner C.; Glass, Tracy R.		Swiss HIV Cohort Study	Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study	PLOS ONE			English	Article							ANTIRETROVIRAL MEDICATION ADHERENCE; DRUG-RESISTANCE; VIROLOGICAL FAILURE; TREATMENT-NAIVE; THERAPY; TRANSMISSION; PROTEASE; HAART; RISK; NONADHERENCE	Background: Non-adherence is one of the strongest predictors of therapeutic failure in HIV-positive patients. Virologic failure with subsequent emergence of resistance reduces future treatment options and long-term clinical success. Methods: Prospective observational cohort study including patients starting new class of antiretroviral therapy (ART) between 2003 and 2010. Participants were naive to ART class and completed >= 1 adherence questionnaire prior to resistance testing. Outcomes were development of any IAS-USA, class-specific, or M184V mutations. Associations between adherence and resistance were estimated using logistic regression models stratified by ART class. Results: Of 314 included individuals, 162 started NNRTI and 152 a PI/r regimen. Adherence was similar between groups with 85% reporting adherence >= 95%. Number of new mutations increased with increasing non-adherence. In NNRTI group, multivariable models indicated a significant linear association in odds of developing IAS-USA (odds ratio (OR) 1.66, 95% confidence interval (CI): 1.04-2.67) or class-specific (OR 1.65, 95% CI: 1.00-2.70) mutations. Levels of drug resistance were considerably lower in PI/r group and adherence was only significantly associated with M184V mutations (OR 8.38, 95% CI: 1.26-55.70). Adherence was significantly associated with HIV RNA in PI/r but not NNRTI regimens. Conclusion: Therapies containing PI/r appear more forgiving to incomplete adherence compared with NNRTI regimens, which allow higher levels of resistance, even with adherence above 95%. However, in failing PI/r regimens good adherence may prevent accumulation of further resistance mutations and therefore help to preserve future drug options. In contrast, adherence levels have little impact on NNRTI treatments once the first mutations have emerged.	[von Wyl, Viktor; Guenthard, Huldrych F.] Univ Zurich, Div Infect Dis & Hosp Epidemiol, Univ Zurich Hosp, Zurich, Switzerland; [Klimkait, Thomas] Univ Basel, Dept Biomed, Basel, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland; [Nicca, Dunja] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Furrer, Hansjakob] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland; [Furrer, Hansjakob] Univ Bern, Bern, Switzerland; [Cavassini, Matthias] Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Div Infect Dis, Lugano, Switzerland; [Boeni, Juerg] Univ Zurich, Inst Med Virol, Swiss Natl Ctr Retroviruses, Zurich, Switzerland; [Aubert, Vincent] CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland; [Bucher, Heiner C.; Glass, Tracy R.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Glass, Tracy R.] Swiss Trop & Publ Hlth Inst, Dept Biostat, Basel, Switzerland	University of Zurich; University Zurich Hospital; University of Basel; University of Geneva; Kantonsspital St. Gallen; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Zurich; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; University of Basel; Swiss Tropical & Public Health Institute	Glass, TR (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland.	Tracy.Glass@unibas.ch	Boeni, Juerg/B-8386-2015; gunthard, huldrych f/F-1724-2011; Ledergerber, Bruno/B-5656-2009; Pantaleo, Giuseppe/K-6163-2016; Furrer, Hansjakob/G-6768-2013; Glass, Tracy R/D-5046-2017; cavassini, matthias/F-8987-2017	gunthard, huldrych f/0000-0002-1142-6723; Ledergerber, Bruno/0000-0002-6881-4401; Furrer, Hansjakob/0000-0002-1375-3146; Glass, Tracy R/0000-0001-7075-9803; Klimkait, Thomas/0000-0003-4945-6511; cavassini, matthias/0000-0003-0933-7833; von Wyl, Viktor/0000-0002-8754-9797	Swiss HIV Cohort Study; Swiss National Science Foundation [33CS30_134277]; SHCS project [654]; Union Bank of Switzerland; Gilead science; Jacob Foundation; European Community under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) [223131]	Swiss HIV Cohort Study; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SHCS project; Union Bank of Switzerland; Gilead science(Gilead Sciences); Jacob Foundation; European Community under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN)	This study has been financed in the framework of the Swiss HIV Cohort Study, supported by the Swiss National Science Foundation (grant # 33CS30_134277) and by SHCS project 654. Furthermore, the SHCS drug resistance database was supported by a research grant of the Union Bank of Switzerland, in the name of a donor to HFG by an unrestricted research grant from Gilead science and by the Jacob Foundation (to HFG) and the European Community's Seventh Framework Program (grant FP7/2007-2013), under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN; grant 223131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J INFECT DIS, V190, P162, DOI 10.1086/420790; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Burman W, 2008, JAIDS-J ACQ IMM DEF, V49, P142, DOI 10.1097/QAI.0b013e318183a9ad; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallego O, 2001, AIDS, V15, P1701, DOI 10.1097/00002030-200109070-00014; Gardner EM, 2010, AIDS, V24, P395, DOI 10.1097/QAD.0b013e328335cd8a; Gardner EM, 2009, AIDS, V23, P1035, DOI 10.1097/QAD.0b013e32832ba8ec; Glass TR, 2008, ANTIVIR THER, V13, P77; Hare CB, 2008, CLIN INFECT DIS, V47, P421, DOI 10.1086/589867; Harrigan PR, 2005, J INFECT DIS, V191, P1325, DOI 10.1086/428852; Jackson JB, 2000, AIDS, V14, pF111, DOI 10.1097/00002030-200007280-00001; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; King MS, 2005, J INFECT DIS, V191, P2046, DOI 10.1086/430387; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Liu HH, 2006, JAIDS-J ACQ IMM DEF, V41, P315, DOI 10.1097/01.qai.0000197071.77482.6e; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Maggiolo F, 2007, HIV CLIN TRIALS, V8, P282, DOI 10.1310/hct0805-282; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Miller RF, 2003, ANTIVIR THER, V8, P253; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Scherrer AU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050307; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Sethi AK, 2003, CLIN INFECT DIS, V37, P1112, DOI 10.1086/378301; Shuter J, 2008, J ANTIMICROB CHEMOTH, V61, P769, DOI 10.1093/jac/dkn020; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Tam LWY, 2008, JAIDS-J ACQ IMM DEF, V49, P266, DOI 10.1097/QAI.0b013e318189a753; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; von Wyl V, 2012, CLIN INFECT DIS, V54, P131, DOI 10.1093/cid/cir728; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; Walsh JC, 2002, J ACQ IMMUN DEF SYND, V30, P278, DOI [10.1097/01.QAI.0000018000.56638.43, 10.1097/00126334-200207010-00003]; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685	41	36	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77691	10.1371/journal.pone.0077691	http://dx.doi.org/10.1371/journal.pone.0077691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147057	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326019400125
J	Yin, J; Zhang, JX; Xie, J; Zou, ZL; Huang, XT				Yin, Jie; Zhang, John X.; Xie, Jing; Zou, Zhiling; Huang, Xiting			Gender Differences in Perception of Romance in Chinese College Students	PLOS ONE			English	Article							FACE PERCEPTION; SEX-DIFFERENCES; EMOTION REGULATION; NEURAL BASIS; LOVE; ATTITUDES; CORTEX; MEMORY; WOMEN; FMRI	Women often complain that their partners are not romantic enough. This raises the question: how romance is recognized and evaluated in a love relationship? However, there has been essentially no empirical research bearing on this issue. The present set of studies examined possible gender differences in perceptions of romance and the associated neural mechanisms in Chinese college students. In Study 1, 303 participants (198 women, 105 men) were administrated a questionnaire consisting of 60 sentences and required to rate the romance level of each sentence. Results showed higher rating scores in males than females for low romance items, but not for high or medium romance items. In Study 2, 69 participants (37 women, 32 men) were recruited to judge the degree of romance in sentences presented on a computer screen one by one. Compared with females, males again showed higher scores and responded more slowly only to low romance items. In Study 3, 36 participants (18 women, 18 men) currently in love with someone were scanned with functional MRI while they did the romance judgment task from Study 2. Compared with females, greater brain activation was found for males in the frontal lobe, precentral gyrus, precuneus and parahippocampal gyrus for low romance items. The results provide the first piece of evidence for gender differences in romance perception, suggesting enhanced cognitive processing in males when evaluating the degree of romance in romantic scenes.	[Yin, Jie; Xie, Jing; Zou, Zhiling; Huang, Xiting] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Zhang, John X.] Fudan Univ, Dept Psychol, Shanghai 200433, Peoples R China	Southwest University - China; Fudan University	Zou, ZL (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	zouzl@swu.edu.cn		Zou, Zhiling/0000-0003-4497-2947	Fundamental Research for the Central Universities [SWU1009104]; Key Discipline Fund of the National 211 Project, China [TR201203-4, NSKD11001]; Social Science Fund of Chongqing, China [2010CQZDW07]	Fundamental Research for the Central Universities; Key Discipline Fund of the National 211 Project, China; Social Science Fund of Chongqing, China	This research was supported by the Fundamental Research for the Central Universities (SWU1009104), Key Discipline Fund of the National 211 Project, China (# TR201203-4, #NSKD11001), the Social Science Fund of Chongqing, China (2010CQZDW07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo BP, 2009, REV GEN PSYCHOL, V13, P59, DOI 10.1037/a0014226; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; [Anonymous], 1981, AM CHINESE PASSAGE D; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Aron A, 2006, CAMBRIDGE HANDBOOK OF PERSONAL RELATIONSHIPS, P595, DOI 10.1017/CBO9780511606632.033; Banyard Victoria L, 2007, Violence Vict, V22, P52, DOI 10.1891/vv-v22i1a004; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BAXTER LA, 1986, J SOC PERS RELAT, V3, P289, DOI 10.1177/0265407586033003; Beauregard M., 2001, J NEUROSCI, V21, P6993, DOI [DOI 10.1523/JNEUROSCI.21-18-J0001.2001, DOI 10.1523/JNEUROSCI.21-18-j0001.2001]; BROTHERS L, 1990, MOTIV EMOTION, V14, P81, DOI 10.1007/BF00991637; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Capellanus Andreas, 1990, ART COURTLY LOVE; Chiao JY, 2008, J COGNITIVE NEUROSCI, V20, P2167, DOI 10.1162/jocn.2008.20151; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Dion K., 1988, PSYCHOL LOVE, P264; DION KK, 1993, J SOC ISSUES, V49, P53, DOI 10.1111/j.1540-4560.1993.tb01168.x; Feeney JA, 1990, ATTACHMENT STYLE PRE, V2, P281, DOI DOI 10.1037/0022-3514.58.2.281; Fischer AH, 2004, EMOTION, V4, P87, DOI 10.1037/1528-3542.4.1.87; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Fisher HE, 2010, J NEUROPHYSIOL, V104, P51, DOI 10.1152/jn.00784.2009; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Gao G, 2001, INT J INTERCULT REL, V25, P329, DOI 10.1016/S0147-1767(01)00007-4; Geer JH, 2005, ARCH SEX BEHAV, V34, P671, DOI 10.1007/s10508-005-7923-8; Gross AM, 2006, VIOLENCE AGAINST WOM, V12, P288, DOI 10.1177/1077801205277358; Halsband U, 1998, BEHAV BRAIN RES, V97, P69, DOI 10.1016/S0166-4328(98)00028-X; Han SH, 2008, NAT REV NEUROSCI, V9, P646, DOI 10.1038/nrn2456; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Hatfield E., 1978, A NEW LOOK AT LOVE; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Hedden T, 2008, PSYCHOL SCI, V19, P12, DOI 10.1111/j.1467-9280.2008.02038.x; Hendrick S., 1992, ROMANTIC LOVE; Henson RNA, 1999, J NEUROSCI, V19, P3962; Impett EA, 2002, PSYCHOL WOMEN QUART, V26, P360, DOI 10.1111/1471-6402.t01-1-00075; Jackson T, 2006, J CROSS CULT PSYCHOL, V37, P446, DOI 10.1177/0022022106288480; JANKOWIAK WR, 1992, ETHNOLOGY, V31, P149, DOI 10.2307/3773618; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 1995, J NEUROPHYSIOL, V74, P1192; KEPHART WM, 1967, J MARRIAGE FAM, V29, P470, DOI 10.2307/349585; KNOX DH, 1968, J MARRIAGE FAM, V30, P638, DOI 10.2307/349508; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; KOMAKI G, 2006, INT C SER, V1287, P135; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; Lu WY, 2010, STUDIES CULTURE ART, V3, P62; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mullally SL, 2011, J NEUROSCI, V31, P7441, DOI 10.1523/JNEUROSCI.0267-11.2011; Najib A, 2004, AM J PSYCHIAT, V161, P2245, DOI 10.1176/appi.ajp.161.12.2245; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Pines AM, 1998, PERS INDIV DIFFER, V25, P147, DOI 10.1016/S0191-8869(98)00054-3; Riehl-Emde A, 2003, FAM PROCESS, V42, P253, DOI 10.1111/j.1545-5300.2003.42205.x; RUBIN Z, 1970, J PERS SOC PSYCHOL, V16, P265, DOI 10.1037/h0029841; RUBIN Z, 1981, SEX ROLES, V7, P821, DOI 10.1007/BF00287767; Shulman S, 2000, J RES ADOLESCENCE, V10, P99, DOI 10.1207/SJRA1001_5; SIMPSON JA, 1986, PERS SOC PSYCHOL B, V12, P363, DOI 10.1177/0146167286123011; SPRECHER S, 1994, PERS RELATIONSHIP, V1, P349, DOI 10.1111/j.1475-6811.1994.tb00070.x; Sternberg R.J., 1988, PSYCHOL LOVE; Sternberg R.J, 1988, THE TRIANGLE OF LOVE; Talairach J., 1988, COPLANAR STEREOTAXIC; Tang L. P., 2005, J SW CHINA NORMAL U, V31, P43; Wang LZ, 2003, TV RATINGS YB 2003; Wei G, 2006, FAMILY LIFE GUIDE, V4, P22; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; Wojciulik E., 1997, Society for Neuroscience Abstracts, V23, P299; Xu WW, 2008, THESIS NE NORMAL U C; Xu XM, 2011, HUM BRAIN MAPP, V32, P249, DOI 10.1002/hbm.21017; Zhang GZ, 2011, CHINESE MED ETHICS, V24, P657; Zhang W, 2007, CHINA J HLTH PSYCHOL, V15, P63; Zhong DP, 2003, YOUTH STUDIES, V5, P37; Zuo XY, 2012, J ADOLESCENT HEALTH, V50, pS18, DOI 10.1016/j.jadohealth.2011.12.001; 宿建沛, 2002, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V11, P693	76	43	43	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76294	10.1371/journal.pone.0076294	http://dx.doi.org/10.1371/journal.pone.0076294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146853	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400052
J	Billaut, F; Kerris, JP; Rodriguez, RF; Martin, DT; Gore, CJ; Bishop, DJ				Billaut, Francois; Kerris, Jarrod P.; Rodriguez, Ramon F.; Martin, David T.; Gore, Christopher J.; Bishop, David J.			Interaction of Central and Peripheral Factors during Repeated Sprints at Different Levels of Arterial O-2 Saturation	PLOS ONE			English	Article							SKELETAL-MUSCLE RECRUITMENT; EXERCISE PERFORMANCE; HEALTHY HUMANS; NEUROMUSCULAR ACTIVITY; CYCLING EXERCISE; SEVERE HYPOXIA; FATIGUE; OXYGENATION; ALTITUDE; METABOLISM	Purpose: To investigate the interaction between the development of peripheral locomotor muscle fatigue, muscle recruitment and performance during repeated-sprint exercise (RSE). Method: In a single-blind, randomised and cross-over design, ten male team-sport athletes performed two RSE (fifteen 5-s cycling sprints interspersed with 25 s of rest; power self-selected) in normoxia and in acute moderate hypoxia (FIO2 0.138). Mechanical work, total electromyographic intensity (summed quadriceps electromyograms, RMSsum) and muscle (vastus lateralis) and pre-fontal cortex near-infrared spectroscopy (NIRS) parameters were calculated for every sprint. Blood lactate concentration ([Lac(-)]) was measured throughout the protocol. Peripheral quadriceps fatigue was assessed via changes in potentiated quadriceps twitch force (Delta Q(tw,pot)) pre- versus post-exercise in response to supra-maximal magnetic femoral nerve stimulation. The central activation ratio (Q(CAR)) was used to quantify completeness of quadriceps activation. Results: Compared with normoxia, hypoxia reduced arterial oxygen saturation (-13.7%, P=0.001), quadriceps RMSsum (-13.7%, P=0.022), Q(CAR) (-3.3%, P=0.041) and total mechanical work (-8.3%, P=0.019). However, the magnitude of quadriceps fatigue induced by RSE was similar in the two conditions (Delta Q(tw),(pot):-53.5% and -55.1%, P=0.71). The lower cycling performance in hypoxia occurred despite similar metabolic (muscle NIRS parameters and blood [Lac(-)]) and functional (twitch and M-wave) muscle states. Conclusion: Results suggest that the central nervous system regulates quadriceps muscle recruitment and, thereby, performance to limit the development of muscle fatigue during intermittent, short sprints. This finding highlights the complex interaction between muscular perturbations and neural adjustments during sprint exercise, and further supports the presence of pacing during intermittent sprint exercise.	[Billaut, Francois] Inst Natl Sport Quebec, Montreal, PQ, Canada; [Billaut, Francois; Kerris, Jarrod P.; Rodriguez, Ramon F.; Bishop, David J.] Victoria Univ Technol, Inst Sport Exercise & Act Living, Coll Sport & Exercise Sci, Melbourne, Vic 3000, Australia; [Martin, David T.; Gore, Christopher J.] Australian Inst Sport, Dept Physiol, Canberra, ACT, Australia; [Gore, Christopher J.] Flinders Univ South Australia, Exercise Physiol Lab, Bedford Pk, SA, Australia	Victoria University; Australian Institute of Sport; Flinders University South Australia	Billaut, F (corresponding author), Inst Natl Sport Quebec, Montreal, PQ, Canada.	fbillaut@insquebec.org	Rodriguez, Ramon F/H-9390-2013; Bishop, David John/X-9826-2019	Rodriguez, Ramon F/0000-0001-5806-7652; Bishop, David John/0000-0002-6956-9188; Martin, David/0000-0002-3051-2811	Victoria University Research Development Grant Scheme grant [RDGS 28/11]	Victoria University Research Development Grant Scheme grant	This study was supported by Victoria University Research Development Grant Scheme grant (RDGS 28/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2007, J PHYSIOL-LONDON, V581, P389, DOI 10.1113/jphysiol.2007.129700; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Amann M, 2006, J APPL PHYSIOL, V101, P119, DOI 10.1152/japplphysiol.01596.2005; Amann M, 2011, MED SCI SPORT EXER, V43, P2039, DOI 10.1249/MSS.0b013e31821f59ab; Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; Ansley L, 2004, MED SCI SPORT EXER, V36, P309, DOI 10.1249/01.MSS.0000113474.31529.C6; BALSOM PD, 1994, ACTA PHYSIOL SCAND, V150, P455, DOI 10.1111/j.1748-1716.1994.tb09711.x; Billaut F, 2012, SPORTS MED, V42, P751, DOI 10.2165/11634050-000000000-00000; Billaut F, 2011, MED SCI SPORT EXER, V43, P665, DOI 10.1249/MSS.0b013e3181f6ee3b; Billaut F, 2010, INT J SPORT PHYSIOL, V5, P197, DOI 10.1123/ijspp.5.2.197; Billaut F, 2009, APPL PHYSIOL NUTR ME, V34, P689, DOI 10.1139/H09-058; Bogdanis GC, 1996, J APPL PHYSIOL, V80, P876, DOI 10.1152/jappl.1996.80.3.876; BOGDANIS GC, 1995, J PHYSIOL-LONDON, V482, P467, DOI 10.1113/jphysiol.1995.sp020533; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Bowtell JL, 2013, J SCI MED SPORT, DOI [10.1016/j.jsams.2013.05.016, DOI 10.1016/J.JSAMS.2013.05.016.PUBMED:23809839]; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Girard O, 2008, J ELECTROMYOGR KINES, V18, P1038, DOI 10.1016/j.jelekin.2007.05.005; Gore CJ, 1997, EUR J APPL PHYSIOL, V75, P136, DOI 10.1007/s004210050138; Hamlin MJ, 2008, J SCI MED SPORT, V11, P593, DOI 10.1016/j.jsams.2007.07.005; Hilty L, 2011, EUR J NEUROSCI, V34, P2035, DOI 10.1111/j.1460-9568.2011.07909.x; Katayama K, 2007, AM J PHYSIOL-REG I, V292, pR1279, DOI 10.1152/ajpregu.00554.2006; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; Marino FE, 2011, BRIT J SPORT MED, V45, P65, DOI 10.1136/bjsm.2009.067611; Marino FE, 2010, SPORTS MED, V40, P265, DOI 10.2165/11533680-000000000-00000; Martin JC, 2001, EUR J APPL PHYSIOL, V84, P413, DOI 10.1007/s004210100400; Mendez-Villanueva A, 2008, EUR J APPL PHYSIOL, V103, P411, DOI 10.1007/s00421-008-0723-9; Mendez-Villanueva A, 2007, MED SCI SPORT EXER, V39, P2219, DOI 10.1249/mss.0b013e31815669dc; Millet GY, 2012, J APPL PHYSIOL, V112, P1335, DOI 10.1152/japplphysiol.00804.2011; Morales-Alamo D, 2012, J APPL PHYSIOL, V113, P917, DOI 10.1152/japplphysiol.00415.2012; Noakes TD, 2007, J PHYSIOL-LONDON, V585, P919, DOI 10.1113/jphysiol.2007.145110; Noakes TD, 2009, J APPL PHYSIOL, V106, P737, DOI 10.1152/japplphysiol.90410.2008; Noakes TD, 2011, APPL PHYSIOL NUTR ME, V36, P23, DOI 10.1139/H10-082; Romer LM, 2007, AM J PHYSIOL-REG I, V292, pR598, DOI 10.1152/ajpregu.00269.2006; Romer LM, 2006, AM J PHYSIOL-REG I, V290, pR365, DOI 10.1152/ajpregu.00332.2005; Smith KJ, 2012, INT J SPORT PHYSIOL, V7, P59, DOI 10.1123/ijspp.7.1.59; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Spencer M, 2006, MED SCI SPORT EXER, V38, P1492, DOI 10.1249/01.mss.0000228944.62776.a7; Subudhi AW, 2008, AM J PHYSIOL-HEART C, V294, pH164, DOI 10.1152/ajpheart.01104.2007; Verges S, 2012, AM J PHYSIOL-REG I, V302, pR903, DOI 10.1152/ajpregu.00555.2011; Weston AR, 2001, MED SCI SPORT EXER, V33, P298; Wittekind AL, 2011, BRIT J SPORT MED, V45, P114, DOI 10.1136/bjsm.2009.061580	44	62	62	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77297	10.1371/journal.pone.0077297	http://dx.doi.org/10.1371/journal.pone.0077297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155938	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325887300072
J	Li, JJ; Pan, YQ; Deng, QJ; Cai, H; Ke, Y				Li, Jingjing; Pan, YaQi; Deng, QiuJu; Cai, Hong; Ke, Yang			Identification and Characterization of Eleven Novel Human Gamma-Papillomavirus Isolates from Healthy Skin, Found at Low Frequency in a Normal Population	PLOS ONE			English	Article							EPIDERMODYSPLASIA-VERRUCIFORMIS; DIVERSITY; BETAPAPILLOMAVIRUSES; SPECTRUM	Eleven novel human papillomavirus (HPV) types were isolated and characterized from healthy individuals in China. HPV163 belongs to the gamma-1 species, HPV 164 and HPV 168 fit in the gamma-8 species, HPV 165 and KC5 belongs to the gamma-12 species, HPV 168 is closely allied with the gamma-4 species, HPV 169 is closely related to the gamma-11 species, and HPV 170 is related to the gamma-12 species. In addition, HPV 161, HPV 162, and HPV 166 may form a new HPV species of the gamma-PV genus. The prevalence of these HPV types in the normal population is low.	[Li, Jingjing; Pan, YaQi; Deng, QiuJu; Cai, Hong; Ke, Yang] Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China	Peking University	Ke, Y (corresponding author), Peking Univ, Canc Hosp & Inst, Minist Educ, Key Lab Carcinogenesis & Translat Res, Beijing 100871, Peoples R China.	keyang@bjmu.edu.cn			973 project [201202014]; National Natural Sciences Foundation of China [30930102]; Beijing Natural Science Foundation [7100001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110001110037]	973 project(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the grants from the 973 project (201202014), the National Natural Sciences Foundation of China (30930102), the Beijing Natural Science Foundation (7100001), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant No. 20110001110037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson A, 2003, J GEN VIROL, V84, P1881, DOI 10.1099/vir.0.18836-0; Antonsson A, 2003, J CLIN MICROBIOL, V41, P2509, DOI 10.1128/JCM.41.6.2509-2514.2003; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Bao Y., 2008, ENCY VIROLOGY, P342; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard Hans-Ulrich, 1994, Trends in Microbiology, V2, P140, DOI 10.1016/0966-842X(94)90602-5; Bravo IG, 2007, VIRUS GENES, V34, P249, DOI 10.1007/s11262-006-0017-4; Chouhy D, 2012, J GEN VIROL; CLAUDY AL, 1982, ARCH DERMATOL RES, V274, P213, DOI 10.1007/BF00403724; Crow JM, 2012, NATURE, V486, pS12, DOI 10.1038/486S12a; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2009, J GEN VIROL, V90, P1999, DOI 10.1099/vir.0.011478-0; DEAU MC, 1991, VIROLOGY, V184, P492, DOI 10.1016/0042-6822(91)90419-C; Dell'Oste V, 2009, J INVEST DERMATOL, V129, P1026, DOI 10.1038/jid.2008.317; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Feltkamp MCW, 2008, J CLIN VIROL, V43, P353, DOI 10.1016/j.jcv.2008.09.009; Forslund O, 2003, BRIT J DERMATOL, V149, P64, DOI 10.1046/j.1365-2133.2003.05376.x; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Forslund O, 2007, J GEN VIROL, V88, P2662, DOI 10.1099/vir.0.82911-0; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Gottschling M, 2007, MOL BIOL EVOL, V24, P1242, DOI 10.1093/molbev/msm039; Gottschling M, 2007, MOL PHYLOGENET EVOL, V42, P213, DOI 10.1016/j.ympev.2006.07.011; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022529; Kovanda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022414; Li Jingjing, 2013, J VIROLOGICAL METHOD; Liu FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031602; Page RD, 2002, CURR PROTOC BIOINFOR; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77116	10.1371/journal.pone.0077116	http://dx.doi.org/10.1371/journal.pone.0077116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155922	Green Published, gold			2022-12-27	WOS:000325887300056
J	Yu, XH; Liu, J; Zhu, H; Xia, YL; Gao, LJ; Li, Z; Jia, N; Shen, WF; Yang, YZ; Niu, WQ				Yu, Xiaohong; Liu, Jun; Zhu, Hao; Xia, Yunlong; Gao, Lianjun; Li, Zhen; Jia, Nan; Shen, Weifeng; Yang, Yanzong; Niu, Wenquan			An Interactive Association of Advanced Glycation End-Product Receptor Gene Four Common Polymorphisms with Coronary Artery Disease in Northeastern Han Chinese	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; RAGE GENE; MYOCARDIAL-INFARCTION; SOLUBLE RECEPTOR; METAANALYSIS; ENDPRODUCTS; EPISTASIS; HAPLOTYPE; PROMOTER; MARKER	Background: Growing evidence indicates that advanced glycation end-product receptor (RAGE) might play a contributory role in the pathogenesis of coronary artery disease (CAD). To shed some light from a genetic perspective, we sought to investigate the interactive association of RAGE gene four common polymorphisms (rs1800625 or T-429C, rs1800624 or T374A, rs2070600 or Gly82Ser, and rs184003 or G1704A) with the risk of developing CAD in a large northeastern Han Chinese population. Methodology/Principal Findings: This was a hospital-based case-control study incorporating 1142 patients diagnosed with CAD and 1106 age-and gender-matched controls. All individuals were angiographically confirmed. Risk estimates were expressed as odds ratio (OR) and 95% confidence interval (CI). Overall there were significant differences in the genotype and allele distributions of rs1800625 and rs184003, even after the Bonferroni correction. Logistic regression analyses indicated that rs1800625 and rs184003 were associated with significant risk of CAD under both additive (OR = 1.20 and 1.23; 95% CI: 1.06-1.37 and 1.06-1.42; P = 0.006 and 0.008) and recessive (OR = 1.75 and 2.39; 95% CI: 1.28-2.40 and 1.47-3.87; P<0.001 and <0.001) models after adjusting for confounders. In haplotype analyses, haplotypes C-T-G-G and T-A-G-T (alleles in order of rs1800625, rs1800624, rs2070600 and rs184003), overrepresented in patients, were associated with 52% (95% CI: 1.19-1.87; P = 0.0052) and 63% (95% CI: 1.14-2.34; P = 0.0075) significant increases in adjusted risk for CAD. Further interactive analyses identified an overall best multifactor dimensionality reduction (MDR) model including rs1800625 and rs184003. This model had a maximal testing accuracy of 0.6856 and a cross-validation consistency of 10 out of 10 (P = 0.0016). The validity of this model was substantiated by classical Logistic regression analysis. Conclusions: Our findings provided strong evidence for the potentially contributory roles of RAGE multiple genetic polymorphisms, especially in the context of locus-to-locus interaction, in the pathogenesis of CAD among northeastern Han Chinese.	[Yu, Xiaohong; Liu, Jun; Zhu, Hao; Xia, Yunlong; Gao, Lianjun; Li, Zhen; Yang, Yanzong] Dalian Med Univ, Affiliated Hosp 1, Dept Cardiol, Dalian, Liaoning, Peoples R China; [Jia, Nan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hypertens, Shanghai 200030, Peoples R China; [Shen, Weifeng] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Shanghai 200030, Peoples R China	Dalian Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, YZ (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Cardiol, Dalian, Liaoning, Peoples R China.	yyzheart@126.com; niuwenquan_shcn@163.com			Liaoning Provincial Department of Education Scientific Research Project [L2011155, L2012321]	Liaoning Provincial Department of Education Scientific Research Project	Grant support: Liaoning Provincial Department of Education Scientific Research Project (Grant No. L2011155 and L2012321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai XY, 2011, ATHEROSCLEROSIS, V217, P536, DOI 10.1016/j.atherosclerosis.2011.05.023; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Falcone C, 2005, ARTERIOSCL THROM VAS, V25, P1032, DOI 10.1161/01.ATV.0000160342.20342.00; Gao JX, 2010, J HUM GENET, V55, P668, DOI 10.1038/jhg.2010.85; Gu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037970; Gui JA, 2010, HUM HERED, V70, P219, DOI 10.1159/000319175; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hegab Z, 2012, WORLD J CARDIOL, V4, P90, DOI 10.4330/wjc.v4.i4.90; Hudson BI, 2001, DIABETES, V50, P1505, DOI 10.2337/diabetes.50.6.1505; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Khanna M, 1999, ONCOGENE, V18, P27, DOI 10.1038/sj.onc.1202291; Laki J, 2007, MOL IMMUNOL, V44, P648, DOI 10.1016/j.molimm.2006.01.011; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Niu WQ, 2009, J HUM HYPERTENS, V23, P68, DOI 10.1038/jhh.2008.77; Niu WQ, 2012, HEART, V98, P1483, DOI 10.1136/heartjnl-2012-302085; Niu WQ, 2012, INT J CARDIOL, V157, P243, DOI 10.1016/j.ijcard.2011.12.098; Park HJ, 2011, CIRC J, V75, P1685, DOI 10.1253/circj.CJ-10-1248; Pattin KA, 2009, GENET EPIDEMIOL, V33, P87, DOI 10.1002/gepi.20360; Pineda-Krch M, 2004, J EVOLUTION BIOL, V17, P1167, DOI 10.1111/j.1420-9101.2004.00808.x; Pollreisz A, 2010, ATHEROSCLEROSIS, V212, P451, DOI 10.1016/j.atherosclerosis.2010.07.011; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Roy SW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-208; Selejan SR, 2012, CRIT CARE MED, V40, P1513, DOI 10.1097/CCM.0b013e318241e536; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Torres MC, 2012, INT J IMMUNOGENET, V39, P155, DOI 10.1111/j.1744-313X.2011.01073.x; Volz HC, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0250-z; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050790; Zintzaras E, 2008, ARCH INTERN MED, V168, P1077, DOI 10.1001/archinte.168.10.1077	30	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76966	10.1371/journal.pone.0076966	http://dx.doi.org/10.1371/journal.pone.0076966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155913	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300047
J	Altemeier, WA; Liles, WC; Villagra-Garcia, A; Matute-Bello, G; Glenny, RW				Altemeier, William A.; Liles, W. Conrad; Villagra-Garcia, Ana; Matute-Bello, Gustavo; Glenny, Robb W.			Ischemia-Reperfusion Lung Injury Is Attenuated in MyD88-Deficient Mice	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MEDIATES ISCHEMIA/REPERFUSION INJURY; PRIMARY GRAFT DYSFUNCTION; KAPPA-B; TRANSPLANTATION; TOLL-LIKE-RECEPTOR-4; INHIBITION; TLR2; PROTECTION; PATHWAYS	Ischemia-reperfusion lung injury is a common cause of acute morbidity and mortality in lung transplant recipients and has been associated with subsequent development of bronchiolitis obliterans syndrome. Recognition of endogenous ligands released during cellular injury (damage-associated molecular patterns; DAMPs) by Toll-like receptors (TLRs), especially TLR4, has increasingly been recognized as a mechanism for inflammation resulting from tissue damage. TLR4 is implicated in the pathogenesis of ischemia-reperfusion injury of multiple organs including heart, liver, kidney and lung. Additionally, activation of TLRs other than TLR4 by DAMPs has been identified in tissues other than the lung. Because all known TLRs, with the exception of TLR3, signal via the MyD88 adapter protein, we hypothesized that lung ischemia-reperfusion injury was mediated by MyD88-dependent signaling. To test this hypothesis, we subjected C57BL/6 wildtype, Myd88(-)/-, and Tlr4(-/-) mice to 1 hr of left lung warm ischemia followed by 4 hr of reperfusion. We found that Myd88(-/-) mice had significantly less MCP-1/CCL2 in the left lung following ischemia-reperfusion as compared with wildtype mice. This difference was associated with dramatically reduced lung permeability. Interestingly, Tlr4(-/-) mice had only partial protection from ischemia-reperfusion as compared to Myd88(-/-) mice, implicating other MyD88-dependent pathways in lung injury following ischemia-reperfusion. We also found that left lung ischemia-reperfusion caused remote inflammation in the right lung. Finally, using chimeric mice with MyD88 expression restricted to either myeloid or non-myeloid cells, we found that MyD88-dependent signaling in myeloid cells was necessary for ischemia-reperfusion induced lung permeability. We conclude that MyD88-dependent signaling through multiple receptors is important in the pathogenesis of acute lung inflammation and injury following ischemia and reperfusion.	[Altemeier, William A.; Liles, W. Conrad; Matute-Bello, Gustavo] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Altemeier, William A.; Liles, W. Conrad; Matute-Bello, Gustavo; Glenny, Robb W.] Univ Washington, Dept Med, Seattle, WA USA; [Liles, W. Conrad; Villagra-Garcia, Ana] Univ Toronto, Toronto Gen Res Inst, McLaughlin Rotman Ctr Global Hlth, Dept Med, Toronto, ON, Canada; [Glenny, Robb W.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Washington; University of Washington Seattle	Altemeier, WA (corresponding author), Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA.	billa@u.washington.edu		Altemeier, William/0000-0001-8860-405X	National Institutes of Health [HL71020, HL086883, HL73996]; Centro de Investigacion Biomedica en Red Enfermedades Respiratorias (CIBERES); Instituto de Salud de Carlos III (ISC III) [F1S01F015]; Canada Research Chair in Infectious Disease and Inflammation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL073996, R01HL086883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centro de Investigacion Biomedica en Red Enfermedades Respiratorias (CIBERES); Instituto de Salud de Carlos III (ISC III)(Instituto de Salud Carlos III); Canada Research Chair in Infectious Disease and Inflammation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by: National Institutes of Health (HL71020, HL086883 and HL73996; www.nih.gov), Centro de Investigacion Biomedica en Red Enfermedades Respiratorias (CIBERES - www.ciberes.org) and Instituto de Salud de Carlos III (ISC III - www.isciii.es) (F1S01F015), and Canada Research Chair in Infectious Disease and Inflammation (www.chairs-chaires.gc.ca). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Belperio JA, 2005, J IMMUNOL, V175, P6931, DOI 10.4049/jimmunol.175.10.6931; Chong AJ, 2004, J THORAC CARDIOV SUR, V128, P170, DOI 10.1016/j.jtcvs.2003.11.036; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; De Perrot M, 2002, AM J RESP CRIT CARE, V165, P211, DOI 10.1164/ajrccm.165.2.2011151; EPPINGER MJ, 1995, J SURG RES, V58, P713, DOI 10.1006/jsre.1995.1112; Farrar CA, 2012, FASEB J, V26, P799, DOI 10.1096/fj.11-195396; Fiser SM, 2002, ANN THORAC SURG, V73, P1041, DOI 10.1016/S0003-4975(01)03606-2; Haddad JJ, 2003, CRIT CARE, V7, P47, DOI 10.1186/cc1840; Henderson WR, 2002, J IMMUNOL, V169, P5294, DOI 10.4049/jimmunol.169.9.5294; Hoffman SA, 2009, AM J TRANSPLANT, V9, P389, DOI 10.1111/j.1600-6143.2008.02497.x; Hua F, 2007, J IMMUNOL, V178, P7317, DOI 10.4049/jimmunol.178.11.7317; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Ishii M, 2004, J IMMUNOL, V172, P2569, DOI 10.4049/jimmunol.172.4.2569; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kim KH, 2005, AM J RESP CELL MOL, V33, P271, DOI 10.1165/rcmb.2005-0111OC; King RC, 2000, ANN THORAC SURG, V69, P1681, DOI 10.1016/S0003-4975(00)01425-9; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Land WG, 2005, TRANSPLANTATION, V79, P505, DOI 10.1097/01.TP.0000153160.82975.86; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lu C, 2011, J IMMUNOL, V187, P1458, DOI 10.4049/jimmunol.1003428; Mathur S, 2011, SHOCK, V36, P478, DOI 10.1097/SHK.0b013e31822d6442; Matute-Bello G, 2004, J IMMUNOL METHODS, V292, P25, DOI 10.1016/j.jim.2004.05.010; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Miyake K, 2007, SEMIN IMMUNOL, V19, P3, DOI 10.1016/j.smim.2006.12.002; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Naidu BV, 2003, J HEART LUNG TRANSPL, V22, P784, DOI 10.1016/S1053-2498(02)00556-9; Oyama J, 2004, CIRCULATION, V109, P784, DOI 10.1161/01.CIR.0000112575.66565.84; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Ross SD, 2000, AM J PHYSIOL-LUNG C, V279, pL528, DOI 10.1152/ajplung.2000.279.3.L528; Shah RJ, 2012, TRANSL RES, V160, P435, DOI 10.1016/j.trsl.2012.08.003; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Shimamoto A, 2006, ANN THORAC SURG, V82, P2017, DOI 10.1016/j.athoracsur.2006.06.079; Shimamoto A, 2006, CIRCULATION, V114, pI270, DOI 10.1161/CIRCULATIONAHA.105.000901; Stapel H, 2006, EUR J HEART FAIL, V8, P665, DOI 10.1016/j.ejheart.2006.03.005; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wu He-Shui, 2004, Hepatobiliary Pancreat Dis Int, V3, P250; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Zanotti G, 2009, AM J PHYSIOL-LUNG C, V297, pL52, DOI 10.1152/ajplung.90406.2008; Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200	46	23	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77123	10.1371/journal.pone.0077123	http://dx.doi.org/10.1371/journal.pone.0077123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146959	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400098
J	Angeler, DG; Allen, CR; Rojo, C; Alvarez-Cobelas, M; Rodrigo, MA; Sanchez-Carrillo, S				Angeler, David G.; Allen, Craig R.; Rojo, Carmen; Alvarez-Cobelas, Miguel; Rodrigo, Maria A.; Sanchez-Carrillo, Salvador			Inferring the Relative Resilience of Alternative States	PLOS ONE			English	Article							WHOLE-ECOSYSTEM EXPERIMENT; WETLAND CENTRAL SPAIN; REGIME SHIFTS; COMPLEX-SYSTEMS; SHALLOW LAKES; STABLE STATES; DIVERSITY; DROUGHT; DISCONTINUITIES; RESPONSES	Ecological systems may occur in alternative states that differ in ecological structures, functions and processes. Resilience is the measure of disturbance an ecological system can absorb before changing states. However, how the intrinsic structures and processes of systems that characterize their states affects their resilience remains unclear. We analyzed time series of phytoplankton communities at three sites in a floodplain in central Spain to assess the dominant frequencies or "temporal scales" in community dynamics and compared the patterns between a wet and a dry alternative state. The identified frequencies and cross-scale structures are expected to arise from positive feedbacks that are thought to reinforce processes in alternative states of ecological systems and regulate emergent phenomena such as resilience. Our analyses show a higher species richness and diversity but lower evenness in the dry state. Time series modeling revealed a decrease in the importance of short-term variability in the communities, suggesting that community dynamics slowed down in the dry relative to the wet state. The number of temporal scales at which community dynamics manifested, and the explanatory power of time series models, was lower in the dry state. The higher diversity, reduced number of temporal scales and the lower explanatory power of time series models suggest that species dynamics tended to be more stochastic in the dry state. From a resilience perspective our results highlight a paradox: increasing species richness may not necessarily enhance resilience. The loss of cross-scale structure (i.e. the lower number of temporal scales) in community dynamics across sites suggests that resilience erodes during drought. Phytoplankton communities in the dry state are therefore likely less resilient than in the wet state. Our case study demonstrates the potential of time series modeling to assess attributes that mediate resilience. The approach is useful for assessing resilience of alternative states across ecological and other complex systems.	[Angeler, David G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Allen, Craig R.] Univ Nebraska, Sch Nat Resources, Nebraska Cooperat Fish & Wildlife Res Unit, US Geol Survey, Lincoln, NE USA; [Rojo, Carmen; Rodrigo, Maria A.] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Alvarez-Cobelas, Miguel; Sanchez-Carrillo, Salvador] Spanish Natl Res Council, Natl Museum Nat Hist, Madrid, Spain	Swedish University of Agricultural Sciences; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC)	Angeler, DG (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	david.angeler@slu.se	Rojo, Carmen/L-5358-2014; Rodrigo, Maria/K-9079-2014; Sanchez-Carrillo, Salvador/L-1098-2014	Rodrigo, Maria/0000-0003-4106-0643; SANCHEZ-CARRILLO, SALVADOR/0000-0002-5471-977X	August T. Larsson Foundation of the Swedish University of Agricultural Sciences; Spanish Ministry of Economy and Competitiveness [2009 10292]; Spanish Ministry of Environment and National Parks Authority [001/2008]; U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service; Wildlife Management Institute	August T. Larsson Foundation of the Swedish University of Agricultural Sciences; Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Environment and National Parks Authority; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska-Lincoln; United States Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	The authors acknowledge financial support from the August T. Larsson Foundation of the Swedish University of Agricultural Sciences. This study was also funded by the projects CGL 2009 10292 (Spanish Ministry of Economy and Competitiveness) and 001/2008 (Spanish Ministry of Environment and National Parks Authority). The Nebraska Cooperative Fish and Wildlife Research Unit is jointly supported by a cooperative agreement between the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska-Lincoln, the United States Fish and Wildlife Service, and the Wildlife Management Institute. Reference to trade names does not imply endorsement by the authors or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; Allen CR, 2005, ECOSYSTEMS, V8, P958, DOI 10.1007/s10021-005-0147-x; Allen CR., 2008, DISCONTINUITIES ECOS; Angeler DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069174; Angeler DG, 2013, J APPL ECOL, V50, P572, DOI 10.1111/1365-2664.12092; Angeler DG, 2012, ECOL SOC, V17, DOI 10.5751/ES-04928-170232; Angeler DG, 2011, ECOL SOC, V16, DOI 10.5751/ES-04175-160305; Angeler DG, 2009, ECOLOGY, V90, P3245, DOI 10.1890/07-0391.1; Angeler DG, 2000, J PLANKTON RES, V22, P2075, DOI 10.1093/plankt/22.11.2075; [Anonymous], 2001, PANARCHY UNDERSTANDI; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; Bogan MT, 2011, FRESHWATER BIOL, V56, P2070, DOI 10.1111/j.1365-2427.2011.02638.x; Bond NR, 2008, HYDROBIOLOGIA, V600, P3, DOI 10.1007/s10750-008-9326-z; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; Downing AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046135; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Foti R, 2012, P NATL ACAD SCI USA, V109, P19596, DOI 10.1073/pnas.1218056109; Garmestani AS, 2009, ECOL SOC, V14; Gasith A, 1999, ANNU REV ECOL SYST, V30, P51, DOI 10.1146/annurev.ecolsys.30.1.51; Gosselink J.G., 2000, WETLANDS; Heinrich G, 2012, INT J CLIMATOL, V32, P1951, DOI 10.1002/joc.2421; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; HOLLING CS, 1992, ECOL MONOGR, V62, P447, DOI 10.2307/2937313; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P389, DOI 10.1016/j.tree.2013.05.019; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Ireland AW, 2012, WETLANDS, V32, P989, DOI 10.1007/s13157-012-0324-6; Ireland AW, 2011, ECOLOGY, V92, P11, DOI 10.1890/10-0770.1; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Jiang L, 2011, J ANIM ECOL, V80, P577, DOI 10.1111/j.1365-2656.2010.01799.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kreyling J, 2011, ECOL LETT, V14, P758, DOI 10.1111/j.1461-0248.2011.01637.x; Lake PS, 2000, J N AM BENTHOL SOC, V19, P573, DOI 10.2307/1468118; Loverde-Oliveira SM, 2009, ECOSYSTEMS, V12, P807, DOI 10.1007/s10021-009-9258-0; Middleton B., 1999, WETLAND RESTORATION; Newbery DM, 2009, PLANT ECOL, V201, P147, DOI 10.1007/s11258-008-9533-8; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Peterson TJ, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012150; Peterson TJ, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006886; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Rojo C, 2000, HYDROBIOLOGIA, V424, P133, DOI 10.1023/A:1003917414959; Rojo C, 2012, BIODIVERS CONSERV, V21, P2453, DOI 10.1007/s10531-012-0307-1; Sanchez-Carrillo S, 2004, ADV WATER RESOUR, V27, P643, DOI 10.1016/j.advwatres.2004.02.018; SanchezCarrillo S, 2010, WETL ECOL CONSERV MA, V2, P1; Sandgren C.D., 1988, GROWTH REPROD STRATE; Sasaki T, 2011, OECOLOGIA, V166, P761, DOI 10.1007/s00442-011-1916-1; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Seekell DA, 2013, THEOR ECOL-NETH, V6, P385, DOI 10.1007/s12080-013-0183-7; Seekell DA, 2012, ECOSYSTEMS, V15, P741, DOI 10.1007/s10021-012-9542-2; Stow C, 2007, ECOL SOC, V12; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Tuomisto H, 2012, OIKOS, V121, P1203, DOI 10.1111/j.1600-0706.2011.19897.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Van Geest GJ, 2007, ECOSYSTEMS, V10, P36, DOI 10.1007/s10021-006-9000-0; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Walker B, 2004, ECOL SOC, V9; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Yang T, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015192	69	19	19	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77338	10.1371/journal.pone.0077338	http://dx.doi.org/10.1371/journal.pone.0077338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146980	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400110
J	Han, AW; Sandy, M; Fishman, B; Trindade-Silva, AE; Soares, CAG; Distel, DL; Butler, A; Haygood, MG				Han, Andrew W.; Sandy, Moriah; Fishman, Brian; Trindade-Silva, Amaro E.; Soares, Carlos A. G.; Distel, Daniel L.; Butler, Alison; Haygood, Margo G.			Turnerbactin, a Novel Triscatecholate Siderophore from the Shipworm Endosymbiont Teredinibacter turnerae T7901	PLOS ONE			English	Article							NATURAL ORGANIC-LIGANDS; IRON TRANSPORT; ESCHERICHIA-COLI; GENE-CLUSTER; BIOSYNTHESIS; ENTEROBACTIN; SEQUENCE; BIVALVIA; COMPLEXATION; POLYKETIDE	Shipworms are marine bivalve mollusks (Family Teredinidae) that use wood for shelter and food. They harbor a group of closely related, yet phylogenetically distinct, bacterial endosymbionts in bacteriocytes located in the gills. This endosymbiotic community is believed to support the host's nutrition in multiple ways, through the production of cellulolytic enzymes and the fixation of nitrogen. The genome of the shipworm endosymbiont Teredinibacter turnerae T7901 was recently sequenced and in addition to the potential for cellulolytic enzymes and diazotrophy, the genome also revealed a rich potential for secondary metabolites. With nine distinct biosynthetic gene clusters, nearly 7% of the genome is dedicated to secondary metabolites. Bioinformatic analyses predict that one of the gene clusters is responsible for the production of a catecholate siderophore. Here we describe this gene cluster in detail and present the siderophore product from this cluster. Genes similar to the entCEBA genes of enterobactin biosynthesis involved in the production and activation of dihydroxybenzoic acid (DHB) are present in this cluster, as well as a two-module non-ribosomal peptide synthetase (NRPS). A novel triscatecholate siderophore, turnerbactin, was isolated from the supernatant of iron-limited T. turnerae T7901 cultures. Turnerbactin is a trimer of N-(2,3-DHB)-L-Orn-L-Ser with the three monomeric units linked by Ser ester linkages. A monomer, dimer, dehydrated dimer, and dehydrated trimer of 2,3-DHB-L-Orn-L-Ser were also found in the supernatant. A link between the gene cluster and siderophore product was made by constructing a NRPS mutant, TtAH03. Siderophores could not be detected in cultures of TtAH03 by HPLC analysis and Fe-binding activity of culture supernatant was significantly reduced. Regulation of the pathway by iron is supported by identification of putative Fur box sequences and observation of increased Fe-binding activity under iron restriction. Evidence of a turnerbactin fragment was found in shipworm extracts, suggesting the production of turnerbactin in the symbiosis.	[Han, Andrew W.; Fishman, Brian; Haygood, Margo G.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Beaverton, OR USA; [Sandy, Moriah; Butler, Alison] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA; [Trindade-Silva, Amaro E.; Soares, Carlos A. G.] Univ Fed Rio de Janeiro, Inst Biol, Ilha Fundao, CCS, Rio De Janeiro, Brazil; [Distel, Daniel L.] Ocean Genome Legacy Inc, Ipswich, MA USA	Oregon Health & Science University; University of California System; University of California Santa Barbara; Universidade Federal do Rio de Janeiro	Haygood, MG (corresponding author), Oregon Hlth & Sci Univ, Inst Environm Hlth, Beaverton, OR USA.	haygoodm@ebs.ogi.edu	Soares, Carlos A G/H-9464-2016; Trindade-Silva, Amaro/AAO-5685-2020; Distel, Daniel/A-8047-2017; Butler, Alison/D-5094-2015	Soares, Carlos A G/0000-0001-9058-9266; Trindade-Silva, Amaro/0000-0003-4321-065X; Distel, Daniel/0000-0002-3860-194X; Butler, Alison/0000-0002-3525-7864	United States National Institutes of Health [1U01TW008163]; United States National Science Foundation [1059067]; FOGARTY INTERNATIONAL CENTER [U19TW008163, U01TW008163] Funding Source: NIH RePORTER; Direct For Biological Sciences [1442676] Funding Source: National Science Foundation; Division Of Chemistry [1059067] Funding Source: National Science Foundation	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States National Science Foundation(National Science Foundation (NSF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	1. Agency: United States National Institutes of Health, Grant number: 1U01TW008163 (URL: http://grants.nih.gov/grants/oer.htm); 2. Agency: United States National Science Foundation, Grant number: 1059067 (URL: http://www.nsf.gov/funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; BACHHAWAT AK, 1987, J GEN MICROBIOL, V133, P1759; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Bagley MC, 2005, CHEM REV, V105, P685, DOI 10.1021/cr0300441; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Betcher MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045309; Bister B, 2004, BIOMETALS, V17, P471, DOI 10.1023/B:BIOM.0000029432.69418.6a; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; DELORENZO V, 1987, J BACTERIOL, V169, P2624, DOI 10.1128/jb.169.6.2624-2630.1987; Dertz EA, 2006, J AM CHEM SOC, V128, P22, DOI 10.1021/ja055898c; Dias GM, 2012, J BACTERIOL, V194, P904, DOI 10.1128/JB.06583-11; DISTEL DL, 1991, APPL ENVIRON MICROB, V57, P2376, DOI 10.1128/AEM.57.8.2376-2382.1991; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Distel DL, 2002, APPL ENVIRON MICROB, V68, P6292, DOI 10.1128/AEM.68.12.6292-6299.2002; Drummond A. J., 2011, GENEIOUS V5 4; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elshahawi SI, 2013, P NATL ACAD SCI USA, V110, pE295, DOI 10.1073/pnas.1213892110; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; HOFFMANN K, 1994, J BIOL CHEM, V269, P12710; Homann VV, 2009, J NAT PROD, V72, P884, DOI 10.1021/np800640h; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KESTER DR, 1967, LIMNOL OCEANOGR, V12, P176, DOI 10.4319/lo.1967.12.1.0176; KLOEPPER JW, 1980, NATURE, V286, P885, DOI 10.1038/286885a0; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; LOOMIS LD, 1991, INORG CHEM, V30, P906, DOI 10.1021/ic00005a008; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P585, DOI 10.1007/BF02908687; Matsuo Y, 2011, J NAT PROD, V74, P2371, DOI 10.1021/np200290j; Miller M.A., 2010, P GAT COMP ENV WORKS; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nishizawa T, 1999, J BIOCHEM-TOKYO, V126, P520, DOI 10.1093/oxfordjournals.jbchem.a022481; Nishizawa T, 2000, J BIOCHEM, V127, P779, DOI 10.1093/oxfordjournals.jbchem.a022670; OBRIEN IG, 1970, BIOCHIM BIOPHYS ACTA, V215, P393, DOI 10.1016/0304-4165(70)90038-3; PERSMARK M, 1989, J BIOL CHEM, V264, P3187; POLLACK JR, 1970, BIOCHEM BIOPH RES CO, V38, P989, DOI 10.1016/0006-291X(70)90819-3; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; RAYMOND KN, 1984, TOP CURR CHEM, V123, P49; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rock JL, 2006, INFECT IMMUN, V74, P2777, DOI 10.1128/IAI.74.5.2777-2786.2006; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Sandy M, 2011, J NAT PROD, V74, P1207, DOI 10.1021/np200126z; Sandy M, 2010, J NAT PROD, V73, P1038, DOI 10.1021/np900750g; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; SCARROW RC, 1991, INORG CHEM, V30, P900, DOI 10.1021/ic00005a007; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Soengas RG, 2006, TETRAHEDRON LETT, V47, P7113, DOI 10.1016/j.tetlet.2006.07.104; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Wilson MK, 2006, BIOCHEM BIOPH RES CO, V348, P320, DOI 10.1016/j.bbrc.2006.07.055; Winkelmann G, 2002, BIOCHEM SOC T, V30, P691, DOI 10.1042/BST0300691; WU JF, 1995, MAR CHEM, V50, P159, DOI 10.1016/0304-4203(95)00033-N; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085	66	43	43	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76151	10.1371/journal.pone.0076151	http://dx.doi.org/10.1371/journal.pone.0076151			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146831	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400043
J	Pan, S; Liu, C; Zhang, WP; Xu, SS; Wang, N; Li, Y; Gao, J; Wang, Y; Wang, GX				Pan, Sha; Liu, Chao; Zhang, Weiping; Xu, Shanshan; Wang, Nan; Li, Yan; Gao, Jing; Wang, Yang; Wang, Genxuan			The Scaling Relationships between Leaf Mass and Leaf Area of Vascular Plant Species Change with Altitude	PLOS ONE			English	Article							ALLOMETRIC RELATIONSHIPS; BIOMASS INVESTMENT; SIZE; SUPPORT; DISPLAY; LAMINA; LEAVES; FORM	The scaling relationship between leaf dry mass and leaf surface area has important implications for understanding the ability of plants to harvest sunlight and grow. Whether and how the scaling relationships vary across environmental gradients are poorly understood. We analyzed the scaling relationships between leaf mass and leaf area of 121 vascular plant species along an altitudinal gradient in a subtropical monsoon forest. The slopes increased significantly with altitude, it varied from less than 1 at low altitude to more than 1 at high altitude. This means that plants growing at high altitude allocate proportionately more biomass to support tissues in larger leaves and less in smaller leaves, whereas the reverse is true at low altitude. This pattern can be explained by different leaf strategies in response to environmental pressure and constrains.	[Pan, Sha; Liu, Chao; Xu, Shanshan; Wang, Nan; Li, Yan; Gao, Jing; Wang, Yang; Wang, Genxuan] Zhejiang Univ, Coll Life Sci, Inst Ecol, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Weiping] China Agr Univ, Coll Resources & Environm Sci, Minist Educ, Key Lab Plant & Soil Interact, Beijing 100094, Peoples R China	Zhejiang University; China Agricultural University	Wang, GX (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Ecol, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	wang-gx@zju.edu.cn			Zhejiang Provincial Natural Science Foundation of China [LZ13C030002]; Natural Science Fund of China [31330010]; Ministry of Science and Technology of China [2011AA100503]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The study was financially supported by Zhejiang Provincial Natural Science Foundation of China (LZ13C030002), Natural Science Fund of China (31330010) and Ministry of Science and Technology of China (2011AA100503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 1999, AM J BOT, V86, P1272, DOI 10.2307/2656775; Calvo-Alvarado JC, 2008, TREE PHYSIOL, V28, P1601, DOI 10.1093/treephys/28.11.1601; Falster D.S., 2006, USERS GUIDE SMATR ST; Givnish TJ., 1986, P 6 MAR MOORS CAB S, V6; Li GY, 2008, FUNCT ECOL, V22, P557, DOI 10.1111/j.1365-2435.2008.01407.x; Milla R, 2008, FUNCT ECOL, V22, P565, DOI 10.1111/j.1365-2435.2008.01406.x; Milla R, 2007, P ROY SOC B-BIOL SCI, V274, P2109, DOI 10.1098/rspb.2007.0417; Niinemets U, 2004, TREE PHYSIOL, V24, P141, DOI 10.1093/treephys/24.2.141; NIINEMETS U, 1994, FOREST ECOL MANAG, V70, P1, DOI 10.1016/0378-1127(94)90070-1; Niinemets U, 1999, TREE PHYSIOL, V19, P349; Niinemets U, 2007, PLANT CELL ENVIRON, V30, P1052, DOI 10.1111/j.1365-3040.2007.01683.x; Niinemets U, 2007, ANN BOT-LONDON, V100, P283, DOI 10.1093/aob/mcm107; Niinemets U, 2006, NEW PHYTOL, V171, P91, DOI 10.1111/j.1469-8137.2006.01741.x; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2007, P NATL ACAD SCI USA, V104, P8891, DOI 10.1073/pnas.0701135104; Niklas KJ, 2011, AM J BOT, V98, P1381, DOI 10.3732/ajb.1100106; Niklas KJ, 2009, AM J BOT, V96, P531, DOI 10.3732/ajb.0800250; Niklas KJ, 1999, NEW PHYTOL, V143, P19, DOI 10.1046/j.1469-8137.1999.00441.x; Niklas KJ., 1992, PLANT BIOMECHANICS E, DOI DOI 10.1007/BF01875445; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Poorter L, 2008, OECOLOGIA, V158, P35, DOI 10.1007/s00442-008-1131-x; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; SHIPLEY B, 1995, FUNCT ECOL, V9, P312, DOI 10.2307/2390579; Takenaka A, 2001, FUNCT ECOL, V15, P660, DOI 10.1046/j.0269-8463.2001.00562.x; Tomlinson KW, 2013, J ECOL, V101, P430, DOI 10.1111/1365-2745.12056; Zhang WP, 2012, ECOL RES, V27, P819, DOI 10.1007/s11284-012-0959-z; Zhang WP, 2011, ECOL RES, V26, P819, DOI 10.1007/s11284-011-0843-2	27	27	31	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76872	10.1371/journal.pone.0076872	http://dx.doi.org/10.1371/journal.pone.0076872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146938	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400088
J	Alegret, M; Espinosa, A; Valero, S; Vinyes-Junque, G; Ruiz, A; Hernandez, I; Rosende-Roca, M; Mauleon, A; Becker, JT; Tarraga, L; Boada, M				Alegret, Montserrat; Espinosa, Ana; Valero, Sergi; Vinyes-Junque, Georgina; Ruiz, Agustin; Hernandez, Isabel; Rosende-Roca, Maitee; Mauleon, Ana; Becker, James T.; Tarraga, Lluis; Boada, Merce			Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEURONORMA PROJECT NORMS; BOSTON NAMING TEST; NORMATIVE DATA; NATIONAL INSTITUTE; ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; DEMENTIA; ASSOCIATION; VERSION	The neuropsychological battery used in Fundacio ACE (NBACE) is a relatively brief, and easy to administer, test battery that was designed to detect cognitive impairment in the adulthood. The NBACE includes measures of cognitive information processing speed, orientation, attention, verbal learning and memory, language, visuoperception, praxis and executive functions. The aim of the present study was to establish the cut-off scores for impairment for different levels of age and education that could be useful in the cognitive assessment of Spanish subjects who are at risk for cognitive impairment, especially dementia. Data from 1018 patients with a mild dementia syndrome, and 512 cognitively healthy subjects, older than 44 years, from the Memory Clinic of Fundacio ACE (Barcelona, Spain) were analyzed. In the whole sample, cut-off scores and sensitivity/specificity values were calculated for six conditions after combining 3 age ranges (44 to 64; 65 to 74; and older than 74 years old) by 2 educational levels (until Elementary school; and more than Elementary school). Moreover, general cut-offs are reported for Catalan and Spanish speakers. The results showed that most of NBACE tests reached good sensitivity and specificity values, except for Ideomotor praxis, Repetition and Verbal Comprehension tests, which had a ceiling effect. Word List Learning from the Wechsler Memory Scale-III and Semantic Verbal Fluency were the most useful tests to discriminate between cognitively healthy and demented subjects. The NBACE has been shown to be a useful tool able to detect cognitive impairment, especially dementia, in older than 44 years Spanish persons.	[Alegret, Montserrat; Espinosa, Ana; Valero, Sergi; Vinyes-Junque, Georgina; Ruiz, Agustin; Hernandez, Isabel; Rosende-Roca, Maitee; Mauleon, Ana; Tarraga, Lluis; Boada, Merce] Fundacio ACE, Inst Catala Neurociencies Aplicades, Memory Clin, Barcelona, Spain; [Valero, Sergi] Univ Autonoma Barcelona, CIBERSAM, Dept Psychiat, Hosp Univ Vall dHebron, E-08193 Barcelona, Spain; [Becker, James T.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Becker, James T.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Becker, James T.] Univ Pittsburgh, Dept Psychol, Sch Med, Pittsburgh, PA 15260 USA; [Boada, Merce] Univ Autonoma Barcelona VHIR UAB, Inst Recerca, Hosp Univ Vall dHebron, Barcelona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Hospital Universitari Vall d'Hebron; University of Barcelona; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Alegret, M (corresponding author), Fundacio ACE, Inst Catala Neurociencies Aplicades, Memory Clin, Barcelona, Spain.	malegret@fundacioace.com	Valero, Sergi/AAB-7596-2019; Alegret, Montserrat/AAB-8239-2019; Ruiz, Agustín/L-4469-2019; Rosende-Roca, Maitee/AAB-8427-2019; Ruiz, Agustin/G-5677-2012	Alegret, Montserrat/0000-0002-8164-9500; Ruiz, Agustín/0000-0003-2633-2495; Becker, James/0000-0003-4425-4726; Espinosa, Ana/0000-0001-8414-6522; Valero, Sergi/0000-0002-6599-948X	Spanish Ministry of Health from Instituto de Salud Carlos III (Madrid) [FISS PI10/00945]; Agencia d'Avaluacio de Tecnologia i Recerca Mediques. Departament de Salut de la Generalitat de Catalunya (Health Department of the Catalan Government) [390]	Spanish Ministry of Health from Instituto de Salud Carlos III (Madrid); Agencia d'Avaluacio de Tecnologia i Recerca Mediques. Departament de Salut de la Generalitat de Catalunya (Health Department of the Catalan Government)	This work was supported by the Spanish Ministry of Health from Instituto de Salud Carlos III (Madrid) (FISS PI10/00945) and by the Agencia d'Avaluacio de Tecnologia i Recerca Mediques. Departament de Salut de la Generalitat de Catalunya (Health Department of the Catalan Government) (390). Fundacio ACE is grateful to Mrs. Trinitat Port for her legacy to support their research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo A, 2009, ALZ DIS ASSOC DIS, V23, P102, DOI 10.1097/WAD.0b013e318193e376; Alegret M, 2012, J CLIN EXP NEUROPSYC, V34, P209, DOI 10.1080/13803395.2011.630652; Artiola I Fortuny L., 1999, MANUAL NORMAS PROCED; Benton A.L., 1994, CONTRIBUTIONS NEUROP; Blesa R, 2001, NEUROPSYCHOLOGIA, V39, P1150, DOI 10.1016/S0028-3932(01)00055-0; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Boada M, 2002, NEUROLOGIA, V17, P317; Boada M, 2013, ALZHEIMERS IN PRESS; Bohm P, 2005, NEUROLOGIA, V20, P402; Chester JG, 2011, AM J MED, V124, P662, DOI 10.1016/j.amjmed.2011.02.023; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Espinosa A, 2013, J ALZHEIMERS DIS, V34, P769, DOI 10.3233/JAD-122002; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Freitas S, 2013, ALZ DIS ASSOC DIS, V27, P37, DOI 10.1097/WAD.0b013e3182420bfe; Gollan TH, 2007, J INT NEUROPSYCH SOC, V13, P197, DOI 10.1017/S1355617707070038; Gollan TH, 2010, NEUROPSYCHOLOGIA, V48, P1356, DOI 10.1016/j.neuropsychologia.2009.12.038; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Hanninen Tuomo, 2010, Duodecim, V126, P2013; Heaton R.K., 2004, REVISED COMPREHENSIV; LINN MW, 1982, J AM GERIATR SOC, V30, P378, DOI 10.1111/j.1532-5415.1982.tb02835.x; Manubens JM, 2005, NEUROLOGIA, V20, P174; Maruta C, 2011, EUR J NEUROL, V18, P279, DOI 10.1111/j.1468-1331.2010.03134.x; McKeith IG, 2005, NEUROLOGY, V65, P1654; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mitroshima M, 2005, HDB NORMATIVE DATA N; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nordlund A, 2005, J NEUROL NEUROSUR PS, V76, P1485, DOI 10.1136/jnnp.2004.050385; Pasquier F, 1999, J NEUROL, V246, P6, DOI 10.1007/s004150050299; Pena-Casanova J, 1997, Neurologia, V12, P61; Pena-Casanova J, 1997, Neurologia, V12, P69; Pena-Casanova J, 1997, Neurologia, V12, P99; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P343, DOI 10.1093/arclin/acp039; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P395, DOI 10.1093/arclin/acp042; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P371, DOI 10.1093/arclin/acp041; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P355, DOI 10.1093/arclin/acp040; Pendlebury ST, 2012, STROKE, V43, P464, DOI 10.1161/STROKEAHA.111.633586; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Poewe W, 2008, INT J CLIN PRACT, V62, P1581, DOI 10.1111/j.1742-1241.2008.01869.x; Quijano TD, 2004, MED CLIN-BARCELONA, V122, P727, DOI 10.1157/13062190; Quijano TDS, 2004, NEUROLOGIA, V19, P344; Quintana M, 2011, ARCH CLIN NEUROPSYCH, V26, P144, DOI 10.1093/arclin/acq098; Rami L, 2009, REV NEUROLOGIA, V49, P169, DOI 10.33588/rn.4904.2008623; Rami L, 2008, J CLIN EXP NEUROPSYC, V30, P1, DOI 10.1080/13803390701743954; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Rountree SD, 2007, DEMENT GERIATR COGN, V24, P476, DOI 10.1159/000110800; Solomon P R, 1998, Fam Med, V30, P265; Sylvestre G, 2011, REV NEUROL-FRANCE, V167, P495, DOI 10.1016/j.neurol.2010.12.004; TINETTI ME, 1986, AM J MED, V80, P429, DOI 10.1016/0002-9343(86)90717-5	51	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76436	10.1371/journal.pone.0076436	http://dx.doi.org/10.1371/journal.pone.0076436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146868	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400060
J	Weston, C; Bond, M; Croft, W; Ladds, G				Weston, Cathryn; Bond, Michael; Croft, Wayne; Ladds, Graham			The Coordination of Cell Growth during Fission Yeast Mating Requires Ras1-GTP Hydrolysis (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							NUCLEOTIDE EXCHANGE FACTOR; SCHIZOSACCHAROMYCES-POMBE; PROTEIN-KINASE; P-FACTOR; RAS; PHEROMONE; GTPASE; CDC42; POLARITY; ACTIVATION	The spatial and temporal control of polarity is fundamental to the survival of all organisms. Cells define their polarity using highly conserved mechanisms that frequently rely upon the action of small GTPases, such as Ras and Cdc42. Schizosaccharomyces pombe is an ideal system with which to study the control of cell polarity since it grows from defined tips using Cdc42-mediated actin remodeling. Here we have investigated the importance of Ras1-GTPase activity for the coordination of polarized cell growth during fission yeast mating. Following pheromone stimulation, Ras1 regulates both a MAPK cascade and the activity of Cdc42 to enable uni-directional cell growth towards a potential mating partner. Like all GTPases, when bound to GTP, Ras1 adopts an active conformation returning to an inactive state upon GTP-hydrolysis, a process accelerated through interaction with negative regulators such as GAPs. Here we show that, at low levels of pheromone stimulation, loss of negative regulation of Ras1 increases signal transduction via the MAPK cascade. However, at the higher concentrations observed during mating, hyperactive Ras1 mutations promote cell death. We demonstrate that these cells die due to their failure to coordinate active Cdc42 into a single growth zone resulting in disorganized actin deposition and unsustainable elongation from multiple tips. These results provide a striking demonstration that the deactivation stage of Ras signaling is fundamentally important in modulating cell polarity.	[Weston, Cathryn; Bond, Michael; Croft, Wayne; Ladds, Graham] Univ Warwick, Div Biomed Cell Biol, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Warwick	Weston, C (corresponding author), Univ Warwick, Div Biomed Cell Biol, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	Cathryn.weston@warwick.ac.uk		Ladds, Graham/0000-0001-7320-9612	Warwick Postgraduate Research Scholarships; University Hospitals of Coventry and Warwickshire NHS Trust; Biotechnology and Biological Sciences Research Council [BB/G01227X/1]; Birmingham Science City Research Alliance; BBSRC [BB/G01227X/1] Funding Source: UKRI	Warwick Postgraduate Research Scholarships; University Hospitals of Coventry and Warwickshire NHS Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Birmingham Science City Research Alliance; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Warwick Postgraduate Research Scholarships, the University Hospitals of Coventry and Warwickshire NHS Trust, the Biotechnology and Biological Sciences Research Council grant number (BB/G01227X/1) and Birmingham Science City Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Bendezu FO, 2013, CURR BIOL, V23, P42, DOI 10.1016/j.cub.2012.10.042; Brown JL, 1997, GENE DEV, V11, P2972, DOI 10.1101/gad.11.22.2972; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Coll PM, 2003, MOL BIOL CELL, V14, P313, DOI 10.1091/mbc.E02-07-0400; Das M, 2012, SCIENCE, V337, P239, DOI 10.1126/science.1218377; DAVEY J, 1992, EMBO J, V11, P951, DOI 10.1002/j.1460-2075.1992.tb05134.x; Davey J, 1998, YEAST, V14, P1529, DOI 10.1002/(SICI)1097-0061(199812)14:16<1529::AID-YEA357>3.0.CO;2-0; DAVEY J, 1995, METH MOL G, V6, P247, DOI DOI 10.1016/S1067-2389(06)80016-6; Didmon M, 2002, CURR GENET, V41, P241, DOI 10.1007/s00294-002-0301-3; EGEL R, 1994, YEAST, V10, P1347, DOI 10.1002/yea.320101012; FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7; Garcia P, 2006, YEAST, V23, P1031, DOI 10.1002/yea.1409; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Hachet-Haas M, 2006, MICROSC RES TECHNIQ, V69, P941, DOI 10.1002/jemt.20376; Hamilton M, 1998, ONCOGENE, V16, P1417, DOI 10.1038/sj.onc.1201653; Hirota K, 2003, MOL BIOL CELL, V14, P3617, DOI 10.1091/mbc.E02-10-0665; HUGHES DA, 1994, J CELL SCI, V107, P3635; IMAI Y, 1991, MOL CELL BIOL, V11, P3088, DOI 10.1128/MCB.11.6.3088; IMAI Y, 1992, MOL CELL BIOL, V12, P1827, DOI 10.1128/MCB.12.4.1827; JUNG V, 1994, MOL CELL BIOL, V14, P3707, DOI 10.1128/MCB.14.6.3707; Kelly FD, 2011, MOL BIOL CELL, V22, P3801, DOI 10.1091/mbc.E11-01-0057; KITAMURA K, 1991, EMBO J, V10, P3743, DOI 10.1002/j.1460-2075.1991.tb04943.x; Ladds G, 2005, MOL MICROBIOL, V55, P482, DOI 10.1111/j.1365-2958.2004.04394.x; Ladds G, 1996, MOL MICROBIOL, V20, P35, DOI 10.1111/j.1365-2958.1996.tb02486.x; Ladds G, 2000, MOL MICROBIOL, V36, P377, DOI 10.1046/j.1365-2958.2000.01855.x; Ladds G, 2003, MOL MICROBIOL, V47, P781, DOI 10.1046/j.1365-2958.2003.03336.x; Ladds G, 2000, MOL MICROBIOL, V38, P839, DOI 10.1046/j.1365-2958.2000.02180.x; Ladds G, 2007, CELL SIGNAL, V19, P103, DOI 10.1016/j.cellsig.2006.05.027; MAEDA T, 1990, P NATL ACAD SCI USA, V87, P7814, DOI 10.1073/pnas.87.20.7814; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARKS J, 1986, J CELL SCI, P229; MASUDA T, 1995, J BIOL CHEM, V270, P1979, DOI 10.1074/jbc.270.5.1979; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Merla A, 2000, EUR J CELL BIOL, V79, P469, DOI 10.1078/0171-9335-00073; MITCHISON JM, 1985, J CELL SCI, V75, P357; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Nakano K, 2001, GENES CELLS, V6, P1031, DOI 10.1046/j.1365-2443.2001.00485.x; NIELSEN O, 1992, EMBO J, V11, P1391, DOI 10.1002/j.1460-2075.1992.tb05184.x; Onken B, 2006, P NATL ACAD SCI USA, V103, P9045, DOI 10.1073/pnas.0603318103; OTTILIE S, 1995, EMBO J, V14, P5908, DOI 10.1002/j.1460-2075.1995.tb00278.x; Papadaki P, 2002, MOL CELL BIOL, V22, P4598, DOI 10.1128/MCB.22.13.4598-4606.2002; Rincon SA, 2009, MOL BIOL CELL, V20, P4390, DOI 10.1091/mbc.E09-03-0207; SAZER S, 1990, J CELL SCI, V97, P509; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; SNELL V, 1993, DEVELOPMENT, P289; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Toya M, 1999, MOL BIOL CELL, V10, P2745, DOI 10.1091/mbc.10.8.2745; Tratner I, 1997, GENE, V193, P203, DOI 10.1016/S0378-1119(97)00115-7; Tu H, 1997, MOL CELL BIOL, V17, P5876, DOI 10.1128/MCB.17.10.5876; Vanni C, 2005, CELL CYCLE, V4, P1675, DOI 10.4161/cc.4.11.2170; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1	54	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77487	10.1371/journal.pone.0077487	http://dx.doi.org/10.1371/journal.pone.0077487			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147005	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400112
J	Lee, S; Kim, BK; Kim, SU; Park, Y; Chang, S; Park, JY; Kim, DY; Ahn, SH; Chon, CY; Han, KH				Lee, Sangheun; Kim, Beom Kyung; Kim, Seung Up; Park, Yehyun; Chang, Sooyun; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub			Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CONCURRENT TRANSARTERIAL CHEMOEMBOLIZATION; INFUSION CHEMOTHERAPY; CLINICAL-TRIAL; PHASE-III; RADIOTHERAPY; EXPRESSION; THERAPY; 5-FLUOROURACIL	Background: Although sorafenib is accepted as the standard of care in advanced hepatocellular carcinoma (HCC), its therapeutic benefit is marginal. Here, we aimed to compare the efficacy and safety of sorafenib monotherapy (S-M) and sorafenib-based loco-regional treatments (S-LRTs) in advanced HCC. Methods: From 2007 to 2012, 290 patients with advanced HCC (Barcelona Clinic Liver Cancer stage C) with S-M (n = 226) or S-LRTs (n = 64) were reviewed retrospectively. Survival outcomes and treatment-related toxicities between two groups were analyzed. Results: Variables related to tumor burden and liver function were similar between the groups (all P > 0.05). Within the entire population, the S-LRTs group had both longer median overall survival (OS) (8.5 vs 5.5 months, P = 0.001) and progression-free survival (PFS) (5.3 vs 3.0 months, P = 0.002) than the S-M group. Furthermore, the S-LRTs group had longer Os than the S-M group in a subgroup with neither extrahepatic spread (EHS) nor regional nodal involvement (RNI) (18.0 vs 7.8 months, P = 0.019) and in a subgroup with EHS and/or RNI (8.3 vs 4.8 months, P = 0.028). In addition, the S-LRTs group had longer PFS than the S-M group in the subgroup with neither EHS nor RNI (9.6 vs 3.2 months, P = 0.027). Treatment: Related toxicity was similar between two groups. Conclusion: Combined use of sorafenib and LRTs may provide better treatment outcomes without significantly increasing treatment-related toxicities, even in patients with EHS and/or RNI. Therefore, addition of active LRTs might be considered, if feasible.	[Lee, Sangheun; Kim, Beom Kyung; Kim, Seung Up; Park, Yehyun; Chang, Sooyun; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Liver Canc Special Clin, Seoul, South Korea; [Kim, Seung Up; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Ahn, Sang Hoon; Han, Kwang-Hyub] Brain Korea Project Med Sci, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, SU (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ksukorea@yuhs.ac; gihankhys@yuhs.ac	Park, Jun Yong/H-7127-2019; Park, Yehyun/AAC-8861-2022	Park, Yehyun/0000-0001-8811-0631; Kim, Beom Kyung/0000-0002-5363-2496; Han, Kwang-Hyub/0000-0003-3960-6539; Kim, Seung Up/0000-0002-9658-8050; Ahn, Sang Hoon/0000-0002-3629-4624; Park, Jun Yong/0000-0001-6324-2224	Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea [A102065]	Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea	This study was supported in part by a grant of the Korea Healthcare technology R & D project, Ministry of Health and Welfare, Republic of Korea (number A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.202001; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; Cabrera R, 2011, ALIMENT PHARM THER, V34, P205, DOI 10.1111/j.1365-2036.2011.04697.x; Cao C, 2006, CANCER RES, V66, P11409, DOI 10.1158/0008-5472.CAN-06-2414; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Chung YL, 2006, CLIN CANCER RES, V12, P2706, DOI 10.1158/1078-0432.CCR-05-2721; Di Costanzo GG, 2012, DIGEST LIVER DIS, V44, P788, DOI 10.1016/j.dld.2012.04.001; Han KH, 2008, CANCER-AM CANCER SOC, V113, P995, DOI 10.1002/cncr.23684; Jiang HC, 2007, INT J CANCER, V121, P416, DOI 10.1002/ijc.22655; Kim BK, 2011, J CANCER RES CLIN, V137, P659, DOI 10.1007/s00432-010-0917-5; Kim BK, 2011, CANCER-AM CANCER SOC, V117, P4779, DOI 10.1002/cncr.26099; Kim BK, 2011, LIVER INT, V31, P369, DOI 10.1111/j.1478-3231.2010.02368.x; Kim HY, 2011, J GASTROEN HEPATOL, V26, P1612, DOI 10.1111/j.1440-1746.2011.06751.x; Kim JK, 2006, CLIN CANCER RES, V12, P543, DOI 10.1158/1078-0432.CCR-05-1730; Koom WS, 2010, INT J RADIAT ONCOL, V77, P1433, DOI 10.1016/j.ijrobp.2009.07.1676; Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007; Lee JM, 2010, ONCOLOGY-BASEL, V78, P167, DOI 10.1159/000315246; Lencioni R, 2012, RADIOLOGY, V262, P43, DOI 10.1148/radiol.11110144; Li X, 2004, WORLD J GASTROENTERO, V10, P2878; Lipworth AD, 2009, ONCOLOGY-BASEL, V77, P257, DOI 10.1159/000258880; Liver Korean Cancer Study Group and National Cancer Center, 2009, KOREAN J HEPATOL, V15, P391, DOI [10.3350/kjhep.2009.15.3.391, DOI 10.3350/KJHEP.2009.15.3.391.PUBMED:19783891]; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma BBY, 2003, J CLIN ONCOL, V21, P2760, DOI 10.1200/JCO.2003.10.044; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Park JY, 2007, CANCER-AM CANCER SOC, V110, P129, DOI 10.1002/cncr.22759; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Qu XD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-263; Seong J, 2009, LIVER INT, V29, P147, DOI 10.1111/j.1478-3231.2008.01873.x; Sergio A, 2008, AM J GASTROENTEROL, V103, P914, DOI 10.1111/j.1572-0241.2007.01712.x; Sieghart W, 2012, EUR RADIOL, V22, P1214, DOI 10.1007/s00330-011-2368-z; Wang B, 2008, ACTA RADIOL, V49, P523, DOI 10.1080/02841850801958890; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yoo DJ, 2011, J GASTROEN HEPATOL, V26, P145, DOI 10.1111/j.1440-1746.2010.06341.x; Yoon S, 2012, INT J RADIAT ONCOL, V82, P2004, DOI 10.1016/j.ijrobp.2011.03.019	39	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77240	10.1371/journal.pone.0077240	http://dx.doi.org/10.1371/journal.pone.0077240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155932	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300066
J	Liu, YT; Fan, YY; Xu, CH; Lin, XL; Lu, YK; Zhang, XL; Zhang, CX; Chen, YM				Liu, Yuan-ting; Fan, Yu-ying; Xu, Chun-hua; Lin, Xiao-ling; Lu, Yun-kai; Zhang, Xing-lan; Zhang, Cai-xia; Chen, Yu-ming			Habitual Consumption of Soy Products and Risk of Nasopharyngeal Carcinoma in Chinese Adults: A Case-Control Study	PLOS ONE			English	Article							PROSPECTIVE COHORT; FOOD-CONSUMPTION; PRESERVED FOODS; LUNG-CANCER; METAANALYSIS; INHIBITION; FRUIT	Background and Objectives: Many studies have shown a negative association between the consumption of soy products and the risk of some cancers, but little is known about the effect of soy consumption on nasopharyngeal carcinoma. We assessed the association between the consumption of soy products on nasopharyngeal carcinoma risk in Chinese individuals. Methods: This case-control study included 600 (448 males and 152 females) incident cases of nasopharyngeal carcinoma, and an equal number of controls, matched according to gender, age (+/- 3 y) and household type to the nasopharyngeal carcinoma cases. All subjects were recruited from hospitals in Guangzhou, China. A face-to-face interview was conducted with each study individual to collect general information and habitual dietary intake using a 78-item quantitative food-frequency questionnaire. Odds ratios and their 95% confidence intervals were estimated using conditional logistic regression analyses. Results: The median intakes of soy foods (in protein) were 0.5/0.5, 1.4/1.7, 2.7/3.3 and 6.1/7.7 (male/female) g/d in the quartiles 1 to 4. Both univariate and multivariate analyses showed no significant association between the consumption of soy proteins or soy isoflavones and the risk of nasopharyngeal carcinoma. The adjusted odds ratios (95% confidence intervals) between extreme quartiles were 0.97 (0.66-1.45) for soy proteins and 0.97 (0.66-1.42) for total isoflavones. Null associations were also observed between intake of the individual isoflavones daidzein, genistein and glycitein and NPC risk, with adjusted odds ratios for the extreme quartiles ranging between 0.73 and 1.23. Conclusion: Habitual consumption of soy products had no significant effect on the risk of nasopharyngeal carcinoma in Chinese adults with a relatively low intake.	[Liu, Yuan-ting; Xu, Chun-hua; Zhang, Cai-xia; Chen, Yu-ming] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yuan-ting] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Fan, Yu-ying; Lin, Xiao-ling; Zhang, Xing-lan] Sun Yat Sen Univ, Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Yun-kai] Cent Hosp Panyu Dist, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, YM (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China.	chenyum@mail.sysu.edu.cn	Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022	chen, Yu-ming/0000-0003-1658-5528	Sun Yat-sen University, Guangzhou, People's Republic of China	Sun Yat-sen University, Guangzhou, People's Republic of China	This study was supported by the 5010 Program for Clinical Researches of Sun Yat-sen University, Guangzhou, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayhen Xukurhan, 2007, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V42, P783; Chan SG, 2009, J AGR FOOD CHEM, V57, P5386, DOI 10.1021/jf803870k; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Chen YM, 2006, BRIT J NUTR, V96, P745, DOI 10.1079/BJN20061883; Han HY, 2010, NUTR CANCER, V62, P641, DOI 10.1080/01635581003605490; Huang C, 2009, J CELL PHYSIOL, V221, P394, DOI 10.1002/jcp.21867; Hwang YW, 2009, NUTR CANCER, V61, P598, DOI 10.1080/01635580902825639; Jia WH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-178; Johnson J, 2011, MOL NUTR FOOD RES, V55, P58, DOI 10.1002/mnfr.201000420; Keinan-Boker L, 2004, AM J CLIN NUTR, V79, P282; Kim J, 2011, CANCER SCI, V102, P231, DOI 10.1111/j.1349-7006.2010.01770.x; LEE HP, 1994, INT J CANCER, V59, P585, DOI 10.1002/ijc.2910590502; Liu YT, 2012, CANCER CAUSE CONTROL, V23, P589, DOI 10.1007/s10552-012-9923-z; Lobo RA, 2011, MENOPAUSE, V18, P237, DOI [10.1097/gme.0b013e3181e9e538, 10.1097/gme.0b013e31821fc8e0]; Mao YP, 2009, INT J RADIAT ONCOL, V73, P1326, DOI 10.1016/j.ijrobp.2008.07.062; Shimazu T, 2010, AM J CLIN NUTR, V91, P722, DOI 10.3945/ajcn.2009.28161; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Xie Y, 2001, CHINESE MED J-PEKING, V114, P530; XU B, 1999, J CLIN ORL, V13, P347; Yang G, 2012, AM J EPIDEMIOL, V176, P846, DOI 10.1093/aje/kws168; Yang G, 2009, AM J CLIN NUTR, V89, P577, DOI 10.3945/ajcn.2008.26742; Yang YX, 2004, CHINA FOOD COMPOSITI; YU MC, 1988, CANCER RES, V48, P1954; Yu WM, 2009, J LARYNGOL OTOL, V123, P1067, DOI 10.1017/S0022215109005623; Zhang C, 2009, CANCER SCI, V101, P501; Zhang CX, 2009, ASIA PAC J CLIN NUTR, V18, P240; Zou J, 2000, J Radiat Res, V41 Suppl, P53	30	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77822	10.1371/journal.pone.0077822	http://dx.doi.org/10.1371/journal.pone.0077822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155974	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300108
J	Lo, SC; Hung, GC; Li, BJ; Lei, HY; Li, TW; Nagamine, K; Zhang, J; Tsai, S; Bryant, R				Lo, Shyh-Ching; Hung, Guo-Chiuan; Li, Bingjie; Lei, Haiyan; Li, Tianwei; Nagamine, Kenjiro; Zhang, Jing; Tsai, Shien; Bryant, Richard			Isolation of Novel Afipia septicemium and Identification of Previously Unknown Bacteria Bradyrhizobium sp OHSU_III from Blood of Patients with Poorly Defined Illnesses	PLOS ONE			English	Article							NEWLY DISCOVERED MYCOPLASMA; GENOME SEQUENCE; SP-NOV; STRAIN; SPIROPLASMA; INFECTION; PENETRANS; 16S	Cultures previously set up for isolation of mycoplasmal agents from blood of patients with poorly-defined illnesses, although not yielding positive results, were cryopreserved because of suspicion of having low numbers of unknown microbes living in an inactive state in the broth. We re-initiated a set of 3 cultures for analysis of the "uncultivable" or poorly-grown microbes using NGS technology. Broth of cultures from 3 blood samples, submitted from OHSU between 2000 and 2004, were inoculated into culture flasks containing fresh modified SP4 medium and kept at room temperature (RT), 30 degrees C and 35 degrees C. The cultures showing evidence of microbial growth were expanded and subjected to DNA analysis by genomic sequencing using Illumina MiSeq. Two of the 3 re-initiated blood cultures kept at RT after 7-8 weeks showed evidence of microbial growth that gradually reached into a cell density with detectable turbidity. The microbes in the broth when streaked on SP4 agar plates produced microscopic colonies in similar to 2 weeks. Genomic studies revealed that the microbes isolated from the 2 blood cultures were a novel Afipia species, tentatively named Afipia septicemium. Microbes in the 3 rd culture (OHSU_III) kept at RT had a limited level of growth and could not reach a plateau with high cell density. Genomic sequencing identified the microbe in the culture as a previously unknown species of Bradyrhizobium bacteria. This study reports on the isolation of novel Afipia and Bradyrhizobium species. Isolation of Bradyrhizobium species bacteria has never been reported in humans. The study also reveals a previously unrecognized nature of hematogenous infections by the 2 unique groups of Bradyrhizobiaceae. Our studies show that improvement of culture system plus effective use of NGS technology can facilitate findings of infections by unusual microbes in patients having poorly-defined, sometimes mysterious illnesses.	[Lo, Shyh-Ching; Hung, Guo-Chiuan; Li, Bingjie; Lei, Haiyan; Li, Tianwei; Nagamine, Kenjiro; Zhang, Jing; Tsai, Shien] US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies,Ctr Biol Eva, Bethesda, MD 20014 USA; [Bryant, Richard] Oregon Hlth & Sci Univ, Dept Infect Dis, Portland, OR 97201 USA	US Food & Drug Administration (FDA); Oregon Health & Science University	Lo, SC (corresponding author), US FDA, Tissue Microbiol Lab, Div Cellular & Gene Therapies, Off Cellular Tissue & Gene Therapies,Ctr Biol Eva, Bethesda, MD 20014 USA.	shyhching.lo@fda.hhs.gov			FDA Modernizing Science research grant	FDA Modernizing Science research grant	The study was supported in part by FDA Modernizing Science research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; BEECHAM HJ, 1991, LANCET, V338, P1014, DOI 10.1016/0140-6736(91)91874-T; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Biesecker LG, 2012, GENET MED, V14, P393, DOI 10.1038/gim.2011.78; BRENNER DJ, 1991, J CLIN MICROBIOL, V29, P2450, DOI 10.1128/JCM.29.11.2450-2460.1991; CHEN TA, 1975, SCIENCE, V188, P1015, DOI 10.1126/science.188.4192.1015; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Galardini M, 2011, SOURCE CODE BIOL MED, V6, DOI 10.1186/1751-0473-6-11; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; La Scola B, 2000, FEMS MICROBIOL ECOL, V34, P129, DOI 10.1016/S0168-6496(00)00084-2; La Scola B, 2002, INT J SYST EVOL MICR, V52, P1773, DOI [10.1099/ijs.0.02149-0, 10.1099/00207713-52-5-1773]; LO SC, 1991, LANCET, V338, P1415, DOI 10.1016/0140-6736(91)92721-D; LO SC, 1992, INT J SYST BACTERIOL, V42, P357, DOI 10.1099/00207713-42-3-357; de Souza JAM, 2012, J BACTERIOL, V194, P3547, DOI 10.1128/JB.00563-12; McCook A, 2011, NATURE, V476, P270, DOI 10.1038/476270a; Pagnier I, 2012, J BACTERIOL, V194, P7018, DOI 10.1128/JB.01918-12; Pearce SL, 2011, J BACTERIOL, V193, P5057, DOI 10.1128/JB.05647-11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TULLY JG, 1981, LANCET, V1, P1288; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; WANG RYH, 1992, LANCET, V340, P1312, DOI 10.1016/0140-6736(92)92493-Y; Willems A, 2001, INT J SYST EVOL MICR, V51, P111, DOI 10.1099/00207713-51-1-111; WILLIAMSON DL, 1975, SCIENCE, V188, P1018, DOI 10.1126/science.188.4192.1018; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001	28	8	8	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76142	10.1371/journal.pone.0076142	http://dx.doi.org/10.1371/journal.pone.0076142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155888	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300022
J	Alm, PA; Karlsson, R; Sundberg, M; Axelson, HW				Alm, Per A.; Karlsson, Ragnhild; Sundberg, Madeleine; Axelson, Hans W.			Hemispheric Lateralization of Motor Thresholds in Relation to Stuttering	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; NON-SPEECH; FLUENT; ADULTS	Stuttering is a complex speech disorder. Previous studies indicate a tendency towards elevated motor threshold for the left hemisphere, as measured using transcranial magnetic stimulation (TMS). This may reflect a monohemispheric motor system impairment. The purpose of the study was to investigate the relative side-to-side difference (asymmetry) and the absolute levels of motor threshold for the hand area, using TMS in adults who stutter (n = 15) and in controls (n = 15). In accordance with the hypothesis, the groups differed significantly regarding the relative side-to-side difference of finger motor threshold (p = 0.0026), with the stuttering group showing higher motor threshold of the left hemisphere in relation to the right. Also the absolute level of the finger motor threshold for the left hemisphere differed between the groups (p = 0.049). The obtained results, together with previous investigations, provide support for the hypothesis that stuttering tends to be related to left hemisphere motor impairment, and possibly to a dysfunctional state of bilateral speech motor control.	[Alm, Per A.; Karlsson, Ragnhild; Sundberg, Madeleine] Uppsala Univ, Dept Neurosci Speech & Language Pathol, Uppsala, Sweden; [Axelson, Hans W.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Uppsala University; Uppsala University	Alm, PA (corresponding author), Uppsala Univ, Dept Neurosci Speech & Language Pathol, Uppsala, Sweden.	per.alm@neuro.uu.se	Axelson, Hans/K-2246-2019	Alm, Per/0000-0003-1506-5897	Uppsala University	Uppsala University	The study was funded by Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awiszus F., 2010, TMS MOTOR THRESHOLD; Borckardt JJ, 2006, J ECT, V22, P169, DOI 10.1097/01.yct.0000235923.52741.72; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Choo AL, 2010, FOLIA PHONIATR LOGO, V62, P143, DOI 10.1159/000287213; Cicinelli P, 1997, MUSCLE NERVE, V20, P535, DOI 10.1002/(SICI)1097-4598(199705)20:5<535::AID-MUS1>3.0.CO;2-A; de Felicio CM, 2007, INT J PEDIATR OTORHI, V71, P1187, DOI 10.1016/j.ijporl.2007.04.008; HELMESTABROOKS N, 1986, NEUROLOGY, V36, P1109, DOI 10.1212/WNL.36.8.1109; Johnson W., 1948, SPEECH HANDICAPPED S, V2nd; JONES RK, 1966, J NEUROL NEUROSUR PS, V29, P192, DOI 10.1136/jnnp.29.3.192; Kammer T, 2001, CLIN NEUROPHYSIOL, V112, P250, DOI 10.1016/S1388-2457(00)00513-7; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; MILLER AE, 1985, NEUROLOGY, V35, P1341, DOI 10.1212/WNL.35.9.1341; Mishory A, 2004, J ECT, V20, P160, DOI 10.1097/00124509-200409000-00007; Neef NE, 2011, CLIN NEUROPHYSIOL, V122, P1802, DOI 10.1016/j.clinph.2011.02.003; Neef NE, 2011, CORTEX, V47, P945, DOI 10.1016/j.cortex.2010.06.007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Riley G., 1994, STUTTERING SEVERITY; RINGO JL, 1994, CEREB CORTEX, V4, P331, DOI 10.1093/cercor/4.4.331; Sandbrink F, 2008, OXFORD HDB TRANSCRAN, P237, DOI DOI 10.1093/OXFORDHB/9780198568926.001.0001; Smith A, 1996, J SPEECH HEAR RES, V39, P329, DOI 10.1044/jshr.3902.329; Smits-Bandstra S, 2007, J FLUENCY DISORD, V32, P251, DOI 10.1016/j.jfludis.2007.06.001; Sommer M, 2003, MOVEMENT DISORD, V18, P826, DOI 10.1002/mds.10443; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Stier E, 1911, UNTERSUCHUNGEN UNKSH; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Zelaznik HN, 1997, ACTA PSYCHOL, V96, P229, DOI 10.1016/S0001-6918(97)00014-0	28	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76824	10.1371/journal.pone.0076824	http://dx.doi.org/10.1371/journal.pone.0076824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146930	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400084
J	Han, S; Lee, CW; Trevino, JG; Hughes, SJ; Sarosi, GA				Han, Song; Lee, Constance W.; Trevino, Jose G.; Hughes, Steven J.; Sarosi, George A., Jr.			Autocrine Extra-Pancreatic Trypsin 3 Secretion Promotes Cell Proliferation and Survival in Esophageal Adenocarcinoma	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTOR-2; COLON-CANCER CELL; NAFAMOSTAT MESILATE; EXPRESSION; GROWTH; FIBRONECTIN; GEMCITABINE; ADHESION	Trypsin or Tumor associated trypsin (TAT) activation of Protease-activated receptor 2 (PAR-2) promotes tumor cell proliferation in gastrointestinal cancers. The role of the trypsin/PAR-2 network in esophageal adenocarcinoma (EA) development has not yet been investigated. The aim of this study is to investigate the role of trypsin/PAR-2 activation in EA tumorogenesis and therapy. We found that esophageal adenocarcinoma cells (EACs) and Barrett's Metaplasia (BART) expressed high levels of type 3 extra-pancreatic trypsinogen (PRSS3), a novel type of TAT. Activity of secreted trypsin was detected in cultured media from EA OE19 and OE33 cultures but not from BART culture. Surface PAR-2 expression in BART and EACs was confirmed by both flow cytometry and immunofluorescence. Trypsin induced cell proliferation (similar to 2 fold; P<0.01) in all tested cell lines at a concentration of 10 nM. Inhibition of PAR-2 activity in EACs via the PAR-2 antagonist ENMD (500 mu M), anti-PAR2 antibody SAM-11 (2 mu g/ml), or siRNA PAR-2 knockdown, reduced cell proliferation and increased apoptosis by up to 4 fold (P<0.01). Trypsin stimulation led to phosphorylation of ERK1/2, suggesting involvement of MAPK pathway in PAR-2 signal transduction. Inhibition of PAR-2 activation or siRNA PAR-2 knockdown in EACs prior to treatment with 5 FU reduced cell viability of EACs by an additional 30% (P<0.01) compared to chemotherapy alone. Our data suggest that extra-pancreatic trypsinogen 3 is produced by EACs and activates PAR-2 in an autocrine manner. PAR-2 activation increases cancer cell proliferation, and promotes cancer cell survival. Targeting the trypsin activated PAR-2 pathway in conjunction with current chemotherapeutic agents may be a viable therapeutic strategy in EA.	[Han, Song; Lee, Constance W.; Trevino, Jose G.; Hughes, Steven J.; Sarosi, George A., Jr.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA; [Sarosi, George A., Jr.] North Florida South Georgia VA Med Ctr, Gainesville, FL USA	State University System of Florida; University of Florida	Sarosi, GA (corresponding author), Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA.	george.sarosi@surgery.ufl.edu	Sarosi, George/M-2977-2019	Han, Song/0000-0002-6542-335X; Hughes, Steven/0000-0002-5688-6942	VA Merit Review; Cracchiolo Family Foundation at the University of Florida; University of Florida Foundation	VA Merit Review(US Department of Veterans Affairs); Cracchiolo Family Foundation at the University of Florida; University of Florida Foundation(University of Florida)	George A. Sarosi: The VA Merit Review; University of Florida Foundation. Steven J. Hughes: The Cracchiolo Family Foundation at the University of Florida. Jose G. Trevino: The University of Florida Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cottrell GS, 2007, GASTROENTEROLOGY, V132, P2422, DOI 10.1053/j.gastro.2007.03.101; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Ducroc R, 2002, LIFE SCI, V70, P1359, DOI 10.1016/S0024-3205(01)01519-3; Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0; Inci K, 2009, SCAND J GASTROENTERO, V44, P664, DOI 10.1080/00365520902783683; Jaiswal K, 2006, AM J PHYSIOL-GASTR L, V290, pG335, DOI 10.1152/ajpgi.00167.2005; Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105; Kandulski A, 2010, AM J GASTROENTEROL, V105, P1934, DOI 10.1038/ajg.2010.265; KOIVUNEN E, 1989, J BIOL CHEM, V264, P14095; Maeda K, 2005, PANCREAS, V31, P54, DOI 10.1097/01.mpa.0000163178.37050.0d; Miyata S, 1998, CLIN EXP METASTAS, V16, P613, DOI 10.1023/A:1006576313979; Miyata S, 2000, J BIOL CHEM, V275, P4592, DOI 10.1074/jbc.275.7.4592; Nakanuma S, 2010, INT J ONCOL, V36, P793, DOI 10.3892/ijo_00000555; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Perini R, 2005, DIGEST DIS SCI, V50, pS12, DOI 10.1007/s10620-005-2801-8; Phillips WA, 2011, J GASTROEN HEPATOL, V26, P639, DOI 10.1111/j.1440-1746.2010.06602.x; Rajendra S, 2012, THER ADV GASTROENTER, V5, P285, DOI 10.1177/1756283X12446668; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; Sharma A, 2005, AM J PHYSIOL-GASTR L, V288, pG388, DOI 10.1152/ajpgi.00341.2004; Shimamoto R, 2004, INT J ONCOL, V24, P1401; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Tajima H, 2001, INT J CANCER, V94, P699, DOI 10.1002/ijc.1531.abs; TERADA T, 1995, HUM PATHOL, V26, P746, DOI 10.1016/0046-8177(95)90222-8; Uchima Y, 2007, J PANCREAS, V8, P479; Uwagawa T, 2009, ANN ONCOL, V20, P239, DOI 10.1093/annonc/mdn640; Uwagawa T, 2011, AM J CLIN ONCOL; Uwagawa T, 2007, CANCER-AM CANCER SOC, V109, P2142, DOI 10.1002/cncr.22658; Uwagawa T, 2009, ANTICANCER RES, V29, P3173; Williams SJ, 2001, INT J CANCER, V93, P67, DOI 10.1002/ijc.1304	34	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76667	10.1371/journal.pone.0076667	http://dx.doi.org/10.1371/journal.pone.0076667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146905	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400071
J	Okoro, DR; Arva, N; Gao, C; Polotskaia, A; Puente, C; Rosso, M; Bargonetti, J				Okoro, Danielle R.; Arva, Nicoleta; Gao, Chong; Polotskaia, Alla; Puente, Cindy; Rosso, Melissa; Bargonetti, Jill			Endogenous Human MDM2-C Is Highly Expressed in Human Cancers and Functions as a p53-Independent Growth Activator	PLOS ONE			English	Article							ACCELERATES TUMOR-FORMATION; RIBOSOMAL-PROTEIN L26; SOFT-TISSUE TUMORS; MESSENGER-RNA; ONCOPROTEIN MDM2; BREAST-CANCER; DNA-DAMAGE; CELL-CYCLE; GENE AMPLIFICATION; SPLICE VARIANT	Human cancers over-expressing mdm2, through a T to G variation at a single nucleotide polymorphism at position 309 (mdm2 SNP309), have functionally inactivated p53 that is not effectively degraded. They also have high expression of the alternatively spliced transcript, mdm2-C. Alternatively spliced mdm2 transcripts are expressed in many forms of human cancer and when they are exogenously expressed they transform human cells. However no study to date has detected endogenous MDM2 protein isoforms. Studies with exogenous expression of splice variants have been carried out with mdm2-A and mdm2-B, but the mdm2-C isoform has remained virtually unexplored. We addressed the cellular influence of exogenously expressed MDM2-C, and asked if endogenous MDM2-C protein was present in human cancers. To detect endogenous MDM2-C protein, we created a human MDM2-C antibody to the splice junction epitope of exons four and ten (MDM2 C410) and validated the antibody with in vitro translated full length MDM2 compared to MDM2-C. Interestingly, we discovered that MDM2-C co-migrates with MDM2-FL at approximately 98 kDa. Using the validated C410 antibody, we detected high expression of endogenous MDM2-C in human cancer cell lines and human cancer tissues. In the estrogen receptor positive (ER+) mdm2 G/G SNP309 breast cancer cell line, T47D, we observed an increase in endogenous MDM2-C protein with estrogen treatment. MDM2-C localized to the nucleus and the cytoplasm. We examined the biological activity of MDM2-C by exogenously expressing the protein and observed that MDM2-C did not efficiently target p53 for degradation or reduce p53 transcriptional activity. Exogenous expression of MDM2-C in p53-null human cancer cells increased colony formation, indicating p53-independent tumorigenic properties. Our data indicate a role for MDM2-C that does not require the inhibition of p53 for increasing cancer cell proliferation and survival.	[Bargonetti, Jill] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; CUNY, Grad Ctr, Dept Biol, New York, NY USA; CUNY, Grad Ctr, Dept Biochem, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Bargonetti, J (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	Bargonetti@genectr.hunter.cuny.edu		Bargonetti, Jill/0000-0003-2692-0991	National Science Foundation [MCB-0744316]; Breast Cancer Research Foundation; Clinical Translational Science Center (CTSC) of the National Center for Advancing Tranlsational Sciences of the National Institutes of Health [TR000457]; National Institute on Minority Health and Health Disparities, a component of the National Institutes of Health (NIH) [MD007599]; MBRS-RISE Program [3R25-GM060665]; CUNY Magnet Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060665] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007599] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Breast Cancer Research Foundation; Clinical Translational Science Center (CTSC) of the National Center for Advancing Tranlsational Sciences of the National Institutes of Health; National Institute on Minority Health and Health Disparities, a component of the National Institutes of Health (NIH); MBRS-RISE Program; CUNY Magnet Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by a grant from the National Science Foundation (MCB-0744316), a grant from The Breast Cancer Research Foundation, and a grant from the Clinical Translational Science Center (CTSC) TR000457 of the National Center for Advancing Tranlsational Sciences of the National Institutes of Health to J. Bargonetti. It was also made possible in part by an infrastructure award to Hunter College, grant number MD007599 from the National Institute on Minority Health and Health Disparities, a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIMHD or NIH. D.O. was partially supported by a CUNY Magnet Award and M. R. was supported by the MBRS-RISE Program to Hunter College 3R25-GM060665. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2001, INT J SURG PATHOL, V9, P99, DOI 10.1177/106689690100900203; Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Anderson JJ, 2007, INT J ONCOL, V31, P545; Arva NC, 2005, J BIOL CHEM, V280, P26776, DOI 10.1074/jbc.M505203200; Arva NC, 2008, ETHNIC DIS, V18; BAKER SJ, 1990, CANCER RES, V50, P7717; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Bartel F, 2002, CANCER CELL, V2, P9, DOI 10.1016/S1535-6108(02)00091-0; Bartel F, 2001, ONCOL RES, V12, P451, DOI 10.3727/096504001108747459; Boersma BJ, 2006, J NATL CANCER I, V98, P911, DOI 10.1093/jnci/djj245; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Bouska A, 2009, CANCER RES, V69, P1697, DOI 10.1158/0008-5472.CAN-08-3732; Brekman A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3130; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Chandler DS, 2006, CANCER RES, V66, P9502, DOI 10.1158/0008-5472.CAN-05-4271; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Clancy S., 2008, NATURE ED, V1; CORDONCARDO C, 1994, CANCER RES, V54, P794; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; Deb SP, 2003, MOL CANCER RES, V1, P1009; Dias CS, 2006, CANCER RES, V66, P9467, DOI 10.1158/0008-5472.CAN-05-3013; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fridman JS, 2003, CANCER RES, V63, P5703; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; HAINES DS, 1994, MOL CELL BIOL, V14, P1171, DOI 10.1128/MCB.14.2.1171; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Jeyaraj SC, 2009, FRONT BIOSCI-LANDMRK, V14, P2647, DOI 10.2741/3402; KASTAN MB, 1991, CANCER RES, V51, P6304; Kubbutat MHG, 1998, MOL CELL BIOL, V18, P5690, DOI 10.1128/MCB.18.10.5690; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; LANDERS JE, 1994, ONCOGENE, V9, P2745; Liang HL, 2004, GENE, V338, P217, DOI 10.1016/j.gene.2004.05.015; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; Lukas J, 2001, CANCER RES, V61, P3212; Ma JH, 2006, BIOCHEMISTRY-US, V45, P9238, DOI 10.1021/bi060661u; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Matsumoto R, 1998, CANCER RES, V58, P609; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mozzherin DJ, 1996, BIOCHEMISTRY-US, V35, P3572, DOI 10.1021/bi952142p; NAKAYAMA T, 1995, INT J CANCER, V64, P342, DOI 10.1002/ijc.2910640511; Naski N, 2009, CELL CYCLE, V8, P31, DOI 10.4161/cc.8.1.7326; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ofir-Rosenfeld Y, 2008, MOL CELL, V32, P180, DOI 10.1016/j.molcel.2008.08.031; Okoro DE, 2012, SPLICING MDM2 CANC P; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Sanchez-Aguilera A, 2006, ONCOGENE, V25, P2565, DOI 10.1038/sj.onc.1209282; Sandberg AA, 2004, CANCER GENET CYTOGEN, V155, P1, DOI 10.1016/j.cancergencyto.2004.08.005; Schneider-Stock R, 1998, J CANCER RES CLIN, V124, P532; Schuster K, 2007, MOL CANCER RES, V5, P403, DOI 10.1158/1541-7786.MCR-06-0146; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Sigalas I, 1996, NAT MED, V2, P912, DOI 10.1038/nm0896-912; Soos TJ, 1996, CELL GROWTH DIFFER, V7, P135; Steinman HA, 2004, J BIOL CHEM, V279, P4877, DOI 10.1074/jbc.M305966200; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tamborini E, 2001, INT J CANCER, V92, P790, DOI 10.1002/ijc.1271; Thut CJ, 1997, GENE DEV, V11, P1974, DOI 10.1101/gad.11.15.1974; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Trinh E, 2001, MOL CELL NEUROSCI, V17, P342, DOI 10.1006/mcne.2000.0928; Udayakumar T, 2010, SEMIN RADIAT ONCOL, V20, P258, DOI 10.1016/j.semradonc.2010.05.007; Volk EL, 2009, DIS MODEL MECH, V2, P47, DOI 10.1242/dmm.000992; Volk EL, 2009, MOL CANCER RES, V7, P863, DOI 10.1158/1541-7786.MCR-08-0418; White DE, 2006, CANCER RES, V66, P3463, DOI 10.1158/0008-5472.CAN-05-1381; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yu GW, 2006, P NATL ACAD SCI USA, V103, P1227, DOI 10.1073/pnas.0510343103	73	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77643	10.1371/journal.pone.0077643	http://dx.doi.org/10.1371/journal.pone.0077643			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147044	Green Published, gold			2022-12-27	WOS:000325819400131
J	Bunday, KL; Oudega, M; Perez, MA				Bunday, Karen L.; Oudega, Martin; Perez, Monica A.			Aberrant Crossed Corticospinal Facilitation in Muscles Distant from a Spinal Cord Injury	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; WALLERIAN DEGENERATION; HAND ACTIVATION; REORGANIZATION; CONTRACTIONS; PLASTICITY; PROJECTIONS; CONTUSION; RESPONSES	Crossed facilitatory interactions in the corticospinal pathway are impaired in humans with chronic incomplete spinal cord injury (SCI). The extent to which crossed facilitation is affected in muscles above and below the injury remains unknown. To address this question we tested 51 patients with neurological injuries between C2-T12 and 17 age-matched healthy controls. Using transcranial magnetic stimulation we elicited motor evoked potentials (MEPs) in the resting first dorsal interosseous, biceps brachii, and tibialis anterior muscles when the contralateral side remained at rest or performed 70% of maximal voluntary contraction (MVC) into index finger abduction, elbow flexion, and ankle dorsiflexion, respectively. By testing MEPs in muscles with motoneurons located at different spinal cord segments we were able to relate the neurological level of injury to be above, at, or below the location of the motoneurons of the muscle tested. We demonstrate that in patients the size of MEPs was increased to a similar extent as in controls in muscles above the injury during 70% of MVC compared to rest. MEPs remained unchanged in muscles at and within 5 segments below the injury during 70% of MVC compared to rest. However, in muscles beyond 5 segments below the injury the size of MEPs increased similar to controls and was aberrantly high, 2-fold above controls, in muscles distant (>15 segments) from the injury. These aberrantly large MEPs were accompanied by larger F-wave amplitudes compared to controls. Thus, our findings support the view that corticospinal degeneration does not spread rostral to the lesion, and highlights the potential of caudal regions distant from an injury to facilitate residual corticospinal output after SCI.	[Bunday, Karen L.; Oudega, Martin; Perez, Monica A.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Bunday, Karen L.; Perez, Monica A.] Univ Pittsburgh, Syst Neurosci Inst, Pittsburgh, PA USA; [Oudega, Martin] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Oudega, Martin] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Perez, MA (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA.	perezmo@pitt.edu		Bunday, Karen Louise/0000-0003-4543-9183	National Institute of Neurological Disorders and Stroke; National Institutes of Health [R01 NS076589]; Paralyzed Veterans of America [2821]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076589] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paralyzed Veterans of America; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by The National Institute of Neurological Disorders and Stroke, The National Institutes of Health (R01 NS076589 to MAP), and the Paralyzed Veterans of America (2821 to KLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeeva N, 1997, EXP NEUROL, V148, P399, DOI 10.1006/exnr.1997.6689; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BECERRA JL, 1995, AM J NEURORADIOL, V16, P125; BRESNAHAN JC, 1978, J NEUROL SCI, V37, P59, DOI 10.1016/0022-510X(78)90228-9; BRONSON R, 1978, HUM PATHOL, V9, P602, DOI 10.1016/S0046-8177(78)80143-9; Brus-Ramer M, 2009, J NEUROSCI, V29, P6196, DOI 10.1523/JNEUROSCI.5852-08.2009; Bunday KL, 2012, J NEUROPHYSIOL, V107, P2901, DOI 10.1152/jn.00850.2011; Calancie B, 1999, J NEUROTRAUM, V16, P49, DOI 10.1089/neu.1999.16.49; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Carson RG, 2008, NEUROSCI LETT, V441, P153, DOI 10.1016/j.neulet.2008.06.041; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Davey NJ, 1999, EXP BRAIN RES, V127, P382, DOI 10.1007/s002210050806; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Fenrich KK, 2009, J NEUROSCI, V29, P12145, DOI 10.1523/JNEUROSCI.0897-09.2009; FISHMAN PS, 1987, ARCH NEUROL-CHICAGO, V44, P1082, DOI 10.1001/archneur.1987.00520220078021; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Fouad K, 2011, BRAIN RES BULL, V84, P337, DOI 10.1016/j.brainresbull.2010.04.017; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Han DS, 2008, J REHABIL MED, V40, P208, DOI 10.2340/16501977-0154; Harkema Susan, 2012, Handb Clin Neurol, V109, P259, DOI 10.1016/B978-0-444-52137-8.00016-4; HASSLER O, 1966, ARCH NEUROL-CHICAGO, V15, P302, DOI 10.1001/archneur.1966.00470150080013; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Hoffman LR, 2010, J NEUROL PHYS THER, V34, P193, DOI 10.1097/NPT.0b013e3181fbe692; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Husch A, 2012, J NEUROSCI, V32, P13145, DOI 10.1523/JNEUROSCI.2995-12.2012; KALIL K, 1975, BRAIN RES, V89, P15, DOI 10.1016/0006-8993(75)90130-4; Kashani H, 2010, J COMPUT ASSIST TOMO, V34, P251, DOI 10.1097/RCT.0b013e3181c34626; Kennedy NC, 2008, NEUROSCI LETT, V445, P7, DOI 10.1016/j.neulet.2008.08.064; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Kowalczewski J, 2011, NEUROREHAB NEURAL RE, V25, P412, DOI 10.1177/1545968310394869; LANCE JW, 1954, BRAIN, V77, P314, DOI 10.1093/brain/77.2.314; LASSEK AM, 1946, J COMP NEUROL, V85, P45, DOI 10.1002/cne.900850105; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; McNeil CJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00152; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; NIELSEN J, 1995, J PHYSIOL-LONDON, V484, P791, DOI 10.1113/jphysiol.1995.sp020704; Onifer SM, 2011, NEUROTHERAPEUTICS, V8, P283, DOI 10.1007/s13311-011-0034-4; Oudega M, 1999, EUR J NEUROSCI, V11, P2453, DOI 10.1046/j.1460-9568.1999.00666.x; Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189; PEREZ MA, 2006, ABSTRACT VIEWER ITIN; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Perez MA, 2007, J NEUROSCI, V27, P1045, DOI 10.1523/JNEUROSCI.4128-06.2007; Perez MA, 2009, CORTEX, V45, P1065, DOI 10.1016/j.cortex.2008.12.006; PierrotDeseilligny E, 1996, PROG NEUROBIOL, V48, P489, DOI 10.1016/0301-0082(96)00002-0; Valencia MP, 2006, CLIN IMAG, V30, P431, DOI 10.1016/j.clinimag.2006.05.031; Puckett WR, 1997, EXP NEUROL, V148, P424, DOI 10.1006/exnr.1997.6692; Renner CIE, 2005, J NEUROL SCI, V239, P25, DOI 10.1016/j.jns.2005.07.005; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Rosenzweig ES, 2009, J COMP NEUROL, V513, P151, DOI 10.1002/cne.21940; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Roy FD, 2011, CLIN NEUROPHYSIOL, V122, P1387, DOI 10.1016/j.clinph.2010.11.020; Scholtes F, 2006, NEUROSURGERY, V59, P671, DOI 10.1227/01.NEU.0000228929.15492.A9; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Stedman A, 1998, MUSCLE NERVE, V21, P1033, DOI 10.1002/(SICI)1097-4598(199808)21:8<1033::AID-MUS7>3.0.CO;2-9; STROMBERG BV, 1986, AM J PHYS MED REHAB, V65, P135; TERAE S, 1993, J COMPUT ASSIST TOMO, V17, P700, DOI 10.1097/00004728-199309000-00006; TURNBULL IM, 1966, J NEUROSURG, V24, P951, DOI 10.3171/jns.1966.24.6.0951; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Woldag H, 2004, STROKE, V35, P2556, DOI 10.1161/01.STR.0000144651.07122.da	59	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76747	10.1371/journal.pone.0076747	http://dx.doi.org/10.1371/journal.pone.0076747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146921	Green Published, gold			2022-12-27	WOS:000326022200019
J	Danyagri, G; Dang, QL				Danyagri, Gabriel; Dang, Qing-Lai			Effects of Elevated [CO2] and Low Soil Moisture on the Physiological Responses of Mountain Maple (Acer spicatum L.) Seedlings to Light	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATION; ATMOSPHERIC CO2; ARISAEMA-HETEROPHYLLUM; FUNCTIONAL-RESPONSES; NET PHOTOSYNTHESIS; WATER AVAILABILITY; SHADE TOLERANCE; GAS-EXCHANGE; FOREST; GROWTH	Global climate change is expected to affect how plants respond to their physical and biological environments. In this study, we examined the effects of elevated CO2 ([CO2]) and low soil moisture on the physiological responses of mountain maple (Acer spicatum L.) seedlings to light availability. The seedlings were grown at ambient (392 mu mol mol(-1)) and elevated (784 mu mol mol(-1)) [CO2], low and high soil moisture (M) regimes, at high light (100%) and low light (30%) in the greenhouse for one growing season. We measured net photosynthesis (A), stomatal conductance (g(s)), instantaneous water use efficiency (IWUE), maximum rate of carboxylation (V-cmax), rate of photosynthetic electron transport (J), triose phosphate utilization (TPU)), leaf respiration (R-d), light compensation point (LCP) and mid-day shoot water potential (Psi(x)). A and g(s) did not show significant responses to light treatment in seedlings grown at low soil moisture treatment, but the high light significantly decreased the C-i/C-a in those seedlings. IWUE was significantly higher in the elevated compared with the ambient [CO2], and the effect was greater at high than the low light treatment. LCP did not respond to the soil moisture treatments when seedlings were grown in high light under both [CO2]. The low soil moisture significantly reduced Psi(x) but had no significant effect on the responses of other physiological traits to light or [CO2]. These results suggest that as the atmospheric [CO2] rises, the physiological performance of mountain maple seedlings in high light environments may be enhanced, particularly when soil moisture conditions are favourable.	[Danyagri, Gabriel; Dang, Qing-Lai] Lakehead Univ, Fac Nat Resources Management, Thunder Bay, ON P7B 5E1, Canada	Lakehead University	Danyagri, G (corresponding author), Lakehead Univ, Fac Nat Resources Management, Thunder Bay, ON P7B 5E1, Canada.	gdery@lakeheadu.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada grant to Q-LD. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1990, TREE PHYSIOL, V6, P305, DOI 10.1093/treephys/6.3.305; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ambebe TF, 2010, TREE PHYSIOL, V30, P234, DOI 10.1093/treephys/tpp109; Ambebe TF, 2009, TREE PHYSIOL, V29, P1341, DOI 10.1093/treephys/tpp079; Archambault L, 1998, FOREST ECOL MANAG, V102, P61, DOI 10.1016/S0378-1127(97)00109-6; Aubin I, 2005, ECOSCIENCE, V12, P540, DOI 10.2980/i1195-6860-12-4-540.1; Aubin I, 2000, CAN J FOREST RES, V30, P168, DOI 10.1139/cjfr-30-1-168; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; CANHAM CD, 1989, ECOLOGY, V70, P548, DOI 10.2307/1940200; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Cornic G, 2000, TRENDS PLANT SCI, V5, P187, DOI 10.1016/S1360-1385(00)01625-3; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dawes MA, 2011, NEW PHYTOL, V191, P806, DOI 10.1111/j.1469-8137.2011.03722.x; Drake BG, 1997, ANNU REV PLANT PHYS, V48, P609, DOI 10.1146/annurev.arplant.48.1.609; Eermak J, 1993, TREE PHYSIOL, V12, P281; Eermak J, 1993, WATER TRANSPORT PLAN; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; GAUTHIER S, 1993, J VEG SCI, V4, P783, DOI 10.2307/3235615; Korner C, 2006, NEW PHYTOL, V172, P393, DOI 10.1111/j.1469-8137.2006.01886.x; Korner C, 2003, PHILOS T ROY SOC A, V361, P2023, DOI 10.1098/rsta.2003.1241; Kubiske ME, 1996, TREE PHYSIOL, V16, P351; KUBISKE ME, 1994, OECOLOGIA, V98, P303, DOI 10.1007/BF00324218; Kubiske ME, 1997, FUNCT ECOL, V11, P24, DOI 10.1046/j.1365-2435.1997.00050.x; Lambers H, 2008, PLANT PHYSL ECLOGY; Lawlor DW, 2002, ANN BOT-LONDON, V89, P871, DOI 10.1093/aob/mcf110; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; LEI TT, 1990, OECOLOGIA, V84, P224, DOI 10.1007/BF00318275; Lei TT, 1997, PHOTOSYNTHETICA, V33, P277, DOI 10.1023/A:1022124732716; Liang NH, 2001, TREE PHYSIOL, V21, P1047, DOI 10.1093/treephys/21.14.1047; Medlyn BE, 1999, PLANT CELL ENVIRON, V22, P1475, DOI 10.1046/j.1365-3040.1999.00523.x; Meehl GA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030948; Messier C, 1999, CAN J FOREST RES, V29, P812, DOI 10.1139/cjfr-29-6-812; Moore BD, 1999, PLANT CELL ENVIRON, V22, P567, DOI 10.1046/j.1365-3040.1999.00432.x; Muraoka H, 1997, OECOLOGIA, V112, P26, DOI 10.1007/s004420050279; Muraoka H, 2002, J PLANT RES, V115, P419, DOI 10.1007/s10265-002-0052-8; NORBY RJ, 1991, NEW PHYTOL, V117, P515, DOI 10.1111/j.1469-8137.1991.tb00956.x; Nowak RS, 2004, NEW PHYTOL, V162, P253, DOI 10.1111/j.1469-8137.2004.01033.x; Osborne CP, 1997, PLANT PHYSIOL, V114, P337, DOI 10.1104/pp.114.1.337; Paula MP, 2004, PLANT PHYSIOL, P195; PEARCY RW, 1990, ANNU REV PLANT PHYS, V41, P421, DOI 10.1146/annurev.pp.41.060190.002225; POORTER L, 1993, OECOLOGIA, V96, P193, DOI 10.1007/BF00317732; Pothier D, 2002, TREES-STRUCT FUNCT, V16, P365, DOI 10.1007/s00468-001-0158-y; Pregitzer KS, 2005, NUTR ACQUISITION PLA; RIND D, 1990, J GEOPHYS RES-ATMOS, V95, P9983, DOI 10.1029/JD095iD07p09983; Saxe H, 1998, NEW PHYTOL, V139, P395, DOI 10.1046/j.1469-8137.1998.00221.x; Sharkey TD, 2007, PLANT CELL ENVIRON, V30, P1035, DOI 10.1111/j.1365-3040.2007.01710.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Sullivan J, 1993, FIRE EFFECTS INFORM; Takeuchi Y, 2001, PLANT CELL ENVIRON, V24, P1257, DOI 10.1046/j.0016-8025.2001.00787.x; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; Tognetti R, 2000, PLANT CELL ENVIRON, V23, P1341, DOI 10.1046/j.1365-3040.2000.00645.x; TSCHAPLINSKI TJ, 1995, NEW PHYTOL, V129, P63, DOI 10.1111/j.1469-8137.1995.tb03010.x; TSCHAPLINSKI TJ, 1993, TREE PHYSIOL, V13, P283, DOI 10.1093/treephys/13.3.283; Watanabe M, 2011, TREE PHYSL; WAYNE PM, 1993, OECOLOGIA, V94, P235, DOI 10.1007/BF00341322; Wertin TM, 2012, TREE PHYSIOL, V32, P847, DOI 10.1093/treephys/tps051; Wertin TM, 2010, GLOBAL CHANGE BIOL, V16, P2089, DOI 10.1111/j.1365-2486.2009.02053.x; Wullschleger SD, 1998, TREE PHYSIOL, V18, P71; Wullschleger SD, 1998, TREE PHYSIOL, V18, P499	61	13	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76586	10.1371/journal.pone.0076586	http://dx.doi.org/10.1371/journal.pone.0076586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146894	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200018
J	Mitchell, DE; Dai, CK; Rahman, MA; Ahn, JH; Della Santina, CC; Cullen, KE				Mitchell, Diana E.; Dai, Chenkai; Rahman, Mehdi A.; Ahn, Joong Ho; Della Santina, Charles C.; Cullen, Kathleen E.			Head Movements Evoked in Alert Rhesus Monkey by Vestibular Prosthesis Stimulation: Implications for Postural and Gaze Stabilization	PLOS ONE			English	Article							HIGH-ACCELERATION ROTATIONS; WHOLE-BODY ROTATION; VESTIBULOOCULAR REFLEX; SQUIRREL-MONKEY; VESTIBULOCOLLIC REFLEX; MULTIMODAL INTEGRATION; QUADRUPEDAL LOCOMOTION; CERVICOCOLLIC REFLEX; SEMICIRCULAR CANALS; NERVE AFFERENTS	The vestibular system detects motion of the head in space and in turn generates reflexes that are vital for our daily activities. The eye movements produced by the vestibulo-ocular reflex (VOR) play an essential role in stabilizing the visual axis (gaze), while vestibulo-spinal reflexes ensure the maintenance of head and body posture. The neuronal pathways from the vestibular periphery to the cervical spinal cord potentially serve a dual role, since they function to stabilize the head relative to inertial space and could thus contribute to gaze (eye-in-head + head-in-space) and posture stabilization. To date, however, the functional significance of vestibular-neck pathways in alert primates remains a matter of debate. Here we used a vestibular prosthesis to 1) quantify vestibularly-driven head movements in primates, and 2) assess whether these evoked head movements make a significant contribution to gaze as well as postural stabilization. We stimulated electrodes implanted in the horizontal semicircular canal of alert rhesus monkeys, and measured the head and eye movements evoked during a 100ms time period for which the contribution of longer latency voluntary inputs to the neck would be minimal. Our results show that prosthetic stimulation evoked significant head movements with latencies consistent with known vestibulo-spinal pathways. Furthermore, while the evoked head movements were substantially smaller than the coincidently evoked eye movements, they made a significant contribution to gaze stabilization, complementing the VOR to ensure that the appropriate gaze response is achieved. We speculate that analogous compensatory head movements will be evoked when implanted prosthetic devices are transitioned to human patients.	[Mitchell, Diana E.; Cullen, Kathleen E.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Dai, Chenkai; Rahman, Mehdi A.; Ahn, Joong Ho; Della Santina, Charles C.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA	McGill University; Johns Hopkins University	Cullen, KE (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	kathleen.cullen@mcgill.ca			Canadian Institutes of Health Research (CIHR); National Institute on Deafness and Other Communication Disorders (NIDCD) [R01-DC002390, R01-DC009255]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, R01DC009255, R01DC002390] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the Canadian Institutes of Health Research (CIHR) and the National Institute on Deafness and Other Communication Disorders (NIDCD) grants R01-DC002390 and R01-DC009255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aw ST, 2008, NEUROLOGY, V71, P1776, DOI 10.1212/01.wnl.0000335971.43443.d9; Berthoz A, 1985, Rev Oculomot Res, V1, P177; BLANKS RHI, 1985, BRAIN RES, V340, P315, DOI 10.1016/0006-8993(85)90928-X; Brown ET, 2009, IEEE ENG MED BIO, P7261, DOI 10.1109/IEMBS.2009.5334734; Chiang B, 2011, IEEE T NEUR SYS REH, V19, P588, DOI 10.1109/TNSRE.2011.2164937; Cohen B, 2009, ANN NY ACAD SCI, V1164, P89, DOI 10.1111/j.1749-6632.2009.03845.x; COLEBATCH JG, 1994, J NEUROL NEUROSUR PS, V57, P190, DOI 10.1136/jnnp.57.2.190; Cremer PD, 2000, NEUROLOGY, V55, P1833, DOI 10.1212/WNL.55.12.1833; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Cullen KE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0002.2002; Dai CK, 2011, HEARING RES, V281, P74, DOI 10.1016/j.heares.2011.08.008; Della Santina CC, 2005, P ANN INT IEEE EMBS, P7380, DOI 10.1109/IEMBS.2005.1616217; DIERINGER N, 1987, BRAIN RES, V404, P33, DOI 10.1016/0006-8993(87)91352-7; Ehtemam F, 2012, IEEE T BIO-MED ENG, V59, P1978, DOI 10.1109/TBME.2012.2195178; Elsley JK, 2007, J NEUROPHYSIOL, V98, P1333, DOI 10.1152/jn.00386.2007; Forbes PA, 2013, EXP BRAIN RES, V226, P1, DOI 10.1007/s00221-012-3388-x; Gdowski GT, 1999, J NEUROPHYSIOL, V82, P436, DOI 10.1152/jn.1999.82.1.436; GIOANNI H, 1988, EXP BRAIN RES, V69, P583, DOI 10.1007/BF00247311; GOLDBERG J, 1986, J NEUROPHYSIOL, V56, P857, DOI 10.1152/jn.1986.56.3.857; Goldberg JM, 2011, EXP BRAIN RES, V210, P331, DOI 10.1007/s00221-011-2611-5; GOLDBERG JM, 1984, J NEUROPHYSIOL, V51, P1236, DOI 10.1152/jn.1984.51.6.1236; GUITTON D, 1986, EXP BRAIN RES, V64, P59; Haque A, 2005, J NEUROPHYSIOL, V93, P1165, DOI 10.1152/jn.00966.2004; HASLWANTER T, 1995, VISION RES, V35, P1727, DOI 10.1016/0042-6989(94)00257-M; Hedjoudje A, 2012, ASS RES OTOLARYNGOL, P292; Hullar TE, 2006, HEARING RES, V213, P17, DOI 10.1016/j.heares.2005.11.009; Huterer M, 2002, J NEUROPHYSIOL, V88, P13, DOI 10.1152/jn.2002.88.1.13; LISBERGER SG, 1990, J NEUROPHYSIOL, V63, P676, DOI 10.1152/jn.1990.63.4.676; Migliaccio AA, 2004, EXP BRAIN RES, V159, P433, DOI 10.1007/s00221-004-1974-2; Migliaccio AA, 1999, SUPPORTED AUSTRALASI, V22, P73; MONEY KE, 1972, COMP BIOCHEM PHYSIOL, V42, P353, DOI 10.1016/0300-9629(72)90116-8; Nie KB, 2013, IEEE T BIO-MED ENG, V60, P1685, DOI 10.1109/TBME.2013.2241433; Nijhuis LBO, 2007, J PHYSIOL-LONDON, V584, P97, DOI 10.1113/jphysiol.2007.136291; PAIGE GD, 1991, J NEUROPHYSIOL, V65, P1170, DOI 10.1152/jn.1991.65.5.1170; Peng GCY, 1999, IEEE T BIO-MED ENG, V46, P1269, DOI 10.1109/10.797986; Peng GCY, 1996, BIOL CYBERN, V75, P309, DOI 10.1007/s004220050297; PETERSON BW, 1985, J NEUROPHYSIOL, V54, P90, DOI 10.1152/jn.1985.54.1.90; RAMPRASHAD F, 1984, AM J ANAT, V169, P295, DOI 10.1002/aja.1001690306; Reynolds JS, 2008, J NEUROPHYSIOL, V99, P3123, DOI 10.1152/jn.00793.2007; Reynolds JS, 2008, J NEUROPHYSIOL, V99, P2369, DOI 10.1152/jn.00320.2007; Roy JE, 2004, J NEUROSCI, V24, P2102, DOI 10.1523/JNEUROSCI.3988-03.2004; Roy JE, 2001, J NEUROSCI, V21, P2131, DOI 10.1523/JNEUROSCI.21-06-02131.2001; Sadeghi SG, 2007, J NEUROPHYSIOL, V97, P1503, DOI 10.1152/jn.00829.2006; Sadeghi SG, 2012, J NEUROSCI, V32, P14685, DOI 10.1523/JNEUROSCI.2493-12.2012; Sadeghi SG, 2011, J NEUROPHYSIOL, V105, P661, DOI 10.1152/jn.00788.2010; Shanidze N, 2012, J NEUROPHYSIOL, V107, P2260, DOI 10.1152/jn.00314.2011; SUZUKI JI, 1964, EXP NEUROL, V10, P393, DOI 10.1016/0014-4886(64)90031-7; Sylvestre PA, 1999, J NEUROPHYSIOL, V82, P2612, DOI 10.1152/jn.1999.82.5.2612; Thompson LA, 2012, J VESTIBUL RES-EQUIL, V22, P11, DOI 10.3233/VES-2012-0442; Tullio P, 1929, OHR ENTSTEHUNG SPRAC; Wellenius GA, 2000, EXP BRAIN RES, V133, P139, DOI 10.1007/s002210000369; Xiang YQ, 2008, J NEUROPHYSIOL, V100, P763, DOI 10.1152/jn.90256.2008; ZANGEMEISTER WH, 1981, BIOL CYBERN, V41, P19, DOI 10.1007/BF01836124	53	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78767	10.1371/journal.pone.0078767	http://dx.doi.org/10.1371/journal.pone.0078767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147142	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200101
J	Nguyen, TY; Liew, CG; Liu, HN				Thanh Yen Nguyen; Liew, Chee Gee; Liu, Huinan			An In Vitro Mechanism Study on the Proliferation and Pluripotency of Human Embryonic Stems Cells in Response to Magnesium Degradation	PLOS ONE			English	Article							ELECTROCHEMICAL DEPOSITION; CORROSION; ALLOYS; CYTOTOXICITY; CYTOCOMPATIBILITY; DIFFERENTIATION; MANAGEMENT; DERIVATION; ECLAMPSIA; IMPLANTS	Magnesium (Mg) is a promising biodegradable metallic material for applications in cellular/tissue engineering and biomedical implants/devices. To advance clinical translation of Mg-based biomaterials, we investigated the effects and mechanisms of Mg degradation on the proliferation and pluripotency of human embryonic stem cells (hESCs). We used hESCs as the in vitro model system to study cellular responses to Mg degradation because they are sensitive to toxicants and capable of differentiating into any cell types of interest for regenerative medicine. In a previous study when hESCs were cultured in vitro with either polished metallic Mg (99.9% purity) or pre-degraded Mg, cell death was observed within the first 30 hours of culture. Excess Mg ions and hydroxide ions induced by Mg degradation may have been the causes for the observed cell death; hence, their respective effects on hESCs were investigated for the first time to reveal the potential mechanisms. For this purpose, the mTeSR (R) 1 hESC culture media was either modified to an alkaline pH of 8.1 or supplemented with 0.4-40 mM of Mg ions. We showed that the initial increase of media pH to 8.1 had no adverse effect on hESC proliferation. At all tested Mg ion dosages, the hESCs grew to confluency and retained pluripotency as indicated by the expression of OCT4, SSEA3, and SOX2. When the supplemental Mg ion dosages increased to greater than 10 mM, however, hESC colony morphology changed and cell counts decreased. These results suggest that Mg-based implants or scaffolds are promising in combination with hESCs for regenerative medicine applications, providing their degradation rate is moderate. Additionally, the hESC culture system could serve as a standard model for cytocompatibility studies of Mg in vitro, and an identified 10 mM critical dosage of Mg ions could serve as a design guideline for safe degradation of Mg-based implants/scaffolds.	[Thanh Yen Nguyen; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Liew, Chee Gee; Liu, Huinan] Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA; [Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Liu, HN (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	huinan.liu@ucr.edu	Liu, Huinan H/N-2891-2015	Liu, Huinan H/0000-0001-9366-6204	Hellman Faculty Fellowship; University of California Regents Faculty Fellowship	Hellman Faculty Fellowship; University of California Regents Faculty Fellowship(University of California System)	Hellman Faculty Fellowship and University of California Regents Faculty Fellowship supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Aal DEM, 2012, INT J GYNECOL OBSTET, V116, P232, DOI 10.1016/j.ijgo.2011.10.018; Chatterjee P, 2011, JOVE-J VIS EXP, DOI 10.3791/3110; Cipriano AF, 2013, J MATER SCI-MATER M, V24, P989, DOI 10.1007/s10856-013-4853-1; Cipriano AF, 2012, IEEE ENG MED BIO, P2432, DOI 10.1109/EMBC.2012.6346455; di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012; Euser AG, 2009, STROKE, V40, P1169, DOI 10.1161/STROKEAHA.108.527788; Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024; Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020; Grillo CA, 2011, COLLOID SURFACE B, V88, P471, DOI 10.1016/j.colsurfb.2011.07.035; Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021; Guan RG, 2012, J BIOMED MATER RES A, V100A, P999, DOI 10.1002/jbm.a.34042; Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008; Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530; Johnson I., 2012, BIOMATERIALS FORUM, V34, P9; Johnson I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065603; Johnson I, 2012, J BIOMED MATER RES A, V100A, P477, DOI 10.1002/jbm.a.33290; Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014; Laires MJ, 2004, FRONT BIOSCI-LANDMRK, V9, P262, DOI 10.2741/1223; Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004; Liu HN, 2011, J BIOMED MATER RES A, V99A, P249, DOI 10.1002/jbm.a.33188; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Luo XL, 2011, ACTA BIOMATER, V7, P441, DOI 10.1016/j.actbio.2010.09.006; Ma L, 2010, BRAIN INJURY, V24, P730, DOI 10.3109/02699051003610516; Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c; MIKI H, 1987, CARCINOGENESIS, V8, P1757, DOI 10.1093/carcin/8.11.1757; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Sebaa MA, 2013, J MATER SCI-MATER M, V24, P307, DOI 10.1007/s10856-012-4796-y; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Nguyen TY, 2012, IEEE ENG MED BIO, P723, DOI 10.1109/EMBC.2012.6346033; Vazin T, 2010, RESTOR NEUROL NEUROS, V28, P589, DOI 10.3233/RNN-2010-0543; Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z; West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007; Wu WL, 2011, NEUROSCI LETT, V491, P73, DOI 10.1016/j.neulet.2011.01.009; Yang JX, 2011, ANN BIOMED ENG, V39, P1857, DOI 10.1007/s10439-011-0300-y; Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]; Yun Y, 2009, MAT SCI ENG C-MATER, V29, P1814, DOI 10.1016/j.msec.2009.02.008	36	57	57	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76547	10.1371/journal.pone.0076547	http://dx.doi.org/10.1371/journal.pone.0076547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146887	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200016
J	Barbour, A; Philip, K; Muniandy, S				Barbour, Abdelahhad; Philip, Koshy; Muniandy, Sekaran			Enhanced Production, Purification, Characterization and Mechanism of Action of Salivaricin 9 Lantibiotic Produced by Streptococcus salivarius NU10	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; NISIN PRODUCTION; SUPPLEMENTED WHEY; PH PROFILES; BIOSYNTHESIS; BACTERIOCIN; INHIBITION; MODE; CELL; AUTOREGULATION	Background: Lantibiotics are small lanthionine-containing bacteriocins produced by lactic acid bacteria. Salivaricin 9 is a newly discovered lantibiotic produced by Streptococcus salivarius. In this study we present the mechanism of action of salivaricin 9 and some of its properties. Also we developed new methods to produce and purify the lantibiotic from strain NU10. Methodology / Principal Findings: Salivaricin 9 was found to be auto-regulated when an induction assay was applied and this finding was used to develop a successful salivaricin 9 production system in liquid medium. A combination of XAD-16 and cation exchange chromatography was used to purify the secondary metabolite which was shown to have a molecular weight of approximately 3000 Da by SDS-PAGE. MALDI-TOF MS analysis indicated the presence of salivaricin 9, a 2560 Da lantibiotic. Salivaricin 9 is a bactericidal molecule targeting the cytoplasmic membrane of sensitive cells. The membrane permeabilization assay showed that salivaricin 9 penetrated the cytoplasmic membrane and induced pore formation which resulted in cell death. The morphological changes of test bacterial strains incubated with salivaricin 9 were visualized using Scanning Electron Microscopy which confirmed a pore forming mechanism of inhibition. Salivaricin 9 retained biological stability when exposed to high temperature (90-100 degrees C) and stayed bioactive at pH ranging 2 to 10. When treated with proteinase K or peptidase, salivaricin 9 lost all antimicrobial activity, while it remained active when treated with lyticase, catalase and certain detergents. Conclusion: The mechanism of antimicrobial action of a newly discovered lantibiotic salivaricin 9 was elucidated in this study. Salivaricin 9 penetrated the cytoplasmic membrane of its targeted cells and induced pore formation. This project has given new insights on lantibiotic peptides produced by S. salivarius isolated from the oral cavities of Malaysian subjects.	[Barbour, Abdelahhad; Philip, Koshy] Univ Malaya, Fac Sci, Inst Biol Sci, Div Microbiol, Kuala Lumpur, Malaysia; [Muniandy, Sekaran] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Philip, K (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Div Microbiol, Kuala Lumpur, Malaysia.	kphil@um.edu.my	MUNIANDY, SEKARAN/B-5345-2010; Barbour, Abdelahhad/AAG-1953-2021; PHILIP, Koshy/B-8803-2010; Barbour, Abdelahhad/C-5168-2015	MUNIANDY, SEKARAN/0000-0003-1310-3634; Barbour, Abdelahhad/0000-0003-0184-8890	University of Malaya and the High Impact Research - Malaysian Ministry of Higher Education [UM.C/625/1/HIR/MOHE/SC/08]	University of Malaya and the High Impact Research - Malaysian Ministry of Higher Education	The authors wish to acknowledge the support by way of facilities from University of Malaya and the High Impact Research - Malaysian Ministry of Higher Education grant designated as UM.C/625/1/HIR/MOHE/SC/08 with account F000008-21001 under the Principal Investigator Koshy Philip for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 1995, INT J FOOD MICROBIOL, V28, P169, DOI 10.1016/0168-1605(95)00055-0; Al-Mahrous MM, 2011, EXPERT OPIN DRUG DIS, V6, P155, DOI 10.1517/17460441.2011.545387; Bikandi J, 2004, BIOINFORMATICS, V20, P798, DOI 10.1093/bioinformatics/btg491; Bourbon C, 2008, ANAL BIOCHEM, V381, P279, DOI 10.1016/j.ab.2008.07.005; Chehimi S, 2010, CAN J MICROBIOL, V56, P162, DOI [10.1139/W09-125, 10.1139/w09-125]; Cheigh CI, 2005, BIOTECHNOL LETT, V27, P155, DOI 10.1007/s10529-004-7661-3; CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Chung W, 2000, INT J FOOD MICROBIOL, V60, P25, DOI 10.1016/S0168-1605(00)00330-5; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Flores SH, 2001, BIOTECHNOL APPL BIOC, V34, P103, DOI 10.1042/BA20010030; Furmanek B, 1999, J APPL MICROBIOL, V87, P856, DOI 10.1046/j.1365-2672.1999.00937.x; GARCERA MJG, 1993, EUR J BIOCHEM, V212, P417, DOI 10.1111/j.1432-1033.1993.tb17677.x; Gonzalez-Toledo SY, 2010, J FOOD SCI, V75, pM347, DOI 10.1111/j.1750-3841.2010.01670.x; Gut IM, 2011, ACS CHEM BIOL, V6, P744, DOI 10.1021/cb1004178; Hyink O, 2007, APPL ENVIRON MICROB, V73, P1107, DOI 10.1128/AEM.02265-06; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Klocke M, 2005, APPL MICROBIOL BIOT, V67, P532, DOI 10.1007/s00253-004-1838-5; Knerr PJ, 2012, ACS CHEM BIOL, V7, P1791, DOI 10.1021/cb300372b; KORDEL M, 1989, FEBS LETT, V244, P99, DOI 10.1016/0014-5793(89)81171-8; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Lee JH, 2011, APPL ENVIRON MICROB, V77, P5879, DOI 10.1128/AEM.00571-11; Liu W, 2010, APPL MICROBIOL BIOT, V85, P1401, DOI 10.1007/s00253-009-2217-z; Lv WH, 2005, APPL MICROBIOL BIOT, V68, P322, DOI 10.1007/s00253-005-1892-7; Moll GN, 1996, ANTON LEEUW INT J G, V69, P185, DOI 10.1007/BF00399423; Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005; Ni JQ, 2011, APPL ENVIRON MICROB, V77, P407, DOI 10.1128/AEM.01278-10; Nicolas GG, 2011, BMC MICROBIOL, V11, P1, DOI [10.1186/1471-2180-11-1, DOI 10.1186/1471-2180-11-1]; Papagianni M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-3; Perin LM, 2012, FOLIA MICROBIOL, V57, P183, DOI 10.1007/s12223-012-0113-x; Pongtharangkul T, 2006, APPL MICROBIOL BIOT, V73, P73, DOI 10.1007/s00253-006-0459-6; Qi FX, 2000, APPL ENVIRON MICROB, V66, P3221, DOI 10.1128/AEM.66.8.3221-3229.2000; ROSS KF, 1993, APPL ENVIRON MICROB, V59, P2014, DOI 10.1128/AEM.59.7.2014-2021.1993; SAHL HG, 1994, APPL ENVIRON MICROB, V60, P752, DOI 10.1128/AEM.60.2.752-755.1994; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SPYR CA, 1995, FEBS LETT, V375, P134, DOI 10.1016/0014-5793(95)01197-M; Swe PM, 2009, J ANTIMICROB CHEMOTH, V63, P679, DOI 10.1093/jac/dkn552; Tiwari SK, 2008, APPL MICROBIOL BIOT, V79, P759, DOI 10.1007/s00253-008-1482-6; Tolonen M, 2004, APPL MICROBIOL BIOT, V63, P659, DOI 10.1007/s00253-003-1413-5; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; van Heusden HE, 2002, BIOCHEMISTRY-US, V41, P12171, DOI 10.1021/bi026090x; Wan X, 2013, APPL MICROBIOL BIOT, V97, P3509, DOI 10.1007/s00253-012-4406-4; Wescombe PA, 2011, MICROBIOL-SGM, V157, P1290, DOI 10.1099/mic.0.044719-0; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wescombe Philip A, 2012, Int J Microbiol, V2012, P738503, DOI 10.1155/2012/738503; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wilson-Stanford Shawanda, 2011, Recent Pat Antiinfect Drug Discov, V6, P175; Zendo T, 2010, APPL MICROBIOL BIOT, V88, P1, DOI 10.1007/s00253-010-2764-3; Zhao M, 2011, AMINO ACIDS, V41, P1071, DOI 10.1007/s00726-009-0386-9	50	36	36	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77751	10.1371/journal.pone.0077751	http://dx.doi.org/10.1371/journal.pone.0077751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147072	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400132
J	He, XH; Patfield, S; Hnasko, R; Rasooly, R; Mandrell, RE				He, Xiaohua; Patfield, Stephanie; Hnasko, Robert; Rasooly, Reuven; Mandrell, Robert E.			A Polyclonal Antibody Based Immunoassay Detects Seven Subtypes of Shiga Toxin 2 Produced by Escherichia coli in Human and Environmental Samples	PLOS ONE			English	Article							UNITED-STATES; VARIANTS; NON-O157; INFECTIONS; PROFILES; STRAINS; ASSAY	Background: Shiga toxin-producing Escherichia coli (STEC) are frequent causes of severe human diseases ranging from diarrhea to hemolytic uremic syndrome. The existing strategy for detection of STEC relies on the unique sorbitol-negative fermentation property of the O157 strains, the most commonly identified serotype has been E. coli O157. It is becoming increasingly evident, however, that numerous non-O157 STEC serotypes also cause outbreaks and severe illnesses. It is necessary to have new methods that are capable of detecting all STEC strains. Methods and Findings: Here we describe the development of a sandwich ELISA assay for detecting both O157 and non-O157 STECs by incorporating a novel polyclonal antibody (pAb) against Stx2. The newly established immunoassay was capable of detecting Stx2a spiked in environmental samples with a limit of detection between 10 and 100 pg/mL in soil and between 100 and 500 pg/mL in feces. When applied to 36 bacterial strains isolated from human and environmental samples, this assay detected Stx2 in all strains that were confirmed to be stx2-positive by real-time PCR, demonstrating a 100% sensitivity and specificity. Conclusions: The sandwich ELISA developed in this study will enable any competent laboratory to identify and characterize Stx2-producing O157 and non-O157 strains in human and environmental samples, resulting in rapid diagnosis and patient care. The results of epitope mapping from this study will be useful for further development of a peptide-based antibody and vaccine.	[He, Xiaohua; Patfield, Stephanie; Hnasko, Robert; Rasooly, Reuven; Mandrell, Robert E.] ARS, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	He, XH (corresponding author), ARS, Western Reg Res Ctr, USDA, Albany, CA USA.	xiaohua.he@ars.usda.gov	Mandrell, Robert E/O-9814-2018		USDA-ARS [5325-42000-048-00D, 5325-42000-046-00D]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the USDA-ARS National Program NP108 CRIS projects 5325-42000-048-00D and 5325-42000-046-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; CAPRIOLI A, 1994, J INFECT DIS, V169, P208, DOI 10.1093/infdis/169.1.208; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P489; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; ENDO Y, 1988, J BIOL CHEM, V263, P8735; Fey PD, 2000, EMERG INFECT DIS, V6, P530, DOI 10.3201/eid0605.000513; Fremaux B, 2008, VET MICROBIOL, V132, P1, DOI 10.1016/j.vetmic.2008.05.015; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; He X, 2012, J IMMUNOL METHODS; He XH, 2012, TOXINS, V4, P487, DOI 10.3390/toxins4070487; He XH, 2011, APPL ENVIRON MICROB, V77, P3558, DOI 10.1128/AEM.02205-10; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; KHINE AA, 1994, J CELL PHYSIOL, V161, P319, DOI 10.1002/jcp.1041610217; Klein EJ, 2002, J PEDIATR-US, V141, P172, DOI 10.1067/mpd.2002.125908; Manning SD, 2007, EMERG INFECT DIS, V13, P318, DOI 10.3201/eid1302.060813; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; OJEDA A, 1995, J CLIN MICROBIOL, V33, P2199, DOI 10.1128/JCM.33.8.2199-2201.1995; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; Persson S, 2007, J CLIN MICROBIOL, V45, P2020, DOI 10.1128/JCM.02591-06; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Sonntag AK, 2005, APPL ENVIRON MICROB, V71, P8855, DOI 10.1128/AEM.71.12.8855-8863.2005; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; Starr M, 1998, CLIN INFECT DIS, V27, P310, DOI 10.1086/514656; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741	28	28	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76368	10.1371/journal.pone.0076368	http://dx.doi.org/10.1371/journal.pone.0076368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146860	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400056
J	Johnsen, AB; Rolim, NPL; Stolen, T; Alves, M; Sousa, MML; Slupphaug, G; Britton, SL; Koch, LG; Smith, GL; Wisloff, U; Hoydal, MA				Johnsen, Anne Berit; Rolim, Natale P. L.; Stolen, Tomas; Alves, Marcia; Sousa, Mirta M. L.; Slupphaug, Geir; Britton, Steven L.; Koch, Lauren G.; Smith, Godfrey L.; Wisloff, Ulrik; Hoydal, Morten A.			Atrial Myocyte Function and Ca2+ Handling Is Associated with Inborn Aerobic Capacity	PLOS ONE			English	Article							RETICULUM CALCIUM LEAK; HEART-FAILURE; ARTIFICIAL SELECTION; RYANODINE RECEPTORS; EJECTION FRACTION; PROTEIN-KINASE; EXERCISE; CARDIOMYOCYTES; MYOCARDIUM; RELEASE	Background: Although high aerobic capacity is associated with effective cardiac function, the effect of aerobic capacity on atrial function, especially in terms of cellular mechanisms, is not known. We aimed to investigate whether rats with low inborn maximal oxygen uptake (VO2 max) had impaired atrial myocyte contractile function when compared to rats with high inborn VO2 max. Methods and Results: Atrial myocyte function was depressed in Low Capacity Runners (LCR) relative to High Capacity Runners (HCR) which was associated with impaired Ca2+ handling. Fractional shortening was 52% lower at 2 Hz and 60% lower at 5 Hz stimulation while time to 50% relengthening was 43% prolonged and 55% prolonged, respectively. Differences in Ca2+ amplitude and diastolic Ca2+ level were observed at 5 Hz stimulation where Ca2+ amplitude was 70% lower and diastolic Ca2+ level was 11% higher in LCR rats. Prolonged time to 50% Ca2+ decay was associated with reduced sarcoplasmic reticulum (SR) Ca2+ ATPase function in LCR (39%). Na+/Ca2+ exchanger activity was comparable between the groups. Diastolic SR Ca2+ leak was increased by 109%. This could be partly explained by increased ryanodine receptors phosphorylation at the Ca2+-calmodulin-dependent protein kinase-II specific Ser-2814 site in LCR rats. T-tubules were present in 68% of HCR cells whereas only 33% LCR cells had these structures. In HCR, the significantly higher numbers of cells with T-tubules were combined with greater numbers of myocytes where Ca2+ release in the cell occurred simultaneously in central and peripheral regions, giving rise to faster and more spatial homogenous Ca2+-signal onset. Conclusion: This data demonstrates that contrasting for low or high aerobic capacity leads to diverse functional and structural remodelling of atrial myocytes, with impaired contractile function in LCR compared to HCR rats.	[Johnsen, Anne Berit; Rolim, Natale P. L.; Stolen, Tomas; Alves, Marcia; Smith, Godfrey L.; Wisloff, Ulrik; Hoydal, Morten A.] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway; [Sousa, Mirta M. L.; Slupphaug, Geir] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Sousa, Mirta M. L.; Slupphaug, Geir] Norwegian Univ Sci & Technol, Prote & Metabol Core Facil, N-7034 Trondheim, Norway; [Sousa, Mirta M. L.; Slupphaug, Geir] Cent Norway Reg Hlth Author, Trondheim, Norway; [Britton, Steven L.; Koch, Lauren G.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Smith, Godfrey L.] Univ Glasgow, Inst Biomed & Life Sci, Glasgow, Lanark, Scotland	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Michigan System; University of Michigan; University of Glasgow	Johnsen, AB (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, KG Jebsen Ctr Exercise Med, N-7034 Trondheim, Norway.	anne.b.johnsen@ntnu.no	Høydal, Morten A/K-2806-2012; Wisloff, Ulrik/K-2899-2012; Slupphaug, Geir/AAN-3794-2020	Høydal, Morten A/0000-0003-1804-2578; Wisloff, Ulrik/0000-0002-7211-3587; Slupphaug, Geir/0000-0002-7498-3500	K.G. Jebsen Foundation; Norwegian Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089503] Funding Source: NIH RePORTER	K.G. Jebsen Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the K.G. Jebsen Foundation and the Norwegian Research Council Funding for Outstanding Young investigators (to U. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Bootman MD, 2006, J CELL SCI, V119, P3915, DOI 10.1242/jcs.03223; Chelu MG, 2007, BIOCHEM SOC T, V35, P952, DOI 10.1042/BST0350952; CLAUSEN JP, 1977, PHYSIOL REV, V57, P779, DOI 10.1152/physrev.1977.57.4.779; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; Hoydal MA, 2007, EUR J CARDIOV PREV R, V14, P319, DOI 10.1097/01.hjr.0b013e3280128bef; Kemi OJ, 2010, ACTA PHYSIOL, V199, P425, DOI 10.1111/j.1748-1716.2010.02132.x; Kirk MM, 2003, J PHYSIOL-LONDON, V547, P441, DOI 10.1113/jphysiol.2002.034355; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kusunose K, 2012, HEART, V98, P1311, DOI 10.1136/heartjnl-2012-302007; Lehnart SE, 2007, CURR OPIN PHARMACOL, V7, P225, DOI 10.1016/j.coph.2006.09.010; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; Picht E, 2007, J MOL CELL CARDIOL, V42, P196, DOI 10.1016/j.yjmcc.2006.09.007; Seidler T, 2003, CIRC RES, V93, P132, DOI 10.1161/01.RES.0000081596.90205.E2; Shannon TR, 2002, CIRC RES, V91, P594, DOI 10.1161/01.RES.0000036914.12686.28; Sheehan KA, 2003, J PHYSIOL-LONDON, V546, P119, DOI 10.1113/jphysiol.2002.026963; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Smyrnias I, 2010, CELL CALCIUM; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Tan YT, 2010, HEART, V96, P1017, DOI 10.1136/hrt.2009.189118; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76568	10.1371/journal.pone.0076568	http://dx.doi.org/10.1371/journal.pone.0076568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146891	Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400072
J	de Chiara, C; Menon, RP; Kelly, G; Pastore, A				de Chiara, Cesira; Menon, Rajesh P.; Kelly, Geoff; Pastore, Annalisa			Protein-Protein Interactions as a Strategy towards Protein-Specific Drug Design: The Example of Ataxin-1	PLOS ONE			English	Article							POLYGLUTAMINE DISEASE PROTEIN; AXH DOMAIN; SPINOCEREBELLAR ATAXIA; NEURODEGENERATIVE DISEASE; FUNCTIONAL INTERACTIONS; REPRESSOR CAPICUA; SCA1; AGGREGATION; NMR; TYPE-1	A main challenge for structural biologists is to understand the mechanisms that discriminate between molecular interactions and determine function. Here, we show how partner recognition of the AXH domain of the transcriptional coregulator ataxin-1 is fine-tuned by a subtle balance between self-and hetero-associations. Ataxin-1 is the protein responsible for the hereditary spinocerebellar ataxia type 1, a disease linked to protein aggregation and transcriptional dysregulation. Expansion of a polyglutamine tract is essential for ataxin-1 aggregation, but the sequence-wise distant AXH domain plays an important aggravating role in the process. The AXH domain is also a key element for non-aberrant function as it intervenes in interactions with multiple protein partners. Previous data have shown that AXH is dimeric in solution and forms a dimer of dimers when crystallized. By solving the structure of a complex of AXH with a peptide from the interacting transcriptional repressor CIC, we show that the dimer interface of AXH is displaced by the new interaction and that, when blocked by the CIC peptide AXH aggregation and misfolding are impaired. This is a unique example in which palindromic self-and hetero-interactions within a sequence with chameleon properties discriminate the partner. We propose a drug design strategy for the treatment of SCA1 that is based on the information gained from the AXH/CIC complex.	[de Chiara, Cesira; Menon, Rajesh P.; Pastore, Annalisa] Natl Inst Med Res, Med Res Council, London NW7 1AA, England; [Kelly, Geoff] Med Res Council Biomed NMR Ctr, London, England	MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Pastore, A (corresponding author), Natl Inst Med Res, Med Res Council, Mill Hill, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk		de Chiara, Cesira/0000-0002-9766-2515	MRC [U117584256]; MRC [MC_PC_13054, MC_U117533887, MC_U117584256] Funding Source: UKRI; Medical Research Council [MC_U117584256, MC_PC_13054, MC_U117533887] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the MRC (Grant ref. U117584256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Bolger TA, 2007, J BIOL CHEM, V282, P29186, DOI 10.1074/jbc.M704182200; Burright EN, 1997, HUM MOL GENET, V6, P513, DOI 10.1093/hmg/6.4.513; Chen YW, 2004, J BIOL CHEM, V279, P3758, DOI 10.1074/jbc.M309817200; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; de Chiara C, 2005, J MOL BIOL, V354, P883, DOI 10.1016/j.jmb.2005.09.083; de Chiara C, 2005, STRUCTURE, V13, P743, DOI 10.1016/j.str.2005.02.016; de Chiara C, 2003, FEBS LETT, V551, P107, DOI 10.1016/S0014-5793(03)00818-4; de Chiara C, 2013, BIOMOL NMR ASSIGN; de Chiara C, 2013, BIOPHYS J, V104, P1304, DOI 10.1016/j.bpj.2013.01.048; de Chiara C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008372; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fryer JD, 2011, SCIENCE, V334, P690, DOI 10.1126/science.1212673; Gehrking KM, 2011, HUM MOL GENET, V20, P2204, DOI 10.1093/hmg/ddr108; Goold R, 2007, HUM MOL GENET, V16, P2122, DOI 10.1093/hmg/ddm162; Irwin S, 2005, J CELL SCI, V118, P233, DOI 10.1242/jcs.01611; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kim E, 2013, GENE DEV, V27, P590, DOI 10.1101/gad.212068.112; Koeppen AH, 2005, CEREBELLUM, V4, P62, DOI 10.1080/14734220510007950; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Masino L, 2004, PROTEIN PEPTIDE LETT, V11, P239, DOI 10.2174/0929866043407147; Masino L, 2011, FASEB J, V25, P45, DOI 10.1096/fj.10-161208; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Mushegian AR, 1997, P NATL ACAD SCI USA, V94, P5831, DOI 10.1073/pnas.94.11.5831; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; Pastore A, 2012, CURR OPIN STRUC BIOL, V22, P30, DOI 10.1016/j.sbi.2011.11.007; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; RAMACHANDRAN GN, 1971, BIOPOLYMERS, V10, P2113, DOI 10.1002/bip.360101108; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Russell RB, 2004, CURR OPIN STRUC BIOL, V14, P313, DOI 10.1016/j.sbi.2004.04.006; Sardiu ME, 2011, J BIOL CHEM, V286, P23645, DOI 10.1074/jbc.R110.174052; Saunders HM, 2011, PROTEIN SCI, V20, P1675, DOI 10.1002/pro.698; Saunders HM, 2009, PROTEIN ENG DES SEL, V22, P447, DOI 10.1093/protein/gzp033; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Thomas D, 2005, ACTA CRYSTALLOGR D, V61, P112, DOI 10.1107/S0907444904027684; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wang ZM, 2013, ANGEW CHEM INT EDIT, V52, P562, DOI 10.1002/anie.201206561; Yue S, 2001, HUM MOL GENET, V10, P25, DOI 10.1093/hmg/10.1.25; Zen A, 2009, BIOINFORMATICS, V25, P1876, DOI 10.1093/bioinformatics/btp339; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	48	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76456	10.1371/journal.pone.0076456	http://dx.doi.org/10.1371/journal.pone.0076456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155902	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300036
J	Ogawara, K; Fukutomi, M; Uchida, S; Feng, Y				Ogawara, Koichi; Fukutomi, Masahiro; Uchida, Seiichi; Feng, Yaokai			A Voting-Based Sequential Pattern Recognition Method	PLOS ONE			English	Article								We propose a novel method for recognizing sequential patterns such as motion trajectory of biological objects (i.e., cells, organelle, protein molecules, etc.), human behavior motion, and meteorological data. In the proposed method, a local classifier is prepared for every point (or timing or frame) and then the whole pattern is recognized by majority voting of the recognition results of the local classifiers. The voting strategy has a strong benefit that even if an input pattern has a very large deviation from a prototype locally at several points, they do not severely influence the recognition result; they are treated just as several incorrect votes and thus will be neglected successfully through the majority voting. For regularizing the recognition result, we introduce partial-dependency to local classifiers. An important point is that this dependency is introduced to not only local classifiers at neighboring point pairs but also to those at distant point pairs. Although, the dependency makes the problem non-Markovian (i.e., higher-order Markovian), it can still be solved efficiently by using a graph cut algorithm with polynomial-order computations. The experimental results revealed that the proposed method can achieve better recognition accuracy while utilizing the above characteristics of the proposed method.	[Ogawara, Koichi] Wakayama Univ, Fac Syst Engn, Wakayama, Japan; [Fukutomi, Masahiro] Kyushu Univ, Grad Sch Informat Sci & Elect Engn, Nishi Ku, Fukuoka 812, Japan; [Uchida, Seiichi; Feng, Yaokai] Kyushu Univ, Fac Informat Sci & Elect Engn, Nishi Ku, Fukuoka 812, Japan	Wakayama University; Kyushu University; Kyushu University	Ogawara, K (corresponding author), Wakayama Univ, Fac Syst Engn, Wakayama, Japan.	ogawara@sys.wakayama-u.ac.jp		Uchida, Seiichi/0000-0001-8592-7566				Anguelov D, 2005, PROC CVPR IEEE, P169; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Boykov YY, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P105, DOI 10.1109/ICCV.2001.937505; Cremers D, 2006, LECT NOTES COMPUT SC, V3953, P263, DOI 10.1007/11744078_21; Ishiguro K, 2010, P BMVC, P241; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kolmogorov V, 2004, IEEE T PATTERN ANAL, V26, P147, DOI 10.1109/TPAMI.2004.1262177; Kolmogorov V, 2007, IEEE T PATTERN ANAL, V29, P1274, DOI 10.1109/TPAMI.2007.1031; KUMAR S, 2003, P NIPS; Liu X., 2008, CVPR, P1; Price B, 2010, P CVPR, P1; Schlesinger D., 2006, TUDFI0601; Schmidt F, 2009, P CVPR, P1; Schmidt FR, 2007, IEEE I CONF COMP VIS, P1479; Schoenemann T, 2009, IEEE I CONF COMP VIS, P17, DOI 10.1109/ICCV.2009.5459209; Uchida S, 2008, P ICPR	16	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76980	10.1371/journal.pone.0076980	http://dx.doi.org/10.1371/journal.pone.0076980			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155915	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300049
J	Rozsas, A; Berta, J; Rojko, L; Horvath, LZ; Keszthelyi, M; Kenessey, I; Laszlo, V; Berger, W; Grusch, M; Hoda, MA; Torok, S; Klepetko, W; Renyi-Vamos, F; Hegedus, B; Dome, B; Tovari, J				Rozsas, Anita; Berta, Judit; Rojko, Livia; Horvath, Laszlo Z.; Keszthelyi, Magdolna; Kenessey, Istvan; Laszlo, Viktoria; Berger, Walter; Grusch, Michael; Hoda, Mir Alireza; Torok, Szilvia; Klepetko, Walter; Renyi-Vamos, Ferenc; Hegedus, Balazs; Doeme, Balazs; Tovari, Jozsef			Erythropoietin Receptor Expression Is a Potential Prognostic Factor in Human Lung Adenocarcinoma	PLOS ONE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; STIMULATING AGENTS; TUMOR-CELLS; IN-VITRO; CANCER; GROWTH; XENOGRAFT; SURVIVAL; HYPOXIA; IMPACT	Recombinant human erythropoietins (rHuEPOs) are used to treat cancer-related anemia. Recent preclinical studies and clinical trials, however, have raised concerns about the potential tumor-promoting effects of these drugs. Because the clinical significance of erythropoietin receptor (EPOR) signaling in human non-small cell lung cancer (NSCLC) also remains controversial, our aim was to study whether EPO treatment modifies tumor growth and if EPOR expression has an impact on the clinical behavior of this malignancy. A total of 43 patients with stage III-IV adenocarcinoma (ADC) and complete clinicopathological data were included. EPOR expression in human ADC samples and cell lines was measured by quantitative real-time polymerase chain reaction. Effects of exogenous rHuEPO alpha were studied on human lung ADC cell lines in vitro. In vivo growth of human ADC xenografts treated with rHuEPO alpha with or without chemotherapy was also assessed. In vivo tumor and endothelial cell (EC) proliferation was determined by 5-bromo-2'-deoxy-uridine (BrdU) incorporation and immunofluorescent labeling. Although EPOR mRNA was expressed in all of the three investigated ADC cell lines, rHuEPO alpha treatment (either alone or in combination with gemcitabine) did not alter ADC cell proliferation in vitro. However, rHuEPO alpha significantly decreased tumor cell proliferation and growth of human H1975 lung ADC xenografts. At the same time, rHuEPO alpha treatment of H1975 tumors resulted in accelerated tumor endothelial cell proliferation. Moreover, in patients with advanced stage lung ADC, high intratumoral EPOR mRNA levels were associated with significantly increased overall survival. This study reveals high EPOR level as a potential novel positive prognostic marker in human lung ADC.	[Rozsas, Anita; Berta, Judit; Keszthelyi, Magdolna; Torok, Szilvia; Doeme, Balazs; Tovari, Jozsef] Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary; [Rojko, Livia] Natl Koranyi Inst Pulmonol, Dept Bronchoscopy, Budapest, Hungary; [Rozsas, Anita; Laszlo, Viktoria; Hoda, Mir Alireza; Klepetko, Walter; Renyi-Vamos, Ferenc; Hegedus, Balazs; Doeme, Balazs] Med Univ Vienna, Div Thorac Surg, Vienna, Austria; [Kenessey, Istvan; Hegedus, Balazs; Doeme, Balazs] Semmelweis Univ, Dept Pathol 2, H-1085 Budapest, Hungary; [Berger, Walter; Grusch, Michael; Hoda, Mir Alireza] Med Univ Vienna, Inst Canc Res, Dept Internal Med 1, Vienna, Austria; [Horvath, Laszlo Z.; Tovari, Jozsef] Natl Inst Oncol, Dept Expt Pharmacol, Budapest, Hungary; [Renyi-Vamos, Ferenc; Doeme, Balazs] Natl Inst Oncol, Dept Thorac Surg, Budapest, Hungary; [Torok, Szilvia] Lund Univ, Dept Measurement Technol & Ind Elect Engn, Lund, Sweden	Medical University of Vienna; Semmelweis University; Medical University of Vienna; National Institute of Oncology Hungary; National Institute of Oncology Hungary; Lund University	Dome, B (corresponding author), Natl Koranyi Inst Pulmonol, Dept Tumor Biol, Budapest, Hungary.	balazs.dome@meduniwien.ac.at; tozsi@oncol.hu	Hegedus, Balazs/B-6076-2008; Grusch, Michael/C-1183-2008; Keszthelyi, Magdolna/E-6424-2017; laszlo, viktoria/A-4667-2017	Hegedus, Balazs/0000-0002-4341-4153; Grusch, Michael/0000-0001-5486-9340; Keszthelyi, Magdolna/0000-0001-9148-7675; laszlo, viktoria/0000-0002-6567-3965; Dome, Balazs/0000-0001-8799-8624; Berger, Walter/0000-0003-0014-1658	Tarsadalmi Megujulas Operativ Program [424A/1-11-1-2012-0001]; Orszagos Tudomanyos Kutatasi Alap (OTKA) [K109626, OTKA K108465]; Kutatasi es Technologiai Innovacios Alap - Nemzetkozi egyuttmukodessel magvalosulo alap es ipari kutatasi valamint infokommunikacios technologiai fejlesztesei projektek tamogatasa a kozepmagyarorszagi regioban [12-1-2013-0041]; Hungarian Oncological Association; Hungarian Pulmonology Foundation	Tarsadalmi Megujulas Operativ Program; Orszagos Tudomanyos Kutatasi Alap (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Kutatasi es Technologiai Innovacios Alap - Nemzetkozi egyuttmukodessel magvalosulo alap es ipari kutatasi valamint infokommunikacios technologiai fejlesztesei projektek tamogatasa a kozepmagyarorszagi regioban; Hungarian Oncological Association; Hungarian Pulmonology Foundation	This work was supported by the Tarsadalmi Megujulas Operativ Program 424A/1-11-1-2012-0001; Orszagos Tudomanyos Kutatasi Alap (OTKA) K109626, OTKA K108465 (BD); Kutatasi es Technologiai Innovacios Alap - Nemzetkozi egyuttmukodessel magvalosulo alap es ipari kutatasi valamint infokommunikacios technologiai fejlesztesei projektek tamogatasa a kozepmagyarorszagi regioban 12-1-2013-0041 (BD, JT, FRV). OTKA K76293, K84173 (JT); OTKA MOB (OTKA - Mobilitas Palyazat) 80325 (BH); AR is recipient of an European Association for Cancer Research travel fellowship. JB is recipient of a research fellowship of the Hungarian Oncological Association for PhD students. ST is recipient of an Hungarian Pulmonology Foundation research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro M, 2012, BRIT J CANCER, V106, P1249, DOI 10.1038/bjc.2012.42; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; BERDEL WE, 1991, ANN HEMATOL, V63, P5, DOI 10.1007/BF01714953; BERDEL WE, 1992, SEMIN ONCOL, V19, P41; Bertalanffy P, 1999, CLIN CHEM LAB MED, V37, P259, DOI 10.1515/CCLM.1999.045; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Brown WM, 2007, STEM CELLS, V25, P718, DOI 10.1634/stemcells.2006-0687; Bugyik E, 2011, J NEUROPATH EXP NEUR, V70, P979, DOI 10.1097/NEN.0b013e318233afd7; Carvalho G, 2005, ONCOGENE, V24, P737, DOI 10.1038/sj.onc.1208205; Crawford J, 2006, J THORAC ONCOL, V1, P716; Dagnon K, 2005, CLIN CANCER RES, V11, P993; Dezso K, 2009, AM J PATHOL, V175, P835, DOI 10.2353/ajpath.2009.090095; Dome B, 2003, J NEUROPATH EXP NEUR, V62, P655; Dome B, 2002, J PATHOL, V197, P355, DOI 10.1002/path.1124; Dunlop EA, 2006, NEURODEGENER DIS, V3, P94, DOI 10.1159/000092099; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Elliott S, 2010, J IMMUNOL METHODS, V352, P126, DOI 10.1016/j.jim.2009.10.006; Fandrey J, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.13-S3-16; Higgins B, 2004, ANTI-CANCER DRUG, V15, P503, DOI 10.1097/01.cad.0000127664.66472.60; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; July LV, 2004, MOL CANCER THER, V3, P223; Kadara H, 2012, RESPIROLOGY, V17, P50, DOI 10.1111/j.1440-1843.2011.02095.x; Kelly K, 2008, J THORAC ONCOL, V3, P664, DOI 10.1097/JTO.0b013e3181758141; Lovey J, 2008, STRAHLENTHER ONKOL, V184, P1, DOI 10.1007/s00066-008-1745-2; Mittelman M, 2001, P NATL ACAD SCI USA, V98, P5181, DOI 10.1073/pnas.081275298; MUNDT D, 1992, ARZNEIMITTELFORSCH, V42-1, P92; NAKAMURA Y, 1992, SCIENCE, V257, P1138, DOI 10.1126/science.257.5073.1138; Paul I, 2006, LUNG CANCER-J IASLC, V51, P329, DOI 10.1016/j.lungcan.2005.10.020; Rades D, 2011, INT J RADIAT ONCOL, V80, P499, DOI 10.1016/j.ijrobp.2010.02.003; ROSTI V, 1993, HAEMATOLOGICA, V78, P208; Saintigny P, 2007, CLIN CANCER RES, V13, P4825, DOI 10.1158/1078-0432.CCR-06-3061; Tovari J, 2005, CANCER RES, V65, P7186, DOI 10.1158/0008-5472.CAN-04-2498; Tovari J, 2008, CURR MOL MED, V8, P481, DOI 10.2174/156652408785747979; Vansteenkiste J, 2012, LUNG CANCER, V76, P478, DOI 10.1016/j.lungcan.2011.12.015; Wu Y, 2005, ANTI-CANCER DRUG, V16, P551, DOI 10.1097/00001813-200506000-00011; Yasuda Y, 2010, ANAT SCI INT, V85, P204, DOI 10.1007/s12565-010-0081-7	37	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77459	10.1371/journal.pone.0077459	http://dx.doi.org/10.1371/journal.pone.0077459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155958	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300092
J	Hellstrand, E; Nowacka, A; Topgaard, D; Linse, S; Sparr, E				Hellstrand, Erik; Nowacka, Agnieszka; Topgaard, Daniel; Linse, Sara; Sparr, Emma			Membrane Lipid Co-Aggregation with alpha-Synuclein Fibrils	PLOS ONE			English	Article							SOLID-STATE NMR; POLARIZATION TRANSFER; PARKINSONS-DISEASE; AMYLOID FIBRILS; PHOSPHOLIPID-BILAYERS; LEWY BODY; VESICLES; BINDING; PHOSPHATIDYLSERINE; DISRUPTION	Amyloid deposits from several human diseases have been found to contain membrane lipids. Co-aggregation of lipids and amyloid proteins in amyloid aggregates, and the related extraction of lipids from cellular membranes, can influence structure and function in both the membrane and the formed amyloid deposit. Co-aggregation can therefore have important implications for the pathological consequences of amyloid formation. Still, very little is known about the mechanism behind co-aggregation and molecular structure in the formed aggregates. To address this, we study in vitro co-aggregation by incubating phospholipid model membranes with the Parkinson's disease-associated protein, a-synuclein, in monomeric form. After aggregation, we find spontaneous uptake of phospholipids from anionic model membranes into the amyloid fibrils. Phospholipid quantification, polarization transfer solid-state NMR and cryo-TEM together reveal co-aggregation of phospholipids and a-synuclein in a saturable manner with a strong dependence on lipid composition. At low lipid to protein ratios, there is a close association of phospholipids to the fibril structure, which is apparent from reduced phospholipid mobility and morphological changes in fibril bundling. At higher lipid to protein ratios, additional vesicles adsorb along the fibrils. While interactions between lipids and amyloid-protein are generally discussed within the perspective of different protein species adsorbing to and perturbing the lipid membrane, the current work reveals amyloid formation in the presence of lipids as a co-aggregation process. The interaction leads to the formation of lipid-protein co-aggregates with distinct structure, dynamics and morphology compared to assemblies formed by either lipid or protein alone.	[Hellstrand, Erik] Lund Univ, Ctr Chem & Chem Engn, Div Biophys Chem, S-22100 Lund, Sweden; [Nowacka, Agnieszka; Topgaard, Daniel; Sparr, Emma] Lund Univ, Ctr Chem & Chem Engn, Div Phys Chem, S-22100 Lund, Sweden; [Linse, Sara] Lund Univ, Ctr Chem & Chem Engn, Div Biochem, S-22100 Lund, Sweden	Lund University; Lund University; Lund University	Hellstrand, E (corresponding author), Lund Univ, Ctr Chem & Chem Engn, Div Biophys Chem, S-22100 Lund, Sweden.	erik.hellstrand@bpc.lu.se		Topgaard, Daniel/0000-0001-9373-6348; Linse, Sara/0000-0001-9629-7109; Sparr, Emma/0000-0001-8343-9657	Linnaeus Center of Excellence; Swedish Foundation for Strategic Research; Crafoord Foundation; Royal Physiographic Society;  [2011 4334];  [2005-2936];  [2008-4281];  [2012-3932]	Linnaeus Center of Excellence; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Crafoord Foundation; Royal Physiographic Society; ; ; ; 	The Swedish Research Council (VR) is gratefully acknowledged for financial support both through regular grants 2011 4334 (DT), 2005-2936 (DT), 2008-4281 (SL), 2012-3932 (ES) and the Linnaeus Center of Excellence "Organizing molecular matter" 2009-6794 (DT, SL, ES). ES, SL and EH also acknowledges The Swedish Foundation for Strategic Research (ES), the Crafoord Foundation (SL) and the Royal Physiographic Society (EH) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1483, P199, DOI 10.1016/S1388-1981(99)00188-2; Chen L, 2002, J MAGN RESON, V158, P164, DOI 10.1016/S1090-7807(02)00069-1; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dimitrievski K, 2010, LANGMUIR, V26, P3008, DOI 10.1021/la904743d; Domanov YA, 2008, J MOL BIOL, V376, P42, DOI 10.1016/j.jmb.2007.11.077; Evans D.F., 1999, COLLOIDAL DOMAIN; Ferreira TM, 2013, PHYS CHEM CHEM PHYS, V15, P1976, DOI 10.1039/c2cp42738a; Gai WP, 2000, SOC NEUR ABSTR; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Grey M, 2011, J PARKINSON DIS, V1, P359, DOI 10.3233/JPD-2011-11067; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; HAYASHI S, 1991, B CHEM SOC JPN, V64, P685, DOI 10.1246/bcsj.64.685; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Milanesi L, 2012, P NATL ACAD SCI USA, V109, P20455, DOI 10.1073/pnas.1206325109; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Nowacka A, 2013, J MAGN RESON, V230, P165, DOI 10.1016/j.jmr.2013.02.016; Nowacka A, 2012, SOFT MATTER, V8, P1482, DOI 10.1039/c1sm06273e; Nowacka A, 2010, LANGMUIR, V26, P16848, DOI 10.1021/la102935t; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; PINES A, 1972, J CHEM PHYS, V56, P1776, DOI 10.1063/1.1677439; Reviakine I, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3687351; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SEELIG J, 1978, BIOCHEMISTRY-US, V17, P3310, DOI 10.1021/bi00609a021; Shvadchak VV, 2011, J BIOL CHEM, V286, P13023, DOI 10.1074/jbc.M110.204776; Song C, 2008, BIOPHYS CHEM, V134, P47, DOI 10.1016/j.bpc.2008.01.002; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; van Beek JD, 2007, J MAGN RESON, V187, P19, DOI 10.1016/j.jmr.2007.03.017; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; Vance JE, 2008, J LIPID RES, V49, P1377, DOI 10.1194/jlr.R700020-JLR200; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y; Warschawski DE, 2000, J MAGN RESON, V145, P367, DOI 10.1006/jmre.2000.2135; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	41	80	81	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77235	10.1371/journal.pone.0077235	http://dx.doi.org/10.1371/journal.pone.0077235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146972	gold, Green Published			2022-12-27	WOS:000325819400107
J	Luebbering, N; Charlton-Perkins, M; Kumar, JP; Rollmann, SM; Cook, T; Cleghon, V				Luebbering, Nathan; Charlton-Perkins, Mark; Kumar, Justin P.; Rollmann, Stephanie M.; Cook, Tiffany; Cleghon, Vaughn			Drosophila Dyrk2 Plays a Role in the Development of the Visual System	PLOS ONE			English	Article							PROTEIN-KINASE; OLFACTORY BEHAVIOR; CELL; GENE; SPECIFICITY; DIFFERENTIATION; EXPRESSION; MNB/DYRK1A; FAMILY; GROWTH	The DYRKs (dual-specificity tyrosine phosphorylation-regulated kinases) are a conserved family of protein kinases that are associated with a number of neurological disorders, but whose biological targets are poorly understood. Drosophila encodes three Dyrks: minibrain/Dyrk1A, DmDyrk2, and DmDyrk3. Here we describe the creation and characterization of a DmDyrk2 null allele, DmDyrk2(1w17). We provide evidence that the smell impaired allele smi35A(1), is likely to encode DmDyrk2. We also demonstrate that DmDyrk2 is expressed late in the developing third antennal segment, an anatomical structure associated with smell. In addition, we find that DmDyrk2 is expressed in the morphogenetic furrow of the developing eye, that loss of DmDyrk2 in the eye produced a subtle but measurable defect, and that ectopic DmDyrk2 expression in the eye produced a strong rough eye phenotype characterized by increased secondary, tertiary and bristle interommatidial cells. This phenotype was dependent on DmDyrk2 kinase activity and was only manifest when expressed in post-mitotic non-neuronal progenitors. Together, these data indicate that DmDyrk2 is expressed in developing sensory systems, that it is required for the development of the visual system, and that the eye is a good model to identify DmDyrk2 targets.	[Luebbering, Nathan; Charlton-Perkins, Mark; Cook, Tiffany; Cleghon, Vaughn] Cincinnati Childrens Hosp Med Ctr, Dept Dev Biol, Cincinnati, OH 45229 USA; [Charlton-Perkins, Mark; Cook, Tiffany] Cincinnati Childrens Hosp Med Ctr, Dept Pediat Opthalmol, Cincinnati, OH 45229 USA; [Rollmann, Stephanie M.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Kumar, Justin P.] Indiana Univ, Dept Biol, Bloomington, IN USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Indiana University System; Indiana University Bloomington	Cleghon, V (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Dev Biol, Cincinnati, OH 45229 USA.	vaughn.cleghon@cchmc.org		Charlton-Perkins, Mark/0000-0002-7597-1130; Cook, Tiffany/0000-0002-3100-5248; Charlton-Perkins, Mark/0000-0002-5602-6109	National Institutes of Health [R01GM087374-01A1]; NATIONAL EYE INSTITUTE [R56EY014863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by a grant from the National Institutes of Health (R01GM087374-01A1 to VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 1996, GENETICS, V143, P293; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Ashburner M, 1999, GENETICS, V153, P179; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAGAN RL, 1989, DEV BIOL, V136, P346, DOI 10.1016/0012-1606(89)90261-3; Charlton-Perkins M, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-20; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Goodwin SF, 1997, J NEUROSCI, V17, P8817; Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Han JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029702; HELFAND SL, 1989, P NATL ACAD SCI USA, V86, P2908, DOI 10.1073/pnas.86.8.2908; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Jordan KW, 2006, GENETICS, V174, P271, DOI 10.1534/genetics.106.058099; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kim EJ, 2006, J BIOL CHEM, V281, P33250, DOI 10.1074/jbc.M606147200; Kimura R, 2007, HUM MOL GENET, V16, P15, DOI 10.1093/hmg/ddl437; Kumar JP, 2012, DEV DYNAM, V241, P136, DOI 10.1002/dvdy.23707; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lochhead PA, 2003, BIOCHEM J, V374, P381, DOI 10.1042/BJ20030500; Marygold SJ, 2013, NUCLEIC ACIDS RES, V41, pD751, DOI 10.1093/nar/gks1024; McDonald EC, 2010, DEV BIOL, V347, P122, DOI 10.1016/j.ydbio.2010.08.016; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Mercer SE, 2006, CELL BIOCHEM BIOPHYS, V45, P303, DOI 10.1385/CBB:45:3:303; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Oegema R, 2010, MOL SYNDROMOL, V1, P113, DOI 10.1159/000320113; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Raich WB, 2003, GENETICS, V163, P571; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Richgels PK, 2012, CHEM SENSES, V37, P229, DOI 10.1093/chemse/bjr097; Saul VV, 2013, J MOL CELL BIOL, V5, P27, DOI 10.1093/jmcb/mjs053; Souza GM, 1998, DEVELOPMENT, V125, P2291; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; van Bon BWM, 2011, CLIN GENET, V79, P296, DOI 10.1111/j.1399-0004.2010.01544.x; Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010; YAO KM, 1994, J NEUROCHEM, V63, P41	44	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76775	10.1371/journal.pone.0076775	http://dx.doi.org/10.1371/journal.pone.0076775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146926	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400082
J	Ren, YY; Overmyer, KA; Qi, NR; Treutelaar, MK; Heckenkamp, L; Kalahar, M; Koch, LG; Britton, SL; Burant, CF; Li, JZ				Ren, Yu-yu; Overmyer, Katherine A.; Qi, Nathan R.; Treutelaar, Mary K.; Heckenkamp, Lori; Kalahar, Molly; Koch, Lauren G.; Britton, Steven L.; Burant, Charles F.; Li, Jun Z.			Genetic Analysis of a Rat Model of Aerobic Capacity and Metabolic Fitness	PLOS ONE			English	Article							ENDURANCE RUNNING CAPACITY; QUANTITATIVE TRAIT LOCI; ALL-CAUSE MORTALITY; EXERCISE CAPACITY; CARDIORESPIRATORY FITNESS; ARTIFICIAL SELECTION; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; INBRED STRAINS; RISK	Aerobic capacity is a strong predictor of all-cause mortality and can influence many complex traits. To explore the biological basis underlying this connection, we developed via artificial selection two rat lines that diverge for intrinsic (i.e. inborn) aerobic capacity and differ in risk for complex disease traits. Here we conduct the first in-depth pedigree and molecular genetic analysis of these lines, the high capacity runners (HCR) and low capacity runners (LCR). Our results show that both HCR and LCR lines maintain considerable narrow-sense heritability (h(2)) for the running capacity phenotype over 28 generations (h(2) = 0.47 +/- 0.02 and 0.43 +/- 0.02, respectively). To minimize inbreeding, the lines were maintained by rotational mating. Pedigree records predict that the inbreeding coefficient increases at a rate of <1% per generation, similar to 37-38% slower than expected for random mating. Genome-wide 10K SNP genotype data for generations 5, 14, and 26 demonstrate substantial genomic evolution: between-line differentiation increased progressively, while within-line diversity deceased. Genome-wide average heterozygosity decreased at a rate of <1% per generation, consistent with pedigree-based predictions and confirming the effectiveness of rotational breeding. Linkage disequilibrium index r(2) decreases to 0.3 at similar to 3 Mb, suggesting that the resolution for mapping quantitative trait loci (QTL) can be as high as 2-3 cM. To establish a test population for QTL mapping, we conducted an HCR-LCR intercross. Running capacity of the F1 population (n=176) was intermediate of the HCR and LCR parentals (28 pairs); and the F2 population (n=645) showed a wider range of phenotypic distribution. Importantly, heritability in the F0-F2 pedigree remained high (h(2)similar to 0.6). These results suggest that the HCR-LCR lines can serve as a valuable system for studying genomic evolution, and a powerful resource for mapping QTL for a host of characters relevant to human health.	[Ren, Yu-yu; Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Overmyer, Katherine A.; Qi, Nathan R.; Treutelaar, Mary K.; Burant, Charles F.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Heckenkamp, Lori; Kalahar, Molly; Koch, Lauren G.; Britton, Steven L.] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Li, JZ (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	junzli@med.umich.edu	Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003; Li, Jun/0000-0001-6727-0812	Ellison Medical Foundation; Michigan Diabetes Research Center; National Institute of Diabetes & Digestive & Kidney Diseases [NIH5P60 DK20572]; National Institutes of Health [RO1 DK077200]; University of Michigan Animal Phenotyping Core; Michigan Nutrition Obesity Research Center [DK 089503]; Michigan Diabetes Research and Training Center [NIH5P60 DK20572]; National Center for Research Resources [R24 RR017718]; Office of Research Infrastructure Programs/OD grant from the National Institutes of Health [ROD012098A]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR017718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077200, P60DK020572, P30DK089503, P30DK020572, R01DK099034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Michigan Diabetes Research Center; National Institute of Diabetes & Digestive & Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Animal Phenotyping Core; Michigan Nutrition Obesity Research Center; Michigan Diabetes Research and Training Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs/OD grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a New Scholar in Aging award (J.Z.L) from the Ellison Medical Foundation and a pilot grant (J.Z.L) from the Michigan Diabetes Research Center, funded by NIH5P60 DK20572 from the National Institute of Diabetes & Digestive & Kidney Diseases. This work is also supported by National Institutes of Health grants RO1 DK077200 (C. F. B.) and the University of Michigan Animal Phenotyping Core, supported by Michigan Nutrition Obesity Research Center (DK 089503) and Michigan Diabetes Research and Training Center (NIH5P60 DK20572). The LCR-HCR rat model system was funded by the National Center for Research Resources grant R24 RR017718 and is currently supported by the Office of Research Infrastructure Programs/OD grant ROD012098A (to L. G. K. and S. L. B.) from the National Institutes of Health. Contact L. G. K. (lgkoch@med.umich.edu) or S. L. B. (brittons@umich.edu) for information on the LCR and HCR rats, which are maintained as an international collaborative resource at the University of Michigan, Ann Arbor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert FW, 2009, GENETICS, V182, P541, DOI 10.1534/genetics.109.102186; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 2010, R LANG ENV STAT COMP; Barbato JC, 1998, J APPL PHYSIOL, V85, P530, DOI 10.1152/jappl.1998.85.2.530; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bastiaansen JWM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-3; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Bouchard C, 2000, J APPL PHYSIOL, V88, P551, DOI 10.1152/jappl.2000.88.2.551; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Bray MS, 2000, J APPL PHYSIOL, V88, P788, DOI 10.1152/jappl.2000.88.2.788; Bunger L, 1999, MAMM GENOME, V10, P645, DOI 10.1007/s003359901063; Burghardt PR, 2011, NEUROPSYCHOPHARMACOL, V36, P390, DOI 10.1038/npp.2010.144; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Castle W E, 1921, Science, V54, P223, DOI 10.1126/science.54.1393.223; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Dworkin I, 2003, CURR BIOL, V13, P1888, DOI 10.1016/j.cub.2003.10.001; ENGSTROM LM, 1977, ACTA GENET MED GEMEL, V26, P159, DOI 10.1017/S0001566000009958; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FARID A, 1987, THEOR APPL GENET, V73, P506, DOI 10.1007/BF00289187; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; HANSEN C, 1984, ALCOHOL CLIN EXP RES, V8, P477, DOI 10.1111/j.1530-0277.1984.tb05706.x; HOWALD H, 1976, ANN HUM BIOL, V3, P455, DOI 10.1080/03014467600001721; James PT, 2004, EUR J CARDIOV PREV R, V11, P3, DOI 10.1097/01.hjr.0000114707.27531.48; Johannesson M, 2009, GENOME RES, V19, P150, DOI 10.1101/gr.081497.108; Kaprio J, 1981, Prog Clin Biol Res, V69 Pt C, P37; KLISSOUR.V, 1971, J APPL PHYSIOL, V31, P338, DOI 10.1152/jappl.1971.31.3.338; Koch LG, 2012, TRENDS CARDIOVAS MED, V22, P29, DOI 10.1016/j.tcm.2012.06.007; Koch LG, 2011, CIRC RES, V109, P1162, DOI 10.1161/CIRCRESAHA.111.253807; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; LAKKA TA, 1994, NEW ENGL J MED, V330, P1549, DOI 10.1056/NEJM199406023302201; Leeper NJ, 2013, J VASC SURG, V57, P728, DOI 10.1016/j.jvs.2012.07.051; Lessard SJ, 2009, ENDOCRINOLOGY, V150, P4883, DOI 10.1210/en.2009-0158; Lujan HL, 2006, AM J PHYSIOL-HEART C, V291, pH2933, DOI 10.1152/ajpheart.00514.2006; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Muncey AR, 2010, ANESTHESIOLOGY, V113, P1176, DOI 10.1097/ALN.0b013e3181f56248; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Noland RC, 2007, AM J PHYSIOL-ENDOC M, V293, pE31, DOI 10.1152/ajpendo.00500.2006; Nomura T, 1996, GENET SEL EVOL, V28, P141, DOI 10.1051/gse:19960202; Novak CM, 2010, HORM BEHAV, V58, P355, DOI 10.1016/j.yhbeh.2010.03.013; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; PERUSSE L, 1989, AM J EPIDEMIOL, V129, P1012, DOI 10.1093/oxfordjournals.aje.a115205; PRUDHOMME D, 1984, MED SCI SPORT EXER, V16, P489, DOI 10.1249/00005768-198410000-00012; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; SIMONEAU JA, 1986, INT J SPORTS MED, V7, P167, DOI 10.1055/s-2008-1025756; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Valdar W, 2006, GENETICS, V172, P1783, DOI 10.1534/genetics.104.039313; Valdar WSJ, 2003, MAMM GENOME, V14, P830, DOI 10.1007/s00335-003-3021-1; Wikgren J, 2012, PHYSIOL BEHAV, V106, P95, DOI 10.1016/j.physbeh.2012.01.011; Windig JJ, 2008, ANIMAL, V2, P1733, DOI 10.1017/S1751731108003029; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Wright S., 1968, GENETIC BIOMETRIC FD	58	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77588	10.1371/journal.pone.0077588	http://dx.doi.org/10.1371/journal.pone.0077588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147032	Green Published, gold			2022-12-27	WOS:000325819400128
J	Sun, XJ; Qiu, JJ; Zhu, ST; Cao, BW; Sun, L; Li, S; Li, P; Zhang, ST; Dong, S				Sun, Xiujing; Qiu, Jihui Julia; Zhu, Shengtao; Cao, Bangwei; Sun, Lin; Li, Sen; Li, Peng; Zhang, Shutian; Dong, Shuo			Oncogenic Features of PHF8 Histone Demethylase in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; INHIBITION; CANCER; GENE; METHYLATION; EXPRESSION; DISEASE	Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. It has been reported that histone demethylases are involved in the carcinogenesis of certain types of tumors. Here, we studied the role of one of the histone lysine demethylases, plant homeodomain finger protein 8 (PHF8), in the carcinogenesis of esophageal squamous cell carcinoma (ESCC). Using short hairpin RNA via lentiviral infection, we established stable ESCC cell lines with constitutive downregulation of PHF8 expression. Knockdown of PHF8 in ESCC cells resulted in inhibition of cell proliferation and an increase of apoptosis. Moreover, there were reductions of both anchorage-dependent and -independent colony formation. In vitro migration and invasion assays showed that knockdown of PHF8 led to a reduction in the number of migratory and invasive cells. Furthermore, downregulation of PHF8 attenuated the tumorigenicity of ESCC cells in vivo. Taken together, our study revealed the oncogenic features of PHF8 in ESCC, suggesting that PHF8 may be a potential diagnostic marker and therapeutic target for ESCC.	[Sun, Xiujing; Qiu, Jihui Julia; Sun, Lin; Li, Sen; Dong, Shuo] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Sun, Xiujing; Qiu, Jihui Julia; Sun, Lin; Li, Sen; Dong, Shuo] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Sun, Xiujing; Zhu, Shengtao; Li, Peng; Zhang, Shutian] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Qiu, Jihui Julia] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA USA; [Cao, Bangwei] Capital Med Univ, Beijing Friendship Hosp, Dept Oncol, Beijing, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Capital Medical University	Dong, S (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	sdong@bcm.edu			Albert and Margaret Alkek Foundation of Department of Medicine of Baylor College of Medicine; National Natural Science Foundation of China [81272447]; National Key Basic Research Program of China [2012CB526600]	Albert and Margaret Alkek Foundation of Department of Medicine of Baylor College of Medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by the Albert and Margaret Alkek Foundation of Department of Medicine of Baylor College of Medicine, the National Natural Science Foundation of China (81272447), and the National Key Basic Research Program of China (2012CB526600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga MF, 2013, CANCER CELL, V23, P376, DOI 10.1016/j.ccr.2013.02.014; Bjorkman M, 2012, ONCOGENE, V31, P3444, DOI 10.1038/onc.2011.512; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072335; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Laumonnier F, 2005, J MED GENET, V42, P780, DOI 10.1136/jmg.2004.029439; Lim HJ, 2013, MOL CELL BIOL; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lv TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035065; Lynch JT, 2012, EXPERT OPIN THER TAR, V16, P1239, DOI 10.1517/14728222.2012.722206; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Meng XY, 2011, DIS ESOPHAGUS, V24, P444, DOI 10.1111/j.1442-2050.2010.01159.x; Meng XY, 2012, J DIGEST DIS, V13, P208, DOI 10.1111/j.1751-2980.2012.00578.x; Meng Y, 2011, DIGEST DIS SCI, V56, P3195, DOI 10.1007/s10620-011-1734-7; Miller PG, 2013, CANCER CELL, V24, P45, DOI 10.1016/j.ccr.2013.05.004; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Qiu JJ, 2011, ONCOGENE, V30, P967, DOI 10.1038/onc.2010.473; Qiu JH, 2010, CELL RES, V20, P908, DOI 10.1038/cr.2010.81; Rotili Dante, 2011, Genes Cancer, V2, P663, DOI 10.1177/1947601911417976; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shi HY, 2011, CANCER LETT, V309, P19, DOI 10.1016/j.canlet.2011.05.010; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Yang ZQ, 2000, CANCER RES, V60, P4735; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Zhao SL, 2011, DIS ESOPHAGUS, V24, P601, DOI 10.1111/j.1442-2050.2011.01199.x; Zhao YQ, 2013, INT J CANCER, V132, P2901, DOI 10.1002/ijc.27954	31	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77353	10.1371/journal.pone.0077353	http://dx.doi.org/10.1371/journal.pone.0077353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146981	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400111
J	Loepfe, L; Cabrales, A; Sanchez, A				Loepfe, Lasse; Cabrales, Antonio; Sanchez, Angel			Towards a Proper Assignment of Systemic Risk: The Combined Roles of Network Topology and Shock Characteristics	PLOS ONE			English	Article							FINANCIAL NETWORKS; INTERBANK MARKET; CONTAGION; MODELS	The 2007-2008 financial crisis solidified the consensus among policymakers that a macro-prudential approach to regulation and supervision should be adopted. The currently preferred policy option is the regulation of capital requirements, with the main focus on combating procyclicality and on identifying the banks that have a high systemic importance, those that are "too big to fail". Here we argue that the concept of systemic risk should include the analysis of the system as a whole and we explore systematically the most important properties for policy purposes of networks topology on resistance to shocks. In a thorough study going from analytical models to empirical data, we show two sharp transitions from safe to risky regimes: 1) diversification becomes harmful with just a small fraction (similar to 2%) of the shocks sampled from a fat tailed shock distributions and 2) when large shocks are present a critical link density exists where an effective giant cluster forms and most firms become vulnerable. This threshold depends on the network topology, especially on modularity. Firm size heterogeneity has important but diverse effects that are heavily dependent on shock characteristics. Similarly, degree heterogeneity increases vulnerability only when shocks are directed at the most connected firms. Furthermore, by studying the structure of the core of the transnational corporation network from real data, we show that its stability could be clearly increased by removing some of the links with highest centrality betweeness. Our results provide a novel insight and arguments for policy makers to focus surveillance on the connections between firms, in addition to capital requirements directed at the nodes.	[Loepfe, Lasse; Sanchez, Angel] Univ Carlos III Madrid, Dept Math, Grp Interdisciplinar Sistemas Complejos, Madrid, Spain; [Cabrales, Antonio] UCL, Dept Econ, London, England	Universidad Carlos III de Madrid; University of London; University College London	Loepfe, L (corresponding author), Univ Carlos III Madrid, Dept Math, Grp Interdisciplinar Sistemas Complejos, Madrid, Spain.	lasse.loepfe@gmail.com	Sánchez, Angel/A-9229-2008; Cabrales, Antonio/AAC-1805-2020	Sánchez, Angel/0000-0003-1874-2881; Cabrales, Antonio/0000-0003-0209-0399	ERA-Net on Complexity through grant RESINEE; MINECO (Spain) through grant PRODIEVO; Comunidad de Madrid through grant MODELICO-CM	ERA-Net on Complexity through grant RESINEE; MINECO (Spain) through grant PRODIEVO; Comunidad de Madrid through grant MODELICO-CM	This project was founded by ERA-Net on Complexity through grant RESINEE (http://www.complexitynet.eu/Pages/default.aspx), by MINECO (Spain, http://www.mineco.gob.es/portal/site/mineco/) through grant PRODIEVO and by Comunidad de Madrid through grant MODELICO-CM (http://modelico.es/index.php/es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen F, 2000, J POLIT ECON, V108, P1, DOI 10.1086/262109; Allen F, 2010, FINANCIAL CONNECTION; Amini H, 2012, INT J THEOR APPL FIN, V15, DOI 10.1142/S0219024911006504; [Anonymous], 2011, MAPPING SYSTEMIC RIS; [Anonymous], 2012, RISE NETWORK SOC, DOI DOI 10.1002/9781444319514; Arinaminpathy N, 2012, P NATL ACAD SCI USA, V109, P18338, DOI 10.1073/pnas.1213767109; Battiston S, 2012, J EC DYN CONTR; Battiston S, 2013, NAT PHYS, V9, P123, DOI 10.1038/nphys2575; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Beale N, 2011, P NATL ACAD SCI USA, V108, P12647, DOI 10.1073/pnas.1105882108; Board FS, 2009, REPORT FINANCIAL STA; Borio C.E.V., 2009, OPERATIONAL FRAMEWOR; Boss M, 2004, QUANT FINANC, V4, P677, DOI 10.1080/14697680400020325; Cabrales A, 2013, UC3M WORKING PAPERS, V13; Caccioli F, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500580; Chinazzi M, 2012, POSTMORTEM EXAMINATI; Cont R, 2011, EE BASTOS NETWORK ST; Delpini D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01626; Drehmann M., 2011, BIS Q REV; Eguiluz VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.108701; Elliott M, 2012, FINANCIAL NETWORKS C; Estrada E, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066102; Farmer JD, 2012, EUR PHYS J-SPEC TOP, V214, P295, DOI 10.1140/epjst/e2012-01696-9; Financial Services Authority (FSA), 2009, TURNER REV REGULATOR; Freixas X, 2000, J MONEY CREDIT BANK, V32, P611, DOI 10.2307/2601198; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; Gentleman Robert, 1997, R PROJECT STAT COMPU; Gini C., 1912, J R STAT SOC, V76, P326; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Hale G, 2012, J INT EC; Hurd T, 2011, FRAMEWORK ANAL CONTA; Iori G, 2006, J ECON BEHAV ORGAN, V61, P525, DOI 10.1016/j.jebo.2004.07.018; May RM, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0376; Muller J, 2003, 2 APPROACHES ASSESS; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Shirley MDF, 2005, ECOL COMPLEX, V2, P287, DOI 10.1016/j.ecocom.2005.04.005; Sobol I. M., 1976, COMP MATH MATH PHYS+, V16, P236, DOI DOI 10.1016/0041-5553(76)90154-3; Stiroh KJ, 2006, J BANK FINANC, V30, P2131, DOI 10.1016/j.jbankfin.2005.04.030; Stouffer DB, 2011, P NATL ACAD SCI USA, V108, P3648, DOI 10.1073/pnas.1014353108; Taleb N, 2010, BLACK SWAN IMPACT HI; Tasca P, 2011, DIVERSIFICATION FINA; Tasca P, 2013, ARXIV13035552; Tedeschi G, 2011, BANKRUPTCY CASCADES; Tessone CJ, 2012, ARXIV12090959; Thurner S, 2003, QUANT FINANC, V3, P306, DOI 10.1088/1469-7688/3/4/307; Upper C, 2011, J FINANC STABIL, V7, P111, DOI 10.1016/j.jfs.2010.12.001; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995	53	13	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77526	10.1371/journal.pone.0077526	http://dx.doi.org/10.1371/journal.pone.0077526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147017	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200042
J	Muthuswami, M; Ramesh, V; Banerjee, S; Thangaraj, SV; Periasamy, J; Rao, DB; Barnabas, GD; Raghavan, S; Ganesan, K				Muthuswami, Muthulakshmi; Ramesh, Vignesh; Banerjee, Saikat; Thangaraj, Soundara Viveka; Periasamy, Jayaprakash; Rao, Divya Bhaskar; Barnabas, Georgina D.; Raghavan, Swetha; Ganesan, Kumaresan			Breast Tumors with Elevated Expression of 1q Candidate Genes Confer Poor Clinical Outcome and Sensitivity to Ras/PI3K Inhibition	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CANCER-CELL-LINES; SINGLE-NUCLEOTIDE POLYMORPHISM; EXO1 GENE; CHROMOSOMAL INSTABILITY; MOLECULAR TARGET; ABERRATIONS; PROFILES; SUSCEPTIBILITY; ASSOCIATION	Genomic aberrations are common in cancers and the long arm of chromosome 1 is known for its frequent amplifications in breast cancer. However, the key candidate genes of 1q, and their contribution in breast cancer pathogenesis remain unexplored. We have analyzed the gene expression profiles of 1635 breast tumor samples using meta-analysis based approach and identified clinically significant candidates from chromosome 1q. Seven candidate genes including exonuclease 1 (EXO1) are consistently over expressed in breast tumors, specifically in high grade and aggressive breast tumors with poor clinical outcome. We derived a EXO1 co-expression module from the mRNA profiles of breast tumors which comprises 1q candidate genes and their co-expressed genes. By integrative functional genomics investigation, we identified the involvement of EGFR, RAS, PI3K / AKT, MYC, E2F signaling in the regulation of these selected 1q genes in breast tumors and breast cancer cell lines. Expression of EXO1 module was found as indicative of elevated cell proliferation, genomic instability, activated RAS/AKT/MYC/E2F1 signaling pathways and loss of p53 activity in breast tumors. mRNA-drug connectivity analysis indicates inhibition of RAS/PI3K as a possible targeted therapeutic approach for the patients with activated EXO1 module in breast tumors. Thus, we identified seven 1q candidate genes strongly associated with the poor survival of breast cancer patients and identified the possibility of targeting them with EGFR/RAS/PI3K inhibitors.	[Muthuswami, Muthulakshmi; Ramesh, Vignesh; Banerjee, Saikat; Thangaraj, Soundara Viveka; Periasamy, Jayaprakash; Rao, Divya Bhaskar; Barnabas, Georgina D.; Ganesan, Kumaresan] Madurai Kamaraj Univ, Sch Biol Sci, Ctr Excellence Genom Sci, Canc Genet Lab,Dept Genet, Madurai 625021, Tamil Nadu, India; [Raghavan, Swetha] Indian Inst Technol Madras, Dept Biotechnol, Chenna, India	Madurai Kamaraj University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Ganesan, K (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Ctr Excellence Genom Sci, Canc Genet Lab,Dept Genet, Madurai 625021, Tamil Nadu, India.	kumar@oncocellomics.org		Raghavan, Swetha/0000-0001-6951-0592; Ganesan, Kumaresan/0000-0003-0533-3181; Thangaraj, Soundara Viveka/0000-0003-4902-468X	Council of Scientific and Industrial Research (CSIR), Govt. of India [27(0223)/10/EMR-II]	Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This project was funded by Council of Scientific and Industrial Research (CSIR), Govt. of India through the research grant 27(0223)/10/EMR-II to Kumaresan Ganesan, Madurai Kamaraj University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; ATKIN NB, 1986, CANCER GENET CYTOGEN, V21, P279, DOI 10.1016/0165-4608(86)90206-2; Bau DT, 2009, CHINESE J PHYSIOL, V52, P411, DOI 10.4077/CJP.2009.AMH076; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Baudis M, 2012, PROGENETIX ONCOGENOM; Berkovich E, 2001, J BIOL CHEM, V276, P42851, DOI 10.1074/jbc.M103596200; BIECHE I, 1995, CLIN CANCER RES, V1, P123; Blum R, 2007, CANCER RES, V67, P3320, DOI 10.1158/0008-5472.CAN-06-4287; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Corson TW, 2006, INT J CANCER, V119, P1088, DOI 10.1002/ijc.21954; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Desmedt C, 2006, CELL CYCLE, V5, P2198, DOI 10.4161/cc.5.19.3254; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fang M, 2011, CANCER-AM CANCER SOC, V117, P2024, DOI 10.1002/cncr.25770; Farabegoli F, 2004, MODERN PATHOL, V17, P449, DOI 10.1038/modpathol.3800059; FICHTINGERSCHEPMAN AMJ, 1995, CARCINOGENESIS, V16, P2447, DOI 10.1093/carcin/16.10.2447; Fonseca FLA, 2005, BREAST CANCER RES, V7, pR28, DOI 10.1186/bcr950; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; Gao YX, 2009, J MOL MED, V87, P145, DOI 10.1007/s00109-008-0408-1; Ghazani AA, 2007, NEOPLASIA, V9, P511, DOI 10.1593/neo.07301; Gronwald J, 2005, INT J CANCER, V114, P230, DOI 10.1002/ijc.20723; Habermann JK, 2009, INT J CANCER, V124, P1552, DOI 10.1002/ijc.24017; Hagemann C, 2008, ONCOL REP, V20, P301, DOI 10.3892/or_00000007; Harrouk W, 2000, MUTAT RES-DNA REPAIR, V461, P229, DOI 10.1016/S0921-8777(00)00053-7; Hobday Timothy J, 2005, Cancer Control, V12, P73; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Karlsson E, 2007, CANCER GENET CYTOGEN, V172, P139, DOI 10.1016/j.cancergencyto.2006.09.019; Kim TM, 2005, CLIN CANCER RES, V11, P79; Korkmaz A, 2007, CELL BIOL TOXICOL, V23, P303, DOI 10.1007/s10565-006-0078-0; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Luo XP, 2012, INT J GYNECOL CANCER, V22, P220, DOI 10.1097/IGC.0b013e318234fd8a; Melchor L, 2008, CARCINOGENESIS, V29, P1475, DOI 10.1093/carcin/bgn157; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; O'Brien SL, 2007, INT J CANCER, V120, P1434, DOI 10.1002/ijc.22413; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Orsetti B, 2006, BRIT J CANCER, V95, P1439, DOI 10.1038/sj.bjc.6603433; Park SC, 2007, CLIN EXP MED, V7, P1, DOI 10.1007/s10238-007-0123-1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Schild C, 2009, MOL CARCINOGEN, V48, P1149, DOI 10.1002/mc.20569; Schmutte C, 1998, CANCER RES, V58, P4537; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stange DE, 2006, CLIN CANCER RES, V12, P345, DOI 10.1158/1078-0432.CCR-05-1633; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; T T, 2012, PACK SURV AN S; Therneau M, 2000, MODELING SURVIVAL DA; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waddell N, 2010, BREAST CANCER RES TR, V123, P661, DOI 10.1007/s10549-009-0653-1; Wang HC, 2009, ANTICANCER RES, V29, P3897; Wang SL, 2011, HISTOPATHOLOGY, V59, P631, DOI 10.1111/j.1365-2559.2011.03941.x; Wang XC, 2009, BIOCHEM BIOPH RES CO, V379, P1107, DOI 10.1016/j.bbrc.2009.01.028; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weber-Mangal S, 2003, INT J CANCER, V107, P583, DOI 10.1002/ijc.11460; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124	68	38	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77553	10.1371/journal.pone.0077553	http://dx.doi.org/10.1371/journal.pone.0077553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147022	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200045
J	Phillips, CM; Dillon, C; Harrington, JM; McCarthy, VJC; Kearney, PM; Fitzgerald, AP; Perry, IJ				Phillips, Catherine M.; Dillon, Christina; Harrington, Janas M.; McCarthy, Vera J. C.; Kearney, Patricia M.; Fitzgerald, Anthony P.; Perry, Ivan J.			Defining Metabolically Healthy Obesity: Role of Dietary and Lifestyle Factors	PLOS ONE			English	Article							BODY-MASS INDEX; NORMAL-WEIGHT; RISK; POPULATION; WOMEN; MEN; IDENTIFICATION; INFLAMMATION; INDIVIDUALS; PREVALENCE	Background: There is a current lack of consensus on defining metabolically healthy obesity (MHO). Limited data on dietary and lifestyle factors and MHO exist. The aim of this study is to compare the prevalence, dietary factors and lifestyle behaviours of metabolically healthy and unhealthy obese and non-obese subjects according to different metabolic health criteria. Method: Cross-sectional sample of 1,008 men and 1,039 women aged 45-74 years participated in the study. Participants were classified as obese (BMI >= 30kg/m(2)) and non-obese (BMI <30kg/m(2)). Metabolic health status was defined using five existing MH definitions based on a range of cardiometabolic abnormalities. Dietary composition and quality, food pyramid servings, physical activity, alcohol and smoking behaviours were examined. Results: The prevalence of MHO varied considerably between definitions (2.2% to 11.9%), was higher among females and generally increased with age. Agreement between MHO classifications was poor. Among the obese, prevalence of MH was 6.8% to 36.6%. Among the non-obese, prevalence of metabolically unhealthy subjects was 21.8% to 87%. Calorie intake, dietary macronutrient composition, physical activity, alcohol and smoking behaviours were similar between the metabolically healthy and unhealthy regardless of BMI. Greater compliance with food pyramid recommendations and higher dietary quality were positively associated with metabolic health in obese (OR 1.45-1.53 unadjusted model) and non-obese subjects (OR 1.37-1.39 unadjusted model), respectively. Physical activity was associated with MHO defined by insulin resistance (OR 1.87, 95% CI 1.19-2.92, p = 0.006). Conclusion: A standard MHO definition is required. Moderate and high levels of physical activity and compliance with food pyramid recommendations increase the likelihood of MHO. Stratification of obese individuals based on their metabolic health phenotype may be important in ascertaining the appropriate therapeutic or intervention strategy.	[Phillips, Catherine M.; Dillon, Christina; Harrington, Janas M.; McCarthy, Vera J. C.; Kearney, Patricia M.; Fitzgerald, Anthony P.; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Hlth Res Board Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Fitzgerald, Anthony P.] Natl Univ Ireland Univ Coll Cork, Dept Stat, Cork, Ireland	University College Cork; University College Cork	Phillips, CM (corresponding author), Natl Univ Ireland Univ Coll Cork, Hlth Res Board Ctr Diet & Hlth Res, Dept Epidemiol & Publ Hlth, Cork, Ireland.	c.phillips@ucc.ie	Fitzgerald, Tony/AAB-5331-2020; Harrington, Janas/AAV-8123-2021; Kearney, Patricia M/AAE-8501-2020	Harrington, Janas/0000-0002-6238-7031; Perry, Ivan/0000-0002-4965-9792; Phillips, Catherine/0000-0003-4916-4463; Kearney, Patricia/0000-0001-9599-3540; Fitzgerald, Tony/0000-0001-6437-5686	Irish Health Research Board [HRC/2007/13]	Irish Health Research Board	This work was supported by a research grant from the Irish Health Research Board (reference HRC/2007/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Cena H, 2011, NUTR REV, V69, P745, DOI 10.1111/j.1753-4887.2011.00446.x; Choi J, 2012, NUTR METAB CARDIOVAS, V22, P567, DOI 10.1016/j.numecd.2010.09.001; Ekelund U, 2011, AM J CLIN NUTR, V93, P826, DOI 10.3945/ajcn.110.006593; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Gomez-Ambrosi J, 2012, DIABETES CARE, V35, P383, DOI 10.2337/dc11-1334; Hankinson AL, 2012, OBESITY; Harrington J, 2013, CURR DIABETES REP; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; International Physical Activity Questionnaire, GUID DAT PROC AN INT; Janiszewski PM, 2010, DIABETES CARE, V33, P1957, DOI 10.2337/dc10-0547; Kantartzis K, 2011, DIABETOLOGIA, V54, P864, DOI 10.1007/s00125-010-2006-3; Karelis A, 2004, DIABETES METAB, V30, P569, DOI 10.1016/S1262-3636(07)70156-8; Karelis AD, 2008, DIABETOLOGIA, V51, P1752, DOI 10.1007/s00125-008-1038-4; Karelis AD, 2008, DIABETES METAB, V34, P183, DOI 10.1016/j.diabet.2007.11.004; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Kearney PM, 2013, INT J EPIDEMIOL, V42, P1253, DOI 10.1093/ije/dys131; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Manu P, 2012, OBES RES CLIN PRACT, V6, pE9, DOI 10.1016/j.orcp.2011.04.003; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2006, J CLIN ENDOCR METAB, V91, P2906, DOI 10.1210/jc.2006-0594; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; NHLBI Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Obesity in Adults (US), 1998, CLIN GUID ID EV TREA; Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754; Pataky Z, 2010, INT J OBESITY, V34, pS18, DOI 10.1038/ijo.2010.235; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; Phillips CM, 2013, NUTRIENTS, V5, P32, DOI 10.3390/nu5010032; PHILLIPS CM, 2013, OBESITY, V21, pE154, DOI DOI 10.1038/OBY.2012.188; RUDERMAN NB, 1981, AM J CLIN NUTR, V34, P1617, DOI 10.1093/ajcn/34.8.1617; Shin MJ, 2006, INT J OBESITY, V30, P1529, DOI 10.1038/sj.ijo.0803304; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Villegas R, 2004, PUBLIC HEALTH NUTR, V7, P1017, DOI 10.1079/PHN2004638; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Wildman RP, 2009, CURR OPIN CLIN NUTR, V12, P438, DOI 10.1097/MCO.0b013e32832c6db7; Yoo HK, 2013, KOREAN J FAM MED, V34, P19, DOI 10.4082/kjfm.2013.34.1.19	45	150	156	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76188	10.1371/journal.pone.0076188	http://dx.doi.org/10.1371/journal.pone.0076188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146838	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200011
J	Silva-Sanchez, J; Cruz-Trujillo, E; Barrios, H; Reyna-Flores, F; Sanchez-Perez, A; Garza-Ramos, U				Silva-Sanchez, Jesus; Cruz-Trujillo, Enrique; Barrios, Humberto; Reyna-Flores, Fernando; Sanchez-Perez, Alejandro; Garza-Ramos, Ulises		Bacterial Resistance Consortium	Characterization of Plasmid-Mediated Quinolone Resistance (PMQR) Genes in Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae Pediatric Clinical Isolates in Mexico	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA; FLUOROQUINOLONES; PREVALENCE; ESBL; PCR	This work describes the characterization of plasmid-mediated quinolone-resistance (PMQR) genes from a multicenter study of ESBL-producing Enterobacteriaceae pediatric clinical isolates in Mexico. The PMQR gene-positive isolates were characterized with respect to ESBLs, and mutations in the GyrA and ParC proteins were determined. The phylogenetic relationship was established by PFGE and the transfer of PMQR genes was determined by mating assays. The prevalence of the PMQR genes was 32.1%, and the rate of qnr-positive isolates was 15.1%; 93.3% of the latter were qnrB and 6.4% were qnrA1. The distribution of isolates in terms of bacterial species was as follows: 23.5% (4/17) corresponded to E. cloacae, 13.7% (7/51) to K. pneumoniae, and 13.6% (6/44) to E. coli. In addition, the prevalence of aac(6')-Ib-cr and qepA was 15.1% and 1.7%, respectively. The molecular characteristics of qnr- and qepA-positive isolates pointed to extended-spectrum beta-lactamase (ESBL) CTX-M-15 as the most prevalent one (70.5%), and to SHV-12 in the case of aac(6')-Ib-cr-positive isolates. GyrA mutations at codons Ser-83 and Asp-87, and ParC mutations at codons Ser-80 were observed in 41.1% and 35.2% of the qnr-positive isolates, respectively. The analysis of the transconjugants revealed a co-transmission of blaCTX-M-15 with the qnrB alleles. In general, the prevalence of PMQR genes (qnr and aac(6')-Ib-cr) presented in this work was much lower in the pediatric isolates, in comparison to the adult isolates in Mexico. Also, ESBL CTX-M-15 was the main ESBL identified in the pediatric isolates, whereas in the adult ones, ESBLs corresponded to the CTX-M and the SHV families. In comparison with other studies, among the PMQR-genes identified in this study, the qnrB-alleles and the aac(6')-Ib-cr gene were the most prevalent, whereas the qnrS1, qnrA1 and qnrB-like alleles were the most prevalent in China and Uruguay.	[Silva-Sanchez, Jesus; Cruz-Trujillo, Enrique; Barrios, Humberto; Reyna-Flores, Fernando; Sanchez-Perez, Alejandro; Garza-Ramos, Ulises] Inst Nacl Salud Publ, CISEI, Dept Diagnost Epidemiol, Cuernavaca, Morelos, Mexico; [Bacterial Resistance Consortium] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Patol, Hosp Civil Guadalajara Fray Antonio Alcalde, Guadalajara 44430, Jalisco, Mexico	Instituto Nacional de Salud Publica; Universidad de Guadalajara	Garza-Ramos, U (corresponding author), Inst Nacl Salud Publ, CISEI, Dept Diagnost Epidemiol, Cuernavaca, Morelos, Mexico.	ulises.garza@insp.mx	Barrios, Humberto/A-6907-2015	Rodriguez-Noriega, Eduardo/0000-0002-1386-4815; Silva-Sanchez, Jesus/0000-0002-6580-2990; Garza Ramos, Ulises/0000-0002-5013-3050	CONACyT (Mexican Council for Science and Technology) [SALUD-2008-01-87334, 136339]	CONACyT (Mexican Council for Science and Technology)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants SALUD-2008-01-87334, and 136339 from CONACyT (Mexican Council for Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MI, 2003, J ANTIMICROB CHEMOTH, V51, P1, DOI 10.1093/jac/dkg212; Barrios H, 2012, ANTIMICROB AGENTS CH, V56, P4032, DOI 10.1128/AAC.05980-11; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Cattoir V, 2007, J ANTIMICROB CHEMOTH, V60, P394, DOI 10.1093/jac/dkm204; *CLIN LAB STAND I, 2012, M07MA9 CLIN LAB STAN; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Emmerson AM, 2003, J ANTIMICROB CHEMOTH, V51, P13, DOI 10.1093/jac/dkg208; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Fulgueiras V, 2011, J ANTIMICROB CHEMOTH, V66, P1725, DOI 10.1093/jac/dkr222; Han C, 2010, MICROBIOL IMMUNOL, V54, P123, DOI 10.1111/j.1348-0421.2010.00200.x; Kaufmann ME, 1998, METH MOLEC MED, V15, P33, DOI 10.1385/0-89603-498-4:33; KIESER T, 1984, PLASMID, V12, P19, DOI 10.1016/0147-619X(84)90063-5; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Langley J, 2001, Paediatr Child Health, V6, P322; Rodriguez-Martinez JM, 2011, J INFECT CHEMOTHER, V17, P149, DOI 10.1007/s10156-010-0120-2; Martinez-Martinez L, 2008, EXPERT REV ANTI-INFE, V6, P685, DOI 10.1586/14787210.6.5.685; Mosqueda-Gomez JL, 2008, INT J INFECT DIS, V12, P653, DOI 10.1016/j.ijid.2008.03.008; Philippon LN, 1997, ANTIMICROB AGENTS CH, V41, P2188, DOI 10.1128/AAC.41.10.2188; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Silva-Sanchez J, 2011, MICROB DRUG RESIST, V17, P497, DOI 10.1089/mdr.2011.0086; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Wirtz VJ, 2010, REV PANAM SALUD PUBL, V27, P219, DOI 10.1590/S1020-49892010000300009; Zhanel GG, 2002, DRUGS, V62, P13, DOI 10.2165/00003495-200262010-00002; Zhao XL, 1997, P NATL ACAD SCI USA, V94, P13991, DOI 10.1073/pnas.94.25.13991	28	40	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77968	10.1371/journal.pone.0077968	http://dx.doi.org/10.1371/journal.pone.0077968			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147104	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200089
J	Bettcher, BM; Walsh, CM; Watson, C; Miller, JW; Green, R; Patel, N; Miller, BL; Neuhaus, J; Yaffe, K; Kramer, JH				Bettcher, Brianne Magouirk; Walsh, Christine M.; Watson, Christa; Miller, Joshua W.; Green, Ralph; Patel, Nihar; Miller, Bruce L.; Neuhaus, John; Yaffe, Kristine; Kramer, Joel H.			Body Mass and White Matter Integrity: The Influence of Vascular and Inflammatory Markers	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CEREBRAL HYPOPERFUSION; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; FOLLOW-UP; INDEX; RISK; DYSFUNCTION; OBESITY; ATLAS	High adiposity is deleteriously associated with brain health, and may disproportionately affect white matter integrity; however, limited information exists regarding the mechanisms underlying the association between body mass (BMI) and white matter integrity. The present study evaluated whether vascular and inflammatory markers influence the relationship between BMI and white matter in healthy aging. We conducted a cross-sectional evaluation of white matter integrity, BMI, and vascular/inflammatory factors in a cohort of 138 healthy older adults (mean age: 71.3 years). Participants underwent diffusion tensor imaging, provided blood samples, and participated in a health evaluation. Vascular risk factors and vascular/inflammatory blood markers were assessed. The primary outcome measure was fractional anisotropy (FA) of the genu, body, and splenium (corpus callosum); exploratory measures included additional white matter regions, based on significant associations with BMI. Regression analyses indicated that higher BMI was associated with lower FA in the corpus callosum, cingulate, and fornix (p<.001). Vascular and inflammatory factors influenced the association between BMI and FA. Specifically, BMI was independently associated with the genu [beta=-.21; B=-.0024; 95% CI, -.0048 to -.0000; p=.05] and cingulate fibers [beta=-.39; B=-.0035; 95% CI,-.0056 to -.0015; p<.001], even after controlling for vascular/inflammatory risk factors and blood markers. In contrast, BMI was no longer significantly associated with the fornix and middle/posterior regions of the corpus callosum after controlling for these markers. Results partially support a vascular/inflammatory hypothesis, but also suggest a more complex relationship between BMI and white matter characterized by potentially different neuroanatomic vulnerability.	[Bettcher, Brianne Magouirk; Walsh, Christine M.; Watson, Christa; Patel, Nihar; Miller, Bruce L.; Neuhaus, John; Yaffe, Kristine; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Watson, Christa] Stanford Univ, Dept Psychiat, Neuropsychol & Neuroimaging Lab, Palo Alto, CA 94304 USA; [Miller, Joshua W.] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Miller, Joshua W.; Green, Ralph] Univ Calif Davis, Med Ctr, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Stanford University; Rutgers State University New Brunswick; University of California System; University of California Davis; University of California System; University of California San Francisco	Bettcher, BM (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA.	bbettcher@memory.ucsf.edu			NIH-NINDS [HHSN271200623661C]; NIH-NIA [K23 AG042492-01, R01 AG032289]; Larry L. Hillblom Foundation; Alzheimer's Association New Investigator Research Grant [NIRP-12-259223]; UCSF Alzheimer's Disease Research Center Resource Allocation Program (RAP); NATIONAL INSTITUTE ON AGING [K23AG042492, R01AG032289] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Larry L. Hillblom Foundation; Alzheimer's Association New Investigator Research Grant; UCSF Alzheimer's Disease Research Center Resource Allocation Program (RAP); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study described was supported by grant number HHSN271200623661C from the NIH-NINDS, and numbers K23 AG042492-01 and R01 AG032289 from the NIH-NIA. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of Neurological Disorders and Strokes, National Institute on Aging or NIH. This work was also supported by the Larry L. Hillblom Foundation, an Alzheimer's Association New Investigator Research Grant (NIRP-12-259223), and the UCSF Alzheimer's Disease Research Center Resource Allocation Program (RAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Bobb JF, 2012, HUM BRAIN MAPP; Bonora E, 2006, ANN MED, V38, P64, DOI 10.1080/07853890500401234; Brickman AM, 2012, NEUROBIOL AGING, V33, P1699, DOI 10.1016/j.neurobiolaging.2011.06.001; Espinola-Klein C, 2011, FRONT BIOSCI-LANDMRK, V16, P1663, DOI 10.2741/3812; Farkas E, 2004, ACTA NEUROPATHOL, V108, P57, DOI 10.1007/s00401-004-0864-9; Gilfix BM, 1997, CLIN CHEM, V43, P687; Gons RAR, 2012, J ALZHEIMERS DIS, V32, P623, DOI 10.3233/JAD-2012-121006; Gustafson D, 2004, NEUROLOGY, V63, P1876, DOI 10.1212/01.WNL.0000141850.47773.5F; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Gustafson DR, 2012, J ALZHEIMERS DIS, V28, P162, DOI 10.3233/JAD-2011-110917; Huang YH, 2010, J NEUROL SCI, V299, P72, DOI 10.1016/j.jns.2010.08.035; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kern KC, 2012, NEUROIMAGE, V59, P2932, DOI 10.1016/j.neuroimage.2011.09.071; Knowlton RC, 2002, ARCH NEUROL-CHICAGO, V59, P1882, DOI 10.1001/archneur.59.12.1882; Lee DY, 2010, STROKE, V41, P1791, DOI 10.1161/STROKEAHA.110.582163; Lee EB, 2011, ANN NY ACAD SCI, V1243, P15, DOI 10.1111/j.1749-6632.2011.06274.x; Mazer SP, 2004, J THROMB THROMBOLYS, V17, P95, DOI 10.1023/B:THRO.0000037664.77460.d8; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Mueller K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018544; Refsum H, 1998, ANNU REV MED, V49, P31, DOI 10.1146/annurev.med.49.1.31; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Segura B, 2009, NEUROLOGY, V73, P438, DOI 10.1212/WNL.0b013e3181b163cd; Shimoji K, 2013, DIABETES CARE, V36, P696, DOI 10.2337/dc12-0666; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stanek KM, 2011, OBESITY, V19, P500, DOI 10.1038/oby.2010.312; Verstynen TD, 2012, PSYCHOSOM MED, V74, P682, DOI 10.1097/PSY.0b013e318261909c; Villain N, 2010, BRAIN, V133, P3301, DOI 10.1093/brain/awq203; Walther K, 2010, HUM BRAIN MAPP, V31, P1052, DOI 10.1002/hbm.20916; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Wilson AM, 2006, INT J CARDIOL, V106, P291, DOI 10.1016/j.ijcard.2005.01.068; XU J, 2011, HUM BRAIN MAPP; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang H, 2010, LECT NOTES COMPUT SC, V6204, P83, DOI 10.1007/978-3-642-14366-3_8	40	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77741	10.1371/journal.pone.0077741	http://dx.doi.org/10.1371/journal.pone.0077741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147070	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400131
J	Kwon, S; Weiden, MD; Echevarria, GC; Comfort, AL; Naveed, B; Prezant, DJ; Rom, WN; Nolan, A				Kwon, Sophia; Weiden, Michael D.; Echevarria, Ghislaine C.; Comfort, Ashley L.; Naveed, Bushra; Prezant, David J.; Rom, William N.; Nolan, Anna			Early Elevation of Serum MMP-3 and MMP-12 Predicts Protection from World Trade Center-Lung Injury in New York City Firefighters: A Nested Case-Control Study	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CENTER DUST; ALPHA(1)-ANTITRYPSIN DEFICIENCY; RESCUE WORKERS; CENTER SITE; EXPOSURE; DISEASE; HEALTH; EXPRESSION; BIOMARKERS	Objective: After 9/11/2001, some Fire Department of New York (FDNY) workers had excessive lung function decline. We hypothesized that early serum matrix metalloproteinases (MMP) expression predicts World Trade Center-Lung Injury (WTC-LI) years later. Methods: This is a nested case-control analysis of never-smoking male firefighters with normal pre-exposure Forced Expiratory Volume in one second (FEV1) who had serum drawn up to 155 days post 9/11/2001. Serum MMP-1, 2,3,7,8, 9, 12 and 13 were measured. Cases of WTC-LI (N = 70) were defined as having an FEV1 one standard deviation below the mean (FEV1 <= 77%) at subspecialty pulmonary evaluation (SPE) which was performed 32 months (IQR 21-53) post-9/11. Controls (N = 123) were randomly selected. We modeled MMP's ability as a predictor of cases status with logistic regression adjusted for time to blood draw, exposure intensity, weight gain and pre-9/11 FEV1. Results: Each log-increase in MMP-3 and MMP-12 showed reduced odds of developing WTC-LI by 73% and 54% respectively. MMP-3 and MMP-12 consistently clustered together in cases, controls, and the cohort. Increasing time to blood draw significantly and independently increased the risk of WTC-LI. Conclusions: Elevated serum levels of MMP-3 and MMP-12 reduce the risk of developing WTC-LI. At any level of MMP-3 or 12, increased time to blood draw is associated with a diminished protective effect.	[Kwon, Sophia; Weiden, Michael D.; Echevarria, Ghislaine C.; Comfort, Ashley L.; Naveed, Bushra; Rom, William N.; Nolan, Anna] NYU, Sch Med, Div Pulm Crit Care & Sleep, New York, NY USA; [Weiden, Michael D.; Rom, William N.; Nolan, Anna] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; [Weiden, Michael D.; Prezant, David J.; Nolan, Anna] Bur Hlth Serv, Brooklyn, NY USA; [Weiden, Michael D.; Prezant, David J.; Nolan, Anna] Fire Dept New York, Off Med Affairs, Brooklyn, NY USA; [Prezant, David J.] Montefiore Med Ctr, Dept Med, Div Pulm Med, Bronx, NY 10467 USA; [Prezant, David J.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Echevarria, Ghislaine C.] Pontificia Univ Catolica Chile, Div Anestesiol, Escuela Med, Santiago, Chile	New York University; New York University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Pontificia Universidad Catolica de Chile	Nolan, A (corresponding author), NYU, Sch Med, Div Pulm Crit Care & Sleep, New York, NY USA.	anna.nolan@med.nyu.edu	Nolan, Anna/C-2796-2012	Nolan, Anna/0000-0002-0631-1171; Comfort, Ashley/0000-0002-8213-8374; Rom, William/0000-0002-8793-7028; Kwon, Sophia/0000-0003-3639-5107	NIH-NHLBI [K23HL084191]; NIAID [K24A1080298, NIH-R01HL057879]; NIOSH [U10-OH008243, U10-OH008242, UL1RR029893]; NYU-HHC Clinical and Translational Science Institute; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000038];  [NIEHST32ES007267]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057879, K23HL084191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U10OH008243, U10OH008242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007267] Funding Source: NIH RePORTER; NIOSH [3U10OH008243-05S1] Funding Source: Federal RePORTER	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NYU-HHC Clinical and Translational Science Institute; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was supported by NIEHST32ES007267 (BN), NIH-NHLBI K23HL084191(AN), NIAID (MDW) K24A1080298, NIH-R01HL057879 (MDW), and NIOSH (U10-OH008243, U10-OH008242) and UL1RR029893 (DJP). This work was also partially funded by the NYU-HHC Clinical and Translational Science Institute and is supported in part by grant UL1TR000038 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The funding agencies did not participate in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Acuff HB, 2006, CANCER RES, V66, P7968, DOI 10.1158/0008-5472.CAN-05-4279; Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; Banauch GI, 2005, CURR OPIN PULM MED, V11, P160, DOI 10.1097/01.mcp.0000151716.96241.0a; Banauch GI, 2003, AM J RESP CRIT CARE, V168, P54, DOI 10.1164/rccm.200211-1329OC; Banauch GI, 2006, AM J RESP CRIT CARE, V174, P312, DOI 10.1164/rccm.200511-1736OC; Banauch Gisela I, 2005, Crit Care Med, V33, pS102, DOI 10.1097/01.CCM.0000151138.10586.3A; Banauch GI, 2010, CHEST, V138, P1116, DOI 10.1378/chest.10-0187; Claudio L, 2001, ENVIRON HEALTH PERSP, V109, pA528, DOI 10.2307/3454848; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; Death AK, 2002, J AM COLL CARDIOL, V39, P1943, DOI 10.1016/S0735-1097(02)01907-1; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; Fireman EM, 2004, ENVIRON HEALTH PERSP, V112, P1564, DOI 10.1289/ehp.7233; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Kelly KJ, 2002, ARCH ENVIRON HEALTH, V57, P282, DOI 10.1080/00039890209601411; King MS, 2011, NEW ENGL J MED, V365, P222, DOI 10.1056/NEJMoa1101388; Landrigan PJ, 2001, ENVIRON HEALTH PERSP, V109, pA514, DOI 10.1289/ehp.109-a514; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Lioy PJ, 2006, ENVIRON SCI TECHNOL, V40, P6876, DOI 10.1021/es062980e; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Naveed B, 2012, AM J RESP CRIT CARE, V185, P392, DOI 10.1164/rccm.201109-1672OC; Nolan A, 2012, CHEST, V142, P412, DOI 10.1378/chest.11-1202; Omachi TA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-35; Posthumus MD, 1999, RHEUMATOLOGY, V38, P1081, DOI 10.1093/rheumatology/38.11.1081; PRENTICE RL, 1986, BIOMETRICS, V42, P301, DOI 10.2307/2531051; Prezant D, 2008, 9 11 HLTH EFFECTS FE; Prezant DJ, 2008, MT SINAI J MED, V75, P89, DOI 10.1002/msj.20028; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Rom WN, 2002, AM J RESP CRIT CARE, V166, P797, DOI 10.1164/rccm.200206-576OC; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Rundle AG, 2005, CANCER EPIDEM BIOMAR, V14, P1899, DOI 10.1158/1055-9965.EPI-04-0860; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Vandenbroucke RE, 2011, EUR RESPIR J, V38, P1200, DOI 10.1183/09031936.00027411; Weiden MD, 2012, EUR RESP J; Weiden MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040016; Weiden MD, 2010, CHEST, V137, P566, DOI 10.1378/chest.09-1580	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76099	10.1371/journal.pone.0076099	http://dx.doi.org/10.1371/journal.pone.0076099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146820	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400036
J	Meriki, HD; Tufon, KA; Atanga, PN; Ane-Anyangwe, IN; Anong, DN; Cho-Ngwa, F; Nkuo-Akenji, T				Meriki, Henry D.; Tufon, Kukwah A.; Atanga, Pascal N.; Ane-Anyangwe, Irene N.; Anong, Damian N.; Cho-Ngwa, Fidelis; Nkuo-Akenji, Theresa			Drug Resistance Profiles of Mycobacterium tuberculosis Complex and Factors Associated with Drug Resistance in the Northwest and Southwest Regions of Cameroon	PLOS ONE			English	Article							RISK-FACTORS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; HIV-INFECTION; PREVALENCE; WEST; EPIDEMIOLOGY; DETERMINANTS; BURDEN; IMPACT	Background: Anti-tuberculosis drug resistance continues to be a major obstacle to tuberculosis (TB) control programmes with HIV being a major risk factor in developing TB. We investigated anti-TB drug resistance profiles and the impact of socioeconomic as well as behavioural factors on the prevalence of TB and drug resistance in two regions of Cameroon with such data paucity. Methods: This was a hospital-based study in which 1706 participants, comprising 1133 females and 573 males consecutively enrolled from selected TB and HIV treatment centres of the Northwest and Southwest regions. Demographic, clinical and self-reported risk behaviours and socioeconomic data were obtained with the consent of participants using questionnaires. Culture and drug resistance testing were performed according to standard procedures. Results: The prevalence of resistance to at least one anti-TB drug was 27.7% and multi-drug resistance was 5.9%. Smoking, concurrent alcohol consumption and smoking, being on antiretroviral therapy for <= 12 months and previous household contact with TB patient were independently associated with tuberculosis prevalence, while only previous tuberculosis infection was associated with drug resistance in a univariate analysis. Conclusion: The study showed a high prevalence of drug resistance TB in the study population with only previous TB infection associated with drug resistance in a univariate analysis. It also provides evidence in our context, of the role of alcohol and smoking in increasing the risk of developing TB, which is more likely in people living with HIV/AIDS. Therefore, it is important for public health authorities to integrate and intensify alcohol/smoking abstention interventions in TB and HIV control programs in Cameroon.	[Meriki, Henry D.; Tufon, Kukwah A.; Atanga, Pascal N.; Ane-Anyangwe, Irene N.; Anong, Damian N.; Nkuo-Akenji, Theresa] Univ Buea, Dept Microbiol & Parasitol, Fac Sci, Buea, Southwest Regio, Cameroon; [Cho-Ngwa, Fidelis] Univ Buea, Dept Biochem & Mol Biol, Fac Sci, Buea, Southwest Regio, Cameroon; [Atanga, Pascal N.] Reg Delegat Publ Hlth, Reg Tech Grp Fight HIV & AIDS, Buea, Southwest Regio, Cameroon; [Meriki, Henry D.; Nkuo-Akenji, Theresa] Univ Buea, Clin Diagnost Lab, Fac Sci, Buea, Southwest Regio, Cameroon		Nkuo-Akenji, T (corresponding author), Univ Buea, Dept Microbiol & Parasitol, Fac Sci, Buea, Southwest Regio, Cameroon.	wifon@yahoo.com	Meriki, Henry Dilonga/V-4634-2019; Atanga, Pascal Nji/AAB-8620-2020	Meriki, Henry Dilonga/0000-0002-9148-0171; 	University of Buea	University of Buea	Financial assistance was received from the University of Buea 2009-2010 research grant awarded to Prof. Theresa Nkuo-Akenji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOBAL TUBERCULOSIS, P1; Assam-Assam JP, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-94; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bekker LG, 2010, CLIN INFECT DIS, V50, pS208, DOI 10.1086/651493; Bercion R, 1998, B SOC PATHOL EXOT, V91, P199; Bureau Central des Recensements et des Etudes de la Population (BUCREP), 2010, EM REC GEN POP HAB 3; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Crampin AC, 2004, INT J TUBERC LUNG D, V8, P194; Daniel O, 2011, ASIAN PAC J TROP MED, V4, P148, DOI 10.1016/S1995-7645(11)60057-6; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Fatkenheuer G, 1999, DIAGN MICR INFEC DIS, V34, P139, DOI 10.1016/S0732-8893(99)00006-1; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Gajalakshmi V, 2009, INT J EPIDEMIOL, V38, P1018, DOI 10.1093/ije/dyp225; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Glynn JR, 2000, T ROY SOC TROP MED H, V94, P500, DOI 10.1016/S0035-9203(00)90065-8; Golub JE, 2001, ARCH INTERN MED, V161, P2254, DOI 10.1001/archinte.161.18.2254; Haar CH, 2007, EMERG INFECT DIS, V13, P776, DOI 10.3201/eid1305.060334; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Harper M, 2003, T ROY SOC TROP MED H, V97, P506, DOI 10.1016/S0035-9203(03)80007-X; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Institut National de la Statistique Ministere de l'Economie de la Planification et de l'Amenagement du Territoire Ministere de la Sante Publique Yaounde Cameroun, 2011, NQUET DEM SANT IND M; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kuaban C, 2000, INT J TUBERC LUNG D, V4, P356; Liu JJ, 2005, INT J TUBERC LUNG D, V9, P450; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Marais BJ, 2005, INT J TUBERC LUNG D, V9, P1305; Narasimhan P, 2013, PULM MED, V2013, DOI 10.1155/2013/828939; Niemann S, 2000, J CLIN MICROBIOL, V38, P152; Noeske Jurgen, 2012, BMC Res Notes, V5, P160, DOI 10.1186/1756-0500-5-160; Paramasivan CN, 2004, INDIAN J MED RES, V120, P377; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Sethi S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-137; Sia IG, 2011, MAYO CLIN PROC, V86, P348, DOI 10.4065/mcp.2010.0820; Skolnik NS, 2005, HELPING PATIENTS WHO; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; The National Tuberculosis Control Programme Northwest Regional Delegation of Public Health Bamenda Cameroon, 2012, REG TUB CONTR UN ANN; The National Tuberculosis Control Programme Southwest Regional Delegation of Public Health Buea Cameroon, 2012, EG TUB CONTR UN ANN; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; *WHO, 2008, WHOHTMTB2008394; World Health Organization, 2004, WHOHTMTB2004329TB	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77410	10.1371/journal.pone.0077410	http://dx.doi.org/10.1371/journal.pone.0077410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146991	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400104
J	Severino, V; Malorni, L; Cicatiello, AE; D'Esposito, V; Longobardi, S; Colacurci, N; Miraglia, N; Sannolo, N; Farina, A; Chambery, A				Severino, Valeria; Malorni, Livia; Cicatiello, Anna Emilia; D'Esposito, Vittoria; Longobardi, Salvatore; Colacurci, Nicola; Miraglia, Nadia; Sannolo, Nicola; Farina, Annarita; Chambery, Angela			An Integrated Approach Based on Multiplexed Protein Array and iTRAQ Labeling for In-Depth Identification of Pathways Associated to IVF Outcome	PLOS ONE			English	Article							HUMAN FOLLICULAR-FLUID; MATURE HUMAN FOLLICLES; LARGE GENE LISTS; PROTEOMIC ANALYSIS; POTENTIAL BIOMARKERS; MASS-SPECTROMETRY; COMPLEMENT; CYTOKINES; ACTIVATION; GENERATION	The emergence of high-throughput protein quantification methodologies has enabled the comprehensive characterization by longitudinal and cross-sectional studies of biological fluids under physiological and pathological conditions. In particular, the simultaneous investigation of cytokines and growth factors signaling pathways and their associated downstream effectors by integrated multiplexed approaches offers a powerful strategy to gain insights into biological networks and processes in living systems. A growing body of research indicates that bioactive molecules of human reproductive fluids, including human follicular fluid (hFF), may affect oocyte quality, fertilization and embryo development, thus potentially influencing the physiopathology of pregnancy-related conditions. In this work, an iTRAQ labeling strategy has been complemented with a multiplexed protein array approach to analyze hFFs with the aim to investigate biological processes and pathways related to in vitro fertilization (IVF) outcome. The iTRAQ labeling strategy lead to the quantification of 89 proteins, 30 of which were differentially expressed in hFFs with successful compared to unsuccessful IVF outcome. The targeted study, based on multiplexed antibody protein arrays, allowed the simultaneous quantification of 27 low abundance proteins, including growth factors, chemokines and cytokines endowed with pro-and anti-inflammatory activity. A significant number of differentially regulated proteins were involved in biological functions related to blood coagulation, acute phase response signaling and complement system. Overall, the present results provide an integrated overview of protein changes in hFFs associated to IVF outcome, thus improving current knowledge in reproductive medicine and fertility research.	[Severino, Valeria; Cicatiello, Anna Emilia; Chambery, Angela] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [Severino, Valeria] CNR, IBB, I-80125 Naples, Italy; [Malorni, Livia; Miraglia, Nadia; Sannolo, Nicola] Univ Naples 2, Sch Med, Dept Expt Med, Sect Hyg Occupat Med & Forens Med, Naples, Italy; [D'Esposito, Vittoria] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Longobardi, Salvatore] MerckSerono SpA, Dept Med, Rome, Italy; [Colacurci, Nicola] Univ Naples 2, Dept Obstet Gynaecol & Reprod Sci, Naples, Italy; [Farina, Annarita] Univ Geneva, Biomed Prote Res Grp, Dept Bioinformat & Struct Biol, Geneva, Switzerland; [Severino, Valeria; Chambery, Angela] CIRPEB Ctr Interuniv Ric Peptidi Bioattivi, Naples, Italy	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Universita della Campania Vanvitelli; University of Naples Federico II; Universita della Campania Vanvitelli; University of Geneva	Chambery, A (corresponding author), Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy.	angela.chambery@unina2.it	Farina, Annarita/Y-7835-2019; D'Esposito, Vittoria/K-7633-2016; Malorni, Livia/AAB-9710-2022	Farina, Annarita/0000-0002-0099-4557; D'Esposito, Vittoria/0000-0002-3675-8062; Severino, Valeria/0000-0001-5275-1007; Chambery, Angela/0000-0002-5136-0941	Second University of Naples; National Insurance Institute against Work Accidents (INAIL-Istituto Nazionale Assicurazioni Infortuni sul Lavoro); MerckSerono S.p.A	Second University of Naples; National Insurance Institute against Work Accidents (INAIL-Istituto Nazionale Assicurazioni Infortuni sul Lavoro); MerckSerono S.p.A	This work was partially supported by funds from Second University of Naples, National Insurance Institute against Work Accidents (INAIL-Istituto Nazionale Assicurazioni Infortuni sul Lavoro) and MerckSerono S.p.A. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anahory T, 2002, ELECTROPHORESIS, V23, P1197, DOI 10.1002/1522-2683(200204)23:7/8<1197::AID-ELPS1197>3.0.CO;2-2; Angelucci S, 2006, BBA-PROTEINS PROTEOM, V1764, P1775, DOI 10.1016/j.bbapap.2006.09.001; Bianchi L, 2013, J PROTEOMICS, DOI [10.1016/j.jprot.2013.1002.1025, DOI 10.1016/J.JPR0T.2013.1002.1025]; Blaber SP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-172; Bungay SD, 2006, B MATH BIOL, V68, P2283, DOI 10.1007/s11538-006-9115-7; Buscher U, 1999, HUM REPROD, V14, P162, DOI 10.1093/humrep/14.1.162; Celis JE, 2005, MOL CELL PROTEOMICS, V4, P492, DOI 10.1074/mcp.M500030-MCP200; Chaouat G, 2007, J ASSIST REPROD GEN, V24, P491, DOI 10.1007/s10815-007-9142-9; de Agostini AI, 2008, J BIOL CHEM, V283, P28115, DOI 10.1074/jbc.M805338200; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Farina A, 2011, PROTEOMICS, V11, P3972, DOI 10.1002/pmic.201100063; FORTUNE JE, 1994, BIOL REPROD, V50, P225, DOI 10.1095/biolreprod50.2.225; Gadher SJ, 2009, EXPERT REV PROTEOMIC, V6, P591, DOI [10.1586/epr.09.79, 10.1586/EPR.09.79]; Gentry PA, 2000, FERTIL STERIL, V73, P848, DOI 10.1016/S0015-0282(99)00635-4; GHEBREHIWET B, 1981, J EXP MED, V153, P665, DOI 10.1084/jem.153.3.665; Gluck F, 2013, J PROTEOMICS, V79, P146, DOI 10.1016/j.jprot.2012.12.012; GOROSPE WC, 1993, BIOL REPROD, V48, P538, DOI 10.1095/biolreprod48.3.538; Hammadeh ME, 2002, AM J REPROD IMMUNOL, V47, P82, DOI 10.1034/j.1600-0897.2002.1o024.x; Hanrieder J, 2008, J PROTEOME RES, V7, P443, DOI 10.1021/pr070277z; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Jarkovska K, 2010, J PROTEOME RES, V9, P1289, DOI 10.1021/pr900802u; Kim YS, 2006, PROTEOMICS, V6, P3445, DOI 10.1002/pmic.200500775; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Kolialexi A, 2008, MASS SPECTROM REV, V27, P624, DOI 10.1002/mas.20181; Kolialexi A, 2007, PROTEOM CLIN APPL, V1, P853, DOI 10.1002/prca.200700040; Kushnir MM, 2012, J PROTEOME RES, V11, P5090, DOI 10.1021/pr300535g; Ledee N, 2013, HUM REPROD, V28, P406, DOI 10.1093/humrep/des354; Lee HC, 2005, J KOREAN MED SCI, V20, P456, DOI 10.3346/jkms.2005.20.3.456; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Li HB, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-146; Liu AX, 2007, BBA-GEN SUBJECTS, V1770, P29, DOI 10.1016/j.bbagen.2006.06.017; Melton L, 2004, NATURE, V429, P101, DOI 10.1038/429101a; Mendoza C, 2002, HUM REPROD, V17, P1017, DOI 10.1093/humrep/17.4.1017; Overgaard Anne Julie, 2010, Clin Proteomics, V6, P105; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Richani K, 2005, J MATERN-FETAL NEO M, V17, P239, DOI 10.1080/14767050500072722; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rocco M, 2011, J PROTEOME RES, V10, P4703, DOI 10.1021/pr200511f; Sarapik A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/606459; Schweigert FJ, 2006, HUM REPROD, V21, P2960, DOI 10.1093/humrep/del257; Severino Valeria, 2013, Methods Mol Biol, V1002, P37, DOI 10.1007/978-1-62703-360-2_4; Shimada H, 2001, BIOL REPROD, V64, P1739, DOI 10.1095/biolreprod64.6.1739; Terranova PF, 1997, AM J REPROD IMMUNOL, V37, P50; Terranova PF, 1997, DOMEST ANIM ENDOCRIN, V14, P1, DOI 10.1016/S0739-7240(96)00094-X; Twigt J, 2012, PROTEOMICS, V12, P1463, DOI 10.1002/pmic.201100240	47	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77303	10.1371/journal.pone.0077303	http://dx.doi.org/10.1371/journal.pone.0077303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146976	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400100
J	Tian, T; Qin, W; Liu, B; Wang, DW; Wang, JP; Jiang, TZ; Yu, CS				Tian, Tian; Qin, Wen; Liu, Bing; Wang, Dawei; Wang, Junping; Jiang, Tianzi; Yu, Chunshui			Catechol-O-Methyltransferase Val158Met Polymorphism Modulates Gray Matter Volume and Functional Connectivity of the Default Mode Network	PLOS ONE			English	Article							COMT VAL(158)MET GENOTYPE; VAL(108/158) MET GENOTYPE; WORKING-MEMORY; GENE POLYMORPHISM; COGNITIVE PERFORMANCE; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; DOWN-REGULATION; FRONTAL-CORTEX; BRAIN	The effect of catechol-O-methyltransferase (COMT) Val158Met polymorphism on brain structure and function has been previously investigated separately and regionally; this prevents us from obtaining a full picture of the effect of this gene variant. Additionally, gender difference must not be overlooked because estrogen exerts an interfering effect on COMT activity. We examined 323 young healthy Chinese Han subjects and analyzed the gray matter volume (GMV) differences between Val/Val individuals and Met carriers in a voxel-wise manner throughout the whole brain. We were interested in genotype effects and genotype x gender interactions. We then extracted these brain regions with GMV differences as seeds to compute resting-state functional connectivity (rsFC) with the rest of the brain; we also tested the genotypic differences and gender interactions in the rsFCs. Val/Val individuals showed decreased GMV in the posterior cingulate cortex (PCC) compared with Met carriers; decreased GMV in the medial superior frontal gyrus (mSFG) was found only in male Val/Val subjects. The rsFC analysis revealed that both the PCC and mSFG were functionally correlated with brain regions of the default mode network (DMN). Both of these regions showed decreased rsFCs with different parts of the frontopolar cortex of the DMN in Val/Val individuals than Met carriers. Our findings suggest that the COMT Val158Met polymorphism modulates both the structure and functional connectivity within the DMN and that gender interactions should be considered in studies of the effect of this genetic variant, especially those involving prefrontal morphology.	[Tian, Tian; Qin, Wen; Wang, Dawei; Wang, Junping; Yu, Chunshui] Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Tian, Tian; Qin, Wen; Wang, Dawei; Wang, Junping; Yu, Chunshui] Tianjin Med Univ Gen Hosp, Tianjin Key Lab Funct Imaging, Tianjin, Peoples R China; [Liu, Bing; Jiang, Tianzi] Chinese Acad Sci, Brainnetome Ctr, Inst Automat, Beijing, Peoples R China; [Liu, Bing; Jiang, Tianzi] Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Jiang, Tianzi] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Tianjin Medical University; Tianjin Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Automation, CAS; University of Electronic Science & Technology of China; University of Queensland	Yu, CS (corresponding author), Tianjin Med Univ Gen Hosp, Dept Radiol, Tianjin, Peoples R China.	chunshuiyu@tijmu.edu.cn	Jiang, Tianzi/I-4256-2012; QIN, WEN/F-3783-2015	Jiang, Tianzi/0000-0001-9531-291X; QIN, WEN/0000-0002-9121-8296; liu, bing/0000-0003-2029-5187; Yu, Chunshui/0000-0001-5648-5199	National Basic Research Program of China (973 program) [2011CB707801]; Natural Science Foundation of China [81271551, 81061120533]; Natural Science Foundation of Tianjin [11JCZDJC19300]	National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Basic Research Program of China (973 program, No. 2011CB707801), the Natural Science Foundation of China (Grant Nos. 81271551 and 81061120533), and the Natural Science Foundation of Tianjin (No. 11JCZDJC19300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera M, 2008, AM J MED GENET B, V147B, P898, DOI 10.1002/ajmg.b.30705; Apud JA, 2007, NEUROPSYCHOPHARMACOL, V32, P1011, DOI 10.1038/sj.npp.1301227; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barnes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033964; Barnett JH, 2007, MOL PSYCHIATR, V12, P502, DOI 10.1038/sj.mp.4001973; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Beck A, 1993, MANUAL BECK DEPRESSI; Bertolino A, 2006, BIOL PSYCHIAT, V60, P1250, DOI 10.1016/j.biopsych.2006.03.078; Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542; Bishop SJ, 2008, CEREB CORTEX, V18, P2132, DOI 10.1093/cercor/bhm240; Bishop SJ, 2006, COGN AFFECT BEHAV NE, V6, P62, DOI 10.3758/CABN.6.1.62; Bixo M, 1995, J STEROID BIOCHEM, V55, P297, DOI 10.1016/0960-0760(95)00179-4; Blasi G, 2005, J NEUROSCI, V25, P5038, DOI 10.1523/JNEUROSCI.0476-05.2005; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bruder GE, 2005, BIOL PSYCHIAT, V58, P901, DOI 10.1016/j.biopsych.2005.05.010; Cerasa A, 2010, NEUROSCIENCE, V167, P809, DOI 10.1016/j.neuroscience.2010.02.040; Cerasa A, 2008, NEUROREPORT, V19, P405, DOI 10.1097/WNR.0b013e3282f5f784; Chen CH, 2011, NEUROPSYCHOPHARMACOL, V36, P1593, DOI 10.1038/npp.2011.39; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; de Frias CM, 2005, J COGNITIVE NEUROSCI, V17, P1018, DOI 10.1162/0898929054475136; de Frias CM, 2004, BEHAV GENET, V34, P533, DOI 10.1023/B:BEGE.0000038491.06972.8c; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396; Dumontheil I, 2011, BIOL PSYCHIAT, V70, P222, DOI 10.1016/j.biopsych.2011.02.027; Dutt A, 2009, PSYCHOL MED, V39, P1783, DOI 10.1017/S0033291709990316; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ehrlich S, 2010, NEUROIMAGE, V53, P992, DOI 10.1016/j.neuroimage.2009.12.046; Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006; Ettinger U, 2008, NEUROPSYCHOPHARMACOL, V33, P3046, DOI 10.1038/sj.npp.1301658; Fallon SJ, 2013, CEREB CORTEX, V23, P361, DOI 10.1093/cercor/bhs025; Favaro A, 2013, J PSYCHIATR NEUROSCI, V38, P241, DOI 10.1503/jpn.120068; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fumagalli F, 2003, MOL PSYCHIATR, V8, P898, DOI 10.1038/sj.mp.4001370; Gennatas ED, 2012, NEUROLOGY, V78, P1663, DOI 10.1212/WNL.0b013e3182574fa1; Giakoumaki SG, 2008, NEUROPSYCHOPHARMACOL, V33, P3058, DOI 10.1038/npp.2008.82; Gianotti LRR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00054; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Goldberg TE, 2003, ARCH GEN PSYCHIAT, V60, P889, DOI 10.1001/archpsyc.60.9.889; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; Gong Y. X., 1982, MANUAL MODIFIED WECH; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Green AE, 2013, CEREB CORTEX, V23, P552, DOI 10.1093/cercor/bhs035; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Ho BC, 2005, MOL PSYCHIATR, V10, P287, DOI 10.1038/sj.mp.4001616; Holtzer R, 2010, NEUROBIOL AGING, V31, P523, DOI 10.1016/j.neurobiolaging.2008.05.011; Honea R, 2009, NEUROIMAGE, V45, P44, DOI 10.1016/j.neuroimage.2008.10.064; Hoth Karin F, 2006, Neuropsychiatr Dis Treat, V2, P219, DOI 10.2147/nedt.2006.2.2.219; Jiang H, 2003, NEUROPHARMACOLOGY, V45, P1011, DOI 10.1016/S0028-3908(03)00286-7; Joober R, 2002, ARCH GEN PSYCHIAT, V59, P662, DOI 10.1001/archpsyc.59.7.662; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; Kempton MJ, 2009, INT J NEUROPSYCHOPH, V12, P371, DOI 10.1017/S1461145708009395; Kimberg DY, 1997, NEUROREPORT, V8, P3581, DOI 10.1097/00001756-199711100-00032; Kuppers E, 2001, NEUROREPORT, V12, P1175; Lang UE, 2007, NEUROPSYCHOPHARMACOL, V32, P1950, DOI 10.1038/sj.npp.1301335; Lee TW, 2011, BRAIN RES, V1377, P21, DOI 10.1016/j.brainres.2010.12.073; Li J, 2009, AM J MED GENET B, V150B, P375, DOI 10.1002/ajmg.b.30825; Liu B, 2010, J NEUROSCI, V30, P64, DOI 10.1523/JNEUROSCI.3941-09.2010; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Mattay VS, 2000, NEUROIMAGE, V12, P268, DOI 10.1006/nimg.2000.0610; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; McIntosh AM, 2007, BIOL PSYCHIAT, V61, P1127, DOI 10.1016/j.biopsych.2006.05.020; Mechelli A, 2009, BIOL PSYCHIAT, V66, P231, DOI 10.1016/j.biopsych.2009.01.033; Mehta MA, 2000, J NEUROSCI, V20; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Montag C, 2008, BEHAV NEUROSCI, V122, P901, DOI 10.1037/0735-7044.122.4.901; O'Hara R, 2006, NEUROSCI LETT, V409, P205, DOI 10.1016/j.neulet.2006.09.047; Ohnishi T, 2006, BRAIN, V129, P399, DOI 10.1093/brain/awh702; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Qin SZ, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00016; Rasch B, 2010, NEUROIMAGE, V52, P1712, DOI 10.1016/j.neuroimage.2010.05.054; Raz N, 2009, NEUROPSYCHOLOGY, V23, P105, DOI 10.1037/a0013487; Raznahan A, 2011, NEUROIMAGE, V57, P1517, DOI 10.1016/j.neuroimage.2011.05.032; Reuter M, 2005, NEUROREPORT, V16, P1135, DOI 10.1097/00001756-200507130-00020; Rowe JB, 2010, NEUROBIOL AGING, V31, P1064, DOI 10.1016/j.neurobiolaging.2008.07.009; Sambataro F, 2012, CNS NEUROL DISORD-DR, V11, P195, DOI 10.2174/187152712800672463; Sambataro F, 2009, BIOL PSYCHIAT, V66, P540, DOI 10.1016/j.biopsych.2009.04.014; Santiago M, 2000, BRAIN RES, V858, P26, DOI 10.1016/S0006-8993(99)02485-3; Schmahl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0023658; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shaw P, 2009, MOL PSYCHIATR, V14, P348, DOI 10.1038/mp.2008.121; Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005; Stokes PRA, 2011, NEUROPSYCHOPHARMACOL, V36, P763, DOI 10.1038/npp.2010.210; Swart M, 2011, NEUROIMAGE, V55, P338, DOI 10.1016/j.neuroimage.2010.12.017; Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007; Taylor WD, 2007, PSYCHIAT RES-NEUROIM, V155, P173, DOI 10.1016/j.pscychresns.2007.01.005; Thomas G, 2004, ELECTROPHORESIS, V25, P1668, DOI 10.1002/elps.200405886; Thomason ME, 2010, NEUROIMAGE, V53, P926, DOI 10.1016/j.neuroimage.2010.01.033; Tunbridge EM, 2013, NEUROIMAGE, V68, P49, DOI 10.1016/j.neuroimage.2012.11.059; Voets NL, 2012, BRAIN, V135, P2350, DOI 10.1093/brain/aws137; Wacker J, 2012, J PERS SOC PSYCHOL, V102, P427, DOI 10.1037/a0026544; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Witte AV, 2012, BRAIN RES BULL, V88, P418, DOI 10.1016/j.brainresbull.2011.11.012; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yi P, 2009, PRENATAL DIAG, V29, P217, DOI 10.1002/pd.2072; Zhang KJ, 2007, NEUROPSYCHOBIOLOGY, V56, P98, DOI 10.1159/000112950; Zinkstok J, 2006, NEUROSCI LETT, V405, P34, DOI 10.1016/j.neulet.2006.06.034; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	109	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78697	10.1371/journal.pone.0078697	http://dx.doi.org/10.1371/journal.pone.0078697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147141	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400160
J	Yasugi, M; Kubota-Koketsu, R; Yamashita, A; Kawashita, N; Du, A; Misaki, R; Kuhara, M; Boonsathorn, N; Fujiyama, K; Okuno, Y; Nakaya, T; Ikuta, K				Yasugi, Mayo; Kubota-Koketsu, Ritsuko; Yamashita, Akifumi; Kawashita, Norihito; Du, Anariwa; Misaki, Ryo; Kuhara, Motoki; Boonsathorn, Naphatsawan; Fujiyama, Kazuhito; Okuno, Yoshinobu; Nakaya, Takaaki; Ikuta, Kazuyoshi			Emerging Antigenic Variants at the Antigenic Site Sb in Pandemic A(H1N1)2009 Influenza Virus in Japan Detected by a Human Monoclonal Antibody	PLOS ONE			English	Article							STRUCTURAL BASIS; ESCAPE MUTANTS; HEMAGGLUTININ; SPECIFICITY; EVOLUTION; SEQUENCES; EPITOPE	The swine-origin pandemic A(H1N1) 2009 virus, A(H1N1)pdm09, is still circulating in parts of the human population. To monitor variants that may escape from vaccination specificity, antigenic characterization of circulating viruses is important. In this study, a hybridoma clone producing human monoclonal antibody against A(H1N1) pdm09, designated 5E4, was prepared using peripheral lymphocytes from a vaccinated volunteer. The 5E4 showed viral neutralization activity and inhibited hemagglutination. 5E4 escape mutants harbored amino acid substitutions (A189T and D190E) in the hemagglutinin (HA) protein, suggesting that 5E4 recognized the antigenic site Sb in the HA protein. To study the diversity of Sb in A(H1N1) pdm09, 58 viral isolates were obtained during the 2009/10 and 2010/11 winter seasons in Osaka, Japan. Hemagglutination-inhibition titers were significantly reduced against 5E4 in the 2010/11 compared with the 2009/10 samples. Viral neutralizing titers were also significantly decreased in the 2010/11 samples. By contrast, isolated samples reacted well to ferret anti-A(H1N1) pdm09 serum from both seasons. Nonsynonymous substitution rates revealed that the variant Sb and Ca2 sequences were being positively selected between 2009/10 and 2010/11. In 7,415 HA protein sequences derived from GenBank, variants in the antigenic sites Sa and Sb increased significantly worldwide from 2009 to 2013. These results indicate that the antigenic variants in Sb are likely to be in global circulation currently.	[Yasugi, Mayo; Kubota-Koketsu, Ritsuko; Du, Anariwa; Ikuta, Kazuyoshi] Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 565, Japan; [Yasugi, Mayo] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan; [Kubota-Koketsu, Ritsuko; Okuno, Yoshinobu] Osaka Univ, Kanonji Inst, Res Fdn Microbial Dis, Kanonji, Kagawa, Japan; [Yamashita, Akifumi] Osaka Univ, Dept Genome Informat, RIMD, Suita, Osaka, Japan; [Kawashita, Norihito] Osaka Univ, Dept Environm Pharmacometr, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Misaki, Ryo; Fujiyama, Kazuhito] Osaka Univ, Appl Microbiol Lab, Int Ctr Biotechnol, Suita, Osaka, Japan; [Kuhara, Motoki] Med & Biol Labs Corp Ltd, Ina Lab, Ina, Nagano, Japan; [Boonsathorn, Naphatsawan] Minist Publ Hlth, Dept Med Sci, Muang, Nonthaburi, Thailand; [Nakaya, Takaaki] Osaka Univ, Int Res Ctr Infect Dis, RIMD, Suita, Osaka, Japan; [Yasugi, Mayo; Kubota-Koketsu, Ritsuko; Du, Anariwa; Misaki, Ryo; Kuhara, Motoki; Boonsathorn, Naphatsawan; Fujiyama, Kazuhito; Nakaya, Takaaki; Ikuta, Kazuyoshi] Japan Int Cooperat Agcy Sci & Res Partnership Sus, Japan Sci & Technol Agcy, SATREPS, Tokyo, Japan	Osaka University; Osaka Metropolitan University; Osaka University; Osaka University; Osaka University; Osaka University; Ministry of Public Health - Thailand; Osaka University; Japan Science & Technology Agency (JST)	Ikuta, K (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Virol, Suita, Osaka 565, Japan.	ikuta@biken.osaka-u.ac.jp			Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/ JICA, SATREPS); Japan Society for the Promotion of Science [23790660]; Grants-in-Aid for Scientific Research [23406017] Funding Source: KAKEN	Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/ JICA, SATREPS); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Science and Technology Agency/Japan International Cooperation Agency, Science and Technology Research Partnership for Sustainable Development (JST/ JICA, SATREPS) (http://www.jst.go.jp/global/kadai/h2011_thailand.html); and a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science to MY. (#23790660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arora DJS, 1997, ARCH VIROL, V142, P401, DOI 10.1007/s007050050086; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Barr IG, 2010, EURO SURVEILL, V15; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; de Vries RP, 2011, J BIOL CHEM, V286, P5868, DOI 10.1074/jbc.M110.193557; Di Lonardo A, 2002, J VIROL METHODS, V101, P189, DOI 10.1016/S0166-0934(01)00437-2; Ding XF, 2010, VIRUS GENES, V41, P329, DOI 10.1007/s11262-010-0526-z; El-Shesheny R, 2012, J GEN VIROL, V93, P2564, DOI 10.1099/vir.0.043299-0; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; GIRC, 2011, RETR ONP WHILST DEC; GISRS, 2013, INFL LAB SURV INF; Gulati U, 2002, J VIROL, V76, P12274, DOI 10.1128/JVI.76.23.12274-12280.2002; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Ilyushina NA, 2004, VIRUS RES, V100, P237, DOI 10.1016/j.virusres.2003.12.032; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Kubota-Koketsu R, 2009, BIOCHEM BIOPH RES CO, V387, P180, DOI 10.1016/j.bbrc.2009.06.151; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; Lerdsamran H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016164; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Mak G, 2011, EURO SURVEILL, V16; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; Moreno A, 2013, J VIROL METHODS, V187, P424, DOI 10.1016/j.jviromet.2012.11.006; Nakagawa N, 2002, J CLIN MICROBIOL, V40, P3068, DOI 10.1128/JCM.40.8.3068-3070.2002; NIID, 2013, INFECT AGENTS SURVEI; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; O'Donnell CD, 2012, MBIO, V3, DOI 10.1128/mBio.00120-12; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; RAYMOND FL, 1986, VIROLOGY, V148, P275, DOI 10.1016/0042-6822(86)90325-9; Rudneva I, 2012, VIRUS RES, V166, P61, DOI 10.1016/j.virusres.2012.03.003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Setthapramote C, 2013, BIOCHEM BIOPH RES CO, V432, P200, DOI 10.1016/j.bbrc.2013.01.107; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shirahata S, 1998, METHOD CELL BIOL, V57, P111; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsibane T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003067; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; WHO, 2012, REC COMP INFL VIR VA; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Xu Z, 2010, ACTA VIROL, V54, P113, DOI 10.4149/av_2010_02_113; Yasugi M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003150; Yasugi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030946	50	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77892	10.1371/journal.pone.0077892	http://dx.doi.org/10.1371/journal.pone.0077892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147093	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400141
J	Pereira-Fernandes, A; Demaegdt, H; Vandermeiren, K; Hectors, TLM; Jorens, PG; Blust, R; Vanparys, C				Pereira-Fernandes, Anna; Demaegdt, Heidi; Vandermeiren, Karine; Hectors, Tine L. M.; Jorens, Philippe G.; Blust, Ronny; Vanparys, Caroline			Evaluation of a Screening System for Obesogenic Compounds: Screening of Endocrine Disrupting Compounds and Evaluation of the PPAR Dependency of the Effect	PLOS ONE			English	Article							BISPHENOL-A; ADIPOCYTE DIFFERENTIATION; IN-VITRO; ORGANOTIN COMPOUNDS; MUSK COMPOUNDS; STROMAL CELLS; ADIPOGENESIS; CHEMICALS; PHTHALATE; GAMMA	Recently the environmental obesogen hypothesis has been formulated, proposing a role for endocrine disrupting compounds (EDCs) in the development of obesity. To evaluate this hypothesis, a screening system for obesogenic compounds is urgently needed. In this study, we suggest a standardised protocol for obesogen screening based on the 3T3-L1 cell line, a well-characterised adipogenesis model, and direct fluorescent measurement using Nile red lipid staining technique. In a first phase, we characterised the assay using the acknowledged obesogens rosiglitazone and tributyltin. Based on the obtained dose-response curves for these model compounds, a lipid accumulation threshold value was calculated to ensure the biological relevance and reliability of statistically significant effects. This threshold based method was combined with the well described strictly standardized mean difference (SSMD) method for classification of non-, weak-or strong obesogenic compounds. In the next step, a range of EDCs, used in personal and household care products (parabens, musks, phthalates and alkylphenol compounds), were tested to further evaluate the obesogenicity screening assay for its discriminative power and sensitivity. Additionally, the peroxisome proliferator activated receptor gamma (PPAR gamma) dependency of the positive compounds was evaluated using PPAR. activation and antagonist experiments. Our results showed the adipogenic potential of all tested parabens, several musks and phthalate compounds and bisphenol A (BPA). PPAR gamma activation was associated with adipogenesis for parabens, phthalates and BPA, however not required for obesogenic effects induced by Tonalide, indicating the role of other obesogenic mechanisms for this compound.	[Pereira-Fernandes, Anna; Hectors, Tine L. M.; Blust, Ronny; Vanparys, Caroline] Univ Antwerp, System Physiol & Ecotoxicol Res SPHERE, Dept Biol, B-2020 Antwerp, Belgium; [Demaegdt, Heidi; Vandermeiren, Karine] Chem Safety Food Chain Vet & Agrochem Res Ctr COD, Brussels, Belgium; [Jorens, Philippe G.] Univ Antwerp, Dept Clin Pharmacol Clin Toxicol, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Pereira-Fernandes, A (corresponding author), Univ Antwerp, System Physiol & Ecotoxicol Res SPHERE, Dept Biol, B-2020 Antwerp, Belgium.	Anna.Pereira-Fernandes@ua.ac.be		Demaegdt, Heidi/0000-0001-6384-8824; Vandermeiren, Karine/0000-0002-3770-3450	University of Antwerp [FA020000/2/3565]; 'Institute for the promotion of innovation by science and technology' in Flanders (Belgium)	University of Antwerp; 'Institute for the promotion of innovation by science and technology' in Flanders (Belgium)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by a GOA project (Endocrine disrupting environmental chemicals: From accumulation to their role in the global "neuro-endocrine" epidemic of obesity and its metabolic consequences; FA020000/2/3565) of the University of Antwerp. APF acknowledges the 'Institute for the promotion of innovation by science and technology' in Flanders (Belgium) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge A, 2013, CYTOTHERAPY, V15, P89, DOI 10.1016/j.jcyt.2012.07.001; ARMBRUSTER DA, 1994, CLIN CHEM, V40, P1233; Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020; Bonefeld-Jorgensen EC, 2007, ENVIRON HEALTH PERSP, V115, P69, DOI 10.1289/ehp.9368; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Delgado-Saborit JM, 2011, ENVIRON INT, V37, P383, DOI 10.1016/j.envint.2010.10.011; Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017; Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Grun F, 2006, MOL ENDOCRINOL, V20, P2141, DOI 10.1210/me.2005-0367; Hao Chanjuan, 2013, Front Biosci (Elite Ed), V5, P725; Harvey PW, 2006, BEST PRACT RES CL EN, V20, P145, DOI 10.1016/j.beem.2005.09.008; Harvey PW, 2004, J APPL TOXICOL, V24, P167, DOI 10.1002/jat.978; Hassan M, 2007, BIOCHEM BIOPH RES CO, V361, P208, DOI 10.1016/j.bbrc.2007.07.021; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011; Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62; Hu P, 2013, TOXICOL SCI, V131, P56, DOI 10.1093/toxsci/kfs262; Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145; Janderova L, 2003, OBES RES, V11, P65, DOI 10.1038/oby.2003.11; Janesick A, 2011, J STEROID BIOCHEM, V127, P4, DOI 10.1016/j.jsbmb.2011.01.005; Kanayama T, 2005, MOL PHARMACOL, V67, P766, DOI 10.1124/mol.104.008409; Kannan K, 2005, CHEMOSPHERE, V61, P693, DOI 10.1016/j.chemosphere.2005.03.041; Larsen TM, 2003, INT J OBESITY, V27, P147, DOI 10.1038/sj.ijo.802223; Li X, 2012, ENVIRON HEALTH PERSP, V120, P1720, DOI 10.1289/ehp.1205383; Li X, 2011, J STEROID BIOCHEM, V127, P9, DOI 10.1016/j.jsbmb.2011.03.012; Masuno H, 2002, J LIPID RES, V43, P676; Masuno H, 2005, TOXICOL SCI, V84, P319, DOI 10.1093/toxsci/kfi088; Masuno H, 2003, TOXICOL SCI, V75, P314, DOI 10.1093/toxsci/kfg203; McKim JM, 2010, COMB CHEM HIGH T SCR, V13, P188, DOI 10.2174/138620710790596736; Moon HB, 2012, CHEMOSPHERE, V86, P485, DOI 10.1016/j.chemosphere.2011.10.008; Muller S, 1996, CHEMOSPHERE, V33, P17, DOI 10.1016/0045-6535(96)00160-9; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; OECD, 2012, OECD ENV HLTH SAF PU; *OSPAR, 2004, FRONT BIOSCI ELITE E, P1465; Pereira-Fernandes A, 2013, MOL CELL ENDOCRINOL, V370, P52, DOI 10.1016/j.mce.2013.02.011; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.0.CO;2-8; Rimkus GG, 1996, CHEMOSPHERE, V33, P2033, DOI 10.1016/0045-6535(96)00321-9; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Schiavone A, 2010, ENVIRON POLLUT, V158, P599, DOI 10.1016/j.envpol.2009.08.011; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Taxvig C, 2012, MOL CELL ENDOCRINOL, V361, P106, DOI 10.1016/j.mce.2012.03.021; van Meeuwen JA, 2008, TOXICOL APPL PHARM, V230, P372, DOI 10.1016/j.taap.2008.03.002; Vanparys C, 2006, TOXICOL IN VITRO, V20, P1238, DOI 10.1016/j.tiv.2006.05.002; Vanparys C, 2010, SCI TOTAL ENVIRON, V408, P4451, DOI 10.1016/j.scitotenv.2010.06.049; Wang YF, 2010, BIOTECHNOL LETT, V32, P1789, DOI 10.1007/s10529-010-0359-9; Witorsch RJ, 2010, CRIT REV TOXICOL, V40, P1, DOI 10.3109/10408444.2010.515563; Zhang XD, 2007, J BIOMOL SCREEN, V12, P645, DOI 10.1177/1087057107300645; Zhang XD, 2007, GENOMICS, V89, P552, DOI 10.1016/j.ygeno.2006.12.014; Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422	54	111	114	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77481	10.1371/journal.pone.0077481	http://dx.doi.org/10.1371/journal.pone.0077481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155963	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300097
J	Peterson, M; Svardsudd, K; Appel, L; Engler, H; Aarnio, M; Gordh, T; Langstrom, B; Sorensen, J				Peterson, Magnus; Svardsudd, Kurt; Appel, Lieuwe; Engler, Henry; Aarnio, Mikko; Gordh, Torsten; Langstrom, Bengt; Sorensen, Jens			PET-Scan Shows Peripherally Increased Neurokinin 1 Receptor Availability in Chronic Tennis Elbow: Visualizing Neurogenic Inflammation?	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; SUBSTANCE-P; ANTAGONISTS; TENDON; INTERNALIZATION; EXPRESSION; MEDIATORS; EXERCISE; DISEASES; MUSCLE	In response to pain, neurokinin 1 (NK1) receptor availability is altered in the central nervous system. The NK1 receptor and its primary agonist, substance P, also play a crucial role in peripheral tissue in response to pain, as part of neurogenic inflammation. However, little is known about alterations in NK1 receptor availability in peripheral tissue in chronic pain conditions and very few studies have been performed on human beings. Ten subjects with chronic tennis elbow were therefore examined by positron emission tomography (PET) with the NK1 specific radioligand [C-11]GR205171 before and after treatment with graded exercise. The radioligand signal intensity was higher in the affected arm as compared with the unaffected arm, measured as differences between the arms in volume of voxels and signal intensity of this volume above a reference threshold set as 2.5 SD above mean signal intensity of the unaffected arm before treatment. In the eight subjects examined after treatment, pain ratings decreased in all subjects but signal intensity decreased in five and increased in three. In conclusion, NK1 receptors may be activated, or up-regulated in the peripheral, painful tissue of a chronic pain condition. This up-regulation does, however, have moderate correlation to pain ratings. The increased NK1 receptor availability is interpreted as part of ongoing neurogenic inflammation and may have correlation to the pathogenesis of chronic tennis elbow.	[Peterson, Magnus; Svardsudd, Kurt] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Appel, Lieuwe; Engler, Henry; Langstrom, Bengt; Sorensen, Jens] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala PET Ctr, Uppsala, Sweden; [Engler, Henry] Univ Republica, Fac Med, Uruguayan Ctr Mol Imaging CUDIM, Montevideo, Uruguay; [Engler, Henry] Univ Republica, Fac Sci, Montevideo, Uruguay; [Aarnio, Mikko; Gordh, Torsten] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Langstrom, Bengt] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden; [Langstrom, Bengt] Univ London Imperial Coll Sci Technol & Med, Fac Med, Neuropsychopharmacol Sect, London, England	Uppsala University; Uppsala University; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Uppsala University; Uppsala University; Imperial College London	Peterson, M (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	magnus.peterson@pubcare.uu.se		Gordh, Torsten/0000-0003-1454-3148	Swedish Research Council [K2005-27X-15293-01A]; Amersham Fund at Uppsala University; Research Fund at Uppsala County Council; Family Medicine Foundation; Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Amersham Fund at Uppsala University; Research Fund at Uppsala County Council; Family Medicine Foundation; Uppsala University	The study was supported by grants from the Swedish Research Council (grant no. K2005-27X-15293-01A), The Amersham Fund at Uppsala University, The Research Fund at Uppsala County Council, The Family Medicine Foundation, and Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALLANDER E, 1974, SCAND J RHEUMATOL, V3, P145, DOI 10.3109/03009747409097141; Andersson G, 2008, REGUL PEPTIDES, V150, P81, DOI 10.1016/j.regpep.2008.02.005; Assendelft Willem, 2002, Clin Evid, P1290; Backman LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027209; Bergstrom M, 2000, NEUROPHARMACOLOGY, V39, P664, DOI 10.1016/S0028-3908(99)00182-3; BOWDEN JJ, 1994, P NATL ACAD SCI USA, V91, P8964, DOI 10.1073/pnas.91.19.8964; Boyce S, 2000, PROG PAIN RES MANAG, V16, P313; BUCHBINDER R, 2008, CLIN EVID, P1117; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; Goldie I, 1964, ACTA CHIR SCAND S, V57, P331; HARMAR A, 1982, BRAIN RES, V231, P379, DOI 10.1016/0006-8993(82)90374-2; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; HOEHANSEN C, 2001, SUBACROMIAL INFLAMMA, P1465; IMAGEJ I, 2013, JAVA, P5; King T, 2005, PAIN, V116, P276, DOI 10.1016/j.pain.2005.04.014; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kjaer M, 2000, SCAND J MED SCI SPOR, V10, P326, DOI 10.1034/j.1600-0838.2000.010006326.x; KREAM RM, 1993, P NATL ACAD SCI USA, V90, P3564, DOI 10.1073/pnas.90.8.3564; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; LEADBETTER WB, 1992, CLIN SPORT MED, V11, P533; Linnman C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019182; Linnman C, 2010, PAIN, V149, P64, DOI 10.1016/j.pain.2010.01.008; Ljung BO, 2004, J ORTHOPAED RES, V22, P321, DOI 10.1016/S0736-0266(03)00183-9; Ljung BO, 1999, J ORTHOPAED RES, V17, P554, DOI 10.1002/jor.1100170414; MANTYH PW, 1995, P NATL ACAD SCI USA, V92, P2622, DOI 10.1073/pnas.92.7.2622; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; McCarson KE, 1999, NEUROSCIENCE, V93, P361, DOI 10.1016/S0306-4522(99)00102-5; McMahon SB, 2005, EXP NEUROL, V192, P444, DOI 10.1016/j.expneurol.2004.11.001; Michelgard A, 2007, BIOL PSYCHIAT, V61, P1002, DOI 10.1016/j.biopsych.2006.07.003; MURRAY CW, 1991, PAIN, V44, P179, DOI 10.1016/0304-3959(91)90135-K; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Paavola M, 2002, J BONE JOINT SURG AM, V84A, P2062, DOI 10.2106/00004623-200211000-00024; Paavola Mika, 2002, Foot Ankle Clin, V7, P501, DOI 10.1016/S1083-7515(02)00056-6; Page NM, 2003, P NATL ACAD SCI USA, V100, P6245, DOI 10.1073/pnas.0931458100; Patel HJ, 2005, P NATL ACAD SCI USA, V102, P17436, DOI 10.1073/pnas.0506351102; Patel L, 2003, EXPERT OPIN PHARMACO, V4, P2279; PEDERSENBJERGAARD U, 1991, PEPTIDES, V12, P333, DOI 10.1016/0196-9781(91)90022-H; Peterson M, 2011, UPSALA J MED SCI, V116, P269, DOI 10.3109/03009734.2011.600476; POTTER HG, 1995, RADIOLOGY, V196, P43, DOI 10.1148/radiology.196.1.7784585; Quartara L, 1998, NEUROPEPTIDES, V32, P1, DOI 10.1016/S0143-4179(98)90015-4; REGAN W, 1992, AM J SPORT MED, V20, P746, DOI 10.1177/036354659202000618; SAKURADA T, 1995, PAIN, V60, P175, DOI 10.1016/0304-3959(94)00107-P; SEGUIN L, 1995, PAIN, V61, P325, DOI 10.1016/0304-3959(94)00194-J; *SIEM, SIEM ECAT SOFTW VERS, P1465; Traub RJ, 1996, PAIN, V67, P151, DOI 10.1016/0304-3959(96)03076-X; Woodley BL, 2007, BRIT J SPORT MED, V41, P188, DOI 10.1136/bjsm.2006.029769; Yelin E, 2003, J RHEUMATOL, V30, P8	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75859	10.1371/journal.pone.0075859	http://dx.doi.org/10.1371/journal.pone.0075859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155873	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300007
J	Glotzbach, B; Reinwarth, M; Weber, N; Fabritz, S; Tomaszowski, M; Fittler, H; Christmann, A; Avrutina, O; Kolmar, H				Glotzbach, Bernhard; Reinwarth, Michael; Weber, Niklas; Fabritz, Sebastian; Tomaszowski, Michael; Fittler, Heiko; Christmann, Andreas; Avrutina, Olga; Kolmar, Harald			Combinatorial Optimization of Cystine-Knot Peptides towards High-Affinity Inhibitors of Human Matriptase-1	PLOS ONE			English	Article							ELATERIUM TRYPSIN-INHIBITOR; FACTOR ACTIVATOR INHIBITOR-1; SERINE-PROTEASE MATRIPTASE; YEAST SURFACE DISPLAY; MOMORDICA-COCHINCHINENSIS; ALPHA(V)BETA(3) INTEGRIN; PLASMINOGEN ACTIVATION; ENVELOPE GLYCOPROTEIN; PLATELET-AGGREGATION; SELECTIVE INHIBITORS	Cystine-knot miniproteins define a class of bioactive molecules with several thousand natural members. Their eponymous motif comprises a rigid structured core formed by six disulfide-connected cysteine residues, which accounts for its exceptional stability towards thermic or proteolytic degradation. Since they display a remarkable sequence tolerance within their disulfide-connected loops, these molecules are considered promising frameworks for peptide-based pharmaceuticals. Natural open-chain cystine-knot trypsin inhibitors of the MCoTI (Momordica cochinchinensis trypsin inhibitor) and SOTI (Spinacia oleracea trypsin inhibitor) families served as starting points for the generation of inhibitors of matriptase-1, a type II transmembrane serine protease with possible clinical relevance in cancer and arthritic therapy. Yeast surface-displayed libraries of miniproteins were used to select unique and potent matriptase-1 inhibitors. To this end, a knowledge-based library design was applied that makes use of detailed information on binding and folding behavior of cystine-knot peptides. Five inhibitor variants, four of the MCoTI family and one of the SOTI family, were identified, chemically synthesized and oxidatively folded towards the bioactive conformation. Enzyme assays revealed inhibition constants in the low nanomolar range for all candidates. One subnanomolar binder (K-i = 0.83 nM) with an inverted selectivity towards trypsin and matriptase-1 was identified.	[Glotzbach, Bernhard; Reinwarth, Michael; Weber, Niklas; Tomaszowski, Michael; Fittler, Heiko; Christmann, Andreas; Avrutina, Olga; Kolmar, Harald] Tech Univ Darmstadt, Clemens Schopf Inst Organ Chem & Biochem, Darmstadt, Germany; [Fabritz, Sebastian] AB SCIEX Germany GmbH, Darmstadt, Germany	Technical University of Darmstadt	Kolmar, H (corresponding author), Tech Univ Darmstadt, Clemens Schopf Inst Organ Chem & Biochem, Darmstadt, Germany.	Kolmar@Biochemie-TUD.de	Kolmar, Harald/AAK-8316-2021	Kolmar, Harald/0000-0002-8210-1993	Deutsche Forschungsgemeinschaft [KO-1390/9-1, SPP 1623, 1390/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) through grants KO-1390/9-1 and SPP 1623 grant 1390/10-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Avrutina O, 2005, BIOL CHEM, V386, P1301, DOI 10.1515/BC.2005.148; Avrutina O, 2012, ORG BIOMOL CHEM; Avrutina O, 2008, CHEMBIOCHEM, V9, P33, DOI 10.1002/cbic.200700452; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boy RG, 2010, MOL IMAGING BIOL, V12, P377, DOI 10.1007/s11307-009-0287-z; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen JZ, 2012, J AM SOC MASS SPECTR, V23, P225, DOI 10.1007/s13361-011-0294-6; Chen MQ, 2007, BBA-MOL CELL RES, V1773, P1133, DOI 10.1016/j.bbamcr.2007.04.013; CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Christmann A, 1999, PROTEIN ENG, V12, P797, DOI 10.1093/protein/12.9.797; Colombo E, 2012, ACS MED CHEM LETT, V3, P530, DOI 10.1021/ml3000534; Craik DJ, 2006, BIOPOLYMERS, V84, P250, DOI 10.1002/bip.20451; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Desilets A, 2006, FEBS LETT, V580, P2227, DOI 10.1016/j.febslet.2006.03.030; Domoto T, 2012, CANCER SCI, V103, P448, DOI 10.1111/j.1349-7006.2011.02162.x; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634; Gelly JC, 2004, NUCLEIC ACIDS RES, V32, pD156, DOI 10.1093/nar/gkh015; Gera N, 2012, PROTEIN SELECTION US; Getz JA, 2011, ACS CHEM BIOL, V6, P837, DOI 10.1021/cb200039s; Glotzbach B, 2013, ACTA CRYSTALLOGR D, V69, P114, DOI 10.1107/S0907444912043880; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; HEITZ A, 1989, BIOCHEMISTRY-US, V28, P2392, DOI 10.1021/bi00432a009; Heitz A, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-54; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Jiang L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/368075; Jiang L, 2010, J NUCL MED, V51, P251, DOI 10.2967/jnumed.109.069831; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kimura RH, 2009, CANCER RES, V69, P2435, DOI 10.1158/0008-5472.CAN-08-2495; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Kowalska J, 2007, PHYTOCHEMISTRY, V68, P1487, DOI 10.1016/j.phytochem.2007.03.012; Kratzner R, 2005, ACTA CRYSTALLOGR D, V61, P1255, DOI 10.1107/S0907444905021207; Lahti JL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000499; LeBeau AM, 2013, P NATL ACAD SCI USA, V110, P93, DOI 10.1073/pnas.1218694110; Lee JW, 2005, HUM PATHOL, V36, P626, DOI 10.1016/j.humpath.2005.03.003; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; LENGUYEN D, 1993, PROTEIN SCI, V2, P165; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Puttamadappa SS, 2010, ANGEW CHEM INT EDIT, V49, P7030, DOI 10.1002/anie.201002906; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; Reinwarth M, 2013, CHEMBIOCHEM, V14, P137, DOI 10.1002/cbic.201200604; Reinwarth M, 2012, MOLECULES, V17, P12533, DOI 10.3390/molecules171112533; Reiss S, 2006, PLATELETS, V17, P153, DOI 10.1080/09537100500436663; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Silverman AP, 2011, J MOL RECOGNIT, V24, P127, DOI 10.1002/jmr.1036; Silverman AP, 2009, J MOL BIOL, V385, P1064, DOI 10.1016/j.jmb.2008.11.004; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Steinmetzer T, 2006, J MED CHEM, V49, P4116, DOI 10.1021/jm051272l; Stricher F, 2008, J MOL BIOL, V382, P510, DOI 10.1016/j.jmb.2008.06.069; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; TAN MH, 1981, J NATL CANCER I, V67, P563; Thongyoo P, 2007, CHEMBIOCHEM, V8, P1107, DOI 10.1002/cbic.200700187; Tischler M, 2012, ANGEW CHEM INT EDIT, V51, P3708, DOI 10.1002/anie.201108983; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Uhland K, 2009, INT J ONCOL, V35, P347, DOI 10.3892/ijo_00000346; Van den Brulle J, 2008, BIOTECHNIQUES, V45, P340, DOI 10.2144/000112953; Vita C, 1999, P NATL ACAD SCI USA, V96, P13091, DOI 10.1073/pnas.96.23.13091; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wentzel A, 1999, J BIOL CHEM, V274, P21037, DOI 10.1074/jbc.274.30.21037; Werle M, 2007, INT J PHARMACEUT, V332, P72, DOI 10.1016/j.ijpharm.2006.09.028; Werle M, 2006, J DRUG TARGET, V14, P137, DOI 10.1080/10611860600648254; Yamasaki Y, 2003, J NUTR SCI VITAMINOL, V49, P27, DOI 10.3177/jnsv.49.27; Yuan C, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-30	79	41	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76956	10.1371/journal.pone.0076956	http://dx.doi.org/10.1371/journal.pone.0076956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146945	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400091
J	Kompaniez, E; Abbey, CK; Boone, JM; Webster, MA				Kompaniez, Elysse; Abbey, Craig K.; Boone, John M.; Webster, Michael A.			Adaptation Aftereffects in the Perception of Radiological Images	PLOS ONE			English	Article							VISUAL-ADAPTATION; TEXTURE DENSITY; MAMMOGRAPHIC DENSITY; CONTRAST ADAPTATION; NATURAL IMAGES; BREAST-CANCER; SEARCH; SENSITIVITY; MECHANISMS; AMPLITUDE	Radiologists must classify and interpret medical images on the basis of visual inspection. We examined how the perception of radiological scans might be affected by common processes of adaptation in the visual system. Adaptation selectively adjusts sensitivity to the properties of the stimulus in current view, inducing an aftereffect in the appearance of stimuli viewed subsequently. These perceptual changes have been found to affect many visual attributes, but whether they are relevant to medical image perception is not well understood. To examine this we tested whether aftereffects could be generated by the characteristic spatial structure of radiological scans, and whether this could bias their appearance along dimensions that are routinely used to classify them. Measurements were focused on the effects of adaptation to images of normal mammograms, and were tested in observers who were not radiologists. Tissue density in mammograms is evaluated visually and ranges from "dense" to "fatty." Arrays of images varying in intermediate levels between these categories were created by blending dense and fatty images with different weights. Observers first adapted by viewing image samples of dense or fatty tissue, and then judged the appearance of the intermediate images by using a texture matching task. This revealed pronounced perceptual aftereffects - prior exposure to dense images caused an intermediate image to appear more fatty and vice versa. Moreover, the appearance of the adapting images themselves changed with prolonged viewing, so that they became less distinctive as textures. These aftereffects could not be accounted for by the contrast differences or power spectra of the images, and instead tended to follow from the phase spectrum. Our results suggest that observers can selectively adapt to the properties of radiological images, and that this selectivity could strongly impact the perceived textural characteristics of the images.	[Kompaniez, Elysse; Webster, Michael A.] Univ Nevada, Dept Psychol, Reno, NV 89557 USA; [Abbey, Craig K.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Boone, John M.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Abbey, Craig K.; Boone, John M.] Univ Calif Davis, Med Ctr, Dept Radiol, Sacramento, CA 95817 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California Santa Barbara; University of California System; University of California Davis; University of California System; University of California Davis	Kompaniez, E (corresponding author), Univ Nevada, Dept Psychol, Reno, NV 89557 USA.	ekompaniez@unr.edu		Webster, Michael/0000-0001-8262-7525	National Eye Institute [RO1-EY10834]; National Institute of Biomedical Imaging and Bioengineering [RO1-EB002138]; NATIONAL EYE INSTITUTE [R01EY010834] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the following: National Eye Institute (RO1-EY10834 to MW), and National Institute of Biomedical Imaging and Bioengineering (RO1-EB002138 to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Radiology, 1998, BREAST IM REP DAT SY, V3rd; Bao M, 2012, P NATL ACAD SCI USA, V109, P5898, DOI 10.1073/pnas.1113503109; Belmore SC, 2011, VISION RES, V51, P362, DOI 10.1016/j.visres.2010.11.011; Bex PJ, 2009, J VISION, V9, DOI 10.1167/9.10.1; Bochud FO, 1999, OPT EXPRESS, V4, P33, DOI 10.1364/OE.4.000033; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Boyd NF, 2011, JNCI-J NATL CANCER I, V103, P704, DOI 10.1093/jnci/djr115; Burgess AE, 1997, J OPT SOC AM A, V14, P2420, DOI 10.1364/JOSAA.14.002420; Burgess AE, 2001, MED PHYS, V28, P419, DOI 10.1118/1.1355308; Chen L, 2012, MED PHYS, V39, P7; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Delahunt PB, 2004, VISUAL NEUROSCI, V21, P301, DOI 10.1017/S0952523804213025; Drew T, 2013, RADIOGRAPHICS, V33, P263, DOI 10.1148/rg.331125023; Durgin FH, 1997, VISION RES, V37, P3273, DOI 10.1016/S0042-6989(97)00126-0; Durgin FH, 1996, SPATIAL VISION, V9, P423, DOI 10.1163/156856896X00204; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Eckstein M. P., 2000, HDB MED IMAGING, V1, P593, DOI [10.1117/3.832716, DOI 10.1117/3.832716]; ECKSTEIN MP, 2011, J VIS, V11, P9816, DOI DOI 10.1167/11.5.14; Evans KK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064366; Gale A, 1984, ELSEVIER SCI PUB, V295; Greene MR, 2010, J EXP PSYCHOL HUMAN, V36, P1430, DOI 10.1037/a0019058; Harris H, 2012, CURR BIOL, V22, P1813, DOI 10.1016/j.cub.2012.07.059; Hersh M, 2004, APPL RADIOL, V33, P23; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; Krupinski EA, 2011, SEMIN NUCL MED, V41, P392, DOI 10.1053/j.semnuclmed.2011.05.002; Kundel HL, 2004, PROC SPIE, V5372, P1, DOI 10.1117/12.542717; Kwon MY, 2009, J VISION, V9, DOI 10.1167/9.2.20; Manning DJ, 2005, BRIT J RADIOL, V78, P683, DOI 10.1259/bjr/72087985; McDermott KC, 2010, J VISION, V10, DOI 10.1167/10.13.17; Motoyoshi I, 2007, NATURE, V447, P206, DOI 10.1038/nature05724; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Ouhnana M, 2013, J VISION, V13, DOI 10.1167/13.8.18; PIOTROWSKI LN, 1982, PERCEPTION, V11, P337, DOI 10.1068/p110337; Rhodes G., 2005, FITTING MIND WORLD A, P213, DOI DOI 10.1093/ACPROF:OSO/9780198529699.003.0009; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; Sowden PT, 2000, J EXP PSYCHOL HUMAN, V26, P379, DOI 10.1037/0096-1523.26.1.379; TADMOR Y, 1993, VISION RES, V33, P141, DOI 10.1016/0042-6989(93)90067-7; Thompson P, 2009, CURR BIOL, V19, pR11, DOI 10.1016/j.cub.2008.10.014; Vul E, 2008, J VISION, V8, DOI 10.1167/8.12.4; Webster MA, 1997, J OPT SOC AM A, V14, P2355, DOI 10.1364/JOSAA.14.002355; Webster MA, 2002, NAT NEUROSCI, V5, P839, DOI 10.1038/nn906; Webster MA, 2013, 86518621 SPIE; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; Webster MA, 2011, PHILOS T R SOC B, V366, P1702, DOI 10.1098/rstb.2010.0360; Webster MA, 2008, J OPT SOC AM A, V25, P2817, DOI 10.1364/JOSAA.25.002817; Wissig SC, 2013, J VISION, V13, DOI 10.1167/13.2.6; Yehezkel O, 2010, VISION RES, V50, P1550, DOI 10.1016/j.visres.2010.05.014	48	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76175	10.1371/journal.pone.0076175	http://dx.doi.org/10.1371/journal.pone.0076175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24146833	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400045
J	Lalle, M; Leptourgidou, F; Camerini, S; Pozio, E; Skoulakis, EMC				Lalle, Marco; Leptourgidou, Flora; Camerini, Serena; Pozio, Edoardo; Skoulakis, Efthimios M. C.			Interkingdom Complementation Reveals Structural Conservation and Functional Divergence of 14-3-3 Proteins	PLOS ONE			English	Article							GIARDIA; BINDING; POLYGLYCYLATION; PHOSPHORYLATION; MUTANTS; NEURONS	The 14-3-3s are small acidic cytosolic proteins that interact with multiple clients and participate in essential cellular functions in all eukaryotes. Available structural and functional information about 14-3-3s is largely derived from higher eukaryotes, which contain multiple members of this protein family suggesting functional specialization. The exceptional sequence conservation among 14-3-3 family members from diverse species suggests a common ancestor for 14-3-3s, proposed to have been similar to modern 14-3-3 epsilon isoforms. Structural features of the sole family member from the protozoan Giardia duodenalis (g14-3-3), are consistent with this hypothesis, but whether g14-3-3 is functionally homologous to the epsilon isoforms is unknown. We use inter-kingdom reciprocal functional complementation and biochemical methods to determine whether g14-3-3 is structurally and functionally homologous with members of the two 14-3-3 conservation groups of the metazoan Drosophila melanogaster. Our results indicate that although g14-3-3 is structurally homologous to D14-3-3 epsilon, functionally it diverges presenting characteristics of other 14-3-3s. Given the basal position of Giardia in eukaryotic evolution, this finding is consistent with the hypothesis that 14-3-3 epsilon isoforms are ancestral to other family members.	[Lalle, Marco; Pozio, Edoardo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, I-00161 Rome, Italy; [Leptourgidou, Flora; Skoulakis, Efthimios M. C.] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece; [Camerini, Serena] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Alexander Fleming Biomedical Sciences Research Center; Istituto Superiore di Sanita (ISS)	Lalle, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	marco.lalle@iss.it	Camerini, Serena/A-4637-2017; Lalle, Marco/O-2287-2015	Camerini, Serena/0000-0001-6131-4335; Lalle, Marco/0000-0001-5168-2150	Hellenic general Secretariat for Research and Technology	Hellenic general Secretariat for Research and Technology(Greek Ministry of Development-GSRT)	Initial stages of the work were funded by the Hellenic general Secretariat for Research and Technology. Later phases and presently there are no funds supporting this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo SF, 2007, GENETICS, V177, P239, DOI 10.1534/genetics.107.072280; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bre MH, 1996, J CELL SCI, V109, P727; Elmendorf HG, 2000, MOL BIOCHEM PARASIT, V106, P315, DOI 10.1016/S0166-6851(99)00219-4; Ferl RJ, 2002, GENOME BIOL, V3; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Lalle M, 2006, J BIOL CHEM, V281, P5137, DOI 10.1074/jbc.M509673200; Lalle M, 2012, J PROTEOME RES, V11, P2666, DOI 10.1021/pr3000199; Lalle M, 2011, J BIOL CHEM, V286, P4471, DOI 10.1074/jbc.M110.181511; Lalle M, 2010, INT J PARASITOL, V40, P201, DOI 10.1016/j.ijpara.2009.07.010; Lane S, 2002, CRIT REV MICROBIOL, V28, P123, DOI 10.1080/10408410490435133; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lisbin MJ, 2001, GENE DEV, V15, P2546, DOI 10.1101/gad.903101; Messaritou G, 2010, J BIOL CHEM, V285, P1692, DOI 10.1074/jbc.M109.045989; Messaritou G, 2009, FEBS LETT, V583, P2934, DOI 10.1016/j.febslet.2009.08.003; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nino CA, 2003, PARASITOL INT, V52, P291, DOI 10.1016/S1383-5769(03)00032-1; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Philip N, 2001, J NEUROSCI, V21, P8417, DOI 10.1523/JNEUROSCI.21-21-08417.2001; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Skoulakis EMC, 1998, MOL NEUROBIOL, V16, P269, DOI 10.1007/BF02741386; Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7; Tinti M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120103; Tsigkari KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036702; van Hemert MJ, 2001, BIOESSAYS, V23, P936, DOI 10.1002/bies.1134; Wang WF, 1996, J MOL EVOL, V43, P384; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	36	10	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78090	10.1371/journal.pone.0078090	http://dx.doi.org/10.1371/journal.pone.0078090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147113	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400142
J	MacPherson, H; Maschino, AC; Lewith, G; Foster, NE; Witt, C; Vickers, AJ				MacPherson, Hugh; Maschino, Alexandra C.; Lewith, George; Foster, Nadine E.; Witt, Claudia; Vickers, Andrew J.		Acupuncture Trialists'	Characteristics of Acupuncture Treatment Associated with Outcome: An Individual Patient Meta-Analysis of 17,922 Patients with Chronic Pain in Randomised Controlled Trials	PLOS ONE			English	Article							LOW-BACK-PAIN; TREATING PATIENTS; OSTEOARTHRITIS; CARE; KNEE	Background: Recent evidence shows that acupuncture is effective for chronic pain. However we do not know whether there are characteristics of acupuncture or acupuncturists that are associated with better or worse outcomes. Methods: An existing dataset, developed by the Acupuncture Trialists' Collaboration, included 29 trials of acupuncture for chronic pain with individual data involving 17,922 patients. The available data on characteristics of acupuncture included style of acupuncture, point prescription, location of needles, use of electrical stimulation and moxibustion, number, frequency and duration of sessions, number of needles used and acupuncturist experience. We used random-effects meta-regression to test the effect of each characteristic on the main effect estimate of pain. Where sufficient patient-level data were available, we conducted patient-level analyses. Results: When comparing acupuncture to sham controls, there was little evidence that the effects of acupuncture on pain were modified by any of the acupuncture characteristics evaluated, including style of acupuncture, the number or placement of needles, the number, frequency or duration of sessions, patient-practitioner interactions and the experience of the acupuncturist. When comparing acupuncture to non-acupuncture controls, there was little evidence that these characteristics modified the effect of acupuncture, except better pain outcomes were observed when more needles were used (p=0.010) and, from patient level analysis involving a sub-set of five trials, when a higher number of acupuncture treatment sessions were provided (p<0.001). Conclusion: There was little evidence that different characteristics of acupuncture or acupuncturists modified the effect of treatment on pain outcomes. Increased number of needles and more sessions appear to be associated with better outcomes when comparing acupuncture to non-acupuncture controls, suggesting that dose is important. Potential confounders include differences in control group and sample size between trials. Trials to evaluate potentially small differences in outcome associated with different acupuncture characteristics are likely to require large sample sizes.	[MacPherson, Hugh] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Maschino, Alexandra C.; Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Lewith, George] Univ Southampton, Southampton, Hants, England; [Foster, Nadine E.] Keele Univ, Inst Primary Care & Hlth Sci, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Witt, Claudia] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany	University of York - UK; Memorial Sloan Kettering Cancer Center; University of Southampton; Keele University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	MacPherson, H (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	hugh.macpherson@york.ac.uk	Witt, Claudia M./AAX-2370-2021; Lao, Lixing/P-9107-2019; Brinkhaus, Benno/AAU-2428-2021	Witt, Claudia M./0000-0002-5440-7805; Lao, Lixing/0000-0003-0198-9714; Brinkhaus, Benno/0000-0001-6290-744X; Lewith, George/0000-0002-2364-3960; Vickers, Andrew/0000-0003-1525-6503; Foster, Nadine/0000-0003-4429-9756; MacPherson, Hugh/0000-0003-4255-4768; Linde, Klaus/0000-0002-2902-970X	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH); United Kingdom National Institute for Health Research (NIHR) [RP-PG-0707-10186]; Carstens Foundation; National Institute of Health Research; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006794] Funding Source: NIH RePORTER; National Institute for Health Research [RP-PG-0707-10186] Funding Source: researchfish	National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); United Kingdom National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Carstens Foundation; National Institute of Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR))	The Acupuncture Trialists' Collaboration is funded by an R21 (AT004189I from the National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH) to AV) and by a grant from the Samueli Institute. HM's work has been supported in part by the United Kingdom National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (RP-PG-0707-10186). CW's work has been supported by the Carstens Foundation within the grant for the Chair for Complementary Medicine Research. NF is supported by a Research Professorship from the National Institute of Health Research. The views expressed in this publication are those of the author(s) and not necessarily those of the NCCAM, NHS, NIHR or the Department of Health in England. No sponsor had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch S., 2007, J CHIN MED, V83, P12; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Foster NE, 2007, BMJ-BRIT MED J, V335, P436, DOI 10.1136/bmj.39280.509803.BE; Hanfileti L, 2013, MED ACUPUNCTURE TRAD; Hopton AK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000456; Hughes JG, 2007, COMPLEMENT THER MED, V15, P101, DOI 10.1016/j.ctim.2006.09.008; Lewis M, 2010, EUR J PAIN, V14, P1033, DOI 10.1016/j.ejpain.2010.04.002; Moffett JAK, 2004, SPINE, V29, P1167, DOI 10.1097/00007632-200406010-00002; National Institute for Health and Clinical Excellence, 2009, LOW BACK PAIN EARL M; Paterson C, 2004, J ALTERN COMPLEM MED, V10, P791; Price S, 2006, PATIENT EDUC COUNS, V63, P239, DOI 10.1016/j.pec.2005.11.006; Scheid V., 2012, INTEGRATING E ASIAN, P13; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; Underwood MR, 2007, RHEUMATOLOGY, V46, P1297, DOI 10.1093/rheumatology/kem113; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Wampold BE, 2005, J CONSULT CLIN PSYCH, V73, P914, DOI 10.1037/0022-006X.73.5.914; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Witt CM, 2010, J PAIN, V11, P431, DOI 10.1016/j.jpain.2009.08.010	19	79	86	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77438	10.1371/journal.pone.0077438	http://dx.doi.org/10.1371/journal.pone.0077438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146995	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000325819400118
J	Tam, ZY; Gruber, J; Halliwell, B; Gunawan, R				Tam, Zhi Yang; Gruber, Jan; Halliwell, Barry; Gunawan, Rudiyanto			Mathematical Modeling of the Role of Mitochondrial Fusion and Fission in Mitochondrial DNA Maintenance	PLOS ONE			English	Article							IN-VIVO; DELETION MUTATIONS; CLONAL EXPANSION; HUMAN-CELLS; TURNOVER; DYNAMICS; MTDNA; COMPLEMENTATION; NUCLEOIDS; MUSCLE	Accumulation of mitochondrial DNA (mtDNA) mutations has been implicated in a wide range of human pathologies, including neurodegenerative diseases, sarcopenia, and the aging process itself. In cells, mtDNA molecules are constantly turned over (i.e. replicated and degraded) and are also exchanged among mitochondria during the fusion and fission of these organelles. While the expansion of a mutant mtDNA population is believed to occur by random segregation of these molecules during turnover, the role of mitochondrial fusion-fission in this context is currently not well understood. In this study, an in silico modeling approach is taken to investigate the effects of mitochondrial fusion and fission dynamics on mutant mtDNA accumulation. Here we report model simulations suggesting that when mitochondrial fusion-fission rate is low, the slow mtDNA mixing can lead to an uneven distribution of mutant mtDNA among mitochondria in between two mitochondrial autophagic events leading to more stochasticity in the outcomes from a single random autophagic event. Consequently, slower mitochondrial fusion-fission results in higher variability in the mtDNA mutation burden among cells in a tissue over time, and mtDNA mutations have a higher propensity to clonally expand due to the increased stochasticity. When these mutations affect cellular energetics, nuclear retrograde signalling can upregulate mtDNA replication, which is expected to slow clonal expansion of these mutant mtDNA. However, our simulations suggest that the protective ability of retrograde signalling depends on the efficiency of fusion-fission process. Our results thus shed light on the interplay between mitochondrial fusion-fission and mtDNA turnover and may explain the mechanism underlying the experimentally observed increase in the accumulation of mtDNA mutations when either mitochondrial fusion or fission is inhibited.	[Tam, Zhi Yang; Gunawan, Rudiyanto] ETH, Inst Chem & Bioengn, Zurich, Switzerland; [Gruber, Jan; Halliwell, Barry] Natl Univ Singapore, Dept Biochem, Ctr Life Sci, Singapore 117548, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; National University of Singapore	Gunawan, R (corresponding author), ETH, Inst Chem & Bioengn, Zurich, Switzerland.	rudi.gunawan@chem.ethz.ch	Halliwell, Barry/C-8318-2009; Gunawan, Rudiyanto/D-4650-2009	Gunawan, Rudiyanto/0000-0002-6480-7976; Halliwell, Barry/0000-0002-3560-7123	ETH Zurich; National University of Singapore (FRC) [R-279-000-299-112]; Ministry of Education Singapore [MOE2010-T2-2-048]	ETH Zurich(ETH Zurich); National University of Singapore (FRC)(National University of Singapore); Ministry of Education Singapore(Ministry of Education, Singapore)	This study was supported by funding from ETH Zurich, the National University of Singapore (FRC Grant R-279-000-299-112) and the Ministry of Education Singapore (MOE2010-T2-2-048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; Arimura S, 2004, P NATL ACAD SCI USA, V101, P7805, DOI 10.1073/pnas.0401077101; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480; Busch KB, 2006, MOL MEMBR BIOL, V23, P509, DOI 10.1080/09687860600877292; Capaldi RA, 2002, BBA-BIOENERGETICS, V1555, P192, DOI 10.1016/S0005-2728(02)00277-3; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chinnery PF, 1999, AM J HUM GENET, V64, P1158, DOI 10.1086/302311; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; Collins ML, 2003, J APPL PHYSIOL, V94, P2203, DOI 10.1152/japplphysiol.00691.2002; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Durham SE, 2007, AM J HUM GENET, V81, P189, DOI 10.1086/518901; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Greaves LC, 2009, BBA-GEN SUBJECTS, V1790, P1015, DOI 10.1016/j.bbagen.2009.04.018; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Hori A, 2011, GENES CELLS, V16, P527, DOI 10.1111/j.1365-2443.2011.01504.x; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; HUEMER RP, 1971, EXP GERONTOL, V6, P259, DOI 10.1016/0531-5565(71)90038-6; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4; JOHNSTON W, 1995, ANN NEUROL, V37, P16, DOI 10.1002/ana.410370106; Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012; Kraytsberg Y, 2003, MECH AGEING DEV, V124, P49, DOI 10.1016/S0047-6374(02)00169-0; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Malena A, 2009, HUM MOL GENET, V18, P3407, DOI 10.1093/hmg/ddp281; Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Miwa S, 2008, AGING CELL, V7, P920, DOI 10.1111/j.1474-9726.2008.00426.x; Mouli PK, 2009, BIOPHYS J, V96, P3509, DOI 10.1016/j.bpj.2008.12.3959; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Poovathingal SK, 2012, BIOGERONTOLOGY, V13, P557, DOI 10.1007/s10522-012-9390-7; Poovathingal SK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000572; Reeve AK, 2009, AGING CELL, V8, P496, DOI 10.1111/j.1474-9726.2009.00492.x; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Saunter CD, 2009, FEBS LETT, V583, P1267, DOI 10.1016/j.febslet.2009.02.041; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com	50	27	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76230	10.1371/journal.pone.0076230	http://dx.doi.org/10.1371/journal.pone.0076230			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146842	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400049
J	Matsuda, H; Parsons, MJ; Leach, SD				Matsuda, Hiroki; Parsons, Michael J.; Leach, Steven D.			Aldh1-Expressing Endocrine Progenitor Cells Regulate Secondary Islet Formation in Larval Zebrafish Pancreas	PLOS ONE			English	Article							HORMONE-EXPRESSING CELLS; EXOCRINE PANCREAS; CONSERVED ROLE; STEM-CELLS; BETA-CELLS; DIFFERENTIATION; SYSTEM; MOUSE; PTF1A; PDX1	Aldh1 expression is known to mark candidate progenitor populations in adult and embryonic mouse pancreas, and Aldh1 enzymatic activity has been identified as a potent regulator of pancreatic endocrine differentiation in zebrafish. However, the location and identity of Aldh1-expressing cells in zebrafish pancreas remain unknown. In this study we demonstrate that Aldh1-expressing cells are located immediately adjacent to 2F11-positive pancreatic ductal epithelial cells, and that their abundance dramatically increases during zebrafish secondary islet formation. These cells also express neurod, a marker of endocrine progenitor cells, but do not express markers of more mature endocrine cells such as pax6b or insulin. Using formal cre/lox-based lineage tracing, we further show that Aldh1-expressing pancreatic epithelial cells are the direct progeny of pancreatic notch-responsive progenitor cells, identifying them as a critical intermediate between multi-lineage progenitors and mature endocrine cells. Pharmacologic manipulation of Aldh1 enzymatic activity accelerates cell entry into the Aldh1-expressing endocrine progenitor pool, and also leads to the premature maturation of these cells, as evidenced by accelerated pax6b expression. Together, these findings suggest that Aldh1-expressing cells act as both participants and regulators of endocrine differentiation during zebrafish secondary islet formation.	[Leach, Steven D.] Johns Hopkins Univ, Dept Surg, Baltimore, MD 21218 USA; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Leach, SD (corresponding author), Johns Hopkins Univ, Dept Surg, Baltimore, MD 21218 USA.	stleach@jhmi.edu	Matsuda, Hiroki/K-5055-2019		NIH [DK56211, RR027443, HD058530, DK080730, DK090816]; JDRF [17-2012-408]; Paul K. Neumann Professorship at Johns Hopkins University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058530] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080730, R01DK056211, P30DK079637, RC4DK090816] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); Paul K. Neumann Professorship at Johns Hopkins University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK56211 and RR027443 (to SDL), NIH HD058530 (to SDL and MJP), NIH grants DK080730 and DK090816 (to MJP), and JDRF 17-2012-408 (to MJP). SDL is also supported by the Paul K. Neumann Professorship at Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3; Arkhipova V, 2012, DEV BIOL, V365, P290, DOI 10.1016/j.ydbio.2012.03.001; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Cross LM, 2003, ARTERIOSCL THROM VAS, V23, P911, DOI 10.1161/01.ATV.0000068685.72914.7E; Dalgin G, 2011, DEVELOPMENT, V138, P4597, DOI 10.1242/dev.067736; Delous M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002754; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Dong PDS, 2008, GENE DEV, V22, P1445, DOI 10.1101/gad.1663208; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Esni F, 2004, DEVELOPMENT, V131, P4213, DOI 10.1242/dev.01280; Field HA, 2003, DEV BIOL, V261, P197, DOI 10.1016/S0012-1606(03)00308-7; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Ioannou M, 2013, DEV BIOL, V374, P153, DOI 10.1016/j.ydbio.2012.10.030; Kimmel RA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-75; Lin JW, 2004, DEV BIOL, V270, P474, DOI 10.1016/j.ydbio.2004.02.023; Manfroid I, 2012, DEV BIOL, V366, P268, DOI 10.1016/j.ydbio.2012.04.002; Mastracci TL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003278; Milewski WM, 1998, ENDOCRINOLOGY, V139, P1440, DOI 10.1210/en.139.3.1440; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107; Rieck S, 2012, SEMIN CELL DEV BIOL, V23, P673, DOI 10.1016/j.semcdb.2012.06.005; Rovira M, 2011, P NATL ACAD SCI USA, V108, P19264, DOI 10.1073/pnas.1113081108; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Seymour PA, 2011, DIABETES, V60, P364, DOI 10.2337/db10-1068; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Wang A, 2012, J MOL MED, V90, P763, DOI 10.1007/s00109-012-0923-y; Wang YY, 2011, DEVELOPMENT, V138, P609, DOI 10.1242/dev.059097; Wendik B, 2004, DEV BIOL, V268, P372, DOI 10.1016/j.ydbio.2003.12.026; Yee NS, 2001, GENESIS, V30, P137, DOI 10.1002/gene.1049; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2013	8	9							e74350	10.1371/journal.pone.0074350	http://dx.doi.org/10.1371/journal.pone.0074350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219YJ	24147152	Green Published, gold, Green Submitted			2022-12-27	WOS:000324547300035
J	Hedman, E; Andersson, E; Andersson, G; Lindefors, N; Lekander, M; Ruck, C; Ljotsson, B				Hedman, Erik; Andersson, Erik; Andersson, Gerhard; Lindefors, Nils; Lekander, Mats; Ruck, Christian; Ljotsson, Brjann			Mediators in Internet-Based Cognitive Behavior Therapy for Severe Health Anxiety	PLOS ONE			English	Article							HYPOCHONDRIASIS; INTOLERANCE; UNCERTAINTY; DISORDERS; SYMPTOMS	According to the cognitive behavioral model of severe health anxiety (hypochondriasis) four central maintaining mechanisms are how the individual perceives the risk of disease and how negative its consequences would be, attention to bodily sensations, and intolerance of uncertainty. The aim of the present study was to investigate the mediating role of these putative mechanisms in Internet-delivered CBT for severe health anxiety. We analyzed data from an RCT where participants were randomized to Internet-delivered CBT (n=40) or to a control condition (n=41). Mediators and outcome, i.e. health anxiety, were assessed weekly throughout the treatment, enabling fulfillment of the criterion of temporal precedence of changes occurring in the mediator in relation to the outcome to be met. The results showed that reduced perceived risk of disease, less attention to bodily symptoms, and reduced intolerance of uncertainty significantly mediated improvement in health anxiety. The study supports the validity of the cognitive behavioral model of health anxiety. The findings have theoretical and clinical implications as they indicate processes that may be causally related to the improvements observed after CBT for health anxiety.	[Hedman, Erik; Andersson, Erik; Andersson, Gerhard; Lindefors, Nils; Ruck, Christian; Ljotsson, Brjann] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden; [Hedman, Erik; Lekander, Mats] Karolinska Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Hedman, Erik; Ljotsson, Brjann] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Gerhard] Linkoping Univ, Swedish Inst Disabil Res, Dept Behav Sci & Learning, Linkoping, Sweden; [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Linkoping University; Stockholm University	Hedman, E (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden.	kire.hedman@ki.se	Andersson, Gerhard/J-8529-2012; Rück, Christian/J-4396-2012	Andersson, Gerhard/0000-0003-4753-6745; Rück, Christian/0000-0002-8742-0168; Andersson, Erik/0000-0003-0088-8719; Ljotsson, Brjann/0000-0001-8086-1668; Hedman-Lagerlof, Erik/0000-0002-7939-9848	Karolinska Institutet; Stockholm County Council	Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	This study was funded by Karolinska Institutet and by research grants from Stockholm County Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz JS, 2007, BEHAV THER, V38, P86, DOI 10.1016/j.beth.2006.05.001; Alberts NM, 2013, J ANXIETY DISORD, V27, P68, DOI 10.1016/j.janxdis.2012.10.009; American Psychiatric Association American Psychiatric Association Task Force on DSM-IV, 2000, DIAGN STAT MAN MENT; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Baer RA, 2003, CLIN PSYCHOL-SCI PR, V10, P125, DOI 10.1093/clipsy/bpg015; Barlow D. H., 2002, ANXIETY ITS DISORDER, Vxvi, P704; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BARSKY AJ, 1990, SOC PSYCH PSYCH EPID, V25, P89; Barsky AJ, 1998, ARCH GEN PSYCHIAT, V55, P737, DOI 10.1001/archpsyc.55.8.737; Beck AT, 1985, ANXIETY DISORDERS PH; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Clark DM, 1998, BRIT J PSYCHIAT, V173, P218, DOI 10.1192/bjp.173.3.218; Dugas MJ, 2000, BEHAV MODIF, V24, P635, DOI 10.1177/0145445500245002; Faravelli C, 1997, SOC PSYCH PSYCH EPID, V32, P24, DOI 10.1007/BF00800664; FURER P, 2007, TREATING HLTH ANXIET, V15; Gerolimatos LA, 2012, INT PSYCHOGERIATR, V24, P1998, DOI 10.1017/S1041610212001329; Greeven A, 2007, AM J PSYCHIAT, V164, P91, DOI 10.1176/appi.ajp.164.1.91; Hedman E., 2012, PSYCHOL MED, V21, P1; HEDMAN E, 2013, ACTA PSYCHIAT SCAND, P6572; Hedman E, 2011, BRIT J PSYCHIAT, V198, P230, DOI 10.1192/bjp.bp.110.086843; Hedman Erik, 2010, Cognitive Behaviour Therapy, V39, P239, DOI 10.1080/16506073.2010.496460; Hofmann SG, 2004, J CONSULT CLIN PSYCH, V72, P392, DOI 10.1037/0022-006X.72.3.392; Hofmann SG, 2000, CLIN PSYCHOL-SCI PR, V7, P3, DOI 10.1093/clipsy/7.1.3; Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Ladouceur R, 2000, BEHAV RES THER, V38, P933, DOI 10.1016/S0005-7967(99)00133-3; LITTLE RJA, 1987, STAT ANAL MISSING DA, V14; Lovas DA, 2010, J ANXIETY DISORD, V24, P931, DOI 10.1016/j.janxdis.2010.06.019; LUCOCK MP, 1988, BEHAV RES THER, V26, P297, DOI 10.1016/0005-7967(88)90081-2; McCracken LM, 1997, BEHAV THER, V28, P271, DOI 10.1016/S0005-7894(97)80047-0; McManus F, 2012, J CONSULT CLIN PSYCH; Mehling WE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005614; NOYES R, 1994, GEN HOSP PSYCHIAT, V16, P78, DOI 10.1016/0163-8343(94)90049-3; PILOWSKY I, 1967, BRIT J PSYCHIAT, V113, P89, DOI 10.1192/bjp.113.494.89; Salkovskis P. M., 2003, BRIEF TREATMENT CRIS, V3, P353, DOI [DOI 10.1093/BRIEF-TREATMENT/MHG026, 10.1093/brief-treatment/mhg026]; Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822; Seivewright H, 2008, BRIT J PSYCHIAT, V193, P332, DOI 10.1192/bjp.bp.108.052936; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, pS22; Smits JAJ, 2012, J CONSULT CLIN PSYCH, V80, P624, DOI 10.1037/a0028957; SPECKENS AEM, 1995, BRIT MED J, V311, P1328, DOI 10.1136/bmj.311.7016.1328; TAYLOR S, 2004, TREATING HLTH ANXIET, V15; Warwick HMC, 1996, BRIT J PSYCHIAT, V169, P189, DOI 10.1192/bjp.169.2.189; Weck F, 2012, PSYCHOSOMATICS, V53, P148, DOI 10.1016/j.psym.2011.11.007; White KS, 2010, BEHAV RES THER, V48, P394, DOI 10.1016/j.brat.2010.01.001	44	23	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77752	10.1371/journal.pone.0077752	http://dx.doi.org/10.1371/journal.pone.0077752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239KL	24147073	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200072
J	Liao, YJ; Lin, MW; Yen, CH; Lin, YT; Wang, CK; Huang, SF; Chen, KH; Yang, CP; Chen, TL; Hou, MF; Chen, YMA				Liao, Yi-Jen; Lin, Meng-Wei; Yen, Chia-Hung; Lin, Yu-Ting; Wang, Chung-Kwe; Huang, Shiu-Feng; Chen, Kuan-Hsuan; Yang, Ching-Ping; Chen, Tzu-Lang; Hou, Ming-Feng; Chen, Yi-Ming Arthur			Characterization of Niemann-Pick Type C2 Protein Expression in Multiple Cancers Using a Novel NPC2 Monoclonal Antibody	PLOS ONE			English	Article							GLYCINE N-METHYLTRANSFERASE; CHOLESTEROL TRAFFICKING; BREAST-CANCER; DISEASE; LUNG; IDENTIFICATION; HOMEOSTASIS; CARCINOMA; PLASMA; LIVER	Niemann-Pick Type C2 (NPC2) plays an important role in the regulation of intracellular cholesterol homeostasis via direct binding with free cholesterol. However, little is known about the significance of NPC2 in cancer. In this study, we have pinpointed the impact of various different cancers on NPC2 expression. A series of anti-NPC2 monoclonal antibodies (mAbs) with the IgG2a isotype were generated and peptide screening demonstrated that the reactive epitope were amino acid residues 31-40 of the human NPC2 protein. The specificity of these mAbs was confirmed by Western blotting using shRNA mediated knock-down of NPC2 in human SK-Hep1 cells. By immunohistochemical staining, NPC2 is expressed in normal kidney, liver, breast, colon, lung, esophageal, uterine cervical, pancreatic and stomach tissue. Strong expression of NPC2 was found in the distal and proximal convoluted tubule of kidney and the hepatocytes of liver. Normal esophageal, uterine cervical, pancreatic, stomach, breast, colon and lung tissue stained moderately to weakly. When compared to their normal tissue equivalents, NPC2 overexpression was observed in cancers of the breast, colon and lung. Regarding to breast cancer, NPC2 up-regulation is associated with estrogen receptor (-), progesterone receptor (-) and human epidermal growth factor receptor (+). On the other hand, NPC2 was found to be down-regulated in renal cell carcinoma, liver cirrhosis and hepatoma tissues. By antigen-capture enzyme immunoassay ELISA, the serum NPC2 is increased in patients with cirrhosis and liver cancer. According to western blot data, the change of glycosylated pattern of NPC2 in serum is associated with cirrhosis and liver cancer. To the best of our knowledge, this is the first comprehensive immunohistochemical and serological study investigating the expression of NPC2 in a variety of different human cancers. These novel monoclonal antibodies should help with elucidating the roles of NPC2 in tumor development, especially in liver and breast cancers.	[Liao, Yi-Jen] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Lin, Meng-Wei] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yen, Chia-Hung] Kaohsiung Med Univ, Coll Pharm, Grad Inst Natl Prod, Kaohsiung, Taiwan; [Lin, Yu-Ting; Chen, Kuan-Hsuan; Yang, Ching-Ping; Chen, Tzu-Lang; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Coll Med, Dept Microbiol, Kaohsiung, Taiwan; [Wang, Chung-Kwe] Taipei City Hosp, Ranai Branch, Dept Int Med, Taipei, Taiwan; [Huang, Shiu-Feng] Natl Hlth Res Inst, Div Mol & Genom Med, Miaoli, Taiwan; [Hou, Ming-Feng] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan	Taipei Medical University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University; Taipei City Hospital; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Chen, YMA (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Microbiol, Kaohsiung, Taiwan.	arthur@kmu.edu.tw	Huang, Shiu-Feng Kathy/E-3977-2010	Yen, Chia-Hung/0000-0002-6939-5528; Hou, Ming-Feng/0000-0001-6030-9702	National Science Council of the Republic of China [NSC100-2325-B-010-008, NSC102-2320-B-038-003]; Taipei Medical University [TMU101-AE1-B29]; National Science Council [NSC 100-2325-B-182-006]; National Health Research Institutes, Taiwan	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Taipei Medical University; National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by a grant from the National Science Council of the Republic of China (grant NSC100-2325-B-010-008 and NSC102-2320-B-038-003) and Taipei Medical University (grant TMU101-AE1-B29). TLCN has been supported by grants from the National Science Council since 2005 (NSC 100-2325-B-182-006) and the National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Araki N, 2009, BIOCHEM BIOPH RES CO, V388, P290, DOI 10.1016/j.bbrc.2009.07.158; Asakawa JI, 2002, ENDOCRINOLOGY, V143, P4422, DOI 10.1210/en.2002-220550; Caldarella A, 2011, PATHOL ONCOL RES, V17, P753, DOI 10.1007/s12253-011-9381-z; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chikh K, 2004, MOL GENET METAB, V83, P220, DOI 10.1016/j.ymgme.2004.06.013; CHU TM, 1993, HYBRIDOMA, V12, P417, DOI 10.1089/hyb.1993.12.417; Csepeggi C, 2011, J BIOL CHEM, V286, P2078, DOI 10.1074/jbc.M110.135897; Day CP, 2002, BEST PRACT RES CL GA, V16, P663, DOI 10.1053/bega.2002.0333; Griese M, 2010, CLIN GENET, V77, P119, DOI 10.1111/j.1399-0004.2009.01325.x; Kirchhoff C, 1996, BIOL REPROD, V54, P847, DOI 10.1095/biolreprod54.4.847; Klein A, 2006, HEPATOLOGY, V43, P126, DOI 10.1002/hep.20985; Liao YJ, 2012, MOL MED, V18, P412, DOI 10.2119/molmed.2011.00258; Liu HH, 2003, J BIOMED SCI, V10, P87, DOI 10.1159/000068083; Lowery AJ, 2012, BREAST CANCER RES TR, V133, P831, DOI 10.1007/s10549-011-1891-6; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nielsen GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027287; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Pernemalm M, 2009, PROTEOMICS, V9, P3414, DOI 10.1002/pmic.200800814; Roszell BR, 2012, AM J PHYSIOL-LUNG C, V302, pL919, DOI 10.1152/ajplung.00383.2011; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Storch J, 2009, BBA-MOL CELL BIOL L, V1791, P671, DOI 10.1016/j.bbalip.2009.02.001; Sugawara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015777; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Vanier MT, 2004, BBA-MOL CELL BIOL L, V1685, P14, DOI 10.1016/j.bbalip.2004.08.007	26	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77586	10.1371/journal.pone.0077586	http://dx.doi.org/10.1371/journal.pone.0077586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147030	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200049
J	Maus, B; Jung, C; John, JMM; Hugot, JP; Genin, E; Van Steen, K				Maus, Baerbel; Jung, Camille; John, Jestinah M. Mahachie; Hugot, Jean-Pierre; Genin, Emmanuelle; Van Steen, Kristel			Molecular Reclassification of Crohn's Disease: A Cautionary Note on Population Stratification	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CLASSIFICATION; GENE; DIFFERENTIATION; CARD15; SNP	Complex human diseases commonly differ in their phenotypic characteristics, e. g., Crohn's disease (CD) patients are heterogeneous with regard to disease location and disease extent. The genetic susceptibility to Crohn's disease is widely acknowledged and has been demonstrated by identification of over 100 CD associated genetic loci. However, relating CD subphenotypes to disease susceptible loci has proven to be a difficult task. In this paper we discuss the use of cluster analysis on genetic markers to identify genetic-based subgroups while taking into account possible confounding by population stratification. We show that it is highly relevant to consider the confounding nature of population stratification in order to avoid that detected clusters are strongly related to population groups instead of disease-specific groups. Therefore, we explain the use of principal components to correct for population stratification while clustering affected individuals into genetic-based subgroups. The principal components are obtained using 30 ancestry informative markers (AIM), and the first two PCs are determined to discriminate between continental origins of the affected individuals. Genotypes on 51 CD associated single nucleotide polymorphisms (SNPs) are used to perform latent class analysis, hierarchical and Partitioning Around Medoids (PAM) cluster analysis within a sample of affected individuals with and without the use of principal components to adjust for population stratification. It is seen that without correction for population stratification clusters seem to be influenced by population stratification while with correction clusters are unrelated to continental origin of individuals.	[Maus, Baerbel; Jung, Camille; John, Jestinah M. Mahachie; Hugot, Jean-Pierre; Van Steen, Kristel] INSERM, UMR843, Paris, France; [Maus, Baerbel; John, Jestinah M. Mahachie; Van Steen, Kristel] Univ Liege, GIGA R, Liege, Belgium; [Jung, Camille; Hugot, Jean-Pierre] Hop Robert Debre, APHP, Serv Gastroenterol Pediat, F-75019 Paris, France; [Jung, Camille] CHI Creteil, CRC CRB, Creteil, France; [Hugot, Jean-Pierre] Univ Paris Diderot, Labex Inflamex, Paris, France; [Genin, Emmanuelle] INSERM, Genet Genom Fonct & Biotechnol UMR1078, Brest, France; [Genin, Emmanuelle] Ctr Hosp Reg Univ Brest, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); University of Liege; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest	Maus, B (corresponding author), INSERM, UMR843, Paris, France.	baerbel.maus@outlook.com	Genin, Emmanuelle/C-4974-2013	Genin, Emmanuelle/0000-0003-4117-2813; JUNG, Camille/0000-0001-8486-8939; Van Steen, Kristel/0000-0001-9868-5033; Hugot, Jean-Pierre/0000-0002-8446-6056	Interuniversity Attraction Poles Programme; IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning) [IST-2007-216886]; FNRS PDR Convention [2.4609.11 (1906648)]; European Commission; Walloon Region through the Interreg IV Program.; ANR GENOPATH 2009 - CROHN MODEL; Ministere de la Sante (PHRC)	Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning); FNRS PDR Convention(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); Walloon Region through the Interreg IV Program.; ANR GENOPATH 2009 - CROHN MODEL(French National Research Agency (ANR)); Ministere de la Sante (PHRC)	Barbel Maus, Jestinah M. Mahachie John and Kristel Van Steen acknowledge research opportunities offered by the Belgian Network DYSCO (Dynamical Systems, Control, and Optimization), funded by the Interuniversity Attraction Poles Programme and initiated by the Belgian State, Science Policy Office. Their work was also in part supported by the IST Programme of the European Community, under the PASCAL2 Network of Excellence (Pattern Analysis, Statistical Modelling and Computational Learning), IST-2007-216886, and by the FNRS PDR Convention no 2.4609.11 (1906648). Kristel Van Steen also acknowledges support by Alma in Silico, funded by the European Commission and Walloon Region through the Interreg IV Program. Emmanuelle Genin acknowledges funding by the grant ANR GENOPATH 2009 - CROHN MODEL. This work was financially supported by the Ministere de la Sante (PHRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; [Anonymous], 2012, SNPSTATS SNPMATRIX X; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Cleynen I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012952; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Hennig C, 2013, FPC FLEXIBLE PROCEDU; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Joy GJ, 2009, PRACT GASTROENTEROL, V33, P23; Jung C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052223; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liu Y, 2010, J BIOMED INFORM, V43, P233, DOI 10.1016/j.jbi.2009.11.004; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Marsh S, 2003, GUT, V52, P770, DOI 10.1136/gut.52.5.770; Myles S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-22; Nakamura T, 2005, J HUM GENET, V50, P53, DOI 10.1007/s10038-004-0220-x; Neuman RJ, 2000, GENET EPIDEMIOL, V19, pS57; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Steinley D, 2004, PSYCHOL METHODS, V9, P386, DOI 10.1037/1082-989X.9.3.386; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Thornton-Wells TA, 2004, TRENDS GENET, V20, P640, DOI 10.1016/j.tig.2004.09.007; Thornton-Wells TA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-204; Vermeire S, 2002, AM J HUM GENET, V71, P74, DOI 10.1086/341124; Vermeire S, 2012, DIGEST DIS, V30, P425, DOI 10.1159/000338147; Vermunt J., 2016, TECHNICAL GUIDE LATE; Weersma RK, 2009, AM J GASTROENTEROL, V104, P630, DOI 10.1038/ajg.2008.112; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Zhao Y, 2012, INT J EPIDEMIOL, V41, P1798, DOI 10.1093/ije/dys183	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77720	10.1371/journal.pone.0077720	http://dx.doi.org/10.1371/journal.pone.0077720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147066	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200069
J	Olin, JA; Hussey, NE; Grgicak-Mannion, A; Fritts, MW; Wintner, SP; Fisk, AT				Olin, Jill A.; Hussey, Nigel E.; Grgicak-Mannion, Alice; Fritts, Mark W.; Wintner, Sabine P.; Fisk, Aaron T.			Variable delta N-15 Diet-Tissue Discrimination Factors among Sharks: Implications for Trophic Position, Diet and Food Web Models	PLOS ONE			English	Article							PROTECTIVE GILL NETS; INTERPRETING STABLE-ISOTOPES; SOUTH-AFRICA; CARCHARODON-CARCHARIAS; LABORATORY EXPERIMENTS; MOVEMENT PATTERNS; LIPID EXTRACTION; MARINE PREDATORS; SPHYRNA-TIBURO; AMINO-ACIDS	The application of stable isotopes to characterize the complexities of a species foraging behavior and trophic relationships is dependent on assumptions of delta N-15 diet-tissue discrimination factors (Delta N-15). As Delta N-15 values have been experimentally shown to vary amongst consumers, tissues and diet composition, resolving appropriate speciesspecific Delta N-15 values can be complex. Given the logistical and ethical challenges of controlled feeding experiments for determining Delta N-15 values for large and/or endangered species, our objective was to conduct an assessment of a range of reported Delta N-15 values that can hypothetically serve as surrogates for describing the predator-prey relationships of four shark species that feed on prey from different trophic levels (i.e., different mean delta N-15 dietary values). Overall, the most suitable species-specific Delta N-15 values decreased with increasing dietary-delta N-15 values based on stable isotope Bayesian ellipse overlap estimates of shark and the principal prey functional groups contributing to the diet determined from stomach content analyses. Thus, a single Delta N-15 value was not supported for this speciose group of marine predatory fishes. For example, the Delta N-15 value of 3.7% provided the highest percent overlap between prey and predator isotope ellipses for the bonnethead shark (mean diet delta N-15 = 9%) whereas a Delta N-15 value < 2.3% provided the highest percent overlap between prey and predator isotope ellipses for the white shark (mean diet delta N-15 = 15%). These data corroborate the previously reported inverse Delta N-15-dietary delta N-15 relationship when both isotope ellipses of principal prey functional groups and the broader identified diet of each species were considered supporting the adoption of different Delta N-15 values that reflect the predators' delta N-15-dietary value. These findings are critical for refining the application of stable isotope modeling approaches as inferences regarding a species' ecological role in their community will be influenced with consequences for conservation and management actions.	[Olin, Jill A.; Hussey, Nigel E.; Grgicak-Mannion, Alice; Fisk, Aaron T.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Fritts, Mark W.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Wintner, Sabine P.] KwaZulu Natal Sharks Board, Umhlanga Rocks, South Africa; [Wintner, Sabine P.] Univ KwaZulu Natal, Biomed Resource Unit, Durban, South Africa	University of Windsor; University System of Georgia; University of Georgia; University of Kwazulu Natal	Hussey, NE (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	nehussey@uwindsor.ca	Hussey, Nigel E/F-9699-2015	Fritts, Mark/0000-0003-0438-7671; Olin, Jill/0000-0002-2748-1970	Canada Research Chair funds	Canada Research Chair funds	Funding for this research was provided by Canada Research Chair funds to ATF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2014, FISH FISH, V15, P170, DOI 10.1111/faf.12026; Bethea DM, 2007, MAR BIOL, V152, P1009, DOI 10.1007/s00227-007-0728-7; Blanchet-Aurigny A, 2012, J EXP MAR BIOL ECOL, V426, P68, DOI 10.1016/j.jembe.2012.05.013; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Brunnschweiler JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058522; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Carlson JK, 2008, ESTUAR COAST, V31, P931, DOI 10.1007/s12237-008-9075-2; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; Cliff G, 1996, GREAT WHITE SHARKS, P351, DOI 10.1016/B978-012415031-7/50033-1; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dennis CA, 2010, RAPID COMMUN MASS SP, V24, P3515, DOI 10.1002/rcm.4807; Drymon JM, 2012, ENVIRON BIOL FISH, V95, P21, DOI 10.1007/s10641-011-9922-z; Dudley SFJ, 2005, AFR J MAR SCI, V27, P107, DOI 10.2989/18142320509504072; Estrada JA, 2003, J MAR BIOL ASSOC UK, V83, P1347, DOI 10.1017/S0025315403008798; Fry B., 2006, STABLE ISOTOPE ECOLO; Gannes LZ, 1997, ECOLOGY, V78, P1271, DOI 10.1890/0012-9658(1997)078[1271:SIIAEA]2.0.CO;2; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2013, MAR ECOL PROG SER, V481, P225, DOI 10.3354/meps10235; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Hussey NE, 2012, J EXP MAR BIOL ECOL, V434, P7, DOI 10.1016/j.jembe.2012.07.012; Hussey Nigel E., 2012, P27; Hussey NE, 2011, CAN J FISH AQUAT SCI, V68, P2029, DOI 10.1139/F2011-115; Hussey NE, 2010, HYDROBIOLOGIA, V654, P1, DOI 10.1007/s10750-010-0361-1; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; Kim SL, 2012, J EXP BIOL, V215, P2495, DOI 10.1242/jeb.070656; Kim SL, 2012, ENVIRON BIOL FISH, V95, P37, DOI 10.1007/s10641-011-9919-7; Layman CA, 2012, MAR ECOL PROG SER, V448, P131, DOI 10.3354/meps09511; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Logan JM, 2011, MAR BIOL, V158, P73, DOI 10.1007/s00227-010-1543-0; Logan JM, 2010, HYDROBIOLOGIA, V644, P231, DOI 10.1007/s10750-010-0120-3; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Madigan DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049220; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; McCauley DJ, 2012, ECOL APPL, V22, P1711, DOI 10.1890/11-1653.1; Milakovic B, 2011, J MAMMAL, V92, P295, DOI 10.1644/10-MAMM-A-038.1; Milessi AC, 2010, ECOL MODEL, V221, P2859, DOI 10.1016/j.ecolmodel.2010.08.037; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Olin JA, 2011, RAPID COMMUN MASS SP, V25, P1008, DOI 10.1002/rcm.4946; Overmyer JP, 2008, RAPID COMMUN MASS SP, V22, P694, DOI 10.1002/rcm.3413; Parnell A, 2011, STABLE ISOTOPE ANAL; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Perga ME, 2010, J APPL ECOL, V47, P942, DOI 10.1111/j.1365-2664.2009.01730.x; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Prado P, 2012, MAR ECOL PROG SER, V462, P175, DOI 10.3354/meps09786; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Vaudo JJ, 2011, MAR ECOL PROG SER, V425, P247, DOI 10.3354/meps08988; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	67	35	35	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77567	10.1371/journal.pone.0077567	http://dx.doi.org/10.1371/journal.pone.0077567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147026	Green Published, gold			2022-12-27	WOS:000326022200046
J	Kalev, I; Habeck, M				Kalev, Ivan; Habeck, Michael			Confidence-Guided Local Structure Prediction with HHfrag	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; SECONDARY STRUCTURE PREDICTION; ALGORITHM; LIBRARY	We present a method to assess the reliability of local structure prediction from sequence. We introduce a greedy algorithm for filtering and enrichment of dynamic fragment libraries, compiled with remote-homology detection methods such as HHfrag. After filtering false hits at each target position, we reduce the fragment library to a minimal set of representative fragments, which are guaranteed to have correct local structure in regions of detectable conservation. We demonstrate that the location of conserved motifs in a protein sequence can be predicted by examining the recurrence and structural homogeneity of detected fragments. The resulting confidence score correlates with the local RMSD of the representative fragments and allows us to predict torsion angles from sequence with better accuracy compared to existing machine learning methods.	[Kalev, Ivan] Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany; [Habeck, Michael] Univ Gottingen, Inst Math Stochast, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Kalev, I (corresponding author), Max Planck Inst Dev Biol, Dept Prot Evolut, Tubingen, Germany.	ivan.kalev@tuebingen.mpg.de; mhabeck@gwdg.de		Habeck, Michael/0000-0002-2188-5667	contract research "Methoden in den Lebenswissenschaften" of the Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG) [HA 5918/1-1]; Max Planck Society	contract research "Methoden in den Lebenswissenschaften" of the Baden-Wurttemberg Stiftung; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	This work has been supported by contract research "Methoden in den Lebenswissenschaften" of the Baden-Wurttemberg Stiftung, by Deutsche Forschungsgemeinschaft (DFG) grant HA 5918/1-1, and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2009, PROTEIN SCI, V18, P1961, DOI 10.1002/pro.207; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bystroff C, 1998, J MOL BIOL, V281, P565, DOI 10.1006/jmbi.1998.1943; Bystroff C, 1996, CURR OPIN BIOTECH, V7, P417, DOI 10.1016/S0958-1669(96)80117-0; Bystroff C., 2002, BIOINFORMATICS, V18, pS54; Bystroff C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-429; Fernandez-Fuentes N, 2006, NUCLEIC ACIDS RES, V34, P2085, DOI 10.1093/nar/gkl156; Fernandez-Fuentes N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000750; Griep S, 2010, NUCLEIC ACIDS RES, V38, pD318, DOI 10.1093/nar/gkp786; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalev I, 2012, BIOINFORMATICS, V28, P2996, DOI 10.1093/bioinformatics/bts538; Kalev I, 2011, BIOINFORMATICS, V27, P3110, DOI 10.1093/bioinformatics/btr541; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Moult J, 2011, PROTEINS, V79, P1, DOI 10.1002/prot.23200; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030361; Wu ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003400; Xu D, 2013, PROTEINS, V81, P229, DOI 10.1002/prot.24179	24	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76512	10.1371/journal.pone.0076512	http://dx.doi.org/10.1371/journal.pone.0076512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146881	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400067
J	Engelberth, J; Contreras, CF; Dalvi, C; Li, T; Engelberth, M				Engelberth, Jurgen; Contreras, Claudia Fabiola; Dalvi, Chinmay; Li, Ting; Engelberth, Marie			Early Transcriptome Analyses of Z-3-Hexenol-Treated Zea mays Revealed Distinct Transcriptional Networks and Anti-Herbivore Defense Potential of Green Leaf Volatiles	PLOS ONE			English	Article							FEEDING SPODOPTERA-LITTORALIS; LIMA-BEAN LEAVES; JASMONIC ACID; HYDROPEROXIDE LYASE; PLANT VOLATILES; LIPOXYGENASE PATHWAY; INDUCED RESISTANCE; MAIZE; RESPONSES; EMISSION	Green leaf volatiles (GLV), which are rapidly emitted by plants in response to insect herbivore damage, are now established as volatile defense signals. Receiving plants utilize these molecules to prime their defenses and respond faster and stronger when actually attacked. To further characterize the biological activity of these compounds we performed a microarray analysis of global gene expression. The focus of this project was to identify early transcriptional events elicited by Z-3-hexenol (Z-3-HOL) as our model GLV in maize (Zea mays) seedlings. The microarray results confirmed previous studies on Z-3-HOL -induced gene expression but also provided novel information about the complexity of Z-3-HOL -induced transcriptional networks. Besides identifying a distinct set of genes involved in direct and indirect defenses we also found significant expression of genes involved in transcriptional regulation, Ca2+-and lipid-related signaling, and cell wall reinforcement. By comparing these results with those obtained by treatment of maize seedlings with insect elicitors we found a high degree of correlation between the two expression profiles at this early time point, in particular for those genes related to defense. We further analyzed defense gene expression induced by other volatile defense signals and found Z-3-HOL to be significantly more active than methyl jasmonate, methyl salicylate, and ethylene. The data presented herein provides important information on early genetic networks that are activated by Z-3-HOL and demonstrates the effectiveness of this compound in the regulation of typical plant defenses against insect herbivores in maize.	[Engelberth, Jurgen; Contreras, Claudia Fabiola; Dalvi, Chinmay; Li, Ting; Engelberth, Marie] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Texas System; University of Texas at San Antonio (UTSA)	Engelberth, J (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX USA.	jurgen.engelberth@utsa.edu	Engelberth, Jurgen/D-3131-2011	Engelberth, Jurgen/0000-0002-6853-1954	National Science Foundation [IOS-0925613]; USDA, NIFA [03836]; College of Science at The University of Texas at San Antonio	National Science Foundation(National Science Foundation (NSF)); USDA, NIFA(United States Department of Agriculture (USDA)); College of Science at The University of Texas at San Antonio	This work was supported by National Science Foundation Award IOS-0925613, USDA, NIFA award 03836 to JE. Furthermore, support by the The College of Science at The University of Texas at San Antonio was greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankala A, 2009, MOL PLANT MICROBE IN, V22, P1555, DOI 10.1094/MPMI-22-12-1555; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2010, PHYTOCHEMISTRY, V71, P1642, DOI 10.1016/j.phytochem.2010.06.021; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Bricchi I, 2010, PLANTA, V232, P719, DOI 10.1007/s00425-010-1203-0; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Christensen SA, 2013, PLANT J, V74, P59, DOI 10.1111/tpj.12101; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Curtius T., 1911, CHEM ZBL, V2, P1142; Davoine C, 2006, PLANT PHYSIOL, V140, P1484, DOI 10.1104/pp.105.074690; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Deepak S, 2010, J PHYTOPATHOL, V158, P585, DOI 10.1111/j.1439-0434.2010.01669.x; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; ENGELBERTH J, 2011, BIOCOMMUNICATION PLA, P1465; Engelberth J, 2007, MOL PLANT MICROBE IN, V20, P707, DOI 10.1094/MPMI-20-6-0707; Engelberth J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034855; Engelberth Jurgen, 2011, BMC Res Notes, V4, P377, DOI 10.1186/1756-0500-4-377; Engelberth J, 2011, J CHEM ECOL, V37, P263, DOI 10.1007/s10886-011-9926-3; FRY SC, 1987, J EXP BOT, V38, P853, DOI 10.1093/jxb/38.5.853; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Halitschke R, 2004, PLANT J, V40, P35, DOI 10.1111/j.1365-313X.2004.02185.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Heil M, 2006, ECOL LETT, V9, P813, DOI 10.1111/j.1461-0248.2006.00932.x; Hirao T, 2012, J BIOSCI BIOENG, V114, P540, DOI 10.1016/j.jbiosc.2012.06.010; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Karban R, 2006, ECOLOGY, V87, P922, DOI 10.1890/0012-9658(2006)87[922:DRISVA]2.0.CO;2; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; Kishimoto K, 2006, PLANT SCI, V170, P715, DOI 10.1016/j.plantsci.2005.11.002; Kollner TG, 2010, PLANT PHYSIOL, V153, P1795, DOI 10.1104/pp.110.158360; Maffei M, 2004, PLANT PHYSIOL, V134, P1752, DOI 10.1104/pp.103.034165; Maffei ME, 2006, PLANT PHYSIOL, V140, P1022, DOI 10.1104/pp.105.071993; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Matsui K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036433; Matthes MC, 2010, PLANTA, V232, P1163, DOI 10.1007/s00425-010-1244-4; MCCALL PJ, 1994, J CHEM ECOL, V20, P3039, DOI 10.1007/BF02033709; MCCALL PJ, 1993, J INSECT BEHAV, V6, P625, DOI 10.1007/BF01048128; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; RHOADES DF, 1983, ACS SYM SER, V208, P55; Ruther J, 2005, Z NATURFORSCH C, V60, P743; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Schmelz EA, 2003, PLANTA, V216, P665, DOI 10.1007/s00425-002-0898-y; Schmelz EA, 2003, PHYSIOL PLANTARUM, V117, P403, DOI 10.1034/j.1399-3054.2003.00054.x; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Szczegielniak J, 2005, PLANT PHYSIOL, V139, P1970, DOI 10.1104/pp.105.066472; Szczegielniak J, 2012, PHYSIOL PLANTARUM, V146, P1, DOI 10.1111/j.1399-3054.2012.01587.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Tumlinson James H., 2008, P389, DOI 10.1007/978-1-4020-8182-8_19; TURLINGS TCJ, 1992, P NATL ACAD SCI USA, V89, P8399, DOI 10.1073/pnas.89.17.8399; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; YE ZH, 1991, PLANT J, V1, P175, DOI 10.1111/j.1365-313X.1991.00175.x; Zebelo SA, 2012, PLANT SCI, V196, P93, DOI 10.1016/j.plantsci.2012.08.006	63	54	57	10	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77465	10.1371/journal.pone.0077465	http://dx.doi.org/10.1371/journal.pone.0077465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155960	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300094
J	Rahman, CV; Smith, SJ; Morgan, PS; Langmack, KA; Clarke, PA; Ritchie, AA; Macarthur, DC; Rose, FR; Shakesheff, KM; Grundy, RG; Rahman, R				Rahman, Cheryl V.; Smith, Stuart J.; Morgan, Paul S.; Langmack, Keith A.; Clarke, Phil A.; Ritchie, Alison A.; Macarthur, Donald C.; Rose, Felicity R.; Shakesheff, Kevin M.; Grundy, Richard G.; Rahman, Ruman			Adjuvant Chemotherapy for Brain Tumors Delivered via a Novel Intra-Cavity Moldable Polymer Matrix	PLOS ONE			English	Article							DRUG-DELIVERY; LOCAL-DELIVERY; RADIATION-THERAPY; NANOPARTICLES; BIOCOMPATIBILITY; RELEASE; MICROSPHERES; PACLITAXEL; CANCER; GLIOMA	Introduction: Polymer-based delivery systems offer innovative intra-cavity administration of drugs, with the potential to better target micro-deposits of cancer cells in brain parenchyma beyond the resected cavity. Here we evaluate clinical utility, toxicity and sustained drug release capability of a novel formulation of poly(lactic-co-glycolic acid) (PLGA)/poly(ethylene glycol) (PEG) microparticles. Methods: PLGA/PEG microparticle-based matrices were molded around an ex vivo brain pseudo-resection cavity and analyzed using magnetic resonance imaging and computerized tomography. In vitro toxicity of the polymer was assessed using tumor and endothelial cells and drug release from trichostatin A-, etoposide-and methotrexate-loaded matrices was determined. To verify activity of released agents, tumor cells were seeded onto drug-loaded matrices and viability assessed. Results: PLGA/PEG matrices can be molded around a pseudo-resection cavity wall with no polymer-related artifact on clinical scans. The polymer withstands fractionated radiotherapy, with no disruption of microparticle structure. No toxicity was evident when tumor or endothelial cells were grown on control matrices in vitro. Trichostatin A, etoposide and methotrexate were released from the matrices over a 3-4 week period in vitro and etoposide released over 3 days in vivo, with released agents retaining cytotoxic capabilities. PLGA/PEG microparticle-based matrices molded around a resection cavity wall are distinguishable in clinical scanning modalities. Matrices are non-toxic in vitro suggesting good biocompatibility in vivo. Active trichostatin A, etoposide and methotrexate can be incorporated and released gradually from matrices, with radiotherapy unlikely to interfere with release. Conclusion: The PLGA/PEG delivery system offers an innovative intra-cavity approach to administer chemotherapeutics for improved local control of malignant brain tumors.	[Rahman, Cheryl V.; Rose, Felicity R.; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Div Drug Delivery & Tissue Engn, Nottingham NG7 2RD, England; [Smith, Stuart J.; Grundy, Richard G.; Rahman, Ruman] Univ Nottingham, Childrens Brain Tumor Res Ctr, Sch Clin Sci, Nottingham NG7 2RD, England; [Smith, Stuart J.; Clarke, Phil A.; Ritchie, Alison A.] Univ Nottingham, Div Preclin Oncol, Nottingham NG7 2RD, England; [Morgan, Paul S.; Langmack, Keith A.] Univ Nottingham Hosp, Nottingham NG7 2UH, England; [Macarthur, Donald C.] Univ Nottingham Hosp, Queens Med Ctr, Dept Neurosurg, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Rahman, R (corresponding author), Univ Nottingham, Childrens Brain Tumor Res Ctr, Sch Clin Sci, Nottingham NG7 2RD, England.	ruman.rahman@nottingham.ac.uk	Shakesheff, Kevin/AAR-6603-2021; Rahman, Ruman/FFR-5799-2022; Shakesheff, Kevin/O-6371-2018	Rahman, Ruman/0000-0002-6541-9983; Rose, Felicity/0000-0001-6640-8840; Clarke, Philip/0000-0002-9042-4856; Shakesheff, Kevin/0000-0003-3236-2439; Smith, Stuart/0000-0002-4556-2707; Morgan, Paul/0000-0002-5870-1446	Joseph Foote Foundation; Nottingham Advanced Research Fellowship; Medical Research Council [MC_G0900866] Funding Source: researchfish; MRC [MC_G0900866] Funding Source: UKRI	Joseph Foote Foundation; Nottingham Advanced Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Joseph Foote Foundation and a Nottingham Advanced Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3; Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1; Bagley CA, 2007, J NEUROSURG-SPINE, V7, P194, DOI 10.3171/SPI-07/08/194; Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409; Brem H, 1995, J NEURO-ONCOL, V26, P111, DOI 10.1007/BF01060217; Brem H, 2001, J CONTROL RELEASE, V74, P63, DOI 10.1016/S0168-3659(01)00311-X; Brem S, 2007, CANCER CHEMOTH PHARM, V60, P643, DOI 10.1007/s00280-006-0407-2; Dhillon A, 2011, J MATER SCI-MATER M, V22, P2599, DOI 10.1007/s10856-011-4443-z; DOMB AJ, 1995, BIOMATERIALS, V16, P1069, DOI 10.1016/0142-9612(95)98902-Q; Duffner PK, 2004, NEUROLOGIST, V10, P293, DOI 10.1097/01.nrl.0000144287.35993.96; DuValla GA, 2009, ANTI-CANCER DRUG, V20, P89, DOI 10.1097/CAD.0b013e3283222c12; Elstad NL, 2009, ADV DRUG DELIVER REV, V61, P785, DOI 10.1016/j.addr.2009.04.010; Emerich DF, 1999, CELL TRANSPLANT, V8, P47, DOI 10.1177/096368979900800114; Fleming AB, 2002, CLIN PHARMACOKINET, V41, P403, DOI 10.2165/00003088-200241060-00002; Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049; Gould TW, 2013, LARYNGOSCOPE; Grundy RG, 2007, LANCET ONCOL, V8, P696, DOI 10.1016/S1470-2045(07)70208-5; Hadjipanayis CG, 2010, CANCER RES, V70, P6303, DOI 10.1158/0008-5472.CAN-10-1022; Higaki M, 2005, ANN RHEUM DIS, V64, P1132, DOI 10.1136/ard.2004.030759; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; Kasperczyk J, 2009, INT J PHARMACEUT, V382, P124, DOI 10.1016/j.ijpharm.2009.08.022; Kim S, 2010, BIOMATERIALS, V31, P4157, DOI 10.1016/j.biomaterials.2010.01.139; Langer R, 1998, NATURE, V392, P5; Menei P, 2010, ANN SURG ONCOL, V17, P1740, DOI 10.1245/s10434-010-1081-5; Missirlis D, 2006, EUR J PHARM SCI, V29, P120, DOI 10.1016/j.ejps.2006.06.003; Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9; Ong BYS, 2009, BIOMATERIALS, V30, P3189, DOI 10.1016/j.biomaterials.2009.02.030; Petri B, 2007, J CONTROL RELEASE, V117, P51, DOI 10.1016/j.jconrel.2006.10.015; Price SJ, 2006, AM J NEURORADIOL, V27, P1969; Rahman C.V., 2012, J TISSUE ENG REGEN M; Rahman CV, 2013, J BIOMED MATER RES B, V101B, P648, DOI 10.1002/jbm.b.32867; Rahman R, 2010, MOL CANCER THER, V9, P2568, DOI 10.1158/1535-7163.MCT-10-0272; Ranganath SH, 2010, BIOMATERIALS, V31, P5199, DOI 10.1016/j.biomaterials.2010.03.002; Ranganath SH, 2009, PHARM RES-DORDR, V26, P2101, DOI 10.1007/s11095-009-9922-2; Stummer W, 2008, NEURO-ONCOLOGY, V10, P1092; Tang BC, 2010, BIOMATERIALS, V31, P339, DOI 10.1016/j.biomaterials.2009.09.033; Trapani A, 2011, AAPS PHARMSCITECH, V12, P1302, DOI 10.1208/s12249-011-9695-x; Tyler B, 2010, J NEUROSURG, V113, P210, DOI 10.3171/2009.11.JNS08162; Urbinati G, 2010, INT J PHARMACEUT, V397, P184, DOI 10.1016/j.ijpharm.2010.06.046; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3; Wolff JE, 2010, NEURO-ONCOLOGY, V12, pII89; Wright KD, 2009, CHILD NERV SYST, V25, P1275, DOI 10.1007/s00381-009-0809-7; Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0; Zhang YH, 2011, MED ONCOL, V28, P901, DOI 10.1007/s12032-010-9531-2	45	25	28	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77435	10.1371/journal.pone.0077435	http://dx.doi.org/10.1371/journal.pone.0077435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155955	Green Accepted, Green Published, gold			2022-12-27	WOS:000325887300089
J	Rishi, G; Crampton, EM; Wallace, DF; Subramaniam, VN				Rishi, Gautam; Crampton, Emily M.; Wallace, Daniel F.; Subramaniam, V. Nathan			In Situ Proximity Ligation Assays Indicate That Hemochromatosis Proteins Hfe and Transferrin Receptor 2 (Tfr2) Do Not Interact	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS; HEPCIDIN; GENE; CELLS; LOCALIZATION; COMPLEXES; MICE	The hemochromatosis associated proteins HFE and Transferrin Receptor 2 (TFR2) have been shown to be important for the proper regulation of hepcidin. A number of in vitro studies using transient overexpression systems have suggested that an interaction between HFE and TFR2 is required for the regulation of hepcidin. This model of iron sensing which centers upon the requirement for an interaction between HFE and TFR2 has recently been questioned with in vivo studies in mice from our laboratory and others which suggest that Hfe and Tfr2 can regulate hepcidin independently of each other. To re-examine the postulated interaction between Hfe and Tfr2 we developed a novel expression system in which both proteins are stably co-expressed and used the proximity ligation assay to examine the interactions between Hfe, Tfr1 and Tfr2 at a cellular level. We were able to detect the previously described interaction between Hfe and Tfr1, and heterodimers between Tfr1 and Tfr2; however no interaction between Hfe and Tfr2 was observed in our system. The results from this study indicate that Hfe and Tfr2 do not interact with each other when they are stably expressed at similar levels. Furthermore, these results support in vivo studies which suggest that Hfe and Tfr2 can independently regulate hepcidin.	[Rishi, Gautam; Crampton, Emily M.; Wallace, Daniel F.; Subramaniam, V. Nathan] Queensland Inst Med Res, Membrane Transport Lab, Brisbane, Qld 4006, Australia; [Rishi, Gautam; Subramaniam, V. Nathan] Univ Queensland, Sch Med, Liver Res Ctr, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland	Subramaniam, VN (corresponding author), Queensland Inst Med Res, Membrane Transport Lab, Brisbane, Qld 4006, Australia.	Nathan.Subramaniam@qimr.edu.au	Wallace, Daniel F/D-2638-2009; Rishi, Gautam/M-5443-2014; Subramaniam, V. Nathan/A-1901-2010	Wallace, Daniel F/0000-0002-6019-9424; Rishi, Gautam/0000-0003-1022-2347; Subramaniam, V. Nathan/0000-0002-4583-7790	National Health and Medical Research Council (NHMRC) of Australia [APP1031325]; Gastroenterological Society of Australia Senior Research Fellowship; NHMRC Senior Research Fellowship [1024672]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Gastroenterological Society of Australia Senior Research Fellowship; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was Supported in part by a Project Grant (APP1031325) from the National Health and Medical Research Council (NHMRC) of Australia to VNS. DFW is the recipient of the Gastroenterological Society of Australia Senior Research Fellowship. VNS is the recipient of an NHMRC Senior Research Fellowship (1024672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Camaschella C, 2000, NAT GENET, V25, P14, DOI 10.1038/75534; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fleming RE, 2002, P NATL ACAD SCI USA, V99, P10653, DOI 10.1073/pnas.162360699; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Girelli D, 2011, HAEMATOL-HEMATOL J, V96, P500, DOI 10.3324/haematol.2010.033449; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Griffiths WJH, 2003, J HISTOCHEM CYTOCHEM, V51, P613, DOI 10.1177/002215540305100507; Hu Y, 2002, J CELL SCI, V115, P4755, DOI 10.1242/jcs.00177; Kawabata H, 2000, J BIOL CHEM, V275, P16618, DOI 10.1074/jbc.M908846199; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lisenbee CS, 2003, TRAFFIC, V4, P491, DOI 10.1034/j.1600-0854.2003.00107.x; Nantel A, 1999, J BIOL CHEM, V274, P35719, DOI 10.1074/jbc.274.50.35719; Nemeth E, 2005, BLOOD, V105, P1803, DOI 10.1182/blood-2004-08-3042; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P13198, DOI 10.1073/pnas.94.24.13198; Pietrangelo A, 2005, GASTROENTEROLOGY, V128, P470, DOI 10.1053/j.gastro.2004.11.057; Schmidt PJ, 2012, AM J HEMATOL, V87, P588, DOI 10.1002/ajh.23173; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Vogt TM, 2003, BLOOD, V101, P2008, DOI 10.1182/blood-2002-09-2742; Wallace DF, 2008, AM J PHYSIOL-CELL PH, V294, pC383, DOI 10.1152/ajpcell.00492.2007; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018; West AP, 2000, J BIOL CHEM, V275, P38135, DOI 10.1074/jbc.C000664200	26	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77267	10.1371/journal.pone.0077267	http://dx.doi.org/10.1371/journal.pone.0077267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155934	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300068
J	Smith, LD; Lucas, CM; Eperon, IC				Smith, Lindsay D.; Lucas, Christian M.; Eperon, Ian C.			Intron Retention in the Alternatively Spliced Region of RON Results from Weak 3 ' Splice Site Recognition	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PRE-MESSENGER-RNA; COMPLEX E; SCATTER-FACTOR; PROTEIN; EXPRESSION; BINDING; CARCINOMA; SF2/ASF; MET	The RON gene encodes a tyrosine kinase receptor for macrophage-stimulating protein. A constitutively active isoform that arises by skipping of exon 11 is expressed in carcinomas and contributes to an invasive phenotype. However, a high proportion of the mRNA expressed from the endogenous gene, or from transfected minigenes, appears to retain introns 10 and 11. It is not known whether this represents specific repression or the presence of weak splicing signals. We have used chimeric pre-mRNAs spliced in vitro to investigate the reason for intron retention. A systematic test showed that, surprisingly, the exon sequences known to modulate exon 11 skipping were not limiting, but the 3' splice site regions adjacent to exons 11 and 12 were too weak to support splicing when inserted into a globin intron. UV-crosslinking experiments showed binding of hnRNP F/H just 5' of these regions, but the hnRNP F/H target sequences did not mediate inhibition. Instead, the failure of splicing is linked to weak binding of U2AF65, and spliceosome assembly stalls prior to formation of any of the ATP-dependent complexes. We discuss mechanisms by which U2AF65 binding is facilitated in vivo.	[Smith, Lindsay D.; Lucas, Christian M.; Eperon, Ian C.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England	University of Leicester	Eperon, IC (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.	eci@leicester.ac.uk	Eperon, Ian C./E-8799-2011	Eperon, Ian C./0000-0002-4903-1911	Medical Research Council	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council postgraduate studentship to L. D. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2012, CELL REP, V1, P543, DOI 10.1016/j.celrep.2012.03.013; Berglund JA, 1998, GENE DEV, V12, P858, DOI 10.1101/gad.12.6.858; BEZERRA JA, 1994, BIOCHEM BIOPH RES CO, V203, P666, DOI 10.1006/bbrc.1994.2234; Camp ER, 2005, ANN SURG ONCOL, V12, P273, DOI 10.1245/ASO.2005.08.013; Caputi M, 2001, J BIOL CHEM, V276, P43850, DOI 10.1074/jbc.M102861200; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; Chen QY, 1997, HEPATOLOGY, V26, P59; Cheng HL, 2005, BRIT J CANCER, V92, P1906, DOI 10.1038/sj.bjc.6602593; Cherny D, 2010, EMBO J, V29, P2161, DOI 10.1038/emboj.2010.103; Collesi C, 1996, MOL CELL BIOL, V16, P5518; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Corrionero A, 2011, RNA, V17, P401, DOI 10.1261/rna.2444811; CUNNINGHAM SA, 1991, J MOL BIOL, V217, P265, DOI 10.1016/0022-2836(91)90541-D; Das R, 2006, GENE DEV, V20, P1100, DOI 10.1101/gad.1397406; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; de Araujo MM, 2009, RNA, V15, P515, DOI 10.1261/rna.1273209; Dominguez C, 2010, NAT STRUCT MOL BIOL, V17, P853, DOI 10.1038/nsmb.1814; Eckerich C, 2009, J NEUROCHEM, V109, P969, DOI 10.1111/j.1471-4159.2009.06027.x; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Ghigna C, 2010, RNA BIOL, V7, P495, DOI 10.4161/rna.7.4.12744; Ghigna C, 2008, CURR GENOMICS, V9, P556, DOI 10.2174/138920208786847971; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hodson MJ, 2012, NUCLEIC ACIDS RES, V40, P6850, DOI 10.1093/nar/gks322; Huang T, 2002, EMBO J, V21, P5516, DOI 10.1093/emboj/cdf555; JAMISON SF, 1992, P NATL ACAD SCI USA, V89, P5482, DOI 10.1073/pnas.89.12.5482; Kafasla P, 2012, BIOCHEM SOC T, V40, P815, DOI 10.1042/BST20120044; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kent OA, 2005, MOL CELL BIOL, V25, P233, DOI 10.1128/MCB.25.1.233-240.2005; Kurihara N, 1996, BLOOD, V87, P3704, DOI 10.1182/blood.V87.9.3704.bloodjournal8793704; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; LeFave CV, 2011, EMBO J, V30, P4084, DOI 10.1038/emboj.2011.259; Lefevre S H, 2002, J Med Genet, V39, pE21, DOI 10.1136/jmg.39.5.e21; Leonis NA, 2002, HEPATOLOGY, V36, P1053, DOI 10.1053/jhep.2002.36822; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Lu Y, 2007, CANCER LETT, V257, P157, DOI 10.1016/j.canlet.2007.08.007; Maggiora P, 2003, EXP CELL RES, V288, P382, DOI 10.1016/S0014-4827(03)00250-7; Makarov EM, 2012, NUCLEIC ACIDS RES, V40, P2639, DOI 10.1093/nar/gkr1056; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P81, DOI 10.1093/nar/gki148; MICHAUD S, 1993, GENE DEV, V7, P1008, DOI 10.1101/gad.7.6.1008; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Ortuno-Pineda C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040315; Pandit S, 2008, CURR OPIN CELL BIOL, V20, P260, DOI 10.1016/j.ceb.2008.03.001; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Peled-Zehavi H, 2001, MOL CELL BIOL, V21, P5232, DOI 10.1128/MCB.21.15.5232-5241.2001; Rampino T, 2003, AM J SURG PATHOL, V27, P779, DOI 10.1097/00000478-200306000-00008; Samatanga B, 2013, NUCLEIC ACIDS RES, V41, P2505, DOI 10.1093/nar/gks1289; Shukla S, 2012, BBA-GENE REGUL MECH, V1819, P673, DOI 10.1016/j.bbagrm.2012.01.014; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thobe MN, 2010, ONCOGENE, V29, P214, DOI 10.1038/onc.2009.331; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; Wagh PK, 2011, ONCOGENE, V30, P3694, DOI 10.1038/onc.2011.86; Waltz SE, 1998, ONCOGENE, V16, P27, DOI 10.1038/sj.onc.1201508; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; Wang DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017945; Wang J, 2010, BIOCHEMISTRY-US, V49, P7972, DOI 10.1021/bi100409w; Wang MH, 2003, CARCINOGENESIS, V24, P1291, DOI 10.1093/carcin/bgg089; Wang MH, 1996, EXP CELL RES, V226, P39, DOI 10.1006/excr.1996.0200; WANG MH, 1994, J BIOL CHEM, V269, P14027; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; Wijnhoven BPL, 2000, BRIT J SURG, V87, P992, DOI 10.1046/j.1365-2168.2000.01513.x; Yue BG, 1999, FEBS LETT, V451, P10, DOI 10.1016/S0014-5793(99)00521-9; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhou DH, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-353	72	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77208	10.1371/journal.pone.0077208	http://dx.doi.org/10.1371/journal.pone.0077208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155930	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000325887300064
J	Egger, J				Egger, Jan			PCG-Cut: Graph Driven Segmentation of the Prostate Central Gland	PLOS ONE			English	Article							IMAGE SEGMENTATION; AUTOMATIC SEGMENTATION; MR-IMAGES; MODELS	Prostate cancer is the most abundant cancer in men, with over 200,000 expected new cases and around 28,000 deaths in 2012 in the US alone. In this study, the segmentation results for the prostate central gland (PCG) in MR scans are presented. The aim of this research study is to apply a graph-based algorithm to automated segmentation (i.e. delineation) of organ limits for the prostate central gland. The ultimate goal is to apply automated segmentation approach to facilitate efficient MR-guided biopsy and radiation treatment planning. The automated segmentation algorithm used is graph-driven based on a spherical template. Therefore, rays are sent through the surface points of a polyhedron to sample the graph's nodes. After graph construction - which only requires the center of the polyhedron defined by the user and located inside the prostate center gland - the minimal cost closed set on the graph is computed via a polynomial time s-t-cut, which results in the segmentation of the prostate center gland's boundaries and volume. The algorithm has been realized as a C++ module within the medical research platform MeVisLab and the ground truth of the central gland boundaries were manually extracted by clinical experts (interventional radiologists) with several years of experience in prostate treatment. For evaluation the automated segmentations of the proposed scheme have been compared with the manual segmentations, yielding an average Dice Similarity Coefficient (DSC) of 78.94 +/- 10.85%.	Univ Hosp Marburg UKGM, Dept Med, Marburg, Hesse, Germany	University Hospital of Giessen & Marburg	Egger, J (corresponding author), Univ Hosp Marburg UKGM, Dept Med, Marburg, Hesse, Germany.	egger@med.uni-marburg.de						Artan Y, 2011, I S BIOMED IMAGING, P1459, DOI 10.1109/ISBI.2011.5872675; Birkbecky N, 2012, REGION SPECIFIC HIER; Bowes M., 2012, FULLY AUTOMATIC SEGM; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Cootes T., 2005, 16 BRIT MACH VIS C, V2, P879; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; Cootes TF, 2001, IEEE T PATTERN ANAL, V23, P681, DOI 10.1109/34.927467; D'Amico AV, 2001, NEW ENGL J MED, V344, P776, DOI 10.1056/NEJM200103083441017; Dowling JA, 2011, LECT NOTES COMPUT SC, V6963, P10, DOI 10.1007/978-3-642-23944-1_2; Egger J, 2010, P INT BIOS PROC C BE, P1; Egger J., 2010, LNCS, V6376, P383; Egger J, 2007, COMP MED SY, P177, DOI 10.1109/CBMS.2007.5; Egger J, 2012, J MED SYST, V36, P2829, DOI 10.1007/s10916-011-9761-7; Egger J, 2012, J MED SYST, V36, P2097, DOI 10.1007/s10916-011-9673-6; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fedorov A, 2012, J MAGN RESON IMAGING, V36, P987, DOI 10.1002/jmri.23688; Gao Q, 2012, MED IMAGE COMPUTING; Geremia E, 2010, LECT NOTES COMPUT SC, V6361, P111; Ghose S, 2012, INT C PATT REC ICPR, P1; Ghose S, 2012, RANDOM FOREST BASED; Ghose S, 2012, COMPUT METH PROG BIO, V108, P262, DOI 10.1016/j.cmpb.2012.04.006; Kapur T, 2014, COLOR IN PRESS; Kirschner M, 2011, SPIE MED IMAGING IMA, V7962; Kirschner M, 2012, AUTOMATIC PROSTATE S; Klein S, 2008, MED PHYS, V35, P1407, DOI 10.1118/1.2842076; Kroon DJ, 2012, P SPIE MED IMAGING C, V8315; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Li W, 2011, LECT NOTES COMPUT SC, V6893, P570, DOI 10.1007/978-3-642-23626-6_70; Lindeberg T, 1996, PROC CVPR IEEE, P465, DOI 10.1109/CVPR.1996.517113; Litjens G, 2012, MED IMAGE COMPUTING; Maan B, 2012, MED IMAGE COMPUTING; Makni N, 2009, INT J COMPUT ASS RAD, V4, P181, DOI 10.1007/s11548-008-0281-y; Malmberg F, 2012, SMART PAINT NEW INTE; Martin S, 2008, INT J COMPUT ASS RAD, V3, P485, DOI 10.1007/s11548-008-0247-0; Medical Image Computing and Computer Assisted Intervention (MICCAI), 2012, GRAND CHALL PROST MR; Moschidis E, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1727, DOI 10.1109/ISBI.2012.6235913; Ou Y, 2012, MULTIATLAS SEGMENTAI; Samiee M, 2006, 2006 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P203, DOI 10.1109/ISSPIT.2006.270797; Sampa MP, 2006, IEEE IMAGE PROC, P81, DOI 10.1109/ICIP.2006.312367; Strekalovskiy E, 2011, IEEE I CONF COMP VIS, P2619, DOI 10.1109/ICCV.2011.6126551; Toth R, 2012, DEFORMABLE LANDMARK; Veksler O, 2008, LECT NOTES COMPUT SC, V5304, P454, DOI 10.1007/978-3-540-88690-7_34; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Xin L, 2009, IEEE T MED IMAGING, V28, P906, DOI 10.1109/TMI.2009.2012888; Yin Y, 2012, SPIE MED IAMGING IMA, V8314; Yuan J., 2012, EFFICIENT CONVEX OPT; Zheng YF, 2008, IEEE T MED IMAGING, V27, P1668, DOI 10.1109/TMI.2008.2004421; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8; Zwiggelaar R, 2003, LECT NOTES COMPUT SC, V2652, P1108	51	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76645	10.1371/journal.pone.0076645	http://dx.doi.org/10.1371/journal.pone.0076645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146901	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400068
J	Singh, NK; Repsilber, D; Liebscher, V; Taher, L; Fuellen, G				Singh, Nitesh Kumar; Repsilber, Dirk; Liebscher, Volkmar; Taher, Leila; Fuellen, Georg			Identifying Genes Relevant to Specific Biological Conditions in Time Course Microarray Experiments	PLOS ONE			English	Article							EXPRESSION; CLASSIFICATION; ASSOCIATIONS; PREDICTION; SELECTION; NETWORKS; PROTEINS; DATABASE; MODEL	Microarrays have been useful in understanding various biological processes by allowing the simultaneous study of the expression of thousands of genes. However, the analysis of microarray data is a challenging task. One of the key problems in microarray analysis is the classification of unknown expression profiles. Specifically, the often large number of non-informative genes on the microarray adversely affects the performance and efficiency of classification algorithms. Furthermore, the skewed ratio of sample to variable poses a risk of overfitting. Thus, in this context, feature selection methods become crucial to select relevant genes and, hence, improve classification accuracy. In this study, we investigated feature selection methods based on gene expression profiles and protein interactions. We found that in our setup, the addition of protein interaction information did not contribute to any significant improvement of the classification results. Furthermore, we developed a novel feature selection method that relies exclusively on observed gene expression changes in microarray experiments, which we call "relative Signal-to-Noise ratio" (rSNR). More precisely, the rSNR ranks genes based on their specificity to an experimental condition, by comparing intrinsic variation, i.e. variation in gene expression within an experimental condition, with extrinsic variation, i.e. variation in gene expression across experimental conditions. Genes with low variation within an experimental condition of interest and high variation across experimental conditions are ranked higher, and help in improving classification accuracy. We compared different feature selection methods on two time-series microarray datasets and one static microarray dataset. We found that the rSNR performed generally better than the other methods.	[Singh, Nitesh Kumar; Taher, Leila; Fuellen, Georg] Univ Rostock, Dept Med, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany; [Repsilber, Dirk] Leibniz Inst Farm Anim Biol, Inst Genet & Biometry, Dummerstorf, Germany; [Liebscher, Volkmar] Ernst Moritz Arndt Univ Greifswald, Inst Math & Informat, Greifswald, Germany	University of Rostock; Forschungsinstitut fur Nutztierbiologie (FBN); Ernst Moritz Arndt Universitat Greifswald	Taher, L (corresponding author), Univ Rostock, Dept Med, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany.	leila.taher@uni-rostock.de; fuellen@uni-rostock.de	Liebscher, Volkmar/R-6865-2019; Liebscher, Volkmar/P-3543-2018	Liebscher, Volkmar/0000-0003-1446-4423; Liebscher, Volkmar/0000-0003-1446-4423; Singh, Nitesh/0000-0002-4536-2318; Taher, Leila/0000-0002-2013-5426	German Research Foundation (DFG) [FUE 583/2-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	LT and GF are funded by the German Research Foundation (DFG, FUE 583/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Joseph Z, 2004, BIOINFORMATICS, V20, P2493, DOI 10.1093/bioinformatics/bth283; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Constantinides CD, 2005, MAGNETIC RESONANCE M, V38, P852, DOI DOI 10.1002/MRM.1910380524/ABSTRACT; Daly TM, 2005, J MOL DIAGN, V7, P404, DOI 10.1016/S1525-1578(10)60570-3; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Duval B, 2010, BRIEF BIOINFORM, V11, P127, DOI 10.1093/bib/bbp035; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engreitz JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-603; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goh L., 2004, P 2 C AS PAC BIOINF, P161; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hafemeister C, 2011, BIOINFORMATICS, V27, P946, DOI 10.1093/bioinformatics/btr037; Hayes KR, 2005, MOL PHARMACOL, V67, P1360, DOI 10.1124/mol.104.009175; Hengpraprohm S, 2009, INT J INNOVATIVE COM, V5; Huang CJ, 2003, PROC INT C TOOLS ART, P451, DOI 10.1109/TAI.2003.1250224; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Lakshmi K, 2006, THIRD INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY: NEW GENERATIONS, PROCEEDINGS, P541, DOI 10.1109/ITNG.2006.30; Ma XT, 2007, BIOINFORMATICS, V23, P215, DOI 10.1093/bioinformatics/btl569; Mishra D., 2011, INT J SCI ENG RES, V2; Mutch DM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-17; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Raman T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-493; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Ryu J, 2002, IEEE IJCNN, P198, DOI 10.1109/IJCNN.2002.1005469; Scheubert L, 2011, DNA RES, V18, P233, DOI 10.1093/dnares/dsr016; Slonim D. K., 2000, RECOMB 2000. Proceedings of the Fourth Annual International Conference on Computational Molecular Biology, P263, DOI 10.1145/332306.332564; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Staiger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034796; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Wu C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-182; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	46	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76561	10.1371/journal.pone.0076561	http://dx.doi.org/10.1371/journal.pone.0076561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146889	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400064
J	Curtis, KA; Longosz, AF; Kennedy, MS; Keating, S; Heitman, J; Laeyendecker, O; Owen, SM				Curtis, Kelly A.; Longosz, Andrew F.; Kennedy, M. Susan; Keating, Sheila; Heitman, John; Laeyendecker, Oliver; Owen, S. Michele			Inter-Laboratory Assessment of a Prototype Multiplex Kit for Determination of Recent HIV-1 Infection	PLOS ONE			English	Article							BED-ENZYME-IMMUNOASSAY; PERFORMANCE-CHARACTERISTICS; TYPE-1 SEROCONVERSION; VACCINE PREPAREDNESS; UNITED-STATES; ASSAY; IDENTIFICATION; SEROINCIDENCE; TRIALS	Background: Accurate and reliable laboratory-based assays are needed for estimating HIV-1 incidence from cross-sectional samples. We recently described the development of a customized, HIV-1-specific Bio-Plex assay that allows for the measurement of HIV-specific antibody levels and avidity to multiple analytes for improved HIV-1 incidence estimates. Methods: To assess intra-and inter-laboratory assay performance, prototype multiplex kits were developed and evaluated by three distinct laboratories. Longitudinal seroconversion specimens were tested in parallel by each laboratory and kit performance was compared to that of an in-house assay. Additionally, the ability of the kit to distinguish recent from long-term HIV-1 infection, as compared to the in-house assay, was determined by comparing the reactivity of known recent (infected <6 months) and long-term (infected >12 months) drug naive specimens. Results: Although the range of reactivity for each analyte varied between the prototype kit and in-house assay, a measurable distinction in reactivity between recent and long-term specimens was observed with both assays in all three laboratories. Additionally, kit performance was consistent between all three laboratories. The intra-assay coefficient of variation (CV), between sample replicates for all laboratories, ranged from 0.5% to 6.1%. The inter-laboratory CVs ranged from 8.5% to 21.3% for gp160-avidity index (a) and gp120-normalized mean fluorescent intensity (MFI) value (n), respectively. Conclusion: We demonstrate the feasibility of producing a multiplex kit for measuring HIV antibody levels and avidity, with the potential for improved incidence estimates based on multi-analyte algorithms. The availability of a commercial kit will facilitate the transfer of technology among diverse laboratories for widespread assay use.	[Curtis, Kelly A.; Kennedy, M. Susan; Owen, S. Michele] Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Atlanta, GA 30329 USA; [Longosz, Andrew F.; Laeyendecker, Oliver] NIAID, Immunoregulat Lab, Div Intramural Res, NIH, Baltimore, MD USA; [Keating, Sheila; Heitman, John] Blood Syst Res Inst, San Francisco, CA USA; [Laeyendecker, Oliver] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Vitalant; Vitalant Research Institute; Johns Hopkins University	Curtis, KA (corresponding author), Ctr Dis Control & Prevent, Branch Lab, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Hepatitis STD & TB Prevent, Atlanta, GA 30329 USA.	czv2@cdc.gov		Laeyendecker, Oliver/0000-0002-6429-4760; Keating, Sheila/0000-0002-8324-3694	Centers for Disease Control; Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); HIV Prevention Trials Network; NIAID, National Institutes of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, Department of Health and Human Services (DHHS) [U01-AI46745, U01-AI48054, UM1-AI068613, R01-AI095068]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046745, R01AI095068, U01AI048054, UM1AI068613, ZIAAI000361] Funding Source: NIH RePORTER	Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HIV Prevention Trials Network; NIAID, National Institutes of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, Department of Health and Human Services (DHHS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this research was provided in part through intramural funding from the Centers for Disease Control. Additional funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funders included: The Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); the HIV Prevention Trials Network sponsored by NIAID, National Institutes of Child Health and Human Development, National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, Department of Health and Human Services (DHHS, U01-AI46745, U01-AI48054, and UM1-AI068613), R01-AI095068.	[Anonymous], 2006, WKLY EPIDEMIOL REC, V81, P40; Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018402; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Celum CL, 2001, J INFECT DIS, V183, P23, DOI 10.1086/317658; Curtis KA, 2012, AIDS RES HUM RETROV, V28, P188, DOI [10.1089/aid.2011.0037, 10.1089/AID.2011.0037]; Curtis KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064201; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Dobbs T, 2011, J CLIN MICROBIOL, V49, P3470, DOI 10.1128/JCM.01122-11; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Laeyendecker O, 2012, AIDS RES HUM RETROVI; Laeyendecker O, 2012, AIDS RES HUM RETROV, V28, P816, DOI [10.1089/aid.2011.0258, 10.1089/AID.2011.0258]; Laeyendecker O, 2013, J INFECT DIS, V207, P232, DOI 10.1093/infdis/jis659; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Saphonn V, 2005, JAIDS-J ACQ IMM DEF, V39, P587; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Smolen-Dzirba J, 2011, MED SCI MONITOR, V17, pRA124, DOI 10.12659/MSM.881757; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Westreich Daniel, 2007, S Afr Med J, V97, P480	28	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77765	10.1371/journal.pone.0077765	http://dx.doi.org/10.1371/journal.pone.0077765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147075	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200073
J	Guo, XY; Yang, GL; Yuan, J; Ruan, P; Zhang, MX; Chen, XC; Zhou, BP				Guo, Xiaoyan; Yang, Guilin; Yuan, Jin; Ruan, Peng; Zhang, Mingxia; Chen, Xincun; Zhou, Boping			Genetic Variation in Interleukin 28B and Response to Antiviral Therapy in Patients with Dual Chronic Infection with Hepatitis B and C Viruses	PLOS ONE			English	Article							PEGYLATED-INTERFERON-ALPHA; HBEAG-POSITIVE PATIENTS; RIBAVIRIN THERAPY; IFN-LAMBDA; IL28B; PEGINTERFERON; PREVALENCE; CLEARANCE; DIAGNOSIS	Concurrent infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) was not uncommon in China. To date, information on predictors of response to treatment of dually-infected HCV/HBV is limited. The aim of this study was to evaluated whether determination of the interleukin 28B (IL-28B) polymorphism statuses sufficient to predict treatment response of interferon (IFN)-based therapy in patients chronically infected with both hepatitis B and C viruses. We investigated the role of IL28B variations (rs8099917 and rs12979860) in response to IFN-based treatment and evaluated its association with the risk of the null virological response (NVR) in HCV /HBV dually-infected patients. We found that the overall distributions of the genotypes among the sustained virological response (SVR), NVR groups were significantly different (P<0.001): patients with the rs8099917 TG genotype had an increased risk of NVR (odds ratio [OR] =2.37 95% confidence interval [CI] = 1.16-4.83, P = 0.017), and those with the GG genotype had a further increased risk of NVR (OR=4.23, 95% CI = 1.17-15.3, P=0.027). The rs12979860 allele was also highly associated with treatment failure (CT/TT vs. CC; OR =2.04, 95% CI = 1.05-3.97, P =0.037). Moreover, we found that IL28B rs8099917 G variants (TG+GG) interact with HCV genotype 1(G1) to result in higher risk of NVR (P=0.009), and that they are also associated with HBV DNA reactivation (TG+GG vs. TT, P=0.005). Furthermore, multivariate regression analysis show that the rs8099917 G allele was the most important factor significantly associated with a NVR in HCV G1 patients. This study suggest that IL28B genotyping may be a valid pretreatment predictor of which patients are likely to respond to treatment in this group of difficult-to-treat HCV/HBV dually-infected patients.	[Guo, Xiaoyan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Guilin; Yuan, Jin; Ruan, Peng; Zhang, Mingxia; Chen, Xincun; Zhou, Boping] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Guo, Xiaoyan] Shenzhen Third Peoples Hosp, Inst Hepatol, Shenzhen, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Chen, XC (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China.	chenxinchun@hotmail.com; zhoubp@hotmail.com			Ministry of Education [820003191004]; National Science and Technology Major Project [2012ZX10002004, 2012ZX10002003]; Sun Yat-Sen University Clinical Research 5010 Program [2007029, 2010011]	Ministry of Education; National Science and Technology Major Project; Sun Yat-Sen University Clinical Research 5010 Program	This study was supported by Scholarship Award for Excellent Doctoral Student granted by Ministry of Education (No. 820003191004). National Science and Technology Major Project (2012ZX10002004, 2012ZX10002003), Sun Yat-Sen University Clinical Research 5010 Program (2007029, 2010011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Ank N, 2006, J INTERF CYTOK RES, V26, P373, DOI 10.1089/jir.2006.26.373; Aparicio E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013771; Bini EJ, 2010, HEPATOLOGY, V51, P759, DOI 10.1002/hep.23461; Cacciola I, 1999, NEW ENGL J MED, V341, P22, DOI 10.1056/NEJM199907013410104; Chiaramonte M, 1999, CANCER-AM CANCER SOC, V85, P2132, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.0.CO;2-H; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; CRESPO J, 1994, AM J GASTROENTEROL, V89, P1147; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Georgel P, 2010, TRENDS MOL MED, V16, P277, DOI 10.1016/j.molmed.2010.04.003; Guo XY, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-123; Hung CH, 2005, J GASTROEN HEPATOL, V20, P727, DOI 10.1111/j.1440-1746.2005.03791.x; Hung CH, 2003, J GASTROENTEROL, V38, P153, DOI 10.1007/s005350300025; Hung CH, 2010, HEPATOLOGY, V52, P1521, DOI 10.1002/hep.23740; Jamma Shailaja, 2010, Curr Hepat Rep, V9, P260, DOI 10.1007/s11901-010-0060-4; Lampertico P, 2013, HEPATOLOGY, V57, P890, DOI 10.1002/hep.25749; Li D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054815; Liaw YF, 2004, GASTROENTEROLOGY, V126, P1024, DOI 10.1053/j.gastro.2004.01.011; Liu CJ, 2009, GASTROENTEROLOGY, V136, P496, DOI 10.1053/j.gastro.2008.10.049; Liu CJ, 2003, HEPATOLOGY, V37, P568, DOI 10.1053/jhep.2003.50096; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; PONTISSO P, 1993, GASTROENTEROLOGY, V105, P1529, DOI 10.1016/0016-5085(93)90161-5; Sonneveld MJ, 2012, GASTROENTEROLOGY, V142, P513, DOI 10.1053/j.gastro.2011.11.025; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; ter Borg MJ, 2006, HEPATOLOGY, V44, P721, DOI 10.1002/hep.21302; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; YU ML, 2013, HEPATOLOGY	33	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77911	10.1371/journal.pone.0077911	http://dx.doi.org/10.1371/journal.pone.0077911			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147097	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200086
J	Khanna, V; Jain, M; Singh, V; Kanshana, JS; Prakash, P; Barthwal, MK; Murthy, PSR; Dikshit, M				Khanna, Vivek; Jain, Manish; Singh, Vishal; Kanshana, Jitendra S.; Prakash, Prem; Barthwal, Manoj K.; Murthy, Puvvada S. R.; Dikshit, Madhu			Cholesterol Diet Withdrawal Leads to an Initial Plaque Instability and Subsequent Regression of Accelerated Iliac Artery Atherosclerosis in Rabbits	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BALLOON INJURY; METALLOPROTEINASE ACTIVITY; MATRIX METALLOPROTEINASES; NEOINTIMAL FORMATION; PROGENITOR CELLS; VASCULAR INJURY; MIGRATION; MODELS; AORTA	Effect of long term cholesterol diet withdrawal on accelerated atherosclerosis in iliac artery of New Zealand White (NZW) rabbits has not been explored so far. Atherosclerosis was thus induced in rabbits by a combination of balloon injury and atherogenic diet (AD) (1% cholesterol and 6% peanut oil) feeding for 8 weeks (baseline) followed by chow diet (CD) feeding for 4, 8, 16, 32, 50 and 64 weeks. The plaque characterization was done using histology, real time RT-PCR and vasoreactivity studies. Significant elevation in plasma lipids with AD feeding was normalized following 16 weeks of CD feeding. However, baseline comparison showed advanced plaque features even after 8 weeks of CD period with significant elevation in intima/media thickness ratio and plaque area later showing reduction at 50 and 64 weeks CD periods. Lesion lipid accumulation and CD68 positivity was maintained till 16 weeks of CD feeding which significantly reduced from 32 to 64 weeks CD periods. Baseline comparison showed significant increase in ground substance, MMP-9 and significant decrease in alpha-actin and collagen content at 8 weeks CD period indicating features of unstable plaque. These features regressed up to 64 weeks of CD. Partial restoration of functional vasoconstriction and vasorelaxation was seen after 64 weeks of CD feeding. mRNA expression of MCP-1, VCAM-1, collagen type I and III, MMP-9, TIMP-1, IFN-gamma, TNF-alpha, IL-10 and eNOS supported the above findings. The study thus reveals insights into initial plaque instability and subsequent regression on AD withdrawal in this model. These results are suggestive of an appropriate window for drug intervention for plaque stability/regression and restenosis as well as improves understanding of plaque regression phenomenon in this model.	[Khanna, Vivek; Jain, Manish; Singh, Vishal; Kanshana, Jitendra S.; Prakash, Prem; Barthwal, Manoj K.; Dikshit, Madhu] CSIR Cent Drug Res Inst, Div Pharmacol, Lucknow, Uttar Pradesh, India; [Murthy, Puvvada S. R.] CSIR Cent Drug Res Inst, Div Toxicol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Dikshit, M (corresponding author), CSIR Cent Drug Res Inst, Div Pharmacol, BS 10-1,Sect 10, Lucknow, Uttar Pradesh, India.	madhu_dikshit@cdri.res.in	Jain, Manish/ABE-7652-2021; Kanshana, Jitendra/AEW-5567-2022; Singh, Vishal/N-1838-2019; Prakash, Prem/AAI-1672-2020	Jain, Manish/0000-0002-7263-9829; Prakash, Prem/0000-0001-9501-0065; Singh, Vishal/0000-0003-3577-1713	CSIR project THUNDER [BSC0102]; CSIR-Network project, India [BSC0103]; Council of Scientific and Industrial Research (CSIR), New Delhi, India; Indian Council of Medical Research, New Delhi, India	CSIR project THUNDER; CSIR-Network project, India; Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	The study was supported by a Financial grant to M. D. from the CSIR project THUNDER (BSC0102) and CSIR-Network project (BSC0103), India. The authors gratefully acknowledge the award of research fellowships by the Council of Scientific and Industrial Research (CSIR), New Delhi, India to V. K., V. S., J.S.K., P. P., and Indian Council of Medical Research, New Delhi, India to M.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A CWM, 1967, VASCULAR HISTOCHEMIS; Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Aikawa M, 1998, CIRCULATION, V97, P2433, DOI 10.1161/01.CIR.97.24.2433; Al-Mallah MH, 2011, ATHEROSCLEROSIS, V219, P395, DOI 10.1016/j.atherosclerosis.2011.08.023; Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161/hc0302.102610; CANDIPAN RC, 1994, CIRCULATION, V89, P777, DOI 10.1161/01.CIR.89.2.777; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; COOKE JP, 1992, J CLIN INVEST, V90, P1168, DOI 10.1172/JCI115937; Dapson RW, 2011, BIOTECH HISTOCHEM, V86, P133, DOI 10.3109/10520295.2011.570277; Dollery CM, 1999, CIRCULATION, V99, P3199, DOI 10.1161/01.CIR.99.24.3199; Dong B, 2008, ARTERIOSCL THROM VAS, V28, P1270, DOI 10.1161/ATVBAHA.108.164715; Dornas WC, 2010, ARQ BRAS CARDIOL, V95, P272, DOI 10.1590/S0066-782X2010001200020; DOWELL FJ, 1995, ARTERIOSCL THROM VAS, V15, P1152, DOI 10.1161/01.ATV.15.8.1152; Feig JE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00286; Ferrer MD, 2010, RADIOLOGIA-MADRID, V52, P45, DOI 10.1016/j.rx.2009.09.011; Francis AA, 2011, EXP CLIN CARDIOL, V16, P77; FREIMAN PC, 1986, CIRC RES, V58, P783, DOI 10.1161/01.RES.58.6.783; FRIEDMAN M, 1963, AM J PATHOL, V43, P349; Fuster V, 2007, CIRCULATION, V116, P1966, DOI 10.1161/CIRCULATIONAHA.107.733444; Gomez-Garre D, 2009, BRIT J PHARMACOL, V156, P1218, DOI 10.1111/j.1476-5381.2008.00091.x; Haarer S. L., 1998, Basic Research in Cardiology, V93, P210, DOI 10.1007/s003950050089; Hagensen MK, 2012, CARDIOVASC RES, V93, P223, DOI 10.1093/cvr/cvr278; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Herrero-Beaumont G, 2008, BRIT J PHARMACOL, V154, P843, DOI 10.1038/bjp.2008.113; Khanna V, 2011, PHARMACOL RES, V64, P274, DOI 10.1016/j.phrs.2011.03.016; Krejcy K, 1996, ATHEROSCLEROSIS, V122, P59, DOI 10.1016/0021-9150(95)05747-1; Lee HM, 2008, J VASC RES, V45, P259, DOI 10.1159/000112941; Li CJ, 2007, J ENDOCRINOL, V193, P137, DOI 10.1677/JOE-06-0173; Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012; Liu MW, 1996, ATHEROSCLEROSIS, V127, P221, DOI 10.1016/S0021-9150(96)05959-X; Loftus IM, 2002, BRIT J SURG, V89, P680, DOI 10.1046/j.1365-2168.2002.02099.x; MALINOW MR, 1980, CIRC RES, V46, P311, DOI 10.1161/01.RES.46.3.311; MALINOW MR, 1983, ATHEROSCLEROSIS, V48, P105, DOI 10.1016/0021-9150(83)90097-7; Meguro K, 2009, AM J PHYSIOL-HEART C, V296, pH211, DOI 10.1152/ajpheart.00960.2008; MINOR RL, 1990, J CLIN INVEST, V86, P2109, DOI 10.1172/JCI114949; Moreno PR, 2009, J AM COLL CARDIOL, V53, P2315, DOI 10.1016/j.jacc.2009.02.057; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Nadkarni SK, 2009, LASER MED SCI, V24, P439, DOI 10.1007/s10103-007-0535-x; Nakazawa Gaku, 2008, Expert Rev Cardiovasc Ther, V6, P1379, DOI 10.1586/14779072.6.10.1379; Newby AC, 1999, CARDIOVASC RES, V41, P345, DOI 10.1016/S0008-6363(98)00286-7; Okabe T, 2011, INT J CARDIOL, V147, P271, DOI 10.1016/j.ijcard.2009.09.528; Orlandi A, 2000, ARTERIOSCL THROM VAS, V20, P1123, DOI 10.1161/01.ATV.20.4.1123; Pasterkamp G, 1998, ATHEROSCLEROSIS, V137, P205, DOI 10.1016/S0021-9150(97)00255-4; Phinikaridou A, 2009, J LIPID RES, V50, P787, DOI 10.1194/jlr.M800460-JLR200; Riedmuller K, 2010, ATHEROSCLEROSIS, V210, P407, DOI 10.1016/j.atherosclerosis.2010.01.009; Shinohara M, 2005, CARDIOVASC RES, V68, P249, DOI 10.1016/j.cardiores.2005.06.016; Singh V, 2009, CURR VASC PHARMACOL, V7, P75, DOI 10.2174/157016109787354097; Son DJ, 2008, PROSTAG LEUKOTR ESS, V78, P383, DOI 10.1016/j.plefa.2008.04.010; STCLAIR RW, 1983, PROG CARDIOVASC DIS, V26, P109; Tian JW, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/121867; Tzafriri AR, 2010, J CONTROL RELEASE, V142, P332, DOI 10.1016/j.jconrel.2009.11.007; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wang BY, 1996, J AM COLL CARDIOL, V28, P1573, DOI 10.1016/S0735-1097(96)00337-3; Watanabe Noboru, 2004, Curr Atheroscler Rep, V6, P112, DOI 10.1007/s11883-004-0099-1; Wissler R W, 1988, J Clin Apher, V4, P52, DOI 10.1002/jca.2920040203; Zaltsman AB, 1999, ARTERIOSCL THROM VAS, V19, P1700, DOI 10.1161/01.ATV.19.7.1700	56	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77037	10.1371/journal.pone.0077037	http://dx.doi.org/10.1371/journal.pone.0077037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146955	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200030
J	Finnamore, H; Le Couteur, J; Hickson, M; Busbridge, M; Whelan, K; Shovlin, CL				Finnamore, Helen; Le Couteur, James; Hickson, Mary; Busbridge, Mark; Whelan, Kevin; Shovlin, Claire L.			Hemorrhage-Adjusted Iron Requirements, Hematinics and Hepcidin Define Hereditary Hemorrhagic Telangiectasia as a Model of Hemorrhagic Iron Deficiency	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; MENSTRUAL BLOOD-LOSS; ANEMIA; MANAGEMENT; EPISTAXIS; PREVALENCE; FREQUENCY; DIAGNOSIS; SEVERITY; CRITERIA	Background: Iron deficiency anemia remains a major global health problem. Higher iron demands provide the potential for a targeted preventative approach before anemia develops. The primary study objective was to develop and validate a metric that stratifies recommended dietary iron intake to compensate for patient-specific non-menstrual hemorrhagic losses. The secondary objective was to examine whether iron deficiency can be attributed to under-replacement of epistaxis (nosebleed) hemorrhagic iron losses in hereditary hemorrhagic telangiectasia (HHT). Methodology/Principal Findings: The hemorrhage adjusted iron requirement (HAIR) sums the recommended dietary allowance, and iron required to replace additional quantified hemorrhagic losses, based on the pre-menopausal increment to compensate for menstrual losses (formula provided). In a study population of 50 HHT patients completing concurrent dietary and nosebleed questionnaires, 43/50 (86%) met their recommended dietary allowance, but only 10/50 (20%) met their HAIR. Higher HAIR was a powerful predictor of lower hemoglobin (p = 0.009), lower mean corpuscular hemoglobin content (p<0.001), lower log-transformed serum iron (p = 0.009), and higher log-transformed red cell distribution width (p<0.001). There was no evidence of generalised abnormalities in iron handling Ferritin and ferritin(2) explained 60% of the hepcidin variance (p<0.001), and the mean hepcidinferritin ratio was similar to reported controls. Iron supplement use increased the proportion of individuals meeting their HAIR, and blunted associations between HAIR and hematinic indices. Once adjusted for supplement use however, reciprocal relationships between HAIR and hemoglobin/serum iron persisted. Of 568 individuals using iron tablets, most reported problems completing the course. For patients with hereditary hemorrhagic telangiectasia, persistent anemia was reported three-times more frequently if iron tablets caused diarrhea or needed to be stopped. Conclusions/significance: HAIR values, providing an indication of individuals' iron requirements, may be a useful tool in prevention, assessment and management of iron deficiency. Iron deficiency in HHT can be explained by under-replacement of nosebleed hemorrhagic iron losses.	[Finnamore, Helen; Shovlin, Claire L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Le Couteur, James; Hickson, Mary; Busbridge, Mark; Shovlin, Claire L.] Imperial Coll Healthcare NHS Trust, London, England; [Whelan, Kevin] Kings Coll London, Sch Med, Diabet & Nutr Sci Div, London WC2R 2LS, England; [Finnamore, Helen] Univ Liverpool, Sch Med, Liverpool L69 3BX, Merseyside, England	Imperial College London; Imperial College London; University of London; King's College London; University of Liverpool	Shovlin, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	c.shovlin@imperial.ac.uk	Hickson, Mary/D-3672-2011; Whelan, Kevin/ABD-5350-2021; Whelan, Kevin/ABD-5154-2021	Hickson, Mary/0000-0001-7996-0095; Whelan, Kevin/0000-0001-5414-2950; Shovlin, Claire/0000-0001-9007-5775; Busbridge, Mark/0000-0002-5452-6986	Medical Research Council UK [G9502233, G0300128]; Cancer Research UK [C865/A2883]; National Institute of Health Research Biomedical Research Centre Funding Scheme (Imperial BRC); MRC [G0300128] Funding Source: UKRI; Medical Research Council [G0300128] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute of Health Research Biomedical Research Centre Funding Scheme (Imperial BRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study received support from donations by families and friends of British patients with hereditary haemorrhagic telangiectasia, and internal Bachelor of Science project funding (for HF). EPIC-Norfolk is supported by programme grants from the Medical Research Council UK (G9502233, G0300128) and Cancer Research UK (C865/A2883). CLS and MH acknowledge support from the National Institute of Health Research Biomedical Research Centre Funding Scheme (Imperial BRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah SM, 2011, BLOOD TRANSFUS-ITALY, V9, P167, DOI 10.2450/2010.0040-10; Alleyne M, 2008, AM J MED, V121, P943, DOI 10.1016/j.amjmed.2008.07.012; ANAND IS, 1995, J AM COLL CARDIOL, V25, P1402, DOI 10.1016/0735-1097(95)00007-Q; Androne AS, 2003, CIRCULATION, V107, P226, DOI 10.1161/01.CIR.0000052623.16194.80; ARONSTAM A, 1982, PHARMATHERAPEUTICA, V3, P263; Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102; Boulton F, 2008, TRANSFUSION MED, V18, P13, DOI 10.1111/j.1365-3148.2007.00818.x; BURDETT E, 2006, BR J HOSP MED LOND, V67, P200; Busbridge M, 2009, BRIT J BIOMED SCI, V66, P150, DOI 10.1080/09674845.2009.11730263; Buscarini E, 2011, DIGEST DIS SCI, V56, P2166, DOI 10.1007/s10620-011-1585-2; *CDCP, 2011, NUTR EV BAS IR IR DE; Centers for Disease Control and Prevention, 1998, MMWR RECOMM REP, V47, p1; *CTR DIS CONTR, 2002, MMWR WEEKLY, V51, P897; Curtis L, 2015, UNIT COSTS HLTH SOCI; Department of Health, 1991, DIET REF VAL FOOD EN; Devlin HL, 2013, NEW ENGL J MED, V368, P876, DOI 10.1056/NEJMc1213554; Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013; Franzini C, 2000, CLIN CHIM ACTA, V298, P181, DOI 10.1016/S0009-8981(00)00273-4; FRYKMAN E, 1994, J LAB CLIN MED, V123, P561; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; Goddard AF, 2011, GUT, V60, P1309, DOI 10.1136/gut.2010.228874; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hallberg L., 2000, Scandinavian Journal of Nutrition/Naringsforskning, V44, P150; Hallberg L, 2001, ANNU REV NUTR, V21, P1, DOI 10.1146/annurev.nutr.21.1.1; HALLBERG L, 1966, ACTA MED SCAND, VS, P3; HALLBERG L, 1966, ACTA MED SCAND, V180, P639; *HMSO, 2004, NAT DIET NUTR SURV A; Hoag JB, 2010, LARYNGOSCOPE, V120, P838, DOI 10.1002/lary.20818; *INT AG RES CANC W, 2010, EUR PROSP INV CANC N; KERR DNS, 1958, LANCET, V2, P489; Livesey JA, 2012, THORAX, V67, P328, DOI 10.1136/thoraxjnl-2011-201076; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Milman N, 2012, ANN HEMATOL, V91, P143, DOI 10.1007/s00277-011-1381-2; Nelson M, 2007, LOW INCOME DIET NUTR, V3, P38; *NICE, 2011, COL CANC COST REP IM; *NICE, CLIN KNOWL SUMM INT; Pasricha SR, 2012, PATHOLOGY, V44, P139, DOI 10.1097/PAT.0b013e32834e8291; Pipemo A, 2007, BLOOD, V110, P4096, DOI 10.1182/blood-2007-06-096503; Pope LER, 2005, POSTGRAD MED J, V81, P309, DOI 10.1136/pgmj.2004.025007; Rhodes CJ, 2011, J AM COLL CARDIOL, V58, P300, DOI 10.1016/j.jacc.2011.02.057; Rimon E, 2005, AM J MED, V118, P1142, DOI 10.1016/j.amjmed.2005.01.065; Roked F, 2011, AM J RESP CRIT CARE, V183, P828, DOI 10.1164/ajrccm.183.6.828; *ROY COLL OBST GYN, 2009, PREV MAN POSTP HEM G, V52; *ROY PHARM SOC GRE, 2012, BRIT NATL FORM 63; *ROYAL PHARM SOC G, 2012, BRIT NAT FORM 63; Saban Y, 2012, ARCH FACIAL PLAST S, V14, P429, DOI 10.1001/archfacial.2012.202; SANTHIRAPALA V, 2013, HEMATOLOGY REPORTS, V5, P33; SHAW ST, 1972, CONTRACEPTION, V5, P497, DOI 10.1016/0010-7824(72)90015-7; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Silva BM, 2013, LARYNGOSCOPE, V123, P1092, DOI 10.1002/lary.23893; Smith TG, 2008, J PHYSIOL-LONDON, V586, P5999, DOI 10.1113/jphysiol.2008.160960; Spielmann M, 2012, EUR J CANCER, V48, P101, DOI 10.1016/j.ejca.2011.09.011; Swain DG, 2000, INJURY, V31, P7, DOI 10.1016/S0020-1383(99)00191-6; Tan TCH, 2012, LIVER INT, V32, P1391, DOI 10.1111/j.1478-3231.2012.02828.x; Tay HL, 1998, ANN OTO RHINOL LARYN, V107, P671, DOI 10.1177/000348949810700808; Thane CW, 2003, PUBLIC HEALTH NUTR, V6, P485, DOI 10.1079/PHN2002455; *UN CHILDR FDN, 2001, WHONHD013 UN CHILDR; VALBERG LS, 1980, CAN MED ASSOC J, V122, P1240; Welch AA, 2005, J HUM NUTR DIET, V18, P99, DOI 10.1111/j.1365-277X.2005.00593.x; WHYTE MKB, 1993, J APPL PHYSIOL, V75, P321, DOI 10.1152/jappl.1993.75.1.321; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zeidman A, 2004, ISR MED ASSOC J, V6, P16	65	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76516	10.1371/journal.pone.0076516	http://dx.doi.org/10.1371/journal.pone.0076516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146883	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400069
J	Kassa, A; Dey, AK; Sarkar, P; Labranche, C; Go, EP; Clark, DF; Sun, YD; Nandi, A; Hartog, K; Desaire, H; Montefiori, D; Carfi, A; Srivastava, IK; Barnett, SW				Kassa, Aemro; Dey, Antu K.; Sarkar, Pampi; Labranche, Celia; Go, Eden P.; Clark, Daniel F.; Sun, Yide; Nandi, Avishek; Hartog, Karin; Desaire, Heather; Montefiori, David; Carfi, Andrea; Srivastava, Indresh K.; Barnett, Susan W.			Stabilizing Exposure of Conserved Epitopes by Structure Guided Insertion of Disulfide Bond in HIV-1 Envelope Glycoprotein	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 INNER DOMAIN; NEUTRALIZING ANTIBODIES; CD4; IMMUNOGENICITY; RECEPTOR; PURIFICATION; SPECIFICITY; EXPRESSION; COMPLEX	Entry of HIV-1 into target cells requires binding of the viral envelope glycoprotein (Env) to cellular receptors and subsequent conformational changes that culminates in fusion of viral and target cell membranes. Recent structural information has revealed that these conformational transitions are regulated by three conserved but potentially flexible layers stacked between the receptor-binding domain (gp120) and the fusion arm (gp41) of Env. We hypothesized that artificial insertion of a covalent bond will 'snap' Env into a conformation that is less mobile and stably expose conserved sites. Therefore, we analyzed the interface between these gp120 layers (layers 1, 2 and 3) and identified residues that may form disulfide bonds when substituted with cysteines. We subsequently probed the structures of the resultant mutant gp120 proteins by assaying their binding to a variety of ligands using Surface Plasmon Resonance (SPR) assay. We found that a single disulfide bond strategically inserted between the highly conserved layers 1 and 2 (C65-C115) is able to 'lock' gp120 in a CD4 receptor bound conformation (in the absence of CD4), as indicated by the lower dissociation constant (Kd) for the CD4-induced (CD4i) epitope binding 17b antibody. When disulfide-stabilized monomeric (gp120) and trimeric (gp140) Envs were used to immunize rabbits, they were found to elicit a higher proportion of antibodies directed against both CD4i and CD4 binding site epitopes than the wild-type proteins. These results demonstrate that structure-guided stabilization of inter-layer interactions within HIV-1 Env can be used to expose conserved epitopes and potentially overcome the sequence diversity of these molecules.	[Kassa, Aemro; Dey, Antu K.; Sarkar, Pampi; Nandi, Avishek; Carfi, Andrea; Srivastava, Indresh K.; Barnett, Susan W.] Novartis Vaccines & Diagnost Inc, Vaccines Res, Cambridge, MA USA; [Sun, Yide; Hartog, Karin] Novartis Vaccines & Diagnost Inc, Vaccines Res, Emeryville, CA USA; [Labranche, Celia; Montefiori, David] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Go, Eden P.; Clark, Daniel F.; Desaire, Heather] Univ Kansas, Dept Chem, Lawrence, KS 66045 USA	Novartis; Novartis; Duke University; University of Kansas	Dey, AK (corresponding author), Novartis Vaccines & Diagnost Inc, Vaccines Res, Cambridge, MA USA.	antu.dey@novartis.com; susan.barnett@novartis.com		Dey, Antu/0000-0001-7438-9379	NIAID-NIH HIV Vaccine Research and Design (HIVRAD) grant [5P01 AI066287]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094797, P01AI066287] Funding Source: NIH RePORTER	NIAID-NIH HIV Vaccine Research and Design (HIVRAD) grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the NIAID-NIH HIV Vaccine Research and Design (HIVRAD) grant # 5P01 AI066287. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533; [Anonymous], 2010, GLOBAL REPORT UNAIDS; Beddows S, 2007, VIROLOGY, V360, P329, DOI 10.1016/j.virol.2006.10.032; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Crooks Emma T., 2005, Human Antibodies, V14, P101; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; DeVico A, 2007, P NATL ACAD SCI USA, V104, P17477, DOI 10.1073/pnas.0707399104; Dey AK, 2005, J VIROL, V79, P13806, DOI 10.1128/JVI.79.21.13806-13810.2005; Dey AK, 2012, USE POLYANIONI UNPUB; Dey AK, 2008, VIROLOGY, V372, P187, DOI 10.1016/j.virol.2007.10.018; Dey AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030233; Dey AK, 2012, VACCINE, V30, P2749, DOI 10.1016/j.vaccine.2012.02.027; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dey B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000445; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Forsell MNE, 2009, CURR OPIN HIV AIDS, V4, P380, DOI 10.1097/COH.0b013e32832edc19; Go EP, 2011, J PROTEOME RES, V10, P578, DOI 10.1021/pr100764a; Grundner C, 2005, VIROLOGY, V331, P33, DOI 10.1016/j.virol.2004.09.022; Guan Y, 2012, P NATL ACAD IN PRESS; Guan YJ, 2013, P NATL ACAD SCI USA, V110, pE69, DOI 10.1073/pnas.1217609110; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Jobes DV, 2006, AIDS RES HUM RETROV, V22, P1014, DOI 10.1089/aid.2006.22.1014; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kassa A, 2009, J VIROL, V83, P4476, DOI 10.1128/JVI.02110-08; Kovacs JM, 2012, P NATL ACAD IN PRESS; Kwong PD, 2005, NATURE, V433, P815, DOI 10.1038/433815a; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Martin G, 2011, J BIOL CHEM; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Srivastava IK, 2008, VIROLOGY, V372, P273, DOI 10.1016/j.virol.2007.10.022; THALI M, 1991, J VIROL, V65, P5007, DOI 10.1128/JVI.65.9.5007-5012.1991; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; Vaine M, 2008, J VIROL, V82, P7369, DOI 10.1128/JVI.00562-08; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Xiang SH, 2002, AIDS RES HUM RETROV, V18, P1207, DOI 10.1089/08892220260387959; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903; Yu B, 2010, J VIROL, V84, P1513, DOI 10.1128/JVI.01765-09; Zhang PF, 2007, P NATL ACAD SCI USA, V104, P10193, DOI 10.1073/pnas.0608635104; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	54	15	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76139	10.1371/journal.pone.0076139	http://dx.doi.org/10.1371/journal.pone.0076139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146829	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400040
J	Chen, H; Zhang, Y; Zheng, DH; Praseedom, RK; Dong, JH				Chen, Hao; Zhang, Ying; Zheng, Donghang; Praseedom, Raaj Kumar; Dong, Jiahong			Orthotopic Kidney Transplantation in Mice: Technique Using Cuff for Renal Vein Anastomosis	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; HEART; MODEL	Mouse renal transplantation is a technically challenging procedure. Although the first kidney transplants in mice were performed over 34 years ago and refined some years later, the classical techniques of mouse renal transplantation required clamping both vena cava and aorta simultaneously and carry out suture anastomoses of the renal artery and vein in a heterotopic position. In our laboratory, we have successfully developed mouse orthotopic kidney transplantation for the first time, using a rapid "cuffed" renal vein technique for vessel anastomosis, wherein the donor's renal vein was inserted through an intravenous catheter, folded back and tied. During grafting, the cuffed renal vein was directly inserted into the recipient's renal vein without the need for the clamping vena cava and suturing of renal vein. This technique allowed for the exact transplantation of the kidney into the original position, compared to the classical technique, and has significantly shortened the clamping time due to a quicker and precise anastomosis of renal vein as described. This also allowed for a quicker recovery of the lower extremity activity, reduction in myoglobinuria with resultant kidney graft survival of 88.9%. Thus we believe that the cuffed renal vein technique simplifies microvascular anastomoses and affords important additional benefits.	[Chen, Hao; Dong, Jiahong] Chinese Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Beijing, Peoples R China; [Chen, Hao; Zheng, Donghang] Univ Florida, Coll Med, Dept Cardiol, Gainesville, FL USA; [Chen, Hao] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Ying] Chinese Peoples Liberat Army Gen Hosp, Dept Microbiol, Beijing, Peoples R China; [Praseedom, Raaj Kumar] Addenbrookes Hosp, Dept HPB Transplant Surg, Cambridge, England	Chinese People's Liberation Army General Hospital; State University System of Florida; University of Florida; Zhejiang University; Chinese People's Liberation Army General Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Chen, H (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Beijing, Peoples R China.	chenhao.dr@gmail.com			973 project [2003CB5500]; National Nature Science Foundation of China	973 project(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was funded by grants from the 973 project 2003CB5500, the National Nature Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COFFMAN T, 1993, J IMMUNOL, V151, P425; Gok MA, 2006, J UROLOGY, V175, P641, DOI 10.1016/S0022-5347(05)00170-9; Gueler F, 2008, J IMMUNOL, V181, P1179, DOI 10.4049/jimmunol.181.2.1179; Huang LJ, 2012, INT BRAZ J UROL, V38, P395, DOI 10.1590/S1677-55382012000300013; Loverre A, 2007, KIDNEY INT, V72, P994, DOI 10.1038/sj.ki.5002468; Mannon RB, 1999, KIDNEY INT, V55, P1935, DOI 10.1046/j.1523-1755.1999.00423.x; Martins Paulo N., 2006, Int. braz j urol., V32, P713, DOI 10.1590/S1677-55382006000600013; Miller CC, 2008, EUR J CARDIO-THORAC, V33, P691, DOI 10.1016/j.ejcts.2008.01.006; Rong S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/127215; SKOSKIEWICZ M, 1973, TRANSPL P, V5, P721; Takahashi N, 2007, KIDNEY INT, V71, P266, DOI 10.1038/sj.ki.5002033; Wang Hao, 2012, Methods Mol Biol, V885, P125, DOI 10.1007/978-1-61779-845-0_9; Wang JJ, 2009, J VIS EXP, V10, P29; Wang MH, 2003, MICROSURG, V23, P164, DOI 10.1002/micr.10111; Zarjou A, 2012, KIDNEY INT, V82, P1231, DOI 10.1038/ki.2012.277; ZHANG Z, 1995, MICROSURG, V16, P103, DOI 10.1002/micr.1920160212	16	5	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77278	10.1371/journal.pone.0077278	http://dx.doi.org/10.1371/journal.pone.0077278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155935	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300069
J	Lin, JZ; Wu, HF; Shi, H; Pan, W; Yu, HB; Zhu, JG				Lin, Jianzhong; Wu, Hongfei; Shi, Hui; Pan, Wei; Yu, Hongbo; Zhu, Jiageng			Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Leads to Greater Anti-tumor Activity of Docetaxel in Advanced Prostate Cancer	PLOS ONE			English	Article							PHASE-II TRIAL; FACTOR-KAPPA-B; TUMOR-GROWTH; ANDROGEN RECEPTOR; BREAST-CANCER; CELL-LINES; EXPRESSION; GEFITINIB; EFFICACY; DRUGS	The epidermal growth factor receptor (EGFR) and cyclooxygenase-2(COX-2) play a critical role in disease progression, relapse and therapeutic resistance of advanced prostate cancer (PCa). In this paper, we evaluated, for the first time, the therapeutic benefit of blocking EGRF and/or COX-2 (using gefitinib and NS-398, respectively) in terms of improving the efficacy of the conventional clinical chemotherapeutic drug docetaxel in vitro and vivo. We showed that EGFR and COX-2 expression was higher in metastatic than non-metastatic PCa tissues and cells. Docetaxel, alone or in combination with gefitinib or NS-398, resulted in a small decrease in cell viability. The three drug combination decreased cell viability to a greater extent than docetaxel alone or in combination with gefitinib or NS-398. Docetaxel resulted in a modest increase in apoptotic cell in metastatic and non-metastatic cell lines. NS-398 markedly enhanced docetaxel-induced cell apoptosis. The combination of the three drugs caused even more marked apoptosis and resulted in greater suppression of invasive potential than docetaxel alone or in association with gefitinib or NS-398. The combination of all three drugs also resulted in a more marked decrease in NF-kappa B, MMP-9 and VEGF levels in PC-3M cells. These in vitro findings were supported by in vivo studies showing that docetaxel in combination with gefitinib and NS-398 was significantly more effective than any individual agent. Based on previous preclinical research, we conclude that simultaneously blocking EGFR and COX-2 by gefitinib and NS-398 sensitizes advanced PCa cells to docetaxel-induced cytotoxicity.	[Lin, Jianzhong; Wu, Hongfei; Yu, Hongbo] Nanjing Med Univ, BenQ Med Ctr, Dept Urol, Nanjing, Jiangsu, Peoples R China; [Shi, Hui] Jiangsu Inst Planned Parenthood Res, Lab Reprod Hlth, Nanjing, Jiangsu, Peoples R China; [Pan, Wei] Second Hosp Nanjing Jiangning, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Zhu, Jiageng] Nanjing Med Univ, Nanjing Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhu, JG (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	zhujiageng1972@hotmail.com			Science and Technology planning project of Nanjing, China [201201088]	Science and Technology planning project of Nanjing, China	The work has supported by Science and Technology planning project of Nanjing, China (201201088). The URL of funder's website is http://202.127.12.44/XMSB/Show_JBXXB.jsp?XMBH=2012sc315043&DJXH=20121069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedinpour P, 2011, PROSTATE, V71, P813, DOI 10.1002/pros.21297; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Ali S, 2010, J CELL BIOCHEM, V110, P171, DOI 10.1002/jcb.22523; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043726; Borghese C, 2013, J CELL BIOCHEM, V114, P1135, DOI 10.1002/jcb.24456; Cathomas R, 2012, CLIN CANCER RES, V18, P6049, DOI 10.1158/1078-0432.CCR-12-2219; Chan Emily, 2011, Am J Clin Oncol, V34, P581, DOI 10.1097/COC.0b013e3181fe46a1; Cho KS, 2008, PROSTATE, V68, P803, DOI 10.1002/pros.20743; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clarke NW, 2006, EUR UROL, V50, P428, DOI 10.1016/j.eururo.2006.05.017; Codony-Servat J, 2013, PROSTATE, V73, P512, DOI 10.1002/pros.22591; Cohen BL, 2006, INT J CANCER, V119, P1082, DOI 10.1002/ijc.21749; Dandekar DS, 2005, INT J CANCER, V115, P484, DOI 10.1002/ijc.20878; Dandekar DS, 2004, CLIN CANCER RES, V10, P8037, DOI 10.1158/1078-0432.CCR-04-1208; Farnebo L, 2011, J ORAL PATHOL MED, V40, P739, DOI 10.1111/j.1600-0714.2011.01036.x; Feng Ni, 2012, PLOS ONE, V7; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Galsky MD, 2010, ANN ONCOL, V21, P2135, DOI 10.1093/annonc/mdq050; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Halabi S, 2011, CANCER, V117, P526; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kang JH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-334; Kim SM, 2010, EUR J PHARMACOL, V10, P631; Lanza-Jacoby S, 2006, CLIN CANCER RES, V12, P6161, DOI 10.1158/1078-0432.CCR-06-0042; Li YW, 2006, CANCER RES, V66, P4816, DOI 10.1158/0008-5472.CAN-05-3752; Mathew P, 2011, J INTERF CYTOK RES, V31, P539, DOI 10.1089/jir.2010.0142; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2007, MOL CANCER THER, V6, P967, DOI 10.1158/1535-7163.MCT-06-0648; O'Neill AJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-126; Ortholan C, 2010, EUR J CANCER, V46, P3022, DOI 10.1016/j.ejca.2010.07.021; Pan YQ, 2003, CANCER EPIDEM BIOMAR, V12, P769; Park SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-222; Reuter CWM, 2010, WORLD J UROL, V28, P391, DOI 10.1007/s00345-010-0527-5; Salzberg M, 2007, ONKOLOGIE, V30, P355, DOI 10.1159/000102452; Stavridi F, 2010, CANCER TREAT REV, V36, P122, DOI 10.1016/j.ctrv.2009.06.001; Stock D, 2008, UROL CLIN N AM, V35, P117, DOI 10.1016/j.ucl.2007.09.006; Stoppoloni D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-27; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Walter B, 2010, WORLD J UROL, V28, P745, DOI 10.1007/s00345-010-0567-x; Zhang X, 2005, CLIN CANCER RES, V11, P6261, DOI 10.1158/1078-0432.CCR-04-2102	41	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76169	10.1371/journal.pone.0076169	http://dx.doi.org/10.1371/journal.pone.0076169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155892	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300026
J	Matito, A; Morgado, JM; Alvarez-Twose, I; Sanchez-Munoz, L; Pedreira, CE; Jara-Acevedo, M; Teodosio, C; Sanchez-Lopez, P; Fernandez-Nunez, E; Moreno-Borque, R; Garcia-Montero, A; Orfao, A; Escribano, L				Matito, Almudena; Mario Morgado, Jose; Alvarez-Twose, Ivan; Sanchez-Munoz, Laura; Eduardo Pedreira, Carlos; Jara-Acevedo, Maria; Teodosio, Cristina; Sanchez-Lopez, Paula; Fernandez-Nunez, Elisa; Moreno-Borque, Ricardo; Garcia-Montero, Andres; Orfao, Alberto; Escribano, Luis			Serum Tryptase Monitoring in Indolent Systemic Mastocytosis: Association with Disease Features and Patient Outcome	PLOS ONE			English	Article							MARROW MAST-CELLS; IMMUNOPHENOTYPIC CHARACTERIZATION; SPANISH NETWORK; KIT MUTATION; ANAPHYLAXIS; DIAGNOSIS; SEVERITY; CRITERIA; ALPHA; BLOOD	Background: Serum baseline tryptase (sBT) is a minor diagnostic criterion for systemic mastocytosis (SM) of undetermined prognostic impact. We monitored sBT levels in indolent SM (ISM) patients and investigated its utility for predicting disease behaviour and outcome. Methods: In total 74 adult ISM patients who were followed for >= 48 months and received no cytoreductive therapy were retrospectively studied. Patients were classified according to the pattern of evolution of sBT observed. Results: Overall 16/74 (22%) cases had decreasing sBT levels, 48 (65%) patients showed increasing sBT levels and 10 (13%) patients showed a fluctuating pattern. Patients with significantly increasing sBT (sBT slope >= 0.15) after 48 months of follow-up showed a slightly greater rate of development of diffuse bone sclerosis (13% vs. 2%) and hepatomegaly plus splenomegaly (16% vs. 5%), as well as a significantly greater frequency of multilineage vs. mast cells (MC)-restricted KIT mutation (p = 0.01) together with a greater frequency of cases with progression of ISM to smouldering and aggressive SM (p = 0.03), and a shorter progression-free survival (p = 0.03). Conclusions: Monitoring of sBT in ISM patients is closely associated with poor prognosis disease features as well as with disease progression, pointing out the need for a closer follow-up in ISM patients with progressively increasing sBT values.	[Matito, Almudena; Mario Morgado, Jose; Alvarez-Twose, Ivan; Sanchez-Munoz, Laura; Sanchez-Lopez, Paula; Fernandez-Nunez, Elisa; Escribano, Luis] Hosp Virgen del Valle, Inst Estudios Mastocitosis Castilla La Mancha, Toledo, Spain; [Eduardo Pedreira, Carlos] COPPE Inst Alberto Luiz Coimbra Posgrad & Pesquis, Rio De Janeiro, Brazil; [Eduardo Pedreira, Carlos] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Jara-Acevedo, Maria; Teodosio, Cristina; Garcia-Montero, Andres; Orfao, Alberto] Ctr Invest Canc IBMCC CSIC USAL, Serv Gen Citometria, Salamanca, Spain; [Jara-Acevedo, Maria; Teodosio, Cristina; Garcia-Montero, Andres; Orfao, Alberto] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Sanchez-Lopez, Paula; Moreno-Borque, Ricardo] Hosp Rey Juan Carlos, Dept Allergy, Mostoles, Spain	Complejo Hospitalario de Toledo; Universidade Federal do Rio de Janeiro; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Escribano, L (corresponding author), Hosp Virgen del Valle, Inst Estudios Mastocitosis Castilla La Mancha, Toledo, Spain.	escribanomoraluis@gmail.com	Nuñez, Elisa Fernandez/Z-1796-2019; Montero, Andres/HGA-9093-2022; Orfao, Alberto/B-5801-2017; Garcia-Montero, Andres C/B-6558-2017; Pedreira, Carlos Eduardo/I-5629-2013	Nuñez, Elisa Fernandez/0000-0001-6651-2576; Garcia-Montero, Andres C/0000-0003-4360-1386; Jara-Acevedo, Maria/0000-0001-7965-7512; Alvarez-Twose, Ivan/0000-0002-1190-4473; Pedreira, Carlos Eduardo/0000-0002-9312-4023; Teodosio, Cristina/0000-0002-2097-7199; Matito, Almudena/0000-0002-9547-4844; Sanchez-Munoz, Laura/0000-0003-1757-7255	Fondo de Investigaciones Sanitarias (FIS) of the Ministerio de Ciencia e Innovacion of Spain [RETICS RD06/0020/0035-FEDER, PS09/00032]; Fundacion Sociosanitaria de Castilla-La Mancha [FISCAM 2007/36, FISCAM 2010/008, G-2010/C-002]; Instituto de Salud Carlos III of the Ministerio de Economia y Competitividad of Spain [PI11/02399]; Junta de Castilla y Leon [SAN/103/2011]; Fundacion Ramon Areces; Fundacion Espanola de Mastocitosis (FEM);  [RETICS RD09/0076/00074]	Fondo de Investigaciones Sanitarias (FIS) of the Ministerio de Ciencia e Innovacion of Spain(Instituto de Salud Carlos III); Fundacion Sociosanitaria de Castilla-La Mancha; Instituto de Salud Carlos III of the Ministerio de Economia y Competitividad of Spain; Junta de Castilla y Leon(Junta de Castilla y Leon); Fundacion Ramon Areces; Fundacion Espanola de Mastocitosis (FEM); 	This work was supported by grants from the Fondo de Investigaciones Sanitarias (FIS) of the Ministerio de Ciencia e Innovacion of Spain (RETICS RD06/0020/0035-FEDER and PS09/00032); Fundacion Sociosanitaria de Castilla-La Mancha (FISCAM 2007/36, FISCAM 2010/008 and G-2010/C-002); Instituto de Salud Carlos III of the Ministerio de Economia y Competitividad of Spain (PI11/02399); Junta de Castilla y Leon (SAN/103/2011); Fundacion Ramon Areces; Fundacion Espanola de Mastocitosis (FEM 2010); Hospital Virgen de la Salud Biobank (BioB-HVS) supported by grant of RETICS RD09/0076/00074, (Toledo, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin C, 2004, BLOOD, V103, P3222, DOI 10.1182/blood-2003-11-3816; CASTELLS MC, 1987, J IMMUNOL, V138, P2184; Caughey GH, 2006, J ALLERGY CLIN IMMUN, V117, P1411, DOI 10.1016/j.jaci.2006.02.026; Caughey GH, 2000, J IMMUNOL, V164, P6566, DOI 10.4049/jimmunol.164.12.6566; Escribano L, 1998, BLOOD, V91, P2731, DOI 10.1182/blood.V91.8.2731.2731_2731_2736; Escribano L, 2004, CYTOM PART B-CLIN CY, V58B, P1, DOI 10.1002/cyto.b.10072; Escribano L, 2002, INT ARCH ALLERGY IMM, V127, P127, DOI 10.1159/000048183; Escribano Luis, 2006, Inflammation & Allergy Drug Targets, V5, P61, DOI 10.2174/187152806775269303; Escribano L, 2009, J ALLERGY CLIN IMMUN, V124, P514, DOI 10.1016/j.jaci.2009.05.003; Sirvent AE, 2010, J NEPHROL, V23, P282; Ferrer M, 2010, CLIN EXP ALLERGY, V40, P1760, DOI 10.1111/j.1365-2222.2010.03582.x; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Gonzalez-Quintela A, 2010, CLIN CHEM LAB MED, V48, P701, DOI 10.1515/CCLM.2010.124; Haeberli G, 2003, CLIN EXP ALLERGY, V33, P1216, DOI 10.1046/j.1365-2222.2003.01755.x; Horny HP, 2001, LEUKEMIA RES, V25, P543, DOI 10.1016/S0145-2126(01)00021-2; Horny HP AC, 2008, WHO CLASSIFICATION T, P54; Huang CF, 1999, J BIOL CHEM, V274, P19670, DOI 10.1074/jbc.274.28.19670; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; Kushnir-Sukhov NM, 2006, INT ARCH ALLERGY IMM, V139, P265, DOI 10.1159/000091172; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; Miller PD, 2006, REV ENDOCR METAB DIS, V7, P75, DOI 10.1007/s11154-006-9006-0; Orfao A, 1996, AM J PATHOL, V149, P1493; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Pallaoro M, 1999, J BIOL CHEM, V274, P3355, DOI 10.1074/jbc.274.6.3355; Sanchez-Munoz L, 2011, MODERN PATHOL, V24, P1157, DOI 10.1038/modpathol.2011.84; Sanchez-Munoz L, 2011, METHOD CELL BIOL, V103, P333, DOI 10.1016/B978-0-12-385493-3.00014-0; Schwartz LB, 1995, J CLIN INVEST, V96, P2702, DOI 10.1172/JCI118337; Schwartz LB, 2001, LEUKEMIA RES, V25, P553, DOI 10.1016/S0145-2126(01)00020-0; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; SCHWARTZ LB, 1994, J CLIN IMMUNOL, V14, P190, DOI 10.1007/BF01533368; Simon MR, 2010, INT ARCH ALLERGY IMM, V152, P28, DOI 10.1159/000260080; Sperr WR, 2009, EUR J CLIN INVEST, V39, P914, DOI 10.1111/j.1365-2362.2009.02184.x; Sperr WR, 2002, INT ARCH ALLERGY IMM, V128, P136, DOI 10.1159/000059404; Sperr WR, 2001, LEUKEMIA RES, V25, P529, DOI 10.1016/S0145-2126(01)00041-8; Teodosio C, 2012, LEUKEMIA, V26, P951, DOI 10.1038/leu.2011.293; Teodosio C, 2010, J ALLERGY CLIN IMMUN, V125, P719, DOI 10.1016/j.jaci.2009.10.020; Valent P, 2001, WHO CLASSIFICATION T, P291; VANDERLINDEN PWG, 1992, J ALLERGY CLIN IMMUN, V90, P110, DOI 10.1016/S0091-6749(06)80017-5	38	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76116	10.1371/journal.pone.0076116	http://dx.doi.org/10.1371/journal.pone.0076116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155887	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300021
J	Narendra, A; Alkaladi, A; Raderschall, CA; Robson, SKA; Ribi, WA				Narendra, Ajay; Alkaladi, Ali; Raderschall, Chloe A.; Robson, Simon K. A.; Ribi, Willi A.			Compound Eye Adaptations for Diurnal and Nocturnal Lifestyle in the Intertidal Ant, Polyrhachis sokolova	PLOS ONE			English	Article							INSECT PUPIL MECHANISMS; BEE MEGALOPTA-GENALIS; POLARIZED SKYLIGHT; RETINULA CELLS; SPECTRAL SENSITIVITY; FLY PHOTORECEPTORS; VISUAL ADAPTATIONS; MELOPHORUS-BAGOTI; PIGMENT MIGRATION; DESERT ANTS	The Australian intertidal ant, Polyrhachis sokolova lives in mudflat habitats and nests at the base of mangroves. They are solitary foraging ants that rely on visual cues. The ants are active during low tides at both day and night and thus experience a wide range of light intensities. We here ask the extent to which the compound eyes of P. sokolova reflect the fact that they operate during both day and night. The ants have typical apposition compound eyes with 596 ommatidia per eye and an interommatidial angle of 6.0 degrees. We find the ants have developed large lenses (33 mu m in diameter) and wide rhabdoms (5 mu m in diameter) to make their eyes highly sensitive to low light conditions. To be active at bright light conditions, the ants have developed an extreme pupillary mechanism during which the primary pigment cells constrict the crystalline cone to form a narrow tract of 0.5 mu m wide and 16 mu m long. This pupillary mechanism protects the photoreceptors from bright light, making the eyes less sensitive during the day. The dorsal rim area of their compound eye has specialised photoreceptors that could aid in detecting the orientation of the pattern of polarised skylight, which would assist the animals to determine compass directions required while navigating between nest and food sources.	[Narendra, Ajay; Raderschall, Chloe A.; Ribi, Willi A.] Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Alkaladi, Ali] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah, Saudi Arabia; [Robson, Simon K. A.] James Cook Univ, Fac Sci & Engn, Sch Marine & Trop Biol, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia; [Ribi, Willi A.] Private Univ Liechtenstein, Triesen, Liechtenstein	Australian National University; King Abdulaziz University; James Cook University	Narendra, A (corresponding author), Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia.	ajay.narendra@anu.edu.au	Robson, Simon KA/D-1168-2011; Raderschall, Chloe/AAF-3516-2022; Raderschall, Chloe/AFH-9100-2022; Narendra, Ajay/A-4960-2008	Robson, Simon KA/0000-0001-8870-1933; Narendra, Ajay/0000-0002-1286-5373; Raderschall, Chloe/0000-0003-2005-1705	Australian Research Council's (ARC) Centres of Excellence Scheme [CEO561903]; ARC Discovery Early Career Award [DE120100019]; ARC Discovery grant [DP1093553]; King Abdulaziz University	Australian Research Council's (ARC) Centres of Excellence Scheme(Australian Research Council); ARC Discovery Early Career Award(Australian Research Council); ARC Discovery grant(Australian Research Council); King Abdulaziz University	This work was funded by Australian Research Council's (ARC) Centres of Excellence Scheme (CEO561903); ARC Discovery Early Career Award (DE120100019); ARC Discovery grant (DP1093553); King Abdulaziz University travel grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEPLI F, 1985, CELL TISSUE RES, V239, P19, DOI 10.1007/BF00214897; Andersen Alan N., 2013, Diversity-Basel, V5, P139; BRUNNERT A, 1973, J MORPHOL, V140, P15, DOI 10.1002/jmor.1051400103; Collett TS, 2007, J EXP BIOL, V210, P2025, DOI 10.1242/jeb.000315; Dacke M, 2004, P ROY SOC B-BIOL SCI, V271, P361, DOI 10.1098/rspb.2003.2594; Esch HE, 1996, J EXP BIOL, V199, P155; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Greiner B, 2006, J COMP NEUROL, V495, P255, DOI 10.1002/cne.20882; Greiner B, 2005, CELL TISSUE RES, V322, P313, DOI 10.1007/s00441-005-0034-y; Greiner B, 2004, CELL TISSUE RES, V316, P377, DOI 10.1007/s00441-004-0883-9; Greiner B, 2007, CURR BIOL, V17, pR879, DOI 10.1016/j.cub.2007.08.015; KOHOUT R J, 1988, Memoirs of the Queensland Museum, V25, P429; Labhart T, 1999, MICROSC RES TECHNIQ, V47, P368, DOI 10.1002/(SICI)1097-0029(19991215)47:6<368::AID-JEMT2>3.3.CO;2-H; Land M.F., 1981, HDB SENSORY PHYSL, P471, DOI DOI 10.1007/978-3-642-66907-14; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Mappes M, 2004, J COMP PHYSIOL A, V190, P61, DOI 10.1007/s00359-003-0473-4; MENZEL R, 1975, CYTOBIOLOGIE, V11, P279; MENZI U, 1987, J COMP PHYSIOL A, V160, P11, DOI 10.1007/BF00613437; Narendra A, 2007, J EXP BIOL, V210, P1804, DOI 10.1242/jeb.02769; Narendra A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0683; Narendra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058801; Narendra A, 2011, P ROY SOC B-BIOL SCI, V278, P1141, DOI 10.1098/rspb.2010.1378; Reid SF, 2011, J EXP BIOL, V214, P363, DOI 10.1242/jeb.049338; Reid SF, 2010, THESIS AUSTR NATL U; RIBI WA, 1989, ENTOMOL GEN, V14, P233; Robson Simon K.A., 2007, Asian Myrmecology, V1, P81; Robson SKA, 2009, ANT ECOLOGY, P185; Schwarz S, 2011, ARTHROPOD STRUCT DEV, V40, P128, DOI 10.1016/j.asd.2010.10.003; Somanathan H, 2009, J COMP PHYSIOL A, V195, P571, DOI 10.1007/s00359-009-0432-9; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P189, DOI 10.1007/s00359-003-0390-6; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P1, DOI 10.1007/s00359-002-0370-2; STAVENGA DG, 1977, J COMP PHYSIOL, V113, P73, DOI 10.1007/BF00610454; STAVENGA DG, 1977, J COMP PHYSIOL, V113, P55, DOI 10.1007/BF00610453; Stavenga DG, 2006, INVERTEBRATE VISION, P1; Streinzer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057702; Theobald JC, 2006, VISION RES, V46, P2298, DOI 10.1016/j.visres.2006.01.002; VANHATEREN JH, 1993, J COMP PHYSIOL A, V172, P583, DOI 10.1007/BF00213681; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Walcott B., 1975, P20; WALCOTT B, 1969, NATURE, V223, P971, DOI 10.1038/223971a0; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Warrant EJ, 1996, J COMP PHYSIOL A, V39, P223; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; WEHNER R, 1979, EXPERIENTIA, V35, P1569, DOI 10.1007/BF01953197; Wehner R, 1996, J EXP BIOL, V199, P129; WEHNER R, 1989, TRENDS NEUROSCI, V12, P353, DOI 10.1016/0166-2236(89)90043-X; Wehner R., 1972, INFORMATION PROCESSI, P37; Wehner R, 1982, NEUROPHYSIOLOGIE VER, P1; Wehner R, 2006, P NATL ACAD SCI USA, V103, P12575, DOI 10.1073/pnas.0604430103; Wehner R, 2006, INVERTEBRATE VISION, P291; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008; ZOLLIKOFER CPE, 1995, J EXP BIOL, V198, P1637	53	25	26	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76015	10.1371/journal.pone.0076015	http://dx.doi.org/10.1371/journal.pone.0076015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155883	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325887300017
J	Zhang, ZC; Jian, XD; Zhang, W; Wang, JR; Zhou, Q				Zhang, Zhongchen; Jian, Xiangdong; Zhang, Wei; Wang, Jieru; Zhou, Qian			Using Bosentan to Treat Paraquat Poisoning-Induced Acute Lung Injury in Rats	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; RECEPTOR ANTAGONIST BOSENTAN; ENDOTHELIN-1; HYPERTENSION	Background: Paraquat poisoning is well known for causing multiple organ function failure (MODS) and high mortality. Acute lung injury and advanced pulmonary fibrosis are the most serious complications. Bosentan is a dual endothelin receptor antagonist. It plays an important role in treating PF. There is no related literature on the use of bosentan therapy for paraquat poisoning. Objective: To study the use of bosentan to treat acute lung injury and pulmonary fibrosis as induced by paraquat. Method: A total of 120 adult Wister male rats were randomly assigned to three groups: the paraquat poisoning group (rats were intragastrically administered with paraquat at 50 mg/kg body weight once at the beginning); the bosentan therapy group (rats were administered bosentan at 100 mg/kg body weight by intragastric administration half an hour after paraquat was administered, then the same dose was administered once a day); and a control group (rats were administered intragastric physiological saline). On the 3rd, 7th, 14th, and 21st days following paraquat exposure, rats were sacrificed, and samples of lung tissue and venous blood were collected. The levels of transforming growth factor-beta 1 (TGF-beta 1), endothelin-1 (ET-1), and hydroxyproline (HYP) in the plasma and lung homogenate were determined. Optical and electronic microscopes were used to examine pathological changes. Result: The TGF-beta 1, ET-1, and HYP of the paraquat poisoning group were significantly higher than in the control group, and they were significantly lower in the 21st day therapy group than in the paraquat poisoning group on the same day. Under the optical and electronic microscopes, lung tissue damage was observed to be more severe but was then reduced after bosentan was administered. Conclusion: Bosentan can reduce inflammation factor release. It has a therapeutic effect on acute lung injury as induced by paraquat.	[Zhang, Zhongchen; Jian, Xiangdong; Zhang, Wei; Wang, Jieru; Zhou, Qian] Shandong Univ, Qilu Hosp, Dept Poisoning & Occupat Dis, Jinan 250100, Shandong, Peoples R China	Shandong University	Jian, XD (corresponding author), Shandong Univ, Qilu Hosp, Dept Poisoning & Occupat Dis, Jinan 250100, Shandong, Peoples R China.	j6anxian@public.jn.sd.cn			Natural Science Foundation of Shandong Provience [Y2008C123]	Natural Science Foundation of Shandong Provience	This work was supported by the Natural Science Foundation of Shandong Provience, the project number Y2008C123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awadalla EA, 2012, EXP TOXICOL PATHOL, V64, P431, DOI 10.1016/j.etp.2010.10.009; BULLIVANT CM, 1966, BMJ-BRIT MED J, V1, P1272, DOI 10.1136/bmj.1.5498.1272; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Chen HW, 2009, J CHIN MED ASSOC, V72, P547, DOI 10.1016/S1726-4901(09)70426-5; CHOI Y, 2008, AM J EMERG MED, V26; Comellas AP, 2009, TRANSL RES, V153, P263, DOI 10.1016/j.trsl.2009.02.007; Ghaffari AR, 2011, SAUDI MED J, V32, P249; Gunther A, 2007, EUR RESPIR J, V29, P713, DOI 10.1183/09031936.00149205; Hong Joong-Rock, 2010, Korean Journal of Internal Medicine, V25, P422, DOI 10.3904/kjim.2010.25.4.422; Kim HR, 2006, LUNG, V184, P287, DOI 10.1007/s00408-005-2592-x; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; Knobloch J, 2009, THORAX, V64, P1044, DOI 10.1136/thx.2008.111047; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Le Saux O, 2008, AM J PHYSIOL-LUNG C, V295, pL1007, DOI 10.1152/ajplung.90207.2008; Li XX, 2011, CHINESE MED J-PEKING, V124, P1923, DOI 10.3760/cma.j.issn.0366-6999.2011.13.001; Liu Shi-ping, 2008, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V26, P242; McLaughlin VV, 2006, EUR J CLIN INVEST, V36, P10, DOI 10.1111/j.1365-2362.2006.01688.x; Meoli DF, 2010, CAN J PHYSIOL PHARM, V88, P830, DOI 10.1139/Y10-059; Mohammadi-Karakani A, 2006, CLIN CHIM ACTA, V367, P170, DOI 10.1016/j.cca.2005.12.012; Ning Qiong, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P667; Ross B, 2010, AM J RESP CELL MOL, V42, P16, DOI 10.1165/rcmb.2009-0175TR; Schroll S, 2010, RESP PHYSIOL NEUROBI, V170, P32, DOI 10.1016/j.resp.2009.11.005; Trabold B, 2009, INJURY, V40, P946, DOI 10.1016/j.injury.2008.11.016; Wang Wei-hua, 2005, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V17, P293; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhao Bo, 2010, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V28, P220	26	14	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75943	10.1371/journal.pone.0075943	http://dx.doi.org/10.1371/journal.pone.0075943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155875	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300009
J	Jaouadi, NZ; Rekik, H; Badis, A; Trabelsi, S; Belhoul, M; Yahiaoui, AB; Ben Aicha, H; Toumi, A; Bejar, S; Jaouadi, B				Jaouadi, Nadia Zarai; Rekik, Hatem; Badis, Abdelmalek; Trabelsi, Sahar; Belhoul, Mouna; Yahiaoui, Amina Benkiar; Ben Aicha, Houda; Toumi, Abdessatar; Bejar, Samir; Jaouadi, Bassem			Biochemical and Molecular Characterization of a Serine Keratinase from Brevibacillus brevis US575 with Promising Keratin-Biodegradation and Hide-Dehairing Activities	PLOS ONE			English	Article							BACILLUS-PUMILUS CBS; ALKALINE PROTEASE; PURIFICATION; IDENTIFICATION; PROTEINASE; BACTERIUM	Dehairing is one of the highly polluting operations in the leather industry. The conventional lime-sulfide process used for dehairing produces large amounts of sulfide, which poses serious toxicity and disposal problems. This operation also involves hair destruction, a process that leads to increased chemical oxygen demand (COD), biological oxygen demand (BOD), and total suspended solid (TSS) loads in the effluent. With these concerns in mind, enzyme-assisted dehairing has often been proposed as an alternative method. The main enzyme preparations so far used involved keratinases. The present paper reports on the purification of an extracellular keratinase (KERUS) newly isolated from Brevibacillus brevis strain US575. Matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF/MS) analysis revealed that the purified enzyme was a monomer with a molecular mass of 29121.11 Da. The sequence of the 27 N-terminal residues of KERUS showed high homology with those of Bacillus keratinases. Optimal activity was achieved at pH 8 and 40 degrees C. Its thermoactivity and thermostability were upgraded in the presence of 5 mM Ca2+. The enzyme was completely inhibited by phenylmethanesulfonyl fluoride (PMSF) and diiodopropyl fluorophosphates (DFP), which suggests that it belongs to the serine protease family. KERUS displayed higher levels of hydrolysis, substrate specificity, and catalytic efficiency than NUE 12 MG and KOROPON (R) MK EG keratinases. The enzyme also exhibited powerful keratinolytic activity that made it able to accomplish the entire feather-biodegradation process on its own. The kerUS gene encoding KERUS was cloned, sequenced, and expressed in Escherichia coli. The biochemical properties of the extracellular purified recombinant enzyme (rKERUS) were similar to those of native KERUS. Overall, the findings provide strong support for the potential candidacy of this enzyme as an effective and eco-friendly alternative to the conventional chemicals used for the dehairing of rabbit, goat, sheep and bovine hides in the leather processing industry.	[Jaouadi, Nadia Zarai; Rekik, Hatem; Trabelsi, Sahar; Belhoul, Mouna; Bejar, Samir; Jaouadi, Bassem] Univ Sfax, CBS, LMB, Sfax, Tunisia; [Badis, Abdelmalek] Univ Saad Dahlab USD Blida, LNPCB, Blida, Algeria; [Badis, Abdelmalek; Yahiaoui, Amina Benkiar] Natl Ctr Res & Dev Fisheries & Aquaculture CNRDPA, Bousmail, W Tipaza, Algeria; [Ben Aicha, Houda; Toumi, Abdessatar] Natl Leather & Shoe Ctr CNCC, Megrine, Ben Arous, Tunisia	Centre de Biotechnologie de Sfax; Universite de Sfax	Jaouadi, B (corresponding author), Univ Sfax, CBS, LMB, Sfax, Tunisia.	bassem.jaouadi@yahoo.fr	JAOUADI, Bassem/AAN-8106-2021	Bassem, JAOUADI/0000-0002-5182-7353	Tunisian Ministry of Higher Education and Scientific Research; Algerian Ministry of Higher Education and Scientific Research and Technology "Project Tuniso-Algerian JAOUADI/BADIS" [TNDZ-MicrooZymes_2012-2015]; Tunisian Ministry of Higher Education and Scientific Research "Contract program LMB-CBS" [LR10CBS04]; Tunisian Ministry of Industry; Tunisian Ministry of Higher Education and Scientific Research "National Programme for the Promotion of Technological Innovation PNRI-ENZYMES"	Tunisian Ministry of Higher Education and Scientific Research; Algerian Ministry of Higher Education and Scientific Research and Technology "Project Tuniso-Algerian JAOUADI/BADIS"; Tunisian Ministry of Higher Education and Scientific Research "Contract program LMB-CBS"; Tunisian Ministry of Industry; Tunisian Ministry of Higher Education and Scientific Research "National Programme for the Promotion of Technological Innovation PNRI-ENZYMES"	This work was funded by The Tunisian Ministry of Higher Education and Scientific Research and the Algerian Ministry of Higher Education and Scientific Research and Technology "Project Tuniso-Algerian JAOUADI/BADIS grant no. TNDZ-MicrooZymes_2012-2015;" The Tunisian Ministry of Higher Education and Scientific Research "Contract program LMB-CBS, grant no. LR10CBS04;" The Tunisian Ministry of Industry and The Tunisian Ministry of Higher Education and Scientific Research "National Programme for the Promotion of Technological Innovation PNRI-ENZYMES 2012-2013." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler-Nissen J., 1986, ENZYMIC HYDROLYSIS F; Benkiar A, 2013, INT BIODETER BIODEGR, V83, P129, DOI 10.1016/j.ibiod.2013.05.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandelli A, 2010, APPL MICROBIOL BIOT, V85, P1735, DOI 10.1007/s00253-009-2398-5; Burtt E. H., 1999, US Patent, Patent No. 6214676; Cavello IA, 2013, PROCESS BIOCHEM, V48, P972, DOI 10.1016/j.procbio.2013.03.012; Chaudhari PN, 2013, PROCESS BIOCHEM, V48, P144, DOI 10.1016/j.procbio.2012.11.009; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Dayanandan A, 2003, J CLEAN PROD, V11, P533, DOI 10.1016/S0959-6526(02)00056-2; El-Refai HA, 2005, PROCESS BIOCHEM, V40, P2325, DOI 10.1016/j.procbio.2004.09.006; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fakhfakh-Zouari N, 2010, APPL BIOCHEM BIOTECH, V162, P329, DOI 10.1007/s12010-009-8774-x; Grazziotin A, 2007, BIORESOURCE TECHNOL, V98, P3172, DOI 10.1016/j.biortech.2006.10.034; Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Gurtler V, 1996, MICROBIOL-SGM, V142, P3, DOI 10.1099/13500872-142-1-3; Hu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058393; Huang Q, 2003, CURR MICROBIOL, V46, P169, DOI 10.1007/s00284-002-3850-2; Jaouadi B, 2008, BIOCHIMIE, V90, P1291, DOI 10.1016/j.biochi.2008.03.004; Jaouadi B, 2010, BIORESOURCE TECHNOL, V101, P8361, DOI 10.1016/j.biortech.2010.05.066; Jaouadi B, 2010, BIOCHIMIE, V92, P360, DOI 10.1016/j.biochi.2010.01.008; Jaouadi B, 2009, BIOTECHNOL BIOPROC E, V14, P503, DOI 10.1007/s12257-008-0244-8; Jaouadi NZ, 2012, BIORESOURCE TECHNOL, V105, P142, DOI 10.1016/j.biortech.2011.11.115; Kumar AG, 2008, J APPL MICROBIOL, V104, P411, DOI 10.1111/j.1365-2672.2007.03564.x; Kumar CG, 2002, LETT APPL MICROBIOL, V34, P13, DOI [10.1046/j.1472-765x.2002.01044.x, 10.1046/j.1472-765X.2002.01044.x]; Kumar CG, 1999, BIOTECHNOL ADV, V17, P561, DOI 10.1016/S0734-9750(99)00027-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Miyaji T, 2006, LETT APPL MICROBIOL, V42, P242, DOI 10.1111/j.1472-765X.2005.01851.x; Pan J, 2004, CURR MICROBIOL, V49, P165, DOI 10.1007/s00284-004-4305-8; Pandeeti EVP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016742; Pillai P, 2008, APPL MICROBIOL BIOT, V78, P643, DOI 10.1007/s00253-008-1355-z; Pillai P, 2012, PROCESS BIOCHEM, V47, P2116, DOI 10.1016/j.procbio.2012.07.030; Rajput Rinky, 2010, Enzyme Res, V2010, P132148, DOI 10.4061/2010/132148; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Riffel A, 2002, J IND MICROBIOL BIOT, V29, P255, DOI 10.1038/sj.jim.7000307; Sambrook J., 1989, MOL CLONING LAB MANU, P23; Shih J. C. H., 1992, US Patent, Patent No. [US5171682, 5171682]; SHIH JCH, 1990, Patent No. 4908220; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Son HJ, 2008, BIOTECHNOL LETT, V30, P461, DOI 10.1007/s10529-007-9567-3; Vetter R, 2003, European Patent, Patent No. [EP0572992 B1, 0572992]; Wang HY, 2007, LETT APPL MICROBIOL, V44, P1, DOI 10.1111/j.1472-765X.2006.02039.x; WILLIAMS CM, 1990, APPL ENVIRON MICROB, V56, P1509, DOI 10.1128/AEM.56.6.1509-1515.1990	43	97	104	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76722	10.1371/journal.pone.0076722	http://dx.doi.org/10.1371/journal.pone.0076722			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146914	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400076
J	Li, ZJ; Sohn, KC; Choi, DK; Shi, G; Hong, D; Lee, HE; Whang, KU; Lee, YH; Im, M; Lee, Y; Seo, YJ; Kim, CD; Lee, JH				Li, Zheng Jun; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Shi, Ge; Hong, Dongkyun; Lee, Han-Eul; Whang, Kyu Uang; Lee, Young Ho; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon			Roles of TLR7 in Activation of NF-kappa B Signaling of Keratinocytes by Imiquimod	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; HUMAN EPIDERMAL-KERATINOCYTES; IMMUNE-RESPONSE MODIFIER; CYTOKINE GENE-EXPRESSION; ACID-SENSING TLRS; DENDRITIC CELLS; TOPICAL IMMUNOMODULATOR; AUTOIMMUNITY; PATHOGENESIS; RECOGNITION	Imiquimod is known to exert its effects through Toll-like receptor 7 (TLR7) and/or TLR8, resulting in expression of proinflammatory cytokines and chemokines. Keratinocytes have not been reported to constitutively express TLR7 and TLR8, and the action of imiquimod is thought to be mediated by the adenine receptor, not TLR7 or TLR8. In this study, we revealed the expression of TLR7 in keratinocytes after calcium-induced differentiation. After addition of calcium to cultured keratinocytes, the immunological responses induced by imiquimod, such as activation of NF-kappa B and induction of TNF-alpha and IL-8, were more rapid and stronger. In addition, imiquimod induced the expression TLR7, and acted synergistically with calcium to induce proinflammatory cytokines. We confirmed that the responses induced by imiquimod were significantly inhibited by microRNAs suppressing TLR7 expression. These results suggest that TLR7 expressed in keratinocytes play key roles in the activation of NF-kB signaling by imiquimod, and that their modulation in keratinocytes could provide therapeutic potential for many inflammatory skin diseases.	[Li, Zheng Jun; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Hong, Dongkyun; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea; [Li, Zheng Jun; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Hong, Dongkyun; Im, Myung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Res Inst Med Sci, Taejon, South Korea; [Shi, Ge] Guangdong Med Coll, Affiliated Hosp 1, Dept Dermatol, Zhanjiang, Peoples R China; [Lee, Han-Eul; Whang, Kyu Uang] Soonchunhyang Univ, Coll Med, Dept Dermatol, Cheonan, South Korea; [Lee, Young Ho] Chungnam Natl Univ, Sch Med, Dept Anat, Taejon, South Korea	Chungnam National University; Chungnam National University; Guangdong Medical University; Soonchunhyang University; Chungnam National University	Lee, JH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea.	jhoon@cnu.ac.kr		Lee, Young/0000-0001-9205-1785; Lee, Young Ho/0000-0001-8238-2345; Kim, Chang Deok/0000-0001-9341-6491; Seo, Young-Joon/0000-0002-4955-590X	Korea Ministry of Health and Welfare [2012RA1A2008920]	Korea Ministry of Health and Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Ministry of Health and Welfare (2012RA1A2008920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Bong AB, 2002, DERMATOLOGY, V205, P135, DOI 10.1159/000063904; De Pita O, 2011, INT J IMMUNOPATH PH, V24, P185, DOI 10.1177/039463201102400121; Deane JA, 2006, J IMMUNOL, V177, P6573, DOI 10.4049/jimmunol.177.10.6573; Fujisawa H, 1996, J INTERF CYTOK RES, V16, P555, DOI 10.1089/jir.1996.16.555; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Geisse JK, 2002, J AM ACAD DERMATOL, V47, P390, DOI 10.1067/mjd.2002.126215; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; KONO T, 1994, LYMPHOKINE CYTOK RES, V13, P71; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Lee Y, 2010, EXP DERMATOL, V19, pE44, DOI 10.1111/j.1600-0625.2009.00963.x; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Marek LR, 2011, FRONT BIOSCI-LANDMRK, V16, P2060, DOI 10.2741/3839; McInturff JE, 2005, J INVEST DERMATOL, V125, P1, DOI 10.1111/j.0022-202X.2004.23459.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miller LS, 2007, SEMIN IMMUNOPATHOL, V29, P15, DOI 10.1007/s00281-007-0061-8; Mohty M, 2003, J IMMUNOL, V171, P3385, DOI 10.4049/jimmunol.171.7.3385; Morizane S, 2012, J INVEST DERMATOL, V132, P135, DOI 10.1038/jid.2011.259; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Seo EY, 2005, GENOMICS, V86, P528, DOI 10.1016/j.ygeno.2005.06.013; Shi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054355; Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wu Jason K, 2004, Australas J Dermatol, V45, P47, DOI 10.1111/j.1440-0960.2004.00030.x	31	45	45	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77159	10.1371/journal.pone.0077159	http://dx.doi.org/10.1371/journal.pone.0077159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146965	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400102
J	Wang, YM; O'Connor, JK; Li, DQ; You, HL				Wang, Ya-Ming; O'Connor, Jingmai K.; Li, Da-Qing; You, Hai-Lu			Previously Unrecognized Ornithuromorph Bird Diversity in the Early Cretaceous Changma Basin, Gansu Province, Northwestern China	PLOS ONE			English	Article							ENANTIORNITHINE BIRD; AVES ORNITHOTHORACES; ORNITHURINE BIRD; FOSSIL BIRDS; EVOLUTION; MORPHOLOGY; CLADE	Here we report on three new species of ornithuromorph birds from the Lower Cretaceous Xiagou Formation in the Changma Basin of Gansu Province, northwestern China: Yumenornis huangi gen. et sp. nov., Changmaornis houi gen. et sp. nov., and Jiuquanornis niui gen. et sp. nov.. The last of these is based on a previously published but unnamed specimen: GSGM-05-CM-021. Although incomplete, the specimens can be clearly distinguished from each other and from Gansus yumenensis Hou and Liu, 1984. Phylogenetic analysis resolves the three new taxa as basal ornithuromorphs. This study reveals previously unrecognized ornithuromorph diversity in the Changma avifauna, which is largely dominated by Gansus but with at least three other ornithuromorphs. Body mass estimates demonstrate that enantiornithines were much smaller than ornithuromorphs in the Changma avifauna. In addition, Changma enantiornithines preserve long and recurved pedal unguals, suggesting an arboreal lifestyle; in contrast, Changma ornithuromorphs tend to show terrestrial or even aquatic adaptions. Similar differences in body mass and ecology are also observed in the Jehol avifauna in northeastern China, suggesting niche partitioning between these two clades developed early in their evolutionary history.	[Wang, Ya-Ming] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; [Wang, Ya-Ming; O'Connor, Jingmai K.; You, Hai-Lu] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [O'Connor, Jingmai K.; You, Hai-Lu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Li, Da-Qing] Gansu Geol Museum, Lanzhou, Gansu, Peoples R China	Chinese Academy of Geological Sciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wang, YM (corresponding author), Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China.	yaming21@hotmail.com		You, Hai-Lu/0000-0003-2203-6461	Hundred Talents Project of the Chinese Academy of Sciences; National Natural Science Foundation of China [40672007, 41072019]; Department of Land and Resources of Gansu Province	Hundred Talents Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Land and Resources of Gansu Province	This research was supported by the Hundred Talents Project of the Chinese Academy of Sciences, the National Natural Science Foundation of China (40672007,41072019), and the Department of Land and Resources of Gansu Province to LDQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnolin FL, 2009, J S AM EARTH SCI, V27, P42, DOI 10.1016/j.jsames.2008.09.003; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; Chiappe Luis M., 1995, Courier Forschungsinstitut Senckenberg, V181, P55; Clarke J, 2004, B AM MUS NAT HIST, P1; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; Clarke JA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)387<0001:TMAPPO>2.0.CO;2; Connor JKO, 2009, J VERTEBR PALEONTOL, V29, P188; Dyke GJ, 2010, GEOL J, V45, P434, DOI 10.1002/gj.1209; Novas FE, 2010, CR PALEVOL, V9, P499, DOI 10.1016/j.crpv.2010.09.005; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Harris JD, 2006, CAN J EARTH SCI, V43, P547, DOI 10.1139/E06-007; Hopson JA, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P211; Hou L., 1997, MESOZOIC BIRDS CHINA; HOU LH, 1984, SCI SIN B-CHEM B A M, V27, P1296; Ji S.-A, 2006, GEOLOGICAL B CHINA, V25, P1296; Ji SA, 2011, ZOOL J LINN SOC-LOND, V162, P201, DOI 10.1111/j.1096-3642.2010.00671.x; Kurochkin EN., 1982, PALAEONTOL J, V1982, P215; Lamanna MC, 2006, ACTA PALAEONTOL POL, V51, P423; [李岩 Li Yan], 2011, [古脊椎动物学报, Vertebrata Palasiatica], V49, P435; Linnaeus C, 1758, SYSTEMS NATURAE; Liu Di, 2012, Vertebrata Palasiatica, V50, P39; Martin LD, 1983, CURRENT ORNITHOLOGY, V4; Morschhauser EM, 2009, J VERTEBR PALEONTOL, V29, P545, DOI 10.1671/039.029.0210; Nudds RL, 2013, J EVOLUTION BIOL, V26, P150, DOI 10.1111/jeb.12036; O'Connor, 2009, SYSTEMATIC REV ENANT; O'Connor J.J.M., 2012, J EVOLUTIONARY PSYCH, V10, P1, DOI [10.1556/JEP.10.2012.1.1, DOI 10.1556/JEP.10.2012.1.1]; O'Connor JK, 2010, J VERTEBR PALEONTOL, V30, P311, DOI 10.1080/02724631003617498; O'Connor JK, 2011, LIVING DINOSAURS EVO; Suarez MB, 2013, GEOL SOC SPEC PUBL, V382, P143, DOI 10.1144/SP382.1; You H., 2005, HIST BIOL, V17, P7, DOI DOI 10.1080/08912960500284851; You HL, 2006, SCIENCE, V312, P1640, DOI 10.1126/science.1126377; You HL, 2010, ACTA PALAEONTOL POL, V55, P617, DOI 10.4202/app.2009.0095; Zhang Yu-Guang, 2008, Vertebrata Palasiatica, V46, P317; Zhou S, 2013, J VERTEBR PALEONTOL, V33, P141, DOI 10.1080/02724634.2012.714431; Zhou Shuang, 2012, Vertebrata Palasiatica, V50, P9; Zhou Z.-H., 2001, CHINESE SCI BULL, V46, P1, DOI DOI 10.1007/BF02900665; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P571, DOI 10.1007/s00114-004-0567-z; Zhou ZH, 2002, NATURE, V420, P285, DOI 10.1038/420285a; Zhou Zhong-He, 2009, Vertebrata Palasiatica, V47, P299; Zhou ZH, 2006, ZOOL SCR, V35, P363, DOI 10.1111/j.1463-6409.2006.00234.x	43	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77693	10.1371/journal.pone.0077693	http://dx.doi.org/10.1371/journal.pone.0077693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147058	gold, Green Published			2022-12-27	WOS:000325819400135
J	Acheson, SK; Bearison, C; Risher, ML; Abdelwahab, SH; Wilson, WA; Swartzwelder, HS				Acheson, Shawn K.; Bearison, Craig; Risher, M. Louise; Abdelwahab, Sabri H.; Wilson, Wilkie A.; Swartzwelder, H. Scott			Effects of Acute or Chronic Ethanol Exposure during Adolescence on Behavioral Inhibition and Efficiency in a Modified Water Maze Task	PLOS ONE			English	Article							COGNITIVE EFFICIENCY; RESPONSE-INHIBITION; SPATIAL MEMORY; BINGE DRINKING; ALCOHOL-USE; AGE; RATS; SENSITIVITY; WITHDRAWAL; DEFICITS	Ethanol is well known to adversely affect frontal executive functioning, which continues to develop throughout adolescence and into young adulthood. This is also a developmental window in which ethanol is misused by a significant number of adolescents. We examined the effects of acute and chronic ethanol exposure during adolescence on behavioral inhibition and efficiency using a modified water maze task. During acquisition, rats were trained to find a stable visible platform onto which they could escape. During the test phase, the stable platform was converted to a visible floating platform (providing no escape) and a new hidden platform was added in the opposite quadrant. The hidden platform was the only means of escape during the test phase. In experiment 1, adolescent animals received ethanol (1.0g/kg) 30min before each session during the test phase. In experiment 2, adolescent animals received chronic intermittent ethanol (5.0g/kg) for 16 days (PND30 To PND46) prior to any training in the maze. At PND72, training was initiated in the same modified water maze task. Results from experiment 1 indicated that acute ethanol promoted behavioral disinhibition and inefficiency. Experiment 2 showed that chronic intermittent ethanol during adolescence appeared to have no lasting effect on behavioral disinhibition or new spatial learning during adulthood. However, chronic ethanol did promote behavioral inefficiency. In summary, results indicate that ethanol-induced promotion of perseverative behavior may contribute to the many adverse behavioral sequelae of alcohol intoxication in adolescents and young adults. Moreover, the long-term effect of adolescent chronic ethanol exposure on behavioral efficiency is similar to that observed after chronic exposure in humans.	[Acheson, Shawn K.; Risher, M. Louise; Abdelwahab, Sabri H.; Wilson, Wilkie A.; Swartzwelder, H. Scott] Durham Vet Affairs Med Ctr, Neurobiol Res Lab, Durham, NC USA; [Acheson, Shawn K.; Risher, M. Louise; Abdelwahab, Sabri H.; Swartzwelder, H. Scott] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Bearison, Craig; Swartzwelder, H. Scott] Duke Univ, Dept Psychol, Durham, NC 27706 USA; [Bearison, Craig; Swartzwelder, H. Scott] Duke Univ, Dept Neurosci, Durham, NC USA; [Wilson, Wilkie A.] Duke Univ, Social Sci Res Inst, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; Duke University; Duke University	Acheson, SK (corresponding author), Durham Vet Affairs Med Ctr, Neurobiol Res Lab, Durham, NC USA.	shawn.acheson@duke.edu	Risher, Louise/AAP-2646-2020; Acheson, Shawn/A-3299-2016	Risher, Louise/0000-0002-3139-4378; Abdelwahab, Sabri/0000-0001-8745-570X; Bearison, Craig/0000-0003-4451-9560	National Institute of Alcoholism and Alcohol Abuse [U01-AA019925-01-NADIA]; Veteran Affairs Senior Research Career Scientist award; VA Career Development Award [I01BX007080]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA019925] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX001267] Funding Source: NIH RePORTER	National Institute of Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veteran Affairs Senior Research Career Scientist award; VA Career Development Award; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institute of Alcoholism and Alcohol Abuse grant U01-AA019925-01-NADIA to HSS; Veteran Affairs Senior Research Career Scientist award to HSS; VA Career Development Award I01BX007080 to SKA; The NIH and VA had no further role in the study design, collection, analysis, and interpretation of data, writing of the report, or decision to submit the article for publication.	Acheson SK, 1998, ALCOHOL CLIN EXP RES, V22, P1437, DOI 10.1111/j.1530-0277.1998.tb03932.x; Acheson SK, 2001, ALCOHOL, V23, P167, DOI 10.1016/S0741-8329(01)00127-6; Cain DP, 1996, BEHAV NEUROSCI, V110, P86, DOI 10.1037/0735-7044.110.1.86; Casbon TS, 2003, J ABNORM PSYCHOL, V112, P476, DOI 10.1037/0021-843X.112.3.476; Cha YM, 2006, ALCOHOL CLIN EXP RES, V30, P113, DOI 10.1111/j.1530-0277.2006.00005.x; Chin VS, 2011, ALCOHOL, V45, P473, DOI 10.1016/j.alcohol.2011.03.001; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Coleman LG, 2011, ALCOHOL CLIN EXP RES, V35, P671, DOI 10.1111/j.1530-0277.2010.01385.x; Dawson DA, 2004, J STUD ALCOHOL, V65, P477, DOI 10.15288/jsa.2004.65.477; DEVENPORT LD, 1983, PHARMACOL BIOCHEM BE, V18, P55, DOI 10.1016/0091-3057(83)90251-4; Doremus TL, 2003, PHARMACOL BIOCHEM BE, V75, P411, DOI 10.1016/S0091-3057(03)00134-5; Doremus-Fitzwater TL, 2007, ALCOHOL CLIN EXP RES, V31, P1516, DOI 10.1111/j.1530-0277.2007.00457.x; Doremus-Fitzwater TL, 2012, BEHAV NEUROSCI, V126, P735, DOI 10.1037/a0029697; Fillmore MT, 2000, J STUD ALCOHOL, V61, P239, DOI 10.15288/jsa.2000.61.239; Fleming RL, 2007, J NEUROPHYSIOL, V97, P3806, DOI 10.1152/jn.00101.2007; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goudriaan AE, 2007, ALCOHOL CLIN EXP RES, V31, P928, DOI 10.1111/j.1530-0277.2007.00378.x; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Hefner K, 2007, PSYCHOPHARMACOLOGY, V191, P311, DOI 10.1007/s00213-006-0646-2; Kroener S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037541; Little PJ, 1996, ALCOHOL CLIN EXP RES, V20, P1346, DOI 10.1111/j.1530-0277.1996.tb01133.x; Livy DJ, 2003, ALCOHOL, V29, P165, DOI 10.1016/S0741-8329(03)00025-9; LOH EA, 1989, ALCOHOL, V6, P311, DOI 10.1016/0741-8329(89)90088-8; LYVERS MF, 1991, BRIT J ADDICT, V86, P399; Lyvers M, 2010, ADDICT BEHAV, V35, P1021, DOI 10.1016/j.addbeh.2010.06.022; Malkki HAI, 2011, NEUROBIOL LEARN MEM, V96, P280, DOI 10.1016/j.nlm.2011.05.005; Markwiese BJ, 1998, ALCOHOL CLIN EXP RES, V22, P416, DOI 10.1111/j.1530-0277.1998.tb03668.x; Middlemore-Risher ML, 2010, NEUROTOXICOL TERATOL, V32, P415, DOI 10.1016/j.ntt.2010.03.008; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Newsletter N, 2004, NIAAA COUNCIL APPROV; Nixon SJ, 1998, ALCOHOL CLIN EXP RES, V22, P1414, DOI 10.1111/j.1530-0277.1998.tb03929.x; Nixon SJ, 1996, ALCOHOL CLIN EXP RES, V20, P21, DOI 10.1111/j.1530-0277.1996.tb01037.x; NIXON SJ, 1995, ALCOHOL CLIN EXP RES, V19, P577, DOI 10.1111/j.1530-0277.1995.tb01551.x; NIXON SJ, 1991, ALCOHOL CLIN EXP RES, V15, P601, DOI 10.1111/j.1530-0277.1991.tb00567.x; Novier A, 2012, NEUROSCI LETT, V512, P38, DOI 10.1016/j.neulet.2012.01.059; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Odell W. D., 1990, CONTROL ONSET PUBERT, P183; Pyapali GK, 1999, ALCOHOL, V19, P107, DOI 10.1016/S0741-8329(99)00021-X; Rajendran P, 2004, ANN NY ACAD SCI, V1021, P441, DOI 10.1196/annals.1308.060; Rhoads DE, 2012, PHARMACOL BIOCHEM BE, V102, P58, DOI 10.1016/j.pbb.2012.03.024; Risher ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062940; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Saucier D, 1996, BEHAV NEUROSCI, V110, P103, DOI 10.1037/0735-7044.110.1.103; SAUCIER D, 1995, NATURE, V378, P186, DOI 10.1038/378186a0; Silveri MM, 1998, ALCOHOL CLIN EXP RES, V22, P670, DOI 10.1111/j.1530-0277.1998.tb04310.x; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Swartzwelder HS, 1995, ALCOHOL CLIN EXP RES, V19, P1480, DOI 10.1111/j.1530-0277.1995.tb01011.x; SWARTZWELDER HS, 1995, ALCOHOL CLIN EXP RES, V19, P320, DOI 10.1111/j.1530-0277.1995.tb01509.x; TARTER RE, 1995, DRUG ALCOHOL DEPEN, V39, P15, DOI 10.1016/0376-8716(95)01129-M; Taylor SJ, 2013, DEV PSYCHOL, V49, P1253, DOI 10.1037/a0029871; Tivis LJ, 1999, PSYCHOL ADDICT BEHAV, V13, P284; Varlinskaya EI, 2004, ALCOHOL CLIN EXP RES, V28, P40, DOI 10.1097/01.ALC.0000108655.51087.DF; Vidal J, 2012, BRAIN COGNITION, V79, P49, DOI 10.1016/j.bandc.2011.12.011; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; White Aaron M, 2005, Recent Dev Alcohol, V17, P161, DOI 10.1007/0-306-48626-1_8; White AM, 2002, PHARMACOL BIOCHEM BE, V73, P673, DOI 10.1016/S0091-3057(02)00860-2	58	22	22	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77768	10.1371/journal.pone.0077768	http://dx.doi.org/10.1371/journal.pone.0077768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147077	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200074
J	Sampath, S; Bhat, S; Gupta, S; O'Connor, A; West, AB; Arking, DE; Chakravarti, A				Sampath, Srirangan; Bhat, Shambu; Gupta, Simone; O'Connor, Ashley; West, Andrew B.; Arking, Dan E.; Chakravarti, Aravinda			Defining the Contribution of CNTNAP2 to Autism Susceptibility	PLOS ONE			English	Article							CARRIER SLC25A12 GENE; GENOMIC SCREEN; GENOTYPE-IMPUTATION; SPECTRUM DISORDERS; UNIFIED APPROACH; ASSOCIATION; LINKAGE; CHILDREN; LOCI; SCAN	Multiple lines of genetic evidence suggest a role for CNTNAP2 in autism. To assess its population impact we studied 2148 common single nucleotide polymorphisms (SNPs) using transmission disequilibrium test (TDT) across the entire similar to 3.3 Mb CNTNAP2 locus in 186 (408 trios) multiplex and 323 simplex families with autistic spectrum disorder (ASD). This analysis yielded two SNPs with nominal statistical significance (rs17170073, p = 2.0 x 10(-4); rs2215798, p = 1.6 x 10(-4)) that did not survive multiple testing. In a combined analysis of all families, two highly correlated (r(2) = 0.99) SNPs in intron 14 showed significant association with autism (rs2710093, p = 9.0 x 10(-6); rs2253031, p = 2.5 x 10(-5)). To validate these findings and associations at SNPs from previous autism studies (rs7794745, rs2710102 and rs17236239) we genotyped 2051 additional families (572 multiplex and 1479 simplex). None of these variants were significantly associated with ASD after corrections for multiple testing. The analysis of Mendelian errors within each family did not indicate any segregating deletions. Nevertheless, a study of CNTNAP2 gene expression in brains of autistic patients and of normal controls, demonstrated altered expression in a subset of patients (p = 1.9 x 10(-5)). Consequently, this study suggests that although CNTNAP2 dysregulation plays a role in some cases, its population contribution to autism susceptibility is limited.	[Sampath, Srirangan; Bhat, Shambu; Gupta, Simone; O'Connor, Ashley; Arking, Dan E.; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21218 USA; [West, Andrew B.] Univ Alabama Birmingham, Dept Neurol & Neurobiol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham	Sampath, S (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21218 USA.	aravinda@jhmi.edu		West, Andrew/0000-0002-3034-4061	Simons Foundation [SFARI 102882]; National Institutes of Health (ACE Genetics Consortium) [MH081754]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052708, R24MH068855, R01MH081754, R01MH064547, R01MH100027, P01MH039437] Funding Source: NIH RePORTER	Simons Foundation; National Institutes of Health (ACE Genetics Consortium)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Simons Foundation (SFARI 102882 to AC) and the National Institutes of Health (ACE Genetics Consortium, MH081754) to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2005, MOL PSYCHIATR, V10, P747, DOI 10.1038/sj.mp.4001666; Alarcon M, 2002, AM J HUM GENET, V70, P60, DOI 10.1086/338241; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Ashley-Koch A, 1999, GENOMICS, V61, P227, DOI 10.1006/geno.1999.5968; Bailey A, 1998, HUM MOL GENET, V7, P571; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Barrett S, 1999, AM J MED GENET, V88, P609; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Brun CC, 2009, HUM BRAIN MAPP, V30, P3887, DOI 10.1002/hbm.20814; Cantor RM, 2005, AM J HUM GENET, V76, P1050, DOI 10.1086/430278; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Damarla SR, 2010, AUTISM RES, V3, P273, DOI 10.1002/aur.153; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; FOLSTEIN S, 1977, J CHILD PSYCHOL PSYC, V18, P297, DOI 10.1111/j.1469-7610.1977.tb00443.x; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Gupta AR, 2007, BIOL PSYCHIAT, V61, P429, DOI 10.1016/j.biopsych.2006.06.020; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lamb JA, 2005, J MED GENET, V42, P132, DOI 10.1136/jmg.2004.025668; Leveille C, 2010, AUTISM RES, V3, P280, DOI 10.1002/aur.155; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Molloy CA, 2005, MOL PSYCHIATR, V10, P741, DOI 10.1038/sj.mp.4001691; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Noonan SK, 2009, BRAIN RES, V1262, P48, DOI 10.1016/j.brainres.2008.12.076; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Palferman S, 2001, HUM MOL GENET, V10, P973; Palferman S, 2001, AM J HUM GENET, V69, P570; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Penagarikano O, 2011, CELL, V147, P235, DOI 10.1016/j.cell.2011.08.040; Petrin AL, 2010, AM J MED GENET A, V152A, P3164, DOI 10.1002/ajmg.a.33749; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poot M, 2010, NEUROGENETICS, V11, P81, DOI 10.1007/s10048-009-0205-1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radua J, 2011, PSYCHOL MED, V41, P1539, DOI 10.1017/S0033291710002187; Ramoz N, 2004, AM J PSYCHIAT, V161, P662, DOI 10.1176/appi.ajp.161.4.662; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Rossi E, 2008, EUR J MED GENET, V51, P631, DOI 10.1016/j.ejmg.2008.06.010; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schaaf CP, 2011, NEURON, V70, P806, DOI 10.1016/j.neuron.2011.05.025; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Segurado R, 2005, AM J PSYCHIAT, V162, P2182, DOI 10.1176/appi.ajp.162.11.2182; Shao YJ, 2002, AM J MED GENET, V114, P99, DOI 10.1002/ajmg.10153; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Stroganova TA, 2012, CORTEX, V48, P701, DOI 10.1016/j.cortex.2011.02.016; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Viding E, 2007, BEHAV GENET, V37, P51, DOI 10.1007/s10519-006-9105-4; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	70	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77906	10.1371/journal.pone.0077906	http://dx.doi.org/10.1371/journal.pone.0077906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147096	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200085
J	DeAnda, F; Hightower, KE; Nolte, RT; Hattori, K; Yoshinaga, T; Kawasuji, T; Underwood, MR				DeAnda, Felix; Hightower, Kendra E.; Nolte, Robert T.; Hattori, Kazunari; Yoshinaga, Tomokazu; Kawasuji, Takashi; Underwood, Mark R.			Dolutegravir Interactions with HIV-1 Integrase-DNA: Structural Rationale for Drug Resistance and Dissociation Kinetics	PLOS ONE			English	Article							VIRUS TYPE-1 INTEGRASE; PHOTO-CROSS-LINKING; VIRAL-DNA; NON-INFERIORITY; STRAND TRANSFER; DOUBLE-BLIND; NAIVE ADULTS; RALTEGRAVIR; INHIBITOR; BINDING	Signature HIV-1 integrase mutations associated with clinical raltegravir resistance involve 1 of 3 primary genetic pathways, Y143C/R, Q148H/K/R and N155H, the latter 2 of which confer cross-resistance to elvitegravir. In accord with clinical findings, in vitro drug resistance profiling studies with wild-type and site-directed integrase mutant viruses have shown significant fold increases in raltegravir and elvitegravir resistance for the specified viral mutants relative to wild-type HIV-1. Dolutegravir, in contrast, has demonstrated clinical efficacy in subjects failing raltegravir therapy due to integrase mutations at Y143, Q148 or N155, which is consistent with its distinct in vitro resistance profile as dolutegravir's antiviral activity against these viral mutants is equivalent to its activity against wild-type HIV-1. Kinetic studies of inhibitor dissociation from wild-type and mutant integrase-viral DNA complexes have shown that dolutegravir also has a distinct off-rate profile with dissociative half-lives substantially longer than those of raltegravir and elvitegravir, suggesting that dolutegravir's prolonged binding may be an important contributing factor to its distinct resistance profile. To provide a structural rationale for these observations, we constructed several molecular models of wild-type and clinically relevant mutant HIV-1 integrase enzymes in complex with viral DNA and dolutegravir, raltegravir or elvitegravir. Here, we discuss our structural models and the posited effects that the integrase mutations and the structural and electronic properties of the integrase inhibitors may have on the catalytic pocket and inhibitor binding and, consequently, on antiviral potency in vitro and in the clinic.	[DeAnda, Felix; Nolte, Robert T.] GlaxoSmithKline, Chem Sci, Res Triangle Pk, NC USA; [Hightower, Kendra E.] GlaxoSmithKline, Biol Sci, Res Triangle Pk, NC USA; [Hattori, Kazunari] Shionogi & Co Ltd, Discovery Chem, Osaka, Japan; [Yoshinaga, Tomokazu] Shionogi & Co Ltd, Infect Dis, Osaka, Japan; [Kawasuji, Takashi] Shionogi & Co Ltd, Chem Infect Dis, Osaka, Japan; [Underwood, Mark R.] GlaxoSmithKline, Med Dev Infect Dis, Res Triangle Pk, NC USA	GlaxoSmithKline; GlaxoSmithKline; Shionogi & Company Limited; Shionogi & Company Limited; Shionogi & Company Limited; GlaxoSmithKline	Underwood, MR (corresponding author), GlaxoSmithKline, Med Dev Infect Dis, Res Triangle Pk, NC USA.	mark.r.underwood@gsk.com		Underwood, Mark/0000-0002-6803-2346	ViiV Healthcare	ViiV Healthcare	Funding for this work was provided by ViiV Healthcare. The sponsor participated in the study design, data collection, data analysis, data interpretation and drafting of the report in collaboration with the authors.	Abram ME, 2013, ANTIMICROB AGENTS CH, V57, P2654, DOI 10.1128/AAC.02568-12; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen X, 2008, J MOL BIOL, V380, P504, DOI 10.1016/j.jmb.2008.04.054; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Dicker IB, 2008, J BIOL CHEM, V283, P23599, DOI 10.1074/jbc.M804213200; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Goethals O, 2011, ANTIVIR RES, V91, P167, DOI 10.1016/j.antiviral.2011.05.011; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Hightower KE, 2011, ANTIMICROB AGENTS CH, V55, P4552, DOI 10.1128/AAC.00157-11; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson BC, 2012, ANTIMICROB AGENTS CH, V56, P411, DOI 10.1128/AAC.05292-11; Karki RG, 2004, J COMPUT AID MOL DES, V18, P739, DOI 10.1007/s10822-005-0365-5; Kawasuji T, 2006, BIOORGAN MED CHEM, V14, P8430, DOI 10.1016/j.bmc.2006.08.044; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Markowitz M, 2007, JAIDS-J ACQ IMM DEF, V46, P125, DOI 10.1097/QAI.0b013e318157131c; Metifiot M, 2010, BIOCHEMISTRY-US, V49, P3715, DOI 10.1021/bi100130f; Molina JM, 2012, LANCET INFECT DIS, V12, P27, DOI 10.1016/S1473-3099(11)70249-3; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Steiniger-White M, 2004, CURR OPIN STRUC BIOL, V14, P50, DOI 10.1016/j.sbi.2004.01.008; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wielens J, 2005, J COMPUT AID MOL DES, V19, P301, DOI 10.1007/s10822-005-5256-2; Zhao Z, 2008, J BIOL CHEM, V283, P5632, DOI 10.1074/jbc.M705241200	34	23	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77448	10.1371/journal.pone.0077448	http://dx.doi.org/10.1371/journal.pone.0077448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146996	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400107
J	Dowdy, DW; Lotia, I; Azman, AS; Creswell, J; Sahu, S; Khan, AJ				Dowdy, David W.; Lotia, Ismat; Azman, Andrew S.; Creswell, Jacob; Sahu, Suvanand; Khan, Aamir J.			Population-Level Impact of Active Tuberculosis Case Finding in an Asian Megacity	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; ANNUAL RISK; TB; REINFECTION; MICROSCOPY; STRATEGIES; INFECTION; RELAPSE; HIV	Background: The potential population-level impact of private-sector initiatives for tuberculosis (TB) case finding in Southeast Asia remains uncertain. In 2011, the Indus Hospital TB Control Program in Karachi, Pakistan, undertook an aggressive case-finding campaign that doubled notification rates, providing an opportunity to investigate potential population-level effects. Methods: We constructed an age-structured compartmental model of TB in the intervention area. We fit the model using field and literature data, assuming that TB incidence equaled the estimated nationwide incidence in Pakistan (primary analysis), or 1.5 times greater (high-incidence scenario). We modeled the intervention as an increase in the rate of formal-sector TB diagnosis and evaluated the potential impact of sustaining this rate for five years. Results: In the primary analysis, the five-year intervention averted 24% (95% uncertainty range, UR: 18-30%) of five-year cumulative TB cases and 52% (95% UR: 45-57%) of cumulative TB deaths. Corresponding reductions in the high-incidence scenario were 12% (95% UR: 8-17%) and 27% (95% UR: 21-34%), although the absolute number of lives saved was higher. At the end of five years, TB notification rates in the primary analysis were below their 2010 baseline, incidence had dropped by 45%, and annual mortality had fallen by 72%. About half of the cumulative impact on incidence and mortality could be achieved with a one-year intervention. Conclusions: Sustained, multifaceted, and innovative approaches to TB case-finding in Asian megacities can have substantial community-wide epidemiological impact.	[Dowdy, David W.; Azman, Andrew S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Dowdy, David W.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Lotia, Ismat; Khan, Aamir J.] Interact Res & Dev, Karachi, Sindh, Pakistan; [Creswell, Jacob; Sahu, Suvanand] Stop TB Partnership, Geneva, Switzerland; [Khan, Aamir J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dowdy, DW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.	ddowdy@jhsph.edu		Azman, Andrew/0000-0001-8662-9077; Creswell, Jacob/0000-0002-4885-940X	TB REACH; Stop TB Partnership	TB REACH; Stop TB Partnership	This work was supported by TB REACH and the Stop TB Partnership. The primary modelers (DWD and ASA) received no dedicated funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Ayles H, 2012, SEATTL WASH 19 C RET; Ayles H, 2011, SYMPOSIUM; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Cauthen GM, 2002, B WORLD HEALTH ORGAN, V80, P503; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Dewan PK, 2006, BMJ-BRIT MED J, V332, P574, DOI 10.1136/bmj.38738.473252.7C; Dodd PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029130; Dye C, 2008, LANCET INFECT DIS, V8, P233, DOI 10.1016/S1473-3099(07)70291-8; Getahun H, 2010, LANCET, V376, P1205, DOI 10.1016/S0140-6736(10)61503-6; Golub JE, 2005, INT J TUBERC LUNG D, V9, P1183; Hinderaker SG, 2011, INT J TUBERC LUNG D, V15, P71; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Lonnroth K, 2003, INT J TUBERC LUNG D, V7, P165; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Shanaube K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007749; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wells WA, 2011, INT J TUBERC LUNG D, V15, P746, DOI 10.5588/ijtld.10.0094; Wells WA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018964; WHO, 2010, GLOB TUB CONTR 2010; World Health Organization, 2011, GLOB TUB CONTR WHO; Yimer S, 2009, INT J TUBERC LUNG D, V13, P1399; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	32	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77517	10.1371/journal.pone.0077517	http://dx.doi.org/10.1371/journal.pone.0077517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147015	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400118
J	Kovacs, E; Wirth, R; Maroti, G; Bagi, Z; Rakhely, G; Kovacs, KL				Kovacs, Etelka; Wirth, Roland; Maroti, Gergely; Bagi, Zoltan; Rakhely, Gabor; Kovacs, Kornel L.			Biogas Production from Protein-Rich Biomass: Fed-Batch Anaerobic Fermentation of Casein and of Pig Blood and Associated Changes in Microbial Community Composition	PLOS ONE			English	Article							WASTE-WATER TREATMENT; METHANOGENIC BACTERIA; CO-DIGESTION; BY-PRODUCTS; AMMONIA CONCENTRATIONS; METHANE FERMENTATION; REDUCING BACTERIUM; INDUSTRIAL-WASTE; GENOME SEQUENCE; CATTLE MANURE	It is generally accepted as a fact in the biogas technology that protein-rich biomass substrates should be avoided due to inevitable process inhibition. Substrate compositions with a low C/N ratio are considered difficult to handle and may lead to process failure, though protein-rich industrial waste products have outstanding biogas generation potential. This common belief has been challenged by using protein-rich substrates, i.e. casein and precipitated pig blood protein in laboratory scale continuously stirred mesophilic fed-batch biogas fermenters. Both substrates proved suitable for sustained biogas production (0.447 L CH4/g protein oDM, i.e. organic total solids) in high yield without any additives, following a period of adaptation of the microbial community. The apparent key limiting factors in the anaerobic degradation of these proteinaceous materials were the accumulation of ammonia and hydrogen sulfide. Changes in time in the composition of the microbiological community were determined by next-generation sequencing-based metagenomic analyses. Characteristic rearrangements of the biogas-producing community upon protein feeding and specific differences due to the individual protein substrates were recognized. The results clearly demonstrate that sustained biogas production is readily achievable, provided the system is well-characterized, understood and controlled. Biogas yields (0.45 L CH4/g oDM) significantly exceeding those of the commonly used agricultural substrates (0.25-0.28 L CH4/g oDM) were routinely obtained. The results amply reveal that these high-energy-content waste products can be converted to biogas, a renewable energy carrier with flexible uses that can replace fossil natural gas in its applications. Process control, with appropriate acclimation of the microbial community to the unusual substrate, is necessary. Metagenomic analysis of the microbial community by next-generation sequencing allows a precise determination of the alterations in the community composition in the course of the process.	[Kovacs, Etelka; Wirth, Roland; Bagi, Zoltan; Rakhely, Gabor; Kovacs, Kornel L.] Univ Szeged, Dept Biotechnol, Szeged, Hungary; [Maroti, Gergely] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Rakhely, Gabor; Kovacs, Kornel L.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary	Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Kovacs, KL (corresponding author), Univ Szeged, Dept Biotechnol, Szeged, Hungary.	kovacs.kornel@brc.mta.hu	Rakhely, Gabor/K-3696-2014; Dr. Wirth, Roland/L-8886-2018	Rakhely, Gabor/0000-0003-2557-3641; Dr. Wirth, Roland/0000-0002-2383-2323; Maroti, Gergely/0000-0002-3705-0461	EU [HUSRB/1002/214/041 IPA, HURO/1001/193/2.2.2. CBC, IEE/10/235 SI2.591589 GreenGasGrids];  [Baross_ALGOLABH OMFB-00356/2010];  [TAMOP 4.2.4.A/2-11-1-2012-0001];  [TAMOP-4.2.2/B-10/1-2010-0012]	EU(European Commission); ; ; 	This work was supported by EU projects HUSRB/1002/214/041 IPA, HURO/1001/193/2.2.2. CBC, and IEE/10/235 SI2.591589 GreenGasGrids. Funding from Baross_ALGOLABH OMFB-00356/2010, TAMOP 4.2.4.A/2-11-1-2012-0001 and TAMOP-4.2.2/B-10/1-2010-0012 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRING BK, 1994, WATER SCI TECHNOL, V30, P241, DOI 10.2166/wst.1994.0619; Andreesen J.R., 1989, INTRO PHYSL BIOCH GE; ANGELIDAKI I, 1993, APPL MICROBIOL BIOT, V38, P560; [Anonymous], 2013, International Patent, Patent No. [WO; 2013/038216 A1, 2013038216]; Banks CJ, 1999, WATER SCI TECHNOL, V40, P69, DOI 10.1016/S0273-1223(99)00365-0; Borja R, 1996, J ENVIRON SCI HEAL A, V31, P479, DOI 10.1080/10934529609376369; Braun R, 2003, APPL BIOCHEM BIOTECH, V109, P139, DOI 10.1385/ABAB:109:1-3:139; BRAUN R, 1981, BIOTECHNOL LETT, V3, P159; Caspari C., 2010, POULTRY EGG SECTORS; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; Coates JD, 2005, APPL ENVIRON MICROB, V71, P4728, DOI 10.1128/AEM.71.8.4728-4735.2005; CONRAD R, 1989, FEMS MICROBIOL ECOL, V62, P285, DOI 10.1111/j.1574-6968.1989.tb03382.x; Danish Environmental Protection Agency, SURV WAST SPREAD LAN; DEBAERE LA, 1984, WATER RES, V18, P543, DOI 10.1016/0043-1354(84)90201-X; Demirel B, 2002, J CHEM TECHNOL BIOT, V77, P743, DOI 10.1002/jctb.630; Edstrom M, 2003, APPL BIOCHEM BIOTECH, V109, P127, DOI 10.1385/ABAB:109:1-3:127; Entcheva P, 2001, APPL ENVIRON MICROB, V67, P89, DOI 10.1128/AEM.67.1.89-99.2001; Fardeau ML, 2000, INT J SYST EVOL MICR, V50, P2141, DOI 10.1099/00207713-50-6-2141; Fisher E, 2008, ANN NY ACAD SCI, V1125, P230, DOI 10.1196/annals.1419.006; Fonknechten N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-555; Gallert C, 1998, APPL MICROBIOL BIOT, V50, P495, DOI 10.1007/s002530051326; Gerardi M.H., 2003, MICROBIOLOGY ANAEROB; Grabkowsky B, 2009, WORLD POULT, V25; HAJARNIS SR, 1994, WORLD J MICROB BIOT, V10, P350, DOI 10.1007/BF00414879; Hansen H.K., 1996, WATER RES, V32, P5; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Hejnfelt A, 2009, BIOMASS BIOENERG, V33, P1046, DOI 10.1016/j.biombioe.2009.03.004; Hewitt C. J, 2010, COMPREHENSIVE BIOPRO, P295; Hill T., 2007, STAT METHODS APPL; Kaparaju P, 2002, WATER SCI TECHNOL, V45, P275, DOI 10.2166/wst.2002.0352; KAYHANIAN M, 1994, J CHEM TECHNOL BIOT, V59, P349, DOI 10.1002/jctb.280590406; KOSTER IW, 1988, BIOL WASTE, V25, P51, DOI 10.1016/0269-7483(88)90127-9; Kovacs KL, 2013, J BIOMED BIOTECHNOL, V2013, DOI [10.1155/2013/482653, DOI 10.1155/2013/482653.ACCESSED]; Krause L, 2008, J BIOTECHNOL, V136, P91, DOI 10.1016/j.jbiotec.2008.06.003; Krober M, 2009, J BIOTECHNOL, V142, P38, DOI 10.1016/j.jbiotec.2009.02.010; KROEKER EJ, 1979, J WATER POLLUT CON F, V51, P718; Kuratoriumfur Technik und Bauwesen in der Landwirtschaft, 2004, POS GAS LANDW BIOG; LAHRING B.K., 2003, ADV BIOCHEM ENG BIOT, V81; Luste S, 2010, BIORESOURCE TECHNOL, V101, P2657, DOI 10.1016/j.biortech.2009.10.071; Macias-Corral M, 2008, BIORESOURCE TECHNOL, V99, P8288, DOI 10.1016/j.biortech.2008.03.057; Magot M, 1997, INT J SYST BACTERIOL, V47, P818, DOI 10.1099/00207713-47-3-818; MCGHEE T J, 1968, Water and Sewage Works, V115, P162; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Minas K, 2011, FEMS MICROBIOL LETT, V325, P162, DOI 10.1111/j.1574-6968.2011.02424.x; Mitchell R, 2009, ENVIRON MICROBIOL; Nielsen HB, 2008, BIORESOURCE TECHNOL, V99, P7995, DOI 10.1016/j.biortech.2008.03.049; NISMAN B, 1954, BACTERIOL REV, V18, P16, DOI 10.1128/MMBR.18.1.16-42.1954; Acs N, 2013, BIORESOURCE TECHNOL, V131, P121, DOI 10.1016/j.biortech.2012.12.134; Nordmann W, 1977, UBERWACHTUNG SCHLAMM, V3, P77; Onyenwoke RU, 2007, INT J SYST EVOL MICR, V57, P2191, DOI 10.1099/ijs.0.65051-0; Parkin G.F., 1983, P 37 PURD IND WAST C; PARKIN GF, 1983, J WATER POLLUT CON F, V55, P44; Pelletier E, 2008, J BACTERIOL, V190, P2572, DOI 10.1128/JB.01248-07; PERLE M, 1995, WATER RES, V29, P1549, DOI 10.1016/0043-1354(94)00248-6; Pohland F G, 1971, Environ Lett, V1, P255; Rajeshwari KV, 2000, RENEW SUST ENERG REV, V4, P135, DOI 10.1016/S1364-0321(99)00014-3; Ramsay IR, 2001, BIODEGRADATION, V12, P247, DOI 10.1023/A:1013116728817; Schluter A, 2008, J BIOTECHNOL, V136, P77, DOI 10.1016/j.jbiotec.2008.05.008; Schnurer A, 2008, WATER SCI TECHNOL, V57, P735, DOI 10.2166/wst.2008.097; SPROTT GD, 1986, SYST APPL MICROBIOL, V7, P358; SPROTT GD, 1984, J BIOL CHEM, V259, P2602; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Symons GE, 1933, J AM CHEM SOC, V55, P2028, DOI 10.1021/ja01332a039; Tafdrup S, 1995, BIOMASS BIOENERG, V9, P303, DOI 10.1016/0961-9534(95)00098-4; van Bodegom PM, 2004, FEMS MICROBIOL ECOL, V49, P261, DOI 10.1016/j.femsec.2004.03.017; VDI 4630, 2006, VEREIN DTSCH INGENIE; Vigneron V, 2007, 11 INT WAST MAN LAND; Westerholm M, 2012, BIORESOURCE TECHNOL, V114, P314, DOI 10.1016/j.biortech.2012.03.005; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Ye Q, 2004, APPL ENVIRON MICROB, V70, P5595, DOI 10.1128/AEM.70.9.5595-5602.2004	70	64	64	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77265	10.1371/journal.pone.0077265	http://dx.doi.org/10.1371/journal.pone.0077265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146974	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000326019400098
J	Vega, RP; van Leeuwen, PM; Velez, ER; Lemij, HG; de Winter, JCF				Vega, Rocio Prado; van Leeuwen, Peter M.; Velez, Elizabeth Rendon; Lemij, Hans G.; de Winter, Joost C. F.			Obstacle Avoidance, Visual Detection Performance, and Eye-Scanning Behavior of Glaucoma Patients in a Driving Simulator: A Preliminary Study	PLOS ONE			English	Article							MOTOR-VEHICLE COLLISIONS; FIELD-OF-VIEW; ON-ROAD; OLDER DRIVERS; IMPAIRMENT; REAL; RISK; VIOLATIONS; DEFECTS; FITNESS	The objective of this study was to evaluate differences in driving performance, visual detection performance, and eye-scanning behavior between glaucoma patients and control participants without glaucoma. Glaucoma patients (n = 23) and control participants (n = 12) completed four 5-min driving sessions in a simulator. The participants were instructed to maintain the car in the right lane of a two-lane highway while their speed was automatically maintained at 100 km/h. Additional tasks per session were: Session 1: none, Session 2: verbalization of projected letters, Session 3: avoidance of static obstacles, and Session 4: combined letter verbalization and avoidance of static obstacles. Eye-scanning behavior was recorded with an eye-tracker. Results showed no statistically significant differences between patients and control participants for lane keeping, obstacle avoidance, and eye-scanning behavior. Steering activity, number of missed letters, and letter reaction time were significantly higher for glaucoma patients than for control participants. In conclusion, glaucoma patients were able to avoid objects and maintain a nominal lane keeping performance, but applied more steering input than control participants, and were more likely than control participants to miss peripherally projected stimuli. The eye-tracking results suggest that glaucoma patients did not use extra visual search to compensate for their visual field loss. Limitations of the study, such as small sample size, are discussed.	[Vega, Rocio Prado; van Leeuwen, Peter M.; Velez, Elizabeth Rendon; de Winter, Joost C. F.] Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands; [Lemij, Hans G.] ROI, Rotterdam, Netherlands; [Lemij, Hans G.] REH, Rotterdam, Netherlands	Delft University of Technology	de Winter, JCF (corresponding author), Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands.	j.c.f.dewinter@tudelft.nl	de Winter, Joost/AAD-7043-2020	de Winter, Joost/0000-0002-1281-8200; Rendon-Velez, Elizabeth/0000-0001-6624-5930	Dutch Technology Foundation (Stichting voor de Technische Wetenschappen); Applied Science Division of the Netherlands Organisation for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); Technology Program of the Ministry of Economic Affairs	Dutch Technology Foundation (Stichting voor de Technische Wetenschappen); Applied Science Division of the Netherlands Organisation for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); Technology Program of the Ministry of Economic Affairs	The research of Joost de Winter was supported by the Dutch Technology Foundation (Stichting voor de Technische Wetenschappen), the Applied Science Division of the Netherlands Organisation for Scientific Research (Nederlandse Organisatie voor Wetenschappelijk Onderzoek), and the Technology Program of the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinwuntan AE, 2003, ARCH PHYS MED REHAB, V84, P1792, DOI 10.1016/S0003-9993(03)00767-6; Baughan C, 2002, 529 TRL; Bowers A, 2005, OPTOMETRY VISION SCI, V82, P657, DOI 10.1097/01.opx.0000175558.33268.b5; Bowers AR, 2009, INVEST OPHTH VIS SCI, V50, P5137, DOI 10.1167/iovs.09-3799; Brookhuis KA, 2003, ERGONOMICS, V46, P433, DOI 10.1080/001401302/1000039556; Coeckelbergh TRM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1509, DOI 10.1001/archopht.120.11.1509; Crabb DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009710; Crabb DP, 2004, BRIT J OPHTHALMOL, V88, P1191, DOI 10.1136/bjo.2003.035949; de Winter JCF, 2013, ACCIDENT ANAL PREV, V52, P71, DOI 10.1016/j.aap.2012.12.018; de Winter JCF, 2008, IEEE T SYST MAN CY B, V38, P189, DOI 10.1109/TSMCB.2007.908860; Deary IJ, 2011, BEHAV RES METHODS, V43, P258, DOI 10.3758/s13428-010-0024-1; Dijksterhuis C, 2011, ACCIDENT ANAL PREV, V43, P1074, DOI 10.1016/j.aap.2010.12.014; Engstrom J, 2005, TRANSPORT RES F-TRAF, V8, P97, DOI 10.1016/j.trf.2005.04.012; Fiedler K, 2012, PERSPECT PSYCHOL SCI, V7, P661, DOI 10.1177/1745691612462587; Gallimore JJ, 1998, HUM FAC ERG SOC P, P6; Hart S.G., 2006, P HUM FACT ERG SOC A, DOI [10.1177/154193120605000909, DOI 10.1177/154193120605000909]; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Horberry T, 2006, ACCIDENT ANAL PREV, V38, P185, DOI 10.1016/j.aap.2005.09.007; Hornof AJ, 2002, BEHAV RES METH INS C, V34, P592, DOI 10.3758/BF03195487; Hu PS, 1998, ACCIDENT ANAL PREV, V30, P569, DOI 10.1016/S0001-4575(98)00019-0; Hunt LA, 1997, ALZ DIS ASSOC DIS, V11, P13, DOI 10.1097/00002093-199706001-00004; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jagacinski R. J., 2011, CONTROL THEORY HUMAN; Kasper EF, 1997, P SOC PHOTO-OPT INS, V3058, P34, DOI 10.1117/12.276658; Kirby E, 2010, J ALZHEIMERS DIS, V21, P15, DOI 10.3233/JAD-2010-080785; Lee HC, 2003, ACCIDENT ANAL PREV, V35, P797, DOI 10.1016/S0001-4575(02)00083-0; Lin JJW, 2002, P IEEE VIRT REAL ANN, P164, DOI 10.1109/VR.2002.996519; Lockhart J, 2009, 811062 DOT HS NAT HI; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; MCRUER DT, 1967, IEEE TRANS HUM FACT, VHFE8, P231, DOI 10.1109/THFE.1967.234304; Medeiros FA, 2012, J GLAUCOMA, V21, P221, DOI 10.1097/IJG.0b013e3182071832; Mudge JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032734; Owen VMF, 2008, INVEST OPHTH VIS SCI, V49, P2449, DOI 10.1167/iovs.07-0877; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Parrish R K 2nd, 1996, Trans Am Ophthalmol Soc, V94, P919; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramulu PY, 2009, OPHTHALMOLOGY, V116, P1846, DOI 10.1016/j.ophtha.2009.03.033; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; RIZZO M, 2002, GERONTECHNOLOGY, V1, P291; Rosen P, 2011, P INT DRIV S HUM FAC, P233; Saffarian M, 2012, ERGONOMICS, V55, P971, DOI 10.1080/00140139.2012.691993; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Santos J, 2005, TRANSPORT RES F-TRAF, V8, P135, DOI 10.1016/j.trf.2005.04.001; Saunders LJ, 2012, BRIT J OPHTHALMOL, V96, P1185, DOI 10.1136/bjophthalmol-2012-301827; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Szlyk JP, 2002, J REHABIL RES DEV, V39, P467; Szoboszlay Z, 1995, P SOC PHOTO-OPT INS, P142; Underwood G, 2011, TRANSPORT RES F-TRAF, V14, P435, DOI 10.1016/j.trf.2011.04.008	52	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77294	10.1371/journal.pone.0077294	http://dx.doi.org/10.1371/journal.pone.0077294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146975	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400099
J	Aldaz, B; Sagardoy, A; Nogueira, L; Guruceaga, E; Grande, L; Huse, JT; Aznar, MA; Diez-Valle, R; Tejada-Solis, S; Alonso, MM; Fernandez-Luna, JL; Martinez-Climent, JA; Malumbres, R				Aldaz, Beatriz; Sagardoy, Ainara; Nogueira, Lorena; Guruceaga, Elizabeth; Grande, Lara; Huse, Jason T.; Aznar, Maria A.; Diez-Valle, Ricardo; Tejada-Solis, Sonia; Alonso, Marta M.; Fernandez-Luna, Jose L.; Martinez-Climent, Jose A.; Malumbres, Raquel			Involvement of miRNAs in the Differentiation of Human Glioblastoma Multiforme Stem-Like Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; TARGET RECOGNITION; SELF-RENEWAL; BRAIN-TUMORS; IN-VITRO; EXPRESSION; GLIOMA; MICRORNAS; INHIBIT; GROWTH	Glioblastoma multiforme (GBM)-initiating cells (GICs) represent a tumor subpopulation with neural stem cell-like properties that is responsible for the development, progression and therapeutic resistance of human GBM. We have recently shown that blockade of NF kappa B pathway promotes terminal differentiation and senescence of GICs both in vitro and in vivo, indicating that induction of differentiation may be a potential therapeutic strategy for GBM. MicroRNAs have been implicated in the pathogenesis of GBM, but a high-throughput analysis of their role in GIC differentiation has not been reported. We have established human GIC cell lines that can be efficiently differentiated into cells expressing astrocytic and neuronal lineage markers. Using this in vitro system, a microarray-based high-throughput analysis to determine global expression changes of microRNAs during differentiation of GICs was performed. A number of changes in the levels of microRNAs were detected in differentiating GICs, including overexpression of hsa-miR-21, hsa-miR-29a, hsa-miR-29b, hsa-miR-221 and hsa-miR-222, and down-regulation of hsa-miR-93 and hsa-miR-106a. Functional studies showed that miR-21 over-expression in GICs induced comparable cell differentiation features and targeted SPRY1 mRNA, which encodes for a negative regulator of neural stem-cell differentiation. In addition, miR-221 and miR-222 inhibition in differentiated cells restored the expression of stem cell markers while reducing differentiation markers. Finally, miR-29a and miR-29b targeted MCL1 mRNA in GICs and increased apoptosis. Our study uncovers the microRNA dynamic expression changes occurring during differentiation of GICs, and identifies miR-21 and miR-221/222 as key regulators of this process.	[Aldaz, Beatriz; Sagardoy, Ainara; Aznar, Maria A.; Alonso, Marta M.; Martinez-Climent, Jose A.; Malumbres, Raquel] Univ Navarra, Div Oncol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Nogueira, Lorena; Grande, Lara; Fernandez-Luna, Jose L.] Hosp Univ Marques de Valdecilla, Mol Genet Unit, Santander, Spain; [Nogueira, Lorena; Grande, Lara; Fernandez-Luna, Jose L.] Inst Formac & Invest Marques de Valdecilla IFIMA, Santander, Spain; [Guruceaga, Elizabeth] Univ Navarra, Unit Prote Genom & Bioinformat, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Aldaz, Beatriz; Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Diez-Valle, Ricardo; Tejada-Solis, Sonia] Univ Navarra Clin, Dept Neurosurg, Pamplona, Spain	University of Navarra; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); University of Navarra; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Navarra	Martinez-Climent, JA (corresponding author), Univ Navarra, Div Oncol, Ctr Appl Med Res CIMA, E-31080 Pamplona, Spain.	jamcliment@unav.es; rmalumbres@unav.es	Martinez-Climent, Jose A/I-9199-2012; Alonso, Marta M/AAI-9457-2020; Malumbres, Raquel/N-3745-2014; Aznar Gomez, M Angela/K-1925-2014; Aznar, M Angela/K-1688-2014; Guruceaga, Elizabeth/B-1796-2008	Martinez-Climent, Jose A/0000-0002-7938-3950; Alonso, Marta M/0000-0002-7520-7351; Malumbres, Raquel/0000-0003-0767-9442; Aznar Gomez, M Angela/0000-0002-7970-1672; Aznar, M Angela/0000-0002-7970-1672; Guruceaga, Elizabeth/0000-0003-0547-681X	Instituto de Salud Carlos III-FIS, Spanish Ministries of Science, Innovation and Health [PI11/00684, PI10/02002, PI12/0202]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC) [RD12/0036/0063, RD06/0020/0074, RD12/0036/0022]; Fundacion Mutua Madrilena [FMM 8553/2011]; Spanish Association Against Cancer (AECC) Scientific Foundation; Instituto de Formacion e Investigacion Marques de Valdecilla [API2011-04]; Instituto de Salud Carlos III-FIS	Instituto de Salud Carlos III-FIS, Spanish Ministries of Science, Innovation and Health; Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Association Against Cancer (AECC) Scientific Foundation; Instituto de Formacion e Investigacion Marques de Valdecilla; Instituto de Salud Carlos III-FIS(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by Grants from the Instituto de Salud Carlos III-FIS, Spanish Ministries of Science, Innovation and Health (PI11/00684 to R. M., PI10/02002 to J.L.F.-L. and PI12/0202 to J.A.M.-C.); from Red Tematica de Investigacion Cooperativa en Cancer (RTICC, RD12/0036/0063 to J.A.M.-C. and RD06/0020/0074 and RD12/0036/0022 to J.L.F.-L.); from Fundacion Mutua Madrilena (FMM 8553/2011 to R. M.); from the Spanish Association Against Cancer (AECC) Scientific Foundation (to R. M.); and from Instituto de Formacion e Investigacion Marques de Valdecilla (API2011-04). B. A. work was supported by a predoctoral fellowship from Instituto de Salud Carlos III-FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Cormack B, 2001, CURR PROTOC NEUROSCI, V4; Corsten MF, 2007, CANCER RES, V67, P8994, DOI 10.1158/0008-5472.CAN-07-1045; Day BW, 2011, NEUROONCOLOGY; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faedo A, 2010, J NEUROSCI, V30, P4015, DOI 10.1523/JNEUROSCI.0307-10.2010; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Gomes AL, 2007, CELL ONCOL, V29, P399; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo JJ, 2012, PATHOL ONCOL RES, V18, P1047, DOI 10.1007/s12253-012-9543-7; Hamada N, 2012, NEUROCHEM INT, V60, P743, DOI 10.1016/j.neuint.2012.03.010; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang YW, 2011, NEOPLASIA, V13, P492, DOI 10.1593/neo.11314; Jung JE, 2012, STEM CELLS DEV, V21, P554, DOI 10.1089/scd.2011.0110; Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Mathupala SP, 2006, TECHNOL CANCER RES T, V5, P261, DOI 10.1177/153303460600500313; Miller CR, 2007, ARCH PATHOL LAB MED, V131, P397; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nogueira L, 2011, ONCOGENE, V30, P3537, DOI 10.1038/onc.2011.74; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Ruiz-Ontanon P, 2013, STEM CELLS, V31, P1075, DOI 10.1002/stem.1349; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Zhang JX, 2010, INT J ONCOL, V36, P913, DOI 10.3892/ijo_00000570; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003; Zhou XA, 2010, ONCOL REP, V24, P195, DOI 10.3892/or_00000846	48	56	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77098	10.1371/journal.pone.0077098	http://dx.doi.org/10.1371/journal.pone.0077098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155920	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300054
J	Bucur, O; Stancu, AL; Goganau, I; Petrescu, SM; Pennarun, B; Bertomeu, T; Dewar, R; Khosravi-Far, R				Bucur, Octavian; Stancu, Andreea Lucia; Goganau, Ioana; Petrescu, Stefana Maria; Pennarun, Bodvael; Bertomeu, Thierry; Dewar, Rajan; Khosravi-Far, Roya			Combination of Bortezomib and Mitotic Inhibitors Down-Modulate Bcr-Abl and Efficiently Eliminates Tyrosine-Kinase Inhibitor Sensitive and Resistant Bcr-Abl-Positive Leukemic Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITORS; BONE-MARROW MICROENVIRONMENT; ADAPTER PROTEIN CRKL; TUMOR MICROENVIRONMENT; INDUCED APOPTOSIS; INDUCE APOPTOSIS; IMATINIB; ACTIVATION; CANCER	Emergence of resistance to Tyrosine-Kinase Inhibitors (TKIs), such as imatinib, dasatinib and nilotinib, in Chronic Myelogenous Leukemia (CML) demands new therapeutic strategies. We and others have previously established bortezomib, a selective proteasome inhibitor, as an important potential treatment in CML. Here we show that the combined regimens of bortezomib with mitotic inhibitors, such as the microtubule-stabilizing agent Paclitaxel and the PLK1 inhibitor BI2536, efficiently kill TKIs-resistant and -sensitive Bcr-Abl-positive leukemic cells. Combined treatment activates caspases 8, 9 and 3, which correlate with caspase-induced PARP cleavage. These effects are associated with a marked increase in activation of the stress-related MAP kinases p38MAPK and JNK. Interestingly, combined treatment induces a marked decrease in the total and phosphorylated Bcr-Abl protein levels, and inhibits signaling pathways downstream of Bcr-Abl: downregulation of STAT3 and STAT5 phosphorylation and/or total levels and a decrease in phosphorylation of the Bcr-Abl-associated proteins CrkL and Lyn. Moreover, we found that other mitotic inhibitors (Vincristine and Docetaxel), in combination with bortezomib, also suppress the Bcr-Abl-induced pro-survival signals and result in caspase 3 activation. These results open novel possibilities for the treatment of Bcr-Abl-positive leukemias, especially in the imatinib, dasatinib and nilotinib-resistant CML cases.	[Bucur, Octavian; Stancu, Andreea Lucia; Goganau, Ioana; Pennarun, Bodvael; Bertomeu, Thierry; Dewar, Rajan; Khosravi-Far, Roya] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bucur, Octavian; Stancu, Andreea Lucia; Goganau, Ioana; Pennarun, Bodvael; Bertomeu, Thierry; Dewar, Rajan; Khosravi-Far, Roya] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Bucur, Octavian; Petrescu, Stefana Maria] Romanian Acad, Inst Biochem, Bucharest, Romania; [Stancu, Andreea Lucia; Goganau, Ioana] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Khosravi-Far, Roya] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Romanian Academy of Sciences; Institute of Biochemistry, Bucharest; Carol Davila University of Medicine & Pharmacy; Harvard University; Harvard Medical School	Khosravi-Far, R (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	rkhosrav@bidmc.harvard.edu	Dewar, Rajan/L-2883-2019; Petrescu, Stefana/AAJ-9505-2021; Bucur, Octavian/G-2823-2010; Dewar, Rajan/AAW-2571-2021; Petrescu, Stefana M/I-9240-2012	Petrescu, Stefana/0000-0002-4047-0811; Bucur, Octavian/0000-0002-8501-588X; Petrescu, Stefana M/0000-0002-4047-0811; Bertomeu, Thierry/0000-0002-5313-7057	Lady TATA Memorial Trust, London, UK; Romanian Ministry of Education and Research; National Institutes of Health [CA105306, CA131664, HL080192]; NATIONAL CANCER INSTITUTE [R01CA131664, R01CA105306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080192] Funding Source: NIH RePORTER	Lady TATA Memorial Trust, London, UK; Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Octavian Bucur received a fellowship from the Lady TATA Memorial Trust, London, UK. Ioana Goganau received a fellowship from Romanian Ministry of Education and Research. This work was also supported by the National Institutes of Health grants CA105306, CA131664, and HL080192 (to Roya Khosravi-Far). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewry NN, 2008, MOL CANCER THER, V7, P3169, DOI 10.1158/1535-7163.MCT-08-0314; Bucur O, 2006, FRONT BIOSCI-LANDMRK, V11, P1549, DOI 10.2741/1903; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coppo P, 2003, ONCOGENE, V22, P4102, DOI 10.1038/sj.onc.1206607; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Cortes J, 2012, BLOOD, V120, P2573, DOI 10.1182/blood-2012-03-415307; Dai Y, 2004, BLOOD, V104, P509, DOI 10.1182/blood-2003-12-4121; Dai Y, 2001, CANCER RES, V61, P5106; Dewar R, 2011, CANCER BIOL THER, V11, P552, DOI 10.4161/cbt.11.6.14675; Etet PFS, 2012, CELL SIGNAL, V24, P1883, DOI 10.1016/j.cellsig.2012.05.015; Gangemi RMR, 2000, INT J CANCER, V85, P527, DOI 10.1002/(SICI)1097-0215(20000215)85:4<527::AID-IJC14>3.0.CO;2-#; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Gleixner KV, 2010, CANCER RES, V70, P1513, DOI 10.1158/0008-5472.CAN-09-2181; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Habermann TM, 2012, HEMATOLOGY, V17, pS93, DOI 10.1179/102453312X13336169156014; Hantschel O, 2012, NAT CHEM BIOL, V8, P285, DOI [10.1038/NCHEMBIO.775, 10.1038/nchembio.775]; He YP, 2002, BLOOD, V99, P2957, DOI 10.1182/blood.V99.8.2957; Hemmeryckx B, 2001, CANCER RES, V61, P1398; Hotchkiss KA, 2002, MOL CANCER THER, V1, P1191; Jagani Z, 2008, BBA-REV CANCER, V1785, P63, DOI 10.1016/j.bbcan.2007.10.003; Jagani Z, 2009, CANCER RES, V69, P6546, DOI 10.1158/0008-5472.CAN-09-0605; Johnson KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007439; Khoury HJ, 2012, BLOOD, V119, P3403, DOI 10.1182/blood-2011-11-390120; Kim SY, 2011, ANN DERMATOL, V23, P504, DOI 10.5021/ad.2011.23.4.504; Marech I, 2012, INT J ONCOL, V40, P1313, DOI 10.3892/ijo.2012.1364; Mehnert JM, 2011, MOL CANCER THER, V10, P1509, DOI 10.1158/1535-7163.MCT-10-0944; Melet A, 2008, ADV EXP MED BIOL, V615, P47, DOI 10.1007/978-1-4020-6554-5_4; Mizuno H, 2012, LEUKEMIA, V26, P2269, DOI 10.1038/leu.2012.81; Mow BMF, 2002, BLOOD, V99, P664, DOI 10.1182/blood.V99.2.664; Myssina S, 2009, EXP HEMATOL, V37, P206, DOI 10.1016/j.exphem.2008.10.013; Nardi V, 2009, BLOOD, V113, P3813, DOI 10.1182/blood-2008-07-167189; Nimmanapalli R, 2002, CANCER RES, V62, P5761; Nimmanapalli R, 2003, BLOOD, V101, P3236, DOI 10.1182/blood-2002-08-2675; Plati J, 2008, J CELL BIOCHEM, V104, P1124, DOI 10.1002/jcb.21707; Plati J, 2011, INTEGR BIOL-UK, V3, P279, DOI 10.1039/c0ib00144a; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Ptasznik A, 2002, J EXP MED, V196, P667, DOI 10.1084/jem.20020519; Ray S, 2005, APOPTOSIS, V10, P1411, DOI 10.1007/s10495-005-2490-y; Razzak Mina, 2013, Nat Rev Clin Oncol, V10, P65, DOI 10.1038/nrclinonc.2012.226; Santos FPS, 2011, CL LYMPH MYELOM LEUK, V11, P355, DOI 10.1016/j.clml.2011.06.004; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; Seo JH, 2010, CANCER RES, V70, P7325, DOI 10.1158/0008-5472.CAN-10-0607; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Stein SJ, 2011, ONCOGENE, V30, P4557, DOI 10.1038/onc.2011.156; Uemura N, 1999, J BIOL CHEM, V274, P37525, DOI 10.1074/jbc.274.53.37525; Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; Wei GQ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-47; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wohrle FU, 2013, LEUKEMIA, V27, P118, DOI 10.1038/leu.2012.222; Wu J, 2008, J NATL CANCER I, V100, P926, DOI 10.1093/jnci/djn188; Wu J, 2008, BLOOD, V111, P3821, DOI 10.1182/blood-2007-08-109330; Yu CR, 2003, BLOOD, V102, P3765, DOI 10.1182/blood-2003-03-0737; Yu CR, 2003, CANCER RES, V63, P2118; Yusuf RZ, 2012, NAT MED, V18, P865, DOI 10.1038/nm.2831	55	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77390	10.1371/journal.pone.0077390	http://dx.doi.org/10.1371/journal.pone.0077390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155950	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300084
J	Cuervo, G; Garcia-Vidal, C; Nucci, M; Puchades, F; Fernandez-Ruiz, M; Mykietiuk, A; Manzur, A; Gudiol, C; Peman, J; Viasus, D; Ayats, J; Carratala, J				Cuervo, Guillermo; Garcia-Vidal, Carolina; Nucci, Marcio; Puchades, Francesc; Fernandez-Ruiz, Mario; Mykietiuk, Analia; Manzur, Adriana; Gudiol, Carlota; Peman, Javier; Viasus, Diego; Ayats, Josefina; Carratala, Jordi			Effect of Statin Use on Outcomes of Adults with Candidemia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ESCMID-ASTERISK GUIDELINE; BLOOD-STREAM INFECTIONS; MORTALITY; EPIDEMIOLOGY; THERAPY; MANAGEMENT; SEPSIS; SIMVASTATIN; DIAGNOSIS	Background: Statins have immunomodulatory properties and hinder Candida growth. However, it is unknown whether they may improve prognosis in patients with candidemia. We sought to determine the effect of prior statin use on the clinical outcomes of patients suffering candidemia. Methods and Findings: Multicenter cohort study of hospitalized adults with candidemia between 2005 and 2011 in six hospitals in Spain, Brazil and Argentina. Of 326 candidemias, 44 (13.5%) occurred in statin users and 282 (86.5%) in statin non-users. The median value of APACHE II at candidemia diagnosis was similar between groups (18 vs. 16; p=.36). Candida albicans was the most commonly isolated species, followed by C. parapsilosis, C. tropicalis, C. glabrata, and C. krusei. There were no differences regarding appropriate empirical antifungal treatment. Statin users had a lower early (5 d) case-fatality rate than non-users (4.5 vs. 17%; p=031). This effect was not observed with other cardiovascular drugs (aspirin, beta blockers and ACE inhibitors). Independent factor related to early case-fatality rate was APACHE II score (AOR, 1.08; 95% CI, 1.03-1.14; p=.002). An appropriate empirical antifungal therapy (AOR, 0.11; 95% CI, 0.04-0.26; p=<001) and prior statin use were independently associated with lower early case-fatality (AOR, 0.17; 95% CI, 0.03-0.93; p=.041). Fourteen days (14d) and overall (30d) case-fatality rates were similar between groups (27% vs. 29%; p=0.77 and 40% vs. 44%; p=.66). Conclusions: The use of statins might have a beneficial effect on outcomes of patients with candidemia. This hypothesis deserves further evaluation in randomized trials.	[Cuervo, Guillermo; Garcia-Vidal, Carolina; Gudiol, Carlota; Viasus, Diego; Ayats, Josefina; Carratala, Jordi] Univ Barcelona, IDIBELL Inst Invest Biomed Bellvitge, Hosp Univ Bellvitge, Barcelona, Spain; [Nucci, Marcio] Univ Fed Rio de Janeiro, Univ Hosp, Rio De Janeiro, Brazil; [Puchades, Francesc; Peman, Javier] Hosp Univ & Politecn La Fe, Valencia, Spain; [Fernandez-Ruiz, Mario] Hosp Univ 12 Octubre, Inst Invest Hosp 12 Octubre I 12, Madrid, Spain; [Mykietiuk, Analia] Hosp Interzonal Agudos Dr Rodolfo Rossi, La Plata, Buenos Aires, Argentina; [Manzur, Adriana] Hosp Dr Guillermo Rawson, San Juan, Argentina	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universidade Federal do Rio de Janeiro; Hospital Universitari i Politecnic La Fe; Hospital Universitario 12 de Octubre	Garcia-Vidal, C (corresponding author), Univ Barcelona, IDIBELL Inst Invest Biomed Bellvitge, Hosp Univ Bellvitge, Barcelona, Spain.	carolgv75@hotmail.com	Carratalà, Jordi/B-8410-2011; Peman, Javier/I-3102-2015; Cuervo, Guillermo L/K-1178-2016; Cuervo, Guillermo/B-1883-2012; Viasus, Diego/HDN-6634-2022; Carratala, Jordi/AAC-2639-2020; Gimeno, Francesc/AAK-5835-2021; Nucci, Marcio/G-4515-2012	Carratalà, Jordi/0000-0003-3209-2563; Peman, Javier/0000-0003-3222-5653; Cuervo, Guillermo L/0000-0002-7075-943X; Cuervo, Guillermo/0000-0002-7075-943X; Carratala, Jordi/0000-0003-3209-2563; Gimeno, Francesc/0000-0002-0937-6819; Gudiol, Carlota/0000-0003-3095-4422; Ayats, Josefina/0000-0002-9998-1325; Garcia-Vidal, Carolina/0000-0002-8915-0683; Nucci, Marcio/0000-0003-4867-0014; Viasus, Diego/0000-0001-8408-3947	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS 10/01318]; Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]; Juan de la Cierva research grant from the Instituto de Salud Carlos III, Madrid, Spain; REIPI	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases; Juan de la Cierva research grant from the Instituto de Salud Carlos III, Madrid, Spain; REIPI	This study was supported by research grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS 10/01318] and Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III - co-financed by the European Development Regional Fund "A way to achieve Europe" ERDF, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]. Dr. Garcia-Vidal is the recipient of a Juan de la Cierva research grant from the Instituto de Salud Carlos III, Madrid, Spain. Dr. Viasus is the recipient of a research grant from REIPI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; de Sotomayor MA, 2008, PHARMACOLOGY, V82, P89, DOI 10.1159/000135629; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; Bearman Gonzalo M L, 2010, Recent Pat Antiinfect Drug Discov, V5, P152; BRUGTS JJ, 2009, BMJ-BRIT MED J, V338, DOI DOI 10.1136/BMJ.B2376; CLSI, 1908, M27A3 CLSI; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Fluckiger U, 2006, SWISS MED WKLY, V136, P447; Forrest GN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-152; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Gao F, 2008, BRIT J ANAESTH, V100, P288, DOI 10.1093/bja/aem406; Garcia-Vidal C, 2008, EUR RESPIR J, V32, P733, DOI 10.1183/09031936.00128107; Garcia-Vidal C, 2010, THORAX, V65, P77, DOI 10.1136/thx.2009.123612; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Khan AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052929; Kwong JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008087; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051548; McGown CC, 2007, BRIT J ANAESTH, V98, P163, DOI 10.1093/bja/ael358; Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581; Nace HL, 2009, DIAGN MICR INFEC DIS, V64, P289, DOI 10.1016/j.diagmicrobio.2009.03.010; Nash JD, 2002, J MED MICROBIOL, V51, P105, DOI 10.1099/0022-1317-51-2-105; Novack V, 2009, INTENS CARE MED, V35, P1255, DOI 10.1007/s00134-009-1429-0; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Peman J, 2005, EUR J CLIN MICROBIOL, V24, P23, DOI 10.1007/s10096-004-1267-5; PITTET D, 1995, ARCH INTERN MED, V155, P1177, DOI 10.1001/archinte.155.11.1177; Subramani J, 2009, J CARDIOVASC PHARM, V54, P526, DOI 10.1097/FJC.0b013e3181bfafd6; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Thomsen RW, 2008, ARCH INTERN MED, V168, P2081, DOI 10.1001/archinte.168.19.2081; Ullmann AJ, 2012, CLIN MICROBIOL INFEC, V18, P53, DOI 10.1111/1469-0691.12041; Viasus D, 2010, EUR J CLIN MICROBIOL, V29, P143, DOI 10.1007/s10096-009-0835-0; Welch ML, 2013, MED MYCOL, V51, P219, DOI 10.3109/13693786.2012.692490; Westermeyer C, 2007, FEMS YEAST RES, V7, P436, DOI 10.1111/j.1567-1364.2006.00194.x; Wiersinga WJ, 2011, CURR OPIN CRIT CARE, V17, P480, DOI 10.1097/MCC.0b013e32834a4aeb	38	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77317	10.1371/journal.pone.0077317	http://dx.doi.org/10.1371/journal.pone.0077317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155941	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300075
J	Yuan, XW; Zhang, SZ; Sun, MH; Liu, SY; Qi, BX; Li, XZ				Yuan, Xiaowei; Zhang, Shizhong; Sun, Meihong; Liu, Shiyang; Qi, Baoxiu; Li, Xinzheng			Putative DHHC-Cysteine-Rich Domain S-Acyltransferase in Plants	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN PALMITOYLATION; TIP GROWTH; ACYLATION; GENE; LOCALIZATION; MEMBRANE; ACID; RAS; CALCIUM	Protein S-acyltransferases (PATs) containing Asp-His-His-Cys within a Cys-rich domain (DHHC-CRD) are polytopic transmembrane proteins that are found in eukaryotic cells and mediate the S-acylation of target proteins. S-acylation is an important secondary and reversible modification that regulates the membrane association, trafficking and function of target proteins. However, little is known about the characteristics of PATs in plants. Here, we identified 804 PATs from 31 species with complete genomes. The analysis of the phylogenetic relationships suggested that all of the PATs fell into 8 groups. In addition, we analysed the phylogeny, genomic organization, chromosome localisation and expression pattern of PATs in Arabidopsis, Oryza sative, Zea mays and Glycine max. The microarray data revealed that PATs genes were expressed in different tissues and during different life stages. The preferential expression of the ZmPATs in specific tissues and the response of Zea mays to treatments with phytohormones and abiotic stress demonstrated that the PATs play roles in plant growth and development as well as in stress responses. Our data provide a useful reference for the identification and functional analysis of the members of this protein family.	[Yuan, Xiaowei; Zhang, Shizhong; Sun, Meihong; Liu, Shiyang; Qi, Baoxiu; Li, Xinzheng] Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China; [Zhang, Shizhong] Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An 271018, Shandong, Peoples R China; [Yuan, Xiaowei] Huasheng Agr Ltd Liabil Co, Qingzhou 262500, Shandong, Peoples R China; [Yuan, Xiaowei] Qingzhou City Bur Agr, Qingzhou 262500, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Li, XZ (corresponding author), Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China.	lxz@sdau.edu.cn		Qi, Baoxiu/0000-0002-9425-935X	Natural Science Foundation of China [31170233, 31110103917]; National Basic Research Program of China [2011CB100706]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Natural Science Foundation of China (31170233), Natural Science Foundation of China (31110103917) and National Basic Research Program of China (2011CB100706). The funders had roles in study design, data collection and analysis and decision to publish.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], LECT NOTES; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2012, PLANT PHYSIOL, V160, P1597, DOI 10.1104/pp.112.203968; Batistic O, 2012, CELL RES, V22, P1155, DOI 10.1038/cr.2012.71; CHAO S, 1984, NUCLEIC ACIDS RES, V12, P6629, DOI 10.1093/nar/12.16.6629; Dong QF, 2004, NUCLEIC ACIDS RES, V32, pD354, DOI 10.1093/nar/gkh046; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hemsley PA, 2005, PLANT CELL, V17, P2554, DOI 10.1105/tpc.105.031237; Hemsley PA, 2008, TRENDS PLANT SCI, V13, P295, DOI 10.1016/j.tplants.2008.04.006; Hemsley PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028799; Hemsley PA, 2009, MOL MEMBR BIOL, V26, P114, DOI 10.1080/09687680802680090; Jacob Arpith, 2008, ACM Trans Reconfigurable Technol Syst, V1, P9; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kong XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057714; Kordyukova LV, 2008, J VIROL, V82, P9288, DOI 10.1128/JVI.00704-08; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Liu Ren-Hu, 2003, Yichuan, V25, P317; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Mesilaty-Gross S, 1999, GENE, V231, P173, DOI 10.1016/S0378-1119(99)00053-0; Mistry Jaina, 2007, V396, P43; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Ryan E, 1998, NEW PHYTOL, V138, P49, DOI 10.1046/j.1469-8137.1998.00896.x; SCHIEFELBEIN J, 1993, PLANT PHYSIOL, V103, P979, DOI 10.1104/pp.103.3.979; SCHLESINGER MJ, 1980, J BIOL CHEM, V255, P21; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Schroeder H, 1997, BIOCHEMISTRY-US, V36, P13102, DOI 10.1021/bi9709497; Singaraja RR, 2009, CIRC RES, V105, P138, DOI 10.1161/CIRCRESAHA.108.193011; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Sorek N, 2009, CURR OPIN PLANT BIOL, V12, P714, DOI 10.1016/j.pbi.2009.09.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200; Zhou LZ, 2013, PLANT CELL, V25, P1093, DOI 10.1105/tpc.112.108829	53	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75985	10.1371/journal.pone.0075985	http://dx.doi.org/10.1371/journal.pone.0075985			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155879	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000325887300013
J	Jin, XK; Guo, XN; Li, S; Wu, MH; Zhu, YT; Yu, AQ; Tan, SJ; Li, WW; Zhang, P; Wang, Q				Jin, Xing-Kun; Guo, Xiao-Nv; Li, Shuang; Wu, Min-Hao; Zhu, You-Ting; Yu, Ai-Qing; Tan, Shang-Jian; Li, Wei-Wei; Zhang, Ping; Wang, Qun			Association of a Hepatopancreas-Specific C-Type Lectin with the Antibacterial Response of Eriocheir sinensis	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; CARBOHYDRATE-RECOGNITION DOMAINS; CHINESE MITTEN CRAB; MANDUCA-SEXTA; CELLULAR ENCAPSULATION; INVERTEBRATE IMMUNITY; LITOPENAEUS-VANNAMEI; TOBACCO HORNWORM; GENE-EXPRESSION; ANIMAL LECTINS	Pattern recognition receptors (PPRs) are part of the initial step of a host defense against pathogens in detecting pathogen-associated molecular patterns. However, determinants of the specificity of this recognition by innate immune molecules of invertebrates remain largely unknown. In this study, we investigated the potential involvement of an invertebrate PRR C-type lectin in the antimicrobial response of the crustacean Eriocheir sinensis. Based on the initial expressed sequence tags (EST) of a hepatopancreatic cDNA library, the full-length EsLecF cDNA was cloned and determined to contain a 477-bp open reading frame encoding a putative 158-amino-acid protein. A comparison with other reported invertebrate and vertebrate C-type lectin superfamily sequences revealed the presence of a common carbohydrate recognition domain (CRD). EsLecF transcripts in E. sinensis were mainly detected in the hepatopancreas and were inducible by a lipopolysaccharide (LPS) injection. The recombinant EsLecF (rEsLecF) protein produced via a prokaryotic expression system and affinity chromatography was found to have a wide spectrum of binding activities towards various microorganisms, and its microbial-binding activity was calcium-independent. Moreover, the binding of rEsLecF induced the aggregation of microbial pathogens. Results of the microorganism growth inhibitory assay and antibacterial assay revealed capabilities of rEsLecF in suppressing microorganism growth and directly killing bacteria, respectively. Furthermore, rEsLecF could enhance cellular encapsulation in vitro. Collectively, the findings presented here demonstrated the successful isolation of a novel C-type lectin in a crustacean and highlighted its critical role in the innate immunity of an invertebrate.	[Jin, Xing-Kun; Guo, Xiao-Nv; Li, Shuang; Wu, Min-Hao; Zhu, You-Ting; Yu, Ai-Qing; Tan, Shang-Jian; Li, Wei-Wei; Zhang, Ping; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Zhang, P (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	pzhang@bio.ecnu.edu.cn; qwang@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013; Jin, Xingkun/H-4366-2013; LI, WEIWEI/J-3538-2013	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; 	National Natural Science Foundation of China [31172393]; National Science and Technology Support Program of China [2012BAD26B04]; National Research Foundation for the Doctoral Program of Higher Education of China [20110076110016]; Innovation Program of Shanghai Municipal Education Commission [13zz031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This research was supported by grants from the National Natural Science Foundation of China (No. 31172393), the National Science and Technology Support Program of China (2012BAD26B04), the National Research Foundation for the Doctoral Program of Higher Education of China (20110076110016) and the Innovation Program of Shanghai Municipal Education Commission (13zz031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao JQ, 2007, MOL IMMUNOL, V44, P2541, DOI 10.1016/j.molimm.2006.12.024; Cerenius L, 2010, ADV EXP MED BIOL, V708, P239; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Cheng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054053; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Dodd RB, 2001, GLYCOBIOLOGY, V11, p71R, DOI 10.1093/glycob/11.5.71R; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Du Pasquier L, 2001, COMP BIOCHEM PHYS B, V129, P1, DOI 10.1016/S1096-4959(01)00306-2; Guo HZ, 2011, FISH SHELLFISH IMMUN, V30, P515, DOI 10.1016/j.fsi.2010.11.027; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Jin XK, 2013, DEV COMP IMMUNOL, V41, P544, DOI 10.1016/j.dci.2013.07.016; Jin XK, 2012, FISH SHELLFISH IMMUN, V33, P1149, DOI 10.1016/j.fsi.2012.08.027; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; Junkunlo K, 2012, DEV COMP IMMUNOL, V37, P334, DOI 10.1016/j.dci.2011.12.010; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; Li FH, 2013, DEV COMP IMMUNOL, V39, P11, DOI 10.1016/j.dci.2012.03.016; Ling EJ, 2006, DEV COMP IMMUNOL, V30, P289, DOI 10.1016/j.dci.2005.05.005; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Smith V.J., 1992, Fish & Shellfish Immunology, V2, P1, DOI 10.1016/S1050-4648(06)80024-0; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Soderhall K., 1986, P208; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Soderhall Kenneth, 1992, Annual Review of Fish Diseases, V2, P3, DOI 10.1016/0959-8030(92)90053-Z; Sun YD, 2008, MOL IMMUNOL, V45, P348, DOI 10.1016/j.molimm.2007.06.355; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; Tunkijjanukij S, 1998, DEV COMP IMMUNOL, V22, P139, DOI 10.1016/S0145-305X(98)00017-2; Wang LL, 2013, FISH SHELLFISH IMMUN, V34, P832, DOI 10.1016/j.fsi.2012.12.010; Wang XW, 2013, DEV COMP IMMUNOL, V39, P27, DOI 10.1016/j.dci.2012.04.009; Wang XW, 2009, FISH SHELLFISH IMMUN, V27, P556, DOI 10.1016/j.fsi.2009.07.011; Wang XW, 2009, DEV COMP IMMUNOL, V33, P1039, DOI 10.1016/j.dci.2009.05.004; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Xu WT, 2010, AMINO ACIDS, V39, P1227, DOI 10.1007/s00726-010-0558-7; Yu XQ, 2006, INSECT BIOCHEM MOLEC, V36, P505, DOI 10.1016/j.ibmb.2006.03.010; Yu XQ, 2005, INSECT BIOCHEM MOLEC, V35, P285, DOI 10.1016/j.ibmb.2005.01.004; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang H, 2011, FISH SHELLFISH IMMUN, V31, P358, DOI 10.1016/j.fsi.2011.06.001; Zhang XW, 2009, MOL IMMUNOL, V46, P1626, DOI 10.1016/j.molimm.2009.02.029; Zhao ZY, 2009, J VIROL, V83, P347, DOI 10.1128/JVI.00707-08	51	31	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76132	10.1371/journal.pone.0076132	http://dx.doi.org/10.1371/journal.pone.0076132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146827	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400040
J	Lippman, SA; Maman, S; MacPhail, C; Twine, R; Peacock, D; Kahn, K; Pettifor, A				Lippman, Sheri A.; Maman, Suzanne; MacPhail, Catherine; Twine, Rhian; Peacock, Dean; Kahn, Kathleen; Pettifor, Audrey			Conceptualizing Community Mobilization for HIV Prevention: Implications for HIV Prevention Programming in the African Context	PLOS ONE			English	Article							FEMALE SEX WORKERS; SOCIAL-MOVEMENTS; PROJECT ACCEPT; INTERVENTION; EMPOWERMENT; PREVALENCE; INFECTION; CAPACITY; IDENTITY; HEALTH	Introduction: Community mobilizing strategies are essential to health promotion and uptake of HIV prevention. However, there has been little conceptual work conducted to establish the core components of community mobilization, which are needed to guide HIV prevention programming and evaluation. Objectives: We aimed to identify the key domains of community mobilization (CM) essential to change health outcomes or behaviors, and to determine whether these hypothesized CM domains were relevant to a rural South African setting. Method: We studied social movements and community capacity, empowerment and development literatures, assessing common elements needed to operationalize HIV programs at a community level. After synthesizing these elements into six essential CM domains, we explored the salience of these CM domains qualitatively, through analysis of 10 key informant in-depth-interviews and seven focus groups in three villages in Bushbuckridge. Results: CM domains include: 1) shared concerns, 2) critical consciousness, 3) organizational structures/networks, 4) leadership (individual and/or institutional), 5) collective activities/actions, and 6) social cohesion. Qualitative data indicated that the proposed domains tapped into theoretically consistent constructs comprising aspects of CM processes. Some domains, extracted from largely Western theory, required little adaptation for the South African context; others translated less effortlessly. For example, critical consciousness to collectively question and resolve community challenges functioned as expected. However, organizations/networks, while essential, operated differently than originally hypothesized - not through formal organizations, but through diffuse family networks. Conclusions: To date, few community mobilizing efforts in HIV prevention have clearly defined the meaning and domains of CM prior to intervention design. We distilled six CM domains from the literature; all were pertinent to mobilization in rural South Africa. While some adaptation of specific domains is required, they provide an extremely valuable organizational tool to guide CM programming and evaluation of critically needed mobilizing initiatives in Southern Africa.	[Lippman, Sheri A.] Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA; [Maman, Suzanne; Pettifor, Audrey] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [MacPhail, Catherine; Pettifor, Audrey] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Wits Reprod Hlth & HIV Inst WRHI, Johannesburg, South Africa; [MacPhail, Catherine] Univ New England, Collaborat Res Network, Armidale, NSW, Australia; [Twine, Rhian; Kahn, Kathleen; Pettifor, Audrey] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Med Res Council,Wits Rural Publ Hlth & Hlth Trans, Johannesburg, South Africa; [Peacock, Dean] Sonke Gender Justice Network, Cape Town, South Africa	University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of New England; South African Medical Research Council; University of Witwatersrand	Lippman, SA (corresponding author), Univ Calif San Francisco, Dept Med, Ctr AIDS Prevent Studies, San Francisco, CA USA.	sheri.lippman@ucsf.edu	Pettifor, Audrey/H-6793-2019; MacPhail, Catherine/N-4234-2014; Maman, Suzanne/A-3802-2016	Pettifor, Audrey/0000-0002-3387-0817; MacPhail, Catherine/0000-0002-0614-0157; Lippman, Sheri/0000-0003-3152-9372; Kahn, Kathleen/0000-0003-3339-3931; Twine, Rhian/0000-0002-0766-6556	United States National Institute of Mental Health [1R21MH090887-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH090887] Funding Source: NIH RePORTER	United States National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the United States National Institute of Mental Health (1R21MH090887-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG EA, 2002, FORGING GAY IDENTITI, P1950; Ballard R, 2005, AFR AFFAIRS, V104, P615, DOI 10.1093/afraf/adi069; BANDYOPADHYAY N, 2003, ROLE COMMUNITY DEV A; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Beeker C, 1998, SOC SCI MED, V46, P831, DOI 10.1016/S0277-9536(97)00208-6; BUECHLER SM, 1995, SOCIOL QUART, V36, P441, DOI 10.1111/j.1533-8525.1995.tb00447.x; Campbell C., 2003, LETTING THEM DIE; *CDCP, CTR DIS CONTR PREVEN; COATES T, 2013, ATL PROJ ACC 20 C RE; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Diani M, 2004, THEOR SOC, V33, P281, DOI 10.1023/B:RYSO.0000038610.00045.07; Edelman M, 2001, ANNU REV ANTHROPOL, V30, P285, DOI 10.1146/annurev.anthro.30.1.285; Evans C, 2010, GLOB PUBLIC HEALTH, V5, P449, DOI 10.1080/17441690902942472; Evans C, 2008, SOC SCI MED, V66, P467, DOI 10.1016/j.socscimed.2007.08.030; Fawcett SB, 1995, AM J COMMUN PSYCHOL, V23, P677, DOI 10.1007/BF02506987; Foster-Fishman PG, 2007, AM J COMMUN PSYCHOL, V39, P91, DOI 10.1007/s10464-007-9097-0; Freire P., 2013, PEDAGOGY OPPRESSED T; FRIEDMAN S, 2006, 164 INT I LAB; GAMSON WA, 1991, SOCIOL FORUM, V6, P27, DOI 10.1007/BF01112726; Gomez-Olive FX, 2013, AIDS CARE, V25, P1122, DOI 10.1080/09540121.2012.750710; Goodman RM, 1998, HEALTH EDUC BEHAV, V25, P258, DOI 10.1177/109019819802500303; Goodwin J, 1999, SOCIOL FORUM, V14, P27, DOI 10.1023/A:1021684610881; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; *HIV PREV TRIALS N, 2011, HPTN 068 EFF CASH TR; Jana S, 2004, AIDS EDUC PREV, V16, P405, DOI 10.1521/aeap.16.5.405.48734; Jana S, 1995, Indian J Public Health, V39, P125; LAMBERT H, 2012, J EPIDEMIOL COMMU S2, V66, P3, DOI DOI 10.1136/JECH-2012-201566.PUBMED:22826295; Laverack G, 2001, HEALTH PROMOT INT, V16, P179, DOI 10.1093/heapro/16.2.179; Lippman SA, 2012, SEX TRANSM DIS, V39, P209, DOI 10.1097/OLQ.0b013e31823b1937; Mainkar MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S2; McAdam Doug, 1999, POLITICAL PROCESS DE, V2nd; Melucci A., 1995, SOCIAL MOVEMENTS CUL, V4, P41; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Minkler M, 2002, HLTH BEHAV HLTH ED T; Murray LR, 2010, CULT HEALTH SEX, V12, P293, DOI 10.1080/13691050903450122; Norton BL, 2002, EMERGING THEORIES HL, P194; Parker RG, 1996, AIDS, V10, pS27; Paul J. P., 1995, LESBIAN GAY BISEXUAL, P347; Polletta F, 2001, ANNU REV SOCIOL, V27, P283, DOI 10.1146/annurev.soc.27.1.283; Pronyk PM, 2008, SOC SCI MED, V67, P1559, DOI 10.1016/j.socscimed.2008.07.022; Putnam RD., 2000, BOWLING ALONE COLLAP; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Swidler A, 2009, WORLD DEV, V37, P1182, DOI 10.1016/j.worlddev.2008.11.002; Tedrow VA, 2012, AIDS BEHAV, V16, P1217, DOI 10.1007/s10461-011-0009-9; Thomas T, 2012, J EPIDEMIOL COMMUN H, V66, pII26, DOI 10.1136/jech-2011-200590; TILLY C, 2004, SOCIAL MOVEMENTS, V262, P1768; Ulin PR, 2005, QUALITATIVE METHODS; *UNAIDS, 1997, COMM MOB AIDS UNAIDS; UNAIDS, 2005, HIV REL STIGM DISCR; Wallerstein N, 2002, SCAND J PUBLIC HEALT, V30, P72, DOI 10.1177/14034948020300031201; *WHO, 2011, EY FACTS HIV EP PROG; WHO, 2003, SOC MOB HLTH PROM	57	43	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78208	10.1371/journal.pone.0078208	http://dx.doi.org/10.1371/journal.pone.0078208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147121	Green Published, gold			2022-12-27	WOS:000325819400146
J	Jimenez-Lopez, JC; Rodriguez-Garcia, MI; Alche, JD				Jimenez-Lopez, Jose C.; Rodriguez-Garcia, Maria I.; Alche, Juan D.			Analysis of the Effects of Polymorphism on Pollen Profilin Structural Functionality and the Generation of Conformational, T- and B-Cell Epitopes	PLOS ONE			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; HIGH-LEVEL EXPRESSION; BET V 1; CROSS-REACTIVITY; MAJOR ALLERGEN; FOOD ALLERGENS; ANTIGENIC DETERMINANTS; ESCHERICHIA-COLI; PHOSPHOINOSITIDE 3-KINASE; PANALLERGEN PROFILIN	An extensive polymorphism analysis of pollen profilin, a fundamental regulator of the actin cytoskeleton dynamics, has been performed with a major focus in 3D-folding maintenance, changes in the 2-D structural elements, surface residues involved in ligands-profilin interactions and functionality, and the generation of conformational and lineal B-and T-cell epitopes variability. Our results revealed that while the general fold is conserved among profilins, substantial structural differences were found, particularly affecting the special distribution and length of different 2-D structural elements (i.e. cysteine residues), characteristic loops and coils, and numerous micro-heterogeneities present in fundamental residues directly involved in the interacting motifs, and to some extension these residues nearby to the ligand-interacting areas. Differential changes as result of polymorphism might contribute to generate functional variability among the plethora of profilin isoforms present in the olive pollen from different genetic background (olive cultivars), and between plant species, since biochemical interacting properties and binding affinities to natural ligands may be affected, particularly the interactions with different actin isoforms and phosphoinositides lipids species. Furthermore, conspicuous variability in lineal and conformational epitopes was found between profilins belonging to the same olive cultivar, and among different cultivars as direct implication of sequences polymorphism. The variability of the residues taking part of IgE-binding epitopes might be the final responsible of the differences in cross-reactivity among olive pollen cultivars, among pollen and plant-derived food allergens, as well as between distantly related pollen species, leading to a variable range of allergy reactions among atopic patients. Identification and analysis of commonly shared and specific epitopes in profilin isoforms is essential to gain knowledge about the interacting surface of these epitopes, and for a better understanding of immune responses, helping design and development of rational and effective immunotherapy strategies for the treatment of allergy diseases.	[Jimenez-Lopez, Jose C.; Rodriguez-Garcia, Maria I.; Alche, Juan D.] High Council Sci Res CSIC, EEZ, Dept Biochem Cell & Mol Biol plants, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Jimenez-Lopez, JC (corresponding author), High Council Sci Res CSIC, EEZ, Dept Biochem Cell & Mol Biol plants, Granada, Spain.	josecarlos.jimenez@eez.csic.es; juandedios.alche@eez.csic.es	Jimenez-Lopez, Jose C./H-5896-2011; Rodriguez-Garcia, Maria/K-5833-2014; De Dios Alche, Juan/K-6079-2014	Jimenez-Lopez, Jose C./0000-0002-1470-360X; Rodriguez-Garcia, Maria/0000-0002-7664-3235; De Dios Alche, Juan/0000-0002-7547-6025	MCINN BFU [2004-00601/BFI]; BFU [2008-00629]; CICE (Junta de Andalucia) [P2010-CVI15767, P2010-AGR6274, P2011-CVI-7487]; Spain/Germany MEC [HA2004-0094]; Spanish CSIC [I3P-BPD-CSIC]; European Marie Curie research program [PIOF-GA-2011-301550];  [BFU2011-22779]	MCINN BFU; BFU; CICE (Junta de Andalucia)(Junta de Andalucia); Spain/Germany MEC; Spanish CSIC; European Marie Curie research program; 	This study was supported by the following European Regional Development Fund co-financed grants: MCINN BFU 2004-00601/BFI, BFU 2008-00629, BFU2011-22779, CICE (Junta de Andalucia) P2010-CVI15767, P2010-AGR6274 and P2011-CVI-7487, and by the coordinated project Spain/Germany MEC HA2004-0094. JCJ-L thanks Spanish CSIC and the European Marie Curie research program for his I3P-BPD-CSIC, and PIOF-GA-2011-301550 grants, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2001, ALLERGY, V56, P478, DOI 10.1034/j.1398-9995.2001.056006478.x; Aparicio-Fabre R, 2006, PLANT J, V47, P491, DOI 10.1111/j.1365-313X.2006.02787.x; Arcangeli C, 2008, J STRUCT BIOL, V164, P119, DOI 10.1016/j.jsb.2008.06.013; ARCHER SJ, 1993, BIOCHEMISTRY-US, V32, P6680, DOI 10.1021/bi00077a022; Asero R, 2003, J ALLERGY CLIN IMMUN, V112, P427, DOI 10.1067/mai.2003.1611; Asturias JA, 1997, J ALLERGY CLIN IMMUN, V100, P365, DOI 10.1016/S0091-6749(97)70250-1; Asturias JA, 1997, CLIN EXP ALLERGY, V27, P1307, DOI 10.1111/j.1365-2222.1997.tb01176.x; Asturias JA, 2002, INT IMMUNOL, V14, P993, DOI 10.1093/intimm/dxf070; Babich M, 2005, P W PHARMACOL SOC, V48, P39; Babich M, 1996, BIOCHEM BIOPH RES CO, V218, P125, DOI 10.1006/bbrc.1996.0022; Bannon GA, 2006, MOL NUTR FOOD RES, V50, P638, DOI 10.1002/mnfr.200500276; Behrendt H, 1997, INT ARCH ALLERGY IMM, V113, P69, DOI 10.1159/000237511; BjorkegrenSjogren C, 1997, FEBS LETT, V418, P258, DOI 10.1016/S0014-5793(97)01376-8; BLASCO R, 1991, J VIROL, V65, P4598, DOI 10.1128/JVI.65.9.4598-4608.1991; BOND JF, 1991, J IMMUNOL, V146, P3380; BREITENEDER H, 1993, EUR J BIOCHEM, V212, P355, DOI 10.1111/j.1432-1033.1993.tb17669.x; Bufe A, 1998, INT ARCH ALLERGY IMM, V117, P215, DOI 10.1159/000024013; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; Carlos Jimenez-Lopez Jose, 2011, P245; CEDERGRENZEPPEZAUER ES, 1994, J MOL BIOL, V240, P459, DOI 10.1006/jmbi.1994.1461; Czaplewski C, 2004, PROTEIN ENG DES SEL, V17, P29, DOI 10.1093/protein/gzh003; Deeks MJ, 2002, TRENDS PLANT SCI, V7, P492, DOI 10.1016/S1360-1385(02)02341-5; Fedorov AA, 1997, INT ARCH ALLERGY IMM, V113, P109, DOI 10.1159/000237520; FEDOROV AA, 1994, P NATL ACAD SCI USA, V91, P8636, DOI 10.1073/pnas.91.18.8636; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Fritsch R, 1998, J ALLERGY CLIN IMMUN, V102, P679, DOI 10.1016/S0091-6749(98)70287-8; Gao ZS, 2005, THEOR APPL GENET, V110, P479, DOI 10.1007/s00122-004-1856-9; Garcia-Casado G, 2003, J ALLERGY CLIN IMMUN, V112, P599, DOI 10.1037/mai.2003.1638; Gibbon BC, 1998, PLANT CELL, V10, P981, DOI 10.1105/tpc.10.6.981; Haikarainen T, 2009, ACTA CRYSTALLOGR D, V65, P303, DOI 10.1107/S0907444909000699; Hamman-Khalifa A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-10; Hauser M., 2008, OPEN IMMUNOL J, V1, P1, DOI DOI 10.2174/1874226200801010001; Hauser Michael, 2010, Allergy Asthma Clin Immunol, V6, P1, DOI 10.1186/1710-1492-6-1; Heiss S, 1996, J ALLERGY CLIN IMMUN, V98, P938, DOI 10.1016/S0091-6749(96)80010-8; HONORE B, 1993, FEBS LETT, V330, P151, DOI 10.1016/0014-5793(93)80262-S; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jenkins JA, 2005, J ALLERGY CLIN IMMUN, V115, P163, DOI 10.1016/j.jaci.2004.10.026; Jimenez-Lopez JC, 2012, CURRENT INSIGHTS POL, P71; Jimenez-Lopez JC, 2012, J MOL MODEL, V18, P4965, DOI 10.1007/s00894-012-1492-2; Jimenez-Lopez JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030878; Jimenez-Lopez JC, 2012, MOL BIOL REP, V39, P123, DOI 10.1007/s11033-011-0717-2; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Kaiser DA, 1999, J CELL SCI, V112, P3779; Kolaskar AS, 1999, VIROLOGY, V261, P31, DOI 10.1006/viro.1999.9859; Kovar DR, 2001, BIOCHEM J, V358, P49, DOI 10.1042/0264-6021:3580049; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lambrechts A, 2000, MOL CELL BIOL, V20, P8209, DOI 10.1128/MCB.20.21.8209-8219.2000; Lambrechts A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-12; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Limmongkon A, 2004, BIOCHEM BIOPH RES CO, V324, P382, DOI 10.1016/j.bbrc.2004.09.071; Lu PJ, 1996, BIOCHEMISTRY-US, V35, P14027, DOI 10.1021/bi961878z; Mahoney NM, 1997, NAT STRUCT BIOL, V4, P953, DOI 10.1038/nsb1197-953; Meno KH, 2011, ALLERGY, V66, P19, DOI 10.1111/j.1398-9995.2011.02625.x; METZLER WJ, 1993, BIOCHEMISTRY-US, V32, P13818, DOI 10.1021/bi00213a010; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Mittag D, 2006, MOL IMMUNOL, V43, P268, DOI 10.1016/j.molimm.2005.02.008; MITTERMANN I, 1995, PLANT MOL BIOL, V27, P137, DOI 10.1007/BF00019185; Nodelman IM, 1999, J MOL BIOL, V294, P1271, DOI 10.1006/jmbi.1999.3318; Pierce J.R., 1980, INTRO INFORM THEORY; Polet D, 2006, CELL MOTIL CYTOSKEL, V63, P14, DOI 10.1002/cm.20102; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Psaradellis Telly, 2000, Allergology International, V49, P27, DOI 10.1046/j.1440-1592.2000.00155.x; Radauer C, 2006, CLIN EXP ALLERGY, V36, P920, DOI 10.1111/j.1365-2222.2006.02521.x; Rothkegel M, 1996, J CELL SCI, V109, P83; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schimek EM, 2005, J ALLERGY CLIN IMMUN, V116, P1327, DOI 10.1016/j.jaci.2005.09.007; Schluter K, 1998, J CELL SCI, V111, P3261; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHUTT CE, 1993, NATURE, V365, P810, DOI 10.1038/365810a0; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; SILVANOVICH A, 1991, J BIOL CHEM, V266, P1204; Skare P, 2002, FEBS LETT, V522, P119, DOI 10.1016/S0014-5793(02)02913-7; Staiger CJ, 2006, CURR OPIN PLANT BIOL, V9, P554, DOI 10.1016/j.pbi.2006.09.013; STAIGER CJ, 1993, PLANT J, V4, P631, DOI 10.1046/j.1365-313X.1993.04040631.x; Tanabe S, 2004, J NUTR SCI VITAMINOL, V50, P367, DOI 10.3177/jnsv.50.367; Thorn KS, 1997, STRUCTURE, V5, P19, DOI 10.1016/S0969-2126(97)00163-9; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; VALENTA R, 1992, J EXP MED, V175, P377, DOI 10.1084/jem.175.2.377; VALENTA R, 1991, SCIENCE, V253, P557, DOI 10.1126/science.1857985; VALENTA R, 1994, BIOCHEM BIOPH RES CO, V199, P106, DOI 10.1006/bbrc.1994.1201; Valenta Rudolf, 1996, P269; VALLIER P, 1995, CLIN EXP ALLERGY, V25, P332, DOI 10.1111/j.1365-2222.1995.tb01051.x; Vieira T, 2012, ALLERGOL IMMUNOPATH, V40, P172, DOI 10.1016/j.aller.2011.03.013; Vieths S, 2002, ANN NY ACAD SCI, V964, P47; VINSON VK, 1993, J CELL BIOL, V122, P1277, DOI 10.1083/jcb.122.6.1277; Vrtala S, 1996, BIOCHEM BIOPH RES CO, V226, P42, DOI 10.1006/bbrc.1996.1309; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; WESTHOF E, 1984, NATURE, V311, P123, DOI 10.1038/311123a0; Wilkies DE, 2003, J EUKARYOT MICROBIOL, V50, P252, DOI 10.1111/j.1550-7408.2003.tb00130.x; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188; Wopfner N, 2002, BIOL CHEM, V383, P1779, DOI 10.1515/BC.2002.199; Wu ST, 2010, STRUCTURE, V18, P858, DOI 10.1016/j.str.2010.04.007; ZHU XJ, 1995, J IMMUNOL, V155, P5064; Zienkiewicz K, 2012, CURRENT INSIGHTS POL, P41	98	18	136	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76066	10.1371/journal.pone.0076066	http://dx.doi.org/10.1371/journal.pone.0076066			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146818	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200009
J	Rajamoorthi, A; Shrivastava, S; Steele, R; Nerurkar, P; Gonzalez, JG; Crawford, S; Varvares, M; Ray, RB				Rajamoorthi, Ananthi; Shrivastava, Shubham; Steele, Robert; Nerurkar, Pratibha; Gonzalez, Juan G.; Crawford, Susan; Varvares, Mark; Ray, Ratna B.			Bitter Melon Reduces Head and Neck Squamous Cell Carcinoma Growth by Targeting c-Met Signaling	PLOS ONE			English	Article							MOMORDICA-CHARANTIA; CANCER; CYCLE; APOPTOSIS; PATHWAYS; KINASE; DEATH; GAMMA; MCL-1	Head and neck squamous cell carcinoma (HNSCC) remains difficult to treat, and despite of advances in treatment, the overall survival rate has only modestly improved over the past several years. Thus, there is an urgent need for additional therapeutic modalities. We hypothesized that treatment of HNSCC cells with a dietary product such as bitter melon extract (BME) modulates multiple signaling pathways and regresses HNSCC tumor growth in a preclinical model. We observed a reduced cell proliferation in HNSCC cell lines. The mechanistic studies reveal that treatment of BME in HNSCC cells inhibited c-Met signaling pathway. We also observed that BME treatment in HNSCC reduced phosphoStat3, c-myc and Mcl-1 expression, downstream signaling molecules of c-Met. Furthermore, BME treatment in HNSCC cells modulated the expression of key cell cycle progression molecules leading to halted cell growth. Finally, BME feeding in mice bearing HNSCC xenograft tumor resulted in an inhibition of tumor growth and c-Met expression. Together, our results suggested that BME treatment in HNSCC cells modulates multiple signaling pathways and may have therapeutic potential for treating HNSCC.	[Rajamoorthi, Ananthi; Shrivastava, Shubham; Steele, Robert; Gonzalez, Juan G.; Crawford, Susan; Ray, Ratna B.] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA; [Crawford, Susan; Varvares, Mark; Ray, Ratna B.] St Louis Univ, Ctr Canc, St Louis, MO 63103 USA; [Nerurkar, Pratibha] Univ Hawaii, Coll Trop Agr & Human Resources, Dept Mol Biosci & Bioengn, Lab Metab Disorders & Alternat Med, Honolulu, HI 96822 USA	Saint Louis University; Saint Louis University; University of Hawaii System	Ray, RB (corresponding author), St Louis Univ, Dept Pathol, St Louis, MO 63103 USA.	rayrb@slu.edu	Nerurkar, Pratibha/AAP-5734-2021	Shrivastava, Shubham/0000-0002-5980-8536	NIH [R21CA137424]; Lottie Caroline Hardy Charitable Trust Fund; Saint Louis University Cancer Center seed grant; NATIONAL CANCER INSTITUTE [R21CA137424] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lottie Caroline Hardy Charitable Trust Fund; Saint Louis University Cancer Center seed grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grant R21CA137424 from the NIH, The Lottie Caroline Hardy Charitable Trust Fund, and Saint Louis University Cancer Center seed grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christiansen A, 2013, CANCER LETT, V331, P18, DOI 10.1016/j.canlet.2012.12.013; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Ghosh AK, 2006, CANCER RES, V66, P11907, DOI 10.1158/0008-5472.CAN-06-2754; Kanda T, 2009, CANCER RES, V69, P9354, DOI 10.1158/0008-5472.CAN-09-2974; Kanda T, 2009, J VIROL, V83, P8463, DOI 10.1128/JVI.00751-09; Kaur M, 2013, CARCINOGENESIS, V34, P1585, DOI 10.1093/carcin/bgt081; Knowles LM, 2009, CLIN CANCER RES, V15, P3740, DOI 10.1158/1078-0432.CCR-08-3252; Kobayashi S, 2007, J BIOL CHEM, V282, P18407, DOI 10.1074/jbc.M610010200; Kwatra D, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/702869; Le Gouill S, 2004, CELL CYCLE, V3, P1259; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Nerurkar PV, 2006, BRIT J PHARMACOL, V148, P1156, DOI 10.1038/sj.bjp.0706821; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Raj SK, 2005, INT J FOOD SCI NUTR, V56, P185, DOI 10.1080/09637480500103946; Ray RB, 2010, CANCER RES, V70, P1925, DOI 10.1158/0008-5472.CAN-09-3438; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Ru P, 2011, CANCER PREV RES, V4, P2122, DOI 10.1158/1940-6207.CAPR-11-0376; Sahu N, 2011, ANTI-CANCER DRUG, V22, P656, DOI 10.1097/CAD.0b013e32834249ba; SCHER RL, 1993, ARCH OTOLARYNGOL, V119, P432; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Stabile LP, 2013, CLIN CANCER RES, V19, P380, DOI 10.1158/1078-0432.CCR-12-1555; Steele Robert, 2010, Genes Cancer, V1, P381; Tabata K, 2012, CANCER SCI, V103, P2153, DOI 10.1111/cas.12021; Tran HM, 2004, OTOLARYNG HEAD NECK, V131, P477, DOI 10.1016/j.otohns.2004.04.019; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022	26	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78006	10.1371/journal.pone.0078006	http://dx.doi.org/10.1371/journal.pone.0078006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147107	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200092
J	Mori, T; Wakabayashi, T; Ogawa, H; Hirahara, Y; Koike, T; Yamada, H				Mori, Tetsuji; Wakabayashi, Taketoshi; Ogawa, Haruyuki; Hirahara, Yukie; Koike, Taro; Yamada, Hisao			Increased Histone H3 Phosphorylation in Neurons in Specific Brain Structures after Induction of Status Epilepticus in Mice	PLOS ONE			English	Article							GYRUS GRANULE NEURONS; EARLY GENE-EXPRESSION; C-FOS; PILOCARPINE MODEL; STRIATAL NEURONS; DOPAMINE NEUROTRANSMISSION; GLUCOCORTICOID-RECEPTOR; EPIGENETIC MECHANISMS; PHOSPHATASE CASCADE; CHRONIC EPILEPSY	Status epilepticus (SE) induces pathological and morphological changes in the brain. Recently, it has become clear that excessive neuronal excitation, stress and drug abuse induce chromatin remodeling in neurons, thereby altering gene expression. Chromatin remodeling is a key mechanism of epigenetic gene regulation. Histone H3 phosphorylation is frequently used as a marker of chromatin remodeling and is closely related to the upregulation of mRNA transcription. In the present study, we analyzed H3 phosphorylation levels in vivo using immunohistochemistry in the brains of mice with pilocarpine-induced SE. A substantial increase in H3 phosphorylation was detected in neurons in specific brain structures. Increased H3 phosphorylation was dependent on neuronal excitation. In particular, a robust upregulation of H3 phosphorylation was detected in the caudate putamen, and there was a gradient of phosphorylated H3(+) (PH3(+)) neurons along the medio-lateral axis. After unilateral ablation of dopaminergic neurons in the substantia nigra by injection of 6-hydroxydopamine, the distribution of PH3(+) neurons changed in the caudate putamen. Moreover, our histological analysis suggested that, in addition to the well-known MSK1 (mitogen and stress-activated kinase)/H3 phosphorylation/c-fos pathway, other signaling pathways were also activated. Together, our findings suggest that a number of genes involved in the pathology of epileptogenesis are upregulated in PH3(+) brain regions, and that H3 phosphorylation is a suitable indicator of strong neuronal excitation.	[Mori, Tetsuji; Wakabayashi, Taketoshi; Ogawa, Haruyuki; Hirahara, Yukie; Koike, Taro; Yamada, Hisao] Kansai Med Univ, Dept Anat & Cell Sci, Hirakata, Osaka, Japan	Kansai Medical University	Mori, T (corresponding author), Kansai Med Univ, Dept Anat & Cell Sci, Hirakata, Osaka, Japan.	morite@hirakata.kmu.ac.jp	Koike, Taro/AAZ-3465-2021; Yamada, Hisao/L-8108-2018	Yamada, Hisao/0000-0003-0403-2061	Japan Society for the Promotion of Science [25430044]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by Grants-in-Aid for Scientific Research (C) #25430044 from the Japan Society for the Promotion of Science (T.Mori). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALHEID GF, 1988, NEUROSCIENCE, V27, P1, DOI 10.1016/0306-4522(88)90217-5; ALTAJIR G, 1993, J NEURAL TRANSM-PARK, V5, P89, DOI 10.1007/BF02251199; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Ballion B, 2008, EUR J NEUROSCI, V27, P2313, DOI 10.1111/j.1460-9568.2008.06192.x; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; BERNARD V, 1993, EUR J NEUROSCI, V5, P1218, DOI 10.1111/j.1460-9568.1993.tb00976.x; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Bilang-Bleuel A, 2005, EUR J NEUROSCI, V22, P1691, DOI 10.1111/j.1460-9568.2005.04358.x; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Brami-Cherrier K, 2007, J NEUROCHEM, V101, P697, DOI 10.1111/j.1471-4159.2006.04352.x; Cardoso A, 2009, EPILEPSY BEHAV, V14, P293, DOI 10.1016/j.yebeh.2008.11.004; CENDES F, 1994, BRAIN, V117, P739, DOI 10.1093/brain/117.4.739; Chandramohan Y, 2007, J NEUROCHEM, V101, P815, DOI 10.1111/j.1471-4159.2006.04396.x; Choi HS, 2008, FASEB J, V22, P113, DOI 10.1096/fj.07-9078com; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; David HN, 2005, BRAIN RES REV, V50, P336, DOI 10.1016/j.brainresrev.2005.09.002; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; de Oliveira GNM, 2010, SEIZURE-EUR J EPILEP, V19, P479, DOI 10.1016/j.seizure.2010.07.004; Deransart C, 2002, EPILEPTIC DISORD, V4, pS61; Haut SR, 2008, NEUROLOGY, V71, P784, DOI 10.1212/01.wnl.0000325637.38931.27; Healy S, 2012, BIOCHEM CELL BIOL, V90, P39, DOI [10.1139/o11-092, 10.1139/O11-092]; Heimer L, 1997, NEUROSCIENCE, V76, P957, DOI 10.1016/S0306-4522(96)00405-8; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Lesting J, 2011, EPILEPSIA, V52, P337, DOI 10.1111/j.1528-1167.2010.02758.x; Li JH, 2004, J NEUROCHEM, V90, P1117, DOI 10.1111/j.1471-4159.2004.02569.x; MELLO LEAM, 1993, EPILEPSIA, V34, P985, DOI 10.1111/j.1528-1157.1993.tb02123.x; Mori T, 2012, EUR J NEUROSCI, V36, P3184, DOI 10.1111/j.1460-9568.2012.08244.x; Mori T, 2009, ACTA HISTOCHEM CYTOC, V42, P1, DOI 10.1267/ahc.08037; Muller CJ, 2009, EUR J PHARMACOL, V619, P15, DOI 10.1016/j.ejphar.2009.07.020; Parent JM, 2002, PROG BRAIN RES, V135, P121; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Reul JMHM, 2009, EPIGENETICS-US, V4, P434, DOI 10.4161/epi.4.7.9806; Rice AC, 1998, BRAIN RES, V782, P240, DOI 10.1016/S0006-8993(97)01285-7; Rotllant D, 2012, NEUROPHARMACOLOGY, V62, P1073, DOI 10.1016/j.neuropharm.2011.10.019; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SHEHAB S, 1992, EXP NEUROL, V118, P261, DOI 10.1016/0014-4886(92)90183-Q; Sng JCG, 2006, EUR J NEUROSCI, V23, P1269, DOI 10.1111/j.1460-9568.2006.04641.x; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Tamura Y, 2004, NEUROSCI RES, V50, P129, DOI 10.1016/j.neures.2004.06.011; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Walker DL, 2008, BRAIN STRUCT FUNCT, V213, P29, DOI 10.1007/s00429-008-0183-3; Walker DL, 2003, EUR J PHARMACOL, V463, P199, DOI 10.1016/S0014-2999(03)01282-2; WALTON NY, 1991, BRAIN RES, V553, P97, DOI 10.1016/0006-8993(91)90235-N; Wang L, 2008, BRAIN RES, V1241, P157, DOI 10.1016/j.brainres.2008.07.097; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	56	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77710	10.1371/journal.pone.0077710	http://dx.doi.org/10.1371/journal.pone.0077710			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147063	gold, Green Submitted, Green Published			2022-12-27	WOS:000326019400127
J	van Hoek, AJ; Andrews, N; Campbell, H; Amirthalingam, G; Edmunds, WJ; Miller, E				van Hoek, Albert Jan; Andrews, Nick; Campbell, Helen; Amirthalingam, Gayatri; Edmunds, W. John; Miller, Elizabeth			The Social Life of Infants in the Context of Infectious Disease Transmission; Social Contacts and Mixing Patterns of the Very Young	PLOS ONE			English	Article							SCHOOL-CHILDREN; PERTUSSIS; SPREAD; VACCINATION	Insight into how humans interact helps further understanding of the transmission of infectious diseases. For diseases such as pertussis, infants are at particular risk for severe outcomes. To understand the contact pattern of infants, especially those too young to be vaccinated, we sent contact diaries to a representative sample of 1000 mothers in the United Kingdom. We received 115 responses with a total of 758 recorded contacts. The average number of daily contacts for an infant was 6.68 overall and 5.7 for those aged <= 10 weeks. Of the latter, 2.1 (37%) contacts were with non-household members and were >15 minutes duration, suggesting that a cocooning programme may miss a substantial proportion of exposures leading to disease transmission. The least contact was between adolescents and infants. Thus the impact of adolescent (pertussis) vaccination on infants would likely be limited, unless it reduces transmission to other age groups whose contact with infants is greater.	[van Hoek, Albert Jan; Andrews, Nick; Campbell, Helen; Amirthalingam, Gayatri; Miller, Elizabeth] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England; [Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Public Health England; University of London; London School of Hygiene & Tropical Medicine	van Hoek, AJ (corresponding author), Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, London, England.	albertjan.vanhoek@phe.gov.uk			Public Health England	Public Health England	This study was funded by Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUID VIR RASH PREGN; Bind R, 2012, CHILDCARE EARLY YEAR; Campbell H, 2012, EMERG INFECT DIS, V18, P38, DOI 10.3201/eid1801.110784; de Greeff SC, 2012, EPIDEMIOLOGY, V23, P852, DOI 10.1097/EDE.0b013e31826c2b9e; Eames KTD, 2011, EPIDEMICS-NETH, V3, P103, DOI 10.1016/j.epidem.2011.03.003; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Hallander Hans O, 2011, Expert Rev Clin Pharmacol, V4, P705, DOI 10.1586/ecp.11.55; Health Protection Agency, 2013, HLTH PROTECTION REPO, V7; Health Protection Agency, HPA NAT MEASL GUID L; Horby P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016965; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Office for National Statistics, 2010, CHAR BIRTH 2 TABL 5; Office for National Statistics, 2012, MID 2011 POP EST UK; Office for National Statistics, 2012, MID 2011 POP ES ENGL; R Core Team, 2020, R LANG ENV STAT COMP; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Tartof SY, 2013, PEDIATRICS, V131, pE1047, DOI 10.1542/peds.2012-1928; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220; Zepp F, 2011, LANCET INFECT DIS, V11, P557, DOI 10.1016/S1473-3099(11)70007-X	24	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76180	10.1371/journal.pone.0076180	http://dx.doi.org/10.1371/journal.pone.0076180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146835	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400042
J	Vares, G; Cui, X; Wang, B; Nakajima, T; Nenoi, M				Vares, Guillaume; Cui, Xing; Wang, Bing; Nakajima, Tetsuo; Nenoi, Mitsuru			Generation of Breast Cancer Stem Cells by Steroid Hormones in Irradiated Human Mammary Cell Lines	PLOS ONE			English	Article							MEMBRANE PROGESTIN RECEPTORS; MESSENGER-RNA; RADIATION; ESTROGEN; EXPRESSION; APOPTOSIS; MICRORNAS; RADIOSENSITIVITY; IDENTIFICATION; PROGRESSION	Exposure to ionizing radiation was shown to result in an increased risk of breast cancer. There is strong evidence that steroid hormones influence radiosensitivity and breast cancer risk. Tumors may be initiated by a small subpopulation of cancer stem cells (CSCs). In order to assess whether the modulation of radiation-induced breast cancer risk by steroid hormones could involve CSCs, we measured by flow cytometry the proportion of CSCs in irradiated breast cancer cell lines after progesterone and estrogen treatment. Progesterone stimulated the expansion of the CSC compartment both in progesterone receptor (PR)-positive breast cancer cells and in PR-negative normal cells. In MCF10A normal epithelial PR-negative cells, progesterone-treatment and irradiation triggered cancer and stemness-associated microRNA regulations (such as the downregulation of miR-22 and miR-29c expression), which resulted in increased proportions of radiation-resistant tumor-initiating CSCs.	[Vares, Guillaume; Wang, Bing; Nakajima, Tetsuo; Nenoi, Mitsuru] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 260, Japan; [Cui, Xing] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology	Vares, G (corresponding author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 260, Japan.	vares@nirs.go.jp	Vares, Guillaume/S-6530-2019; Vares, Guillaume/A-9257-2011	Vares, Guillaume/0000-0002-6191-9032; Vares, Guillaume/0000-0002-6191-9032	JSPS KAKENHI [24710066]; Grants-in-Aid for Scientific Research [24710066] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by JSPS KAKENHI Grant Number 24710066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Andarawewa KL, 2011, INT J RADIAT ONCOL, V79, P1523, DOI 10.1016/j.ijrobp.2010.11.058; Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Anderson E, 2002, BREAST CANCER RES, V4, P197, DOI 10.1186/bcr452; Arora S, 2011, INT J CANCER, V129, P2621, DOI 10.1002/ijc.25939; Ashley RL, 2006, ENDOCRINOLOGY, V147, P4151, DOI 10.1210/en.2006-0002; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Axlund SD, 2012, MOL CELL ENDOCRINOL, V357, P71, DOI 10.1016/j.mce.2011.09.021; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Behera MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE1089, DOI 10.1152/ajpendo.00209.2009; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Boyle P, 2008, WORLD CANC REPORT 20; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clarke RB, 1997, CANCER RES, V57, P4987; Cui X, 2011, CANCER RES, V71, P3676, DOI 10.1158/0008-5472.CAN-10-2926; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DiRenzo J, 2002, CANCER RES, V62, P89; Dressing GE, 2007, STEROIDS, V72, P111, DOI 10.1016/j.steroids.2006.10.006; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fillmore CM, 2010, P NATL ACAD SCI USA, V107, P21737, DOI 10.1073/pnas.1007863107; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gompel A, 2000, STEROIDS, V65, P593, DOI 10.1016/S0039-128X(00)00172-0; Hankinson SE, 2004, BREAST CANCER RES, V6, P213, DOI 10.1186/bcr921; Hulka BS, 2008, MATURITAS, V61, P203, DOI 10.1016/j.maturitas.2008.11.016; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; John EM, 2007, INT J CANCER, V121, P386, DOI 10.1002/ijc.22668; Keysar SB, 2010, MOL CANCER THER, V9, P2450, DOI 10.1158/1535-7163.MCT-10-0530; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kramer EA, 2006, EUR J OBSTET GYN R B, V129, P77, DOI 10.1016/j.ejogrb.2005.12.004; Kramer EA, 2006, J STEROID BIOCHEM, V98, P174, DOI 10.1016/j.jsbmb.2005.11.002; Krietsch T, 2006, MOL ENDOCRINOL, V20, P3146, DOI 10.1210/me.2006-0129; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu HP, 2010, P NATL ACAD SCI USA, V107, P18115, DOI 10.1073/pnas.1006732107; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Oeffinger KC, 2009, JAMA-J AM MED ASSOC, V301, P404, DOI 10.1001/jama.2008.1039; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ricoul M, 1997, MUTAT RES-FUND MOL M, V374, P73, DOI 10.1016/S0027-5107(96)00220-5; RICOUL M, 1991, MUTAT RES, V250, P331, DOI 10.1016/0027-5107(91)90189-U; Sartorius CA, 2005, CANCER RES, V65, P9779, DOI 10.1158/0008-5472.CAN-05-0505; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; SOULE HD, 1990, CANCER RES, V50, P6075; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vares G, 2004, ONCOGENE, V23, P4603, DOI 10.1038/sj.onc.1207601; Wang S, 2011, GENES IMMUN, V12, P149, DOI 10.1038/gene.2010.53; WAZER DE, 1989, BRIT J RADIOL, V62, P1079, DOI 10.1259/0007-1285-62-744-1079; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Xiong JH, 2010, FEBS J, V277, P1684, DOI 10.1111/j.1742-4658.2010.07594.x; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100	63	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77124	10.1371/journal.pone.0077124	http://dx.doi.org/10.1371/journal.pone.0077124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146960	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400094
J	Arum, O; Rasche, ZA; Rickman, DJ; Bartke, A				Arum, Oge; Rasche, Zachary Andrew; Rickman, Dustin John; Bartke, Andrzej			Prevention of Neuromusculoskeletal Frailty in Slow-Aging Ames Dwarf Mice: Longitudinal Investigation of Interaction of Longevity Genes and Caloric Restriction	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; GROWTH-HORMONE; LIFE-SPAN; DIETARY RESTRICTION; OLDER-ADULTS; HEALTH; ASSOCIATION; EXTENSION; INSULIN; GLUCOSE	Ames dwarf (Prop1(df/df)) mice are remarkably long-lived and exhibit many characteristics of delayed aging and extended healthspan. Caloric restriction (CR) has similar effects on healthspan and lifespan, and causes an extension of longevity in Ames dwarf mice. Our study objective was to determine whether Ames dwarfism or CR influence neuromusculoskeletal function in middle-aged (82 +/- 12 weeks old) or old (128 +/- 14 w.o.) mice. At the examined ages, strength was improved by dwarfism, CR, and dwarfism plus CR in male mice; balance/motor coordination was improved by CR in old animals and in middle-aged females; and agility/motor coordination was improved by a combination of dwarfism and CR in both genders of middle-aged mice and in old females. Therefore, extension of longevity by congenital hypopituitarism is associated with improved maintenance of the examined measures of strength, agility, and motor coordination, key elements of frailty during human aging, into advanced age. This study serves as a particularly important example of knowledge related to addressing aging-associated diseases and disorders that results from studies in long-lived mammals.	[Arum, Oge; Rasche, Zachary Andrew; Rickman, Dustin John; Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62702 USA	Southern Illinois University System; Southern Illinois University	Arum, O (corresponding author), So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL 62702 USA.	oge.arum@gmail.com	Bartke, Andzej/D-6640-2017	Bartke, Andzej/0000-0002-2569-557X	National Institute on Aging [AG19899, U19 AG023122, 3R01AG019899-07S1]; Ellison Medical Foundation; Glenn Foundation for Medical Research; Center for Alzheimer's Disease and Related Disorders at The Southern Illinois University; NATIONAL INSTITUTE ON AGING [U19AG023122, R01AG019899] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research; Center for Alzheimer's Disease and Related Disorders at The Southern Illinois University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging Grants AG19899, U19 AG023122, and 3R01AG019899-07S1, as well as a Senior Scholar Award in Aging from The Ellison Medical Foundation, and The Glenn Foundation for Medical Research; this work was vitally supported by a grant from the Center for Alzheimer's Disease and Related Disorders at The Southern Illinois University, and the authors would especially like to thank Drs. Thomas A. Ala, M.D. & Robert G. Struble, Ph.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Anisimov VN, 2009, BIOGERONTOLOGY, V10, P323, DOI 10.1007/s10522-008-9209-8; ARCE VM, 1991, NEUROENDOCRINOLOGY, V53, P467, DOI 10.1159/000125759; Aronow WS, 2006, MED CLIN N AM, V90, P849, DOI 10.1016/j.mcna.2006.05.009; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bartke A, 2004, HORM METAB RES, V36, P550, DOI 10.1055/s-2004-825796; Bartke A, 2001, NATURE, V414, P412, DOI 10.1038/35106646; Bartke A, 2001, HDB BIOL AGING; Bartke A, 2008, CLIN INTERV AGING, V3, P659, DOI 10.2147/CIA.S3697; Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Bonkowski MS, 2006, J GERONTOL A-BIOL, V61, P562, DOI 10.1093/gerona/61.6.562; BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0; Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608; Coschigano KT, 2003, ENDOCRINOLOGY, V144, P3799, DOI 10.1210/en.2003-0374; Crawley J. N., 2007, WHATS WRONG MY MOUSE; CREW MD, 1987, ENDOCRINOLOGY, V121, P1251, DOI 10.1210/endo-121-4-1251; De Laet CEDH, 2000, BEST PRACT RES CL EN, V14, P171, DOI 10.1053/beem.2000.0067; Dennison E, 2000, HORM RES, V54, P58, DOI 10.1159/000053299; Finch CE, 2009, NEUROBIOL AGING, V30, P515, DOI 10.1016/j.neurobiolaging.2008.11.011; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Gage PJ, 1996, DEVELOPMENT, V122, P151; Garcia AM, 2008, MECH AGEING DEV, V129, P528, DOI 10.1016/j.mad.2008.04.013; Giannoulis MG, 2012, ENDOCR REV, V33, P314, DOI 10.1210/er.2012-1002; Glantz SA, 2002, PRIMER BIOSTATISTICS; Kalyani RR, 2012, J GERONTOL A-BIOL, V67, P1300, DOI 10.1093/gerona/glr141; Kandel ER, 1991, PRINCIPLES NEURAL SC; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kinsella K, 2008, INT POPULATION REPOR; Ko FCY, 2011, CLIN GERIATR MED, V27, P89, DOI 10.1016/j.cger.2010.08.007; Landi F, 2010, BIOGERONTOLOGY, V11, P537, DOI 10.1007/s10522-010-9296-1; Lang PO, 2009, GERONTOLOGY, V55, P539, DOI 10.1159/000211949; Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P712, DOI 10.1093/gerona/glq082; Lee DM, 2013, J GERONTOL A-BIOL, V68, P837, DOI 10.1093/gerona/gls217; Levers MJ, 2006, J ADV NURS, V56, P282, DOI 10.1111/j.1365-2648.2006.04021.x; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Liu CK, 2011, CLIN GERIATR MED, V27, P101, DOI 10.1016/j.cger.2010.08.001; Marin RV, 2010, J CLIN DENSITOM, V13, P96, DOI 10.1016/j.jocd.2009.12.001; Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Mattson MP, 2010, AGING CELL, V9, P448, DOI 10.1111/j.1474-9726.2010.00561.x; MCCAY CM, 1989, NUTRITION, V5, P155; Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005; Miller RA, 1999, J GERONTOL A-BIOL, V54, pB358, DOI 10.1093/gerona/54.8.B358; Miller RA, 2009, J GERONTOL A-BIOL, V64, P157, DOI 10.1093/gerona/gln062; Montero-Odasso M, 2011, J GERONTOL A-BIOL, V66, P568, DOI 10.1093/gerona/glr007; Moreschi C, 1909, EXPER THERAP, V2, P651; Norrelund H, 2002, GROWTH HORM IGF RES, V12, P198, DOI 10.1016/S1096-6374(02)00043-6; Olshansky SJ, 2007, ANN NY ACAD SCI, V1114, P11, DOI 10.1196/annals.1396.050; Panici JA, 2009, J GERONTOL A-BIOL, V64, P1126, DOI 10.1093/gerona/glp111; Parks RJ, 2012, J GERONTOL A-BIOL, V67, P217, DOI 10.1093/gerona/glr193; Rajan KB, 2013, J GERONTOL A-BIOL, V68, P624, DOI 10.1093/gerona/gls208; Raji MA, 2010, J GERONTOL A-BIOL, V65, P1228, DOI 10.1093/gerona/glq121; Rantanen T, 2003, SCAND J MED SCI SPOR, V13, P3, DOI 10.1034/j.1600-0838.2003.00298.x; Roth LW, 2012, MATURITAS, V71, P315, DOI 10.1016/j.maturitas.2011.12.017; Rous P, 1914, J EXP MED, V20, P433, DOI 10.1084/jem.20.5.433; Schaible R., 1961, Genetics, V46, P896; Shamsi KS, 2012, J GERONTOL A-BIOL, V67, P853, DOI 10.1093/gerona/glr224; Shardell M, 2009, J GERONTOL A-BIOL, V64, P69, DOI 10.1093/gerona/gln007; SONNTAG WE, 1995, NEUROENDOCRINOLOGY, V61, P601, DOI 10.1159/000126885; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Sourial N, 2012, J GERONTOL A-BIOL, V67, P1197, DOI 10.1093/gerona/gls084; Strawbridge WJ, 2002, GERONTOLOGIST, V42, P727, DOI 10.1093/geront/42.6.727; Syed Farhan A, 2011, Curr Osteoporos Rep, V9, P219, DOI 10.1007/s11914-011-0074-z; Syed Farhan A, 2010, Curr Osteoporos Rep, V8, P235, DOI 10.1007/s11914-010-0035-y; Thorner MO, 2009, J GERONTOL A-BIOL, V64, P1039, DOI 10.1093/gerona/glp091; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; Wan H., 2005, CURRENT POPULATION R; Warner HR, 2009, CAN J AGING, V28, P391, DOI 10.1017/S0714980809990286; Weiss CO, 2011, CLIN GERIATR MED, V27, P39, DOI 10.1016/j.cger.2010.08.003; White DK, 2013, J GERONTOL A-BIOL, V68, P456, DOI 10.1093/gerona/gls197	74	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e72255	10.1371/journal.pone.0072255	http://dx.doi.org/10.1371/journal.pone.0072255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155868	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300002
J	Hsu, JL; Khan, MA; Sobel, RA; Jiang, XG; Clemons, KV; Nguyen, TT; Stevens, DA; Martinez, M; Nicolls, MR				Hsu, Joe L.; Khan, Mohammad A.; Sobel, Raymond A.; Jiang, Xinguo; Clemons, Karl V.; Nguyen, Tom T.; Stevens, David A.; Martinez, Marife; Nicolls, Mark R.			Aspergillus fumigatus Invasion Increases with Progressive Airway Ischemia	PLOS ONE			English	Article							SOLID-ORGAN TRANSPLANTATION; LUNG-TRANSPLANTATION; FUNGAL-INFECTIONS; RECIPIENTS; FIBROSIS; REJECTION; HYPOXIA; CELLS; PCR	Despite the prevalence of Aspergillus-related disease in immune suppressed lung transplant patients, little is known of the host-pathogen interaction. Because of the mould's angiotropic nature and because of its capacity to thrive in hypoxic conditions, we hypothesized that the degree of Aspergillus invasion would increase with progressive rejection-mediated ischemia of the allograft. To study this relationship, we utilized a novel orthotopic tracheal transplant model of Aspergillus infection, in which it was possible to assess the effects of tissue hypoxia and ischemia on airway infectivity. Laser Doppler flowmetry and FITC-lectin were used to determine blood perfusion, and a fiber optic microsensor was used to measure airway tissue oxygen tension. Fungal burden and depth of invasion were graded using histopathology. We demonstrated a high efficacy (80%) for producing a localized fungal tracheal infection with the majority of infection occurring at the donor-recipient anastomosis; Aspergillus was more invasive in allogeneic compared to syngeneic groups. During the study period, the overall kinetics of both non-infected and infected allografts was similar, demonstrating a progressive loss of perfusion and oxygenation, which reached a nadir by days 10-12 post-transplantation. The extent of Aspergillus invasion directly correlated with the degree of graft hypoxia and ischemia. Compared to the midtrachea, the donor-recipient anastomotic site exhibited lower perfusion and more invasive disease; a finding consistent with clinical experience. For the first time, we identify ischemia as a putative risk factor for Aspergillus invasion. Therapeutic approaches focused on preserving vascular health may play an important role in limiting Aspergillus infections.	[Hsu, Joe L.; Nicolls, Mark R.] Stanford Univ, Dept Med, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Hsu, Joe L.; Khan, Mohammad A.; Jiang, Xinguo; Nguyen, Tom T.; Nicolls, Mark R.] Vet Affairs Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA USA; [Sobel, Raymond A.] Vet Affairs Palo Alto Hlth Care Syst, Pathol & Lab Serv, Palo Alto, CA USA; [Sobel, Raymond A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Clemons, Karl V.; Stevens, David A.; Martinez, Marife] Calif Inst Med Res, Infect Dis Res Lab, San Jose, CA 95128 USA; [Clemons, Karl V.; Stevens, David A.] Stanford Univ, Dept Med, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Hsu, JL (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA.	joehsu@stanford.edu	Khan, Mohammad Afzal/AAG-3800-2021; Nicolls, Mark/K-6085-2019	Khan, Mohammad Afzal/0000-0002-4738-7893; Sobel, Raymond/0000-0002-0477-9002	National Institutes of Health [HL095686]; Veterans Affairs Merit Award [BX000509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108797, R01HL095686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health grant HL095686 and by a Veterans Affairs Merit Award BX000509 to M. R. Nicolls. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu AN, 2007, J CLIN INVEST, V117, P3774, DOI 10.1172/JCI32311; Ben-Ami R, 2009, BLOOD, V114, P5393, DOI 10.1182/blood-2009-07-231209; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Challier S, 2004, J CLIN MICROBIOL, V42, P844, DOI 10.1128/JCM.42.2.844-846.2004; Chow L, 2002, CLIN INFECT DIS, V35, pE106, DOI 10.1086/343743; Dhillon GS, 2010, AM J RESP CRIT CARE, V182, P230, DOI 10.1164/rccm.200910-1573OC; Fleiss J., 1981, STATISTICAL METHODS, P8; Grahl N, 2012, EUKARYOT CELL, V11, P560, DOI 10.1128/EC.00031-12; Grahl N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002145; HALL LA, 1994, J MED MICROBIOL, V41, P311, DOI 10.1099/00222615-41-5-311; Hsu JL, 2011, CRIT REV MICROBIOL, V37, P277, DOI 10.3109/1040841X.2011.581223; Jiang X, 2011, J CLIN INVEST, V121, P2336, DOI 10.1172/JCI46192; Kamai Y, 2006, MED MYCOL, V44, pS115, DOI 10.1080/13693780600897989; Khan MA, 2012, AM J PHYSIOL-LUNG C, V303, pL861, DOI 10.1152/ajplung.00162.2012; Khan MA, 2011, CIRC RES, V109, P1290, DOI 10.1161/CIRCRESAHA.111.250167; Kontoyiannis DP, 2010, VIRULENCE, V1, P192, DOI 10.4161/viru.1.3.11380; Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nunley DR, 2002, CHEST, V122, P1185, DOI 10.1378/chest.122.4.1185; Rodland EK, 2010, INFECT IMMUN, V78, P1269, DOI 10.1128/IAI.01091-09; Silveira FP, 2007, MED MYCOL, V45, P305, DOI 10.1080/13693780701200372; Singh G, 2005, ANTIMICROB AGENTS CH, V49, P1369, DOI 10.1128/AAC.49.4.1369-1376.2005; Singh N, 2005, CLIN MICROBIOL REV, V18, P44, DOI 10.1128/CMR.18.1.44-69.2005; Singh N, 2003, INFECT DIS CLIN N AM, V17, P113, DOI 10.1016/S0891-5520(02)00067-3; Sole A, 2005, CLIN MICROBIOL INFEC, V11, P359, DOI 10.1111/j.1469-0691.2005.01128.x; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; Verleden GM, 2010, CURR OPIN ORGAN TRAN, V15, P568, DOI 10.1097/MOT.0b013e32833debd0; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Weigt SS, 2013, AM J TRANSPLANT, V13, P919, DOI 10.1111/ajt.12131	29	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77136	10.1371/journal.pone.0077136	http://dx.doi.org/10.1371/journal.pone.0077136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155924	Green Submitted, gold, Green Published			2022-12-27	WOS:000325887300058
J	Kudumala, S; Freund, J; Hortsch, M; Godenschwege, TA				Kudumala, Sirisha; Freund, Julie; Hortsch, Michael; Godenschwege, Tanja A.			Differential Effects of Human L1CAM Mutations on Complementing Guidance and Synaptic Defects in Drosophila melanogaster	PLOS ONE			English	Article							ADHESION MOLECULE L1; NEURAL-CELL-ADHESION; PATHOLOGICAL MISSENSE MUTATIONS; NEURITE OUTGROWTH; NERVOUS-SYSTEM; EXTRACELLULAR DOMAIN; LOCOMOTOR BEHAVIOR; AXON OUTGROWTH; HUMAN L1-CAM; FAMILY	A large number of different pathological L1CAM mutations have been identified that result in a broad spectrum of neurological and non-neurological phenotypes. While many of these mutations have been characterized for their effects on homophilic and heterophilic interactions, as well as expression levels in vitro, there are only few studies on their biological consequences in vivo. The single L1-type CAM gene in Drosophila, neuroglian (nrg), has distinct functions during axon guidance and synapse formation and the phenotypes of nrg mutants can be rescued by the expression of human L1CAM. We previously showed that the highly conserved intracellular FIGQY Ankyrin-binding motif is required for L1CAM-mediated synapse formation, but not for neurite outgrowth or axon guidance of the Drosophila giant fiber (GF) neuron. Here, we use the GF as a model neuron to characterize the pathogenic L120V, Y1070C, C264Y, H210Q, E309K and R184Q extracellular L1CAM missense mutations and a L1CAM protein with a disrupted ezrin-moesin-radixin (ERM) binding site to investigate the signaling requirements for neuronal development. We report that different L1CAM mutations have distinct effects on axon guidance and synapse formation. Furthermore, L1CAM homophilic binding and signaling via the ERM motif is essential for axon guidance in Drosophila. In addition, the human pathological H210Q, R184Q and Y1070C, but not the E309K and L120V L1CAM mutations affect outside-in signaling via the FIGQY Ankyrin binding domain which is required for synapse formation. Thus, the pathological phenotypes observed in humans are likely to be caused by the disruption of signaling required for both, guidance and synaptogenesis.	[Kudumala, Sirisha; Freund, Julie; Godenschwege, Tanja A.] Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL USA; [Hortsch, Michael] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	State University System of Florida; Florida Atlantic University; University of Michigan System; University of Michigan	Godenschwege, TA (corresponding author), Florida Atlantic Univ, Dept Biol Sci, John D MacArthur Campus, Jupiter, FL USA.	godensch@fau.edu	Godenschwege, Tanja A/A-2830-2010	Godenschwege, Tanja A/0000-0003-3322-4134	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD050725]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050725] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD050725 to T. A. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. J., 2010, COLD SPRING HARB PRO; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Boerner J, 2011, JOVE-J VIS EXP, DOI 10.3791/3080; Boerner J, 2010, J NEUROGENET, V24, P158, DOI 10.3109/01677063.2010.489624; BRAND AH, 1993, DEVELOPMENT, V118, P401; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Cheng L, 2004, MOL CELL NEUROSCI, V27, P522, DOI 10.1016/j.mcn.2004.08.005; Cheng L, 2005, J NEUROSCI, V25, P395, DOI 10.1523/JNEUROSCI.4097-04.2005; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; Dickson TC, 2002, J CELL BIOL, V157, P1105, DOI 10.1083/jcb.200111076; Dityatev A, 2008, NEURON GLIA BIOL, V4, P197, DOI 10.1017/S1740925X09990111; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Godenschwege TA, 2009, J NEUROGENET, V23, P147, DOI 10.1080/01677060802441380; Goossens T, 2011, DEVELOPMENT, V138, P1595, DOI 10.1242/dev.052787; HORTSCH M, 1990, NEURON, V4, P697, DOI 10.1016/0896-6273(90)90196-M; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; Itoh K, 2004, J CELL BIOL, V165, P145, DOI 10.1083/jcb.200312107; Itoh K, 2011, J NEUROSCI RES, V89, P1637, DOI 10.1002/jnr.22695; Jenkins SM, 2001, J CELL SCI, V114, P3823; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Michelson P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9096; Mintz CD, 2003, J COMP NEUROL, V464, P438, DOI 10.1002/cne.10809; Mualla R, 2013, NEUROCHEM RES, V38, P1196, DOI 10.1007/s11064-012-0892-0; Nagaraj K, 2009, HUM MOL GENET, V18, P3822, DOI 10.1093/hmg/ddp325; Nakamura Y, 2006, J CELL SCI, V119, P1341, DOI 10.1242/jcs.02862; Nayeem N, 1999, J CELL SCI, V112, P4739; Needham LK, 2001, J NEUROSCI, V21, P1490, DOI 10.1523/JNEUROSCI.21-05-01490.2001; Runker AE, 2003, J NEUROSCI, V23, P277; Schafer MKE, 2010, NEUROBIOL DIS, V40, P222, DOI 10.1016/j.nbd.2010.05.029; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6	43	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76974	10.1371/journal.pone.0076974	http://dx.doi.org/10.1371/journal.pone.0076974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155914	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300048
J	Schaum, CE; Batty, R; Last, KS				Schaum, C. Elisa; Batty, Robert; Last, Kim S.			Smelling Danger - Alarm Cue Responses in the Polychaete Nereis (Hediste) diversicolor (Muller, 1776) to Potential Fish Predation	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; CHEMICAL CUES; PREY INTERACTIONS; RISK-ASSESSMENT; SENSE-ORGANS; BEHAVIOR; ECOLOGY; VIRENS; HABITUATION; KAIROMONES	The harbour ragworm, Nereis (Hediste) diversicolor is a common intertidal marine polychaete that lives in burrows from which it has to partially emerge in order to forage. In doing so, it is exposed to a variety of predators. One way in which predation risk can be minimised is through chemical detection from within the relative safety of the burrows. Using CCTV and motion capture software, we show that H. diversicolor is able to detect chemical cues associated with the presence of juvenile flounder (Platichthys flesus). Number of emergences, emergence duration and distance from burrow entrance are all significantly reduced during exposure to flounder conditioned seawater and flounder mucous spiked seawater above a threshold with no evidence of behavioural habituation. Mucous from bottom-dwelling juvenile plaice (Pleuronectes platessa) and pelagic adult herring (Clupea harengus) elicit similar responses, suggesting that the behavioural reactions are species independent. The data implies that H. diversicolor must have well developed chemosensory mechanisms for predator detection and is consequently able to effectively minimize risk.	[Schaum, C. Elisa; Batty, Robert; Last, Kim S.] Scottish Marine Inst, Scottish Assoc Marine Sci, Dunstaffnage, Scotland		Last, KS (corresponding author), Scottish Marine Inst, Scottish Assoc Marine Sci, Dunstaffnage, Scotland.	kim.last@sams.ac.uk			ARC fellowship (SAMS)	ARC fellowship (SAMS)	Funding was provided to KSL through an ARC fellowship (SAMS). ES was self-funded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Allan BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058520; Batty RS, 1995, J FISH BIOL, V47, P931, DOI 10.1111/j.1095-8649.1995.tb06019.x; Beklioglu M, 2006, FRESHWATER BIOL, V51, P2200, DOI 10.1111/j.1365-2427.2006.01642.x; Boeing WJ, 2006, ARCH HYDROBIOL, V166, P241, DOI 10.1127/0003-9136/2006/0166-0241; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; CLARK R. B., 1960, ANIMAL BEHAVIOUR, V8, P82, DOI 10.1016/0003-3472(60)90013-0; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; DAVEY JT, 1986, OPHELIA, V26, P151, DOI 10.1080/00785326.1986.10421985; DORSETT DA, 1964, PROC R SOC SER B-BIO, V159, P652, DOI 10.1098/rspb.1964.0024; DORSETT DA, 1969, Z ZELLFORSCH MIK ANA, V97, P512, DOI 10.1007/BF00332800; ESSELINK P, 1989, MAR ECOL PROG SER, V56, P243, DOI 10.3354/meps056243; EVANS SM, 1969, BIOL BULL, V137, P95, DOI 10.2307/1539933; EVANS SM, 1966, ANIM BEHAV, V14, P107, DOI 10.1016/S0003-3472(66)80018-0; Ferland-Raymond B, 2008, CAN J ZOOL, V86, P1329, DOI 10.1139/Z08-117; Ferrari MCO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031478; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Forward RB, 2000, J EXP MAR BIOL ECOL, V245, P277, DOI 10.1016/S0022-0981(99)00169-0; GAMBI MC, 1996, ATTI, V11, P779; HOLOMUZKI JR, 1994, FRESHWATER BIOL, V32, P585, DOI 10.1111/j.1365-2427.1994.tb01149.x; HOVERMAN JT, 2001, PREDATOR INDUCED PLA, P1465, DOI DOI 10.1002/9780470015902.A0003305.PUB2; Intergovernmental Panel on Climate Change (IPCC) Working Group II., 2007, SUMM POL MAK; Karlson AML, 2007, ICES J MAR SCI, V64, P479, DOI 10.1093/icesjms/fsl049; Kicklighter CE, 2007, ANIM BEHAV, V74, P1481, DOI 10.1016/j.anbehav.2007.02.015; KRISTENSEN E, 1984, HOLARCTIC ECOL, V7, P249; Lass S, 2003, HYDROBIOLOGIA, V491, P221, DOI 10.1023/A:1024487804497; Last KS, 2009, CHRONOBIOL INT, V26, P167, DOI 10.1080/07420520902774524; Last KS, 2003, J EXP MAR BIOL ECOL, V287, P237, DOI 10.1016/S0022-0981(02)00576-2; Lincoln RJ, 1982, DICT ECOLOGY EVOLUTI, P298; Lindsay SM, 2009, ZOOSYMPOSIA, V2, P339, DOI 10.11646/zoosymposia.2.1.24; Mach ME, 2011, J EXP MAR BIOL ECOL, V409, P166, DOI 10.1016/j.jembe.2011.08.018; MARER YB, 1980, J EXP ZOOL, V213, P33, DOI DOI 10.1002/JEZ.1402130106; Mathuru AS, 2012, CURR BIOL, V22, P538, DOI 10.1016/j.cub.2012.01.061; Mccoy MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047495; McKelvey LM, 1995, J PLANKTON RES, V17, P2191, DOI 10.1093/plankt/17.12.2191; Meager JJ, 2007, PHILOS T R SOC B, V362, P2123, DOI 10.1098/rstb.2007.2104; Mermillod-Blondin F, 2005, J EXP MAR BIOL ECOL, V315, P187, DOI 10.1016/j.jembe.2004.09.013; MIRON G, 1993, MAR ECOL PROG SER, V101, P147, DOI 10.3354/meps101147; Mueller F., 1776, ZDP, P1; Nunes AL, 2013, OECOLOGIA, V171, P115, DOI 10.1007/s00442-012-2389-6; OLIVE PJW, 1981, B SOC ZOOL FR, V106, P263; PESTANA J, 2013, MAR FRESHW RES, P1465; Rahman YJ, 2000, J CHEM ECOL, V26, P679, DOI 10.1023/A:1005428221952; RIISGARD HU, 1991, MAR ECOL PROG SER, V70, P29, DOI 10.3354/meps070029; Ringelberg J, 1998, J PLANKTON RES, V20, P1847, DOI 10.1093/plankt/20.9.1847; Riordan TJ, 2002, J EXP MAR BIOL ECOL, V277, P79, DOI 10.1016/S0022-0981(02)00292-7; Rosenberg R, 2000, MAR BIOL, V136, P43, DOI 10.1007/s002270050006; Scaps P, 2002, HYDROBIOLOGIA, V470, P203, DOI 10.1023/A:1015681605656; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; SHEPHARD KL, 1994, REV FISH BIOL FISHER, V4, P401, DOI 10.1007/BF00042888; SMITH JE, 1957, PHILOS T ROY SOC B, V240, P135, DOI 10.1098/rstb.1957.0001; SMITH RI, 1955, BIOL BULL, V108, P326, DOI 10.2307/1538519; SMITH RJF, 1986, AM NAT, V128, P604, DOI 10.1086/284591; Tsie MS, 2008, CELL TISSUE RES, V333, P469, DOI 10.1007/s00441-008-0660-2; Tvete T, 2008, J FISH DIS, V31, P343, DOI 10.1111/j.1365-2761.2008.00906.x; Watson GJ, 2005, ANIM BEHAV, V70, P1125, DOI 10.1016/j.anbehav.2005.03.011; Weber A, 2003, HYDROBIOLOGIA, V498, P143, DOI 10.1023/A:1026297106626; Wisenden BD, 2001, ANIM BEHAV, V62, P761, DOI 10.1006/anbe.2001.1797	60	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77431	10.1371/journal.pone.0077431	http://dx.doi.org/10.1371/journal.pone.0077431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155953	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300087
J	Chen, JF; Marks, E; Lai, B; Zhang, ZJ; Duce, JA; Lam, LQ; Volitakis, I; Bush, AI; Hersch, S; Fox, JH				Chen, Jianfang; Marks, Eileen; Lai, Barry; Zhang, Zhaojie; Duce, James A.; Lam, Linh Q.; Volitakis, Irene; Bush, Ashley I.; Hersch, Steven; Fox, Jonathan H.			Iron Accumulates in Huntington's Disease Neurons: Protection by Deferoxamine	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; OXIDATIVE STRESS; MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; IN-VIVO; BRAIN; MICROGLIA; FERRITIN; ALPHA; HOMEOSTASIS	Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a polyglutamine-encoding CAG expansion in the huntingtin gene. Iron accumulates in the brains of HD patients and mouse disease models. However, the cellular and subcellular sites of iron accumulation, as well as significance to disease progression are not well understood. We used independent approaches to investigate the location of brain iron accumulation. In R6/2 HD mouse brain, synchotron x-ray fluorescence analysis revealed iron accumulation as discrete puncta in the perinuclear cytoplasm of striatal neurons. Further, perfusion Turnbull's staining for ferrous iron (II) combined with transmission electron microscope ultra-structural analysis revealed increased staining in membrane bound perinuclear vesicles in R6/2 HD striatal neurons. Analysis of iron homeostatic proteins in R6/2 HD mice revealed decreased levels of the iron response proteins (IRPs 1 and 2) and accordingly decreased expression of iron uptake transferrin receptor (TfR) and increased levels of neuronal iron export protein ferroportin (FPN). Finally, we show that intra-ventricular delivery of the iron chelator deferoxamine results in an improvement of the motor phenotype in R6/2 HD mice. Our data supports accumulation of redox-active ferrous iron in the endocytic / lysosomal compartment in mouse HD neurons. Expression changes of IRPs, TfR and FPN are consistent with a compensatory response to an increased intra-neuronal labile iron pool leading to increased susceptibility to iron-associated oxidative stress. These findings, together with protection by deferoxamine, support a potentiating role of neuronal iron accumulation in HD.	[Chen, Jianfang; Marks, Eileen; Fox, Jonathan H.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Chen, Jianfang; Marks, Eileen; Fox, Jonathan H.] Univ Wyoming, Grad Program Neurosci, Laramie, WY 82071 USA; [Lai, Barry] Argonne Natl Lab, Lemont, IL USA; [Zhang, Zhaojie] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Duce, James A.; Lam, Linh Q.; Volitakis, Irene; Bush, Ashley I.] Mental Hlth Res Inst, Melbourne, Vic, Australia; [Duce, James A.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Hersch, Steven] MassGen Inst Neurodegenerat Dis, Charlestown, MA USA	University of Wyoming; University of Wyoming; United States Department of Energy (DOE); Argonne National Laboratory; University of Wyoming; University of Leeds	Fox, JH (corresponding author), Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA.	jfox7@uwyo.edu	Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Duce, James/0000-0002-8762-2245; Volitakis, Irene/0000-0003-0766-817X	National Institutes of Health; Huntington's Disease Society of America; National Center for Research Resources from the National Institutes of Health [5P30RR032128-02]; National Institute of General Medical Sciences from the National Institutes of Health [8 P30GM103398-02]; National Institute of Neurological Disorders and Stroke from the National Institutes of Health [RO1NS079450]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR032128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079450] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntington's Disease Society of America; National Center for Research Resources from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); National Institute of Neurological Disorders and Stroke from the National Institutes of Health; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health and by the Huntington's Disease Society of America, the National Center for Research Resources (5P30RR032128-02), the National Institute of General Medical Sciences (8 P30GM103398-02) and National Institute of Neurological Disorders and Stroke (RO1NS079450) from the National Institutes of Health. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Ayton S, 2013, ANN NEUROL; BROWNE SE, 1994, BIOCHEM SOC T, V22, P1002, DOI 10.1042/bst0221002; Cherny RA, HUNTINGTONS DIS, V1, P211; Cheville N., 2009, ULTRASTRUCTURAL PATH; Chopra V, 2007, P NATL ACAD SCI USA, V104, P16685, DOI 10.1073/pnas.0707842104; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Davies P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015814; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Duan WZ, 2008, NEUROBIOL DIS, V30, P312, DOI 10.1016/j.nbd.2008.01.015; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Dumas EM, 2012, NEUROIMAGE, V61, P558, DOI 10.1016/j.neuroimage.2012.03.056; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Duong TTH, 2009, J NEUROCHEM, V108, P1143, DOI 10.1111/j.1471-4159.2008.05846.x; Firdaus WJJ, 2006, FEBS J, V273, P5428, DOI 10.1111/j.1742-4658.2006.05537.x; Fox JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000334; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Galaris D, 2008, CRIT REV CL LAB SCI, V45, P1, DOI [10.1080/10408360701713104, 10.1080/10408360701713104 ]; Grundy MA, 2004, J BIOCHEM BIOPH METH, V59, P195, DOI 10.1016/j.jbbm.2004.01.001; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Jeong SY, 2009, J NEUROSCI, V29, P570, DOI 10.1523/JNEUROSCI.5443-08.2009; Katayama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040813; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Kuehnel W., 2003, COLOR ATLAS CYTOLOGY; Kurz T, 2006, FEBS J, V273, P3106, DOI 10.1111/j.1742-4658.2006.05321.x; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Lippard J.M.B.S.J., 1994, PRINCIPLES BIOINORGA; Lumsden AL, 2007, HUM MOL GENET, V16, P1905, DOI 10.1093/hmg/ddm138; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mastroberardino PG, 2009, NEUROBIOL DIS, V34, P417, DOI 10.1016/j.nbd.2009.02.009; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; McColl G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032685; Meguro R, 2008, ARCH HISTOL CYTOL, V71, P205, DOI 10.1679/aohc.71.205; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Neher JJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00027; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Paunesku T, 2006, J CELL BIOCHEM, V99, P1489, DOI 10.1002/jcb.21047; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Rathore KI, 2012, GLIA, V60, P738, DOI 10.1002/glia.22303; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rosas HD, 2012, ARCH NEUROL-CHICAGO; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369	59	79	83	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77023	10.1371/journal.pone.0077023	http://dx.doi.org/10.1371/journal.pone.0077023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146952	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400095
J	Geiling, B; Vandal, G; Posner, AR; de Bruyns, A; Dutchak, KL; Garnett, S; Dankort, D				Geiling, Benjamin; Vandal, Guillaume; Posner, Ada R.; de Bruyns, Angeline; Dutchak, Kendall L.; Garnett, Samantha; Dankort, David			A Modular Lentiviral and Retroviral Construction System to Rapidly Generate Vectors for Gene Expression and Gene Knockdown In Vitro and In Vivo	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; RNA INTERFERENCE; TUMOR SUPPRESSION; MESSENGER-RNA; PROTEIN; CELLS; VIRUS; P53; DELIVERY; MOUSE	The ability to express exogenous cDNAs while suppressing endogenous genes via RNAi represents an extremely powerful research tool with the most efficient non-transient approach being accomplished through stable viral vector integration. Unfortunately, since traditional restriction enzyme based methods for constructing such vectors are sequence dependent, their construction is often difficult and not amenable to mass production. Here we describe a non-sequence dependent Gateway recombination cloning system for the rapid production of novel lentiviral (pLEG) and retroviral (pREG) vectors. Using this system to recombine 3 or 4 modular plasmid components it is possible to generate viral vectors expressing cDNAs with or without inhibitory RNAs (shRNAmirs). In addition, we demonstrate a method to rapidly produce and triage novel shRNAmirs for use with this system. Once strong candidate shRNAmirs have been identified they may be linked together in tandem to knockdown expression of multiple targets simultaneously or to improve the knockdown of a single target. Here we demonstrate that these recombinant vectors are able to express cDNA and effectively knockdown protein expression using both cell culture and animal model systems.	[Geiling, Benjamin; Vandal, Guillaume; Posner, Ada R.; de Bruyns, Angeline; Dutchak, Kendall L.; Garnett, Samantha; Dankort, David] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Dankort, D (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	david.dankort@mcgill.ca		Dankort, David/0000-0002-5862-6829	Canadian Institutes of Health Research [MOP-97925]; Melanoma Research Alliance; Canadian Cancer Society [CCSRI] [2011-700876]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Melanoma Research Alliance; Canadian Cancer Society [CCSRI]	This work was supported by the Canadian Institutes of Health Research [operating grant MOP-97925 to DD, Graduate scholarship to GV]; the Melanoma Research Alliance [New Investigator Award]; and the Canadian Cancer Society [CCSRI# 2011-700876]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Audouy S, 2001, MOL MEMBR BIOL, V18, P129, DOI 10.1080/713816122; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; BERNARD P, 1991, MOL GEN GENET, V226, P297, DOI 10.1007/BF00273616; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bitzer M, 2003, J GENE MED, V5, P543, DOI 10.1002/jgm.426; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Deyle DR, 2009, CURR OPIN MOL THER, V11, P442; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Fewell GD, 2006, DRUG DISCOV TODAY, V11, P975, DOI 10.1016/j.drudis.2006.09.008; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hampf M, 2006, ANAL BIOCHEM, V356, P94, DOI 10.1016/j.ab.2006.04.046; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Johnson LG, 2003, HUM GENE THER, V14, P729, DOI 10.1089/104303403765255138; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kamimura Kenya, 2011, Pharmaceut Med, V25, P293; Kesireddy V, 2010, MOL BIOL REP, V37, P2863, DOI 10.1007/s11033-009-9840-8; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kovesdi I, 1997, CURR OPIN BIOTECH, V8, P583, DOI 10.1016/S0958-1669(97)80033-X; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Martin P, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-4; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mitta B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf112; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; NASH HA, 1980, COLD SPRING HARB SYM, V45, P417, DOI 10.1101/SQB.1981.045.01.056; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Rashtchian Ayoub, 1995, Current Opinion in Biotechnology, V6, P30, DOI 10.1016/0958-1669(95)80006-9; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Sebastian T, 2005, EMBO J, V24, P3301, DOI 10.1038/sj.emboj.7600789; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; SHUMAN S, 1994, J BIOL CHEM, V269, P32678; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smith RH, 2008, GENE THER, V15, P817, DOI 10.1038/gt.2008.55; Stauffer Y, 1998, J MOL BIOL, V283, P529, DOI 10.1006/jmbi.1998.2113; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Van Craenenbroeck K, 2000, EUR J BIOCHEM, V267, P5665, DOI 10.1046/j.1432-1327.2000.01645.x; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Verkhusha VV, 2003, BIOCHEMISTRY-US, V42, P7879, DOI 10.1021/bi034555t; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Wong SP, 2009, CURR OPIN MOL THER, V11, P433; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang J, 2010, BIOTECHNIQUES, V49, P817, DOI 10.2144/000113520; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	86	13	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76279	10.1371/journal.pone.0076279	http://dx.doi.org/10.1371/journal.pone.0076279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146852	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400051
J	Pena, JM; Torres-Sanchez, J; de Castro, AI; Kelly, M; Lopez-Granados, F				Manuel Pena, Jose; Torres-Sanchez, Jorge; Isabel de Castro, Ana; Kelly, Maggi; Lopez-Granados, Francisca			Weed Mapping in Early-Season Maize Fields Using Object-Based Analysis of Unmanned Aerial Vehicle (UAV) Images	PLOS ONE			English	Article							PRECISION AGRICULTURE; DIGITAL IMAGES; MANAGEMENT; IDENTIFICATION; ACQUISITION; PATCHES; SYSTEM	The use of remote imagery captured by unmanned aerial vehicles (UAV) has tremendous potential for designing detailed site-specific weed control treatments in early post-emergence, which have not possible previously with conventional airborne or satellite images. A robust and entirely automatic object-based image analysis (OBIA) procedure was developed on a series of UAV images using a six-band multispectral camera (visible and near-infrared range) with the ultimate objective of generating a weed map in an experimental maize field in Spain. The OBIA procedure combines several contextual, hierarchical and object-based features and consists of three consecutive phases: 1) classification of crop rows by application of a dynamic and auto-adaptive classification approach, 2) discrimination of crops and weeds on the basis of their relative positions with reference to the crop rows, and 3) generation of a weed infestation map in a grid structure. The estimation of weed coverage from the image analysis yielded satisfactory results. The relationship of estimated versus observed weed densities had a coefficient of determination of r(2)=0.89 and a root mean square error of 0.02. A map of three categories of weed coverage was produced with 86% of overall accuracy. In the experimental field, the area free of weeds was 23%, and the area with low weed coverage (<5% weeds) was 47%, which indicated a high potential for reducing herbicide application or other weed operations. The OBIA procedure computes multiple data and statistics derived from the classification outputs, which permits calculation of herbicide requirements and estimation of the overall cost of weed management operations in advance.	[Manuel Pena, Jose; Torres-Sanchez, Jorge; Isabel de Castro, Ana; Lopez-Granados, Francisca] CSIC, IAS, Dept Crop Protect, Cordoba, Spain; [Kelly, Maggi] Univ Calif Berkeley, Environm Sci Policy & Management Dept, Berkeley, CA 94720 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); University of California System; University of California Berkeley	Pena, JM (corresponding author), CSIC, IAS, Dept Crop Protect, Cordoba, Spain.	jmpena@ias.csic.es	Peña, Jose M/K-4201-2014; MA, Lei/I-4597-2014; Torres-Sánchez, Jorge/H-4714-2019; De Castro Megías, Ana Isabel/K-7429-2017; Lopez-Granados, Francisca/J-5617-2014	Peña, Jose M/0000-0003-4592-3792; Torres-Sánchez, Jorge/0000-0003-1420-0145; De Castro Megías, Ana Isabel/0000-0002-6699-2204; Lopez-Granados, Francisca/0000-0001-9165-7558	European Union [245986]; Marie Curie Program [FP7-PEOPLE-2011-CIG-293991]; Spanish Ministry of Economy and Competition, FEDER Funds [AGL2011-30442-CO2-01]; JAEDoc Program; JAEPre Program; FPI Program; FEDER funds	European Union(European Commission); Marie Curie Program(European Commission); Spanish Ministry of Economy and Competition, FEDER Funds; JAEDoc Program; JAEPre Program; FPI Program; FEDER funds(European Commission)	This research was partly financed by the 7th Framework Programme of the European Union under the Grant Agreement No. 245986 (RHEA Project) and the Marie Curie Program (FP7-PEOPLE-2011-CIG-293991 project) and by the Spanish Ministry of Economy and Competition, FEDER Funds (AGL2011-30442-CO2-01 project). Research of Dr. Pena, Dr. de Castro and Mr. Torres-Sanchez was financed by JAEDoc, JAEPre and FPI Programs, respectively. The stay of Dr. Pena at the University of California, Berkeley (USA) was financed by FEDER funds approved by the Consejer a de Economia, Innovacion y Ciencia de la Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Burgos-Artizzu XP, 2009, COMPUT ELECTRON AGR, V65, P176, DOI 10.1016/j.compag.2008.09.001; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Donald WW, 2006, WEED SCI, V54, P373; Fridgen JJ, 2004, AGRON J, V96, P100, DOI 10.2134/agronj2004.0100; Gibson KD, 2004, WEED TECHNOL, V18, P742, DOI 10.1614/WT-03-170R1; Goktogan AH, 2010, J INTELL ROBOT SYST, V57, P467, DOI 10.1007/s10846-009-9371-5; Gomez-Candon D, 2012, PRECIS AGRIC, V13, P322, DOI 10.1007/s11119-011-9249-y; Gomez-Candon D, 2012, PRECIS AGRIC, V13, P337, DOI 10.1007/s11119-011-9250-5; Heijting S, 2007, WEED RES, V47, P381, DOI 10.1111/j.1365-3180.2007.00580.x; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; de Castro AI, 2012, PRECIS AGRIC, V13, P302, DOI 10.1007/s11119-011-9247-0; Koger CH, 2003, WEED TECHNOL, V17, P696, DOI 10.1614/WT02-122; Laliberte AS, 2010, PHOTOGRAMM ENG REM S, V76, P661, DOI 10.14358/PERS.76.6.661; Lopez-Granados F, 2011, WEED RES, V51, P1, DOI 10.1111/j.1365-3180.2010.00829.x; Pedersen SM, 2006, PRECIS AGRIC, V7, P295, DOI 10.1007/s11119-006-9014-9; Pena J.M., 2012, P 4 INT C GEOGR OBJ, P426; Pena-Barragan JM, 2007, WEED RES, V47, P164, DOI 10.1111/j.1365-3180.2007.00553.x; Pena-Barragan JM, 2011, REMOTE SENS ENVIRON, V115, P1301, DOI 10.1016/j.rse.2011.01.009; Romeo J, 2013, EXPERT SYST APPL, V40, P2275, DOI 10.1016/j.eswa.2012.10.033; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Shaw DR, 2005, WEED SCI, V53, P264, DOI 10.1614/WS-04-072R1; Srinavasan A., 2006, HDB PRECISION AGR PR, V1st ed., P3, DOI [10.1300/5627_01, DOI 10.1300/5627_01]; Stafford JV, 2000, J AGR ENG RES, V76, P267, DOI 10.1006/jaer.2000.0577; Strobl J., 2000, ANGEW GEOGRAPHISCHE, P12; Torres-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058210; Williams J. C., 2011, Aspects of Applied Biology, P269; WOEBBECKE DM, 1995, T ASAE, V38, P259, DOI 10.13031/2013.27838; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5	29	252	266	12	233	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77151	10.1371/journal.pone.0077151	http://dx.doi.org/10.1371/journal.pone.0077151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146963	Green Published, gold			2022-12-27	WOS:000325819400100
J	Lin, SY; Hsieh, CJ; Chen, YL; Shaw, SWS; Lin, MW; Chen, PC; Lee, CN				Lin, Shin-Yu; Hsieh, Chia-Jung; Chen, Yi-Li; Shaw, Sheng-Wen Steven; Lin, Ming-Wei; Chen, Pau-Chung; Lee, Chien-Nan			The Impact of Down Syndrome Screening on Taiwanese Down Syndrome Births: A Nationwide Retrospective Study and a Screening Result from a Single Medical Centre	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; ALPHA-FETOPROTEIN; COST-EFFECTIVENESS; ASIAN POPULATION; MATERNAL AGE; TRENDS; PREVALENCE; TRISOMIES; RISK	A retrospective analysis of the Taiwanese National Birth Defect Registration and Notification System was conducted in order to determine the live birth- and stillbirth rates in infants with Down syndrome, trisomy 18, trisomy 13 and Turner syndrome between 2001 and 2010. The objective was to investigate the impact of Down syndrome screening on the Taiwanese Down syndrome live birth rate. In addition, the results of first-trimester Down syndrome screening between 2006 and 2011, and of second-trimester quadruple testing between 2008 and 2011, were obtained from the National Taiwan University Hospital. All Taiwanese infants born between 2001 and 2010 were included in the first part of the analysis, and women receiving first-trimester Down syndrome screening or second-trimester quadruple testing from the National Taiwan University Hospital were included in the second part. The live birth rate of infants with Down syndrome, per 100 000 live births, decreased from 22.28 in 2001 to 7.79 in 2010. The ratio of liveborn DS to total DS was 48.74% in 2001, and then decreased to 25.88% in 2006, when first-trimester screening was widely introduced in Taiwan. This ratio dropped to 20.64% in 2008, when the second-trimester quadruple test was implemented. The overall positive rate in first-trimester screening in the National Taiwan University Hospital was 3.1%, with a Down syndrome detection rate of 100%; the quadruple test had values of 9.0% and 75%, respectively. The use of first-trimester screening and the second-trimester quadruple test may be responsible for the marked decrease in the Taiwanese Down syndrome live birth rate observed between 2001 and 2010.	[Lin, Shin-Yu] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Hsin Chu Branch, Hsinchu, Taiwan; [Lin, Shin-Yu] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Hsieh, Chia-Jung] Tzu Chi Univ, Dept Publ Hlth, Hualien, Taiwan; [Chen, Yi-Li] Natl Taiwan Univ, Grad Inst Mol Med, Coll Med, Taipei 10764, Taiwan; [Shaw, Sheng-Wen Steven] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Shaw, Sheng-Wen Steven] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Lin, Ming-Wei; Lee, Chien-Nan] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Tzu Chi University; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lee, CN (corresponding author), Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan.	leecn@ntu.edu.tw	Hsieh, Chia-Jung/AAX-3086-2020; Chen, Pau-Chung/H-5686-2011	Hsieh, Chia-Jung/0000-0002-0381-7783; Chen, Pau-Chung/0000-0002-6242-5974; LIN, SHIN-YU/0000-0002-0753-2793; Lee, Chien-Nan/0000-0002-1725-0407				American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P217; Benn PA, 2003, OBSTET GYNECOL, V101, P451, DOI 10.1016/S0029-7844(02)03159-9; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Egan JFX, 2004, AM J OBSTET GYNECOL, V191, P1044, DOI 10.1016/j.ajog.2004.06.050; EIBEN B, 1990, AM J HUM GENET, V47, P656; Gilbert RE, 2001, BRIT MED J, V323, P423, DOI 10.1136/bmj.323.7310.423; HADDOW JE, 1994, NEW ENGL J MED, V330, P1114, DOI 10.1056/NEJM199404213301603; Hoshi N, 1999, AM J MED GENET, V84, P340, DOI 10.1002/(SICI)1096-8628(19990604)84:4<340::AID-AJMG6>3.0.CO;2-N; Hsu JJ, 1996, OBSTET GYNECOL, V87, P943, DOI 10.1016/0029-7844(96)00042-7; Hwa HL, 2008, J EVAL CLIN PRACT, V14, P191, DOI 10.1111/j.1365-2753.2007.00831.x; International Clearinghouse for Birth Defects Montoring Systems International Centre for Birth Defects WHGP European Registration of Congenital Anomalies, 2003, WORLD ATL BIRTH DEF; Jon HJ, 2005, PRENATAL DIAG, V25, P665, DOI 10.1002/pd.1220; Jou HJ, 2000, FETAL DIAGN THER, V15, P108, DOI 10.1159/000020986; KAJII T, 1980, HUM GENET, V55, P87, DOI 10.1007/BF00329132; KELLNER LH, 1995, AM J OBSTET GYNECOL, V173, P1306, DOI 10.1016/0002-9378(95)91376-9; Khoshnood B, 2004, BJOG-INT J OBSTET GY, V111, P485, DOI 10.1111/j.1471-0528.2004.00117.x; LAI FM, 2002, SINGAP MED J, V43, P93893; LIN S, 1991, INCIDENCE GROWTH SYN; Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94; MacRae AR, 2010, PRENATAL DIAG, V30, P459, DOI 10.1002/pd.2502; Maiz N, 2009, ULTRASOUND OBST GYN, V33, P512, DOI 10.1002/uog.6330; NICOLAIDES KH, 2001, PRENAT DIAGN, V31, P7; Olsen CL, 1997, PRENATAL DIAG, V17, P1113, DOI 10.1002/(SICI)1097-0223(199712)17:12<1113::AID-PD200>3.0.CO;2-7; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Shaw SWS, 2010, TAIWAN J OBSTET GYNE, V49, P30, DOI 10.1016/S1028-4559(10)60005-8; SNIJDERS RJM, 1995, FETAL DIAGN THER, V10, P356, DOI 10.1159/000264259; Spencer K, 2003, BJOG-INT J OBSTET GY, V110, P281, DOI 10.1016/S1470-0328(03)02946-X; Wald NJ, 2003, LANCET, V361, P835, DOI 10.1016/S0140-6736(03)12680-3; WALD NJ, 1988, BRIT MED J, V297, P883, DOI 10.1136/bmj.297.6653.883	29	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2013	8	9							e75428	10.1371/journal.pone.0075428	http://dx.doi.org/10.1371/journal.pone.0075428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	222YC	24147155	Green Published, Green Submitted, gold			2022-12-27	WOS:000324768000075
J	Hu, SX; Sheng, WS; Rock, RB				Hu, Shuxian; Sheng, Wen S.; Rock, R. Bryan			CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ACTIVE ANTIRETROVIRAL THERAPY; NEUROTROPHIC FACTOR PREVENTS; NECROSIS-FACTOR-ALPHA; 2ND CONSTANT DOMAIN; BLOOD-BRAIN-BARRIER; VIRUS TYPE-1 GP120; NIGRA IN-VIVO; OXIDATIVE STRESS; NADPH OXIDASE	Despite the therapeutic impact of anti-retroviral therapy, HIV-1-associated neurocognitive disorder (HAND) remains a serious threat to AIDS patients, and there currently remains no specific therapy for the neurological manifestations of HIV-1. Recent work suggests that the nigrostriatal dopaminergic area is a critical brain region for the neuronal dysfunction and death seen in HAND and that human dopaminergic neurons have a particular sensitivity to gp120-induced damage, manifested as reduced function (decreased dopamine uptake), morphological changes, and reduced viability. Synthetic cannabinoids inhibit HIV-1 expression in human microglia, suppress production of inflammatory mediators in human astrocytes, and there is substantial literature demonstrating the neuroprotective properties of cannabinoids in other neuropathogenic processes. Based on these data, experiments were designed to test the hypothesis that synthetic cannabinoids will protect dopaminergic neurons against the toxic effects of the HIV-1 protein gp120. Using a human mesencephalic neuronal/glial culture model, which contains dopaminergic neurons, microglia, and astrocytes, we were able to show that the CB1/CB2 agonist WIN55,212-2 blunts gp120-induced neuronal damage as measured by dopamine transporter function, apoptosis and lipid peroxidation; these actions were mediated principally by the CB2 receptor. Adding supplementary human microglia to our cultures enhances gp120-induced damage; WIN55,212-2 is able to alleviate this enhanced damage. Additionally, WIN55,212-2 inhibits gp120-induced superoxide production by purified human microglial cells, inhibits migration of human microglia towards supernatants generated from gp120-stimulated human mesencephalic neuronal/glial cultures and reduces chemokine and cytokine production from the human mesencephalic neuronal/glial cultures. These data suggest that synthetic cannabinoids are capable of protecting human dopaminergic neurons from gp120 in a variety of ways, acting principally through the CB2 receptors and microglia.	[Hu, Shuxian; Sheng, Wen S.; Rock, R. Bryan] Univ Minnesota, Sch Med, Dept Med, Ctr Infect Dis & Microbiol Translat Res,Div Infec, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Rock, RB (corresponding author), Univ Minnesota, Sch Med, Dept Med, Ctr Infect Dis & Microbiol Translat Res,Div Infec, Minneapolis, MN 55455 USA.	rockx012@umn.edu			U.S. Public Health Service [DA025525]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025525] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the U.S. Public Health Service grant DA025525. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2006, NEUROTOXICOLOGY, V27, P217, DOI 10.1016/j.neuro.2005.10.003; Aksenov MY, 2003, BRAIN RES, V987, P1, DOI 10.1016/S0006-8993(03)03194-9; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; AURIAULT C, 1983, FEBS LETT, V153, P11, DOI 10.1016/0014-5793(83)80109-4; AURIAULT C, 1985, INT J IMMUNOPHARMACO, V7, P73, DOI 10.1016/0192-0561(85)90011-6; AYLWARD EH, 1993, NEUROLOGY, V43, P2099, DOI 10.1212/WNL.43.10.2099; Bachis A, 2006, J NEUROSCI, V26, P6771, DOI 10.1523/JNEUROSCI.1054-06.2006; Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Becker Y., 2006, VIRUS GENES; Bennett BA, 1995, BRAIN RES, V705, P168, DOI 10.1016/0006-8993(95)01166-8; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Boisse L, 2008, NEUROL CLIN, V26, P799, DOI 10.1016/j.ncl.2008.04.002; BRENNEMAN DE, 1988, NATURE, V335, P639, DOI 10.1038/335639a0; Cabral G. A., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P159, DOI 10.2174/187153008785700118; CHAO CC, 1994, J PHARMACOL EXP THER, V269, P198; Chao CC, 1996, P NATL ACAD SCI USA, V93, P8051, DOI 10.1073/pnas.93.15.8051; CHAO CC, 1995, J LEUKOCYTE BIOL, V58, P65, DOI 10.1002/jlb.58.1.65; CHAO CC, 1992, J CLIN INVEST, V90, P1786, DOI 10.1172/JCI116053; Chen YQ, 2000, J PHARMACOL EXP THER, V293, P807; Choi SH, 2005, J NEUROCHEM, V95, P1755, DOI 10.1111/j.1471-4159.2005.03503.x; Chung ES, 2012, BRAIN RES, V1451, P110, DOI 10.1016/j.brainres.2012.02.058; Clements JE, 2005, J NEUROVIROL, V11, P180, DOI 10.1080/13550280590922829; Combadiere B, 2003, AIDS, V17, P1279, DOI 10.1097/00002030-200306130-00002; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; Corasaniti MT, 2000, BIOCHEM BIOPH RES CO, V274, P664, DOI 10.1006/bbrc.2000.3160; Cosenza MA, 2002, BRAIN PATHOL, V12, P442, DOI 10.1111/j.1750-3639.2002.tb00461.x; Cotter R, 2002, J NEUROVIROL, V8, P585, DOI 10.1080/13550280290100950; Croxford JL, 2003, J CLIN INVEST, V111, P1231, DOI 10.1172/JCI200317652; Czub S, 2004, ACTA NEUROPATHOL, V107, P216, DOI 10.1007/s00401-003-0801-3; D'Aversa TG, 2005, J NEUROSCI RES, V81, P436, DOI 10.1002/jnr.20486; DONG JF, 1993, NEUROSCIENCE, V56, P53, DOI 10.1016/0306-4522(93)90561-S; Ehrlich LC, 1998, J IMMUNOL, V160, P1944; Eljaschewitsch E, 2006, NEURON, V49, P67, DOI 10.1016/j.neuron.2005.11.027; Erichsen D, 2003, J NEUROIMMUNOL, V138, P144, DOI 10.1016/S0165-5728(03)00117-6; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Facchinetti F, 2003, GLIA, V41, P161, DOI 10.1002/glia.10177; Fernandez-Lopez D, 2012, NEUROSCIENCE, V207, P307, DOI 10.1016/j.neuroscience.2012.01.008; Ferris MJ, 2009, SYNAPSE, V63, P181, DOI 10.1002/syn.20594; Fraga D, 2011, J NEUROIMMUNE PHARM, V6, P566, DOI 10.1007/s11481-011-9291-6; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gelman BB, 2006, J NEUROIMMUNE PHARM, V1, P410, DOI 10.1007/s11481-006-9030-6; GENDELMAN HE, 2005, NEUROLOGY AIDS; Ghorpade A, 2005, J NEUROIMMUNOL, V163, P145, DOI 10.1016/j.jneuroim.2005.01.022; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Hu SX, 2006, J PHARMACOL EXP THER, V318, P1280, DOI 10.1124/jpet.106.103853; Hu SX, 2009, J NEUROVIROL, V15, P401, DOI 10.3109/13550280903296346; Hu SX, 2005, J INFECT DIS, V191, P886, DOI 10.1086/427830; Itoh K, 2000, ACTA NEUROPATHOL, V99, P376, DOI 10.1007/s004010051139; Jones MV, 2000, AIDS, V14, P2709, DOI 10.1097/00002030-200012010-00010; Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaul M, 2006, J NEUROIMMUNE PHARM, V1, P138, DOI 10.1007/s11481-006-9011-9; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kim HJ, 2011, MOL PHARMACOL, V80, P357, DOI 10.1124/mol.111.071647; Klegeris A, 2003, BRIT J PHARMACOL, V139, P775, DOI 10.1038/sj.bjp.0705304; Klein TW, 2006, J NEUROIMMUNE PHARM, V1, P50, DOI 10.1007/s11481-005-9007-x; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Koutsilieri E, 2002, J NEURAL TRANSM, V109, P767, DOI 10.1007/s007020200063; Koutsilieri E, 2002, J NEURAL TRANSM, V109, P399, DOI 10.1007/s007020200032; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, J NEUROCHEM, V80, P448, DOI 10.1046/j.0022-3042.2001.00716.x; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; Mehla R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-239; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Minghetti L, 2004, NEUROCHEM RES, V29, P965, DOI 10.1023/B:NERE.0000021241.90133.89; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Mocchetti I, 2007, ANN NY ACAD SCI, V1122, P144, DOI 10.1196/annals.1403.010; Moldzio R, 2012, PHYTOMEDICINE, V19, P819, DOI 10.1016/j.phymed.2012.04.002; Mollace V, 2001, TRENDS NEUROSCI, V24, P411, DOI 10.1016/S0166-2236(00)01819-1; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nath A, 2000, J PSYCHOPHARMACOL, V14, P222, DOI 10.1177/026988110001400305; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; Nosheny RL, 2007, EUR J NEUROSCI, V25, P2275, DOI 10.1111/j.1460-9568.2007.05506.x; Nosheny RL, 2006, J NEUROBIOL, V66, P1311, DOI 10.1002/neu.20288; Palazuelos J, 2009, BRAIN, V132, P3152, DOI 10.1093/brain/awp239; Paul RH, 2005, J NEUROPSYCH CLIN N, V17, P167, DOI 10.1176/appi.neuropsych.17.2.167; Peterson PK, 2004, J NEUROIMMUNOL, V147, P123, DOI 10.1016/j.jneuroim.2003.10.026; Pocernich CB, 2005, BRAIN RES REV, V50, P14, DOI 10.1016/j.brainresrev.2005.04.002; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Raborn ES, 2010, J PHARMACOL EXP THER, V333, P319, DOI 10.1124/jpet.109.163055; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Rock RB, 2006, J NEUROIMMUNE PHARM, V1, P117, DOI 10.1007/s11481-006-9012-8; Rock RB, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-32; Rock RB, 2007, J NEUROIMMUNE PHARM, V2, P178, DOI 10.1007/s11481-006-9040-4; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Sardar AM, 1996, NEUROREPORT, V7, P910, DOI 10.1097/00001756-199603220-00015; Scheller C, 2005, J NEUROCHEM, V95, P377, DOI 10.1111/j.1471-4159.2005.03373.x; Sevigny JJ, 2007, ARCH NEUROL-CHICAGO, V64, P97, DOI 10.1001/archneur.64.1.97; Shen MX, 1998, MOL PHARMACOL, V54, P459, DOI 10.1124/mol.54.3.459; Sheng WS, 2009, J NEUROIMMUNE PHARM, V4, P244, DOI 10.1007/s11481-009-9147-5; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Sheng WS, 2000, CLIN IMMUNOL, V96, P243, DOI 10.1006/clim.2000.4905; Shohami E, 2000, DRUG DEVELOP RES, V50, P211, DOI 10.1002/1098-2299(200007/08)50:3/4<211::AID-DDR3>3.0.CO;2-G; SILANI V, 1994, EXP NEUROL, V128, P59, DOI 10.1006/exnr.1994.1113; Silvers JM, 2006, J NEUROVIROL, V12, P140, DOI 10.1080/13550280600724319; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; THANOS S, 1993, J NEUROSCI, V13, P455; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Tong N, 2000, J IMMUNOL, V164, P1333, DOI 10.4049/jimmunol.164.3.1333; Turchan-Cholewo J, 2006, NEUROBIOL DIS, V23, P109, DOI 10.1016/j.nbd.2006.02.005; United Nations Program on HIV/AIDS (UNAIDS), 2011, WHO REP GLOB AIDS EP, P2011; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Wallace DR, 2006, SYNAPSE, V59, P51, DOI 10.1002/syn.20214; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wang GJ, 2004, BRAIN, V127, P2452, DOI 10.1093/brain/awh269; Weiss JM, 1998, J IMMUNOL, V161, P6896; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; Williams R, 2010, GLIA, V58, P611, DOI 10.1002/glia.20949; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Yang YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013427; Yang ZQ, 2007, TOXICOL SCI, V98, P488, DOI 10.1093/toxsci/kfm106; Yao HH, 2010, BLOOD, V115, P4951, DOI 10.1182/blood-2010-01-266221; Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375; Yi YJ, 2004, J NEUROVIROL, V10, P91, DOI 10.1080/13550280490268313; Yoshida H, 2001, NEUROSCI LETT, V303, P132, DOI 10.1016/S0304-3940(01)01699-8; Zink MC, 2001, J INFECT DIS, V184, P1015, DOI 10.1086/323478	130	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77577	10.1371/journal.pone.0077577	http://dx.doi.org/10.1371/journal.pone.0077577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147028	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200048
J	Li, YH; Ding, WY; Wang, H; Song, NP; Lin, LY; Wang, ZH; Zhong, M; Zhang, Y; Zhang, W				Li, Yihui; Ding, Wenyuan; Wang, Hua; Song, Nianpeng; Lin, Leyu; Wang, Zhihao; Zhong, Ming; Zhang, Yun; Zhang, Wei			Relationship of CHA(2)DS(2)-VASc and CHADS(2) Score to Left Atrial Remodeling Detected by Velocity Vector Imaging in Patients with Atrial Fibrillation	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; RISK STRATIFICATION; PREDICTING STROKE; RECOMMENDATIONS; DYSFUNCTION; ANTAGONIST; STRAIN; IMPACT; SIZE	Background: The CHADS(2)/CHA(2)DS(2)-VASc scores are used to predict thrombo-embolic/stroke in patients with nonvalvular atrial fibrillation (AF). Nevertheless, limited data are available regarding the association between these risk stratification for stroke and left atrial (LA) remodeling status of AF patients. The purpose of this study was to explore the association between these scores and LA remodeling status assessed quantificationally by echocardiography in AF patients. Methods: One hundred AF patients were divided into 3 groups based on the CHA(2)DS(2)-VASc/CHADS(2) score: the score of 0 (low stroke risk), the score of 1 (moderate stroke risk) and the score of >= 2 (high stroke risk). All patients were performed through conventional and velocity vector imaging echocardiography. Echocardiographic parameters: maximum LA volume index (LAVImax), LA total emptying fraction (LAEFt) and LA mean strain were obtained to assess quantificationally LA remodeling status. Results: On categorizing with CHA(2)DS(2)-VASc, the score of 1 group showed augment in LAVImax and attenuation in LA mean strain derived from VVI, compared with the score of 0 group (LAVImax: 40.27 +/- 21.91 vs. 26.79 +/- 7.87, p=0.002; LA mean strain: 15.18 +/- 6.36 vs. 22 +/- 8.54, p=0.001). On categorizing with the CHADS(2) score, similar trends were seen between the score of >= 2 and 1 groups (LAVImax: 43.72 +/- 13.77 vs. 31.41 +/- 9.50, p<0.001; LA mean strain: 11.01 +/- 5.31 vs. 18.63 +/- 7.00, p<0.001). With multivariate logistic regression, LAVImax (odds ratio: 0.92, 95% C=I: 0.85 to 0.98, p=0.01) and LA mean strain reflecting LA remodeling (odds ratio: 1.10, 95% CI: 1.02 to 1.19, p=0.01) were strongly predictive of the CHA(2)DS(2)-VASc score of 0. Conclusions: The superiority of the CHADS(2) score may lay in identifying LA remodeling of AF patients with high stroke risk. Whereas, the CHA(2)DS(2)-VASc score was better than the CHADS(2) score at identifying LA remodeling of AF patients presenting low stroke risk.	[Li, Yihui; Ding, Wenyuan; Wang, Hua; Song, Nianpeng; Lin, Leyu; Wang, Zhihao; Zhong, Ming; Zhang, Yun; Zhang, Wei] Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China; [Li, Yihui; Ding, Wenyuan; Wang, Hua; Song, Nianpeng; Lin, Leyu; Wang, Zhihao; Zhong, Ming; Zhang, Yun; Zhang, Wei] Chinese Minist Hlth, Jinan, Peoples R China; [Li, Yihui; Ding, Wenyuan; Wang, Hua; Song, Nianpeng; Lin, Leyu; Wang, Zhihao; Zhong, Ming; Zhang, Yun; Zhang, Wei] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China	Shandong University	Zhang, W (corresponding author), Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Peoples R China.	zhangweisduqilu@gmail.com			Key Technologies R & D Program of Shandong Province [2010G0020262]; Independent Innovation Foundation of Shandong University [2012JC034]; Natural Science Foundation of Shandong Province [ZR2009CM022, ZR2009CM025, Y2008C47]; National Natural Science Foundation of China [30971215, 81070192, 81070141, 81100605, 81270352, 81270287]; National Basic Research Program of China (973 Program) [2009CB521904]	Key Technologies R & D Program of Shandong Province; Independent Innovation Foundation of Shandong University; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the research grants from Key Technologies R & D Program of Shandong Province (2010G0020262), the Independent Innovation Foundation of Shandong University (2012JC034), the Natural Science Foundation of Shandong Province (ZR2009CM022, ZR2009CM025, Y2008C47), the National Natural Science Foundation of China (30971215, 81070192, 81070141, 81100605, 81270352 and 81270287), the National Basic Research Program of China (973 Program, grant number 2009CB521904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Dokainish H, 2010, J AM SOC ECHOCARDIOG, V23, P156, DOI 10.1016/j.echo.2009.11.015; Eshoo S, 2009, CIRC-CARDIOVASC IMAG, V2, P93, DOI 10.1161/CIRCIMAGING.108.793190; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; GUTMAN J, 1983, AM J CARDIOL, V51, P336, DOI 10.1016/S0002-9149(83)80061-7; Guyatt GH, 2012, CHEST, V141, p48S, DOI 10.1378/chest.11-2286; Harrell F, 2001, J AM STAT ASSOC, V98, P257; Jarnert C, 2008, EUR J HEART FAIL, V10, P1080, DOI 10.1016/j.ejheart.2008.08.012; Jurcut R, 2008, J AM SOC ECHOCARDIOG, V21, P879, DOI 10.1016/j.echo.2008.02.002; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Kuppahally SS, 2010, CIRC-CARDIOVASC IMAG, V3, P231, DOI 10.1161/CIRCIMAGING.109.865683; Lane DA, 2012, CIRCULATION, V126, P860, DOI 10.1161/CIRCULATIONAHA.111.060061; Lang RM, J AM SOC ECHOCARDIOG, P1440; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; Leung DY, 2008, AM HEART J, V156, P1056, DOI 10.1016/j.ahj.2008.07.021; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; McManus DD, 2010, CIRCULATION, V121, P667, DOI 10.1161/CIRCULATIONAHA.109.885806; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Nakashima H, 2000, CIRCULATION, V101, P2612, DOI 10.1161/01.CIR.101.22.2612; Olesen JB, 2012, THROMB HAEMOSTASIS, V107, P1172, DOI 10.1160/TH12-03-0175; Saha SK, 2011, J AM SOC ECHOCARDIOG, V24, P506, DOI 10.1016/j.echo.2011.02.012; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Stroke Prevention in Atrial Fibrillation Investigators, 1995, J Stroke Cerebrovasc Dis, V5, P147, DOI 10.1016/S1052-3057(10)80166-1; Tayyareci Y, 2010, CIRC J, V74, P2109, DOI 10.1253/circj.CJ-10-0197; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52; Yan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051204	32	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77653	10.1371/journal.pone.0077653	http://dx.doi.org/10.1371/journal.pone.0077653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147047	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200059
J	Lv, ZB; Zou, HC; Peng, KW; Wang, JM; Ding, Y; Li, YL; Ren, XL; Wang, FF; Chang, R; Liang, L; Ding, YQ				Lv, Zhenbing; Zou, Huichun; Peng, Kaiwen; Wang, Jianmei; Ding, Yi; Li, Yuling; Ren, Xiaoli; Wang, Feifei; Chang, Rui; Liang, Li; Ding, Yanqing			The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma	PLOS ONE			English	Article							CANDIDATE TUMOR-SUPPRESSOR; BREAST-CANCER CELLS; DOWN-REGULATION; COLORECTAL-CANCER; POOR-PROGNOSIS; GENE; FAMILY; CYCLE; HYPERMETHYLATION; DEMETHYLATION	Background: BTG3 (B-cell translocation gene 3) has been identified as a tumor suppressor and hypermethylation contributes to its down-regulation in some tumors, but its role in hepatocellular carcinoma (HCC) remain unknown. This study aimed to detect the expression and methylation status of BTG3 in HCC cell lines or tissues, and determine its function in HCC progression. Methodology: The expression of BTG3 was detected in HCC cell lines and HCC tissue by real-time RT-PCR, Western blot or immunohistochemistry. The promoter methylation status of BTG3 was measured by using methylation-specific PCR in HCC cell lines. A series of assays were performed to evaluate the effect of BTG3 on proliferation, invasion and cell cycle transition in vitro. Results: BTG3 expression was lower in HCC cell lines than in hepatocyte cell line LO2 (P<0.05). BTG3 was also down-regulated in HCC tissues. Its expression was positively correlated with differentiation and distant metastasis (P<0.05). Patients with lower BTG3 expression had shorter overall survival time (P=0.029). DNA methylation directed repression of BTG3 mRNA expression in HCC cell lines. BTG3 suppressed proliferation, invasion and induces G1/S cycle arrest of HCC cells in vitro. Conclusion: Down-regulation of BTG3 due to the promoter hypermethylation is closely associated with proliferation, invasion and cell cycle arrest of HCC cells. It may be a novel prognostic biomarker for HCC patients.	[Lv, Zhenbing; Wang, Jianmei; Li, Yuling; Ren, Xiaoli; Wang, Feifei; Liang, Li; Ding, Yanqing] Southern Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wang, Jianmei; Li, Yuling; Ren, Xiaoli; Wang, Feifei; Liang, Li; Ding, Yanqing] Southern Med Univ, Dept Pathol, Sch Basic Med Sci, Guangzhou, Guangdong, Peoples R China; [Lv, Zhenbing] Nanchong Cent Hosp, Dept Gen Surg, Nanchong City, Sichuan Provinc, Peoples R China; [Zou, Huichun; Peng, Kaiwen] Southern Med Univ, Grad Sch, Guangzhou, Guangdong, Peoples R China; [Ding, Yi] Southern Med Univ, Nanfang Hosp, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Chang, Rui] Southern Med Univ, Sch Clin Med 2, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Liang, L (corresponding author), Southern Med Univ, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	redsnow007@hotmail.com; dyq@fimmu.com	Chang, Rui/ABC-2118-2021; liang, li/AAB-9126-2022; Wang, Jianmei/HHZ-0585-2022	Chang, Rui/0000-0001-5763-5371; 	National Natural Science Foundation of China [81272759, 81172382, 81071735]; Major projects of National Natural Science Foundation of China [81090422]; Natural Science Foundation of Guangdong Province [S2012010009669]; Research Fund for Subject and Profession development of Higher Education of Guangdong Province [2012KJCX0026]; Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province [2011J2200074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major projects of National Natural Science Foundation of China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Research Fund for Subject and Profession development of Higher Education of Guangdong Province; Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province	This work was supported by the National Natural Science Foundation of China (81272759, 81172382, 81071735, http://www.nsfc.gov.cn); Major projects of National Natural Science Foundation of China (81090422, http://www.nsfc.gov.cn); Natural Science Foundation of Guangdong Province (S2012010009669, http://gdsf.gdstc.gov.cn/); Research Fund for Subject and Profession development of Higher Education of Guangdong Province (2012KJCX0026, http://202.116.224.16/website/index.jsp); Research Fund for the Science and technology Star of Zhujiang City of Guangzhou Province (2011J2200074, http://www.gzsi.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura E, 2005, WORLD J GASTROENTERO, V11, P5601, DOI 10.3748/wjg.v11.i36.5601; Bender CM, 1998, CANCER RES, V58, P95; Chen JG, 2011, SEMIN CANCER BIOL, V21, P59, DOI 10.1016/j.semcancer.2010.11.002; Cheng YC, 2013, P NATL ACAD SCI USA, V110, P5993, DOI 10.1073/pnas.1220635110; Deng B, 2013, TUMOUR BIOL; Dong WJ, 2009, BIOCHEM BIOPH RES CO, V387, P132, DOI 10.1016/j.bbrc.2009.06.140; Du J, 2013, ONCOL LETT, V5, P381, DOI 10.3892/ol.2012.974; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; Jiang YF, 2000, WORLD J GASTROENTERO, V6, P61, DOI 10.3748/wjg.v6.i1.61; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Li KW, 2012, HEPATO-GASTROENTEROL, V59, P1944, DOI 10.5754/hge11845; Liang L, 2011, HUM PATHOL, V42, P1603, DOI 10.1016/j.humpath.2010.08.025; Lim IK, 2006, J CANCER RES CLIN, V132, P417, DOI 10.1007/s00432-006-0080-1; Lin SY, 2012, ONCOL LETT, V4, P981, DOI 10.3892/ol.2012.864; Lin TY, 2012, ONCOGENE, V31, P3287, DOI 10.1038/onc.2011.491; Macheiner D, 2006, J HEPATOL, V45, P81, DOI 10.1016/j.jhep.2005.12.017; Majid S, 2010, CANCER-AM CANCER SOC, V116, P66, DOI 10.1002/cncr.24662; Majid S, 2009, CARCINOGENESIS, V30, P662, DOI 10.1093/carcin/bgp042; Matsubara N, 2012, DIS COLON RECTUM, V55, P96, DOI 10.1097/DCR.0b013e318233a1ef; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; O'Malley S, 2009, INT J CANCER, V125, P1805, DOI 10.1002/ijc.24490; Ou YH, 2007, EMBO J, V26, P3968, DOI 10.1038/sj.emboj.7601825; Putnik M, 2012, BIOCHEM BIOPH RES CO, V426, P26, DOI 10.1016/j.bbrc.2012.08.007; Sakata J, 2008, EJSO-EUR J SURG ONC, V34, P900, DOI 10.1016/j.ejso.2008.01.031; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Yamamoto N, 2001, BRIT J CANCER, V84, P754, DOI 10.1054/bjoc.2000.1656; Yoneda M, 2009, CANCER SCI, V100, P225, DOI 10.1111/j.1349-7006.2008.01030.x; Yu JW, 2008, GENE EXPRESSION, V14, P173; Zhang XJ, 2012, J GASTROEN HEPATOL, V27, P1117, DOI 10.1111/j.1440-1746.2011.07049.x; Zhang ZM, 2009, HEPATOB PANCREAT DIS, V8, P288	33	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77473	10.1371/journal.pone.0077473	http://dx.doi.org/10.1371/journal.pone.0077473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147003	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200038
J	Craje, C; Santello, M; Gordon, AM				Craje, Celine; Santello, Marco; Gordon, Andrew M.			Effects of Visual Cues of Object Density on Perception and Anticipatory Control of Dexterous Manipulation	PLOS ONE			English	Article							CENTER-OF-MASS; UNDERLYING MOTOR COMMANDS; SENSORIMOTOR MEMORY; PRECISION GRIP; FORCE CONTROL; WEIGHT; SIZE; REPRESENTATIONS; INFORMATION; INDEPENDENCE	Anticipatory force planning during grasping is based on visual cues about the object's physical properties and sensorimotor memories of previous actions with grasped objects. Vision can be used to estimate object mass based on the object size to identify and recall sensorimotor memories of previously manipulated objects. It is not known whether subjects can use density cues to identify the object's center of mass (CM) and create compensatory moments in an anticipatory fashion during initial object lifts to prevent tilt. We asked subjects (n = 8) to estimate CM location of visually symmetric objects of uniform densities (plastic or brass, symmetric CM) and non-uniform densities (mixture of plastic and brass, asymmetric CM). We then asked whether subjects can use density cues to scale fingertip forces when lifting the visually symmetric objects of uniform and non-uniform densities. Subjects were able to accurately estimate an object's center of mass based on visual density cues. When the mass distribution was uniform, subjects could scale their fingertip forces in an anticipatory fashion based on the estimation. However, despite their ability to explicitly estimate CM location when object density was non-uniform, subjects were unable to scale their fingertip forces to create a compensatory moment and prevent tilt on initial lifts. Hefting object parts in the hand before the experiment did not affect this ability. This suggests a dichotomy between the ability to accurately identify the object's CM location for objects with non-uniform density cues and the ability to utilize this information to correctly scale their fingertip forces. These results are discussed in the context of possible neural mechanisms underlying sensorimotor integration linking visual cues and anticipatory control of grasping.	[Craje, Celine; Gordon, Andrew M.] Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA; [Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA	Columbia University; Columbia University Teachers College; Arizona State University; Arizona State University-Tempe	Gordon, AM (corresponding author), Columbia Univ, Teachers Coll, Dept Biobehav Sci, New York, NY 10027 USA.	ag275@columbia.edu		Gordon, Andrew/0000-0003-1041-0479	National Science Foundation (NSF) [BCS 1152916, BCS-1153034]; Direct For Social, Behav & Economic Scie [1153034, 1152916] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by a Collaborative Research Grant BCS 1152916 (AG) and BCS-1153034 (MS) from the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Ahmed AA, 2008, CURR BIOL, V18, P763, DOI 10.1016/j.cub.2008.04.061; Albert F, 2009, NEUROSCI LETT, V463, P188, DOI 10.1016/j.neulet.2009.07.080; Baud-Bovy G, 2001, J EXP PSYCHOL HUMAN, V27, P692, DOI 10.1037//0096-1523.27.3.692; Baugh LA, 2012, J NEUROPHYSIOL, V108, P1262, DOI 10.1152/jn.00263.2012; BINGHAM GP, 1993, PERCEPT PSYCHOPHYS, V54, P617, DOI 10.3758/BF03211785; BINGHAM GP, 1993, PERCEPT PSYCHOPHYS, V54, P633, DOI 10.3758/BF03211786; Bruno N, 2009, NEUROPSYCHOLOGIA, V47, P1421, DOI 10.1016/j.neuropsychologia.2008.10.031; Buckingham G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054709; Buckingham G, 2009, J NEUROPHYSIOL, V102, P3111, DOI 10.1152/jn.00515.2009; Bursztyn LLCD, 2008, EXP BRAIN RES, V184, P127, DOI 10.1007/s00221-007-1173-z; Carey DP, 2001, TRENDS COGN SCI, V5, P109, DOI 10.1016/S1364-6613(00)01592-8; Chang EC, 2008, EXP BRAIN RES, V185, P319, DOI 10.1007/s00221-007-1156-0; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Chouinard PA, 2009, NEUROIMAGE, V44, P200, DOI 10.1016/j.neuroimage.2008.08.023; Cole KJ, 2008, EXP BRAIN RES, V188, P551, DOI 10.1007/s00221-008-1392-y; DAVI M, 1992, PERCEPT PSYCHOPHYS, V52, P151, DOI 10.3758/BF03206768; EDIN BB, 1992, J PHYSIOL-LONDON, V450, P547, DOI 10.1113/jphysiol.1992.sp019142; Ellis RR, 1999, PERCEPT PSYCHOPHYS, V61, P1564, DOI 10.3758/BF03213118; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Fu QS, 2012, J NEUROSCI, V32, P15086, DOI 10.1523/JNEUROSCI.2468-12.2012; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GORDON AM, 1994, NEUROPSYCHOLOGIA, V32, P555, DOI 10.1016/0028-3932(94)90144-9; GORDON AM, 1991, EXP BRAIN RES, V85, P226; GORDON AM, 1991, EXP BRAIN RES, V83, P477; GORDON AM, 1993, J NEUROPHYSIOL, V69, P1789, DOI 10.1152/jn.1993.69.6.1789; Gordon AM, 2004, P ANN INT IEEE EMBS, V26, P4641; Grandy MS, 2006, J NEUROPHYSIOL, V95, P3887, DOI 10.1152/jn.00851.2005; Grezes J, 2004, NEUROIMAGE, V21, P744, DOI 10.1016/S1053-8119(03)00665-7; Hamilton AFD, 2006, NEUROIMAGE, V29, P524, DOI 10.1016/j.neuroimage.2005.07.037; Jenmalm P, 1997, J NEUROSCI, V17, P4486; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Liby BW, 2010, PERCEPT MOTOR SKILL, V110, P195, DOI 10.2466/PMS.110.1.195-212; Loh MN, 2010, J NEUROSCI, V30, P6984, DOI 10.1523/JNEUROSCI.6207-09.2010; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; Mon-Williams M, 2000, EXP BRAIN RES, V135, P405, DOI 10.1007/s002210000538; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Salimi I, 2003, EXP BRAIN RES, V150, P9, DOI 10.1007/s00221-003-1394-8; Salimi I, 2000, J NEUROPHYSIOL, V84, P2390, DOI 10.1152/jn.2000.84.5.2390; Seashore CE, 1899, U IOWA STUDIES PSYCH, V2, P36; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	45	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76855	10.1371/journal.pone.0076855	http://dx.doi.org/10.1371/journal.pone.0076855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146935	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400090
J	Ridenhour, BJ; Campitelli, MA; Kwong, JC; Rosella, LC; Armstrong, BG; Mangtani, P; Calzavara, AJ; Shay, DK				Ridenhour, Benjamin J.; Campitelli, Michael A.; Kwong, Jeffrey C.; Rosella, Laura C.; Armstrong, Ben G.; Mangtani, Punam; Calzavara, Andrew J.; Shay, David K.			Effectiveness of Inactivated Influenza Vaccines in Preventing Influenza-Associated Deaths and Hospitalizations among Ontario Residents Aged >= 65 Years: Estimates with Generalized Linear Models Accounting for Healthy Vaccinee Effects	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY SYNCYTIAL VIRUS; ALL-CAUSE MORTALITY; ELDERLY-PEOPLE; HERD-IMMUNITY; VACCINATION; IMPACT; BIAS; IMMUNIZATION; EFFICACY	Background: Estimates of the effectiveness of influenza vaccines in older adults may be biased because of difficulties identifying and adjusting for confounders of the vaccine-outcome association. We estimated vaccine effectiveness for prevention of serious influenza complications among older persons by using methods to account for underlying differences in risk for these complications. Methods: We conducted a retrospective cohort study among Ontario residents aged >= 65 years from September 1993 through September 2008. We linked weekly vaccination, hospitalization, and death records for 1.4 million community-dwelling persons aged >= 65 years. Vaccine effectiveness was estimated by comparing ratios of outcome rates during weeks of high versus low influenza activity (defined by viral surveillance data) among vaccinated and unvaccinated subjects by using log-linear regression models that accounted for temperature and time trends with natural spline functions. Effectiveness was estimated for three influenza-associated outcomes: all-cause deaths, deaths occurring within 30 days of pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations. Results: During weeks when 5% of respiratory specimens tested positive for influenza A, vaccine effectiveness among persons aged >= 65 years was 22% (95% confidence interval [CI], -6%-42%) for all influenza-associated deaths, 25% (95% CI, 13%-37%) for deaths occurring within 30 days after an influenza-associated pneumonia/influenza hospitalization, and 19% (95% CI, 4%-31%) for influenza-associated pneumonia/influenza hospitalizations. Because small proportions of deaths, deaths after pneumonia/influenza hospitalizations, and pneumonia/influenza hospitalizations were associated with influenza virus circulation, we estimated that vaccination prevented 1.6%, 4.8%, and 4.1% of these outcomes, respectively. Conclusions: By using confounding-reducing techniques with 15 years of provincial-level data including vaccination and health outcomes, we estimated that influenza vaccination prevented similar to 4% of influenza-associated hospitalizations and deaths occurring after hospitalizations among older adults in Ontario.	[Ridenhour, Benjamin J.; Shay, David K.] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Ridenhour, Benjamin J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, South Bend, IN USA; [Campitelli, Michael A.; Kwong, Jeffrey C.; Calzavara, Andrew J.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.; Rosella, Laura C.] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Kwong, Jeffrey C.; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Armstrong, Ben G.; Mangtani, Punam] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Calzavara, Andrew J.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	Centers for Disease Control & Prevention - USA; University of Notre Dame; University of Toronto; University of Toronto; University of Toronto; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Ridenhour, BJ (corresponding author), US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.	ridenhour.1@nd.edu		Mangtani, Punam/0000-0001-7074-2999; Ridenhour, Benjamin/0000-0001-8271-4629; armstrong, benedict/0000-0003-4407-0409; Shay, David/0000-0001-9619-4820				ANDERSON RM, 1987, EPIDEMIOL INFECT, V99, P65, DOI 10.1017/S0950268800066875; Armstrong BG, 2004, BMJ-BRIT MED J, V329, P660, DOI 10.1136/bmj.38198.594109.AE; Baxter R, 2010, VACCINE, V28, P7267, DOI 10.1016/j.vaccine.2010.08.088; Campitelli MA, 2010, VACCINE, V29, P240, DOI 10.1016/j.vaccine.2010.10.049; Chan B, 1999, Hosp Q, V3, P17; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Falagas ME, 2009, CAN MED ASSOC J, V181, P484, DOI 10.1503/cmaj.090694; Ferdinands JM, 2013, EPIDEMIOLOGY, V24, P530, DOI 10.1097/EDE.0b013e3182953065; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Fireman B, 2009, AM J EPIDEMIOL, V170, P650, DOI 10.1093/aje/kwp173; GOVAERT TME, 1994, VACCINE, V12, P1185, DOI 10.1016/0264-410X(94)90241-0; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Iron K, 2008, LIVING DYING ONTARIO; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Keitel WA, 2009, VACCINE, V28, P379, DOI 10.1016/j.vaccine.2009.10.037; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Kwong JC, 2007, VACCINE, V25, P1270, DOI 10.1016/j.vaccine.2006.10.004; Kwong JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008087; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Mangtani P, 2006, CLIN INFECT DIS, V42, P640, DOI 10.1086/499810; Mangtani P, 2004, J INFECT DIS, V190, P1, DOI 10.1086/421274; MARTEL L, 2007, PORTRAIT CANADIAN PO; National Advisory Committee on Immunization (NACI), 2008, Can Commun Dis Rep, V34, P1; Naylor D, 1999, CARDIOVASCULAR HLTH; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Schanzer DL, 2007, EPIDEMIOL INFECT, V135, P1109, DOI 10.1017/S0950268807007923; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Talbot HK, 2009, VACCINE, V27, P1923, DOI 10.1016/j.vaccine.2009.01.108; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Wong K, 2012, ARCH INTERN MED, V172, P484, DOI 10.1001/archinternmed.2011.2038; Zeger SL, 2006, ANNU REV PUBL HEALTH, V27, P57, DOI 10.1146/annurev.publhealth.26.021304.144517	41	29	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76318	10.1371/journal.pone.0076318	http://dx.doi.org/10.1371/journal.pone.0076318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146855	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000326019400053
J	Archibald, LMD; Cardy, JO; Joanisse, MF; Ansari, D				Archibald, Lisa M. D.; Cardy, Janis Oram; Joanisse, Marc F.; Ansari, Daniel			Language, Reading, and Math Learning Profiles in an Epidemiological Sample of School Age Children	PLOS ONE			English	Article							SHORT-TERM-MEMORY; DEVELOPMENTAL DYSLEXIA; SENTENCE COMPREHENSION; NONWORD REPETITION; GENETIC INFLUENCES; YOUNG-CHILDREN; IMPAIRMENT; SPEECH; DEFICIT; DIFFICULTIES	Dyscalculia, dyslexia, and specific language impairment (SLI) are relatively specific developmental learning disabilities in math, reading, and oral language, respectively, that occur in the context of average intellectual capacity and adequate environmental opportunities. Past research has been dominated by studies focused on single impairments despite the widespread recognition that overlapping and comorbid deficits are common. The present study took an epidemiological approach to study the learning profiles of a large school age sample in language, reading, and math. Both general learning profiles reflecting good or poor performance across measures and specific learning profiles involving either weak language, weak reading, weak math, or weak math and reading were observed. These latter four profiles characterized 70% of children with some evidence of a learning disability. Low scores in phonological short-term memory characterized clusters with a language-based weakness whereas low or variable phonological awareness was associated with the reading (but not language-based) weaknesses. The low math only group did not show these phonological deficits. These findings may suggest different etiologies for language-based deficits in language, reading, and math, reading-related impairments in reading and math, and isolated math disabilities.	[Archibald, Lisa M. D.; Cardy, Janis Oram] Univ Western Ontario, Sch Commun Sci & Disorders, London, ON, Canada; [Archibald, Lisa M. D.; Joanisse, Marc F.; Ansari, Daniel] Univ Western Ontario, Dept Psychol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Archibald, LMD (corresponding author), Univ Western Ontario, Sch Commun Sci & Disorders, London, ON, Canada.	larchiba@uwo.ca	Joanisse, Marc/B-5772-2015; Cardy, Janis Oram/AAF-4147-2019; Ansari, Daniel/B-2832-2009	Joanisse, Marc/0000-0002-6352-291X; Cardy, Janis Oram/0000-0002-7170-6145; Ansari, Daniel/0000-0002-7625-618X	Natural Science and Engineering Research Council of Canada [371201-2009]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Discovery Grant to the first author by the Natural Science and Engineering Research Council of Canada (371201-2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway T.P., 2007, AUTOMATED WORKING ME; Archibald LMD, 2006, INT J LANG COMM DIS, V41, P675, DOI 10.1080/13682820500442602; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Arvedson PJ, 2002, J SPEECH LANG HEAR R, V45, P970, DOI 10.1044/1092-4388(2002/079); Badian NA, 1999, ANN DYSLEXIA, V49, P45; Bishop D, 2008, RUTTERS CHILD ADOLES, P32, DOI DOI 10.1002/9781444300895.CH3; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; BISHOP DVM, 1990, J CHILD PSYCHOL PSYC, V31, P1027, DOI 10.1111/j.1469-7610.1990.tb00844.x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Bishop DVM, 2001, J CHILD PSYCHOL PSYC, V42, P189, DOI 10.1111/1469-7610.00710; Broomfield J, 2004, INT J LANG COMM DIS, V39, P303, DOI 10.1080/13682820310001625589; BUTTERWORTH B, 2002, MATH DIFF PSYCH NEUR, P1465; Conti-Ramsden G, 2003, J SPEECH LANG HEAR R, V46, P1029, DOI 10.1044/1092-4388(2003/082); Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2001, MIND LANG, V16, P16, DOI 10.1111/1468-0017.00154; Dehaene S., 2011, NUMBER SENSE MIND CR; DeThorne LS, 2006, J SPEECH LANG HEAR R, V49, P1280, DOI 10.1044/1092-4388(2006/092); Donlan C, 1998, INT J LANG COMM DIS, V33, P149, DOI 10.1080/136828298247802; Everett J, 1999, PERCEPTION, V28, P243, DOI 10.1068/p2743; FAZIO BB, 1994, J SPEECH HEAR RES, V37, P358, DOI 10.1044/jshr.3702.358; Fazio BB, 1996, J SPEECH HEAR RES, V39, P839, DOI 10.1044/jshr.3904.839; Flax JF, 2003, J SPEECH LANG HEAR R, V46, P530, DOI 10.1044/1092-4388(2003/043); Frith U., 1985, SURFACE DYSLEXIA NEU, P301, DOI DOI 10.4324/9781315108346-18; Fuchs LS, 2002, J LEARN DISABIL-US, V35, P563, DOI 10.1177/00222194020350060701; FUNHAM A, 2009, LEARN INDIVID DIFFER, V19, P28, DOI DOI 10.1016/J.LINDIF.2008.02.001; Furnham, 2005, PERSONALITY INTELLEC; Gathercole SE, 1999, APPL COGNITIVE PSYCH, V13, P65, DOI 10.1002/(SICI)1099-0720(199902)13:1<65::AID-ACP548>3.0.CO;2-O; GEARY DC, 1993, PSYCHOL BULL, V114, P345, DOI 10.1037/0033-2909.114.2.345; Geary DC, 2004, J LEARN DISABIL-US, V37, P4, DOI 10.1177/00222194040370010201; Germano E, 2010, DEV NEUROPSYCHOL, V35, P475, DOI 10.1080/87565641.2010.494748; GrossTsur V, 1996, DEV MED CHILD NEUROL, V38, P25, DOI 10.1111/j.1469-8749.1996.tb15029.x; Gupta P, 1997, BRAIN LANG, V59, P267, DOI 10.1006/brln.1997.1819; Hill EL, 2001, INT J LANG COMM DIS, V36, P149, DOI 10.1080/13682820010019874; Jordan NC, 2000, J LEARN DISABIL-US, V33, P567, DOI 10.1177/002221940003300605; Jordan NC, 1997, J LEARN DISABIL-US, V30, P624, DOI 10.1177/002221949703000606; Jordan NC, 2003, CHILD DEV, V74, P834, DOI 10.1111/1467-8624.00571; Kleemans T, 2011, LEARN INDIVID DIFFER, V21, P555, DOI 10.1016/j.lindif.2011.07.008; Lahey M, 1999, J SPEECH LANG HEAR R, V42, P195, DOI 10.1044/jslhr.4201.195; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Leinonen S, 2001, READ WRIT, V14, P265, DOI 10.1023/A:1011117620895; Leonard L. B., 2004, MIT ENCY COMMUNICATI, P402; LEWIS C, 1994, J CHILD PSYCHOL PSYC, V35, P283, DOI 10.1111/j.1469-7610.1994.tb01162.x; Lonigan CJ, 2000, DEV PSYCHOL, V36, P596, DOI 10.1037//0012-1649.36.5.596; Mayes Susan Dickerson, 2006, J Atten Disord, V9, P486, DOI 10.1177/1087054705283616; McArthur GM, 2000, J CHILD PSYCHOL PSYC, V41, P869, DOI 10.1111/1469-7610.00674; McLean JF, 1999, J EXP CHILD PSYCHOL, V74, P240, DOI 10.1006/jecp.1999.2516; Montgomery J, 2004, INT J LANG COMM DIS, V39, P115, DOI 10.1080/13682820310001616985; MURPHY L, 1994, ANN DYSLEXIA, V44, P120, DOI 10.1007/BF02648158; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Pennington BF, 2005, ADV CHILD DEV BEHAV, V33, P263, DOI 10.1016/S0065-2407(05)80010-2; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; POLLATSEK A, 1992, J EXP PSYCHOL HUMAN, V18, P148, DOI 10.1037/0096-1523.18.1.148; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; RECORDS NL, 1994, J SPEECH HEAR RES, V37, P144, DOI 10.1044/jshr.3701.144; Redmond SM, 2005, CLIN LINGUIST PHONET, V19, P109, DOI 10.1080/02699200410001669870; Rice ML, 2009, J NEURODEV DISORD, V1, P264, DOI 10.1007/s11689-009-9031-x; Rice ML, 2003, LANGUAGE COMPETENCE ACROSS POPULATIONS, P63; RICE ML, 1995, J SPEECH HEAR RES, V38, P850, DOI 10.1044/jshr.3804.850; Robertson EK, 2010, APPL PSYCHOLINGUIST, V31, P141, DOI 10.1017/S0142716409990208; Robertson EK, 2009, DEVELOPMENTAL SCI, V12, P753, DOI 10.1111/j.1467-7687.2009.00806.x; ROURKE BP, 1993, J LEARN DISABIL, V26, P214, DOI 10.1177/002221949302600402; Rourke BP, 1997, J LEARN DISABIL, V30, P34, DOI 10.1177/002221949703000103; ROURKE BP, 1978, J ABNORM CHILD PSYCH, V6, P121, DOI 10.1007/BF00915788; Rubinsten O, 2006, J EDUC PSYCHOL, V98, P854, DOI 10.1037/0022-0663.98.4.854; Rubinsten O, 2009, TRENDS COGN SCI, V13, P92, DOI 10.1016/j.tics.2008.11.002; Schleifer P, 2011, DEVELOPMENTAL SCI, V14, P280, DOI 10.1111/j.1467-7687.2010.00976.x; Semel E., 2003, CLIN EVALUATION LANG, V4th Edn; Shalev R. S., 1997, MATH COGN, V33, P105, DOI DOI 10.1080/135467997387434; Snowling M J, 2001, Dyslexia, V7, P37; Tirosh E, 1998, J CHILD NEUROL, V13, P493, DOI 10.1177/088307389801301005; Torgensen J., 1999, TEST WORD READING EF; TORGENSEN JK, 2004, LANGUAGE BASIS READI, P1465; Torgesen J.K., 1999, COMPREHENSIVE TEST P; Trauner D, 2000, DEV MED CHILD NEUROL, V42, P470, DOI 10.1017/S0012162200000876; van Weerdenburg M, 2006, J CHILD PSYCHOL PSYC, V47, P176, DOI 10.1111/j.1469-7610.2005.01454.x; vanderLely HKJ, 1996, LINGUA, V98, P243, DOI 10.1016/0024-3841(95)00044-5; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Willburger E, 2008, LEARN INDIVID DIFFER, V18, P224, DOI 10.1016/j.lindif.2008.01.003; Willcutt EG, 2010, CORTEX, V46, P1345, DOI 10.1016/j.cortex.2010.06.009; Woodcock R, 2001, WOODCOCK JOHNSON TES	83	39	39	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77463	10.1371/journal.pone.0077463	http://dx.doi.org/10.1371/journal.pone.0077463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155959	Green Published, gold			2022-12-27	WOS:000325887300093
J	Plainis, S; Petratou, D; Giannakopoulou, T; Radhakrishnan, H; Pallikaris, IG; Charman, WN				Plainis, Sotiris; Petratou, Dionysia; Giannakopoulou, Trisevgeni; Radhakrishnan, Hema; Pallikaris, Ioannis G.; Charman, W. Neil			Small-Aperture Monovision and the Pulfrich Experience: Absence of Neural Adaptation Effects	PLOS ONE			English	Article							CORNEAL INLAY; SURGICAL-CORRECTION; VISUAL-FIELD; FOLLOW-UP; INTRACORNEAL INLAY; INCREASE DEPTH; PRESBYOPIA; LUMINANCE; LATENCY; FOCUS	Purpose: To explore whether adaptation reduces the interocular visual latency differences and the induced Pulfrich effect caused by the anisocoria implicit in small-aperture monovision. Methods: Anisocoric vision was simulated in two adults by wearing in the non-dominant eye for 7 successive days, while awake, an opaque soft contact lens (CL) with a small, central, circular aperture. This was repeated with aperture diameters of 1.5 and 2.5 mm. Each day, monocular and binocular pattern-reversal Visual Evoked Potentials (VEP) were recorded. Additionally, the Pulfrich effect was measured: the task of the subject was to state whether a a 2-deg spot appeared in front or behind the plane of a central cross when moved left-to-right or right-to-left on a display screen. The retinal illuminance of the dominant eye was varied using neutral density (ND) filters to establish the ND value which eliminated the Pulfrich effect for each lens. All experiments were performed at luminance levels of 5 and 30 cd/m(2). Results: Interocular differences in monocular VEP latency (at 30 cd/m(2)) rose to about 12-15 ms and 20-25 ms when the CL aperture was 2.5 and 1.5 mm, respectively. The effect was more pronounced at 5 cd/m(2) (i.e. with larger natural pupils). A strong Pulfrich effect was observed under all conditions, with the effect being less striking for the 2.5 mm aperture. No neural adaptation appeared to occur: neither the interocular differences in VEP latency nor the ND value required to null the Pulfrich effect reduced over each 7-day period of anisocoric vision. Conclusions: Small-aperture monovision produced marked interocular differences in visual latency and a Pulfrich experience. These were not reduced by adaptation, perhaps because the natural pupil diameter of the dominant eye was continually changing throughout the day due to varying illumination and other factors, making adaptation difficult.	[Plainis, Sotiris; Petratou, Dionysia; Giannakopoulou, Trisevgeni; Pallikaris, Ioannis G.] Univ Crete, IVO, Iraklion, Greece; [Plainis, Sotiris; Radhakrishnan, Hema; Charman, W. Neil] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Crete; University of Manchester	Plainis, S (corresponding author), Univ Crete, IVO, Iraklion, Greece.	plainis@med.uoc.gr		Petratou, Dionysia/0000-0002-5521-7747; Plainis, Sotiris/0000-0002-8304-5073				ALPERN M, 1961, Am J Ophthalmol, V52, P762; ANZAI A, 1995, VISUAL NEUROSCI, V12, P77, DOI 10.1017/S0952523800007331; Bach M, 1986, Fortschr Ophthalmol, V83, P532; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Breyer A, 2006, GRAEF ARCH CLIN EXP, V244, P1555, DOI 10.1007/s00417-006-0272-z; Carkeet A, 2012, OPTOMETRY VISION SCI, V89, P38, DOI 10.1097/OPX.0b013e31823874bb; Dexl AK, 2012, AM J OPHTHALMOL, V153, P994, DOI 10.1016/j.ajo.2011.08.044; Dexl AK, 2011, J REFRACT SURG, V27, P876, DOI 10.3928/1081597X-20110802-02; Dexl AK, 2011, J CATARACT REFR SURG, V37, P525, DOI 10.1016/j.jcrs.2010.10.044; Diaper CJM, 1997, SURV OPHTHALMOL, V41, P493, DOI 10.1016/S0039-6257(97)00014-3; Heron G, 2002, GRAEF ARCH CLIN EXP, V240, P644, DOI 10.1007/s00417-002-0501-z; INSLER MS, 1988, ARCH OPHTHALMOL-CHIC, V106, P1680, DOI 10.1001/archopht.1988.01060140852025; JOSEPHSON JE, 1987, AM J OPTOM PHYS OPT, V64, P38; LANDRIGAN DT, 1984, J PSYCHOL, V117, P125, DOI 10.1080/00223980.1984.9923668; Mojon DS, 1998, OPHTHALMOLOGY, V105, P1337, DOI 10.1016/S0161-6420(98)97044-0; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; OSAKA N, 1978, ELECTROEN CLIN NEURO, V44, P785, DOI 10.1016/0013-4694(78)90214-6; Plainis S., 2012, J OPTOM, V5, P156; Plainis S, 2013, OPHTHAL PHYSL OPT, V33, P123, DOI 10.1111/opo.12018; Seyeddain O, 2012, J CATARACT REFR SURG, V38, P35, DOI 10.1016/j.jcrs.2011.07.027; Seyeddain O, 2010, J REFRACT SURG, V26, P707, DOI 10.3928/1081597X-20100408-01; Tabernero J, 2012, J CATARACT REFR SURG, V38, P270, DOI 10.1016/j.jcrs.2011.07.040; Tabernero J, 2011, INVEST OPHTH VIS SCI, V52, P5273, DOI 10.1167/iovs.10-6436; TRICK GL, 1982, INVEST OPHTH VIS SCI, V22, P394; TUCKER J, 1975, AM J OPTOM PHYS OPT, V52, P3; Waring GO, 2011, J REFRACT SURG, V27, P842, DOI 10.3928/1081597X-20111005-04; WERTENBAKER C, 1985, SURV OPHTHALMOL, V29, P297, DOI 10.1016/0039-6257(85)90153-5; WOLPERT DM, 1993, VISION RES, V33, P1421, DOI 10.1016/0042-6989(93)90048-2; Yilmaz OF, 2008, J CATARACT REFR SURG, V34, P1921, DOI 10.1016/j.jcrs.2008.07.015; Yilmaz OF, 2011, J CATARACT REFR SURG, V37, P1275, DOI 10.1016/j.jcrs.2011.01.027; Zhang P, 2011, OPTOMETRY VISION SCI, V88, P1072, DOI 10.1097/OPX.0b013e3182217295	31	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75987	10.1371/journal.pone.0075987	http://dx.doi.org/10.1371/journal.pone.0075987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155881	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300015
J	Polce, C; Termansen, M; Aguirre-Gutierrez, J; Boatman, ND; Budge, GE; Crowe, A; Garratt, MP; Pietravalle, S; Potts, SG; Ramirez, JA; Somerwill, KE; Biesmeijer, JC				Polce, Chiara; Termansen, Mette; Aguirre-Gutierrez, Jesus; Boatman, Nigel D.; Budge, Giles E.; Crowe, Andrew; Garratt, Michael P.; Pietravalle, Stephane; Potts, Simon G.; Ramirez, Jorge A.; Somerwill, Kate E.; Biesmeijer, Jacobus C.			Species Distribution Models for Crop Pollination: A Modelling Framework Applied to Great Britain	PLOS ONE			English	Article							CLIMATE-CHANGE; LONG-TERM; SERVICES; RISK; COLONIES; DECLINES; HONEYBEE; BIAS; BEES	Insect pollination benefits over three quarters of the world's major crops. There is growing concern that observed declines in pollinators may impact on production and revenues from animal pollinated crops. Knowing the distribution of pollinators is therefore crucial for estimating their availability to pollinate crops; however, in general, we have an incomplete knowledge of where these pollinators occur. We propose a method to predict geographical patterns of pollination service to crops, novel in two elements: the use of pollinator records rather than expert knowledge to predict pollinator occurrence, and the inclusion of the managed pollinator supply. We integrated a maximum entropy species distribution model (SDM) with an existing pollination service model (PSM) to derive the availability of pollinators for crop pollination. We used nationwide records of wild and managed pollinators (honey bees) as well as agricultural data from Great Britain. We first calibrated the SDM on a representative sample of bee and hoverfly crop pollinator species, evaluating the effects of different settings on model performance and on its capacity to identify the most important predictors. The importance of the different predictors was better resolved by SDM derived from simpler functions, with consistent results for bees and hoverflies. We then used the species distributions from the calibrated model to predict pollination service of wild and managed pollinators, using field beans as a test case. The PSM allowed us to spatially characterize the contribution of wild and managed pollinators and also identify areas potentially vulnerable to low pollination service provision, which can help direct local scale interventions. This approach can be extended to investigate geographical mismatches between crop pollination demand and the availability of pollinators, resulting from environmental change or policy scenarios.	[Polce, Chiara; Biesmeijer, Jacobus C.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Termansen, Mette] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Aguirre-Gutierrez, Jesus; Biesmeijer, Jacobus C.] Nat Biodivers Ctr, Leiden, Netherlands; [Aguirre-Gutierrez, Jesus; Biesmeijer, Jacobus C.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Boatman, Nigel D.; Budge, Giles E.; Crowe, Andrew; Pietravalle, Stephane; Somerwill, Kate E.] Food & Environm Res Agcy, York, N Yorkshire, England; [Garratt, Michael P.; Potts, Simon G.] Univ Reading, Sch Agr Policy & Dev, Reading, Berks, England; [Ramirez, Jorge A.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; Aarhus University; Naturalis Biodiversity Center; University of Amsterdam; Food & Environment Research Agency; University of Reading; University of Leeds	Polce, C (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	chiara.polce@gmail.com	Crowe, Andrew/AAF-9669-2020; Garratt, Michael/AAT-2259-2020; Potts, Simon/ABF-9221-2020; Potts, Simon G/C-7250-2008	Crowe, Andrew/0000-0003-3521-7501; Garratt, Michael/0000-0002-0196-6013; Potts, Simon/0000-0002-2045-980X; Potts, Simon G/0000-0002-2045-980X; Biesmeijer, Koos/0000-0003-0328-0573; Ramirez, Jorge/0000-0002-6816-308X; Aguirre Gutierrez, Jesus/0000-0001-9190-3229; Termansen, Mette/0000-0003-4875-2810	BBSRC; Defra; NERC; Scottish Government; Wellcome Trust; LWEC, under the Insect Pollinators Initiative; Mexican National Council for Science and Technology (CONACyT) [214731/310005]; BBSRC [BB/I000429/1, BB/I000275/1, BB/I000348/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000348/1, BB/I000275/1, BB/I000429/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission); LWEC, under the Insect Pollinators Initiative; Mexican National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was carried out within the project "Sustainable pollination services for UK crops" (http://www.reading.ac.uk/caer/Project_IPI_Crops/project_ipi_crops_index.html), funded jointly by BBSRC, Defra, NERC, the Scottish Government, the Wellcome Trust and the LWEC, under the Insect Pollinators Initiative (https://wiki.ceh.ac.uk/display/ukipi/Home). JA-G received funding from the Mexican National Council for Science and Technology (CONACyT), reference 214731/310005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Anonymous, 2010, Bulletin OEPP, V40, P323, DOI 10.1111/j.1365-2338.2010.02419.x; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Blach-Overgaard A, 2010, ECOGRAPHY, V33, P380, DOI 10.1111/j.1600-0587.2010.06273.x; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Carvalheiro LG, 2012, J APPL ECOL, V49, P1373, DOI 10.1111/j.1365-2664.2012.02217.x; Carvalheiro LG, 2010, J APPL ECOL, V47, P810, DOI 10.1111/j.1365-2664.2010.01829.x; Crawley M.J., 2007, R BOOK; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; ESRI, 2009, ARCGIS DESKT 10; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Giannini TC, 2012, ECOL MODEL, V244, P127, DOI 10.1016/j.ecolmodel.2012.06.035; Gordo O, 2005, OECOLOGIA, V146, P484, DOI 10.1007/s00442-005-0240-z; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hagen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019997; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JOLLIFFE IT, 1973, ROY STAT SOC C-APP, V22, P21; Keil P, 2011, ECOGRAPHY, V34, P392, DOI 10.1111/j.1600-0587.2010.06554.x; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2012, J APPL ECOL, V49, P723, DOI 10.1111/j.1365-2664.2012.02144.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; Lautenbach S, 2011, ECOL INDIC, V11, P676, DOI 10.1016/j.ecolind.2010.09.007; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Mineau P, 2008, ENVIRON ENTOMOL, V37, P546, DOI 10.1603/0046-225X(2008)37[546:UROBMI]2.0.CO;2; Morton D., 2011, FINAL REPORT LCM2007; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Safriel U., 2005, ECOSYSTEMS HUMAN WEL; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Termansen M, 2006, ECOL MODEL, V192, P410, DOI 10.1016/j.ecolmodel.2005.07.009; Tognelli MF, 2009, REV CHIL HIST NAT, V82, P347, DOI 10.4067/S0716-078X2009000300003; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; UK National Ecosystem Assessment, 2011, UK NAT EC ASS TECHN; VISSCHER PK, 1982, ECOLOGY, V63, P1790, DOI 10.2307/1940121; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Wilensky U., 1999, NETLOGO; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Winfree R, 2005, AM NAT, V165, P707, DOI 10.1086/430009	59	39	39	5	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76308	10.1371/journal.pone.0076308	http://dx.doi.org/10.1371/journal.pone.0076308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155899	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000325887300033
J	Yuan, SQ; Zheng, HL; Zheng, ZH; Yan, W				Yuan, Shuiqiao; Zheng, Huili; Zheng, Zhihong; Yan, Wei			Proteomic Analyses Reveal a Role of Cytoplasmic Droplets as an Energy Source during Epididymal Sperm Maturation	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; IN-VITRO; ARTIFICIAL CRYPTORCHIDISM; ALKALINE-PHOSPHATASE; ACROSOME REACTION; LIFE-HISTORY; SPERMATOZOA; MOTILITY; HYPERACTIVATION; CAPACITATION	A small portion of cytoplasm is generally retained as the cytoplasmic droplet (CD) on the flagellum of spermatozoa after spermiation in mice. CDs are believed to play a role in osmoadaptation by allowing water entrance or exit. However, many lines of evidence suggest that CDs may have roles beyond osmoregulation. To gain more insights, we purified CDs from murine epididymal spermatozoa and conducted proteomic analyses on proteins highly enriched in CDs. Among 105 proteins identified, 71 (68%) were enzymes involved in energy metabolism. We also found that sperm mitochondria underwent a reactivation process and glycolytic enzymes were further distributed and incorporated into different regions of the flagellum during epididymal sperm maturation. Both processes appeared to require CDs. Our data suggest that the CD represents a transient organelle that serves as an energy source essential for epididymal sperm maturation.	[Yuan, Shuiqiao; Zheng, Zhihong; Yan, Wei] China Med Univ, Dept Lab Anim Med, Shenyang, Peoples R China; [Yuan, Shuiqiao; Zheng, Huili; Yan, Wei] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	China Medical University; Nevada System of Higher Education (NSHE); University of Nevada Reno	Yan, W (corresponding author), China Med Univ, Dept Lab Anim Med, Shenyang, Peoples R China.	wyan@unr.edu	Yan, Wei/AAH-7943-2019; Yuan, Shuiqiao/AAX-1467-2021	Yuan, Shuiqiao/0000-0003-1460-7682	University of Nevada, Reno; National Institutes of Health [HD0068006]; National Center for Research Resources [5P20RR016464-11]; National Institute of General Medical Sciences from the National Institutes of Health [P20 GM103440-11]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018751, P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440, P20GM103513] Funding Source: NIH RePORTER	University of Nevada, Reno; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by a startup fund from the University of Nevada, Reno and a grant (HD0068006 to W.Y.) from the National Institutes of Health. The proteomic analyses were conducted in the Nevada Proteomic Center, which is supported by grants from the National Center for Research Resources (5P20RR016464-11) and the National Institute of General Medical Sciences (P20 GM103440-11) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2007, ASIAN J ANDROL, V9, P554, DOI 10.1111/j.1745-7262.2007.00280.x; Aitken RJ, 2004, FREE RADICAL BIO MED, V36, P994, DOI 10.1016/j.freeradbiomed.2004.01.017; Amann RP, 2000, THERIOGENOLOGY, V54, P1499, DOI 10.1016/S0093-691X(00)00470-2; Bao JQ, 2011, MOL CELL ENDOCRINOL, V333, P134, DOI 10.1016/j.mce.2010.12.021; Bao JQ, 2010, MOL CELL ENDOCRINOL, V327, P89, DOI 10.1016/j.mce.2010.06.006; BAVDEK S, 1970, J REPROD FERTIL, V22, P371, DOI 10.1530/jrf.0.0220371; Beardsley A, 2003, BIOL REPROD, V68, P1299, DOI 10.1095/biolreprod.102.009811; Cao WL, 2009, BIOL REPROD, V80, P124, DOI 10.1095/biolreprod.108.068882; Chen Q, 2011, CELL RES, V21, P922, DOI 10.1038/cr.2010.169; Cooper TG, 2005, HUM REPROD, V20, P9, DOI 10.1093/humrep/deh555; Cooper TG, 2011, ASIAN J ANDROL, V13, P130, DOI 10.1038/aja.2010.97; Cooper TG, 2009, J ANDROL, V30, P214, DOI 10.2164/jandrol.108.005819; CUMMINS JM, 1970, J REPROD FERTIL, V23, P423; CUMMINS JM, 1973, J REPROD FERTIL, V33, P469, DOI 10.1530/jrf.0.0330469; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; DOTT HM, 1968, EXP CELL RES, V52, P523, DOI 10.1016/0014-4827(68)90493-X; Fetic S, 2006, J ANDROL, V27, P294, DOI 10.2164/jandrol.05122; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; Gabers D. L, 1970, Biology Reprod., V3, P327; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; HARRISON RA, 1972, J REPROD FERTIL, V30, P105, DOI 10.1530/jrf.0.0300105; HERMO L, 1988, AM J ANAT, V183, P107, DOI 10.1002/aja.1001830202; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P243, DOI 10.1002/jemt.20783; Hermo L, 2010, MICROSC RES TECHNIQ, V73, P320, DOI 10.1002/jemt.20784; Jha KN, 2002, MOL REPROD DEV, V63, P119, DOI 10.1002/mrd.10152; Jin JL, 2007, BIOL REPROD, V77, P37, DOI 10.1095/biolreprod.107.060186; Kulanand J, 2001, ANDROLOGIA, V33, P95, DOI 10.1046/j.1439-0272.2001.00410.x; Kuster CE, 2004, J ANDROL, V25, P340; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; MONIEM KA, 1972, J REPROD FERTIL, V29, P65, DOI 10.1530/jrf.0.0290065; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; NOLAND TD, 1983, BIOL REPROD, V29, P987, DOI 10.1095/biolreprod29.4.987; Odet F, 2011, BIOL REPROD, V85, P556, DOI 10.1095/biolreprod.111.091546; OKO R, 1993, J CELL BIOL, V123, P809, DOI 10.1083/jcb.123.4.809; Pena AI, 2007, REPROD DOMEST ANIM, V42, P471, DOI 10.1111/j.1439-0531.2006.00809.x; Perl A, 2006, P NATL ACAD SCI USA, V103, P14813, DOI 10.1073/pnas.0602678103; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rengan AK, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-92; RETZIUS G, 1909, BIOL UNTERSUCH, V14, P163; ROBERTS ML, 1976, BIOL REPROD, V14, P421, DOI 10.1095/biolreprod14.4.421; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Si YM, 1999, BIOL REPROD, V61, P240, DOI 10.1095/biolreprod61.1.240; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Suzuki T, 2010, REPRODUCTION, V139, P847, DOI 10.1530/REP-08-0366; Thundathil J, 2001, ANIM REPROD SCI, V65, P181, DOI 10.1016/S0378-4320(00)00231-1; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Wang SH, 2006, BIOL REPROD, V74, P102, DOI 10.1095/biolreprod.105.045484; Williams AC, 2001, J ANDROL, V22, P680; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053; Xu H, 2013, ASIAN J ANDROL, V15, P799, DOI 10.1038/aja.2013.69; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT; Yeung CH, 1999, BIOL REPROD, V61, P1062, DOI 10.1095/biolreprod61.4.1062; Zheng HL, 2007, P NATL ACAD SCI USA, V104, P6852, DOI 10.1073/pnas.0701669104; Zini A, 2000, FERTIL STERIL, V74, P461, DOI 10.1016/S0015-0282(00)00703-2	58	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77466	10.1371/journal.pone.0077466	http://dx.doi.org/10.1371/journal.pone.0077466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155961	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300095
J	Burtnick, MN; Brett, PJ				Burtnick, Mary N.; Brett, Paul J.			Burkholderia mallei and Burkholderia pseudomallei Cluster 1 Type VI Secretion System Gene Expression Is Negatively Regulated by Iron and Zinc	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; GLANDERS; VIRULENCE; PROTEIN; IDENTIFICATION; MUTAGENESIS; REQUIRES; MELIOIDOSIS; INFECTION; PHOSPHATE	Burkholderia mallei is a facultative intracellular pathogen that causes glanders in humans and animals. Previous studies have demonstrated that the cluster 1 type VI secretion system (T6SS-1) expressed by this organism is essential for virulence in hamsters and is positively regulated by the VirAG two-component system. Recently, we have shown that T6SS-1 gene expression is up-regulated following internalization of this pathogen into phagocytic cells and that this system promotes multinucleated giant cell formation in infected tissue culture monolayers. In the present study, we further investigated the complex regulation of this important virulence factor. To assess T6SS-1 expression, B. mallei strains were cultured in various media conditions and Hcp1 production was analyzed by Western immunoblotting. Transcript levels of several VirAG-regulated genes (bimA, tssA, hcp1 and tssM) were also determined using quantitative real time PCR. Consistent with previous observations, T6SS-1 was not expressed during growth of B. mallei in rich media. Curiously, growth of the organism in minimal media (M9G) or minimal media plus casamino acids (M9CG) facilitated robust expression of T6SS-1 genes whereas growth in minimal media plus tryptone (M9TG) did not. Investigation of this phenomenon confirmed a regulatory role for VirAG in this process. Additionally, T6SS-1 gene expression was significantly down-regulated by the addition of iron and zinc to M9CG. Other genes under the control of VirAG did not appear to be as tightly regulated by these divalent metals. Similar results were observed for B. pseudomallei, but not for B. thailandensis. Collectively, our findings indicate that in addition to being positively regulated by VirAG, B. mallei and B. pseudomallei T6SS-1 gene expression is negatively regulated by iron and zinc.	[Burtnick, Mary N.; Brett, Paul J.] Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of South Alabama	Burtnick, MN (corresponding author), Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA.	mburtnick@southalabama.edu			National Institute of Allergy and Infectious Diseases [AI065359, AI091783]; University of South Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091783, U54AI065359] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of South Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by award numbers AI065359 and AI091783 from the National Institute of Allergy and Infectious Diseases, and lab start-up funds from the University of South Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arun S, 1999, VET REC, V144, P255, DOI 10.1136/vr.144.10.255; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Brett PJ, 2008, CELL MICROBIOL, V10, P487, DOI 10.1111/j.1462-5822.2007.01063.x; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Burtnick MN, 2011, INFECT IMMUN, V79, P1512, DOI 10.1128/IAI.01218-10; Burtnick MN, 2010, INFECT IMMUN, V78, P88, DOI 10.1128/IAI.00985-09; Burtnick MN, 2001, MICROBIOL-UK, V147, P111, DOI 10.1099/00221287-147-1-111; Cellier MF, 2007, MICROBES INFECT, V9, P1662, DOI 10.1016/j.micinf.2007.09.006; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chakraborty S, 2010, J BIOL CHEM, V285, P38876, DOI 10.1074/jbc.M110.179150; Chen YH, 2011, INFECT IMMUN, V79, P3064, DOI 10.1128/IAI.05148-11; Cotter P, 2011, NATURE, V475, P301, DOI 10.1038/475301a; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Elschner MC, 2009, EQUINE VET EDUC, V21, P147, DOI 10.2746/095777309X401071; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Fritz DL, 2000, VET PATHOL, V37, P626, DOI 10.1354/vp.37-6-626; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Hamad MA, 2009, GENE, V430, P123, DOI 10.1016/j.gene.2008.10.011; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; HOWE C, 1947, ANN INTERN MED, V26, P93, DOI 10.7326/0003-4819-26-1-93; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Ishikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006734; Khaki P, 2012, IRAN J MICROBIOL, V4, P3; Khan I, 2013, TRANSBOUND EMERG DIS, V60, P204, DOI 10.1111/j.1865-1682.2012.01342.x; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Leung KY, 2010, CURR OPIN MICROBIOL, V14, P1; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Lopez J, 2003, MICROBES INFECT, V5, P1125, DOI 10.1016/j.micinf.2003.07.004; Loprasert S, 2000, GENE, V254, P129, DOI 10.1016/S0378-1119(00)00279-1; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Malik P, 2012, VET ITAL, V48, P167; MILLER WR, 1948, J BACTERIOL, V55, P127, DOI 10.1128/JB.55.1.127-135.1948; Miyata ST, 2013, J MED MICROBIOL, V62, P663, DOI 10.1099/jmm.0.053983-0; Miyata ST, 2011, INFECT IMMUN, V79, P2941, DOI 10.1128/IAI.01266-10; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Neubauer H, 2005, J VET MED B, V52, P201, DOI 10.1111/j.1439-0450.2005.00855.x; Nierman WC, 2004, P NATL ACAD SCI USA, V101, P14246, DOI 10.1073/pnas.0403306101; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; REDFEARN MS, 1966, J GEN MICROBIOL, V43, P293, DOI 10.1099/00221287-43-2-293; Ribot WJ, 2006, INFECT IMMUN, V74, P4349, DOI 10.1128/IAI.01939-05; Rogge ML, 2011, APPL ENVIRON MICROB, V77, P4293, DOI 10.1128/AEM.00195-11; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Russell AB, 2013, NATURE, V496, P508, DOI 10.1038/nature12074; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Shalom G, 2007, MICROBIOL-SGM, V153, P2689, DOI 10.1099/mic.0.2007/006585-0; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Srinivasan A, 2001, NEW ENGL J MED, V345, P256, DOI 10.1056/NEJM200107263450404; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Sun GW, 2010, MOL MICROBIOL, V76, P677, DOI 10.1111/j.1365-2958.2010.07124.x; Ulrich RL, 2006, DIAGN MICR INFEC DIS, V55, P37, DOI 10.1016/j.diagmicrobio.2005.11.007; Urich RL, 2004, INFECT IMMUN, V72, P1150, DOI 10.1128/IAI.72.2.1150-1154.2004; Voskuhl Gene W, 2003, J Okla State Med Assoc, V96, P214; Waag DM., 2004, BIOL WEAPONS DEFENSE, P209; Wernery U, 2011, EMERG INFECT DIS, V17, P1277, DOI 10.3201/eid1707.110222; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Yuan ZC, 2008, J BACTERIOL, V190, P494, DOI 10.1128/JB.01387-07; Zheng J, 2010, P NATL ACAD SCI USA, V107, P21128, DOI 10.1073/pnas.1014998107	75	34	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76767	10.1371/journal.pone.0076767	http://dx.doi.org/10.1371/journal.pone.0076767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146925	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400081
J	Zhang, CX; Knudsen, DE; Liu, M; Robertson, DC; Zhang, WP				Zhang, Chengxian; Knudsen, David E.; Liu, Mei; Robertson, Donald C.; Zhang, Weiping		STa Toxoid Vaccine Consortium Grp	Toxicity and Immunogenicity of Enterotoxigenic Escherichia coli Heat-Labile and Heat-Stable Toxoid Fusion 3xSTa(A14Q)-LTS63K/R192G/L211A in a Murine Model	PLOS ONE			English	Article							MUCOSAL IMMUNE-RESPONSES; SUBLINGUAL IMMUNIZATION; CHOLERA-TOXIN; COLONIZATION FACTORS; ENTERO-TOXIN; VACCINE; DIARRHEA; ANTIBODIES; INFECTION; ADJUVANT	Diarrhea is the second leading cause of death to young children. Enterotoxigenic Escherichia coli (ETEC) are the most common bacteria causing diarrhea. Adhesins and enterotoxins are the virulence determinants in ETEC diarrhea. Adhesins mediate bacterial attachment and colonization, and enterotoxins including heat-labile (LT) and heat-stable type Ib toxin (STa) disrupt fluid homeostasis in host cells that leads to fluid hyper-secretion and diarrhea. Thus, adhesins and enterotoxins have been primarily targeted in ETEC vaccine development. A recent study reported toxoid fusions with STa toxoid (STaP13F) fused at the N- or C-terminus, or inside the A subunit of LTR192G elicited neutralizing antitoxin antibodies, and suggested application of toxoid fusions in ETEC vaccine development (Liu et al., Infect. Immun. 79:4002-4009, 2011). In this study, we generated a different STa toxoid (STaA14Q) and a triple-mutant LT toxoid (LTS63K/R192G/L211A, tmLT), constructed a toxoid fusion (3xSTa(A14Q)-tmLT) that carried 3 copies of STaA14Q for further facilitation of anti-STa immunogenicity, and assessed antigen safety and immunogenicity in a murine model to explore its potential for ETEC vaccine development. Mice immunized with this fusion antigen showed no adverse effects, and developed antitoxin antibodies particularly through the IP route. Anti-LT antibodies were detected and were shown neutralizing against CT in vitro. Anti-STa antibodies were also detected in the immunized mice, and serum from the IP immunized mice neutralized STa toxin in vitro. Data from this study indicated that toxoid fusion 3xSTa(A14Q)-tmLT is safe and can induce neutralizing antitoxin antibodies, and provided helpful information for vaccine development against ETEC diarrhea.	[Zhang, Chengxian; Knudsen, David E.; Liu, Mei; Zhang, Weiping] S Dakota State Univ, Ctr Infect Dis Res & Vaccinol, Vet & Biomed Sci Dept, Brookings, SD 57007 USA; [Robertson, Donald C.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	South Dakota State University; Kansas State University	Zhang, WP (corresponding author), S Dakota State Univ, Ctr Infect Dis Res & Vaccinol, Vet & Biomed Sci Dept, Brookings, SD 57007 USA.	weiping.zhang@sdstate.edu			NIH [AI083897]; EVI/PATH STa Toxoid Vaccine Consortium; South Dakota Agricultural Experiment Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083897] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EVI/PATH STa Toxoid Vaccine Consortium; South Dakota Agricultural Experiment Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this study was provided by NIH AI083897 (W. Zhang), EVI/PATH STa Toxoid Vaccine Consortium (JP Nataro, subaward to W. Zhang), and the South Dakota Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuguni JH, 2011, VACCINE, V29, P4778, DOI 10.1016/j.vaccine.2011.04.083; Andrew DW, 2011, J REPROD IMMUNOL, V91, P9, DOI 10.1016/j.jri.2011.06.100; [Anonymous], 1999, WORLD HLTH REPORT 19; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boedeker EC, 2005, CURR OPIN GASTROEN, V21, P15; Cho HJ, 2010, VACCINE, V28, P2598, DOI 10.1016/j.vaccine.2010.01.013; CLEMENTS JD, 1990, INFECT IMMUN, V58, P1159, DOI 10.1128/IAI.58.5.1159-1166.1990; Council NR, 1996, GUIDE CARE USE LAB A; Cuburu N, 2007, VACCINE, V25, P8598, DOI 10.1016/j.vaccine.2007.09.073; Czerkinsky C, 2011, HUM VACCINES, V7, P110, DOI 10.4161/hv.7.1.13739; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; Delisle B, 2012, J PHARM PHARM SCI, V15, P642, DOI 10.18433/J30W32; Dupont HL, 2008, ALIMENT PHARM THER, V27, P741, DOI 10.1111/j.1365-2036.2008.03647.x; FRANTZ JC, 1981, INFECT IMMUN, V33, P193, DOI 10.1128/IAI.33.1.193-198.1981; Frantz JC, 1983, P 4 INT S NEON DIARR; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Jackson EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041529; Joensuu JJ, 2006, VACCINE, V24, P2387, DOI 10.1016/j.vaccine.2005.11.056; KLIPSTEIN FA, 1982, INFECT IMMUN, V37, P550, DOI 10.1128/IAI.37.2.550-557.1982; Kurono Y, 2011, ADV OTO-RHINO-LARYNG, V72, P146, DOI 10.1159/000324773; Laurelle L, 1889, CELLULE, V5, P60; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Liu M, 2011, TOXINS, V3, P1146, DOI 10.3390/toxins3091146; Liu M, 2011, INFECT IMMUN, V79, P4002, DOI 10.1128/IAI.00165-11; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Negri DRM, 2010, VACCINE, V28, P4175, DOI 10.1016/j.vaccine.2010.04.013; Olvera-Gomez I, 2012, P NATL ACAD SCI USA, V109, P2072, DOI 10.1073/pnas.1105771109; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Ruan XS, 2011, CLIN VACCINE IMMUNOL, V18, P1593, DOI 10.1128/CVI.05120-11; Sack DA, 2007, VACCINE, V25, P4392, DOI 10.1016/j.vaccine.2007.03.034; SANCHEZ J, 1988, GENE, V64, P265, DOI 10.1016/0378-1119(88)90341-1; Sanders JW, 2005, CURR OPIN GASTROEN, V21, P9; Svennerholm AM, 1992, IMMUNOLOGY GASTROINT, P227; Svennerholm AM, 2011, INDIAN J MED RES, V133, P188; Taxt A, 2010, INFECT IMMUN, V78, P1824, DOI 10.1128/IAI.01397-09; Walker RI, 2005, EXPERT REV VACCINES, V4, P807, DOI 10.1586/14760584.4.6.807; Wenneras C, 2004, J HEALTH POPUL NUTR, V22, P370; [WHO] World Health Organization, 2006, WKLY EPIDEMIOL REC, V81, P97; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; Yamamoto M, 2001, SCAND J IMMUNOL, V53, P211, DOI 10.1046/j.1365-3083.2001.00883.x; Zhang WP, 2008, APPL ENVIRON MICROB, V74, P5832, DOI 10.1128/AEM.00893-08; Zhang WP, 2012, EXPERT REV VACCINES, V11, P677, DOI [10.1586/erv.12.37, 10.1586/ERV.12.37]; Zhang WP, 2010, INFECT IMMUN, V78, P316, DOI 10.1128/IAI.00497-09	44	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77386	10.1371/journal.pone.0077386	http://dx.doi.org/10.1371/journal.pone.0077386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146989	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400115
J	Amro, A; Hamdi, S; Lemrani, M; Mouna, I; Mohammed, H; Mostafa, S; Rhajaoui, M; Hamarsheh, O; Schonian, G				Amro, Ahmad; Hamdi, Salsabil; Lemrani, Meryem; Mouna, Idrissi; Mohammed, Hida; Mostafa, Sabri; Rhajaoui, Mohamed; Hamarsheh, Omar; Schoenian, Gabriele			Moroccan Leishmania infantum: Genetic Diversity and Population Structure as Revealed by Multi-Locus Microsatellite Typing	PLOS ONE			English	Article							PHLEBOTOMUS-PERNICIOSUS; VISCERAL LEISHMANIASIS; PALESTINIAN AUTHORITY; MEDITERRANEAN COAST; CLINICAL-SAMPLES; STRAINS; DIFFERENTIATION; EPIDEMIOLOGY; POLYMORPHISM; LONGICUSPIS	Leishmania infantum causes Visceral and cutaneous leishmaniasis in northern Morocco. It predominantly affects children under 5 years with incidence of 150 cases/year. Genetic variability and population structure have been investigated for 33 strains isolated from infected dogs and humans in Morocco. A multilocus microsatellite typing (MLMT) approach was used in which a MLMtype based on size variation in 14 independent microsatellite markers was compiled for each strain. MLMT profiles of 10 Tunisian, 10 Algerian and 21 European strains which belonged to zymodeme MON-1 and non-MON-1 according to multilocus enzyme electrophoresis (MLEE) were included for comparison. A Bayesian model-based approach and phylogenetic analysis inferred two L. infantum sub-populations; Sub-population A consists of 13 Moroccan strains grouped with all European strains of MON-1 type; and sub-population B consists of 15 Moroccan strains grouped with the Tunisian and Algerian MON-1 strains. Theses sub-populations were significantly different from each other and from the Tunisian, Algerian and European non MON-1 strains which constructed one separate population. The presence of these two sub-populations co-existing in Moroccan endemics suggests multiple introduction of L. infantum from/to Morocco; (1) Introduction from/to the neighboring North African countries, (2) Introduction from/to the Europe. These scenarios are supported by the presence of sub-population B and sub-population A respectively. Gene flow was noticed between sub-populations A and B. Five strains showed mixed A/B genotypes indicating possible recombination between the two populations. MLMT has proven to be a powerful tool for eco-epidemiological and population genetic investigations of Leishmania.	[Amro, Ahmad] Alquds Univ, Fac Pharm, Jerusalem, Israel; [Hamdi, Salsabil; Lemrani, Meryem] Inst Pasteur Maroc, Lab Leishmanioses, Casablanca, Morocco; [Mostafa, Sabri] Ibn Sina Hosp, Parasitol Lab, Rabat, Morocco; [Rhajaoui, Mohamed] Natl Inst Hyg, Dept Parasitol, Rabat, Morocco; [Hamarsheh, Omar] Al Quds Univ, Dept Biol Sci, Jerusalem, Israel; [Amro, Ahmad; Schoenian, Gabriele] Charite, Inst Microbiol & Hyg, D-13353 Berlin, Germany	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Amro, A (corresponding author), Alquds Univ, Fac Pharm, Jerusalem, Israel.	ahmadymm@hotmail.com	Hamarsheh, Omar/AAA-4256-2019; Amro, Ahmad/AAB-1778-2019	Hamarsheh, Omar/0000-0002-3258-9759; Amro, Ahmad/0000-0003-4123-2679; Schoenian, Gabriele/0000-0002-1565-4942	Pastur Institute in Morocco	Pastur Institute in Morocco	The fieldwork and data collection was granted by Pastur Institute in Morocco for Dr. Meryem Lemrani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amro A, 2009, MICROBES INFECT, V11, P484, DOI 10.1016/j.micinf.2009.02.001; Amro A, 2009, T ROY SOC TROP MED H, V103, P731, DOI 10.1016/j.trstmh.2008.10.008; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Azmi K, 2012, T ROY SOC TROP MED H, V106, P554, DOI 10.1016/j.trstmh.2012.06.005; Belkaid P M, 1996, Bull Soc Pathol Exot, V89, P276; Benabdennbi I, 1999, J MED ENTOMOL, V36, P116, DOI 10.1093/jmedent/36.1.116; Chargui N, 2009, INT J PARASITOL, V39, P801, DOI 10.1016/j.ijpara.2008.11.016; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; GuessousIdrissi N, 1997, PARASITE, V4, P181, DOI 10.1051/parasite/1997042181; Haralambous C, 2007, ACTA TROP, V103, P69, DOI 10.1016/j.actatropica.2007.05.008; Jaffe CL, 2004, TRENDS PARASITOL, V20, P328, DOI 10.1016/j.pt.2004.05.001; Kuhls K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000261; Kuhls K, 2007, MICROBES INFECT, V9, P334, DOI 10.1016/j.micinf.2006.12.009; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Ochsenreither S, 2006, J CLIN MICROBIOL, V44, P495, DOI 10.1128/JCM.44.2.495-503.2006; Pesson B, 2004, MED VET ENTOMOL, V18, P25, DOI 10.1111/j.0269-283x.2004.0471.x; Pratlong F, 2004, J CLIN MICROBIOL, V42, P4077, DOI 10.1128/JCM.42.9.4077-4082.2004; Pritchard JK, 2000, GENETICS, V155, P945; Rami M, 2003, PARASITE, V10, P79, DOI 10.1051/parasite/2003101p77; Rhajaoui M, 2007, EMERG INFECT DIS, V13, P1358, DOI 10.3201/eid1309.060946; Schonian G, 2008, TRENDS PARASITOL, V24, P135, DOI 10.1016/j.pt.2007.12.006; Schonian G, 2010, TRENDS PARASITOL, V26, P466, DOI 10.1016/j.pt.2010.06.013; Schonian G, 1996, MOL BIOCHEM PARASIT, V77, P19, DOI 10.1016/0166-6851(96)02572-8; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Seridi N, 2008, MICROBES INFECT, V10, P1309, DOI 10.1016/j.micinf.2008.07.031; Wright S., 1978, EVOLUTION GENETICS P, P4	28	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77778	10.1371/journal.pone.0077778	http://dx.doi.org/10.1371/journal.pone.0077778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147078	gold, Green Published			2022-12-27	WOS:000326022200075
J	Gharanei, M; Hussain, A; Janneh, O; Maddock, H				Gharanei, Mayel; Hussain, Afthab; Janneh, Omar; Maddock, Helen			Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy Inhibitor	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CONGESTIVE-HEART-FAILURE; INDUCED CARDIOMYOPATHY; CHILDHOOD-CANCER; OXIDATIVE STRESS; BREAST-CANCER; CYTOCHROME-C; CELL-DEATH; FISSION; FRAGMENTATION	Doxorubicin is one of the most effective anti-cancer agents. However, its use is associated with adverse cardiac effects, including cardiomyopathy and progressive heart failure. Given the multiple beneficial effects of the mitochondrial division inhibitor (mdivi-1) in a variety of pathological conditions including heart failure and ischaemia and reperfusion injury, we investigated the effects of mdivi-1 on doxorubicin-induced cardiac dysfunction in naive and stressed conditions using Langendorff perfused heart models and a model of oxidative stress was used to assess the effects of drug treatments on the mitochondrial depolarisation and hypercontracture of cardiac myocytes. Western blot analysis was used to measure the levels of p-Akt and p-Erk 1/2 and flow cytometry analysis was used to measure the levels p-Drp1 and p-p53 upon drug treatment. The HL60 leukaemia cell line was used to evaluate the effects of pharmacological inhibition of mitochondrial division on the cytotoxicity of doxorubicin in a cancer cell line. Doxorubicin caused a significant impairment of cardiac function and increased the infarct size to risk ratio in both naive conditions and during ischaemia/reperfusion injury. Interestingly, co-treatment of doxorubicin with mdivi-1 attenuated these detrimental effects of doxorubicin. Doxorubicin also caused a reduction in the time taken to depolarisation and hypercontracture of cardiac myocytes, which were reversed with mdivi-1. Finally, doxorubicin caused a significant elevation in the levels of signalling proteins p-Akt, p-Erk 1/2, p-Drp1 and p-p53. Co-incubation of mdivi-1 with doxorubicin did not reduce the cytotoxicity of doxorubicin against HL-60 cells. These data suggest that the inhibition of mitochondrial fission protects the heart against doxorubicin-induced cardiac injury and identify mitochondrial fission as a new therapeutic target in ameliorating doxorubicin-induced cardiotoxicity without affecting its anti-cancer properties.	[Gharanei, Mayel; Hussain, Afthab; Janneh, Omar; Maddock, Helen] Coventry Univ, Dept Biomol & Sport Sci, Coventry, W Midlands, England; [Janneh, Omar] Univ London, Div Biomed Sci, London, England	Coventry University; University of London	Maddock, H (corresponding author), Coventry Univ, Dept Biomol & Sport Sci, Coventry, W Midlands, England.	h.maddock@coventry.ac.uk		Hussain, Dr Afthab/0000-0001-8127-4991; Maddock, Helen/0000-0002-6052-1217; Gharanei, Mayel/0000-0002-2411-952X	Coventry University	Coventry University	Funding came from Coventry University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arai M, 2000, CIRC RES, V86, P8, DOI 10.1161/01.RES.86.1.8; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Cai C, 2010, J PHARMACOL EXP THER, V335, P223, DOI 10.1124/jpet.110.167965; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen L, 2010, MINERVA CARDIOANGIOL, V58, P213; Chen L, 2009, CARDIOVASC RES, V84, P91, DOI 10.1093/cvr/cvp181; Crivellari D, 2000, J CLIN ONCOL, V18, P1412, DOI 10.1200/JCO.2000.18.7.1412; Das A, 2010, P NATL ACAD SCI USA, V107, P18202, DOI 10.1073/pnas.1006965107; Davidson SM, 2006, INT J BIOCHEM CELL B, V38, P414, DOI 10.1016/j.biocel.2005.09.017; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; Deres P, 2005, J CARDIOVASC PHARM, V45, P36, DOI 10.1097/00005344-200501000-00007; Doyle JJ, 2005, J CLIN ONCOL, V23, P8597, DOI 10.1200/JCO.2005.02.5841; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; GANEY PE, 1991, CIRC RES, V68, P1610, DOI 10.1161/01.RES.68.6.1610; Geiger S, 2010, ANTI-CANCER DRUG, V21, P578, DOI 10.1097/CAD.0b013e3283394624; Gharanei M, 2013, TOXICOL APPL PHARM, V268, P149, DOI 10.1016/j.taap.2012.12.003; Givvimani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032388; Granger CB, 2006, CIRCULATION, V114, P2432, DOI 10.1161/CIRCULATIONAHA.106.666248; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hausenloy DJ, 2003, CARDIOVASC RES, V60, P617, DOI 10.1016/j.cardiores.2003.09.025; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; Ichihara S, 2007, BIOCHEM BIOPH RES CO, V359, P27, DOI 10.1016/j.bbrc.2007.05.027; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jirkovsky E, 2012, J PHARMACOL EXP THER, V343, P468, DOI 10.1124/jpet.112.198358; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Koka S, 2010, J PHARMACOL EXP THER, V334, P1023, DOI 10.1124/jpet.110.170191; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Maddock HL, 2002, AM J PHYSIOL-HEART C, V283, pH1307, DOI 10.1152/ajpheart.00851.2001; Marechal X, 2011, CLIN SCI, V121, P405, DOI 10.1042/CS20110069; Marin-Garcia J, 2013, HEART FAIL REV, V18, P439, DOI 10.1007/s10741-012-9330-2; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Mertens AC, 2008, PEDIATR BLOOD CANCER, V50, P90, DOI 10.1002/pbc.21177; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Montaigne D, 2011, MITOCHONDRION, V11, P22, DOI 10.1016/j.mito.2010.06.001; MYERS CE, 1977, SCIENCE, V197, P165, DOI 10.1126/science.877547; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Papanicolaou KN, 2012, AM J PHYSIOL-HEART C, V302, pH167, DOI 10.1152/ajpheart.00833.2011; Papanicolaou KN, 2011, MOL CELL BIOL, V31, P1309, DOI 10.1128/MCB.00911-10; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Plotnikov EY, 2008, FEBS LETT, V582, P3117, DOI 10.1016/j.febslet.2008.08.002; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; So EC, 2012, EUR J PHARMACOL, V683, P1, DOI 10.1016/j.ejphar.2012.02.012; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Zucchi Riccardo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P151, DOI 10.2174/1568011033353434	57	88	94	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77713	10.1371/journal.pone.0077713	http://dx.doi.org/10.1371/journal.pone.0077713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147064	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200068
J	Podoll, AS; Kozar, R; Holcomb, JB; Finkel, KW				Podoll, Amber S.; Kozar, Rosemary; Holcomb, John B.; Finkel, Kevin W.			Incidence and Outcome of Early Acute Kidney Injury in Critically-Ill Trauma Patients	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INTENSIVE-CARE-UNIT; HOSPITAL MORTALITY; COHORT ANALYSIS; MULTICENTER; RIFLE; SCORE	Objective: To determine the incidence and effect on mortality of early acute kidney injury in severely injured trauma patients using the Acute Kidney Injury Network creatinine criteria. Design: A retrospective cohort study of severely injured trauma patients admitted to the shock trauma intensive care unit. Setting: Texas Trauma Institute, a state designated level I trauma unit certified by the American College of Surgeons Committee on Trauma. Patients: 901 severely injured trauma patients admitted over a 15 month period to the shock trauma intensive care unit. Interventions: Retrospective analysis of prospectively collected data abstracted from an electronic trauma database. Measurements and Main Results: Of 901 eligible patients admitted to the shock trauma intensive care unit after traumatic injury, 54 patients (6%) developed acute kidney injury, of whom 10 (19%) required renal replacement therapy. The 30-day mortality rate for the entire cohort was 83/901 (9.2%). Patients with early acute kidney injury had a mortality rate of 16/54 (29.6%). When corrected for multiple covariates including injury severity scores, the development of early acute kidney injury was associated with a significantly higher risk of death at 30 days with an OR of 3.4 (95% CI 1.6-7.4). Conclusions: Applying the Acute Kidney Injury Network creatinine criteria in severely injured trauma patients, the incidence of early acute kidney injury was 6%. After correction for injury severity, development of early acute kidney injury was independently associated with significantly higher 30-day mortality.	[Podoll, Amber S.; Finkel, Kevin W.] Univ Texas UT Hlth Sci Ctr Houston, Sch Med, Sect Crit Care Nephrol, Dept Internal Med,Div Renal Dis & Hypertens, Houston, TX USA; [Kozar, Rosemary; Holcomb, John B.] UTHlth Sci Ctr Houston, Sch Med, Trauma & Crit Care Sect, Dept Surg,Div Acute Care Surg,Ctr Translat Injury, Houston, TX USA; [Podoll, Amber S.; Kozar, Rosemary; Holcomb, John B.; Finkel, Kevin W.] UTHlth Sci Ctr Houston, Sch Med, Mem Hermann Hosp, Texas Trauma Inst,Texas Med Ctr, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Finkel, KW (corresponding author), Univ Texas UT Hlth Sci Ctr Houston, Sch Med, Sect Crit Care Nephrol, Dept Internal Med,Div Renal Dis & Hypertens, Houston, TX USA.	kevin.w.finkel@uth.tmc.edu		holcomb, john/0000-0001-8312-9157				Abosaif NY, 2005, AM J KIDNEY DIS, V46, P1038, DOI 10.1053/j.ajkd.2005.08.033; Ala-Kokko T, 2006, ACTA ANAESTH SCAND, V50, P828, DOI 10.1111/j.1399-6576.2006.01082.x; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Brandt MM, 2007, J TRAUMA, V62, P1362, DOI 10.1097/TA.0b013e318047983d; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Kuitunen A, 2006, ANN THORAC SURG, V81, P542, DOI 10.1016/j.athoracsur.2005.07.047; Levy EM, 1996, JAMA-J AM MED ASSOC, V275, P1489, DOI 10.1001/jama.275.19.1489; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; MORRIS JA, 1991, J TRAUMA, V31, P1584, DOI 10.1097/00005373-199112000-00003; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Wohlauer MV, 2012, J TRAUMA ACUTE CARE, V72, P373, DOI 10.1097/TA.0b013e318244869b	15	46	48	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77376	10.1371/journal.pone.0077376	http://dx.doi.org/10.1371/journal.pone.0077376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146987	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200035
J	Tsanev, R; Vanatalu, K; Jarvet, J; Tanner, R; Laur, K; Tiigimagi, P; Kragelund, BB; Osterlund, T; Kogerman, P				Tsanev, Robert; Vanatalu, Kalju; Jarvet, Jueri; Tanner, Risto; Laur, Kristi; Tiigimaegi, Piret; Kragelund, Birthe B.; Osterlund, Torben; Kogerman, Priit			The Transcriptional Repressor Domain of Gli3 Is Intrinsically Disordered	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN; SUPPRESSOR; BINDING; LONG	The transcription factor Gli3 is acting mainly as a transcriptional repressor in the Sonic hedgehog signal transduction pathway. Gli3 contains a repressor domain in its N-terminus from residue G106 to E236. In this study we have characterized the intracellular structure of the Gli3 repressor domain using a combined bioinformatics and experimental approach. According to our findings the Gli3 repressor domain while being intrinsically disordered contains predicted anchor sites for partner interactions. The obvious interaction partners to test were Ski and DNA; however, with both of these the structure of Gli3 repressor domain remained disordered. To locate residues important for the repressor function we mutated several residues within the Gli3 repressor domain. Two of these, H141A and H157N, targeting predicted helical regions, significantly decreased transcriptional repression and thus identify important functional parts of the domain.	[Tsanev, Robert; Vanatalu, Kalju; Laur, Kristi; Tiigimaegi, Piret; Kogerman, Priit] Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia; [Jarvet, Jueri; Tanner, Risto] NICPB, Tallinn, Estonia; [Kragelund, Birthe B.] Univ Copenhagen, Struct Biol & Nucl Magnet Resonance Lab, Copenhagen, Denmark; [Osterlund, Torben] Zealand Pharma AS, Mol Pharmacol, Glostrup, Denmark	Tallinn University of Technology; National Institute of Chemical Physics & Biophysics (NICPB); University of Copenhagen; Zealand Pharma A/S	Tsanev, R (corresponding author), Tallinn Univ Technol, Dept Gene Technol, EE-19086 Tallinn, Estonia.	robert.tsanev@ttu.ee	Jarvet, Jüri/A-7330-2008; Kragelund, Birthe/M-3927-2014	Jarvet, Jüri/0000-0002-7863-1887; Kragelund, Birthe/0000-0002-7454-1761; Tanner, Risto/0000-0001-6926-2752; Osterlund, Torben/0000-0002-2047-767X	Wellcome Trust; Estonian Science Foundation [8116, 7279, 6847]; Estonian Ministry of Education and Research Targeted Financing Theme [SF0690034s09]	Wellcome Trust(Wellcome TrustEuropean Commission); Estonian Science Foundation; Estonian Ministry of Education and Research Targeted Financing Theme	This study was supported by the Wellcome Trust and Estonian Science Foundation (grant 8116 to P. K., 7279 to T.O., and 6847 to K. V.) and Estonian Ministry of Education and Research Targeted Financing Theme SF0690034s09 to J.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batey S, 2008, J MOL BIOL, V378, P297, DOI 10.1016/j.jmb.2008.02.032; Bienkiewicz EA, 2000, J MOL BIOL, V297, P119, DOI 10.1006/jmbi.2000.3545; Briscoe J, 2009, EMBO J, V28, P457, DOI 10.1038/emboj.2009.12; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Crowley PB, 2011, CHEMBIOCHEM, V12, P1043, DOI 10.1002/cbic.201100063; Dai P, 2002, GENE DEV, V16, P2843, DOI 10.1101/gad.1017302; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fuxreiter M, 2011, TRENDS BIOCHEM SCI, V36, P415, DOI 10.1016/j.tibs.2011.04.006; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Johansen D, 2011, BIOPHYS J, V100, P1120, DOI 10.1016/j.bpj.2011.01.020; Kalff-Suske M, 1999, HUM MOL GENET, V8, P1769, DOI 10.1093/hmg/8.9.1769; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14231, DOI 10.1073/pnas.94.26.14231; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Polyanichko AM, 2006, BIOPOLYMERS, V83, P182, DOI 10.1002/bip.20544; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; SUZUKI M, 1990, NATURE, V344, P562, DOI 10.1038/344562a0; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Tompa P, 2006, J PROTEOME RES, V5, P1996, DOI 10.1021/pr0600881; Tsanev R, 2009, FEBS LETT, V583, P224, DOI 10.1016/j.febslet.2008.12.010; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; ZHANG YZ, 1995, PROTEIN SCI, V4, P804	37	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76972	10.1371/journal.pone.0076972	http://dx.doi.org/10.1371/journal.pone.0076972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146948	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200028
J	Gazi, M; Caro-Gomez, E; Goez, Y; Cespedes, MA; Hidalgo, M; Correa, P; Valbuena, G				Gazi, Michal; Caro-Gomez, Erika; Goez, Yenny; Cespedes, Maria A.; Hidalgo, Marylin; Correa, Paula; Valbuena, Gustavo			Discovery of a Protective Rickettsia prowazekii Antigen Recognized by CD8(+) T Cells, RP884, Using an In Vivo Screening Platform	PLOS ONE			English	Article							FEVER GROUP RICKETTSIAE; EPIDEMIC TYPHUS; SPOTTED-FEVER; GAMMA-INTERFERON; VACCINIA VIRUS; RESPONSES; IMMUNITY; CONORII; PROTEIN; IMMUNIZATION	Rickettsia prowazekii has been tested for biological warfare due to the high mortality that it produces after aerosol transmission of very low numbers of rickettsiae. Epidemic typhus, the infection caused by these obligately intracellular bacteria, continues to be a threat because it is difficult to diagnose due to initial non-specific symptoms and the lack of commercial diagnostic tests that are sensitive and specific during the initial clinical presentation. A vaccine to prevent epidemic typhus would constitute an effective deterrent to the weaponization of R. prowazekii; however, an effective and safe vaccine is not currently available. Due to the cytoplasmic niche of Rickettsia, CD8(+) T-cells are critical effectors of immunity; however, the identification of antigens recognized by these cells has not been systematically addressed. To help close this gap, we designed an antigen discovery strategy that uses cell-based vaccination with antigen presenting cells expressing microbe's proteins targeted to the MHC class I presentation pathway. We report the use of this method to discover a protective T-cell rickettsial antigen, RP884, among a test subset of rickettsial proteins.	[Gazi, Michal; Caro-Gomez, Erika; Goez, Yenny; Cespedes, Maria A.; Valbuena, Gustavo] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Hidalgo, Marylin] Pontificia Univ Javeriana, Fac Ciencias, Dept Microbiol, Bogota, Colombia; [Correa, Paula] Univ Antioquia, Grp Inmunomodulac, Fac Med, Medellin, Colombia; [Valbuena, Gustavo] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Ctr Trop Dis, Ctr Biodef & Emerging Infect Dis,Inst Translat Sc, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Pontificia Universidad Javeriana; Universidad de Antioquia; University of Texas System; University of Texas Medical Branch Galveston	Valbuena, G (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	gvalbuen@utmb.edu	Hidalgo, Marylin/AAF-5736-2019	Correa, Paula/0000-0002-0941-9700; Caro, Erika/0000-0002-5960-1295; Hidalgo, Marylin/0000-0001-8960-0616	NIAID/NIH [5U54AI057156-09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant Number 5U54AI057156-09 from NIAID/NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the RCE Programs Office, NIAID, or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Azad AF, 2007, CLIN INFECT DIS, V45, pS52, DOI 10.1086/518147; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bechah Y, 2008, LANCET INFECT DIS, V8, P417, DOI 10.1016/S1473-3099(08)70150-6; CHURILLA A, 1990, ANN NY ACAD SCI, V590, P215, DOI 10.1111/j.1749-6632.1990.tb42222.x; Croquet-Valdes PA, 2001, VACCINE, V20, P979; Farhang Azad A., 1988, P51; Feng HM, 1997, J IMMUNOL, V158, P5314; Feng HM, 2003, VACCINE, V21, P3901, DOI 10.1016/S0264-410X(03)00301-3; FENG HM, 1994, INFECT IMMUN, V62, P1952, DOI 10.1128/IAI.62.5.1952-1960.1994; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Hailing-Brown M, 2008, TRENDS IMMUNOL, V29, P374, DOI 10.1016/j.it.2008.06.001; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Jing L, 2008, J VIROL, V82, P7120, DOI 10.1128/JVI.00453-08; Katzen F, 2007, EXPERT OPIN DRUG DIS, V2, P571, DOI 10.1517/17460441.2.4.571; LI H, 1987, INFECT IMMUN, V55, P1252, DOI 10.1128/IAI.55.5.1252-1255.1987; Li Z, 2003, INFECT IMMUN, V71, P3920, DOI 10.1128/IAI.71.7.3920-3926.2003; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MASON RA, 1976, J BIOL STAND, V4, P217, DOI 10.1016/S0092-1157(76)80006-6; MOE JB, 1980, MIL MED, V145, P780; Moutaftsi M, 2007, J IMMUNOL, V178, P6814, DOI 10.4049/jimmunol.178.11.6814; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Raoult D, 2004, INFECT DIS CLIN N AM, V18, P127, DOI 10.1016/S0891-5520(03)00093-X; Riedl P, 2009, J IMMUNOL, V183, P370, DOI 10.4049/jimmunol.0900505; Ruckwardt TJ, 2010, J IMMUNOL, V185, P4673, DOI 10.4049/jimmunol.1001606; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Stemke-Hale K, 2005, VACCINE, V23, P3016, DOI 10.1016/j.vaccine.2004.12.013; Stuehler C, 2011, BLOOD, V117, P5881, DOI 10.1182/blood-2010-12-325084; SUMNER JW, 1995, VACCINE, V13, P29, DOI 10.1016/0264-410X(95)80007-Z; Sykes K, 2008, EXPERT REV VACCINES, V7, P1395, DOI 10.1586/14760584.7.9.1395; Valbuena G, 2004, J INFECT DIS, V190, P1221, DOI 10.1086/423819; Walker DH, 2009, VACCINE, V27, pD52, DOI 10.1016/j.vaccine.2009.07.045; Walker DH, 2000, LAB INVEST, V80, P1361, DOI 10.1038/labinvest.3780144; Walker DH, 2001, INFECT IMMUN, V69, P1841, DOI 10.1128/IAI.69.3.1841-1846.2001; WALKER DH, 1980, LAB INVEST, V43, P388; WOODWARD TE, 1986, S AFR MED J, P73; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814; Zinsser H, 1933, NEW ENGL J MED, V209, P815, DOI 10.1056/NEJM193310262091701	41	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76253	10.1371/journal.pone.0076253	http://dx.doi.org/10.1371/journal.pone.0076253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146844	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400046
J	Lupatini, M; Suleiman, AKA; Jacques, RJS; Antoniolli, ZI; Kuramae, EE; Camargo, FAD; Roesch, LFW				Lupatini, Manoeli; Ahmad Suleiman, Afnan Khalil; Seminoti Jacques, Rodrigo Josemar; Antoniolli, Zaida Ines; Kuramae, Eiko Eurya; de Oliveira Camargo, Flavio Anastacio; Wuerdig Roesch, Luiz Fernando			Soil-Borne Bacterial Structure and Diversity Does Not Reflect Community Activity in Pampa Biome	PLOS ONE			English	Article							LAND-USE; MICROBIAL COMMUNITIES; FUNGAL COMMUNITIES; ENZYME-ACTIVITIES; PSEUDOREPLICATION; PH	The Pampa biome is considered one of the main hotspots of the world's biodiversity and it is estimated that half of its original vegetation was removed and converted to agricultural land and tree plantations. Although an increasing amount of knowledge is being assembled regarding the response of soil bacterial communities to land use change, to the associated plant community and to soil properties, our understanding about how these interactions affect the microbial community from the Brazilian Pampa is still poor and incomplete. In this study, we hypothesized that the same soil type from the same geographic region but under distinct land use present dissimilar soil bacterial communities. To test this hypothesis, we assessed the soil bacterial communities from four land-uses within the same soil type by 454-pyrosequencing of 16S rRNA gene and by soil microbial activity analyzes. We found that the same soil type under different land uses harbor similar (but not equal) bacterial communities and the differences were controlled by many microbial taxa. No differences regarding diversity and richness between natural areas and areas under anthropogenic disturbance were detected. However, the measures of microbial activity did not converge with the 16S rRNA data supporting the idea that the coupling between functioning and composition of bacterial communities is not necessarily correlated.	[Lupatini, Manoeli; Ahmad Suleiman, Afnan Khalil; Seminoti Jacques, Rodrigo Josemar; Antoniolli, Zaida Ines] Univ Fed Santa Maria, Dept Solos, BR-97119900 Santa Maria, RS, Brazil; [Kuramae, Eiko Eurya] Netherlands Inst Ecol NIOO KANW, Dept Microbial Ecol, Wageningen, Netherlands; [de Oliveira Camargo, Flavio Anastacio] Univ Fed Rio Grande do Sul, Dept Solos, Porto Alegre, RS, Brazil; [Wuerdig Roesch, Luiz Fernando] Univ Fed PAMPA, Sao Gabriel, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Universidade Federal do Rio Grande do Sul; Universidade Federal do Pampa	Roesch, LFW (corresponding author), Univ Fed PAMPA, Campus Sao Gabriel, Sao Gabriel, RS, Brazil.	luizroesch@unipampa.edu.br	Kuramae, Eiko Eurya/F-4738-2012; Roesch, Luiz/GRS-4638-2022; Jacques, Rodrigo/AAX-1211-2021; Roesch, Luiz F W/D-2838-2009; Camargo, Flavio A O/J-6914-2013; KNAW, NIOO-KNAW/A-4320-2012	Kuramae, Eiko Eurya/0000-0001-6701-8668; Roesch, Luiz F W/0000-0003-1450-8828; KNAW, NIOO-KNAW/0000-0002-3835-159X; camargo, flavio/0000-0003-1080-0549; Suleiman, Afnan/0000-0002-1388-9190; Josemar Seminoti Jacques, Rodrigo/0000-0002-8240-5145	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [479133/2012-3, 476121/2010-8]; CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - grant numbers 479133/2012-3 and 476121/2010-8). RJS Jacques, ZI Antoniolli, FAO Camargo and LFW Roesch receive research fellowships from the CNPq. M Lupatini and AKA Suleiman receive research fellowships from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Suleiman AKA, 2013, SYST APPL MICROBIOL, V36, P137, DOI 10.1016/j.syapm.2012.10.007; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Baker KL, 2009, SOIL BIOL BIOCHEM, V41, P2292, DOI 10.1016/j.soilbio.2009.08.010; Brazilian Institute of Geography and Statistics-IBGE, 2004, MAP VEG BRAZ MAP BIO; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faoro H, 2010, APPL ENVIRON MICROB, V76, P4744, DOI 10.1128/AEM.03025-09; Felske A, 1998, MICROB ECOL, V36, P31, DOI 10.1007/s002489900090; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; Ge Y, 2008, ISME J, V2, P254, DOI 10.1038/ismej.2008.2; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; HARGROVE WW, 1992, LANDSCAPE ECOL, V6, P251, DOI 10.1007/BF00129703; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kindt R., 2005, WORLD; Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88; Kuramae E, 2011, FEMS MICROBIOL ECOL, V77, P285, DOI 10.1111/j.1574-6941.2011.01110.x; Kuramae EE, 2012, FEMS MICROBIOL ECOL, V79, P12, DOI 10.1111/j.1574-6941.2011.01192.x; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lombard N, 2011, FEMS MICROBIOL ECOL, V78, P31, DOI 10.1111/j.1574-6941.2011.01140.x; Lorenzo P, 2010, APPL SOIL ECOL, V44, P245, DOI 10.1016/j.apsoil.2010.01.001; Marshall CB, 2011, SOIL BIOL BIOCHEM, V43, P78, DOI 10.1016/j.soilbio.2010.09.016; Ministry of the Environment-MMA, 2007, BRAZ BIOD PRIOR AR C; MMA (Ministerio do Meio Ambiente), 2002, BRAZILIAN BIODIVERSI; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Osborne CA, 2011, FEMS MICROBIOL ECOL, V78, P70, DOI 10.1111/j.1574-6941.2011.01105.x; Overbeck GE, 2007, PERSPECT PLANT ECOL, V9, P101, DOI 10.1016/j.ppees.2007.07.005; Pillar VP, 2009, SO FIELDS CONSERVATI; R Development Core Team, 2012, R LANG ENV STAT COMP; Roesch L. F. W., 2009, Diversity, V1, P182; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schank JC, 2009, J COMP PSYCHOL, V123, P421, DOI 10.1037/a0013579; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silva FC, 2009, HDB CHEM ANAL SOILS; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Stotzky G., 1965, METHODS SOIL ANAL 2, V9, P1550; Suzuki C, 2009, SOIL SCI PLANT NUTR, V55, P80, DOI 10.1111/j.1747-0765.2008.00344.x; Thomson BC, 2010, MICROB ECOL, V59, P335, DOI 10.1007/s00248-009-9575-z; TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223; Upchurch R, 2008, SOIL BIOL BIOCHEM, V40, P1294, DOI 10.1016/j.soilbio.2007.06.027; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wakelin SA, 2008, SOIL BIOL BIOCHEM, V40, P803, DOI 10.1016/j.soilbio.2007.10.015; Wallenius K, 2011, SOIL BIOL BIOCHEM, V43, P1464, DOI 10.1016/j.soilbio.2011.03.018; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Williams MA, 2013, SOIL BIOL BIOCHEM, V57, P749, DOI 10.1016/j.soilbio.2012.08.023; Zhang C, 2011, GEODERMA, V161, P115, DOI 10.1016/j.geoderma.2010.12.003	64	37	37	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76465	10.1371/journal.pone.0076465	http://dx.doi.org/10.1371/journal.pone.0076465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146873	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400061
J	Mirza, M; Shen, WK; Sofi, A; Tran, C; Jahangir, A; Sultan, S; Khan, U; Viqar, M; Cho, C; Jahangir, A				Mirza, Mahek; Shen, Win-Kuang; Sofi, Aamir; Canh Tran; Jahangir, Ahad; Sultan, Sulaiman; Khan, Uzma; Viqar, Maria; Cho, Chi; Jahangir, Arshad			Frequent Periodic Leg Movement During Sleep Is an Unrecognized Risk Factor for Progression of Atrial Fibrillation	PLOS ONE			English	Article							HEART-RATE RESPONSE; CARDIOVASCULAR-DISEASE; CARDIAC ACTIVATION; AUTONOMIC ACTIVITY; LIMB MOVEMENTS; BLOOD-PRESSURE; TASK-FORCE; ASSOCIATION; APNEA; PATHOPHYSIOLOGY	Sleep apnea has been recognized as a factor predisposing to atrial fibrillation recurrence and progression. The effect of other sleep-disturbing conditions on atrial fibrillation progression is not known. We sought to determine whether frequent periodic leg movement during sleep is a risk factor for progression of atrial fibrillation. In this retrospective study, patients with atrial fibrillation and a clinical suspicion of restless legs syndrome who were referred for polysomnography were divided into two groups based on severity of periodic leg movement during sleep: frequent (periodic movement index >35/h) and infrequent (<= 35/h). Progression of atrial fibrillation to persistent or permanent forms between the two groups was compared using Wilcoxon rank-sum test, chi-square tests and logistic regression analysis. Of 373 patients with atrial fibrillation (77% paroxysmal, 23% persistent), 108 (29%) progressed to persistent or permanent atrial fibrillation during follow-up (median, 33 months; interquartile range, 16-50). Compared to patients with infrequent periodic leg movement during sleep (n=168), patients with frequent periodic leg movement during sleep (n=205) had a higher rate of atrial fibrillation progression (23% vs. 34%; p=0.01). Patients with frequent periodic leg movement during sleep were older and predominantly male; however, there were no significant differences at baseline in clinical factors that promote atrial fibrillation progression between both groups. On multivariate analysis, independent predictors of atrial fibrillation progression were persistent atrial fibrillation at baseline, female gender, hypertension and frequent periodic leg movement during sleep. In patients with frequent periodic leg movement during sleep, dopaminergic therapy for control of leg movements in patients with restless legs syndrome reduced risk of atrial fibrillation progression. Frequent leg movement during sleep in patients with restless legs syndrome is associated with progression of atrial fibrillation to persistent and permanent forms.	[Mirza, Mahek; Cho, Chi; Jahangir, Arshad] Aurora Univ, Wisconsin Med Grp, CIRCA, Milwaukee, WI USA; [Mirza, Mahek; Shen, Win-Kuang; Jahangir, Ahad; Khan, Uzma; Jahangir, Arshad] Mayo Clin, Div Cardiovasc Dis, Scottsdale, AZ USA; [Shen, Win-Kuang; Sofi, Aamir; Canh Tran; Sultan, Sulaiman; Viqar, Maria] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic	Jahangir, A (corresponding author), Aurora Univ, Wisconsin Med Grp, CIRCA, Milwaukee, WI USA.	publishing44@aurora.org	Sofi, Aamir/J-7962-2019; Jahangir, Arshad/M-7916-2016	Cho, Chi/0000-0002-3109-9707	National Heart, Lung, and Blood Institute [RO1 HL101240, R01 HL089542]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089542, R01HL101240] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Drs. Jahangir and Mirza's research effort was supported in part by National Heart, Lung, and Blood Institute grants (RO1 HL101240 and R01 HL089542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALI NJ, 1991, SLEEP, V14, P163; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; ANCOLIISRAEL S, 1991, SLEEP, V14, P496, DOI 10.1093/sleep/14.6.496; BONNET M, 1993, SLEEP, V16, P748; Braga B, 2009, SLEEP MED, V10, P212, DOI 10.1016/j.sleep.2007.12.007; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; COLEMAN RM, 1980, ANN NEUROL, V8, P416, DOI 10.1002/ana.410080413; de Vos CB, 2010, J AM COLL CARDIOL, V55, P725, DOI 10.1016/j.jacc.2009.11.040; Deguchi Y, 2009, ANN NONINVAS ELECTRO, V14, P280, DOI 10.1111/j.1542-474X.2009.00311.x; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Ferrillo F, 2004, SLEEP MED, V5, P407, DOI 10.1016/j.sleep.2004.01.008; Fuster V, 2006, PUBMED, V116, pe138, DOI [10.1161/ CIRCULATIONAHA. 106.177292, DOI 10.1161/CIRCULATI0NAHA.106.177292.PUBMED:16908781]; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Gami AS, 2004, CIRCULATION, V110, P364, DOI 10.1161/01.CIR.0000136587.68725.8E; Ghias M, 2009, J AM COLL CARDIOL, V54, P2075, DOI 10.1016/j.jacc.2009.09.014; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Guggisberg AG, 2007, SLEEP, V30, P755, DOI 10.1093/sleep/30.6.755; Horner RL, 2000, LUNG BIOL HEALTH DIS, V146, P113; Hornyak M, 2007, SLEEP, V30, P861, DOI 10.1093/sleep/30.7.861; Jahangir A, 2007, J APPL PHYSIOL, V103, P2120, DOI 10.1152/japplphysiol.00647.2007; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; Jahangir A, 2010, J AM COLL CARDIOL, V55, P732, DOI 10.1016/j.jacc.2009.12.010; Javaheri S, 2012, CURR HYPERTENS REP, V14, P442, DOI 10.1007/s11906-012-0289-0; Jongnarangsin K, 2008, J CARDIOVASC ELECTR, V19, P668, DOI 10.1111/j.1540-8167.2008.01118.x; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lubitz SA, 2010, NAT REV CARDIOL, V7, P451, DOI 10.1038/nrcardio.2010.86; Manconi M, 2011, SLEEP MED, V12, P47, DOI 10.1016/j.sleep.2010.03.019; Mirza M, 2013, J AM SOC ECHOCARDIOG, V26, P783, DOI 10.1016/j.echo.2013.03.018; Mirza M, 2012, CLIN GERIATR MED, V28, P555, DOI 10.1016/j.cger.2012.08.005; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Montplaisir J, 1997, MOVEMENT DISORD, V12, P61, DOI 10.1002/mds.870120111; Narkiewicz K, 1998, CIRCULATION, V97, P943; National Institute of Neurological Disorders and Stroke, 2010, OSTL LEGS SYNDR FACT, P10; Nicolas A, 1998, EUR NEUROL, V40, P22, DOI 10.1159/000007951; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Sforza E, 2002, CLIN NEUROPHYSIOL, V113, P883, DOI 10.1016/S1388-2457(02)00066-4; Sforza E, 2000, CLIN NEUROPHYSIOL, V111, P1611, DOI 10.1016/S1388-2457(00)00363-1; Sforza E, 2005, CLIN NEUROPHYSIOL, V116, P1096, DOI 10.1016/j.clinph.2004.12.018; Sforza E, 1999, NEUROLOGY, V52, P786, DOI 10.1212/WNL.52.4.786; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Spiegelhalder K, 2008, CLIN GERIATR MED, V24, P167, DOI 10.1016/j.cger.2007.08.004; Trenkwalder C, 2010, NAT REV NEUROL, V6, P337, DOI 10.1038/nrneurol.2010.55; Ulfberg J, 2001, MOVEMENT DISORD, V16, P1159, DOI 10.1002/mds.1209; Varagic J, 2001, CURR OPIN CARDIOL, V16, P336, DOI 10.1097/00001573-200111000-00004; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Winkelman JW, 2008, NEUROLOGY, V70, P35, DOI 10.1212/01.wnl.0000287072.93277.c9; Winkelman JW, 1999, SLEEP, V22, P575, DOI 10.1093/sleep/22.5.575; Yang CK, 2006, SLEEP, V29, P553, DOI 10.1093/sleep/29.4.553; Zucconi M, 2006, SLEEP MED, V7, P175, DOI 10.1016/j.sleep.2006.01.001	51	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78359	10.1371/journal.pone.0078359	http://dx.doi.org/10.1371/journal.pone.0078359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147132	gold, Green Submitted, Green Published			2022-12-27	WOS:000326019400156
J	Schroder, J; Noack, S; Marhofer, RJ; Mottram, JC; Coombs, GH; Selzer, PM				Schroeder, Joerg; Noack, Sandra; Marhoefer, Richard J.; Mottram, Jeremy C.; Coombs, Graham H.; Selzer, Paul M.			Identification of Semicarbazones, Thiosemicarbazones and Triazine Nitriles as Inhibitors of Leishmania mexicana Cysteine Protease CPB	PLOS ONE			English	Article							CATHEPSIN-B; TRYPANOSOMA-BRUCEI; CRYSTAL-STRUCTURE; SPECIFICITY; DESIGN; CHEMOTHERAPY; PROTEINASES; EXPRESSION; DIFFERENTIATION; VALIDATION	Cysteine proteases of the papain superfamily are present in nearly all eukaryotes. They play pivotal roles in the biology of parasites and inhibition of cysteine proteases is emerging as an important strategy to combat parasitic diseases such as sleeping sickness, Chagas' disease and leishmaniasis. Homology modeling of the mature Leishmania mexicana cysteine protease CPB2.8 suggested that it differs significantly from bovine cathepsin B and thus could be a good drug target. High throughput screening of a compound library against this enzyme and bovine cathepsin B in a counter assay identified four novel inhibitors, containing the warhead-types semicarbazone, thiosemicarbazone and triazine nitrile, that can be used as leads for antiparasite drug design. Covalent docking experiments confirmed the SARs of these lead compounds in an effort to understand the structural elements required for specific inhibition of CPB2.8. This study has provided starting points for the design of selective and highly potent inhibitors of L. mexicana cysteine protease CPB that may also have useful efficacy against other important cysteine proteases.	[Schroeder, Joerg; Noack, Sandra; Marhoefer, Richard J.; Selzer, Paul M.] MSD Anim Hlth Innovat GmbH, Mol Discovery Sci, Schwabenheim, Germany; [Mottram, Jeremy C.; Selzer, Paul M.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Coombs, Graham H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Selzer, Paul M.] Univ Tubingen, Interfak Inst Biochem, Tubingen, Germany	Merck & Company; Intervet International B.V.; University of Glasgow; University of Strathclyde; Eberhard Karls University of Tubingen	Coombs, GH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	graham.coombs@strath.ac.uk; paul.selzer@msd.de		Mottram, Jeremy/0000-0001-5574-3766	MSD Animal Health; MRC [G0700127] Funding Source: UKRI; Medical Research Council [G0700127] Funding Source: researchfish	MSD Animal Health(Merck & CompanyIntervet International B.V.); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JS, SN, RM and PS are or have been paid employees of MSD Animal Health. In that sense MSD Animal Health was the funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr SC, 2005, ANTIMICROB AGENTS CH, V49, P5160, DOI 10.1128/AAC.49.12.5160-5161.2005; Besteiro S, 2007, INT J PARASITOL, V37, P1063, DOI 10.1016/j.ijpara.2007.03.008; Brickmann J, 2000, J MOL MODEL, V6, P328, DOI 10.1007/s0089400060328; Brooks DR, 2001, J BIOL CHEM, V276, P47061, DOI 10.1074/jbc.M108498200; BURDEN FR, 1989, J CHEM INF COMP SCI, V29, P225, DOI 10.1021/ci00063a011; Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290; Caffrey CR, 2011, ADV EXP MED BIOL, V712, P84, DOI 10.1007/978-1-4419-8414-2_6; Castanys-Munoz E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.113; Cavasotto CN, 2009, DRUG DISCOV TODAY, V14, P676, DOI 10.1016/j.drudis.2009.04.006; Chan VJ, 1999, BIOCHEM J, V340, P113, DOI 10.1042/0264-6021:3400113; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Du XH, 2002, J MED CHEM, V45, P2695, DOI 10.1021/jm010459j; EAKIN AE, 1993, J BIOL CHEM, V268, P6115; El-Fadili AK, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.51; Engel JC, 1998, J EXP MED, V188, P725, DOI 10.1084/jem.188.4.725; Frame MJ, 2000, PARASITOLOGY, V121, P367, DOI 10.1017/S0031182099006435; Gillmor SA, 1997, PROTEIN SCI, V6, P1603, DOI 10.1002/pro.5560060801; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; HASNAIN S, 1993, J BIOL CHEM, V268, P235; Hernandez AA, 2002, CURR OPIN CHEM BIOL, V6, P459, DOI 10.1016/S1367-5931(02)00345-9; IHLENFELDT WD, 1994, J CHEM INF COMP SCI, V34, P109, DOI 10.1021/ci00017a013; Ihlenfeldt WD, 2002, J CHEM INF COMP SCI, V42, P46, DOI 10.1021/ci010056s; JIA ZC, 1995, J BIOL CHEM, V270, P5527, DOI 10.1074/jbc.270.10.5527; KARGEL HJ, 1980, FEBS LETT, V114, P257, DOI 10.1016/0014-5793(80)81128-8; Katunuma N, 2011, P JPN ACAD B-PHYS, V87, P29, DOI 10.2183/pjab.87.29; Kopitar-Jerala N, 2012, CURR PROTEIN PEPT SC, V13, P767, DOI 10.2174/138920312804871102; Li RS, 1996, BIOORGAN MED CHEM, V4, P1421, DOI 10.1016/0968-0896(96)00136-8; Macarron R, 2006, DRUG DISCOV TODAY, V11, P277, DOI 10.1016/j.drudis.2006.02.001; MCGRATH ME, 1995, J MOL BIOL, V247, P251, DOI 10.1006/jmbi.1994.0137; McKerrow JH, 1999, BIOORGAN MED CHEM, V7, P639, DOI 10.1016/S0968-0896(99)00008-5; MENARD R, 1993, FEBS LETT, V328, P107, DOI 10.1016/0014-5793(93)80975-Z; Mottram JC, 1997, J BIOL CHEM, V272, P14285, DOI 10.1074/jbc.272.22.14285; Mottram JC, 1996, P NATL ACAD SCI USA, V93, P6008, DOI 10.1073/pnas.93.12.6008; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; Oprea TI, 2000, MOL DIVERS, V5, P199, DOI 10.1023/A:1021368007777; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pearlman RS, 1999, J CHEM INF COMP SCI, V39, P28, DOI 10.1021/ci980137x; Pearlman RS, 1998, PERSPECT DRUG DISCOV, V9-11, P339, DOI 10.1023/A:1027232610247; Proto WR, 2011, J BIOL CHEM, V286, P39914, DOI 10.1074/jbc.M111.292334; Rankovic Z, 2010, BIOORG MED CHEM LETT, V20, P1524, DOI 10.1016/j.bmcl.2010.01.100; Robertson CD, 1996, PERSPECT DRUG DISCOV, V6, P99, DOI 10.1007/BF02174048; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanderson SJ, 2000, BIOCHEM J, V347, P383, DOI 10.1042/0264-6021:3470383; Schaeffer M, 2012, ANTIMICROB AGENTS CH, V56, P1190, DOI 10.1128/AAC.05528-11; Schroder J, 2013, J MED CHEM, V56, P1478, DOI 10.1021/jm3013932; Scory S, 1999, EXP PARASITOL, V91, P327, DOI 10.1006/expr.1998.4381; Selzer PM, 1997, EXP PARASITOL, V87, P212, DOI 10.1006/expr.1997.4220; Selzer PM, 1999, P NATL ACAD SCI USA, V96, P11015, DOI 10.1073/pnas.96.20.11015; SHAW E, 1990, ADV ENZYMOL RAMB, V63, P271; Spencer RW, 1998, BIOTECHNOL BIOENG, V61, P61, DOI 10.1002/(SICI)1097-0290(199824)61:1<61::AID-BIT11>3.0.CO;2-C; St Hilaire PM, 2000, CHEMBIOCHEM, V1, P115, DOI 10.1002/1439-7633(20000818)1:2<115::AID-CBIC115>3.3.CO;2-#; Steert K, 2010, CHEMMEDCHEM, V5, P1734, DOI 10.1002/cmdc.201000265; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Yamamoto A, 2000, J BIOCHEM-TOKYO, V127, P635, DOI 10.1093/oxfordjournals.jbchem.a022651; Yamashita DS, 1997, J AM CHEM SOC, V119, P11351, DOI 10.1021/ja972204u; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	58	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77460	10.1371/journal.pone.0077460	http://dx.doi.org/10.1371/journal.pone.0077460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146999	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000326019400110
J	Beranger, R; Le Cornet, C; Schuz, J; Fervers, B				Beranger, Remi; Le Cornet, Charlotte; Schuez, Joachim; Fervers, Beatrice			Occupational and Environmental Exposures Associated with Testicular Germ Cell Tumours: Systematic Review of Prenatal and Life-Long Exposures	PLOS ONE			English	Review							PAPER-MILL WORKERS; US-AIR-FORCE; CANCER INCIDENCE; PESTICIDE APPLICATORS; DYSGENESIS SYNDROME; PROGRAMMING WINDOW; SWEDISH PULP; RISK; TESTIS; MEN	Background: Testicular germ cell tumours (TGCT) are the most common cancers in men aged between 15 and 44 years and the incidence has increased steeply over the past 30 years. The rapid increase in the incidence, the spatial variation and the evolution of incidence in migrants suggest that environmental risk factors play a role in TGCT aetiology. The purpose of our review is to summarise the current state of knowledge on occupational and environmental factors thought to be associated with TGCT. Methods: A systematic literature search of PubMed. All selected articles were quality appraised by two independent researchers using the 'Newcastle-Ottawa Quality Assessment Scale'. Results: After exclusion of duplicate reports, 72 relevant articles were selected; 65 assessed exposure in adulthood, 7 assessed parental exposures and 2 assessed both. Associations with occupation was reported for agricultural workers, construction workers, firemen, policemen, military personnel, as well as workers in paper, plastic or metal industries. Electromagnetic fields, PCBs and pesticides were also suggested. However, results were inconsistent and studies showing positive associations tended to had lower quality ranking using the assessment scale (p=0.02). Discussion: Current evidence does not allow concluding on existence of any clear association between TGCT and adulthood occupational or environmental exposure. The limitations of the studies may partly explain the inconsistencies observed. The lack of association with adulthood exposure is in line with current hypotheses supporting the prenatal origin of TGCT. Future research should focus on prenatal or early life exposure, as well as combined effect of prenatal and later life exposure. National and international collaborative studies should allow for more adequately powered epidemiological studies. More sophisticated methods for assessing exposure as well as evaluating gene-environment interactions will be necessary to establish clear conclusion.	[Beranger, Remi; Le Cornet, Charlotte; Fervers, Beatrice] Ctr Leon Berard, Unite Canc & Environm, F-69373 Lyon, France; [Beranger, Remi; Le Cornet, Charlotte; Schuez, Joachim] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon, France; [Beranger, Remi] Univ Lyon 1, F-69365 Lyon, France	UNICANCER; Centre Leon Berard; World Health Organization; International Agency for Research on Cancer (IARC); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Beranger, R (corresponding author), Ctr Leon Berard, Unite Canc & Environm, F-69373 Lyon, France.	r.beranger26@gmail.com	Béranger, Rémi/H-6339-2016; Fervers, Béatrice/AAD-1847-2022	Béranger, Rémi/0000-0002-6608-8020; Fervers, Béatrice/0000-0003-3498-6499	Rhone-Alpes region [12 008645 01]; French national cancer institute [2010-372]; Canceropole CLARA	Rhone-Alpes region(Region Auvergne-Rhone-Alpes); French national cancer institute(Institut National du Cancer (INCA) France); Canceropole CLARA	RB recived a doctoral grant from the Rhone-Alpes region (grant no 12 008645 01; http://www.arc.rhonealpes.fr/). The authors received a grant from the French national cancer institute (grant no 2010-372; http://www.e-cancer.fr/en). The authors also received a grant from the 'Canceropole CLARA' (no grant number; http://www.canceropole-clara.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akre O, 2009, HUM REPROD, V24, P2053, DOI 10.1093/humrep/dep174; Alavanja MCR, 2005, SCAND J WORK ENV HEA, V31, P39; Andersson E, 2003, AM J IND MED, V43, P642, DOI 10.1002/ajim.10223; Andersson E, 2013, INT ARCH OCC ENV HEA, V86, P529, DOI 10.1007/s00420-012-0785-1; Band PR, 2001, SCAND J WORK ENV HEA, V27, P113, DOI 10.5271/sjweh.597; Bates MN, 2007, AM J IND MED, V50, P339, DOI 10.1002/ajim.20446; Bates MN, 2001, AM J IND MED, V40, P263, DOI 10.1002/ajim.1097; Baumgardt-Elms C, 2005, INT ARCH OCC ENV HEA, V78, P20, DOI 10.1007/s00420-004-0550-1; Baumgardt-Elms C, 2002, CANCER CAUSE CONTROL, V13, P895, DOI 10.1023/A:1021999000651; Behrens T, 2012, OCCUP ENVIRON MED, V69, P224, DOI 10.1136/oemed-2011-100070; Biggs ML, 2008, CANCER EPIDEM BIOMAR, V17, P2012, DOI 10.1158/1055-9965.EPI-08-0032; Bullman Tim A., 1994, Annals of Epidemiology, V4, P11; Chia VM, 2010, INT J ANDROL, V33, P588, DOI 10.1111/j.1365-2605.2009.00975.x; Cohn BA, 2010, ARCH ENVIRON OCCUP H, V65, P127, DOI 10.1080/19338241003730887; Dalgaard MD, 2012, J MED GENET, V49, P58, DOI 10.1136/jmedgenet-2011-100174; DAVIS RL, 1993, AM J IND MED, V24, P231, DOI 10.1002/ajim.4700240209; Dement J, 2003, J OCCUP ENVIRON MED, V45, P1059, DOI 10.1097/01.jom.0000085892.01486.6a; Dich J, 1996, SCAND J WORK ENV HEA, V22, P66, DOI 10.5271/sjweh.112; Eble JN, 2004, TUMOURS URINARY SYST; Feldman DR, 2008, JAMA-J AM MED ASSOC, V299, P672, DOI 10.1001/jama.299.6.672; Finkelstein MM, 1998, AM J IND MED, V34, P157, DOI 10.1002/(SICI)1097-0274(199808)34:2<157::AID-AJIM8>3.0.CO;2-U; Fleming LE, 1999, J OCCUP ENVIRON MED, V41, P279, DOI 10.1097/00043764-199904000-00010; Floderus B, 1999, CANCER CAUSE CONTROL, V10, P323, DOI 10.1023/A:1008953920877; FOLEY S, 1995, BRIT J UROL, V76, P495, DOI 10.1111/j.1464-410X.1995.tb07755.x; Frost G, 2011, OCCUP MED-OXFORD, V61, P303, DOI 10.1093/occmed/kqr067; Garner M, 2008, J TOXICOL ENV HEAL B, V11, P260, DOI 10.1080/10937400701873696; Garner MJ, 2005, INT J CANCER, V116, P331, DOI 10.1002/ijc.21032; Giannandrea F, 2011, J ENVIRON SCI HEAL B, V46, P780, DOI 10.1080/03601234.2012.597704; Giles G, 1993, Health Rep, V5, P33; Grayson JK, 1996, AVIAT SPACE ENVIR MD, V67, P101; Guo J, 2005, CANCER CAUSE CONTROL, V16, P97, DOI 10.1007/s10552-004-2236-0; Guo J, 2004, INT J CANCER, V111, P286, DOI 10.1002/ijc.20263; Gustavsson P, 2004, OCCUP ENVIRON MED, V61, P171, DOI 10.1136/oem.2002.005538; Hansen J, 1999, INT J CANCER, V82, P911, DOI 10.1002/(SICI)1097-0215(19990909)82:6<911::AID-IJC23>3.0.CO;2-O; Hansen KS, 1996, AM J IND MED, V30, P373, DOI 10.1002/(SICI)1097-0274(199610)30:4<373::AID-AJIM1>3.0.CO;2-X; Hardell L, 2006, INT J ANDROL, V29, P228, DOI 10.1111/j.1365-2605.2005.00622.x; Hardell L, 2004, INT J CANCER, V109, P425, DOI 10.1002/ijc.11709; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P982, DOI 10.1016/j.jclinepi.2013.03.003; HAYES RB, 1990, INT J EPIDEMIOL, V19, P825, DOI 10.1093/ije/19.4.825; Helmfrid I, 2012, ENVIRON INT, V44, P53, DOI 10.1016/j.envint.2012.01.009; Hemminki K, 2002, EUR J CANCER, V38, P2428, DOI 10.1016/S0959-8049(02)00496-3; Hobbesland A, 1999, OCCUP ENVIRON MED, V56, P625, DOI 10.1136/oem.56.9.625; Joffe M., 2011, REPROD ADAPTATION TO, P17; KARDAUN JWPF, 1991, AM J IND MED, V20, P219, DOI 10.1002/ajim.4700200208; Kelleher C, 1998, J EPIDEMIOL COMMUN H, V52, P651, DOI 10.1136/jech.52.10.651; Knight JA, 1997, J OCCUP ENVIRON MED, V39, P333, DOI 10.1097/00043764-199704000-00011; Knight JA, 1996, J OCCUP ENVIRON MED, V38, P884, DOI 10.1097/00043764-199609000-00010; Knoke JD, 1998, EPIDEMIOLOGY, V9, P648, DOI 10.1097/00001648-199811000-00015; Koifman Sergio, 2002, Cad. Saúde Pública, V18, P435, DOI 10.1590/S0102-311X2002000200008; Kristensen P, 2000, SCAND J WORK ENV HEA, V26, P331, DOI 10.5271/sjweh.550; Kristensen P, 1996, CANCER EPIDEM BIOMAR, V5, P3; Langard S, 2000, OCCUP ENVIRON MED, V57, P65, DOI 10.1136/oem.57.1.65; Ma FC, 2006, J OCCUP ENVIRON MED, V48, P883, DOI 10.1097/01.jom.0000235862.12518.04; Marsa K, 2008, EUR J CANCER, V44, P2018, DOI 10.1016/j.ejca.2008.06.012; MARSHALL EG, 1990, INT J EPIDEMIOL, V19, P269, DOI 10.1093/ije/19.2.269; McGlynn KA, 2008, JNCI-J NATL CANCER I, V100, P663, DOI 10.1093/jnci/djn101; McGlynn KA, 2012, NAT REV UROL, V9, P339, DOI 10.1038/nrurol.2012.61; McGlynn KA, 2009, FUTURE ONCOL, V5, P1389, DOI [10.2217/fon.09.116, 10.2217/FON.09.116]; McGlynn KA, 2009, CANCER RES, V69, P1901, DOI 10.1158/0008-5472.CAN-08-3935; Meyts ERD, 2007, ANN NY ACAD SCI, V1120, P168, DOI 10.1196/annals.1411.013; Milanov L, 1999, AVIAT SPACE ENVIR MD, V70, P681; Mills PK, 1998, ARCH ENVIRON HEALTH, V53, P410, DOI 10.1080/00039899809605729; MILLS PK, 1984, LANCET, V1, P207; Moller H, 1997, CANCER EPIDEM BIOMAR, V6, P141; Myrup C, 2008, JNCI-J NATL CANCER I, V100, P41, DOI 10.1093/jnci/djm276; Nori F, 2006, ARCH ENVIRON OCCUP H, V61, P87, DOI 10.3200/AEOH.61.2.87-95; Ohlson CG, 2000, CHEMOSPHERE, V40, P1277, DOI 10.1016/S0045-6535(99)00380-X; Pollan M, 2001, ANN EPIDEMIOL, V11, P554, DOI 10.1016/S1047-2797(01)00234-4; Provost D, 2007, OCCUP ENVIRON MED, V64, P509, DOI 10.1136/oem.2006.028100; Purdue MP, 2009, ENVIRON HEALTH PERSP, V117, P1514, DOI 10.1289/ehp.0800359; Purdue MP, 2005, INT J CANCER, V115, P822, DOI 10.1002/ijc.20931; Rajpert-De Meyts E, 2006, HUM REPROD UPDATE, V12, P303, DOI 10.1093/humupd/dmk006; RHOMBERG W, 1995, AM J IND MED, V28, P79, DOI 10.1002/ajim.4700280107; Rix BA, 1998, J OCCUP ENVIRON MED, V40, P55, DOI 10.1097/00043764-199801000-00011; Rodvall Y, 2003, OCCUP ENVIRON MED, V60, P798, DOI 10.1136/oem.60.10.798; Ryder S J, 1997, J R Nav Med Serv, V83, P130; Sarfati D, 2011, INT J CANCER, V128, P1683, DOI 10.1002/ijc.25486; Schmiedel S, 2010, J UROLOGY, V183, P1378, DOI 10.1016/j.juro.2009.12.058; Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413; Shah MN, 2007, INT J ANDROL, V30, P206, DOI 10.1111/j.1365-2605.2007.00795.x; Sharpe RM, 2008, TOXICOL SCI, V105, P1, DOI 10.1093/toxsci/kfn123; Sigurdson AJ, 2003, CANCER-AM CANCER SOC, V97, P3080, DOI 10.1002/cncr.11444; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Sonneveld DJA, 1999, BRIT J CANCER, V81, P1262, DOI 10.1038/sj.bjc.6690839; Stang A, 2003, AM J IND MED, V43, P291, DOI 10.1002/ajim.10178; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stenlund C, 1997, CANCER CAUSE CONTROL, V8, P184, DOI 10.1023/A:1018468112964; Sulem P, 2003, SCAND J WORK ENV HEA, V29, P100, DOI 10.5271/sjweh.711; SWERDLOW AJ, 1991, BRIT J IND MED, V48, P670; TARONE RE, 1991, J NATL CANCER I, V83, P1497, DOI 10.1093/jnci/83.20.1497; Teschke K, 2002, OCCUP ENVIRON MED, V59, P575, DOI 10.1136/oem.59.9.575; TYNES T, 1992, AM J EPIDEMIOL, V136, P81, DOI 10.1093/oxfordjournals.aje.a116423; VANDENEEDEN SK, 1991, AM J IND MED, V19, P327; Walschaerts M, 2007, INT J ANDROL, V30, P222, DOI 10.1111/j.1365-2605.2007.00805.x; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Yamane GK, 2003, AVIAT SPACE ENVIR MD, V74, P846; Yamane GK, 2006, AVIAT SPACE ENVIR MD, V77, P789; ZANDJANI F, 1994, INT ARCH OCC ENV HEA, V66, P189, DOI 10.1007/BF00380779; ZHANG ZF, 1995, ARCH ENVIRON HEALTH, V50, P13, DOI 10.1080/00039896.1995.9955007	99	29	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77130	10.1371/journal.pone.0077130	http://dx.doi.org/10.1371/journal.pone.0077130			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155923	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300057
J	Giakoumi, S; Sini, M; Gerovasileiou, V; Mazor, T; Beher, J; Possingham, HP; Abdulla, A; Cinar, ME; Dendrinos, P; Gucu, AC; Karamanlidis, AA; Rodic, P; Panayotidis, P; Taskin, E; Jaklin, A; Voultsiadou, E; Webster, C; Zenetos, A; Katsanevakis, S				Giakoumi, Sylvaine; Sini, Maria; Gerovasileiou, Vasilis; Mazor, Tessa; Beher, Jutta; Possingham, Hugh P.; Abdulla, Ameer; Cinar, Melih Ertan; Dendrinos, Panagiotis; Gucu, Ali Cemal; Karamanlidis, Alexandros A.; Rodic, Petra; Panayotidis, Panayotis; Taskin, Ergun; Jaklin, Andrej; Voultsiadou, Eleni; Webster, Chloe; Zenetos, Argyro; Katsanevakis, Stelios			Ecoregion-Based Conservation Planning in the Mediterranean: Dealing with Large-Scale Heterogeneity	PLOS ONE			English	Article							MARINE PROTECTED AREAS; POSIDONIA-OCEANICA MEADOWS; FISH ASSEMBLAGES; CORALLIGENOUS ASSEMBLAGES; PARAMURICEA-CLAVATA; TRADE-OFFS; SEA; SEAGRASS; COASTAL; BIODIVERSITY	Spatial priorities for the conservation of three key Mediterranean habitats, i.e. seagrass Posidonia oceanica meadows, coralligenous formations, and marine caves, were determined through a systematic planning approach. Available information on the distribution of these habitats across the entire Mediterranean Sea was compiled to produce basin-scale distribution maps. Conservation targets for each habitat type were set according to European Union guidelines. Surrogates were used to estimate the spatial variation of opportunity cost for commercial, non-commercial fishing, and aquaculture. Marxan conservation planning software was used to evaluate the comparative utility of two planning scenarios: (a) a whole-basin scenario, referring to selection of priority areas across the whole Mediterranean Sea, and (b) an ecoregional scenario, in which priority areas were selected within eight predefined ecoregions. Although both scenarios required approximately the same total area to be protected in order to achieve conservation targets, the opportunity cost differed between them. The whole-basin scenario yielded a lower opportunity cost, but the Alboran Sea ecoregion was not represented and priority areas were predominantly located in the Ionian, Aegean, and Adriatic Seas. In comparison, the ecoregional scenario resulted in a higher representation of ecoregions and a more even distribution of priority areas, albeit with a higher opportunity cost. We suggest that planning at the ecoregional level ensures better representativeness of the selected conservation features and adequate protection of species, functional, and genetic diversity across the basin. While there are several initiatives that identify priority areas in the Mediterranean Sea, our approach is novel as it combines three issues: (a) it is based on the distribution of habitats and not species, which was rarely the case in previous efforts, (b) it considers spatial variability of cost throughout this socioeconomically heterogeneous basin, and (c) it adopts ecoregions as the most appropriate level for large-scale planning.	[Giakoumi, Sylvaine; Zenetos, Argyro] Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Ag Kosmas, Greece; [Giakoumi, Sylvaine; Mazor, Tessa; Beher, Jutta; Possingham, Hugh P.; Abdulla, Ameer] Univ Queensland, Sch Biol Sci, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia; [Sini, Maria] Univ Aegean, Dept Marine Sci, Mitilini, Lesvos Island, Greece; [Gerovasileiou, Vasilis; Voultsiadou, Eleni] Aristotle Univ Thessaloniki, Sch Biol, Dept Zool, GR-54006 Thessaloniki, Greece; [Abdulla, Ameer] UNEP World Conservat Monitoring Ctr, Cambridge, England; [Cinar, Melih Ertan] Ege Univ, Fac Fisheries, Dept Hydrobiol, Izmir, Turkey; [Dendrinos, Panagiotis; Karamanlidis, Alexandros A.] MOm Hellen Soc Study & Protect Monk Seal, Athens, Greece; [Gucu, Ali Cemal] Middle E Tech Univ, Inst Marine Sci, Erdemli, Mersin, Turkey; [Rodic, Petra] State Inst Nat Protect, Zagreb, Croatia; [Panayotidis, Panayotis] Hellen Ctr Marine Res, Inst Oceanog, Anavyssos, Greece; [Taskin, Ergun] Celal Bayar Univ, Fac Arts & Sci, Dept Biol, Manisa, Turkey; [Jaklin, Andrej] Rudjer Boskovic Inst Zagreb, Ctr Marine Res Rovinj, Zagreb, Croatia; [Webster, Chloe] Network Managers Marine Protected Areas Mediterra, MedPAN, Marseille, France; [Katsanevakis, Stelios] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Water Resources Unit, I-21020 Ispra, Italy	Hellenic Centre for Marine Research; University of Queensland; University of Aegean; Aristotle University of Thessaloniki; Ege University; Middle East Technical University; Hellenic Centre for Marine Research; Celal Bayar University; University of Zagreb; European Commission Joint Research Centre; EC JRC ISPRA Site	Giakoumi, S (corresponding author), Hellen Ctr Marine Res, Inst Marine Biol Resources & Inland Waters, Ag Kosmas, Greece.	sylvaine@aegean.gr	Possingham, Hugh/B-1337-2008; Gerovasileiou, Vasilis/H-6376-2019; TASKIN, ERGUN/C-3828-2014; Katsanevakis, Stelios/AGR-7012-2022; beher, jutta/AAQ-5350-2020; GUCU, Ali Cemal/ABI-4301-2020; Giakoumi, Sylvaine/I-2702-2014; Katsanevakis, Stelios/AAD-8289-2020; Gücü, Ali/ABA-3135-2020; TASKIN, ERGUN/AAE-3163-2020; Karamanlidis, Alexandros/S-8239-2017; Zenetos, Argyro/AAS-3208-2020; POSSINGHAM, HUGH/R-8310-2019; Mazor, Tessa/G-2017-2012; Voultsiadou, Eleni/P-9890-2017; CINAR, Melih Ertan/H-3737-2013	Possingham, Hugh/0000-0001-7755-996X; Gerovasileiou, Vasilis/0000-0002-9143-7480; Katsanevakis, Stelios/0000-0002-5137-7540; beher, jutta/0000-0003-2119-0440; GUCU, Ali Cemal/0000-0001-9727-5358; TASKIN, ERGUN/0000-0003-0531-4546; Karamanlidis, Alexandros/0000-0003-0943-1619; POSSINGHAM, HUGH/0000-0001-7755-996X; Mazor, Tessa/0000-0001-7307-5693; Voultsiadou, Eleni/0000-0003-3429-6754; Giakoumi, Sylvaine/0000-0002-3301-5538; SINI, MARIA/0000-0002-9608-3503; CINAR, Melih Ertan/0000-0002-1802-2801	European Social Fund (ESF); Greek State	European Social Fund (ESF)(European Social Fund (ESF)); Greek State	This work is a contribution of the project "NETMED" implemented within the framework of the Action "Supporting Postdoctoral Researchers" of the Operational Program "Education and Lifelong Learning" (Action's Beneficiary: General Secretariat for Research and Technology), and is co-financed by the European Social Fund (ESF) and the Greek State. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbiati M, 2009, P 1 S CONS COR BIOC, P269; Abdulahi A., 2008, Safflower: unexploited potential and world adaptability. 7th International Safflower Conference, Wagga Wagga, New South Wales, Australia, 3-6 November, 2008., P1; Abdulla A, 2009, ICES J MAR SCI, V66, P22, DOI 10.1093/icesjms/fsn164; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Annoni A, 2001, 20120 EUR EUR COMM; [Anonymous], 2009, BUILDINGS CLIMATE CH, P1; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ballesteros E., 2003, CORALLIGENOUS MEDITE, P1; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Ban NC, 2009, MAR POLICY, V33, P794, DOI 10.1016/j.marpol.2009.02.011; Barr LM, 2013, MAR POLICY, V42, P39, DOI 10.1016/j.marpol.2013.01.012; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; Beck MW, 2001, AQUAT CONSERV, V11, P235, DOI 10.1002/aqc.449; Beger M, 2010, CONSERV LETT, V3, P359, DOI 10.1111/j.1755-263X.2010.00123.x; Bianchi Carlo Nike, 2010, Travaux Scientifiques du Parc National de Port-Cros, V24, P39; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Bonacorsi M, 2013, MEDITERR MAR SCI, V14, P193, DOI 10.12681/mms.334; Boudouresque C.-F, 2004, TRAV SCI PARC NATL P, V20, P97; Boudouresque C.F., 2012, RAMOGE PUBLICATION, P1, DOI DOI 10.1007/S10750-015-2333-Y; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; Bussoletti E, 2010, P INT WORKSH RED COR, P1; Cebrian E, 2012, BIOL INVASIONS, V14, P2647, DOI 10.1007/s10530-012-0261-6; Celebi B., 2006, BIOL MARINA MEDITERR, V13, P34; Cerrano C, 2001, MEDITERRANEAN ECOSYSTEMS: STRUCTURES AND PROCESSES, P235; Chevaldonne P, 2003, ECOL LETT, V6, P371, DOI 10.1046/j.1461-0248.2003.00439.x; Cicogna F., 2003, GROTTE MARINE CINQUA, P1; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Conides A., 2007, STATE HELLENIC FISHE, P172; CREOCEAN-DREAL, 2010, REC GROTT SUBM SEM L, P1; Dendrinos P, 2007, MAR MAMMAL SCI, V23, P615, DOI 10.1111/j.1748-7692.2007.00121.x; Doerries MB, 2003, DEEP-SEA RES PT I, V50, P749, DOI 10.1016/S0967-0637(03)00052-9; European Commission, 2008, EUR STAT FOC AGR FIS; FAO, 2011, GFCM TASK 1 STAT B 2, V2008; FAO, 2010, GLOB EUR PRIC REP; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Francour P, 2006, MANAGEMENT GUIDE MAR; Fraschetti S, 2009, MAR ECOL PROG SER, V375, P13, DOI 10.3354/meps07781; Fraschetti S, 2008, J EXP MAR BIOL ECOL, V366, P109, DOI 10.1016/j.jembe.2008.07.015; Gabrie C, 2012, STATUT AIRES MARINES, P1; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Garrabou J, 2000, EUR J PHYCOL, V35, P1; Gaudin C, 2007, STUDIES REV, P1; Gerovasileiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039873; Giakoumi S, 2012, AQUAT CONSERV, V22, P762, DOI 10.1002/aqc.2273; Giakoumi S, 2012, REV FISH BIOL FISHER, V22, P943, DOI 10.1007/s11160-012-9272-8; Giakoumi S, 2011, BIOL CONSERV, V144, P753, DOI 10.1016/j.biocon.2010.11.006; Gili JM, 1998, TRENDS ECOL EVOL, V13, P316, DOI 10.1016/S0169-5347(98)01365-2; Guarnieri G, 2012, MAR BIOL, V159, P1155, DOI 10.1007/s00227-012-1895-8; Halpern BS, 2013, P NATL ACAD SCI USA, V110, P6229, DOI 10.1073/pnas.1217689110; Harmelin J.-G., 1985, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V29, P149; Harmelin JG, 1997, VIE MILIEU, V47, P351; HARMELIN JG, 1985, TETHYS, V11, P214; ICES CM, 2008, 1 RES PIL SURV RECR, P15; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Kalogirou S, 2010, J FISH BIOL, V77, P2338, DOI 10.1111/j.1095-8649.2010.02817.x; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Katsanevakis S, 2011, OCEAN COAST MANAGE, V54, P807, DOI 10.1016/j.ocecoaman.2011.09.002; Lejeusne C, 2006, MOL ECOL, V15, P4123, DOI 10.1111/j.1365-294X.2006.03101.x; Lejeusne C, 2010, TRENDS ECOL EVOL, V25, P250, DOI 10.1016/j.tree.2009.10.009; Liquete C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067737; Lleonart J, 2003, SCI MAR, V67, P37, DOI 10.3989/scimar.2003.67s137; Lourie SA, 2004, CONSERV BIOL, V18, P1004, DOI 10.1111/j.1523-1739.2004.00137.x; Luna B, 2009, ICES J MAR SCI, V66, P517, DOI 10.1093/icesjms/fsp020; Maiorano L, 2009, ICES J MAR SCI, V66, P137, DOI 10.1093/icesjms/fsn148; Maldonado M, 2013, MAR ECOL PROG SER, V479, P127, DOI 10.3354/meps10172; MAPAMED, 2013, DAT MED MAR PROT AR; Marba N, 2002, ENVIRON CONSERV, V29, P509, DOI 10.1017/S037689290200036X; Mazor T, 2013, DIVERS DISTRIB, V19, P1380, DOI 10.1111/ddi.12095; McArthur MA, 2010, ESTUAR COAST SHELF S, V88, P21, DOI 10.1016/j.ecss.2010.03.003; Medio D, 1997, BIOL CONSERV, V79, P91, DOI 10.1016/S0006-3207(96)00074-2; Micheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059038; Milazzo M, 2002, MAR ECOL-P S Z N I, V23, P280, DOI 10.1111/j.1439-0485.2002.tb00026.x; Mokhtar-Jamai K, 2011, MOL ECOL, V20, P3291, DOI 10.1111/j.1365-294X.2011.05176.x; MOm, 2009, ANN TECHN REP 2008 S, P1; Montefalcone M, 2007, MAR POLLUT BULL, V54, P206, DOI 10.1016/j.marpolbul.2006.10.005; Montefalcone M, 2009, MAR POLLUT BULL, V58, P515, DOI 10.1016/j.marpolbul.2008.12.001; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; Moranta J, 2006, ESTUAR COAST SHELF S, V68, P579, DOI 10.1016/j.ecss.2006.03.008; Mouillot D, 2011, CURR BIOL, V21, P1044, DOI 10.1016/j.cub.2011.05.005; Muricy G, 1996, MAR ECOL PROG SER, V138, P181, DOI 10.3354/meps138181; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Notarbartolo diSciara G, 2010, OVERVIEW SCI FINDING; OCEANA, 2008, EST BION CABR EST BI, P1; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pergent G., 2012, MEDITERRANEAN SEAGRA; Piazzi L, 2005, ESTUAR COAST SHELF S, V64, P467, DOI 10.1016/j.ecss.2005.03.010; Piazzi L, 2012, MAR POLLUT BULL, V64, P2623, DOI 10.1016/j.marpolbul.2012.07.027; Portman ME, 2013, MAR POLICY, V42, P270, DOI 10.1016/j.marpol.2013.03.004; Richardson EA, 2006, CONSERV BIOL, V20, P1191, DOI 10.1111/j.1523-1739.2006.00426.x; Riedl R., 1966, BIOL MEERESHOHLEN, P1; Romero J, 2007, MAR POLLUT BULL, V55, P196, DOI 10.1016/j.marpolbul.2006.08.032; Rovere A, 2011, AQUAT CONSERV, V21, P541, DOI 10.1002/aqc.1214; Salomidi M, 2012, MEDITERR MAR SCI, V13, P49, DOI 10.12681/mms.23; Sartoretto S, 1997, J MAR BIOL ASSOC UK, V77, P565, DOI 10.1017/S0025315400071885; SPA/BD, 1995, BARC CONV BARC 9 10; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spalding MD, 2012, OCEAN COAST MANAGE, V60, P19, DOI 10.1016/j.ocecoaman.2011.12.016; Stewart IS, 2009, COASTAL GEOMORPHOLOG, P385; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Suric M, 2010, ENVIRON EARTH SCI, V61, P1473, DOI 10.1007/s12665-010-0463-0; Teixido N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053742; Teixido N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023744; Trujillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030546; Tulloch VJ, BIOL CONSER IN PRESS, V162, P41; Unal V, 2010, MEDITERR MAR SCI, V11, P315, DOI 10.12681/mms.79; UNEP-MAP-RAC/SPA, 2008, ACTION PLAN CONSERVA, P1; UNEP-MAP-RAC/SPA, PROP MIS PL IN PRESS, P1; VACELET J, 1994, DEEP-SEA RES PT I, V41, P965, DOI 10.1016/0967-0637(94)90013-2; Voultsiadou E, 2009, HYDROBIOLOGIA, V628, P1, DOI 10.1007/s10750-009-9725-9; Ward TJ, 1999, ECOL APPL, V9, P691; Watling L, 2013, PROG OCEANOGR, V111, P91, DOI 10.1016/j.pocean.2012.11.003; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Zenetos A, 2012, MEDITERR MAR SCI, V13, P328, DOI 10.12681/mms.327	119	130	132	5	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76449	10.1371/journal.pone.0076449	http://dx.doi.org/10.1371/journal.pone.0076449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155901	Green Published, gold			2022-12-27	WOS:000325887300035
J	Hughes, CM; Damon, IK; Reynolds, MG				Hughes, Christine M.; Damon, Inger K.; Reynolds, Mary G.			Understanding US Healthcare Providers' Practices and Experiences with Molluscum Contagiosum	PLOS ONE			English	Article							PULSED DYE-LASER; EPIDEMIOLOGY; INFECTION; CHILDREN	Introduction: Molluscum contagiosum is a common superficial skin infection caused by the poxvirus, Molluscum Contagiosum virus. The study objective is to obtain a better understanding of physician practices and experiences with molluscum contagiosum in order to focus informational and guidance material. Methods: A cross-sectional survey to assess medical practitioners' knowledge and practices with molluscum contagiosum was conducted using the 2009 DocStyles survey. Questions regarding category and number of molluscum contagiosum patients seen, treatments used and advice given to patients were included in the survey. Results: Dermatologists saw the most cases, with the majority seeing 51-100 molluscum contagiosum cases/year. The most common cases seen were children with multiple lesions and adults with genital lesions. Respondents were most likely to recommend treatment to immunocompromised individuals, HIV patients, adults with genital lesions and children with multiple lesions. Cryotherapy was the top choice for all specialties with the exception of OB/GYNs, whose top choice was curettage. "Avoid intimate contact until lesions resolve'', "Avoid touching lesions to reduce further spread'', and "Don't be concerned, this will go away'' were the top advice choices. Discussion: Most survey respondents have dealt with molluscum contagiosum in their practice during the previous year. Overall, respondents picked appropriate choices for treatment and advice given; however some ineffective or unnecessary treatments were chosen and recommendations to prevent spread were chosen infrequently. Knowledge gaps for appropriate transmission precaution advice might cause unnecessary spread or autoinoculation. This survey has demonstrated that molluscum contagiosum is a common infection seen by many types of practitioners and therefore guidance on treatment considerations and infection control is valuable.	[Hughes, Christine M.; Damon, Inger K.; Reynolds, Mary G.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Poxvirus & Rabies Branch, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Hughes, CM (corresponding author), Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Poxvirus & Rabies Branch, Atlanta, GA 30329 USA.	christine.hughes@cdc.hhs.gov		Reynolds, Mary/0000-0001-7882-4614	U.S. federal government - Centers for Disease Control and Prevention (CDC)	U.S. federal government - Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	U.S. federal government - Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER MW, 1984, BRIT MED J, V288, P213, DOI 10.1136/bmj.288.6412.213; BECKER TM, 1986, SEX TRANSM DIS, V13, P88, DOI 10.1097/00007435-198604000-00007; Berger EM, 2012, ARCH DERMATOL, V20, P1; Binder B, 2008, J DTSCH DERMATOL GES, V6, P121, DOI 10.1111/j.1610-0387.2007.06556.x; Braue A, 2005, PEDIATR DERMATOL, V22, P287, DOI 10.1111/j.1525-1470.2005.22401.x; Brown T, 2005, J AM ACAD DERMATOL, V52, P715, DOI 10.1016/j.jaad.2004.10.861; Campanelli Alexandre, 2005, J Am Acad Dermatol, V52, pE1, DOI 10.1016/j.jaad.2004.10.858; CASTILLA MT, 1995, DERMATOLOGY, V191, P165, DOI 10.1159/000246540; Choong K Y, 1999, Australas J Dermatol, V40, P89, DOI 10.1046/j.1440-0960.1999.00327.x; Cohen JI, 2012, J INFECT DIS, V205, P794, DOI 10.1093/infdis/jir853; Coloe J, 2009, PEDIATR ANN, V38, P321, DOI 10.3928/00904481-20090513-01; Coloe J, 2009, PEDIATR DERMATOL, V26, P405, DOI 10.1111/j.1525-1470.2008.00860.x; COTTON DWK, 1987, BRIT J DERMATOL, V116, P871, DOI 10.1111/j.1365-2133.1987.tb04908.x; Dohil MA, 2006, J AM ACAD DERMATOL, V54, P47, DOI 10.1016/j.jaad.2005.08.035; Hancox JG, 2003, CUTIS, V71, P414; Hanna D, 2006, PEDIATR DERMATOL, V23, P574, DOI 10.1111/j.1525-1470.2006.00313.x; Hayashida S, 2010, J DERMATOL SCI, V60, P173, DOI 10.1016/j.jdermsci.2010.09.003; HUGHES WT, 1991, PEDIATR INFECT DIS J, V10, P152, DOI 10.1097/00006454-199102000-00015; Lee B, 2004, J AM ACAD DERMATOL, V51, P478, DOI 10.1016/j.jaad.2003.12.047; Medicis Pharmaceutical Corporation, PACK INS ZYCL IM CRE; Mosher JS, 2012, PEDIATRICS, V129, pE519, DOI 10.1542/peds.2011-0936; NIIZEKI K, 1984, DERMATOLOGICA, V169, P197, DOI 10.1159/000249604; Pannell RS, 2005, EPIDEMIOL INFECT, V133, P985, DOI 10.1017/S0950268805004425; Pickering LK, 2012, RED BOOK 2012 REPORT, P511; Reynolds MG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005255; Rich JD, 1999, CLIN INFECT DIS, V28, P1171, DOI 10.1086/517770; SCHWARTZ JJ, 1992, J AM ACAD DERMATOL, V27, P583, DOI 10.1016/0190-9622(92)70226-6; Villa L, 2010, SEX TRANSM DIS, V37, P423, DOI 10.1097/OLQ.0b013e3181cfca1c	28	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76948	10.1371/journal.pone.0076948	http://dx.doi.org/10.1371/journal.pone.0076948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155912	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300046
J	Nandakumar, KV; Duraisamy, K; Balakrishnan, S; Sunilkumar, M; Sankar, SJ; Sagili, KD; Satyanarayana, S; Kumar, MVA; Enarson, DA				Nandakumar, K., V; Duraisamy, Karthickeyan; Balakrishnan, Shibu; Sunilkumar, M.; Sankar, Jaya S.; Sagili, Karuna D.; Satyanarayana, Srinath; Kumar, Ajay M., V; Enarson, Donald A.			Outcome of Tuberculosis Treatment in Patients with Diabetes Mellitus Treated in the Revised National Tuberculosis Control Programme in Malappuram District, Kerala, India	PLOS ONE			English	Article							IMPACT	Settings: Kerala State, India has reported the greatest dual burden of Tuberculosis (TB) and Diabetes Mellitus (DM). Malappuram district in Kerala has monitored and recorded DM status and its control from 2010 under Revised National Tuberculosis Control Program (RNTCP). Objectives: To assess, under programme conditions, comprehensiveness of recording DM status among TB cases and the TB treatment outcomes among DM patients (disaggregated by glycemic control) and compare with-non DM patients. Design: This retrospective record review included 3,116TB patients from April 2010 to September 2011. DM was defined as per international guidelines and TB treatment outcomes were categorized as favourable(cured and treatment completed) and unfavourable(death, default, failure and transfer out). Relative Risk (RR) and 95% confidence intervals(CI) were calculated to assess the risk of unfavourable outcomes. Results: DM status was recorded in 90% of TB cases and 667 (24%) had DM. 17% of DM patients and 23% of patients with unknown DM status had unfavourable outcomes but this difference was not statistically significant. Unadjusted RR for poor glycemic control or unknown control status for unfavourable outcome were (2.00; 95% CI 0.97-4.13) and (2.14; 95% CI 1.11-4.13). Conclusion: This study could not confirm an adverse association between DM or its control during treatment and the course of response to TB treatment. DM screening in TB cases and recording of DM care needs to be improved to enable more conclusive evidence.	[Nandakumar, K., V] Dist TB Ctr, Manjeri, Kerala, India; [Duraisamy, Karthickeyan; Balakrishnan, Shibu] WHO Country Off India, Dept TB, New Delhi, India; [Sunilkumar, M.] State TB Training & Demonstrat Ctr, Trivandrum, Kerala, India; [Sankar, Jaya S.] State TB Cell, Trivandrum, Kerala, India; [Sagili, Karuna D.; Satyanarayana, Srinath; Kumar, Ajay M., V] South East Asia Reg Off, Int Union TB & Lung Dis, New Delhi, India; [Enarson, Donald A.] Int Union TB & Lung Dis, Montreal, PQ, Canada		Nandakumar, KV (corresponding author), Dist TB Ctr, Manjeri, Kerala, India.	dr.nandakumar.k.v.66@gmail.com		Satyanarayana, Srinath/0000-0002-5420-2551; Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Funding for the operational research course was made possible by the support of the American People through the United States Agency for International Development (USAID). Funders had no role in study design, data collection, analysis or interpretation of data. The contents of this paper do not necessarily reflect the views of USAID or the United States Government.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Balakrishnan S, 2012, PLOS ONE, V7; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; HemalathaSuryakant, 2012, GJP ASC TECH, V02; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; International Diabetes Federation, 2011, IDF DIABETES ATLAS; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kumar A, 2013, TROP MED INT HEALTH, V18, P646, DOI 10.1111/tmi.12083; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Morrato EH, 2006, DIABETES CARE, V29, P543, DOI 10.2337/diacare.29.03.06.dc05-2165; Niaz AK, 2012, J DIABETES METABOLIC; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Restrepo BI, 2008, AM J TROP MED HYG, V79, P541, DOI 10.4269/ajtmh.2008.79.541; Sen Tiyas, 2009, J Assoc Physicians India, V57, P660; Suleiman SAS, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/645362; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; WHO, 2011, COLLABORATIVE FRAMEW; World Health Organization, 2006, DEF DIAGN DIAB MELL	26	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76275	10.1371/journal.pone.0076275	http://dx.doi.org/10.1371/journal.pone.0076275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155897	gold, Green Submitted, Green Published			2022-12-27	WOS:000325887300031
J	Wu, XY; Li, YR; Wang, JH; Wen, X; Marcus, MT; Daniels, G; Zhang, DY; Ye, F; Wang, LH; Du, XX; Adams, S; Singh, B; Zavadil, J; Lee, P; Monaco, ME				Wu, Xinyu; Li, Yirong; Wang, Jinhua; Wen, Xin; Marcus, Max T.; Daniels, Garrett; Zhang, David Y.; Ye, Fei; Wang, Ling Hang; Du, Xinxin; Adams, Sylvia; Singh, Baljit; Zavadil, Jiri; Lee, Peng; Monaco, Marie E.			Long Chain Fatty Acyl-CoA Synthetase 4 Is a Biomarker for and Mediator of Hormone Resistance in Human Breast Cancer	PLOS ONE			English	Article							ANDROGEN RECEPTOR; GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; BASAL-LIKE; IDENTIFICATION; PATHWAY; PROGNOSIS; MECHANISMS; SELECTION; EFFICACY	The purpose of this study was to determine the role of long-chain fatty acyl-CoA synthetase 4 (ACSL4) in breast cancer. Public databases were utilized to analyze the relationship between ACSL4 mRNA expression and the presence of steroid hormone and human epidermal growth factor receptor 2 (HER2) in both breast cancer cell lines and tissue samples. In addition, cell lines were utilized to assess the consequences of either increased or decreased levels of ACSL4 expression. Proliferation, migration, anchorage-independent growth and apoptosis were used as biological end points. Effects on mRNA expression and signal transduction pathways were also monitored. A meta-analysis of public gene expression databases indicated that ACSL4 expression is positively correlated with a unique subtype of triple negative breast cancer (TNBC), characterized by the absence of androgen receptor (AR) and therefore referred to as quadruple negative breast cancer (QNBC). Results of experiments in breast cancer cell lines suggest that simultaneous expression of ACSL4 and a receptor is associated with hormone resistance. Forced expression of ACSL4 in ACSL4-negative, estrogen receptor a (ER)-positive MCF-7 cells resulted in increased growth, invasion and anchorage independent growth, as well as a loss of dependence on estrogen that was accompanied by a reduction in the levels of steroid hormone receptors. Sensitivity to tamoxifen, triacsin C and etoposide was also attenuated. Similarly, when HER2-positive, ACSL4-negative, SKBr3 breast cancer cells were induced to express ACSL4, the proliferation rate increased and the apoptotic effect of lapatinib was reduced. The growth stimulatory effect of ACSL4 expression was also observed in vivo in nude mice when MCF-7 control and ACSL4-expressing cells were utilized to induce tumors. Our data strongly suggest that ACSL4 can serve as both a biomarker for, and mediator of, an aggressive breast cancer phenotype.	[Wu, Xinyu; Marcus, Max T.; Monaco, Marie E.] NYU, Sch Med, Dept Neurosci & Physiol, New York, NY USA; [Li, Yirong; Daniels, Garrett; Wang, Ling Hang; Du, Xinxin; Singh, Baljit; Zavadil, Jiri; Lee, Peng] NYU, Sch Med, Dept Pathol, New York, NY USA; [Wang, Jinhua; Wen, Xin] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Adams, Sylvia] NYU, Dept Med, Sch Med, New York, NY 10016 USA; [Wang, Jinhua; Wen, Xin; Adams, Sylvia; Singh, Baljit; Zavadil, Jiri; Lee, Peng; Monaco, Marie E.] NYU, NYU Canc Inst, Sch Med, New York, NY 10016 USA; [Wang, Jinhua; Wen, Xin] NYU, NYU Ctr Hlth Informat & Bioinformat, Sch Med, New York, NY 10016 USA; [Zhang, David Y.; Ye, Fei] Mt Sinai Sch Med, Dept Pathol, New York, NY USA; [Lee, Peng; Monaco, Marie E.] VA New York Harbor Healthcare Syst, New York, NY USA	New York University; New York University; New York University; New York University; New York University; New York University; Icahn School of Medicine at Mount Sinai	Lee, P (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY USA.	peng.lee@nyumc.org; mem6@nyu.edu	Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Adams, Sylvia/0000-0003-4737-1952	Department of Defense [W81XWH-09-1-0572]; NYU School of Medicine's Clinical and Translational Science Institute [1UL1RR029893]; New York University Molecular Oncology and Immunology Training grant [T32CA009161]; NATIONAL CANCER INSTITUTE [T32CA009161, P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NYU School of Medicine's Clinical and Translational Science Institute; New York University Molecular Oncology and Immunology Training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the Department of Defense, W81XWH-09-1-0572, to Marie Monaco (https://cdmrp.org/); by a grant from NYU School of Medicine's Clinical and Translational Science Institute (1UL1RR029893) to Peng Lee (www.nyumc.org); and by the New York University Molecular Oncology and Immunology Training grant (T32CA009161) to Garrett Daniels (www.nyumc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020610; Anderson E, 2004, J MAMMARY GLAND BIOL, V9, P3, DOI 10.1023/B:JOMG.0000023584.01750.16; Black PN, 2000, J NUTR, V130, p305S, DOI 10.1093/jn/130.2.305S; Cai CQ, 2008, ONCOGENE, V27, P3201, DOI 10.1038/sj.onc.1210983; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cao Y, 2001, CANCER RES, V61, P8429; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Curigliano Giuseppe, 2011, Journal of the National Cancer Institute Monographs, P108, DOI 10.1093/jncimonographs/lgr038; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; EMAD A, 2007, CANCER, V109, P25, DOI DOI 10.1002/CNCR.22381.PUBMED:17146782; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Gajria D, 2011, EXPERT REV ANTICANC, V11, P263, DOI 10.1586/ERA.10.226; Golej DL, 2011, J LIPID RES, V52, P782, DOI 10.1194/jlr.M013292; Gucalp A, 2010, CANCER J, V16, P62, DOI 10.1097/PPO.0b013e3181ce4ae1; He J, 2011, MED ONCOL, V28, P1218, DOI 10.1007/s12032-010-9651-8; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Hughes-Fulford M, 2006, CANCER RES, V66, P1427, DOI 10.1158/0008-5472.CAN-05-0914; Kantojarvi K, 2011, AUTISM RES, V4, P228, DOI 10.1002/aur.187; Klopocki E, 2004, INT J ONCOL, V25, P641; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lewin TM, 2001, J BIOL CHEM, V276, P24674, DOI 10.1074/jbc.M102036200; Liang YC, 2005, WORLD J GASTROENTERO, V11, P2557, DOI 10.3748/wjg.v11.i17.2557; Luo Xiang, 2010, Chin J Cancer, V29, P585; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Maloberti PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015540; Mashima T, 2009, ONCOGENE, V28, P9, DOI 10.1038/onc.2008.355; Mashima T, 2009, CANCER SCI, V100, P1556, DOI 10.1111/j.1349-7006.2009.01203.x; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Meloni I, 2002, NAT GENET, V30, P436, DOI 10.1038/ng857; Monaco ME, 2010, TRANSL ONCOL, V3, P91, DOI 10.1593/tlo.09202; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Ogawa Y, 2008, INT J CLIN ONCOL, V13, P431, DOI 10.1007/s10147-008-0770-6; Oksenberg N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003221; Orlando UD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040794; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Sirchia SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005559; Stepanova M, 2010, OBES SURG, V20, P640, DOI 10.1007/s11695-010-0078-2; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Taneja S, 2001, P NATL ACAD SCI USA, V98, P8804, DOI 10.1073/pnas.161011798; Van Horn CG, 2005, BIOCHEMISTRY-US, V44, P1635, DOI 10.1021/bi047721l; Waddell N, 2010, BREAST CANCER RES TR, V123, P661, DOI 10.1007/s10549-009-0653-1; Wang DG, 2011, AM J PATHOL, V179, P1657, DOI 10.1016/j.ajpath.2011.06.010; Wang HX, 2011, MUTAT RES-GEN TOX EN, V723, P171, DOI 10.1016/j.mrgentox.2011.04.008; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Ye F, 2009, NUTR CANCER, V61, P530, DOI 10.1080/01635580902803719; Yu Q, 2011, ANN ONCOL, V22, P1288, DOI 10.1093/annonc/mdq586; Zhang Dakang, 2009, Cement Engineering, P4	52	47	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77060	10.1371/journal.pone.0077060	http://dx.doi.org/10.1371/journal.pone.0077060			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155918	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300052
J	Zhong, W; Zhao, YT; Sun, XG; Song, ZY; McClain, CJ; Zhou, ZX				Zhong, Wei; Zhao, Yantao; Sun, Xinguo; Song, Zhenyuan; McClain, Craig J.; Zhou, Zhanxiang			Dietary Zinc Deficiency Exaggerates Ethanol-Induced Liver Injury in Mice: Involvement of Intrahepatic and Extrahepatic Factors	PLOS ONE			English	Article							HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; OXIDATIVE-STRESS; ADIPOSE-TISSUE; DISEASE; ACID; HOMEOSTASIS; EXPRESSION; BARRIER; GUT; ADIPONECTIN	Clinical studies have demonstrated that alcoholics have a lower dietary zinc intake compared to health controls. The present study was undertaken to determine the interaction between dietary zinc deficiency and ethanol consumption in the pathogenesis of alcoholic liver disease. C57BL/6N mice were subjected to 8-week feeding of 4 experimental liquid diets: (1) zinc adequate diet, (2) zinc adequate diet plus ethanol, (3) zinc deficient diet, and (4) zinc deficient diet plus ethanol. Ethanol exposure with adequate dietary zinc resulted in liver damage as indicated by elevated plasma alanine aminotransferase level and increased hepatic lipid accumulation and inflammatory cell infiltration. Dietary zinc deficiency alone increased hepatic lipid contents, but did not induce hepatic inflammation. Dietary zinc deficiency showed synergistic effects on ethanol-induced liver damage. Dietary zinc deficiency exaggerated ethanol effects on hepatic genes related to lipid metabolism and inflammatory response. Dietary zinc deficiency worsened ethanol-induced imbalance between hepatic pro-oxidant and antioxidant enzymes and hepatic expression of cell death receptors. Dietary zinc deficiency exaggerated ethanol-induced reduction of plasma leptin, although it did not affect ethanol-induced reduction of white adipose tissue mass. Dietary zinc deficiency also deteriorated ethanol-induced gut permeability increase and plasma endotoxin elevation. These results demonstrate, for the first time, that dietary zinc deficiency is a risk factor in alcoholic liver disease, and multiple intrahepatic and extrahepatic factors may mediate the detrimental effects of zinc deficiency.	[Zhong, Wei; Sun, Xinguo; Zhou, Zhanxiang] Univ North Carolina Greensboro, Ctr Translat Biomed Res, Kannapolis, NC USA; [Zhou, Zhanxiang] Univ North Carolina Greensboro, Dept Nutr, Kannapolis, NC USA; [Zhao, Yantao; McClain, Craig J.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [McClain, Craig J.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [McClain, Craig J.] Robley Rex Louisville VAMC, Louisville, KY USA; [Song, Zhenyuan] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA	University of North Carolina; University of North Carolina Greensboro; University of North Carolina; University of North Carolina Greensboro; University of Louisville; University of Louisville; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Zhou, ZX (corresponding author), Univ North Carolina Greensboro, Ctr Translat Biomed Res, North Carolina Res Campus, Kannapolis, NC USA.	z_zhou@uncg.edu			National Institutes of Health [R01AA018844, R01AA020212, P01AA 017103, R37AA 010742]; Veterans Administration; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018844, R01AA020212, R01AA016013, P01AA017103, U01AA021901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported in part by the National Institutes of Health grants R01AA018844 (Z.Z.), R01AA020212 (Z.Z.), P01AA 017103 (CJM), R37AA 010742 (C.J.M.); and the Veterans Administration (CJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Bergheim I, 2003, EUR J CLIN NUTR, V57, P431, DOI 10.1038/sj.ejcn.1601557; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; Cabre M, 2001, INT J VITAM NUTR RES, V71, P229, DOI 10.1024/0300-9831.71.4.229; Chen XC, 2007, AM J PHYSIOL-ENDOC M, V292, pE621, DOI 10.1152/ajpendo.00387.2006; Crabb David W, 2007, Novartis Found Symp, V285, P4; De Minicis S, 2008, J GASTROEN HEPATOL, V23, pS98, DOI 10.1111/j.1440-1746.2007.05277.x; Dieck HT, 2005, J NUTR, V135, P199, DOI 10.1093/jn/135.2.199; Farrell CP, 2011, GASTROENTEROL RES, V4, P243, DOI 10.4021/gr379w; Goel A, 2005, CHEM-BIOL INTERACT, V156, P131, DOI 10.1016/j.cbi.2005.08.004; Han MS, 2011, J LIPID RES, V52, P1234, DOI 10.1194/jlr.M014787; Havel PJ, 2002, CURR OPIN LIPIDOL, V13, P51, DOI 10.1097/00041433-200202000-00008; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Jing L, 2012, MOL CELL BIOCHEM, V359, P283, DOI 10.1007/s11010-011-1022-z; Kang M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-91; Kang XQ, 2009, HEPATOLOGY, V50, P1241, DOI 10.1002/hep.23090; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Kim JY, 2007, J AM COLL NUTR, V26, P1; Li Q, 2013, ALCOHOL CLIN EXP RES, V37, P587, DOI 10.1111/acer.12013; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; Lu ZH, 2003, BIOCHEM BIOPH RES CO, V303, P1002, DOI 10.1016/S0006-291X(03)00449-2; Maher Jacquelyn J, 2002, Semin Gastrointest Dis, V13, P31; Manari AP, 2003, ADDICT BIOL, V8, P201, DOI 10.1080/1355621031000117437; MCCLAIN CJ, 1983, ALCOHOL CLIN EXP RES, V7, P5, DOI 10.1111/j.1530-0277.1983.tb05402.x; McClain CJ, 2002, ALCOHOL, V27, P185, DOI 10.1016/S0741-8329(02)00224-0; MILMAN N, 1983, SCAND J GASTROENTERO, V18, P871, DOI 10.3109/00365528309182108; PERSSON J, 1990, SCAND J GASTROENTERO, V25, P173, DOI 10.3109/00365529009107940; Pravdova E, 2009, Endocr Regul, V43, P117; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; Schmitz H, 1999, J CELL SCI, V112, P137; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; Shen H, 2007, J NUTR, V137, P2339, DOI 10.1093/jn/137.11.2339; Snel M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/983814; Sun XH, 2012, AM J PHYSIOL-GASTR L, V302, pG548, DOI 10.1152/ajpgi.00342.2011; Szabo G, 2010, WORLD J GASTROENTERO, V16, P1321, DOI 10.3748/wjg.v16.i11.1321; Tan XB, 2012, AM J PATHOL, V181, P1279, DOI 10.1016/j.ajpath.2012.06.013; Wei XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055382; Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61; Yousef MI, 2002, TOXICOLOGY, V175, P223, DOI 10.1016/S0300-483X(02)00049-5; Zhao YT, 2011, AM J PATHOL, V179, P693, DOI 10.1016/j.ajpath.2011.04.006; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017; Zhong W, 2010, AM J PHYSIOL-GASTR L, V299, pG643, DOI 10.1152/ajpgi.00515.2009; Zhong W, 2010, AM J PHYSIOL-GASTR L, V298, pG625, DOI 10.1152/ajpgi.00350.2009; Zhou SL, 1998, HEPATOLOGY, V27, P1064, DOI 10.1002/hep.510270423; Zhou ZX, 2010, DIGEST DIS, V28, P745, DOI 10.1159/000324282; Zhou ZX, 2005, AM J PATHOL, V166, P1681, DOI 10.1016/S0002-9440(10)62478-9; Zhu H, 2012, J DIGEST DIS, V13, P133, DOI 10.1111/j.1751-2980.2011.00569.x	52	47	49	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76522	10.1371/journal.pone.0076522	http://dx.doi.org/10.1371/journal.pone.0076522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155903	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300037
J	Conidi, A; van den Berghe, V; Leslie, K; Stryjewska, A; Xue, H; Chen, YG; Seuntjens, E; Huylebroeck, D				Conidi, Andrea; van den Berghe, Veronique; Leslie, Kris; Stryjewska, Agata; Xue, Hua; Chen, Ye-Guang; Seuntjens, Eve; Huylebroeck, Danny			Four Amino Acids within a Tandem QxVx Repeat in a Predicted Extended alpha-Helix of the Smad-Binding Domain of Sip1 Are Necessary for Binding to Activated Smad Proteins	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; REGULATES E-CADHERIN; GROWTH-FACTOR-BETA; TGF-BETA; INTERACTING PROTEIN-1; HIRSCHSPRUNG-DISEASE; SIGNAL-TRANSDUCTION; STEM-CELLS; CANCER PROGRESSION; MENTAL-RETARDATION	The zinc finger transcription factor Smad-interacting protein-1 (Sip1; Zeb2, Zfhx1b) plays an important role during vertebrate embryogenesis in various tissues and differentiating cell types, and during tumorigenesis. Previous biochemical analysis suggests that interactions with several partner proteins, including TGF beta family receptor-activated Smads, regulate the activities of Sip1 in the nucleus both as a DNA-binding transcriptional repressor and activator. Using a peptide aptamer approach we mapped in Sip1 its Smad-binding domain (SBD), initially defined as a segment of 51 amino acids, to a shorter stretch of 14 amino acids within this SBD. Modelling suggests that this short SBD stretch is part of an extended a-helix that may fit the binding to a hydrophobic corridor within the MH2 domain of activated Smads. Four amino acids (two polar Q residues and two non-polar V residues) that form the tandem repeat (QxVx)(2) in this 14-residue stretch were found to be crucial for binding to both TGF beta/Nodal/Activin-Smads and BMP-Smads. A full-length Sip1 with collective mutation of these Q and V residues (to A) no longer binds to Smads, while it retains its binding activity to its cognate bipartite target DNA sequence. This missense mutant Sip1(AxAx)(2) provides a new molecular tool to identify SBD (in) dependent target genes in Sip1-controlled TGF beta and/or BMP (de) regulated cellular, developmental and pathological processes.	[Conidi, Andrea; van den Berghe, Veronique; Stryjewska, Agata; Seuntjens, Eve; Huylebroeck, Danny] Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Mol Biol Celgen, Louvain, Belgium; [Conidi, Andrea; Leslie, Kris; Huylebroeck, Danny] Erasmus Univ, Dept Cell Biol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Xue, Hua; Chen, Ye-Guang] Tsinghua Univ, Sch Life Sci, Tsinghua Beijing Ctr Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	KU Leuven; Erasmus University Rotterdam; Erasmus MC; Tsinghua University	Huylebroeck, D (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Lab Mol Biol Celgen, Louvain, Belgium.	danny.huylebroeck@med.kuleuven.be	Seuntjens, Eve/AAM-2478-2021; Chen, Ye-Guang/L-6998-2019	Huylebroeck, Danny/0000-0003-4862-1079; van den Berghe, Veronique/0000-0001-8787-4365; Seuntjens, Eve/0000-0002-0126-461X	Research Council of KU Leuven [GOA-11/012, BIL08/10]; Fund of Scientific Research-Flanders FWO-V [G.0954.11N]; Belgian Science Policy Office in the Interuniversity Attraction Poles program [IAP-VII/07]; Agency for Innovation by Science and Technology (IWT)	Research Council of KU Leuven(KU Leuven); Fund of Scientific Research-Flanders FWO-V(FWO); Belgian Science Policy Office in the Interuniversity Attraction Poles program; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was funded by the Research Council of KU Leuven (grant GOA-11/012 to D.H.; grant BIL08/10 (to D.H. and Y.-G.C.) within the framework agreements between KU Leuven and Tsinghua University; https://admin.kuleuven.be/raden/en/research-council), by the Fund of Scientific Research-Flanders FWO-V (G.0954.11N, to D.H. and E.S.; http://www.fwo.be/), and by the Belgian Science Policy Office in the Interuniversity Attraction Poles program (IAP-VII/07 funding to D.H.; http://www.belspo.be/IAP/). V.v.d.B. was supported by the Agency for Innovation by Science and Technology (IWT; http://www.iwt.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484; Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Araki K, 2011, BRIT J CANCER, V105, P1885, DOI 10.1038/bjc.2011.452; Baines IC, 2006, DRUG DISCOV TODAY, V11, P334, DOI 10.1016/j.drudis.2006.02.007; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Chng ZZ, 2010, CELL STEM CELL, V6, P59, DOI 10.1016/j.stem.2009.11.015; Chong PA, 2004, J BIOL CHEM, V279, P40707, DOI 10.1074/jbc.M404375200; Colas P, 2000, CURR OPIN CHEM BIOL, V4, P54, DOI 10.1016/S1367-5931(99)00051-4; Colas Pierre, 2008, Curr Drug Discov Technol, V5, P190, DOI 10.2174/157016308785739875; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Conidi A, 2011, CYTOKINE GROWTH F R, V22, P287, DOI 10.1016/j.cytogfr.2011.11.006; Cui QQ, 2005, ONCOGENE, V24, P3864, DOI 10.1038/sj.onc.1208556; Dang LTH, 2012, STEM CELLS DEV, V21, P2838, DOI 10.1089/scd.2011.0593; Dang LTH, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-13; Das S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-94; Dzwonek J, 2009, MOL CANCER RES, V7, P1342, DOI 10.1158/1541-7786.MCR-08-0558; Eisaki A, 2000, BIOCHEM BIOPH RES CO, V271, P151, DOI 10.1006/bbrc.2000.2545; Evans E, 2012, AM J MED GENET A, V158A, P358, DOI 10.1002/ajmg.a.34405; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Higashi Y, 2002, GENESIS, V32, P82, DOI 10.1002/gene.10048; Hill CS, 2009, CELL RES, V19, P36, DOI 10.1038/cr.2008.325; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikushima H, 2012, CELL TISSUE RES, V347, P37, DOI 10.1007/s00441-011-1179-5; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jeub M, 2011, PAIN, V152, P2384, DOI 10.1016/j.pain.2011.07.006; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Lerchner W, 2000, DEVELOPMENT, V127, P2729; Maira M, 2010, J NEURODEV DISORD, V2, P48, DOI [10.1007/s11689-009-9035-6, 10.1007/s11689-009-9040-9]; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; McKinsey GL, 2013, NEURON, V77, P83, DOI 10.1016/j.neuron.2012.11.035; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peterson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036548; Polleux F, 2002, SCI STKE, V136, P19; Pradier B, 2013, EUR J PAIN; Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Schiro MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025021; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Seuntjens E, CYTOKINE GROWTH FACT, V20, P449; Seuntjens E, 2009, NAT NEUROSCI, V12, P1373, DOI 10.1038/nn.2409; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Sousa VH, 2009, CEREB CORTEX, V19, pI1, DOI 10.1093/cercor/bhp038; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; van den Berghe V, 2013, NEURON, V77, P70, DOI 10.1016/j.neuron.2012.11.009; van Grunsven LA, 2003, J BIOL CHEM, V278, P26135, DOI 10.1074/jbc.M300597200; van Grunsven LA, 2000, MECH DEVELOP, V94, P189, DOI 10.1016/S0925-4773(00)00318-X; van Grunsven LA, 2007, DEV BIOL, V306, P34, DOI 10.1016/j.ydbio.2007.02.045; Van Grunsven LA, 2006, DEV DYNAM, V235, P1491, DOI 10.1002/dvdy.20727; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Verstappen G, 2008, HUM MOL GENET, V17, P1175, DOI 10.1093/hmg/ddn007; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Weng QJ, 2012, NEURON, V73, P713, DOI 10.1016/j.neuron.2011.12.021; Zakin L, 2010, CURR BIOL, V20, pR89, DOI 10.1016/j.cub.2009.11.021; Zhao BM, 2006, MOL BIOL CELL, V17, P3819, DOI 10.1091/mbc.e05-10-0990	69	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76733	10.1371/journal.pone.0076733	http://dx.doi.org/10.1371/journal.pone.0076733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146916	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400078
J	Hammerstingl, C; Schueler, R; Wiesen, M; Momcilovic, D; Pabst, S; Nickenig, G; Skowasch, D				Hammerstingl, Christoph; Schueler, Robert; Wiesen, Martin; Momcilovic, Diana; Pabst, Stefan; Nickenig, Georg; Skowasch, Dirk			Impact of Untreated Obstructive Sleep Apnea on Left and Right Ventricular Myocardial Function and Effects of CPAP Therapy	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; QUANTITATIVE ASSESSMENT; DYSFUNCTION; ECHOCARDIOGRAPHY; HEART; COMMITTEE; TRACKING; STRAIN	Background: Obstructive sleep apnea (OSA) has deteriorating effect on LV function, whereas its impact on RV function is controversial. We aimed to determine the effect of OSA and continuous positive airway pressure (CPAP) treatment on left and right ventricular (LV, RV) function using transthoracic echocardiography (TTE) and 2 dimensional speckle tracking (2D ST) analysis of RV deformation capability. Methods and Results: 82 patients with OSA and need for CPAP therapy were prospectively enrolled and underwent TTE at study inclusion and after 6 months of follow up (FU). Multivariate regression analysis revealed an independent association between baseline apical right ventricular longitudinal strain (RV-Sl), BMI and the severity of OSA (apical RV-Sl: P = 0.0002, BMI: P = 0.02). After CPAP therapy, LV functional parameters (LVEF: P<0.0001, LV performance index: P = 0.03, stroke volume: P = 0.042), and apical RV-Sl (P = 0.001) improved significantly. The effect of CPAP therapy was related to severity of OSA (LVEF: AHI 5-14, 66.4 +/- 8.8%, 68.5 +/- 10.6% [P = ns]; AHI 15-30:59.8 +/- 7.7%, 68.6 +/- 9.3% [P = 0.002]; AHI>30:54.1 +/- 12.4%, 68.2 +/- 13.6%[P<0.0001]; apical RV-Sl: AHI 5-14: -17.3 +/- 8.7%, -16.0 +/- 10.8% [P = ns], AHI 15-30: -9.8 +/- 6.0%, -15.4 +/- 10.9% [P = 0.028], AHI>30: -6.3 +/- 5.7%, -17.9 +/- 11.2% [P<0.0001]). Conclusions: OSA seems to have deteriorating effect on LV and RV function. We found a beneficial effect of CPAP on LV and RV functional parameters predominately in patients with severe OSA. 2D speckle tracking might be of value to determine early changes in global and regional right ventricular function.	[Hammerstingl, Christoph; Schueler, Robert; Wiesen, Martin; Momcilovic, Diana; Pabst, Stefan; Nickenig, Georg; Skowasch, Dirk] Univ Bonn, Dept Internal Med Cardiol Pulmonol & Angiol 2, Bonn, Germany	University of Bonn	Schueler, R (corresponding author), Univ Bonn, Dept Internal Med Cardiol Pulmonol & Angiol 2, Bonn, Germany.	robert.schueler@ukb.uni-bonn.de	Schueler, Robert/D-7407-2017; Hammerstingl, Christoph/GQQ-3316-2022					Altekin RE, 2012, CARDIOL J, V19, P130, DOI 10.5603/CJ.2012.0024; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Artis NJ, 2008, INT J CARDIOL, V123, P240, DOI 10.1016/j.ijcard.2007.02.046; Becker M, 2006, HEART, V92, P1102, DOI 10.1136/hrt.2005.077107; BERMAN EJ, 1991, CHEST, V100, P347, DOI 10.1378/chest.100.2.347; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; BRADLEY TD, 1992, CLIN CHEST MED, V13, P459; Butt M, 2012, CIRC-HEART FAIL, V5, P226, DOI 10.1161/CIRCHEARTFAILURE.111.964106; Chami HA, 2008, CIRCULATION, V117, P2599, DOI 10.1161/CIRCULATIONAHA.107.717892; Chan JYS, 2009, THORAX, V64, P233, DOI 10.1136/thx.2007.094904; Colish J, 2012, CHEST, V141, P674, DOI 10.1378/chest.11-0615; D'hooge J, 2000, Eur J Echocardiogr, V1, P154, DOI 10.1053/euje.2000.0031; Danbrauskaite V, 2007, J AM SOC ECHOCARDIOG, V20, P1172, DOI 10.1016/j.echo.2007.02.005; Douglas PS, 2011, J AM SOC ECHOCARDIOG, V24, P229, DOI 10.1016/j.echo.2010.12.008; Fernandez-Friera L, 2011, HEART, V97, P1250, DOI 10.1136/hrt.2010.216101; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; German Society of Sleep Research and Sleep medicine (DGSM), 2009, SOMNOLOGIE, V13, P1; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Guidry UC, 2001, AM J RESP CRIT CARE, V164, P933, DOI 10.1164/ajrccm.164.6.2001092; Hammerstingl C, 2012, INT J CARDIOL, V155, P465, DOI 10.1016/j.ijcard.2011.12.026; Haruki N, 2009, EUR J ECHOCARDIOGR, V10, P769, DOI 10.1093/ejechocard/jep068; Jurcut R, 2010, EUR J ECHOCARDIOGR, V11, P81, DOI 10.1093/ejechocard/jep234; Kim SH, 2008, AM J CARDIOL, V101, P1663, DOI 10.1016/j.amjcard.2008.01.056; Koshino Y, 2010, CIRC-CARDIOVASC IMAG, V3, P282, DOI 10.1161/CIRCIMAGING.109.901561; Langeland S, 2005, CIRCULATION, V112, P2157, DOI 10.1161/CIRCULATIONAHA.105.554006; Lopez-Candales A, 2009, CAN J CARDIOL, V25, pE73, DOI 10.1016/S0828-282X(09)70045-5; Lopez-Jimenez F, 2008, CHEST, V133, P793, DOI 10.1378/chest.07-0800; Masood A, 2000, Curr Opin Pulm Med, V6, P479, DOI 10.1097/00063198-200011000-00003; Park JG, 2011, MAYO CLIN PROC, V86, P549, DOI 10.4065/mcp.2010.0810; Romero-Corral A, 2007, CHEST, V132, P1863, DOI 10.1378/chest.07-0966; Rydman R, 2010, ECHOCARDIOGR-J CARD, V27, P286, DOI 10.1111/j.1540-8175.2009.01015.x; Sanner BM, 1997, EUR RESPIR J, V10, P2079, DOI 10.1183/09031936.97.10092079; Shivalkar B, 2006, J AM COLL CARDIOL, V47, P1433, DOI 10.1016/j.jacc.2005.11.054; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Tei C, 1995, J Cardiol, V26, P357; Teske AJ, 2009, J AM SOC ECHOCARDIOG, V22, P920, DOI 10.1016/j.echo.2009.05.014; Usui Y, 2013, SLEEP MED, V14, P155, DOI 10.1016/j.sleep.2010.09.014; Weidemann F, 2001, BASIC RES CARDIOL, V96, P595, DOI 10.1007/s003950170011	39	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76352	10.1371/journal.pone.0076352	http://dx.doi.org/10.1371/journal.pone.0076352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146857	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400053
J	O'Shea, OR; Braccini, M; McAuley, R; Speed, CW; Meekan, MG				O'Shea, Owen R.; Braccini, Matias; McAuley, Rory; Speed, Conrad W.; Meekan, Mark G.			Growth of Tropical dasyatid Rays Estimated Using a Multi-Analytical Approach	PLOS ONE			English	Article							AGE-DETERMINATION; NEOTRYGON-KUHLII; COMMON STINGRAY; VALIDATION; REPRODUCTION; PARAMETERS; PASTINACA; PRECISION; SELECTION; MATURITY	We studied the age and growth of four sympatric stingrays: reticulate whipray, Himanutra uarnak (n=19); blue mask, Neotrygon kuhlii (n=34); cowtail, Pastinachus atrus (n=32) and blue-spotted fantail, Taeniura lymma (n=40) rays at Ningaloo Reef, a fringing coral reef on the north-western coast of western Australia. Age estimates derived from band counts within sectioned vertebrae ranged between 1 and 27 years (H. uarnak, 1 - 25 yrs.; N. kuhlii, 1.5 - 13 yrs.; P. atrus, 1 - 27 yrs. and T. lymma, 1 -11 yrs.). Due to limitations of sample sizes, we combined several analytical methods for estimating growth parameters. First, we used nonlinear least squares (NLS) to identify the growth model that best fitted the data. We then used this model, prior information and the data within a Bayesian framework to approximate the posterior distribution of the growth parameters. For all species the two-parameter von Bertalanffy growth model provided the best fit to size-at-age datasets. Based on this model, the Bayesian approach allowed the estimation of median values of W-D infinity (cm) and k (yr(-1)) for the four species (H. uarnak: 149 and 0.12; N. kuhlii: 42 and 0.38; P. atrus 156 and 0.16, and T. lymma 33 and 0.24, respectively). Our approach highlights the value of combining different analytical methods and prior knowledge for estimating growth parameters when data quality and quantity are limited.	[O'Shea, Owen R.; Speed, Conrad W.; Meekan, Mark G.] Australian Inst Marine Sci, Crawley, WA, Australia; [O'Shea, Owen R.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Braccini, Matias; McAuley, Rory] WA Fisheries & Marine Res Labs, Shark & Ray Sustainabil Grp, Hillarys Boat Harbour, WA, Australia	Australian Institute of Marine Science; Murdoch University	O'Shea, OR (corresponding author), Australian Inst Marine Sci, Crawley, WA, Australia.	oshea@ceibahamas.org	Speed, Conrad W/F-2913-2015	Speed, Conrad W/0000-0003-3186-8710; Meekan, Mark/0000-0002-3067-9427	Australian Institute of Marine Science	Australian Institute of Marine Science	This study was funded by the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Beverton RJ, 1993, DYNAMICS EXPLOITED F; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 2001, J FISH BIOL, V59, P197, DOI [10.1111/j.1095-8649.2001.tb00127.x, 10.1006/jfbi.2001.1668]; CHANG WYB, 1982, CAN J FISH AQUAT SCI, V39, P1208, DOI 10.1139/f82-158; Cowley PD, 1997, S AFR J MARINE SCI, V18, P31; Dale JJ, 2012, MAR FRESHWATER RES, V63, P475, DOI 10.1071/MF11231; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; DAVENPORT S, 1988, AUST J MAR FRESH RES, V39, P417; Dell Q, 2009, FISHERIES MANAG ECOL, V16, P191, DOI 10.1111/j.1365-2400.2009.00655.x; Dulvy NK, 2010, CRC MAR BIOL SER, P639; EDWARDS RRC, 1980, AUST J MAR FRESH RES, V31, P459; FABENS AJ, 1965, GROWTH, V29, P265; FORD E., 1933, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V19, P305; Gelman A., 2003, BAYESIAN DATA ANAL; Goldman K.J., 2005, FAO FISH TECH PAP, P76; Hale LF, 2008, J FISH BIOL, V73, P510, DOI 10.1111/j.1095-8649.2008.01940.x; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; HOENIG J M, 1990, NOAA Technical Report NMFS, P1; Ismen A, 2003, FISH RES, V60, P169, DOI 10.1016/S0165-7836(02)00058-9; Jacobsen IP, 2011, J FISH BIOL, V78, P1249, DOI 10.1111/j.1095-8649.2011.02933.x; Jacobsen IP, 2010, J FISH BIOL, V77, P2405, DOI 10.1111/j.1095-8649.2010.02829.x; McAuley RB, 2006, ENVIRON BIOL FISH, V77, P385, DOI 10.1007/s10641-006-9126-0; Musick JA, 1999, LIF SLOW LAN EC CONS; O'Shea OR, 2013, P AUSTR NZ COUNC CAR; Pierce SJ, 2009, J FISH BIOL, V75, P2490, DOI 10.1111/j.1095-8649.2009.02435.x; R Development Core Team, 2012, R LANG ENV STAT COMP; RICKER W E, 1975, P382; Ridewood WG, 1921, PHILOS T R SOC LON B, V210, P311, DOI 10.1098/rstb.1921.0008; Siegfried KI, 2006, ENVIRON BIOL FISH, V77, P301, DOI 10.1007/s10641-006-9112-6; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Smart JJ, 2013, AQUAT CONSERV, V23, P124, DOI 10.1002/aqc.2274; Smith WD, 2007, MAR FRESHWATER RES, V58, P54, DOI 10.1071/MF06083; Thorson JT, 2009, FISH RES, V98, P75, DOI 10.1016/j.fishres.2009.03.016; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; WALFORD LA, 1946, BIOL BULL, V90, P141, DOI 10.2307/1538217; White W.T., 2006, EC IMPORTANT SHARKS; White WT, 2002, MAR BIOL, V140, P699, DOI 10.1007/s00227-001-0756-7; White WT, 2001, MAR BIOL, V138, P135, DOI 10.1007/s002270000436; Yigin CC, 2012, MAR BIOL RES, V8, P644, DOI 10.1080/17451000.2012.659667; Zhu LX, 2009, CHIN J OCEANOL LIMN, V27, P457, DOI 10.1007/s00343-009-9236-6	44	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77194	10.1371/journal.pone.0077194	http://dx.doi.org/10.1371/journal.pone.0077194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146968	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400104
J	Wang, CJ; Funk, CC; Eddy, JA; Price, ND				Wang, Chunjing; Funk, Cory C.; Eddy, James A.; Price, Nathan D.			Transcriptional Analysis of Aggressiveness and Heterogeneity across Grades of Astrocytomas	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; GENE-EXPRESSION; PILOCYTIC ASTROCYTOMAS; MALIGNANT GLIOMAS; FACTOR RECEPTOR; GLIOBLASTOMA; CELLS; CLASSIFICATION; TARGET; MITOCHONDRIA	Astrocytoma is the most common glioma, accounting for half of all primary brain and spinal cord tumors. Late detection and the aggressive nature of high-grade astrocytomas contribute to high mortality rates. Though many studies identify candidate biomarkers using high-throughput transcriptomic profiling to stratify grades and subtypes, few have resulted in clinically actionable results. This shortcoming can be attributed, in part, to pronounced lab effects that reduce signature robustness and varied individual gene expression among patients with the same tumor. We addressed these issues by uniformly preprocessing publicly available transcriptomic data, comprising 306 tumor samples from three astrocytoma grades (Grade 2, 3, and 4) and 30 non-tumor samples (normal brain as control tissues). Utilizing Differential Rank Conservation (DIRAC), a network-based classification approach, we examined the global and individual patterns of network regulation across tumor grades. Additionally, we applied gene-based approaches to identify genes whose expression changed consistently with increasing tumor grade and evaluated their robustness across multiple studies using statistical sampling. Applying DIRAC, we observed a global trend of greater network dysregulation with increasing tumor aggressiveness. Individual networks displaying greater differences in regulation between adjacent grades play well-known roles in calcium/PKC, EGF, and transcription signaling. Interestingly, many of the 90 individual genes found to monotonically increase or decrease with astrocytoma grade are implicated in cancer-affected processes such as calcium signaling, mitochondrial metabolism, and apoptosis. The fact that specific genes monotonically increase or decrease with increasing astrocytoma grade may reflect shared oncogenic mechanisms among phenotypically similar tumors. This work presents statistically significant results that enable better characterization of different human astrocytoma grades and hopefully can contribute towards improvements in diagnosis and therapy choices. Our results also identify a number of testable hypotheses relating to astrocytoma etiology that may prove helpful in developing much-needed biomarkers for earlier disease detection.	[Wang, Chunjing; Funk, Cory C.; Eddy, James A.; Price, Nathan D.] Inst Syst Biol, Seattle, WA USA; [Wang, Chunjing; Price, Nathan D.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Eddy, James A.; Price, Nathan D.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA	Institute for Systems Biology (ISB); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Price, ND (corresponding author), Inst Syst Biol, Seattle, WA USA.	Nathan.Price@systemsbiology.org		Price, Nathan/0000-0002-4157-0267	National Institute of Health Howard Temin Pathway [4R00CA126184]; Grand Duchy of Luxembourg-Institute for Systems Biology Consortium; Roy J. Carver Foundation Young Investigator Grant, an NIH Center for Systems Biology [P50 GM076547]; Camille Dreyfus Teacher-Scholar program; NATIONAL CANCER INSTITUTE [R00CA126184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	National Institute of Health Howard Temin Pathway(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Duchy of Luxembourg-Institute for Systems Biology Consortium; Roy J. Carver Foundation Young Investigator Grant, an NIH Center for Systems Biology; Camille Dreyfus Teacher-Scholar program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institute of Health Howard Temin Pathway to Independence Award (4R00CA126184), the Grand Duchy of Luxembourg-Institute for Systems Biology Consortium, a Roy J. Carver Foundation Young Investigator Grant, an NIH Center for Systems Biology (P50 GM076547), and the Camille Dreyfus Teacher-Scholar program (NDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Cheng Y, 2000, HISTOPATHOLOGY, V37, P437, DOI 10.1046/j.1365-2559.2000.01005.x; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Ducker CE, 2005, MOL CANCER RES, V3, P463, DOI 10.1158/1541-7786.MCR-05-0037; Eddy JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000792; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Frey H, 2013, FEBS J; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Giorgi C, 2010, SCIENCE, V330, P1247, DOI 10.1126/science.1189157; Godard S, 2003, CANCER RES, V63, P6613; Gorovets D, 2012, CLIN CANCER RES, V18, P2490, DOI 10.1158/1078-0432.CCR-11-2977; Grzmil M, 2010, BBA-PROTEINS PROTEOM, V1804, P476, DOI 10.1016/j.bbapap.2009.10.018; Guo DL, 2011, CANCER DISCOV, V1, P442, DOI 10.1158/2159-8290.CD-11-0102; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holand K, 2011, CURR CANCER DRUG TAR, V11, P894, DOI 10.2174/156800911797264743; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Horikawa I, 2003, CARCINOGENESIS, V24, P1167, DOI 10.1093/carcin/bgg085; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Kim W, 2012, NEUROSURG CLIN N AM, V23, P471, DOI 10.1016/j.nec.2012.04.009; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Kyo S, 2002, ONCOGENE, V21, P688, DOI 10.1038/sj.onc.1205163; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; LEENSTRA S, 1992, CANCER RES, V52, P1568; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Liu ZH, 2011, J NEUROSCI, V31, P2052, DOI 10.1523/JNEUROSCI.3278-10.2011; Llaguno SRA, 2009, CLIN CANCER RES, V15, P7124, DOI 10.1158/1078-0432.CCR-09-0433; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lynes EM, 2012, EMBO J, V31, P457, DOI 10.1038/emboj.2011.384; Maloberti P, 2005, FEBS J, V272, P1804, DOI 10.1111/j.1742-4658.2005.04616.x; Markert JM, 2001, PHYSIOL GENOMICS, V5, P21, DOI 10.1152/physiolgenomics.2001.5.1.21; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Nutt CL, 2003, CANCER RES, V63, P1602; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Palty R, 2012, CELL, V149, P425, DOI 10.1016/j.cell.2012.01.055; Peng SC, 2010, NUCLEIC ACIDS RES, V38, P7446, DOI 10.1093/nar/gkq634; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rich JN, 2005, CANCER RES, V65, P4051, DOI 10.1158/0008-5472.CAN-04-3936; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Roderick HL, 2000, J CELL BIOL, V149, P1235, DOI 10.1083/jcb.149.6.1235; Shannon P, 2005, AM J PATHOL, V167, P859, DOI 10.1016/S0002-9440(10)62057-3; Shirahata M, 2007, CLIN CANCER RES, V13, P7341, DOI 10.1158/1078-0432.CCR-06-2789; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Stockhausen MT, 2010, NEURO-ONCOLOGY, V12, P199, DOI 10.1093/neuonc/nop022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sung J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003148; Turkheimer FE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-526; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Wong KK, 2005, CANCER RES, V65, P76; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wypych D, 2013, ADV EXP MED BIOL, V986, P61, DOI 10.1007/978-94-007-4719-7_4; Zhu J, 2012, J MOL NEUROSCI	63	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76694	10.1371/journal.pone.0076694	http://dx.doi.org/10.1371/journal.pone.0076694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146911	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400073
J	Wang, J; Li, MX; Ma, XR; Bai, KH; Wang, L; Yan, Z; Lv, TT; Zhao, ZQ; Zhao, RR; Liu, HR				Wang, Jin; Li, Meixia; Ma, Xiurui; Bai, Kehua; Wang, Li; Yan, Zi; Lv, Tingting; Zhao, Zhiqing; Zhao, Rongrui; Liu, Huirong			Autoantibodies against the beta(3)-Adrenoceptor Protect from Cardiac Dysfunction in a Rat Model of Pressure Overload	PLOS ONE			English	Article							IDIOPATHIC DILATED CARDIOMYOPATHY; FUNCTIONAL AUTOIMMUNE EPITOPE; LEFT-VENTRICULAR HYPERTROPHY; HEART-FAILURE; BETA-1-ADRENERGIC RECEPTOR; ACETYLCHOLINE-RECEPTORS; INTERNATIONAL-SOCIETY; SERUM AUTOANTIBODIES; UP-REGULATION; BETA(1)-ADRENOCEPTORS	beta(3)-adrenoceptors (beta(3)-ARs) mediate a negative inotropic effect in human ventricular cardiomyocytes, which is opposite to that of beta(1)- and beta(2)-ARs. It has been previously demonstrated that autoantibodies against the beta(1/)beta(2)-AR exist in the sera of some patients with heart failure (HF) and these autoantibodies display agonist-like effects. Our aim in this study was to observe whether autoantibodies against the beta(3)-AR (beta(3)-AR Abs) exist in the sera of patients with HF and to assess the effects of beta(3)-AR Abs on rat model of pressure overload cardiomyopthy. In the present study, the level of beta(3)-AR Abs in the sera of HF patients was screened by ELISA. beta(3)-AR Abs from HF patients were administrated to male adult rats with abdominal aortic banding (AAB), and the cardiac function was measured by echocardiographic examination and hemodynamic studies. The biological effects of this autoantibody on cardiomyocytes were evaluated using a motion-edge detection system, intracellular calcium transient assay, and patch clamp techniques. Compared to healthy subjects, the frequency of occurrence and titer of beta(3)-AR Abs in the sera of HF patients were greatly increased, and beta(3)-AR Abs could prevent LV dilation and improve the cardiac function of rats with AAB. beta(3)-AR Abs exhibited negative chronotropic and inotropic effects and were accompanied by a decreased intracellular Ca2+ transient and membrane L-type Ca2+ current in cardiomyocytes. Our results demonstrated the existence of beta(3)-AR Abs in the sera of patients with HF and found that this autoantibody could alleviate the cardiac dysfunction induced by pressure-overload in AAB rats.	[Wang, Jin; Bai, Kehua; Wang, Li; Yan, Zi; Zhao, Zhiqing; Zhao, Rongrui; Liu, Huirong] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China; [Li, Meixia] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Ma, Xiurui] Shanxi Cardiovasc Dis Hosp, Taiyuan, Shanxi, Peoples R China; [Lv, Tingting; Liu, Huirong] Capital Med Univ, Sch Basic Med Sci, Cardiovasc Res Inst, Beijing, Peoples R China; [Zhao, Zhiqing] Mercer Univ, Dept Basic Biomed Sci, Sch Med, Savannah, GA USA	Shanxi Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Capital Medical University; Mercer University	Liu, HR (corresponding author), Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China.	liuhr2000@126.com			Key Laboratory of Cellular Physiology Director Fund of Shanxi Medical University [2010-06]; Youth Fund of Shanxi Medical University; NSFC (National Nature Science Foundation of People's Republic of China) [30973163]	Key Laboratory of Cellular Physiology Director Fund of Shanxi Medical University; Youth Fund of Shanxi Medical University; NSFC (National Nature Science Foundation of People's Republic of China)(National Natural Science Foundation of China (NSFC))	This research is supported in part by grants from Key Laboratory of Cellular Physiology Director Fund of Shanxi Medical University (2010-06) to Jin Wang, Youth Fund of Shanxi Medical University to Jin Wang, and NSFC (National Nature Science Foundation of People's Republic of China, 30973163) to Huirong Liu. And the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornholz B, 2013, CARDIOVASC RES, V97, P472, DOI 10.1093/cvr/cvs350; BRISTOW MR, 1992, J CLIN INVEST, V89, P803, DOI 10.1172/JCI115659; BRISTOW MR, 1990, CIRCULATION, V82, P12; CHIALE PA, 1995, J AM COLL CARDIOL, V26, P864, DOI 10.1016/0735-1097(95)00262-2; DELCAYRE C, 1991, J HYPERTENS, V9, pS23, DOI 10.1097/00004872-199112002-00004; Du YH, 2012, J CELL BIOCHEM, V113, P3218, DOI 10.1002/jcb.24198; Elies R, 1996, J IMMUNOL, V157, P4203; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; FU LX, 1993, J CLIN INVEST, V91, P1964, DOI 10.1172/JCI116416; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holthoff HP, 2012, CIRC RES, V111, P675, DOI 10.1161/CIRCRESAHA.112.272682; Jahns R, 2004, J CLIN INVEST, V113, P1419, DOI 10.1172/JCI200420149; James MA, 2000, J CARDIOVASC RISK, V7, P187; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Kaya Z, 2012, CIRC RES, V110, P145, DOI 10.1161/CIRCRESAHA.111.243360; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Krause E G, 1996, Blood Press Suppl, V3, P37; Kupari M, 2005, EUR HEART J, V26, P1790, DOI 10.1093/eurheartj/ehi290; Liu HR, 1999, AUTOIMMUNITY, V29, P43, DOI 10.3109/08916939908995971; Liu HR, 2002, J AM COLL CARDIOL, V39, P1866, DOI 10.1016/S0735-1097(02)01865-X; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lorenz JN, 1997, AM J PHYSIOL-HEART C, V272, pH1137, DOI 10.1152/ajpheart.1997.272.3.H1137; MAGNUSSON Y, 1994, CIRCULATION, V89, P2760, DOI 10.1161/01.CIR.89.6.2760; MAGNUSSON Y, 1990, J CLIN INVEST, V86, P1658, DOI 10.1172/JCI114888; MAGNUSSON Y, 1989, CLIN EXP IMMUNOL, V78, P42; Matsui S, 1997, J MOL CELL CARDIOL, V29, P641, DOI 10.1006/jmcc.1996.0307; Matsui S, 2000, HERZ, V25, P267, DOI 10.1007/s000590050018; Moens AL, 2009, J MOL CELL CARDIOL, V47, P576, DOI 10.1016/j.yjmcc.2009.06.005; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Morimoto A, 2004, AM J PHYSIOL-HEART C, V286, pH2425, DOI 10.1152/ajpheart.01045.2003; Nagatomo Y, 2009, J CARD FAIL, V15, P224, DOI 10.1016/j.cardfail.2008.10.027; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Niu XL, 2012, J AM COLL CARDIOL, V59, P1979, DOI 10.1016/j.jacc.2011.12.046; Pei JH, 2012, EUR J HEART FAIL, V14, P887, DOI 10.1093/eurjhf/hfs082; PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W; Rasmussen HH, 2009, CURR OPIN INVEST DR, V10, P955; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Ren Jun, 2001, Biological Procedures Online, V3, P43, DOI 10.1251/bpo22; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; ROSENBAUM MB, 1994, J CARDIOVASC ELECTR, V5, P367, DOI 10.1111/j.1540-8167.1994.tb01174.x; SIPIDO KR, 1995, CARDIOVASC RES, V29, P717, DOI 10.1016/S0008-6363(96)88645-7; Stein AB, 2007, BASIC RES CARDIOL, V102, P28, DOI 10.1007/s00395-006-0627-y; Suzuki M, 1998, CARDIOVASC RES, V39, P589, DOI 10.1016/S0008-6363(98)00166-7; Taylor DO, 2007, J HEART LUNG TRANSPL, V26, P769, DOI 10.1016/j.healun.2007.06.004; XIAO RP, 1994, J CLIN INVEST, V94, P2051, DOI 10.1172/JCI117559; Yang XL, 2008, J HYPERTENS, V26, P1629, DOI 10.1097/HJH.0b013e328304dbff; Zhang WG, 1999, CIRC RES, V84, P722, DOI 10.1161/01.RES.84.6.722; Zhang ZS, 2005, J PHARMACOL EXP THER, V315, P1203, DOI 10.1124/jpet.105.089672; Zhao Q, 2007, CARDIOVASC DRUG THER, V21, P85, DOI 10.1007/s10557-007-6016-4; Zhao Q, 2013, J CARDIOVASC PHARM T, V18, P133, DOI 10.1177/1074248412460123; Zuo L, 2011, INT J CARDIOL, V149, P89, DOI 10.1016/j.ijcard.2009.12.023	53	3	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78207	10.1371/journal.pone.0078207	http://dx.doi.org/10.1371/journal.pone.0078207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147120	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400145
J	Niu, LL; Qian, M; Yang, W; Meng, L; Xiao, Y; Wong, KKL; Abbott, D; Liu, X; Zheng, HR				Niu, Lili; Qian, Ming; Yang, Wei; Meng, Long; Xiao, Yang; Wong, Kelvin K. L.; Abbott, Derek; Liu, Xin; Zheng, Hairong			Surface Roughness Detection of Arteries via Texture Analysis of Ultrasound Images for Early Diagnosis of Atherosclerosis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CAROTID-ARTERY; B-MODE; CLASSIFICATION; RISK; PROGRESSION; FEATURES; PLAQUES; SIGNAL; ASSOCIATION	There is a strong research interest in identifying the surface roughness of the carotid arterial inner wall via texture analysis for early diagnosis of atherosclerosis. The purpose of this study is to assess the efficacy of texture analysis methods for identifying arterial roughness in the early stage of atherosclerosis. Ultrasound images of common carotid arteries of 15 normal mice fed a normal diet and 28 apoE(-/-) mice fed a high-fat diet were recorded by a high-frequency ultrasound system (Vevo 2100, frequency: 40 MHz). Six different texture feature sets were extracted based on the following methods: first-order statistics, fractal dimension texture analysis, spatial gray level dependence matrix, gray level difference statistics, the neighborhood gray tone difference matrix, and the statistical feature matrix. Statistical analysis indicates that 11 of 19 texture features can be used to distinguish between normal and abnormal groups (p<0.05). When the 11 optimal features were used as inputs to a support vector machine classifier, we achieved over 89% accuracy, 87% sensitivity and 93% specificity. The accuracy, sensitivity and specificity for the k-nearest neighbor classifier were 73%, 75% and 70%, respectively. The results show that it is feasible to identify arterial surface roughness based on texture features extracted from ultrasound images of the carotid arterial wall. This method is shown to be useful for early detection and diagnosis of atherosclerosis.	[Niu, Lili; Qian, Ming; Yang, Wei; Meng, Long; Xiao, Yang; Liu, Xin; Zheng, Hairong] Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Wong, Kelvin K. L.; Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Wong, Kelvin K. L.; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; University of Adelaide; University of Adelaide	Qian, M (corresponding author), Chinese Acad Sci, Paul C Lauterbur Res Ctr Biomed Imaging, Inst Biomed & Hlth Engn, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	ming.qian@siat.ac.cn; hr.zheng@siat.ac.cn	XIAO, YANG/GPW-5529-2022; Abbott, Derek/E-8352-2011; Wong, Kelvin Kian Loong/ABA-3915-2021; Wong, Kelvin/AAL-8636-2021	Abbott, Derek/0000-0002-0945-2674; Wong, Kelvin Kian Loong/0000-0002-8600-1105; 	National Research Program (973 Grant) from Ministry of Science and Technology, China [2011CB707903, 2013CB733800]; National Science Foundation Grants (NSFC) [11302239, 11304341, 81027006, 61020106008, 11002152, 11272329, 61002001]	National Research Program (973 Grant) from Ministry of Science and Technology, China; National Science Foundation Grants (NSFC)	The work was supported by National Research Program (973 Grant Nos. 2011CB707903 and 2013CB733800) from Ministry of Science and Technology, China, and National Science Foundation Grants (NSFC Grant Nos. 11302239, 11304341, 81027006, 61020106008, 11002152, 11272329, and 61002001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Asvestas P, 2002, ULTRASOUND MED BIOL, V28, P1129, DOI 10.1016/S0301-5629(02)00550-1; Bellman R., 1957, DYNAMIC PROGRAMMING; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Christodoulou CI, 2003, IEEE T MED IMAGING, V22, P902, DOI 10.1109/TMI.2003.815066; Ciccone MM, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-32; Cinthio M, 2011, IEEE T ULTRASON FERR, V58, P853, DOI 10.1109/TUFFC.2011.1879; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Dogan S, 2009, J AM SOC ECHOCARDIOG, V22, P1137, DOI 10.1016/j.echo.2009.07.008; Engler O, 2010, INTRODUCTION TO TEXTURE ANALYSIS: MACROTEXTURE, MICROTEXTURE, AND ORIENTATION MAPPING, 2ND EDITION, P1; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gunarathne GPP, 2001, IEEE T INSTRUM MEAS, V50, P1144, DOI 10.1109/19.963174; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hoeks APG, 1997, ULTRASOUND MED BIOL, V23, P1017, DOI 10.1016/S0301-5629(97)00119-1; Hsue PY, 2004, CIRCULATION, V109, P1603, DOI 10.1161/01.CIR.0000124480.32233.8A; Kadah YM, 1996, IEEE T MED IMAGING, V15, P466, DOI 10.1109/42.511750; Keerthi SS, 2001, NEURAL COMPUT, V13, P637, DOI 10.1162/089976601300014493; Lefebvre F, 2000, ULTRASOUND MED BIOL, V26, P1421, DOI 10.1016/S0301-5629(00)00302-1; Li R, 2008, ADV SPACE RES, V42, P1469, DOI 10.1016/j.asr.2007.12.015; Loizou CP, 2005, IEEE T ULTRASON FERR, V52, P1653, DOI 10.1109/TUFFC.2005.1561621; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; McCrindle BW, 2007, CIRCULATION, V115, P1948, DOI 10.1161/CIRCULATIONAHA.107.181946; Nicolaides AN, 2010, J VASC SURG, V52, P1486, DOI 10.1016/j.jvs.2010.07.021; Niu LL, 2011, ULTRASOUND MED BIOL, V37, P1280, DOI 10.1016/j.ultrasmedbio.2011.05.006; Osowski S, 2004, IEEE T BIO-MED ENG, V51, P582, DOI 10.1109/TBME.2004.824138; Platt J., 1998, SEQUENTIAL MINIMAL O; Polak JF, 1998, RADIOLOGY, V208, P649, DOI 10.1148/radiology.208.3.9722841; Rakebrandt F, 2000, ULTRASOUND MED BIOL, V26, P1393, DOI 10.1016/S0301-5629(00)00314-8; Romero MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055340; Rubba P, 2001, STROKE, V32, P1953, DOI 10.1161/hs0901.095601; Schmidt-Trucksass A, 2003, ATHEROSCLEROSIS, V166, P57, DOI 10.1016/S0021-9150(02)00245-9; Tou J. T., 1974, PATTERN RECOGN; Tsiaparas NN, 2011, IEEE T INF TECHNOL B, V15, P130, DOI 10.1109/TITB.2010.2091511; van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454; Vapnik V., 1998, STAT LEARNING THEORY; Vince DG, 2000, COMPUT MED IMAG GRAP, V24, P221, DOI 10.1016/S0895-6111(00)00011-2; WESZKA JS, 1976, IEEE T SYST MAN CYB, V6, P269, DOI 10.1109/TSMC.1976.5408777; Wilhjelm JE, 2001, IEEE T ULTRASON FERR, V48, P511, DOI 10.1109/58.911734; Wilhjelm JE, 1998, IEEE T MED IMAGING, V17, P910, DOI 10.1109/42.746624; Willekes C, 1999, ULTRASOUND MED BIOL, V25, P57, DOI 10.1016/S0301-5629(98)00138-0; WU CM, 1992, IEEE T MED IMAGING, V11, P141, DOI 10.1109/42.141636; Xie J, 2005, IEEE T MED IMAGING, V24, P45, DOI 10.1109/TMI.2004.837792; Zhang H., 2006, 2006 IEEE COMP SOC C, V2, P2126, DOI [DOI 10.1109/CVPR.2006.301, 10.1109/CVPR.2006.301]; Zhang WY, 2004, ULTRASOUND MED BIOL, V30, P1461, DOI 10.1016/j.ultrasmedbio.2004.08.020; ZWEIG MH, 1993, CLIN CHEM, V39, P561	47	32	34	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76880	10.1371/journal.pone.0076880	http://dx.doi.org/10.1371/journal.pone.0076880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146940	Green Published, gold			2022-12-27	WOS:000326022200023
J	Sahu, SK; Choudhuri, T				Sahu, Sushil Kumar; Choudhuri, Tathagata			Lack of Association between Bax Promoter (-248G > A) Single Nucleotide Polymorphism and Susceptibility towards Cancer: Evidence from a Meta-Analysis	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; BCL-2 PROTEIN EXPRESSION; MICROSATELLITE INSTABILITY; LUNG-CANCER; PANCREATIC-CANCER; PROAPOPTOTIC BAX; CERVICAL-CANCER; GENE-EXPRESSION; GASTRIC-CANCER; CYTOCHROME-C	Background: The Bcl-2-associated X protein (Bax) is a proapoptotic member of the Bcl-2 family known to be activated and upregulated during apoptosis. Single nucleotide polymorphisms (SNPs) in Bax promoter may participate in the process of carcinogenesis by altering its own expression and the cancer related genes. Bax-248G>A polymorphism has been implicated to alter the risk of cancer, but the listed results are inconsistent and inconclusive. In the present study, we performed a meta-analysis to systematically summarize the possible association of this polymorphism with the risk of cancer. Methodology: We conducted a search of case-control studies on the associations of Bax-248G>A polymorphism with susceptibility to cancer in Pub Med, Science Direct, Wiley Online Library and hand search. Data from all eligible studies based on some key search terms, inclusion and exclusion criteria were extracted for this meta-analysis. Hardy-Weinberg equilibrium (HWE) in controls, power calculation, heterogeneity analysis, Begg's funnel plot, Egger's linear regression test, forest plot and sensitivity analysis were performed in the present study. Results: Cancer risk associated with Bax-248G>A polymorphism was estimated by pooled odds ratios (ORs) and 95% confidence intervals (95% CIs). The pooled ORs were calculated in allele contrast, homozygous comparison, heterozygous comparison, dominant and recessive model. Statistical significance was checked through Z and p-value in forest plot. A total of seven independent studies including 1772 cases and 1708 controls were included in our meta-analysis. Our results showed that neither allele frequency nor genotype distributions of this polymorphism were associated with risk for cancer in any of the genetic model. Furthermore, Egger's test did not show any substantial evidence of publication bias. Conclusions/Significance: This meta-analysis suggests that the Bax-248G>A polymorphism is not an important cancer risk factor. Nevertheless, additional well-designed studies with larger sample size focusing on different ethnicities and cancer types are required to further validate the results.	[Sahu, Sushil Kumar; Choudhuri, Tathagata] Inst Life Sci, Div Infect Dis Biol, Bhubaneswar, Orissa, India; [Choudhuri, Tathagata] Visva Bharati, Siksha Vhabana, Dept Biotechnol, Santini Ketan, Bolpur, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Visva Bharati University	Choudhuri, T (corresponding author), Inst Life Sci, Div Infect Dis Biol, Bhubaneswar, Orissa, India.	tatha@ils.res.in	Choudhuri, Tathagata/F-8139-2011		Council of Scientific and Industrial Research, Government of India; Institute of Life Sciences, Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Institute of Life Sciences, Department of Biotechnology, Government of India	SKS was supported by Council of Scientific and Industrial Research, Government of India. This work was supported by an intramural grant of Institute of Life Sciences, Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvari K, 2012, UROL J, V9, P381; Bilim VN, 1998, ANTICANCER RES, V18, P1655; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chen KX, 2007, CARCINOGENESIS, V28, P2008, DOI 10.1093/carcin/bgm172; Chou D, 1996, CANCER GENET CYTOGEN, V88, P136, DOI 10.1016/0165-4608(95)00341-X; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eltahir HA, 2012, MOL BIOL REP, V39, P10833, DOI 10.1007/s11033-012-1978-0; Fegan C, 2006, LEUKEMIA, V20, P1460, DOI 10.1038/sj.leu.2404280; Friess H, 1998, GUT, V43, P414, DOI 10.1136/gut.43.3.414; Gazzaniga P, 1998, ONCOL REP, V5, P901; Gil J, 1999, CANCER RES, V59, P2034; Harima Y, 1998, J CANCER RES CLIN, V124, P503, DOI 10.1007/s004320050206; Ikeguchi M, 2001, INT J MOL MED, V7, P413; Irina A, 2012, INT J BIOMEDICINE, V2, P197; Jeong SH, 2011, DIGEST DIS SCI, V56, P131, DOI 10.1007/s10620-010-1280-8; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Khan MS, 2013, TUMOR BIOL, V34, P521, DOI 10.1007/s13277-012-0577-y; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Krug LM, 2003, LUNG CANCER-J IASLC, V39, P139, DOI 10.1016/S0169-5002(02)00443-9; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lalier L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-153; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lima VP, 2008, WORLD J GASTROENTERO, V14, P884, DOI 10.3748/wjg.14.884; Liu Y, 2012, MOL CELLS, V33, P517, DOI 10.1007/s10059-012-0022-5; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Lopes-Costa PV, 2012, DIAGN CYTOPATHOL, V40, P570, DOI 10.1002/dc.21580; Melarangi T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.102; Ming L, 2006, J BIOL CHEM, V281, P16034, DOI 10.1074/jbc.M513587200; Miquel C, 2005, AM J CLIN PATHOL, V123, P562, DOI 10.1309/JQ2X3RV3L8F9TGYW; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Miyauchi M, 2000, J ORAL PATHOL MED, V29, P180, DOI 10.1034/j.1600-0714.2000.290406.x; Moshynska O, 2005, ONCOGENE, V24, P2042, DOI 10.1038/sj.onc.1208377; Moshynska O, 2003, J CLIN PATHOL-MOL PA, V56, P205, DOI 10.1136/mp.56.4.205; Nardiello T, 2011, CLIN CANCER RES, V17, P4309, DOI 10.1158/1078-0432.CCR-10-1820; Nehls O, 2007, BRIT J CANCER, V96, P1409, DOI 10.1038/sj.bjc.6603728; Nehls O, 2009, INT J COLORECTAL DIS, V24, P655, DOI 10.1007/s00384-009-0635-0; Nueckel H, 2006, LEUKEMIA, V20, P724, DOI 10.1038/sj.leu.2404126; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pirocanac EC, 2002, J SURG RES, V106, P346, DOI 10.1006/jsre.2002.6473; Porebska I, 2006, IN VIVO, V20, P599; Rassidakis GZ, 2002, CLIN CANCER RES, V8, P488; Rodrigues P, 2012, BREAST CANCER RES TR, V133, P769, DOI 10.1007/s10549-012-1980-1; Salah-eldin A, 2000, JPN J CANCER RES, V91, P1269, DOI 10.1111/j.1349-7006.2000.tb00914.x; Saxena A, 2002, CANCER LETT, V187, P199, DOI 10.1016/S0304-3835(02)00378-6; Skogsberg A, 2006, LEUKEMIA, V20, P77, DOI 10.1038/sj.leu.2404030; Starczynski J, 2005, J CLIN ONCOL, V23, P1514, DOI 10.1200/JCO.2005.02.192; Sturm I, 1999, J CLIN ONCOL, V17, P1364, DOI 10.1200/JCO.1999.17.5.1364; Susin SA, 1996, J EXP MED, V184, P1331, DOI 10.1084/jem.184.4.1331; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Thakur N, 2012, MOL BIOL REP, V39, P407, DOI 10.1007/s11033-011-0752-z; Tian X, 2013, ASIAN PAC J CANCER P, V14, P1925, DOI 10.7314/APJCP.2013.14.3.1925; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wojcik I, 2005, NEOPLASMA, V52, P318; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yemliha Yildiz IY, 2013, AM J MOL BIOL, V3, P10, DOI [10.4236/ajmb.2013.31002, DOI 10.4236/AJMB.2013.31002]; Yigit S, 2012, NEOPLASMA, V59, P475, DOI 10.4149/neo_2012_061	60	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77534	10.1371/journal.pone.0077534	http://dx.doi.org/10.1371/journal.pone.0077534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147019	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200043
J	Waltz, X; Romana, M; Hardy-Dessources, MD; Lamarre, Y; Divialle-Doumdo, L; Petras, M; Tarer, V; Hierso, R; Baltyde, KC; Tressieres, B; Lalanne-Mistrih, ML; Maillard, F; Hue, O; Etienne-Julan, M; Connes, P				Waltz, Xavier; Romana, Marc; Hardy-Dessources, Marie-Dominique; Lamarre, Yann; Divialle-Doumdo, Lydia; Petras, Marie; Tarer, Vanessa; Hierso, Regine; Baltyde, Kizzy-Clara; Tressieres, Benoit; Lalanne-Mistrih, Marie-Laure; Maillard, Frederic; Hue, Olivier; Etienne-Julan, Maryse; Connes, Philippe			Hematological and hemorheological Determinants of the Six-Minute Walk Test Performance in Children with Sickle Cell Anemia	PLOS ONE			English	Article							VASOOCCLUSIVE CRISIS; AGGREGATE STRENGTH; IN-VIVO; BLOOD; EXERCISE; DISEASE; RISK; DEFORMABILITY; HEMOGLOBIN; CAPACITY	The six-minute walk test is a well-established submaximal exercise reflecting the functional status and the clinical severity of sickle cell patients. The aim of the present cross-sectional study was to investigate the biological determinants of the six-minute walk test performance in children with sickle cell anemia. Hematological and hemorheological parameters, pulmonary function and the six-minute walk test performance were determined in 42 children with sickle cell anemia at steady state. The performance during the six-minute walk test was normalized for age, sex and height and expressed as percentage of the predicted six-minute walk distance. We showed that a high level of anemia, a low fetal hemoglobin expression and low red blood cell deformability were independent predictors of a low six-minute walk test performance. This study describes for the first time the impact of blood rheology in the six-minute walk test performance in children with sickle cell anemia.	[Waltz, Xavier; Romana, Marc; Hardy-Dessources, Marie-Dominique; Lamarre, Yann; Hierso, Regine; Baltyde, Kizzy-Clara; Lalanne-Mistrih, Marie-Laure; Etienne-Julan, Maryse; Connes, Philippe] Univ Antilles Guyane, UMR Inserm 665, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Hue, Olivier; Connes, Philippe] Univ Antilles Guyane, Dept Physiol, Lab ACTES, EA 3596, Pointe A Pitre, Guadeloupe, France; [Waltz, Xavier; Romana, Marc; Hardy-Dessources, Marie-Dominique; Lamarre, Yann; Hierso, Regine; Baltyde, Kizzy-Clara; Connes, Philippe] PRES Sorbonne Paris Cite, Lab Excellence GR Ex Red Cell Genesis Death, Paris, France; [Divialle-Doumdo, Lydia; Petras, Marie; Etienne-Julan, Maryse] Ctr Hosp & Univ Pointe A Pitre, Unite Transversale Drepanocytose, Pointe A Pitre, Guadeloupe, France; [Tarer, Vanessa; Etienne-Julan, Maryse] Ctr Hosp & Univ Pointe A Pitre, Ctr Reference Malad Rares Drepanocytose Antilles, Pointe A Pitre, Guadeloupe, France; [Tressieres, Benoit; Lalanne-Mistrih, Marie-Laure] Ctr Hosp Univ Pointe A Pitre, CIC EC Inserm 802, Pointe A Pitre, Guadeloupe, France; [Maillard, Frederic] Ctr Hosp & Univ Pointe A Pitre, Serv Pediat, Pointe A Pitre, Guadeloupe, France; [Connes, Philippe] Inst Univ France, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite des Antilles; Universite des Antilles; CHU Guadeloupe; CHU Guadeloupe; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Guadeloupe; Institut Universitaire de France	Connes, P (corresponding author), Univ Antilles Guyane, UMR Inserm 665, Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	WALTZ, Xavier/M-3606-2016; Connes, Philippe/J-7835-2019; Romana, Marc/K-6442-2017; TRESSIERES, Benoit/ABH-1085-2020; Lamarre, Yann/ABC-2074-2020; , Hardy-dessources/K-9189-2017	WALTZ, Xavier/0000-0002-0838-290X; Connes, Philippe/0000-0002-9232-0268; Romana, Marc/0000-0002-8715-9836; , Hardy-dessources/0000-0003-0861-3648; Philippe, Connes/0000-0001-8449-7998; ETIENNE-JULAN, Maryse/0000-0003-1339-6545; Hue, Olivier/0000-0002-2155-0816; Lamarre, Yann/0000-0003-0669-793X	"Projet Hospitalier de Recherche Clinique Interregional" (PHRC); regional council of Guadeloupe; "Projet Hospitalier de Recherche Clinique Interregional" (PHRC); regional council of Guadeloupe	"Projet Hospitalier de Recherche Clinique Interregional" (PHRC); regional council of Guadeloupe; "Projet Hospitalier de Recherche Clinique Interregional" (PHRC); regional council of Guadeloupe	This work was supported by the "Projet Hospitalier de Recherche Clinique Interregional" (PHRC). X. W. thesis was funded by the regional council of Guadeloupe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; Anthi A, 2007, AM J RESP CRIT CARE, V175, P1272, DOI 10.1164/rccm.200610-1498OC; Aufradet E, 2013, CLIN HEMORHEOL MICRO, V54, P297, DOI 10.3233/CH-131735; BALLAS SK, 1992, BLOOD, V79, P2154, DOI 10.1182/blood.V79.8.2154.2154; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Baskurt O, 2008, MICROCIRCULATION, V15, P585, DOI 10.1080/10739680802107447; Caboot JB, 2010, 6 MINUTE WALK TEST C, pA3306; CHARACHE S, 1983, AM J MED, V74, P757, DOI 10.1016/0002-9343(83)91063-X; CHIEN S, 1970, J CLIN INVEST, V49, P623, DOI 10.1172/JCI106273; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Hackney AC, 1997, CLIN SCI, V92, P481, DOI 10.1042/cs0920481; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Kaul DK, 2004, MICROCIRCULATION, V11, P153, DOI 10.1080/10739680490278457; Lamarre Y, 2012, HAEMATOL-HEMATOL J, V97, P1641, DOI 10.3324/haematol.2012.066670; Lemonne N, 2013, BLOOD, V121, P3054, DOI 10.1182/blood-2013-01-480277; Liem RI, 2009, AM J HEMATOL, V84, P645, DOI 10.1002/ajh.21507; Machado RF, 2005, BRIT J HAEMATOL, V130, P445, DOI 10.1111/j.1365-2141.2005.05625.x; Moheeb H, 2007, AM J HEMATOL, V82, P91, DOI 10.1002/ajh.20755; Parthasarathi K, 1999, AM J PHYSIOL-HEART C, V277, pH2145, DOI 10.1152/ajpheart.1999.277.6.H2145; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Smith JA, 1999, AM J PHYSIOL-HEART C, V276, pH2188, DOI 10.1152/ajpheart.1999.276.6.H2188; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Vaya A, 2013, CLIN HEMORHEOL MICRO; Waltz X, HAEMATOLOGI IN PRESS; Waltz X., CLIN HEMORH IN PRESS; Waltz X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052471; Waltz X, 2012, AM J HEMATOL, V87, P1070, DOI 10.1002/ajh.23318; Waltz X, 2012, CLIN HEMORHEOL MICRO, V52, P15, DOI 10.3233/CH-2012-1540	30	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77830	10.1371/journal.pone.0077830	http://dx.doi.org/10.1371/journal.pone.0077830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147086	Green Published, gold			2022-12-27	WOS:000326022200080
J	Buonanno, M; Randers-Pehrson, G; Bigelow, AW; Trivedi, S; Lowy, FD; Spotnitz, HM; Hammer, SM; Brenner, DJ				Buonanno, Manuela; Randers-Pehrson, Gerhard; Bigelow, Alan W.; Trivedi, Sheetal; Lowy, Franklin D.; Spotnitz, Henry M.; Hammer, Scott M.; Brenner, David J.			207-nm UV Light - A Promising Tool for Safe Low-Cost Reduction of Surgical Site Infections. I: In Vitro Studies	PLOS ONE			English	Article							ULTRAVIOLET GERMICIDAL IRRADIATION; RESISTANT STAPHYLOCOCCUS-AUREUS; CARE-ASSOCIATED INFECTIONS; MAMMALIAN-CELLS; LASER-RADIATION; VACUUM ULTRAVIOLET; AIR DISINFECTION; SKIN-CANCER; DNA-DAMAGE; NM	Background: 0.5% to 10% of clean surgeries result in surgical-site infections, and attempts to reduce this rate have had limited success. Germicidal UV lamps, with a broad wavelength spectrum from 200 to 400 nm are an effective bactericidal option against drug-resistant and drug-sensitive bacteria, but represent a health hazard to patient and staff. By contrast, because of its limited penetration, similar to 200 nm far-UVC light is predicted to be effective in killing bacteria, but without the human health hazards to skin and eyes associated with conventional germicidal UV exposure. Aims: The aim of this work was to test the biophysically-based hypothesis that,200 nm UV light is significantly cytotoxic to bacteria, but minimally cytotoxic or mutagenic to human cells either isolated or within tissues. Methods: A Kr-Br excimer lamp was used, which produces 207-nm UV light, with a filter to remove higher-wavelength components. Comparisons were made with results from a conventional broad spectrum 254-nm UV germicidal lamp. First, cell inactivation vs. UV fluence data were generated for methicillin-resistant S. aureus (MRSA) bacteria and also for normal human fibroblasts. Second, yields of the main UV-associated pre-mutagenic DNA lesions (cyclobutane pyrimidine dimers and 6-4 photoproducts) were measured, for both UV radiations incident on 3-D human skin tissue. Results: We found that 207-nm UV light kills MRSA efficiently but, unlike conventional germicidal UV lamps, produces little cell killing in human cells. In a 3-D human skin model, 207-nm UV light produced almost no pre-mutagenic UV-associated DNA lesions, in contrast to significant yields induced by a conventional germicidal UV lamp. Conclusions: As predicted based on biophysical considerations, 207-nm light kills bacteria efficiently but does not appear to be significantly cytotoxic or mutagenic to human cells. Used appropriately, 207-nm light may have the potential for safely and inexpensively reducing surgical-site infection rates, including those of drug-resistant origin.	[Buonanno, Manuela; Randers-Pehrson, Gerhard; Bigelow, Alan W.; Brenner, David J.] Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA; [Trivedi, Sheetal; Lowy, Franklin D.; Hammer, Scott M.] Columbia Univ, Dept Med, Div Infect Dis, Med Ctr, New York, NY USA; [Spotnitz, Henry M.] Columbia Univ, Dept Med, Dept Surg, Med Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University	Brenner, DJ (corresponding author), Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA.	djb3@columbia.edu	buonanno, manuela/AAM-1588-2020	buonanno, manuela/0000-0002-3455-3602	Columbia University Medical Center	Columbia University Medical Center	This was funded through internal funding at Columbia University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P1047, DOI 10.1086/520731; Avdeev SM, 2008, LIGHT ENG, V16, P32; BASFORD JR, 1986, ARCH PHYS MED REHAB, V67, P151, DOI 10.1016/0003-9993(86)90053-5; BERG M, 1991, J BONE JOINT SURG BR, V73, P811, DOI 10.1302/0301-620X.73B5.1894672; Broex ECJ, 2009, J HOSP INFECT, V72, P193, DOI 10.1016/j.jhin.2009.03.020; Conner-Kerr T A, 1998, Ostomy Wound Manage, V44, P50; COOHILL TP, 1986, PHOTOCHEM PHOTOBIOL, V44, P359, DOI 10.1111/j.1751-1097.1986.tb04676.x; Crolla RMPH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044599; Dai TH, 2012, EXPERT REV ANTI-INFE, V10, P185, DOI [10.1586/eri.11.166, 10.1586/ERI.11.166]; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Escombe AR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000043; Frei E, 2011, VASC ENDOVASC SURG, V45, P688, DOI 10.1177/1538574411419528; Fry DE, 2011, SURG INFECT, V12, P191, DOI 10.1089/sur.2011.068; GOLDFARB AR, 1951, SCIENCE, V114, P156, DOI 10.1126/science.114.2954.156; Gosden PE, 1998, J HOSP INFECT, V39, P173, DOI 10.1016/S0195-6701(98)90255-9; GREEN H, 1987, CANCER RES, V47, P410; Haley VB, 2012, INFECT CONT HOSP EP, V33, P565, DOI 10.1086/665710; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Hitzschke L, 2001, P 9 INT S SCI TECHN, P411; JOSE JG, 1985, EXP EYE RES, V41, P545, DOI 10.1016/S0014-4835(85)80011-7; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Koch-Paiz CA, 2004, MUTAT RES-FUND MOL M, V549, P65, DOI 10.1016/j.mrfmmm.2004.01.010; KOCHEVAR IE, 1991, CANCER RES, V51, P288; KOCHEVAR IE, 1990, RADIAT RES, V122, P142, DOI 10.2307/3577598; Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165; Kreusch S, 2003, ANAL BIOCHEM, V313, P208, DOI 10.1016/S0003-2697(02)00460-8; Kubilus J, 2004, ATLA-ALTERN LAB ANIM, V32, P75, DOI 10.1177/026119290403201s12; Lessa FC, 2012, CLIN INFECT DIS, V55, P232, DOI 10.1093/cid/cis408; LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5; LORIAN V, 1985, DIAGN MICR INFEC DIS, V3, P433, DOI 10.1016/0732-8893(85)90082-3; Matafonova GG, 2008, LETT APPL MICROBIOL, V47, P508, DOI 10.1111/j.1472-765X.2008.02461.x; McDonald RS, 2013, EUR CELLS MATER, V25, P204, DOI 10.22203/eCM.v025a15; Metzler DE., 2001, BIOCH CHEM REACTIONS; Miller J, 2011, APPL OPTICS, V50, P876, DOI 10.1364/AO.50.000876; MITCHELL DL, 1988, PHOTODERMATOLOGY, V5, P61; Nardell EA, 2008, PUBLIC HEALTH REP, V123, P52, DOI 10.1177/003335490812300108; PAPADOPOULO D, 1990, P NATL ACAD SCI USA, V87, P8383, DOI 10.1073/pnas.87.21.8383; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; PREISS JW, 1956, J CHEM PHYS, V25, P138, DOI 10.1063/1.1742806; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; QIN XS, 1994, CANCER LETT, V83, P291, DOI 10.1016/0304-3835(94)90332-8; QUICKENDEN TI, 1980, J CHEM PHYS, V72, P4416, DOI 10.1063/1.439733; Rao BK, 2011, OSTOMY WOUND MANAG, V57, P46; Reed NG, 2010, PUBLIC HEALTH REP, V125, P15, DOI 10.1177/003335491012500105; Ritter MA, 2007, J BONE JOINT SURG AM, V89A, P1935, DOI 10.2106/JBJS.F.01037; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Russell LM, 2008, EUR J PHARM BIOPHARM, V69, P861, DOI 10.1016/j.ejpb.2008.02.002; Salvermoser M, 2003, APPL PHYS LETT, V83, P1932, DOI 10.1063/1.1605798; Scott RD, 2009, DIRECT MED COSTS HEA; Sliney D, 2013, PHOTOCHEM PHOTOBIOL, V89, P770, DOI 10.1111/php.12093; SODERBERG PG, 1988, ACTA OPHTHALMOL, V66, P141; Sommer R, 1996, APPL ENVIRON MICROB, V62, P1977, DOI 10.1128/AEM.62.6.1977-1983.1996; Sosnin EA, 2005, INSTRUM EXP TECH+, V48, P663, DOI 10.1007/s10786-005-0118-7; Sosnin EA, 2006, J PHOTOCH PHOTOBIO C, V7, P145, DOI 10.1016/j.jphotochemrev.2006.12.002; Stocks GW, 2011, J ARTHROPLASTY, V26, P771, DOI 10.1016/j.arth.2010.07.001; Stolper G, 2011, 651 MATTEK CORP; TAYLOR GJS, 1995, J HOSP INFECT, V30, P85, DOI 10.1016/0195-6701(95)90148-5; Tscherteu G, 2012, KPN TOWER ROTTERDAM; Volkova G. A., 1984, Journal of Applied Spectroscopy, V41, P1194, DOI 10.1007/BF00659516; Vollkommer F., 1998, Proceedings of 8th International Symposium on the Science and Technology of Light Sources (LS-8), P51; Wang D, 2010, PHOTOCHEM PHOTOBIOL, V86, P176, DOI 10.1111/j.1751-1097.2009.00640.x; Wengraitis S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1480, DOI 10.1111/j.1751-1097.2012.01193.x; ZOLZER F, 1984, PHOTOCHEM PHOTOBIOL, V40, P49, DOI 10.1111/j.1751-1097.1984.tb04552.x	66	78	82	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76968	10.1371/journal.pone.0076968	http://dx.doi.org/10.1371/journal.pone.0076968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146947	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400091
J	Christley, RM; Mort, M; Wynne, B; Wastling, JM; Heathwaite, AL; Pickup, R; Austin, Z; Latham, SM				Christley, Robert M.; Mort, Maggie; Wynne, Brian; Wastling, Jonathan M.; Heathwaite, A. Louise; Pickup, Roger; Austin, Zoe; Latham, Sophia M.			"Wrong, but Useful": Negotiating Uncertainty in Infectious Disease Modelling	PLOS ONE			English	Article							2001 UK FOOT; MOUTH EPIDEMIC; VACCINATION STRATEGIES; SCIENCE; POLICY; OUTBREAK	For infectious disease dynamical models to inform policy for containment of infectious diseases the models must be able to predict; however, it is well recognised that such prediction will never be perfect. Nevertheless, the consensus is that although models are uncertain, some may yet inform effective action. This assumes that the quality of a model can be ascertained in order to evaluate sufficiently model uncertainties, and to decide whether or not, or in what ways or under what conditions, the model should be 'used'. We examined uncertainty in modelling, utilising a range of data: interviews with scientists, policy-makers and advisors, and analysis of policy documents, scientific publications and reports of major inquiries into key livestock epidemics. We show that the discourse of uncertainty in infectious disease models is multi-layered, flexible, contingent, embedded in context and plays a critical role in negotiating model credibility. We argue that usability and stability of a model is an outcome of the negotiation that occurs within the networks and discourses surrounding it. This negotiation employs a range of discursive devices that renders uncertainty in infectious disease modelling a plastic quality that is amenable to 'interpretive flexibility'. The utility of models in the face of uncertainty is a function of this flexibility, the negotiation this allows, and the contexts in which model outputs are framed and interpreted in the decision making process. We contend that rather than being based predominantly on beliefs about quality, the usefulness and authority of a model may at times be primarily based on its functional status within the broad social and political environment in which it acts.	[Christley, Robert M.; Wastling, Jonathan M.; Latham, Sophia M.] Univ Liverpool, Inst Infect & Global Hlth, Neston, Cheshire, England; [Christley, Robert M.; Latham, Sophia M.] Natl Consortium Zoonosis Res, Neston, Cheshire, England; [Mort, Maggie] Univ Lancaster, Dept Sociol, Lancaster, England; [Mort, Maggie] Univ Lancaster, Sch Med, Lancaster, England; [Wynne, Brian] Univ Lancaster, Ctr Econ & Social Aspects Genom, Lancaster, England; [Heathwaite, A. Louise; Austin, Zoe] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Pickup, Roger] Univ Lancaster, Biomed & Life Sci Div, Lancaster, England	University of Liverpool; Lancaster University; Lancaster University; Lancaster University; Lancaster University; Lancaster University	Christley, RM (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Neston, Cheshire, England.	robc@liverpool.ac.uk	Heathwaite, Ann Louise/F-7002-2014	Heathwaite, Ann Louise/0000-0001-8791-0039; Mort, Margaret Mary Elizabeth/0000-0003-0188-324X; Christley, Robert/0000-0001-9250-3032; Pickup, Roger William/0000-0002-9469-1724	UK Research Councils' Rural Economy and Land Use (RELU) programme [RES-229-25-0015]; Economic and Social Research Council; Biotechnology and Biological Sciences Research Council; Natural Environment Research Council; Department for Environment, Food and Rural Affairs (Defra); Scottish Government; Natural Environment Research Council [ceh010010] Funding Source: researchfish	UK Research Councils' Rural Economy and Land Use (RELU) programme; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this project has come from the UK Research Councils' Rural Economy and Land Use (RELU) programme grant number RES-229-25-0015. RELU is funded jointly by the Economic and Social Research Council, the Biotechnology and Biological Sciences Research Council and the Natural Environment Research Council, with additional funding from the Department for Environment, Food and Rural Affairs (Defra) and the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, VET REC, V168, P578, DOI 10.1136/vr.d3377; [Anonymous], 1984, OPENING PANDORAS BOX; [Anonymous], 2001, MINUTES EVIDENCE ENV; Barnes B., 1996, SCI KNOWLEDGE SOCIOL; Beven K., 2009, ENV MODELLING UNCERT; Box GEP, 1979, ROB STAT P WORKSH; Campbell D, 2003, SOC LEGAL STUD, V12, P425, DOI 10.1177/0964663903012004002; Defra, 2011, DEFR CONT PLAN EX NO; Department of Health, 2007, PAND FLU NAT FRAM RE; Environment Food and Rural Affairs Committee, 2002, IMP FOOT MOUTH DIS; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2010, SAC MOD MODELLING UN; Fish R, 2011, PHILOS T R SOC B, V366, P2023, DOI 10.1098/rstb.2010.0400; Guitian J, 2006, VET J, V172, P393, DOI 10.1016/j.tvjl.2006.03.001; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191; Jewell CP, 2009, PREV VET MED, V91, P19, DOI 10.1016/j.prevetmed.2009.05.019; Keeling M, 2006, STAT OF SCI REV PRED; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2003, NATURE, V421, P136, DOI 10.1038/nature01343; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; KEEPIN B, 1984, NATURE, V312, P691, DOI 10.1038/312691a0; Kitching RP, 2006, REV SCI TECH OIE, V25, P293, DOI 10.20506/rst.25.1.1665; Lahsen M, 2005, SOC STUD SCI, V35, P895, DOI 10.1177/0306312705053049; Leach M, 2013, SOC SCI MED, V88, P10, DOI 10.1016/j.socscimed.2013.03.017; MacKenzie Donald, 1990, INVENTING ACCURACY H; Mansley LM, 2011, REV SCI TECH OIE, V30, P483; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; National Audit Office, 2002, 2001 OUTBR FOOT MOUT; Peiso OO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022066; Pinch T, 1992, SHAPING TECHNOLOGY B; Shackley S, 1996, SCI TECHNOL HUM VAL, V21, P275, DOI 10.1177/016224399602100302; Shackley S, 1996, FUTURES, V28, P201, DOI 10.1016/0016-3287(96)00002-X; Shackley S, 1994, WEATHER, V49, P110; Singleton V., 1998, DIFFERENCES MED UNRA, P86; Ster IC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000502; Ster IC, 2009, EPIDEMICS-NETH, V1, P21, DOI 10.1016/j.epidem.2008.09.001; Stirling A, 2010, NATURE, V468, P1029, DOI 10.1038/4681029a; The Royal Society, 2002, INFECT DIS LIVESTOCK; Tildesley MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3239, DOI 10.1098/rspb.2009.0427; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Vynnycky E, 2010, INTR INF DIS MOD; WOOLHOUSE M, 2011, GUIDE GOOD PRACTICE; Woolhouse M, 2011, PHILOS T R SOC B, V366, P2045, DOI 10.1098/rstb.2010.0387; Woolhouse MEJ, 2003, J APPL MICROBIOL, V94, p126S; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; WYNNE B, 1992, GLOBAL ENVIRON CHANG, V2, P111, DOI 10.1016/0959-3780(92)90017-2; Wynne B, 1997, SCI PUBL POLICY, P95	48	29	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76277	10.1371/journal.pone.0076277	http://dx.doi.org/10.1371/journal.pone.0076277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146851	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400051
J	Hao, CZ; Wu, F; Lu, L; Wang, J; Guo, Y; Liu, AJ; Liao, WJ; Zheng, GQ				Hao, Chi-zi; Wu, Fan; Lu, Lin; Wang, Juan; Guo, Yi; Liu, Ai-ju; Liao, Wei-jing; Zheng, Guo-qing			Chinese Herbal Medicine for Diabetic Peripheral Neuropathy: An Updated Meta-Analysis of 10 High-Quality Randomized Controlled Studies	PLOS ONE			English	Article							GLYCEMIC CONTROL; TRIALS; GUIDELINES; STATEMENT; EXERCISE	Background: Diabetic peripheral neuropathy (DPN) is very common in people with diabetes. Chinese herbal medicine (CHM) therapy has been developed for DPN empirically over the years. The aim of this systematic review and meta-analysis was to assess the efficacy and safety of CHMs for patients suffering from DPN. Methods: We performed a meta-analysis of randomized-controlled clinical trials (RCTs) evaluating the efficacy and safety of CHM on DPN. Six databases were searched up to November 2012. The primary outcome measures were the absolute values or changing of motor or sensory nerve conduction velocity (NCV), and the secondary outcome measurements were clinical symptoms improvements and adverse events. The methodological quality was assessed by Jadad scale and the twelve criteria recommended by the Cochrane Back Review Group. Results: One hundred and sixty-three studies claimed RCTs. Ten studies with 653 individuals were further identified based on the Jadad score >= 3. These 10 studies were all of high methodological quality with a low risk of bias. Meta-analysis showed the effects of NCV favoring CHMs when compared with western conventional medicines (WCM) (P<0.05 or P<0.01). There is a significant difference in the total efficacy rate between the two groups (P<0.001). Adverse effects were reported in all of the ten included studies, and well tolerated in all patients with DPN. Conclusion: Despite of the apparently positive findings and low risk of bias, it is premature to conclude the efficacy of CHMs for the treatment of DPN because of the high clinical heterogeneity and small sample sizes of the included studies. However, CHM therapy was safe for DPN. Further standardized preparation, large sample-size and rigorously designed RCTs are required.	[Hao, Chi-zi; Wang, Juan; Liao, Wei-jing] Wuhan Univ, Dept Rehabil, Zhongnan Hosp, Wuhan 430072, Peoples R China; [Wu, Fan; Lu, Lin; Liu, Ai-ju; Zheng, Guo-qing] Wenzhou Med Coll, Ctr Neurol, Affiliated Hosp 2, Wenzhou, Peoples R China; [Guo, Yi] Wuhan Univ, Sch Publ Hlth, Dept Epidemiol, Wuhan 430072, Peoples R China; [Guo, Yi] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University; Wenzhou Medical University; Wuhan University; Wuhan University	Liao, WJ (corresponding author), Wuhan Univ, Dept Rehabil, Zhongnan Hosp, Wuhan 430072, Peoples R China.	weijingliao@sina.com; gq_zheng@sohu.com	Zheng, Guo-qing/A-4412-2019	Zheng, Guo-qing/0000-0001-5286-5696				Agrawal Y, 2010, OTOL NEUROTOL, V31, P1445, DOI 10.1097/MAO.0b013e3181f2f035; *AM DIAB ASS, 1997, DIABETES CARE S, V1, pS1; Balducci S, 2006, J DIABETES COMPLICAT, V20, P216, DOI 10.1016/j.jdiacomp.2005.07.005; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; CAO Y, 2011, THESIS SHANDONG U TR; CHEN L, 2011, THESIS BEIJING U CHI; Chen W, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007796.pub2; Chen W, 2011, FORSCH KOMPLEMENTMED, V18, P134, DOI 10.1159/000328457; CHEN ZQ, 2010, SHANDONG MED J, V50, P9; DAHLJORGENSEN K, 1986, BRIT MED J, V293, P1195, DOI 10.1136/bmj.293.6556.1195; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; GAO B, 2005, MED J LIAONING, V19, P12; HENG XP, 2004, J TRADIT CHIN MED, V45, P917; HU JP, 2012, THESIS GUANGZHOU U C; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; JI JL, 2009, J EMERGENCY TRADITIO, V8, P1304; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kluding PM, 2012, J DIABETES COMPLICAT, V26, P424, DOI 10.1016/j.jdiacomp.2012.05.007; LI L, 2011, THESIS NANJING U CHI; LI YZ, 2005, THESIS HEBEI MED U; LIU Q, 2005, THESIS CHENGDU U TRA; LIU SG, 2004, THESIS FUJIAN COLL T; MA ST, 2005, SICHUAN J PHYSL SCI, V27, P103; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moser JT, 2013, DIABETES RES CLIN PR, V100, pE3, DOI 10.1016/j.diabres.2013.01.015; Perkins BA, 2001, DIABETES CARE, V24, P748, DOI 10.2337/diacare.24.4.748; Rubino Annalisa, 2007, Prim Care Diabetes, V1, P129, DOI 10.1016/j.pcd.2007.07.006; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Stracke H, 1996, EXP CLIN ENDOCR DIAB, V104, P311, DOI 10.1055/s-0029-1211460; Sun W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039647; Sun Yu, 2005, Acta Neurol Taiwan, V14, P48; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WANG MX, 2010, HENAN TRADITIONAL CH, V30, P354; Wang Y, 2012, COMPLEMENT THER MED, V20, P143, DOI 10.1016/j.ctim.2011.12.004; Wooten K, 2009, PHYS MED REH CLIN N, V20, P657, DOI 10.1016/j.pmr.2009.06.011; World Health Organization, 1999, DEF DIAGN CLASS DI 1; WU J, 2010, CHONGQING MED, V39, P1377; Wu Q.L., 2012, WORLD J INTEGRATED T, V7, P860, DOI [10.13935/j.cnki.sjzx.2012.10.008, DOI 10.13935/J.CNKI.SJZX.2012.10.008]; Xu HB, 2012, J ETHNOPHARMACOL, V143, P701, DOI 10.1016/j.jep.2012.07.034; XUE HL, 2005, J CHINESE INTEGRATIV, V3, P31; YAQUB BA, 1992, CLIN NEUROL NEUROSUR, V94, P105, DOI 10.1016/0303-8467(92)90066-C; Zeng Jiang-zheng, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P49; ZHANG Q, 2011, THESIS BEIJING U CHI; ZHANG TJ, 2008, THESIS BEIJING U CHI; ZHANG XK, 2005, SHANXI J TRADITIONAL, V26, P728; Zheng X., 2002, GUIDING PRINCIPLES C, P233; ZHOU XH, 2010, THESIS CHENGDU U TRA	51	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76113	10.1371/journal.pone.0076113	http://dx.doi.org/10.1371/journal.pone.0076113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146822	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400037
J	Larrasoana, JC; Roberts, AP; Rohling, EJ				Larrasoana, Juan C.; Roberts, Andrew P.; Rohling, Eelco J.			Dynamics of Green Sahara Periods and Their Role in Hominin Evolution	PLOS ONE			English	Article							DAKHLA OASIS REGION; WESTERN DESERT; NORTH-AFRICA; MONSOON VARIABILITY; LATE QUATERNARY; PLUVIAL EPISODES; HUMAN DISPERSAL; WATER-BALANCE; PAST CLIMATE; FAZZAN BASIN	Astronomically forced insolation changes have driven monsoon dynamics and recurrent humid episodes in North Africa, resulting in green Sahara Periods (GSPs) with savannah expansion throughout most of the desert. Despite their potential for expanding the area of prime hominin habitats and favouring out-of-Africa dispersals, GSPs have not been incorporated into the narrative of hominin evolution due to poor knowledge of their timing, dynamics and landscape composition at evolutionary timescales. We present a compilation of continental and marine paleoenvironmental records from within and around North Africa, which enables identification of over 230 GSPs within the last 8 million years. By combining the main climatological determinants of woody cover in tropical Africa with paleoenvironmental and paleoclimatic data for representative (Holocene and Eemian) GSPs, we estimate precipitation regimes and habitat distributions during GSPs. Their chronology is consistent with the ages of Saharan archeological and fossil hominin sites. Each GSP took 2-3 kyr to develop, peaked over 4-8 kyr, biogeographically connected the African tropics to African and Eurasian mid latitudes, and ended within 2-3 kyr, which resulted in rapid habitat fragmentation. We argue that the well-dated succession of GSPs presented here may have played an important role in migration and evolution of hominins.	[Larrasoana, Juan C.] Inst Geol & Minero Espana, Zaragoza, Spain; [Larrasoana, Juan C.; Roberts, Andrew P.; Rohling, Eelco J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Rohling, Eelco J.] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr, Southampton, Hants, England	Australian National University; NERC National Oceanography Centre; University of Southampton	Larrasoana, JC (corresponding author), Inst Geol & Minero Espana, Zaragoza, Spain.	jc.larra@igme.es	Roberts, Andrew P/E-6422-2010; Rohling, Eelco J/B-9736-2008; Larrasoana, Juan C./O-1350-2013	Roberts, Andrew P/0000-0003-0566-8117; Rohling, Eelco J/0000-0001-5349-2158; Larrasoana, Juan Cruz/0000-0003-4568-631X	UK Natural Environment Research Council [NE/E01531X/1]; Spanish Ministry of Education [PR2011-0480]; AQUIFER: Hidrologia Subterranea (E72) of the Aragon Government; NERC [NE/E01531X/1, NE/H004424/1, NE/I009906/1] Funding Source: UKRI; Natural Environment Research Council [NE/I009906/1, NE/H004424/1, NE/E01531X/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Spanish Ministry of Education(Spanish Government); AQUIFER: Hidrologia Subterranea (E72) of the Aragon Government; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by projects NE/E01531X/1 (RESET) of the UK Natural Environment Research Council, PR2011-0480 of the Spanish Ministry of Education, and AQUIFER: Hidrologia Subterranea (E72) of the Aragon Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, QUATERNARY SCI REV, V30, P1338, DOI 10.1016/j.quascirev.2010.04.012; Armitage SJ, 2007, QUAT GEOCHRONOL, V2, P181, DOI 10.1016/j.quageo.2006.05.019; Arz HW, 2003, SCIENCE, V300, P118, DOI 10.1126/science.1080325; Ashley GM, 2010, QUATERNARY RES, V74, P333, DOI 10.1016/j.yqres.2010.08.006; Bailey GN, 2011, J HUM EVOL, V60, P257, DOI 10.1016/j.jhevol.2010.01.004; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Bergner AGN, 2003, GLOBAL PLANET CHANGE, V36, P117, DOI 10.1016/S0921-8181(02)00178-9; Blackwell BAB, 2012, QUAT GEOCHRONOL, V10, P430, DOI 10.1016/j.quageo.2012.01.005; Blome MW, 2012, J HUM EVOL, V62, P563, DOI 10.1016/j.jhevol.2012.01.011; BROOKES IA, 1993, QUATERNARY SCI REV, V12, P529, DOI 10.1016/0277-3791(93)90068-W; Brookes IA, 2010, QUATERNARY RES, V74, P252, DOI 10.1016/j.yqres.2010.05.001; Brown FH, 2012, J HUM EVOL, V63, P577, DOI 10.1016/j.jhevol.2012.05.014; Caley T, 2011, QUATERNARY SCI REV, V30, P3705, DOI 10.1016/j.quascirev.2011.09.015; Carrion JS, 2011, QUATERNARY SCI REV, V30, P1281, DOI 10.1016/j.quascirev.2011.04.003; Castaneda IS, 2009, P NATL ACAD SCI USA, V106, P20159, DOI 10.1073/pnas.0905771106; CAUSSE C, 1988, CR ACAD SCI II, V306, P1459; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Crombie MK, 1997, PALAEOGEOGR PALAEOCL, V130, P337, DOI 10.1016/S0031-0182(96)00134-4; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Derricourt R, 2005, J WORLD PREHIST, V19, P119, DOI 10.1007/s10963-006-9002-z; Drake NA, 2008, PALAEOGEOGR PALAEOCL, V263, P131, DOI 10.1016/j.palaeo.2008.02.005; Drake NA, 2013, QUATERN INT, V300, P48, DOI 10.1016/j.quaint.2012.12.018; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Elton S, 2008, J ANAT, V212, P377, DOI 10.1111/j.1469-7580.2008.00872.x; Emeis KC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2000PA000617; Emeis KC, 2000, PALAEOGEOGR PALAEOCL, V158, P371, DOI 10.1016/S0031-0182(00)00059-6; Feibel CS, 2011, NATURE, V476, P39, DOI 10.1038/476039a; Fernandes CA, 2006, J BIOGEOGR, V33, P961, DOI 10.1111/j.1365-2699.2006.01478.x; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Gasse F, 2008, QUATERNARY SCI REV, V27, P2316, DOI 10.1016/j.quascirev.2008.08.027; Geraads D, 2010, QUATERN INT, V212, P159, DOI 10.1016/j.quaint.2009.06.002; Geyh MA, 2008, PALAEOGEOGR PALAEOCL, V257, P1, DOI 10.1016/j.palaeo.2007.07.001; Good SP, 2011, P NATL ACAD SCI USA, V108, P4902, DOI 10.1073/pnas.1013100108; Grant KM, 2012, NATURE, V491, P744, DOI 10.1038/nature11593; Griffin DL, 2002, PALAEOGEOGR PALAEOCL, V182, P65, DOI 10.1016/S0031-0182(01)00453-9; Groucutt HS, 2012, EVOL ANTHROPOL, V21, P113, DOI 10.1002/evan.21308; Hamdan M.A.E., 2000, SEDIMENTOLOGY EGYPT, V8, P49; Hilgen FJ, 1995, EARTH PLANET SC LETT, V136, P495, DOI 10.1016/0012-821X(95)00207-S; Hoelzmann P, 2000, GLOBAL PLANET CHANGE, V26, P105, DOI 10.1016/S0921-8181(00)00038-2; Hooghiemstra H, 2006, QUATERN INT, V148, P29, DOI 10.1016/j.quaint.2005.11.005; Husing SK, 2009, EARTH PLANET SC LETT, V282, P140, DOI 10.1016/j.epsl.2009.03.010; Issawi B., 1992, FOLLOWERS HORUS, P1; Joordens JCA, 2011, EARTH PLANET SC LETT, V307, P1, DOI 10.1016/j.epsl.2011.05.005; Kieniewicz JM, 2009, GEOL SOC AM BULL, V121, P1154, DOI 10.1130/B26301.1; Kleindienst M.R., 2008, OASIS PAPERS 2 P 2 D, P25; KOWALSKI K, 1989, QUATERNARY RES, V32, P335, DOI 10.1016/0033-5894(89)90099-9; Krinner G, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL050992; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; KUTZBACH JE, 1980, QUATERNARY RES, V14, P210, DOI 10.1016/0033-5894(80)90049-6; Lahr MM, 2010, VERTEBR PALEOBIOL PA, P27, DOI 10.1007/978-90-481-9036-2_3; Larrasoana JC, 2003, CLIM DYNAM, V21, P689, DOI 10.1007/s00382-003-0355-z; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lebamba J, 2010, CLIM PAST DISCUSS, V6, P2703; Lebatard AE, 2010, EARTH PLANET SC LETT, V297, P57, DOI 10.1016/j.epsl.2010.06.003; LEZINE AM, 1991, GEOLOGY, V19, P307, DOI 10.1130/0091-7613(1991)019<0307:COACRD>2.3.CO;2; Lezine AM, 2011, QUATERNARY SCI REV, V30, P3001, DOI 10.1016/j.quascirev.2011.07.006; Macgregor DS, 2012, PETROL GEOSCI, V18, P417, DOI 10.1144/petgeo2011-074; Magill CR, 2013, P NATL ACAD SCI USA, V110, P1175, DOI 10.1073/pnas.1209405109; Maslin MA, 2007, J HUM EVOL, V53, P443, DOI 10.1016/j.jhevol.2007.06.005; Maslin Mark A., 2009, P151, DOI 10.1007/978-1-4020-9980-9_13; McBrearty S, 2005, NATURE, V437, P105, DOI 10.1038/nature04008; MCHUGH WP, 1988, J FIELD ARCHAEOL, V15, P361, DOI 10.1179/jfa.1988.15.4.361; MEES F, 1991, Journal of Paleolimnology, V5, P227; Negri A, 2003, PALAEOGEOGR PALAEOCL, V190, P243, DOI 10.1016/S0031-0182(02)00608-9; Nicoll K, 2004, QUATERNARY SCI REV, V23, P561, DOI 10.1016/j.quascirev.2003.10.004; O'Regan HJ, 2011, QUATERNARY SCI REV, V30, P1343, DOI 10.1016/j.quascirev.2009.11.028; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Osinski GR, 2007, EARTH PLANET SC LETT, V253, P378, DOI 10.1016/j.epsl.2006.10.039; Osmond JK, 2004, QUATERNARY RES, V61, P85, DOI 10.1016/j.yqres.2003.09.004; Ouda B, 1998, CR ACAD SCI II A, V326, P855, DOI 10.1016/S1251-8050(98)80024-4; Pachur HJ, 2000, J AFR EARTH SCI, V30, P929, DOI 10.1016/S0899-5362(00)00061-0; Paillou P, 2012, CR GEOSCI, V344, P406, DOI 10.1016/j.crte.2012.07.002; Petit Maire N, 1994, CR HEBD ACAD SCI, V319, P805; Petit-Maire N, 1997, EPISODES, V20, P232, DOI 10.18814/epiiugs/1997/v20i4/004; PETITMAIRE N, 1986, EPISODES, V9, P7; PRELL WL, 1987, J GEOPHYS RES-ATMOS, V92, P8411, DOI 10.1029/JD092iD07p08411; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Ritchie J.C., 1994, HOLOCENE, V4, P9, DOI DOI 10.1177/095968369400400102; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Rohling EJ, 2004, MAR MICROPALEONTOL, V50, P89, DOI 10.1016/S0377-8398(03)00068-9; Rohling EJ, 2002, EARTH PLANET SC LETT, V202, P61, DOI 10.1016/S0012-821X(02)00775-6; Rohling EJ, 2002, CLIM DYNAM, V18, P587, DOI 10.1007/s00382-001-0194-8; ROSSIGNOLSTRICK M, 1983, NATURE, V304, P46, DOI 10.1038/304046a0; Schenau SJ, 1999, MAR GEOL, V153, P117, DOI 10.1016/S0025-3227(98)00086-3; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002995; Smith JR, 2007, J HUM EVOL, V52, P690, DOI 10.1016/j.jhevol.2007.01.004; Smith JR, 2004, GEOARCHAEOLOGY, V19, P407, DOI 10.1002/gea.20004; Smits JM, 2012, MIND AND METHOD OF THE LEGAL ACADEMIC, P35; Sultan M, 1997, QUATERNARY RES, V48, P29, DOI 10.1006/qres.1997.1907; SZABO BJ, 1995, PALAEOGEOGR PALAEOCL, V113, P227, DOI 10.1016/0031-0182(95)00052-N; Templeton AR, 2005, YEARB PHYS ANTHROPOL, V48, P33, DOI 10.1002/ajpa.20351; Tjallingii R, 2008, NAT GEOSCI, V1, P670, DOI 10.1038/ngeo289; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Vaks A, 2007, GEOLOGY, V35, P831, DOI 10.1130/G23794A.1; van der Laan E, 2012, PALAEOGEOGR PALAEOCL, V313, P107, DOI 10.1016/j.palaeo.2011.10.013; van der Made J, 2011, QUATERNARY SCI REV, V30, P1353, DOI 10.1016/j.quascirev.2010.02.028; Watrin J, 2009, CR GEOSCI, V341, P656, DOI 10.1016/j.crte.2009.06.007; Wehausen R, 2000, PALAEOGEOGR PALAEOCL, V158, P325, DOI 10.1016/S0031-0182(00)00057-2; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; WENDORF F, 1993, EGYPT LAST INTERGLAC, P552; Wendorf F, 1994, LATE QUATERNARY CHRO, P147; White F., 1983, VEGETATION AFRICA DE; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004; Zhao YL, 2012, QUATERNARY SCI REV, V57, P58, DOI 10.1016/j.quascirev.2012.10.009	106	156	156	6	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76514	10.1371/journal.pone.0076514	http://dx.doi.org/10.1371/journal.pone.0076514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	239JR	24146882	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400068
J	von Stechow, L; Ruiz-Aracama, A; van de Water, B; Peijnenburg, A; Danen, E; Lommen, A				von Stechow, Louise; Ruiz-Aracama, Ainhoa; van de Water, Bob; Peijnenburg, Ad; Danen, Erik; Lommen, Arjen			Identification of Cisplatin-Regulated Metabolic Pathways in Pluripotent Stem Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; PROFILING REVEALS; CANCER; GENE; RESISTANCE; PROLINE; NUCLEOSIDES; MECHANISMS; APOPTOSIS; METSCAPE	The chemotherapeutic compound, cisplatin causes various kinds of DNA lesions but also triggers other pertubations, such as ER and oxidative stress. We and others have shown that treatment of pluripotent stem cells with cisplatin causes a plethora of transcriptional and post-translational alterations that, to a major extent, point to DNA damage response (DDR) signaling. The orchestrated DDR signaling network is important to arrest the cell cycle and repair the lesions or, in case of damage beyond repair, eliminate affected cells. Failure to properly balance the various aspects of the DDR in stem cells contributes to ageing and cancer. Here, we performed metabolic profiling by mass spectrometry of embryonic stem (ES) cells treated for different time periods with cisplatin. We then integrated metabolomics with transcriptomics analyses and connected cisplatin-regulated metabolites with regulated metabolic enzymes to identify enriched metabolic pathways. These included nucleotide metabolism, urea cycle and arginine and proline metabolism. Silencing of identified proline metabolic and catabolic enzymes indicated that altered proline metabolism serves as an adaptive, rather than a toxic response. A group of enriched metabolic pathways clustered around the metabolite S-adenosylmethionine, which is a hub for methylation and transsulfuration reactions and polyamine metabolism. Enzymes and metabolites with pro-or antioxidant functions were also enriched but enhanced levels of reactive oxygen species were not measured in cisplatin-treated ES cells. Lastly, a number of the differentially regulated metabolic enzymes were identified as target genes of the transcription factor p53, pointing to p53-mediated alterations in metabolism in response to genotoxic stress. Altogether, our findings reveal interconnecting metabolic pathways that are responsive to cisplatin and may serve as signaling modules in the DDR in pluripotent stem cells.	[von Stechow, Louise; van de Water, Bob; Danen, Erik] Leiden Univ, Dept Toxicol, LACDR, Leiden, Netherlands; [Ruiz-Aracama, Ainhoa; Peijnenburg, Ad; Lommen, Arjen] RIKILT Inst Food Safety, Wageningen, Netherlands; [von Stechow, Louise; Ruiz-Aracama, Ainhoa] Netherlands Toxicogen Ctr, Maastricht, Netherlands	Leiden University; Leiden University - Excl LUMC; Wageningen University & Research	Danen, E (corresponding author), Leiden Univ, Dept Toxicol, LACDR, Leiden, Netherlands.	e.danen@lacdr.leidenuniv.nl; arjen.lommen@wur.nl	Aracama, Ainhoa Ruiz/S-2836-2019; Ruiz, Ainhoa/G-1842-2015	Ruiz, Ainhoa/0000-0002-2004-425X; danen, erik/0000-0002-0491-6345	Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO) [050-060-510]	Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO): nr 050-060-510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Ben-David U, 2011, NAT REV CANCER, V11, P268, DOI 10.1038/nrc3034; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cano KE, 2010, J PROTEOME RES, V9, P5382, DOI 10.1021/pr100614a; Cavill R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001113; Cervelli M, 2012, AMINO ACIDS, V42, P441, DOI 10.1007/s00726-011-1014-z; Chen Helen H. W., 2010, Metal-Based Drugs, P430939, DOI 10.1155/2010/430939; Christensen KE, 2008, VITAM HORM, V79, P393, DOI 10.1016/S0083-6729(08)00414-7; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Duarte IF, 2010, J PROTEOME RES, V9, P5877, DOI 10.1021/pr100635n; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gao J, 2010, BIOINFORMATICS, V26, P971, DOI 10.1093/bioinformatics/btq048; GEHRKE CW, 1979, CANCER RES, V39, P1150; Hector S, 2004, MOL CANCER THER, V3, P813; Hsu WY, 2009, CLIN CHIM ACTA, V402, P31, DOI 10.1016/j.cca.2008.12.009; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jansen BAJ, 2002, J INORG BIOCHEM, V89, P197, DOI 10.1016/S0162-0134(02)00381-1; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Liu Y, 2008, ONCOGENE, V27, P6729, DOI 10.1038/onc.2008.322; Loffler M, 2005, TRENDS MOL MED, V11, P430, DOI 10.1016/j.molmed.2005.07.003; Lommen A, 2011, METABOLOMICS, V7, P15, DOI 10.1007/s11306-010-0230-y; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu SC, 2008, J GASTROEN HEPATOL, V23, pS73, DOI 10.1111/j.1440-1746.2007.05289.x; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Morris SM, 2004, J NUTR, V134, p2765S, DOI 10.1093/jn/134.10.2765S; Morris SM, 2004, J NUTR, V134, p2743S, DOI 10.1093/jn/134.10.2743S; Motorin Y, 2011, WIRES RNA, V2, P611, DOI 10.1002/wrna.79; Niehrs C, 2009, DIFFERENTIATION, V77, P1, DOI 10.1016/j.diff.2008.09.004; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pederzolli CD, 2009, METAB BRAIN DIS, V24, P283, DOI 10.1007/s11011-009-9137-6; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; Pines A, 2011, MOL CELL BIOL, V31, P4964, DOI 10.1128/MCB.05258-11; Puigvert JC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003208; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Ruiz-Aracama A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-251; Seidel A, 2006, BRIT J CANCER, V94, P1726, DOI 10.1038/sj.bjc.6603164; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Tan XL, 2011, CLIN CANCER RES, V17, P5801, DOI 10.1158/1078-0432.CCR-11-1133; Tichy ED, 2011, EXP BIOL MED, V236, P987, DOI 10.1258/ebm.2011.011107; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang XY, 2007, ANTI-CANCER AGENT ME, V7, P19, DOI 10.2174/187152007779314062; Welin M, 2010, BIOCHEM BIOPH RES CO, V396, P157, DOI 10.1016/j.bbrc.2010.04.054; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Yan XD, 2007, J PROTEOME RES, V6, P772, DOI 10.1021/pr060402r; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Zhang GF, 2011, J BIOL CHEM, V286, P23631, DOI 10.1074/jbc.R110.171405	53	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76476	10.1371/journal.pone.0076476	http://dx.doi.org/10.1371/journal.pone.0076476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146875	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400063
J	Chiba, Y; Mizoguchi, I; Mitobe, K; Higuchi, K; Nagai, H; Nishigori, C; Mizuguchi, J; Yoshimoto, T				Chiba, Yukino; Mizoguchi, Izuru; Mitobe, Kana; Higuchi, Kaname; Nagai, Hiroshi; Nishigori, Chikako; Mizuguchi, Junichiro; Yoshimoto, Takayuki			IL-27 Enhances the Expression of TRAIL and TLR3 in Human Melanomas and Inhibits Their Tumor Growth in Cooperation with a TLR3 Agonist Poly(I:C) Partly in a TRAIL-Dependent Manner	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; NATURAL-KILLER-CELLS; ANTITUMOR ACTIVITIES; COMPLETE REGRESSION; INDUCED APOPTOSIS; I INTERFERONS; RIG-I; T-BET; INTERLEUKIN-27; CYTOKINE	Interleukin (IL)-27 is a member of the IL-6/IL-12 cytokine family and possesses potent antitumor activity, which is mediated by multiple mechanisms. Toll-like receptor (TLR) 3 is the critical sensor of the innate immune system that serves to identify viral double-stranded RNA. TLR3 is frequently expressed by various types of malignant cells, and recent studies reported that a synthetic TLR3 agonist, polyinosinic-polycytidylic acid [poly(I:C)], induces antitumor effects on malignant cells. In the present study, we have explored the effect of IL-27 on human melanomas and uncovered a previously unknown mechanism. We found that IL-27 inhibits in vitro tumor growth of human melanomas and greatly enhances the expression of TNF-related apoptosis inducing ligand (TRAIL) in a dose-dependent manner. Neutralizing antibody against TRAIL partly but significantly blocked the IL-27-mediated inhibition of tumor growth. In addition, IL-27 and poly(I: C) cooperatively augmented TRAIL expression and inhibited tumor growth. The cooperative effect could be ascribed to the augmented expression of TLR3, but not retinoic acid-inducible gene-I or anti-melanoma differentiation-associated gene 5, by IL-27. The inhibition of tumor growth by the combination was also significantly abrogated by anti-TRAIL neutralizing antibody. Moreover, IL-27 and poly(I:C) cooperatively suppressed in vivo tumor growth of human melanoma in immunodeficient mice. Taken together, these results suggest that IL-27 enhances the expression of TRAIL and TLR3 in human melanomas and inhibits their tumor growth in cooperation with poly(I:C), partly in a TRAIL-dependent manner. Thus, IL-27 and the combination of IL-27 and poly(I:C) may be attractive candidates for cancer immunotherapy.	[Chiba, Yukino; Mizoguchi, Izuru; Mitobe, Kana; Higuchi, Kaname; Yoshimoto, Takayuki] Tokyo Med Univ, Inst Med Sci, Dept Immunoregulat, Tokyo 1608402, Japan; [Higuchi, Kaname; Mizuguchi, Junichiro] Tokyo Med Univ, Dept Immunol, Tokyo 1608402, Japan; [Nagai, Hiroshi; Nishigori, Chikako] Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Dermatol, Kobe, Hyogo 657, Japan	Tokyo Medical University; Tokyo Medical University; Kobe University	Yoshimoto, T (corresponding author), Tokyo Med Univ, Inst Med Sci, Dept Immunoregulat, Tokyo 1608402, Japan.	yoshimot@tokyo-med.ac.jp	Yoshimoto, Takayuki/AAN-7995-2020	Yoshimoto, Takayuki/0000-0002-2847-0341	Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [24659595, 25118727, 23590475] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grant-in-Aid for Scientific Research and "University-Industry Joint Research'' Project from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Airoldi I, 2011, J LEUKOCYTE BIOL, V90, P875, DOI 10.1189/jlb.0511237; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Canale S, 2011, LEUKEMIA, V25, P1815, DOI 10.1038/leu.2011.158; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chawla-Sarkar M, 2001, CLIN CANCER RES, V7, P1821; Cheng YS, 2010, CANCER BIOL THER, V10, P1219, DOI 10.4161/cbt.10.12.13450; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Clarke N, 2004, EMBO J, V23, P3051, DOI 10.1038/sj.emboj.7600302; Cocco C, 2012, LEUKEMIA, V26, P1365, DOI 10.1038/leu.2011.363; Cocco C, 2010, CLIN CANCER RES, V16, P4188, DOI 10.1158/1078-0432.CCR-10-0173; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guzzo C, 2012, J IMMUNOL, V188, P864, DOI 10.4049/jimmunol.1101912; Heinz S, 2003, J BIOL CHEM, V278, P21502, DOI 10.1074/jbc.M301476200; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Ho MY, 2009, J IMMUNOL, V183, P6217, DOI 10.4049/jimmunol.0901272; Huang B, 2005, CANCER RES, V65, P5009, DOI 10.1158/0008-5472.CAN-05-0784; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Inao T, 2012, BREAST CANCER RES TR, V134, P89, DOI 10.1007/s10549-011-1930-3; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; Kitahara Y, 2010, EUR J IMMUNOL, V40, P2590, DOI 10.1002/eji.201040604; KROWN SE, 1985, J BIOL RESP MODIF, V4, P640; Kuo RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063431; Liu L, 2008, SCAND J IMMUNOL, V68, P22, DOI 10.1111/j.1365-3083.2008.02111.x; Matsui M, 2009, CANCER RES, V69, P2523, DOI 10.1158/0008-5472.CAN-08-2793; Matsumoto M, 2004, MICROBIOL IMMUNOL, V48, P147, DOI 10.1111/j.1348-0421.2004.tb03500.x; Moschos S, 2007, CYTOKINE GROWTH F R, V18, P451, DOI 10.1016/j.cytogfr.2007.06.020; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Owaki T, 2008, J IMMUNOL, V180, P2903, DOI 10.4049/jimmunol.180.5.2903; Owaki T, 2006, J IMMUNOL, V176, P2773, DOI 10.4049/jimmunol.176.5.2773; Papageorgiou A, 2007, CANCER BIOL THER, V6, P872, DOI 10.4161/cbt.6.6.4088; Park SY, 2004, EUR J BIOCHEM, V271, P4222, DOI 10.1111/j.1432-1033.2004.04362.x; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Ryffel B, 1997, CLIN IMMUNOL IMMUNOP, V83, P18, DOI 10.1006/clin.1996.4306; Salaun B, 2007, CLIN CANCER RES, V13, P4565, DOI 10.1158/1078-0432.CCR-07-0274; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Salaun B, 2011, CANCER RES, V71, P1607, DOI 10.1158/0008-5472.CAN-10-3490; Salcedo R, 2004, J IMMUNOL, V173, P7170, DOI 10.4049/jimmunol.173.12.7170; Salcedo R, 2009, J IMMUNOL, V182, P4328, DOI 10.4049/jimmunol.0800471; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Taura M, 2010, CANCER SCI, V101, P1610, DOI 10.1111/j.1349-7006.2010.01567.x; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yoshimoto T, 2003, J IMMUNOL, V171, P1352, DOI 10.4049/jimmunol.171.3.1352; Yoshimoto T, 2008, J IMMUNOL, V180, P6527, DOI 10.4049/jimmunol.180.10.6527; Zorzoli A, 2012, CLIN CANCER RES, V18, P1630, DOI 10.1158/1078-0432.CCR-11-2432	55	25	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76159	10.1371/journal.pone.0076159	http://dx.doi.org/10.1371/journal.pone.0076159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155891	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300025
J	Dietrich, D; Uhl, B; Sailer, V; Holmes, EE; Jung, M; Meller, S; Kristiansen, G				Dietrich, Dimo; Uhl, Barbara; Sailer, Verena; Holmes, Emily Eva; Jung, Maria; Meller, Sebastian; Kristiansen, Glen			Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition	PLOS ONE			English	Article							METHYLATION BIOMARKERS; GENOMIC DNA; CANCER; PITX2; AMPLIFICATION; POLYMERASE; EXTRACTION; RETRIEVAL; DIAGNOSIS; RECOVERY	Formalin-fixed and paraffin-embedded (FFPE) tissues represent a valuable source for biomarker studies and clinical routine diagnostics. However, they suffer from degradation of nucleic acids due to the fixation process. Since genetic and epigenetic studies usually require PCR amplification, this degradation hampers its use significantly, impairing PCR robustness or necessitating short amplicons. In routine laboratory medicine a highly robust PCR performance is mandatory for the clinical utility of genetic and epigenetic biomarkers. Therefore, methods to improve PCR performance using DNA from FFPE tissue are highly desired and of wider interest. The effect of template DNA derived from FFPE tissues on PCR performance was investigated by means of qPCR and conventional PCR using PCR fragments of different sizes. DNA fragmentation was analyzed via agarose gel electrophoresis. This study showed that poor PCR amplification was partly caused by inhibition of the DNA polymerase by fragmented DNA from FFPE tissue and not only due to the absence of intact template molecules of sufficient integrity. This PCR inhibition was successfully minimized by increasing the polymerase concentration, dNTP concentration and PCR elongation time thereby allowing for the robust amplification of larger amplicons. This was shown for genomic template DNA as well as for bisulfite-converted template DNA required for DNA methylation analyses. In conclusion, PCR using DNA from FFPE tissue suffers from inhibition which can be alleviated by adaptation of the PCR conditions, therefore allowing for a significant improvement of PCR performance with regard to variability and the generation of larger amplicons. The presented solutions to overcome this PCR inhibition are of tremendous value for clinical chemistry and laboratory medicine.	[Dietrich, Dimo; Uhl, Barbara; Sailer, Verena; Holmes, Emily Eva; Jung, Maria; Meller, Sebastian; Kristiansen, Glen] Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany	University of Bonn	Dietrich, D (corresponding author), Univ Hosp Bonn UKB, Inst Pathol, Bonn, Germany.	dimo.dietrich@gmail.com						Banez LL, 2010, J UROLOGY, V184, P149, DOI 10.1016/j.juro.2010.03.012; Benson LM, 2003, J AM SOC MASS SPECTR, V14, P601, DOI 10.1016/S1044-0305(03)00148-X; Bereczki L, 2007, PATHOL ONCOL RES, V13, P209, DOI 10.1007/BF02893501; Bielawski K, 2001, INT J MOL MED, V8, P573; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Bonin S, 2003, J CLIN PATHOL-MOL PA, V56, P184, DOI 10.1136/mp.56.3.184; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dietrich D, 2013, J MOL DIAGN, V15, P270, DOI 10.1016/j.jmoldx.2012.11.002; Dietrich D, 2012, DIAGN MOL PATHOL, V21, P93, DOI 10.1097/PDM.0b013e318240503b; Dietrich D, 2012, INT J ONCOL, V40, P825, DOI 10.3892/ijo.2011.1264; Dietrich D, 2009, J HISTOCHEM CYTOCHEM, V57, P477, DOI 10.1369/jhc.2009.953026; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000537; Gnanapragasam VJ, 2010, BJU INT, V105, P274, DOI 10.1111/j.1464-410X.2009.08665.x; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Huang WY, 2010, CANCER EPIDEM BIOMAR, V19, P973, DOI 10.1158/1055-9965.EPI-10-0091; Huijsmans Cornelis Jj, 2010, BMC Res Notes, V3, P239, DOI 10.1186/1756-0500-3-239; Inadome Y, 2003, DIAGN MOL PATHOL, V12, P231, DOI 10.1097/00019606-200312000-00007; Kneip C, 2011, J THORAC ONCOL, V6, P1632, DOI 10.1097/JTO.0b013e318220ef9a; Kneip C, 2009, BIOTECHNIQUES, V47, P737, DOI 10.2144/000113208; Kristensen LS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-453; KUYKENDALL JR, 1992, MUTAT RES, V283, P131, DOI 10.1016/0165-7992(92)90145-8; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Mikeska T, 2012, EXPERT REV MOL DIAGN, V12, P473, DOI [10.1586/ERM.12.45, 10.1586/erm.12.45]; Nimmrich I, 2008, BREAST CANCER RES TR, V111, P429, DOI 10.1007/s10549-007-9800-8; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Sam SS, 2012, PATHOL RES PRACT, V208, P705, DOI 10.1016/j.prp.2012.08.008; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Vinarskaja A, 2011, UROL ONCOL, DOI [10.1016/j.urolonc.2011.04.01, DOI 10.1016/J.UROLONC.2011.04.01]; Weiss G, 2009, J UROLOGY, V181, P1678, DOI 10.1016/j.juro.2008.11.120; Zsikla V, 2004, J CLIN PATHOL, V57, P654, DOI 10.1136/jcp.2003.013961	35	86	90	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77771	10.1371/journal.pone.0077771	http://dx.doi.org/10.1371/journal.pone.0077771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155973	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300107
J	Schmitt, LHM; Brugere, C				Schmitt, Laetitia Helene Marie; Brugere, Cecile			Capturing Ecosystem Services, Stakeholders' Preferences and Trade-Offs in Coastal Aquaculture Decisions: A Bayesian Belief Network Application	PLOS ONE			English	Article							SHRIMP AQUACULTURE; FARMING SYSTEMS; MANAGEMENT; INTEGRATION; VALUATION; CONFLICTS; THAILAND; DELTA	Aquaculture activities are embedded in complex social-ecological systems. However, aquaculture development decisions have tended to be driven by revenue generation, failing to account for interactions with the environment and the full value of the benefits derived from services provided by local ecosystems. Trade-offs resulting from changes in ecosystem services provision and associated impacts on livelihoods are also often overlooked. This paper proposes an innovative application of Bayesian belief networks - influence diagrams - as a decision support system for mediating trade-offs arising from the development of shrimp aquaculture in Thailand. Senior experts were consulted (n = 12) and primary farm data on the economics of shrimp farming (n = 20) were collected alongside secondary information on ecosystem services, in order to construct and populate the network. Trade-offs were quantitatively assessed through the generation of a probabilistic impact matrix. This matrix captures nonlinearity and uncertainty and describes the relative performance and impacts of shrimp farming management scenarios on local livelihoods. It also incorporates export revenues and provision and value of ecosystem services such as coastal protection and biodiversity. This research shows that Bayesian belief modeling can support complex decision-making on pathways for sustainable coastal aquaculture development and thus contributes to the debate on the role of aquaculture in social-ecological resilience and economic development.	[Schmitt, Laetitia Helene Marie] Univ York, Dept Econ & Related Studies, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Brugere, Cecile] Univ York, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK	Brugere, C (corresponding author), Univ York, Stockholm Environm Inst, York YO10 5DD, N Yorkshire, England.	cecile.brugere@sei-international.org			Marie Curie Intra European Fellowship project ECOLIVA "Sustainable ECOsystem services and LIVelihoods through Aquaculture development" [PIEF-GA-2009-235835]; European Community	Marie Curie Intra European Fellowship project ECOLIVA "Sustainable ECOsystem services and LIVelihoods through Aquaculture development"; European Community(European Commission)	This research was supported by the Marie Curie Intra European Fellowship project ECOLIVA "Sustainable ECOsystem services and LIVelihoods through Aquaculture development" (Project No: PIEF-GA-2009-235835, 2010-11) funded under the European Community 7th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	(ADB) Asian Development Bank (NACA) Network of Aquaculture Centres in Asia-Pacific, 1997, SHRIMP CARP AQ SUST; Ashley Caroline, 1999, SUSTAINABLE LIVELIHO; Bailey C., 2008, FAO Fisheries and Aquaculture Proceedings, P37; Baran E, 2006, COMPR ASSESS WAT MAN, V2, P206, DOI 10.1079/9781845931070.0206; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Binh CT, 1997, AQUAC RES, V28, P599, DOI 10.1046/j.1365-2109.1997.00901.x; Borsuk ME, 2004, ECOL MODEL, V173, P219, DOI 10.1016/j.ecolmodel.2003.08.020; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Brander LM, 2006, ENVIRON RESOUR ECON, V33, P223, DOI 10.1007/s10640-005-3104-4; Brugere C, 2006, COMP ASSESS WAT MAN, V2, P258, DOI 10.1079/9781845931070.0258; Bunting SW, 2013, AQUACULT ECON MANAG, V17, P51, DOI 10.1080/13657305.2013.747226; Bush SR, 2010, ECOL SOC, V15; Cain J, 2001, PLANNING IMPROVEMENT; Castelletti A, 2007, ENVIRON MODELL SOFTW, V22, P1073, DOI 10.1016/j.envsoft.2006.06.001; Davy FB, 2011, SUCCESS STORIES ASIA; FAO, 2011, AQ PROD QUANT VAL 19; FAO NACA UNEP WB, 2006, INT PRINC RESP SHRIM; Farmani R, 2009, ENVIRON MODELL SOFTW, V24, P303, DOI 10.1016/j.envsoft.2008.08.005; Fisher B, 2008, ECOL APPL, V18, P2050, DOI 10.1890/07-1537.1; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fisheries Department, 2008, THAIL EXP OPP AQ CER; Funge-Smith SJ, 1995, EC FACTORS RISKS INF; Hishamunda N, 2009, FOOD POLICY, V34, P102, DOI 10.1016/j.foodpol.2008.06.006; Huitric M, 2002, ECOL ECON, V40, P441, DOI 10.1016/S0921-8009(02)00011-3; Kasai C, 2005, FISHERIES SCI, V71, P791, DOI 10.1111/j.1444-2906.2005.01029.x; Kongkeo H, 1997, AQUAC RES, V28, P789; Kragt M, 2009, INTEGRATED HYDROECON; Levontin P, 2011, ICES J MAR SCI, V68, P632, DOI 10.1093/icesjms/fsr004; Lewis III R.R., 2001, MANGROVE RESTORATION; Loawapong A, 2010, BACKGROUND REPORT FI; Marcot BG, 2001, FOREST ECOL MANAG, V153, P29, DOI 10.1016/S0378-1127(01)00452-2; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Martinez-Alier J, 2001, ENVIRON PLANN C, V19, P713, DOI 10.1068/c15s; McCann RK, 2006, CAN J FOREST RES, V36, P3053, DOI 10.1139/X06-238; McNay RS, 2006, CAN J FOREST RES, V36, P3117, DOI 10.1139/X06-258; NACA WWF, 2010, SUPP DEM SMALL SCAL; Neiland AE, 2001, MAR POLICY, V25, P265, DOI 10.1016/S0308-597X(01)00017-3; Primavera J.H, 2000, INTEGRATED MANGROVE, P121; Raux P, 2001, LIT REV WORLD SHRIMP, P5; Sadoddin A, 2012, INT J ENV RESOURCES, V1, P1; Sathirathai S., 1998, EC VALUATION MANGROV; Senanan W, 2007, J SHELLFISH RES, V26, P1187, DOI 10.2983/0730-8000(2007)26[1187:TPOTPW]2.0.CO;2; Slater MJ, 2013, OCEAN COAST MANAGE, V73, P22, DOI 10.1016/j.ocecoaman.2012.12.002; Soto D., 2008, FAO Fisheries and Aquaculture Proceedings, P15; Stevenson NJ, 1997, COAST MANAGE, V25, P425, DOI 10.1080/08920759709362334; Szuster B, 2006, COMPR ASSESS WAT MAN, V2, P86, DOI 10.1079/9781845931070.0086; Thailand Customs Department, 2007, STAT SHRIMP IMP EXP; Ticehurst JL, 2007, ENVIRON MODELL SOFTW, V22, P1129, DOI 10.1016/j.envsoft.2006.03.003; Troell M., 2009, FAO Fisheries and Aquaculture Technical Paper, P47; Umesh NR, 2010, SUCCESS STORIES IN ASIAN AQUACULTURE, P41, DOI 10.1007/978-90-481-3087-0_3; Umesh N. R., 2007, Aquaculture Asia Magazine, V12, P8; Uusitalo L, 2007, ECOL MODEL, V203, P312, DOI 10.1016/j.ecolmodel.2006.11.033; Varis O, 1999, ECOL MODEL, V119, P177, DOI 10.1016/S0304-3800(99)00061-7; Wyban J., 2007, Aqua Culture Asia Pacific, V3, P16	54	46	47	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75956	10.1371/journal.pone.0075956	http://dx.doi.org/10.1371/journal.pone.0075956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155876	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300010
J	Chen, AT; Tang, DD; Chen, XF				Chen, Antao; Tang, Dandan; Chen, Xuefei			Training Reveals the Sources of Stroop and Flanker Interference Effects	PLOS ONE			English	Article							STIMULUS-RESPONSE COMPATIBILITY; COGNITIVE CONTROL; ANTERIOR CINGULATE; CONFLICT; TASK; MECHANISMS; CORTEX; AUTOMATICITY; OVERLAP; WORDS	In the field of cognitive control, dimensional overlap and pathway automaticity are generally believed to be critical for the generation of congruency effects. However, their specific roles in the generation of congruency effects are unclear. In two experiments, with the 4: 2 mapping design, we investigated this issue by examining the training-related effects on congruency effects (the Stroop interference effect and the Flanker interference effect in Experiments 1 and 2, respectively) normally expressed as incongruent minus congruent difference and on their subcomponents (the stimulus interference and response interference). Experiment 1 revealed that the stimulus interference in the Stroop task, wherein the task-relevant (printed color of word) and the task-irrelevant (semantics of word) dimensions of the stimuli were processed in different pathways, was present during early training but was virtually eliminated at the late stage of training. This indicates that the two dimensions overlap at the early stage but separate at the late stage. In contrast, Experiment 2 showed that the response interference in a variant of the Flanker task, wherein the task-relevant (central color word printed in black font) and the task-irrelevant (flanking color words printed in black font) dimensions of the stimuli were processed in the same pathway, was enhanced after training. This indicates that the enhanced automaticity of irrelevant-dimension processing induces stronger response competition, which therefore results in the larger response interference. Taken together, the present study demonstrates that (1) dimensional overlap is necessary for the generation of congruency effects, (2) pathway automaticity can affect the size of congruency effects, and (3) training enhances the degree of automatic processing in a given pathway.	[Chen, Antao; Tang, Dandan] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Chen, Antao; Tang, Dandan] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Chen, Antao] Liaoning Normal Univ, Sch Psychol, Dalian, Liaoning, Peoples R China; [Chen, Xuefei] Qujing Normal Univ, Teacher Educ Sch, Qujing, Yunnan, Peoples R China	Southwest University - China; Southwest University - China; Liaoning Normal University	Chen, AT (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xscat@swu.edu.cn; 524802481@qq.com			Fundamental Research Funds for the Central Universities [SWU1009001]; National Natural Science Foundation of China [31170980, 81271477]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]; New Century Excellent Talents in University [NCET-11-0698]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the Fundamental Research Funds for the Central Universities (SWU1009001), the National Natural Science Foundation of China (31170980, 81271477), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), and the New Century Excellent Talents in University (NCET-11-0698). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Chen AT, 2011, INT J PSYCHOPHYSIOL, V80, P129, DOI 10.1016/j.ijpsycho.2011.02.012; Chen ZC, 2013, NEUROIMAGE, V66, P577, DOI 10.1016/j.neuroimage.2012.10.028; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; COHEN JD, 1992, AM J PSYCHOL, V105, P239, DOI 10.2307/1423029; Dalrymple-Alford E, 1972, ATTEN PERCEPT PSYCHO, V11, P274; David IA, 2011, EXP BRAIN RES, V208, P595, DOI 10.1007/s00221-010-2507-9; De Houwer J, 2003, MEM COGNITION, V31, P353, DOI 10.3758/BF03194393; DULANEY CL, 1994, J EXP PSYCHOL LEARN, V20, P470, DOI 10.1037/0278-7393.20.2.470; DYER FN, 1973, J EXP PSYCHOL, V98, P102, DOI 10.1037/h0034278; Erickson KI, 2004, HUM BRAIN MAPP, V21, P98, DOI 10.1002/hbm.10158; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; KLEIN GS, 1964, AM J PSYCHOL, V77, P576, DOI 10.2307/1420768; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Liu PD, 2012, J COGN PSYCHOL, V24, P457, DOI 10.1080/20445911.2011.651080; MACLEOD CM, 1988, J EXP PSYCHOL LEARN, V14, P126, DOI 10.1037/0278-7393.14.1.126; MacLeod CM, 1998, MEM COGNITION, V26, P201, DOI 10.3758/BF03201133; Matsumoto K, 2004, SCIENCE, V303, P969, DOI 10.1126/science.1094733; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Polk TA, 2008, J NEUROSCI, V28, P13786, DOI 10.1523/JNEUROSCI.1026-08.2008; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; SCHEIBE KE, 1967, ACTA PSYCHOL, V26, P286, DOI 10.1016/0001-6918(67)90028-5; Schmidt JR, 2005, CAN J EXP PSYCHOL, V59, P132, DOI 10.1037/h0087468; SEYMOUR PHK, 1977, Q J EXP PSYCHOL, V29, P245, DOI 10.1080/14640747708400601; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; STIRLING N, 1979, Q J EXP PSYCHOL, V31, P121, DOI 10.1080/14640747908400712; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; THEIOS J, 1989, PSYCHOL REV, V96, P5, DOI 10.1037/0033-295X.96.1.5; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Wendt M, 2007, J COGNITIVE NEUROSCI, V19, P1104, DOI 10.1162/jocn.2007.19.7.1104; Zhang HZ, 1998, J EXP PSYCHOL HUMAN, V24, P3, DOI 10.1037/0096-1523.24.1.3; Zhang HZH, 1999, COGNITIVE PSYCHOL, V38, P386, DOI 10.1006/cogp.1998.0703; Zhang L, 2012, PSYCHOL RES, P1; Zhao XA, 2010, PSYCHON B REV, V17, P687, DOI 10.3758/PBR.17.5.687	37	14	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76580	10.1371/journal.pone.0076580	http://dx.doi.org/10.1371/journal.pone.0076580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24146892	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400065
J	Sommer, E; Koler, M; Frank, V; Sourjik, V; Vaknin, A				Sommer, Erik; Koler, Moriah; Frank, Vered; Sourjik, Victor; Vaknin, Ady			The Sensory Histidine Kinases TorS and EvgS Tend to Form Clusters in Escherichia coli Cells	PLOS ONE			English	Article							RESPONSE REGULATOR; 2-COMPONENT; RECEPTOR; CHEMORECEPTORS; LOCALIZATION; ORGANIZATION; COMPONENTS; PROTEINS; SYSTEMS	Microorganisms use multiple two-component sensory systems to detect changes in their environment and elicit physiological responses. Despite their wide spread and importance, the intracellular organization of two-component sensory proteins in bacteria remains little investigated. A notable exception is the well-studied clustering of the chemoreceptor-kinase complexes that mediate chemotaxis behaviour. However, these chemosensory complexes differ fundamentally from other systems, both structurally and functionally. Therefore, studying the organization of typical sensory kinases in bacteria is essential for understanding the general role of receptor clustering in bacterial sensory signalling. Here, by studying mYFP-tagged sensory kinases in Escherichia coli, we show that the tagged TorS and EvgS sensors have a clear tendency for self-association and clustering. These sensors clustered even when expressed at a level of a few hundred copies per cell. Moreover, the mYFP-tagged response regulator TorR showed clear TorS-dependent clustering, indicating that untagged TorS sensors also tend to form clusters. We also provide evidence for the functionality of these tagged sensors. Experiments with truncated TorS or EvgS proteins suggested that clustering of EvgS sensors depends on the cytoplasmic part of the protein, whereas clustering of TorS sensors can be potentially mediated by the periplasmic/transmembrane domain. Overall, these findings support the notion that sensor clustering plays a role in bacterial sensory signalling beyond chemotaxis.	[Sommer, Erik; Sourjik, Victor] Heidelberg Univ, Dept Mol Biol, Heidelberg, Germany; [Koler, Moriah; Frank, Vered; Vaknin, Ady] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Ruprecht Karls University Heidelberg; Hebrew University of Jerusalem	Sourjik, V (corresponding author), Heidelberg Univ, Dept Mol Biol, Heidelberg, Germany.	v.sourjik@zmbh.uni-heidelberg.de; avaknin@phys.huji.ac.il			GIF grant [I-909-54.13/2006]; ERC advanced grant [294761]; Minerva center for bio-hybrid complex systems	GIF grant; ERC advanced grant; Minerva center for bio-hybrid complex systems	This work was supported by the GIF grant I-909-54.13/2006, the ERC advanced grant 294761, and the Minerva center for bio-hybrid complex systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baraquet C, 2006, J BIOL CHEM, V281, P38189, DOI 10.1074/jbc.M604321200; Batchelor E, 2006, MOL MICROBIOL, V59, P1767, DOI 10.1111/j.1365-2958.2006.05048.x; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P113, DOI 10.1016/j.mib.2010.02.003; Briegel A, 2012, P NATL ACAD SCI USA, V109, P3766, DOI 10.1073/pnas.1115719109; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Eguchi Y, 2011, J BACTERIOL, V193, P1222, DOI 10.1128/JB.01124-10; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Vescovi EG, 2010, CURR OPIN MICROBIOL, V13, P210, DOI 10.1016/j.mib.2009.12.012; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Kenney LJ, 2010, CURR OPIN MICROBIOL, V13, P168, DOI 10.1016/j.mib.2010.01.013; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Kirby JR, 2009, ANNU REV MICROBIOL, V63, P45, DOI 10.1146/annurev.micro.091208.073221; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; MADDOCK JR, 1993, SCIENCE, V259, P1717; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Moore JO, 2012, STRUCTURE, V20, P729, DOI 10.1016/j.str.2012.02.021; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Scheu P, 2008, MICROBIOL-SGM, V154, P2463, DOI 10.1099/mic.0.2008/018614-0; Sciara MI, 2008, MOL MICROBIOL, V70, P479, DOI 10.1111/j.1365-2958.2008.06427.x; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Thanbichler M, 2009, CURR OPIN MICROBIOL, V12, P715, DOI 10.1016/j.mib.2009.09.013; Vaknin A, 2006, P NATL ACAD SCI USA, V103, P592, DOI 10.1073/pnas.0510047103; Vaknin A, 2007, J MOL BIOL, V366, P1416, DOI 10.1016/j.jmb.2006.12.024; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhang PJ, 2007, P NATL ACAD SCI USA, V104, P3777, DOI 10.1073/pnas.0610106104	44	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77708	10.1371/journal.pone.0077708	http://dx.doi.org/10.1371/journal.pone.0077708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147062	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400137
J	Wang, YX; Xu, L; Zhang, XH; You, QS; Zhao, L; Jonas, JB				Wang, Ya Xing; Xu, Liang; Zhang, Xiao Hui; You, Qi Sheng; Zhao, Liang; Jonas, Jost B.			Five-Year Change in Intraocular Pressure Associated with Changes in Arterial Blood Pressure and Body Mass Index. The Beijing Eye Study	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; CENTRAL CORNEAL THICKNESS; SYSTEMIC FACTORS; GLAUCOMA; ANGLE; POPULATION; ADULTS; AGE	Purpose: To examine a potential association between longitudinal changes in intraocular pressure (IOP), arterial blood pressure and body mass index (BMI) in a population-based setting. Methods: The longitudinal population-based Beijing Eye Study included 2355 subjects with an age of 45+ years who were examined in 2006 and in 2011. The participants underwent a detailed ophthalmic examination including tonometry and measurement of arterial blood pressure and BMI. Results: Data on IOP, arterial blood pressure and BMI measured in 2006 and in 2011 were available for 2257 (95.8%) subjects with a mean age of 59.5 +/- 9.7 years. The mean change in IOP was -1.25 +/- 2.26 mm Hg, mean change in mean blood pressure -7.4 +/- 12.1 mmHg, and mean change in BMI was 0.01 +/- 2.04 kg/m(2). In multivariate analysis, the 5-year change in IOP was significantly associated with a higher change in mean blood pressure (P<0.001; standardized regression coefficient Beta: 0.11; regression coefficient B:0.02; 95% confidence interval (CI): 0.01,0.03) after adjusting for younger age (P<0.001; Beta: -0.18; B: -0.04; 95% CI: -0.05,-0.03), shorter body stature (P = 0.002; Beta: -0.06; B: -0.06; 95% CI: -0.03,-0.01), thicker central corneal thickness (P<0.001; Beta: 0.19; B: 0.02; 95% CI: 0.01,0.02), deeper anterior chamber depth (P = 0.01; Beta: 0.05; B: 0.33; 95% CI: 0.07,0.60), and lower intraocular pressure at baseline (P<0.001; Beta: -0.56; B: -0.42; 95% CI: -0.45,-0.39). If the analysis included only longitudinal parameters, the change in IOP was significantly associated with a higher change in mean arterial blood pressure (P<0.001; Beta: 0.10; B: 0.02; 95% CI: 0.01,0.03) and a higher change in body mass index (P<0.04; Beta:0.04; B: 0.04; 95% CI: 0.01,0.09). Conclusions: In the 5-year follow-up of our population-based sample, a change in IOP was associated with a corresponding change in arterial blood pressure and with a corresponding change in body mass index. These longitudinal data support the notion of a physiological relationship between arterial blood pressure, intraocular pressure and body mass index. These findings may be of interest for the discussion of the pathogenesis of glaucomatous optic neuropathy.	[Wang, Ya Xing; Xu, Liang; Zhang, Xiao Hui; You, Qi Sheng; Zhao, Liang; Jonas, Jost B.] Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Fac Clin Med Mannheim, Dept Ophthalmol, Mannheim, Germany	Capital Medical University; Ruprecht Karls University Heidelberg	Xu, L (corresponding author), Capital Univ Med Sci, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing, Peoples R China.	xlbio1@163.com; Jost.Jonas@augen.ma.uni-heidelberg.de	wang, YA XING/K-9671-2016; You, Qisheng/AAG-7153-2020; You, Qisheng/A-3619-2014	wang, YA XING/0000-0003-2749-7793; You, Qisheng/0000-0003-0743-7320; You, Qisheng/0000-0003-0743-7320	National Natural Science Foundation of China [81770890]; Beijing NOVA Program [2011058]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing NOVA Program(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China 81770890; Beijing NOVA Program 2011058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Czarnik T, 2009, INJURY, V40, P33, DOI 10.1016/j.injury.2008.10.010; Fukuoka S, 2008, ACTA OPHTHALMOL, V86, P434, DOI 10.1111/j.1600-0420.2007.01068.x; Gasser P, 1999, J GLAUCOMA, V8, P8; Jonas JB, 2012, CLIN EXP OPHTHALMOL, V40, pE233, DOI 10.1111/j.1442-9071.2011.02625.x; Jonas JB, 2011, J GLAUCOMA, V20, P405, DOI 10.1097/IJG.0b013e3181f7af9b; Kawase K, 2008, BRIT J OPHTHALMOL, V92, P1175, DOI 10.1136/bjo.2007.128819; Khawaja AP, 2013, INVEST OPHTH VIS SCI, V54, P5028, DOI 10.1167/iovs.13-11971; Klein BEK, 2005, BRIT J OPHTHALMOL, V89, P284, DOI 10.1136/bjo.2004.048710; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; MCLEOD SD, 1990, INVEST OPHTH VIS SCI, V31, P2361; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Mitchell P, 2005, AM J OPHTHALMOL, V140, P131, DOI 10.1016/j.ajo.2004.12.088; MORGAN WH, 1995, INVEST OPHTH VIS SCI, V36, P1163; Nakano T, 2005, OPHTHALMOLOGY, V112, P609, DOI 10.1016/j.ophtha.2004.10.046; Nangia V, 2013, PLOS ONE; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Nomura H, 1999, OPHTHALMOLOGY, V106, P2016, DOI 10.1016/S0161-6420(99)90417-7; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Tomoyose E, 2010, AM J OPHTHALMOL, V150, P279, DOI 10.1016/j.ajo.2010.03.009; Wang DD, 2011, AM J OPHTHALMOL, V152, P454, DOI 10.1016/j.ajo.2011.03.005; Wang NL, 2012, OPHTHALMOLOGY, V119, P2065, DOI 10.1016/j.ophtha.2012.03.054; Wong TT, 2009, INVEST OPHTH VIS SCI, V50, P4097, DOI 10.1167/iovs.08-2822; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2007, AM J OPHTHALMOL, V144, P461, DOI 10.1016/j.ajo.2007.05.013; Xu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030104; Zheng YF, 2010, INVEST OPHTH VIS SCI, V51, P2998, DOI 10.1167/iovs.09-4470; Zhou Q, 2012, OPHTHAL EPIDEMIOL, V19, P278, DOI 10.3109/09286586.2012.708084	31	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77180	10.1371/journal.pone.0077180	http://dx.doi.org/10.1371/journal.pone.0077180			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146967	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400103
J	Butail, S; Bartolini, T; Porfiri, M				Butail, Sachit; Bartolini, Tiziana; Porfiri, Maurizio			Collective Response of Zebrafish Shoals to a Free-Swimming Robotic Fish	PLOS ONE			English	Article							DANIO-RERIO RESPONDS; TAIL BEAT FREQUENCY; BEHAVIORAL-RESPONSES; MODEL; PREFERENCES; MECHANISMS; ALCOHOL; MOTION; SCHOOL; SIZE	In this work, we explore the feasibility of regulating the collective behavior of zebrafish with a free-swimming robotic fish. The visual cues elicited by the robot are inspired by salient features of attraction in zebrafish and include enhanced coloration, aspect ratio of a fertile female, and carangiform/subcarangiform locomotion. The robot is autonomously controlled with an online multi-target tracking system and swims in circular trajectories in the presence of groups of zebrafish. We investigate the collective response of zebrafish to changes in robot speed, achieved by varying its tail-beat frequency. Our results show that the speed of the robot is a determinant of group cohesion, quantified through zebrafish nearest-neighbor distance, which increases with the speed of the robot until it reaches 3cm/s. We also find that the presence of the robot causes a significant decrease in the group speed, which is not accompanied by an increase in the freezing response of the subjects. Findings of this study are expected to inform the design of experimental protocols that leverage the use of robots to study the zebrafish animal model.	[Butail, Sachit; Bartolini, Tiziana; Porfiri, Maurizio] NYU, Polytech Inst, Dept Mech & Aerosp Engn, Brooklyn, NY USA	New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Polytech Inst, Dept Mech & Aerosp Engn, Brooklyn, NY USA.	mporfiri@poly.edu	Butail, Sachit/O-2928-2013	Butail, Sachit/0000-0001-9785-7374; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [CMMI-0745753, CMMI-1129820]; Mitsui USA Foundation; Div Of Civil, Mechanical, & Manufact Inn [0745753] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Mitsui USA Foundation; Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the National Science Foundation under Grant nos. CMMI-0745753 and CMMI-1129820 and the Mitsui USA Foundation through a fellowship to Tiziana Bartolini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Abaid N, 2012, BEHAV BRAIN RES, V232, P406, DOI 10.1016/j.bbr.2012.03.028; Bass SLS, 2008, BEHAV BRAIN RES, V186, P107, DOI 10.1016/j.bbr.2007.07.037; Bode NWF, 2010, P ROY SOC B-BIOL SCI, V277, P3065, DOI 10.1098/rspb.2010.0855; BREDER CM, 1946, PHYSIOL ZOOL, V19, P154, DOI 10.1086/physzool.19.2.30151891; Buske C, 2011, PROG NEURO-PSYCHOPH, V35, P1409, DOI 10.1016/j.pnpbp.2010.09.003; Cahill GM, 2002, CELL TISSUE RES, V309, P27, DOI 10.1007/s00441-002-0570-7; Cianca V, 2013, PLOS ONE IN PRESS; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; de Margerie E, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/034001; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fernandez-Juricic E, 2011, BEHAV ECOL, V22, P1304, DOI 10.1093/beheco/arr132; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Grossman L, 2010, BEHAV BRAIN RES, V214, P277, DOI 10.1016/j.bbr.2010.05.039; Grunwald DJ, 2002, NAT REV GENET, V3, P717, DOI 10.1038/nrg892; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Kolpas A, 2008, MATH BIOSCI, V214, P49, DOI 10.1016/j.mbs.2008.06.003; Kopman V, 2013, IEEE-ASME T MECH, V18, P471, DOI 10.1109/TMECH.2012.2222431; Kopman V, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0540; Krause J, 2011, TRENDS ECOL EVOL, V26, P369, DOI 10.1016/j.tree.2011.03.015; Marras S, 2012, J R SOC INTERFACE, V9, P1856, DOI 10.1098/rsif.2012.0084; Mathur P, 2010, NEUROBIOL DIS, V40, P66, DOI 10.1016/j.nbd.2010.05.016; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Miklosi A, 2006, ZEBRAFISH, V3, P227, DOI 10.1089/zeb.2006.3.227; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Miller N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048865; Miller N, 2013, BEHAV BRAIN RES, V240, P192, DOI 10.1016/j.bbr.2012.11.033; Partan SR, 2009, ANIM BEHAV, V77, P1127, DOI 10.1016/j.anbehav.2008.12.029; Patricelli GL, 2006, ANIM BEHAV, V71, P49, DOI 10.1016/j.anbehav.2005.03.029; Plaut I, 2000, J EXP BIOL, V203, P813; Polverino G, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036019; Polverino G, 2013, BIOINSPIRAT IN PRESS; Polverino G, 2013, BEHAV BRAIN RES, V250, P133, DOI 10.1016/j.bbr.2013.05.008; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; Rosenthal GG, 2005, ANIM BEHAV, V70, P1063, DOI 10.1016/j.anbehav.2005.02.005; Rossi C, 2012, SWIMMING PHYSL FISH, P407; Saverino C, 2008, BEHAV BRAIN RES, V191, P77, DOI 10.1016/j.bbr.2008.03.013; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Spinello C, 2013, ALCOHOL, V47, P391, DOI 10.1016/j.alcohol.2013.04.003; Svendsen JC, 2003, J FISH BIOL, V62, P834, DOI 10.1046/j.1095-8649.2003.00068.x; Swain DT, 2012, P IEEE, V100, P150, DOI 10.1109/JPROC.2011.2165449; Thomas JK, 2011, AQUAT TOXICOL, V102, P79, DOI 10.1016/j.aquatox.2010.12.020; Tien JH, 2004, EVOL ECOL RES, V6, P555; Todd DJ, 1993, ROBOT BIOL SYST NEW, V102, P193; Vaughan R, 2000, ROBOT AUTON SYST, V31, P109, DOI 10.1016/S0921-8890(99)00084-6; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Webb B, 2000, ANIM BEHAV, V60, P545, DOI 10.1006/anbe.2000.1514; Webster MM, 2007, BEHAV ECOL SOCIOBIOL, V62, P273, DOI 10.1007/s00265-007-0462-7; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023	56	80	80	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76123	10.1371/journal.pone.0076123	http://dx.doi.org/10.1371/journal.pone.0076123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146825	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400039
J	Houssaye, A; Lindgren, J; Pellegrini, R; Lee, AH; Germain, D; Polcyn, MJ				Houssaye, Alexandra; Lindgren, Johan; Pellegrini, Rodrigo; Lee, Andrew H.; Germain, Damien; Polcyn, Michael J.			Microanatomical and Histological Features in the Long Bones of Mosasaurine Mosasaurs (Reptilia, Squamata) - Implications for Aquatic Adaptation and Growth Rates	PLOS ONE			English	Article							LIFE-STYLE; VERTEBRAL MICROANATOMY; MARINE REPTILES; AMNIOTES; PHYLOGENY; EVOLUTION; SKELETOCHRONOLOGY; MASS	Background: During their evolution in the Late Cretaceous, mosasauroids attained a worldwide distribution, accompanied by a marked increase in body size and open ocean adaptations. This transition from land-dwellers to highly marine-adapted forms is readily apparent not only at the gross anatomic level but also in their inner bone architecture, which underwent profound modifications. Methodology/Principal Findings: The present contribution describes, both qualitatively and quantitatively, the internal organization (microanatomy) and tissue types and characteristics (histology) of propodial and epipodial bones in one lineage of mosasauroids; i.e., the subfamily Mosasaurinae. By using microanatomical and histological data from limb bones in combination with recently acquired knowledge on the inner structure of ribs and vertebrae, and through comparisons with extant squamates and semi-aquatic to fully marine amniotes, we infer possible implications on mosasaurine evolution, aquatic adaptation, growth rates, and basal metabolic rates. Notably, we observe the occurrence of an unusual type of parallel-fibered bone, with large and randomly shaped osteocyte lacunae (otherwise typical of fibrous bone) and particular microanatomical features in Dallasaurus, which displays, rather than a spongious inner organization, bone mass increase in its humeri and a tubular organization in its femora and ribs. Conclusions/Significance: The dominance of an unusual type of parallel-fibered bone suggests growth rates and, by extension, basal metabolic rates intermediate between that of the extant leatherback turtle, Dermochelys, and those suggested for plesiosaur and ichthyosaur reptiles. Moreover, the microanatomical features of the relatively primitive genus Dallasaurus differ from those of more derived mosasaurines, indicating an intermediate stage of adaptation for a marine existence. The more complete image of the various microanatomical trends observed in mosasaurine skeletal elements supports the evolutionary convergence between this lineage of secondarily aquatically adapted squamates and cetaceans in the ecological transition from a coastal to a pelagic lifestyle.	[Houssaye, Alexandra] Univ Bonn, Steinmann Inst Geol Palaontol & Mineral, Bonn, Germany; [Lindgren, Johan] Lund Univ, Dept Geol, Lund, Sweden; [Pellegrini, Rodrigo] New Jersey State Museum, Trenton, NJ USA; [Lee, Andrew H.] Midwestern Univ, Dept Anat, Glendale, AZ USA; [Germain, Damien] UPMC, MNHN, CNRS, UMR7207,Dept Hist Terre, Paris, France; [Polcyn, Michael J.] So Methodist Univ, Huffington Dept Earth Sci, Dallas, TX 75275 USA	University of Bonn; Lund University; Midwestern University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Southern Methodist University	Houssaye, A (corresponding author), Univ Bonn, Steinmann Inst Geol Palaontol & Mineral, Bonn, Germany.	houssaye@uni-bonn.de	Houssaye, Alexandra/J-5631-2015; Pellegrini, Rodrigo/GSI-5160-2022	Pellegrini, Rodrigo/0000-0003-2163-8524; Germain, Damien/0000-0002-7608-2212; Lee, Andrew/0000-0001-7829-334X	A. v. Humboldt Foundation; Swedish Research Council; Crafoord Foundation; Royal Swedish Academy of Sciences; Institute for the Study of Earth and Man at Southern Methodist University; Projecto PaleoAngola	A. v. Humboldt Foundation(Alexander von Humboldt Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Royal Swedish Academy of Sciences; Institute for the Study of Earth and Man at Southern Methodist University; Projecto PaleoAngola	A.H. acknowledges financial support from the A. v. Humboldt Foundation and J.L. from the Swedish Research Council, the Crafoord Foundation and the Royal Swedish Academy of Sciences. M.J. Polcyn acknowledges financial support from Institute for the Study of Earth and Man at Southern Methodist University, and Projecto PaleoAngola. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amprino R., 1947, ARCH BIOL SCI, V58, P315; Bell GL, 2005, NETH J GEOSCI, V84, P177, DOI 10.1017/S0016774600020965; Bell Gorden L. Jr, 1997, P293, DOI 10.1016/B978-012155210-7/50017-X; Bell Jr GL, 1986, J ALA ACAD SCI, V57, P2; Bernard A, 2010, SCIENCE, V328, P1379, DOI 10.1126/science.1187443; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Caldwell MW, 2007, J VERTEBR PALEONTOL, V27, P863, DOI 10.1671/0272-4634(2007)27[863:ANBMFT]2.0.CO;2; Caldwell MW, 1996, ZOOL J LINN SOC-LOND, V116, P407, DOI 10.1006/zjls.1996.0027; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Carroll Robert L., 1997, P467, DOI 10.1016/B978-012155210-7/50025-9; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; CURREY JD, 1985, J ZOOL, V206, P453; de Buffrenil V, 2008, J MORPHOL, V269, P533, DOI 10.1002/jmor.10604; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; Enlow D. H., 1969, pUnpaginated; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Francillon-Vieillot H., 1990, P471; Germain D, 2005, ZOOL SCR, V34, P335, DOI 10.1111/j.1463-6409.2005.00198.x; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Houssaye A, 2008, P 2 MOSASAUR M FORT, P81; Houssaye A, 2013, BIOL J LINN SOC, V108, P3, DOI 10.1111/j.1095-8312.2012.02002.x; Houssaye A, 2013, BIOL REV, V88, P117, DOI 10.1111/j.1469-185X.2012.00243.x; Houssaye A, 2012, J VERTEBR PALEONTOL, V32, P1042, DOI 10.1080/02724634.2012.680999; Houssaye A, 2012, LETHAIA, V45, P200, DOI 10.1111/j.1502-3931.2011.00273.x; Houssaye A, 2010, J ANAT, V217, P715, DOI 10.1111/j.1469-7580.2010.01307.x; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Hua S, 1996, J VERTEBR PALEONTOL, V16, P703, DOI 10.1080/02724634.1996.10011359; Klein N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011613; Klein N, 2009, FOSS REC, V12, P121, DOI 10.1002/mmng.200900002; Laurin M, 2004, PALEOBIOLOGY, V30, P589, DOI 10.1666/0094-8373(2004)030<0589:TEOLBM>2.0.CO;2; Laurin M, 2011, CR PALEVOL, V10, P381, DOI 10.1016/j.crpv.2011.02.003; Lindgren J, 2004, ACTA PALAEONTOL POL, V49, P219; Lindgren J, 2011, PALEOBIOLOGY, V37, P445, DOI 10.1666/09023.1; Lindgren J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011998; LINGHAMSOLIAR T, 1995, PHILOS T ROY SOC B, V347, P155, DOI 10.1098/rstb.1995.0019; Lopuchowycz Victoria B., 2002, Paludicola, V3, P139; MASSARE JA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P133; Montes L, 2007, BIOL J LINN SOC, V92, P63, DOI 10.1111/j.1095-8312.2007.00881.x; Motani R, 2002, PALEOBIOLOGY, V28, P251, DOI 10.1666/0094-8373(2002)028<0251:SSEOEM>2.0.CO;2; Motani R, 1998, J PALEONTOL, V72, P133, DOI 10.1017/S0022336000024069; Motani R, 2010, SCIENCE, V328, P1361, DOI 10.1126/science.1191409; Nopcia F., 1934, Acta Zoologica Stockholm, V15, P431; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Pellegrini Rodrigo, 2007, Transactions of the Kansas Academy of Science, V110, P83, DOI 10.1660/0022-8443(2007)110[83:SOTLEO]2.0.CO;2; Polcyn MJ, 2008, P 2 MOSASAUR M FORT, P137; Polcyn MJ, PALAEOGEOGR IN PRESS; Quemeneur S, 2013, BIOL J LINN SOC, V109, P644, DOI 10.1111/bij.12066; R Development Core Team, 2011, R LANG ENV STAT COMP; Reid R.E.H., 1987, Modern Geology, V11, P133; Robbins J.A., 2008, P 2 MOS M FORT HAYS, V3, P123; Russell D. A., 1967, Bulletin of the Peabody Museum of Natural History, V23, P1; Salgado L, 2007, AMEGHINIANA, V44, P513; Scheyer TM, 2010, SEMIN CELL DEV BIOL, V21, P462, DOI 10.1016/j.semcdb.2009.11.005; Sheldon A, 1998, PALUDICOLA, V2, P190; Sheldon A, 1997, ANCIENT MARINE REPTI, P293; Sheldon A, 1995, THESIS U ROCHESTER N; Sheldon Amy, 1996, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P369; TAYLOR MA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P151; Uhen MD, 2010, ANNU REV EARTH PL SC, V38, P189, DOI 10.1146/annurev-earth-040809-152453	62	38	39	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76741	10.1371/journal.pone.0076741	http://dx.doi.org/10.1371/journal.pone.0076741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146919	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400084
J	Kyle, CH; Plantz, AL; Shelton, T; Burks, RL				Kyle, Colin H.; Plantz, Allyson L.; Shelton, Therese; Burks, Romi L.			Count Your Eggs Before They Invade: Identifying and Quantifying Egg Clutches of Two Invasive Apple Snail Species (Pomacea)	PLOS ONE			English	Article							ENVIRONMENTAL DNA; UNITED-STATES; RISK-ASSESSMENT; AQUATIC PLANTS; INSULARUM; BIOLOGY; AMPULLARIIDAE; FECUNDITY; GROWTH; FIELD	Winning the war against invasive species requires early detection of invasions. Compared to terrestrial invaders, aquatic species often thrive undetected under water and do not garner notice until too late for early action. However, fortunately for managers, apple snails (Family Ampullariidae, Genus Pomacea) provide their own conspicuous sign of invasion in the form of vibrantly colored egg clutches. Managers can potentially use egg clutches laid in the riparian zone as a means of early detection and species identification. To facilitate such efforts, we quantified differences in characteristics (length, width, depth, mass, egg number) of field-laid clutches for the two most common invasive species of apple snail, P. canaliculata and P. maculata, in native and non-native populations. Pomacea canaliculata native and non-native populations differed noticeably only in width. Native P. maculata clutches possessed significantly greater width, mass and eggs numbers compared with native P. canaliculata. Non-native P. maculata clutches significantly exceeded all other populations in all measured characteristics. Consequently, these traits may successfully distinguish between species. Fecundity data also allowed us to develop models that accurately estimated the number of eggs per clutch for each species based on clutch dimensions. We tested one, two and three dimensional models of clutches, including rendering a clutch as either a complete ellipsoid or an ellipsoid intersected by a cylinder to represent the oviposition site. Model comparisons found the product of length and depth, with a different function for each population, best predicted egg number for both species. Comparisons of egg number to clutch volume and mass implied non-native P. canaliculata may be food limited, while non-native P. maculata appeared to produce such enormous clutches by having access to greater nutrients than the native population. With these new tools, researchers and managers can quickly identify, quantify and begin eradication of new non-native apple snail populations.	[Kyle, Colin H.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Plantz, Allyson L.; Burks, Romi L.] Southwestern Univ, Dept Biol, Georgetown, TX USA; [Shelton, Therese] Southwestern Univ, Dept Math & Comp Sci, Georgetown, TX USA	University of Chicago	Kyle, CH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA.	ckyle@uchicago.edu		Shelton, Therese/0000-0003-4909-0767	NSF-IRES [1130297, 1130694]; NSF-ROA [DEB-1214171]; Southwestern University Faculty-Student Collaborative Funds; University of Chicago's Department of Ecology and Evolution Student Research Fund	NSF-IRES(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF-ROA(National Science Foundation (NSF)); Southwestern University Faculty-Student Collaborative Funds; University of Chicago's Department of Ecology and Evolution Student Research Fund	Collaborative NSF-IRES Grant (1130297 & 1130694), NSF-ROA Grant (DEB-1214171), Southwestern University Faculty-Student Collaborative Funds (www.southwestern.edu), The University of Chicago's Department of Ecology and Evolution Student Research Fund ($675 for publication fees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker P, 2010, J MOLLUS STUD, V76, P138, DOI 10.1093/mollus/eyp050; Barnes MA, 2008, J N AM BENTHOL SOC, V27, P738, DOI 10.1899/08-013.1; Burks RL, 2010, HYDROBIOLOGIA, V646, P243, DOI 10.1007/s10750-010-0167-1; Burlakova LE, 2009, RESTOR ECOL, V17, P433, DOI 10.1111/j.1526-100X.2008.00429.x; Burnham K. P., 1998, MODEL SELECTION INFE; Byers JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056812; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Cazzaniga NJ, 1998, COMP PHYS ECOL, V133, P89; Conner SL, 2008, J MOLLUS STUD, V74, P355, DOI 10.1093/mollus/eyn024; Cowie RH, 2009, AM MALACOL BULL, V27, P113, DOI 10.4003/006.027.0210; Crawley MJ, 2009, R BOOK, P489; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Hanshew BA, 2012, FRESHWATER BIOL, V57, P2285, DOI 10.1111/fwb.12002; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2012, ZOOL J LINN SOC-LOND, V166, P723, DOI 10.1111/j.1096-3642.2012.00867.x; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Joshi R. C., 2006, GLOBAL ADV; Kaefer IL, 2007, ANN ZOOL FENN, V44, P435; Keller RP, 2007, CONSERV BIOL, V21, P191, DOI 10.1111/j.1523-1739.2006.00563.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kyle CH, 2011, CURR ZOOL, V57, P630, DOI 10.1093/czoolo/57.5.630; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Martin Charles W., 2012, Gulf of Mexico Science, V30, P30; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; Morrison WE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017227; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Siegel S., 1988, NONPARAMETRIC STAT B, P399; Simberloff D, 2005, J AGR ENVIRON ETHIC, V18, P595, DOI 10.1007/s10806-005-2851-0; Tamburi NE, 2011, BIOL INVASIONS, V13, P2351, DOI 10.1007/s10530-011-0047-2; Tanaka K, 1999, RES POPUL ECOL, V41, P253, DOI 10.1007/s101440050029; Van Dyke J, 2012, SNAILBUSTERS BLOG IS; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Zar, 2011, BIOSTAT ANAL	35	19	19	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77736	10.1371/journal.pone.0077736	http://dx.doi.org/10.1371/journal.pone.0077736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147069	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400130
J	Zettler, ML; Proffitt, CE; Darr, A; Degraer, S; Devriese, L; Greathead, C; Kotta, J; Magni, P; Martin, G; Reiss, H; Speybroeck, J; Tagliapietra, D; Van Hoey, G; Ysebaert, T				Zettler, Michael L.; Proffitt, C. Edward; Darr, Alexander; Degraer, Steven; Devriese, Lisa; Greathead, Clare; Kotta, Jonne; Magni, Paolo; Martin, Georg; Reiss, Henning; Speybroeck, Jeroen; Tagliapietra, Davide; Van Hoey, Gert; Ysebaert, Tom			On the Myths of Indicator Species: Issues and Further Consideration in the Use of Static Concepts for Ecological Applications	PLOS ONE			English	Article							HEDISTE-DIVERSICOLOR POLYCHAETA; POLLUTION-INDUCED CHANGE; PROFESSIONAL JUDGMENT; BIOTIC INDEXES; OBJECTIVE SELECTION; BENTHIC COMMUNITIES; SALINITY GRADIENT; ORGANIC-CARBON; ESTUARINE; SEDIMENTS	The use of static indicator species, in which species are expected to have a similar sensitivity or tolerance to either natural or human-induced stressors, does not account for possible shifts in tolerance along natural environmental gradients and between biogeographic regions. Their indicative value may therefore be considered at least questionable. In this paper we demonstrate how species responses (i.e. abundance) to changes in sediment grain size and organic matter (OM) alter along a salinity gradient and conclude with a plea for prudency when interpreting static indicator-based quality indices. Six model species (three polychaetes, one amphipod and two bivalves) from the North Sea, Baltic Sea and the Mediterranean Sea region were selected. Our study demonstrated that there were no generic relationships between environment and biota and half of the studied species showed different responses in different seas. Consequently, the following points have to be carefully considered when applying static indicator-based quality indices: (1) species tolerances and preferences may change along environmental gradients and between different biogeographic regions, (2) as environment modifies species autecology, there is a need to adjust indicator species lists along major environmental gradients and (3) there is a risk of including sibling or cryptic species in calculating the index value of a species.	[Zettler, Michael L.; Darr, Alexander] Leibniz Inst Balt Sea Res, Rostock, Germany; [Proffitt, C. Edward] Florida Atlantic Univ, Dept Biol Sci, Ft Pierce, FL USA; [Degraer, Steven] Royal Belgian Inst Nat Sci, Marine Ecosyst Management Sect, Brussels, Belgium; [Devriese, Lisa; Van Hoey, Gert] Inst Agr & Fisheries Res, Oostende, Belgium; [Greathead, Clare] Marine Scotland Sci Marine Lab, Aberdeen, Scotland; [Kotta, Jonne; Martin, Georg] Univ Tartu, Estonian Marine Inst, Tallinn, Estonia; [Magni, Paolo] Ist Ambiente Marino Costiero CNR IAMC, CNR, Oristano, Italy; [Reiss, Henning] Univ Nordland, Fac Biosci, Bodo, Norway; [Speybroeck, Jeroen] Res Inst Nat & Forest, Brussels, Belgium; [Magni, Paolo; Tagliapietra, Davide] Ist Sci Marine CNR ISMAR, CNR, Venice, Italy; [Reiss, Henning] Senckenberg Meer, Marine Res Dept, Wilhelmshaven, Germany; [Ysebaert, Tom] Netherlands Inst Sea Res NIOZ, Yerseke, Netherlands; [Ysebaert, Tom] Wageningen Univ, Inst Marine Resources & Ecosyst Studies IMARES, Yerseke, Netherlands	Leibniz Institut fur Ostseeforschung Warnemunde; State University System of Florida; Florida Atlantic University; Royal Belgian Institute of Natural Sciences; Institute For Agricultural & Fisheries Research; Marine Scotland Science (MSS); University of Tartu; Estonian Marine Institute; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Nord University; Research Institute for Nature & Forest; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Senckenberg Gesellschaft fur Naturforschung (SGN); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Wageningen University & Research	Zettler, ML (corresponding author), Leibniz Inst Balt Sea Res, Rostock, Germany.	michael.zettler@io-warnemuende.de	Magni, Paolo/F-2691-2012; Zettler, Michael Lothar/R-3186-2019; Van Hoey, Gert/H-5491-2019; Tagliapietra, Davide/AAW-8744-2020; Kotta, Jonne/B-5542-2009; CNR, Ismar/P-1247-2014	Magni, Paolo/0000-0001-5955-6829; Zettler, Michael Lothar/0000-0002-5437-5495; Tagliapietra, Davide/0000-0002-3394-4089; Kotta, Jonne/0000-0002-4970-6755; CNR, Ismar/0000-0001-5351-1486; Reiss, Henning/0000-0003-1393-0269; Speybroeck, Jeroen/0000-0002-7241-7804; Devriese, Lisa/0000-0002-6996-6335; Bui, Binh/0000-0001-6729-9180; Van Hoey, Gert/0000-0003-2055-5292	Estonian Research Council [IUT02-20]	Estonian Research Council	Data on C. glaucum and H. diversicolor from the Venice lagoon are from the Ministry of Infrastructures and Transport - Magistrato alle Acque di Venezia (Water Authority of Venice) through the "Consorzio Venezia Nuova". The collection and analyses of Estonian data was supported by institutional research funding IUT02-20 of the Estonian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2008, J EXP MAR BIOL ECOL, V366, P16, DOI 10.1016/j.jembe.2008.07.006; [Anonymous], 2009, RISK ANAL WATER POLL; Baird HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034363; Barbone E, 2012, ECOL INDIC, V12, P105, DOI 10.1016/j.ecolind.2011.04.014; Bellan G, 1972, MARINE POLLUTION SEA, P396; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cai MH, 2011, MAR POLLUT BULL, V63, P523, DOI 10.1016/j.marpolbul.2011.02.007; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Covich AP, 1999, BIOSCIENCE, V49, P119, DOI 10.2307/1313537; CREMA R, 1991, MAR POLLUT BULL, V22, P503, DOI 10.1016/0025-326X(91)90405-H; Dauvin JC, 2012, ECOL INDIC, V12, P143, DOI 10.1016/j.ecolind.2011.03.019; Dauvin JC, 2010, MAR POLLUT BULL, V60, P947, DOI 10.1016/j.marpolbul.2010.03.028; DEATON LE, 1986, ESTUARIES, V9, P20, DOI 10.2307/1352189; Dowdall JRT, 2012, THESIS COLO STATE, P162; dUdekem dAcoz C, 2004, ZOOLOGISCHE VERHANDE, V348, P1; Fleischer D, 2009, MAR POLLUT BULL, V58, P351, DOI 10.1016/j.marpolbul.2008.10.016; Gamenick I, 1998, MAR ECOL PROG SER, V175, P155, DOI 10.3354/meps175155; Grall J, 1997, ESTUAR COAST SHELF S, V44, P43, DOI 10.1016/S0272-7714(97)80006-6; Gray J.S., 2009, ECOLOGY MARINE SEDIM, DOI DOI 10.1093/OSO/9780198569015.001.0001/ISBN-9780198569015; GRAY JS, 1982, MAR ECOL PROG SER, V9, P111, DOI 10.3354/meps009111; Gremare A, 2009, MAR ECOL PROG SER, V382, P297, DOI 10.3354/meps08030; Hartmann-Schroder G, 1996, TIERWELT DEUTSCHLAND, P648; Hastie T., 1992, STAT MODELS S; Heink U, 2010, ECOL INDIC, V10, P584, DOI 10.1016/j.ecolind.2009.09.009; Herkul K, 2006, OCEANOLOGIA, V48, P267; Hrs-Brenko Mirjana, 2006, Acta Adriatica, V47, P49; Hyland J, 2005, MAR ECOL PROG SER, V295, P91, DOI 10.3354/meps295091; Jirkov I.A., 2001, POLYCHAETA ARCTIC OC; Keeley NB, 2012, ECOL INDIC, V12, P154, DOI 10.1016/j.ecolind.2011.03.022; Kesaniemi JE, 2012, ECOL EVOL, V2, P994, DOI 10.1002/ece3.226; Khlebovich VV, 2000, HYDROBIOLOGIA, V417, P109, DOI 10.1023/A:1003863623267; Kinne O, 1971, MARINE ECOLOGY     2, P821; Koenker R., 2012, QUANTREG QUANTILE RE; Kolkwitz R., 1902, MITT PRUFUNGSANST WA, V1, P33; Kolkwitz R, 1908, BERICHTE DTSCH BOTAN, V26, P505, DOI DOI 10.1111/J.1438-8677.1908.TBO6722.X; Kolkwitz R., 1909, INT REV GES HYDROBIO, V2, P126, DOI DOI 10.1002/IROH.19090020108; Krause JC, 2002, THESIS U ROSTOCK; LEPPAKOSKI E, 1975, Acta Academiae Aboensis Ser B Mathematica et Physica, V35, P1; Luttikhuizen PC, 2011, J SEA RES, V66, P231, DOI 10.1016/j.seares.2011.07.002; Magni P, 2008, MAR POLLUT BULL, V56, P549, DOI 10.1016/j.marpolbul.2007.12.004; Magni P, 2009, MAR POLLUT BULL, V58, P478, DOI 10.1016/j.marpolbul.2008.12.009; Magni P, 2005, IOC WORKSHOP REPORTS, P195; MAJEED SA, 1987, MAR POLLUT BULL, V18, P490, DOI 10.1016/0025-326X(87)90360-2; Marchand M, 1976, MAR POLLUT B, V7, P65, DOI [10.1016/0025-326X(76)90014-X, DOI 10.1016/0025-326X(76)90014-X]; Marques JC, 2009, ECOLOGICAL INDICATORS FOR COASTAL AND ESTUARINE ENVIRONMENTAL ASSESSMENT: A USER GUIDE, P1; Maurer D, 1999, ECOL APPL, V9, P699, DOI 10.1890/1051-0761(1999)009[0699:TITIII]2.0.CO;2; MEBIUS LJ, 1960, ANAL CHIM ACTA, V22, P120, DOI 10.1016/S0003-2670(00)88254-9; Meng TT, 2009, ANN BOT-LONDON, V104, P1217, DOI 10.1093/aob/mcp230; Meyer T., 2008, OSTSEE MAKROZOOBENTH, P131; Nikula R, 2003, MAR BIOL, V143, P339, DOI 10.1007/s00227-003-1088-6; Pantle R., 1955, GAS WASSWERFACH, V96, P604; Parapar J, 2012, HELGOLAND MAR RES, V66, P331, DOI 10.1007/s10152-011-0274-z; PEARSON TH, 1983, MAR ECOL PROG SER, V12, P237, DOI 10.3354/meps012237; Pelletier MC, 2010, ECOL INDIC, V10, P1037, DOI 10.1016/j.ecolind.2010.03.005; Peres JM, 1972, MARINE POLLUTION SEA, P375; R Development Core Team, 2012, R LANG ENV STAT COMP; Rakocinski CF, 1997, ECOL APPL, V7, P1278; Reish DJ, 1957, BIOL PROBLEMS WATER, P195; Reusser DA, 2011, J BIOGEOGR, V38, P1225, DOI 10.1111/j.1365-2699.2011.02515.x; Rohner M, 1997, MAR BIOL, V130, P171, DOI 10.1007/s002270050236; Rosenberg R, 2004, MAR POLLUT BULL, V49, P728, DOI 10.1016/j.marpolbul.2004.05.013; Rubio B, 2000, MAR POLLUT BULL, V40, P968, DOI 10.1016/S0025-326X(00)00039-4; RUSSELL P J C, 1973, Malacologia, V14, P223; Scaps P, 2002, HYDROBIOLOGIA, V470, P203, DOI 10.1023/A:1015681605656; SIMBOURA N., 2002, MEDITERRANEAN MARINE, V3, P77, DOI DOI 10.12681/MMS.249; Southern California Coastal Water Research Project, 1979, SO CALIFORNIA COASTA, P19; Tagliapietra D, 2012, HYDROBIOLOGIA, V686, P15, DOI 10.1007/s10750-012-1001-8; Teixeira H, 2010, MAR POLLUT BULL, V60, P589, DOI 10.1016/j.marpolbul.2009.11.005; Telesh IV, 2010, MAR POLLUT BULL, V61, P149, DOI 10.1016/j.marpolbul.2010.02.008; Thompson B, 2012, ECOL INDIC, V12, P167, DOI 10.1016/j.ecolind.2011.03.020; Thrush SF, 2005, MAR ECOL PROG SER, V302, P13, DOI 10.3354/meps302013; Van Hoey G, 2010, MAR POLLUT BULL, V60, P2187, DOI 10.1016/j.marpolbul.2010.09.015; Virgilio M, 2009, MOL ECOL, V18, P1980, DOI 10.1111/j.1365-294X.2009.04170.x; WARWICK RM, 1993, AUST J ECOL, V18, P63, DOI 10.1111/j.1442-9993.1993.tb00435.x; Weisberg SB, 1997, ESTUARIES, V20, P149, DOI 10.2307/1352728; Weisberg SB, 2008, ECOL INDIC, V8, P389, DOI 10.1016/j.ecolind.2007.04.001; Wilhelmi J, 1916, UBERSICHT BIOL BEURT, P297; Word JQ, 1977, ANIMALS ARE INDICATO, P199; YONGE CM, 1946, J MAR BIOL ASSOC UK, V26, P358, DOI 10.1017/S0025315400012182; Ysebaert T, 2003, ESTUAR COAST SHELF S, V57, P335, DOI 10.1016/S0272-7714(02)00359-1; ZELINKA MILO, 1961, ARCH HYDROBIOL, V57, P389; Zettler M. L., 2008, STATE EVOLUTION BALT, P517; Zettler ML, 2007, MAR POLLUT BULL, V55, P258, DOI 10.1016/j.marpolbul.2006.08.024; Zettler ML, 2013, BIOL OCEANO IN PRESS	86	55	55	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78219	10.1371/journal.pone.0078219	http://dx.doi.org/10.1371/journal.pone.0078219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147123	Green Accepted, gold, Green Published			2022-12-27	WOS:000326019400153
J	Zhang, GZ; Ducatelle, R; Pasmans, F; D'Herde, K; Huang, LP; Smet, A; Haesebrouck, F; Flahou, B				Zhang, Guangzhi; Ducatelle, Richard; Pasmans, Frank; D'Herde, Katharina; Huang, Liping; Smet, Annemieke; Haesebrouck, Freddy; Flahou, Bram			Effects of Helicobacter suis gamma-Glutamyl Transpeptidase on Lymphocytes: Modulation by Glutamine and Glutathione Supplementation and Outer Membrane Vesicles as a Putative Delivery Route of the Enzyme	PLOS ONE			English	Article							TISSUE EXPRESSION PATTERN; PYLORI SPIRAL ORGANISMS; T-CELL PROLIFERATION; PERSISTENCE STRATEGIES; GASTRIC-MUCOSA; HOST-CELLS; METABOLISM; TRANSPORT; INFECTION; VIRULENCE	Helicobacter (H.) suis colonizes the stomach of the majority of pigs as well as a minority of humans worldwide. Infection causes chronic inflammation in the stomach of the host, however without an effective clearance of the bacteria. Currently, no information is available about possible mechanisms H. suis utilizes to interfere with the host immune response. This study describes the effect on various lymphocytes of the.-glutamyl transpeptidase (GGT) from H. suis. Compared to whole cell lysate from wild-type H. suis, lysate from a H. suis ggt mutant strain showed a decrease of the capacity to inhibit Jurkat T cell proliferation. Incubation of Jurkat T cells with recombinantly expressed H. suis GGT resulted in an impaired proliferation, and cell death was shown to be involved. A similar but more pronounced inhibitory effect was also seen on primary murine CD4(+) T cells, CD8(+) T cells, and CD19(+) B cells. Supplementation with known GGT substrates was able to modulate the observed effects. Glutamine restored normal proliferation of the cells, whereas supplementation with reduced glutathione strengthened the H. suis GGT-mediated inhibition of proliferation. H. suis GGT treatment abolished secretion of IL-4 and IL-17 by CD4(+) T cells, without affecting secretion of IFN-Upsilon. Finally, H. suis outer membrane vesicles (OMV) were identified as a possible delivery route of H. suis GGT to lymphocytes residing in the deeper mucosal layers. Thus far, this study is the first to report that the effects on lymphocytes of this enzyme, not only important for H. suis metabolism but also for that of other Helicobacter species, depend on the degradation of two specific substrates: glutamine and reduced glutatione. This will provide new insights into the pathogenic mechanisms of H. suis infection in particular and infection with gastric helicobacters in general.	[Zhang, Guangzhi; Ducatelle, Richard; Pasmans, Frank; Smet, Annemieke; Haesebrouck, Freddy; Flahou, Bram] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [D'Herde, Katharina] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, B-9000 Ghent, Belgium; [Huang, Liping] Chinese Acad Agr Sci, Div Swine Infect Dis, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China	Ghent University; Ghent University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Zhang, GZ (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	guangzhi.zhang@ugent.be	Haesebrouck, Freddy/M-3857-2014; Pasmans, Frank/D-3667-2014; D'Herde, Katharina/AAM-4570-2020; Smet, Annemieke/M-9295-2017	Haesebrouck, Freddy/0000-0002-1709-933X; D'Herde, Katharina/0000-0001-6591-0476; Smet, Annemieke/0000-0002-1271-6191	Research Fund of Ghent University, Ghent, Belgium [GOA01G00408, 01SC2411]; China Scholarship Council (CSC) [2010676001]	Research Fund of Ghent University, Ghent, Belgium(Ghent University); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by grants from the Research Fund of Ghent University, Ghent, Belgium (Grant No. GOA01G00408 and 01SC2411), and a grant from China Scholarship Council (CSC) (Grant no. 2010676001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2000, J BIOTECHNOL, V83, P77, DOI 10.1016/S0168-1656(00)00301-1; Akhiani AA, 2002, J IMMUNOL, V169, P6977, DOI 10.4049/jimmunol.169.12.6977; Aledo JC, 2004, BIOESSAYS, V26, P778, DOI 10.1002/bies.20063; Axon ATR, 1999, GUT, V45, pI1, DOI 10.1136/gut.45.2008.i1; Baele M, 2008, INT J SYST EVOL MICR, V58, P1350, DOI 10.1099/ijs.0.65133-0; Beigier-Bompadre M, 2011, J INFECT DIS, V204, P1339, DOI 10.1093/infdis/jir547; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Blachier F, 2009, AM J CLIN NUTR, V90, p814S, DOI 10.3945/ajcn.2009.27462S; Bode BP, 2001, J NUTR, V131, p2475S, DOI 10.1093/jn/131.9.2475S; CALDER PC, 1994, CLIN NUTR, V13, P2, DOI 10.1016/0261-5614(94)90003-5; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang WK, 2002, CLIN IMMUNOL, V104, P151, DOI 10.1006/clim.2002.5257; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; EECKHAUT V, 2013, GUT; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Flahou B, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-75; Flahou B, 2011, CELL MICROBIOL, V13, P1933, DOI 10.1111/j.1462-5822.2011.01682.x; Flahou B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014083; Gong M, 2010, GASTROENTEROLOGY, V139, P564, DOI 10.1053/j.gastro.2010.03.050; Grimble RF, 2001, P NUTR SOC, V60, P389, DOI 10.1079/PNS2001102; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; Hagen SJ, 2009, J NUTR, V139, P912, DOI 10.3945/jn.108.097790; Hatanaka T, 2000, BBA-BIOMEMBRANES, V1467, P1, DOI 10.1016/S0005-2736(00)00252-2; Hu X, 2012, BIOCHEMISTRY-US, V51, P1199, DOI 10.1021/bi200987b; Huang LP, 2011, VIRUS RES, V161, P115, DOI 10.1016/j.virusres.2011.05.015; Johnson IR, 2006, DEV COMP IMMUNOL, V30, P1191, DOI 10.1016/j.dci.2006.03.003; Joosten M, 2013, HELICOBACTER, V18, P392, DOI 10.1111/hel.12054; Josenhans C, 1999, MOL MICROBIOL, V33, P350, DOI 10.1046/j.1365-2958.1999.01478.x; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kirchhoff P, 2006, PFLUG ARCH EUR J PHY, V451, P738, DOI 10.1007/s00424-005-1507-2; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; LEE A, 1989, AUST NZ J MED, V19, P156, DOI 10.1111/j.1445-5994.1989.tb00232.x; Maellaro E, 2000, J CELL SCI, V113, P2671; Nakamura E, 2002, AM J PHYSIOL-GASTR L, V283, pG1264, DOI 10.1152/ajpgi.00235.2002; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P1343, DOI 10.1006/bbrc.2001.4504; Newsholme F, 1999, J NUTR BIOCHEM, V10, P316; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; O'Rourke JL, 2004, J PATHOL, V203, P896, DOI 10.1002/path.1593; Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110; Olofsson A, 2010, MOL MICROBIOL, V77, P1539, DOI 10.1111/j.1365-2958.2010.07307.x; ORIORDAIN MG, 1994, ANN SURG, V220, P212, DOI 10.1097/00000658-199408000-00014; Paolicchi A, 2002, BIOCHEM PHARMACOL, V64, P1027, DOI 10.1016/S0006-2952(02)01173-5; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Perego P, 1997, INT J CANCER, V71, P246; Reeds PJ, 2001, J NUTR, V131, p2505S, DOI 10.1093/jn/131.9.2505S; REINHERZ EL, 1980, CELL, V19, P821, DOI 10.1016/0092-8674(80)90072-0; Rhoads JM, 1997, AM J PHYSIOL-GASTR L, V272, pG943, DOI 10.1152/ajpgi.1997.272.5.G943; Rieder G, 2005, CURR OPIN MICROBIOL, V8, P67, DOI 10.1016/j.mib.2004.12.004; Rossi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030543; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Schmees C, 2007, GASTROENTEROLOGY, V132, P1820, DOI 10.1053/j.gastro.2007.02.031; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; SOLNICK JV, 1993, J INFECT DIS, V168, P379, DOI 10.1093/infdis/168.2.379; Sundrud MS, 2004, P NATL ACAD SCI USA, V101, P7727, DOI 10.1073/pnas.0401528101; Suzuki A, 2010, HELICOBACTER, V15, P538, DOI 10.1111/j.1523-5378.2010.00801.x; Trebesius K, 2001, J CLIN MICROBIOL, V39, P1510, DOI 10.1128/JCM.39.4.1510-1516.2001; Van den Bulck K, 2005, J CLIN MICROBIOL, V43, P2256, DOI 10.1128/JCM.43.5.2256-2260.2005; Verbrugghe Elin, 2012, Vet Res, V43, P22, DOI 10.1186/1297-9716-43-22; Verbrugghe E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-118; Vermoote M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-51; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; WILDE SW, 1991, BIOCHEM J, V277, P687, DOI 10.1042/bj2770687; WINDMUELLER HG, 1980, J BIOL CHEM, V255, P107; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yaqoob P, 1997, NUTRITION, V13, P646, DOI 10.1016/S0899-9007(97)83008-0; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	74	22	23	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77966	10.1371/journal.pone.0077966	http://dx.doi.org/10.1371/journal.pone.0077966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147103	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400145
J	Davis, TR; Zucchi, PC; Kumamoto, CA				Davis, Talya R.; Zucchi, Paola C.; Kumamoto, Carol A.			Calmodulin Binding to Dfi1p Promotes Invasiveness of Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SIGNAL-TRANSDUCTION; GROWTH; CALCINEURIN; PHOSPHATASE; STRESS; SEARCH; GENE	Candida albicans, a dimorphic fungus, undergoes hyphal development in response to many different environmental cues, including growth in contact with a semi-solid matrix. C. albicans forms hyphae that invade agar when cells are embedded in or grown on the surface of agar, and the integral membrane protein Dfi1p is required for this activity. In addition, Dfi1p is required for full activation of mitogen activated protein kinase Cek1p during growth on agar. In this study, we identified a putative calmodulin binding motif in the C-terminal tail of Dfi1p. This region of Dfi1p bound to calmodulin in vitro, and mutations that affected this region affected both calmodulin binding in vitro and invasive filamentation when incorporated into the full length Dfi1p protein. Moreover, increasing intracellular calcium levels led to calcium-dependent, Dfi1p-dependent Cek1p activation. We propose that conformational changes in Dfi1p in response to environmental conditions encountered during growth allow the protein to bind calmodulin and initiate a signaling cascade that activates Cek1p.	[Davis, Talya R.; Zucchi, Paola C.] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Mol Microbiol, Boston, MA 02111 USA; [Kumamoto, Carol A.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University; Tufts University	Kumamoto, CA (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.	carol.kumamoto@tufts.edu			National Institutes of Health [AI081794]; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081794, R56AI081794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grant AI081794 from the National Institutes of Health (to CAK). TRD was supported in part by a predoctoral fellowship from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Burgoyne RD, 2003, BBA-MOL CELL RES, V1641, P137, DOI 10.1016/S0167-4889(03)00089-2; Cannon RD, 2007, MICROBIOL-SGM, V153, P3211, DOI 10.1099/mic.0.2007/010405-0; Csank C, 1997, MOL BIOL CELL, V8, P2539, DOI 10.1091/mbc.8.12.2539; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302; De Haro L, 2003, BIOL CELL, V95, P459, DOI 10.1016/S0248-4900(03)00076-5; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Monge RA, 2006, MICROBIOL-SGM, V152, P905, DOI 10.1099/mic.0.28616-0; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; Navarro-Garcia F, 2005, MICROBIOL-SGM, V151, P2737, DOI 10.1099/mic.0.28038-0; Nickols HH, 2004, J BIOL CHEM, V279, P46969, DOI 10.1074/jbc.M407351200; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Roman E, 2009, EUKARYOT CELL, V8, P1235, DOI 10.1128/EC.00081-09; SABIE FT, 1989, MYCOPATHOLOGIA, V108, P47, DOI 10.1007/BF00436783; Sanchez-Gonzalez P, 2010, FEBS J, V277, P327, DOI 10.1111/j.1742-4658.2009.07469.x; Sato T, 2004, BIOL PHARM BULL, V27, P1281, DOI 10.1248/bpb.27.1281; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Sugiura R, 2002, GENES CELLS, V7, P619, DOI 10.1046/j.1365-2443.2002.00557.x; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; TRECO DA, 1993, CURRENT PROTOCOLS MO, pCH13; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zucchi PC, 2010, MOL MICROBIOL, V76, P733, DOI 10.1111/j.1365-2958.2010.07137.x	32	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76239	10.1371/journal.pone.0076239	http://dx.doi.org/10.1371/journal.pone.0076239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155896	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300030
J	Hayashizaki, S; Hirai, S; Ito, Y; Honda, Y; Arime, Y; Sora, I; Okado, H; Kodama, T; Takada, M				Hayashizaki, Seiji; Hirai, Shinobu; Ito, Yumi; Honda, Yoshiko; Arime, Yosefu; Sora, Ichiro; Okado, Haruo; Kodama, Tohru; Takada, Masahiko			Methamphetamine Increases Locomotion and Dopamine Transporter Activity in Dopamine D5 Receptor-Deficient Mice	PLOS ONE			English	Article							EXTRACELLULAR DOPAMINE; PREFRONTAL CORTEX; SELF-STIMULATION; KNOCKOUT MICE; DRD5 GENE; AMPHETAMINE; COCAINE; REWARD; PIMOZIDE; RATS	Dopamine regulates the psychomotor stimulant activities of amphetamine-like substances in the brain. The effects of dopamine are mediated through five known dopamine receptor subtypes in mammals. The functional relevance of D5 dopamine receptors in the central nervous system is not well understood. To determine the functional relevance of D5 dopamine receptors, we created D5 dopamine receptor-deficient mice and then used these mice to assess the roles of D5 dopamine receptors in the behavioral response to methamphetamine. Interestingly, D5 dopamine receptor-deficient mice displayed increased ambulation in response to methamphetamine. Furthermore, dopamine transporter threonine phosphorylation levels, which regulate amphetamine-induced dopamine release, were elevated in D5 dopamine receptor-deficient mice. The increase in methamphetamine-induced locomotor activity was eliminated by pretreatment with the dopamine transporter blocker GBR12909. Taken together, these results suggest that dopamine transporter activity and threonine phosphorylation levels are regulated by D5 dopamine receptors.	[Hayashizaki, Seiji; Hirai, Shinobu; Ito, Yumi; Honda, Yoshiko; Okado, Haruo; Kodama, Tohru; Takada, Masahiko] Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan; [Hayashizaki, Seiji; Arime, Yosefu; Sora, Ichiro; Takada, Masahiko] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Arime, Yosefu; Sora, Ichiro] Tohoku Univ, Grad Sch Med, Dept Biol Psychiat, Sendai, Miyagi 980, Japan; [Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Inuyama, Aichi 484, Japan	Tokyo Metropolitan Institute of Medical Science; Japan Science & Technology Agency (JST); Tohoku University; Kyoto University	Hayashizaki, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Tokyo 113, Japan.	hayashizaki-sj@igakuken.or.jp		KODAMA, TOHRU/0000-0001-6915-4428	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology (JST) Agency; Grants-in-Aid for Scientific Research [24650192] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology (JST) Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology (JST) Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Cunningham CL, 2000, PHARMACOL BIOCHEM BE, V67, P693, DOI 10.1016/S0091-3057(00)00414-7; Darracq L, 1998, J NEUROSCI, V18, P2729; DELFS JM, 1990, J NEUROSCI, V10, P303; DEWIT H, 1977, CAN J PSYCHOL, V31, P195, DOI 10.1037/h0081662; Elliot EE, 2003, PSYCHOPHARMACOLOGY, V169, P161, DOI 10.1007/s00213-003-1494-y; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; FOURIEZOS G, 1976, BRAIN RES, V103, P377, DOI 10.1016/0006-8993(76)90809-X; Holmes A, 2001, BEHAV NEUROSCI, V115, P1129, DOI 10.1037//0735-7044.115.5.1129; Housley DJE, 2009, ANN HUM GENET, V73, P274, DOI 10.1111/j.1469-1809.2009.00513.x; Kamens HM, 2005, GENES BRAIN BEHAV, V4, P110, DOI 10.1111/j.1601-183X.2004.00101.x; Karlsson RM, 2008, PSYCHOPHARMACOLOGY, V200, P117, DOI 10.1007/s00213-008-1165-0; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; LIEBMAN JM, 1974, N-S ARCH PHARMACOL, V284, P167, DOI 10.1007/BF00501121; Matsuda K, I REC FREE SOFTWARE; MILLER R, 1990, PROG NEUROBIOL, V34, P143, DOI 10.1016/0301-0082(90)90005-2; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Ouyang M, 2012, J NEUROSCI, V32, P1932, DOI 10.1523/JNEUROSCI.5231-11.2012; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Riday TT, 2012, NEUROPHARMACOLOGY, V62, P1858, DOI 10.1016/j.neuropharm.2011.12.011; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Scibelli AC, 2011, PSYCHOPHARMACOLOGY, V214, P791, DOI 10.1007/s00213-010-2086-2; Sellings LHL, 2006, SYNAPSE, V59, P374, DOI 10.1002/syn.20247; Sucic S, 2010, J BIOL CHEM, V285, P10924, DOI 10.1074/jbc.M109.083154; Torkamanzehi A, 2006, BEHAV GENET, V36, P903, DOI 10.1007/s10519-006-9078-3; Tran AH, 2008, J NEUROSCI, V28, P13390, DOI 10.1523/JNEUROSCI.2680-08.2008; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; Vanyukov MM, 1998, BEHAV GENET, V28, P75, DOI 10.1023/A:1021463722326; Vanyukov MM, 2000, AM J MED GENET, V96, P654, DOI 10.1002/1096-8628(20001009)96:5<654::AID-AJMG11>3.0.CO;2-Y; Ventura R, 2003, J NEUROSCI, V23, P1879; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4; YOKEL RA, 1975, SCIENCE, V187, P547, DOI 10.1126/science.1114313	36	11	11	8	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75975	10.1371/journal.pone.0075975	http://dx.doi.org/10.1371/journal.pone.0075975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155877	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300011
J	Jamison, J; Lauffenburger, D; Wang, JCH; Wells, A				Jamison, Joshua; Lauffenburger, Douglas; Wang, James C-H; Wells, Alan			PKC delta Localization at the Membrane Increases Matrix Traction Force Dependent on PLC gamma 1/EGFR Signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; FIBROBLAST CONTRACTILITY; PLASMA-MEMBRANE; M-CALPAIN; CELL; RECEPTOR; ACTIVATION; BINDING; MICROSCOPY	Introduction: During wound healing, fibroblasts initially migrate into the wound bed and later contract the matrix. Relevant mediators of transcellular contractility revealed by systems analyses are protein kinase c delta/myosin light chain-2 (PKC delta/MLC-2). PKC delta is activated by growth factor-driven PLC gamma 1 hydrolysis of phosphoinositide bisphosphate (PIP2) hydrolysis when it becomes tranlocated to the membrane. This leads to MLC-2 phosphorylation that regulates myosin for contractility. Furthermore, PKC delta n-terminus mediates PKC delta localization to the membrane in relative proximity to PLC gamma 1 activity. However, the role this localization and the relationship to its activation and signaling of force is not well understood. Therefore, we investigated whether the membrane localization of PKC delta mediates the transcellular contractility of fibroblasts. Methods: To determine PKC delta activation in targeted membrane locations in mouse fibroblast cells (NR6-WT), two PKC delta constructs were generated; PKC delta-CaaX with farnesylation moiety targeting PKC delta to the membrane and PKC delta-SaaX a non-targeting control. Results: Increased mean cell force was observed before and during EGF stimulation in fibroblasts expressing membrane-targeted PKC delta (PKC delta-CaaX) when analyzed with 2D cell traction force and 3D compaction of collagen matrix. This effect was reduced in cells deficient in EGFR/PLCy1 signaling. In cells expressing non-membrane targeted PKC delta (PKC delta-SaaX), the cell force exerted outside the ECM (extracellular matrix) was less, but cell motility/speed/persistence was increased after EGF stimulation. Change in cell motility and increased force exertion was also preceded by change in cell morphology. Organization of actin stress fibers was also decreased as a result of increasing membrane targeting of PKC delta. Conclusion: From these results membrane tethering of PKC delta leads to increased force exertion on ECM. Furthermore, our data show PLC gamma 1 regulation of PKC delta, at least in part, drives transcellular contractility in fibroblasts.	[Jamison, Joshua; Wells, Alan] Univ Pittsburgh, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Wang, James C-H] Univ Pittsburgh, Dept Orthoped Surg, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Lauffenburger, Douglas] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Massachusetts Institute of Technology (MIT)	Wells, A (corresponding author), Univ Pittsburgh, Dept Pathol, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA.	wellsa@upmc.edu		Wells, Alan/0000-0002-1637-8150	National Institute of Health [T32 HL094295, R01 GM069668, AR061395, AR060920]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668, R01GM063569] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	All from National Institute of Health: T32 HL094295; R01 GM069668, AR061395, AR060920 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FD, 2002, WOUND REPAIR REGEN, V10, P67, DOI 10.1046/j.1524-475X.2002.10701.x; ANDUJAR MB, 1992, J SUBMICR CYTOL PATH, V24, P145; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; DICKINSON RB, 1993, J MATH BIOL, V31, P563, DOI 10.1007/BF00161199; Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kharait S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-9; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Leloup L, 2010, J BIOL CHEM, V285, P33549, DOI 10.1074/jbc.M110.123604; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; Marinkovic A, 2012, AM J PHYSIOL-LUNG C, V303, pL169, DOI 10.1152/ajplung.00108.2012; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Seki T, 2005, GENES CELLS, V10, P225, DOI 10.1111/j.1365-2443.2005.00830.x; Shao HS, 2006, MOL CELL BIOL, V26, P5481, DOI 10.1128/MCB.02243-05; SHERRATT JA, 1992, IMA J MATH APPL MED, V9, P177; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Wang JHC, 2010, OPER TECH ORTHOP, V20, P106, DOI 10.1053/j.oto.2009.10.007; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; Wang JHC, 2009, METHODS MOL BIOL, V586, P301, DOI 10.1007/978-1-60761-376-3_17; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; Wells A, 2005, INT REV CYTOL, V245, P1, DOI 10.1016/S0074-7696(05)45001-9; Wells A, 1999, CELL MOTIL CYTOSKEL, V44, P227, DOI 10.1002/(SICI)1097-0169(199912)44:4<227::AID-CM1>3.0.CO;2-B; Yates CC, 2007, AM J PATHOL, V171, P484, DOI 10.2353/ajpath.2007.061092	28	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77434	10.1371/journal.pone.0077434	http://dx.doi.org/10.1371/journal.pone.0077434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155954	gold, Green Submitted, Green Published			2022-12-27	WOS:000325887300088
J	Shapiro, LR; Salvaudon, L; Mauck, KE; Pulido, H; De Moraes, CM; Stephenson, AG; Mescher, MC				Shapiro, Lori R.; Salvaudon, Lucie; Mauck, Kerry E.; Pulido, Hannier; De Moraes, Consuelo M.; Stephenson, Andrew G.; Mescher, Mark C.			Disease Interactions in a Shared Host Plant: Effects of Pre-Existing Viral Infection on Cucurbit Plant Defense Responses and Resistance to Bacterial Wilt Disease	PLOS ONE			English	Article							ACALYMMA-VITTATUM COLEOPTERA; SALICYLIC-ACID; ERWINIA-TRACHEIPHILA; FEEDING-BEHAVIOR; VIRUS; PATHOGEN; PHYTOHORMONES; BIOSYNTHESIS; TRANSMISSION; MECHANISMS	Both biotic and abiotic stressors can elicit broad-spectrum plant resistance against subsequent pathogen challenges. However, we currently have little understanding of how such effects influence broader aspects of disease ecology and epidemiology in natural environments where plants interact with multiple antagonists simultaneously. In previous work, we have shown that healthy wild gourd plants (Cucurbita pepo ssp. texana) contract a fatal bacterial wilt infection (caused by Erwinia tracheiphila) at significantly higher rates than plants infected with Zucchini yellow mosaic virus (ZYMV). We recently reported evidence that this pattern is explained, at least in part, by reduced visitation of ZYMV-infected plants by the cucumber beetle vectors of E. tracheiphila. Here we examine whether ZYMV-infection may also directly elicit plant resistance to subsequent E. tracheiphila infection. In laboratory studies, we assayed the induction of key phytohormones (SA and JA) in single and mixed infections of these pathogens, as well as in response to the feeding of A. vittatum cucumber beetles on healthy and infected plants. We also tracked the incidence and progression of wilt disease symptoms in plants with prior ZYMV infections. Our results indicate that ZYMV-infection slightly delays the progression of wilt symptoms, but does not significantly reduce E. tracheiphila infection success. This observation supports the hypothesis that reduced rates of wilt disease in ZYMV-infected plants reflect reduced visitation by beetle vectors. We also documented consistently strong SA responses to ZYMV infection, but limited responses to E. tracheiphila in the absence of ZYMV, suggesting that the latter pathogen may effectively evade or suppress plant defenses, although we observed no evidence of antagonistic cross-talk between SA and JA signaling pathways. We did, however, document effects of E. tracheiphila on induced responses to herbivory that may influence host-plant quality for (and hence pathogen acquisition by) cucumber beetles.	[Shapiro, Lori R.; Mauck, Kerry E.; Pulido, Hannier; De Moraes, Consuelo M.; Mescher, Mark C.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Salvaudon, Lucie] Univ Paris 11, Lab Ecol Systemat & Evolut, Orsay, France; [Stephenson, Andrew G.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Shapiro, Lori R.; Salvaudon, Lucie; Mauck, Kerry E.; Stephenson, Andrew G.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [De Moraes, Consuelo M.; Mescher, Mark C.] ETH, Dept Environm Syst Sci, Zurich, Switzerland	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Swiss Federal Institutes of Technology Domain; ETH Zurich	Mescher, MC (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	mescher@usys.ethz.ch		Mauck, Kerry/0000-0001-9678-0619	U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative [2008-35302-04577]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program; US National Science Foundation; USDA AFRI NIFA Pre-doctoral Fellowship	U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program; US National Science Foundation(National Science Foundation (NSF)); USDA AFRI NIFA Pre-doctoral Fellowship	Funding for this research was provided by Grant 2008-35302-04577 from the U.S. Department of Agriculture/Cooperative State Research, Education and Extension Service/National Research Initiative. L. Salvaudon was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program. L. Shapiro was supported by a Graduate Research Fellowship from the US National Science Foundation. K. Mauck was supported by a USDA AFRI NIFA Pre-doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; [Anonymous], R LANG ENV STAT COMP; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Belliure B, 2010, BASIC APPL ECOL, V11, P162, DOI 10.1016/j.baae.2009.09.004; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; DEAN RA, 1987, PHYSIOL MOL PLANT P, V31, P69, DOI 10.1016/0885-5765(87)90007-5; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; DECKER DS, 1988, ECON BOT, V42, P4, DOI 10.1007/BF02859022; Desbiez C, 1997, PLANT PATHOL, V46, P809, DOI 10.1046/j.1365-3059.1997.d01-87.x; Eben A, 2007, COLEOPTS BULL, V61, P57, DOI 10.1649/923.1; Engelberth J, 2007, MOL PLANT MICROBE IN, V20, P707, DOI 10.1094/MPMI-20-6-0707; ESAU K, 1967, ANNU REV PHYTOPATHOL, V5, P45, DOI 10.1146/annurev.py.05.090167.000401; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; Ferrari MJ, 2007, INT J PLANT SCI, V168, P603, DOI 10.1086/513487; Gal-On A, 2007, MOL PLANT PATHOL, V8, P139, DOI 10.1111/J.1364-3703.2007.00381.X; Garcia-Salazar C, 2000, ENVIRON ENTOMOL, V29, P542, DOI 10.1603/0046-225X-29.3.542; GESSLER C, 1982, J EXP BOT, V33, P58, DOI 10.1093/jxb/33.1.58; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; KUC J, 1982, BIOSCIENCE, V32, P854, DOI 10.2307/1309008; LEWIS PA, 1990, ENVIRON ENTOMOL, V19, P8, DOI 10.1093/ee/19.1.8; LISA V, 1981, PHYTOPATHOLOGY, V71, P667, DOI 10.1094/Phyto-71-667; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Mouttet R, 2013, OECOLOGIA, V173, P1379, DOI 10.1007/s00442-013-2716-6; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; MUCHARROMAH E, 1991, CROP PROT, V10, P265, DOI 10.1016/0261-2194(91)90004-B; Musser RO, 2003, J INSECT BEHAV, V16, P247, DOI 10.1023/A:1023919902976; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; SAS, 2011, BAS SAS 9 3 PROC GUI; Sasu MA, 2010, ENVIRON ENTOMOL, V39, P140, DOI 10.1603/EN09190; Sasu MA, 2010, INT J PLANT SCI, V171, P1048, DOI 10.1086/656531; Sasu MA, 2010, AM J BOT, V97, P1025, DOI 10.3732/ajb.0900381; Sasu MA, 2009, P NATL ACAD SCI USA, V106, P19067, DOI 10.1073/pnas.0905106106; Schmelz EA, 2004, PLANT J, V39, P790, DOI 10.1111/j.1365-313X.2004.02168.x; Schmelz EA, 2003, P NATL ACAD SCI USA, V100, P10552, DOI 10.1073/pnas.1633615100; Shapiro L, 2012, ECOL LETT, V15, P1430, DOI 10.1111/ele.12001; TALLAMY DW, 1985, ECOLOGY, V66, P1574, DOI 10.2307/1938019; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079	46	31	31	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77393	10.1371/journal.pone.0077393	http://dx.doi.org/10.1371/journal.pone.0077393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155951	Green Submitted, gold, Green Published			2022-12-27	WOS:000325887300085
J	Lin, M; Lai, DY; Pang, CY; Fan, SL; Song, MZ; Yu, SX				Lin, Min; Lai, Deyong; Pang, Chaoyou; Fan, Shuli; Song, Meizhen; Yu, Shuxun			Generation and Analysis of a Large-Scale Expressed Sequence Tag Database from a Full-Length Enriched cDNA Library of Developing Leaves of Gossypium hirsutum L.	PLOS ONE			English	Article							LEAF SENESCENCE; GENE-EXPRESSION; TRANSCRIPTOME ANALYSIS; SIGNALING PATHWAYS; MOLECULAR MARKERS; ARABIDOPSIS; IDENTIFICATION; REVEALS; ANNOTATION; BLAST2GO	Background: Cotton (Gossypium hirsutum L.) is one of the world's most economically-important crops. However, its entire genome has not been sequenced, and limited resources are available in GenBank for understanding the molecular mechanisms underlying leaf development and senescence. Methodology/Principal Findings: In this study, 9,874 high-quality ESTs were generated from a normalized, full-length cDNA library derived from pooled RNA isolated from throughout leaf development during the plant blooming stage. After clustering and assembly of these ESTs, 5,191 unique sequences, representative 1,652 contigs and 3,539 singletons, were obtained. The average unique sequence length was 682 bp. Annotation of these unique sequences revealed that 84.4% showed significant homology to sequences in the NCBI non-redundant protein database, and 57.3% had significant hits to known proteins in the Swiss-Prot database. Comparative analysis indicated that our library added 2,400 ESTs and 991 unique sequences to those known for cotton. The unigenes were functionally characterized by gene ontology annotation. We identified 1,339 and 200 unigenes as potential leaf senescence-related genes and transcription factors, respectively. Moreover, nine genes related to leaf senescence and eleven MYB transcription factors were randomly selected for quantitative real-time PCR (qRT-PCR), which revealed that these genes were regulated differentially during senescence. The qRT-PCR for three GhYLSs revealed that these genes express express preferentially in senescent leaves. Conclusions/Significance: These EST resources will provide valuable sequence information for gene expression profiling analyses and functional genomics studies to elucidate their roles, as well as for studying the mechanisms of leaf development and senescence in cotton and discovering candidate genes related to important agronomic traits of cotton. These data will also facilitate future whole-genome sequence assembly and annotation in G. hirsutum and comparative genomics among Gossypium species.	[Lin, Min; Lai, Deyong; Pang, Chaoyou; Fan, Shuli; Song, Meizhen; Yu, Shuxun] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yu, SX (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	yu@cricaas.com.cn	Lin, Min/HDN-8028-2022	Lin, Min/0000-0001-9242-115X	National Basic Research Program of China [2010CB126006]; China Agriculture Research System [CARS-18]	National Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System	This work was supported by the National Basic Research Program of China (No. 2010CB126006) and the earmarked fund for the China Agriculture Research System (CARS-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r24; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bleecker AB, 1997, PLANT CELL, V9, P1169, DOI 10.1105/tpc.9.7.1169; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Brautigam M, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-18; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Bremer B, 2003, BOT J LINN SOC, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Chu ZH, 2003, CHINESE SCI BULL, V48, P229, DOI 10.1360/03tb9047; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Michele R, 2009, NEW PHYTOL, V181, P563, DOI 10.1111/j.1469-8137.2008.02684.x; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gregersen PL, 2007, PLANT BIOTECHNOL J, V5, P192, DOI 10.1111/j.1467-7652.2006.00232.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; Han ZG, 2004, MOL GENET GENOMICS, V272, P308, DOI 10.1007/s00438-004-1059-8; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Hung KT, 2004, J PLANT PHYSIOL, V161, P1347, DOI 10.1016/j.jplph.2004.05.011; Hung KT, 2003, J PLANT PHYSIOL, V160, P871, DOI 10.1078/0176-1617-01118; Karsi A, 2002, GENE, V285, P157, DOI 10.1016/S0378-1119(02)00414-6; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kong ZS, 2006, PLANT PHYSIOL, V141, P1376, DOI 10.1104/pp.106.082941; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Lee BY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-278; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim PO, 2003, TRENDS PLANT SCI, V8, P272, DOI 10.1016/S1360-1385(03)00103-1; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Lindqvist C, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-16; Liu L, 2008, PLANT MOL BIOL, V67, P37, DOI 10.1007/s11103-008-9300-1; Liu XC, 2011, NUCLEIC ACIDS RES, V39, pD1103, DOI 10.1093/nar/gkq1169; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sekhon RS, 2012, PLANT PHYSIOL, V159, P1730, DOI 10.1104/pp.112.199224; Shi YH, 2006, PLANT CELL, V18, P651, DOI 10.1105/tpc.105.040303; Shuxun Y, 2010, INT COTT IN GEN ICGI, P2; Taliercio E, 2006, GENOME, V49, P306, DOI 10.1139/G05-115; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson J, 2000, BIOCHEM SOC T, V28, P775, DOI 10.1042/BST0280775; Thompson JE, 1998, PROG LIPID RES, V37, P119, DOI 10.1016/S0163-7827(98)00006-X; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Van der Graaff E, 2006, PLANT PHYSIOL, V141, P776, DOI 10.1104/pp.106.079293; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang C, 2006, THEOR APPL GENET, V112, P770, DOI 10.1007/s00122-005-0183-0; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yoshida S, 2001, PLANT CELL PHYSIOL, V42, P170, DOI 10.1093/pcp/pce021; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang H, 2011, NUCLEIC ACIDS RES, V39, pD1114, DOI 10.1093/nar/gkq1141; Zhang JY, 2013, PLANT J, V74, P160, DOI 10.1111/tpj.12104; Zhang X, 2011, PLANT CELL PHYSIOL, V52, P138, DOI 10.1093/pcp/pcq180; Zheng MS, 2004, PLANTA, V218, P740, DOI 10.1007/s00425-003-1169-2	62	8	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76443	10.1371/journal.pone.0076443	http://dx.doi.org/10.1371/journal.pone.0076443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146870	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400058
J	Shah, MMR; Liu, TX				Shah, M. Mostafizur Rahman; Liu, Tong-Xian			Feeding Experience of Bemisia tabaci (Hemiptera: Aleyrodidae) Affects Their Performance on Different Host Plants	PLOS ONE			English	Article							PHYTOPHAGOUS INSECTS; SPECIES COMPLEX; NATURAL ENEMIES; SWEET-POTATO; B-BIOTYPE; OVIPOSITION; CHINA; ARGENTIFOLII; WHITEFLIES; PREFERENCE	The sweetpotato whitefly, Bemisia tabaci biotype B is extremely polyphagous with >600 species of host plants. We hypothesized that previous experience of the whitefly on a given host plant affects their host selection and performance on the plants without previous experience. We investigated the host selection for feeding and oviposition of adults and development and survival of immatures of three host-plant-experienced populations of B. tabaci, namely Bemisia-eggplant, Bemisia-tomato and Bemisia-cucumber, on their experienced host plant and each of the three other plant species (eggplant, tomato, cucumber and pepper) without previous experience. We found that the influence of previous experience of the whiteflies varied among the populations. All populations refused pepper for feeding and oviposition, whereas the Bemisia-cucumber and the Bemisia-eggplant strongly preferred cucumber. Bemisia-tomato did not show strong preference to any of the three host palnts. Development time from egg to adult eclosion varied among the populations, being shortest on eggplant, longest on pepper, and intermediate on tomato and cucumber except for the Bemisia-cucumber developed similarly on tomato and pepper. The survivorship from egg to adult eclosion of all populations was highest on eggplant (80-98%), lowest on pepper (0-20%), and intermediate on tomato and cucumber. In conclusion, the effects of previous experience of whiteflies on host selection for feeding and oviposition, development, and survivorship varied depending on host plants, and host plants play a stronger role than previous experience. Preference of feeding and oviposition by adults may not accurately reflect host suitability of immatures. These results provided important information for understanding whitefly population dynamics and dispersal among different crop systems.	[Shah, M. Mostafizur Rahman; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Shah, M. Mostafizur Rahman; Liu, Tong-Xian] Northwest A&F Univ, Key Lab Integrated Pest Management Loess Plateau, Minist Agr, Yangling, Shaanxi, Peoples R China; [Shah, M. Mostafizur Rahman] Bangladesh Agr Res Inst, Wheat Res Ctr, Dinajpur, Bangladesh	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Bangladesh Agricultural Research Institute (BARI)	Liu, TX (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn			National Basic Research 359 Program of Ministry of Science and Technology, China (973 Program) [2012CB114105, 2012CB017359]; Special Fund for Agro-Scientific Research in the Public Interest [201303019]; China Agriculture Research System [CARS-25-B-06]	National Basic Research 359 Program of Ministry of Science and Technology, China (973 Program); Special Fund for Agro-Scientific Research in the Public Interest; China Agriculture Research System	This work was partially supported by the National Basic Research 359 Program of Ministry of Science and Technology, China (973 Program, 2012CB114105 and 2012CB017359), Special Fund for Agro-Scientific Research in the Public Interest (201303019), and China Agriculture Research System (CARS-25-B-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabeni P, 2001, OIKOS, V92, P225, DOI 10.1034/j.1600-0706.2001.920204.x; Berdegue M, 1998, ENTOMOL EXP APPL, V89, P57, DOI 10.1023/A:1003464102518; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Carabali A, 2005, CROP PROT, V24, P643, DOI 10.1016/j.cropro.2004.11.008; Chou I, 1949, J CHIN ENTOMOL, V3, P1; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2012, INSECT SCI, V19, P595, DOI 10.1111/j.1744-7917.2011.01500.x; De Barro P, 2010, BIOL INVASIONS, V12, P3013, DOI 10.1007/s10530-010-9691-1; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2006, BIOL INVASIONS, V8, P287, DOI 10.1007/s10530-005-1261-6; De Barro PJ, 2005, B ENTOMOL RES, V95, P193, DOI 10.1079/BER2004351; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; ENKEGAARD A, 1993, B ENTOMOL RES, V83, P535, DOI 10.1017/S0007485300039961; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Gruenhagen NM, 2001, ENTOMOL EXP APPL, V99, P387, DOI 10.1023/A:1019296603574; Institute SAS, 2011, SAS STAT 9 2 US GUID; Islam M. Touhidul, 2007, Journal of Entomology, V4, P231; Jiao XG, 2012, J PEST SCI, V85, P423, DOI 10.1007/s10340-012-0441-2; Khan MR, 2011, AFR J BIOTECHNOL, V10, P1467; Lee DH, 2011, BIOL CONTROL, V58, P302, DOI 10.1016/j.biocontrol.2011.06.005; Lee DH, 2009, ENTOMOL EXP APPL, V133, P105, DOI 10.1111/j.1570-7458.2009.00920.x; Lei H, 1998, ENTOMOL EXP APPL, V88, P73, DOI 10.1023/A:1003215227403; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Lin Ke-Jian, 2003, Acta Ecologica Sinica, V23, P870; LIU TX, 1995, J ECON ENTOMOL, V88, P992, DOI 10.1093/jee/88.4.992; Baldin ELL, 2010, J PEST SCI, V83, P221, DOI 10.1007/s10340-010-0289-2; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mansaray A, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0101; Martin JH, 2000, B ENTOMOL RES, V90, P407, DOI 10.1017/S0007485300000547; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; Naranjo SE, 2009, BIOL CONTROL, V51, P458, DOI 10.1016/j.biocontrol.2009.08.006; Noldus LPJJ, 2009, J APPL ENTOMOL, V101, P492; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Omondi AB, 2005, ENTOMOL EXP APPL, V115, P393, DOI 10.1111/j.1570-7458.2005.00296.x; PAPAJ DR, 1989, ANNU REV ENTOMOL, V34, P315, DOI 10.1146/annurev.en.34.010189.001531; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Thomas DC, 1993, THESIS WAGENINGEN AG; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Tsueda H, 2011, ENTOMOL EXP APPL, V141, P197, DOI 10.1111/j.1570-7458.2011.01189.x; VANLENTEREN JC, 1991, SYMP BIOL HUNG, V39, P365; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Wu XX, 2003, PROG NAT SCI-MATER, V13, P276, DOI 10.1360/03jz9049; Xu J, 2011, J APPL ENTOMOL, V135, P771, DOI 10.1111/j.1439-0418.2010.01581.x; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x; Zhao L, 2000, J AGR SCI, V1, P27	50	23	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77368	10.1371/journal.pone.0077368	http://dx.doi.org/10.1371/journal.pone.0077368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146985	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400112
J	Tay, EL; Grant, K; Kirk, M; Mounts, A; Kelly, H				Tay, Ee Laine; Grant, Kristina; Kirk, Martyn; Mounts, Anthony; Kelly, Heath			Exploring a Proposed WHO Method to Determine Thresholds for Seasonal Influenza Surveillance	PLOS ONE			English	Article							DISEASE SURVEILLANCE; INFECTIOUS-DISEASE; AUSTRALIA; VICTORIA; EPIDEMICS; OUTBREAKS; VACCINE	Introduction: Health authorities find thresholds useful to gauge the start and severity of influenza seasons. We explored a method for deriving thresholds proposed in an influenza surveillance manual published by the World Health Organization (WHO). Methods: For 2002-2011, we analysed two routine influenza-like-illness (ILI) datasets, general practice sentinel surveillance and a locum medical service sentinel surveillance, plus laboratory data and hospital admissions for influenza. For each sentinel dataset, we created two composite variables from the product of weekly ILI data and the relevant laboratory data, indicating the proportion of tested specimens that were positive. For all datasets, including the composite datasets, we aligned data on the median week of peak influenza or ILI activity and assigned three threshold levels: seasonal threshold, determined by inspection; and two intensity thresholds termed average and alert thresholds, determined by calculations of means, medians, confidence intervals (CI) and percentiles. From the thresholds, we compared the seasonal onset, end and intensity across all datasets from 2002-2011. Correlation between datasets was assessed using the mean correlation coefficient. Results: The median week of peak activity was week 34 for all datasets, except hospital data (week 35). Means and medians were comparable and the 90% upper CIs were similar to the 95th percentiles. Comparison of thresholds revealed variations in defining the start of a season but good agreement in describing the end and intensity of influenza seasons, except in hospital admissions data after the pandemic year of 2009. The composite variables improved the agreements between the ILI and other datasets. Datasets were well correlated, with mean correlation coefficients of >0.75 for a range of combinations. Conclusions: Thresholds for influenza surveillance are easily derived from historical surveillance and laboratory data using the approach proposed by WHO. Use of composite variables is helpful for describing influenza season characteristics.	[Tay, Ee Laine; Grant, Kristina; Kelly, Heath] Victoria Infect Dis Reference Lab, Melbourne, Vic, Australia; [Tay, Ee Laine; Kirk, Martyn; Kelly, Heath] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Mounts, Anthony] WHO, Global Influenza Programme, CH-1211 Geneva, Switzerland	Victorian Infectious Diseases Reference Laboratory; Australian National University; World Health Organization	Tay, EL (corresponding author), Victoria Infect Dis Reference Lab, Melbourne, Vic, Australia.	eelaine.tay@mh.org.au		Kirk, Martyn/0000-0001-5432-5984	Master of Philosophy in Applied Epidemiology Scholarship; Victorian Infectious Diseases Reference Laboratory; Victorian Department of Health; Victorian Government Department of Health	Master of Philosophy in Applied Epidemiology Scholarship; Victorian Infectious Diseases Reference Laboratory; Victorian Department of Health; Victorian Government Department of Health	The General Practitioner Sentinel Surveillance system is funded by the Victorian Government Department of Health. Ee Laine Tay was supported by a Master of Philosophy in Applied Epidemiology Scholarship funded by the Victorian Infectious Diseases Reference Laboratory and the Victorian Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso TV, 2004, INT CONGR SER, V1263, P281, DOI 10.1016/j.ics.2004.02.121; Atlanta, 2013, PREV CFDCA; Atlanta, 2012, PREV CFDCA; Clothier HJ, 2006, COMMUN DIS INTELL, V30, P345; Cooper DL, 2009, J PUBLIC HEALTH-UK, V31, P17, DOI 10.1093/pubmed/fdm068; Coory M, 2009, EUROSURVEILLANCE, V14, P1; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Dedman DJ, 1997, PHLS MICROBIOL DIGES, V14, P206; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; European Centre for Disease Prevention and Control, 2013, WEEKL INFL SURV OV; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Goldstein E, 2012, EPIDEMIOLOGY; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Hashimoto S, 2000, INT J EPIDEMIOL, V29, P905, DOI 10.1093/ije/29.5.905; Kelly H, 2000, Commun Dis Intell, V24, P379; Kelly HA, 2012, INFLUENZA OTHER RESP; Kelly H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005079; Kelly H, 2009, INFLUENZA OTHER RESP, V3, P183, DOI 10.1111/j.1750-2659.2009.00088.x; Kelly HA, 2011, VACCINE, V29, P6419, DOI 10.1016/j.vaccine.2011.03.055; Kuang J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-418; Lambert SB, 2010, MED J AUSTRALIA, V193, P43, DOI 10.5694/j.1326-5377.2010.tb03741.x; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2008, VACCINE, V26, pD45, DOI 10.1016/j.vaccine.2008.07.066; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; OBrien SJ, 1997, PUBLIC HEALTH, V111, P255, DOI 10.1016/S0033-3506(97)00044-9; Parantharnan K, 2008, EMERG INFECT DIS, V14, P520, DOI 10.3201/eid1403.071275; Public Health Surveillance New; Zealand, 2013, RES IOESA; Quigley C, 2004, BRIT MED J, V329, P1239, DOI 10.1136/bmj.329.7476.1239; Sentinel Influenza Surveillance, 2013, CURR INFL SURV REP; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Steiner SH, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-37; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Turner J, 2005, Euro Surveill, V10, P96; Vega T, 2012, INFLUENZA OTHER RESP; Watts CG, 2003, AUST NZ J PUBL HEAL, V27, P409, DOI 10.1111/j.1467-842X.2003.tb00418.x; World Health Organization, 2009, INFL SEAS FACTSH; World Health Organization, 2012, WHO GLOB SURV STAND	38	35	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77244	10.1371/journal.pone.0077244	http://dx.doi.org/10.1371/journal.pone.0077244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146973	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400108
J	de Zilva, D; Vu, L; Newell, B; Pearson, J				de Zilva, Daniel; Vu, Luke; Newell, Ben R.; Pearson, Joel			Exposure Is Not Enough: Suppressing Stimuli from Awareness Can Abolish the Mere Exposure Effect	PLOS ONE			English	Article							AFFECTIVE DISCRIMINATION; PERCEPTUAL FLUENCY; CORTICAL RESPONSES; MEMORY; FACES; RECOGNITION; ILLUSIONS; OBJECTS; LIKING; DORSAL	Passive exposure to neutral stimuli increases subsequent liking of those stimuli - the mere exposure effect. Because of the broad implications for understanding and controlling human preferences, the role of conscious awareness in mere exposure has received much attention. Previous studies have claimed that the mere exposure effect can occur without conscious awareness of the stimuli. In two experiments, we applied a technique new to the mere exposure literature, called continuous flash suppression, to expose stimuli for a controlled duration with and without awareness. To ensure the reliability of the awareness manipulation, awareness was monitored on a trial-by-trial basis. Our results show that under these conditions the mere exposure effect does not occur without conscious awareness. In contrast, only when participants were aware of the stimuli did exposure increase liking and recognition. Together these data are consistent with the idea that the mere exposure effect requires conscious awareness and has important implications for theories of memory and affect.	[de Zilva, Daniel; Vu, Luke; Newell, Ben R.; Pearson, Joel] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Pearson, J (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	joel@pearsonlab.org	de Zilva, Daniel/S-7120-2019	Newell, Benjamin/0000-0003-1898-205X; Pearson, Joel/0000-0003-3704-5037	Australian NHMRC [APP1024800, APP1046198, APP1049596]; ARC [FT 110100151]	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	This work was supported by Australian NHMRC (http://www.nhmrc.gov.au/) project grants (APP1024800, APP1046198), a Career Development Fellowship (APP1049596) held by JP, and an ARC (www.arc.gov.au/) Future Fellowship (FT 110100151) held by BRN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida J, 2010, PSYCHOL SCI, V21, P772, DOI 10.1177/0956797610371343; Ap Dijksterhuis, 2002, EMOTION, V2, P203, DOI 10.1037/1528-3542.2.3.203; BALL PM, 1974, PERCEPT MOTOR SKILL, V39, P883, DOI 10.2466/pms.1974.39.2.883; Berlyne D. E., 1974, STUDIES NEW EXPT AES; BORNSTEIN RF, 1992, J PERS SOC PSYCHOL, V63, P545, DOI 10.1037//0022-3514.63.4.545; BORNSTEIN RF, 1994, SOC COGNITION, V12, P103, DOI 10.1521/soco.1994.12.2.103; BORNSTEIN RF, 1987, J PERS SOC PSYCHOL, V53, P1070, DOI 10.1037/0022-3514.53.6.1070; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; de Zilva D, 2013, COGNITION EMOTION, V27, P1345, DOI 10.1080/02699931.2013.775110; Faivre N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00129; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Gray KLH, 2013, EMOTION, V13, P537, DOI 10.1037/a0031403; Harris JJ, 2011, PSYCHOL SCI, V22, P399, DOI 10.1177/0956797611399293; JANISZEWSKI C, 1993, J CONSUM RES, V20, P376, DOI 10.1086/209356; Jiang Y, 2006, CURR BIOL, V16, P2023, DOI 10.1016/j.cub.2006.08.084; KUNSTWILSON WR, 1980, SCIENCE, V207, P557, DOI 10.1126/science.7352271; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lovibond PF, 2002, J EXP PSYCHOL-ANIM B, V28, P3, DOI 10.1037//0097-7403.28.1.3; Maruya K, 2008, J VISION, V8, DOI 10.1167/8.11.7; Monahan JL, 2000, PSYCHOL SCI, V11, P462, DOI 10.1111/1467-9280.00289; Newell BR, 2007, EUR J COGN PSYCHOL, V19, P103, DOI 10.1080/09541440500487454; Newell BR, BEHAV BRAIN SCI; Pasley BN, 2004, NEURON, V42, P163, DOI 10.1016/S0896-6273(04)00155-2; Pearson J, 2012, CURR BIOL, V22, pR495, DOI 10.1016/j.cub.2012.04.042; PLINER P, 1982, APPETITE, V3, P283, DOI 10.1016/S0195-6663(82)80026-3; Raio CM, 2012, CURR BIOL, V22, pR477, DOI 10.1016/j.cub.2012.04.023; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; SEAMON JG, 1984, J EXP PSYCHOL LEARN, V10, P465, DOI 10.1037/0278-7393.10.3.465; SEAMON JG, 1995, J EXP PSYCHOL LEARN, V21, P711, DOI 10.1037/0278-7393.21.3.711; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Stafford T, 2012, PSYCHOL MARKET, V29, P995, DOI 10.1002/mar.20581; Stein T, 2011, J VISION, V11, DOI 10.1167/11.8.5; Szpunar KK, 2004, J EXP PSYCHOL LEARN, V30, P370, DOI 10.1037/0278-7393.30.2.370; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Van den Bergh O, 1998, COGNITION EMOTION, V12, P533, DOI 10.1080/026999398379556; Vizueta N, 2012, NEUROIMAGE, V59, P761, DOI 10.1016/j.neuroimage.2011.07.015; WHITTLESEA BWA, 1993, J EXP PSYCHOL LEARN, V19, P1235, DOI 10.1037/0278-7393.19.6.1235; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	42	20	20	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77726	10.1371/journal.pone.0077726	http://dx.doi.org/10.1371/journal.pone.0077726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239KL	24147067	Green Published, gold			2022-12-27	WOS:000326022200070
J	Ghafoory, S; Breitkopf-Heinlein, K; Li, Q; Scholl, C; Dooley, S; Wolfl, S				Ghafoory, Shahrouz; Breitkopf-Heinlein, Katja; Li, Qi; Scholl, Catharina; Dooley, Steven; Woelfl, Stefan			Zonation of Nitrogen and Glucose Metabolism Gene Expression upon Acute Liver Damage in Mouse	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CARBON-TETRACHLORIDE; HEPATOCYTE HETEROGENEITY; AMMONIA METABOLISM; RAT-LIVER; GLUTAMINE; HEPATOTOXICITY; GLUCOSE-6-PHOSPHATASE; NECROSIS; INJURY	Zonation of metabolic activities within specific structures and cell types is a phenomenon of liver organization and ensures complementarity of variant liver functions like protein production, glucose homeostasis and detoxification. To analyze damage and regeneration of liver tissue in response to a toxic agent, expression of liver specific enzymes was analyzed by in situ hybridization in mouse over a 6 days time course following carbon tetrachloride (CCl4) injection. CCl4 mixed with mineral oil was administered to BALB/c mice by intraperitoneal injection, and mice were sacrificed at different time points post injection. Changes in the expression of albumin (Alb), arginase (Arg1), glutaminase 2 (Gls2), Glutamine synthetase (Gs), glucose-6-phosphatase (G6pc), glycogen synthase 2 (Gys2), Glycerinaldehyd-3-phosphat-Dehydrogenase (Gapdh), Cytochrom p450 2E1 (Cyp2e1) and glucagon receptor (Gcgr) genes in the liver were studied by in situ hybridization and qPCR. We observed significant changes in gene expression of enzymes involved in nitrogen and glucose metabolism and their local distribution following CCl4 injury. We also found that Cyp2e1, the primary metabolizing enzyme for CCl4, was strongly expressed in the pericentral zone during recovery. Furthermore, cells in the damaged area displayed distinct gene expression profiles during the analyzed time course and showed complete recovery with strong albumin production 6 days after CCl4 injection. Our results indicate that despite severe damage, liver cells in the damaged area do not simply die but instead display locally adjusted gene expression supporting damage response and recovery.	[Ghafoory, Shahrouz; Scholl, Catharina; Woelfl, Stefan] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Breitkopf-Heinlein, Katja; Li, Qi; Dooley, Steven] Heidelberg Univ, Med Fac Mannheim, Sect Mol Hepatol Alcohol Associated Dis, Dept Med 2, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Wolfl, S (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	wolfl@uni-hd.de	Dooley, Steven/T-6491-2018	Dooley, Steven/0000-0002-4840-6240	German Federal Ministry of Education and Research (BMBF) "Virtual Liver"; German Research Foundation (DFG) [FOR630]	German Federal Ministry of Education and Research (BMBF) "Virtual Liver"(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	The work was supported by grants of the German Federal Ministry of Education and Research (BMBF) "Virtual Liver" and German Research Foundation (DFG) FOR630 to SD, KBH and SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTELS H, 1988, HISTOCHEMISTRY, V89, P253, DOI 10.1007/BF00493149; Diehl AM, 2002, FRONT BIOSCI-LANDMRK, V7, pE301, DOI 10.2741/diehl; EVARTS RP, 1987, CANCER RES, V47, P5469; Ferreira EA, 2010, LIBYAN J MED, V5, DOI 10.3402/ljm.v5i0.4891; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Ghafoory S, 2012, HISTOPATHOLOGY, V61, P306, DOI 10.1111/j.1365-2559.2012.04237.x; Ghosh A, 2002, J BIOL CHEM, V277, P32837, DOI 10.1074/jbc.M201853200; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Haussinger D, 2007, FRONT BIOSCI-LANDMRK, V12, P371, DOI 10.2741/2070; HAUSSINGER D, 1983, EUR J BIOCHEM, V133, P269, DOI 10.1111/j.1432-1033.1983.tb07458.x; HAUSSINGER D, 1990, JPEN-PARENTER ENTER, V14, pS56, DOI 10.1177/014860719001400405; HAUSSINGER D, 1984, CHEM-BIOL INTERACT, V48, P191, DOI 10.1016/0009-2797(84)90120-0; Ichi I, 2007, J NUTR SCI VITAMINOL, V53, P53, DOI 10.3177/jnsv.53.53; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; JONGES GN, 1992, J BIOL CHEM, V267, P4878; Jungermann K, 1997, KIDNEY INT, V51, P402, DOI 10.1038/ki.1997.53; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; LINDROS KO, 1990, HEPATOLOGY, V12, P1092, DOI 10.1002/hep.1840120503; Lindros KO, 1997, GEN PHARMACOL, V28, P191, DOI 10.1016/S0306-3623(96)00183-8; MASUDA Y, 1980, J PHARMACOBIO-DYNAM, V3, P53, DOI 10.1248/bpb1978.3.53; Meng ZP, 2010, MOL ENDOCRINOL, V24, P886, DOI 10.1210/me.2009-0286; MOKUDA O, 1995, BIOCHEM MOL MED, V54, P38, DOI 10.1006/bmme.1995.1006; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; MOORMAN AFM, 1994, FEBS LETT, V356, P76, DOI 10.1016/0014-5793(94)01230-X; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; REYNOLDS ES, 1963, J CELL BIOL, V19, P139, DOI 10.1083/jcb.19.1.139; SCHOLS L, 1990, HISTOCHEMISTRY, V94, P49; Snider NT, 2011, J CELL BIOL, V195, P217, DOI 10.1083/jcb.201102142; STEUP DR, 1993, TOXICOL PATHOL, V21, P327, DOI 10.1177/019262339302100309; Sun F, 2001, BBA-MOL BASIS DIS, V1535, P186, DOI 10.1016/S0925-4439(00)00098-3; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547; Yu H, 2003, J HISTOCHEM CYTOCHEM, V51, P1151, DOI 10.1177/002215540305100905	35	36	37	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78262	10.1371/journal.pone.0078262	http://dx.doi.org/10.1371/journal.pone.0078262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147127	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200096
J	Gong, JH; Zhang, DX; Tseng, Y; Li, BL; Wirtz, D; Schafer, BW				Gong, Jinghai; Zhang, Daxu; Tseng, Yiider; Li, Baolong; Wirtz, Denis; Schafer, Benjamin William			Form-Finding Model Shows How Cytoskeleton Network Stiffness Is Realized	PLOS ONE			English	Article							A ABP-280 MOLECULES; MECHANICAL-PROPERTIES; ACTIN NETWORKS; CELLULAR TENSEGRITY; VISCOELASTICITY; ELASTICITY	In eukaryotic cells the actin-cytoskeletal network provides stiffness and the driving force that contributes to changes in cell shape and cell motility, but the elastic behavior of this network is not well understood. In this paper a two dimensional form-finding model is proposed to investigate the elasticity of the actin filament network. Utilizing an initially random array of actin filaments and actin-cross-linking proteins the form-finding model iterates until the random array is brought into a stable equilibrium configuration. With some care given to actin filament density and length, distance between host sites for cross-linkers, and overall domain size the resulting configurations from the form-finding model are found to be topologically similar to cytoskeletal networks in real cells. The resulting network may then be mechanically exercised to explore how the actin filaments deform and align under load and the sensitivity of the network's stiffness to actin filament density, length, etc. Results of the model are consistent with the experimental literature, e. g. actin filaments tend to re-orient in the direction of stretching; and the filament relative density, filament length, and actin-cross-linking protein's relative density, control the actin-network stiffness. The model provides a ready means of extension to more complicated domains and a three-dimensional form-finding model is under development as well as models studying the formation of actin bundles.	[Gong, Jinghai; Schafer, Benjamin William] Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21218 USA; [Gong, Jinghai; Zhang, Daxu; Li, Baolong] Shanghai Jiao Tong Univ, Dept Civil Engn, Shanghai 200030, Peoples R China; [Tseng, Yiider] Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA; [Wirtz, Denis] Johns Hopkins Univ, Dept Oncol, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University; Shanghai Jiao Tong University; State University System of Florida; University of Florida; Johns Hopkins University	Schafer, BW (corresponding author), Johns Hopkins Univ, Dept Civil Engn, Baltimore, MD 21218 USA.	schafer@jhu.edu	Zhang, Daxu/H-9674-2012	Zhang, Daxu/0000-0002-6586-5238	Institute for NanoBio Technology at the Johns Hopkins University	Institute for NanoBio Technology at the Johns Hopkins University(Johns Hopkins University)	The authors would like to recognize the Institute for NanoBio Technology at the Johns Hopkins University for partial funding in the development of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baudriller H, 2006, CR MECANIQUE, V334, P662, DOI 10.1016/j.crme.2006.08.004; Bausch AR, 2006, NAT PHYS, V2, P231, DOI 10.1038/nphys260; Broedersz CP, 2011, NAT PHYS, V7, P983, DOI [10.1038/nphys2127, 10.1038/NPHYS2127]; Canadas P, 2002, J THEOR BIOL, V218, P155, DOI 10.1006/jtbi.2002.3064; Chu JW, 2006, BIOPHYS J, V90, P1572, DOI 10.1529/biophysj.105.073924; Coughlin MF, 2003, BIOPHYS J, V84, P1328, DOI 10.1016/S0006-3495(03)74948-0; Ethier CR, 2007, CAMB TEXT BIOMED ENG, P1, DOI 10.2277/ 0521841127; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Ferrer JM, 2008, P NATL ACAD SCI USA, V105, P9221, DOI 10.1073/pnas.0706124105; Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8; Gardel ML, 2006, P NATL ACAD SCI USA, V103, P1762, DOI 10.1073/pnas.0504777103; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; INGBER DE, 1993, J CELL SCI, V104, P613; INGBER DE, 1981, P NATL ACAD SCI-BIOL, V78, P3901, DOI 10.1073/pnas.78.6.3901; JANMEY PA, 1990, NATURE, V345, P89, DOI 10.1038/345089a0; Kang J, 2011, J THEOR BIOL, V274, P109, DOI 10.1016/j.jtbi.2011.01.011; Kasza KE, 2010, BIOPHYS J, V99, P1091, DOI 10.1016/j.bpj.2010.06.025; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kim T, 2009, EXP MECH, V49, P91, DOI 10.1007/s11340-007-9091-3; Kim T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000439; Lam RHW, 2012, INTEGR BIOL-UK, V4, P1289, DOI 10.1039/c2ib20134h; Luo YZ, 2008, J BIOMECH, V41, P2379, DOI 10.1016/j.jbiomech.2008.05.026; Mizuno D, 2007, SCIENCE, V315, P370, DOI 10.1126/science.1134404; Niediek V, 2012, EUR J CELL BIOL, V91, P118, DOI 10.1016/j.ejcb.2011.10.003; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; RUDDIES R, 1993, EUR BIOPHYS J BIOPHY, V22, P309, DOI 10.1007/BF00213554; Satcher RL, 1996, BIOPHYS J, V71, P109, DOI 10.1016/S0006-3495(96)79206-8; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Stamenovic D, 2000, J BIOMECH ENG-T ASME, V122, P39, DOI 10.1115/1.429631; Tempel M, 1996, PHYS REV E, V54, P1802, DOI 10.1103/PhysRevE.54.1802; WACHSSTOCK DH, 1994, BIOPHYS J, V66, P801, DOI 10.1016/S0006-3495(94)80856-2; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Wang N, 2002, AM J PHYSIOL-CELL PH, V282, pC606, DOI 10.1152/ajpcell.00269.2001; WOLOSEWICK JJ, 1979, J CELL BIOL, V82, P114, DOI 10.1083/jcb.82.1.114; Xu JY, 1998, J BIOL CHEM, V273, P9570, DOI 10.1074/jbc.273.16.9570; Yamazaki M, 2002, J MUSCLE RES CELL M, V23, P525, DOI 10.1023/A:1023418725001	36	8	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77417	10.1371/journal.pone.0077417	http://dx.doi.org/10.1371/journal.pone.0077417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146992	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200036
J	Kumar, S; Maiti, S				Kumar, Santosh; Maiti, Souvik			The Effect of N-acetylation and N-methylation of Lysine Residue of Tat Peptide on its Interaction with HIV-1 TAR RNA	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; ARGININE METHYLATION; HISTONE ACETYLATION; TRANSACTIVATOR TAT; PROTEIN; BINDING; RECOGNITION; TRANSITIONS; DOMAIN	Post-translational modification (PTM) of RNA binding proteins (RBPs) play a very important role in determining their binding to cognate RNAs and therefore regulate the downstream effects. Lysine can undergo various PTMs and thereby contribute to the regulation of different cellular processes. It can be reversibly acetylated and methylated using a pool of respective enzymes, to act as a switch for controlling the binding efficiency of RBPs. Here we have delineated the thermodynamic and kinetic effects of N-acetylation and N-monomethylation of lysine on interaction between HIV-1 TAR RNA and its cognate binder Tat peptide (a model system). Our results indicate that acetylation of lysine 50 (K50), leads to eight-fold reduction in binding affinity, originating exclusively from entropy changes whereas, lysine 51 (K51) acetylation resulted only in three fold decrease with large enthalpy-entropy compensation. The measurement of kinetic parameters indicated major change (4.5 fold) in dissociation rate in case of K50 acetylation however, K51 acetylation showed similar effect on both association and dissociation rates. In contrast, lysine methylation did not affect the binding affinity of Tat peptide to TAR RNA at K50, nonetheless three fold enhancement in binding affinity was observed at K51 position. In spite of large enthalpy-entropy compensation, lysine methylation seems to have more pronounced position specific effect on the kinetic parameters. In case of K50 methylation, simultaneous increase was observed in the rate of association and dissociation leaving binding affinity unaffected. The increased binding affinity for methylated Tat at K51 stems from faster association rate with slightly slower dissociation rate.	[Kumar, Santosh; Maiti, Souvik] CSIR, Inst Genom & Integrat Biol, Prote & Struct Biol Unit, Delhi, India; [Maiti, Souvik] CSIR, Natl Chem Lab, Pune, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Maiti, S (corresponding author), CSIR, Inst Genom & Integrat Biol, Prote & Struct Biol Unit, Delhi, India.	souvik@igib.res.in	Kumar, Santosh/ABF-3590-2021	Kumar, Santosh/0000-0002-3594-4795; Maiti, Souvik/0000-0001-9897-1419	Council of Scientific and Industrial Research (CSIR), Government of India [BSC0123]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This project was financially supported by Council of Scientific and Industrial Research (CSIR), Government of India, (BSC0123 project)."The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Black JC, 2013, BIOPOLYMERS, V99, P127, DOI 10.1002/bip.22136; Bres V, 2002, J BIOL CHEM, V277, P22215, DOI 10.1074/jbc.M201895200; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cujec TP, 1997, GENE DEV, V11, P2645, DOI 10.1101/gad.11.20.2645; Deng LW, 2000, VIROLOGY, V277, P278, DOI 10.1006/viro.2000.0593; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Easley R, 2010, BBA-GENE REGUL MECH, V1799, P275, DOI 10.1016/j.bbagrm.2009.08.008; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GORLACH M, 1992, EMBO J, V11, P3289, DOI 10.1002/j.1460-2075.1992.tb05407.x; Hermann T, 1999, CHEM BIOL, V6, pR335, DOI 10.1016/S1074-5521(00)80003-4; Hetzer C, 2005, MICROBES INFECT, V7, P1364, DOI 10.1016/j.micinf.2005.06.003; Hyun S, 2007, J AM CHEM SOC, V129, P4514, DOI 10.1021/ja068265m; Indyk L, 1998, METHOD ENZYMOL, V295, P350; Invernizzi CF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-93; Johri MK, 2011, EXPERT OPIN BIOL TH, V11, P269, DOI 10.1517/14712598.2011.546339; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee EK, 2012, CURR PROTEIN PEPT SC, V13, P331; Long KS, 1999, BIOCHEMISTRY-US, V38, P10059, DOI 10.1021/bi990590h; MARKY LA, 1983, BIOPOLYMERS, V22, P1247, DOI 10.1002/bip.360220416; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; Michael LA, 2009, J MOL BIOL, V392, P774, DOI 10.1016/j.jmb.2009.07.047; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Pagans S, 2010, CELL HOST MICROBE, V7, P234, DOI 10.1016/j.chom.2010.02.005; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; RUBEN S, 1989, J VIROL, V63, P1; Sakane N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002184; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sivakumaran H, 2009, J VIROL, V83, P11694, DOI 10.1128/JVI.00499-09; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Suryawanshi H, 2010, J PHYS CHEM B, V114, P11155, DOI 10.1021/jp1000545; Terreni M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-18; Van Duyne R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-40; WEEKS KM, 1991, CELL, V66, P577, DOI 10.1016/0092-8674(81)90020-9; Wu Yuntao, 2004, Retrovirology, V1, P13, DOI 10.1186/1742-4690-1-13; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	43	9	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77595	10.1371/journal.pone.0077595	http://dx.doi.org/10.1371/journal.pone.0077595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147034	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200050
J	Auclair, S; Rossetti, R; Meslin, C; Monestier, O; Di Pasquale, E; Pascal, G; Persani, L; Fabre, S				Auclair, Sylvain; Rossetti, Raffaella; Meslin, Camille; Monestier, Olivier; Di Pasquale, Elisa; Pascal, Geraldine; Persani, Luca; Fabre, Stephane			Positive Selection in Bone Morphogenetic Protein 15 Targets a Natural Mutation Associated with Primary Ovarian Insufficiency in Human	PLOS ONE			English	Article							INCREASED OVULATION RATE; BIASED GENE CONVERSION; TGF-BETA; MAMMALIAN GENOMES; EVOLUTION; OOCYTE; BMP15; STERILITY; PROGESTERONE; PHYLOGENIES	Bone Morphogenetic Protein 15 (BMP15) is a TGF beta-like oocyte-derived growth factor involved in ovarian folliculogenesis as a critical regulator of many granulosa cell processes. Alterations of the BMP15 gene have been found associated with different ovarian phenotypic effects depending on the species, from sterility to increased prolificacy in sheep, slight subfertility in mouse or associated with primary ovarian insufficiency (POI) in women. To investigate the evolving role of BMP15, a phylogenetic analysis of this particular TGF beta family member was performed. A maximum likelihood phylogenetic tree of several TGF beta/BMP family members expressed by the ovary showed that BMP15 has a very strong divergence and a rapid evolution compared to others. Moreover, among 24 mammalian species, we detected signals of positive selection in the hominidae clade corresponding to F146, L189 and Y235 residues in human BMP15. The biological importance of these residues was tested functionally after site directed-mutagenesis in a COV434 cells luciferase assay. By replacing the positively selected amino acid either by alanine or the most represented residue in other studied species, only L189A, Y235A and Y235C mutants showed a significant increase of BMP15 signaling when compared to wild type. Additionally, the Y235C mutant was more potent than wild type in inhibiting progesterone secretion of ovine granulosa cells in primary culture. Interestingly, the Y235C mutation was previously identified in association with POI in women. In conclusion, this study evidences that the BMP15 gene has evolved faster than other members of the TGF beta family and was submitted to a positive selection pressure in the hominidae clade. Some residues under positive selection are of great importance for the normal function of the protein and thus for female fertility. Y235 represents a critical residue in the determination of BMP15 biological activity, thus indirectly confirming its role in the onset of POI in women.	[Auclair, Sylvain; Meslin, Camille; Pascal, Geraldine; Fabre, Stephane] INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France; [Auclair, Sylvain; Meslin, Camille; Pascal, Geraldine; Fabre, Stephane] CNRS, Physiol Reprod & Comportements UMR7247, Nouzilly, France; [Auclair, Sylvain; Meslin, Camille; Pascal, Geraldine; Fabre, Stephane] Univ Tours, Tours, France; [Auclair, Sylvain; Meslin, Camille; Pascal, Geraldine; Fabre, Stephane] IFCE, Nouzilly, France; [Rossetti, Raffaella; Persani, Luca] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Monestier, Olivier; Fabre, Stephane] INRA ENVT, UMR 444, Lab Genet Cellulaire, Castanet Tolosan, France; [Di Pasquale, Elisa] Ist Clin Humanitas, Natl Res Council Italy, Inst Genet & Biomed Res UOS Milan, Milan, Italy; [Persani, Luca] Ist Auxol Italiano, Lab Ric Endocrinometabol, Milan, Italy	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Tours; University of Milan; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); IRCCS Humanitas Research Hospital; IRCCS Istituto Auxologico Italiano	Fabre, S (corresponding author), INRA, Physiol Reprod & Comportements UMR85, F-37380 Nouzilly, France.	stephane.fabre@tours.inra.fr	Rossetti, Raffaella/B-4972-2013; Di Pasquale, Elisa/A-4751-2014; Di Pasquale, Elisa/ABI-6252-2020; Monestier, Olivier/AAB-2220-2020; Persani, Luca/B-6543-2008; Di Pasquale, Elisa/ABI-6210-2020; Pascal, Geraldine/P-8125-2019; Monestier, Olivier/E-2926-2013; PASCAL, Géraldine/L-4519-2013; FABRE, Stéphane/AAQ-8400-2020; Fabre, Stéphane/ABC-1483-2020	Rossetti, Raffaella/0000-0001-9112-6175; Di Pasquale, Elisa/0000-0003-2373-5635; Di Pasquale, Elisa/0000-0003-2373-5635; Monestier, Olivier/0000-0002-3236-0807; Persani, Luca/0000-0003-2068-9581; Pascal, Geraldine/0000-0002-5250-6594; Monestier, Olivier/0000-0002-3236-0807; PASCAL, Géraldine/0000-0002-5250-6594; FABRE, Stéphane/0000-0001-7350-9500; 	French "Agence Nationale de la Recherche" [ANR 2010 BLAN 1608 01]; French "Centre National de la Recherche Scientifique" (CNRS PICS program); Italian Telethon [GGP09126]	French "Agence Nationale de la Recherche"(French National Research Agency (ANR)); French "Centre National de la Recherche Scientifique" (CNRS PICS program); Italian Telethon(Fondazione Telethon)	This work was sponsored by grants from the French "Agence Nationale de la Recherche" (ANR 2010 BLAN 1608 01, MONOPOLY), the French "Centre National de la Recherche Scientifique" (CNRS PICS program), and was also partially supported by the Italian Telethon (grant GGP09126). The computations were hosted by the Toulouse Midi-Pyrenees bioinformatics platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Musawi SL, 2013, ENDOCRINOLOGY, V154, P888, DOI 10.1210/en.2012-2015; Beck-Peccoz P, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-9; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; Busset J, 2011, NUCLEIC ACIDS RES, V39, pW479, DOI 10.1093/nar/gkr243; Chang H, 2002, ENDOCR REV, V23, P787, DOI 10.1210/er.2002-0003; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Derynck Rik, 2008, P29; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dorus S, 2010, MOL BIOL EVOL, V27, P1235, DOI 10.1093/molbev/msq007; Dudoit S, 2002, STAT SINICA, V12, P111; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ely JJ, 2006, AM J PHYS ANTHROPOL, V130, P96, DOI 10.1002/ajpa.20310; Fabre S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-20; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Galtier N, 2001, GENETICS, V159, P907; Gharib WH, 2013, MOL BIOL EVOL, V30, P1675, DOI 10.1093/molbev/mst062; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Hashimoto O, 2005, P NATL ACAD SCI USA, V102, P5426, DOI 10.1073/pnas.0409533102; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Juengel JL, 2005, HUM REPROD UPDATE, V11, P144, DOI 10.1093/humupd/dmh061; Katoh Y, 2006, INT J MOL MED, V17, P951; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Martinez-Royo A, 2008, ANIM GENET, V39, P294, DOI 10.1111/j.1365-2052.2008.01707.x; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MCMAHON HE, 2008, ENDOCRINOLOGY; McNatty KP, 2004, REPRODUCTION, V128, P379, DOI 10.1530/rep.1.00280; Meslin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044548; Moore RK, 2005, MOL CELL ENDOCRINOL, V234, P67, DOI 10.1016/j.mce.2004.10.012; Persani L, 2011, J ENDOCRINOL INVEST, V34, P244, DOI [10.1007/BF03347073, 10.3275/7502]; Pierre A, 2004, J MOL ENDOCRINOL, V33, P805, DOI 10.1677/jme.1.01545; Ratnakumar A, 2010, PHILOS T R SOC B, V365, P2571, DOI 10.1098/rstb.2010.0007; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; Rossetti R, 2009, HUM MUTAT, V30, P804, DOI 10.1002/humu.20961; SAUMANDE J, 1985, THERIOGENOLOGY, V23, P719, DOI 10.1016/0093-691X(85)90147-5; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Studer RA, 2008, GENOME RES, V18, P1393, DOI 10.1101/gr.076992.108; VANDENBERGBAKKER CAM, 1993, INT J CANCER, V53, P613, DOI 10.1002/ijc.2910530415; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	48	17	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78199	10.1371/journal.pone.0078199	http://dx.doi.org/10.1371/journal.pone.0078199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147118	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400151
J	Moret, L; Anthoine, E; Aubert-Wastiaux, H; Le Rhun, A; Leux, C; Mazereeuw-Hautier, J; Stalder, JF; Barbarot, S				Moret, Leila; Anthoine, Emmanuelle; Aubert-Wastiaux, Helene; Le Rhun, Anne; Leux, Christophe; Mazereeuw-Hautier, Juliette; Stalder, Jean-Francois; Barbarot, Sebastien			TOPICOP (c): A New Scale Evaluating Topical Corticosteroid Phobia among Atopic Dermatitis Outpatients and Their Parents	PLOS ONE			English	Article							CHILDREN; VALIDATION; ADHERENCE; PATIENT; BURDEN; FAMILY; IMPACT	Background: The fear of using topical corticosteroids, usually called topical corticophobia, is a frequent concern for atopic dermatitis patients and/or their parents. Assessing patients' atopic dermatitis and their parents' topical corticosteroid phobia is an essential step to improving adherence to treatment. Because topical corticophobia appears to be a complex phenomenon, its evaluation by binary responses (yes/no) is too simplistic. Thus, a scale is needed, which is capable of identifying the subtleties of topical corticosteroid phobia. Objectives: To develop and validate a scale, TOPICOP (c), measuring worries and beliefs about topical corticosteroids among atopic dermatitis outpatients and their parents. Methods: An initial statistical validation of TOPICOP was carried out, collecting qualitative data about patients' topical corticophobia behaviors and beliefs using focus-group methodology. Then, 208 outpatients or their parents from five French centers completed a self-administered questionnaire built from focus-group results. The scale-development process comprised an explanatory principal component analysis, Cronbach's a-coefficients and structural equation modeling. Results: The validated questionnaire comprised 12 items, covering two important dimensions relative to "worries" (6 items) and "beliefs" (6 items). Psychometric properties showed that items had very good communality (>0.60) within their own dimension. The final two-factor solution accounted for 47.3% of the variance. Cronbach's a-coefficients were, respectively, 0.79 and 0.78. Structural equation modeling strongly supported the possibility of calculating a global score. Conclusions: TOPICOP (c) is the first scale aimed at assessing topical corticophobia in adult patients and parents of children with eczema. TOPICOP (R) has excellent psychometric properties and should be easy to use in everyday clinical practice for clinicians and researchers. Further studies are needed to confirm our results and validate TOPICOP (c) in other cultures.	[Moret, Leila; Anthoine, Emmanuelle; Le Rhun, Anne; Leux, Christophe] Univ Hosp Nantes, Dept Publ Hlth, Nantes, France; [Moret, Leila; Anthoine, Emmanuelle] Univ Nantes, Fac Pharmaceut Sci, EA 4275, Nantes, France; [Aubert-Wastiaux, Helene; Stalder, Jean-Francois; Barbarot, Sebastien] Univ Hosp Nantes, Dept Dermatol, Nantes, France; [Mazereeuw-Hautier, Juliette] Univ Larrey Hosp, Dept Dermatol, Toulouse, France	Nantes Universite; CHU de Nantes; Nantes Universite; Nantes Universite; CHU de Nantes; CHU de Toulouse	Barbarot, S (corresponding author), Univ Hosp Nantes, Dept Dermatol, Nantes, France.	sebastien.barbarot@chu-nantes.fr	Moret, Leila/L-8775-2015; Anthoine, Emmanuelle/L-9048-2015	Barbarot, Sebastien/0000-0002-6629-9100; Moret, Leila/0000-0003-1285-6394	Foundation Pierre-Fabre; Pierre Fabre Laboratory (Toulouse, France)	Foundation Pierre-Fabre; Pierre Fabre Laboratory (Toulouse, France)	The Foundation Pierre-Fabre sponsored this study on AD; Pierre Fabre Laboratory (Toulouse, France) provided funds to cover logistic expenses, but had no access to the data collected and played no role in their analysis, the writing of the manuscript or the decision to submit it for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDERSON JC, 1984, PSYCHOMETRIKA, V49, P155, DOI 10.1007/BF02294170; Aubert-Wastiaux H, 2011, BR J DERMATOL; Barbeau M, 2006, INT J DERMATOL, V45, P31, DOI 10.1111/j.1365-4632.2004.02345.x; Beattie PE, 2006, BRIT J DERMATOL, V155, P145, DOI 10.1111/j.1365-2133.2006.07185.x; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carroll CL, 2005, PEDIATR DERMATOL, V22, P192, DOI 10.1111/j.1525-1470.2005.22303.x; Charman CR, 2000, BRIT J DERMATOL, V142, P931, DOI 10.1046/j.1365-2133.2000.03473.x; Coste J, 1997, J CLIN EPIDEMIOL, V50, P247, DOI 10.1016/S0895-4356(96)00363-0; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; DAVID TJ, 1987, ARCH DIS CHILD, V62, P876, DOI 10.1136/adc.62.9.876; Fischer G, 1996, Australas J Dermatol, V37 Suppl 1, pS10, DOI 10.1111/j.1440-0960.1996.tb01070.x; Foley P, 2001, ARCH DERMATOL, V137, P293; Fukaya M, 2000, DERMATOLOGY, V201, P242, DOI 10.1159/000018495; Gosselin P, 2003, ENCEPHALE, V29, P351; Gosselin P, 2001, ENCEPHALE, V27, P475; Hoare C, 2000, Health Technol Assess, V4, P1; Hon KLE, 2006, ACTA PAEDIATR, V95, P1451, DOI 10.1080/08035250600612298; Horii KA, 2007, PEDIATRICS, V120, pE527, DOI 10.1542/peds.2007-0289; Hoyle R. H., 1995, STRUCTURAL EQUATION; Kiebert G, 2002, INT J DERMATOL, V41, P151, DOI 10.1046/j.1365-4362.2002.01436.x; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Krejci-Manwaring J, 2007, J AM ACAD DERMATOL, V56, P211, DOI 10.1016/j.jaad.2006.05.073; Lawson V, 1998, BRIT J DERMATOL, V138, P107; MCHENRY PM, 1995, BMJ-BRIT MED J, V310, P843, DOI 10.1136/bmj.310.6983.843; Nunnaly J., 1978, PSYCHOMETRIC THEORY; Ou HT, 2010, SEMIN CUTAN MED SURG, V29, P137, DOI 10.1016/j.sder.2010.03.012; PATTERSON R, 1989, ALLERGY PROC, V10, P423, DOI 10.2500/108854189778935773; Pelletier O, 2002, ENCEPHALE, V28, P298; Schmitt J, 2010, Br J Dermatol, V163, P1166, DOI 10.1111/j.1365-2133.2010.10054.x; STERRY W, 1992, ARCH DERMATOL RES, V284, pS27, DOI 10.1007/BF00638237; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x	33	49	50	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76493	10.1371/journal.pone.0076493	http://dx.doi.org/10.1371/journal.pone.0076493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146878	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400065
J	Shultz, S; Maslin, M				Shultz, Susanne; Maslin, Mark			Early Human Speciation, Brain Expansion and Dispersal Influenced by African Climate Pulses	PLOS ONE			English	Article							TURKANA BASIN; HUMAN-EVOLUTION; KOOBI-FORA; VARIABILITY; PATTERNS; HISTORY; RIFT; COMPETITION; DIVERSITY; HABITATS	Early human evolution is characterised by pulsed speciation and dispersal events that cannot be explained fully by global or continental paleoclimate records. We propose that the collated record of ephemeral East African Rift System (EARS) lakes could be a proxy for the regional paleoclimate conditions experienced by early hominins. Here we show that the presence of these lakes is associated with low levels of dust deposition in both West African and Mediterranean records, but is not associated with long-term global cooling and aridification of East Africa. Hominin expansion and diversification seem to be associated with climate pulses characterized by the precession-forced appearance and disappearance of deep EARS lakes. The most profound period for hominin evolution occurs at about 1.9 Ma; with the highest recorded diversity of hominin species, the appearance of Homo (sensu stricto) and major dispersal events out of East Africa into Eurasia. During this period, ephemeral deep-freshwater lakes appeared along the whole length of the EARS, fundamentally changing the local environment. The relationship between the local environment and hominin brain expansion is less clear. The major step-wise expansion in brain size around 1.9 Ma when Homo appeared was coeval with the occurrence of ephemeral deep lakes. Subsequent incremental increases in brain size are associated with dry periods with few if any lakes. Plio-Pleistocene East African climate pulses as evinced by the paleo-lake records seem, therefore, fundamental to hominin speciation, encephalisation and migration.	[Shultz, Susanne] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Maslin, Mark] UCL, Dept Geog, London, England	University of Manchester; University of London; University College London	Maslin, M (corresponding author), UCL, Dept Geog, London, England.	m.maslin@ucl.ac.uk		Shultz, Susanne/0000-0002-7135-4880; Maslin, Mark/0000-0001-9957-3463	Royal Society	Royal Society(Royal Society of London)	This research was supported by a Royal Society Wolfson Research Merit award for work on early human evolution (MM) and a Royal Society Dorothy Hodgkin Fellowship (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, QUATERNARY SCI REV, V30, P1338, DOI 10.1016/j.quascirev.2010.04.012; Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; Deino AL, 2006, EARTH PLANET SC LETT, V247, P41, DOI 10.1016/j.epsl.2006.04.009; Dennell R, 2003, J HUM EVOL, V45, P421, DOI 10.1016/j.jhevol.2003.09.006; Donges JF, 2011, P NATL ACAD SCI USA, V108, P20422, DOI 10.1073/pnas.1117052108; Dunkley PN, 1993, 185 NERC; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Fedorov AV, 2013, NATURE, V496, P43, DOI 10.1038/nature12003; Feibel CS, 2011, EVOL ANTHROPOL, V20, P206, DOI 10.1002/evan.20331; Flinn MV, 2005, EVOL HUM BEHAV, V26, P10, DOI 10.1016/j.evolhumbehav.2004.08.005; Grove M, 2012, J ARCHAEOL SCI, V39, P3085, DOI 10.1016/j.jas.2012.04.023; Grove M, 2011, J ARCHAEOL SCI, V38, P3038, DOI 10.1016/j.jas.2011.07.002; Grove M, 2011, J HUM EVOL, V61, P306, DOI 10.1016/j.jhevol.2011.04.005; HOPF FA, 1993, EVOL ECOL, V7, P142, DOI 10.1007/BF01239385; Joordens JCA, 2011, EARTH PLANET SC LETT, V307, P1, DOI 10.1016/j.epsl.2011.05.005; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kingston JD, 2007, J HUM EVOL, V53, P487, DOI 10.1016/j.jhevol.2006.12.007; KLEIN RG, 1989, HUMAN CAREER; Larrasoana JC, 2003, CLIM DYNAM, V21, P689, DOI 10.1007/s00382-003-0355-z; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lepre CJ, 2007, J HUM EVOL, V53, P504, DOI 10.1016/j.jhevol.2007.01.015; Levin NE, 2004, EARTH PLANET SC LETT, V219, P93, DOI 10.1016/S0012-821X(03)00707-6; Magill CR, 2013, P NATL ACAD SCI USA, V110, P1167, DOI 10.1073/pnas.1206276110; Maslin MA, 2007, J HUM EVOL, V53, P443, DOI 10.1016/j.jhevol.2007.06.005; Maslin Mark A., 2009, P151, DOI 10.1007/978-1-4020-9980-9_13; McDougall I, 2012, J GEOL SOC LONDON, V169, P213, DOI 10.1144/0016-76492010-188; Potts R, 1999, EVOL ANTHROPOL, V7, P81, DOI 10.1002/(SICI)1520-6505(1998)7:3<81::AID-EVAN3>3.3.CO;2-1; Potts R, 2013, QUATERNARY SCI REV, V73, P1, DOI 10.1016/j.quascirev.2013.04.003; Ravelo AC, 2004, NATURE, V429, P263, DOI 10.1038/nature02567; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Reed KE, 2009, VERTEBRATE PALEOBIOL, P159; Roach NT, 2013, NATURE, V498, P483, DOI 10.1038/nature12267; Segalen L, 2007, J HUM EVOL, V53, P549, DOI 10.1016/j.jhevol.2006.12.010; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Shultz S, 2012, PHILOS T R SOC B, V367, P2130, DOI 10.1098/rstb.2012.0115; Shultz S, 2010, J COMP PSYCHOL, V124, P252, DOI 10.1037/a0018894; STRECKER MR, 1990, GEOLOGY, V18, P299, DOI 10.1130/0091-7613(1990)018<0299:ROEDIT>2.3.CO;2; Tiercelin JJ, 2002, ADV GLOB CHANGE RES, V12, P3; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Trauth MH, 2010, QUATERNARY SCI REV, V29, P2981, DOI 10.1016/j.quascirev.2010.07.007; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Venables W., 2002, MODERN APPL STAT S, VFourth; Vrba E.S., 1988, P405; Wells JCK, 2007, YEARB PHYS ANTHROPOL, V50, P191, DOI 10.1002/ajpa.20735; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317	50	53	54	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76750	10.1371/journal.pone.0076750	http://dx.doi.org/10.1371/journal.pone.0076750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146922	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400086
J	Shackleton, R; Shackleton, C; Shackleton, S; Gambiza, J				Shackleton, Ross; Shackleton, Charlie; Shackleton, Sheona; Gambiza, James			Deagrarianisation and Forest Revegetation in a Biodiversity Hotspot on the Wild Coast, South Africa	PLOS ONE			English	Article							OLD-FIELD SUCCESSION; LAND ABANDONMENT; AGRICULTURE; CONSERVATION; DIVERSITY; REGION	Deagraianisation is a worldwide phenomenon with widespread social, ecological and economic effects yet with little consensus on the local or higher level causes. There have been contested views on the causes and consequences of deagrarianisation on South Africa's Wild Coast, which is an international biodiversity hotspot. Using GIS, household interviews and ecological sampling, we compared the perspectives of current and former cultivators as to why some have abandoned farming, whilst also tracking the uses and woody plant cover and composition of fields abandoned at different periods. The GIS analysis showed that field abandonment had been ongoing over several decades, with a decline from 12.5 % field cover in 1961 to 2.7 % in 2009. The area of forests and woodlands almost doubled in the corresponding period. There was a distinct peak in field abandonment during the time of political transition at the national level in the early 1990s. This political change led to a decrease in government support for livestock farming, which in turn resulted in reduced animal draught power at the household and community level, and hence reduced cropping. The study showed it is largely the wealthier households that have remained in arable agriculture and that the poorer households have abandoned farming. The abandoned fields show a distinct trend of increasing woody biomass and species richness with length of time since abandonment, with approximately three woody plant species added per decade. Most local respondents dislike the increases in forest and woodland extent and density because of anxiety about wild animals causing harm to crops and even humans, and the loss of an agricultural identity to livelihoods and the landscape.	[Shackleton, Ross; Shackleton, Charlie; Shackleton, Sheona; Gambiza, James] Rhodes Univ, Dept Environm Sci, ZA-6140 Grahamstown, South Africa	Rhodes University	Shackleton, C (corresponding author), Rhodes Univ, Dept Environm Sci, ZA-6140 Grahamstown, South Africa.	c.shackleton@ru.ac.za	Shackleton, Ross/AAA-8469-2020; Shackleton, Ross/AAE-7865-2020; Shackleton, Charlie M/F-4177-2014; Gambiza, James/GPX-8046-2022; Shackleton, Charlie/GLV-1260-2022	Shackleton, Ross/0000-0001-5628-4506; Shackleton, Charlie/0000-0002-8489-6136; Shackleton, Sheona/0000-0002-6133-9070	Rhodes University	Rhodes University	This work was funded by Rhodes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliber M, 2009, AGREKON, V48, P384, DOI 10.1080/03031853.2009.9523833; Andrew M., 2004, Development Southern Africa, V21, P687, DOI 10.1080/0376835042000288851; Andrew M., 1992, GEOGRAPHICAL STUDY A; [Anonymous], 1997, FAREWELL FARMS DEAGR; [Anonymous], 2004, INDIGENOUS FORESTS W; Berliner D., 2011, 5 NAT FOR WOODL S RI; Bjarnason T, 2006, J RURAL STUD, V22, P290, DOI 10.1016/j.jrurstud.2005.09.004; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Bond WJ, 2000, GLOBAL CHANGE BIOL, V6, P865, DOI 10.1046/j.1365-2486.2000.00365.x; Bonet A, 2004, J ARID ENVIRON, V56, P213, DOI 10.1016/S0140-1963(03)00048-X; Boyes LJ, 2011, PLANT ECOL, V212, P21, DOI 10.1007/s11258-010-9798-6; Castley GH, 1996, PARADOX FOREST CONSE, V85, P35, DOI [10.1016/S0378-1127(96)03748-6, DOI 10.1016/S0378-1127(96)03748-6]; Chalmers N, 2007, ECOL SOC, V12; Cramer VA, 2008, TRENDS ECOL EVOL, V23, P104, DOI 10.1016/j.tree.2007.10.005; Critical Ecosystem Partnership Fund (CEPF), 2010, EC PROF MUP POND ALB; De Klerk H, 2007, THESIS RHODES U GRAH; Du F, 2007, COLLOID SURFACE B, V58, P278, DOI 10.1016/j.colsurfb.2007.04.002; Elands BHM, 2004, FOREST POLICY ECON, V6, P469, DOI 10.1016/j.forpol.2004.01.003; Everatt D, 2001, DEV UPDATE, V3, P32; Fay D, 2003, TRUST IS WE WANT PLO; Feely JM., 1987, BAR INT SERIES, V378, P131; Geldenhuys CJ, 2004, WEED TECHNOL, V18, P1386, DOI 10.1614/0890-037X(2004)018[1386:CAPTCI]2.0.CO;2; Hayward MW, 2009, S AFR J WILDL RES, V39, P70, DOI 10.3957/056.039.0108; Hayward MW, 2005, S AFR J WILDL RES, V35, P117; Hebinck P., 2007, LIVELIHOODS LANDSCAP, P335; Higgins SI, 2012, NATURE, V488, P209, DOI 10.1038/nature11238; Diaz GI, 2011, LANDSCAPE URBAN PLAN, V99, P207, DOI 10.1016/j.landurbplan.2010.11.005; Izquierdo AE, 2009, J ENVIRON MANAGE, V90, P858, DOI 10.1016/j.jenvman.2008.02.013; Khanal N. R., 2006, Mountain Research and Development, V26, P32, DOI 10.1659/0276-4741(2006)026[0032:AOALAI]2.0.CO;2; Local Municipality Mbashe, 2010, INT DEV PLAN 2010 20, P178; Lubke RA, 1996, LANDSCAPE URBAN PLAN, V34, P335, DOI 10.1016/0169-2046(95)00227-8; Mangwale K, 2010, THESIS RHODES U GRAH; McAllister P., 2001, BUILDING HOMESTEAD A; McCusker B, 2006, GEOFORUM, V37, P790, DOI 10.1016/j.geoforum.2005.09.007; Mucina L., 2006, STRELITZIA, V19, P616; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; Nzunda EF, 2011, J TROP ECOL, V27, P195, DOI 10.1017/S0266467410000659; Otto R, 2006, J ARID ENVIRON, V65, P156, DOI 10.1016/j.jaridenv.2005.07.005; Pandolfi JM, 2008, ENCY ECOLOGY; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; Rey Benayas J. M., 2007, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V2, DOI 10.1079/PAVSNNR20072057; Schneider L., 2006, Agricultural and Resource Economics Review, V35, P167; Shackleton C. M., 2007, Agrekon, V46, P135; Shackleton C. M., 2005, African Journal of Range & Forage Science, V22, P127, DOI 10.2989/10220110509485870; Shackleton CM, 2006, ECOL ECON, V57, P306, DOI 10.1016/j.ecolecon.2005.04.011; Timmermans H., 2004, THESIS RHODES U GRAH; Tognetti PM, 2010, BIOL CONSERV, V143, P2494, DOI 10.1016/j.biocon.2010.06.016; van Averbeke W, 2007, WATER SA, V33, P413; vanAarde RJ, 1996, LANDSCAPE URBAN PLAN, V34, P277, DOI 10.1016/0169-2046(95)00237-5; vonMaltitz GP, 1996, S AFR J BOT, V62, P188, DOI 10.1016/S0254-6299(15)30633-5; Wassenaar TD, 2005, ECOLOGY, V86, P655, DOI 10.1890/03-0836; Weissteiner CJ, 2011, GLOBAL PLANET CHANGE, V79, P20, DOI 10.1016/j.gloplacha.2011.07.009; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x	53	48	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76939	10.1371/journal.pone.0076939	http://dx.doi.org/10.1371/journal.pone.0076939			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155911	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300045
J	Theodorou, M; Speletas, M; Mamara, A; Papachristopoulou, G; Lazou, V; Scorilas, A; Katsantoni, E				Theodorou, Marina; Speletas, Matthaios; Mamara, Antigoni; Papachristopoulou, Georgia; Lazou, Vassiliki; Scorilas, Andreas; Katsantoni, Eleni			Identification of a STAT5 Target Gene, Dpf3, Provides Novel Insights in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							B-CELLS; TRANSCRIPTION FACTORS; TRANSGENIC MICE; HISTONE ACETYLATION; SIGNAL TRANSDUCERS; PROSTATE-CANCER; BREAST-CANCER; IN-VIVO; EXPRESSION; ACTIVATION	STAT5 controls essential cellular functions and is encoded by two genes, Stat5a and Stat5b. To provide insight to the mechanisms linking hematologic malignancy to STAT5 activation/regulation of target genes, we identified STAT5 target genes and focused on Dpf3 gene, which encodes for an epigenetic factor. Dpf3 expression was induced upon IL-3 stimulation in Ba/F3 cells, while strong binding of both STAT5a and STAT5b was detected in its promoter. Reduced expression of Dpf3 was detected in Ba/F3 cells with Stat5a and Stat5b knock-down, suggesting that this gene is positively regulated by STAT5, upon IL-3 stimulation. Furthermore, this gene was significantly up-regulated in CLL patients, where DPF3 gene/protein up-regulation and strong STAT5 binding to the DPF3 promoter, correlated with increased STAT5 activation, mainly in non-malignant myeloid cells (granulocytes). Our findings provide insights in the STAT5 dependent transcriptional regulation of Dpf3, and demonstrate for the first time increased STAT5 activation in granulocytes of CLL patients. Novel routes of investigation are opened to facilitate the understanding of the role of STAT5 activation in the communication between non-malignant myeloid and malignant B-cells, and the functions of STAT5 target genes networks in CLL biology.	[Theodorou, Marina; Lazou, Vassiliki; Katsantoni, Eleni] Acad Athens, Biomed Res Fdn, Div Hematol Oncol, Athens, Greece; [Speletas, Matthaios; Mamara, Antigoni] Univ Thessaly, Sch Med, Dept Immunol & Histocompatibil, Larisa, Greece; [Papachristopoulou, Georgia; Scorilas, Andreas] Univ Athens, Fac Biol, Dept Biochem & Mol Biol, Athens, Greece	Academy of Athens; University of Thessaly; National & Kapodistrian University of Athens	Katsantoni, E (corresponding author), Acad Athens, Biomed Res Fdn, Div Hematol Oncol, Athens, Greece.	ekatsantoni@bioacademy.gr		Scorilas, Andreas/0000-0003-2427-4949; Katsantoni, Eleni/0000-0001-8249-6035	EU; BRFAA	EU(European Commission); BRFAA	This work was supported by research funding from the EU (European Reintegration Grant) and BRFAA to EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Bojarska-Junak A, 2009, LEUKEMIA RES, V33, P1319, DOI 10.1016/j.leukres.2009.03.030; Buettner R, 2002, CLIN CANCER RES, V8, P945; BUSCHLE M, 1993, J EXP MED, V177, P213, DOI 10.1084/jem.177.1.213; CHAOUCHI N, 1994, CLIN IMMUNOL IMMUNOP, V73, P197, DOI 10.1006/clin.1994.1188; Choi YP, 2005, PROTEOMICS, V5, P1481, DOI 10.1002/pmic.200401021; Clevenger CV, 2004, AM J PATHOL, V165, P1449, DOI 10.1016/S0002-9440(10)63403-7; DANCESCU M, 1992, J EXP MED, V176, P1319, DOI 10.1084/jem.176.5.1319; Dawson M, 2012, EDITH WHARTON IN CONTEXT, P41; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; de Totero D, 2008, BLOOD, V111, P517, DOI 10.1182/blood-2007-04-087882; diCelle PF, 1996, BLOOD, V87, P4382, DOI 10.1182/blood.V87.10.4382.bloodjournal87104382; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; Gamberale R, 2001, LEUKEMIA, V15, P1860, DOI 10.1038/sj.leu.2402288; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Kang K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-4; Kato Y, 2005, J EXP MED, V202, P169, DOI 10.1084/jem.20042541; Katsantoni E, 2012, SCI SIGNAL, V5, ppt13; Katsantoni EZ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-108; Katsantoni EZ, 2004, EXP HEMATOL, V32, P224, DOI 10.1016/j.exphem.2003.11.001; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Lanvin O, 2004, ONCOGENE, V23, P3040, DOI 10.1038/sj.onc.1207450; Li HZ, 2005, CLIN CANCER RES, V11, P5863, DOI 10.1158/1078-0432.CCR-05-0562; Li HZ, 2004, CANCER RES, V64, P4774, DOI 10.1158/0008-5472.CAN-03-3499; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Lo KC, 2007, GENE CHROMOSOME CANC, V46, P875, DOI 10.1002/gcc.20474; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; MELO JV, 1986, INT J CANCER, V38, P531, DOI 10.1002/ijc.2910380413; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Pestina TI, 2003, EXP HEMATOL, V31, P1198, DOI 10.1016/j.exphem.2003.09.002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PISTOIA V, 1987, BLOOD, V69, P1340; Planelles L, 2007, HAEMATOLOGICA, V92, P1284, DOI 10.3324/haematol.10317; SALTMAN D, 1990, LEUKEMIA RES, V14, P381, DOI 10.1016/0145-2126(90)90167-8; Schwaller J, 2007, BLOOD, V109, P331, DOI 10.1182/blood-2006-02-001800; Siapati EK, 2005, MOL THER, V12, P537, DOI 10.1016/j.ymthe.2005.01.022; Silva M, 1999, J BIOL CHEM, V274, P22165, DOI 10.1074/jbc.274.32.22165; Speletas M, 2007, LEUKEMIA RES, V31, P1053, DOI 10.1016/j.leukres.2006.09.005; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Walker SR, 2009, MOL CANCER RES, V7, P966, DOI 10.1158/1541-7786.MCR-08-0238; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Yamaji D., 2012, NUCL ACIDS RES; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	54	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76155	10.1371/journal.pone.0076155	http://dx.doi.org/10.1371/journal.pone.0076155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155890	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300024
J	Valenti, L; Motta, BM; Soardo, G; Iavarone, M; Donati, B; Sangiovanni, A; Carnelutti, A; Dongiovanni, P; Rametta, R; Bertelli, C; Facchetti, F; Colombo, M; Fargion, S; Fracanzani, AL				Valenti, Luca; Motta, Benedetta Maria; Soardo, Giorgio; Iavarone, Massimo; Donati, Benedetta; Sangiovanni, Angelo; Carnelutti, Alessia; Dongiovanni, Paola; Rametta, Raffaela; Bertelli, Cristina; Facchetti, Floriana; Colombo, Massimo; Fargion, Silvia; Fracanzani, Anna Ludovica			PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GREATER-THAN-G; VARIANT; SUSCEPTIBILITY; ASSOCIATION; PROGRESSION; MANAGEMENT; STEATOSIS; FIBROSIS; RISK	Background & Aims: Aim of this study was to evaluate whether the PNPLA3 I148M polymorphism, previously associated with hepatocellular carcinoma (HCC) risk, influences the clinical presentation of HCC and survival. Methods: we considered 460 consecutive HCC patients referred to tertiary care centers in Northern Italy, 353 with follow-up data. Results: Homozygosity for PNPLA3 148M at risk allele was enriched in HCC patients with alcoholic liver disease or nonalcoholic fatty liver disease (ALD&NAFLD: relative risk 5.9, 95% c.i. 3.5-9.9; other liver diseases: relative risk 1.9, 95% c.i. 1.1-3.4). In ALD&NAFLD patients, the PNPLA3 148M allele was associated with younger age, shorter history of cirrhosis, less advanced (Child A) cirrhosis at HCC diagnosis, and lower HCC differentiation grade (p<0.05). Homozygosity for PNPLA3 148M was associated with reduced survival in the overall series (p = 0.009), and with a higher number of HCC lesions at presentation (p = 0.007) and reduced survival in ALD&NAFLD patients (p = 0.003; median survival 30, 95% c.i. 20-39 vs. 45, 95% c.i. 38-52 months), but not in those with HCC related to other etiologies (p = 0.86; 48, 95% c.i. 32-64 vs. 55, 95% c.i. 4367 months). At multivariate Cox regression analysis, homozygosity for PNPLA3 148M was the only negative predictor of survival in ALD&NAFLD patients (HR of death 1.57, 95% c.i. 1.12-2.78). Conclusions: PNPLA3 148M is over-represented in ALD&NAFLD HCC patients, and is associated with occurrence at a less advanced stage of liver disease in ALD&NAFLD. In ALD&NAFLD, PNPLA3 148M is associated with more diffuse HCC at presentation, and with reduced survival.	[Valenti, Luca; Motta, Benedetta Maria; Donati, Benedetta; Dongiovanni, Paola; Rametta, Raffaela; Colombo, Massimo; Fargion, Silvia; Fracanzani, Anna Ludovica] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Valenti, Luca; Bertelli, Cristina; Fargion, Silvia; Fracanzani, Anna Ludovica] Osped Maggiore Policlin Milano, Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Milan, Italy; [Soardo, Giorgio; Carnelutti, Alessia] Univ Udine, I-33100 Udine, Italy; [Iavarone, Massimo; Sangiovanni, Angelo; Facchetti, Floriana; Colombo, Massimo] Osped Maggiore Policlin Milano, Fdn Ist Ricovero & Cura Carattere Sci IRCCS Ca Gr, Div Gastroenterol 1, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Udine; IRCCS Ca Granda Ospedale Maggiore Policlinico	Valenti, L (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.	luca.valenti@unimi.it	Dongiovanni, Paola/AAC-9965-2019; Iavarone, Massimo/AAC-1699-2019; Valenti, Luca/B-3695-2009; Donati, Benedetta/AAA-7779-2022; Motta, Benedetta Maria/AAA-8559-2020; Fracanzani, Anna Ludovica/J-8986-2018; Donati, Benedetta/H-7741-2018	Dongiovanni, Paola/0000-0003-4343-7213; Iavarone, Massimo/0000-0003-3493-6504; Valenti, Luca/0000-0001-8909-0345; Donati, Benedetta/0000-0002-9163-8194; Motta, Benedetta Maria/0000-0002-6681-2170; Fracanzani, Anna Ludovica/0000-0001-5918-0171; Donati, Benedetta/0000-0002-9163-8194; sangiovanni, angelo/0000-0002-9996-9385; rametta, raffaela/0000-0003-0091-9394	Associazione Malattie Metaboliche del Fegato ONLUS; Centro Studi Malattie Metaboliche del Fegato Universita degli Studi di Milano (Research center, University of Milan)	Associazione Malattie Metaboliche del Fegato ONLUS; Centro Studi Malattie Metaboliche del Fegato Universita degli Studi di Milano (Research center, University of Milan)	This work was supported by Associazione Malattie Metaboliche del Fegato ONLUS (nonprofit organization for the study of metabolic liver diseases) and Centro Studi Malattie Metaboliche del Fegato Universita degli Studi di Milano (Research center, University of Milan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Burza MA, 2012, DIGEST LIVER DIS, V44, P1037, DOI 10.1016/j.dld.2012.05.006; Corradini SG, 2011, HEPATOLOGY, V53, P1776, DOI 10.1002/hep.24244; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Falleti E, 2011, LIVER INT, V31, P1137, DOI 10.1111/j.1478-3231.2011.02534.x; Guyot E, 2012, J HEPATOL IN PRESS; Hassan MM, 2013, MOL CARCINOG; Muller T, 2011, J HEPATOL, V55, P732, DOI 10.1016/j.jhep.2011.01.025; Nahon P, 2012, J HEPATOL, V57, P663, DOI 10.1016/j.jhep.2012.02.035; Nischalke HD, 2012, PLOS ONE, V6; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Salomao M, 2010, AM J SURG PATHOL, V34, P1630, DOI 10.1097/PAS.0b013e3181f31caa; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Takeuchi Y, 2012, J GASTROENTEROL; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Trepo E, 2012, HEPATOLOGY, V55, P1307, DOI 10.1002/hep.25518; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2012, ALIMENT PHARM THER, V35, P1434, DOI 10.1111/j.1365-2036.2012.05109.x; Valenti L, 2012, J HEPATOL, V56, pS129, DOI 10.1016/S0168-8278(12)60328-6; Valenti L, 2013, DIG LIVER DIS; Valenti L, 2012, DIGEST LIVER DIS, V44, P974, DOI 10.1016/j.dld.2012.08.023; Valenti L, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-111; Valenti L, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25634; Valenti L, 2012, WORLD J GASTROENTERO, V18, P2813, DOI 10.3748/wjg.v18.i22.2813; Valenti L, 2011, HEPATOLOGY, V53, P1777, DOI 10.1002/hep.24265; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; Vigano M, 2013, HEPATOLOGY; Wagenknecht LE, 2011, LIVER INT, V31, P412, DOI 10.1111/j.1478-3231.2010.02444.x; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012	35	33	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75982	10.1371/journal.pone.0075982	http://dx.doi.org/10.1371/journal.pone.0075982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155878	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300012
J	Bergmann, J; Kramer, A; Gruber, M				Bergmann, Julian; Kramer, Andreas; Gruber, Markus			Repetitive Hops Induce Postactivation Potentiation in Triceps Surae as well as an Increase in the Jump Height of Subsequent Maximal Drop Jumps	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; LATENCY STRETCH REFLEXES; KNEE EXTENSOR MUSCLES; H-REFLEX; VOLUNTARY CONTRACTION; ISOMETRIC CONTRACTION; TWITCH POTENTIATION; FIBER-TYPE; PERFORMANCE; EXERCISE	Postactivation potentiation (PAP) has been defined as the increase in twitch torque after a conditioning contraction. The present study aimed to investigate the effectiveness of hops as conditioning contractions to induce PAP and increase performance in subsequent maximal drop jumps. In addition, we wanted to test if and how PAP can contribute to increases in drop jump rebound height. Twelve participants performed 10 maximal two-legged hops as conditioning contractions. Twitch peak torques of triceps surae muscles were recorded before and after the conditioning hops. Then, subjects performed drop jumps with and without 10 conditioning hops before each drop jump. Recordings included ground reaction forces, ankle and knee angles and electromyographic activity in five leg muscles. In addition, efferent motoneuronal output during ground contact was estimated with V-wave stimulation. The analyses showed that after the conditioning hops, twitch peak torques of triceps surae muscles were 32% higher compared to baseline values (P < 0.01). Drop jumps performed after conditioning hops were significantly higher (12%, P < 0.05), but V-waves and EMG activity remained unchanged. The amount of PAP and the change in drop jump rebound height were positively correlated (r(2) = 0.26, P < 0.05). These results provide evidence for PAP in triceps surae muscles induced by a bout of hops and indicate that PAP can contribute to the observed performance enhancements in subsequent drop jumps. The lack of change in EMG activity and V-wave amplitude suggests that the underlying mechanisms are more likely intramuscular than neural in origin.	[Bergmann, Julian; Kramer, Andreas; Gruber, Markus] Univ Konstanz, Dept Sport Sci, Sensorimotor Performance Lab, Constance, Germany	University of Konstanz	Bergmann, J (corresponding author), Univ Konstanz, Dept Sport Sci, Sensorimotor Performance Lab, Constance, Germany.	julian.bergmann@uni-konstanz.de	Kramer, Andreas/AAJ-1837-2020	Kramer, Andreas/0000-0002-2586-5508; Gruber, Markus/0000-0002-0233-3912				Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; Batista MAB, 2007, J STRENGTH COND RES, V21, P837, DOI 10.1519/00124278-200708000-00031; Baudry S, 2004, MUSCLE NERVE, V30, P328, DOI 10.1002/mus.20101; Behm DG, 2004, J STRENGTH COND RES, V18, P365; BOBBERT MF, 1987, MED SCI SPORT EXER, V19, P332; Bruhn S, 2004, INT J SPORTS MED, V25, P56; DYHREPOULSEN P, 1991, J PHYSIOL-LONDON, V437, P287, DOI 10.1113/jphysiol.1991.sp018596; Ebben William P, 2002, J Sports Sci Med, V1, P42; Esformes JI, 2010, J STRENGTH COND RES, V24, P1911, DOI 10.1519/JSC.0b013e3181dc47f8; Fimland MS, 2009, EUR J APPL PHYSIOL, V107, P21, DOI 10.1007/s00421-009-1096-4; Folland JP, 2008, EUR J APPL PHYSIOL, V102, P739, DOI 10.1007/s00421-007-0654-x; French DN, 2003, J STRENGTH COND RES, V17, P678, DOI 10.1519/00124278-200311000-00009; GOLLHOFER A, 1991, INT J SPORTS MED, V12, P34, DOI 10.1055/s-2007-1024652; Gossen ER, 2000, EUR J APPL PHYSIOL, V83, P524, DOI 10.1007/s004210000304; GRANGE RW, 1991, J APPL PHYSIOL, V70, P726, DOI 10.1152/jappl.1991.70.2.726; Gullich A., 1996, NEW STUDIES ATHLETIC, V11, P67; Hamada T, 2000, J APPL PHYSIOL, V88, P2131, DOI 10.1152/jappl.2000.88.6.2131; Hamada T, 2003, ACTA PHYSIOL SCAND, V178, P165, DOI 10.1046/j.1365-201X.2003.01121.x; HIRST GDS, 1981, J PHYSIOL-LONDON, V321, P97, DOI 10.1113/jphysiol.1981.sp013973; HOUSTON ME, 1985, PFLUG ARCH EUR J PHY, V403, P348, DOI 10.1007/BF00589245; Jones P, 2003, J STRENGTH COND RES, V17, P694; Komi PV, 1997, J APPL BIOMECH, V13, P451, DOI 10.1123/jab.13.4.451; Kramer A, 2012, EUR J APPL PHYSIOL, V112, P285, DOI 10.1007/s00421-011-1981-5; LUSCHER HR, 1983, J NEUROPHYSIOL, V49, P269, DOI 10.1152/jn.1983.49.1.269; MacIntosh BR, 2003, NEWS PHYSIOL SCI, V18, P222, DOI 10.1152/nips.01456.2003; Mahlfeld K, 2004, MUSCLE NERVE, V29, P597, DOI 10.1002/mus.20021; Miyamoto N, 2011, J STRENGTH COND RES, V25, P186, DOI 10.1519/JSC.0b013e3181b62c1d; Ruben RM, 2010, J STRENGTH COND RES, V24, P358, DOI 10.1519/JSC.0b013e3181cc26e0; Sale D, 2004, BRIT J SPORT MED, V38, P386, DOI 10.1136/bjsm.2002.003392; Sale DG, 2002, EXERC SPORT SCI REV, V30, P138, DOI 10.1097/00003677-200207000-00008; Shima N, 2006, EUR J APPL PHYSIOL, V96, P17, DOI 10.1007/s00421-005-0053-0; Sinkjaer T, 1999, CLIN NEUROPHYSIOL, V110, P951, DOI 10.1016/S1388-2457(99)00034-6; Smith JC, 2007, J STRENGTH COND RES, V21, P73, DOI 10.1519/00124278-200702000-00014; Staudenmann D, 2010, J ELECTROMYOGR KINES, V20, P375, DOI 10.1016/j.jelekin.2009.08.005; Taube W, 2011, SCAND J MED SCI SPOR, DOI 101111/j1600-0838201101293x; Taube W, 2008, J NEUROPHYSIOL, V99, P1243, DOI 10.1152/jn.01118.2007; Taube W, 2012, EXERC SPORT SCI REV, V40, P106, DOI 10.1097/JES.0b013e31824138da; Tillin NA, 2009, SPORTS MED, V39, P147, DOI 10.2165/00007256-200939020-00004; Trimble MH, 1998, MED SCI SPORT EXER, V30, P933, DOI 10.1097/00005768-199806000-00024; UPTON ARM, 1971, J NEUROL NEUROSUR PS, V34, P699, DOI 10.1136/jnnp.34.6.699; VANDERVOORT AA, 1983, EXP NEUROL, V81, P141, DOI 10.1016/0014-4886(83)90163-2; Voigt M, 1998, EUR J APPL PHYSIOL O, V78, P522, DOI 10.1007/s004210050455; Weber KR, 2008, J STRENGTH COND RES, V22, P726, DOI 10.1519/JSC.0b013e3181660899; Zuur AT, 2010, J PHYSIOL-LONDON, V588, P799, DOI 10.1113/jphysiol.2009.182709	44	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77705	10.1371/journal.pone.0077705	http://dx.doi.org/10.1371/journal.pone.0077705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147061	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400136
J	Lopez-Martinez, R; Ramirez-Salinas, GL; Correa-Basurto, J; Barron, BL				Lopez-Martinez, Rogelio; Lizbeth Ramirez-Salinas, G.; Correa-Basurto, Jose; Barron, Blanca L.			Inhibition of Influenza A Virus Infection In Vitro by Peptides Designed In Silico	PLOS ONE			English	Article							FUSION PEPTIDE; HERPES-SIMPLEX; PANDEMIC INFLUENZA; STEM REGION; HEMAGGLUTININ; PREDICTION; OSELTAMIVIR; RESIDUES; IDENTIFICATION; REPLICATION	Influenza A viruses are enveloped, segmented negative single-stranded RNA viruses, capable of causing severe human respiratory infections. Currently, only two types of drugs are used to treat influenza A infections, the M2 H+ ion channel blockers (amantadine and rimantadine) and the neuraminidase inhibitors (NAI) (oseltamivir and zanamivir). Moreover, the emergence of drug-resistant influenza A virus strains has emphasized the need to develop new antiviral agents to complement or replace the existing drugs. Influenza A virus has on the surface a glycoprotein named hemagglutinin (HA) which due to its important role in the initial stage of infection: receptor binding and fusion activities of viral and endosomal membranes, is a potential target for new antiviral drugs. In this work we designed nine peptides using several bioinformatics tools. These peptides were derived from the HA1 and HA2 subunits of influenza A HA with the aim to inhibit influenza A virus infection. The peptides were synthetized and their antiviral activity was tested in vitro against several influenza A viral strains: Puerto Rico/916/34 (H1N1), (H1N1)pdm09, swine (H1N1) and avian (H5N2). We found these peptides were able to inhibit the influenza A viral strains tested, without showing any cytotoxic effect. By docking studies we found evidence that all the peptides were capable to bind to the viral HA, principally to important regions on the viral HA stalk, thus could prevent the HA conformational changes required to carry out its membranes fusion activity.	[Lopez-Martinez, Rogelio; Barron, Blanca L.] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Lab Virol, Mexico City, DF, Mexico; [Lizbeth Ramirez-Salinas, G.; Correa-Basurto, Jose] Inst Politecn Nacl, Escuela Super Med, Lab Modelado Mol & Bioinform, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico	Barron, BL (corresponding author), Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Lab Virol, Carpio & Plan Ayala S-N, Mexico City, DF, Mexico.	bbarron@ipn.mx		RODRIGUEZ-CORTES, OCTAVIO/0000-0002-7380-5665	CONACYT [CB-99164]; ICyT-DF [2009/225]; Secretaria de Investigacion y Posgrado del IPN	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ICyT-DF; Secretaria de Investigacion y Posgrado del IPN	This work is funded by CONACYT CB-99164, ICyT-DF 2009/225, and Secretaria de Investigacion y Posgrado del IPN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906; Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06; Beaufays J, 2012, J PEPT SCI, V18, P17, DOI 10.1002/psc.1410; Betancur-Galvis LA, 2002, MEM I OSWALDO CRUZ, V97, P541, DOI 10.1590/S0074-02762002000400017; Burke J D, 2009, Curr Mol Pharmacol, V2, P32; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Carver T, 2003, BIOINFORMATICS, V19, P1837, DOI 10.1093/bioinformatics/btg251; Chang DK, 2006, BIOCHEM J, V396, P557, DOI 10.1042/BJ20051920; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Cheng PKC, 2010, EMERG INFECT DIS, V16, P155, DOI 10.3201/eid1601.091304; Cohen FS, 2001, NAT STRUCT BIOL, V8, P653, DOI 10.1038/90341; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Costin JM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000721; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Delcroix M, 2010, PHARMACEUTICALS, V3, P448, DOI 10.3390/ph3030448; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Eckert DM, 2010, P NATL ACAD SCI USA, V107, P13563, DOI 10.1073/pnas.1008672107; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Galdiero S, 2013, J PEPT SCI, V19, P148, DOI 10.1002/psc.2489; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Govorkova EA, 2001, ANTIMICROB AGENTS CH, V45, P2723, DOI 10.1128/AAC.45.10.2723-2732.2001; Harris AK, 2013, P NATL ACAD SCI USA, V110, P4592, DOI 10.1073/pnas.1214913110; HAYES PJ, 1994, J MED VIROL, V42, P323, DOI 10.1002/jmv.1890420402; Janies DA, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-13; Jesus T, 2012, BIOINFORMATION, V8, P870, DOI 10.6026/97320630008870; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lin TW, 2009, VIROLOGY, V392, P73, DOI 10.1016/j.virol.2009.06.028; LIU S, 2009, PLOS ONE, V4, DOI DOI 10.1371/J0URNAL.P0NE.0005022.PUBMED:19325912; Lorieau JL, 2012, P NATL ACAD SCI USA, V109, P19994, DOI 10.1073/pnas.1213801109; Lorieau JL, 2010, P NATL ACAD SCI USA, V107, P11341, DOI 10.1073/pnas.1006142107; Luo M, 2012, ADV EXP MED BIOL, V726, P201, DOI 10.1007/978-1-4614-0980-9_9; Mahy BWJ, 1996, VIROLOGY METHODS MAN; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Mullan Lisa J, 2002, Brief Bioinform, V3, P92, DOI 10.1093/bib/3.1.92; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Pannecouque C, 2008, NAT PROTOC, V3, P427, DOI 10.1038/nprot.2007.517; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Rajik M, 2009, INT J BIOL SCI, V5, P543; Rajik M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-74; Real E, 2004, J VIROL, V78, P7410, DOI 10.1128/JVI.78.14.7410-7417.2004; Russell CJ, 2011, NEW ENGL J MED, V365, P1541, DOI 10.1056/NEJMcibr1109447; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Su CTT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S21; SUDO K, 1994, J VIROL METHODS, V49, P169, DOI 10.1016/0166-0934(94)90041-8; Suzuki Y, 2002, MOL BIOL EVOL, V19, P501, DOI 10.1093/oxfordjournals.molbev.a004105; Thakur N, 2012, NUCLEIC ACIDS RES, V40, pW199, DOI 10.1093/nar/gks450; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wilkins MR, 1999, METH MOL B, V112, P531; Xu R, 2011, J VIROL, V85, P5172, DOI 10.1128/JVI.02430-10; Xu X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015781; Xu YT, 2012, PROTEINS, V80, P2154, DOI 10.1002/prot.24105; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	68	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76876	10.1371/journal.pone.0076876	http://dx.doi.org/10.1371/journal.pone.0076876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146939	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400089
J	Olsen, HG; Skovgaard, K; Nielsen, OL; Leifsson, PS; Jensen, HE; Iburg, T; Heegaard, PMH				Olsen, Helle G.; Skovgaard, Kerstin; Nielsen, Ole L.; Leifsson, Pall S.; Jensen, Henrik E.; Iburg, Tine; Heegaard, Peter M. H.			Organization and Biology of the Porcine Serum Amyloid A (SAA) Gene Cluster: Isoform Specific Responses to Bacterial Infection	PLOS ONE			English	Article							A PROTEIN; ACTINOBACILLUS-PLEUROPNEUMONIAE; STAPHYLOCOCCUS-AUREUS; SYNOVIAL-FLUID; MESSENGER-RNAS; EXPRESSION; PIGS; FAMILY; PATHOGENESIS; EVOLUTION	Serum amyloid A (SAA) is a prominent acute phase protein. Although its biological functions are debated, the wide species distribution of highly homologous SAA proteins and their uniform behavior in response to injury or inflammation in itself suggests a significant role for this protein. The pig is increasingly being used as a model for the study of inflammatory reactions, yet only little is known about how specific SAA genes are regulated in the pig during acute phase responses and other responses induced by pro-inflammatory host mediators. We designed SAA gene specific primers and quantified the gene expression of porcine SAA1, SAA2, SAA3, and SAA4 by reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) in liver, spleen, and lung tissue from pigs experimentally infected with the Gram-negative swine specific bacterium Actinobacillus pleuropneumoniae, as well as from pigs experimentally infected with the Gram-positive bacterium Staphylococcus aureus. Our results show that: 1) SAA1 may be a pseudogene in pigs; 2) we were able to detect two previously uncharacterized SAA transcripts, namely SAA2 and SAA4, of which the SAA2 transcript is primarily induced in the liver during acute infection and presumably contributes to circulating SAA in pigs; 3) Porcine SAA3 transcription is induced both hepatically and extrahepatically during acute infection, and may be correlated to local organ affection; 4) Hepatic transcription of SAA4 is markedly induced in pigs infected with A. pleuropneumoniae, but only weakly in pigs infected with S. aureus. These results for the first time establish the infection response patterns of the four porcine SAA genes which will be of importance for the use of the pig as a model for human inflammatory responses, e. g. within sepsis, cancer, and obesity research.	[Olsen, Helle G.; Nielsen, Ole L.; Leifsson, Pall S.; Jensen, Henrik E.; Iburg, Tine] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Skovgaard, Kerstin; Heegaard, Peter M. H.] Tech Univ Denmark, Innate Immunol Grp, Natl Vet Inst, Frederiksberg, Denmark	University of Copenhagen; Technical University of Denmark	Heegaard, PMH (corresponding author), Tech Univ Denmark, Innate Immunol Grp, Natl Vet Inst, Frederiksberg, Denmark.	pmhh@vet.dtu.dk	Heegaard, Peter/E-9794-2015	Heegaard, Peter/0000-0003-4506-4932; Nielsen, Ole Lerberg/0000-0003-2678-6622; Jensen, Henrik Elvang/0000-0001-7277-7829; skovgaard, kerstin/0000-0001-5663-4879; Iburg, Tine Moesgaard/0000-0003-0246-5146; Leifsson, Pall S/0000-0003-1539-9491	Danish Medical Research Council [271-07-0417]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was financed by grant no. 271-07-0417 from the Danish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETTS JC, 1991, SCAND J IMMUNOL, V34, P471, DOI 10.1111/j.1365-3083.1991.tb01570.x; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Butler A, 1996, IMMUNOGENETICS, V44, P468, DOI 10.1007/BF02602809; Chang WC, 2007, ASIAN AUSTRAL J ANIM, V20, P768, DOI 10.5713/ajas.2007.768; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; deBeer MC, 1996, GENOMICS, V34, P139, DOI 10.1006/geno.1996.0253; DEBEER MC, 1994, J BIOL CHEM, V269, P4661; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Heegaard PMH, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-50; HUSBY G, 1994, AMYLOID, V1, P119, DOI 10.3109/13506129409148635; Jacobsen S, 2006, VET IMMUNOL IMMUNOP, V110, P325, DOI 10.1016/j.vetimm.2005.10.012; Jacobsen S, 2005, VET IMMUNOL IMMUNOP, V104, P21, DOI 10.1016/j.vetimm.2004.09.031; Jensen HE, 2010, IN VIVO, V24, P257; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Kjelgaard-Hansen M, 2007, VET IMMUNOL IMMUNOP, V117, P296, DOI 10.1016/j.vetimm.2007.03.008; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Kushner, 1982, ANN NY ACAD SCI, V389, P39; Leifsson PS, 2010, FEMS MICROBIOL LETT, V309, P208, DOI 10.1111/j.1574-6968.2010.02042.x; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Liljegren CH, 2003, APMIS, V111, P531, DOI 10.1034/j.1600-0463.2003.1110501.x; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; McDonald TL, 2001, VET IMMUNOL IMMUNOP, V83, P203, DOI 10.1016/S0165-2427(01)00380-4; MCDONALD TL, 1991, J IMMUNOL METHODS, V144, P149, DOI 10.1016/0022-1759(91)90081-P; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; MEEK RL, 1989, P NATL ACAD SCI USA, V86, P1890, DOI 10.1073/pnas.86.6.1890; MITCHELL TI, 1991, J CLIN INVEST, V87, P1177, DOI 10.1172/JCI115116; MORROW JF, 1981, P NATL ACAD SCI-BIOL, V78, P4718, DOI 10.1073/pnas.78.8.4718; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; RAMADORI G, 1985, J IMMUNOL, V135, P3645; Rodriguez BD, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-4; SELLAR GC, 1994, GENOMICS, V23, P492, DOI 10.1006/geno.1994.1530; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Skovgaard K, 2007, VET IMMUNOL IMMUNOP, V118, P140, DOI 10.1016/j.vetimm.2007.04.010; Skovgaard K, 2010, INNATE IMMUN-LONDON, V16, P343, DOI 10.1177/1753425909342730; Skovgaard K, 2009, VET RES, V40, DOI 10.1051/vetres/2009006; Soerensen KE, 2013, J COMP PATH IN PRESS; Soler L, 2013, J THEOR BIOL, V317, P119, DOI 10.1016/j.jtbi.2012.10.011; Soler L, 2011, VET IMMUNOL IMMUNOP, V141, P109, DOI 10.1016/j.vetimm.2011.02.019; Sorensen NS, 2006, VET IMMUNOL IMMUNOP, V113, P157, DOI 10.1016/j.vetimm.2006.04.008; Souvorov A., 2010, GNOMON NCBI EUKARYOT; Steel DM, 1996, SCAND J IMMUNOL, V44, P493, DOI 10.1046/j.1365-3083.1996.d01-341.x; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Sung HJ, 2012, J PROTEOMICS, V75, P2170, DOI 10.1016/j.jprot.2012.01.018; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; Upragarin N, 2005, HISTOL HISTOPATHOL, V20, P1295, DOI 10.14670/HH-20.1295; WEBB CF, 1989, BIOCHEMISTRY-US, V28, P4785, DOI 10.1021/bi00437a040; WHITEHEAD AS, 1992, J BIOL CHEM, V267, P3862; Yamada T, 1997, J CLIN LAB ANAL, V11, P363; YAMADA T, 1994, AMYLOID, V1, P114, DOI 10.3109/13506129409148634	54	23	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76695	10.1371/journal.pone.0076695	http://dx.doi.org/10.1371/journal.pone.0076695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146912	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400074
J	Poon, K; Mandava, S; Chen, K; Barson, JR; Buschlen, S; Leibowitz, SF				Poon, Kinning; Mandava, Sushma; Chen, Karen; Barson, Jessica R.; Buschlen, Sylvie; Leibowitz, Sarah F.			Prenatal Exposure to Dietary Fat Induces Changes in the Transcriptional Factors, TEF and YAP, Which May Stimulate Differentiation of Peptide Neurons in Rat Hypothalamus	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; HIPPO PATHWAY; CIRCULATING TRIGLYCERIDES; OREXIGENIC PEPTIDES; CELL-PROLIFERATION; METABOLIC SYNDROME; DNA-BINDING; ENKEPHALIN; OBESITY; DOMAIN	Gestational exposure to a high-fat diet (HFD) stimulates the differentiation of orexigenic peptide-expressing neurons in the hypothalamus of offspring. To examine possible mechanisms that mediate this phenomenon, this study investigated the transcriptional factor, transcription enhancer factor-1 (TEF), and co-activator, Yes-associated protein (YAP), which when inactivated stimulate neuronal differentiation. In rat embryos and postnatal offspring prenatally exposed to a HFD compared to chow, changes in hypothalamic TEF and YAP and their relationship to the orexigenic peptide, enkephalin (ENK), were measured. The HFD offspring at postnatal day 15 (P15) exhibited in the hypothalamic paraventricular nucleus a significant reduction in YAP mRNA and protein, and increased levels of inactive and total TEF protein, with no change in mRNA. Similarly, HFD-exposed embryos at embryonic day 19 (E19) showed in whole hypothalamus significantly decreased levels of YAP mRNA and protein and TEF mRNA, and increased levels of inactive TEF protein, suggesting that HFD inactivates TEF and YAP. This was accompanied by increased density and fluorescence intensity of ENK neurons. A close relationship between TEF and ENK was suggested by the finding that TEF co-localizes with this peptide in hypothalamic neurons and HFD reduced the density of TEF/ENK co-labeled neurons, even while the number and fluorescence intensity of single-labeled TEF neurons were increased. Increased YAP inactivity by HFD was further evidenced by a decrease in number and fluorescence intensity of YAP-containing neurons, although the density of YAP/ENK co-labeled neurons was unaltered. Genetic knockdown of TEF or YAP stimulated ENK expression in hypothalamic neurons, supporting a close relationship between these transcription factors and neuropeptide. These findings suggest that prenatal HFD exposure inactivates both hypothalamic TEF and YAP, by either decreasing their levels or increasing their inactive form, and that this contributes to the stimulatory effect of HFD on ENK expression and possibly the differentiation of ENK-expressing neurons.	[Poon, Kinning; Mandava, Sushma; Chen, Karen; Barson, Jessica R.; Buschlen, Sylvie; Leibowitz, Sarah F.] Rockefeller Univ, Lab Behav Neurobiol, New York, NY 10021 USA	Rockefeller University	Leibowitz, SF (corresponding author), Rockefeller Univ, Lab Behav Neurobiol, 1230 York Ave, New York, NY 10021 USA.	leibow@rockefeller.edu		Barson, Jessica/0000-0001-7227-5730; Poon, Kinning/0000-0001-5671-9194	NIH [5R01DA021518]; NARSAD [CEN5401363]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH Grant 5R01DA021518, and by NARSAD grant CEN5401363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Altman J. B. S., 1995, ATLAS PRENATAL RAT B; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; Barson JR, 2013, ALCOHOL CLIN EXP RES, V37, pE141, DOI 10.1111/j.1530-0277.2012.01858.x; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Beck B, 2006, BIOCHEM BIOPH RES CO, V342, P452, DOI 10.1016/j.bbrc.2006.01.158; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Cerf ME, 2010, INT J DEV NEUROSCI, V28, P625, DOI 10.1016/j.ijdevneu.2010.07.226; Chang GQ, 2007, AM J PHYSIOL-ENDOC M, V292, pE561, DOI 10.1152/ajpendo.00087.2006; Chang GQ, 2010, PHYSIOL BEHAV, V101, P360, DOI 10.1016/j.physbeh.2010.06.005; Chang GQ, 2004, ENDOCRINOLOGY, V145, P3904, DOI 10.1210/en.2003-1582; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Dourmashkin JT, 2006, PHYSIOL BEHAV, V87, P666, DOI 10.1016/j.physbeh.2006.01.008; Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Gee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020309; Gregorio BM, 2013, EUR J NUTR, V52, P759, DOI 10.1007/s00394-012-0382-9; Gupta A, 2009, J ENDOCRINOL, V200, P293, DOI 10.1677/JOE-08-0429; Gupta MP, 2000, NUCLEIC ACIDS RES, V28, P3168, DOI 10.1093/nar/28.16.3168; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Jiang SW, 2001, J BIOL CHEM, V276, P23464, DOI 10.1074/jbc.M010934200; Karatayev O, 2009, BRAIN RES, V1298, P111, DOI 10.1016/j.brainres.2009.08.001; Lanham SA, 2010, OSTEOPOROSIS INT, V21, P1703, DOI 10.1007/s00198-009-1118-4; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liang C, 2009, BIRTH DEFECTS RES B, V86, P362, DOI 10.1002/bdrb.20204; Lin S, 1999, BRAIN RES BULL, V49, P215, DOI 10.1016/S0361-9230(99)00049-0; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Muhlhausler BS, 2006, FASEB J, V20, P1257, DOI 10.1096/fj.05-5241fje; Naye F, 2007, INT J DEV BIOL, V51, P745, DOI 10.1387/ijdb.072375fn; Orr BA, 2011, J NEUROPATH EXP NEUR, V70, P568, DOI 10.1097/NEN.0b013e31821ff8d8; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Poon K, 2012, AM J PHYSIOL-ENDOC M, V303, pE432, DOI 10.1152/ajpendo.00238.2012; PRETEL S, 1991, PEPTIDES, V12, P1243, DOI 10.1016/0196-9781(91)90202-Z; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Salvi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004392; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sherwood NM., 1970, STEREOTAXIC ATLAS DE; Sousa-Ferreira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019745; SPIRO C, 1993, P NATL ACAD SCI USA, V90, P4606, DOI 10.1073/pnas.90.10.4606; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yoshida T, 2008, ARTERIOSCL THROM VAS, V28, P8, DOI 10.1161/ATVBAHA.107.155788; Yu FX, 2012, CELL CYCLE, V11, P4097, DOI 10.4161/cc.22322; Zhang HQ, 2012, DEV BIOL, V361, P103, DOI 10.1016/j.ydbio.2011.10.017; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhi X, 2012, AM J PATHOL, V180, P2452, DOI 10.1016/j.ajpath.2012.02.025	58	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77668	10.1371/journal.pone.0077668	http://dx.doi.org/10.1371/journal.pone.0077668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147051	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400132
J	Torres-Espin, A; Hernandez, J; Navarro, X				Torres-Espin, Abel; Hernandez, Joaquim; Navarro, Xavier			Gene Expression Changes in the Injured Spinal Cord Following Transplantation of Mesenchymal Stem Cells or Olfactory Ensheathing Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; ENDOTHELIAL GROWTH-FACTOR; FUNCTIONAL RECOVERY; DELAYED TRANSPLANTATION; LAMINA-PROPRIA; NITRIC-OXIDE; AXON GROWTH; RAT; PROMOTES; GLIA	Transplantation of bone marrow derived mesenchymal stromal cells (MSC) or olfactory ensheathing cells (OEC) have demonstrated beneficial effects after spinal cord injury (SCI), providing tissue protection and improving the functional recovery. However, the changes induced by these cells after their transplantation into the injured spinal cord remain largely unknown. We analyzed the changes in the spinal cord transcriptome after a contusion injury and MSC or OEC transplantation. The cells were injected immediately or 7 days after the injury. The mRNA of the spinal cord injured segment was extracted and analyzed by microarray at 2 and 7 days after cell grafting. The gene profiles were analyzed by clustering and functional enrichment analysis based on the Gene Ontology database. We found that both MSC and OEC transplanted acutely after injury induce an early up-regulation of genes related to tissue protection and regeneration. In contrast, cells transplanted at 7 days after injury down-regulate genes related to tissue regeneration. The most important change after MSC or OEC transplant was a marked increase in expression of genes associated with foreign body response and adaptive immune response. These data suggest a regulatory effect of MSC and OEC transplantation after SCI regarding tissue repair processes, but a fast rejection response to the grafted cells. Our results provide an initial step to determine the mechanisms of action and to optimize cell therapy for SCI.	[Navarro, Xavier] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Inst Neurosci, Grp Neuroplast & Regenerat, Bellaterra, Spain; Ctr Invest Biomed Red Enfermedades Neurodegenerat, Bellaterra, Spain	Autonomous University of Barcelona; CIBERNED	Navarro, X (corresponding author), Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Inst Neurosci, Grp Neuroplast & Regenerat, Bellaterra, Spain.	xavier.navarro@uab.cat	Navarro, Xavier/C-9577-2011; Torres-Espin, Abel/ABD-1354-2020; Torres Espin, Abel/HGA-5068-2022; Hernandez, Joaquim/E-1298-2011	Navarro, Xavier/0000-0001-9849-902X; Torres-Espin, Abel/0000-0002-9787-8738; Hernandez, Joaquim/0000-0003-1409-5568	Ministerio de Ciencia e Innovacion [SAF2009-12495]; CIBERNED; Red de Terapia Celular (TERCEL); Instituto de Salud Carlos III of Spain; FEDER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBERNED(Instituto de Salud Carlos III); Red de Terapia Celular (TERCEL); Instituto de Salud Carlos III of Spain(Instituto de Salud Carlos III); FEDER(European Commission)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (grant SAF2009-12495), and funds from CIBERNED and Red de Terapia Celular (TERCEL), Instituto de Salud Carlos III of Spain, and FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MB, 2009, RESTOR NEUROL NEUROS, V27, P307, DOI 10.3233/RNN-2009-0480; Afjehi-Sadat L, 2010, J PROTEOME RES, V9, P1591, DOI 10.1021/pr901049a; Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Barakat DJ, 2005, CELL TRANSPLANT, V14, P225, DOI 10.3727/000000005783983106; Bieback K, 2012, J MOL MED, V90, P773, DOI 10.1007/s00109-012-0915-y; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carmel JB, 2001, PHYSIOL GENOMICS, V7, P201, DOI 10.1152/physiolgenomics.00074.2001; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Chuah MI, 2011, EXP NEUROL, V229, P46, DOI 10.1016/j.expneurol.2010.08.012; Cole DK, 2012, IMMUNOLOGY, V137, P139, DOI 10.1111/j.1365-2567.2012.03625.x; Collazos-Castro JE, 2005, J NEUROSURG-SPINE, V3, P308, DOI 10.3171/spi.2005.3.4.0308; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dressel R, 2001, IMMUNOL REV, V184, P82, DOI 10.1034/j.1600-065x.2001.1840108.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Garcia-Alias G, 2004, J NEUROSCI RES, V75, P632, DOI 10.1002/jnr.20029; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Gruber R, 2005, TISSUE ENG, V11, P896, DOI 10.1089/ten.2005.11.896; Gunther E, 2001, IMMUNOGENETICS, V53, P520, DOI 10.1007/s002510100361; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Hernandez J, 2011, CURR STEM CELL RES T, V6, P273, DOI 10.2174/157488811796575323; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Holling TM, 2004, HUM IMMUNOL, V65, P282, DOI 10.1016/j.humimm.2004.01.005; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imaizumi T, 1998, J NEUROSCI, V18, P6176; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson WM, 2012, STEM CELL TRANSL MED, V1, P44, DOI 10.5966/sctm.2011-0024; Jeon YK, 2010, WOUND REPAIR REGEN, V18, P655, DOI 10.1111/j.1524-475X.2010.00636.x; Jung DI, 2009, J NEUROL SCI, V285, P67, DOI 10.1016/j.jns.2009.05.027; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim CH, 2011, J KOREAN MED SCI, V26, P726, DOI 10.3346/jkms.2011.26.6.726; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Koda M, 2007, EUR SPINE J, V16, P2206, DOI 10.1007/s00586-007-0499-3; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo Y, 2012, J BIOL CHEM, V287, P38716, DOI 10.1074/jbc.M112.373159; Kwak EK, 2005, J KOREAN MED SCI, V20, P663, DOI 10.3346/jkms.2005.20.4.663; Li Y, 1998, J NEUROSCI, V18, P10514; Lopez-Vales R, 2006, SPINE, V31, P1100; Lopez-Vales R, 2006, NEUROBIOL DIS, V21, P57, DOI 10.1016/j.nbd.2005.06.011; Lopez-Vales R, 2004, J NEUROTRAUM, V21, P1031, DOI 10.1089/0897715041651105; Lopez-Vales R, 2007, GLIA, V55, P303, DOI 10.1002/glia.20457; Lozito TP, 2009, J CELL BIOCHEM, V107, P706, DOI 10.1002/jcb.22166; Lu DY, 2009, J CELL PHYSIOL, V220, P163, DOI 10.1002/jcp.21746; Lu J, 2002, BRAIN, V125, P14, DOI 10.1093/brain/awf014; Lu P, 2006, J NEUROSCI, V26, P11120, DOI 10.1523/JNEUROSCI.3264-06.2006; Mothe AJ, 2012, J CLIN INVEST, V122, P3824, DOI 10.1172/JCI64124; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Okada M, 2007, NEUROSCI RES, V58, P371, DOI 10.1016/j.neures.2007.04.009; Oo YH, 2010, DIGEST DIS, V28, P31, DOI 10.1159/000282062; Park KS, 2010, TRANSPLANTATION, V89, P509, DOI 10.1097/TP.0b013e3181c7dc99; Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Richter MW, 2005, J NEUROSCI, V25, P10700, DOI 10.1523/JNEUROSCI.3632-05.2005; Ronsyn MW, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-90; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Ruitenberg MJ, 2002, GENE THER, V9, P135, DOI 10.1038/sj.gt.3301626; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Siefert SA, 2012, VASCULAR, V20, P210, DOI 10.1258/vasc.2011.201202; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stamegna JC, 2011, EXP NEUROL, V229, P120, DOI 10.1016/j.expneurol.2010.07.002; Steward O, 2006, EXP NEUROL, V198, P483, DOI 10.1016/j.expneurol.2005.12.034; Swanger SA, 2005, CELL TRANSPLANT, V14, P775, DOI 10.3727/000000005783982594; Takami T, 2002, J NEUROSCI, V22, P6670; Teller P, 2009, SURG CLIN N AM, V89, P599, DOI 10.1016/j.suc.2009.03.006; Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177; Tewarie RDSN, 2009, J NEUROTRAUM, V26, P2313, DOI 10.1089/neu.2009.0987; Toriseva M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042596; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Verdu E, 2003, GLIA, V42, P275, DOI 10.1002/glia.10217; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19	89	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76141	10.1371/journal.pone.0076141	http://dx.doi.org/10.1371/journal.pone.0076141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146830	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400042
J	Clement, RJG; Krause, S; von Engelhardt, N; Faria, JJ; Krause, J; Kurvers, RHJM				Clement, Romain J. G.; Krause, Stefan; von Engelhardt, Nikolaus; Faria, Jolyon J.; Krause, Jens; Kurvers, Ralf H. J. M.			Collective Cognition in Humans: Groups Outperform Their Best Members in a Sentence Reconstruction Task	PLOS ONE			English	Article							TO-NUMBERS PROBLEMS; GROUP-PERFORMANCE; INDIVIDUALS; DECISIONS; CONSENSUS; WISDOM; CROWD	Group-living is widespread among animals and one of the major advantages of group-living is the ability of groups to solve cognitive problems that exceed individual ability. Humans also make use of collective cognition and have simultaneously developed a highly complex language to exchange information. Here we investigated collective cognition of human groups regarding language use in a realistic situation. Individuals listened to a public announcement and had to reconstruct the sentence alone or in groups. This situation is often encountered by humans, for instance at train stations or airports. Using recent developments in machine speech recognition, we analysed how well individuals and groups reconstructed the sentences from a syntactic (i.e., the number of errors) and semantic (i.e., the quality of the retrieved information) perspective. We show that groups perform better both on a syntactic and semantic level than even their best members. Groups made fewer errors and were able to retrieve more information when reconstructing the sentences, outcompeting even their best group members. Our study takes collective cognition studies to the more complex level of language use in humans.	[Clement, Romain J. G.; Krause, Jens; Kurvers, Ralf H. J. M.] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany; [Clement, Romain J. G.; Krause, Jens] Humboldt Univ, Dept Crop & Anim Sci, D-10099 Berlin, Germany; [Krause, Stefan] Lubeck Univ Appl Sci, Dept Elect Engn & Comp Sci, Lubeck, Germany; [von Engelhardt, Nikolaus] Univ Bielefeld, Dept Anim Behav, D-33615 Bielefeld, Germany; [Faria, Jolyon J.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Humboldt University of Berlin; Luebeck University of Applied Sciences; University of Bielefeld; Princeton University	Kurvers, RHJM (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Berlin, Germany.	ralf.kurvers@igb-berlin.de	von Engelhardt, Nikolaus/B-6730-2008; Kurvers, Ralf/Q-8830-2017	von Engelhardt, Nikolaus/0000-0003-4971-6408; Kurvers, Ralf/0000-0002-3460-0392	NWO (Nederlandse organisatie voor Wetenschappelijk Onderzoek) [825.11.014]	NWO (Nederlandse organisatie voor Wetenschappelijk Onderzoek)(Netherlands Organization for Scientific Research (NWO))	Ralf Kurvers was funded by an NWO (Nederlandse organisatie voor Wetenschappelijk Onderzoek) Rubicon Grant (825.11.014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrow KJ, 2008, SCIENCE, V320, P877, DOI 10.1126/science.1157679; Bahrami B, 2010, SCIENCE, V329, P1081, DOI 10.1126/science.1185718; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Collins B. E., 1964, SOCIAL PSYCHOL GROUP; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Faria JJ, 2009, ANIM BEHAV, V78, P587, DOI 10.1016/j.anbehav.2009.05.019; Franks NR, 2006, ANIM BEHAV, V72, P611, DOI 10.1016/j.anbehav.2005.11.019; Jurafsky D., 2009, SPEECH LANGUAGE PROC; Katsikopoulos KV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015505; Kerr NL, 2004, ANNU REV PSYCHOL, V55, P623, DOI 10.1146/annurev.psych.55.090902.142009; King AJ, 2012, BIOL LETTERS, V8, P197, DOI 10.1098/rsbl.2011.0795; King AJ, 2011, BIOL LETTERS, V7, P237, DOI 10.1098/rsbl.2010.0808; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; Krause J, 2002, LIVING GROUPS; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Krause S, 2011, ANIM BEHAV, V81, P941, DOI 10.1016/j.anbehav.2010.12.018; Laughlin PR, 2006, J PERS SOC PSYCHOL, V90, P644, DOI 10.1037/0022-3514.90.4.644; Laughlin PR, 2003, J PERS SOC PSYCHOL, V85, P684, DOI 10.1037/0022-3514.85.4.684; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Noble W., 1996, HUMAN EVOLUTION LANG; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Sorkin RD, 2001, PSYCHOL REV, V108, P183, DOI 10.1037//0033-295X.108.1.183; Sunstein CR, 2005, NEW YORK U LAW REV, V80, P962; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; TINDALE RS, 1992, J APPL PSYCHOL, V77, P102, DOI 10.1037/0021-9010.77.1.102; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Wolf Max, 2013, Proceedings of the Royal Society Biological Sciences Series B, V280, P1; Wolfers J, 2004, J ECON PERSPECT, V18, P107, DOI 10.1257/0895330041371321	31	24	24	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77943	10.1371/journal.pone.0077943	http://dx.doi.org/10.1371/journal.pone.0077943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239KL	24147101	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200088
J	Dang, NA; Kuijper, S; Walters, E; Claassens, M; van Soolingen, D; Vivo-Truyols, G; Janssen, HG; Kolk, AHJ				Dang, Ngoc A.; Kuijper, Sjoukje; Walters, Elisabetta; Claassens, Mareli; van Soolingen, Dick; Vivo-Truyols, Gabriel; Janssen, Hans-Gerd; Kolk, Arend H. J.			Validation of Biomarkers for Distinguishing Mycobacterium tuberculosis from Non-Tuberculous Mycobacteria Using Gas Chromatography-Mass Spectrometry and Chemometrics	PLOS ONE			English	Article							DIAGNOSIS; DISEASE; TOOLS	Tuberculosis (TB) remains a major international health problem. Rapid differentiation of Mycobacterium tuberculosis complex (MTB) from non-tuberculous mycobacteria (NTM) is critical for decisions regarding patient management and choice of therapeutic regimen. Recently we developed a 20-compound model to distinguish between MTB and NTM. It is based on thermally assisted hydrolysis and methylation gas chromatography-mass spectrometry and partial least square discriminant analysis. Here we report the validation of this model with two independent sample sets, one consisting of 39 MTB and 17 NTM isolates from the Netherlands, the other comprising 103 isolates (91 MTB and 12 NTM) from Stellenbosch, Cape Town, South Africa. All the MTB strains in the 56 Dutch samples were correctly identified and the model had a sensitivity of 100% and a specificity of 94%. For the South African samples the model had a sensitivity of 88% and specificity of 100%. Based on our model, we have developed a new decision-tree that allows the differentiation of MTB from NTM with 100% accuracy. Encouraged by these findings we will proceed with the development of a simple, rapid, affordable, high-throughput test to identify MTB directly in sputum.	[Dang, Ngoc A.; Kuijper, Sjoukje; Vivo-Truyols, Gabriel; Janssen, Hans-Gerd; Kolk, Arend H. J.] Univ Amsterdam, Amsterdam, Netherlands; [Walters, Elisabetta; Claassens, Mareli] Univ Stellenbosch, Dept Paediat & Child Hlth, Desmond Tutu TB Ctr, ZA-7505 Tygerberg, South Africa; [van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Clin Microbiol, Nijmegen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Pulm Dis, Nijmegen, Netherlands; [Janssen, Hans-Gerd] Unilever Res Labs, Vlaardingen, Netherlands	University of Amsterdam; Stellenbosch University; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen; Unilever	Dang, NA (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.	n.dang@uva.nl	Claassens, Mareli/Y-3544-2019	Claassens, Mareli/0000-0002-5927-284X	UBS Optimus Foundation; NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands	UBS Optimus Foundation; NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands	This work was supported by the UBS Optimus Foundation and NanoNextNL, a micro and nanotechnology consortium of the Government of the Netherlands and 130 partners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOBAL TUBERCULOSIS; Ardito F, 2000, MICROBIOLOGICA, V23, P151; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Dang NA, 2013, METABOLOMICS, V9, P1274, DOI 10.1007/s11306-013-0531-z; Dang TMH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008341; Drobniewski F, 2012, INT J TUBERC LUNG D, V16, P860, DOI 10.5588/ijtld.12.0180; Foulds J, 1998, INT J TUBERC LUNG D, V2, P778; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Glassroth J, 2008, CHEST, V133, P243, DOI 10.1378/chest.07-0358; Hastie T., 2009, UNSUPERVISED LEARNIN; Jackson M, 2007, TUBERCULOSIS, V87, P78, DOI 10.1016/j.tube.2006.05.003; Johnson JA, 1998, J HEALTHC MANAG, V43, P1; Kaal E, 2009, J CHROMATOGR A, V1216, P6319, DOI 10.1016/j.chroma.2009.06.078; Kolk AHJ, 2012, INT J TUBERC LUNG D, V16, P777, DOI 10.5588/ijtld.11.0576; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P1375; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; O'Sullivan DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032836; Olivier I, 2012, J MICROBIOL METH, V88, P419, DOI 10.1016/j.mimet.2012.01.012; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; van Soolingen D, 2012, INT J TUBERC LUNG D, V16, P1279, DOI 10.5588/ijtld.12.0630	24	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76263	10.1371/journal.pone.0076263	http://dx.doi.org/10.1371/journal.pone.0076263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146846	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200012
J	Huo, Q; Zhang, N; Wang, XL; Jiang, LY; Ma, TT; Yang, QF				Huo, Qiang; Zhang, Ning; Wang, Xiaolong; Jiang, Liyu; Ma, Tingting; Yang, Qifeng			Effects of Ambient Particulate Matter on Human Breast Cancer: Is Xenogenesis Responsible?	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; AIR-POLLUTION; NEOADJUVANT CHEMOTHERAPY; RECEPTOR STATUS; LIFE-STYLE; RISK; EXPOSURE; METABOLISM; MORTALITY; DIET	Background: Recently, evidence from several studies has revealed that air pollution is associated with the increased morbidity and mortality of breast cancer patients. However, to date, the underlying mechanism remains largely unclear. Considering the high prevalence of air pollution and breast cancer in China, it is necessary to understand how air pollution may affect breast cancer. Methods: We analyzed 1,832 female patients who had resided in the same cities for at least 10 years prior to their diagnosis. Variables including demographic data as well as clinical and tumor characteristics, including the patient's age at menarche, family history of breast cancer, tumor histopathological type, tumor size, lymph node metastasis, distant metastasis, histological grade, estrogen receptor (ER) status, progesterone receptor (PR) status and human epidermal growth factor receptor 2 (HER-2) status at the time of diagnosis were analyzed. Results: Compared to patients residing in low-pollution areas, patients living in high-pollution areas demonstrated a younger age at menarche (p < 0.001), a greater family history of breast cancer (p = 0.034) and more invasive cancers (p = 0.028) with higher tumor grades (p = 0.028) and estrogen receptor (ER)-positive status (p = 0.022). Differences in tumor grade were only found in ER-positive cases. Conclusions: Our findings and clinical data indicate that long-term air pollution exposure may contribute to the development of breast cancer by playing the role of a xenoestrogen, and also provides new insight into the association between air pollution and the morbidity and mortality of breast cancer patients. Furthermore, it is urgently necessary to study the association between air pollution and breast cancer to improve the living quality and health of females, and applicable public health strategies may need to be established or modified as soon as possible.	[Huo, Qiang; Zhang, Ning; Wang, Xiaolong; Jiang, Liyu; Ma, Tingting; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan, Shandong, Peoples R China; [Huo, Qiang] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Sch Med, Key Lab Expt Teratol, Minist Educ, Jinan 250100, Peoples R China; [Yang, Qifeng] Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Yang, QF (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan, Shandong, Peoples R China.	qifengy@gmail.com	Zhang, Ning/GNP-1966-2022; yang, qiang/GYJ-0971-2022; Zhang, Ning/GOJ-8058-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [30772133, 81072150, 81172529, 81272903]; Shandong Science and Technology Development Plan [2012GZC22115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Science and Technology Development Plan	This work was supported by the National Natural Science Foundation of China (No. 30772133; No. 81072150; No. 81172529; No. 81272903) and the Shandong Science and Technology Development Plan (No. 2012GZC22115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JO, 2012, J MED TOXICOL, V8, P166, DOI 10.1007/s13181-011-0203-1; Bonner MR, 2005, CANCER EPIDEM BIOMAR, V14, P53; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2627, DOI 10.1002/cncr.22656; Chameides William L., 2010, Reviews on Environmental Health, V25, P17; Chen ST, 2013, J ENVIRON SCI HEAL A, V48, P173, DOI 10.1080/10934529.2012.717809; Chen WY, 2007, NAT CLIN PRACT ONCOL, V4, P415, DOI 10.1038/ncponc0851; Crouse DL, 2010, ENVIRON HEALTH PERSP, V118, P1578, DOI 10.1289/ehp.1002221; Hu H, 2013, BREAST CANCER RES TR, V139, P217, DOI 10.1007/s10549-013-2527-9; Ibarluzea JM, 2004, CANCER CAUSE CONTROL, V15, P591, DOI 10.1023/B:CACO.0000036167.51236.86; Li DH, 1996, CANCER RES, V56, P287; Lodovici M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/487074; MANE SS, 1990, ENVIRON MOL MUTAGEN, V15, P78, DOI 10.1002/em.2850150204; MOORE CJ, 1986, CANCER RES, V46, P4946; Nie J, 2007, CANCER CAUSE CONTROL, V18, P947, DOI 10.1007/s10552-007-9036-2; Parl FF, 2009, CANCER INFORM, V7, P109; Pieta B, 2009, EUR J GYNAECOL ONCOL, V30, P186; Rana A, 2010, FUTURE ONCOL, V6, P1369, DOI 10.2217/fon.10.112; Redden MH, 2013, SURG CLIN N AM, V93, P493, DOI 10.1016/j.suc.2013.01.006; Sagiv SK, 2009, ENVIRON RES, V109, P287, DOI 10.1016/j.envres.2008.11.005; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Sprague BL, 2010, BREAST CANCER RES TR, V124, P487, DOI 10.1007/s10549-010-0869-0; Stoll BA, 1998, BREAST CANCER RES TR, V49, P187, DOI 10.1023/A:1006003110909; Yanagi Y, 2012, CAD SAUDE PUBLICA, V28, P1737, DOI 10.1590/S0102-311X2012000900012; Zhang N, 2011, CANCER INVEST, V29, P594, DOI 10.3109/07357907.2011.621913	24	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76609	10.1371/journal.pone.0076609	http://dx.doi.org/10.1371/journal.pone.0076609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146897	Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400076
J	Kouvonen, A; Kivimaki, M; Oksanen, T; Pentti, J; De Vogli, R; Virtanen, M; Vahtera, J				Kouvonen, Anne; Kivimaki, Mika; Oksanen, Tuula; Pentti, Jaana; De Vogli, Roberto; Virtanen, Marianna; Vahtera, Jussi			Obesity and Occupational Injury: A Prospective Cohort Study of 69,515 Public Sector Employees	PLOS ONE			English	Article							BODY-MASS INDEX; HEALTH; RISK; WEIGHT; WORK; MORTALITY; HEIGHT	Background: Obesity and overweight are suggested to increase the risk of occupational injury but longitudinal evidence to confirm this is rare. We sought to evaluate obesity and overweight as risk factors for occupational injuries. Methodology/Principal Findings: A total of 69,515 public sector employees (80% women) responded to a survey in 20002002, 2004 or 2008. Body mass index (kg/m(2)) was derived from self-reported height and weight and was linked to records of subsequent occupational injuries obtained from national registers. Different injury types, locations and events or exposures (the manner in which the injury was produced or inflicted) were analyzed by body mass index category adjusting for baseline socio-demographic characteristics, work characteristics, health-risk behaviors, physical and mental health, insomnia symptoms, and sleep duration. During the mean follow-up of 7.8 years (SD = 3.2), 18% of the employees (N = 12,204) recorded at least one occupational injury. Obesity was associated with a higher overall risk of occupational injury; multivariable adjusted hazard ratio (HR) 1.21 (95% CI 1.14-1.27). A relationship was observed for bone fractures (HR = 1.37; 95% CI: 1.10-1.70), dislocations, sprains and strains (HR = 1.36; 95% CI: 1.25-1.49), concussions and internal injuries (HR = 1.26; 95% CI: 1.11-1.44), injuries to lower extremities (HR = 1.62; 95%: 1.46-1.79) and injuries to whole body or multiple sites (HR = 1.37; 95%: 1.10-1.70). Furthermore, obesity was associated with a higher risk of injuries caused by slipping, tripping, stumbling and falling (HR = 1.55; 95% CI: 1.40-1.73), sudden body movement with or without physical stress (HR = 1.24; 95% CI: 1.10-1.41) and shock, fright, violence, aggression, threat or unexpected presence (HR = 1.33; 95% CI: 1.03-1.72). The magnitude of the associations between overweight and injuries was smaller, but the associations were generally in the same direction as those of obesity. Conclusions/Significance: Obese employees record more occupational injuries than those with recommended healthy weight.	[Kouvonen, Anne] Queens Univ Belfast, Sch Sociol Social Policy & Social Work, Belfast, Antrim, North Ireland; [Kouvonen, Anne] Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth Northern Ireland, Belfast, Antrim, North Ireland; [Kivimaki, Mika; Oksanen, Tuula; Pentti, Jaana; Virtanen, Marianna; Vahtera, Jussi] Finnish Inst Occupat Hlth, Turku, Finland; [Kivimaki, Mika; Oksanen, Tuula; Pentti, Jaana; Virtanen, Marianna; Vahtera, Jussi] Finnish Inst Occupat Hlth, Helsinki, Finland; [Kivimaki, Mika; De Vogli, Roberto] UCL, Dept Epidemiol & Publ Hlth, London, England; [Kivimaki, Mika] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [De Vogli, Roberto] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland	Queens University Belfast; Queens University Belfast; Finnish Institute of Occupational Health; Finnish Institute of Occupational Health; University of London; University College London; University of Helsinki; University of California System; University of California Davis; University of Turku; University of Turku	Kouvonen, A (corresponding author), Queens Univ Belfast, Sch Sociol Social Policy & Social Work, Belfast, Antrim, North Ireland.	a.kouvonen@qub.ac.uk	Kivimaki, Mika/B-3607-2012; Oksanen, Tuula/AAK-5599-2021	Kivimaki, Mika/0000-0002-4699-5627; Kouvonen, Anne/0000-0001-6997-8312; Vahtera, Jussi/0000-0002-6036-061X	Academy of Finland [264944, 258598]; Economic and Social Research Council [RES-590-28-001]; Academy of Finland; Medical Research Council [K013351]; United States National Institutes of Health [R01HL036310, R01AG034454]; Economic and Social Research Council; Economic and Social Research Council (ESRC) [RES-070-27-0034]; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish	Academy of Finland(Academy of Finland); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Academy of Finland(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Finnish Public Sector Study is supported by the Academy of Finland (grant # 264944) and the participating organizations. A Kouvonen is supported by the Economic and Social Research Council funded United Kingdom Clinical Research Collaboration Centre of Excellence for Public Health (Northern Ireland) (RES-590-28-001). M Kivimaki is supported by the Academy of Finland, the Medical Research Council (K013351), the United States National Institutes of Health (R01HL036310; R01AG034454) and a professorial fellowship from the Economic and Social Research Council. R De Vogli is supported by a grant from the Economic and Social Research Council (ESRC) (RES-070-27-0034). M Virtanen is supported by the Academy of Finland (grant # 258598). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bes-Rastrollo M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-213; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Chau N, 2009, OCCUP MED-OXFORD, V59, P114, DOI 10.1093/occmed/kqp002; Cohen A, 2013, J CLIN ENDOCR METAB, V98, P2562, DOI 10.1210/jc.2013-1047; Dimitri P, 2012, BONE, V50, P457, DOI 10.1016/j.bone.2011.05.011; Gauchard GC, 2006, OCCUP MED-OXFORD, V56, P187, DOI 10.1093/occmed/kqj016; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; HEINEMAN EF, 1989, AM J IND MED, V15, P267; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Janssen I, 2011, J OBES, V2011, DOI 10.1155/2011/531403; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Kivimaki M, 2010, DIABETES CARE, V33, P2611, DOI 10.2337/dc10-1187; Koritzky G, 2012, APPETITE, V59, P289, DOI 10.1016/j.appet.2012.05.020; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; Lombardi DA, 2012, CHRONOBIOL INT, V29, P556, DOI 10.3109/07420528.2012.675253; Morgan PJ, 2012, J OCCUP ENVIRON MED, V54, P122, DOI 10.1097/JOM.0b013e31824329ab; Myers AH, 1999, AM J PUBLIC HEALTH, V89, P1036, DOI 10.2105/AJPH.89.7.1036; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; OECD, 2012, OECD OB UPD 2012; Ostbye T, 2007, ARCH INTERN MED, V167, P766, DOI 10.1001/archinte.167.8.766; Pollack KM, 2007, INJURY PREV, V13, P297, DOI 10.1136/ip.2006.014787; Pollack KM, 2007, AM J EPIDEMIOL, V166, P204, DOI 10.1093/aje/kwm058; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Salminen S, 2010, J SLEEP RES, V19, P207, DOI 10.1111/j.1365-2869.2009.00780.x; Statistics Finland, 1987, CLASS OCC, V14; Straker LM, 2009, ERGONOMICS, V52, P1215, DOI 10.1080/00140130903039101; Taylor AW, 2006, AUST NZ J PUBL HEAL, V30, P238, DOI 10.1111/j.1467-842X.2006.tb00864.x; United States Department of Labor Bureau of Labor Statistics, 2012, OCC INJ ILLN CLASS M; Virtanen M, 2011, OCCUPATIONAL ENV MED, V68, P1; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; WOHL AR, 1995, EPIDEMIOLOGY, V6, P110, DOI 10.1097/00001648-199503000-00004; World Health Organization, 2006, GLOB DAT BOD MASS IN	32	37	37	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77178	10.1371/journal.pone.0077178	http://dx.doi.org/10.1371/journal.pone.0077178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146966	Green Published, gold			2022-12-27	WOS:000326019400096
J	Ku, KM; Choi, JH; Kim, HS; Kushad, MM; Jeffery, EH; Juvik, JA				Ku, Kang Mo; Choi, Jeong Hee; Kim, Hyoung Seok; Kushad, Mosbah M.; Jeffery, Elizabeth H.; Juvik, John A.			Methyl Jasmonate and 1-Methylcyclopropene Treatment Effects on Quinone Reductase Inducing Activity and Post-Harvest Quality of Broccoli	PLOS ONE			English	Article							CHLOROPHYLL DEGRADING GENES; CELL-CYCLE ARREST; COLON-CANCER; GLUCOSINOLATE PROFILES; MYROSINASE ACTIVITY; MOLECULAR-CLONING; ETHYLENE-RESPONSE; ARABIDOPSIS; EXPRESSION; ISOTHIOCYANATES	Effect of pre-harvest methyl jasmonate (MeJA) and post-harvest 1-methylcyclopropene (1-MCP) treatments on broccoli floret glucosinolate (GS) concentrations and quinone reductase (QR, an in vitro anti-cancer biomarker) inducing activity were evaluated two days prior to harvest, at harvest and at 10, 20, and 30 days of post-harvest storage at 4 C. MeJA treatments four days prior to harvest of broccoli heads was observed to significantly increase floret ethylene biosynthesis resulting in chlorophyll catabolism during post-harvest storage and reduced product quality. Post-harvest treatment with 1-methylcyclopropene (1-MCP), which competitively binds to protein ethylene receptors, maintained post-harvest floret chlorophyll concentrations and product visual quality in both control and MeJA-treated broccoli. Transcript abundance of BoPPH, a gene which is responsible for the synthesis of pheophytinase, the primary enzyme associated with chlorophyll catabolism in broccoli, was reduced by 1-MCP treatment and showed a significant, negative correlation with floret chlorophyll concentrations. The GS, glucobrassicin, neoglucobrassicin, and gluconasturtiin were significantly increased by MeJA treatments. The products of some of the GS from endogenous myrosinase hydrolysis [sulforaphane (SF), neoascorbigen (NeoASG), N-methoxyindole-3-carbinol (NI3C), and phenethyl isothiocyanate (PEITC)] were also quantified and found to be significantly correlated with QR. Sulforaphane, the isothiocyanate hydrolysis product of the GS glucoraphanin, was found to be the most potent QR induction agent. Increased sulforaphane formation from the hydrolysis of glucoraphanin was associated with up-regulated gene expression of myrosinase (BoMyo) and the myrosinase enzyme co-factor gene, epithiospecifier modifier1 (BoESM1). This study demonstrates the combined treatment of MeJA and 1-MCP increased QR activity without post-harvest quality loss.	[Ku, Kang Mo; Choi, Jeong Hee; Kim, Hyoung Seok; Kushad, Mosbah M.; Juvik, John A.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Jeffery, Elizabeth H.] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL USA; [Choi, Jeong Hee] Korea Food Res Inst, Distribut Syst Res Grp, Gyeonggi Do, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Korea Food Research Institute (KFRI)	Juvik, JA (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	juvik@illinois.edu		Jeffery, Elizabeth/0000-0002-8827-9469; Ku, Kang Mo/0000-0002-8588-1163	Department of Crop Sciences at the University of Illinois at Urbana-Champaign	Department of Crop Sciences at the University of Illinois at Urbana-Champaign	The first author was supported financially by the Boerner Fellowship in the Department of Crop Sciences at the University of Illinois at Urbana-Champaign. AgroFresh, a division of Rohm & Hass Inc., provided 1-MCP and equipment for its application. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerbirk N, 1998, J AGR FOOD CHEM, V46, P1563, DOI 10.1021/jf9708498; Agrawal AA, 2003, J CHEM ECOL, V29, P1403, DOI 10.1023/A:1024265420375; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bak S, 1998, PLANT MOL BIOL, V38, P725, DOI 10.1023/A:1006064202774; Baskar V, 2012, APPL BIOCHEM BIOTECH, V168, P1694, DOI 10.1007/s12010-012-9890-6; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bergmeyer HU, 1974, ETHODS ENZYMATIC ANA; BODNARYK RP, 1994, PHYTOCHEMISTRY, V35, P301, DOI 10.1016/S0031-9422(00)94752-6; Bones AM, 1996, PHYSIOL PLANTARUM, V97, P194, DOI [10.1034/j.1399-3054.1996.970128.x, 10.1111/j.1399-3054.1996.tb00497.x]; Brown AF, 2002, J AM SOC HORTIC SCI, V127, P807, DOI 10.21273/JASHS.127.5.807; Buchert AM, 2011, J PLANT PHYSIOL, V168, P337, DOI 10.1016/j.jplph.2010.07.011; Chang C, 1999, CURR OPIN PLANT BIOL, V2, P352, DOI 10.1016/S1369-5266(99)00004-7; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Cuendet M, 2006, J NAT PROD, V69, P460, DOI 10.1021/np050362q; Dixon G. R., 2007, VEGETABLE BRASSICAS; DROBNICA L, 1967, APPL MICROBIOL, V15, P701; Gomez-Lobato ME, 2012, SCI HORTIC-AMSTERDAM, V144, P208, DOI 10.1016/j.scienta.2012.07.017; Gaofeng Yuan, 2010, Food Chemistry, V118, P774; Gomez-Lobato ME, 2012, J SCI FOOD AGR, V92, P151, DOI 10.1002/jsfa.4555; Hall BP, 2012, PLANT PHYSIOL, V159, P682, DOI 10.1104/pp.112.196790; Hasperue JH, 2013, POSTHARVEST BIOL TEC, V82, P22, DOI 10.1016/j.postharvbio.2013.02.021; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hwang ES, 2003, FOOD CHEM TOXICOL, V41, P1817, DOI 10.1016/S0278-6915(03)00235-7; Jump SM, 2008, BIOCHEM PHARMACOL, V75, P713, DOI 10.1016/j.bcp.2007.09.024; Jun BK, 2011, GENES GENOM, V33, P299, DOI 10.1007/s13258-011-0031-3; Jung S, 2004, PLANT PHYSIOL BIOCH, V42, P225, DOI 10.1016/j.plaphy.2004.01.001; Kai K, 2011, PLANT BIOTECHNOL-NAR, V28, P379, DOI 10.5511/plantbiotechnology.11.0704b; Kim DJ, 2003, MUTAT RES-FUND MOL M, V523, P99, DOI 10.1016/S0027-5107(02)00325-1; Kim H. S., 2011, THESIS U ILLINOIS UR; Kim JH, 2008, PLANT J, V54, P1015, DOI 10.1111/j.1365-313X.2008.03476.x; Kronbak R, 2010, J AGR FOOD CHEM, V58, P8453, DOI 10.1021/jf101806t; Ku KM, 2012, HORTSCIENCE, V47, pS311; Ku KM, 2013, PLANT FOOD HUM NUTR, V68, P113, DOI 10.1007/s11130-013-0356-y; Ku VVV, 1999, POSTHARVEST BIOL TEC, V17, P127, DOI 10.1016/S0925-5214(99)00042-3; Li X, 2004, J AGR FOOD CHEM, V52, P6950, DOI 10.1021/jf0401827; Ma G, 2010, POSTHARVEST BIOL TEC, V58, P121, DOI 10.1016/j.postharvbio.2010.05.011; Ma G, 2009, PLANT GROWTH REGUL, V57, P223, DOI 10.1007/s10725-008-9339-7; Matusheski NV, 2006, J AGR FOOD CHEM, V54, P2069, DOI 10.1021/jf0525277; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Neave AS, 2005, TOXICOL SCI, V83, P126, DOI 10.1093/toxsci/kfi008; Paliyath G., 2008, POSTHARVEST BIOL TEC, P195; Pang QY, 2009, PHYSIOL PLANTARUM, V136, P1, DOI 10.1111/j.1399-3054.2009.01211.x; Penas E, 2011, J AGR FOOD CHEM, V59, P3772, DOI 10.1021/jf200356m; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; PROCHASKA HJ, 1988, ANAL BIOCHEM, V169, P328, DOI 10.1016/0003-2697(88)90292-8; Rodrigues AS, 1999, J SCI FOOD AGR, V79, P1028, DOI [10.1002/(SICI)1097-0010(19990515)79:7<1028::AID-JSFA322>3.0.CO;2-I, 10.1002/(SICI)1097-0010(19990515)79:7&lt;1028::AID-JSFA322&gt;3.0.CO;2-I]; Sellam A, 2006, FEMS MICROBIOL LETT, V258, P241, DOI 10.1111/j.1574-6968.2006.00223.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Stotz HU, 2000, PLANT PHYSIOL, V124, P1007, DOI 10.1104/pp.124.3.1007; van Poppel G, 1999, ADV EXP MED BIOL, V472, P159; Wallig MA, 1998, FOOD CHEM TOXICOL, V36, P365, DOI 10.1016/S0278-6915(97)00156-7; Watanabe K, 2000, J JPN SOC HORTIC SCI, V69, P605, DOI 10.2503/jjshs.69.605; Wilson EA, 2011, CHROMATOGRAPHIA, V73, pS137, DOI 10.1007/s10337-010-1878-1; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	56	48	48	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77127	10.1371/journal.pone.0077127	http://dx.doi.org/10.1371/journal.pone.0077127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146962	gold, Green Submitted, Green Published			2022-12-27	WOS:000326019400095
J	Kumar, A; Rajendran, V; Sethumadhavan, R; Purohit, R				Kumar, Ambuj; Rajendran, Vidya; Sethumadhavan, Rao; Purohit, Rituraj			Molecular Dynamic Simulation Reveals Damaging Impact of RAC1 F28L Mutation in the Switch I Region	PLOS ONE			English	Article							PROTEIN; ALGORITHMS; COMPLEX; CANCER	Ras-related C3 botulinum toxin substrate 1 (RAC1) is a plasma membrane-associated small GTPase which cycles between the active GTP-bound and inactive GDP-bound states. There is wide range of evidences indicating its active participation in inducing cancer-associated phenotypes. RAC1 F28L mutation (RACF28L) is a fast recycling mutation which has been implicated in several cancer associated cases. In this work we have performed molecular docking and molecular dynamics simulation (similar to 0.3 mu s) to investigate the conformational changes occurring in the mutant protein. The RMSD, RMSF and NHbonds results strongly suggested that the loss of native conformation in the Switch I region in RAC1 mutant protein could be the reason behind its oncogenic transformation. The overall results suggested that the mutant protein attained compact conformation as compared to the native. The major impact of mutation was observed in the Switch I region which might be the crucial reason behind the loss of interaction between the guanine ring and F28 residue.	[Kumar, Ambuj; Rajendran, Vidya; Sethumadhavan, Rao; Purohit, Rituraj] Vellore Inst Technol Univ, Bioinformat Div, Sch Bio Sci & Technol, Vellore, Tamil Nadu, India; [Purohit, Rituraj] Human Genet Fdn, Turin, Italy	Vellore Institute of Technology	Purohit, R (corresponding author), Vellore Inst Technol Univ, Bioinformat Div, Sch Bio Sci & Technol, Vellore, Tamil Nadu, India.	riturajpurohit@gmail.com	Purohit, Rituraj/I-8856-2012; Kumar, Ambuj/U-5268-2019; Kumar, Ambuj/E-4649-2012; Purohit, Rituraj/AAF-6257-2021	Purohit, Rituraj/0000-0002-2101-9398; Kumar, Ambuj/0000-0003-3692-3694; Purohit, Rituraj/0000-0002-2101-9398				Akunuru S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016951; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Canduri F, 2008, MED CHEM, V4, P210, DOI 10.2174/157340608784325205; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; Davis MJ, 2013, P NATL ACAD SCI USA, V110, P912, DOI 10.1073/pnas.1220895110; de Azevedo WF, 2011, CURR MED CHEM, V18, P1353; De Azevedo WF, 2010, CURR DRUG TARGETS, V11, P261, DOI 10.2174/138945010790711969; de Azevedo WF, 2008, CURR DRUG TARGETS, V9, P1031, DOI 10.2174/138945008786949405; de Azevedo WF, 2001, BIOCHEM BIOPH RES CO, V287, P277, DOI 10.1006/bbrc.2001.5555; Grizot S, 2001, BIOCHEMISTRY-US, V40, P10007, DOI 10.1021/bi010288k; Heberle G, 2011, CURR MED CHEM, V18, P1339, DOI 10.2174/092986711795029573; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KAMARAJ B, 2013, CELL BIOCH BIOPHYS, DOI DOI 10.1007/S12013-013-9697-2.PUBMED:23824587; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; KUMAR A, 2013, J BIOMOL STRUCT DYN, DOI DOI 10.1080/07391102.2013.770373.PUBMED:23527964; Kumar A, 2014, CELL BIOCHEM BIOPHYS, V68, P233, DOI 10.1007/s12013-013-9705-6; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064364; Kumar A, 2012, MUTAT RES-FUND MOL M, V738, P28, DOI 10.1016/j.mrfmmm.2012.08.005; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Perez PC, 2009, COMPUT BIOL MED, V39, P130, DOI 10.1016/j.compbiomed.2008.11.004; Purohit R, 2014, J BIOMOL STRUCT DYN, V32, P1033, DOI 10.1080/07391102.2013.803264; RAJENDRAN V, 2012, J BIOMOL STRUCT DYN, DOI DOI 10.1080/07391102.2012.759885.PUBMED:23383724; Rajendran V, 2012, AMINO ACIDS, V43, P603, DOI 10.1007/s00726-011-1108-7; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Utsugi M, 2006, J IMMUNOL, V177, P4550, DOI 10.4049/jimmunol.177.7.4550	32	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77453	10.1371/journal.pone.0077453	http://dx.doi.org/10.1371/journal.pone.0077453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146998	gold, Green Submitted, Green Published			2022-12-27	WOS:000326019400109
J	Szopek, M; Schmickl, T; Thenius, R; Radspieler, G; Crailsheim, K				Szopek, Martina; Schmickl, Thomas; Thenius, Ronald; Radspieler, Gerald; Crailsheim, Karl			Dynamics of Collective Decision Making of Honeybees in Complex Temperature Fields	PLOS ONE			English	Article							DECENTRALIZED CONTROL; PUPAL DEVELOPMENT; HEAT-PRODUCTION; BEE; THERMOREGULATION; COLONIES; CLUSTERS; INSECTS; BEHAVIOR; AGE	Endothermic heat production is a crucial evolutionary adaptation that is, amongst others, responsible for the great success of honeybees. Endothermy ensures the survival of the colonies in harsh environments and is involved in the maintenance of the brood nest temperature, which is fundamental for the breeding and further development of healthy individuals and thus the foraging and reproduction success of this species. Freshly emerged honeybees are not yet able to produce heat endothermically and thus developed behavioural patterns that result in the location of these young bees within the warm brood nest where they further develop and perform tasks for the colony. Previous studies showed that groups of young ectothermic honeybees exposed to a temperature gradient collectively aggregate at the optimal place with their preferred temperature of 36 degrees C but most single bees do not locate themselves at the optimum. In this work we further investigate the behavioural patterns that lead to this collective thermotaxis. We tested single and groups of young bees concerning their ability to discriminate a local from a global temperature optimum and, for groups of bees, analysed the speed of the decision making process as well as density dependent effects by varying group sizes. We found that the majority of tested single bees do not locate themselves at the optimum whereas sufficiently large groups of bees are able to collectively discriminate a suboptimal temperature spot and aggregate at 36 degrees C. Larger groups decide faster than smaller ones, but in larger groups a higher percentage of bees may switch to the sub-optimum due to crowding effects. We show that the collective thermotaxis is a simple but well evolved, scalable and robust social behaviour that enables the collective of bees to perform complex tasks despite the limited abilities of each individual.	[Szopek, Martina; Schmickl, Thomas; Thenius, Ronald; Radspieler, Gerald; Crailsheim, Karl] Karl Franzens Univ Graz, Artificial Life Lab, Dept Zool, Graz, Austria	University of Graz	Szopek, M (corresponding author), Karl Franzens Univ Graz, Artificial Life Lab, Dept Zool, Graz, Austria.	martina.szopek@uni-graz.at		Schmickl, Thomas/0000-0001-8598-7462	Austrian Science Fund [P19478-B16, P23943-N13]; European Union [270382, 601074]; Austrian Science Fund (FWF) [P 23943] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund research grants P19478-B16 and P23943-N13 (http://www.fwf.ac.at/en/index.asp) and European Union-Information and Communication Technologies projects 'CoCoRo', no. 270382 and 'ASSISI_bf', no. 601074 (http://cordis.europa.eu/fp7/ict/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2006, LECT NOTES COMPUT SC, V4095, P713; Ame JM, 2004, ANIM BEHAV, V68, P793, DOI 10.1016/j.anbehav.2004.01.009; BECKERS R, 1992, J THEOR BIOL, V159, P397, DOI 10.1016/S0022-5193(05)80686-1; Bodi M, 2011, ADV ARTIFICIAL LIFE, P367; Bodi M, 2012, MATH COMP MODEL DYN, V18, P87, DOI 10.1080/13873954.2011.601420; Bonabeau E, 2001, HARVARD BUS REV, V79, P106; Canonge S, 2009, J INSECT PHYSIOL, V55, P976, DOI 10.1016/j.jinsphys.2009.06.011; Deal J, 1941, J ANIM ECOL, V10, P323, DOI 10.2307/1316; Deneubourg J, 2007, PEDESTRIAN EVACUATIO, V2005, P455; Dixon AFG, 2009, FUNCT ECOL, V23, P257, DOI 10.1111/j.1365-2435.2008.01489.x; FAHRENHOLZ L, 1989, J COMP PHYSIOL B, V159, P551, DOI 10.1007/BF00694379; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Free JB, 1955, BEHAVIOUR, V7, P304; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; Hallman G. J., 1998, TEMPERATURE SENSITIV; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; HARRISON JM, 1987, J EXP BIOL, V129, P53; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; Heran H, 1952, J COMP PHYSIOL A, V34, P179; Himmer A., 1927, J COMP PHYSIOL A, V5, P375; Jeanson R, 2004, BEHAV ECOL SOCIOBIOL, V55, P388, DOI 10.1007/s00265-003-0716-y; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; Karsai I, 1999, ARTIF LIFE, V5, P117, DOI 10.1162/106454699568719; Kernbach S, 2009, ADAPT BEHAV, V17, P237, DOI 10.1177/1059712309104966; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; Kovac H, 2009, APIDOLOGIE, V40, P82, DOI 10.1051/apido/2008069; Langton C. G., 1994, ARTIF LIFE, P417; Latty T, 2011, J R SOC INTERFACE, V8, P1298, DOI 10.1098/rsif.2010.0612; Lecomte J, 1950, J COMP PHYSIOL A, V32, P499; Menzel R, 1977, VERH DTSCH ZOOL GES, P26; Moussaid M, 2009, TOP COGN SCI, V1, P469, DOI 10.1111/j.1756-8765.2009.01028.x; MYERSCOUGH MR, 1993, J THEOR BIOL, V162, P381, DOI 10.1006/jtbi.1993.1094; NIESCHULZ OTTO, 1933, ZOOL AM, V103, P21; OHTANI T, 1992, HUM NATURE, V1, P11; Pratt SC, 1998, BEHAV ECOL SOCIOBIOL, V42, P193, DOI 10.1007/s002650050431; Schmickl T, 2009, AUTON AGENT MULTI-AG, V18, P133, DOI 10.1007/s10458-008-9058-5; Seeley TD, 2003, BEHAV ECOL SOCIOBIOL, V54, P511, DOI 10.1007/s00265-003-0664-6; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; SEELEY TD, 1985, ECOL ENTOMOL, V10, P81, DOI 10.1111/j.1365-2311.1985.tb00537.x; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; SOUTHWICK EE, 1985, J COMP PHYSIOL B, V156, P143, DOI 10.1007/BF00692937; Stabentheiner A, 2003, J EXP BIOL, V206, P353, DOI 10.1242/jeb.00082; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; Sumpter DJT, 2000, J THEOR BIOL, V204, P1, DOI 10.1006/jtbi.1999.1063; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; von Frisch Karl, 1965, TANZSPRACHE ORIENTIE; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; WATMOUGH J, 1995, J THEOR BIOL, V176, P391, DOI 10.1006/jtbi.1995.0207; WILSON EO, 1988, TRENDS ECOL EVOL, V3, P65, DOI 10.1016/0169-5347(88)90018-3	50	39	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76250	10.1371/journal.pone.0076250	http://dx.doi.org/10.1371/journal.pone.0076250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146843	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400045
J	Hebisch, E; Knebel, J; Landsberg, J; Frey, E; Leisner, M				Hebisch, Elke; Knebel, Johannes; Landsberg, Janek; Frey, Erwin; Leisner, Madeleine			High Variation of Fluorescence Protein Maturation Times in Closely Related Escherichia coli Strains	PLOS ONE			English	Article							CELL GENE-EXPRESSION; UNSTABLE VARIANTS; COMPETITION; DYNAMICS; PROMOTES; BIODIVERSITY; COOPERATION; ALLELOPATHY; BACTERIA; GROWTH	Fluorescent proteins (FPs) are widely used in biochemistry, biology and biophysics. For quantitative analysis of gene expression FPs are often used as marking molecules. Therefore, sufficient knowledge of maturation times and their affecting factors is of high interest. Here, we investigate the maturation process of the FPs GFP and mCherry expressed by the three closely related Escherichia coli strains of the Colicin E2 system, a model system for colicinogenic interaction. One strain, the C strain produces Colicin, a toxin to which the S strain is sensitive, and against which the R strain is resistant. Under the growth conditions used in this study, the S and R strain have similar growth rates, as opposed to the C strain whose growth rate is significantly reduced due to the toxin production. In combination with theoretical modelling we studied the maturation kinetics of the two FPs in these strains and could confirm an exponential and sigmoidal maturation kinetic for GFP and mCherry, respectively. Our subsequent quantitative experimental analysis revealed a high variance in maturation times independent of the strain studied. In addition, we determined strain dependent maturation times and maturation behaviour. Firstly, FPs expressed by the S and R strain mature on similar average time-scales as opposed to FPs expressed by the C strain. Secondly, dependencies of maturation time with growth conditions are most pronounced in the GFP expressing C strain: Doubling the growth rate of this C strain results in an increased maturation time by a factor of 1.4. As maturation times can vary even between closely related strains, our data emphasize the importance of profound knowledge of individual strains' maturation times for accurate interpretation of gene expression data.	[Hebisch, Elke] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Knebel, Johannes; Frey, Erwin; Leisner, Madeleine] Univ Munich, Dept Phys, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany; [Knebel, Johannes; Frey, Erwin; Leisner, Madeleine] Univ Munich, Dept Phys, Ctr NanoSci, Munich, Germany; [Landsberg, Janek] Univ Joseph Fourier Grenoble, Lab Interdisciplinaire Phys, St Martin Dheres, France	Max Planck Society; University of Munich; University of Munich; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Leisner, M (corresponding author), Univ Munich, Dept Phys, Arnold Sommerfeld Ctr Theoret Phys, Munich, Germany.	Madeleine.Leisner@physik.uni-muenchen.de	Frey, Erwin/M-2613-2017	Frey, Erwin/0000-0001-8792-3358; Hebisch, Elke/0000-0002-6509-2191	DFG [RA655/5-1, LE2484/4-1]; Nano Initiative Munich (NIM); Center for Nanoscience (CeNS)	DFG(German Research Foundation (DFG)); Nano Initiative Munich (NIM); Center for Nanoscience (CeNS)	This work was supported by DFG grants RA655/5-1 and LE2484/4-1, the Nano Initiative Munich (NIM) and the Center for Nanoscience (CeNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Be'er A, 2010, P NATL ACAD SCI USA, V107, P6258, DOI 10.1073/pnas.1001062107; Bubendorfer S, 2012, MOL MICROBIOL, V83, P335, DOI 10.1111/j.1365-2958.2011.07934.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Czaran TL, 2002, P NATL ACAD SCI USA, V99, P786, DOI 10.1073/pnas.012399899; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Doherty Geoff P, 2010, BMC Res Notes, V3, P303, DOI 10.1186/1756-0500-3-303; Franke GC, 2007, J MICROBIOL METH, V71, P123, DOI 10.1016/j.mimet.2007.08.015; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; INOUYE S, 1994, FEBS LETT, V351, P211, DOI 10.1016/0014-5793(94)00859-0; Iwasa Y, 1998, EVOL ECOL, V12, P785, DOI 10.1023/A:1006590431483; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kremers GJ, 2007, BIOCHEMISTRY-US, V46, P3775, DOI 10.1021/bi0622874; Kuhr JT, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113013; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; Lullmann H, 2006, PHARMAKOLOGIE TOXIKO, P495; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Megerle JA, 2008, BIOPHYS J, V95, P2103, DOI 10.1529/biophysj.107.127191; Miyawaki A, 2003, CURR OPIN CHEM BIOL, V7, P557, DOI 10.1016/S1367-5931(03)00097-8; Munch A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-229; Nakamaru M, 2000, THEOR POPUL BIOL, V57, P131, DOI 10.1006/tpbi.1999.1448; Prakash B, 2003, CURR SCI INDIA, V85, P1299; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Sandoz KM, 2007, P NATL ACAD SCI USA, V104, P15876, DOI 10.1073/pnas.0705653104; Schaechter M, 2006, INT MICROBIOL, V9, P157; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Tweeddale H, 1998, J BACTERIOL, V180, P5109, DOI 10.1128/JB.180.19.5109-5116.1998; van Roessel P, 2002, NAT CELL BIOL, V4, pE15, DOI 10.1038/ncb0102-e15; Verkhusha VV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1342, DOI 10.1023/A:1013325627378; Young JW, 2012, NAT PROTOC, V7, P80, DOI 10.1038/nprot.2011.432; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	47	56	56	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75991	10.1371/journal.pone.0075991	http://dx.doi.org/10.1371/journal.pone.0075991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155882	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300016
J	Jiang, BJ; Yue, YL; Gao, YF; Ma, LM; Sun, S; Wu, CX; Hou, WS; Lam, HM; Han, TF				Jiang, Bingjun; Yue, Yanlei; Gao, Youfei; Ma, Liming; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Lam, Hon-Ming; Han, Tianfu			GmFT2a Polymorphism and Maturity Diversity in Soybeans	PLOS ONE			English	Article							FLOWERING TIME; GENE; CLONING; E1	Background: Soybean is a short-day crop of agricultural, ecological, and economic importance. The sensitive photoperiod responses significantly limit its breeding and adaptation. GmFT2a, a putative florigen gene with different transcription profiles in two cultivars (late-maturing Zigongdongdou and early-maturing Heihe 27) with different maturity profiles, is key to flowering and maturation. However, up to now, its role in the diverse patterns of maturation in soybeans has been poorly understood. Methods: Eighty varieties, including 19 wild accessions, covering 11 of all 13 maturity groups, were collected. They were planted in pots and maintained under different photoperiodicity conditions (SD, short day; LD, long day; and ND, natural day). The day to first flowering was recorded and the sensitivity to photoperiod was investigated. Polymorphisms in the GmFT2a coding sequence were explored by searching the known SNP database (NCBI dbSNP). The GmFT2a promoter regions were then cloned from these varieties and sequenced. Further polymorphism and association analyses were conducted. Results: These varieties varied greatly in time to first flowering under ND and exhibited a consecutive distribution of photoperiod sensitivity, which suggested that there is rich diversity in flowering time. Furthermore, although GmFT2a had only one known synonymous SNP in the coding sequence, there were 17 haplotypes of the GmFT2a promoter region, HT06 of which was extremely abundant. Further association analysis found some SNPs that might be associated with day to first flowering and photoperiod sensitivity. Conclusion: Although GmFT2a is a key flowering gene, GmFT2a polymorphism does not appear to be responsible for maturity diversity in soybean.	[Jiang, Bingjun; Yue, Yanlei; Gao, Youfei; Ma, Liming; Sun, Shi; Wu, Cunxiang; Hou, Wensheng; Han, Tianfu] Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing 100193, Peoples R China; [Yue, Yanlei] Heilongjiang Acad Agr Sci, Mudanjiang Branch, Mudanjiang, Heilongjiang, Peoples R China; [Lam, Hon-Ming] Chinese Univ Hong Kong, Ctr Soybean Res, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China; [Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Heilongjiang Academy of Agricultural Sciences; Chinese University of Hong Kong; Chinese University of Hong Kong	Han, TF (corresponding author), Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing 100193, Peoples R China.	tianfuhan@hotmail.com	Lam, Hon-Ming/A-9866-2008; Jiang, Bingjun/GWQ-4354-2022	Lam, Hon-Ming/0000-0002-6673-8740; 	China Agriculture Research System [CARS-04]; Natural Science Foundation of China [31201232]; Hong Kong RGC General Research Fund [468610]	China Agriculture Research System; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong RGC General Research Fund	This project was supported by the China Agriculture Research System (CARS-04) and the Natural Science Foundation of China (31201232, http://www.nsfc.gov.cn) and the Hong Kong RGC General Research Fund (468610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; BERNARD RL, 1972, CROP SCI, V12, P716, DOI 10.2135/cropsci1972.0011183X001200050067x; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Fei ZhiHong, 2009, Acta Agronomica Sinica, V35, P1525, DOI 10.3724/SP.J.1006.2009.01525; Hao G., 1992, Acta Agronomica Sinica, V18, P275; HARTWIG EE, 1970, TROP SCI, V12, P47; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Kong F, 2010, PLANT PHYSIOL; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazakis CM, 2011, J EXP BOT, V62, P4833, DOI 10.1093/jxb/err129; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Lu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034021; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thakare D, 2011, PLANTA, V234, P933, DOI 10.1007/s00425-011-1450-8; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Wang G. X., 1981, Scientia Agricultura Sinica, P39; Wang Ying, 2008, Acta Agronomica Sinica, V34, P1160, DOI 10.3724/SP.J.1006.2008.01160; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Wu CX, 2006, PLANTA, V223, P725, DOI 10.1007/s00425-005-0130-y; Xia ZJ, 2012, PLANT SYST EVOL, V298, P1217, DOI 10.1007/s00606-012-0628-2; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Zhang, 2007, CROP MANAGE, V6, DOI [10.1094/cm-2007-0927-01-rs, DOI 10.1094/CM-2007-0927-01-RS, 10.1094/CM-2007-0927-01-RS]	35	17	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77474	10.1371/journal.pone.0077474	http://dx.doi.org/10.1371/journal.pone.0077474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155962	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300096
J	Kroeger, DR; Rudulier, CD; Bretscher, PA				Kroeger, David R.; Rudulier, Christopher D.; Bretscher, Peter A.			Antigen Presenting B Cells Facilitate CD4 T Cell Cooperation Resulting in Enhanced Generation of Effector and Memory CD4 T Cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNE-RESPONSE; DENDRITIC CELLS; IN-VIVO; LINKED RECOGNITION; OX40 LIGAND; LYMPHOCYTES; HELPER; DETERMINANTS; INDUCTION	We show that the in vivo generation of cytokine-producing CD4 T cells specific for a given major histocompatibility class-II (MHCII)-binding peptide of hen egg lysozyme (HEL) is facilitated when mice are immunized with splenic antigen presenting cells (APC) pulsed with this HEL peptide and another peptide that binds a different MHCII molecule. This enhanced generation of peptide-specific effector CD4 T cells requires that the same splenic APC be pulsed with both peptides. Pulsed B cells, but not pulsed dendritic cells (DCs), can mediate CD4 T cell cooperation, which can be blocked by disrupting OX40-OX40L (CD134-CD252) interactions. In addition, the generation of HEL peptide-specific CD4 T cell memory is greater when mice are primed with B cells pulsed with the two peptides than with B cells pulsed with the HEL-peptide alone. Based on our findings, we suggest CD4 T cell cooperation is important for vaccine design, underlies the phenomenon of "epitope-spreading" seen in autoimmunity, and that the efficacy of B cell-depletion in the treatment of human cell-mediated autoimmune disease is due to the abrogation of the interactions between autoimmune CD4 T cells that facilitates their activation.	[Kroeger, David R.; Rudulier, Christopher D.; Bretscher, Peter A.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada	University of Saskatchewan	Bretscher, PA (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	peter.bretscher@usask.ca			Natural Sciences and Engineering Research Council of Canada [327335-2008]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada operating grant to PAB (327335-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2000, J EXP MED, V191, P375, DOI 10.1084/jem.191.2.375; Akiba H, 1999, J IMMUNOL, V162, P7058; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BOCKENSTEDT LK, 1995, J IMMUNOL, V154, P3516; BRETSCHER PA, 1983, CELL IMMUNOL, V81, P345, DOI 10.1016/0008-8749(83)90242-3; BRETSCHER PA, 1983, J IMMUNOL, V131, P1103; BRETSCHER PA, 1986, J IMMUNOL, V137, P3726; CLAMAN HN, 1966, P SOC EXP BIOL MED, V122, P1167; Creusot RJ, 2003, J IMMUNOL, V171, P240, DOI 10.4049/jimmunol.171.1.240; CROFT M, 1992, J EXP MED, V176, P1431, DOI 10.1084/jem.176.5.1431; Evans DE, 2000, J IMMUNOL, V164, P688, DOI 10.4049/jimmunol.164.2.688; Gerloni M, 2000, P NATL ACAD SCI USA, V97, P13269, DOI 10.1073/pnas.230429197; GUERDER S, 1992, J EXP MED, V176, P553, DOI 10.1084/jem.176.2.553; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Ismail N, 2005, IMMUNOLOGY, V115, P34, DOI 10.1111/j.1365-2567.2005.02128.x; Ismail N, 2001, EUR J IMMUNOL, V31, P1765, DOI 10.1002/1521-4141(200106)31:6<1765::AID-IMMU1765>3.0.CO;2-T; Jaiswal AI, 1997, J IMMUNOL, V159, P2282; JANSSON L, 1995, EUR J IMMUNOL, V25, P2195, DOI 10.1002/eji.1830250812; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KEENE JA, 1982, J EXP MED, V155, P768, DOI 10.1084/jem.155.3.768; Kleindienst P, 2005, IMMUNOLOGY, V115, P556, DOI 10.1111/j.1365-2567.2005.02196.x; Kroeger DR, 2012, INT IMMUNOL; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Masten BJ, 1999, J IMMUNOL, V162, P1310; METLAY JP, 1989, J EXP MED, V169, P239, DOI 10.1084/jem.169.1.239; MILLER JFA, 1968, J EXP MED, V128, P801, DOI 10.1084/jem.128.4.801; Peters NC, 2009, INT IMMUNOL, V21, P1213, DOI 10.1093/intimm/dxp085; Peters NC, 2005, EUR J IMMUNOL, V35, P56, DOI 10.1002/eji.200425581; Power CA, 1999, J IMMUNOL METHODS, V227, P99, DOI 10.1016/S0022-1759(99)00074-5; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Tsukada N, 2000, BLOOD, V95, P2434, DOI 10.1182/blood.V95.7.2434.007k11_2434_2439; TUCKER MJ, 1982, J EXP MED, V155, P1037, DOI 10.1084/jem.155.4.1037; vanderMost RG, 1996, J IMMUNOL, V157, P5543; Yu M, 1996, J EXP MED, V183, P1777, DOI 10.1084/jem.183.4.1777	40	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77346	10.1371/journal.pone.0077346	http://dx.doi.org/10.1371/journal.pone.0077346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155947	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300081
J	Yi, X; Zhao, HM; Dong, XL; Wang, PD; Hu, MY; Zhong, GH				Yi, Xin; Zhao, Haiming; Dong, Xiaolin; Wang, Peidan; Hu, Meiying; Zhong, Guohua			BdorCSP2 Is Important for Antifeed and Oviposition-Deterring Activities Induced by Rhodojaponin-III against Bactrocera dorsalis	PLOS ONE			English	Article							LOCUSTA-MIGRATORIA ORTHOPTERA; ODORANT-BINDING-PROTEIN; CHEMOSENSORY PROTEINS; EXPRESSION PATTERN; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; FRUIT-FLY; MOTH; IDENTIFICATION; LEPIDOPTERA	Rhodojaponin-III is a nonvolatile botanical grayanoid diterpene compound, which has antifeedant and oviposition deterrence effects against many kinds of insects. However, the molecular mechanism of the chemoreception process remains unknown. In this study, the important role of BdorCSP2 in the recognition of Rhodojaponin-III was identified. The full length cDNA encoding BdorCSP2 was cloned from legs of Bactrocera dorsalis. The results of expression pattern revealed that BdorCSP2 was abundantly expressed in the legs of adult B. dorsalis. Moreover, the expression of BdorCSP2 could be up-regulated by Rhodojaponin-III. In order to gain comprehensive understanding of the recognition process, the binding affinity between BdorCSP2 and Rhodojaponin-III was measured by fluorescence binding assay. Silencing the expression of BdorCSP2 through the ingestion of dsRNA could weaken the effect of oviposition deterrence and antifeedant of Rhodojaponin-III. These results suggested that BdorCSP2 of B. dorsalis could be involved in chemoreception of Rhodojaponin-III and played a critical role in antifeedant and oviposition behaviors induced by Rhodojaponin-III.	[Yi, Xin; Zhao, Haiming; Dong, Xiaolin; Wang, Peidan; Hu, Meiying; Zhong, Guohua] South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Hu, MY (corresponding author), South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Lab Insect Toxicol, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.com; guohuazhong@scau.edu.cn			National Nature Science Foundation, People's Republic of China [31071713]	National Nature Science Foundation, People's Republic of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation, People's Republic of China under grant number 31071713. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Aluja M, 2008, ANNU REV ENTOMOL, V53, P473, DOI 10.1146/annurev.ento.53.103106.093350; Anbutsu H, 2002, J INSECT PHYSIOL, V48, P459, DOI 10.1016/S0022-1910(02)00067-7; Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; Cui SY, 2006, PEPTIDES, V27, P1226, DOI 10.1016/j.peptides.2005.11.011; Danty E, 1998, INSECT BIOCHEM MOLEC, V28, P387, DOI 10.1016/S0965-1748(98)00011-3; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; Ferguson AW, 1999, J INSECT PHYSIOL, V45, P687, DOI 10.1016/S0022-1910(99)00046-3; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; KLOCKE JA, 1991, PHYTOCHEMISTRY, V30, P1797, DOI 10.1016/0031-9422(91)85015-R; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Li KM, 2012, J CHEM ECOL, V38, P287, DOI 10.1007/s10886-012-0085-y; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu XL, 2010, J BIOCHEM, V148, P189, DOI 10.1093/jb/mvq050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Martini X, 2013, B ENTOMOL RES, V103, P14, DOI 10.1017/S000748531200034X; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; MITCHELL ER, 1985, J CHEM ECOL, V11, P609, DOI 10.1007/BF00988571; Nagnan-Le Meillour P, 2000, CHEM SENSES, V25, P541, DOI 10.1093/chemse/25.5.541; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Picimbon JF, 2000, ARCH INSECT BIOCHEM, V44, P120, DOI 10.1002/1520-6327(200007)44:3&lt;120::AID-ARCH3&gt;3.0.CO;2-H; Picimbon JF, 2000, INSECT BIOCHEM MOLEC, V30, P233, DOI 10.1016/S0965-1748(99)00121-6; Picimbon JF, 2001, INSECT BIOCHEM MOLEC, V31, P1173, DOI 10.1016/S0965-1748(01)00063-7; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; RENWICK JAA, 1994, ANNU REV ENTOMOL, V39, P377, DOI 10.1146/annurev.en.39.010194.002113; ROTHSCHILD M, 1988, PHYTOCHEMISTRY, V27, P101, DOI 10.1016/0031-9422(88)80598-3; Spathe A, 2013, CHEM SENSES, V38, P147, DOI 10.1093/chemse/bjs089; STADLER E, 1995, PHYSIOL ENTOMOL, V20, P175, DOI 10.1111/j.1365-3032.1995.tb00814.x; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tomaselli S, 2006, BIOCHEMISTRY-US, V45, P10606, DOI 10.1021/bi060998w; VOLLER A, 1980, ENZYME LINKED IMMUNO, P402; Wanner KW, 2004, J CHEM ECOL, V30, P889, DOI 10.1023/B:JOEC.0000028457.51147.d4; Zhang SA, 2009, CHEM SENSES, V34, P503, DOI 10.1093/chemse/bjp027; Zhang TT, 2012, J INTEGR AGR, V11, P430, DOI 10.1016/S2095-3119(12)60028-8; Zhang YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047611; Zheng WW, 2012, J INSECT PHYSIOL, V58, P1122, DOI 10.1016/j.jinsphys.2012.05.011; Zhong GH, 2006, PEST MANAG SCI, V62, P976, DOI 10.1002/ps.1267; Zhong GuoHua, 2000, Journal of South China Agricultural University, V21, P40; Zhou JJ, 2006, CHEM SENSES, V31, P453, DOI 10.1093/chemse/bjj050; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x; Zhou SH, 2009, J MORPHOL, V270, P1356, DOI 10.1002/jmor.10763	53	19	20	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77295	10.1371/journal.pone.0077295	http://dx.doi.org/10.1371/journal.pone.0077295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155937	Green Submitted, gold, Green Published			2022-12-27	WOS:000325887300071
J	Yu, HC; Lu, MC; Li, C; Huang, HL; Huang, KY; Liu, SQ; Lai, NS; Huang, HB				Yu, Hui-Chun; Lu, Ming-Chi; Li, Chin; Huang, Hsien-Lu; Huang, Kuang-Yung; Liu, Su-Qin; Lai, Ning-Sheng; Huang, Hsien-Bin			Targeted Delivery of an Antigenic Peptide to the Endoplasmic Reticulum: Application for Development of a Peptide Therapy for Ankylosing Spondylitis	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CLASS-I MOLECULES; TRANSGENIC RATS; HLA-B27; SPONDYLOARTHRITIS; SPONDYLARTHRITIS; PATHOGENESIS; DISEASE; CELLS; INTERLEUKIN-23	The development of suitable methods to deliver peptides specifically to the endoplasmic reticulum (ER) can provide some potential therapeutic applications of such peptides. Ankylosing spondylitis (AS) is strongly associated with the expression of human leukocytic antigen-B27 (HLA-B27). HLA-B27 heavy chain (HC) has a propensity to fold slowly resulting in the accumulation of misfolded HLA-B27 HC in the ER, triggering the unfolded protein response, and forming a homodimer, (B27-HC)(2). Natural killer cells and T-helper 17 cells are then activated, contributing to the major pathogenic potentials of AS. The HLA-B27 HC is thus an important target, and delivery of an HLA-B27-binding peptide to the ER capable of promoting HLA-B27 HC folding is a potential mechanism for AS therapy. Here, we demonstrate that a His(6)-ubiquitin-tagged Tat-derived peptide (THU) can deliver an HLA-B27-binding peptide to the ER promoting HLA-B27 HC folding. The THU-HLA-B27-binding peptide fusion protein crossed the cell membrane to the cytosol through the Tat-derived peptide. The HLA-B27-binding peptide was specifically cleaved from THU by cytosolic ubiquitin C-terminal hydrolases and subsequently transported into the ER by the transporter associated with antigen processing. This approach has potential application in the development of peptide therapy for AS.	[Yu, Hui-Chun; Li, Chin; Huang, Hsien-Bin] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Yu, Hui-Chun; Li, Chin; Huang, Hsien-Bin] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan; [Yu, Hui-Chun; Lu, Ming-Chi; Huang, Kuang-Yung; Liu, Su-Qin; Lai, Ning-Sheng] Buddhist DaLin Tzu Chi Hosp, Dept Med, Sect Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming-Chi; Huang, Kuang-Yung; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Huang, Hsien-Lu] Fooyin Univ, Dept Nutr & Hlth Sci, Kaohsiung, Taiwan	National Chung Cheng University; National Chung Cheng University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Fooyin University	Lai, NS (corresponding author), Buddhist DaLin Tzu Chi Hosp, Dept Med, Sect Allergy Immunol & Rheumatol, Chiayi, Taiwan.	Q12015@tzuchi.com.tw; biohbh@ccu.edu.tw			DaLin Tzu Chi Buddhist Hospital [DTCRD SR98-2-3]	DaLin Tzu Chi Buddhist Hospital	This work was supported by grants from the DaLin Tzu Chi Buddhist Hospital [DTCRD SR98-2-3]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RL, 1999, J IMMUNOL, V162, P5045; ANDROLEWICZ MJ, 1994, P NATL ACAD SCI USA, V91, P12716, DOI 10.1073/pnas.91.26.12716; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; Bowness P, 2011, J IMMUNOL, V186, P2672, DOI 10.4049/jimmunol.1002653; BREWERTON DA, 1973, LANCET, V1, P904; Brook H, 2006, ADV DRUG DELIV REV, V57, P559; CAFFREY MFP, 1973, NATURE, V242, P121, DOI 10.1038/242121a0; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Chan AT, 2005, ARTHRITIS RHEUM, V52, P3586, DOI 10.1002/art.21395; Colbert RA, 2010, IMMUNOL REV, V233, P181, DOI 10.1111/j.0105-2896.2009.00865.x; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Garcia F, 1997, TISSUE ANTIGENS, V49, P23, DOI 10.1111/j.1399-0039.1997.tb02705.x; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Kollnberger S, 2002, ARTHRITIS RHEUM, V46, P2972, DOI 10.1002/art.10605; Lu MC, 2008, CLIN IMMUNOL, V129, P462, DOI 10.1016/j.clim.2008.08.001; Mear JP, 1999, J IMMUNOL, V163, P6665; Melis L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2722; Merino E, 2008, ARTHRITIS RHEUM-US, V58, P3693, DOI 10.1002/art.24045; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Ramos M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Ritz U, 2001, MOL MED, V7, P149, DOI 10.1007/BF03401948; Rock KL, 2004, NAT IMMUNOL, V5, P670, DOI 10.1038/ni1089; RUBEN S, 1989, J VIROL, V63, P1; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sieper J, 2012, NAT REV RHEUMATOL, V8, P280, DOI 10.1038/nrrheum.2012.40; Smith JA, 2006, BEST PRACT RES CL RH, V20, P571, DOI 10.1016/j.berh.2006.03.001; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; Tam LS, 2010, NAT REV RHEUMATOL, V6, P399, DOI 10.1038/nrrheum.2010.79; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Tran TM, 2004, J IMMUNOL, V172, P5110, DOI 10.4049/jimmunol.172.8.5110; Turner MJ, 2007, ARTHRITIS RHEUM, V56, P215, DOI 10.1002/art.22295; Turner MJ, 2005, J IMMUNOL, V175, P2438, DOI 10.4049/jimmunol.175.4.2438; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Yan JB, 2006, J EXP MED, V203, P647, DOI 10.1084/jem.20052271; ZEMMOUR J, 1992, J IMMUNOL, V148, P1941; Zeng L, 2011, ARTHRITIS RHEUM-US, V63, P3807, DOI 10.1002/art.30593	43	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77451	10.1371/journal.pone.0077451	http://dx.doi.org/10.1371/journal.pone.0077451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155957	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300091
J	Benatar, JR; Sidhu, K; Stewart, RAH				Benatar, Jocelyne R.; Sidhu, Karishma; Stewart, Ralph A. H.			Effects of High and Low Fat Dairy Food on Cardio-Metabolic Risk Factors: A Meta-Analysis of Randomized Studies	PLOS ONE			English	Article							POSTMENOPAUSAL CHINESE WOMEN; BODY-WEIGHT; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MILK SUPPLEMENTATION; INFLAMMATORY MARKERS; SERUM-LIPIDS; YOUNG-WOMEN; CONSUMPTION; DIETARY	Importance: Clear guidelines on the health effects of dairy food are important given the high prevalence of obesity, cardiovascular disease and diabetes, and increasing global consumption of dairy food. Objective: To evaluate the effects of increased dairy food on cardio metabolic risk factors. Data Sources: Searches were performed until April 2013 using MEDLINE, Science Direct, Google,Embase, the Cochrane Central Register of Controlled Trials, reference lists of articles, and proceedings of major meetings. Study Selection: Randomized controlled studies with healthy adults randomized to increased dairy food for more than one month without additional interventions. Data Extraction and Synthesis: A standard list was used to extract descriptive, methodological and key variables from all eligible studies. If data was not included in the published report corresponding authors were contacted. Results: 20 studies with 1677 participants with a median duration of dietary change of 26 (IQR 10-39) weeks and mean increase in dairy food intake of 3.6 (SD 0.92) serves/day were included. There was an increase in weight with low (+0.82, 0.35 to 1.28 kg, p<0.001) and whole fat dairy food (+0.41, 0.04 to 0.79kg, p=0.03), but no significant change in waist circumference (-0.07, -1.24 to 1.10 cm); HOMA -IR (-0.94, -1.93 to 0.04 units); fasting glucose (+1.32, 0.19 to 2.45 mg/dl); LDL-c (1.85,-2.89 to 6.60 mg/dl); HDL-c (-0.19, -2.10 to 1.71 mg/dl); systolic BP (-0.4, -1.6 to 0.8 mmHg); diastolic BP (-0.4, -1.7 to 0.8 mmHg) or CRP (-1.07, -2.54 to 0.39 mg/L). Changes in other cardio-metabolic risk factors were similar for low and whole fat dairy interventions. Limitations: Most clinical trials were small and of modest quality.. Conclusion: Increasing whole fat and low fat dairy food consumption increases weight but has minor effects on other cardio-metabolic risk factors.	[Benatar, Jocelyne R.; Sidhu, Karishma; Stewart, Ralph A. H.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand	Auckland City Hospital	Benatar, JR (corresponding author), Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand.	Jocelyne.Benatar@adhb.govt.nz	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; benatar, jocelyne/0000-0002-6724-8997				Abargouei AS, 2012, INT J OBESITY, V36, P1485, DOI 10.1038/ijo.2011.269; Agriculture UDo, 2012, US CHOOSEMYPLATE; Alonso A, 2009, J HUM NUTR DIET, V22, P336, DOI 10.1111/j.1365-277X.2009.00967.x; Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Association AD, 2013, DAIR WHAT CAN I EAT; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; BARAN D, 1990, J CLIN ENDOCR METAB, V70, P264, DOI 10.1210/jcem-70-1-264; Barr SI, 2000, J AM DIET ASSOC, V100, P810, DOI 10.1016/S0002-8223(00)00236-4; Benatar JR, 2013, PREV CARDIOL; Benatar JR, 2013, EUR J PREV CARDIOL; Beydoun MA, 2008, AM J CLIN NUTR, V87, P1914, DOI 10.1093/ajcn/87.6.1914; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Chee WSS, 2003, OSTEOPOROSIS INT, V14, P828, DOI 10.1007/s00198-003-1448-6; Chen M, 2012, AM J CLIN NUTR, V96, P735, DOI 10.3945/ajcn.112.037119; Choi HK, 2005, ARCH INTERN MED, V165, P997, DOI 10.1001/archinte.165.9.997; Conditions TNC, 2013, CFC TYP 2 DIAB MAN T; Crichton GE, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-111; Crichton GE, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-19; Development TOfEC-oa, 2011, OECD FAO AGR OUTL 20; Eagan MS, 2006, OBESITY, V14, P2242, DOI 10.1038/oby.2006.263; Elwood PC, 2005, J EPIDEMIOL COMMUN H, V59, P502, DOI 10.1136/jech.2004.027904; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Engberink MF, 2009, J NUTR, V139, P582, DOI 10.3945/jn.108.093088; Esmaillzadeh A, 2010, PUBLIC HEALTH NUTR, V13, P1395, DOI 10.1017/S1368980009992126; Estruch R, 2013, N ENGL J MED; Gardner CD, 2007, J AM COLL NUTR, V26, P669, DOI 10.1080/07315724.2007.10719646; GHADIRIAN P, 1995, EUR J EPIDEMIOL, V11, P275, DOI 10.1007/BF01719431; Gunther CW, 2005, AM J CLIN NUTR, V81, P751, DOI 10.1093/ajcn/81.4.751; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Iggman D, 2011, CLIN LIPIDOL, V6, P209, DOI 10.2217/CLP.11.7; International Diabetes Federation, 2011, MODULE 2 2B NUTR THE; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kelemen LE, 2005, AM J EPIDEMIOL, V161, P239, DOI 10.1093/aje/kwi038; Kukuljan S, 2009, OSTEOPOROSIS INT, V20, P1241, DOI 10.1007/s00198-008-0776-y; Lau EMC, 2001, J BONE MINER RES, V16, P1704, DOI 10.1359/jbmr.2001.16.9.1704; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Liu S, 2005, DIABETES CARE, V28, P2926, DOI 10.2337/diacare.28.12.2926; Ludwig DS, 2013, JAMA PEDIAT, P1; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Manios Y, 2009, MATURITAS, V62, P58, DOI 10.1016/j.maturitas.2008.11.005; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; O'Neil CE, 2009, PUBLIC HEALTH NUTR, V12, P1693, DOI 10.1017/S1368980008003911; Organisation WH, 2012, ATLAS HEART DIS STRO; Palacios C, 2011, NUTRITION, V27, P520, DOI 10.1016/j.nut.2010.02.011; Panagiotakos DB, 2010, J AM COLL NUTR, V29, P357, DOI 10.1080/07315724.2010.10719852; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Poddar KH, 2009, J AM DIET ASSOC, V109, P1433, DOI 10.1016/j.jada.2009.05.005; Recommendations AD, 2012, AUST DIETARY RECOMME; Services USDoHaH, 2010, DIET GUID AM 2010; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Snijder MB, 2007, AM J CLIN NUTR, V85, P989, DOI 10.1093/ajcn/85.4.989; Stancliffe RA, 2011, AM J CLIN NUTR, V94, P422, DOI 10.3945/ajcn.111.013342; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tardy AL, 2009, AM J CLIN NUTR, V90, P88, DOI 10.3945/ajcn.2009.27515; Toledo E, 2009, BRIT J NUTR, V101, P59, DOI 10.1017/S0007114508981496; Truby H, 2006, BMJ-BRIT MED J, V332, P1309, DOI 10.1136/bmj.38833.411204.80; van Meijl LEC, 2011, NUTR METAB CARDIOVAS, V21, P355, DOI 10.1016/j.numecd.2009.10.008; van Meijl LEC, 2010, BRIT J NUTR, V104, P1523, DOI 10.1017/S0007114510002515; Wennersberg MH, 2009, AM J CLIN NUTR, V90, P960, DOI 10.3945/ajcn.2009.27664; Wheeler ML, 2012, DIABETES CARE, V35, P434, DOI 10.2337/dc11-2216; Winkleby MA, 1998, JAMA-J AM MED ASSOC, V280, P356, DOI 10.1001/jama.280.4.356; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144; Zemel MB, 2010, AM J CLIN NUTR, V91, P16, DOI 10.3945/ajcn.2009.28468	67	120	120	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76480	10.1371/journal.pone.0076480	http://dx.doi.org/10.1371/journal.pone.0076480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146877	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400061
J	Gerka-Stuyt, J; Au, A; Peachey, NS; Alagramam, KN				Gerka-Stuyt, John; Au, Adrian; Peachey, Neal S.; Alagramam, Kumar N.			Transient Receptor Potential Melastatin 1: A Hair Cell Transduction Channel Candidate	PLOS ONE			English	Article							MOUSE INNER-EAR; BIPOLAR CELLS; MECHANOTRANSDUCTION; TRPM1; GENE; TRPA1; STEREOCILIA; EXPRESSION; CLARIN-1; DOMINANT	Sound and head movements are perceived through sensory hair cells in the inner ear. Mounting evidence indicates that this process is initiated by the opening of mechanically sensitive calcium-permeable channels, also referred to as the mechanoelectrical transducer (MET) channels, reported to be around the tips of all but the tallest stereocilia. However, the identity of MET channel remains elusive. Literature suggests that the MET channel is a non-selective cation channel with a high Ca2+ permeability and similar to 100 picosiemens conductance. These characteristics make members of the transient receptor potential (TRP) superfamily likely candidates for this role. One of these candidates is the transient receptor potential melastatin 1 protein (TRPM1), which is expressed in various cells types within the cochlea of the mouse including the hair cells. Recent studies demonstrate that mutations in the TRPM1 gene underlie the inherited retinal disease complete congenital stationary night blindness in humans and depolarizing bipolar cell dysfunction in the mouse retina, but auditory function was not assessed. Here we investigate the role of Trpm1 in hearing and as a possible hair cell MET channel using mice homozygous for the null allele of Trpm1 (Trpm1(-/-)) or a missense mutation in the pore domain of TRPM1 (Trpm1(tvrm27/tvrm27)). Hearing thresholds were evaluated in adult (4-5 months old) mice with auditory-evoked brain stem responses. Our data shows no statistically significant difference in hearing thresholds in Trpm1(-/-) or Trpm1(tvrm27/tvrm27) mutants compared to littermate controls. Further, none of the mutant mice showed any sign of balance disorder, such as head bobbing or circling. These data suggest that TRPM1 is not essential for development of hearing or balance and it is unlikely that TRPM1 is a component of the hair cell MET channel.	[Gerka-Stuyt, John; Au, Adrian; Alagramam, Kumar N.] Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Peachey, Neal S.] Louis Stokes Cleveland VA Med Ctr, Res Serv, Cleveland, OH USA; [Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Peachey, Neal S.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Alagramam, KN (corresponding author), Case Western Reserve Univ, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.	kna3@case.edu	Peachey, Neal/G-5533-2010; Au, Adrian/AAE-9654-2019	Peachey, Neal/0000-0002-4419-7226; Au, Adrian/0000-0001-8110-9988	Maniglia Endowed Chair, University Hospitals Case Medical Center; Department of Veterans Affairs(NP); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010816] Funding Source: NIH RePORTER	Maniglia Endowed Chair, University Hospitals Case Medical Center; Department of Veterans Affairs(NP); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by funds from the Maniglia Endowed Chair, University Hospitals Case Medical Center (to KA) and from the Department of Veterans Affairs(NP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bellone RR, 2008, GENETICS, V179, P1861, DOI 10.1534/genetics.108.088807; Beurg M, 2010, J NEUROPHYSIOL, V104, P18, DOI 10.1152/jn.00019.2010; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COREY DP, 1979, NATURE, V281, P675, DOI 10.1038/281675a0; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Devi S, 2013, PIGM CELL MELANOMA R, V26, P348, DOI 10.1111/pcmr.12083; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Geng RS, 2012, J NEUROSCI, V32, P9485, DOI 10.1523/JNEUROSCI.0311-12.2012; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Inoue R, 2006, CIRC RES, V99, P119, DOI 10.1161/01.RES.0000233356.10630.8a; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Peachey NS, 2012, J NEUROPHYSIOL, V108, P2442, DOI 10.1152/jn.00137.2012; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; Selvakumar D, 2013, J BIOL CHEM, V288, P7215, DOI 10.1074/jbc.M112.443226; Selvakumar D, 2012, BIOCHEM J, V443, P463, DOI 10.1042/BJ20111255; Shen Y, 2009, J NEUROSCI, V29, P6088, DOI 10.1523/JNEUROSCI.0132-09.2009; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Takumida M, 2009, ACTA OTO-LARYNGOL, V129, P1050, DOI 10.1080/00016480802570545; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Won JY, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/391384	32	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77213	10.1371/journal.pone.0077213	http://dx.doi.org/10.1371/journal.pone.0077213			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146970	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400105
J	Gomes, H; Romeiro, NC; Braz, GRC; de Oliveira, EAG; Rodrigues, C; da Fonseca, RN; Githaka, N; Isezaki, M; Konnai, S; Ohashi, K; Vaz, ID; Logullo, C; Moraes, J				Gomes, Helga; Romeiro, Nelilma C.; Braz, Gloria R. C.; Gamosa de Oliveira, Eduardo Alves; Rodrigues, Camilla; da Fonseca, Rodrigo Nunes; Githaka, Naftaly; Isezaki, Masayoshi; Konnai, Satoru; Ohashi, Kazuhiko; Vaz, Itabajara da Silva, Jr.; Logullo, Carlos; Moraes, Jorge			Identification and Structural-Functional Analysis of Cyclin-Dependent Kinases of the Cattle Tick Rhipicephalus (Boophilus) microplus	PLOS ONE			English	Article							BOVINE OOCYTES; CRYSTAL-STRUCTURE; CDK INHIBITORS; ROSCOVITINE; APOPTOSIS; MATURATION; NUCLEAR; PRETREATMENT; REPLICATION; ACTIVATION	Cyclin-dependent kinases (CDKs) are a family of serine/threonine kinases essential for cell cycle progression. Herein, we describe the participation of CDKs in the physiology of Rhipicephalus microplus, the southern cattle tick and an important disease vector. Firstly, amino acid sequences homologous with CDKs of other organisms were identified from a R. microplus transcriptome database in silico. The analysis of the deduced amino acid sequences of CDK1 and CDK10 from R. microplus showed that both have caspase-3/7 cleavage motifs despite their differences in motif position and length of encoded proteins. CDK1 has two motifs (DKRGD and SAKDA) located opposite to the ATP binding site while CDK10 has only one motif (SLLDN) for caspase 3-7 near the ATP binding site. Roscovitine (Rosco), a purine derivative that inhibits CDK/cyclin complexes by binding to the catalytic domain of the CDK molecule at the ATP binding site, which prevents the transfer of ATP's cphosphoryl group to the substrate. To determine the effect of Rosco on tick CDKs, BME26 cells derived from R. microplus embryo cells were utilized in vitro inhibition assays. Cell viability decreased in the Rosco-treated groups after 24 hours of incubation in a concentration-dependent manner and this was observed up to 48 hours following incubation. To our knowledge, this is the first report on characterization of a cell cycle protein in arachnids, and the sensitivity of BME26 tick cell line to Rosco treatment suggests that CDKs are potential targets for novel drug design to control tick infestation.	[Gomes, Helga; Rodrigues, Camilla; da Fonseca, Rodrigo Nunes; Moraes, Jorge] NUPEM UFRJ, Lab Integrado Bioquim Hatisaburo Masuda, Macae, RJ, Brazil; [Gomes, Helga; Moraes, Jorge] Univ Fed Rio de Janeiro, Inst Bioquim Med, CCS, Bloco H,Cidade Univ,Ilha Fundao, Rio De Janeiro, RJ, Brazil; [Braz, Gloria R. C.; da Fonseca, Rodrigo Nunes; Vaz, Itabajara da Silva, Jr.; Logullo, Carlos; Moraes, Jorge] Inst Nacl Ciencia Tecnologia Entomol Mol, Rio De Janeiro, RJ, Brazil; [Braz, Gloria R. C.] IQ UFRJ, Inst Quim, Dept Bioquim, Rio De Janeiro, RJ, Brazil; [Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Fac Vet, Porto Alegre, RS, Brazil; [Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Fac Vet, Porto Alegre, RS, Brazil; [Logullo, Carlos] Univ Estadual N Fluminen, CBB, Unidade Expt Anim, Lab Quim Funcao Prot & Peptideos, Campos dos Goytacazes, RJ, Brazil; [Romeiro, Nelilma C.; Gamosa de Oliveira, Eduardo Alves] NUPEM UFRJ, Lab Integrado Comp Cient, Macae, RJ, Brazil; [Githaka, Naftaly; Isezaki, Masayoshi; Konnai, Satoru; Ohashi, Kazuhiko] Hokkaido Univ, Infect Dis Lab, Grad Sch Vet Med, Kita Ku, Sapporo, Hokkaido, Japan	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Hokkaido University	Moraes, J (corresponding author), NUPEM UFRJ, Lab Integrado Bioquim Hatisaburo Masuda, Campus Macae,Ave Sao Jose Barreto, Macae, RJ, Brazil.	jorgemoraes@bioqmed.ufrj.br	da Fonseca, Rodrigo Nunes/S-3964-2018; Fernandes Gomes, Helga/AFV-5696-2022; Silva Vaz Jr., Itabajara/A-5943-2009; Nunes-da-Fonseca, Rodrigo/ABI-1404-2022; vaz, itabajara/F-5244-2014	da Fonseca, Rodrigo Nunes/0000-0001-9576-2849; Silva Vaz Jr., Itabajara/0000-0003-0309-9328; Nunes-da-Fonseca, Rodrigo/0000-0001-9576-2849; vaz, itabajara/0000-0003-0309-9328; Githaka, Dr Naftaly/0000-0003-4530-7164; Satoru, Konnai/0000-0002-3230-7109	CNPq-Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (Brazil); FINEP (Brazil); CAPES (Brazil); CNPq (Brazil); FAPERJ (Brazil); FUNEMAC (Brazil); FAPERGS (Brazil); Japanese Ministry of Health, Labor and Welfare; Japan Society for the Promotion of Science (JSPS) (Japan); Grants-in-Aid for Scientific Research [25257415] Funding Source: KAKEN	CNPq-Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (Brazil); FINEP (Brazil)(Financiadora de Inovacao e Pesquisa (Finep)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ (Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FUNEMAC (Brazil); FAPERGS (Brazil)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS) (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from CNPq-Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular, FINEP, CAPES, CNPq, FAPERJ, FUNEMAC and FAPERGS (Brazil), grants-in-Aid for research on emerging and reemerging infectious diseases from the Japanese Ministry of Health, Labor and Welfare, and Scientific Research from the Japan Society for the Promotion of Science (JSPS) (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin JL, 2005, THERIOGENOLOGY, V64, P1740, DOI 10.1016/j.theriogenology.2005.04.018; Alberts B, 2002, MOL BIOL CELL; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews MJI, 2006, CHEMBIOCHEM, V7, P1909, DOI 10.1002/cbic.200600189; Arisan ED, 2012, AMINO ACIDS, V42, P655, DOI 10.1007/s00726-011-1040-x; Barretto LSS, 2007, ANIM REPROD SCI, V99, P202, DOI 10.1016/j.anireprosci.2006.06.001; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; CAFRUNE MM, 1995, RES VET SCI, V58, P284, DOI 10.1016/0034-5288(95)90119-1; Chiu SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033742; Coley HM, 2007, ANTICANCER RES, V27, P273; Coy P, 2005, REPRODUCTION, V129, P19, DOI 10.1530/rep.1.00299; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Di Talia S, 2012, DEV CELL, V22, P763, DOI 10.1016/j.devcel.2012.01.019; Ellefson ML, 2011, J CELL BIOL, V193, P1229, DOI 10.1083/jcb.201104008; Esposito L, 2013, CURR PHARM DES, V4; Esteves E, 2008, INSECT BIOCHEM MOLEC, V38, P568, DOI 10.1016/j.ibmb.2008.01.006; Farrell JA, 2012, GENE DEV, V26, P714, DOI 10.1101/gad.186429.111; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Gladwin MT, 2012, J CLIN INVEST, V122, P1205, DOI 10.1172/JCI62972; Gould KL, 2000, FR MOLEC B, V29, P277; Hahntow IN, 2004, LEUKEMIA, V18, P747, DOI 10.1038/sj.leu.2403295; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Hoogendijk AJ, 2012, SHOCK, V38, P375, DOI 10.1097/SHK.0b013e3182656e7b; Icreverzi A, 2012, CELL CYCLE, V11, P554, DOI 10.4161/cc.11.3.19062; Jonsson NN, 2000, VET PARASITOL, V88, P79, DOI 10.1016/S0304-4017(99)00189-2; Kaedei Y, 2010, J ANIM VET ADV, V9, P2848, DOI 10.3923/javaa.2010.2848.2853; Kim EH, 2004, ONCOGENE, V23, P446, DOI 10.1038/sj.onc.1207025; KOVAL TM, 1977, GENETICS, V87, P512; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lodish H, 1995, MOL CELL BIOL; Maity AK, 2011, FEBS LETT, V585, P2635, DOI 10.1016/j.febslet.2011.06.017; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2008, TRENDS PHARMACOL SCI, V29, P16, DOI 10.1016/j.tips.2007.10.012; Meijer L, 2000, DRUG RESIST UPDATE, V3, P83, DOI 10.1054/drup.2000.0129; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Pietack N, 2010, J MOL MICROB BIOTECH, V18, P129, DOI 10.1159/000308512; Pohl PC, 2012, PARASITOL RES, V111, P2345, DOI 10.1007/s00436-012-3089-1; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor SL, 2004, J VIROL, V78, P2853, DOI 10.1128/JVI.78.6.2853-2862.2004; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van den Heuvel S., 2005, WORMBOOK, DOI [10.1895/wormbook.1.28.1, DOI 10.1895/W0RMB00K.1.28.1]; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vigneron C, 2003, MOL REPROD DEV, V65, P114, DOI 10.1002/mrd.10265; Weingrill E, 2007, HAEMATOLOGICA, V92, P1286, DOI 10.3324/haematol.10680; Wu PC, 2008, J OCUL PHARMACOL TH, V24, P25, DOI 10.1089/jop.2007.0044	53	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76128	10.1371/journal.pone.0076128	http://dx.doi.org/10.1371/journal.pone.0076128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146826	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400039
J	Huneke, NTM; Brown, CA; Burford, E; Watson, A; Trujillo-Barreto, NJ; El-Deredy, W; Jones, AKP				Huneke, Nathan T. M.; Brown, Christopher A.; Burford, Edward; Watson, Alison; Trujillo-Barreto, Nelson J.; El-Deredy, Wael; Jones, Anthony K. P.			Experimental Placebo Analgesia Changes Resting-State Alpha Oscillations	PLOS ONE			English	Article							WIDESPREAD MUSCULOSKELETAL PAIN; INTERNALLY DIRECTED ATTENTION; ANTERIOR CINGULATE CORTEX; LOW-BACK-PAIN; EEG-ALPHA; PREFRONTAL CORTEX; TONIC PAIN; ANTICIPATION; SYNCHRONIZATION; FIBROMYALGIA	The lack of clear understanding of the pathophysiology of chronic pain could explain why we currently have only a few effective treatments. Understanding how pain relief is realised during placebo analgesia could help develop improved treatments for chronic pain. Here, we tested whether experimental placebo analgesia was associated with altered resting-state cortical activity in the alpha frequency band of the electroencephalogram (EEG). Alpha oscillations have been shown to be influenced by top-down processes, which are thought to underpin the placebo response. Seventy-three healthy volunteers, split into placebo or control groups, took part in a well-established experimental placebo procedure involving treatment with a sham analgesic cream. We recorded ongoing (resting) EEG activity before, during, and after the sham treatment. We show that resting alpha activity is modified by placebo analgesia. Post-treatment, alpha activity increased significantly in the placebo group only (p < 0.001). Source analysis suggested that this alpha activity might have been generated in medial components of the pain network, including dorsal anterior cingulate cortex, medial prefrontal cortex, and left insula. These changes are consistent with a cognitive state of pain expectancy, a key driver of the placebo analgesic response. The manipulation of alpha activity may therefore present an exciting avenue for the development of treatments that directly alter endogenous processes to better control pain.	[Huneke, Nathan T. M.; Burford, Edward] Univ Manchester, Sch Med, Manchester, Lancs, England; [Brown, Christopher A.; Watson, Alison; Jones, Anthony K. P.] Univ Manchester, Inst Brain Behav & Mental Hlth, Human Pain Res Grp, Manchester, Lancs, England; [Trujillo-Barreto, Nelson J.] Cuban Neurosci Ctr, Havana, Cuba; [El-Deredy, Wael] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Brown, CA (corresponding author), Univ Manchester, Inst Brain Behav & Mental Hlth, Human Pain Res Grp, Manchester, Lancs, England.	christopher.brown@manchester.ac.uk	Huneke, Nathan/ABD-9006-2020; El-deredy, Wael/H-6521-2015; Trujillo-Barreto, Nelson J/G-3764-2013	Huneke, Nathan/0000-0001-5981-6707; El-deredy, Wael/0000-0002-9822-1092; Trujillo-Barreto, Nelson J/0000-0001-6581-7503; Jones, Anthony/0000-0001-6944-9365	Dr Hadwen Trust for Humane Research; Arthritis Research UK	Dr Hadwen Trust for Humane Research; Arthritis Research UK(Versus Arthritis)	Funding came from the Dr Hadwen Trust for Humane Research (http://www.drhadwentrust.org/) and Arthritis Research UK (http://www.arthritisresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiloni C, 2003, EUR J NEUROSCI, V18, P1692, DOI 10.1046/j.1460-9568.2003.02851.x; Babiloni C, 2006, J PAIN, V7, P709, DOI 10.1016/j.jpain.2006.03.005; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P5, DOI 10.1016/S0167-8760(97)00753-8; Bedson J, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-116; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown CA, 2008, PAIN, V139, P324, DOI 10.1016/j.pain.2008.04.028; Carlino E, 2011, CURR OPIN ANESTHESIO, V24, P540, DOI 10.1097/ACO.0b013e328349d0c2; CHEN ACN, 1983, INT J NEUROSCI, V18, P269, DOI 10.3109/00207458308987371; Chen Andrew C. N., 1994, Brain Topography, V7, P129, DOI 10.1007/BF01186771; Clauw DJ, 2010, NAT REV RHEUMATOL, V6, P439, DOI 10.1038/nrrheum.2010.120; *COLL ROY GEN PRAC, 1995, MORB STAT GEN PRACT, P1991; Cooper NR, 2006, NEUROREPORT, V17, P205, DOI 10.1097/01.wnr.0000198433.29389.54; Cooper NR, 2003, INT J PSYCHOPHYSIOL, V47, P65, DOI 10.1016/S0167-8760(02)00107-1; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fell J, 2002, INT J NEUROSCI, V112, P1047, DOI 10.1080/00207450290026049; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Franciotti R, 2009, NEUROIMAGE, V46, P1082, DOI 10.1016/j.neuroimage.2009.03.034; FRYMOYER JW, 1984, J BONE JOINT SURG AM, V66A, P1048, DOI 10.2106/00004623-198466070-00011; Goldenberg DL, 2007, BEST PRACT RES CL RH, V21, P499, DOI 10.1016/j.berh.2007.02.012; Grant JA, 2010, EMOTION, V10, P43, DOI 10.1037/a0018334; HARDT JV, 1978, SCIENCE, V201, P79, DOI 10.1126/science.663641; Hsieh JC, 1999, NEUROSCI LETT, V262, P61, DOI 10.1016/S0304-3940(99)00060-9; Jensen KB, 2012, PAIN, V153, P1495, DOI 10.1016/j.pain.2012.04.010; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jones AKP, 2003, BRIT MED BULL, V65, P83, DOI 10.1093/bmb/65.1.83; JONES AKP, 1991, P ROY SOC B-BIOL SCI, V244, P39, DOI 10.1098/rspb.1991.0048; Kamaleri Y, 2008, PAIN, V138, P41, DOI 10.1016/j.pain.2007.11.002; Klimesch W, 1999, COGNITIVE BRAIN RES, V7, P493, DOI 10.1016/S0926-6410(98)00056-1; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Knudsen L, 2011, SCAND J PAIN, V2, P108, DOI 10.1016/j.sjpain.2011.05.005; Knyazev GG, 2011, BRAIN RES, V1402, P67, DOI 10.1016/j.brainres.2011.05.052; Kong J, 2008, J NEUROSCI, V28, P13354, DOI 10.1523/JNEUROSCI.2944-08.2008; Lieberman MD, 2004, NEUROIMAGE, V22, P447, DOI 10.1016/j.neuroimage.2004.01.037; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Mease PJ, 2011, J RHEUMATOL, V38, P1546, DOI 10.3899/jrheum.100759; Meissner K, 2011, J NEUROSCI, V31, P16117, DOI 10.1523/JNEUROSCI.4099-11.2011; Morton DL, 2010, NEUROPSYCHOLOGIA, V48, P1958, DOI 10.1016/j.neuropsychologia.2010.03.016; Natvig B, 2001, J REHABIL MED, V33, P21; Nemoto H, 2007, EXP BRAIN RES, V179, P655, DOI 10.1007/s00221-006-0821-z; Nir RR, 2012, CLIN NEUROPHYSIOL, V123, P605, DOI 10.1016/j.clinph.2011.08.006; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Phillips C, 2008, HEALTH POLICY, V88, P166, DOI 10.1016/j.healthpol.2008.03.008; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Sauseng P, 2005, HUM BRAIN MAPP, V26, P148, DOI 10.1002/hbm.20150; Sawamoto N, 2000, J NEUROSCI, V20, P7438; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schreckenberger M, 2005, NEUROLOGY, V64, P1175, DOI 10.1212/01.WNL.0000156353.17305.52; Seifert F, 2009, J NEUROSCI, V29, P6167, DOI 10.1523/JNEUROSCI.4654-08.2009; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Treede RD, 1999, PAIN, V79, P105, DOI 10.1016/S0304-3959(98)00184-5; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Watson A, 2007, NEUROREPORT, V18, P771, DOI 10.1097/WNR.0b013e3280c1e2a8; Watson A, 2009, PAIN, V145, P24, DOI 10.1016/j.pain.2009.04.003	64	22	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78278	10.1371/journal.pone.0078278	http://dx.doi.org/10.1371/journal.pone.0078278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147129	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400151
J	Karsa, M; Dalla Pozza, L; Venn, NC; Law, T; Shi, R; Giles, JE; Bahar, AY; Cross, S; Catchpoole, D; Haber, M; Marshall, GM; Norris, MD; Sutton, R				Karsa, Mawar; Dalla Pozza, Luciano; Venn, Nicola C.; Law, Tamara; Shi, Rachael; Giles, Jodie E.; Bahar, Anita Y.; Cross, Shamira; Catchpoole, Daniel; Haber, Michelle; Marshall, Glenn M.; Norris, Murray D.; Sutton, Rosemary			Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease	PLOS ONE			English	Article							AIEOP-BFM; T-CELL; GENE REARRANGEMENTS; MOLECULAR RESPONSE; FLOW-CYTOMETRY; THERAPY; IMMUNOGLOBULIN; CHILDREN	The stratification of patients with acute lymphoblastic leukemia (ALL) into treatment risk groups based on quantification of minimal residual disease (MRD) after induction therapy is now well accepted but the relapse rate of about 20% in intermediate risk patients remains a challenge. The purpose of this study was to further improve stratification by MRD measurement at an earlier stage. MRD was measured in stored day 15 bone marrow samples for pediatric patients enrolled on ANZCHOG ALL8 using Real-time Quantitative PCR to detect immunoglobulin and T-cell receptor gene rearrangements with the same assays used at day 33 and day 79 in the original MRD stratification. MRD levels in bone marrow at day 15 and 33 were highly predictive of outcome in 223 precursor B-ALL patients (log rank Mantel-Cox tests both P<0.001) and identified patients with poor, intermediate and very good outcomes. The combined use of MRD at day 15 (>= 1x10(-2)) and day 33 (>= 5x1(-5)) identified a subgroup of medium risk precursor B-ALL patients as poor MRD responders with 5 year relapse-free survival of 55% compared to 84% for other medium risk patients (log rank Mantel-Cox test, P = 0.0005). Risk stratification of precursor B-ALL but not T-ALL could be improved by using MRD measurement at day 15 and day 33 instead of day 33 and day 79 in similar BFM-based protocols for children with this disease.	[Karsa, Mawar; Venn, Nicola C.; Law, Tamara; Shi, Rachael; Giles, Jodie E.; Bahar, Anita Y.; Haber, Michelle; Marshall, Glenn M.; Norris, Murray D.; Sutton, Rosemary] Univ NSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia; [Dalla Pozza, Luciano; Cross, Shamira; Catchpoole, Daniel] Childrens Hosp Westmead, Oncol Unit, Westmead, NSW, Australia; [Marshall, Glenn M.] Sydneys Childrens Hosp, Ctr Childrens Canc & Blood Disorders, Randwick, NSW, Australia	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; University of Sydney	Sutton, R (corresponding author), Univ NSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia.	rsutton@ccia.unsw.edu.au	Sutton, Rosemary/J-3784-2014	Sutton, Rosemary/0000-0002-0188-6005; Norris, Murray/0000-0002-0632-4589; Haber, Michelle/0000-0003-2036-8817; Karsa, Mawar/0000-0001-9682-1118	National Health and Medical Research Council [209599, 350886]; Cancer Council NSW; Leukaemia Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Leukaemia Foundation	This study was funded by project grants 209599 and 350886 from the National Health and Medical Research Council www.nhmrc.gov.au; a 2006 program grant from The Cancer Council NSW www.cancercouncil.com.au and a 2004 grant-in-aid from the Leukaemia Foundation www.leukaemia.org.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso G, 2009, J CLIN ONCOL, V27, P5168, DOI 10.1200/JCO.2008.20.8934; Bruggemann M, 2010, LEUKEMIA, V24, P521, DOI 10.1038/leu.2009.268; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; Coustan-Smith E, 2002, BLOOD, V100, P52, DOI 10.1182/blood-2002-01-0006; Flohr T, 2008, LEUKEMIA, V22, P771, DOI 10.1038/leu.2008.5; Gaynon PS, 1997, CANCER-AM CANCER SOC, V80, P1717, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1717::AID-CNCR4>3.0.CO;2-B; Lauten M, 2012, HAEMATOL-HEMATOL J, V97, P1048, DOI 10.3324/haematol.2011.047613; Marshall GM, 2003, J CLIN ONCOL, V21, P704, DOI 10.1200/JCO.2003.10.080; Marshall GM, 2013, LEUKEMIA, DOI [10.1038/leu.2013.1044, DOI 10.1038/LEU.2013.1044]; Panzer-Grumayer ER, 2000, BLOOD, V95, P790, DOI 10.1182/blood.V95.3.790.003k48_790_794; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Ratei R, 2009, LEUKEMIA, V23, P528, DOI 10.1038/leu.2008.324; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Sutton R, 2008, LEUKEMIA, V22, P2265, DOI 10.1038/leu.2008.121; Sutton R, 2009, BRIT J HAEMATOL, V146, P292, DOI 10.1111/j.1365-2141.2009.07744.x; van der Velden VHJ, 2007, LEUKEMIA, V21, P604, DOI 10.1038/sj.leu.2404586; Volejnikova J, 2013, PEDIATR BLOOD CANCER, V60, P420, DOI 10.1002/pbc.24299; ZWEIG MH, 1993, CLIN CHEM, V39, P561	18	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76455	10.1371/journal.pone.0076455	http://dx.doi.org/10.1371/journal.pone.0076455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146872	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400060
J	Mbonye, M; Seeley, J; Ssembajja, F; Birungi, J; Jaffar, S				Mbonye, Martin; Seeley, Janet; Ssembajja, Fatuma; Birungi, Josephine; Jaffar, Shabbar			Adherence to Antiretroviral Therapy in Jinja, Uganda: A Six-Year Follow-Up Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV-CARE; IDENTITY; STIGMA; ART; POPULATION; PREVENTION; STRATEGIES; COSTS	Introduction: We report on the adherence experience of a group of people living with HIV on ART over six years in Uganda. Methods: Between 2005 and 2009, we followed up 41 participants who were also part of a clinical trial comparing home and facility based delivery of ART in Jinja, eastern Uganda. We conducted qualitative in-depth interviews at enrolment, 3, 6, 18 and 30 months to capture experiences with adherence over time. In 2011 we returned to these participants to find out how they were fairing with long term adherence. We managed to retrace 24 participants and interviewed them about their experience. We thematically analysed the data and compared findings over time. Results: Initially there were few barriers to adherence and many followed the adherence guidance closely. By year six, relaxation of these rules was noticeable although self-reported adherence continued to be high. Alcohol consumption was more common than before. Some relatives of the participants who had died claimed that some deaths were a result of alcohol. While participants reported that ART had allowed them to reclaim independence and return to work the changes in work and social routines created new challenges for adherence. Side effects like lipodystrophy were not only causing some stigma but for some tested their faith in the drugs. Many participants reported resumption of sexual lives but apart from those who selected same status partners, disclosure to new partners was minimal. Conclusion: Good adherence practice to ART wanes over the long-term, and people who may have disclosed at initiation find it difficult to do so to new partners once they are healthy. Further adherence interventions and support with disclosure over the course of therapy may need to be considered. (Words: 283)	[Mbonye, Martin; Seeley, Janet; Ssembajja, Fatuma] MRC UVRI Uganda Res Unit AIDS, Social Sci Programme, Entebbe, Uganda; [Seeley, Janet] Univ E Anglia, Sch Int Dev, Norwich NR4 7TJ, Norfolk, England; [Seeley, Janet; Jaffar, Shabbar] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Birungi, Josephine] AIDS Support Org, Kampala, Uganda	University of East Anglia; University of London; London School of Hygiene & Tropical Medicine	Seeley, J (corresponding author), MRC UVRI Uganda Res Unit AIDS, Social Sci Programme, Entebbe, Uganda.	Janet.seeley@mrcuganda.org		Jaffar, Shabbar/0000-0002-9615-1588; Seeley, Janet/0000-0002-0583-5272	US Centers for Disease Control and Prevention; UK Medical Research Council; Boehringer Ingelheim; Medical Research Council [MC_U950080935, G0700837] Funding Source: researchfish; MRC [MC_U950080935, G0700837] Funding Source: UKRI	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim(Boehringer Ingelheim); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to US Centers for Disease Control and Prevention and the UK Medical Research Council for funding the 2005-2008 research and Boehringer Ingelheim and the UK Medical Research Council for funding the 2011 study. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2011, CULT HEALTH SEX, V13, P529, DOI 10.1080/13691058.2011.558593; Barroso J, 2000, QUAL HEALTH RES, V10, P340, DOI 10.1177/104973200129118480; Baumgartner LM, 2007, QUAL HEALTH RES, V17, P919, DOI 10.1177/1049732307305881; Baumgartner LM, 2009, QUAL HEALTH RES, V19, P1730, DOI 10.1177/1049732309352907; Besada D, 2012, S AFR J HIV MED, P178, DOI 10.7196/SAJHIVMED.864; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; Cauldbeck MB, 2009, AIDS RES THER, V6, P7, DOI DOI 10.1186/1742-6405-6-7; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Chesney MA, 2000, CLIN INFECT DIS, V30, pS171, DOI 10.1086/313849; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dlamini PS, 2009, AIDS PATIENT CARE ST, V23, P377, DOI 10.1089/apc.2008.0164; Foster SD, 2010, AIDS CARE, V22, P35, DOI 10.1080/09540120903500027; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Jaffar S, 2008, TROP MED INT HEALTH, V13, P1096, DOI 10.1111/j.1365-3156.2008.02131.x; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Johnson MO, 2007, AIDS BEHAV, V11, P575, DOI 10.1007/s10461-007-9229-4; King R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-530; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Malta M, 2008, ADDICTION, V103, P1242, DOI 10.1111/j.1360-0443.2008.02269.x; McNicholl IR, 2008, J MANAGE CARE PHARM, V14, pS12; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mpiima D, 2011, 6 IAS C HIV PATH TRE; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Russell S, 2007, HEALTH POLICY PLANN, V22, P344, DOI 10.1093/heapol/czm023; SANDSTROM KL, 1990, J CONTEMP ETHNOGR, V19, P271, DOI 10.1177/089124190019003002; Seeley J, 2009, CULT HEALTH SEX, V11, P703, DOI 10.1080/13691050903003897; Ssebbanja Peter Kitonsa, 2007, UNITED AIDS STORY TA; Verguet S, 2013, J INFECT DIS, V207, P72, DOI 10.1093/infdis/jis635; Ware NC, 2006, AIDS CARE, V18, P904, DOI 10.1080/09540120500330554; Wolff B, 2009, SAHARA J-J SOC ASP H, V6, P188, DOI 10.1080/17290376.2009.9724947	33	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78243	10.1371/journal.pone.0078243	http://dx.doi.org/10.1371/journal.pone.0078243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147126	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400150
J	Pakpour, N; Camp, L; Smithers, HM; Wang, B; Tu, ZJ; Nadler, SA; Luckhart, S				Pakpour, Nazzy; Camp, Lauren; Smithers, Hannah M.; Wang, Bo; Tu, Zhijian; Nadler, Steven A.; Luckhart, Shirley			Protein Kinase C-Dependent Signaling Controls the Midgut Epithelial Barrier to Malaria Parasite Infection in Anopheline Mosquitoes	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; PLASMODIUM-FALCIPARUM; PKC ISOFORMS; REAL-TIME; PHOSPHORYLATION; SOTRASTAURIN; ACTIVATION; OOKINETE; OCCLUDIN	Anopheline mosquitoes are the primary vectors of parasites in the genus Plasmodium, the causative agents of malaria. Malaria parasites undergo a series of complex transformations upon ingestion by the mosquito host. During this process, the physical barrier of the midgut epithelium, along with innate immune defenses, functionally restrict parasite development. Although these defenses have been studied for some time, the regulatory factors that control them are poorly understood. The protein kinase C (PKC) gene family consists of serine/threonine kinases that serve as central signaling molecules and regulators of a broad spectrum of cellular processes including epithelial barrier function and immunity. Indeed, PKCs are highly conserved, ranging from 7 isoforms in Drosophila to 16 isoforms in mammals, yet none have been identified in mosquitoes. Despite conservation of the PKC gene family and their potential as targets for transmission-blocking strategies for malaria, no direct connections between PKCs, the mosquito immune response or epithelial barrier integrity are known. Here, we identify and characterize six PKC gene family members -PKC delta, PKC epsilon, PKC zeta, PKD, PKN, and an indeterminate conventional PKC - in Anopheles gambiae and Anopheles stephensi. Sequence and phylogenetic analyses of the anopheline PKCs support most subfamily assignments. All six PKCs are expressed in the midgut epithelia of A. gambiae and A. stephensi post-blood feeding, indicating availability for signaling in a tissue that is critical for malaria parasite development. Although inhibition of PKC enzymatic activity decreased NF-kappa B-regulated anti-microbial peptide expression in mosquito cells in vitro, PKC inhibition had no effect on expression of a panel of immune genes in the midgut epithelium in vivo. PKC inhibition did, however, significantly increase midgut barrier integrity and decrease development of P. falciparum oocysts in A. stephensi, suggesting that PKC-dependent signaling is a negative regulator of epithelial barrier function and a potential new target for transmission-blocking strategies.	[Pakpour, Nazzy; Smithers, Hannah M.; Wang, Bo; Luckhart, Shirley] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Camp, Lauren; Nadler, Steven A.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Tu, Zhijian] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	University of California System; University of California Davis; University of California System; University of California Davis; Virginia Polytechnic Institute & State University	Pakpour, N (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	npakpour@ucdavis.edu			NIH NIAID [R01 AI080799, R01 AI073745]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080799, R01AI073745] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for these studies was provided by NIH NIAID R01 AI080799 and R01 AI073745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Avila A, 2002, MOL CELL BIOL, V22, P8787, DOI 10.1128/MCB.22.24.8787-8795.2002; Bahia D, 2006, BIOCHEM BIOPH RES CO, V345, P1138, DOI 10.1016/j.bbrc.2006.05.025; Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Beyenbach KW, 2012, ANN NY ACAD SCI, V1258, P166, DOI 10.1111/j.1749-6632.2012.06527.x; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Bradham CA, 2006, DEV BIOL, V300, P180, DOI 10.1016/j.ydbio.2006.08.074; CANNING EU, 1973, PARASITOLOGY, V67, P29, DOI 10.1017/S0031182000046266; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Clerk A, 2001, CIRC RES, V89, P847, DOI 10.1161/res.89.10.847; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Dawes EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-228; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; DISATNIK MH, 1994, EXP CELL RES, V210, P287, DOI 10.1006/excr.1994.1041; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fallon A. M., 1987, Advances in Cell Culture, V5, P97; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Friman S, 2011, AM J TRANSPLANT, V11, P1444, DOI 10.1111/j.1600-6143.2011.03538.x; Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hauck ES, 2013, MICROBES INFECT; Huang X, 2009, J IMMUNOL, V182, P5810, DOI 10.4049/jimmunol.0804073; Jain S, 2011, BIOCHEM J, V437, P289, DOI 10.1042/BJ20110587; Kofler K, 2002, GENOME BIOL, V3; Kovarik JM, 2011, TRANSPL INT, V24, P276, DOI 10.1111/j.1432-2277.2010.01196.x; Koyanagi M, 1998, FEBS LETT, V439, P66, DOI 10.1016/S0014-5793(98)01339-8; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Luckhart S, 1999, GENE, V232, P25, DOI 10.1016/S0378-1119(99)00121-3; Maier D, 2006, GENE EXPR PATTERNS, V6, P849, DOI 10.1016/j.modgep.2006.03.007; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Marinotti O, 2005, INSECT MOL BIOL, V14, P365, DOI 10.1111/j.1365-2583.2005.00567.x; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Miller MA, 2010, CREATING CIPRES SCI; Millholland MG, 2013, CELL HOST MICROBE, V13, P15, DOI 10.1016/j.chom.2012.12.001; Moscat J, 2006, CELL DEATH DIFFER, V13, P702, DOI 10.1038/sj.cdd.4401823; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; Nelson TJ, 2008, EUR J PHARMACOL, V585, P76, DOI 10.1016/j.ejphar.2008.01.051; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pakpour N, 2012, INFECT IMMUN, V80, P2141, DOI 10.1128/IAI.00024-12; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott KGE, 2002, GASTROENTEROLOGY, V123, P1179, DOI 10.1053/gast.2002.36002; Shieh BH, 2002, J BIOCHEM, V132, P523, DOI 10.1093/oxfordjournals.jbchem.a003252; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Valledor AF, 2000, J IMMUNOL, V164, P29, DOI 10.4049/jimmunol.164.1.29; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Wullaert A, 2011, CELL RES, V21, P146, DOI 10.1038/cr.2010.175; Yamashita K, 2012, TRANSPLANTATION, V93, P146, DOI 10.1097/TP.0b013e31823d4b1f; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zolotarevsky Y, 2002, GASTROENTEROLOGY, V123, P163, DOI 10.1053/gast.2002.34235	88	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76535	10.1371/journal.pone.0076535	http://dx.doi.org/10.1371/journal.pone.0076535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146884	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400063
J	Tibiletti, M; Galbusera, F; Ciavarro, C; Brayda-Bruno, M				Tibiletti, Marta; Galbusera, Fabio; Ciavarro, Cristina; Brayda-Bruno, Marco			Is the Transport of a Gadolinium-Based Contrast Agent Decreased in a Degenerated or Aged Disc? A Post Contrast MRI Study	PLOS ONE			English	Article							ISSLS PRIZE WINNER; HUMAN LUMBAR DISCS; INTERVERTEBRAL DISC; END-PLATE; IN-VIVO; SOLUTE TRANSPORT; CELL VIABILITY; DIFFUSION; ENHANCEMENT; CLASSIFICATION	A post contrast magnetic resonance imaging study has been performed in a wide population of low back pain patients to investigate which radiological and phenotypic characteristics influence the penetration of the contrast agent in lumbar discs in vivo. 37 patients affected by different pathologies (disc herniation, spondylolisthesis, foraminal stenosis, central canal stenosis) were enrolled in the study. The selected population included 26 male and 11 female subjects, with a mean age of 42.4 +/- 9.3 years (range 18-60). Magnetic resonance images of the lumbar spine were obtained with a 1.5 T scanner (Avanto, Siemens, Erlangen, Germany) with a phased-array back coil. A paramagnetic non-ionic contrast agent was injected with a dose of 0.4 ml/kg. T1-weighted magnetic resonance images were subsequently acquired at 5 time points, 5 and 10 minutes, 2, 4 and 6 hours after injection. Endplates presented clear enhancement already 5 minutes after injection, and showed an increase in the next 2 hours followed by a decrease. At 5 and 10 minutes, virtually no contrast medium was present inside the intervertebral disc; afterwards, enhancement significantly increased. Highly degenerated discs showed higher enhancement in comparison with low and medium degenerated discs. Discs classified as Pfirrmann 5 showed a statistically significant higher enhancement than Pfirrmann 1, 2 and 3 at all time points but the first one, possibly due to vascularization. Disc height collapse and Modic changes significantly increased enhancement. Presence of endplate defects did not show any significant influence on post contrast enhancement, but the lack of a clear classification of endplate defects as seen on magnetic resonance scans may be shadowing some effects. In conclusion, disc height, high level of degeneration and presence of Modic changes are factors which increase post contrast enhancement in the intervertebral disc. The effect of age could not be demonstrated.	[Tibiletti, Marta; Galbusera, Fabio; Ciavarro, Cristina] IRCCS Galeazzi Orthopaed Inst, Lab Biol Struct Mech, Milan, Italy; [Tibiletti, Marta] Univ Ulm, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Brayda-Bruno, Marco] IRCCS Galeazzi Orthopaed Inst, Dept Spine Surg 3, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; Ulm University; IRCCS Istituto Ortopedico Galeazzi	Galbusera, F (corresponding author), IRCCS Galeazzi Orthopaed Inst, Lab Biol Struct Mech, Milan, Italy.	fabio.galbusera@grupposandonato.it	Galbusera, Fabio/J-8618-2016; Brayda-Bruno, Marco/B-8639-2017	Galbusera, Fabio/0000-0003-1826-9190; Brayda-Bruno, Marco/0000-0002-8608-0114	EU FP7 project GENODISC [HEALTH-F2-2008-201626]	EU FP7 project GENODISC	This work is funded by the EU FP7 project GENODISC (HEALTH-F2-2008-201626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arun R, 2009, SPINE, V34, P2324, DOI 10.1097/BRS.0b013e3181b4df92; Bartels EM, 1998, SPINE, V23, P1, DOI 10.1097/00007632-199801010-00001; Battie MC, 1995, SPINE, V20, P2601, DOI 10.1097/00007632-199512150-00001; Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09; BERNICK S, 1982, SPINE, V7, P97, DOI 10.1097/00007632-198203000-00002; BOOS N, 1994, MAGN RESON IMAGING, V12, P577, DOI 10.1016/0730-725X(94)92452-X; Galbusera F, 2013, COMPUT METHOD BIOMEC, V16, P328, DOI 10.1080/10255842.2011.619184; Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290; HOLM S, 1981, CONNECT TISSUE RES, V8, P101, DOI 10.3109/03008208109152130; Holme S, 2008, TRANSFUSION, V48, P910, DOI 10.1111/j.1537-2995.2007.01619.x; IBRAHIM MA, 1995, AM J NEURORADIOL, V16, P1307; IBRAHIM MA, 1994, AM J NEURORADIOL, V15, P419; IBRAHIM MA, 1994, AM J NEURORADIOL, V15, P1907; Idee JM, 2006, FUND CLIN PHARMACOL, V20, P563, DOI 10.1111/j.1472-8206.2006.00447.x; Junghanns, 1971, HUMAN SPINE HLTH DIS; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Niemelainen R, 2008, CLIN RADIOL, V63, P252, DOI 10.1016/j.crad.2007.08.012; Nunimaki J, 2009, MAGMA, V22, P101; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Rajasekaran S, 2008, EUR SPINE J, V17, P626, DOI 10.1007/s00586-008-0645-6; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Rajasekaran S, 2010, SPINE, V35, P1930, DOI 10.1097/BRS.0b013e3181e9a156; Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3; ROBERTS S, 1993, J ORTHOP RES, V11, P747, DOI 10.1002/jor.1100110517; Rodriguez AG, 2011, SPINE, V36, P512, DOI 10.1097/BRS.0b013e3181f72b94; Shirazi-Adl A, 2010, J BIOMECH, V43, P1330, DOI 10.1016/j.jbiomech.2010.01.023; URBAN JPG, 1982, CLIN ORTHOP RELAT R, P296; Urban MR, 2001, SPINE, V26, P984, DOI 10.1097/00007632-200104150-00028; van der Veen AJ, 2007, J BIOMECH, V40, P2230, DOI 10.1016/j.jbiomech.2006.10.018; Videman T, 2008, SPINE, V33, P2781, DOI 10.1097/BRS.0b013e31817e1d11; Wang Y, 2012, SPINE, V37, P1432, DOI 10.1097/BRS.0b013e31824dd20a; White A.A., 1990, CLIN BIOMECH	32	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76697	10.1371/journal.pone.0076697	http://dx.doi.org/10.1371/journal.pone.0076697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146913	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400075
J	Gao, MH; Lai, NC; Tang, T; Guo, T; Tang, RY; Chun, BJ; Wang, H; Dalton, NN; Suarez, J; Dillmann, WH; Hammond, HK				Gao, Mei Hua; Ngai Chin Lai; Tang, Tong; Guo, Tracy; Tang, Ruoying; Chun, Byeong Jo; Wang, Hong; Dalton, Nancy N.; Suarez, Jorge; Dillmann, Wolfgang H.; Hammond, H. Kirk			Preserved Cardiac Function despite Marked Impairment of cAMP Generation	PLOS ONE			English	Article							ADENYLYL-CYCLASE EXPRESSION; LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; TRANSGENIC MICE; PHOSPHOLAMBAN PHOSPHORYLATION; PROTEIN; CARDIOMYOPATHY; OVEREXPRESSION; MYOCYTES; GENE	Objectives: So many clinical trials of positive inotropes have failed, that it is now axiomatic that agents that increase cAMP are deleterious to the failing heart. An alternative strategy is to alter myocardial Ca2+ handling or myofilament response to Ca2+ using agents that do not affect cAMP. Although left ventricular (LV) function is tightly linked to adenylyl cyclase (AC) activity, the beneficial effects of AC may be independent of cAMP and instead stem from effects on Ca2+ handling. Here we ask whether an AC mutant molecule that reduces LV cAMP production would have favorable effects on LV function through its effects on Ca2+ handling alone. Methods and Results: We generated transgenic mice with cardiac-directed expression of an AC6 mutant (AC6mut). Cardiac myocytes showed impaired cAMP production in response to isoproterenol (74% reduction; p<0.001), but LV size and function were normal. Isolated hearts showed preserved LV function in response to isoproterenol stimulation. AC6mut expression was associated with increased sarcoplasmic reticulum Ca2+ uptake and the EC50 for SERCA2a activation was reduced. Cardiac myocytes isolated from AC6mut mice showed increased amplitude of Ca2+ transients in response to isoproterenol (p = 0.0001). AC6mut expression also was associated with increased expression of LV S100A1 (p = 0.03) and reduced expression of phospholamban protein (p = 0.01). Conclusion: LV AC mutant expression is associated with normal cardiac function despite impaired cAMP generation. The mechanism appears to be through effects on Ca2+ handling - effects that occur despite diminished cAMP.	[Hammond, H. Kirk] Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA; Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Hammond, HK (corresponding author), Univ Calif San Diego, VA San Diego Healthcare Syst, San Diego, CA 92103 USA.	khammond@ucsd.edu		jeon, byeongjo/0000-0002-5240-4213	National Institute of Health [P01 HL66941, HL088426, HL081741]; Merit Review Awards from the Department of Veteran's Affairs [1 I01BX001515-01A1]; American Heart Association Western States Affiliate [0865064Y, 11GRNT7610059]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081741, R01HL088426, P01HL066941] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Review Awards from the Department of Veteran's Affairs; American Heart Association Western States Affiliate(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health grants (P01 HL66941, HL088426, and HL081741), Merit Review Awards from the Department of Veteran's Affairs (1 I01BX001515-01A1), and Grants-in-Aid from the American Heart Association Western States Affiliate (0865064Y and 11GRNT7610059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; Brittsan AG, 2000, J MOL CELL CARDIOL, V32, P2131, DOI 10.1006/jmcc.2000.1270; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Cleland JGF, 2011, LANCET, V378, P676, DOI 10.1016/S0140-6736(11)61126-4; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; FOULKES NS, 1991, CELL, V64, P739, DOI 10.1016/0092-8674(91)90503-Q; Gao MH, 2011, MOL PHARMACOL, V79, P381, DOI 10.1124/mol.110.067298; Gao MH, 2008, J BIOL CHEM, V283, P33527, DOI 10.1074/jbc.M805825200; Gao MH, 2004, J BIOL CHEM, V279, P38797, DOI 10.1074/jbc.M405701200; Gao MH, 1999, CIRCULATION, V99, P1618, DOI 10.1161/01.CIR.99.12.1618; GAUDIN C, 1995, J CLIN INVEST, V95, P1676, DOI 10.1172/JCI117843; Iancu RV, 2008, CLIN EXP PHARMACOL P, V35, P1343, DOI 10.1111/j.1440-1681.2008.05020.x; Lai NC, 2008, J AM COLL CARDIOL, V51, P1490, DOI 10.1016/j.jacc.2008.01.015; Lai NC, 2004, CIRCULATION, V110, P330, DOI 10.1161/01.CIR.0000136033.21777.4D; Liggett SB, 2000, CIRCULATION, V101, P1707; Luo WS, 1998, J BIOL CHEM, V273, P4734, DOI 10.1074/jbc.273.8.4734; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Ping PP, 1997, AM J PHYSIOL-HEART C, V273, pH707, DOI 10.1152/ajpheart.1997.273.2.H707; Roth DM, 2002, CIRCULATION, V105, P1989, DOI 10.1161/01.CIR.0000014968.54967.D3; Roth DM, 1999, CIRCULATION, V99, P3099, DOI 10.1161/01.CIR.99.24.3099; Song W, 1996, BRAIN RES, V721, P204, DOI 10.1016/0006-8993(96)00172-2; Suarez J, 2008, AM J PHYSIOL-REG I, V295, pR1439, DOI 10.1152/ajpregu.00736.2007; Takahashi T, 2006, CIRCULATION, V114, P388, DOI 10.1161/CIRCULATIONAHA.106.632513; Tang T, 2004, AM J PHYSIOL-HEART C, V287, pH1906, DOI 10.1152/ajpheart.00356.2004; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069	30	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2013	8	9							e72151	10.1371/journal.pone.0072151	http://dx.doi.org/10.1371/journal.pone.0072151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219GJ	24147149	Green Published, Green Submitted, gold			2022-12-27	WOS:000324494000005
J	Young, C; Wong, KY; Cheung, LK				Young, Cecilia; Wong, Kin Yau; Cheung, Lim K.			Effectiveness of Educational Poster on Knowledge of Emergency Management of Dental Trauma-Part 1. Cluster Randomised Controlled Trial for Primary and Secondary School Teachers	PLOS ONE			English	Article							TOOTH AVULSION; ORAL-HEALTH; 1ST AID; INJURIES; SCHOOLCHILDREN; TEETH; PROFESSIONALS; INTERVENTION; LEAFLET; ISRAEL	Objective: To investigate the effectiveness of educational posters in improving the knowledge level of primary and secondary school teachers regarding emergency management of dental trauma. Methods: A cluster randomised controlled trial was conducted. 32 schools with a total of 515 teachers were randomised into intervention (poster) and control groups at the school level. Teachers' baseline levels of knowledge about dental trauma were obtained by using a questionnaire. Posters containing information on dental trauma management were displayed in the school medical room, the common room used by staff, and on a notice board for 2 weeks in each school of the intervention group; in the control group, no posters were displayed. Teachers in both groups completed the questionnaire after 2 weeks. Results: The teachers in the intervention schools (where posters were displayed for 2 weeks) showed statistically significant improvement in scores in cases where they had not previously learned about dental emergencies from sources other than first aid training, with an average score increase of 2.6656 (score range of questionnaire, -13 to 9; p-value < 0.0001). Conclusion: Educational posters on the management of dental trauma can significantly improve the level of knowledge of primary and secondary school teachers in Hong Kong.	[Wong, Kin Yau] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Cheung, Lim K.] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of Hong Kong		ceciliatyp@yahoo.com.hk	; Young, Cecilia/K-1699-2018	Cheung, Lim Kwong/0000-0002-2248-286X; , Kin Yau/0000-0001-9066-1619; Young, Cecilia/0000-0003-1698-7738				Al-Asfour A, 2008, DENT TRAUMATOL, V24, P515, DOI 10.1111/j.1600-9657.2008.00651.x; Al-Asfour A, 2008, DENT TRAUMATOL, V24, P43, DOI 10.1111/j.1600-9657.2006.00476.x; Al-Obaida M, 2010, DENT TRAUMATOL, V26, P338, DOI 10.1111/j.1600-9657.2010.00894.x; Andreasen JO, 2002, DENT TRAUMATOL, V18, P116, DOI 10.1034/j.1600-9657.2002.00079.x; Arikan V, 2012, DENT TRAUMATOL, V28, P101, DOI 10.1111/j.1600-9657.2011.01042.x; Bendo CB, 2010, J PUBLIC HEALTH DENT, V70, P313, DOI 10.1111/j.1752-7325.2010.00190.x; DONNER A, 1986, INT STAT REV, V54, P67, DOI 10.2307/1403259; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Fakhruddin KS, 2008, DENT TRAUMATOL, V24, P305, DOI 10.1111/j.1600-9657.2007.00548.x; Froud R, 2012, COMMUNITY DENT ORAL, V40, P3, DOI 10.1111/j.1600-0528.2011.00660.x; Fux-Noy A, 2011, DENT TRAUMATOL, V27, P252, DOI 10.1111/j.1600-9657.2010.00970.x; Holan G, 2006, DENT TRAUMATOL, V22, P323, DOI 10.1111/j.1600-9657.2005.00387.x; Kahabuka F K, 2001, SADJ, V56, P284; Levin L, 2007, DENT TRAUMATOL, V23, P356, DOI 10.1111/j.1600-9657.2006.00473.x; Levin L, 2010, DENT TRAUMATOL, V26, P86, DOI 10.1111/j.1600-9657.2009.00847.x; Lieger O, 2009, DENT TRAUMATOL, V25, P406, DOI 10.1111/j.1600-9657.2009.00798.x; McIntyre JD, 2008, DENT TRAUMATOL, V24, P146, DOI 10.1111/j.1600-9657.2008.00573.x; Mesgarzadeh AH, 2009, ORAL HLTH PREV DENT, V7, P297; Mohandas U, 2009, J Indian Soc Pedod Prev Dent, V27, P242, DOI 10.4103/0970-4388.57660; Mori GG, 2007, J APPL ORAL SCI, V15, P534, DOI 10.1590/S1678-77572007000600015; Naidoo S, 2009, DENT TRAUMATOL, V25, P224, DOI 10.1111/j.1600-9657.2008.00749.x; Pujita Chada, 2013, J Conserv Dent, V16, P21, DOI 10.4103/0972-0707.105293; Skapetis T, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-103; Skapetis T, 2012, AUSTRALAS EMERG NURS, V15, P14, DOI 10.1016/j.aenj.2011.12.003; Skeie MS, 2010, DENT TRAUMATOL, V26, P243, DOI 10.1111/j.1600-9657.2010.00897.x; Underwood M, 1998, BRIT J GEN PRACT, V48, P1089; Frujeri MDV, 2009, DENT TRAUMATOL, V25, P262, DOI 10.1111/j.1600-9657.2008.00760.x; Young C, 2012, HONG KONG MED J, V18, P362	28	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2013	8	9							e74833	10.1371/journal.pone.0074833	http://dx.doi.org/10.1371/journal.pone.0074833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	248VW	24147154	Green Published, gold, Green Submitted			2022-12-27	WOS:000326734500121
J	Cuervo, JJ; Moller, AP				Cuervo, Jose J.; Moller, Anders P.			Temporal Variation in Population Size of European Bird Species: Effects of Latitude and Marginality of Distribution	PLOS ONE			English	Article							CLIMATE-CHANGE; DENSITY-DEPENDENCE; HABITAT FRAGMENTATION; EXTINCTION RISK; ABIOTIC FACTORS; NORTHERN BIRDS; MIGRATORY BIRD; RANGE MARGINS; TIME-SERIES; ABUNDANCE	In the Northern Hemisphere, global warming has been shown to affect animal populations in different ways, with southern populations in general suffering more from increased temperatures than northern populations of the same species. However, southern populations are also often marginal populations relative to the entire breeding range, and marginality may also have negative effects on populations. To disentangle the effects of latitude (possibly due to global warming) and marginality on temporal variation in population size, we investigated European breeding bird species across a latitudinal gradient. Population size estimates were regressed on years, and from these regressions we obtained the slope (a proxy for population trend) and the standard error of the estimate (SEE) (a proxy for population fluctuations). The possible relationships between marginality or latitude on one hand and slopes or SEE on the other were tested among populations within species. Potentially confounding factors such as census method, sampling effort, density-dependence, habitat fragmentation and number of sampling years were controlled statistically. Population latitude was positively related to regression slopes independent of marginality, with more positive slopes (i.e., trends) in northern than in southern populations. The degree of marginality was positively related to SEE independent of latitude, with marginal populations showing larger SEE (i.e., fluctuations) than central ones. Regression slopes were also significantly related to our estimate of density-dependence and SEE was significantly affected by the census method. These results are consistent with a scenario in which southern and northern populations of European bird species are negatively affected by marginality, with southern populations benefitting less from global warming than northern populations, thus potentially making southern populations more vulnerable to extinction.	[Cuervo, Jose J.] CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain; [Moller, Anders P.] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Cuervo, JJ (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Evolutionary Ecol, E-28006 Madrid, Spain.	jjcuervo@mncn.csic.es	Cuervo, José Javier/K-1646-2014; Moller, Anders/O-6665-2016	Cuervo, José Javier/0000-0001-7943-7835; Moller, Anders/0000-0003-3739-4675	Spanish National Research Council [EST001196]; Spanish Ministry of Science and Innovation; European Regional Development Fund [CGL2008-00137/BOS]	Spanish National Research Council; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission)	This studied was supported by the Spanish National Research Council (grant EST001196) and by the Spanish Ministry of Science and Innovation and the European Regional Development Fund (grant CGL2008-00137/BOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brewer AM, 2003, J ANIM ECOL, V72, P82, DOI 10.1046/j.1365-2656.2003.00682.x; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Brommer JE, 2004, ANN ZOOL FENN, V41, P391; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; Cramp S., 1977, HDB BIRDS EUROPE MID, P1; Cramp S., 1980, HDB BIRDS EUROPE MID, VII; Cuervo JJ, 2001, EVOL ECOL, V15, P53, DOI 10.1023/A:1011913804309; Curnutt JL, 1996, OIKOS, V76, P131, DOI 10.2307/3545755; Dixon PA, 1999, SCIENCE, V283, P1528, DOI 10.1126/science.283.5407.1528; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Evans SR, 2008, CONSERV BIOL, V22, P1016, DOI 10.1111/j.1523-1739.2008.00972.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Garcia JT, 2001, ECOGRAPHY, V24, P393, DOI 10.1034/j.1600-0587.2001.d01-195.x; Gilg O, 2003, SCIENCE, V302, P866, DOI 10.1126/science.1087509; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Guo QF, 2005, OIKOS, V108, P47, DOI 10.1111/j.0030-1299.2005.13149.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 1997, EXTREME ENV CHANGE E; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; Inchausti P, 2003, J ANIM ECOL, V72, P899, DOI 10.1046/j.1365-2656.2003.00767.x; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Jump AS, 2003, NEW PHYTOL, V160, P349, DOI 10.1046/j.1469-8137.2003.00873.x; Lampila P, 2005, CONSERV BIOL, V19, P1537, DOI 10.1111/j.1523-1739.2005.00201.x; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lewellen RH, 1998, ECOL MONOGR, V68, P571, DOI 10.1890/0012-9615(1998)068[0571:TEODDA]2.0.CO;2; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; McLaughlin JF, 2002, OECOLOGIA, V132, P538, DOI 10.1007/s00442-002-0997-2; Mitchell TD, 2000, 1 U E ANGL TYND CTR; Moller AP, 2008, J EVOLUTION BIOL, V21, P213, DOI 10.1111/j.1420-9101.2007.01450.x; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; MOLLER AP, 1995, AM NAT, V145, P316, DOI 10.1086/285742; Nagylaki T, 1998, GENETICS, V149, P1599; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pena TS, 2005, OIKOS, V111, P253, DOI 10.1111/j.0030-1299.2005.14067.x; Pertoldi C, 2007, OIKOS, V116, P769, DOI 10.1111/j.2007.0030-1299.15672.x; Pertoldi C, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-47; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Reed DH, 2004, ANIM CONSERV, V7, P181, DOI 10.1017/S1367943004001313; Reed DH, 2004, ANIM CONSERV, V7, P1, DOI 10.1017/S1367943004003476; Renwick AR, 2012, DIVERS DISTRIB, V18, P121, DOI 10.1111/j.1472-4642.2011.00827.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saether BE, 2009, J ANIM ECOL, V78, P1063, DOI 10.1111/j.1365-2656.2009.01565.x; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Sokal R.R., 2012, BIOMETRY; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Virkkala R, 2011, BIOL LETTERS, V7, P395, DOI 10.1098/rsbl.2010.1052; Wakeley J, 1998, THEOR POPUL BIOL, V53, P166, DOI 10.1006/tpbi.1997.1355; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Zuckerberg B, 2009, GLOBAL CHANGE BIOL, V15, P1866, DOI 10.1111/j.1365-2486.2009.01878.x	72	19	22	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77654	10.1371/journal.pone.0077654	http://dx.doi.org/10.1371/journal.pone.0077654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147048	Green Published, gold			2022-12-27	WOS:000326022200060
J	Lenz, M; Schuldt, BM; Muller, FJ; Schuppert, A				Lenz, Michael; Schuldt, Bernhard M.; Mueller, Franz-Josef; Schuppert, Andreas			PhysioSpace: Relating Gene Expression Experiments from Heterogeneous Sources Using Shared Physiological Processes	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PROSTATE-CANCER; MICROARRAY; SIGNATURE; PATTERNS; LUNG; MAP	Relating expression signatures from different sources such as cell lines, in vitro cultures from primary cells and biopsy material is an important task in drug development and translational medicine as well as for tracking of cell fate and disease progression. Especially the comparison of large scale gene expression changes to tissue or cell type specific signatures is of high interest for the tracking of cell fate in (trans-) differentiation experiments and for cancer research, which increasingly focuses on shared processes and the involvement of the microenvironment. These signature relation approaches require robust statistical methods to account for the high biological heterogeneity in clinical data and must cope with small sample sizes in lab experiments and common patterns of co-expression in ubiquitous cellular processes. We describe a novel method, called PhysioSpace, to position dynamics of time series data derived from cellular differentiation and disease progression in a genome-wide expression space. The PhysioSpace is defined by a compendium of publicly available gene expression signatures representing a large set of biological phenotypes. The mapping of gene expression changes onto the PhysioSpace leads to a robust ranking of physiologically relevant signatures, as rigorously evaluated via sample-label permutations. A spherical transformation of the data improves the performance, leading to stable results even in case of small sample sizes. Using PhysioSpace with clinical cancer datasets reveals that such data exhibits large heterogeneity in the number of significant signature associations. This behavior was closely associated with the classification endpoint and cancer type under consideration, indicating shared biological functionalities in disease associated processes. Even though the time series data of cell line differentiation exhibited responses in larger clusters covering several biologically related patterns, top scoring patterns were highly consistent with a priory known biological information and separated from the rest of response patterns.	[Lenz, Michael; Schuldt, Bernhard M.; Schuppert, Andreas] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, Aachen, Germany; [Mueller, Franz-Josef] Zentrum Integrat Psychiat, Kiel, Germany; [Schuppert, Andreas] Bayer Technol Serv GmbH, Leverkusen, Germany	RWTH Aachen University; Bayer AG	Schuppert, A (corresponding author), Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, Aachen, Germany.	schuppert@aices.rwth-aachen.de	Müller, Franz-Josef/E-3336-2010; Lenz, Michael/J-4401-2016	Müller, Franz-Josef/0000-0001-9478-8430; Lenz, Michael/0000-0002-6319-6480; Schuppert, Andreas/0000-0003-3783-6605	German federal state of North Rhine Westphalia (NRW); European Union via the StemCellFactory; MedSys project of the Federal Ministry of Education and Research (BMBF) [0315416A]; Else Kroner-Fresenius-Stiftung	German federal state of North Rhine Westphalia (NRW); European Union via the StemCellFactory; MedSys project of the Federal Ministry of Education and Research (BMBF); Else Kroner-Fresenius-Stiftung	M.L. is supported by the German federal state of North Rhine Westphalia (NRW) and the European Union (European Regional Development Fund: Investing in Your Future) via the StemCellFactory project (stemcellfactory.de). B. M. S. was partially supported by the MedSys project of the Federal Ministry of Education and Research (BMBF, www.bmbf.de, Grant number 0315416A). F-J.M. is supported by an Else Kroner-Fresenius-Stiftung (www.ekfs.de) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Domagala-Kulawik J, 2008, J PHYSIOL PHARMACOL, V59, P19; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gatti DM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-574; Gower AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-381; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38; Jiang Z, 2007, BIOINFORMATICS, V23, P306, DOI 10.1093/bioinformatics/btl599; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; MacArthur BD, 2012, NAT CELL BIOL, V14, P1139, DOI 10.1038/ncb2603; Marchand M, 2011, BIOL REPROD, V84, P1258, DOI 10.1095/biolreprod.110.086413; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mosley JD, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-11; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Muller FJ, 2011, NATURE, V478, pE4, DOI 10.1038/nature10543; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Nam D, 2010, BIOINFORMATICS, V26, pi511, DOI 10.1093/bioinformatics/btq380; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; R Development Core Team, 2011, R LANG ENV STAT COMP; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Schneckener S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-73; Schneider MV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002789; Shao KF, 2013, MOL THER, V21, P240, DOI 10.1038/mt.2012.207; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shigemizu D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002347; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Staaf J, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-22; Starmans MHW, 2008, BRIT J CANCER, V99, P1884, DOI 10.1038/sj.bjc.6604746; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Williams R, 2011, BIOESSAYS, V33, P880, DOI 10.1002/bies.201100073; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-53; Zheng-Bradley X, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r124	49	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77627	10.1371/journal.pone.0077627	http://dx.doi.org/10.1371/journal.pone.0077627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147039	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200053
J	Li, ML; Reynolds, CM; Sloboda, DM; Gray, C; Vickers, MH				Li, Minglan; Reynolds, Clare M.; Sloboda, Deborah M.; Gray, Clint; Vickers, Mark H.			Effects of Taurine Supplementation on Hepatic Markers of Inflammation and Lipid Metabolism in Mothers and Offspring in the Setting of Maternal Obesity	PLOS ONE			English	Article							FATTY LIVER-DISEASE; LOW-PROTEIN DIET; NEONATAL LEPTIN TREATMENT; BETA-CELL FUNCTION; INSULIN-RESISTANCE; GENE-EXPRESSION; NONALCOHOLIC STEATOHEPATITIS; OLIGONUCLEOTIDE MICROARRAY; DIABETES-MELLITUS; N-ACETYLCYSTEINE	Maternal obesity is associated with obesity and metabolic disorders in offspring. However, intervention strategies to reverse or ameliorate the effects of maternal obesity on offspring health are limited. Following maternal undernutrition, taurine supplementation can improve outcomes in offspring, possibly via effects on glucose homeostasis and insulin secretion. The effects of taurine in mediating inflammatory processes as a protective mechanism has not been investigated. Further, the efficacy of taurine supplementation in the setting of maternal obesity is not known. Using a model of maternal obesity, we examined the effects of maternal taurine supplementation on outcomes related to inflammation and lipid metabolism in mothers and neonates. Time-mated Wistar rats were randomised to either: 1) control : control diet during pregnancy and lactation (CON); 2) CON supplemented with 1.5% taurine in drinking water (CT); 3) maternal obesogenic diet (high fat, high fructose) during pregnancy and lactation (MO); or 4) MO supplemented with taurine (MOT). Maternal and neonatal weights, plasma cytokines and hepatic gene expression were analysed. A MO diet resulted in maternal hyperinsulinemia and hyperleptinemia and increased plasma glucose, glutamate and TNF-alpha concentrations. Taurine normalised maternal plasma TNF-alpha and glutamate concentrations in MOT animals. Both MO and MOT mothers displayed evidence of fatty liver accompanied by alterations in key markers of hepatic lipid metabolism. MO neonates displayed a pro-inflammatory hepatic profile which was partially rescued in MOT offspring. Conversely, a pro-inflammatory phenotype was observed in MOT mothers suggesting a possible maternal trade-off to protect the neonate. Despite protective effects of taurine in MOT offspring, neonatal mortality was increased in CT neonates, indicating possible adverse effects of taurine in the setting of normal pregnancy. These data suggest that maternal taurine supplementation may ameliorate the adverse effects observed in offspring following a maternal obesogenic diet but these effects are dependent upon prior maternal nutritional background.	[Li, Minglan; Reynolds, Clare M.; Sloboda, Deborah M.; Gray, Clint; Vickers, Mark H.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Li, Minglan; Reynolds, Clare M.; Sloboda, Deborah M.; Gray, Clint; Vickers, Mark H.] Univ Auckland, Gravida Natl Ctr Growth & Dev, Auckland 1, New Zealand; [Sloboda, Deborah M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada	University of Auckland; University of Auckland; McMaster University	Vickers, MH (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	m.vickers@auckland.ac.nz		Vickers, Mark/0000-0003-4876-9356; Reynolds, Clare/0000-0001-5782-6303; Li, Minglan/0000-0002-3095-7490	Gravida: National Centre for Growth and Development [3607214]; Kelliher Trust [3700171]	Gravida: National Centre for Growth and Development; Kelliher Trust	This work was supported by funding from Gravida: National Centre for Growth and Development (www.gravida.org.nz, Project 3607214) and the Kelliher Trust (kellihercharitabletrust.org.nz, Project 3700171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5; Ainge H, 2011, INT J OBESITY, V35, P325, DOI 10.1038/ijo.2010.149; Anuradha CV, 1999, CAN J PHYSIOL PHARM, V77, P749, DOI 10.1139/cjpp-77-10-749; BANNAI S, 1986, J BIOL CHEM, V261, P2256; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boujendar S, 2002, DIABETOLOGIA, V45, P856, DOI 10.1007/s00125-002-0833-6; Carneiro EA, 2009, J NUTR BIOCHEM, V20, P503, DOI 10.1016/j.jnutbio.2008.05.008; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Chang YY, 2011, J AGR FOOD CHEM, V59, P450, DOI 10.1021/jf103167u; Chen SW, 2006, DIGEST DIS SCI, V51, P2225, DOI 10.1007/s10620-006-9359-y; Cherif H, 1998, J ENDOCRINOL, V159, P341, DOI 10.1677/joe.0.1590341; Chiappini F, 2006, LAB INVEST, V86, P154, DOI 10.1038/labinvest.3700374; Crespo J, 2001, HEPATOLOGY, V34, P1158, DOI 10.1053/jhep.2001.29628; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Davalli AM, 2012, ACTA DIABETOL, V49, P167, DOI 10.1007/s00592-011-0364-z; Elshorbagy AK, 2013, METABOLISM, V62, P509, DOI 10.1016/j.metabol.2012.10.005; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Franconi F, 2004, NEUROCHEM RES, V29, P143, DOI 10.1023/B:NERE.0000010443.05899.2f; Gentile CL, 2011, AM J PHYSIOL-REG I, V301, pR1710, DOI 10.1152/ajpregu.00677.2010; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Goldberg IJ, 2009, J LIPID RES, V50, pS86, DOI 10.1194/jlr.R800085-JLR200; Gray C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053505; Haber CA, 2003, AM J PHYSIOL-ENDOC M, V285, pE744, DOI 10.1152/ajpendo.00355.2002; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Hermanowski-Vosatka A, 2000, BIOCHEM BIOPH RES CO, V279, P330, DOI 10.1006/bbrc.2000.3966; Hermanussen M, 2006, EUR J CLIN NUTR, V60, P25, DOI 10.1038/sj.ejcn.1602263; Hillemeier MM, 2011, J WOMENS HEALTH, V20, P703, DOI 10.1089/jwh.2010.2397; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; IENTILE R, 1992, ITAL J BIOCHEM, V41, P183; Ito T, 2012, AMINO ACIDS, V42, P1529, DOI 10.1007/s00726-011-0883-5; Kaaja R, 1999, METABOLISM, V48, P892, DOI 10.1016/S0026-0495(99)90225-1; Kamari Y, 2011, J HEPATOL, V55, P1086, DOI 10.1016/j.jhep.2011.01.048; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kowluru RA, 2001, NEUROCHEM INT, V38, P385, DOI 10.1016/S0197-0186(00)00112-1; Lin S, 2013, MOL NUTR FOOD RES; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manco M, 2007, AM J CLIN PATHOL, V127, P954, DOI 10.1309/6VJ4DWGYDU0XYJ8Q; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McArthur MJ, 1999, J LIPID RES, V40, P1371; Merezak S, 2004, DIABETOLOGIA, V47, P669, DOI 10.1007/s00125-004-1357-z; METZGER BE, 1993, DIABETES CARE, V16, P1598, DOI 10.2337/diacare.16.12.1598; Mikami N, 2012, J FOOD SCI, V77, pH114, DOI 10.1111/j.1750-3841.2012.02687.x; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Nandhini ATA, 2005, DIABETES METAB, V31, P337; Nodine PM, 2012, MCN-AM J MATERN-CHIL, V37, P110, DOI 10.1097/NMC.0b013e3182430296; OLNEY JW, 1970, NATURE, V227, P609, DOI 10.1038/227609b0; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Poston L, 2011, PEDIATR RES, V69, P175, DOI 10.1203/PDR.0b013e3182055ede; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Schuller-Levis GB, 2003, FEMS MICROBIOL LETT, V226, P195, DOI 10.1016/S0378-1097(03)00611-6; Shivananjappa MM, 2012, REPROD BIOMED ONLINE, V24, P558, DOI 10.1016/j.rbmo.2012.01.016; STEINEGER HH, 1994, EUR J BIOCHEM, V225, P967, DOI 10.1111/j.1432-1033.1994.0967b.x; Stoeckman AK, 2002, J BIOL CHEM, V277, P27029, DOI 10.1074/jbc.M202638200; Tang C, 2013, REPRODUCTION, V145, P609, DOI 10.1530/REP-12-0388; Tiikkainen M, 2002, OBES RES, V10, P859, DOI 10.1038/oby.2002.118; Valladolid-Acebes I, 2012, AM J PHYSIOL-ENDOC M, V302, pE396, DOI 10.1152/ajpendo.00343.2011; Vickers MH, 2011, ENDOCRINOLOGY, V152, P1378, DOI 10.1210/en.2010-1093; Vickers MH, 2008, ENDOCRINOLOGY, V149, P1906, DOI 10.1210/en.2007-0981; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581; WORDEN JA, 1985, COMP BIOCHEM PHYS B, V82, P233, DOI 10.1016/0305-0491(85)90232-9; Yu TX, 1997, BRAIN RES, V747, P195, DOI 10.1016/S0006-8993(96)01181-X; Yu XP, 2008, NEUROCHEM RES, V33, P500, DOI 10.1007/s11064-007-9465-z; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	70	47	49	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76961	10.1371/journal.pone.0076961	http://dx.doi.org/10.1371/journal.pone.0076961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146946	gold, Green Submitted, Green Published			2022-12-27	WOS:000326022200027
J	Salinero-Fort, MA; San Andres-Rebollo, FJ; de Burgos-Lunar, C; Arrieta-Blanco, FJ; Gomez-Campelo, P				Salinero-Fort, Miguel A.; Javier San Andres-Rebollo, Francisco; de Burgos-Lunar, Carmen; Jesus Arrieta-Blanco, Francisco; Gomez-Campelo, Paloma		MADIABETES Grp	Four-Year Incidence of Diabetic Retinopathy in a Spanish Cohort: The MADIABETES Study	PLOS ONE			English	Article							RISK-FACTORS; BLOOD-PRESSURE; FOLLOW-UP; CARDIOVASCULAR EVENTS; ATHEROSCLEROSIS RISK; PRIMARY PREVENTION; VISUAL IMPAIRMENT; 9-YEAR INCIDENCE; 5-YEAR INCIDENCE; PLASMA-GLUCOSE	Objective: To evaluate the incidence of diabetic retinopathy in patients with Type 2 Diabetes Mellitus, to identify the risk factors associated with the incidence of retinopathy and to develop a risk table to predict four-year retinopathy risk stratification for clinical use, from a four-year cohort study. Design: The MADIABETES Study is a prospective cohort study of 3,443 outpatients with Type 2 Diabetes Mellitus, sampled from 56 primary health care centers (131 general practitioners) in Madrid (Spain). Results: The cumulative incidence of retinopathy at four-year follow-up was 8.07% (95% CI = 7.04-9.22) and the incidence density was 2.03 (95% CI = 1.75-2.33) cases per 1000 patient-months or 2.43 (95% CI = 2.10-2.80) cases per 100 patient-years. The highest adjusted hazard ratios of associated risk factors for incidence of diabetic retinopathy were LDL-C >190 mg/dl (HR = 7.91; 95% CI = 3.39-18.47), duration of diabetes longer than 22 years (HR = 2.00; 95% CI = 1.18-3.39), HbA1c>8% (HR = 1.90; 95% CI = 1.30-2.77), and aspirin use (HR = 1.65; 95% CI = 1.22-2.24). Microalbuminuria (HR = 1.17; 95% CI = 0.75-1.82) and being female (HR = 1.12; 95% CI = 0.84-1.49) showed a non-significant increase of diabetic retinopathy. The greatest risk is observed in females who had diabetes for more than 22 years, with microalbuminuria, HbA1c>8%, hypertension, LDL-Cholesterol >190 mg/dl and aspirin use. Conclusions: After a four-year follow-up, the cumulative incidence of retinopathy was relatively low in comparison with other studies. Higher baseline HbA1c, aspirin use, higher LDL-Cholesterol levels, and longer duration of diabetes were the only statistically significant risk factors found for diabetic retinopathy incidence. This is the first study to demonstrate an association between aspirin use and diabetic retinopathy risk in a well-defined cohort of patients with Type 2 Diabetes Mellitus at low risk of cardiovascular events. However, further studies with patients at high cardiovascular and metabolic risk are needed to clarify this issue.	[Salinero-Fort, Miguel A.; Gomez-Campelo, Paloma] Hosp Carlos III, Serv Madrileno Salud, Fdn Invest Biomed, Madrid, Spain; [Javier San Andres-Rebollo, Francisco] Ctr Salud Las Calesas, Serv Madrileno Salud, Madrid, Spain; [de Burgos-Lunar, Carmen] Hosp Carlos III, Unidad Epidemiol Clin, Serv Madrileno Salud, Madrid, Spain; [Jesus Arrieta-Blanco, Francisco] Hosp Ramon & Cajal, Serv Endocrinol & Nutr, Unidad Nutr Obesidad & Metab, CIBER Obesidad & Nutr,IRYCIS,Serv Madrileno Salud, E-28034 Madrid, Spain	Hospital Carlos III; Hospital Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Hospital Universitario Ramon y Cajal	Salinero-Fort, MA (corresponding author), Hosp Carlos III, Serv Madrileno Salud, Fdn Invest Biomed, Madrid, Spain.	miguel.salinero@salud.madrid.org	SALINERO-FORT, MIGUEL A./GOP-2536-2022; de Santa Pau, Enrique Carrillo/AAV-7544-2021; ALVAREZ EMBARBA, BEATRIZ/AHE-8612-2022	SALINERO-FORT, MIGUEL A./0000-0002-9450-4116; de Santa Pau, Enrique Carrillo/0000-0002-2310-2267; ALVAREZ EMBARBA, BEATRIZ/0000-0002-2084-3051; Vich Perez, Pilar/0000-0002-6702-909X; Serrano Serrano, Maria Encarnacion/0000-0003-3150-2348; Gomez Campelo, Paloma/0000-0003-2299-1741	Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III [PI05/0681, PI10/02796, PI12/01806]	Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III	This study has been funded by the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III(PI05/0681, PI10/02796, PI12/01806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajoy MVK, 2011, INDIAN J OPHTHALMOL, V59, P207, DOI 10.4103/0301-4738.81029; American Diabetes Association, 2011, DIABETES CARE S1, V35, pS11; [Anonymous], 1991, Ophthalmology, V98, P786; Benarous R, 2011, INVEST OPHTH VIS SCI, V52, P7464, DOI 10.1167/iovs.11-7598; Bergerhoff K, 2002, ENDOCRIN METAB CLIN, V31, P779, DOI 10.1016/S0889-8529(02)00017-8; Bosomworth NJ, 2011, CAN FAM PHYSICIAN, V57, P417; Brown JB, 2003, DIABETES CARE, V26, P2637, DOI 10.2337/diacare.26.9.2637; Bruno G, 1996, DIABETES CARE, V19, P43, DOI 10.2337/diacare.19.1.43; CHEN MS, 1995, INT J EPIDEMIOL, V24, P787, DOI 10.1093/ije/24.4.787; Chen YH, 2012, DIABETES CARE, V35, P803, DOI 10.2337/dc11-1955; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; CIGNARELLI M, 1992, DIABETES CARE, V15, P1002, DOI 10.2337/diacare.15.8.1002; Cikamatana L, 2007, EYE, V21, P465, DOI 10.1038/sj.eye.6702771; Davies, 2012, DIABETES, P1, DOI DOI 10.1002/9781118405550.CH1; de Burgos-Lunar C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-146; Domenech JM, 2008, ANALISIS SUPERVIVENC; DWYER MS, 1985, DIABETES CARE, V8, P316, DOI 10.2337/diacare.8.4.316; Estacio RO, 2000, DIABETES CARE, V23, pB54; GALL MA, 1991, DIABETOLOGIA, V34, P655, DOI 10.1007/BF00400995; Gimeno-Orna JA, 2003, J DIABETES COMPLICAT, V17, P78, DOI 10.1016/S1056-8727(02)00197-6; Guven D, 1996, OPHTHALMOLOGY, V103, P1245; Hirsch IB, 2010, JAMA-J AM MED ASSOC, V303, P2291, DOI 10.1001/jama.2010.785; Hosseini SM, 2009, J RES MED SCI, V14, P105; Juutilainen A, 2007, DIABETES CARE, V30, P292, DOI 10.2337/dc06-1747; Kim HK, 1998, DIABETES CARE, V21, P134, DOI 10.2337/diacare.21.1.134; Klein BEK, 2012, JAMA-J AM MED ASSOC, V308, P2469, DOI 10.1001/jama.2012.65406; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P244, DOI 10.1001/archopht.1989.01070010250031; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1994, ARCH INTERN MED, V154, P2169, DOI 10.1001/archinte.154.19.2169; KLEIN R, 1988, JAMA-J AM MED ASSOC, V260, P2864, DOI 10.1001/jama.260.19.2864; KLEIN R, 1992, OPHTHALMOLOGY, V99, P58; KLEIN R, 1993, DIABETES CARE, V16, P1325, DOI 10.2337/diacare.16.10.1325; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; Klein R, 2008, CONTEMP DIABETES, P67, DOI 10.1007/978-1-59745-563-3_3; KNOWLER WC, 1980, NEW ENGL J MED, V302, P645, DOI 10.1056/NEJM198003203021201; Kohner EM, 2008, DIABETIC MED, V25, P20, DOI 10.1111/j.1464-5491.2008.02505.x; Leske MC, 2006, ARCH OPHTHALMOL-CHIC, V124, P250, DOI 10.1001/archopht.124.2.250; Leske MC, 2005, OPHTHALMOLOGY, V112, P799, DOI 10.1016/j.ophtha.2004.11.054; Leske MC, 2003, OPHTHALMOLOGY, V110, P941, DOI 10.1016/S0161-6420(03)00086-1; Liu DP, 2002, DIABETES RES CLIN PR, V56, P125, DOI 10.1016/S0168-8227(01)00349-7; LIU QZ, 1993, DIABETOLOGIA, V36, P428, DOI 10.1007/BF00402279; Looker HC, 2003, DIABETES CARE, V26, P320, DOI 10.2337/diacare.26.2.320; López Gálvez MI, 2004, Arch Soc Esp Oftalmol, V79, P149; Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648; Manaviat MR, 2008, EUR J OPHTHALMOL, V18, P572, DOI 10.1177/112067210801800412; Manaviat Masoud R, 2004, BMC Ophthalmol, V4, P9, DOI 10.1186/1471-2415-4-9; Marrugat J, 2003, REV ESP CARDIOL, V56, P253, DOI 10.1157/13043951; McCarty DJ, 2003, CLIN EXP OPHTHALMOL, V31, P397, DOI 10.1046/j.1442-9071.2003.00685.x; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Newman D J, 2005, Health Technol Assess, V9, piii; Perol J, 2012, DIABETES METAB, V38, P225, DOI 10.1016/j.diabet.2012.01.001; Pignone M, 2010, NAT REV ENDOCRINOL, V6, P619, DOI 10.1038/nrendo.2010.169; Potisat Somkiat, 2008, Journal of the Medical Association of Thailand, V91, P846; Pugliese G, 2012, DIABETES RES CLIN PR, V25; Raman R, 2012, CURR EYE RES, V37, P513, DOI 10.3109/02713683.2012.669005; Rani PK, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-9; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Romero-Aroca P, 2012, J DIABETES COMPLICAT, V26, P506, DOI 10.1016/j.jdiacomp.2012.06.010; Santos-Bueso E, 2007, ARCH SOC ESPANOLA OF, V82; Selvin E, 2010, J DIABETES, V2, P118, DOI 10.1111/j.1753-0407.2010.00070.x; Simpson SH, 2011, J GEN INTERN MED, V26, P1336, DOI 10.1007/s11606-011-1757-y; Singh S K, 2001, J Assoc Physicians India, V49, P439; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Tam T. K. W., 2005, Hong Kong Medical Journal, V11, P438; Tam VHK, 2009, J DIABETES COMPLICAT, V23, P185, DOI 10.1016/j.jdiacomp.2008.03.001; Tapp RJ, 2008, DIABETES CARE, V31, P1349, DOI 10.2337/dc07-1707; Tapp RJ, 2006, DIABETES RES CLIN PR, V73, P298, DOI 10.1016/j.diabres.2006.02.009; Targher G, 2008, DIABETIC MED, V25, P45, DOI 10.1111/j.1464-5491.2007.02327.x; Teruel Maicas C, 2005, ARCH SOC ESP OFTALMO, V80; Thomas RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e874; Thompson JW, 1998, HEALTH AFFAIR, V17, P152, DOI 10.1377/hlthaff.17.1.152; Tong PCY, 2007, DIABETIC MED, V24, P741, DOI 10.1111/j.1464-5491.2007.02145.x; Tudor SM, 1998, DIABETES CARE, V21, P53, DOI 10.2337/diacare.21.1.53; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unnikrishnan R, 2007, DIABETES CARE, V30, P2019, DOI 10.2337/dc06-2554; van Leiden HA, 2003, ARCH OPHTHALMOL-CHIC, V121, P245, DOI 10.1001/archopht.121.2.245; Varma R, 2010, AM J OPHTHALMOL, V149, P752, DOI 10.1016/j.ajo.2009.11.014; VIGSTRUP J, 1985, ACTA OPHTHALMOL, V63, P530; Voutilainen-Kaunisto RM, 2001, J DIABETES COMPLICAT, V15, P24, DOI 10.1016/S1056-8727(00)00126-4; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026871; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wirta OR, 1995, J DIABETES COMPLICAT, V9, P177, DOI 10.1016/1056-8727(94)00034-L; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275; Zhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058821	90	38	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76417	10.1371/journal.pone.0076417	http://dx.doi.org/10.1371/journal.pone.0076417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146865	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200013
J	Wang, Y; Huang, XL; Qiao, GX				Wang, Yuan; Huang, Xiao-Lei; Qiao, Ge-Xia			Comparative Analysis of Mitochondrial Genomes of Five Aphid Species (Hemiptera: Aphididae) and Phylogenetic Implications	PLOS ONE			English	Article							TRANSFER-RNA; COMPLETE SEQUENCE; MOLECULAR PHYLOGENY; CODON USAGE; INSECTA; ORGANIZATION; LEPIDOPTERA; EVOLUTION; HYMENOPTERA; PATTERNS	Insect mitochondrial genomes (mitogenomes) are of great interest in exploring molecular evolution, phylogenetics and population genetics. Only two mitogenomes have been previously released in the insect group Aphididae, which consists of about 5,000 known species including some agricultural, forestry and horticultural pests. Here we report the complete 16,317 bp mitogenome of Cavariella salicicola and two nearly complete mitogenomes of Aphis glycines and Pterocomma pilosum. We also present a first comparative analysis of mitochondrial genomes of aphids. Results showed that aphid mitogenomes share conserved genomic organization, nucleotide and amino acid composition, and codon usage features. All 37 genes usually present in animal mitogenomes were sequenced and annotated. The analysis of gene evolutionary rate revealed the lowest and highest rates for COI and ATP8, respectively. A unique repeat region exclusively in aphid mitogenomes, which included variable numbers of tandem repeats in a lineage-specific manner, was highlighted for the first time. This region may have a function as another origin of replication. Phylogenetic reconstructions based on protein-coding genes and the stem-loop structures of control regions confirmed a sister relationship between Cavariella and pterocommatines. Current evidence suggest that pterocommatines could be formally transferred into Macrosiphini. Our paper also offers methodological instructions for obtaining other Aphididae mitochondrial genomes.	[Wang, Yuan; Huang, Xiao-Lei; Qiao, Ge-Xia] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wang, Yuan] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Huang, XL (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangxl@ioz.ac.cn; qiaogx@ioz.ac.cn	Huang, Xiaolei/S-7781-2019	Huang, Xiaolei/0000-0002-6839-9922	National Natural Sciences Foundation of China [31272348]; National Science Funds for Distinguished Young Scientists [31025024]; National Science Fund for Fostering Talents in Basic Research [J1210002]; Ministry of Science and Technology of the People's Republic of China [2011FY120200]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Funds for Distinguished Young Scientists; National Science Fund for Fostering Talents in Basic Research; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences	The work was supported by grants from the National Natural Sciences Foundation of China (31272348), National Science Funds for Distinguished Young Scientists (31025024), National Science Fund for Fostering Talents in Basic Research (J1210002), the Ministry of Science and Technology of the People's Republic of China (2011FY120200), and a grant from the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences (O529YX5105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], APHIDS WORLDS HERBAC; Blackman RL, 1994, APHIDS WORLDS TREES, P987; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Carapelli A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-315; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Davila S, 2005, GENE, V360, P92, DOI 10.1016/j.gene.2005.06.008; Dotson EM, 2001, INSECT MOL BIOL, V10, P205, DOI 10.1046/j.1365-2583.2001.00258.x; Eastop VF., 2000, APHIDS WORLDS CROPS, V2, P466; EASTOP VF, 1979, SYMB BOT UPSAL, V22, P120; Favret C., 2013, APHID SPECIES FILE V; Foottit RG, 2008, MOL ECOL RESOUR, V8, P1189, DOI 10.1111/j.1755-0998.2008.02297.x; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; HEIE OE, 1992, APHIDOIDEA HEMIPTE 1; Hua JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-610; Huang XL, 2012, ZOOL J LINN SOC-LOND, V165, P73, DOI 10.1111/j.1096-3642.2011.00795.x; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kim HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024749, 10.1371/journal.pone.0019867]; Lavrov DV, 2005, MOL BIOL EVOL, V22, P1231, DOI 10.1093/molbev/msi108; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029419; Li H, 2012, INT J BIOL SCI, V8, P93, DOI 10.7150/ijbs.8.93; Li H, 2011, INT J BIOL SCI, V7, P792, DOI 10.7150/ijbs.7.792; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MACKENZIE A, 1990, AM NAT, V136, P132, DOI 10.1086/285086; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Niehuis O, 2006, MOL PHYLOGENET EVOL, V39, P812, DOI 10.1016/j.ympev.2006.01.007; Nieto Nafria Juan M., 2011, P21; Nokkala C, 2007, EUR J ENTOMOL, V104, P661, DOI 10.14411/eje.2007.083; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Remaudiere G., 1997, Catalogue des Aphididae du monde: Homoptera Aphidoidea.; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; Schuh R.T., 1995, CLASSIFICATION NATUR, P336; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; Stoletzki N, 2007, MOL BIOL EVOL, V24, P374, DOI 10.1093/molbev/msl166; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Tomita K, 2001, SCIENCE, V294, P1334, DOI 10.1126/science.1063816; von Dohlen CD, 2006, MOL PHYLOGENET EVOL, V38, P316, DOI 10.1016/j.ympev.2005.04.035; VONDOHLEN CD, 1995, J MOL EVOL, V41, P211, DOI 10.1007/BF00170675; Wei SJ, 2009, GENOME, V52, P308, DOI [10.1139/G09-008, 10.1139/g09-008]; Wilson K, 2000, MOL BIOL EVOL, V17, P863, DOI 10.1093/oxfordjournals.molbev.a026366; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-257; Zhang CM, 2008, NAT STRUCT MOL BIOL, V15, P507, DOI 10.1038/nsmb.1423; Zhou ZJ, 2007, GENOME, V50, P855, DOI 10.1139/G07-057	59	48	53	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77511	10.1371/journal.pone.0077511	http://dx.doi.org/10.1371/journal.pone.0077511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147014	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200040
J	Wu, DY; Jospin, G; Eisen, JA				Wu, Dongying; Jospin, Guillaume; Eisen, Jonathan A.			Systematic Identification of Gene Families for Use as "Markers" for Phylogenetic and Phylogeny-Driven Ecological Studies of Bacteria and Archaea and Their Major Subgroups	PLOS ONE			English	Article							SEQUENCE-ANALYSIS; GENOME; EVOLUTION; ALIGNMENT; DATABASE; PROTEIN; TREES; DIVERSITY; IMPACT; CORE	With the astonishing rate that genomic and metagenomic sequence data sets are accumulating, there are many reasons to constrain the data analyses. One approach to such constrained analyses is to focus on select subsets of gene families that are particularly well suited for the tasks at hand. Such gene families have generally been referred to as "marker" genes. We are particularly interested in identifying and using such marker genes for phylogenetic and phylogeny-driven ecological studies of microbes and their communities (e. g., construction of species trees, phylogenetic based assignment of metagenomic sequence reads to taxonomic groups, phylogeny-based assessment of alpha-and beta-diversity of microbial communities from metagenomic data). We therefore refer to these as PhyEco (for phylogenetic and phylogenetic ecology) markers. The dual use of these PhyEco markers means that we needed to develop and apply a set of somewhat novel criteria for identification of the best candidates for such markers. The criteria we focused on included universality across the taxa of interest, ability to be used to produce robust phylogenetic trees that reflect as much as possible the evolution of the species from which the genes come, and low variation in copy number across taxa. We describe here an automated protocol for identifying potential PhyEco markers from a set of complete genome sequences. The protocol combines rapid searching, clustering and phylogenetic tree building algorithms to generate protein families that meet the criteria listed above. We report here the identification of PhyEco markers for different taxonomic levels including 40 for "all bacteria and archaea", 114 for "all bacteria (greatly expanding on the similar to 30 commonly used), and 100 s to 1000 s for some of the individual phyla of bacteria. This new list of PhyEco markers should allow much more detailed automated phylogenetic and phylogenetic ecology analyses of these groups than possible previously.	[Wu, Dongying; Jospin, Guillaume; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Dept Med Microbiol & Immunol, Dept Evolut & Ecol, Davis, CA 95616 USA; [Wu, Dongying] US DOE, Joint Genome Inst, Walnut Creek, CA USA	University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Wu, DY (corresponding author), Univ Calif Davis, Genome Ctr, Dept Med Microbiol & Immunol, Dept Evolut & Ecol, Davis, CA 95616 USA.	dygwu@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Jospin, Guillaume/0000-0002-8746-2632	Gordon and Betty Moore Foundation [1660, 3300]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Funding for this work was provided by the Gordon and Betty Moore Foundation (grant #1660 and #3300, website: http://www.moore.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abby SS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-324; Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALCH WE, 1977, J MOL EVOL, V9, P305, DOI 10.1007/BF01796092; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeWall MT, 2011, BRIEF FUNCT GENOMICS, V10, P312, DOI 10.1093/bfgp/elr030; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 1995, J MOL EVOL, V41, P1105; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; FOX GE, 1980, SCIENCE, V209, P457, DOI 10.1126/science.6771870; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; HASEGAWA M, 1993, NATURE, V361, P23, DOI 10.1038/361023b0; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; LLOYD AT, 1993, J MOL EVOL, V37, P399; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mollet C, 1997, MOL MICROBIOL, V26, P1005, DOI 10.1046/j.1365-2958.1997.6382009.x; Mulkidjanian AY, 2006, P NATL ACAD SCI USA, V103, P13126, DOI 10.1073/pnas.0605709103; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Oxelman B, 2004, MOL PHYLOGENET EVOL, V32, P462, DOI 10.1016/j.ympev.2004.01.014; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; Sandler SJ, 1999, J BACTERIOL, V181, P907, DOI 10.1128/JB.181.3.907-915.1999; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Shannon CE, 1997, M D COMPUT, V14, P306; Sharpton TJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-264; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Stassen NY, 1997, CURR GENET, V31, P144, DOI 10.1007/s002940050189; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang Z, 2013, MOL BIOL EVOL; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Wu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018011; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu DY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002566; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Yang SX, 2001, J MOL BIOL, V312, P999, DOI 10.1006/jmbi.2001.5025; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999	54	106	106	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77033	10.1371/journal.pone.0077033	http://dx.doi.org/10.1371/journal.pone.0077033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146954	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200029
J	Hirasawa, R; Matoba, S; Inoue, K; Ogura, A				Hirasawa, Ryutaro; Matoba, Shogo; Inoue, Kimiko; Ogura, Atsuo			Somatic Donor Cell Type Correlates with Embryonic, but Not Extra-Embryonic, Gene Expression in Postimplantation Cloned Embryos	PLOS ONE			English	Article							NUCLEAR TRANSFER; STEM-CELLS; MOUSE EMBRYO; TROPHOBLAST DEVELOPMENT; PLACENTAL DEVELOPMENT; BLASTOCYST STAGE; CLONING; MICE; DIFFERENTIATION; PLURIPOTENCY	The great majority of embryos generated by somatic cell nuclear transfer (SCNT) display defined abnormal phenotypes after implantation, such as an increased likelihood of death and abnormal placentation. To gain better insight into the underlying mechanisms, we analyzed genome-wide gene expression profiles of day 6.5 postimplantation mouse embryos cloned from three different cell types (cumulus cells, neonatal Sertoli cells and fibroblasts). The embryos retrieved from the uteri were separated into embryonic (epiblast) and extraembryonic (extraembryonic ectoderm and ectoplacental cone) tissues and were subjected to gene microarray analysis. Genotype- and sex-matched embryos produced by in vitro fertilization were used as controls. Principal component analysis revealed that whereas the gene expression patterns in the embryonic tissues varied according to the donor cell type, those in extraembryonic tissues were relatively consistent across all groups. Within each group, the embryonic tissues had more differentially expressed genes (DEGs) (>2-fold vs. controls) than did the extraembryonic tissues (P<1.0x10(-26)). In the embryonic tissues, one of the common abnormalities was upregulation of Dlk1, a paternally imprinted gene. This might be a potential cause of the occasional placenta-only conceptuses seen in SCNT-generated mouse embryos (1-5% per embryos transferred in our laboratory), because dysregulation of the same gene is known to cause developmental failure of embryos derived from induced pluripotent stem cells. There were also some DEGs in the extraembryonic tissues, which might explain the poor development of SCNT-derived placentas at early stages. These findings suggest that SCNT affects the embryonic and extraembryonic development differentially and might cause further deterioration in the embryonic lineage in a donor cell-specific manner. This could explain donor cell-dependent variations in cloning efficiency using SCNT.	[Hirasawa, Ryutaro; Matoba, Shogo; Inoue, Kimiko; Ogura, Atsuo] RIKEN BioResource Ctr, Tsukuba, Ibaraki, Japan; [Inoue, Kimiko; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ogura, Atsuo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan	RIKEN; University of Tsukuba; University of Tokyo	Ogura, A (corresponding author), RIKEN BioResource Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014; MATOBA, Shogo/D-9995-2016	Ogura, Atsuo/0000-0003-0447-1988; MATOBA, Shogo/0000-0003-0474-232X	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chu JH, 2010, DEV BIOL, V342, P63, DOI 10.1016/j.ydbio.2010.03.009; Couldrey C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055153; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Frankenberg S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-8; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Hajkova P, 2011, PHILOS T R SOC B, V366, P2266, DOI 10.1098/rstb.2011.0042; Hogan B, 1994, MANIPULATING MOUSE E, P220; Inoue K, 2003, BIOL REPROD, V69, P1394, DOI 10.1095/biolreprod.103.017731; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Jouneau A, 2006, DEVELOPMENT, V133, P1597, DOI 10.1242/dev.02317; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lu CC, 2004, DEV BIOL, V273, P149, DOI 10.1016/j.ydbio.2004.06.004; Matoba S, 2011, P NATL ACAD SCI USA, V108, P20621, DOI 10.1073/pnas.1112664108; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Natale DRC, 2009, DEV BIOL, V335, P120, DOI 10.1016/j.ydbio.2009.08.022; Niemann H, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02121.x; Ogura A, 2000, MOL REPROD DEV, V57, P55, DOI 10.1002/1098-2795(200009)57:1&lt;55::AID-MRD8&gt;3.0.CO;2-W; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Ogura A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0329; Pfeffer PL, 2012, REPRODUCTION, V143, P231, DOI 10.1530/REP-11-0374; Rodriguez TA, 2004, MOL CELL BIOL, V24, P228, DOI 10.1128/MCB.24.1.228-244.2004; Rogers ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036483; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Sato S, 2011, GENOMICS, V98, P120, DOI 10.1016/j.ygeno.2011.05.003; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Singh U, 2005, DEV DYNAM, V234, P1034, DOI 10.1002/dvdy.20597; Singh U, 2004, DEV DYNAM, V230, P149, DOI 10.1002/dvdy.20024; Smith SL, 2005, P NATL ACAD SCI USA, V102, P17582, DOI 10.1073/pnas.0508952102; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama T, 1999, SEMIN CELL DEV BIOL, V10, P253, DOI 10.1006/scdb.1998.0267; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 2001, MOL REPROD DEV, V58, P376, DOI 10.1002/1098-2795(20010401)58:4<376::AID-MRD4>3.0.CO;2-L; Wakisaka N, 2008, PLACENTA, V29, P753, DOI 10.1016/j.placenta.2008.05.008; Wakisaka-Saito N, 2006, BIOCHEM BIOPH RES CO, V349, P106, DOI 10.1016/j.bbrc.2006.08.057; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Whitworth KM, 2011, CELL REPROGRAM, V13, P191, DOI 10.1089/cell.2010.0087; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229	49	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76422	10.1371/journal.pone.0076422	http://dx.doi.org/10.1371/journal.pone.0076422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146866	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400059
J	Li, RX; Yu, CG; Jiang, F; Gao, L; Li, JY; Wang, YM; Beckwith, N; Yao, LB; Zhang, J; Wu, GJ				Li, Ruixiao; Yu, Chuigong; Jiang, Feng; Gao, Lei; Li, Jianying; Wang, Yingmei; Beckwith, Noor; Yao, Libo; Zhang, Jing; Wu, Guojun			Overexpression of N-Myc Downstream-Regulated Gene 2 (NDRG2) Regulates the Proliferation and Invasion of Bladder Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							EXPRESSION; SUPPRESSION; TUMORS; LIVER	N-Myc downstream-regulated gene 2 (NDRG2) is a candidate tumor suppressor gene, which plays an important role in controlling tumor growth. The aim of this study was to investigate the expression of NDRG2 gene in bladder cancer (BC) tissues and several bladder cancer cell lines, and to seek its clinical and pathological significance. Ninety-seven bladder carcinoma and 15 normal bladder tissue sections were analyzed retrospectively with immunohistochemistry. The human bladder cancer cell line T24 was infected with LEN-NDRG2 or LEN-LacZ. The effects of NDRG2 overexpression on T24 cells and T24 nude mouse xenografts were measured via cell growth curves, tumor growth curves, flow cytometric analysis, western blot and Transwell assay. NDRG2 was highly expressed in normal bladder tissue, but absent or rarely expressed in cacinomatous tissues (chi(2)=8.761, p<0.01). The NDRG2 level was negatively correlated with tumor grade and pathologic stage(r=-0.248, p<0.05), as well as increased c-myc level (r=-0.454, p<0.001). The expression of NDRG2 was low in the three BC cell lines. T24 cells infected with LEN-NDRG2 showed inhibition of proliferation both in vitro and in vivo, and NDRG2 overexpression can inhibit tumor growth and invasion in vitro.	[Li, Ruixiao; Li, Jianying; Yao, Libo; Zhang, Jing] Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Li, Ruixiao; Yu, Chuigong; Gao, Lei; Wu, Guojun] Fourth Mil Med Univ, Dept Urol, Xijing Hosp, Xian 710032, Peoples R China; [Jiang, Feng] Fourth Mil Med Univ, Dept Obstet & Gynaecol, Tangdu Hosp, Xian 710032, Peoples R China; [Wang, Yingmei] Fourth Mil Med Univ, Dept Pathol, Xian 710032, Peoples R China; [Beckwith, Noor] Harvard Univ, Sch Med, Boston, MA USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Harvard University; Harvard Medical School	Zhang, J (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Dept Biochem & Mol Biol, Xian 710032, Peoples R China.	zhangjing.99@163.com; gunwu@sina.com		Beckwith, Noor/0000-0001-6025-8642	National Natural Science Foundation of China [31070681]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research work was financially supported by National Natural Science Foundation of China (31070681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle H, 2011, CURR OPIN UROL, V21, P409, DOI 10.1097/MOU.0b013e3283495758; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Foletta VC, 2009, J PHYSIOL-LONDON, V587, P1619, DOI 10.1113/jphysiol.2008.167882; Gao L, 2011, CANCER LETT, V310, P94, DOI 10.1016/j.canlet.2011.06.015; Hu XL, 2004, WORLD J GASTROENTERO, V10, P3518; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Lusis EA, 2005, CANCER RES, V65, P7121, DOI 10.1158/0008-5472.CAN-05-0043; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032368; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Mansoor M, 2011, JCPSP-J COLL PHYSICI, V21, P157, DOI 03.2011/JCPSP.157160; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Szarvas T, 2011, NAT REV UROL, V8, P241, DOI 10.1038/nrurol.2011.44; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Yu CG, 2011, CANCER BIOL THER, V12, P304, DOI 10.4161/cbt.12.4.16382; Zaravinos A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018135; Zhao HL, 2008, J ADV MECH DES SYST, V2, P303, DOI 10.1299/jamdsm.2.303; Zhou RH, 2001, GENOMICS, V73, P86, DOI 10.1006/geno.2000.6496	23	21	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76689	10.1371/journal.pone.0076689	http://dx.doi.org/10.1371/journal.pone.0076689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146910	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400082
J	Li, YZ; Wang, HY; Xie, KL; Wang, CY; Yang, Z; Yu, YH; Wang, GL				Li, Yize; Wang, Haiyun; Xie, Keliang; Wang, Chunyan; Yang, Zhuo; Yu, Yonghao; Wang, Guolin			Inhibition of Glycogen Synthase Kinase-3 beta Prevents Remifentanil-Induced Hyperalgesia via Regulating the Expression and Function of Spinal N-Methyl-D-Aspartate Receptors In Vivo and Vitro	PLOS ONE			English	Article							OPIOID-INDUCED HYPERALGESIA; INDUCED POSTOPERATIVE HYPERALGESIA; SYNAPTIC-TRANSMISSION; NEUROPATHIC PAIN; NMDA; TRAFFICKING; NEURONS; GSK-3; CONTRIBUTES; ANESTHETICS	A large number of experimental and clinical studies have confirmed that brief remifentanil exposure can enhance pain sensitivity presenting as opioid-induced hyperalgesia (OIH). N-methyl-D-aspartate (NMDA) receptor antagonists have been reported to inhibit morphine analgesic tolerance in many studies. Recently, we found that glycogen synthase kinase-3 beta (GSK-3 beta) modulated NMDA receptor trafficking in a rat model of remifentanil-induced postoperative hyperalgesia. In the current study, it was demonstrated that GSK-3 beta inhibition prevented remifentanil-induced hyperalgesia via regulating the expression and function of spinal NMDA receptors in vivo and in vitro. We firstly investigated the effects of TDZD-8, a selective GSK-3 beta inhibitor, on thermal and mechanical hyperalgesia using a rat model of remifentanil-induced hyperalgesia. GSK-3 beta activity as well as NMDA receptor subunits (NR1, NR2A and NR2B) expression and trafficking in spinal cord L-4-L-5 segments were measured by Western blot analysis. Furthermore, the effects of GSK-3 beta inhibition on NMDA-induced current amplitude and frequency were studied in spinal cord slices by whole-cell patch-clamp recording. We found that remifentanil infusion at 1 mu g.kg(-1).min(-1) and 2 mu g.kg(-1).min(-1) caused mechanical and thermal hyperalgesia, up-regulated NMDA receptor subunits NR1 and NR2B expression in both membrane fraction and total lysate of the spinal cord dorsal horn and increased GSK-3 beta activity in spinal cord dorsal horn. GSK-3 beta inhibitor TDZD-8 significantly attenuated remifentanil-induced mechanical and thermal hyperalgesia from 2 h to 48 h after infusion, and this was associated with reversal of up-regulated NR1 and NR2B subunits in both membrane fraction and total lysate. Furthermore, remifentanil incubation increased amplitude and frequency of NMDA receptor-induced current in dorsal horn neurons, which was prevented with the application of TDZD-8. These results suggest that inhibition of GSK-3 beta can significantly ameliorate remifentanil-induced hyperalgesia via modulating the expression and function of NMDA receptors, which present useful insights into the mechanistic action of GSK-3 beta inhibitor as potential anti-hyperalgesic agents for treating OIH.	[Li, Yize; Wang, Haiyun; Xie, Keliang; Wang, Chunyan; Yu, Yonghao; Wang, Guolin] Tianjin Med Univ, Dept Anesthesiol, Gen Hosp, Tianjin, Peoples R China; [Li, Yize; Wang, Haiyun; Xie, Keliang; Wang, Chunyan; Yu, Yonghao; Wang, Guolin] Tianjin Res Inst Anesthesiol, Tianjin, Peoples R China; [Yang, Zhuo] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Tianjin Medical University; Nankai University	Wang, GL (corresponding author), Tianjin Med Univ, Dept Anesthesiol, Gen Hosp, Tianjin, Peoples R China.	wangguolinemail@126.com			National Natural Science Foundation of China [NSFC 30972847]; Key Projects in the Tianjin Science & Technology Pillar Program [12ZCZDSY03000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the Tianjin Science & Technology Pillar Program	This work was supported by the National Natural Science Foundation of China (NSFC 30972847) and Key Projects in the Tianjin Science & Technology Pillar Program (12ZCZDSY03000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks MI, 1999, ANESTHESIOLOGY, V90, P120, DOI 10.1097/00000542-199901000-00018; Cappuccio I, 2005, J NEUROSCI, V25, P2647, DOI 10.1523/JNEUROSCI.5230-04.2005; Carroll RC, 2002, TRENDS NEUROSCI, V25, P571, DOI 10.1016/S0166-2236(02)02272-5; Chen P, 2007, MOL PHARMACOL, V72, P40, DOI 10.1124/mol.107.034942; Chu LF, 2011, J PAIN, V12, P108, DOI 10.1016/j.jpain.2010.05.006; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Derrode N, 2003, BRIT J ANAESTH, V91, P842, DOI 10.1093/bja/aeg263; Dobashi T, 2010, NEUROSCI LETT, V485, P125, DOI 10.1016/j.neulet.2010.08.084; Giese KP, 2009, IUBMB LIFE, V61, P516, DOI 10.1002/iub.187; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Gris P, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-33; Guntz E, 2005, ANESTHESIOLOGY, V102, P1235, DOI 10.1097/00000542-200506000-00025; Hahnenkamp K, 2004, ANESTHESIOLOGY, V100, P1531, DOI 10.1097/00000542-200406000-00028; Hang LH, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13195; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Joly V, 2005, ANESTHESIOLOGY, V103, P147, DOI 10.1097/00000542-200507000-00022; Koppert W, 2007, BEST PRACT RES-CLIN, V21, P65, DOI 10.1016/j.bpa.2006.12.004; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lim HS, 2013, BIOL PHARM BULL, V36, P125, DOI 10.1248/bpb.b12-00760; Martins DF, 2011, J PAIN, V12, P315, DOI 10.1016/j.jpain.2010.06.007; Mazzardo-Martins L, 2012, NEUROSCIENCE, V226, P411, DOI 10.1016/j.neuroscience.2012.09.020; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nishimoto T, 2009, NEUROREPORT, V20, P161, DOI 10.1097/WNR.0b013e3283118450; Parkitna JR, 2006, J PHARMACOL EXP THER, V319, P832, DOI 10.1124/jpet.106.107581; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Ruscheweyh R, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-20; Shin SW, 2010, BRIT J ANAESTH, V105, P661, DOI 10.1093/bja/aeq257; Silverman SM, 2009, PAIN PHYSICIAN, V12, P679; Tian YT, 2010, NEUROSCI RES, V68, P167, DOI 10.1016/j.neures.2010.07.2030; Yang K, 2011, EUR J PHARMACOL, V670, P509, DOI 10.1016/j.ejphar.2011.09.009; Yao HB, 2002, J CHEM NEUROANAT, V23, P291, DOI 10.1016/S0891-0618(02)00014-5; Yuan Y, 2013, ANESTH ANALG, V116, P473, DOI 10.1213/ANE.0b013e318274e3f1; Zhao M, 2008, ANESTHESIOLOGY, V109, P308, DOI 10.1097/ALN.0b013e31817f4c5d; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhu LQ, 2010, J NEUROSCI, V30, P3624, DOI 10.1523/JNEUROSCI.5223-09.2010	42	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77790	10.1371/journal.pone.0077790	http://dx.doi.org/10.1371/journal.pone.0077790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147079	Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400134
J	Reilly, KJ; Spencer, KA				Reilly, Kevin J.; Spencer, Kristie A.			Sequence Complexity Effects on Speech Production in Healthy Speakers and Speakers with Hypokinetic or Ataxic Dysarthria	PLOS ONE			English	Article							SHORT-TERM-MEMORY; SYLLABLE FREQUENCY; PHONOLOGICAL SIMILARITY; PHONOTACTIC PROBABILITY; SERIAL ORDER; ARTICULATORY MOVEMENTS; PHONEMIC SIMILARITY; BASAL GANGLIA; MOTOR; CONSTRAINTS	The present study investigated the effects of sequence complexity, defined in terms of phonemic similarity and phonotoactic probability, on the timing and accuracy of serial ordering for speech production in healthy speakers and speakers with either hypokinetic or ataxic dysarthria. Sequences were comprised of strings of consonant-vowel (CV) syllables with each syllable containing the same vowel, /a/, paired with a different consonant. High complexity sequences contained phonemically similar consonants, and sounds and syllables that had low phonotactic probabilities; low complexity sequences contained phonemically dissimilar consonants and high probability sounds and syllables. Sequence complexity effects were evaluated by analyzing speech error rates and within-syllable vowel and pause durations. This analysis revealed that speech error rates were significantly higher and speech duration measures were significantly longer during production of high complexity sequences than during production of low complexity sequences. Although speakers with dysarthria produced longer overall speech durations than healthy speakers, the effects of sequence complexity on error rates and speech durations were comparable across all groups. These findings indicate that the duration and accuracy of processes for selecting items in a speech sequence is influenced by their phonemic similarity and/or phonotactic probability. Moreover, this robust complexity effect is present even in speakers with damage to subcortical circuits involved in serial control for speech.	[Reilly, Kevin J.] Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA; [Spencer, Kristie A.] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA	Northeastern University; University of Washington; University of Washington Seattle	Reilly, KJ (corresponding author), Northeastern Univ, Dept Speech Language Pathol & Audiol, Boston, MA 02115 USA.	k.reilly@neu.edu			National Institute on Deafness and Other Communication Disorders [1-F32-DC006782, 1-RO3-DC007066]; Human Subjects Recruitment Core [P30 DC004661]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC007066, P30DC004661, F32DC006782] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Human Subjects Recruitment Core; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was partially supported by Grants 1-F32-DC006782 and 1-RO3-DC007066 from the National Institute on Deafness and Other Communication Disorders and Grant P30 DC004661 (Human Subjects Recruitment Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann H, 1997, BRAIN LANG, V56, P312, DOI 10.1006/brln.1997.1851; Ackermann H, 2008, TRENDS NEUROSCI, V31, P265, DOI 10.1016/j.tins.2008.02.011; Ackermann H, 2007, CEREBELLUM, V6, P202, DOI 10.1080/14734220701266742; Alario FX, 2006, BRAIN RES, V1076, P129, DOI 10.1016/j.brainres.2005.11.104; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Bohland JW, 2010, J COGNITIVE NEUROSCI, V22, P1504, DOI 10.1162/jocn.2009.21306; Braitenberg V, 1997, BEHAV BRAIN SCI, V20, P229, DOI 10.1017/S0140525X9700143X; Brown JW, 2004, NEURAL NETWORKS, V17, P471, DOI 10.1016/j.neunet.2003.08.006; Carreiras M, 2006, HUM BRAIN MAPP, V27, P963, DOI 10.1002/hbm.20236; Chiu MJ, 1996, EUR NEUROL, V36, P310, DOI 10.1159/000117278; Cholin J, 2006, COGNITION, V99, P205, DOI 10.1016/j.cognition.2005.01.009; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P462, DOI 10.1044/jshr.1203.462; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Dell GS, 1997, PSYCHOL REV, V104, P123, DOI 10.1037/0033-295X.104.1.123; Dell GS, 2000, J EXP PSYCHOL LEARN, V26, P1355, DOI 10.1037//0278-7393.26.6.1355; Duffy JR., 2012, MOTOR SPEECH DISORDE; DWORKIN JP, 1986, J COMMUN DISORD, V19, P115, DOI 10.1016/0021-9924(86)90015-8; ELLIS AW, 1980, J VERB LEARN VERB BE, V19, P624, DOI 10.1016/S0022-5371(80)90672-6; Farrell S, 2004, J MEM LANG, V51, P115, DOI 10.1016/S0749-596X(04)00029-4; Frank MJ, 2011, CURR OPIN NEUROBIOL, V21, P381, DOI 10.1016/j.conb.2011.02.013; Goldrick M, 2004, J MEM LANG, V51, P586, DOI 10.1016/j.jml.2004.07.004; Goldrick M, 2008, COGNITION, V107, P1155, DOI 10.1016/j.cognition.2007.11.009; Goldrick M, 2006, LANG COGNITIVE PROC, V21, P649, DOI 10.1080/01690960500181332; Goldstein L, 2007, COGNITION, V103, P386, DOI 10.1016/j.cognition.2006.05.010; GORDON PC, 1987, LANGUAGE PERCEPTION, P445; Grossberg S, 2008, PSYCHOL REV, V115, P677, DOI 10.1037/a0012618; Hartley T, 1996, J MEM LANG, V35, P1, DOI 10.1006/jmla.1996.0001; Hertrich I, 1999, J SPEECH LANG HEAR R, V42, P367, DOI 10.1044/jslhr.4202.367; Ho AK, 1998, BRAIN LANG, V64, P122, DOI 10.1006/brln.1998.1959; Kendall DL, 2005, APHASIOLOGY, V19, P39, DOI 10.1080/02687030444000606; Kent RD, 2000, FOLIA PHONIATR LOGO, V52, P48, DOI 10.1159/000021512; Kent RD, 1997, FOLIA PHONIATR LOGO, V49, P63, DOI 10.1159/000266440; KENT RD, 1979, J SPEECH HEAR RES, V22, P627, DOI 10.1044/jshr.2203.627; Klapp ST, 2003, J MOTOR BEHAV, V35, P135, DOI 10.1080/00222890309602129; Klein D, 2006, HUM BRAIN MAPP, V27, P153, DOI 10.1002/hbm.20174; Kreisler A, 2000, NEUROLOGY, V54, P1117, DOI 10.1212/WNL.54.5.1117; Kroger B. J., 2010, SPEECH MOTOR CONTROL, P23; Laganaro M, 2006, J MEM LANG, V55, P178, DOI 10.1016/j.jml.2006.05.001; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; LEVELT WJM, 1991, PSYCHOL REV, V98, P122, DOI 10.1037/0033-295X.98.1.122; LEVELT WJM, 1994, COGNITION, V50, P239, DOI 10.1016/0010-0277(94)90030-2; LEVITT AG, 1985, J MEM LANG, V24, P717, DOI 10.1016/0749-596X(85)90055-5; Lewandowsky S, 2008, J MEM LANG, V58, P429, DOI 10.1016/j.jml.2007.01.005; LUDLOW CL, 1987, BRAIN LANG, V32, P195, DOI 10.1016/0093-934X(87)90124-6; MACKAY DG, 1982, PSYCHOL REV, V89, P483, DOI 10.1037/0033-295X.89.5.483; MACKAY DG, 1970, NEUROPSYCHOLOGIA, V8, P323, DOI 10.1016/0028-3932(70)90078-3; MEYER DE, 1985, J MEM LANG, V24, P3, DOI 10.1016/0749-596X(85)90013-0; Mueller ST, 2003, J EXP PSYCHOL LEARN, V29, P1353, DOI 10.1037/0278-7393.29.6.1353; Munson B, 2001, J SPEECH LANG HEAR R, V44, P778, DOI 10.1044/1092-4388(2001/061); Oppenheim GM, 2008, COGNITION, V106, P528, DOI 10.1016/j.cognition.2007.02.006; Page MPA, 2007, J MEM LANG, V56, P49, DOI 10.1016/j.jml.2006.09.002; Page MPA, 1998, PSYCHOL REV, V105, P761, DOI 10.1037/0033-295X.105.4.761-781; Papoutsi M, 2009, CEREB CORTEX, V19, P2156, DOI 10.1093/cercor/bhn239; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Peeva MG, 2010, NEUROIMAGE, V50, P626, DOI 10.1016/j.neuroimage.2009.12.065; Pickett ER, 1998, NEUROPSYCHOLOGIA, V36, P173, DOI 10.1016/S0028-3932(97)00065-1; Rauschecker AM, 2008, HUM BRAIN MAPP, V29, P1231, DOI 10.1002/hbm.20460; REILLY KJ, FRONT HUM NEUROSCI; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; Riecker A, 2008, BRAIN LANG, V107, P102, DOI 10.1016/j.bandl.2008.01.008; Riva D, 1998, CORTEX, V34, P279, DOI 10.1016/S0010-9452(08)70755-X; Rogers MA, 1998, J SPEECH LANG HEAR R, V41, P258, DOI 10.1044/jslhr.4102.258; Schweppe J, 2011, J MEM LANG, V64, P256, DOI 10.1016/j.jml.2010.11.006; SEVALD CA, 1994, COGNITION, V53, P91, DOI 10.1016/0010-0277(94)90067-1; Shuster LI, 2005, BRAIN LANG, V93, P20, DOI 10.1016/j.bandl.2004.07.007; Sidtis JJ, 2006, NEUROIMAGE, V31, P246, DOI 10.1016/j.neuroimage.2005.12.005; Spencer KA, 2005, BRAIN LANG, V94, P347, DOI 10.1016/j.bandl.2005.01.008; STERNBERG S, 1980, PERCEPTION PRODUCTIO, P507; Sternberg S., 1978, INFORMATION PROCESSI, P117, DOI DOI 10.1016/B978-0-12-665960-3.50011-6; Tjaden K, 2005, J SPEECH LANG HEAR R, V48, P554, DOI 10.1044/1092-4388(2005/038); van der Merwe A, 1997, COMSIG '97 - PROCEEDINGS OF THE 1997 SOUTH AFRICAN SYMPOSIUM ON COMMUNICATIONS AND SIGNAL PROCESSING, P1, DOI 10.1109/COMSIG.1997.629970; Vitevitch MS, 2004, BEHAV RES METH INS C, V36, P481, DOI 10.3758/BF03195594; Vitevitch MS, 2004, J EXP PSYCHOL LEARN, V30, P514, DOI 10.1037/0278-7393.30.2.514; YORKSTON KM, 1984, ASSESSMENT INTELLIGE; Yunusova Y, 2008, J SPEECH LANG HEAR R, V51, P596, DOI 10.1044/1092-4388(2008/043)	76	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77450	10.1371/journal.pone.0077450	http://dx.doi.org/10.1371/journal.pone.0077450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146997	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400108
J	Rumah, KR; Linden, J; Fischetti, VA; Vartanian, T				Rumah, Kareem Rashid; Linden, Jennifer; Fischetti, Vincent A.; Vartanian, Timothy			Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease	PLOS ONE			English	Article							MICROCYSTIC MACULAR EDEMA; HIGH-AFFINITY BINDING; INNER NUCLEAR LAYER; D EPSILON-TOXIN; FAROE-ISLANDS; INTESTINAL INFECTIONS; SHEEP; PATHOLOGY; BRAIN; MICE	We have isolated Clostridium perfringens type B, an epsilon toxin-secreting bacillus, from a young woman at clinical presentation of Multiple Sclerosis (MS) with actively enhancing lesions on brain MRI. This finding represents the first time that C. perfringens type B has been detected in a human. Epsilon toxin's tropism for the blood-brain barrier (BBB) and binding to oligodendrocytes/myelin makes it a provocative candidate for nascent lesion formation in MS. We examined a well-characterized population of MS patients and healthy controls for carriage of C. perfringens toxinotypes in the gastrointestinal tract. The human commensal Clostridium perfringens type A was present in approximately 50% of healthy human controls compared to only 23% in MS patients. We examined sera and CSF obtained from two tissue banks and found that immunoreactivity to ETX is 10 times more prevalent in people with MS than in healthy controls, indicating prior exposure to ETX in the MS population. C. perfringens epsilon toxin fits mechanistically with nascent MS lesion formation since these lesions are characterized by BBB permeability and oligodendrocyte cell death in the absence of an adaptive immune infiltrate.	[Rumah, Kareem Rashid] Rockefeller Univ, Tri Inst MD PhD Program, Weill Cornell Med Coll, New York, NY 10021 USA; [Rumah, Kareem Rashid] Mem Sloan Kettering Canc Ctr, New York, NY USA; [Rumah, Kareem Rashid; Linden, Jennifer; Vartanian, Timothy] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA; [Rumah, Kareem Rashid; Linden, Jennifer; Vartanian, Timothy] Weill Cornell Med Coll, Dept Neurol, New York, NY USA; [Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA	Cornell University; Rockefeller University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Rockefeller University	Vartanian, T (corresponding author), Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA.	tiv2002@med.cornell.edu		Vartanian, Timothy/0000-0001-9471-1855	Laurence Tisch Family Research Fund; Dr. Mortimer D. Sackler Family Fund for Neuroregenerative Research; Widgeon Point Charitable Foundation; Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Laurence Tisch Family Research Fund; Dr. Mortimer D. Sackler Family Fund for Neuroregenerative Research; Widgeon Point Charitable Foundation; Rockefeller University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was generously supported in part by The Laurence Tisch Family Research Fund, The Dr. Mortimer D. Sackler Family Fund for Neuroregenerative Research, The Widgeon Point Charitable Foundation, and the Rockefeller University Funds to the Laboratory of Bacterial Pathogenesis and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1952, AM J MED, V12, P510, DOI 10.1016/0002-9343(52)90234-9; Alqurashi Abdelrahman Mohammad, 2013, J Egypt Soc Parasitol, V43, P147; Bakshi R, 2008, LANCET NEUROL, V7, P615, DOI 10.1016/S1474-4422(08)70137-6; Balali-Mood M, 2013, TOXICON, V69, P131, DOI 10.1016/j.toxicon.2013.01.005; Barkhof F, 2003, ANN NEUROL, V53, P718, DOI 10.1002/ana.10551; BARNES D, 1991, BRAIN, V114, P1271, DOI 10.1093/brain/114.3.1271; Barnett MH, 2006, MULT SCLER, V12, P121, DOI 10.1191/135248506ms1304rr; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Barnett MH, 2009, ANN NEUROL, V65, P32, DOI 10.1002/ana.21524; Basilio D, 2011, J GEN PHYSIOL, V137, P343, DOI 10.1085/jgp.201010578; BLACKWELL TE, 1983, CAN J COMP MED, V47, P127; Bokori-Brown M, 2011, FEBS J, V278, P4589, DOI 10.1111/j.1742-4658.2011.08140.x; Bossi P, 2006, CELL MOL LIFE SCI, V63, P2196, DOI 10.1007/s00018-006-6308-z; Carman RJ, 2008, ANAEROBE, V14, P102, DOI 10.1016/j.anaerobe.2008.01.003; Chassin C, 2007, AM J PHYSIOL-RENAL, V293, pF927, DOI 10.1152/ajprenal.00199.2007; Christensen KA, 2005, BIOCHEMISTRY-US, V44, P1047, DOI 10.1021/bi047791s; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Doganay Mehmet, 2010, J Infect Public Health, V3, P98, DOI 10.1016/j.jiph.2010.07.004; Dorca-Arevalo J, 2008, VET MICROBIOL, V131, P14, DOI 10.1016/j.vetmic.2008.02.015; Dorca-Arevalo J, 2012, VET MICROBIOL, V157, P179, DOI 10.1016/j.vetmic.2011.12.020; ENGELL T, 1986, ACTA OPHTHALMOL, V64, P583; ERICKSON JE, 1978, APPL ENVIRON MICROB, V36, P567, DOI 10.1128/AEM.36.4.567-571.1978; FINNIE JW, 1984, J COMP PATHOL, V94, P445, DOI 10.1016/0021-9975(84)90031-8; FINNIE JW, 1992, AUST VET J, V69, P261, DOI 10.1111/j.1751-0813.1992.tb09878.x; FINNIE JW, 1984, J COMP PATHOL, V94, P363, DOI 10.1016/0021-9975(84)90024-0; Garcia JP, 2013, INFECT IMMUN, V81, P2405, DOI 10.1128/IAI.00238-13; Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Ghabriel MN, 2000, ACTA NEUROCHIR SUPPL, V76, P231; GLEESONWHITE MH, 1955, LANCET, V1, P384; Goldstein J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007065; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; HAVARD HL, 1992, FEMS MICROBIOL LETT, V97, P77, DOI 10.1111/j.1574-6968.1992.tb05443.x; HOROWITZ AL, 1989, AM J NEURORADIOL, V10, P303; ITODO AE, 1986, VET MICROBIOL, V12, P93, DOI 10.1016/0378-1135(86)90045-3; KERRISON JB, 1994, RETINA-J RET VIT DIS, V14, P445, DOI 10.1097/00006982-199414050-00010; Kitadokoro K, 2011, J BIOL CHEM, V286, P19549, DOI 10.1074/jbc.M111.228478; Kundi M, 2007, CIENC SAUDE COLETIVA, V12, P419, DOI 10.1590/S1413-81232007000200018; KURTZKE JF, 1979, ANN NEUROL, V5, P6, DOI 10.1002/ana.410050104; KURTZKE JF, 1986, NEUROLOGY, V36, P307, DOI 10.1212/WNL.36.3.307; KURTZKE JF, 1993, CLIN MICROBIOL REV, V6, P382, DOI 10.1128/CMR.6.4.382-427.1993; Kurtzke JF, 2001, J CLIN EPIDEMIOL, V54, P1, DOI 10.1016/S0895-4356(00)00268-7; KURTZKE JF, 1982, NEUROLOGY, V32, P143, DOI 10.1212/WNL.32.2.143; KURTZKE JF, 1988, NEUROEPIDEMIOLOGY, V7, P190, DOI 10.1159/000110154; KURTZKE JF, 1995, ACTA NEUROL SCAND, V91, P321, DOI 10.1111/j.1600-0404.1995.tb07015.x; Li JH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002429; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 1996, BRAIN PATHOL, V6, P259, DOI 10.1111/j.1750-3639.1996.tb00854.x; Meer RR, 1997, AM J VET RES, V58, P702; Miyakawa MEF, 2003, ANAEROBE, V9, P145, DOI 10.1016/S1075-9964(03)00069-6; Miyakawa MEF, 2003, VET RES COMMUN, V27, P231, DOI 10.1023/A:1023348708599; Miyata S, 2002, J BIOL CHEM, V277, P39463, DOI 10.1074/jbc.M206731200; MORABIA A, 1991, EPIDEMIOLOGY, V2, P367, DOI 10.1097/00001648-199109000-00010; MURRELL TGC, 1986, MED HYPOTHESES, V19, P27, DOI 10.1016/0306-9877(86)90134-9; Nablo BJ, 2008, BIOPHYS J, V95, P1157, DOI 10.1529/biophysj.107.121715; NAGAHAMA M, 1992, INFECT IMMUN, V60, P1237, DOI 10.1128/IAI.60.3.1237-1240.1992; NAGAHAMA M, 1991, TOXICON, V29, P211, DOI 10.1016/0041-0101(91)90105-Z; Petit L, 1997, J BACTERIOL, V179, P6480, DOI 10.1128/jb.179.20.6480-6487.1997; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popoff MR, 2011, FEBS J, V278, P4602, DOI 10.1111/j.1742-4658.2011.08145.x; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI 10.2217/FMB.09.72; Prineas JW, 2012, ANN NEUROL, V72, P18, DOI 10.1002/ana.23634; Robertson SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022053; RUCKER CW, 1972, MAYO CLIN PROC, V47, P335; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Souza AM, 2010, GENET MOL RES, V9, P266, DOI 10.4238/vol9-1gmr711; Tamai E, 2003, INFECT IMMUN, V71, P5371, DOI 10.1128/IAI.71.9.5371-5375.2003; Uzal FA, 2004, J VET DIAGN INVEST, V16, P403, DOI 10.1177/104063870401600506; Uzal FA, 2004, ANAEROBE, V10, P135, DOI 10.1016/j.anaerobe.2003.08.005; Uzal FA, 2008, J VET DIAGN INVEST, V20, P253, DOI 10.1177/104063870802000301; VINEIS P, 1991, THEOR MED, V12, P171, DOI 10.1007/BF00489797; Wioland L, 2013, TOXICON, V75, P122, DOI 10.1016/j.toxicon.2013.04.003; Zhu C, 2001, EXP NEUROL, V169, P72, DOI 10.1006/exnr.2001.7652	74	125	129	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76359	10.1371/journal.pone.0076359	http://dx.doi.org/10.1371/journal.pone.0076359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146858	gold, Green Submitted, Green Published			2022-12-27	WOS:000326019400055
J	Wolfram, L; Fischbeck, A; Frey-Wagner, I; Wojtal, KA; Lang, S; Fried, M; Vavricka, SR; Hausmann, M; Rogler, G				Wolfram, Lutz; Fischbeck, Anne; Frey-Wagner, Isabelle; Wojtal, Kacper A.; Lang, Silvia; Fried, Michael; Vavricka, Stephan R.; Hausmann, Martin; Rogler, Gerhard			Regulation of the Expression of Chaperone gp96 in Macrophages and Dendritic Cells	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; ENDOPLASMIC-RETICULUM STRESS; MOLECULAR CHAPERONES; PHYLOGENETIC CONSERVATION; SCAVENGER RECEPTOR; ER STRESS; DIFFERENTIATION; INFLAMMATION; INDUCTION; MONOCYTE	The chaperone function of the ER-residing heat shock protein gp96 plays an important role in protein physiology and has additionally important immunological functions due to its peptide-binding capacity. Low amounts of gp96 stimulate immunity; high quantities induce tolerance by mechanisms not fully understood. A lack of gp96 protein in intestinal macrophages (IMACs) from Crohns disease (CD) patients correlates with loss of tolerance against the host gut flora, leading to chronic inflammation. Since gp96 shows dose-dependent direction of immunological reactions, we studied primary IMACs and developed cell models to understand the regulation of gp96 expression. Induction of gp96-expression was higher in in vitro differentiated dendritic cells (i.v.DCs) than in in vitro differentiated macrophages (i.v.MACs), whereas monocytes (MOs) expressed only low gp96 levels. The highest levels of expression were found in IMACs. Lipopolysaccharide (LPS), muramyl dipeptide (MDP), tumour necrosis factor (TNF), and Interleukin (IL)-4 induced gp96-expression, while IL12, IL-17, IL-23 and interferon (IFN)-gamma were not effective indicating that Th1 and Th17 cells are probably not involved in the induction of gp96. Furthermore, gp96 was able to induce its own expression. The ER-stress inducer tunicamycin increased gp96-expression in a concentration-and time-dependent manner. Both ulcerative colitis (UC) and CD patients showed significantly elevated gp96 mRNA levels in intestinal biopsies which correlated positively with the degree of inflammation of the tissue. Since gp96 is highly expressed on the one hand upon stress induction as during inflammation and on the other hand possibly mediating tolerance, these results will help to understand the whether gp96 plays a role in the pathophysiology of inflammatory bowel disease (IBD).	[Wolfram, Lutz; Fischbeck, Anne; Frey-Wagner, Isabelle; Wojtal, Kacper A.; Lang, Silvia; Fried, Michael; Vavricka, Stephan R.; Hausmann, Martin; Rogler, Gerhard] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Rogler, G (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	gerhard.rogler@usz.ch	Rogler, Gerhard/O-5308-2015	Rogler, Gerhard/0000-0002-1733-9188; Hausmann, Martin/0000-0002-0696-0251	Swiss National Science Foundation [310030-120312, 320000-114009/3, 32473B_135694/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by a research grant from the Swiss National Science Foundation (http://www.snf.ch; Grant No. 310030-120312 to GR and Grant No. 320000-114009/3 and 32473B_135694/1 to SRV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee PP, 2002, J IMMUNOL, V169, P3507, DOI 10.4049/jimmunol.169.7.3507; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Berwin B, 2004, J BIOL CHEM, V279, P51250, DOI 10.1074/jbc.M406202200; Berwin B, 2003, EMBO J, V22, P6127, DOI 10.1093/emboj/cdg572; Berwin B, 2001, TRAFFIC, V2, P690, DOI 10.1034/j.1600-0854.2001.21003.x; Binder RJ, 2004, P NATL ACAD SCI USA, V101, P6128, DOI 10.1073/pnas.0308180101; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cario E, 2008, CURR OPIN GASTROEN, V24, P725, DOI 10.1097/MOG.0b013e32830c4341; Chen YG, 2003, CELL STRESS CHAPERON, V8, P242, DOI 10.1379/1466-1268(2003)008<0242:IOHSPG>2.0.CO;2; Davies EL, 2006, CLIN EXP IMMUNOL, V145, P183, DOI 10.1111/j.1365-2249.2006.03109.x; Han J, 2010, PLOS ONE, V5, P1; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kaser A, 2010, CURR OPIN GASTROENTE, V3; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Klappacher GW, 2002, CELL, V109, P169, DOI 10.1016/S0092-8674(02)00714-6; Kranzer K, 2004, INFECT IMMUN, V72, P4416, DOI 10.1128/IAI.72.8.4416-4423.2004; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; Lammert E, 1997, EUR J IMMUNOL, V27, P923, DOI 10.1002/eji.1830270418; LEE SH, 1985, J EXP MED, V161, P475, DOI 10.1084/jem.161.3.475; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mahida YR, 2000, INFLAMM BOWEL DIS, V6, P21, DOI 10.1097/00054725-200002000-00004; Maloy KJ, 2008, J INTERN MED, V263, P584, DOI 10.1111/j.1365-2796.2008.01950.x; Mao C, 2010, PLOS ONE, V5, P1; Matsutake Toyoshi, 2010, Cancer Immun, V10, P7; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Pockley A, 2007, METHODS, V43; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Robert J, 2001, EUR J IMMUNOL, V31, P186, DOI 10.1002/1521-4141(200101)31:1<186::AID-IMMU186>3.0.CO;2-D; Robert J, 2008, J IMMUNOL, V180, P3176, DOI 10.4049/jimmunol.180.5.3176; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; Schild H, 2000, NAT IMMUNOL, V1, P100, DOI 10.1038/77770; Schreiter K, 2005, GUT, V54, P935, DOI 10.1136/gut.2004.053116; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Singh-Jasuja H, 2000, CELL STRESS CHAPERON, V5, P462, DOI 10.1379/1466-1268(2000)005<0462:THSPGA>2.0.CO;2; Spoettl T, 2007, WORLD J GASTROENTERO, V13, P1032, DOI 10.3748/wjg.v13.i7.1032; Spottl T, 2001, J LEUKOCYTE BIOL, V70, P241; Stoilova D, 2000, CELL STRESS CHAPERON, V5, P395; Suriano R, 2009, GLYCOBIOLOGY, V19, P1427, DOI 10.1093/glycob/cwp096; SUTO R, 1995, SCIENCE, V269, P1585, DOI 10.1126/science.7545313; Suzuki S, 2010, BIOCHEM BIOPH RES CO, V398, P525, DOI 10.1016/j.bbrc.2010.06.112; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; Tsan MF, 2009, J LEUKOCYTE BIOL, V85, P905, DOI 10.1189/jlb.0109005; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Wang XH, 2005, CANCER IMMUNOL IMMUN, V54, P971, DOI 10.1007/s00262-005-0662-9; Wojtal KA, 2009, DRUG METAB DISPOS, V37, P1871, DOI 10.1124/dmd.109.027367	52	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76350	10.1371/journal.pone.0076350	http://dx.doi.org/10.1371/journal.pone.0076350			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146856	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000326019400054
J	Dolfi, DV; Mansfield, KD; Kurupati, RK; Kannan, S; Doyle, SA; Ertl, HCJ; Schmader, KE; Wherry, EJ				Dolfi, Douglas V.; Mansfield, Kathleen D.; Kurupati, Raj K.; Kannan, Senthil; Doyle, Susan A.; Ertl, Hildegund C. J.; Schmader, Kenneth E.; Wherry, E. John			Vaccine-Induced Boosting of Influenza Virus-Specific CD4 T Cells in Younger and Aged Humans	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; MEDIATED PROTECTION; FUNCTIONAL DEFECTS; LIFE-SPAN; A-VIRUS; RESPONSES; MEMORY; MECHANISMS; ANTIBODY; NUCLEOPROTEIN	Current yearly influenza virus vaccines induce strain-specific neutralizing antibody (NAb) responses providing protective immunity to closely matched viruses. However, these vaccines are often poorly effective in high-risk groups such as the elderly and challenges exist in predicting yearly or emerging pandemic influenza virus strains to include in the vaccines. Thus, there has been considerable emphasis on understanding broadly protective immunological mechanisms for influenza virus. Recent studies have implicated memory CD4 T cells in heterotypic immunity in animal models and in human challenge studies. Here we examined how influenza virus vaccination boosted CD4 T cell responses in younger versus aged humans. Our results demonstrate that while the magnitude of the vaccine-induced CD4 T cell response and number of subjects responding on day 7 did not differ between younger and aged subjects, fewer aged subjects had peak responses on day 14. While CD4 T cell responses were inefficiently boosted against NA, both HA and especially nucleocaspid protein- and matrix-(NP+M) specific responses were robustly boosted. Pre-existing CD4 T cell responses were associated with more robust responses to influenza virus NP+M, but not H1 or H3. Finally pre-existing strain-specific NAb decreased the boosting of CD4 T cell responses. Thus, accumulation of pre-existing influenza virus-specific immunity in the form of NAb and cross-reactive T cells to conserved virus proteins (e. g. NP and M) over a lifetime of exposure to infection and vaccination may influence vaccine-induced CD4 T cell responses in the aged.	[Dolfi, Douglas V.; Mansfield, Kathleen D.; Wherry, E. John] Univ Penn, Dept Microbiol, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kurupati, Raj K.; Kannan, Senthil; Ertl, Hildegund C. J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Doyle, Susan A.; Schmader, Kenneth E.] Duke Univ, Med Ctr, Dept Med, Div Geriatr, Durham, NC 27710 USA; [Doyle, Susan A.; Schmader, Kenneth E.] Durham VA Med Ctr, Geriatr Res Educ & Clin Ctr, Durham, NC USA; [Kannan, Senthil] Univ Penn, Biomed Grad Grp, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute; Duke University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of Pennsylvania	Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Wherry, John/ABI-1280-2020	Kannan, Senthil/0000-0001-9218-7578	BAA [26620050030C]; NIA [P30-AG028716];  [A1078897];  [AI082630];  [AI083022]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083022, U19AI082630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716] Funding Source: NIH RePORTER	BAA; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by A1078897, AI082630, and AI083022 to E.J.W. and BAA 26620050030C to HCJE, KES, and EJW and NIA P30-AG028716 to KES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf S, 2011, VACCINE, V29, P3990, DOI 10.1016/j.vaccine.2011.03.066; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Berthoud TK, 2011, CLIN INFECT DIS, V52, P1, DOI 10.1093/cid/ciq015; Bethell D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059674; Bodewes R, 2011, J VIROL, V85, P11995, DOI 10.1128/JVI.05213-11; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554; Co MDT, 2008, VACCINE, V26, P1990, DOI 10.1016/j.vaccine.2008.02.024; Co MDT, 2009, VACCINE, V27, P319, DOI 10.1016/j.vaccine.2008.09.092; Dolfi DV, 2013, J LEUKOCYTE BIOL, V93, P825, DOI 10.1189/jlb.0912438; ERNST DN, 1990, J IMMUNOL, V145, P1295; Garcia-Canas V, 2007, ANAL CHEM, V79, P3164, DOI 10.1021/ac0621120; Garcia-Canas V, 2006, J CHROMATOGR A, V1123, P225, DOI 10.1016/j.chroma.2006.04.003; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Kang IS, 2004, J IMMUNOL, V173, P673, DOI 10.4049/jimmunol.173.1.673; Kang KS, 2013, CLIN IMMUNOL, V147, P79, DOI 10.1016/j.clim.2013.02.022; Koch S, 2008, IMMUN AGEING, V5, DOI [10.1186/1742-4933-5-6, 10.1186/1742-4933-5-11]; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lucas M, 2004, J VIROL, V78, P7284, DOI 10.1128/JVI.78.13.7284-7287.2004; Luo J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-286; Mahnke YD, 2011, VACCINE, V29, P8606, DOI 10.1016/j.vaccine.2011.09.019; Mbawuike I, 2007, VACCINE, V25, P3263, DOI 10.1016/j.vaccine.2007.01.073; McElhaney JE, 2011, AGEING RES REV, V10, P379, DOI 10.1016/j.arr.2010.10.008; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; Naylor K, 2005, J IMMUNOL, V174, P7446, DOI 10.4049/jimmunol.174.11.7446; Richards KA, 2012, VACCINE, V31, P219, DOI 10.1016/j.vaccine.2012.10.039; Strutt TM, 2012, P NATL ACAD SCI USA, V109, pE2551, DOI 10.1073/pnas.1205894109; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Terajima M, 2008, J VIROL, V82, P9283, DOI 10.1128/JVI.01047-08; Tsukamoto H, 2010, J IMMUNOL, V185, P4535, DOI 10.4049/jimmunol.1001668; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; Wagar LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023698; Weaver JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057275; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zhou X, 2011, VACCINE, V29, P2169, DOI 10.1016/j.vaccine.2010.12.029	42	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77164	10.1371/journal.pone.0077164	http://dx.doi.org/10.1371/journal.pone.0077164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155927	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300061
J	Gomez-Cabello, D; Jimeno, S; Fernandez-Avila, MJ; Huertas, P				Gomez-Cabello, Daniel; Jimeno, Sonia; Jesus Fernandez-Avila, Maria; Huertas, Pablo			New Tools to Study DNA Double-Strand Break Repair Pathway Choice	PLOS ONE			English	Article							END RESECTION; HOMOLOGOUS RECOMBINATION; CHECKPOINT ACTIVATION; DAMAGE RESPONSE; INSTABILITY; MECHANISM; INSIGHTS	A broken DNA molecule is difficult to repair, highly mutagenic, and extremely cytotoxic. Such breaks can be repaired by homology-independent or homology-directed mechanisms. Little is known about the network that controls the repair pathway choice except that a licensing step for homology-mediated repair exists, called DNA-end resection. The choice between these two repair pathways is a key event for genomic stability maintenance, and an imbalance of the ratio is directly linked with human diseases, including cancer. Here we present novel reporters to study the balance between both repair options in human cells. In these systems, a double-strand break can be alternatively repaired by homology-independent or -dependent mechanisms, leading to the accumulation of distinct fluorescent proteins. These reporters thus allow the balance between both repair pathways to be analyzed in different experimental setups. We validated the reporters by analyzing the effect of protein downregulation of the DNA end resection and non-homologous end-joining pathways. Finally, we analyzed the role of the DNA damage response on double-strand break (DSB) repair mechanism selection. Our reporters could be used in the future to understand the roles of specific factors, whole pathways, or drugs in DSB repair pathway choice, or for genome-wide screening. Moreover, our findings can be applied to increase gene-targeting efficiency, making it a beneficial tool for a broad audience in the biological sciences.	[Gomez-Cabello, Daniel; Jimeno, Sonia; Jesus Fernandez-Avila, Maria; Huertas, Pablo] Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain; [Jimeno, Sonia; Huertas, Pablo] Univ Seville, Dept Genet, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla	Huertas, P (corresponding author), Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Seville, Spain.	pablo.huertas@cabimer.es	Jimeno, Sonia/C-2514-2017; Jimeno González, Sonia/GJM-5073-2022; Gómez-Cabello, Daniel/AAJ-7788-2021; Huertas, Pablo/N-2245-2016	Jimeno González, Sonia/0000-0002-7034-0081; Gómez-Cabello, Daniel/0000-0002-2807-8438; Huertas, Pablo/0000-0002-1756-4449; Fernandez Avila, Maria Jesus/0000-0001-8476-9922	Spanish Ministry of Economy and Competitivity [SAF2010-14877]; European Research Council (ERC)	Spanish Ministry of Economy and Competitivity(Spanish Government); European Research Council (ERC)(European Research Council (ERC)European Commission)	This work has been funded by a R+D+I grant from the Spanish Ministry of Economy and Competitivity (SAF2010-14877) and an European Research Council (ERC) Starting Grant (DSBRECA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aylon Y, 2004, MUTAT RES-REV MUTAT, V566, P231, DOI 10.1016/j.mrrev.2003.10.001; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FISHMANLOBELL J, 1992, MOL CELL BIOL, V12, P1292, DOI 10.1128/MCB.12.3.1292; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Munoz-Galvan S, 2013, NUCLEIC ACIDS RES, V41, P1669, DOI 10.1093/nar/gks1274; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Wang HC, 2005, CANCER RES, V65, P4020, DOI 10.1158/0008-5472.CAN-04-3055; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	28	30	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77206	10.1371/journal.pone.0077206	http://dx.doi.org/10.1371/journal.pone.0077206			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155929	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300063
J	Taylor, ML; Evans, JP; Garcia-Gonzalez, F				Taylor, Michelle L.; Evans, Jonathan P.; Garcia-Gonzalez, Francisco			No Evidence for Heritability of Male Mating Latency or Copulation Duration across Social Environments in Drosophila melanogaster	PLOS ONE			English	Article							SEXUAL SELECTION; FERTILIZATION SUCCESS; GENETIC VARIANCE; MATE CHOICE; SPERM COMPETITION; FEMALE FITNESS; FIELD CRICKET; COURTSHIP; QUALITY; RELIABILITY	A key assumption underpinning major models of sexual selection is the expectation that male sexual attractiveness is heritable. Surprisingly, however, empirical tests of this assumption are relatively scarce. Here we use a paternal full-sib/half-sib breeding design to examine genetic and environmental variation in male mating latency (a proxy for sexual attractiveness) and copulation duration in a natural population of Drosophila melanogaster. As our experimental design also involved the manipulation of the social environment within each full-sibling family, we were able to further test for the presence of genotype-by-environment interactions (GEIs) in these traits, which have the potential to compromise mate choice for genetic benefits. Our experimental manipulation of the social environment revealed plastic expression of both traits; males exposed to a rival male during the sensitive period of adult sexual maturation exhibited shorter mating latencies and longer copulation durations than those who matured in isolation. However, we found no evidence for GEIs, and no significant additive genetic variation underlying these traits in either environment. These results undermine the notion that the evolution of female choice rests on covariance between female preference and male displays, an expectation that underpins indirect benefit models such as the good genes and sexy sons hypotheses. However, our results may also indicate depletion of genetic variance in these traits in the natural population studied, thus supporting the expectation that traits closely aligned with reproductive fitness can exhibit low levels of additive genetic variance.	[Taylor, Michelle L.] Univ Exeter, Ctr Ecol & Conservat, Penryn, England; [Evans, Jonathan P.; Garcia-Gonzalez, Francisco] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, WA, Australia; [Garcia-Gonzalez, Francisco] Spanish Res Council CSIC, Biol Donana Stn, Seville, Spain	University of Exeter; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC)	Taylor, ML (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, England.	m.l.taylor@exeter.ac.uk	Evans, Jonathan/A-1992-2011; Garcia-Gonzalez, Francisco/A-3780-2008	Garcia-Gonzalez, Francisco/0000-0001-9515-9038; Taylor, Michelle/0000-0001-5435-9623	Australian Research Council; Spanish Ministry of Economy through the Ramon y Cajal program; European Regional Development Fund [CGL2012-34685]	Australian Research Council(Australian Research Council); Spanish Ministry of Economy through the Ramon y Cajal program; European Regional Development Fund(European Commission)	Funding for this work was provided by the Australian Research Council Discovery Projects and ARC fellowships) to JPE and FGG. During the preparation of the manuscript FGG was also supported by the the Spanish Ministry of Economy through the Ramon y Cajal program and grant (co-funded by the European Regional Development Fund) CGL2012-34685. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; Arnqvist Goran, 2005, pUnpaginated; Bates D, 2013, ME4 LINEAR MIXED EFF; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Boake CRB, 1998, EVOLUTION, V52, P1487, DOI 10.1111/j.1558-5646.1998.tb02030.x; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Bretman A, 2009, P ROY SOC B-BIOL SCI, V276, P1705, DOI 10.1098/rspb.2008.1878; Bussiere LF, 2008, GENETICA, V134, P69, DOI 10.1007/s10709-007-9220-z; Byrne PG, 2005, J EVOLUTION BIOL, V18, P1324, DOI 10.1111/j.1420-9101.2005.00918.x; Conner JK, 2003, EVOLUTION, V57, P487, DOI 10.1111/j.0014-3820.2003.tb01540.x; Core R Team, 2013, R LANG ENV STAT COMP; Danielson-Francois AM, 2006, J EVOLUTION BIOL, V19, P532, DOI 10.1111/j.1420-9101.2005.01006.x; David P, 2000, NATURE, V406, P186, DOI 10.1038/35018079; Fisher RA, 1930, GENETICAL THEORY NAT; Garcia-Gonzalez F, 2004, BEHAV ECOL, V15, P23, DOI 10.1093/beheco/arg095; Garcia-Gonzalez F, 2012, EVOLUTION, V66, P2341, DOI 10.1111/j.1558-5646.2011.01565.x; Garcia-Gonzalez F, 2011, EVOLUTION, V65, P746, DOI 10.1111/j.1558-5646.2010.01127.x; Garcia-Gonzalez F, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-140; Greenfield MD, 2004, ANIM BEHAV, V68, P1461, DOI 10.1016/j.anbehav.2004.01.014; Hansen TF, 2011, EVOL BIOL, V38, P258, DOI 10.1007/s11692-011-9127-6; Higginson AD, 2009, P ROY SOC B-BIOL SCI, V276, P1153, DOI 10.1098/rspb.2008.1592; Hine E, 2002, P ROY SOC B-BIOL SCI, V269, P2215, DOI 10.1098/rspb.2002.2149; HOFFMANN AA, 1991, AM NAT, V138, P668, DOI 10.1086/285241; Hoffmann AA, 1999, HEREDITY, V82, P158, DOI 10.1038/sj.hdy.6884640; Hosken DJ, 2008, CURR BIOL, V18, pR553, DOI 10.1016/j.cub.2008.04.028; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; HOULE D, 1992, GENETICS, V130, P195; Ingleby FC, 2010, J EVOLUTION BIOL, V23, P2031, DOI 10.1111/j.1420-9101.2010.02080.x; Kelly CD, 2011, BIOL REV, V86, P863, DOI 10.1111/j.1469-185X.2011.00175.x; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2008, GENETICA, V132, P209, DOI 10.1007/s10709-007-9166-1; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; Lize A, 2012, BIOL LETTERS, V8, P35, DOI 10.1098/rsbl.2011.0544; Lynch M., 1998, GENETICS ANAL QUANTI; Mills SC, 2007, EVOLUTION, V61, P1748, DOI 10.1111/j.1558-5646.2007.00145.x; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; Petfield D, 2005, P NATL ACAD SCI USA, V102, P6045, DOI 10.1073/pnas.0409378102; Priest NK, 2008, AM NAT, V171, P10, DOI 10.1086/523944; Rodriguez RL, 2003, EVOLUTION, V57, P1304, DOI 10.1111/j.0014-3820.2003.tb00338.x; Roff DA, 2008, HEREDITY, V100, P32, DOI 10.1038/sj.hdy.6801048; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; Rundle HD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-36; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P129, DOI 10.1007/BF02395441; StatSoft Inc, 2007, TAT DAT AN SOFTW SYS; Stewart AD, 2008, J EVOLUTION BIOL, V21, P1808, DOI 10.1111/j.1420-9101.2008.01593.x; Svetec N, 2005, CURR BIOL, V15, pR790, DOI 10.1016/j.cub.2005.09.034; Svetec N, 2005, J EXP BIOL, V208, P891, DOI 10.1242/jeb.01454; Taylor ML, 2008, ANIM BEHAV, V76, P963, DOI 10.1016/j.anbehav.2008.05.015; Taylor ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P721, DOI 10.1007/s00265-007-0497-9; Taylor ML, 2007, CURR BIOL, V17, pR959, DOI 10.1016/j.cub.2007.09.054; Thomas ML, 2011, ANIM BEHAV, V82, P49, DOI 10.1016/j.anbehav.2011.03.023; Thomas ML, 2009, BEHAV ECOL, V20, P1118, DOI 10.1093/beheco/arp105; Watson NL, 2012, EVOL ECOL, V26, P139, DOI 10.1007/s10682-011-9484-8; Weir LK, 2011, AM NAT, V177, P167, DOI 10.1086/657918; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036	61	10	11	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77347	10.1371/journal.pone.0077347	http://dx.doi.org/10.1371/journal.pone.0077347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155948	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300082
J	Blasco, R; Rosell, J; Cuartero, F; Peris, JF; Gopher, A; Barkai, R				Blasco, Ruth; Rosell, Jordi; Cuartero, Felipe; Fernandez Peris, Josep; Gopher, Avi; Barkai, Ran			Using Bones to Shape Stones: MIS 9 Bone Retouchers at Both Edges of the Mediterranean Sea	PLOS ONE			English	Article							BOLOMOR CAVE VALENCIA; QESEM CAVE; SITE; ATAPUERCA; CUTMARKS; REMAINS; BURGOS; SIERRA	A significant challenge in Prehistory is to understand the mechanisms involved in the behavioural evolution of human groups. The degree of technological and cultural development of prehistoric groups is assessed mainly through stone tools. However, other elements can provide valuable information as well. This paper presents two bone retouchers dated to the Middle Pleistocene MIS 9 used for the shaping of lithic artefacts. Originating from Bolomor Cave (Spain) and Qesem Cave (Israel), these two bone retouchers are among the earliest of the Old World. Although the emergence of such tools might be found in the latest phases of the Acheulean, their widespread use seems to coincide with independently emergent post-Acheulean cultural complexes at both ends of the Mediterranean Sea: the post-Acheulean/pre-Mousterian of Western Europe and the Acheulo Yabrudian Cultural Complex of the Levant. Both entities seem to reflect convergent processes that may be viewed in a wider cultural context as reflecting new technology-related behavioural patterns as well as new perceptions in stone tool manufacturing.	[Rosell, Jordi] URV, Area Prehist, Tarragona, Spain; [Rosell, Jordi] Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Cuartero, Felipe] Univ Autonoma Madrid, Dept Prehist & Arqueol, Madrid, Spain; [Fernandez Peris, Josep] Museo Prehist, SIP, Valencia, Spain; [Gopher, Avi; Barkai, Ran] Tel Aviv Univ, Inst Archaeol, IL-69978 Tel Aviv, Israel	Universitat Rovira i Virgili; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Autonomous University of Madrid; Tel Aviv University		rblascolopez@gmail.com	Barkai, Ran/L-6495-2019; Blasco, Ruth/AAG-8200-2019; Rosell, Jordi/G-8705-2015; CUARTERO MONTEAGUDO, FELIPE/S-8690-2016	Blasco, Ruth/0000-0001-9804-739X; Rosell, Jordi/0000-0002-6758-6291; CUARTERO MONTEAGUDO, FELIPE/0000-0002-9024-2980; BARKAI, RAN/0000-0002-8125-8788	Spanish Ministry of Science and Innovation [CGL2012-38434-C03-03, CGL2012-38358, CGL-BOS-2012-34717]; Generalitat de Catalunya [2009 SGR 188]; Israel Science Foundation; CARE Archaeological Foundation; Leakey Foundation; Wenner-Gren Foundation; Thyssen Foundation; European Union	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Israel Science Foundation(Israel Science Foundation); CARE Archaeological Foundation; Leakey Foundation; Wenner-Gren Foundation; Thyssen Foundation; European Union(European Commission)	The Bolomor excavation is part of the program of archaeological excavations conducted by the SIP (Prehistoric Investigation Service) of the Prehistory Museum of Valencia under the authority of the Provincial Council of Valencia, Spain. The research is supported with funding from the Spanish Ministry of Science and Innovation, project nos. CGL2012-38434-C03-03, CGL2012-38358, CGL-BOS-2012-34717 and from Generalitat de Catalunya, 2009 SGR 188. The Qesem Cave excavation project is supported by the Israel Science Foundation, CARE Archaeological Foundation, Leakey Foundation, Wenner-Gren Foundation, and Thyssen Foundation. R. Blasco is a Beatriu de Pinos-A post-doctoral scholarship recipient from Generalitat de Catalunya and co-financed by the European Union through Marie Curie Actions, FP7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimene M., 1998, ACT 18 RENC INT ARCH, P193; and D., 1998, EC PREHISTORIQUE COM; Anzidei A.P., 2001, WORLD ELEPHANTS, P415; Auguste P., 2002, RETOUCHOIRS COMPRESS, P39; Barkai R., 2009, HUM EVOL, V24, P57; Barkai R., 2005, EURASIAN PREHISTORY, V3, P39; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Ben-Dor M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028689; Biddittu I, 2001, WORLD ELEPHANTS, P91; Blasco R, 2013, QUATERNARY SCI REV, V70, P124, DOI 10.1016/j.quascirev.2013.03.008; Blasco R, 2012, QUATERN INT, V252, P16, DOI 10.1016/j.quaint.2011.03.019; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Boschian G, 2010, QUATERN INT, V214, P3, DOI 10.1016/j.quaint.2009.10.016; BROMAGE TG, 1984, AM J PHYS ANTHROPOL, V65, P359, DOI 10.1002/ajpa.1330650404; Costa AG, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P23, DOI 10.1007/978-1-4419-6861-6_2; d'Errico F, 2009, J ARCHAEOL SCI, V36, P1764, DOI 10.1016/j.jas.2009.04.005; Daujeard C, 2010, J ANTHROPOL ARCHAEOL, V29, P368, DOI 10.1016/j.jaa.2010.05.002; de Gruchy S, 2002, J FORENSIC SCI, V47, P933; Dobosi, 2001, WORLD ELEPHANTS, P429; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046414; Fernandez Peris J., 2007, SERIE TRABAJOS VARIO, V108; Peris JF, 2012, QUATERN INT, V247, P267, DOI 10.1016/j.quaint.2010.10.014; Fumanal M.P., 1993, CUADERNOS GEOGRAFIA, V54, P223; Gaudzinski S, 2005, QUATERN INT, V126, P179, DOI 10.1016/j.quaint.2004.04.022; Giacobini G., 1998, ATT 13 C UISPP, P167; Gopher A, 2010, QUAT GEOCHRONOL, V5, P644, DOI 10.1016/j.quageo.2010.03.003; Guillem P., 1995, CUATERNARIO PAIS VAL, P227; Hershkovitz I, 2011, AM J PHYS ANTHROPOL, V144, P575, DOI 10.1002/ajpa.21446; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Langlois A, 2004, SUJET CHEVAL MICOQUE, V1; Arsuaga JL, 2012, J HUM EVOL, V62, P629, DOI 10.1016/j.jhevol.2012.02.002; Mallye JB, 2012, J ARCHAEOL SCI, V39, P1131, DOI 10.1016/j.jas.2011.12.018; Mania D., 2005, INDIVIDUAL HOMINID C, P98; Martinez Valle R., 1995, FAUNA CUATERNARIA PA, P235; Mercier N, 2013, J ARCHAEOL SCI, V40, P3011, DOI 10.1016/j.jas.2013.03.002; Moncel MH, 2012, J HUM EVOL, V63, P653, DOI 10.1016/j.jhevol.2012.08.001; Holgueras MM, 2009, TRABAJOS PREHIST, V66, P27, DOI 10.3989/tp.2009.09011; Passemard E, 1922, REV ARCHEOLOGIQUE, V15, P1; Patou-Mathis M., 2002, RETOUCHOIRS COMPRESS; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Rabinovich R, 2012, QUATERN INT, V276, P183, DOI 10.1016/j.quaint.2012.05.009; Roberts M, 1999, ENGLISH HERITAGE MON, V17; Rosell J, 2011, J HUM EVOL, V61, P125, DOI 10.1016/j.jhevol.2011.02.001; Sacca D, 2012, QUATERN INT, V276, P27, DOI 10.1016/j.quaint.2012.03.055; Serra AS, 2008, COMPLUTUM, V19, P25; SEGRE A, 1984, CURR ANTHROPOL, V25, P230, DOI 10.1086/203117; Shimelmitz R, 2011, J HUM EVOL, V61, P458, DOI 10.1016/j.jhevol.2011.06.003; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Smith GM, 2013, J ARCHAEOL SCI, V40, P3754, DOI 10.1016/j.jas.2013.05.002; Stiner MC, 2011, J HUM EVOL, V60, P213, DOI 10.1016/j.jhevol.2010.10.006; Stiner MC, 2009, P NATL ACAD SCI USA, V106, P13207, DOI 10.1073/pnas.0900564106; Tartar E, 2009, OUTIL CARACTERISATIO; Tartar E, 2002, ETUDE FONCTIONNELLE; Tixier J., 1982, STUDIA PRAEHISTORICA, V2, P13; Verna C, 2011, J HUM EVOL, V60, P145, DOI 10.1016/j.jhevol.2010.07.027; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Wenban-Smith FF., 1999, BOXGROVE MIDDLE PLEI, P384	58	69	69	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76780	10.1371/journal.pone.0076780	http://dx.doi.org/10.1371/journal.pone.0076780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146928	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400083
J	Devi, L; Ohno, M				Devi, Latha; Ohno, Masuo			Deletion of the eIF2 alpha Kinase GCN2 Fails to Rescue the Memory Decline Associated with Alzheimer's Disease	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; BETA-SECRETASE; GENE-EXPRESSION; TRANSGENIC MICE; MOUSE MODELS; NEURON LOSS; PHOSPHORYLATION; DEFICITS	Emerging evidence suggests that dysregulated translation through phosphorylation of eukaryotic initiation factor-alpha a (eIF alpha a) may contribute to Alzheimer's disease (AD) and related memory impairments. However, the underlying mechanisms remain unclear. Here, we crossed knockout mice for an eIF2 alpha kinase (GCN2: general control nonderepressible-2 kinase) with 5XFAD transgenic mice, and investigated whether GCN2 deletion affects AD-like traits in this model. As observed in AD brains, 5XFAD mice recapitulated significant elevations in the beta-secretase enzyme BACE1 and the CREB repressor ATF4 concomitant with a dramatic increase of eIF2a phosphorylation. Contrary to expectation, we found that GCN2(-/-) and GCN2(+/-) deficiencies aggravate rather than suppress hippocampal BACE1 and ATF4 elevations in 5XFAD mice, failing to rescue memory deficits as tested by the contextual fear conditioning. The facilitation of these deleterious events resulted in exacerbated b-amyloid accumulation, plaque pathology and CREB dysfunction in 5XFAD mice with GCN2 mutations. Notably, GCN2 deletion caused overactivation of the PKR-endoplasmic reticulum-related kinase (PERK)-dependent eIF2a phosphorylation pathway in 5XFAD mice in the absence of changes in the PKR pathway. Moreover, PERK activation in response to GCN2 deficiency was specific to 5XFAD mice, since phosphorylated PERK levels were equivalent between GCN2(+/-) and wild-type control mice. Our findings suggest that GCN2 may be an important eIF2a kinase under the physiological condition, whereas blocking the GCN2 pathway under exposure to significant beta-amyloidosis rather aggravates eIF2 alpha phosphorylation leading to BACE1 and ATF4 elevations in AD.	[Devi, Latha; Ohno, Masuo] Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY USA; [Ohno, Masuo] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center	Ohno, M (corresponding author), Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY USA.	mohno@nki.rfmh.org			American Health Assistance Foundation [A2011311]; National Institutes of Health [AG044703]	American Health Assistance Foundation(BrightFocus Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the American Health Assistance Foundation grant (A2011311 to MO) and the National Institutes of Health grant (AG044703 to MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang RCC, 2002, NEUROREPORT, V13, P2429, DOI 10.1097/00001756-200212200-00011; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2008, PROG BRAIN RES, V169, P81, DOI 10.1016/S0079-6123(07)00005-2; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Devi L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-34; Devi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012974; Devi L, 2010, EUR J NEUROSCI, V31, P110, DOI 10.1111/j.1460-9568.2009.07031.x; Donnelly N, 2013, CELL MOL LI IN PRESS; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Jawhar S., 2012, NEUROBIOL AGING, V33, pe129, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.027, DOI 10.1016/j.neurobiolaging.2010.05.027]; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Kim HS, 2007, J NEUROSCI RES, V85, P1528, DOI 10.1002/jnr.21267; Kimura R, 2010, J NEUROCHEM, V113, P248, DOI 10.1111/j.1471-4159.2010.06608.x; Kimura R, 2009, NEUROBIOL DIS, V33, P229, DOI 10.1016/j.nbd.2008.10.006; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010489; Leroy K, 2012, AM J PATHOL, V181, P1928, DOI 10.1016/j.ajpath.2012.08.012; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2001, NAT NEUROSCI, V4, P1238, DOI 10.1038/nn771; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Ohno M, 2009, NEUROBIOL LEARN MEM, V92, P455, DOI 10.1016/j.nlm.2009.05.001; Page G, 2006, NEUROSCIENCE, V139, P1343, DOI 10.1016/j.neuroscience.2006.01.047; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Viana RJS, 2012, MOL NEUROBIOL, V46, P522, DOI 10.1007/s12035-012-8301-x; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007	41	43	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77335	10.1371/journal.pone.0077335	http://dx.doi.org/10.1371/journal.pone.0077335			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146979	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400109
J	Pong, WW; Walker, J; Wylie, T; Magrini, V; Luo, JQ; Emnett, RJ; Choi, J; Cooper, ML; Griffith, M; Griffith, OL; Rubin, JB; Fuller, GN; Piwnica-Worms, D; Feng, X; Hambardzumyan, D; DiPersio, JF; Mardis, ER; Gutmann, DH				Pong, Winnie W.; Walker, Jason; Wylie, Todd; Magrini, Vincent; Luo, Jingqin; Emnett, Ryan J.; Choi, Jaebok; Cooper, Matthew L.; Griffith, Malachi; Griffith, Obi L.; Rubin, Joshua B.; Fuller, Gregory N.; Piwnica-Worms, David; Feng, Xi; Hambardzumyan, Dolores; DiPersio, John F.; Mardis, Elaine R.; Gutmann, David H.			F11R Is a Novel Monocyte Prognostic Biomarker for Malignant Glioma	PLOS ONE			English	Article							JUNCTIONAL ADHESION MOLECULE; GENE-EXPRESSION; IN-VIVO; CELL; MICROGLIA; IDENTIFICATION; TRANSCRIPTS; RELEVANT; REVEALS; ROLES	Objective: Brain tumors (gliomas) contain large populations of infiltrating macrophages and recruited microglia, which in experimental murine glioma models promote tumor formation and progression. Among the barriers to understanding the contributions of these stromal elements to high-grade glioma (glioblastoma; GBM) biology is the relative paucity of tools to characterize infiltrating macrophages and resident microglia. In this study, we leveraged multiple RNA analysis platforms to identify new monocyte markers relevant to GBM patient outcome. Methods: High-confidence lists of mouse resident microglia-and bone marrow-derived macrophage-specific transcripts were generated using converging RNA-seq and microarray technologies and validated using qRT-PCR and flow cytometry. Expression of select cell surface markers was analyzed in brain-infiltrating macrophages and resident microglia in an induced GBM mouse model, while allogeneic bone marrow transplantation was performed to trace the origins of infiltrating and resident macrophages. Glioma tissue microarrays were examined by immunohistochemistry, and the Gene Expression Omnibus (GEO) database was queried to determine the prognostic value of identified microglia biomarkers in human GBM. Results: We generated a unique catalog of differentially-expressed bone marrow-derived monocyte and resident microglia transcripts, and demonstrated that brain-infiltrating macrophages acquire F11R expression in GBM and following bone-marrow transplantation. Moreover, mononuclear cell F11R expression positively correlates with human high-grade glioma and additionally serves as a biomarker for GBM patient survival, regardless of GBM molecular subtype. Significance: These studies establish F11R as a novel monocyte prognostic marker for GBM critical for defining a subpopulation of stromal cells for future potential therapeutic intervention.	[Pong, Winnie W.; Emnett, Ryan J.; Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Walker, Jason; Wylie, Todd; Magrini, Vincent; Griffith, Malachi; Griffith, Obi L.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Luo, Jingqin] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Cooper, Matthew L.; DiPersio, John F.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Rubin, Joshua B.] Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA; [Fuller, Gregory N.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO USA; [Piwnica-Worms, David] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Feng, Xi; Hambardzumyan, Dolores] Cleveland Clin Fdn, Dept Stem Cell Biol & Regenerat, Cleveland, OH 44195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Cleveland Clinic Foundation	Gutmann, DH (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	gutmannd@neuro.wustl.edu	Magrini, Vincent/AAT-5830-2020; Griffith, Malachi/P-1285-2014; Mardis, Elaine/W-2202-2019; Feng, Xi/N-7160-2016; Griffith, Obi/P-1286-2014	Magrini, Vincent/0000-0002-2019-4872; Griffith, Malachi/0000-0002-6388-446X; Feng, Xi/0000-0002-6920-1519; Pong, Winnie/0000-0001-8254-3305; Griffith, Obi/0000-0002-0843-4271; Choi, Jaebok/0000-0002-5590-087X; Gutmann, David/0000-0002-3127-5045; Fuller, Gregory/0000-0001-9447-2647	National Cancer Institute [U01-CA160882, U01-CA141549]; National Institutes of Health [RC4-NS072916]; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [U01CA160882, P30CA091842, U01CA141549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC4NS072916] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Cancer Institute (U01-CA160882 to DH and DHG; U01-CA141549 to DHG) and National Institutes of Health (RC4-NS072916 to DHG). WWP was partly supported by a grant from the W. M. Keck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Bengtsson H, 2008, TECH REP, P1; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Cooper LAD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012548; Daginakatte GC, 2007, HUM MOL GENET, V16, P1098, DOI 10.1093/hmg/ddm059; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engler JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043339; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Levy A, 2012, NEURO-ONCOLOGY, V14, P1037, DOI 10.1093/neuonc/nos121; Liu Y, 2000, J CELL SCI, V113, P2363; Mandell KJ, 2005, J BIOL CHEM, V280, P11665, DOI 10.1074/jbc.M412650200; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Markovic DS, 2011, BRAIN BEHAV IMMUN, V25, P624, DOI 10.1016/j.bbi.2011.01.015; Murakami M, 2010, CANCER RES, V70, P1759, DOI 10.1158/0008-5472.CAN-09-1703; Pong WW, 2013, ANN NEUROL, V73, P303, DOI 10.1002/ana.23813; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Rodero M, 2008, J CLIN ONCOL, V26, P5957, DOI 10.1200/JCO.2008.17.2833; Roggendorf W, 1996, ACTA NEUROPATHOL, V92, P288, DOI 10.1007/s004010050520; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Simmons GW, 2011, J NEUROPATH EXP NEUR, V70, P51, DOI 10.1097/NEN.0b013e3182032d37; Stamatovic SM, 2012, MOL CELL BIOL, V32, P3414, DOI 10.1128/MCB.06678-11; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Williams LA, 1999, MOL IMMUNOL, V36, P1175, DOI 10.1016/S0161-5890(99)00122-4; Woodfin A, 2007, BLOOD, V110, P1848, DOI 10.1182/blood-2006-09-047431; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	41	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77571	10.1371/journal.pone.0077571	http://dx.doi.org/10.1371/journal.pone.0077571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147027	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400126
J	Sainio, A; Nyman, M; Lund, R; Vuorikoski, S; Bostrom, P; Laato, M; Bostrom, PJ; Jarvelainen, H				Sainio, Annele; Nyman, Marie; Lund, Riikka; Vuorikoski, Sanna; Bostrom, Pia; Laato, Matti; Bostrom, Peter J.; Jarvelainen, Hannu			Lack of Decorin Expression by Human Bladder Cancer Cells Offers New Tools in the Therapy of Urothelial Malignancies	PLOS ONE			English	Article							LEUCINE-RICH PROTEOGLYCANS; BREAST-CANCER; EXTRACELLULAR-MATRIX; GENE; BIGLYCAN; PROTEIN; CARCINOMA; ORGANIZATION; MODULATION; TISSUES	Decorin, a multifunctional small leucine-rich extracellular matrix proteoglycan, has been shown to possess potent antitumour activity. However, there is some uncertainty whether different cancer cells express decorin in addition to nonmalignant stromal cells. In this study we clarified decorin expression by human bladder cancer cells both in vivo and in vitro. In addition, the effect of adenovirus-mediated decorin expression on human bladder cancer cells in vitro was examined. We first demonstrated using the publicly available GeneSapiens databank that decorin gene expression is present in both normal and malignant human bladder tissues. However, when we applied in situ hybridization with digoxigenin-labeled RNA probes for decorin on human bladder carcinoma tissue samples derived from a large radical cystectomy patient cohort (n = 199), we unambiguously demonstrated that invasive and non-invasive bladder carcinoma cells completely lack decorin mRNA. The cancer cells were also negative for decorin immunoreactivity. Instead, decorin expression was localized solely to original non-malignant stromal areas of bladder tissue. In accordance with the aforementioned results, human bladder cancer cells in vitro were also negative for decorin expression as shown by RT-qPCR analyses. The lack of decorin expression by bladder cancer cells was shown not to be due to the methylation of the proximal promoter region of the decorin gene. When bladder cancer cells were transfected with a decorin adenoviral vector, their proliferation was significantly decreased. In conclusion, we have shown that human bladder cancer cells are totally devoid of decorin expression. We have also shown that adenovirus-mediated decorin gene transduction of human bladder cancer cell lines markedly inhibits their proliferation. Thus, decorin gene delivery offers new potential therapeutic tools in urothelial malignancies.	[Sainio, Annele; Nyman, Marie; Jarvelainen, Hannu] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Lund, Riikka; Vuorikoski, Sanna] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Lund, Riikka; Vuorikoski, Sanna] Abo Akad Univ, Turku, Finland; [Bostrom, Pia] Univ Turku, Dept Pathol, Turku, Finland; [Jarvelainen, Hannu] Turku Univ Hosp, Dept Endocrinol, Div Med, FIN-20520 Turku, Finland; [Laato, Matti; Bostrom, Peter J.] Turku Univ Hosp, Dept Urol, Div Digest Surg & Urol, FIN-20520 Turku, Finland	University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku	Jarvelainen, H (corresponding author), Univ Turku, Dept Med Biochem & Genet, Turku, Finland.	hanjar@utu.fi	Sainio, Annele/R-3140-2019; Lund, Riikka/AAW-7853-2020; Lund, Riikka/K-2441-2019	Sainio, Annele/0000-0002-6284-5696; Lund, Riikka/0000-0002-1068-5918; Bostrom, Peter/0000-0003-3647-0015	Medical Research Fund (EVO) of Turku University Hospital; Cancer Foundations of South-Western Finland; Foundation of Ida Montin; Oskar Oflunds Stiftelse; Finnish Cultural Foundation/Varsinais-Suomi Regional Fund, Biocenter Finland; Academy of Finland; University of Turku	Medical Research Fund (EVO) of Turku University Hospital; Cancer Foundations of South-Western Finland; Foundation of Ida Montin; Oskar Oflunds Stiftelse; Finnish Cultural Foundation/Varsinais-Suomi Regional Fund, Biocenter Finland; Academy of Finland(Academy of Finland); University of Turku	Financially this study was supported by Medical Research Fund (EVO) of Turku University Hospital, Cancer Foundations of South-Western Finland, Foundation of Ida Montin, Oskar Oflunds Stiftelse, The Finnish Cultural Foundation/Varsinais-Suomi Regional Fund, Biocenter Finland, Academy of Finland, and University of Turku. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADANY R, 1990, J BIOL CHEM, V265, P11389; Augoff K, 2008, MED SCI MONITOR, V14, pCR530; Banerjee Abhijit G, 2003, Mol Cancer, V2, P34, DOI 10.1186/1476-4598-2-34; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Bostrom P, 2013, HISTOCHEM CELL BIOL, V139, P161, DOI 10.1007/s00418-012-1026-0; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; DANIELSON KG, 1993, GENOMICS, V15, P146, DOI 10.1006/geno.1993.1022; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Iozzo RV, 2011, J BIOL CHEM, V286, P34712, DOI 10.1074/jbc.M111.262766; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Iozzo RV, 1996, FASEB J, V10, P598, DOI 10.1096/fasebj.10.5.8621059; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; KOBE B, 1993, NATURE, V366, P751, DOI 10.1038/366751a0; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; Lu J, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-33; Maclejewski CC, 2012, J UROLOGY, V188, P1543, DOI 10.1016/j.juro.2012.03.045; Morrione A, 2013, FEBS J, V280, P2138, DOI 10.1111/febs.12149; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Pucci-Minafra I, 2008, CONNECT TISSUE RES, V49, P30, DOI 10.1080/03008200701820443; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Reed CC, 2002, ONCOGENE, V21, P3688, DOI 10.1038/sj.onc.1205470; Salomaki HH, 2008, J HISTOCHEM CYTOCHEM, V56, P639, DOI 10.1369/jhc.2008.950287; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; SCHOLZEN T, 1994, J BIOL CHEM, V269, P28270; Shen ZC, 2008, PHARM RES-DORDR, V25, P1500, DOI 10.1007/s11095-008-9566-7; Shridhar V, 2001, CANCER RES, V61, P5895; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Troup S, 2003, CLIN CANCER RES, V9, P207; Vecchione A, 2009, ONCOGENE, V28, P257, DOI 10.1038/onc.2008.381; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	38	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76190	10.1371/journal.pone.0076190	http://dx.doi.org/10.1371/journal.pone.0076190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146840	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400047
J	Stapinski, LA; Montgomery, AA; Heron, J; Jerrim, J; Vignoles, A; Araya, R				Stapinski, Lexine A.; Montgomery, Alan A.; Heron, Jon; Jerrim, John; Vignoles, Anna; Araya, Ricardo			Depression Symptom Trajectories and Associated Risk Factors among Adolescents in Chile	PLOS ONE			English	Article							PROBLEM-SOLVING ALTERNATIVES; NEGATIVE LIFE EVENTS; PSYCHIATRIC-DISORDERS; MENTAL-DISORDERS; PSYCHOMETRIC PROPERTIES; GENDER-DIFFERENCES; MAJOR DEPRESSION; CONTROLLED-TRIAL; SEX-DIFFERENCES; ANXIETY	Adolescence is a key period for studying the development of depression, with studies in Europe and North America showing a pattern of elevated risk that begins in early adolescence and continues to increase as adolescents age. Few studies have examined the course of adolescent depression and associated risk factors in low and middle-income countries. This longitudinal cohort study examined depression symptom trajectories and risk factors in a sample of socio-economically disadvantaged adolescents in Chile (n = 2,508). Data were collected over an 18-month period as part of a clinical trial for secondary students aged 12 to 18 (median age 14). Clinical levels of depression were prevalent in this sample at baseline (35% for girls and 28% for boys); yet latent growth models of symptom trajectories revealed a pattern of decreasing symptoms over time. There was evidence of an anxiety-depression developmental pathway for girls, with elevated anxiety levels initially predicting poorer depression outcomes later on. Poor problem-solving skills were associated with initial depression levels but did not predict the course of depressive symptoms. Critically, the declining symptom trajectories raise important methodological issues regarding the effects of repeated assessment in longitudinal studies.	[Stapinski, Lexine A.; Montgomery, Alan A.; Heron, Jon; Araya, Ricardo] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Jerrim, John; Vignoles, Anna] Univ London, Inst Educ, London WC1N 1AZ, England; [Vignoles, Anna] Univ Cambridge, Fac Educ, Cambridge, England	University of Bristol; University of London; University College London; UCL Institute of Education; University of Cambridge	Stapinski, LA (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	Lexine.Stapinski@bristol.ac.uk	Heron, Jon/D-5884-2011; Araya, Ricardo/S-3144-2019	Heron, Jon/0000-0001-6199-5644; Araya, Ricardo/0000-0002-0420-5148; Stapinski, Lexine/0000-0002-3656-4655; Montgomery, Alan/0000-0003-0450-1606; Jerrim, John/0000-0001-5705-7954	Wellcome Trust [082584 Z/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This project was funded by the Wellcome Trust (project number 082584 Z/07/Z; http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1993, J CHILD PSYCHOL PSYC, V34, P743, DOI 10.1111/j.1469-7610.1993.tb01068.x; Adams J, 1996, J CHILD PSYCHOL PSYC, V37, P715, DOI 10.1111/j.1469-7610.1996.tb01463.x; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; ARANEDA RM, 2008, TER PSICOL, V26, P59; Araya R, 2001, BRIT J PSYCHIAT, V178, P228, DOI 10.1192/bjp.178.3.228; Araya R, 2013, JAMA PEDIATR, V167, P1004, DOI 10.1001/jamapediatrics.2013.2361; Araya R, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-122; Araya R, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-49; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Barrocas AL, 2011, J ABNORM CHILD PSYCH, V39, P489, DOI 10.1007/s10802-010-9482-2; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; Bierut LJ, 1999, ARCH GEN PSYCHIAT, V56, P557, DOI 10.1001/archpsyc.56.6.557; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1427, DOI 10.1097/00004583-199611000-00011; Birmaher B, 2002, CHILD ADOL PSYCH CL, V11, P619, DOI 10.1016/S1056-4993(02)00011-1; BLOCK JH, 1991, J PERS SOC PSYCHOL, V60, P726, DOI 10.1037/0022-3514.60.5.726; BRADY EU, 1992, PSYCHOL BULL, V111, P244, DOI 10.1037/0033-2909.111.2.244; BRESLAU N, 1995, PSYCHIAT RES, V58, P1, DOI 10.1016/0165-1781(95)02765-O; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Campbell D.T., 1999, PRIMER REGRESSION AR; CANTOR D, 1995, INT STAT REV, V63, P173, DOI DOI 10.2307/1403612; Chaplin TM, 2009, J EARLY ADOLESCENCE, V29, P307, DOI 10.1177/0272431608320125; Cole DA, 1998, J CONSULT CLIN PSYCH, V66, P451, DOI 10.1037/0022-006X.66.3.451; Cole DA, 2002, J ABNORM PSYCHOL, V111, P156, DOI 10.1037//0021-843X.111.1.156; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Cumsille P., 1997, REV CHIL PEDIATR-CHI, V68, P74, DOI [10.4067/S0370, DOI 10.4067/S0370, DOI 10.4067/S0370-41061997000200003]; Curran PJ, 1997, J CONSULT CLIN PSYCH, V65, P130, DOI 10.1037/0022-006X.65.1.130; DZURILLATJ, 2002, TECHNICAL MANUAL; Espada JP, 2012, PREV SCI, V13, P86, DOI 10.1007/s11121-011-0249-y; Frye AA, 2000, COGNITIVE THER RES, V24, P637, DOI 10.1023/A:1005583210589; Gazelle H, 2003, CHILD DEV, V74, P257, DOI 10.1111/1467-8624.00534; GE XJ, 1994, DEV PSYCHOL, V30, P467, DOI 10.1037/0012-1649.30.4.467; GIACONIA RM, 1994, J AM ACAD CHILD PSY, V33, P706, DOI 10.1097/00004583-199406000-00012; GOODMAN SH, 1995, J ABNORM CHILD PSYCH, V23, P473, DOI 10.1007/BF01447209; Hale WW, 2009, J CHILD PSYCHOL PSYC, V50, P1218, DOI 10.1111/j.1469-7610.2009.02115.x; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hankin BL, 2001, PSYCHOL BULL, V127, P773, DOI 10.1037//0033-2909.127.6.773; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jenkins RJ, 2009, DRUG ALCOHOL DEPEN, V100, P107, DOI 10.1016/j.drugalcdep.2008.09.016; JERRIM J, 2011, 1101 DOQSS U LOND I; Joinson C, 2011, BRIT J PSYCHIAT, V198, P17, DOI 10.1192/bjp.bp.110.080861; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; Kessler R C, 1998, Depress Anxiety, V7, P3, DOI 10.1002/(SICI)1520-6394(1998)7:1<3::AID-DA2>3.0.CO;2-F; Kline R.B., 2011, PRINCIPLES PRACTICE; KOVACS M, 1989, ARCH GEN PSYCHIAT, V46, P776; Lee LC, 2002, J AM ACAD CHILD PSY, V41, P419, DOI 10.1097/00004583-200204000-00014; Lewinsohn PM, 2003, J ABNORM PSYCHOL, V112, P353, DOI 10.1037/0021-843X.112.3.353; LEWINSOHN PM, 1994, J AM ACAD CHILD PSY, V33, P809, DOI 10.1097/00004583-199407000-00006; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Maraun MD, 2011, THEOR PSYCHOL, V21, P762, DOI 10.1177/0959354310384910; Maydeu-Olivares A, 2000, PERS INDIV DIFFER, V29, P699, DOI 10.1016/S0191-8869(99)00226-3; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Merry S, 2004, J AM ACAD CHILD PSY, V43, P538, DOI 10.1097/00004583-200405000-00007; Muthen L, 2007, MUTH N MUTH N; NESSELROADE JR, 1980, PSYCHOL BULL, V88, P622, DOI 10.1037/0033-2909.88.3.622; NEZU AM, 1985, J CONSULT CLIN PSYCH, V53, P693, DOI 10.1037/0022-006X.53.5.693; ORVASCHEL H, 1995, J AM ACAD CHILD PSY, V34, P1525, DOI 10.1097/00004583-199511000-00020; Osman A, 2008, J CLIN PSYCHOL, V64, P83, DOI 10.1002/jclp.20433; Ostermann T, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-52; Rao Uma, 2009, Dialogues Clin Neurosci, V11, P45; Rice F, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-43; Roberts C, 2003, J CONSULT CLIN PSYCH, V71, P622, DOI 10.1037/0022-006X.71.3.622; Rogosa D., 1995, ANAL CHANGE, P3; Rose AJ, 2006, PSYCHOL BULL, V132, P98, DOI 10.1037/0033-2909.132.1.98; Sampson SM, 2001, CURR OPIN PEDIATR, V13, P586, DOI 10.1097/00008480-200112000-00017; Sandin B., 2010, REV PSICOPATOLOGIA P, V15, P165, DOI [DOI 10.5944/RPPC.VOL.15.NUM.3.2010.4095, 10.5944/rppc.vol.15.num.3.2010.4095]; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Sawyer MG, 2009, J AFFECT DISORDERS, V117, P48, DOI 10.1016/j.jad.2008.12.013; Schumacker RE, 2010, BEGINNERS GUIDE STRU; Sharpe JP, 1998, PERS INDIV DIFFER, V24, P457, DOI 10.1016/S0191-8869(97)00193-1; Sheffield JK, 2006, J CONSULT CLIN PSYCH, V74, P66, DOI 10.1037/0022-006X.74.1.66; Silberg JL, 2001, BIOL PSYCHIAT, V49, P1040, DOI 10.1016/S0006-3223(01)01161-1; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Spence SH, 2002, J CLIN CHILD ADOLESC, V31, P219, DOI 10.1207/153744202753604494; Stallard P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6058; Stallard P, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-114; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Twenge JM, 2002, J ABNORM PSYCHOL, V111, P578, DOI 10.1037//0021-843X.111.4.578; Vera-Villarroel P, 2010, PSYCHOL REP, V106, P65, DOI 10.2466/PR0.106.1.65-77; Vicente B, 2004, BRIT J PSYCHIAT, V184, P299, DOI 10.1192/bjp.184.4.299; Vicente B, 2012, INT J MENT HEALTH, V41, P7, DOI 10.2753/IMH0020-7411410101; Vicente B, 2012, J CHILD PSYCHOL PSYC, V53, P1026, DOI 10.1111/j.1469-7610.2012.02566.x; Woodward LJ, 2001, J AM ACAD CHILD PSY, V40, P1086, DOI 10.1097/00004583-200109000-00018	84	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e78323	10.1371/journal.pone.0078323	http://dx.doi.org/10.1371/journal.pone.0078323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	236SL	24147131	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400152
J	Kariu, T; Smith, A; Yang, XL; Pal, U				Kariu, Toru; Smith, Alexis; Yang, Xiuli; Pal, Utpal			A Chitin Deacetylase-Like Protein Is a Predominant Constituent of Tick Peritrophic Membrane That Influences the Persistence of Lyme Disease Pathogens within the Vector	PLOS ONE			English	Article							OUTER-MEMBRANE; MATRIX; TRANSMISSION; PENETRATION; LEISHMANIA; COMPLEXES; INFECTION; INVASION; BINDING	Ixodes scapularis is the specific arthropod vector for a number of globally prevalent infections, including Lyme disease caused by the bacterium Borrelia burgdorferi. A feeding-induced and acellular epithelial barrier, known as the peritrophic membrane (PM) is detectable in I. scapularis. However, whether or how the PM influences the persistence of major tick-borne pathogens, such as B. burgdorferi, remains largely unknown. Mass spectrometry-based proteome analyses of isolated PM from fed ticks revealed that the membrane contains a few detectable proteins, including a predominant and immunogenic 60 kDa protein with homology to arthropod chitin deacetylase (CDA), herein termed I. scapularis CDA-like protein or IsCDA. Although IsCDA is primarily expressed in the gut and induced early during tick feeding, its silencing via RNA interference failed to influence either the occurrence of the PM or spirochete persistence, suggesting a redundant role of IsCDA in tick biology and host-pathogen interaction. However, treatment of ticks with antibodies against IsCDA, one of the most predominant protein components of PM, affected B. burgdorferi survival, significantly augmenting pathogen levels within ticks but without influencing the levels of total gut bacteria. These studies suggested a preferential role of tick PM in limiting persistence of B. burgdorferi within the vector. Further understanding of the mechanisms by which vector components contribute to pathogen survival may help the development of new strategies to interfere with the infection.	[Pal, Utpal] Univ Maryland Coll Pk, Dept Vet Med, College Pk, MD 20742 USA; Univ Maryland Coll Pk, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Pal, U (corresponding author), Univ Maryland Coll Pk, Dept Vet Med, College Pk, MD 20742 USA.	upal@umd.edu	Pal, Utpal/I-5265-2015		National Institutes of Health [AI080615]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080615, R56AI080615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the funding from National Institutes of Health (AI080615). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897; Cho YW, 2000, BIOMACROMOLECULES, V1, P609, DOI 10.1021/bm000036j; Dixit R, 2008, INSECT BIOCHEM MOLEC, V38, P440, DOI 10.1016/j.ibmb.2007.12.002; Guo W, 2005, INSECT BIOCHEM MOLEC, V35, P1224, DOI 10.1016/j.ibmb.2005.06.003; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Jakubowska AK, 2010, J VIROL, V84, P2547, DOI 10.1128/JVI.01860-09; Kariu Toru, 2011, J Vis Exp, DOI 10.3791/2544; Kariu T, 2013, MOL MICROBIOL, V88, P510, DOI 10.1111/mmi.12202; Kato N, 2008, VECTOR-BORNE ZOONOT, V8, P701, DOI 10.1089/vbz.2007.0270; Kumar Manish, 2011, Vaccine, V29, P9012, DOI 10.1016/j.vaccine.2011.09.035; Kumar M, 2010, J INFECT DIS, V201, P1084, DOI 10.1086/651172; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Langer RC, 2001, TRENDS PARASITOL, V17, P269, DOI 10.1016/S1471-4922(01)01918-3; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pal U., 2010, BORRELIA MOL BIOL HO, P279; Pimenta PFP, 1997, PARASITOLOGY, V115, P359, DOI 10.1017/S0031182097001510; Promnares K, 2009, MOL MICROBIOL, V74, P112, DOI 10.1111/j.1365-2958.2009.06853.x; RUDZINSKA MA, 1982, CELL TISSUE RES, V221, P471; SCHLEIN Y, 1991, P ROY SOC B-BIOL SCI, V245, P121, DOI 10.1098/rspb.1991.0097; Schulenburg H, 2007, MOL IMMUNOL, V44, P3338, DOI 10.1016/j.molimm.2007.02.019; Tellam RL, 2000, INSECT BIOCHEM MOLEC, V30, P1189, DOI 10.1016/S0965-1748(00)00097-7; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Toprak U, 2008, INSECT MOL BIOL, V17, P573, DOI 10.1111/j.1365-2583.2008.00829.x; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Yang XL, 2011, J PROTEOME RES, V10, P4556, DOI 10.1021/pr200395b; Yang XL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000326; Zhang XY, 2009, J INFECT DIS, V200, P1318, DOI 10.1086/605846; ZHU Z, 1991, PARASITOL RES, V77, P635, DOI 10.1007/BF00931028	31	24	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78376	10.1371/journal.pone.0078376	http://dx.doi.org/10.1371/journal.pone.0078376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147133	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200097
J	Finley, R; Glass-Kaastra, SK; Hutchinson, J; Patrick, DM; Weiss, K; Conly, J				Finley, Rita; Glass-Kaastra, Shiona K.; Hutchinson, Jim; Patrick, David M.; Weiss, Karl; Conly, John			Declines in Outpatient Antimicrobial Use in Canada (1995-2010)	PLOS ONE			English	Article							ANTIBIOTIC USE; RESISTANCE; SURVEILLANCE; IMPACT	Background: With rising reports of antimicrobial resistance in outpatient communities, surveillance of antimicrobial use is imperative for supporting stewardship programs. The primary objective of this article is to assess the levels of antimicrobial use in Canada over time. Methods: Canadian antimicrobial use data from 1995 to 2010 were acquired and assessed by four metrics: population-adjusted prescriptions, Defined Daily Doses, spending on antimicrobials (inflation-adjusted), and average Defined Daily Doses per prescription. Linear mixed models were built to assess significant differences among years and antimicrobial groups, and to account for repeated measurements over time. Measures were also compared to published reports from European countries. Results: Temporal trends in antimicrobial use in Canada vary by metric and antimicrobial grouping. Overall reductions were seen for inflation-adjusted spending, population-adjusted prescription rates and Defined Daily Doses, and increases were observed for the average number of Defined Daily Doses per prescription. The population-adjusted prescription and Defined Daily Doses values for 2009 were comparable to those reported by many European countries, while the average Defined Daily Dose per prescription for Canada ranked high. A significant reduction in the use of broad spectrum penicillins occurred between 1995 and 2004, coupled with increases in macrolide and quinolone use, suggesting that replacement of antimicrobial drugs may occur as new products arrive on the market. Conclusions: There have been modest decreases of antimicrobial use in Canada over the past 15 years. However, continued surveillance of antimicrobial use coupled with data detailing antimicrobial resistance within bacterial pathogens affecting human populations is critical for targeting interventions and maintaining the effectiveness of these products for future generations.	[Finley, Rita; Glass-Kaastra, Shiona K.] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Hutchinson, Jim] Univ British Columbia, Isl Med Program, Div Med Microbiol, Victoria, BC, Canada; [Patrick, David M.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Patrick, David M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Conly, John] Univ Montreal, Dept Infect Dis & Microbiol, Hop Maisonneuve Rosemont, Montreal, PQ, Canada; [Conly, John] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Conly, John] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; [Conly, John] Univ Calgary, Synder Inst Chron Dis, Calgary, AB, Canada	Public Health Agency of Canada; University of British Columbia; University of British Columbia; Universite de Montreal; University of Calgary; University of Calgary; University of Calgary	Finley, R (corresponding author), Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada.	Rita.Finley@phac-aspc.gc.ca			Abbott; Bayer; Gilead; Merck; Pfizer; Optimer Pharma; Roche; Vertex; Alberta Heritage Foundation for Medical Research; Canadian Institutes for Health Research; PHAC; NCCID; Alberta Advanced Education and Technology	Abbott(Abbott Laboratories); Bayer(Bayer AG); Gilead(Gilead Sciences); Merck(Merck & Company); Pfizer(Pfizer); Optimer Pharma; Roche(Roche Holding); Vertex(Vertex Pharmaceuticals); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); PHAC; NCCID; Alberta Advanced Education and Technology	KW has received research funds and/or has been on the advisory board from Abbott, Bayer, Gilead, Merck, Pfizer, Optimer Pharma, Roche, Vertex. JC has received honoraria from the Canadian Agency for Drugs and Technologies in Health for work as an expert reviewer and clinical expert, respectively, for projects on the role of rapid PCR testing for MRSA in hospitalized patients and the use of vancomycin or metronidazole for treatment of Clostridium difficile colitis within the last three years. He has also received speaker's honoraria related to new anti-bacterial agents from Janssen-Ortho and Pfizer within the past three years. He has received financial support for research activities from the Alberta Heritage Foundation for Medical Research, the Canadian Institutes for Health Research, PHAC, NCCID, Alberta Advanced Education and Technology, and Pfizer. RF, SGK, DP and JH do not have any competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data or materials.	Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Bader MS, 2010, POSTGRAD MED, V122, P7, DOI 10.3810/pgm.2010.11.2217; Barbosa TM, 2000, DRUG RESIST UPDATE, V3, P303, DOI 10.1054/drup.2000.0167; Canada Health, 2007, CAN COMM DIS REP S7, V23, P1; Conly J, 2002, CAN MED ASSOC J, V167, P885; Fishman N, 2006, AM J MED, V119, pS53, DOI 10.1016/j.amjmed.2006.04.003; Government of Canada, 2011, CAN INT PROGR ANT RE; IMS Health Canada, 2007, UNL VAL HLTH INF CAN; Koningstein M, 2011, CLIN INFECT DIS, V53, P644, DOI 10.1093/cid/cir504; National Collaborating Centre for Infectious Diseases, 2010, COMM ACQ ANT RES CON; Owens RC, 2008, DIAGN MICR INFEC DIS, V61, P110, DOI 10.1016/j.diagmicrobio.2008.02.012; Richter SS, 2005, CLIN INFECT DIS, V40, P225, DOI 10.1086/426817; Statistics Canada, 2012, TABL 051 0001 EST PO; The Canadian Committee on Antibiotic Resistance, 2009, PANC STAK CONS ANT R; Vernaz N, 2011, J ANTIMICROB CHEMOTH, V66, P928, DOI 10.1093/jac/dkq525; Versporten A, 2011, 21 EUR C CLIN MICR I; Webster PC, 2010, CAN MED ASSOC J, V182, pE737, DOI 10.1503/cmaj.109-3696; Webster PC, 2010, CAN MED ASSOC J, V182, pE141, DOI 10.1503/cmaj.109-3109; Wenzel RP, 2004, NEW ENGL J MED, V351, P523, DOI 10.1056/NEJMp048093; WHO Collaborating Centre for Drug Statistics Methodology, 2012, ATC DDD IND; Zervos MJ, 2003, CLIN INFECT DIS, V37, P1643, DOI 10.1086/379709	21	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76398	10.1371/journal.pone.0076398	http://dx.doi.org/10.1371/journal.pone.0076398			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146863	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400058
J	Luger, D; Yang, YA; Raviv, A; Weinberg, D; Banerjee, S; Lee, MJ; Trepel, J; Yang, L; Wakefield, LM				Luger, Dror; Yang, Yu-an; Raviv, Asaf; Weinberg, Douglas; Banerjee, Subhadra; Lee, Min-Jung; Trepel, Jane; Yang, Li; Wakefield, Lalage M.			Expression of the B-Cell Receptor Component CD79a on Immature Myeloid Cells Contributes to Their Tumor Promoting Effects	PLOS ONE			English	Article							SUPPRESSOR-CELLS; IG-ALPHA; BONE-MARROW; TYROSINE PHOSPHORYLATION; CYTOPLASMIC DOMAIN; CANCER-PATIENTS; ACUTE-LEUKEMIA; BEARING HOST; BETA; LINEAGE	The role of myeloid derived suppressor cells (MDSCs) in promoting tumorigenesis is well-established, and significant effort is being made to further characterize surface markers on MDSCs both for better diagnosis and as potential targets for therapy. Here we show that the B cell receptor adaptor molecule CD79a is unexpectedly expressed on immature bone marrow myeloid cells, and is upregulated on MDSCs generated in multiple different mouse models of metastatic but not nonmetastatic cancer. CD79a on MDSCs is upregulated and activated in response to soluble factors secreted by tumor cells. Activation of CD79a on mouse MDSCs, by crosslinking with a specific antibody, maintained their immature phenotype (CD11b+Gr1+), enhanced their migration, increased their suppressive effect on T cell proliferation, and increased secretion of pro-tumorigenic cytokines such as IL-6 and CCL22. Furthermore, crosslinking CD79a on myeloid cells activated signaling through Syk, BLNK, ERK and STAT3 phosphorylation. In vivo, CD79+ myeloid cells showed enhanced ability to promote primary tumor growth and metastasis. Finally we demonstrate that CD79a is upregulated on circulating myeloid cells from lung cancer patients, and that CD79a+ myeloid cells infiltrate human breast tumors. We propose that CD79a plays a functional role in the tumor promoting effects of myeloid cells, and may represent a novel target for cancer therapy.	[Luger, Dror; Yang, Yu-an; Raviv, Asaf; Weinberg, Douglas; Banerjee, Subhadra; Yang, Li; Wakefield, Lalage M.] NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA; [Lee, Min-Jung; Trepel, Jane] NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Luger, D (corresponding author), NCI, Lab Canc Biol & Genet, Bethesda, MD 20892 USA.	lugerd@mail.nih.gov; lw34g@nih.gov	Wakefield, Lalage M/M-1963-2017	Wakefield, Lalage M/0000-0003-4124-5250	National Institutes of Health (NIH), NCI, Center for Cancer Research, Intramural Research Program [ZIA BC 010881]; NATIONAL CANCER INSTITUTE [ZIABC011163, ZIABC010881] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NCI, Center for Cancer Research, Intramural Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (NIH), NCI, Center for Cancer Research, Intramural Research Program (Grant# ZIA BC 010881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram Clare L, 2007, Sci STKE, V2007, pre2, DOI 10.1126/stke.3772007re2; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Arber DA, 1996, AM J PATHOL, V149, P1105; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Benlagha K, 1999, J BIOL CHEM, V274, P19389, DOI 10.1074/jbc.274.27.19389; Bhargava P, 2007, AM J CLIN PATHOL, V128, P306, DOI 10.1309/UXCDG9PWN7G89Y54; Chiang MY, 2001, J IMMUNOL, V166, P6091, DOI 10.4049/jimmunol.166.10.6091; Day CP, 2009, PIGM CELL MELANOMA R, V22, P283, DOI 10.1111/j.1755-148X.2009.00545.x; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Dworzak MN, 1998, BLOOD, V92, P3203, DOI 10.1182/blood.V92.9.3203.421k34_3203_3209; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Faget J, 2011, CANCER RES, V71, P6143, DOI 10.1158/0008-5472.CAN-11-0573; Figueroa JD, 2009, BREAST CANC RES TREA; Frater JL, 2003, ARCH PATHOL LAB MED, V127, P356; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Fuentes-Panana EM, 2006, J IMMUNOL, V177, P7913, DOI 10.4049/jimmunol.177.11.7913; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hamerman Jessica A, 2006, Sci STKE, V2006, pre1, DOI 10.1126/stke.3202006re1; Hamerman JA, 2009, IMMUNOL REV, V232, P42, DOI 10.1111/j.1600-065X.2009.00841.x; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Kawamoto H, 2010, INT IMMUNOL, V22, P65, DOI 10.1093/intimm/dxp125; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; Kozlov I, 2005, CANCER GENET CYTOGEN, V163, P62, DOI 10.1016/j.cancergencyto.2005.06.002; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; LEDUC I, 1992, CLIN EXP IMMUNOL, V90, P141; MATSUO T, 1993, J IMMUNOL, V150, P3766; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Montero AJ, 2012, J IMMUNOTHER, V35, P107, DOI 10.1097/CJI.0b013e318242169f; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Paredes-Aguilera R, 2001, AM J HEMATOL, V68, P69, DOI 10.1002/ajh.1155; Parish CR, 2009, CURR PROTOC IMMUNOL; Park SR, 2013, CANCER CHEMOTH PHARM, V71, P981, DOI 10.1007/s00280-013-2091-3; Patterson HC, 2011, J IMMUNOL, V187, P2853, DOI 10.4049/jimmunol.1101143; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Pike KA, 2004, J IMMUNOL, V172, P2210, DOI 10.4049/jimmunol.172.4.2210; Reichlin A, 2004, J EXP MED, V199, P855, DOI 10.1084/jem.20031140; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Sims R, 2012, MOL BIOL REP, V39, P3185, DOI 10.1007/s11033-011-1085-7; Sumida K, 2012, EUR J IMMUNOL, V42, P2060, DOI 10.1002/eji.201142335; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Wu CT, 2012, J MOL MED, V90, P1343, DOI 10.1007/s00109-012-0916-x; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Yan HH, 2010, CANCER RES, V70, P6139, DOI 10.1158/0008-5472.CAN-10-0706; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Yu D, 2003, BLOOD, V101, P1950, DOI 10.1182/blood-2002-06-1797; Zumsteg A, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006494	63	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76115	10.1371/journal.pone.0076115	http://dx.doi.org/10.1371/journal.pone.0076115			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146823	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400038
J	Odd, D; Evans, D; Emond, A				Odd, David; Evans, David; Emond, Alan			Preterm Birth, Age at School Entry and Educational Performance	PLOS ONE			English	Article							CHILDREN BORN; ATTAINMENT; OUTCOMES; INFANTS	Objective: To investigate if the lack of gestational age correction may explain some of the school failure seen in ex-preterm infants. Design: A cohort study based on the Avon Longitudinal Study of Parents and Children (ALSPAC). The primary outcome was a low Key Stage 1 score (KS1) score at age 7 or having special educational needs (SEN). Exposure groups were defined as preterm (<37 weeks gestation, n = 722) or term (37-42 weeks, n = 11,268). Conditional regression models were derived, matching preterm to term infants on date of birth (DOB), expected date of delivery (EDD) or expected date of delivery and year of school entry. Multiple imputation was used to account for missing covariate data. Results: When matching for DOB, infants born preterm had an increased odds of a low KS1 score (OR 1.73 (1.45-2.06)) and this association persisted after adjusting for potential confounders (OR 1.57 (1.25-1.97)). The association persisted in the analysis matching for EDD (fully adjusted OR 1.53 (1.21-1.94)) but attenuated substantially after additionally restricting to those infants who entered school at the same time as the control infants (fully adjusted OR 1.25 (0.98-1.60)). A compatible reduction in the population attributable risk fraction was seen from 4.60% to 2.12%, and year of school entry appeared to modify the association between gestational age and the risk of a poor KS1 score (p = 0.029). Conclusions: This study provides evidence that the school year placement and assessment of ex-preterm infants based on their actual birthday (rather than their EDD) may increase their risk of learning difficulties with corresponding school failure.	[Odd, David; Evans, David] North Bristol NHS Trust, Neonatal Unit, Bristol, Avon, England; [Emond, Alan] Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England	North Bristol NHS Trust; University of Bristol	Odd, D (corresponding author), North Bristol NHS Trust, Neonatal Unit, Bristol, Avon, England.	david.odd@nbt.nhs.uk	Odd, David/G-8418-2016	Odd, David/0000-0002-6416-4966	Medical Research Council [G9815508] Funding Source: Medline; Wellcome Trust [092731] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; GUZZETTA F, 1986, PEDIATRICS, V78, P995; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2009, J PEDIATR-US, V155, P488, DOI 10.1016/j.jpeds.2009.04.013; MacKay DF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000289; Odd DE, 2012, DEV MED CHILD NEUROL, V54, P704, DOI 10.1111/j.1469-8749.2012.04315.x; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V1-3; Office of Population Censuses and Surveys, 1991, STAND OCC CLASS, V2; Peacock PJ, 2012, ARCH DIS CHILD, V97, P118, DOI 10.1136/adc.2011.300925; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; van Baar AL, 2009, PEDIATRICS, V124, P251, DOI 10.1542/peds.2008-2315; Wolke D, 2008, J PEDIATR, V152, P256, DOI 10.1016/j.jpeds.2007.06.043; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	16	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76615	10.1371/journal.pone.0076615	http://dx.doi.org/10.1371/journal.pone.0076615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146899	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400077
J	Outani, H; Okada, M; Yamashita, A; Nakagawa, K; Yoshikawa, H; Tsumaki, N				Outani, Hidetatsu; Okada, Minoru; Yamashita, Akihiro; Nakagawa, Kanako; Yoshikawa, Hideki; Tsumaki, Noriyuki			Direct Induction of Chondrogenic Cells from Human Dermal Fibroblast Culture by Defined Factors	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; COLLAGEN GENE; CARTILAGE; SOX9; EXPRESSION; GENERATION; ENHANCER; MICROFRACTURE; EFFICIENT; DEFECTS	The repair of large cartilage defects with hyaline cartilage continues to be a challenging clinical issue. We recently reported that the forced expression of two reprogramming factors (c-Myc and Klf4) and one chondrogenic factor (SOX9) can induce chondrogenic cells from mouse dermal fibroblast culture without going through a pluripotent state. We here generated induced chondrogenic (iChon) cells from human dermal fibroblast (HDF) culture with the same factors. We developed a chondrocyte-specific COL11A2 promoter/enhancer lentiviral reporter vector to select iChon cells. The human iChon cells expressed marker genes for chondrocytes but not fibroblasts, and were derived from non-chondrogenic COL11A2-negative cells. The human iChon cells formed cartilage but not tumors in nude mice. This approach could lead to the preparation of cartilage directly from skin in human, without going through pluripotent stem cells.	[Outani, Hidetatsu; Okada, Minoru; Yamashita, Akihiro; Tsumaki, Noriyuki] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Outani, Hidetatsu; Nakagawa, Kanako; Yoshikawa, Hideki; Tsumaki, Noriyuki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan; [Nakagawa, Kanako; Tsumaki, Noriyuki] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Kyoto University; Osaka University; Japan Science & Technology Agency (JST)	Tsumaki, N (corresponding author), Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan.	ntsumaki@cira.kyoto-u.ac.jp		Tsumaki, Noriyuki/0000-0002-0520-3654	MEXT [18390415, 19659378, 21390421]; JST, CREST	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported in part by Scientific Research Grants Nos. 18390415, 19659378 and 21390421 from MEXT and the JST, CREST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2005, P NATL ACAD SCI USA, V102, P14665, DOI 10.1073/pnas.0504750102; ARGENTIN G, 1993, IN VITRO CELL DEV-AN, V29A, P603; Bae DK, 2006, ARTHROSCOPY, V22, P367, DOI 10.1016/j.arthro.2006.01.015; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P994, DOI 10.2106/JBJS.I.00895; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242; Goessler UR, 2004, INT J MOL MED, V14, P1015; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu Y, 2000, J BIOL CHEM, V275, P12712, DOI 10.1074/jbc.275.17.12712; Mashimo T, 2012, CELL REP, V2, P685, DOI 10.1016/j.celrep.2012.08.009; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Outani H, 2011, BIOCHEM BIOPH RES CO, V411, P607, DOI 10.1016/j.bbrc.2011.06.194; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105	30	67	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77365	10.1371/journal.pone.0077365	http://dx.doi.org/10.1371/journal.pone.0077365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146984	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400103
J	Yu, DH; Yuan, K; Zhao, L; Liang, FR; Qin, W				Yu, Dahua; Yuan, Kai; Zhao, Ling; Liang, Fanrong; Qin, Wei			Regional Homogeneity Abnormalities Affected by Depressive Symptoms in Migraine Patients without Aura: A Resting State Study	PLOS ONE			English	Article							NEURAL ACTIVITY; MAJOR DEPRESSION; WHITE-MATTER; BRAIN; PAIN; METAANALYSIS; FMRI; INTEGRATION; PREVALENCE; DISORDER	Background: Bidirectional relationship between migraine and depression suggests that there might be some etiological risk factors shared. However, few studies investigated resting state abnormalities affected by depressive symptoms in migraine patients without aura (MWoA). Materials and Methods: According to their self-rating depression scale (SDS) score, MWoA were divided into twenty in the SDS (+) (SDS > 49) group and 20 in the SDS (-) (SDS <= 49) group. Regional homogeneity (ReHo) method were employed to assess local features of spontaneous brain activity between 1) all MWoA and healthy controls, 2) each subgroup and healthy controls, and 3) SDS (-) group and SDS (+) group. Results: Compared with healthy controls, decreased ReHo in similar regions were shown in the MWoA group and subgroups. It is noteworthy that the caudate showed increased ReHo in the SDS (-) group compared with healthy controls and the SDS (+) group. Moreover, the average ReHo values of the caudate in SDS (-) group were significantly positively correlated with duration of migraine. Conclusions: Our results suggested that ReHo patterns in migraine patients may be affected by depressive symptoms and serve as a biomarker to reflect depression severity in MWoA.	[Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Yu, Dahua; Yuan, Kai; Qin, Wei] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Zhao, Ling; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China	Inner Mongolia University of Science & Technology; Xidian University; Chengdu University of Traditional Chinese Medicine	Yuan, K (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	kyuan@xidian.edu.cn; lfr@cdutcm.edu.cn	秦, 伟/J-9770-2016; Yuan, Kai/I-4150-2016; Yuan, Kai/M-9403-2013; Yu, Dahua/N-7242-2013	秦, 伟/0000-0003-4583-0406; Yuan, Kai/0000-0002-3098-1124; Yu, Dahua/0000-0001-7850-7512; Liang, Fanrong/0000-0003-2210-2027	National Key Basic Research and Development Program (973) [2012CB518501, 2011CB707700]; National Natural Science Foundation of China [81301281, 81227901, 81271644, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81271546, 61179019, 61261028]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Inner Mongolia [2012MS0908]	National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Inner Mongolia	This paper is supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2012CB518501, 2011CB707700, the National Natural Science Foundation of China under Grant Nos. 81301281, 81227901, 81271644, 30930112, 81000640, 81000641, 81101036, 81101108, 31200837, 81030027, 81271546, 61179019, 61261028, the Fundamental Research Funds for the Central Universities and the Natural Science Foundation of Inner Mongolia under Grant Nos. 2012MS0908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderjan D, 2010, PAIN, V151, P97, DOI 10.1016/j.pain.2010.06.024; BARRETT J, 1978, ARCH GEN PSYCHIAT, V35, P741; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; Delaveau P, 2011, J AFFECT DISORDERS, V130, P66, DOI 10.1016/j.jad.2010.09.032; Eck J, 2011, PAIN, V152, P1104, DOI 10.1016/j.pain.2011.01.026; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gabbay V, 2007, AM J PSYCHIAT, V164, P1881, DOI 10.1176/appi.ajp.2007.06122032; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; GUO W, 2011, J AFFECT DISORD; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hesselmann G, 2008, P NATL ACAD SCI USA, V105, P10984, DOI 10.1073/pnas.0712043105; Koolschijn PCMP, 2009, HUM BRAIN MAPP, V30, P3719, DOI 10.1002/hbm.20801; LAI CH, 2011, J AFFECT DISORD; Lebel A, 2008, BRAIN, V131, P1854, DOI 10.1093/brain/awn123; Liu F, 2012, PROG NEURO-PSYCHOPH, V39, P326, DOI 10.1016/j.pnpbp.2012.07.004; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Maleki N, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-71; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Nagy A, 2006, EUR J NEUROSCI, V24, P917, DOI 10.1111/j.1460-9568.2006.04942.x; Peng DH, 2011, CHINESE MED J-PEKING, V124, P369, DOI 10.3760/cma.j.issn.0366-6999.2011.03.009; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Schwedt TJ, 2009, LANCET NEUROL, V8, P560, DOI 10.1016/S1474-4422(09)70107-3; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Slaughter J R, 2001, CNS Spectr, V6, P306; Slaughter JR, 2001, J NEUROPSYCH CLIN N, V13, P187, DOI 10.1176/appi.neuropsych.13.2.187; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yu DH, 2013, NMR BIOMED, V26, P1103, DOI 10.1002/nbm.2924; Yu DH, 2013, CEPHALALGIA, V33, P34, DOI 10.1177/0333102412466964; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	35	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77933	10.1371/journal.pone.0077933	http://dx.doi.org/10.1371/journal.pone.0077933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147100	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400143
J	Gundavarapu, S; Mishra, NC; Singh, SP; Langley, RJ; Saeed, AI; Feghali-Bostwick, CA; McIntosh, JM; Hutt, J; Hegde, R; Buch, S; Sopori, ML				Gundavarapu, Sravanthi; Mishra, Neerad C.; Singh, Shashi P.; Langley, Raymond J.; Saeed, Ali Imran; Feghali-Bostwick, Carol A.; McIntosh, J. Michael; Hutt, Julie; Hegde, Ramakrishna; Buch, Shilpa; Sopori, Mohan L.			HIV gp120 Induces Mucus Formation in Human Bronchial Epithelial Cells through CXCR4/alpha 7-Nicotinic Acetylcholine Receptors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKING; ANTIRETROVIRAL THERAPY; MUCIN EXPRESSION; ENVELOPE PROTEIN; GENE-EXPRESSION; INFECTION; INDIVIDUALS; APOPTOSIS; ALPHA-7	Lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and lung infections are major causes of morbidity and mortality among HIV-infected patients even in the era of antiretroviral therapy (ART). Many of these diseases are strongly associated with smoking and smoking is more common among HIV-infected than uninfected people; however, HIV is an independent risk factor for chronic bronchitis, COPD, and asthma. The mechanism by which HIV promotes these diseases is unclear. Excessive airway mucus formation is a characteristic of these diseases and contributes to airway obstruction and lung infections. HIV gp120 plays a critical role in several HIV-related pathologies and we investigated whether HIV gp120 promoted airway mucus formation in normal human bronchial epithelial (NHBE) cells. We found that NHBE cells expressed the HIV-coreceptor CXCR4 but not CCR5 and produced mucus in response to CXCR4-tropic gp120. The gp120-induced mucus formation was blocked by the inhibitors of CXCR4, alpha 7-nicotinic acetylcholine receptor (alpha 7-nAChR), and gamma-aminobutyric acid (GABA)(A)R but not the antagonists of CCR5 and epithelial growth factor receptor (EGFR). These results identify two distinct pathways (alpha 7-nAChR-GABA(A)R and EGFR) for airway mucus formation and demonstrate for the first time that HIV-gp120 induces and regulates mucus formation in the airway epithelial cells through the CXCR4-alpha 7-nAChR-GABA(A)R pathway. Interestingly, lung sections from HIV +/- ART and simian immunodeficiency virus (SIV) +/- ART have significantly more mucus and gp120-immunoreactivity than control lung sections from humans and macaques, respectively. Thus, even after ART, lungs from HIV-infected patients contain significant amounts of gp120 and mucus that may contribute to the higher incidence of obstructive pulmonary diseases in this population.	[Gundavarapu, Sravanthi; Mishra, Neerad C.; Singh, Shashi P.; Langley, Raymond J.; Hutt, Julie; Sopori, Mohan L.] Lovelace Resp Res Inst, Resp Immunol Div, Albuquerque, NM USA; [Saeed, Ali Imran] Univ New Mexico, Albuquerque, NM 87131 USA; [Feghali-Bostwick, Carol A.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [McIntosh, J. Michael] George E Wahlen Vet Affairs Med Ctr, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Hegde, Ramakrishna] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	Lovelace Respiratory Research Institute; University of New Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Kansas; University of Kansas Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sopori, ML (corresponding author), Lovelace Resp Res Inst, Resp Immunol Div, Albuquerque, NM USA.	msopori@lrri.org		Buch, Shilpa/0000-0002-3103-6685	United States Army Medical Research and Material Command [GW093005]; Lovelace Respiratory Research Institute (IMMSPT); National Institutes of Health [DA024442];  [GM103801];  [GM48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677, R01GM103801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024442] Funding Source: NIH RePORTER	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Lovelace Respiratory Research Institute (IMMSPT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants from the United States Army Medical Research and Material Command (GW093005), Lovelace Respiratory Research Institute (IMMSPT), and GM103801 and GM48677. This work was also supported by the grant DA024442 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Ballester LY, 2012, J BIOL CHEM, V287, P3079, DOI 10.1074/jbc.M111.262543; BRACCI L, 1992, FEBS LETT, V311, P115, DOI 10.1016/0014-5793(92)81380-5; CORBEIL J, 1995, J GEN VIROL, V76, P681, DOI 10.1099/0022-1317-76-3-681; Cummins NW, 2010, J INFECT DIS, V201, P1273, DOI 10.1086/651434; Dhillon NK, 2011, AM J RESP CELL MOL, V45, P40, DOI 10.1165/rcmb.2010-0097OC; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Duaso Maria, 2012, Br J Community Nurs, V17, P356; El-Zimaity HMT, 1998, ARCH PATHOL LAB MED, V122, P732; Ellison M, 2006, BIOCHEMISTRY-US, V45, P1511, DOI 10.1021/bi0520129; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Grubb JR, 2006, AIDS, V20, P1095, DOI 10.1097/01.aids.0000226949.64600.f9; Gundavarapu S, 2012, J ALLERGY CLIN IMMUN, V130, P770, DOI 10.1016/j.jaci.2012.04.002; HARKEMA JR, 1992, AM J PATHOL, V141, P307; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Kanmogne GD, 2005, J NEUROPATH EXP NEUR, V64, P498, DOI 10.1093/jnen/64.6.498; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maestrelli P, 2010, G Ital Med Lav Ergon, V32, P433; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Morris Alison, 2011, Proc Am Thorac Soc, V8, P320, DOI 10.1513/pats.201006-045WR; MURRAY JF, 1990, AM REV RESPIR DIS, V141, P1582, DOI 10.1164/ajrccm/141.6.1582; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Polosukhin VV, 2011, AM J RESP CRIT CARE, V184, P317, DOI 10.1164/rccm.201010-1629OC; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Raynaud C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-117; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Rubbo PA, 2011, CLIN IMMUNOL, V139, P142, DOI 10.1016/j.clim.2011.01.007; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Segal Leopoldo N, 2011, Proc Am Thorac Soc, V8, P282, DOI 10.1513/pats.201006-044WR; Stevceva L, 2008, J IMMUNOL, V181, P5510, DOI 10.4049/jimmunol.181.8.5510; Tavares Marques MA, 2007, REV PORT PNEUMOL, V13, P175; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; Vidrine DJ, 2009, AIDS EDUC PREV, V21, P3, DOI 10.1521/aeap.2009.21.3_supp.3; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wang DN, 2011, J VIROL, V85, P6403, DOI 10.1128/JVI.02389-10; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Williams MA, 2002, J HEMATOTH STEM CELL, V11, P829, DOI 10.1089/152581602760404630; Xiang YY, 2007, NAT MED, V13, P862, DOI 10.1038/nm1604	45	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77160	10.1371/journal.pone.0077160	http://dx.doi.org/10.1371/journal.pone.0077160			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155926	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300060
J	Li, YS; Ni, SY; Meng, Y; Shi, XL; Zhao, XW; Luo, HH; Li, X				Li, Yu-Sheng; Ni, Shu-Yuan; Meng, Ying; Shi, Xiao-Lan; Zhao, Xu-Wen; Luo, Hai-Hua; Li, Xu			Angiotensin II Facilitates Fibrogenic Effect of TGF-beta 1 through Enhancing the Down-Regulation of BAMBI Caused by LPS: A New Pro-Fibrotic Mechanism of Angiotensin II	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TOLL-LIKE RECEPTOR-4; GROWTH-FACTOR; LIVER FIBROSIS; RAT-LIVER; TRANSGENIC MICE; GENE-EXPRESSION; CROSS-TALK; IN-VITRO; PDGF-B	Angiotensin II has progressively been considered to play an important role in the development of liver fibrosis, although the mechanism isn't fully understood. The aim of this study was to investigate a possible pro-fibrotic mechanism, by which angiotensin II would enhance the pro-fibrotic effect of transforming growth factor beta 1 (TGF-beta 1) through up-regulation of toll-like receptor 4 (TLR4) and enhancing down-regulation of TGF-beta 1 inhibitory pseudo-receptor-BAMBI caused by LPS in hepatic stellate cells (HSCs). Firstly, the synergistic effects of angiotensin II, TGF-beta 1 and LPS on collagen 1 alpha production were confirmed in vitro by ELISA, in which angiotensin II, LPS and TGF-beta 1 were treated sequentially, and in vivo by immunofluorescence, in the experiments single or multiple intra-peritoneally implanted osmotic mini-pumps administrating angiotensin II or LPS combined with intra-peritoneal injections of TGF-beta 1 were used. We also found that only LPS and TGF-beta 1 weren't enough to induce obvious fibrogenesis without angiotensin II. Secondly, to identify the reason of why angiotensin II is so important, the minute level of TLR4 in activated HSCs-T6 and primary quiescent HSCs of rat, up-regulation of TLR4 by angiotensin II and blockage by different angiotensin II receptor type 1 (AT1) blockers in HSCs were assayed by western blotting in vitro and immunofluorescence in vivo. Finally, BAMBI expression level, which is regulated by LPS-TLR4 pathway, was detected by qRT-PCR and results showed angiotensin II enhanced the down-regulation of BAMBI mRNA caused by LPS in vitro and in vivo, and TLR4 neutralization antibody blocked this interactive effect. These data demonstrated that angiotensin II enhances LPS-TLR4 pathway signaling and further down-regulates expression of BAMBI through up-regulation of TLR4, which results in facilitation of pro-fibrotic activity of TGF-beta 1. Angiotensin II, LPS and TGF-beta 1 act synergistically during hepatic fibrogenesis, showing crosstalks between angiotensin II-AT1, LPS-TLR4 and TGF-beta 1-BAMBI signal pathways in rat HSCs.	[Li, Yu-Sheng; Shi, Xiao-Lan; Zhao, Xu-Wen; Luo, Hai-Hua] Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China; [Ni, Shu-Yuan] Guangzhou Med Univ, Affiliated Hosp 3, Dept ICU, Guangzhou, Guangdong, Peoples R China; [Meng, Ying] Southern Med Univ, Nanfang Hosp, Dept Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Xu] Southern Med Univ, Nanfang Hosp, Dept Emergency, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou Medical University; Southern Medical University - China; Southern Medical University - China	Li, YS (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangzhou, Guangdong, Peoples R China.	tobyaron@163.com; aronlee@smu.edu.cn			National Natural Scientific Foundation of China [81070338, 30871155, 81100008]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Scientific Foundation of China (#81070338, 30871155 and 81100008). Website: www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2000, GASTROENTEROLOGY, V118, P1149, DOI 10.1016/S0016-5085(00)70368-4; Beaven SW, 2011, GASTROENTEROLOGY, V140, P1052, DOI 10.1053/j.gastro.2010.11.053; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bondeva T, 2007, AM J NEPHROL, V27, P308, DOI 10.1159/000102551; Breitkopf K, 2005, CYTOKINE, V31, P349, DOI 10.1016/j.cyto.2005.06.005; Clouthier DE, 1997, J CLIN INVEST, V100, P2697, DOI 10.1172/JCI119815; Colmenero J, 2007, GASTROENTEROLOGY, V132, P687, DOI 10.1053/j.gastro.2006.12.036; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; DeBleser PJ, 1997, J HEPATOL, V26, P886, DOI 10.1016/S0168-8278(97)80257-7; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Ikura Y, 2005, HEPATOL RES, V32, P107, DOI 10.1016/j.hepres.2005.01.017; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Iwaki T, 2005, BLOOD, V105, P2364, DOI 10.1182/blood-2004-06-2456; Kamada Y, 2003, HEPATOL RES, V25, P296, DOI 10.1016/S1386-6346(02)00306-6; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kinnman N, 2001, LAB INVEST, V81, P1709, DOI 10.1038/labinvest.3780384; Kisseleva T, 2011, BEST PRACT RES CL GA, V25, P305, DOI 10.1016/j.bpg.2011.02.011; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li YS, 2010, AM J PHYSIOL-LUNG C, V298, pL558, DOI 10.1152/ajplung.00225.2009; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Moreno M, 2008, CLIN LIVER DIS, V12, P825, DOI 10.1016/j.cld.2008.07.013; Otsui K, 2007, HEART VESSELS, V22, P416, DOI 10.1007/s00380-007-1001-1; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Paizis G, 2002, GASTROENTEROLOGY, V123, P1667, DOI 10.1053/gast.2002.36561; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; Pinzani M, 1996, AM J PATHOL, V148, P785; Rockey DC, 2008, CLIN LIVER DIS, V12, P939, DOI 10.1016/j.cld.2008.07.011; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; ROSS R, 1989, LANCET, V1, P1179; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Shirai Y, 2013, J GASTROEN HEPATOL, V28, P723, DOI 10.1111/jgh.12112; Stevenson KM, 2000, HYPERTENSION, V36, P839, DOI 10.1161/01.HYP.36.5.839; Vogel S, 2000, J LIPID RES, V41, P882; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Weiskirchen R, 2005, METH MOLEC MED, V117, P99; Wickert L, 2004, J HEPATOL, V40, P69, DOI 10.1016/j.jhep.2003.09.026; Wolf G, 2006, J AM SOC NEPHROL, V17, P1585, DOI 10.1681/ASN.2005070699; WONG L, 1994, J CLIN INVEST, V94, P1563, DOI 10.1172/JCI117497; Wu J, 2009, INFLAMM RES, V58, P473, DOI 10.1007/s00011-009-0012-z; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	45	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76289	10.1371/journal.pone.0076289	http://dx.doi.org/10.1371/journal.pone.0076289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155898	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300032
J	Liu, ZL; Sun, M; Lu, KH; Liu, J; Zhang, ML; Wu, WQ; De, W; Wang, ZX; Wang, R				Liu, Zhili; Sun, Ming; Lu, Kaihua; Liu, Jing; Zhang, Meiling; Wu, Weiqin; De, Wei; Wang, Zhaoxia; Wang, Rui			The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21(WAF1/CIP1) Expression	PLOS ONE			English	Article							MICRORNA; EZH2; P21; CHEMOTHERAPY; PROMOTES; GROWTH	HOTAIR, a long intervening non-coding RNA (lincRNA), associates with the Polycomb Repressive Complex 2 (PRC2) and is reported to reprogram chromatin organization and promote tumor progression. However, little is known about the roles of this gene in the development of chemoresistance phenotype of lung adenocarcinoma (LAD). Thus, we investigated the involvement of HOTAIR in the resistance of LAD cells to cisplatin. In this study, we show that HOTAIR expression was significantly upregulated in cisplatin-resistant A549/DDP cells compared with in parental A549 cells. Knockdown of HOTAIR by RNA interference could resensitize the responses of A549/DDP cells to cisplatin both in vitro and in vivo. In contrast, overexpression of HOTAIR could decrease the sensitivity of A549 and SPC-A1 cells to cisplatin. We also found that the siRNA/HOTAIR1-mediated chemosensivity enhancement was associated with inhibition of cell proliferation, induction of G(0)/G(1) cell-cycle arrest and apoptosis enhancement through regulation of p21(WAF1/CIP1) (p21) expression. Also, pcDNA/p21or siRNA/p21 could mimic the effects of siRNA/HOTAIR1 or pcDNA/HOTAIR on the sensitivity of LAD cells to cisplatin. Importantly, siRNA/p21 or pcDNA/p21 could partially rescue the effects of siRNA/HOTAIR1 or pcDNA/HOTAIR on both p21 expression and cisplatin sensitivity in LAD cells. Further, HOTAIR was observed to be significantly downregulated in cisplatin-responding LAD tissues, and its expression was inversely correlated with p21 mRNA expression. Taken together, our findings suggest that upregulation of HOTAIR contributes to the cisplatin resistance of LAD cells, at least in part, through the regulation of p21 expression.	[Liu, Zhili; Liu, Jing; Wang, Zhaoxia] Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Sun, Ming; De, Wei] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China; [Lu, Kaihua; Zhang, Meiling; Wu, Weiqin] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Wang, Rui] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing University	Wang, ZX (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Dept Oncol, Nanjing, Jiangsu, Peoples R China.	zhaoxiawang88@163.com; wangrui1977218@163.com			National Natural Science Foundation of China [81272601]; Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project [RC2011080]; Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University; Jiangsu Provincial Personnel Department "the Great of Six Talented Man Peak" Project [09-B1-021]; 333 high class Talented Man Project [2011-III-2630]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project; Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University; Jiangsu Provincial Personnel Department "the Great of Six Talented Man Peak" Project; 333 high class Talented Man Project	This work was supported by grants from the National Natural Science Foundation of China (No. 81272601), the Medical Key Talented Person Foundation of the Jiangsu Provincial Developing Health Project (No. RC2011080), Innovation Team Project of the Second Affiliated Hospital of Nanjing Medical University, the Jiangsu Provincial Personnel Department "the Great of Six Talented Man Peak" Project (No. 09-B1-021) and "333 high class Talented Man Project" (No. 2011-III-2630). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Cao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052984; Chang A, 2011, LUNG CANCER, V71, P3, DOI 10.1016/j.lungcan.2010.08.022; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Chen JH, 2012, EXP BIOL MED, V237, P1110, DOI 10.1258/ebm.2012.012075; Chen YH, 2012, AM J TRANSL RES, V4, P364; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; FUJINO M, 1995, CANCER, V76, P2457, DOI 10.1002/1097-0142(19951215)76:12<2457::AID-CNCR2820761209>3.0.CO;2-X; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Haenisch S, 2012, EPIGENOMICS-UK, V4, P369, DOI [10.2217/EPI.12.39, 10.2217/epi.12.39]; Harries LW, 2012, BIOCHEM SOC T, V40, P902, DOI 10.1042/BST20120020; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Ivanov M, 2012, CLIN PHARMACOL THER, V92, P727, DOI 10.1038/clpt.2012.152; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joshi US, 1998, CANCER GENE THER, V5, P183; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lin J, 2011, CARCINOGENESIS, V32, P1641, DOI 10.1093/carcin/bgr199; Lipovich L, 2010, BBA-GENE REGUL MECH, V1799, P597, DOI 10.1016/j.bbagrm.2010.10.001; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Lu LG, 2012, BREAST CANCER RES TR, V136, P875, DOI 10.1007/s10549-012-2314-z; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Murati A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-304; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Niinuma T, 2012, CANCER RES, V72, P1126, DOI 10.1158/0008-5472.CAN-11-1803; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; Romanov VS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P575, DOI 10.1134/S000629791206003X; Semaan A, 2011, PHARM RES-DORDR, V28, P3079, DOI 10.1007/s11095-011-0547-x; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Strathdee G, 2007, DIS MARKERS, V23, P43, DOI 10.1155/2007/610815; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Wan Y, 2010, CELL CYCLE, V9, P3391, DOI 10.4161/cc.9.17.13122; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Woo CJ, 2007, CELL, V129, P1257, DOI 10.1016/j.cell.2007.06.014; Yi C, 2012, ONCOGENE, V31, P4421, DOI 10.1038/onc.2011.629; Zhuang Y, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-35	42	73	87	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77293	10.1371/journal.pone.0077293	http://dx.doi.org/10.1371/journal.pone.0077293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155936	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300070
J	Singh, R; Rathore, YS; Singh, NS; Peddada, N; Ashish; Raychaudhuri, S				Singh, Richa; Rathore, Yogendra Singh; Singh, Naorem Santa; Peddada, Nagesh; Ashish; Raychaudhuri, Saumya			Substitution of Glutamate Residue by Lysine in the Dimerization Domain Affects DNA Binding Ability of HapR by Inducing Structural Deformity in the DNA Binding Domain	PLOS ONE			English	Article							CONSTITUTIVELY ACTIVE VARIANT; QUORUM-SENSING SYSTEMS; SMALL-ANGLE SCATTERING; VIBRIO-CHOLERAE; RESOLUTION; MUTATIONS; HARVEYI; DIMER; LUXO	HapR has been given the status of a high cell density master regulatory protein in Vibrio cholerae. Though many facts are known regarding its structural and functional aspects, much still can be learnt from natural variants of the wild type protein. This work aims at investigating the nature of functional inertness of a HapR natural variant harboring a substitution of a conserved glutamate residue at position 117 which participates in forming a salt bridge by lysine (HapR(V2G)-(EK)-K-117). Experimental evidence presented here reveals the inability of this variant to interact with various cognate promoters by in vitro gel shift assay. Furthermore, the elution profiles of HapR(V2G)-(EK)-K-117 protein along with the wild type functional HapR(V2G) in size-exclusion chromatography as well as circular dichroism spectra did not reflect any significant differences in its structure, thereby indicating the intactness of dimer in the variant protein. To gain further insight into the global shape of the proteins, small angle X-ray scattering analysis (SAXS) was performed. Intriguingly, increased radius of gyration of HapR(V2G)-(EK)-K-117 of 27.5 A in comparison to the wild type protein from SAXS data analyses implied a significant alteration in the global shape of the dimeric HapR(V2G)-(EK)-K-117 protein. Structure reconstruction brought forth that the DNA binding domains were substantially "parted away" in this variant. Taken together, our data illustrates that substitution of the conserved glutamate residue by lysine in the dimerization domain induces separation of the two DNA binding domains from their native-like positioning without altering the dimeric status of HapR variant.	[Singh, Richa; Rathore, Yogendra Singh; Singh, Naorem Santa; Peddada, Nagesh; Ashish; Raychaudhuri, Saumya] CSIR Inst Microbial Technol, Div Mol Biol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Ashish (corresponding author), CSIR Inst Microbial Technol, Div Mol Biol, Chandigarh, India.	ashgang@imtech.res.in; saumya@rocketmail.com	Peddada, Nagesh/L-6760-2019; Raychaudhuri, Saumya/AFL-0368-2022	Peddada, Nagesh/0000-0003-4033-7305	Department of Biotechnology [BT/PR3583/MED/30/659/2011-GAP/106]; CSIR network project [NWP-UNSEEN/BSC0113]; University Grant Commission; Department of Biotechnology, India	Department of Biotechnology; CSIR network project(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission(University Grants Commission, India); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was partly supported by grants from the Department of Biotechnology (BT/PR3583/MED/30/659/2011-GAP/106) and CSIR network project (NWP-UNSEEN/BSC0113). RS, YSR and NSS acknowledge the University Grant Commission and Department of Biotechnology, India respectively for fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brzovic PS, 1998, J BIOL CHEM, V273, P7795, DOI 10.1074/jbc.273.14.7795; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; De Silva RS, 2007, J BACTERIOL, V189, P5683, DOI 10.1128/JB.01807-06; Dongre M, 2011, J BIOL CHEM, V286, P15043, DOI 10.1074/jbc.M110.209346; Jawanda N, 2008, ARCH BIOCHEM BIOPHYS, V472, P51, DOI 10.1016/j.abb.2008.02.006; Joelsson A, 2006, INFECT IMMUN, V74, P1141, DOI 10.1128/IAI.74.2.1141-1147.2006; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pohl E, 2001, ACTA CRYSTALLOGR D, V57, P619, DOI 10.1107/S090744490100230X; Raychaudhuri S, 2006, GENE, V369, P126, DOI 10.1016/j.gene.2005.10.031; SMITH MD, 1995, J BIOL CHEM, V270, P28331; Stout TJ, 1998, BIOCHEMISTRY-US, V37, P14736, DOI 10.1021/bi981270l; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tsou AM, 2009, NUCLEIC ACIDS RES, V37, P2747, DOI 10.1093/nar/gkp121; Turton JPG, 2005, J CLIN ENDOCR METAB, V90, P4762, DOI 10.1210/jc.2005-0570; Vance RE, 2003, INFECT IMMUN, V71, P2571, DOI 10.1128/IAI.71.5.2571-2576.2003; vanLeeuwen HC, 1997, EMBO J, V16, P2043, DOI 10.1093/emboj/16.8.2043; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; Wang YD, 2011, ENV MICROBIOL REP, V3, P218, DOI 10.1111/j.1758-2229.2010.00212.x; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76033	10.1371/journal.pone.0076033	http://dx.doi.org/10.1371/journal.pone.0076033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155884	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300018
J	Tesfaye, A; Stift, J; Maric, D; Cui, QW; Dienes, HP; Feinstone, SM				Tesfaye, Abeba; Stift, Judith; Maric, Dragan; Cui, Qingwen; Dienes, Hans-Peter; Feinstone, Stephen M.			Chimeric Mouse Model for the Infection of Hepatitis B and C Viruses	PLOS ONE			English	Article							ANIMAL-MODELS; LIVER; MICE; REPLICATION; HEPATOCYTES; CHIMPANZEES; TRANSPLANTATION; REPOPULATION; DYSFUNCTION; MECHANISMS	While the chimpanzee remains the only animal that closely models human hepatitis C virus (HCV) infection, transgenic and immunodeficient mice in which human liver can be engrafted serve as a partial solution to the need for a small animal model for HCV infection. The established system that was based on mice carrying a transgene for urokinase-type plasminogen activator (uPA) gene under the control of the human albumin promoter has proved to be useful for studies of virus infectivity and for testing antiviral drug agents. However, the current Alb-uPA transgenic model with a humanized liver has practical limitations due to the inability to maintain non-engrafted mice as dizygotes for the transgene, poor engraftment of hemizygotes, high neonatal and experimental death rates of dizygous mice and a very short time window for hepatocyte engraftment. To improve the model, we crossed transgenic mice carrying the uPA gene driven by the major urinary protein promoter onto a SCID/Beige background (MUP-uPA SCID/Bg). These transgenic mice are healthy relative to Alb-uPA mice and provide a long window from about age 4 to 12 months for engraftment with human hepatocytes and infection with hepatitis C or hepatitis B (HBV) viruses. We have demonstrated engraftment of human hepatocytes by immunohistochemistry staining for human albumin (30-80% engraftment) and observed a correlation between the number of human hepatocytes inoculated and the level of the concentration of human albumin in the serum. We have shown that these mice support the replication of both HBV and all six major HCV genotypes. Using HBV and HCV inocula that had been previously tittered in chimpanzees, we showed that the mice had approximately the same sensitivity for infection as chimpanzees. These mice should be useful for isolating non-cell culture adapted viruses as well as testing of antiviral drugs, antibody neutralization studies and examination of phenotypic changes in viral mutants.	[Tesfaye, Abeba; Cui, Qingwen; Feinstone, Stephen M.] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Stift, Judith; Dienes, Hans-Peter] Med Univ Vienna, Inst Pathol, Vienna, Austria; [Maric, Dragan] NINDS, Div Intramural Res, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Medical University of Vienna; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tesfaye, A (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	abeba.tesfaye@fda.hhs.gov		Stift, Judith/0000-0001-5334-9343	Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This work was supported by internal funding from the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Billerbeck E, 2013, CURR TOP MICROBIOL, V369, P49, DOI 10.1007/978-3-642-27340-7_3; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Brezillon NM, 2008, CELL TRANSPLANT, V17, P803, DOI 10.3727/096368908786516800; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Bukh J, 2010, J INFECT DIS, V201, P1381, DOI 10.1086/651579; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; GROMPE M, 1995, NAT GENET, V10, P453, DOI 10.1038/ng0895-453; Heo J, 2006, HEPATOLOGY, V44, P1478, DOI 10.1002/hep.21441; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; *I MED NAT AC, 2011, CHIMP BIOM BEH RES A, P1465; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Major ME, 2002, J VIROL, V76, P6586, DOI 10.1128/JVI.76.13.6586-6595.2002; Major ME, 1999, J VIROL, V73, P3317, DOI 10.1128/JVI.73.4.3317-3325.1999; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Momin B, 2012, J COMMUN HEALTH, V37, P912, DOI 10.1007/s10900-011-9507-y; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Petersen J, 1998, P NATL ACAD SCI USA, V95, P310, DOI 10.1073/pnas.95.1.310; Puig M, 2002, J VIROL METHODS, V105, P253, DOI 10.1016/S0166-0934(02)00119-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; TABOR E, 1983, J INFECT DIS, V147, P531, DOI 10.1093/infdis/147.3.531; Vanwolleghem T, 2010, J HEPATOL, V53, P468, DOI 10.1016/j.jhep.2010.03.024; Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3; Yamashita T, 2011, J GASTROEN HEPATOL, V26, P960, DOI 10.1111/j.1440-1746.2011.06723.x	32	46	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77298	10.1371/journal.pone.0077298	http://dx.doi.org/10.1371/journal.pone.0077298			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155939	Green Submitted, gold, Green Published			2022-12-27	WOS:000325887300073
J	Buchberger, E; El Harchi, M; Payrhuber, D; Zommer, A; Schauer, D; Simonitsch-Klupp, I; Bilban, M; Brostjan, C				Buchberger, Elisabeth; El Harchi, Miriam; Payrhuber, Dietmar; Zommer, Anna; Schauer, Dominic; Simonitsch-Klupp, Ingrid; Bilban, Martin; Brostjan, Christine			Overexpression of the Transcriptional Repressor Complex BCL-6/BCoR Leads to Nuclear Aggregates Distinct from Classical Aggresomes	PLOS ONE			English	Article							HISTONE DEACETYLASES; MOLECULAR CHAPERONE; PROTEIN; SUPPRESSION; PROTEASOME; HUNTINGTIN; INCLUSIONS; DISEASE; BODIES; FAMILY	Nuclear inclusions of aggregated proteins have primarily been characterized for molecules with aberrant polyglutamine repeats and for mutated or structurally altered proteins. They were termed "nuclear aggresomes" and misfolding was shown to promote association with molecular chaperones and proteasomes. Here, we report that two components of a transcriptional repressor complex (BCL-6 and BCoR) of wildtype amino acid sequence can independently or jointly induce the formation of nuclear aggregates when overexpressed. The observation that the majority of cells rapidly downregulate BCL-6/BCoR levels, supports the notion that expression of these proteins is under tight control. The inclusions occur when BCL-6/BCoR expression exceeds 150-fold of endogenous levels. They preferentially develop in the nucleus by a gradual increase in aggregate size to form large, spheroid structures which are not associated with heat shock proteins or marked by ubiquitin. In contrast, we find the close association of BCL-6/BCoR inclusions with PML bodies and a reduction in aggregation upon the concomitant overexpression of histone deacetylases or heat shock protein 70. In summary, our data offer a perspective on nuclear aggregates distinct from classical "nuclear aggresomes": Large complexes of spheroid structure can evolve in the nucleus without being marked by the cellular machinery for protein refolding and degradation. However, nuclear proteostasis can be restored by balancing the levels of chaperones.	[Buchberger, Elisabeth; El Harchi, Miriam; Payrhuber, Dietmar; Zommer, Anna; Schauer, Dominic; Brostjan, Christine] Med Univ Vienna, Vienna Gen Hosp, Dept Surg, Vienna, Austria; [Simonitsch-Klupp, Ingrid] Med Univ Vienna, Vienna Gen Hosp, Clin Inst Pathol, Vienna, Austria; [Bilban, Martin] Med Univ Vienna, Vienna Gen Hosp, Core Facil Genom, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Brostjan, C (corresponding author), Med Univ Vienna, Vienna Gen Hosp, Dept Surg, Vienna, Austria.	christine.brostjan@meduniwien.ac.at		Brostjan, Christine/0000-0003-1462-5397; Bilban, Martin/0000-0001-7043-7142	Anniversary Fund of the Oesterreichische Nationalbank [12678]	Anniversary Fund of the Oesterreichische Nationalbank	This work was supported by the Anniversary Fund of the Oesterreichische Nationalbank (http://www.oenb.at/de/ueber_die_oenb/foerderung/jubilaeumsfonds/jubilaeumsfonds.jsp), project number: 12678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albagli O, 2000, MOL CELL BIOL, V20, P8560, DOI 10.1128/MCB.20.22.8560-8570.2000; Albagli O, 1996, BIOCHEM BIOPH RES CO, V220, P911, DOI 10.1006/bbrc.1996.0505; Bader N, 2007, EXP GERONTOL, V42, P864, DOI 10.1016/j.exger.2007.03.010; Barros P, 2009, MOL CELL BIOL, V29, P4156, DOI 10.1128/MCB.01813-08; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chai YH, 1999, J NEUROSCI, V19, P10338; Chen TLL, 2001, EXP CELL RES, V263, P224, DOI 10.1006/excr.2000.5093; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Dellaire G, 2006, J CELL SCI, V119, P1034, DOI 10.1242/jcs.02817; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Fu LW, 2005, NEUROBIOL DIS, V20, P656, DOI 10.1016/j.nbd.2005.05.015; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Fusco C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040440; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Gearhart MD, 2006, MOL CELL BIOL, V26, P6880, DOI 10.1128/MCB.00630-06; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; HUTT DM, 2013, COLD SPRING HARB PER, V5, P86914; Huynh KD, 2000, GENE DEV, V14, P1810; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Jardin F, 2007, PATHOL BIOL, V55, P73, DOI 10.1016/j.patbio.2006.04.001; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Kon M, 2010, FEBS LETT, V584, P1399, DOI 10.1016/j.febslet.2009.12.025; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Lemercier C, 2002, J BIOL CHEM, V277, P22045, DOI 10.1074/jbc.M201736200; Marquard L, 2009, HISTOPATHOLOGY, V54, P688, DOI 10.1111/j.1365-2559.2009.03290.x; Miranker AD, 2005, NATURE, V437, P197, DOI 10.1038/437197a; Moran DM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-32; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Park R, 2011, J BIOL CHEM, V286, P9748, DOI 10.1074/jbc.M110.198325; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Puvion-Dutilleul F, 2003, MICROSC RES TECHNIQ, V61, P389, DOI 10.1002/jemt.10363; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Srinivasan RS, 2003, ONCOGENE, V22, P3395, DOI 10.1038/sj.onc.1206361; Stead MA, 2008, ACTA CRYSTALLOGR F, V64, P1101, DOI 10.1107/S1744309108036063; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang XY, 2006, INVEST OPHTH VIS SCI, V47, P700, DOI 10.1167/iovs.05-0697; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	60	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76845	10.1371/journal.pone.0076845	http://dx.doi.org/10.1371/journal.pone.0076845			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146931	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400085
J	Krishnan, C; Ranganathan, R; Dhaher, YY; Rymer, WZ				Krishnan, Chandramouli; Ranganathan, Rajiv; Dhaher, Yasin Y.; Rymer, William Z.			A Pilot Study on the Feasibility of Robot-Aided Leg Motor Training to Facilitate Active Participation	PLOS ONE			English	Article							STROKE PATIENTS; GAIT; LOCOMOTION; MOVEMENT; THERAPY; REHABILITATION; PERFORMANCE; STRATEGIES; COCONTRACTION; RECOVERY	Robot-aided gait therapy offers a promising approach towards improving gait function in individuals with neurological disorders such as stroke or spinal cord injury. However, incorporation of appropriate control strategies is essential for actively engaging the patient in the therapeutic process. Although several control algorithms (such as assist-as-needed and error augmentation) have been proposed to improve active patient participation, we hypothesize that the therapeutic benefits of these control algorithms can be greatly enhanced if combined with a motor learning task to facilitate neural reorganization and motor recovery. Here, we describe an active robotic training approach (patient-cooperative robotic gait training combined with a motor learning task) using the Lokomat and pilot-tested whether this approach can enhance active patient participation during training. Six neurologically intact adults and three chronic stroke survivors participated in this pilot feasibility study. Participants walked in a Lokomat while simultaneously performing a foot target-tracking task that necessitated greater hip and knee flexion during the swing phase of the gait. We computed the changes in tracking error as a measure of motor performance and changes in muscle activation as a measure of active subject participation. Repeated practice of the motor-learning task resulted in significant reductions in target-tracking error in all subjects. Muscle activation was also significantly higher during active robotic training compared to simply walking in the robot. The data from stroke participants also showed a trend similar to neurologically intact participants. These findings provide a proof-of-concept demonstration that combining robotic gait training with a motor learning task enhances active participation.	[Krishnan, Chandramouli] Univ Michigan, Sch Med, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Krishnan, Chandramouli; Ranganathan, Rajiv; Dhaher, Yasin Y.; Rymer, William Z.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Krishnan, Chandramouli; Ranganathan, Rajiv; Dhaher, Yasin Y.; Rymer, William Z.] Rehabil Inst Chicago, Sensory Motor Performance Program, Chicago, IL USA	University of Michigan System; University of Michigan; Northwestern University; Feinberg School of Medicine; Shirley Ryan AbilityLab	Krishnan, C (corresponding author), Univ Michigan, Sch Med, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA.	mouli@umich.edu	Ranganathan, Rajiv/E-3909-2010; Ranganathan, Rajiv/L-4380-2019; Ranganathan, Rajiv/ABI-2927-2020	Ranganathan, Rajiv/0000-0002-6924-253X; Ranganathan, Rajiv/0000-0002-6924-253X; 	Machines Assisting Recovery From Stroke - Rehabilitation Engineering Research Center Grant [H133E070013]; National Institute on Disability and Rehabilitation Research	Machines Assisting Recovery From Stroke - Rehabilitation Engineering Research Center Grant; National Institute on Disability and Rehabilitation Research	This study was supported by Machines Assisting Recovery From Stroke - Rehabilitation Engineering Research Center Grant (grant no. H133E070013) funded by the National Institute on Disability and Rehabilitation Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1996, BRIT MED J, V313, P1200, DOI 10.1136/bmj.313.7066.1200; Banala SK, 2009, IEEE T NEUR SYS REH, V17, P2, DOI 10.1109/TNSRE.2008.2008280; Bezzola L, 2011, J NEUROSCI, V31, P12444, DOI 10.1523/JNEUROSCI.1996-11.2011; BOGEY RA, 1992, ARCH PHYS MED REHAB, V73, P835; Boyer DM, 2007, J HUM EVOL, V53, P119, DOI 10.1016/j.jhevol.2006.10.007; Casadio M, 2009, FUNCT NEUROL, V24, P195; Colombo G, 2000, J REHABIL RES DEV, V37, P693; Darainy M, 2008, EXP BRAIN RES, V190, P153, DOI 10.1007/s00221-008-1457-y; Dickstein R, 2008, NEUROREHAB NEURAL RE, V22, P649, DOI 10.1177/1545968308315997; Dipietro L, 2012, IEEE T NEUR SYS REH, V20, P48, DOI 10.1109/TNSRE.2011.2175008; Duschau-Wicke A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-43; Duschau-Wicke A, 2010, IEEE T NEUR SYS REH, V18, P38, DOI 10.1109/TNSRE.2009.2033061; Fagenbaum R, 2003, AM J SPORT MED, V31, P233, DOI 10.1177/03635465030310021301; Fattapposta F, 2008, ARCH ITAL BIOL, V146, P147; Finley JM, 2013, J PHYSIOL-LONDON, V591, P1081, DOI 10.1113/jphysiol.2012.245506; Gaser C, 2003, J NEUROSCI, V23, P9240; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632; Hornby TG, 2008, STROKE, V39, P1786, DOI 10.1161/STROKEAHA.107.504779; Hornby TG, 2012, PHYS THER, V92, P1278, DOI 10.2522/ptj.20110310; Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Kao PC, 2013, GAIT POSTURE, V37, P113, DOI 10.1016/j.gaitpost.2012.06.025; Kim SH, 2010, EXP BRAIN RES, V202, P809, DOI 10.1007/s00221-010-2187-5; Kitago Tomoko, 2013, Handb Clin Neurol, V110, P93, DOI 10.1016/B978-0-444-52901-5.00008-3; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Krebs Herman Igo, 2012, Am J Phys Med Rehabil, V91, pS290, DOI 10.1097/PHM.0b013e31826bcd80; Krishnamoorthy Vijaya, 2008, J Neurol Phys Ther, V32, P192, DOI 10.1097/NPT.0b013e31818e8fc2; Krishnan C, 2012, ARCH PHYS MED REHABI; Krishnan C, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-57; Krishnan C, 2010, MUSCLE NERVE, V41, P868, DOI 10.1002/mus.21613; Krishnan C, 2010, EUR J APPL PHYSIOL, V109, P527, DOI 10.1007/s00421-010-1391-0; Krishnan Chandramouli, 2009, Iowa Orthop J, V29, P149; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lewek MD, 2009, PHYS THER, V89, P829, DOI 10.2522/ptj.20080180; Marchal-Crespo L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-20; Masia L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-44; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; Norouzi-Gheidari N, 2012, J REHABIL RES DEV, V49, P479, DOI 10.1682/JRRD.2010.10.0210; Ogawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046349; Page SJ, 2009, NEUROREHAB NEURAL RE, V23, P382, DOI 10.1177/1545968308326427; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Perez MA, 2004, EXP BRAIN RES, V159, P197, DOI 10.1007/s00221-004-1947-5; Plautz EJ, 2000, NEUROBIOL LEARN MEM, V74, P27, DOI 10.1006/nlme.1999.3934; Ranganathan R, 2012, J NEUROPHYSIOL, V108, P1537, DOI 10.1152/jn.01112.2011; Reisman DS, 2009, NEUROREHAB NEURAL RE, V23, P735, DOI 10.1177/1545968309332880; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Roy A, 2011, J REHABIL RES DEV, V48, P417, DOI 10.1682/JRRD.2010.04.0078; Sanguineti V, 2009, STUD HEALTH TECHNOL, V145, P126, DOI 10.3233/978-1-60750-018-6-126; Schwartz I, 2009, PM&R, V1, P516, DOI 10.1016/j.pmrj.2009.03.009; Siengsukon C, 2009, NEUROREHAB NEURAL RE, V23, P327, DOI 10.1177/1545968308326631; Simpkins CA, 2012, NEUROSCIENCE CLIN EV; Vallery H, 2009, INT C REHAB ROBOT, P623, DOI 10.1109/ICORR.2009.5209595; Westlake KP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-18; Williamson EM, 2009, EXP AGING RES, V35, P457, DOI 10.1080/03610730903175790	57	41	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77370	10.1371/journal.pone.0077370	http://dx.doi.org/10.1371/journal.pone.0077370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146986	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400113
J	Naggara, O; Raymond, J; Ayllon, MD; Al-Shareef, F; Touze, E; Chenoufi, M; Gerber, S; Mellerio, C; Zuber, M; Meder, JF; Mas, JL; Oppenheim, C				Naggara, Olivier; Raymond, Jean; Ayllon, Montserrat Domingo; Al-Shareef, Fawaz; Touze, Emmanuel; Chenoufi, Meriem; Gerber, Sophie; Mellerio, Charles; Zuber, Matthieu; Meder, Jean Francois; Mas, Jean-Louis; Oppenheim, Catherine			T2*"Susceptibility Vessel Sign" Demonstrates Clot Location and Length in Acute Ischemic Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INTERNAL CAROTID-ARTERY; INTRAVENOUS THROMBOLYSIS; SUSCEPTIBILITY SIGN; OCCLUSION; RECANALIZATION; BURDEN; SCORE; ANGIOGRAPHY; HEMORRHAGE	Objectives: The aim of our study was to evaluate, in acute ischemic stroke patients, the diagnostic accuracy of the MRI susceptibility vessel sign (SVS) against catheter angiography (DSA) for the detection of the clot and its value in predicting clot location and length. Materials and Methods: We identified consecutive patients (2006-2012) admitted to our center, where 1.5 T MRI is systematically implemented as first-line diagnostic work-up, with: (1) pre-treatment 6-mm-thick multislice 2D T2* sequence; (2) delay from MRI-to-DSA <3 hrs; (3) no fibrinolysis between MRI and DSA. The location and length of SVS on T2* was independently assessed by three readers, and compared per patient, per artery and per segment, to DSA findings, obtained by two different readers. Clot length measured on T2* and DSA were compared using intra-class correlation coefficient (ICC), Bland & Altman test and Passing & Bablok regression analysis. Results: On DSA, a clot was present in 85 patients, in 126 of 1190 (10.6%) arteries and 175 of 1870 (9.4%) segments. Sensitivity of the SVS, as sensed by the used protocol at 1.5 T, was 81.1% (69 of 85 patients) and was higher in anterior (55 of 63, 87.3%), than in posterior circulation stroke (14 of 22, 63.6%, p=0.02). Sensitivity/ specificity was 69.8/99.6% (per artery) and 76.6/99.7% (per segment). Positive (PPV) and negative predictive value (NPV) and accuracy were all >94%. Inter-and intra-observer ICC was excellent for clot length as measured on T2* (kappa >= 0.97) and as measured on DSA (kappa >= 0.94). Correlation between T2* and DSA for clot length was excellent (ICC: ;0.88, 95%CI: 0.81-0.92; Bland & Altman: mean bias of 1.6% [95%CI: -4.7 to 7.8%], Passing & Bablok: 0.91). Conclusions: SVS is a specific marker of clot location in the anterior and posterior circulation. Clot length greater than 6 mm can be reliably measured on T2*.	[Naggara, Olivier; Ayllon, Montserrat Domingo; Al-Shareef, Fawaz; Chenoufi, Meriem; Mellerio, Charles; Meder, Jean Francois; Oppenheim, Catherine] Univ Paris 05, INSERM, Ctr Hosp St Anne, Dept Neuroradiol,UMR 894, Paris, Ile De France, France; [Touze, Emmanuel; Mas, Jean-Louis] Univ Paris 05, INSERM, Ctr Hosp St Anne, Dept Neurol,UMR 894, Paris, Ile De France, France; [Gerber, Sophie] St Joseph Hosp, Dept Radiol, Paris, France; [Zuber, Matthieu] St Joseph Hosp, Dept Neurol, Paris, Ile De France, France; [Raymond, Jean] Univ Montreal, Notre Dame Hosp, Intervent Neuroradiol Res Unit, Dept Radiol,Int Consortium Neuroendovasc Ctr, Montreal, PQ H3C 3J7, Canada	GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal	Naggara, O (corresponding author), Univ Paris 05, INSERM, Ctr Hosp St Anne, Dept Neuroradiol,UMR 894, Paris, Ile De France, France.	o.naggara@ch-sainte-anne.fr	Domingo, Montse/ABH-6596-2020; Oppenheim, Catherine/N-1635-2018; Naggara, Olivier/R-3939-2017	Oppenheim, Catherine/0000-0003-3410-0862; MELLERIO, Charles/0000-0002-9987-9101; Touze, Emmanuel/0000-0002-7254-2162; Naggara, Olivier/0000-0002-9544-379X; Meder, Jean-Francois/0000-0002-0898-0133				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Assouline E, 2005, CEREBROVASC DIS, V20, P6, DOI 10.1159/000086120; ATLAS SW, 1988, RADIOLOGY, V168, P803, DOI 10.1148/radiology.168.3.3406410; Barreto AD, 2008, STROKE, V39, P3231, DOI 10.1161/STROKEAHA.108.521054; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BLINC A, 1992, HAEMOSTASIS, V22, P195; CLARK RA, 1990, RADIOLOGY, V175, P201, DOI 10.1148/radiology.175.1.2315481; Deistung A, 2009, J MAGN RESON IMAGING, V29, P1478, DOI 10.1002/jmri.21673; Derex L, 2002, CEREBROVASC DIS, V13, P225, DOI 10.1159/000057847; Flacke S, 2000, RADIOLOGY, V215, P476, DOI 10.1148/radiology.215.2.r00ma09476; Gralla J, 2008, AM J NEURORADIOL, V29, P247, DOI 10.3174/ajnr.A0790; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; JANSEN O, 1995, AM J NEURORADIOL, V16, P1977; Kidwell CS, 2004, JAMA-J AM MED ASSOC, V292, P1823, DOI 10.1001/jama.292.15.1823; Lee KY, 2007, STROKE, V38, P192, DOI 10.1161/01.STR.0000251788.03914.00; Legrand L, 2013, STROKE, V2013; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Liebeskind DS, 2009, STROKE, V40, pE30, DOI 10.1161/STROKEAHA.108.541441; Linfante I, 2002, STROKE, V33, P2066, DOI 10.1161/01.STR.0000021001.18101.A5; Liu T, 2012, RADIOLOGY, V262, P269, DOI 10.1148/radiol.11110251; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; Molina CA, 2005, STROKE, V36, P2333, DOI 10.1161/01.STR.0000185933.44619.1b; Naggara O, 2011, AM J NEURORADIOL, V32, P869, DOI 10.3174/ajnr.A2553; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; PASSING H, 1983, J CLIN CHEM CLIN BIO, V21, P709; Petkova M, 2010, RADIOLOGY, V257, P782, DOI 10.1148/radiol.10100461; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Radbruch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063459; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Riedel CH, 2011, STROKE, V42, P1775, DOI 10.1161/STROKEAHA.110.609693; Rovira A, 2004, RADIOLOGY, V232, P466, DOI 10.1148/radiol.2322030273; Saqqur M, 2007, STROKE, V38, P948, DOI 10.1161/01.STR.0000257304.21967.ba; Shinohara Y, 2012, NEURORADIOLOGY, V54, P427, DOI 10.1007/s00234-011-0895-6; Soman S, 2013, AJNR AM J NEURORADIO; Taber KH, 1996, JMRI-J MAGN RESON IM, V6, P878, DOI 10.1002/jmri.1880060607; Tisserand M, 2011, NEUROLOGY, V76, P1288, DOI 10.1212/WNL.0b013e3182152855; Turc G, 2013, STROKE, V44, P1323, DOI 10.1161/STROKEAHA.111.000127; Wang S, 2013, STROKE, V44, P2315, DOI 10.1161/STROKEAHA.113.001638	39	50	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76727	10.1371/journal.pone.0076727	http://dx.doi.org/10.1371/journal.pone.0076727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146915	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400077
J	Sridevi, P; Nhiayi, MK; Setten, RL; Wang, JYJ				Sridevi, Priya; Nhiayi, May K.; Setten, Ryan L.; Wang, Jean Y. J.			Persistent Inhibition of ABL Tyrosine Kinase Causes Enhanced Apoptotic Response to TRAIL and Disrupts the Pro-Apoptotic Effect of Chloroquine	PLOS ONE			English	Article							C-ABL; CANCER-CELLS; EXTRINSIC APOPTOSIS; DEATH; ACTIVATION; PROTEIN; PHOSPHORYLATION; CASPASE-8; LIGAND; CHEMOTHERAPY	TNF-Related Apoptosis Inducing Ligand (TRAIL) binds to and activates death receptors to stimulate caspase-8 and apoptosis with higher efficiency in cancer than normal cells but the development of apoptosis resistance has limited its clinical efficacy. We found that stable, but not transient knockdown of the ABL tyrosine kinase enhanced the apoptotic response to TRAIL. Re-expression of Abl, but not its nuclear import-or kinase-defective mutant, in the ABL-knockdown cells re-established apoptosis suppression. TRAIL is known to stimulate caspase-8 ubiquitination (Ub-C8), which can facilitate caspase-8 activation or degradation by the lysosomes. In the ABL-knockdown cells, we found a higher basal level of Ub-C8 that was not further increased by lysosomal inhibition. Re-expression of Abl in the ABL-knockdown cells reduced the basal Ub-C8, correlating with apoptosis suppression. We found that lysosomal inhibition by chloroquine (CQ) could also enhance TRAIL-induced apoptosis. However, this pro-apoptotic effect of CQ was lost in the ABL-knockdown cells but restored by Abl re-expression. Interestingly, kinase inhibition at the time of TRAIL stimulation was not sufficient to enhance apoptosis. Instead, persistent treatment for several days with imatinib, an ABL kinase inhibitor, was required to cause the enhanced and the CQ-insensitive apoptotic response to TRAIL. Together, these results show that persistent loss of nuclear ABL tyrosine kinase function can sensitize cells to TRAIL and suggest that long-term exposure to the FDA-approved ABL kinase inhibitors may potentiate apoptotic response to TRAIL-based cancer therapy.	[Sridevi, Priya; Nhiayi, May K.; Setten, Ryan L.; Wang, Jean Y. J.] Univ Calif San Diego, Sch Med, Moores Canc Ctr, Dept Med,Div Hematol Oncol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, JYJ (corresponding author), Univ Calif San Diego, Sch Med, Moores Canc Ctr, Dept Med,Div Hematol Oncol, La Jolla, CA 92093 USA.	jywang@ucsd.edu		Setten, Ryan/0000-0002-0956-7084	National Cancer Institute [RO1CA043054]; NATIONAL CANCER INSTITUTE [R01CA043054] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the National Cancer Institute RO1CA043054 to JYJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, J CLIN ONCOL, V26, P3621, DOI 10.1200/JCO.2007.15.7198; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Baskaran R, 1996, MOL CELL BIOL, V16, P3361; Baskaran R, 1997, J BIOL CHEM, V272, P18905, DOI 10.1074/jbc.272.30.18905; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; BONNEKOH B, 1989, ARCH DERMATOL RES, V281, P487, DOI 10.1007/BF00510085; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Burton EA, 2003, EMBO J, V22, P5471, DOI 10.1093/emboj/cdg512; Chau BN, 2004, MOL CELL BIOL, V24, P4438, DOI 10.1128/MCB.24.10.4438-4447.2004; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Echarri A, 2001, CURR BIOL, V11, P1759, DOI 10.1016/S0960-9822(01)00538-3; Eggert A, 2001, CANCER RES, V61, P1314; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; French LE, 1999, J EXP MED, V190, P891, DOI 10.1084/jem.190.7.891; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; Gonfloni S, 2009, NAT MED, V15, P1179, DOI 10.1038/nm.2033; Gong JG, 1999, NATURE, V399, P806; Gonzalvez F, 2012, MOL CELL, V48, P888, DOI 10.1016/j.molcel.2012.09.031; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Huang DY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-35; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Jabbour E, 2009, CORE EVID, V4, P207; Jiang ZH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-88; Jin H, 2007, MOL BIOL CELL, V18, P4143, DOI 10.1091/mbc.E07-01-0085; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kelly MM, 2002, CANCER BIOL THER, V1, P520, DOI 10.4161/cbt.1.5.169; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Lacour S, 2003, ONCOGENE, V22, P1807, DOI 10.1038/sj.onc.1206127; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nehme A, 1997, CANCER RES, V57, P3253; Olivieri A, 2007, ANN ONCOL, V18, P42, DOI 10.1093/annonc/mdm223; Ozoren N, 2000, INT J ONCOL, V16, P917; Pan JA, 2011, MOL CELL BIOL, V31, P3158, DOI 10.1128/MCB.05460-11; Preyer M, 2007, CELL DEATH DIFFER, V14, P1139, DOI 10.1038/sj.cdd.4402119; Raina D, 2006, EMBO J, V25, P3774, DOI 10.1038/sj.emboj.7601263; Russo M, 2010, BIOCHEM PHARMACOL, V80, P674, DOI 10.1016/j.bcp.2010.03.011; Shaul Y, 2000, CELL DEATH DIFFER, V7, P10, DOI 10.1038/sj.cdd.4400626; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Sionov RV, 1999, J BIOL CHEM, V274, P8371, DOI 10.1074/jbc.274.13.8371; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Solier S, 2009, MOL CELL BIOL, V29, P68, DOI 10.1128/MCB.00581-08; Sridevi P, 2013, CELL DEATH DIFFER, V20, P953, DOI 10.1038/cdd.2013.42; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ullman E, 2011, MOL CELL BIOL, V31, P2902, DOI 10.1128/MCB.05452-11; VEIGNIE E, 1991, ANN TROP MED PARASIT, V85, P229, DOI 10.1080/00034983.1991.11812550; Wang JYJ, 2004, ADV PROTEIN CHEM, V69, P101; Wang JYJ, 2005, CELL RES, V15, P43, DOI 10.1038/sj.cr.7290263; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; WELCH PJ, 1995, MOL CELL BIOL, V15, P5542; Wen ST, 1996, EMBO J, V15, P1583, DOI 10.1002/j.1460-2075.1996.tb00503.x; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Woodring PJ, 2003, J CELL SCI, V116, P2613, DOI 10.1242/jcs.00622; Xu J, 2006, CANCER RES, V66, P10092, DOI 10.1158/0008-5472.CAN-06-1633; Yogalingam G, 2008, J BIOL CHEM, V283, P35941, DOI 10.1074/jbc.M804543200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan ZM, 1996, J BIOL CHEM, V271, P26457, DOI 10.1074/jbc.271.43.26457; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zhao B, 2011, ASIAN PAC J CANCER P, V12, P2675; Zhu JY, 2004, CURR TOP DEV BIOL, V59, P165, DOI 10.1016/S0070-2153(04)59007-5; Zuckerman V, 2009, J BIOL CHEM, V284, P4031, DOI 10.1074/jbc.M809211200	69	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77495	10.1371/journal.pone.0077495	http://dx.doi.org/10.1371/journal.pone.0077495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147007	Green Published, gold			2022-12-27	WOS:000325819400122
J	Wilkins, BJ; Lorent, K; Matthews, RP; Pack, M				Wilkins, Benjamin J.; Lorent, Kristin; Matthews, Randolph P.; Pack, Michael			p53-Mediated Biliary Defects Caused by Knockdown of cirh1a, the Zebrafish Homolog of the Gene Responsible for North American Indian Childhood Cirrhosis	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; ALAGILLE-SYNDROME; HUMAN JAGGED1; TRANSCRIPTION; MUTATIONS; P53; LOCALIZATION; INHIBITION; LIVER	North American Indian Childhood Cirrhosis (NAIC) is a rare, autosomal recessive, progressive cholestatic disease of infancy affecting the Cree-Ojibway first Nations of Quebec. All NAIC patients are homozygous for a missense mutation (R565W) in CIRH1A, the human homolog of the yeast nucleolar protein Utp4. Utp4 is part of the t-Utp subcomplex of the small subunit (SSU) processome, a ribonucleoprotein complex required for ribosomal RNA processing and small subunit assembly. NAIC has thus been proposed to be a primary ribosomal disorder (ribosomopathy); however, investigation of the pathophysiologic mechanism of this disease has been hindered by lack of an animal model. Here, using a morpholino oligonucleotide (MO)-based loss-of-function strategy, we have generated a model of NAIC in the zebrafish, Danio rerio. Zebrafish Cirhin shows substantial homology to the human homolog, and cirh1a mRNA is expressed in developing hepatocytes and biliary epithelial cells. Injection of two independent MOs directed against cirh1a at the one-cell stage causes defects in canalicular and biliary morphology in 5 dpf larvae. In addition, 5 dpf Cirhin-deficient larvae have dose-dependent defects in hepatobiliary function, as assayed by the metabolism of an ingested fluorescent lipid reporter. Previous yeast and in vitro studies have shown that defects in ribosome biogenesis cause stabilization and nuclear accumulation of p53, which in turn causes p53-mediated cell cycle arrest and/or apoptosis. Thus, the nucleolus appears to function as a cellular stress sensor in some cell types. In accordance with this hypothesis, transcriptional targets of p53 are upregulated in Cirhin-deficient zebrafish embryos, and defects in biliary function seen in Cirhin-deficient larvae are completely abrogated by mutation of tp53. Our data provide the first in vivo evidence of a role for Cirhin in biliary development, and support the hypothesis that congenital defects affecting ribosome biogenesis can activate a cellular stress response mediated by p53.	[Wilkins, Benjamin J.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Lorent, Kristin; Pack, Michael] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Matthews, Randolph P.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Pack, M (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	mpack@mail.med.upenn.edu			National Institutes of Health [R01DK09211]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by National Institutes of Health grant R01DK09211 (M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2006, J BIOL CHEM, V281, P13309, DOI 10.1074/jbc.M601892200; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Betard C, 2000, AM J HUM GENET, V67, P222, DOI 10.1086/302993; Bezerra J A, 2001, Semin Gastrointest Dis, V12, P54; Chagnon P, 2002, AM J HUM GENET, V71, P1443, DOI 10.1086/344580; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Drouin E, 2000, J PEDIATR GASTR NUTR, V31, P395, DOI 10.1097/00005176-200010000-00013; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Farber SA, 2001, SCIENCE, V292, P1385, DOI 10.1126/science.1060418; Freed EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002892; Freed EF, 2010, NUCLEIC ACIDS RES, V38, P4798, DOI 10.1093/nar/gkq185; Freed EF, 2010, MOL BIOSYST, V6, P481, DOI 10.1039/b919670f; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lipton JM, 2009, HEMATOL ONCOL CLIN N, V23, P261, DOI 10.1016/j.hoc.2009.01.004; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; Lorent K, 2010, DEV DYNAM, V239, P855, DOI 10.1002/dvdy.22220; Matthews RP, 2005, DEVELOPMENT, V132, P5295, DOI 10.1242/dev.02140; Matthews RP, 2004, DEV BIOL, V274, P245, DOI 10.1016/j.ydbio.2004.06.016; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Olson Mark O J, 2004, Sci STKE, V2004, ppe10; Pack M, 1996, DEVELOPMENT, V123, P321; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Provost E, 2012, DEVELOPMENT, V139, P3232, DOI 10.1242/dev.077107; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roy Angshumoy, 2010, Surg Pathol Clin, V3, P743, DOI 10.1016/j.path.2010.06.006; Santos Jorge L, 2010, Curr Gastroenterol Rep, V12, P30, DOI 10.1007/s11894-009-0081-8; Schaff Z, 1979, ELECT MICROSCOPY HUM, V8; Skarie JM, 2008, HUM MOL GENET, V17, P2474, DOI 10.1093/hmg/ddn147; Solanas M, 2001, BIOTECHNOL LETT, V23, P263, DOI 10.1023/A:1005693928291; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Wilkins BJ, 2013, COMPR PHYSIOL, V3, P1213, DOI 10.1002/cphy.c120021; Yu B, 2005, EXP CELL RES, V311, P218, DOI 10.1016/j.yexcr.2005.08.012; Yu B, 2009, EXP CELL RES, V315, P3086, DOI 10.1016/j.yexcr.2009.08.017	41	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77670	10.1371/journal.pone.0077670	http://dx.doi.org/10.1371/journal.pone.0077670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147052	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400133
J	Luo, HM; Du, MH; Lin, ZL; Zhang, L; Ma, L; Wang, H; Yu, W; Lv, Y; Lu, JY; Pi, YL; Hu, S; Sheng, ZY				Luo, Hong-Min; Du, Ming-Hua; Lin, Zhi-Long; Zhang, Lin; Ma, Li; Wang, Huan; Yu, Wen; Lv, Yi; Lu, Jiang-Yang; Pi, Yu-Li; Hu, Sen; Sheng, Zhi-Yong			Valproic Acid Treatment Inhibits Hypoxia-Inducible Factor 1 alpha Accumulation and Protects against Burn-Induced Gut Barrier Dysfunction in a Rodent Model	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; LIGHT-CHAIN KINASE; HISTONE DEACETYLASE; GASTROINTESTINAL-TRACT; HEMORRHAGIC-SHOCK; FACTOR-I; VEGF; PERMEABILITY; INJURY; HIF-1	Objective: Burn-induced gut dysfunction plays an important role in the development of sepsis and multiple organ dysfunction. Emerging evidence suggests that hypoxia-inducible factor-1 alpha (HIF-1 alpha) is critical in paracelluar barrier functions via regulating vascular endothelial growth factor (VEGF) and myosin light chain kinase (MLCK) expression. Previous studies have also demonstrated that histone deacetylase inhibitors (HDACIs) can repress HIF-1 alpha. This study aims to examine whether valproic acid (VPA), a HDACI, protects against burn-induced gut barrier dysfunction via repressing HIF-1 alpha-dependent upregulation of VEGF and MLCK expression. Methods: Rats were subjected to third degree 55% TBSA burns and treated with/without VPA (300mg/kg). Intestinal barrier dysfunction was evaluated by permeability of intestinal mucosa to fluorescein isothiocyanate (FITC)-dextran and histologic evaluation. Histone acetylation, tight junction protein zonula occludens 1 (ZO-1), VEGF, MLCK and HIF-1 alpha were measured. In addition, CaCO2 cells were transfected with siRNA directed against HIF-1 alpha and were stimulated with CoCl2 (1mM) for 24 hours with/without VPA (2mM) followed by analysis of HIF-1 alpha, MLCK, VEGF and ZO-1. Results: Burn insults resulted in a significant increase in intestinal permeability and mucosal damage, accompanied by a significant reduction in histone acetylation, ZO-1, upregulation of VEGF, MLCK expression, and an increase in HIF-1 alpha accumulation. VPA significantly attenuated the increase in intestinal permeability, mucosa damage, histone deacetylation and changes in ZO-1 expression. VPA also attenuated the increased VEGF, MLCK and HIF-1 alpha protein levels. VPA reduced HIF-1 alpha, MLCK and VEGF production and prevented ZO-1 loss in CoCl2-stimulated Caco-2 cells. Moreover, transfection of siRNA directed against HIF-1 alpha led to inhibition of MLCK and VEGF production, accompanied by upregulation of ZO-1. Conclusions: These results indicate that VPA can protect against burn-induced gut barrier dysfunction. These protective effects may be due to its inhibitory action on HIF-1 alpha, leading to a reduction in intestinal VEGF and MLCK expression and minimizing ZO-1 degradation.	[Luo, Hong-Min; Du, Ming-Hua; Lin, Zhi-Long; Ma, Li; Wang, Huan; Yu, Wen; Lv, Yi; Hu, Sen; Sheng, Zhi-Yong] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Lab Shock & Organ Dysfunct, Beijing, Peoples R China; [Zhang, Lin] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Obstet & Gynecol, Beijing, Peoples R China; [Lu, Jiang-Yang] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Pathol, Beijing, Peoples R China; [Pi, Yu-Li] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Ophtalmol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Hu, S (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Burns Inst, Lab Shock & Organ Dysfunct, Beijing, Peoples R China.	bs0425@163.com; shengzhy@cae.cn	Luo, Hongmin/ABG-6510-2021		National Basic Research Program of China (973 Program) [2012CB518101]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Basic Research Program of China (973 Program, Grant 2012CB518101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay I, 2008, BRAIN RES, V1234, P198, DOI 10.1016/j.brainres.2008.07.121; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Behzadian MA, 2003, FASEB J, V17, P752, DOI 10.1096/fj.02-0484fje; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034946; Chen SY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/197946; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P478; Chong W, 2012, J TRAUMA ACUTE CARE, V72, P347, DOI 10.1097/TA.0b013e318243d8b2; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Comerford KM, 2002, CANCER RES, V62, P3387; Costantini TW, 2010, MOL IMAGING, V9, P30, DOI 10.2310/7290.2010.00001; Costantini TW, 2009, SHOCK, V31, P416, DOI 10.1097/SHK.0b013e3181863080; EPSTEIN MD, 1992, PLAST RECONSTR SURG, V90, P524, DOI 10.1097/00006534-199209000-00032; Gosain A, 2005, J BURN CARE REHABIL, V26, P85, DOI 10.1097/01.BCR.0000150212.21651.79; Hecht G, 1996, AM J PHYSIOL-CELL PH, V271, pC1678, DOI 10.1152/ajpcell.1996.271.5.C1678; Hindryckx P, 2010, J IMMUNOL, V185, P6306, DOI 10.4049/jimmunol.1002541; Hu S, 2012, BURNS, V38, P83, DOI 10.1016/j.burns.2011.03.015; Ikezu T, 1997, J BIOL CHEM, V272, P25289, DOI 10.1074/jbc.272.40.25289; Kaiser M, 2006, HAEMATOL-HEMATOL J, V91, P248; Kannan KB, 2011, AM J PHYSIOL-GASTR L, V300, pG853, DOI 10.1152/ajpgi.00459.2010; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keely S, 2010, MOL BIOL CELL, V21, P538, DOI 10.1091/mbc.E09-07-0573; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Krzyzaniak M, 2011, J TRAUMA, V70, P1168, DOI 10.1097/TA.0b013e318216f754; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; Lee JY, 2012, J NEUROCHEM, V121, P818, DOI 10.1111/j.1471-4159.2012.07731.x; Li YQ, 2008, J TRAUMA, V64, P863, DOI 10.1097/TA.0b013e318166b822; Li YQ, 2012, ADV EXP MED BIOL, V710, P107, DOI 10.1007/978-1-4419-5638-5_11; Lin T, 2006, SURGERY, V139, P365, DOI 10.1016/j.surg.2005.08.022; Lin T, 2007, SURGERY, V141, P784, DOI 10.1016/j.surg.2007.01.014; Liu H, 2011, CYTOKINE, V56, P581, DOI 10.1016/j.cyto.2011.08.023; Louis NA, 2006, J CELL BIOCHEM, V99, P1616, DOI 10.1002/jcb.20947; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; Mayhan WG, 1999, AM J PHYSIOL-CELL PH, V276, pC1148, DOI 10.1152/ajpcell.1999.276.5.C1148; Morin-Brureau M, 2011, J NEUROSCI, V31, P10677, DOI 10.1523/JNEUROSCI.5692-10.2011; Ogunshola OO, 2012, HIGH ALT MED BIOL, V13, P153, DOI 10.1089/ham.2012.1052; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Schaper J, 2013, ANESTHESIOLOGY, V118, P134, DOI 10.1097/ALN.0b013e3182784c93; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen QA, 2010, CARDIOVASC RES, V87, P272, DOI 10.1093/cvr/cvq144; Shults C, 2008, J TRAUMA, V64, P629, DOI 10.1097/TA.0b013e3181650ff3; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Tinsley JH, 2004, AM J PHYSIOL-LUNG C, V286, pL841, DOI 10.1152/ajplung.00341.2003; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; WANG GL, 1993, J BIOL CHEM, V268, P21513; Wang W, 2001, AM J PHYSIOL-HEART C, V280, pH434, DOI 10.1152/ajpheart.2001.280.1.H434; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Yu D, 2010, P NATL ACAD SCI USA, V107, P8237, DOI 10.1073/pnas.0908869107; Zahs A, 2012, AM J PHYSIOL-GASTR L, V303, pG705, DOI 10.1152/ajpgi.00157.2012; Zgouras D, 2004, BIOCHEM BIOPH RES CO, V316, P693, DOI 10.1016/j.bbrc.2004.02.105	52	17	22	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77523	10.1371/journal.pone.0077523	http://dx.doi.org/10.1371/journal.pone.0077523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147016	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200041
J	Zhang, L; Wang, N; Shen, Q; Cheng, W; Qian, GJ				Zhang, Lei; Wang, Neng; Shen, Qiang; Cheng, Wen; Qian, Guo-Jun			Therapeutic Efficacy of Percutaneous Radiofrequency Ablation versus Microwave Ablation for Hepatocellular Carcinoma	PLOS ONE			English	Article							COAGULATION THERAPY; THERMAL ABLATION; LIVER-TUMORS; MANAGEMENT; MODEL	The aim of this study was to investigate the therapeutic efficacy of percutaneous radiofrequency (RF) ablation versus microwave (MW) ablation for hepatocellular carcinoma (HCC) measuring <= 5 cm in greatest diameter. From January 2006 to December 2006, 78 patients had undergone RF ablation whereas 77 had undergone MW ablation. Complete ablation (CA), local tumour progression (LTP) and distant recurrence (DR) were compared. The overall survival curves were calculated with the Kaplan-Meier technique and compared with the log-rank test. The CA rate was 83.4% (78/93) for RF ablation and 86.7%(91/105 for MW ablation. The LTP rate was 11.8% (11/93) for RF ablation and 10.5% (11/105) for MW ablation. DR was found in 51 (65.4%) in the RF ablation and 62 (80.5%) in the MW ablation. There was no significant difference in the 1-, 3-, and 5-year overall survival rates (P=0.780) and the 1-, 3-, and 5-year disease-free survival rates (P=0.123) between RF and MW ablation. At subgroup analyses, for patients with tumors <= 3.0 cm, there was no significant difference in the 1-, 3-, and 5-year overall survival rates (P=0.067) and the corresponding disease-free survival rates(P=0.849). For patients with tumor diameters of 3.1-5.0 cm, the 1-, 3-, and 5-year overall survival rates were 87.1%, 61.3%, and 40.1% for RF ablation and 85.4%, 36.6%, and 22% for MW ablation, with no significant difference (P=0.068). The corresponding disease-free survival rates were 74.2%, 54.8%, and 45.2% for the RF ablation group and 53.3%, 26.8%, and 17.1% for the MW ablation group. The disease-free survival curve for the RF ablation group was significantly better than that for the MW ablation group (P=0.018). RF ablation and MW ablation are both effective methods in treating hepatocellular carcinomas, with no significant differences in CA, LTP, DR, and overall survival.	[Zhang, Lei; Cheng, Wen] Harbin Med Univ Canc Hosp, Dept Ultrasound, Harbin, Peoples R China; [Zhang, Lei; Wang, Neng; Shen, Qiang; Qian, Guo-Jun] Second Mil Med Univ Eastern Hepatobiliary Surg Ho, Dept Minimal Invas, Ward 1, Shanghai, Peoples R China	Naval Medical University	Cheng, W (corresponding author), Harbin Med Univ Canc Hosp, Dept Ultrasound, Harbin, Peoples R China.	chengwen69@yahoo.com; qgjs@sina.com						Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Buscarini L, 2001, EUR RADIOL, V11, P914, DOI 10.1007/s003300000659; Chen MH, 2004, RADIOLOGY, V232, P260, DOI 10.1148/radiol.2321030821; Cherqui D, 2009, ANN SURG, V250, P738, DOI 10.1097/SLA.0b013e3181bd582b; Dong Bao-wei, 2006, Zhonghua Yi Xue Za Zhi, V86, P797; Dong BW, 2003, AM J ROENTGENOL, V180, P1547, DOI 10.2214/ajr.180.6.1801547; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Goldberg SN, 2002, J CLIN GASTROENTEROL, V35, pS115, DOI 10.1097/00004836-200211002-00008; Itoh S, 2011, ANN SURG ONCOL, V18, P3650, DOI 10.1245/s10434-011-1831-z; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Liang P, 2003, AM J ROENTGENOL, V181, P1319, DOI 10.2214/ajr.181.5.1811319; Livraghi T, 2003, RADIOLOGY, V226, P441, DOI 10.1148/radiol.2262012198; Livraghi T, 2012, CARDIOVASC INTER RAD, V35, P868, DOI 10.1007/s00270-011-0241-8; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng ZW, 2008, EJSO-EUR J SURG ONC, V34, P166, DOI 10.1016/j.ejso.2007.08.004; Peng ZW, 2012, RADIOLOGY, V262, P689, DOI 10.1148/radiol.11110637; Qian GJ, 2012, EUR RADIOL, V22, P1983, DOI 10.1007/s00330-012-2442-1; Shibata T, 2002, RADIOLOGY, V223, P331, DOI 10.1148/radiol.2232010775; Shimada K, 2005, CANCER-AM CANCER SOC, V104, P1939, DOI 10.1002/cncr.21461; Sun YY, 2012, EUR J RADIOL, V81, P553, DOI 10.1016/j.ejrad.2011.02.013; Wright AS, 2005, RADIOLOGY, V236, P132, DOI 10.1148/radiol.2361031249; Xu HX, 2004, CLIN RADIOL, V59, P53, DOI 10.1016/j.crad.2003.09.006; Yamashiki N, 2003, AM J GASTROENTEROL, V98, P2052, DOI 10.1016/S0002-9270(03)00553-7	25	70	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76119	10.1371/journal.pone.0076119	http://dx.doi.org/10.1371/journal.pone.0076119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146824	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200010
J	Debinski, W; Dickinson, P; Rossmeisl, JH; Robertson, J; Gibo, DM				Debinski, Waldemar; Dickinson, Peter; Rossmeisl, John H.; Robertson, John; Gibo, Denise M.			New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; FOS-RELATED ANTIGEN-1; GLIOBLASTOMA-MULTIFORME; PSEUDOMONAS EXOTOXIN; MALIGNANT GLIOMA; RECEPTOR ALPHA-2; T-CELLS; INTERLEUKIN-13; THERAPY; PROTEIN	Interleukin 13 receptor alpha 2 (IL-13RA2) is over-expressed in a vast majority of human patients with high-grade astrocytomas like glioblastoma. Spontaneous astrocytomas in dogs resemble human disease and have been proposed as translational model system for investigation of novel therapeutic strategies for brain tumors. We have generated reagents for both detection and therapeutic targeting of IL-13RA2 in human and canine brain tumors. Peptides from three different regions of IL-13RA2 with 100% sequence identity between human and canine receptors were used as immunogens for generation of monoclonal antibodies. Recombinant canine mutant IL-13 (canIL-13.E13K) and canIL-13.E13K based cytotoxin were also produced. The antibodies were examined for their immunoreactivities in western blots, immunohistochemistry, immunofluorescence and cell binding assays using human and canine tumor specimen sections, tissue lysates and established cell lines; the cytotoxin was tested for specific cell killing. Several isolated MAbs were immunoreactive to IL-13RA2 in western blots of cell and tissue lysates from glioblastomas from both human and canine patients. Human and canine astrocytomas and oligodendrogliomas were also positive for IL-13RA2 to various degrees. Interestingly, both human and canine meningiomas also exhibited strong reactivity. Normal human and canine brain samples were virtually negative for IL-13RA2 using the newly generated MAbs. MAb 1E10B9 uniquely worked on tissue specimens and western blots, bound live cells and was internalized in GBM cells over-expressing IL-13RA2. The canIL-13.E13K cytotoxin was very potent and specific in killing canine GBM cell lines. Thus, we have obtained several monoclonal antibodies against IL-13RA2 cross-reacting with human and canine receptors. In addition to GBM, other brain tumors, such as high grade oligodendrogliomas, meningiomas and canine choroid plexus papillomas, appear to express the receptor at high levels and thus may be appropriate candidates for IL-13RA2-targeted imaging/therapies. Canine spontaneous primary brain tumors represent an excellent translational model for human counterparts.	[Debinski, Waldemar; Gibo, Denise M.] Wake Forest Sch Med, Brain Tumor Ctr Excellence, Thomas K Hearn Brain Tumor Res Ctr, Dept Neurosurg, Winston Salem, NC USA; [Dickinson, Peter] Univ Calif Davis, Dept Surg & Radiol Sci, Sch Vet Med, Davis, CA 95616 USA; [Rossmeisl, John H.; Robertson, John] Virginia Tech, Dept Small Anim Clin Sci & Pathobiol, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA	Wake Forest University; University of California System; University of California Davis; Virginia Polytechnic Institute & State University	Debinski, W (corresponding author), Wake Forest Sch Med, Brain Tumor Ctr Excellence, Thomas K Hearn Brain Tumor Res Ctr, Dept Neurosurg, Winston Salem, NC USA.	debinski@wakehealth.edu; pjdickinson@ucdavis.edu	Rossmeisl, John H/Q-7119-2016	Rossmeisl, John H/0000-0003-1655-7076	NCI [R01 CA74145, CA139099]; Wake Forest University School of Medicine, BTCOE; Paul C. and Borghild T. Petersen Foundation; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA074145, R01CA139099, P30CA093373] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wake Forest University School of Medicine, BTCOE; Paul C. and Borghild T. Petersen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NCI grant R01 CA74145 and CA139099, the Translational Science Institute Team Award grant from Wake Forest University School of Medicine, BTCOE and the Paul C. and Borghild T. Petersen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balyasnikova IV, 2012, J BIOL CHEM, V287, P30215, DOI 10.1074/jbc.M112.370015; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Brown CE, 2012, CLIN CANCER RES, V18, P2199, DOI 10.1158/1078-0432.CCR-11-1669; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Candolfi M, 2010, P NATL ACAD SCI USA, V107, P20021, DOI 10.1073/pnas.1008261107; Debinski W, 1998, CRIT REV ONCOGENESIS, V9, P255; Debinski W, 1999, CLIN CANCER RES, V5, P985; Debinski W, 2005, MOL CANCER RES, V3, P237; Debinski W, 1998, NAT BIOTECHNOL, V16, P449, DOI 10.1038/nbt0598-449; Debinski W, 1995, CLIN CANCER RES, V1, P1253; DEBINSKI W, 1995, J BIOL CHEM, V270, P16775, DOI 10.1074/jbc.270.28.16775; Debinski W, 2000, MOL MED, V6, P440, DOI 10.1007/BF03401786; Dickinson PJ, 2006, VET COMP ONCOL, V4, P132, DOI 10.1111/j.1476-5829.2006.00101.x; Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989; Dickinson PJ, 2010, NEURO-ONCOLOGY, V12, P928, DOI 10.1093/neuonc/noq046; FANKHAUSER R, 1974, B WORLD HEALTH ORGAN, V50, P53; HAYES HM, 1975, INT J CANCER, V15, P39, DOI 10.1002/ijc.2910150106; Hu N., 2005, CANC THER, V3, P531; Joshi BH, 2000, CANCER RES, V60, P1168; Kahlon KS, 2004, CANCER RES, V64, P9160, DOI 10.1158/0008-5472.CAN-04-0454; Lal A, 2002, CANCER RES, V62, P3335; Li CB, 2002, PROTEIN ENG, V15, P419, DOI 10.1093/protein/15.5.419; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; LUGINBUHL H., 1968, PROGR NEUROLOGICAL S, V2, P85; Mintz A, 2003, J NEURO-ONCOL, V64, P117, DOI 10.1007/BF02700026; Mintz A, 2002, NEOPLASIA, V4, P388, DOI 10.1038/sj.neo.7900234; Mintz A, 2000, CRIT REV ONCOGENESIS, V11, P77; Mintz A, 2008, CANCER BIOTHER RADIO, V23, P581, DOI 10.1089/cbr.2008.0462; Okano F, 2002, CLIN CANCER RES, V8, P2851; Pluhar GE, 2010, VACCINE, V28, P3371, DOI 10.1016/j.vaccine.2010.02.082; PRIESTER WA, 1971, JNCI-J NATL CANCER I, V47, P1333; Priester WA, 1980, MONOGRAPH US DEP HLT, P1; Rossmeisl JH, 2013, JAVMA-J AM VET MED A, V242, P193, DOI 10.2460/javma.242.2.193; Sampson JH, 2010, J NEUROSURG, V113, P301, DOI 10.3171/2009.11.JNS091052; Schneider R., 1978, TUMORS DOMESTIC ANIM, P1; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Ulasov IV, 2007, HUM GENE THER, V18, P118, DOI 10.1089/hum.2006.146; Nguyen V, 2011, TRANSL ONCOL, V4, P390, DOI 10.1593/tlo.11175; Wykosky J, 2008, CLIN CANCER RES, V14, P199, DOI 10.1158/1078-0432.CCR-07-1990; York D, 2012, VET PATHOL, V49, P796, DOI 10.1177/0300985811424734; Zhou G, 2002, P NATL ACAD SCI USA, V99, P15124, DOI 10.1073/pnas.232588699	41	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77719	10.1371/journal.pone.0077719	http://dx.doi.org/10.1371/journal.pone.0077719			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147065	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400128
J	Gwynn, EJ; Smith, AJ; Guy, CP; Savery, NJ; McGlynn, P; Dillingham, MS				Gwynn, Emma J.; Smith, Abigail J.; Guy, Colin P.; Savery, Nigel J.; McGlynn, Peter; Dillingham, Mark S.			The Conserved C-Terminus of the PcrA/UvrD Helicase Interacts Directly with RNA Polymerase	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; UVRD HELICASE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; MISMATCH REPAIR; PCRA HELICASE; TRANSCRIPTION; PROTEIN; REPLICATION	UvrD-like helicases play diverse roles in DNA replication, repair and recombination pathways. An emerging body of evidence suggests that their different cellular functions are directed by interactions with partner proteins that target unwinding activity to appropriate substrates. Recent studies in E. coli have shown that UvrD can act as an accessory replicative helicase that resolves conflicts between the replisome and transcription complexes, but the mechanism is not understood. Here we show that the UvrD homologue PcrA interacts physically with B. subtilis RNA polymerase, and that an equivalent interaction is conserved in E. coli where UvrD, but not the closely related helicase Rep, also interacts with RNA polymerase. The PcrA-RNAP interaction is direct and independent of nucleic acids or additional mediator proteins. A disordered but highly conserved C-terminal region of PcrA, which distinguishes PcrA/UvrD from otherwise related enzymes such as Rep, is both necessary and sufficient for interaction with RNA polymerase.	[Gwynn, Emma J.; Smith, Abigail J.; Savery, Nigel J.; Dillingham, Mark S.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol, Avon, England; [Guy, Colin P.; McGlynn, Peter] Univ Aberdeen, Sch Med Sci, Aberdeen, Scotland; [McGlynn, Peter] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Bristol; University of Aberdeen; University of York - UK	Dillingham, MS (corresponding author), Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol, Avon, England.	mark.dillingham@bristol.ac.uk		Savery, Nigel/0000-0002-0803-4075; McGlynn, Peter/0000-0001-8629-4713; Dillingham, Mark/0000-0002-4612-7141	Wellcome Trust [077368]; ERC; BBSRC [BB/I003142/1]; Biotechnology and Biological Sciences Research Council [BB/I001859/1, BB/I001859/2, BB/I003142/1] Funding Source: researchfish; BBSRC [BB/I001859/2, BB/I001859/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); ERC(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Wellcome Trust project grant to MD (Reference: 077368), an ERC starting grant to MD (Acronym: SM-DNA-REPAIR) and a BBSRC project grant to PM, NS and MD (Reference: BB/I003142/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; ARTHUR HM, 1980, MOL GEN GENET, V180, P185, DOI 10.1007/BF00267368; Atkinson J, 2011, NUCLEIC ACIDS RES, V39, P1351, DOI 10.1093/nar/gkq975; Atkinson J, 2009, J BIOL CHEM, V284, P9612, DOI 10.1074/jbc.M808030200; Bird LE, 1998, NUCLEIC ACIDS RES, V26, P2686, DOI 10.1093/nar/26.11.2686; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Centore RC, 2009, J BACTERIOL, V191, P1429, DOI 10.1128/JB.01415-08; CHEN CH, 2011, PLOS ONE, V21, P3150, DOI DOI 10.1371/J0URNAL.P0NE.0018910.PUBMED:21556138; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Delumeau O, 2011, PROTEOMICS, V11, P2992, DOI 10.1002/pmic.201000790; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2010, NATURE, V463, P245, DOI 10.1038/nature08669; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Finkel JS, 2010, GENETICS, V184, P107, DOI 10.1534/genetics.109.110031; Gilhooly Neville Surain, 2013, Front Biosci (Schol Ed), V5, P206; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Hall MC, 1998, EMBO J, V17, P1535, DOI 10.1093/emboj/17.5.1535; IORDANESCU S, 1993, MOL GEN GENET, V241, P185, DOI 10.1007/BF00280216; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jia HF, 2011, J MOL BIOL, V411, P633, DOI 10.1016/j.jmb.2011.06.019; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanagaraj R, 2010, NUCLEIC ACIDS RES, V38, P8131, DOI 10.1093/nar/gkq697; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; McGlynn P, 2012, MOL MICROBIOL, V85, P12, DOI 10.1111/j.1365-2958.2012.08102.x; Mechanic LE, 1999, J BACTERIOL, V181, P2519, DOI 10.1128/JB.181.8.2519-2526.1999; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; MOSZER I, 1995, MICROBIOL-SGM, V141, P261, DOI 10.1099/13500872-141-2-261; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Noirot-Gros MF, 2002, MOL GENET GENOMICS, V267, P391, DOI 10.1007/s00438-002-0670-9; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Petit MA, 1998, MOL MICROBIOL, V29, P261, DOI 10.1046/j.1365-2958.1998.00927.x; Petit MA, 2002, EMBO J, V21, P3137, DOI 10.1093/emboj/cdf317; Qi Y, 1998, MOL MICROBIOL, V28, P1187, DOI 10.1046/j.1365-2958.1998.00882.x; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Savery NJ, 2007, TRENDS MICROBIOL, V15, P326, DOI 10.1016/j.tim.2007.05.005; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; Soultanas P, 1998, NUCLEIC ACIDS RES, V26, P2374, DOI 10.1093/nar/26.10.2374; Soultanas P, 1999, NUCLEIC ACIDS RES, V27, P1421, DOI 10.1093/nar/27.6.1421; Srivastava DB, 2013, P NATL ACAD SCI USA, V110, P12619, DOI 10.1073/pnas.1308270110; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Urban A, 2007, APPL ENVIRON MICROB, V73, P6436, DOI 10.1128/AEM.00586-07; Ursic D, 2004, NUCLEIC ACIDS RES, V32, P2441, DOI 10.1093/nar/gkh561; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; Yang W, 2010, ANNU REV BIOPHYS, V39, P367, DOI 10.1146/annurev.biophys.093008.131415; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Yeeles JTP, 2010, DNA REPAIR, V9, P276, DOI 10.1016/j.dnarep.2009.12.016; Yuce O, 2013, MOL CELL BIOL, V33, P406, DOI 10.1128/MCB.01195-12	62	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78141	10.1371/journal.pone.0078141	http://dx.doi.org/10.1371/journal.pone.0078141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147116	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400149
J	Shakya, M; Gottel, N; Castro, H; Yang, ZMK; Gunter, L; Labbe, J; Muchero, W; Bonito, G; Vilgalys, R; Tuskan, G; Podar, M; Schadt, CW				Shakya, Migun; Gottel, Neil; Castro, Hector; Yang, Zamin K.; Gunter, Lee; Labbe, Jessy; Muchero, Wellington; Bonito, Gregory; Vilgalys, Rytas; Tuskan, Gerald; Podar, Mircea; Schadt, Christopher W.			A Multifactor Analysis of Fungal and Bacterial Community Structure in the Root Microbiome of Mature Populus deltoides Trees	PLOS ONE			English	Article							MYCORRHIZAL FUNGI; BLACK COTTONWOOD; ECOLOGICAL DATA; RHIZOSPHERE; DIVERSITY; POPLAR; ENDOPHYTES; PLANTS; GROWTH; COEXISTENCE	Bacterial and fungal communities associated with plant roots are central to the host health, survival and growth. However, a robust understanding of the root-microbiome and the factors that drive host associated microbial community structure have remained elusive, especially in mature perennial plants from natural settings. Here, we investigated relationships of bacterial and fungal communities in the rhizosphere and root endosphere of the riparian tree species Populus deltoides, and the influence of soil parameters, environmental properties (host phenotype and aboveground environmental settings), host plant genotype (Simple Sequence Repeat (SSR) markers), season (Spring vs. Fall) and geographic setting (at scales from regional watersheds to local riparian zones) on microbial community structure. Each of the trees sampled displayed unique aspects to its associated community structure with high numbers of Operational Taxonomic Units (OTUs) specific to an individual trees (bacteria >90%, fungi >60%). Over the diverse conditions surveyed only a small number of OTUs were common to all samples within rhizosphere (35 bacterial and 4 fungal) and endosphere (1 bacterial and 1 fungal) microbiomes. As expected, Proteobacteria and Ascomycota were dominant in root communities (>50%) while other higher-level phylogenetic groups (Chytridiomycota, Acidobacteria) displayed greatly reduced abundance in endosphere compared to the rhizosphere. Variance partitioning partially explained differences in microbiome composition between all sampled roots on the basis of seasonal and soil properties (4% to 23%). While most variation remains unattributed, we observed significant differences in the microbiota between watersheds (Tennessee vs. North Carolina) and seasons (Spring vs. Fall). SSR markers clearly delineated two host populations associated with the samples taken in TN vs. NC, but overall host genotypic distances did not have a significant effect on corresponding communities that could be separated from other measured effects.	[Shakya, Migun; Gottel, Neil; Castro, Hector; Yang, Zamin K.; Gunter, Lee; Labbe, Jessy; Muchero, Wellington; Tuskan, Gerald; Podar, Mircea; Schadt, Christopher W.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Shakya, Migun; Podar, Mircea; Schadt, Christopher W.] Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN USA; [Castro, Hector; Podar, Mircea; Schadt, Christopher W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Bonito, Gregory; Vilgalys, Rytas] Duke Univ, Dept Biol, Durham, NC USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Duke University	Schadt, CW (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA.	schadtcw@ornl.gov	Labbe, Jessy/G-9532-2011; Schadt, Christopher W./B-7143-2008; Gunter, Lee E/L-3480-2016; Schadt, Christopher/M-8746-2019; Podar, Mircea/B-7299-2012; Tuskan, Gerald/A-6225-2011	Labbe, Jessy/0000-0003-0368-2054; Schadt, Christopher W./0000-0001-8759-2448; Gunter, Lee E/0000-0003-1211-7532; Schadt, Christopher/0000-0001-8759-2448; Podar, Mircea/0000-0003-2776-0205; Tuskan, Gerald/0000-0003-0106-1289; muchero, wellington/0000-0002-0200-9856; Shakya, Migun/0000-0003-3876-691X; Castro, Hector/0000-0001-7323-1123; Vilgalys, Rytas/0000-0001-8299-3605	Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area; U.S. Department of Energy [DE-AC05-00OR22725]	Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This research was sponsored by the Genomic Science Program, U.S. Department of Energy, Office of Science, Biological and Environmental Research, as part of the Plant Microbe Interfaces Scientific Focus Area (http://pmi.ornl.gov). Oak Ridge National Laboratory is managed by UT-Battelle LLC, for the U.S. Department of Energy under contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2010, SOIL BIOL BIOCHEM, V42, P2276, DOI 10.1016/j.soilbio.2010.08.029; Behie SW, 2012, SCIENCE, V336, P1576, DOI 10.1126/science.1222289; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Danielsen L, 2012, ECOL EVOL, V2, P1935, DOI 10.1002/ece3.305; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doty SL, 2009, SYMBIOSIS, V47, P23, DOI 10.1007/BF03179967; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Graff A, 2005, FEMS MICROBIOL ECOL, V53, P401, DOI 10.1016/j.femsec.2005.01.009; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Kai M, 2008, PLANT SIGNAL BEHAV, V3, P482, DOI 10.4161/psb.3.7.5681; Khan AL, 2012, BIOL FERT SOILS, V48, P519, DOI 10.1007/s00374-011-0649-y; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Liu KL, 2012, APPL ENVIRON MICROB, V78, P1523, DOI 10.1128/AEM.06826-11; Lottmann Jana, 2010, Environmental Biosafety Research, V9, DOI 10.1051/ebr/2010007; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; LU XH, 1994, NEW PHYTOL, V128, P211, DOI 10.1111/j.1469-8137.1994.tb04004.x; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Marschner P, 2005, J PLANT NUTR SOIL SC, V168, P343, DOI 10.1002/jpln.200424101; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; MENDES R, 2013, FEMS MICROBIOL REV; Moore FP, 2006, SYST APPL MICROBIOL, V29, P539, DOI 10.1016/j.syapm.2005.11.012; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Roesti D, 2005, APPL ENVIRON MICROB, V71, P6673, DOI 10.1128/AEM.71.11.6673-6679.2005; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Shi SJ, 2011, FEMS MICROBIOL ECOL, V77, P600, DOI 10.1111/j.1574-6941.2011.01150.x; Singh BK, 2008, ENVIRON MICROBIOL, V10, P534, DOI 10.1111/j.1462-2920.2007.01474.x; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2004, CAN J FOREST RES, V34, P85, DOI [10.1139/x03-283, 10.1139/X03-283]; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Lelie D, 2009, CRIT REV PLANT SCI, V28, P346, DOI 10.1080/07352680903241204; Vestergard M, 2008, FEMS MICROBIOL ECOL, V64, P78, DOI 10.1111/j.1574-6941.2008.00447.x; Weinert N, 2009, APPL ENVIRON MICROB, V75, P3859, DOI 10.1128/AEM.00414-09; Weston DJ, 2012, MOL PLANT MICROBE IN, V25, P765, DOI 10.1094/MPMI-09-11-0253	63	184	195	5	209	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76382	10.1371/journal.pone.0076382	http://dx.doi.org/10.1371/journal.pone.0076382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146861	gold, Green Submitted, Green Published			2022-12-27	WOS:000326019400057
J	Auerbach, DS; Jones, J; Clawson, BC; Offord, J; Lenk, GM; Ogiwara, I; Yamakawa, K; Meisler, MH; Parent, JM; Isom, LL				Auerbach, David S.; Jones, Julie; Clawson, Brittany C.; Offord, James; Lenk, Guy M.; Ogiwara, Ikuo; Yamakawa, Kazuhiro; Meisler, Miriam H.; Parent, Jack M.; Isom, Lori L.			Altered Cardiac Electrophysiology and SUDEP in a Model of Dravet Syndrome	PLOS ONE			English	Article							SEVERE MYOCLONIC EPILEPSY; SUDDEN UNEXPECTED DEATH; LONG-QT SYNDROME; NEURONAL SODIUM-CHANNEL; PLURIPOTENT STEM-CELLS; MOUSE MODEL; INHIBITORY INTERNEURONS; POTENTIAL ROLE; RISK-FACTORS; HEART-RATE	Objective: Dravet syndrome is a severe form of intractable pediatric epilepsy with a high incidence of SUDEP: Sudden Unexpected Death in epilepsy. Cardiac arrhythmias are a proposed cause for some cases of SUDEP, yet the susceptibility and potential mechanism of arrhythmogenesis in Dravet syndrome remain unknown. The majority of Dravet syndrome patients have de novo mutations in SCN1A, resulting in haploinsufficiency. We propose that, in addition to neuronal hyperexcitability, SCN1A haploinsufficiency alters cardiac electrical function and produces arrhythmias, providing a potential mechanism for SUDEP. Methods: Postnatal day 15-21 heterozygous SCN1A-R1407X knock-in mice, expressing a human Dravet syndrome mutation, were used to investigate a possible cardiac phenotype. A combination of single cell electrophysiology and in vivo electrocardiogram (ECG) recordings were performed. Results: We observed a 2-fold increase in both transient and persistent Na+ current density in isolated Dravet syndrome ventricular myocytes that resulted from increased activity of a tetrodotoxin-resistant Na+ current, likely Na(v)1.5. Dravet syndrome myocytes exhibited increased excitability, action potential duration prolongation, and triggered activity. Continuous radiotelemetric ECG recordings showed QT prolongation, ventricular ectopic foci, idioventricular rhythms, beat-to-beat variability, ventricular fibrillation, and focal bradycardia. Spontaneous deaths were recorded in 2 DS mice, and a third became moribund and required euthanasia. Interpretation: These data from single cell and whole animal experiments suggest that altered cardiac electrical function in Dravet syndrome may contribute to the susceptibility for arrhythmogenesis and SUDEP. These mechanistic insights may lead to critical risk assessment and intervention in human patients.	[Auerbach, David S.; Clawson, Brittany C.; Offord, James; Isom, Lori L.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Jones, Julie; Lenk, Guy M.; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Meisler, Miriam H.; Parent, Jack M.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Isom, Lori L.] Univ Michigan, Ann Arbor, MI 48109 USA; [Parent, Jack M.] Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Ogiwara, Ikuo; Yamakawa, Kazuhiro] Riken Brain Sci Inst, Neurogenet Lab, Wako, Saitama, Japan	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; RIKEN	Isom, LL (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	lisom@umich.edu	Auerbach, David/AAA-5466-2020; Yamakawa, Kazuhiro/N-5050-2015; Lenk, Guy M./Q-1226-2016; Clawson, Brittany C/U-3808-2017	Auerbach, David/0000-0001-9198-3847; Yamakawa, Kazuhiro/0000-0002-1478-4390; Lenk, Guy M./0000-0001-8092-1405; Clawson, Brittany C/0000-0003-4916-4201; Isom, Lori/0000-0002-9479-6729	University of Michigan Center for Organogenesis; Citizens United for Research in Epilepsy Foundation; Dravet Syndrome Foundation; NIH [T32HL007853]; Epilepsy Foundation;  [NIH-NS076752];  [NIH-NS076916]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS076752, R01NS034509, P20NS076916, R37NS076752, R01NS076752] Funding Source: NIH RePORTER	University of Michigan Center for Organogenesis(University of Michigan System); Citizens United for Research in Epilepsy Foundation; Dravet Syndrome Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epilepsy Foundation; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NIH-NS076752 (to LLI), NIH-NS076916 (to JMP), the University of Michigan Center for Organogenesis (to LLI), Citizens United for Research in Epilepsy Foundation (to JMP) and the Dravet Syndrome Foundation(to JMP and MHM). DSA was supported by NIH T32HL007853 to the University of Michigan Cardiovascular Center and a Postdoctoral Fellowship from the Epilepsy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsit GS, 2013, J MOL CELL CARDIOL, V61, P34, DOI 10.1016/j.yjmcc.2013.03.017; Agullo-Pascual E, 2013, CARDIOVASC RES; Auerbach DS, 2011, J PHYSIOL-LONDON, V589, P2363, DOI 10.1113/jphysiol.2010.200576; Aurlien D, 2009, SEIZURE-EUR J EPILEP, V18, P158, DOI 10.1016/j.seizure.2008.07.008; Baruscotti M, 1997, J PHYSIOL-LONDON, V498, P641, DOI 10.1113/jphysiol.1997.sp021889; Brackenbury WJ, 2008, J NEUROSCI, V28, P3246, DOI 10.1523/JNEUROSCI.5446-07.2008; Brette F, 2006, BIOCHEM BIOPH RES CO, V348, P1163, DOI 10.1016/j.bbrc.2006.07.189; Brotherstone R, 2010, EPILEPSIA, V51, P221, DOI 10.1111/j.1528-1167.2009.02281.x; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Cerrone M, 2007, CIRC RES, V101, P1039, DOI 10.1161/CIRCRESAHA.107.148064; Chatelier A, 2010, PFLUG ARCH EUR J PHY, V460, P77, DOI 10.1007/s00424-010-0801-9; Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Chen Y, 2008, MOL CELL NEUROSCI, V38, P607, DOI 10.1016/j.mcn.2008.05.009; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Delogu AB, 2011, EPILEPSIA, V52, P55, DOI 10.1111/j.1528-1167.2011.03003.x; Dravet Charlotte, 2005, Adv Neurol, V95, P71; Dravet C, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2011.02993.x; Ergul Y, 2013, ACTA NEUROL BELG, V113, P161, DOI 10.1007/s13760-012-0140-z; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Espinosa PS, 2009, NEUROLOGY, V72, P1702, DOI 10.1212/WNL.0b013e3181a55f90; Estrada G, 2011, PEPTIDES, V32, P75, DOI 10.1016/j.peptides.2010.11.001; Fletcher EV, 2011, J BIOL CHEM, V286, P36700, DOI 10.1074/jbc.M111.250225; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Guerrini R, 2003, J CLIN NEUROPHYSIOL, V20, P449, DOI 10.1097/00004691-200311000-00007; Haufe V, 2005, CARDIOVASC RES, V65, P117, DOI 10.1016/j.cardiores.2004.08.017; Herren AW, 2013, AM J PHYSIOL-HEART C, V305, pH431, DOI 10.1152/ajpheart.00306.2013; Inoue N, 2004, J AM COLL CARDIOL, V44, P914, DOI 10.1016/j.jacc.2004.05.054; Johnson JN, 2009, NEUROLOGY, V72, P224, DOI 10.1212/01.wnl.0000335760.02995.ca; Kalume F, 2013, J CLIN INVEST, V123, P1798, DOI 10.1172/JCI66220; Kandler L, 2005, ACTA PAEDIATR, V94, P1243, DOI 10.1080/08035250510031025; Kaufmann SG, 2013, J MOL CELL CARDIOL, V61, P133, DOI 10.1016/j.yjmcc.2013.05.006; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Lei M, 2004, J PHYSIOL-LONDON, V559, P835, DOI 10.1113/jphysiol.2004.068643; Liu Y, 2013, ANN NEUROL, V74, P128, DOI 10.1002/ana.23897; Lopez-Santiago Luis F, 2007, J Mol Cell Cardiol, V43, P636, DOI 10.1016/j.yjmcc.2007.07.062; Lopez-Santiago LF, 2011, J BIOL CHEM, V286, P22913, DOI 10.1074/jbc.M111.242370; Lowe JS, 2008, J CELL BIOL, V180, P173, DOI 10.1083/jcb.200710107; Maier SKG, 2004, CIRCULATION, V109, P1421, DOI 10.1161/01.CIR.0000121421.61896.24; Maier SKG, 2003, P NATL ACAD SCI USA, V100, P3507, DOI 10.1073/pnas.2627986100; Malan D, 2011, CIRC RES, V109, P841, DOI 10.1161/CIRCRESAHA.111.243139; Malhotra JD, 2001, CIRCULATION, V103, P1303; Marionneau C, 2012, J NEUROSCI, V32, P5716, DOI 10.1523/JNEUROSCI.6450-11.2012; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Mercier A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048690; Milstein ML, 2012, P NATL ACAD SCI USA, V109, pE2134, DOI 10.1073/pnas.1109370109; Mistry A, 2012, STRAIN AGE DEPENDENT; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2004, P NATL ACAD SCI USA, V101, P9137, DOI 10.1073/pnas.0402546101; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Moss AJ, 2005, J CLIN INVEST, V115, P2018, DOI 10.1172/JCI25537; Nashef L, 2007, EPILEPSIA, V48, P859, DOI 10.1111/j.1528-1167.2007.01082.x; Nei M, 2010, CURR NEUROL NEUROSCI, V10, P319, DOI 10.1007/s11910-010-0116-4; Noujaim SF, 2007, P NATL ACAD SCI USA, V104, P20985, DOI 10.1073/pnas.0709758104; Noujaim SF, 2007, J PHYSIOL-LONDON, V578, P315, DOI 10.1113/jphysiol.2006.121475; Noujaim SF, 2012, FASEB J, V26, P63, DOI 10.1096/fj.10-179770; Nuyens D, 2001, NAT MED, V7, P1021, DOI 10.1038/nm0901-1021; O-Uchi J, 2005, P NATL ACAD SCI USA, V102, P9400, DOI 10.1073/pnas.0503569102; Oakley JC, 2011, EPILEPSIA, V52, P59, DOI 10.1111/j.1528-1167.2011.03004.x; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; OPPENHEIMER S, 1990, J ROY SOC MED, V83, P134, DOI 10.1177/014107689008300302; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Patino GA, 2011, J NEUROSCI, V31, P14577, DOI 10.1523/JNEUROSCI.0361-11.2011; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Pignier C, 2007, BASIC RES CARDIOL, V102, P553, DOI 10.1007/s00395-007-0676-x; Sato PY, 2009, CIRC RES, V105, P523, DOI 10.1161/CIRCRESAHA.109.201418; Schuele SU, 2007, CLEV CLIN J MED, V74, P121, DOI 10.3949/ccjm.74.Suppl_1.S121; Shorvon S, 2011, LANCET, V378, P2028, DOI 10.1016/S0140-6736(11)60176-1; Surges R, 2010, EPILEPSIA, V51, P738, DOI 10.1111/j.1528-1167.2010.02571.x; Surges R, 2010, EPILEPSIA, V51, P233, DOI 10.1111/j.1528-1167.2009.02330.x; Surges R, 2009, NAT REV NEUROL, V5, P492, DOI 10.1038/nrneurol.2009.118; Tavernor SJ, 1996, SEIZURE, V5, P79, DOI 10.1016/S1059-1311(96)80067-7; Terrenoire C, 2013, J GEN PHYSIOL, V141, P61, DOI 10.1085/jgp.201210899; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Yamaji N, 2009, J BIOL CHEM, V284, P24568, DOI 10.1074/jbc.M109.030841; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zareba W, 2008, PROG CARDIOVASC DIS, V51, P264, DOI 10.1016/j.pcad.2008.10.006	79	101	103	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77843	10.1371/journal.pone.0077843	http://dx.doi.org/10.1371/journal.pone.0077843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155976	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300110
J	Mascarello, A; Mori, M; Chiaradia-Delatorre, LD; Menegatti, ACO; Delle Monache, F; Ferrari, F; Yunes, RA; Nunes, RJ; Terenzi, H; Botta, B; Botta, M				Mascarello, Alessandra; Mori, Mattia; Chiaradia-Delatorre, Louise Domeneghini; Orbem Menegatti, Angela Camila; Delle Monache, Franco; Ferrari, Franco; Yunes, Rosendo Augusto; Nunes, Ricardo Jose; Terenzi, Hernan; Botta, Bruno; Botta, Maurizio			Discovery of Mycobacterium tuberculosis Protein Tyrosine Phosphatase B (PtpB) Inhibitors from Natural Products	PLOS ONE			English	Article							SECRETED PHOSPHATASES; POTENT INHIBITORS; FORCE-FIELD; MPTPB; DERIVATIVES; ANTHRANOIDS; STRATEGIES; IMPAIRS; SITES; MICE	Protein tyrosine phosphatase B (PtpB) is one of the virulence factors secreted into the host cell by Mycobacterium tuberculosis. PtpB attenuates host immune defenses by interfering with signal transduction pathways in macrophages and, therefore, it is considered a promising target for the development of novel anti-tuberculosis drugs. Here we report the discovery of natural compound inhibitors of PtpB among an in house library of more than 800 natural substances by means of a multidisciplinary approach, mixing in silico screening with enzymatic and kinetics studies and MS assays. Six natural compounds proved to inhibit PtpB at low micromolar concentrations (< 30 mu M) with Kuwanol E being the most potent with K-i = 1.6 +/- 0.1 mu M. To the best of our knowledge, Kuwanol E is the most potent natural compound PtpB inhibitor reported so far, as well as it is the first non-peptidic PtpB inhibitor discovered from natural sources. Compounds herein identified may inspire the design of novel specific PtpB inhibitors.	[Mascarello, Alessandra; Chiaradia-Delatorre, Louise Domeneghini; Yunes, Rosendo Augusto; Nunes, Ricardo Jose] Univ Fed Santa Catarina, Lab Estrutura & Atividade, Florianopolis, SC, Brazil; [Mori, Mattia; Delle Monache, Franco; Ferrari, Franco; Botta, Bruno] Univ Roma La Sapienza, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy; [Mori, Mattia; Botta, Maurizio] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy; [Chiaradia-Delatorre, Louise Domeneghini; Orbem Menegatti, Angela Camila; Terenzi, Hernan] Univ Fed Santa Catarina, Ctr Biol Mol Estrutural, Florianopolis, SC, Brazil; [Botta, Maurizio] Temple Univ, Ctr Biotechnol, Sbarro Inst Canc Res & Mol Med, Philadelphia, PA 19122 USA	Universidade Federal de Santa Catarina (UFSC); Sapienza University Rome; University of Siena; Universidade Federal de Santa Catarina (UFSC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Terenzi, H (corresponding author), Univ Fed Santa Catarina, Ctr Biol Mol Estrutural, Florianopolis, SC, Brazil.	hterenzi@ccb.ufsc.br; bruno.botta@uniroma1.it; botta.maurizio@gmail.com	MENEGATTI, Angela Camila Orbem/AAO-8258-2020; Menegatti, Angela/T-8514-2017; Terenzi, Hernan/ABI-1339-2020	MENEGATTI, Angela Camila Orbem/0000-0001-9319-1245; Mori, Mattia/0000-0003-2398-1254; Botta, Bruno/0000-0001-8707-4333	Istituto Italiano di Tecnologia - IIT - Center for Life Nano Science (IIT@Sapienza), viale Regina, Roma (Italy); CNPq; CAPES; MCT (Ministerio da Ciencia e Tecnologia); FAPESC in Brazil; CAPES in Italy	Istituto Italiano di Tecnologia - IIT - Center for Life Nano Science (IIT@Sapienza), viale Regina, Roma (Italy); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); MCT (Ministerio da Ciencia e Tecnologia); FAPESC in Brazil; CAPES in Italy(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding was provided by Istituto Italiano di Tecnologia - IIT (2011/2015) - Center for Life Nano Science (IIT@Sapienza), viale Regina Elena 291, 00161 Roma (Italy). CNPq, CAPES, MCT (Ministerio da Ciencia e Tecnologia) and FAPESC provided for financial support and fellowships in Brazil. This work form part of the doctoral thesis of A. Mascarello, which also thanks CAPES for the PDSE fellowship in Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LIGPREP VERS 2 5; [Anonymous], 2011, QIKPROP VERS 3 4; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Beresford NJ, 2009, J ANTIMICROB CHEMOTH, V63, P928, DOI 10.1093/jac/dkp031; Bringmann G., 1999, Pharmaceutical and Pharmacological Letters, V9, P41; Carosati E, 2004, J MED CHEM, V47, P5114, DOI 10.1021/jm0498349; Case D., 2011, AMBER 11; Chiaradia LD, 2008, BIOORG MED CHEM LETT, V18, P6227, DOI 10.1016/j.bmcl.2008.09.105; Chiaradia LD, 2012, J MED CHEM, V55, P390, DOI 10.1021/jm2012062; Cuca-Suarez LE, 1998, REV COLOMB QUIM, V27, P17; de Oliveira KN, 2011, MEDCHEMCOMM, V2, P500, DOI 10.1039/c0md00253d; DELLEMONACHE F, 1992, PHYTOCHEMISTRY, V31, P259, DOI 10.1016/0031-9422(91)83049-Q; DELLEMONACHE F, 1979, TETRAHEDRON, V35, P2143; DELLEMONACHE G, 1977, GAZZ CHIM ITAL, V107, P189; DeVinney R, 2000, TRENDS MICROBIOL, V8, P29, DOI 10.1016/S0966-842X(99)01657-1; Ecco G, 2010, CHEM COMMUN, V46, P7501, DOI 10.1039/c0cc01704c; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Ferrari F, 1999, PLANTA MED, V65, P85, DOI 10.1055/s-2006-960448; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Grundner C, 2005, STRUCTURE, V13, P1625, DOI 10.1016/j.str.2005.07.017; Grundner C, 2008, FEMS MICROBIOL LETT, V287, P181, DOI 10.1111/j.1574-6968.2008.01309.x; Grundner C, 2007, STRUCTURE, V15, P499, DOI 10.1016/j.str.2007.03.003; Harvey A, 2000, DRUG DISCOV TODAY, V5, P294, DOI 10.1016/S1359-6446(00)01511-7; He YT, 2013, J MED CHEM, V56, P832, DOI 10.1021/jm301781p; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Lachance H, 2012, J MED CHEM, V55, P5989, DOI 10.1021/jm300288g; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; MARINIBETTOLO GB, 1964, ANN CHIM-ROME, V54, P1179; Mascarello A, 2010, BIOORGAN MED CHEM, V18, P3783, DOI 10.1016/j.bmc.2010.04.051; Mori M, 2012, VIRUS RES, V169, P377, DOI 10.1016/j.virusres.2012.05.011; Mori M, 2011, J CHEM INF MODEL, V51, P446, DOI 10.1021/ci100393m; Muller D, 2006, J MED CHEM, V49, P4871, DOI 10.1021/jm060327w; Noren-Muller A, 2006, P NATL ACAD SCI USA, V103, P10606, DOI 10.1073/pnas.0601490103; Noldin VF, 2003, QUIM NOVA, V26, P331, DOI 10.1590/S0100-40422003000300008; PINHEIRO RM, 1984, PHYTOCHEMISTRY, V23, P1737, DOI 10.1016/S0031-9422(00)83481-0; Silva APG, 2010, FUTURE MED CHEM, V2, P1325, DOI 10.4155/fmc.10.214; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; Tabernero L, 2008, FEBS J, V275, P867, DOI 10.1111/j.1742-4658.2008.06251.x; Trani A, 2004, FITOTERAPIA, V75, P99, DOI 10.1016/j.fitote.2003.08.004; Trani M, 1997, GAZZ CHIM ITAL, V127, P415; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Vintonyak VV, 2011, TETRAHEDRON, V67, P6713, DOI 10.1016/j.tet.2011.04.026; Vintonyak VV, 2009, CURR OPIN CHEM BIOL, V13, P272, DOI 10.1016/j.cbpa.2009.03.021; WANDER G, 1925, PHARM J, V115, P520; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107	53	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77081	10.1371/journal.pone.0077081	http://dx.doi.org/10.1371/journal.pone.0077081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155919	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300053
J	Preston, GC; Feijoo-Carnero, C; Schurch, N; Cowling, VH; Cantrell, DA				Preston, Gavin C.; Feijoo-Carnero, Carmen; Schurch, Nick; Cowling, Victoria H.; Cantrell, Doreen A.			The Impact of KLF2 Modulation on the Transcriptional Program and Function of CD8 T Cells	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-2; SERINE-PROTEASE INHIBITOR-6; L-SELECTIN; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; UP-REGULATION; DIFFERENTIATION; TRAFFICKING; MEMORY; MIGRATION	Kruppel-like factor 2 (KLF2) is a transcription factor that is highly expressed in quiescent T lymphocytes and downregulated in effector T cells. We now show that antigen receptor engagement downregulates KLF2 expression in a graded response determined by the affinity of T cell antigen receptor (TCR) ligand and the integrated activation of protein kinase B and the MAP kinases ERK1/2. The present study explores the importance of KLF2 downregulation and reveals that the loss of KLF2 controls a select portion of the CD8 effector T cell transcriptional program. In particular, KLF2 loss is required for CD8 T cells to express the inflammatory chemokine receptor CXCR3 and for maximum clonal expansion of T cells. KLF2 thus negatively controls the ability of CD8 T cells to respond to the CXCR3 ligand CXCL10. Strikingly, the KLF2 threshold for restraining expression of CXCR3 is very low and quite distinct to the KLF2 threshold for restraining T cell proliferation. KLF2 is thus an analogue (tunable) not a digital (on/off) cellular switch where the magnitude of KLF2 expression differentially modifies the T cell responses.	[Preston, Gavin C.; Feijoo-Carnero, Carmen; Cowling, Victoria H.; Cantrell, Doreen A.] Univ Dundee, Dept Cell Signalling & Immunol, Coll Life Sci, Dundee, Scotland; [Schurch, Nick] Univ Dundee, Data Anal Grp, Coll Life Sci, Dept Biol Chem & Drug Discovery, Dundee, Scotland	University of Dundee; University of Dundee	Cantrell, DA (corresponding author), Univ Dundee, Dept Cell Signalling & Immunol, Coll Life Sci, Dundee, Scotland.	d.a.cantrell@dundee.ac.uk	Schurch, Nicholas/I-4339-2019	Schurch, Nicholas/0000-0001-9068-9654; Cantrell, Doreen/0000-0001-7525-3350; Cowling, Victoria/0000-0001-7638-4870	Wellcome Trust [065975/Z/01/A]; Medical Research Council [G0700240] Funding Source: researchfish; MRC [G0700240] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was supported by a Wellcome Trust Principal Research Fellowship (D.A.C.) and Program Grant no. 065975/Z/01/A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bu DX, 2010, J CLIN INVEST, V120, P1961, DOI 10.1172/JCI41384; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Dubois S, 2003, P NATL ACAD SCI USA, V100, P14169, DOI 10.1073/pnas.2335979100; Fabre S, 2005, J IMMUNOL, V174, P4161, DOI 10.4049/jimmunol.174.7.4161; Fabre S, 2008, J IMMUNOL, V181, P2980, DOI 10.4049/jimmunol.181.5.2980; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; GUTIERREZ A, 2009, BLOOD; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hart GT, 2011, P NATL ACAD SCI USA, V108, P716, DOI 10.1073/pnas.1013168108; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Phillips T, 2004, J IMMUNOL, V173, P3801, DOI 10.4049/jimmunol.173.6.3801; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Schober SL, 1999, J IMMUNOL, V163, P3662; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Takada K, 2011, J IMMUNOL, V186, P775, DOI 10.4049/jimmunol.1000094; Taqueti VR, 2006, J IMMUNOL, V177, P5890, DOI 10.4049/jimmunol.177.9.5890; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Winkelmann R, 2011, P NATL ACAD SCI USA, V108, P710, DOI 10.1073/pnas.1012858108; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	44	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77537	10.1371/journal.pone.0077537	http://dx.doi.org/10.1371/journal.pone.0077537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155966	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300100
J	Suarez, C; Espariz, M; Blancato, VS; Magni, C				Suarez, Cristian; Espariz, Martin; Blancato, Victor S.; Magni, Christian			Expression of the Agmatine Deiminase Pathway in Enterococcus faecalis Is Activated by the AguR Regulator and Repressed by CcpA and PTSMan Systems	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; GENE-CLUSTER; MERR FAMILY; OPERON; TRANSCRIPTION; BIOSYNTHESIS; CATABOLISM; RESISTANCE; VECTOR; BACTERIOCIN	Although the agmatine deiminase system (AgDI) has been investigated in Enterococcus faecalis, little information is available with respect to its gene regulation. In this study we demonstrate that the presence of exogenous agmatine induces the expression of agu genes in this bacterium. In contrast to the homologous and extensively characterized AgDI system of S. mutants, the aguBDAC operon in E. faecalis is not induced in response to low pH. In spite of this, agmatine catabolism in this bacterium contributes by neutralizing the external medium while enhancing bacterial growth. Our results indicate that carbon catabolic repression (CCR) operates on the AgDI system via a mechanism that involves interaction of CcpA and P-Ser-HPr with a cre site found in an unusual position considering the aguB promoter (55 nt upstream the + 1 position). In addition, we found that components of the mannose phosphotransferase (PTSMan) system also contributed to CCR in E. faecalis since a complete relief of the PTS-sugars repressive effect was observed only in a PTSMan and CcpA double defective strain. Our gene context analysis revealed that aguR is present in oral and gastrointestinal microorganisms. Thus, regulation of the aguBDAC operon in E. faecalis seems to have evolved to obtain energy and resist low pH conditions in order to persist and colonize gastrointestinal niches.	[Suarez, Cristian; Espariz, Martin; Blancato, Victor S.; Magni, Christian] Consejo Nacl Invest Cient & Tecn IBR CONICET, Inst Biol Mol Rosario, Lab Fisiol & Genet Bacterias Lact, Santa Fe, Argentina; [Suarez, Cristian; Espariz, Martin; Blancato, Victor S.; Magni, Christian] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Microbiol, Santa Fe, Argentina	National University of Rosario	Magni, C (corresponding author), Consejo Nacl Invest Cient & Tecn IBR CONICET, Inst Biol Mol Rosario, Lab Fisiol & Genet Bacterias Lact, Santa Fe, Argentina.	magni@ibr-conicet.gov.ar	Blancato, Víctor/J-8976-2019; Magni, Christian/AAF-6476-2019; Espariz, Martin/AAF-6582-2019	Blancato, Víctor/0000-0003-3945-2859; Magni, Christian/0000-0002-5179-9700; Espariz, Martin/0000-0002-4090-515X	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina [PICT2010-1828, PICT 2008-1562]; European Union grant (BIAMFood) [KBBE-211441]; CONICET [PIP2012-2014]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT); European Union grant (BIAMFood)(European Commission); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, PICT2010-1828 and PICT 2008-1562, Argentina), a European Union grant (BIAMFood, contract KBBE-211441) and CONICET (PIP2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Blancato VS, 2010, LETT APPL MICROBIOL, V50, P542, DOI 10.1111/j.1472-765X.2010.02815.x; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Burrell M, 2010, J BIOL CHEM, V285, P39224, DOI 10.1074/jbc.M110.163154; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chen JS, 2011, MICROBIOL-SGM, V157, P3150, DOI 10.1099/mic.0.049619-0; de Jong A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-299; Deloyer P, 2001, EUR J GASTROEN HEPAT, V13, P1027, DOI 10.1097/00042737-200109000-00005; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Giraffa G, 2003, INT J FOOD MICROBIOL, V88, P215, DOI 10.1016/S0168-1605(03)00183-1; Griswold AR, 2009, ORAL MICROBIOL IMMUN, V24, P79, DOI 10.1111/j.1399-302X.2008.00459.x; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Haenisch B, 2008, AM J PHYSIOL-GASTR L, V295, pG1104, DOI 10.1152/ajpgi.90374.2008; Hechard Y, 2001, MICROBIOL-SGM, V147, P1575, DOI 10.1099/00221287-147-6-1575; Hobman JL, 2007, MOL MICROBIOL, V63, P1275, DOI 10.1111/j.1365-2958.2007.05608.x; ISRAELSEN H, 1995, APPL ENVIRON MICROB, V61, P2540, DOI 10.1128/AEM.61.7.2540-2547.1995; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; Joyet P, 2013, BIOCH BIOPHYS ACTA; Ladero V, 2011, APPL ENVIRON MICROB, V77, P6409, DOI 10.1128/AEM.05507-11; Ladero V, 2010, CURR NUTR FOOD SCI, V6, P145, DOI 10.2174/157340110791233256; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; LeBlanc DJ, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P175, DOI 10.1007/0-387-30744-3_6; Leboeuf C, 2000, J BACTERIOL, V182, P5799, DOI 10.1128/JB.182.20.5799-5806.2000; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Lucas PM, 2007, MICROBIOL-SGM, V153, P2221, DOI 10.1099/mic.0.2007/006320-0; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Marelli B, 2010, WORLD J MICROB BIOT, V26, P999, DOI 10.1007/s11274-009-0262-5; Martin MG, 2004, J BACTERIOL, V186, P5649, DOI 10.1128/JB.186.17.5649-5660.2004; MARTINVERSTRAETE I, 1995, J BACTERIOL, V177, P6919, DOI 10.1128/jb.177.23.6919-6927.1995; Matsumoto M, 2011, MED HYPOTHESES, V77, P469, DOI 10.1016/j.mehy.2011.06.011; Molderings GJ, 2012, PHARMACOL THERAPEUT, V133, P351, DOI 10.1016/j.pharmthera.2011.12.005; Moreno MRF, 2006, INT J FOOD MICROBIOL, V106, P1, DOI 10.1016/j.ijfoodmicro.2005.06.026; Mortera P, 2012, APPL ENVIRON MICROB, V78, P1936, DOI 10.1128/AEM.07280-11; Opsata M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-224; Poyart C, 1997, FEMS MICROBIOL LETT, V156, P193, DOI 10.1016/S0378-1097(97)00423-0; Presecan-Siedel E, 1999, J BACTERIOL, V181, P6889, DOI 10.1128/JB.181.22.6889-6897.1999; Rhee HJ, 2007, J CELL MOL MED, V11, P685, DOI 10.1111/j.1582-4934.2007.00077.x; Sambrook J., 2001, MOL CLONING LAB MANU; Shalaby AR, 1996, SIGNIFICANCE BIOGENI; Sorensen KI, 1996, J BACTERIOL, V178, P1003, DOI 10.1128/jb.178.4.1003-1011.1996; Suarez CA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-227; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tojo S, 2005, MOL MICROBIOL, V56, P1560, DOI 10.1111/j.1365-2958.2005.04635.x; Turinsky AJ, 1998, J BACTERIOL, V180, P5961, DOI 10.1128/JB.180.22.5961-5967.1998	46	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76170	10.1371/journal.pone.0076170	http://dx.doi.org/10.1371/journal.pone.0076170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155893	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300027
J	Bourne, Y; Renault, L; Essono, S; Mondielli, G; Lamourette, P; Boquet, D; Grassi, J; Marchot, P				Bourne, Yves; Renault, Ludovic; Essono, Sosthene; Mondielli, Gregoire; Lamourette, Patricia; Boquet, Didier; Grassi, Jacques; Marchot, Pascale			Molecular Characterization of Monoclonal Antibodies that Inhibit Acetylcholinesterase by Targeting the Peripheral Site and Backdoor Region	PLOS ONE			English	Article							TORPEDO-CALIFORNICA; CONFORMATIONAL FLEXIBILITY; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; VARIABLE REGIONS; ATOMIC-STRUCTURE; SUBSTRATE; BINDING; FASCICULIN; GORGE	The inhibition properties and target sites of monoclonal antibodies (mAbs) Elec403, Elec408 and Elec410, generated against Electrophorus electricus acetylcholinesterase (AChE), have been defined previously using biochemical and mutagenesis approaches. Elec403 and Elec410, which bind competitively with each other and with the peptidic toxin inhibitor fasciculin, are directed toward distinctive albeit overlapping epitopes located at the AChE peripheral anionic site, which surrounds the entrance of the active site gorge. Elec408, which is not competitive with the other two mAbs nor fasciculin, targets a second epitope located in the backdoor region, distant from the gorge entrance. To characterize the molecular determinants dictating their binding site specificity, we cloned and sequenced the mAbs; generated antigen-binding fragments (Fab) retaining the parental inhibition properties; and explored their structure-function relationships using complementary x-ray crystallography, homology modeling and flexible docking approaches. Hypermutation of one Elec403 complementarity-determining region suggests occurrence of antigen-driven selection towards recognition of the AChE peripheral site. Comparative analysis of the 1.9A-resolution structure of Fab408 and of theoretical models of its Fab403 and Fab410 congeners evidences distinctive surface topographies and anisotropic repartitions of charges, consistent with their respective target sites and inhibition properties. Finally, a validated, data-driven docking model of the Fab403-AChE complex suggests a mode of binding at the PAS that fully correlates with the functional data. This comprehensive study documents the molecular peculiarities of Fab403 and Fab410, as the largest peptidic inhibitors directed towards the peripheral site, and those of Fab408, as the first inhibitor directed toward the backdoor region of an AChE and a unique template for the design of new, specific modulators of AChE catalysis.	[Bourne, Yves; Marchot, Pascale] Aix Marseille Univ, CNRS, Marseille, France; [Renault, Ludovic; Marchot, Pascale] Aix Marseille Univ, CNRS, Fac Med, Sect Nord, Marseille, France; [Essono, Sosthene; Lamourette, Patricia; Grassi, Jacques] CEA, iBiTecS, SPI, LERI, Gif Sur Yvette, France; [Mondielli, Gregoire; Marchot, Pascale] Aix Marseille Univ, CNRS, Fac Med, CRN2M,Sect Nord, Marseille, France; [Boquet, Didier] CEA, iBiTecS, SPI, LIAS, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Marchot, P (corresponding author), Aix Marseille Univ, CNRS, Campus Luminy, Marseille, France.	pascale.marchot@univ-amu.fr	Bourne, Yves/AAC-4635-2022; MARCHOT, Pascale/AAC-4752-2022	Bourne, Yves/0000-0003-3850-0548; MARCHOT, Pascale/0000-0003-0630-0541; Mondielli, Gregoire/0000-0001-9608-7961; BOQUET, Didier/0000-0002-4048-7867; Renault, Ludovic/0000-0001-6464-8808	Association Francaise contre les Myopathies (AFM)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by the Association Francaise contre les Myopathies (AFM, http://www.afm-telethon.fr/) to LR (PhD grant) and PM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN L, 1953, BIOCHEM J, V54, P695, DOI 10.1042/bj0540695; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; Brazzolotto X, 2012, FEBS J, V279, P2905, DOI 10.1111/j.1742-4658.2012.08672.x; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; Chardes T, 1999, FEBS LETT, V452, P386, DOI 10.1016/S0014-5793(99)00649-3; Chitlaru T, 1998, BIOCHEM J, V336, P647, DOI 10.1042/bj3360647; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Colletier JP, 2006, J AM CHEM SOC, V128, P4526, DOI 10.1021/ja058683b; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; EASTMAN J, 1995, J BIOL CHEM, V270, P19694, DOI 10.1074/jbc.270.34.19694; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essono S, 2003, J IMMUNOL METHODS, V279, P251, DOI 10.1016/S0022-1759(03)00242-4; Felder CE, 2002, ACTA CRYSTALLOGR D, V58, P1765, DOI 10.1107/S0907444902011642; Felder CE, 1997, J MOL GRAPH MODEL, V15, P318, DOI 10.1016/S1093-3263(98)00005-9; Frobert Y, 1997, BBA-PROTEIN STRUCT M, V1339, P253, DOI 10.1016/S0167-4838(97)00009-5; GILSON MK, 1994, SCIENCE, V263, P1276, DOI 10.1126/science.8122110; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Harel M, 1995, STRUCTURE, V3, P1355, DOI 10.1016/S0969-2126(01)00273-8; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Jackson RM, 1999, PROTEIN SCI, V8, P603; Johnson JL, 2003, J BIOL CHEM, V278, P38948, DOI 10.1074/jbc.M304797200; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; Kryger G, 1999, STRUCTURE, V7, P297, DOI 10.1016/S0969-2126(99)80040-9; Le Minoux D, 2012, MOL IMMUNOL, V50, P160, DOI 10.1016/j.molimm.2012.01.004; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; Mallender WD, 2000, BIOCHEMISTRY-US, V39, P7753, DOI 10.1021/bi000210o; MARCHOT P, 1993, J BIOL CHEM, V268, P12458; Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nachon F, 2008, FEBS J, V275, P2659, DOI 10.1111/j.1742-4658.2008.06413.x; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PyMOL, 2010, PYMOL MOL GRAPH SYST; RADIC Z, 1994, J BIOL CHEM, V269, P11233; RADIC Z, 1995, J BIOL CHEM, V270, P20391, DOI 10.1074/jbc.270.35.20391; RADIC Z, 1991, MOL PHARMACOL, V39, P98; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; REMY MH, 1995, EUR J BIOCHEM, V231, P651, DOI 10.1111/j.1432-1033.1995.tb20744.x; RIPOLL DR, 1993, P NATL ACAD SCI USA, V90, P5128, DOI 10.1073/pnas.90.11.5128; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanson B, 2011, PROTEIN SCI, V20, P1114, DOI 10.1002/pro.661; Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035; Simon S, 1997, J BIOL CHEM, V272, P33045, DOI 10.1074/jbc.272.52.33045; Simon S, 1999, J BIOL CHEM, V274, P27740, DOI 10.1074/jbc.274.39.27740; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Szegletes T, 1999, BIOCHEMISTRY-US, V38, P122, DOI 10.1021/bi9813577; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Taylor P, 1998, NEUROLOGY, V51, pS30, DOI 10.1212/WNL.51.1_Suppl_1.S30; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029; VANDENBORN HKL, 1995, PROTEIN SCI, V4, P703; Xu YC, 2010, BIOPHYS J, V99, P4003, DOI 10.1016/j.bpj.2010.10.047	66	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77226	10.1371/journal.pone.0077226	http://dx.doi.org/10.1371/journal.pone.0077226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146971	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400106
J	Williams, KJ; Robinson, NE; Lim, A; Brandenberger, C; Maes, R; Behan, A; Bolin, SR				Williams, Kurt J.; Robinson, N. Edward; Lim, Ailam; Brandenberger, Christina; Maes, Roger; Behan, Ashley; Bolin, Steven R.			Experimental Induction of Pulmonary Fibrosis in Horses with the Gammaherpesvirus Equine Herpesvirus 5	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; EPITHELIAL-MESENCHYMAL TRANSITION; GAMMA-HERPESVIRUS; INTERSTITIAL PNEUMONIA; LATENT INFECTION; LUNG INJURY; CELLS; DNA; PATHOGENESIS; TISSUE	Gammaherpesviruses (gamma HV) are implicated in the pathogenesis of pulmonary fibrosis in humans and murine models of lung fibrosis, however there is little direct experimental evidence that such viruses induce lung fibrosis in the natural host. The equine gamma HV EHV 5 is associated with equine multinodular pulmonary fibrosis (EMPF), a progressive fibrosing lung disease in its natural host, the horse. Experimental reproduction of EMPF has not been attempted to date. We hypothesized that inoculation of EHV 5 isolated from cases of EMPF into the lungs of clinically normal horses would induce lung fibrosis similar to EMPF. Neutralizing antibody titers were measured in the horses before and after inoculation with EHV 5. PCR and virus isolation was used to detect EHV 5 in antemortem blood and BAL samples, and in tissues collected postmortem. Nodular pulmonary fibrosis and induction of myofibroblasts occurred in EHV 5 inoculated horses. Mean lung collagen in EHV 5 inoculated horses (80 mu g/mg) was significantly increased compared to control horses (26 mu g/mg) (p < 0.5), as was interstitial collagen (32.6% +/- 1.2% vs 23% +/- 1.4%) (mean +/- SEM; p < 0.001). Virus was difficult to detect in infected horses throughout the experiment, although EHV 5 antigen was detected in the lung by immunohistochemistry. We conclude that the gamma HV EHV 5 can induce lung fibrosis in the horse, and hypothesize that induction of fibrosis occurs while the virus is latent within the lung. This is the first example of a gamma HV inducing lung fibrosis in the natural host.	[Williams, Kurt J.; Brandenberger, Christina; Maes, Roger; Bolin, Steven R.] Michigan State Univ, Coll Vet Med, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [Robinson, N. Edward; Behan, Ashley] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA; [Lim, Ailam] Michigan State Univ, Coll Vet Med, Diagnost Ctr Populat & Anim Hlth, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Williams, KJ (corresponding author), Michigan State Univ, Coll Vet Med, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA.	williamsk@dcpah.msu.edu			Pfizer Animal Health, New York, N.Y.	Pfizer Animal Health, New York, N.Y.	Pfizer Animal Health, New York, N.Y. provided funding for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203; Bell SA, 2006, VET MICROBIOL, V116, P249, DOI 10.1016/j.vetmic.2006.05.002; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; BOLIN SR, 1994, J VIROL METHODS, V48, P211, DOI 10.1016/0166-0934(94)90120-1; BRACK M, 1981, VIRCHOWS ARCH A, V392, P81, DOI 10.1007/BF00430551; Castriotta RJ, 2010, CHEST, V138, P693, DOI 10.1378/chest.09-3006; Chomczynski P, 2006, BIOTECHNIQUES, V40, P454, DOI 10.2144/000112149; Collard HR, 2003, ARCH INTERN MED, V163, P17, DOI 10.1001/archinte.163.1.17; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Doran P, 2005, AM J PHYSIOL-LUNG C, V289, pL709, DOI 10.1152/ajplung.00235.2005; Dynon K, 2001, AUST VET J, V79, P695, DOI 10.1111/j.1751-0813.2001.tb10674.x; Egan JJ, 1997, EUR RESPIR J, V10, P1433; EGAN JJ, 1995, THORAX, V50, P1234, DOI 10.1136/thx.50.12.1234; Ehlers B, 2007, J VIROL, V81, P8091, DOI 10.1128/JVI.00255-07; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Hughes DJ, 2010, J VIROL, V84, P3949, DOI 10.1128/JVI.02085-09; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; Kleiboeker SB, 2002, J VET DIAGN INVEST, V14, P273, DOI 10.1177/104063870201400401; Lok S S, 2000, Monaldi Arch Chest Dis, V55, P146; Lok SS, 2002, EUR RESPIR J, V20, P1228, DOI 10.1183/09031936.02.00272902; Lok SS, 2001, RESP MED, V95, P787, DOI 10.1053/rmed.2001.1152; LOVE DN, 1971, VET REC, V89, P178, DOI 10.1136/vr.89.7.178; Malizia AP, 2008, AM J PHYSIOL-LUNG C, V295, pL451, DOI 10.1152/ajplung.00376.2007; Malizia AP, 2009, EXP CELL RES, V315, P1819, DOI 10.1016/j.yexcr.2009.04.001; Marenzoni ML, 2011, J VET DIAGN INVEST, V23, P802, DOI 10.1177/1040638711407890; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mora AL, 2005, AM J PHYSIOL-LUNG C, V289, pL711, DOI 10.1152/ajplung.00007.2005; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Naik PN, 2012, J GERONTOL A-BIOL, V67, P714, DOI 10.1093/gerona/glr211; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Nicholson AG, 2002, HISTOPATHOLOGY, V41, P381, DOI 10.1046/j.1365-2559.2002.01421.x; Nordengrahn A, 2002, VET RES, V33, P251, DOI 10.1051/vetres:2002013; Phan Sem H, 2012, Proc Am Thorac Soc, V9, P148, DOI 10.1513/pats.201201-011AW; PULKKINEN V, 2012, ANN MED; Raghu G, 2004, BRIT J CANCER, V91, pS3, DOI 10.1038/sj.bjc.6602061; Rovnak J, 1998, J VIROL, V72, P4237, DOI 10.1128/JVI.72.5.4237-4242.1998; Sivakumar P, 2012, CURR OPIN PULM MED, V18, P462, DOI 10.1097/MCP.0b013e328356800f; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Stewart JP, 1998, J EXP MED, V187, P1941, DOI 10.1084/jem.187.12.1941; Stoolman JS, 2011, AM J PHYSIOL-LUNG C, V300, pL274, DOI 10.1152/ajplung.00028.2010; SUNILCHANDRA NP, 1992, J GEN VIROL, V73, P3275, DOI 10.1099/0022-1317-73-12-3275; SWEAT F, 1964, ARCH PATHOL, V78, P69; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; Torres-Gonzalez E, 2012, AM J RESP CELL MOL, V46, P748, DOI 10.1165/rcmb.2011-0224OC; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Vannella KM, 2010, AM J RESP CRIT CARE, V181, P465, DOI 10.1164/rccm.200905-0798OC; Vannella KM, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-2; Wang L, 2007, VET MICROBIOL, V121, P18, DOI 10.1016/j.vetmic.2006.11.009; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Williams KJ, 2007, VET PATHOL, V44, P849, DOI 10.1354/vp.44-6-849; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Wong DM, 2008, JAVMA-J AM VET MED A, V232, P898, DOI 10.2460/javma.232.6.898; Xu JG, 2009, J GERONTOL A-BIOL, V64, P731, DOI 10.1093/gerona/glp040; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	59	41	41	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77754	10.1371/journal.pone.0077754	http://dx.doi.org/10.1371/journal.pone.0077754			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147074	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400138
J	Chan, SW; Cheang, CC; Chirapart, A; Gerung, G; Tharith, C; Ang, P				Chan, Sze Wai; Cheang, Chi Chiu; Chirapart, Anong; Gerung, Grevo; Tharith, Chea; Ang, Put			Homogeneous Population of the Brown Alga Sargassum polycystum in Southeast Asia: Possible Role of Recent Expansion and Asexual Propagation	PLOS ONE			English	Article							INDO-MALAY-ARCHIPELAGO; BORING GIANT CLAM; GLACIAL REFUGIA; GENETIC DIVERSITY; PHYLOGEOGRAPHY; PHAEOPHYCEAE; INFERENCE; PACIFIC; FUCALES; GROWTH	Southeast Asia has been known as one of the biodiversity hotspots in the world. Repeated glacial cycles during Pleistocene were believed to cause isolation of marine taxa in refugia, resulting in diversification among lineages. Recently, ocean current was also found to be another factor affecting gene flow by restricting larval dispersal in animals. Macroalgae are unique in having mode of reproduction that differs from that of animals. Our study on the phylogeographical pattern of the brown macroalga Sargassum polycystum using nuclear Internal Transcribed Spacer 2 (ITS2), plastidal RuBisCO spacer (Rub spacer) and mitochondrial cytochrome oxidase subunit-III (Cox3) as molecular markers revealed genetic homogeneity across 27 sites in Southeast Asia and western Pacific, in sharp contrast to that revealed from most animal studies. Our data suggested that S. polycystum persisted in single refugium during Pleistocene in a panmixia pattern. Expansion occurred more recently after the Last Glacial Maximum and recolonization of the newly flooded Sunda Shelf could have involved asexual propagation of the species. High dispersal ability through floating fronds carrying developing germlings may also contribute to the low genetic diversity of the species.	[Chan, Sze Wai; Cheang, Chi Chiu; Ang, Put] Chinese Univ Hong Kong, Marine Sci Lab, Hong Kong, Hong Kong, Peoples R China; [Chirapart, Anong] Kasetsart Univ, Fac Fisheries, Dept Fishery Biol, Algal Bioresources Res Ctr, Bangkok, Thailand; [Gerung, Grevo] Sam Ratulangi Univ, Fac Fisheries & Marine Sci, Manado, Indonesia; [Tharith, Chea] Fisheries Adm, Res & Dev Inst MFReDI, Phnom Penh, Cambodia	Chinese University of Hong Kong; Kasetsart University; Universitas Sam Ratulangi	Ang, P (corresponding author), Chinese Univ Hong Kong, Marine Sci Lab, Hong Kong, Hong Kong, Peoples R China.	put-ang@cuhk.edu.hk	Cheang, Chi Chiu/C-3064-2013; Ang, Put/AAO-5490-2021	Cheang, Chi Chiu/0000-0003-3554-6647; 	Research Grant Council of Hong Kong	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by The Research Grant Council of Hong Kong. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakis N, 2009, MOL ECOL, V18, P212, DOI 10.1111/j.1365-294X.2008.04022.x; Barber PH, 2006, EVOLUTION, V60, P1825; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli Peter, 2009, V17, P42; Cheang CC, 2010, J PHYCOL, V46, P1063, DOI 10.1111/j.1529-8817.2010.00901.x; Cheang CC, 2010, MOL ECOL, V19, P2933, DOI 10.1111/j.1365-294X.2010.04685.x; Chiang Y.-M., 1992, TAXONOMY EC SEAWEEDS, P35; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dannewitz J, 2005, P ROY SOC B-BIOL SCI, V272, P1129, DOI 10.1098/rspb.2005.3064; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DeBoer TS, 2008, CONSERV BIOL, V22, P1255, DOI 10.1111/j.1523-1739.2008.00983.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fraser CI, 2009, MOL ECOL, V18, P2287, DOI 10.1111/j.1365-294X.2009.04201.x; Fu YX, 1997, GENETICS, V147, P915; Gordon AL, 1996, NATURE, V379, P146, DOI 10.1038/379146a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guiry M., 2013, ALGAEBASE, P74; Hoarau G, 2007, MOL ECOL, V16, P3606, DOI 10.1111/j.1365-294X.2007.03408.x; Hu ZM, 2013, MAR BIOL, V160, P1407, DOI 10.1007/s00227-013-2192-x; Hu ZM, 2011, MOL ECOL, V20, P3894, DOI 10.1111/j.1365-294X.2011.05220.x; KENDRICK GA, 1995, J EXP MAR BIOL ECOL, V192, P273, DOI 10.1016/0022-0981(95)00076-4; Knittweis L, 2009, CONSERV GENET, V10, P241, DOI 10.1007/s10592-008-9566-5; Kochzius M, 2008, MOL ECOL, V17, P3775, DOI 10.1111/j.1365-294X.2008.03803.x; Komatsu T, 2007, J MARINE SYST, V67, P245, DOI 10.1016/j.jmarsys.2006.05.018; Lee KM, 2012, MAR BIOL, V159, P1021, DOI 10.1007/s00227-012-1882-0; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Mattio L, 2009, J PHYCOL, V45, P1213, DOI 10.1111/j.1529-8817.2009.00737.x; NEI M, 1989, MOL BIOL EVOL, V6, P290; Nei M., 1987, MOL EVOLUTIONARY GEN; Payo DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2660; Phillips NE, 2005, PHYCOL RES, V53, P1; Rao AS, 2002, INDIAN J MAR SCI, V31, P26; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rousset F, 1997, GENETICS, V145, P1219; Stiger Valerie, 2003, Phycological Research, V51, P1; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatarenkov A, 2005, MOL ECOL, V14, P647, DOI 10.1111/j.1365-294X.2005.02425.x; Timm J, 2008, MOL ECOL, V17, P3999, DOI 10.1111/j.1365-294X.2008.03881.x; TRONO GC, 1990, HYDROBIOLOGIA, V204, P331, DOI 10.1007/BF00040253; Tseng C. K., 1992, TAXONOMY EC SEAWEEDS, V2, P23; Uwai S, 2006, HYDROBIOLOGIA, V553, P345, DOI 10.1007/s10750-005-0883-0; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wyrtki K., 1961, PHYS OCEANOGRAPHY SE, V2, P1; Yeong MLB, 2012, J APPL PHYCOL, V25, P805; Yow YY, 2011, J APPL PHYCOL, V23, P219, DOI 10.1007/s10811-010-9535-5	50	21	21	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77662	10.1371/journal.pone.0077662	http://dx.doi.org/10.1371/journal.pone.0077662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147050	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200062
J	Song, HF; Josleyn, N; Janosko, K; Skinner, J; Reeves, RK; Cohen, M; Jett, C; Johnson, R; Blaney, JE; Bollinger, L; Jennings, G; Jahrling, PB				Song, Haifeng; Josleyn, Nicole; Janosko, Krisztina; Skinner, Jeff; Reeves, R. Keith; Cohen, Melanie; Jett, Catherine; Johnson, Reed; Blaney, Joseph E.; Bollinger, Laura; Jennings, Gerald; Jahrling, Peter B.			Monkeypox Virus Infection of Rhesus Macaques Induces Massive Expansion of Natural Killer Cells but Suppresses Natural Killer Cell Functions	PLOS ONE			English	Article							NK CELLS; LYMPH-NODES; MEDIATED RESISTANCE; SMALLPOX VACCINE; DENDRITIC CELLS; T-CELLS; ACTIVATION; CHEMOKINE; RECEPTOR; EXPRESSION	Natural killer (NK) cells play critical roles in innate immunity and in bridging innate and adaptive immune responses against viral infection. However, the response of NK cells to monkeypox virus (MPXV) infection is not well characterized. In this intravenous challenge study of MPXV infection in rhesus macaques (Macaca mulatta), we analyzed blood and lymph node NK cell changes in absolute cell numbers, cell proliferation, chemokine receptor expression, and cellular functions. Our results showed that the absolute number of total NK cells in the blood increased in response to MPXV infection at a magnitude of 23-fold, manifested by increases in CD56+, CD16+, CD16-CD56-double negative, and CD16+ CD56+ double positive NK cell subsets. Similarly, the frequency and NK cell numbers in the lymph nodes also largely increased with the total NK cell number increasing 46.1-fold. NK cells both in the blood and lymph nodes massively proliferated in response to MPXV infection as measured by Ki67 expression. Chemokine receptor analysis revealed reduced expression of CXCR3, CCR7, and CCR6 on NK cells at early time points (days 2 and 4 after virus inoculation), followed by an increased expression of CXCR3 and CCR5 at later time points (days 7-8) of infection. In addition, MPXV infection impaired NK cell degranulation and ablated secretion of interferon-gamma and tumor necrosis factor-alpha. Our data suggest a dynamic model by which NK cells respond to MPXV infection of rhesus macaques. Upon virus infection, NK cells proliferated robustly, resulting in massive increases in NK cell numbers. However, the migrating capacity of NK cells to tissues at early time points might be reduced, and the functions of cytotoxicity and cytokine secretion were largely compromised. Collectively, the data may explain, at least partially, the pathogenesis of MPXV infection in rhesus macaques.	[Song, Haifeng; Josleyn, Nicole; Janosko, Krisztina; Cohen, Melanie; Jett, Catherine; Bollinger, Laura; Jennings, Gerald; Jahrling, Peter B.] NIAID, Integrated Res Facil, NIH, Frederick, MD USA; [Skinner, Jeff] NIAID, Computat Biol Sect, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD 20892 USA; [Reeves, R. Keith] Harvard Univ, Sch Med, New England Primate Res Ctr, Southborough, MA 01772 USA; [Johnson, Reed; Blaney, Joseph E.; Jahrling, Peter B.] NIAID, Emerging Viral Pathogens Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Song, HF (corresponding author), NIAID, Integrated Res Facil, NIH, Frederick, MD USA.	haifengsong2003@yahoo.com		Skinner, Jeff/0000-0001-5697-0442; Cohen, Melanie/0000-0002-4839-9386	National Institute of Allergy and Infectious Diseases (NIAID) under Battelle Memorial [HHSN272200200016I]; NIAID Division of Intramural Research funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001025] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) under Battelle Memorial; NIAID Division of Intramural Research funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported under Battelle Memorial contract with National Institute of Allergy and Infectious Diseases (NIAID) (contract number HHSN272200200016I) and was also supported in part by NIAID Division of Intramural Research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Andrews DM, 2005, MOL IMMUNOL, V42, P547, DOI 10.1016/j.molimm.2004.07.040; Andrews DM, 2003, NAT IMMUNOL, V4, P175, DOI 10.1038/ni880; ARITA I, 1985, AM J TROP MED HYG, V34, P781, DOI 10.4269/ajtmh.1985.34.781; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BIGGS EW, 1979, J AM POD ASSOC, V69, P241, DOI 10.7547/87507315-69-4-241; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; BUKOWSKI JF, 1983, J IMMUNOL, V131, P1531; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carter DL, 1999, CYTOMETRY, V37, P41, DOI 10.1002/(SICI)1097-0320(19990901)37:1<41::AID-CYTO5>3.0.CO;2-4; Chan A, 2007, J IMMUNOL, V179, P89, DOI 10.4049/jimmunol.179.1.89; Chisholm SE, 2006, J VIROL, V80, P2225, DOI 10.1128/JVI.80.5.2225-2233.2006; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Fang M, 2005, J IMMUNOL, V175, P6829, DOI 10.4049/jimmunol.175.10.6829; Fang M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040030; Fang M, 2011, IMMUNITY, V34, P579, DOI 10.1016/j.immuni.2011.02.015; Fang M, 2010, J EXP MED, V207, P2369, DOI 10.1084/jem.20100282; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fogli M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000101; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Frigerio S, 2002, NAT MED, V8, P1414, DOI 10.1038/nm792; Fritz EA, 2008, VIRAL IMMUNOL, V21, P355, DOI 10.1089/vim.2008.0023; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Giavedoni LD, 2000, J VIROL, V74, P1648, DOI 10.1128/JVI.74.4.1648-1657.2000; Hong HS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00032; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4; JACOBY RO, 1989, ARCH VIROL, V108, P49, DOI 10.1007/BF01313742; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; Johnson RF, 2011, J VIROL, V85, P2112, DOI 10.1128/JVI.01931-10; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; Kim CH, 1999, CELL IMMUNOL, V193, P226, DOI 10.1006/cimm.1999.1483; Kim CH, 1998, J IMMUNOL, V160, P2418; Kottilil S, 2004, J INFECT DIS, V189, P1193, DOI 10.1086/382090; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Lowin B, 1995, Curr Top Microbiol Immunol, V198, P1; Maghazachi AA, 2010, CURR TOP MICROBIOL, V341, P37, DOI 10.1007/82_2010_20; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Mavilio D, 2005, BLOOD, V106, P1718, DOI 10.1182/blood-2004-12-4762; Orr MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015184; Pak-Wittel MA, 2013, P NATL ACAD SCI USA, V110, pE50, DOI 10.1073/pnas.1220456110; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Parham P, 2005, MOL IMMUNOL, V42, P459, DOI 10.1016/j.molimm.2004.07.027; Parker AK, 2007, J VIROL, V81, P4070, DOI 10.1128/JVI.02061-06; Reed DS, 2004, VIRAL IMMUNOL, V17, P390, DOI 10.1089/vim.2004.17.390; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Rodas JD, 2009, MEM I OSWALDO CRUZ, V104, P583, DOI 10.1590/S0074-02762009000400009; Ryan JC, 2001, IMMUNOL REV, V181, P126, DOI 10.1034/j.1600-065X.2001.1810110.x; Shafer-Weaver Kimberly A, 2004, J Transl Med, V2, P31, DOI 10.1186/1479-5876-2-31; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Song HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060533; Vidal SM, 2011, CURR OPIN VIROL, V1, P497, DOI 10.1016/j.coviro.2011.10.017; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373; Zielinski RJ, 2010, VACCINE, V28, P7081, DOI 10.1016/j.vaccine.2010.08.008	68	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77804	10.1371/journal.pone.0077804	http://dx.doi.org/10.1371/journal.pone.0077804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147080	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200078
J	Mazur, A; Westerman, R; Mueller, U				Mazur, Allan; Westerman, Ronny; Mueller, Ulrich			Is Rising Obesity Causing a Secular (Age-Independent) Decline in Testosterone among American Men?	PLOS ONE			English	Article							LIFE-STYLE FACTORS; Y GASTRIC BYPASS; OLDER MEN; SURGERY; HEALTH	The testosterone of men in industrial societies peaks in their twenties and tends to decline with increasing age. Apart from this individual-level decline, there have been reports of a secular (age-independent population-level) decline in testosterone among American and Scandinavian men during the past few decades, possibly an indication of declining male reproductive health. It has been suggested that both declines in testosterone (individual-level and population-level) are due to increasing male obesity because men in industrial society tend to add body fat as they age, and overall rates of obesity are increasing. Using an unusually large and lengthy longitudinal dataset (991 US Air Force veterans examined in six cycles over 20 years), we investigate the relationship of obesity to individual and population-level declines in testosterone. Over twenty years of study, longitudinal decline in mean testosterone was at least twice what would be expected from cross-sectional estimates of the aging decline. Men who put on weight intensified their testosterone decline, some greatly so, but even among those who held their weight constant or lost weight during the study, mean testosterone declined 117 ng/dl (19%) over 20 years. We have not identified the reason for secular decline in testosterone, but we exclude increasing obesity as a sufficient or primary explanation, and we deny the supposition that men who avoid excessive weight will maintain their youthful levels of testosterone.	[Mazur, Allan] Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA; [Westerman, Ronny; Mueller, Ulrich] Univ Marburg, Inst Med Sociol & Social Med, Marburg, Germany	Syracuse University; Philipps University Marburg	Mazur, A (corresponding author), Syracuse Univ, Maxwell Sch, Syracuse, NY 13244 USA.	amazur@syr.edu						Air Force Health Study, 2005, AFRLHEBRSR20050003 E; Andersson AM, 2007, J CLIN ENDOCR METAB, V92, P4696, DOI 10.1210/jc.2006-2633; Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; Bhasin S, 2007, J CLIN ENDOCR METAB, V92, P44, DOI 10.1210/jc.2006-2438; Botella-Carretero JI, 2013, J ENDOCRINOL INVEST, V36, P227, DOI 10.3275/8469; Buffler PA, 2011, ANN EPIDEMIOL, V21, P673, DOI 10.1016/j.annepidem.2011.02.001; Camacho EM, 2013, EUR J ENDOCRINOL, V168, P445, DOI 10.1530/EJE-12-0890; Campbell B, 2006, AM J HUM BIOL, V18, P71, DOI 10.1002/ajhb.20468; Centers for Disease Control, 2010, HLTH PEOPL 2010 FIN; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; Hammoud A, 2009, J CLIN ENDOCR METAB, V94, P1329, DOI 10.1210/jc.2008-1598; Kim YS, 2012, CLIN ENDOCRINOL, V77, P296, DOI 10.1111/j.1365-2265.2012.04375.x; Mazur A, 1998, SOC FORCES, V77, P315, DOI 10.2307/3006019; Mazur A, 2009, AGING MALE, V12, P66, DOI 10.1080/13685530903071802; Michalek JE, 2008, J OCCUP ENVIRON MED, V50, P330, DOI 10.1097/JOM.0b013e31815f889b; Perheentupa A, 2013, EUR J ENDOCRINOL, V168, P227, DOI 10.1530/EJE-12-0288; Ponholzer A, 2005, Aging Male, V8, P190, DOI 10.1080/13685530500298154; Rosenblatt A, 2012, SURG OBES RELAT DIS; Shi Z, 2013, J CLIN ENDOCRIN META; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P549, DOI 10.1210/jc.2006-1859; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375; Trimpou P, 2012, EUR J ENDOCRINOL, V166, P887, DOI 10.1530/EJE-11-0808; Vermeulen A., 1999, Journal of Endocrinological Investigation, V22, P110; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P762, DOI 10.1002/ajhb.20927; Woodard G, 2012, BRIT J SURG, V99, P693, DOI 10.1002/bjs.8693; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76178	10.1371/journal.pone.0076178	http://dx.doi.org/10.1371/journal.pone.0076178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146834	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400041
J	McKay, FC; Hoe, E; Parnell, G; Gatt, P; Schibeci, SD; Stewart, GJ; Booth, DR				McKay, Fiona C.; Hoe, Edwin; Parnell, Grant; Gatt, Prudence; Schibeci, Stephen D.; Stewart, Graeme J.; Booth, David R.			IL7R alpha Expression and Upregulation by IFN beta in Dendritic Cell Subsets Is Haplotype-Dependent	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; T-CELLS; INTERFERON-BETA; INTERLEUKIN-7 RECEPTOR; EPITHELIAL-CELLS; IN-VIVO; IMMUNE-RESPONSE	The IL7R alpha gene is unequivocally associated with susceptibility to multiple sclerosis (MS). Haplotype 2 (Hap 2) confers protection from MS, and T cells and dendritic cells (DCs) of Hap 2 exhibit reduced splicing of exon 6, resulting in production of relatively less soluble receptor, and potentially more response to ligand. We have previously shown in CD4 T cells that IL7R alpha haplotypes 1 and 2, but not 4, respond to interferon beta (IFN beta), the most commonly used immunomodulatory drug in MS, and that haplotype 4 (Hap 4) homozygotes have the highest risk of developing MS. We now show that IL7R expression increases in myeloid cells in response to IFN beta, but that the response is haplotype-dependent, with cells from homozygotes for Hap 4 again showing no response. This was shown using freshly derived monocytes, in vitro cultured immature and mature monocyte-derived dendritic cells, and by comparing homozygotes for the common haplotypes, and relative expression of alleles in heterozygotes (Hap 4 vs not Hap 4). As for T cells, in all myeloid cell subsets examined, Hap 2 homozygotes showed a trend for reduced splicing of exon 6 compared to the other haplotypes, significantly so in most conditions. These data are consistent with increased signaling being protective from MS, constitutively and in response to IFN beta. We also demonstrate significant regulation of immune response, chemokine activity and cytokine biosynthesis pathways by IL7R alpha signaling in IFN beta -treated myeloid subsets. IFN beta-responsive genes are over-represented amongst genes associated with MS susceptibility. IL7R alpha haplotype may contribute to MS susceptibility through reduced capacity for IL7R alpha signalling in myeloid cells, especially in the presence of IFN beta, and is currently under investigation as a predictor of therapeutic response.	[McKay, Fiona C.; Hoe, Edwin; Parnell, Grant; Gatt, Prudence; Schibeci, Stephen D.; Stewart, Graeme J.; Booth, David R.] Westmead Millennium Inst, Inst Immunol & Allergy Res, Sydney, NSW, Australia; [McKay, Fiona C.; Hoe, Edwin; Parnell, Grant; Gatt, Prudence; Schibeci, Stephen D.; Stewart, Graeme J.; Booth, David R.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Stewart, GJ (corresponding author), Westmead Millennium Inst, Inst Immunol & Allergy Res, Sydney, NSW, Australia.	graeme.stewart@sydney.edu.au; david.booth@sydney.edu.au	Parnell, Grant/AAB-8155-2021	Parnell, Grant/0000-0002-2898-0253; McKay, Fiona Catherine/0000-0002-9610-0668	Australian Research Council; Biogen-Idec; Multiple Sclerosis Research Australia; Merck-Serono	Australian Research Council(Australian Research Council); Biogen-Idec(Biogen); Multiple Sclerosis Research Australia; Merck-Serono(Merck & Company)	This work was supported by grants from the Australian Research Council (Linkage grant with Biogen-Idec), and Multiple Sclerosis Research Australia. The authors also declare that we have received funding from a commercial source, Merck-Serono. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Capitini CM, 2009, J INTERN MED, V266, P141, DOI 10.1111/j.1365-2796.2009.02085.x; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Colgan J, 2006, NAT IMMUNOL, V7, P899, DOI 10.1038/ni0906-899; Crawley AM, 2010, J IMMUNOL, V184, P4679, DOI 10.4049/jimmunol.0903758; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Dzionek A, 2002, HUM IMMUNOL, V63, P1133, DOI 10.1016/S0198-8859(02)00752-8; Edstrom M, 2011, MULT SCLER J, V17, P57, DOI 10.1177/1352458510381256; Fazekas de St Groth B, 2012, IMMUNOL CELL BIOL, V90, P256, DOI 10.1038/icb.2011.113; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Gary-Gouy H, 2002, J INTERF CYTOK RES, V22, P653, DOI 10.1089/10799900260100132; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hanabuchi S, 2010, J IMMUNOL, V184, P2999, DOI 10.4049/jimmunol.0804106; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; Hedegaard CJ, 2008, CLIN IMMUNOL, V129, P80, DOI 10.1016/j.clim.2008.06.007; Hedstrom AK, 2011, BRAIN, V134, P653, DOI 10.1093/brain/awq371; Hoe E, 2010, J INTERF CYTOK RES, V30, P291, DOI 10.1089/jir.2009.0060; Hoe E, 2010, J IMMUNOL, V184, P2512, DOI 10.4049/jimmunol.0902900; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Kang SJ, 2010, IMMUNOBIOLOGY, V215, P153, DOI 10.1016/j.imbio.2009.03.001; Kashyap M, 2011, J IMMUNOL, V187, P1207, DOI 10.4049/jimmunol.1100355; Korporal M, 2008, ARCH NEUROL-CHICAGO, V65, P1434, DOI 10.1001/archneur.65.11.1434; Kroncke R, 1996, EUR J IMMUNOL, V26, P2541, DOI 10.1002/eji.1830261040; Krumbiegel D, 2008, PEDIAT ALLERG IMM-UK, V19, P513, DOI 10.1111/j.1399-3038.2007.00685.x; Lande R, 2008, J NEUROPATH EXP NEUR, V67, P388, DOI 10.1097/NEN.0b013e31816fc975; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Lu N, 2009, J EXP MED, V206, P2111, DOI 10.1084/jem.20090153; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Martin-Saavedra FM, 2008, MOL IMMUNOL, V45, P4008, DOI 10.1016/j.molimm.2008.06.006; Martinez-Forero I, 2008, EUR J IMMUNOL, V38, P576, DOI 10.1002/eji.200737271; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mckay FC, 2008, GENES IMMUN, V9, P1, DOI 10.1038/sj.gene.6364436; Mei FJ, 2006, J NEUROL SCI, V246, P71, DOI 10.1016/j.jns.2006.02.008; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Palucka AK, 2003, BLOOD, V102, P3302, DOI 10.1182/blood-2003-02-0384; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Petermann F, 2011, FEBS LETT, V585, P3747, DOI 10.1016/j.febslet.2011.03.064; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rane L, 2010, J NEUROIMMUNOL, V222, P82, DOI 10.1016/j.jneuroim.2010.02.014; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Remoli ME, 2007, EUR J IMMUNOL, V37, P3499, DOI 10.1002/eji.200737566; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Sin WX, 2012, IMMUNOL RES; Sorg RV, 1998, IMMUNOBIOLOGY, V198, P514, DOI 10.1016/S0171-2985(98)80075-2; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; TRAUGOTT U, 1988, ANN NEUROL, V24, P243, DOI 10.1002/ana.410240211; van der Mei IAF, 2011, NEUROL CLIN, V29, P233, DOI 10.1016/j.ncl.2010.12.007; van der Mei IAF, 2010, ANN NEUROL, V67, P261, DOI 10.1002/ana.21849; van Holten J, 2005, ANN RHEUM DIS, V64, P1780, DOI 10.1136/ard.2005.040477; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Zang YCQ, 2004, MULT SCLER J, V10, P499, DOI 10.1191/1352458504ms1081oa; Zeuthen LH, 2008, IMMUNOLOGY, V123, P197, DOI 10.1111/j.1365-2567.2007.02687.x	72	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77508	10.1371/journal.pone.0077508	http://dx.doi.org/10.1371/journal.pone.0077508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147013	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400117
J	Song, GX; Shen, YH; Zhu, JG; Liu, HL; Liu, M; Shen, YQ; Zhu, SS; Kong, XQ; Yu, ZB; Qian, LM				Song, Guixian; Shen, Yahui; Zhu, Jingai; Liu, Hailang; Liu, Ming; Shen, Ya-Qing; Zhu, Shasha; Kong, Xiangqing; Yu, Zhangbin; Qian, Lingmei			Integrated Analysis of Dysregulated lncRNA Expression in Fetal Cardiac Tissues with Ventricular Septal Defect	PLOS ONE			English	Article							LONG NONCODING RNAS; GENE REGULATORY NETWORKS; HEART; ENHANCERS; CELLS; CARDIOGENESIS; ANNOTATION; MECHANISMS; VERTEBRATE; INSIGHTS	Ventricular septal defects (VSD) are the most common form of congenital heart disease, which is the leading noninfectious cause of death in children; nevertheless, the exact cause of VSD is not yet fully understood. Long non-coding RNAs (lncRNAs) have been shown to play key roles in various biological processes, such as imprinting control, circuitry controlling pluripotency and differentiation, immune responses and chromosome dynamics. Notably, a growing number of lncRNAs have been implicated in disease etiology, although an association with VSD has not been reported. In the present study, we conducted an integrated analysis of dysregulated lncRNAs, focusing specifically on the identification and characterization of lncRNAs potentially involving in initiation of VSD. Comparison of the transcriptome profiles of cardiac tissues from VSD-affected and normal hearts was performed using a second-generation lncRNA microarray, which covers the vast majority of expressed RefSeq transcripts (29,241 lncRNAs and 30,215 coding transcripts). In total, 880 lncRNAs were upregulated and 628 were downregulated in VSD. Furthermore, our established filtering pipeline indicated an association of two lncRNAs, ENST00000513542 and RP11-473L15.2, with VSD. This dysregulation of the lncRNA profile provides a novel insight into the etiology of VSD and furthermore, illustrates the intricate relationship between coding and ncRNA transcripts in cardiac development. These data may offer a background/reference resource for future functional studies of lncRNAs related to VSD.	[Song, Guixian; Liu, Hailang; Liu, Ming; Kong, Xiangqing; Qian, Lingmei] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Shen, Yahui] Nanjing Med Univ, Dept MICU, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China; [Zhu, Jingai; Zhu, Shasha; Yu, Zhangbin] Nanjing Med Univ, Dept Pediat, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China; [Shen, Ya-Qing] Taizhou Matern & Child Hlth Care Hosp, Dept Lab Med, Taizhou, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Yu, ZB (corresponding author), Nanjing Med Univ, Dept Pediat, Nanjing Matern & Child Hlth Care Hosp, Nanjing, Jiangsu, Peoples R China.	yuzhangbin@126.com; lmqian@njmu.edu.cn			National Natural Science Foundation of China [81070138]; Natural Science Foundation of Jiangsu Province, China [BK2010582]; Talent Foundation of Jiangsu Province, China [WSN-020]; Postgraduate Research and Innovation Project in Jiangsu Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Talent Foundation of Jiangsu Province, China; Postgraduate Research and Innovation Project in Jiangsu Province, China	This work was supported by grants from the National Natural Science Foundation of China (No. 81070138), the Natural Science Foundation of Jiangsu Province, China (No. BK2010582), the Talent Foundation of Jiangsu Province, China (WSN-020), and the Postgraduate Research and Innovation Project in Jiangsu Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Han T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S9; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mortlock DP, 2012, CURR PROTOC HUM GENE; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sadowski Sharyl L, 2009, Crit Care Nurs Clin North Am, V21, P37, DOI 10.1016/j.ccell.2008.10.001; Satou Y, 2006, GENE DEV, V20, P2634, DOI 10.1101/gad.1485706; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Wilczynski B, 2010, DEV BIOL, V340, P161, DOI 10.1016/j.ydbio.2009.10.032; Wutz A, 2011, PROG MOL BIOL TRANSL, V101, P351, DOI 10.1016/B978-0-12-387685-0.00011-1	30	31	39	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77492	10.1371/journal.pone.0077492	http://dx.doi.org/10.1371/journal.pone.0077492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147006	Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400113
J	Xin, ZQ; Liu, GF				Xin, Ziqiang; Liu, Guofang			Homo Economicus Belief Inhibits Trust	PLOS ONE			English	Article							CONSTRUAL-LEVEL; PSYCHOLOGICAL DISTANCE; PROBABILITY	As a foundational concept in economics, the homo economicus assumption regards humans as rational and self-interested actors. In contrast, trust requires individuals to believe partners' benevolence and unselfishness. Thus, the homo economicus belief may inhibit trust. The present three experiments demonstrated that the direct exposure to homo economicus belief can weaken trust. And economic situations like profit calculation can also activate individuals' homo economicus belief and inhibit their trust. It seems that people's increasing homo economicus belief may serve as one cause of the worldwide decline of trust.	[Xin, Ziqiang] Cent Univ Finance & Econ, Sch Social Dev, Dept Psychol, Beijing, Peoples R China; [Liu, Guofang] Beijing Normal Univ, Inst Dev Psychol, Beijing 100875, Peoples R China	Central University of Finance & Economics; Beijing Normal University	Xin, ZQ (corresponding author), Cent Univ Finance & Econ, Sch Social Dev, Dept Psychol, Beijing, Peoples R China.	xinziqiang@sohu.com		Xin, Ziqiang/0000-0001-9983-2322	MOE of China [NCET-10-0869]; National Social Science Foundation of China [11CSH046]	MOE of China(Ministry of Education, China); National Social Science Foundation of China	The present study was supported by a program (NCET-10-0869) for New Century Excellent Talents in University from MOE of China and a project (11CSH046) from National Social Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerstrom J, 2009, SOC COGNITION, V27, P261, DOI 10.1521/soco.2009.27.2.261; Bauman Y, 2011, J ECON BEHAV ORGAN, V79, P318, DOI 10.1016/j.jebo.2011.02.010; Becker G., 1976, EC APPROACH HUMAN BE; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bjornskov C, 2007, PUBLIC CHOICE, V130, P1, DOI 10.1007/s11127-006-9069-1; Buchan N, 2004, J ECON BEHAV ORGAN, V55, P485, DOI 10.1016/j.jebo.2003.11.005; Deutsch M., 1958, J CONFLICT RESOLUT, V2, P265, DOI [DOI 10.1177/002200275800200401, 10.1177/002200275800200401]; Dinello N, 1998, SOCIOL RELIG, V59, P45, DOI 10.2307/3711965; DOUCOULIAGOS C, 1994, J ECON ISSUES, V28, P877, DOI 10.1080/00213624.1994.11505586; Fujita K, 2006, PSYCHOL SCI, V17, P278, DOI 10.1111/j.1467-9280.2006.01698.x; Fujita K, 2009, PSYCHOL SCI, V20, P799, DOI 10.1111/j.1467-9280.2009.02372.x; Giacomantonio M, 2010, J EXP SOC PSYCHOL, V46, P824, DOI 10.1016/j.jesp.2010.05.001; Henderson MD, 2006, J PERS SOC PSYCHOL, V91, P712, DOI 10.1037/0022-3514.91.4.712; Johnson ND, 2011, J ECON PSYCHOL, V32, P865, DOI 10.1016/j.joep.2011.05.007; MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792; McCrea SM, 2012, J PERS SOC PSYCHOL, V102, P51, DOI 10.1037/a0026108; Rahn WM, 1998, POLIT PSYCHOL, V19, P545, DOI 10.1111/0162-895X.00117; Rubinstein A, 2006, ECON J, V116, P1, DOI DOI 10.1111/J.1468-0297.2006.01071.X; Sanna LJ, 2009, PSYCHOL SCI, V20, P1319, DOI 10.1111/j.1467-9280.2009.02458.x; Smith Adam, 1937, WEALTH NATIONS; Survey Research Center, 1969, 1964 EL STUD; Taylor-Gooby P, 2005, SOC POLICY ADMIN, V39, P217, DOI 10.1111/j.1467-9515.2005.00436.x; Todorov A, 2007, J EXP SOC PSYCHOL, V43, P473, DOI 10.1016/j.jesp.2006.04.002; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Uslaner E., 2002, MORAL FDN TRUST; Wakslak C, 2009, PSYCHOL SCI, V20, P52, DOI 10.1111/j.1467-9280.2008.02250.x; Xin Z, 2012, ADV PSYCHOL SCI, V20, P1; [辛自强 Xin Ziqiang], 2013, [心理科学进展, Advances in Psychological Science], V21, P31	29	14	17	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76671	10.1371/journal.pone.0076671	http://dx.doi.org/10.1371/journal.pone.0076671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146907	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400079
J	Zamir, E; Atkinson, K				Zamir, Ehud; Atkinson, Kaye			Assessment of Diagnostic Skills in Specialist Examinations Should Include Lessons Learnt From Misdiagnosis	PLOS ONE			English	Article							COGNITIVE ERRORS; STRATEGIES	Background: Poor authenticity in high stake clinical exams adversely effects validity. We propose including known misleading diagnostic factors and contextual biases in the assessment of diagnostic skills amongst advanced specialty trainees. We hypothesise that this strategy offers a more realistic and critical assessment of diagnostic skill than strategies in which candidates are presented with directive, bias free information, allowing for assumptions which cannot be made in real life. Methods: Eleven patient based practice clinical exam stations were presented to nine advanced ophthalmology trainees. Four patients had a history of misdiagnosis or near misdiagnosis of key ophthalmic findings, presumed to result from identifiable biases and misleading information. In those four stations, candidates were presented with authentic, file based information and were asked authentic questions, similar to those with which the patients presented. If the candidates were unsuccessful in identifying key findings, the questions were converted into directive questions about the same key findings (i.e. "examine the patient's eyelids, what is your diagnosis?"), and the candidates re-assessed the patient and re-answered. Results: Ninety-eight doctor-patient encounters took place. Of those, 35 encounters were analysed for the purpose of this study. In 63% of those encounters, key findings were missed when the question included authentic biases or misleading background information, but rephrasing the question to a directive exam format led to their correct identification (Fail converted to pass). Key findings were detected despite contextual biases or misleading background information in only 23% of encounters. In 14% the findings were missed with either question phrasing. Conclusions: Presentation authentic questions provide a more realistic and less forgiving measure of diagnostic skills than directive exam questions. Given the prevalence of diagnostic errors and their importance to patient outcomes, known mechanisms contributing to diagnostic errors should be used as one of the assessment tools of advanced speciality trainees.	[Zamir, Ehud] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [Atkinson, Kaye] Royal Australian Coll Gen Practitioners, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	Zamir, E (corresponding author), Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia.	ezamir@unimelb.edu.au			Australian National Health and Medical Research Council Centre for Clinical Research Excellence [529923]	Australian National Health and Medical Research Council Centre for Clinical Research Excellence(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Australian National Health and Medical Research Council Centre for Clinical Research Excellence #529923 - Translational Clinical Research in Major Eye Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzy S, 2009, J EVAL CLIN PRACT, V15, P804, DOI 10.1111/j.1365-2753.2008.01098.x; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Croskerry P, 2003, ANN EMERG MED, V41, P110, DOI 10.1067/mem.2003.22; Elstein A., 1995, CLIN REASONING HLTH, P49; Epstein RM, 2007, NEW ENGL J MED, V356, P387, DOI 10.1056/NEJMra054784; Eva KW, 2005, MED EDUC, V39, P870, DOI 10.1111/j.1365-2929.2005.02258.x; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Groopman J, 2007, DOCTORS THINK; KASSIRER JP, 1989, AM J MED, V86, P433, DOI 10.1016/0002-9343(89)90342-2; Klein JG, 2005, BMJ-BRIT MED J, V330, P781, DOI 10.1136/bmj.330.7494.781; McLaughlin K, 2008, MED EDUC, V42, P496, DOI 10.1111/j.1365-2923.2007.02994.x; the Royal College of General Practitioners, 2012, SEL SAMPL CSA CAS; the Royal College of Paediatrics and Child Health, 2004, MRCPCH CLIN EX TECHN	13	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77813	10.1371/journal.pone.0077813	http://dx.doi.org/10.1371/journal.pone.0077813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147082	Green Published, gold			2022-12-27	WOS:000326019400136
J	Merelo, P; Xie, YK; Brand, L; Ott, F; Weigel, D; Bowman, JL; Heisler, MG; Wenkel, S				Merelo, Paz; Xie, Yakun; Brand, Lucas; Ott, Felix; Weigel, Detlef; Bowman, John L.; Heisler, Marcus G.; Wenkel, Stephan			Genome-Wide Identification of KANADI1 Target Genes	PLOS ONE			English	Article							CLASS IIIHD-ZIP; DEPENDENT AUXIN GRADIENTS; LEAF DEVELOPMENT; CELL FATE; ASYMMETRIC-LEAVES2 GENE; TRANSCRIPTION FACTORS; ARABIDOPSIS SHOOTS; NPY GENES; POLARITY; EXPRESSION	Plant organ development and polarity establishment is mediated by the action of several transcription factors. Among these, the KANADI (KAN) subclade of the GARP protein family plays important roles in polarity-associated processes during embryo, shoot and root patterning. In this study, we have identified a set of potential direct target genes of KAN1 through a combination of chromatin immunoprecipitation/DNA sequencing (ChIP-Seq) and genome-wide transcriptional profiling using tiling arrays. Target genes are over-represented for genes involved in the regulation of organ development as well as in the response to auxin. KAN1 affects directly the expression of several genes previously shown to be important in the establishment of polarity during lateral organ and vascular tissue development. We also show that KAN1 controls through its target genes auxin effects on organ development at different levels: transport and its regulation, and signaling. In addition, KAN1 regulates genes involved in the response to abscisic acid, jasmonic acid, brassinosteroids, ethylene, cytokinins and gibberellins. The role of KAN1 in organ polarity is antagonized by HD-ZIPIII transcription factors, including REVOLUTA (REV). A comparison of their target genes reveals that the REV/KAN1 module acts in organ patterning through opposite regulation of shared targets. Evidence of mutual repression between closely related family members is also shown.	[Merelo, Paz; Heisler, Marcus G.] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Heisler, Marcus G.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Xie, Yakun; Wenkel, Stephan] Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany; [Brand, Lucas; Bowman, John L.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Ott, Felix; Weigel, Detlef] Max Planck Inst Dev Biol, Tubingen, Germany	European Molecular Biology Laboratory (EMBL); University of Sydney; Eberhard Karls University of Tubingen; Monash University; Max Planck Society	Bowman, JL (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	john.bowman@monash.edu; heisler@embl.de; stephan.wenkel@zmbp.uni-tuebingen.de	Weigel, Detlef/AAR-3312-2021; heisler, marcus G/B-9738-2015; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022; Cremades, Paz Merelo/B-8001-2019	heisler, marcus G/0000-0001-5644-8398; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Cremades, Paz Merelo/0000-0002-1301-7835; Bowman, John/0000-0001-7347-3691; Wenkel, Stephan/0000-0001-5764-9423; Xie, Yakun/0000-0003-1943-9577	Australian Research Council [DP0771232, DP110100070]; European Research Council (GA) [261081]; Deutsche Forschungsgemeinschaft [WE4281/6-1, WE4281/7-1]; European Union [256502]; Swiss national Science Foundation [PBZHA-1188060]	Australian Research Council(Australian Research Council); European Research Council (GA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Swiss national Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	MH acknowledges the Australian Research Council (http://www.arc.gov.au/) and European Research Council (GA No261081)(http://erc.europa.eu/) for current funding. The SW laboratory is funded by grants of the Deutsche Forschungsgemeinschaft (WE4281/6-1, WE4281/7-1) (http://www.dfg.de/) and the European Union (FP7 No. 256502) (http://cordis.europa.eu/fp7/home_en.html). LB was supported by the Swiss national Science Foundation (PBZHA-1188060)(http://www.snf.ch/E/Pages/default.aspx) and JLB acknowledges support from the Australian Research Council (DP0771232, DP110100070)(http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Baima S, 1995, DEVELOPMENT, V121, P4171; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bou-Torrent J, 2012, PLANT SIGNAL BEHAV, V7, P1382, DOI 10.4161/psb.21824; Bowman JL, 2008, ANNU REV PLANT BIOL, V59, P67, DOI 10.1146/annurev.arplant.57.032905.105356; Brandt R, 2012, PLANT J, V72, P31, DOI 10.1111/j.1365-313X.2012.05049.x; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Carrier DJ, 2008, PLANT PHYSIOL, V148, P529, DOI 10.1104/pp.108.122044; Causier B, 2012, PLANT PHYSIOL, V158, P423, DOI 10.1104/pp.111.186999; Cecchetti V, 2008, PLANT CELL, V20, P1760, DOI 10.1105/tpc.107.057570; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Fisher K, 2007, CURR BIOL, V17, P1061, DOI 10.1016/j.cub.2007.05.049; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Furutani M, 2007, DEVELOPMENT, V134, P3849, DOI 10.1242/dev.009654; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Hawker NP, 2004, PLANT PHYSIOL, V135, P2261, DOI 10.1104/pp.104.040196; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hirakawa Y, 2008, P NATL ACAD SCI USA, V105, P15208, DOI 10.1073/pnas.0808444105; Ilegems M, 2010, DEVELOPMENT, V137, P975, DOI 10.1242/dev.047662; Iwakawa H, 2002, PLANT CELL PHYSIOL, V43, P467, DOI 10.1093/pcp/pcf077; Iwakawa H, 2007, PLANT J, V51, P173, DOI 10.1111/j.1365-313X.2007.03132.x; Iwasaki M, 2013, DEVELOPMENT, V140, P1958, DOI 10.1242/dev.085365; Izhaki A, 2007, PLANT CELL, V19, P495, DOI 10.1105/tpc.106.047472; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kerstetter RA, 2001, NATURE, V411, P706, DOI 10.1038/35079629; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim YS, 2008, PLANT CELL, V20, P920, DOI 10.1105/tpc.107.057448; Knauss S, 2003, J BIOL CHEM, V278, P23936, DOI 10.1074/jbc.M212585200; Kumar R, 2007, PLANT CELL, V19, P2719, DOI 10.1105/tpc.106.048769; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Lee YK, 2006, DEVELOPMENT, V133, P4305, DOI 10.1242/dev.02604; Li YT, 2011, MOL PLANT, V4, P171, DOI 10.1093/mp/ssq052; Lin RC, 2005, PLANT PHYSIOL, V138, P949, DOI 10.1104/pp.105.061572; LIU T, 2013, COLD SPRING HARB S Q, P1465; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Sarojam R, 2010, PLANT CELL, V22, P2113, DOI 10.1105/tpc.110.075853; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; Sawa S, 1999, GENE DEV, V13, P1079, DOI 10.1101/gad.13.9.1079; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Smith ZR, 2010, NATURE, V464, P423, DOI 10.1038/nature08843; Spalding EP, 2013, AM J BOT, V100, P203, DOI 10.3732/ajb.1200420; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari SB, 2003, PLANT CELL, V15, P533, DOI 10.1105/tpc.008417; Vernoux T, 2000, DEVELOPMENT, V127, P5157; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Weigel M, 2003, J BIOL CHEM, V278, P31286, DOI 10.1074/jbc.M302876200; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Wu G, 2008, P NATL ACAD SCI USA, V105, P16392, DOI 10.1073/pnas.0803997105; Yang TB, 2000, J BIOL CHEM, V275, P3137, DOI 10.1074/jbc.275.5.3137; Yant L, 2010, PLANT CELL, V22, P2156, DOI 10.1105/tpc.110.075606	74	45	47	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77341	10.1371/journal.pone.0077341	http://dx.doi.org/10.1371/journal.pone.0077341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155946	Green Submitted, gold, Green Published			2022-12-27	WOS:000325887300080
J	Banerjee, A; Abdelmegeed, MA; Jang, S; Song, BJ				Banerjee, Atrayee; Abdelmegeed, Mohamed A.; Jang, Sehwan; Song, Byoung-Joon			Zidovudine (AZT) and Hepatic Lipid Accumulation: Implication of Inflammation, Oxidative and Endoplasmic Reticulum Stress Mediators	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVATED PROTEIN-KINASE; HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; MITOCHONDRIAL PROTEINS; LACTIC-ACIDOSIS; FATTY LIVER; STEATOSIS; DYSFUNCTION; MECHANISM	The clinical effectiveness of Zidovudine (AZT) is constrained due to its side-effects including hepatic steatosis and toxicity. However, the mechanism(s) of hepatic lipid accumulation in AZT-treated individuals is unknown. We hypothesized that AZT-mediated oxidative and endoplasmic reticulum (ER) stress may play a role in the AZT-induced hepatic lipid accumulation. AZT treatment of C57BL/6J female mice (400 mg/day/kg body weight, i.p.) for 10 consecutive days significantly increased hepatic triglyceride levels and inflammation. Markers of oxidative stress such as protein oxidation, nitration, glycation and lipid peroxidation were significantly higher in the AZT-treated mice compared to vehicle controls. Further, the levels of ER stress marker proteins like GRP78, p-PERK, and p-eIF2 alpha were significantly elevated in AZT-treated mice. The level of nuclear SREBP-1c, a transcription factor involved in fat synthesis, was increased while significantly decreased protein levels of phospho-acetyl-CoA carboxylase, phospho-AMP kinase and PPAR alpha as well as inactivation of 3-keto-acyl-CoA thiolase in the mitochondrial fatty acid beta-oxidation pathway were observed in AZT-exposed mice compared to those in control animals. Collectively, these data suggest that elevated oxidative and ER stress plays a key role, at least partially, in lipid accumulation, inflammation and hepatotoxicity in AZT-treated mice.	[Banerjee, Atrayee; Abdelmegeed, Mohamed A.; Jang, Sehwan; Song, Byoung-Joon] NIAAA, Lab Membrane Biochem & Biophys, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Song, BJ (corresponding author), NIAAA, Lab Membrane Biochem & Biophys, Bethesda, MD USA.	bj.song@nih.gov			Intramural Program of National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000036] Funding Source: NIH RePORTER	Intramural Program of National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The research was supported by the Intramural Program of National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMEGEED MA, 2013, FREE RADIC BIOL MED; Abdelmegeed MA, 2012, J HEPATOL, V57, P860, DOI 10.1016/j.jhep.2012.05.019; Abdelmegeed MA, 2009, FREE RADICAL BIO MED, V47, P767, DOI 10.1016/j.freeradbiomed.2009.06.017; Acosta BS, 1999, SOUTHERN MED J, V92, P421, DOI 10.1097/00007611-199904000-00015; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Buechler C, 2011, CURR DRUG METAB, V12, P24, DOI 10.2174/138920011794520035; Calvaruso V, 2009, J VIRAL HEPATITIS, V16, P529, DOI 10.1111/j.1365-2893.2009.01150.x; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Chariot P, 1999, J HEPATOL, V30, P156, DOI 10.1016/S0168-8278(99)80020-8; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Corcuera T, 1996, PATHOL RES PRACT, V192, P182, DOI 10.1016/S0344-0338(96)80218-4; de la Asuncion JG, 1999, HEPATOLOGY, V29, P985; de la Asuncion JG, 1998, J CLIN INVEST, V102, P4, DOI 10.1172/JCI1418; Desai VG, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/317695; FREIMAN JP, 1993, AIDS, V7, P379, DOI 10.1097/00002030-199303000-00012; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gao RY, 2011, MOL MED REP, V4, P151, DOI 10.3892/mmr.2010.390; Garcia-Villafranca J, 2008, BIOCHIMIE, V90, P460, DOI 10.1016/j.biochi.2007.09.019; Gentile CL, 2011, BIOFACTORS, V37, P8, DOI 10.1002/biof.135; Georges B, 2003, BIOCHEM PHARMACOL, V65, P1483, DOI 10.1016/S0006-2952(03)00110-2; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Hansen L, 2013, J BIOMECH, V46, P1540, DOI 10.1016/j.jbiomech.2013.03.021; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hardwick JP, 2009, PPAR RES, V2009, DOI 10.1155/2009/952734; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kim BJ, 2006, PROTEOMICS, V6, P1250, DOI 10.1002/pmic.200500447; Kimzey AL, 2003, BIOCHEMISTRY-US, V42, P12691, DOI 10.1021/bi0349975; Lapadula Giuseppe, 2007, J Med Case Rep, V1, P19, DOI 10.1186/1752-1947-1-19; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; MILLER TL, 1993, AM J CLIN NUTR, V57, P588, DOI 10.1093/ajcn/57.4.588; Moon KH, 2008, PROTEOMICS, V8, P3906, DOI 10.1002/pmic.200800215; Moon KH, 2008, GASTROENTEROLOGY, V135, P1344, DOI 10.1053/j.gastro.2008.06.048; Moon KH, 2006, HEPATOLOGY, V44, P1218, DOI 10.1002/hep.21372; Omar RF, 1996, TOXICOL APPL PHARM, V139, P324, DOI 10.1006/taap.1996.0172; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Puoti Massimo, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P30, DOI 10.1177/1545109708330906; Robertson Graham, 2001, American Journal of Physiology, V281, pG1135; Shah I, 2006, J TROP PEDIATRICS, V52, P244, DOI 10.1093/tropej/fmi086; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Sulkowski MS, 2004, AIDS, V18, P2277, DOI 10.1097/00002030-200411190-00008; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Sutinen J, 2002, AIDS, V16, P2183, DOI 10.1097/00002030-200211080-00011; Szabados E, 1999, FREE RADICAL BIO MED, V26, P309, DOI 10.1016/S0891-5849(98)00199-3; Wu DF, 2012, FREE RADICAL BIO MED, V53, P1346, DOI 10.1016/j.freeradbiomed.2012.07.005; Wu J, 2010, ACTA PHARMACOL SIN, V31, P1367, DOI 10.1038/aps.2010.110; Wu SY, 2004, J BIOL CHEM, V279, P34898, DOI 10.1074/jbc.M405616200; You M, 2004, AM J PHYSIOL-GASTR L, V287, pG1, DOI 10.1152/ajpgi.00056.2004; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898	59	27	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76850	10.1371/journal.pone.0076850	http://dx.doi.org/10.1371/journal.pone.0076850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146933	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400086
J	Li, Q; Canosa, S; Flynn, K; Michaud, M; Krauthammer, M; Madri, JA				Li, Qi; Canosa, Sandra; Flynn, Kelly; Michaud, Michael; Krauthammer, Michael; Madri, Joseph A.			Modeling the Neurovascular Niche: Unbiased Transcriptome Analysis of the Murine Subventricular Zone in Response to Hypoxic Insult	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NEURAL STEM-CELLS; ENDOTHELIAL-CELLS; YOUNG ADULTHOOD; MORTALITY; OUTCOMES; OLIG2	Premature infants often experience chronic hypoxia, resulting in cognitive & motor neurodevelopmental handicaps. These sometimes devastating handicaps are thought to be caused by compromised neural precursor cell (NPC) repair/recovery resulting in variable central nervous system (CNS) repair/recovery. We have identified differential responses of two mouse strains (C57BL/6 & CD1) to chronic hypoxia that span the range of responsiveness noted in the premature human population. We previously correlated several CNS tissue and cellular behaviors with the different behavioral parameters manifested by these two strains. In this report, we use unbiased array technology to interrogate the transcriptome of the subventricular zone (SVZ) in these strains. Our results illustrate differences in mRNA expression in the SVZ of both C57BL/6 and CD1 mice following hypoxia as well as differences between C57BL/6 and CD1 SVZ under both normoxic and hypoxic conditions. Differences in expression were found in gene sets associated with Sox10-mediated neural functions that explain, in part, the differential cognitive and motor responsiveness to hypoxic insult. This may shed additional light on our understanding of the variable responses noted in the human premature infant population and facilitate early intervention approaches. Further interrogation of the differentially expressed gene sets will provide a more complete understanding of the differential responses to, and recovery from, hypoxic insult allowing for more informed modeling of the ranges of disease severity observed in the very premature human population.	[Li, Qi; Canosa, Sandra; Flynn, Kelly; Michaud, Michael; Krauthammer, Michael; Madri, Joseph A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Yale University	Madri, JA (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	JOSEPH.MADRI@YALE.EDU		Michaud, Michael/0000-0001-7332-4987; Krauthammer, Michael/0000-0002-4808-1845	Yale University Clinical and Translational Science award [BUL1TR000142]; USPHS [RO1-HL51018, PO1-NS00344738]; Connecticut Stem Cell Grant; Reed Foundation Fellowship;  [T32-DK07556]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007556] Funding Source: NIH RePORTER	Yale University Clinical and Translational Science award; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Stem Cell Grant; Reed Foundation Fellowship; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by a Yale University Clinical and Translational Science award BUL1TR000142 to MK, USPHS grants RO1-HL51018 and PO1-NS00344738 to JAM and a Connecticut Stem Cell Grant to QL. KR was supported by T32-DK07556 and a Reed Foundation Fellowship to JAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Bassan H, 2006, PEDIATR NEUROL, V35, P85, DOI 10.1016/j.pediatrneurol.2006.03.005; Cooke RWI, 2006, ARCH DIS CHILD-FETAL, V91, pF293, DOI 10.1136/adc.2005.080192; Curristin SM, 2002, P NATL ACAD SCI USA, V99, P15729, DOI 10.1073/pnas.232568799; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102; Gaber ZB, 2011, NEURON, V69, P833, DOI 10.1016/j.neuron.2011.02.037; Gonzalez-Perez O, 2011, BRAIN RES REV, V67, P147, DOI 10.1016/j.brainresrev.2011.01.001; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Lee KE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-408; Li Q, 2008, J NEUROSCI RES, V86, P1227, DOI 10.1002/jnr.21597; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Li Q, 2011, ANGIOGENESIS, V14, P173, DOI 10.1007/s10456-011-9201-9; Li Q, 2009, AM J PATHOL, V175, P2133, DOI 10.2353/ajpath.2009.090354; Madri JA, 2009, J PHYSIOL PHARMACOL, V60, P95; Ment LR, 2007, NAT CLIN PRAC NEUROL, V3; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Paul David A, 2006, BMC Pediatr, V6, P2, DOI 10.1186/1471-2431-6-2; Pozniak CD, 2010, P NATL ACAD SCI USA, V107, P21795, DOI 10.1073/pnas.1016485107; Saigal S, 2006, JAMA-J AM MED ASSOC, V295, P667, DOI 10.1001/jama.295.6.667; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schafer RJ, 2009, BRAIN PATHOL; Sheldon RA, 1998, BRAIN RES, V810, P114, DOI 10.1016/S0006-8993(98)00892-0; Srinivasan R, 2012, NUCLEIC ACIDS RES, V40, P6449, DOI 10.1093/nar/gks313; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Y, 2011, NEURON, V69, P906, DOI 10.1016/j.neuron.2011.02.005; Tyson JE, 2005, JAMA-J AM MED ASSOC, V294, P371, DOI 10.1001/jama.294.3.371; Ward NL, 2007, J APPL PHYSIOL, V102, P1927, DOI 10.1152/japplphysiol.00909.2006; Wegner M, GENES DEV, V25, P2423; Weider M, 2013, BIOL CHEM, V394, P1583, DOI 10.1515/hsz-2013-0146; Williams C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053208; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Yalcin B, 2011, NATURE, P477; Yusuf D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r24; Zwemer CF, 2007, J APPL PHYSIOL, V102, P286, DOI 10.1152/japplphysiol.00536.2006	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76265	10.1371/journal.pone.0076265	http://dx.doi.org/10.1371/journal.pone.0076265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146847	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400050
J	Manchia, M; Cullis, J; Turecki, G; Rouleau, GA; Uher, R; Alda, M				Manchia, Mirko; Cullis, Jeffrey; Turecki, Gustavo; Rouleau, Guy A.; Uher, Rudolf; Alda, Martin			The Impact of Phenotypic and Genetic Heterogeneity on Results of Genome Wide Association Studies of Complex Diseases	PLOS ONE			English	Article							BIPOLAR DISORDER; SAMPLE-SIZE; MISCLASSIFICATION; LINKAGE; METAANALYSIS; POWER; REPLICATION; SUPPORTS; ERRORS; RISK	Phenotypic misclassification (between cases) has been shown to reduce the power to detect association in genetic studies. However, it is conceivable that complex traits are heterogeneous with respect to individual genetic susceptibility and disease pathophysiology, and that the effect of heterogeneity has a larger magnitude than the effect of phenotyping errors. Although an intuitively clear concept, the effect of heterogeneity on genetic studies of common diseases has received little attention. Here we investigate the impact of phenotypic and genetic heterogeneity on the statistical power of genome wide association studies (GWAS). We first performed a study of simulated genotypic and phenotypic data. Next, we analyzed the Wellcome Trust Case-Control Consortium (WTCCC) data for diabetes mellitus (DM) type 1 (T1D) and type 2 (T2D), using varying proportions of each type of diabetes in order to examine the impact of heterogeneity on the strength and statistical significance of association previously found in the WTCCC data. In both simulated and real data, heterogeneity (presence of "non-cases") reduced the statistical power to detect genetic association and greatly decreased the estimates of risk attributed to genetic variation. This finding was also supported by the analysis of loci validated in subsequent large-scale meta-analyses. For example, heterogeneity of 50% increases the required sample size by approximately three times. These results suggest that accurate phenotype delineation may be more important for detecting true genetic associations than increase in sample size.	[Manchia, Mirko; Cullis, Jeffrey; Uher, Rudolf; Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	Dalhousie University; McGill University; McGill University	Alda, M (corresponding author), Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada.	malda@dal.ca	Uher, Rudolf/A-5477-2008; Alda, Martin/F-5812-2010; Turecki, Gustavo/K-5100-2015; Manchia, Mirko/A-2907-2010	Uher, Rudolf/0000-0002-2998-0546; Alda, Martin/0000-0001-9544-3944; Manchia, Mirko/0000-0003-4175-6413; Turecki, Gustavo/0000-0003-4075-2736	Canadian Institute of Health Research (CIHR) [64410]	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was in part funded by grant 64410 from Canadian Institute of Health Research (CIHR) to MA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda M, 2005, PROG NEURO-PSYCHOPH, V29, P1038, DOI 10.1016/j.pnpbp.2005.03.021; Angst J, 2007, WORLD PSYCHIATRY, V6, P30; Barral S, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-24; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bienvenu OJ, 2011, PSYCHOL MED, V41, P33, DOI 10.1017/S003329171000084X; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Buyske S, 2009, HUM HERED, V67, P287, DOI 10.1159/000194981; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Corvin A, 2010, PSYCHOL MED, V40, P1063, DOI 10.1017/S0033291709991723; Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751; DAVIES P, 1986, NEUROBIOL AGING, V7, P459, DOI 10.1016/0197-4580(86)90071-0; de Lara CL, 2010, INT J NEUROPSYCHOPH, V13, P1397, DOI 10.1017/S1461145710000714; Edwards BJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-18; Evangelou E, 2011, AM J EPIDEMIOL, V173, P1336, DOI 10.1093/aje/kwr024; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gershon ES, 2011, AM J PSYCHIAT, V168, P253, DOI 10.1176/appi.ajp.2010.10091340; Goes FS, 2007, AM J PSYCHIAT, V164, P236, DOI 10.1176/appi.ajp.164.2.236; GORDON D, 2004, STAT APPL GENET MOL, V3; Gordon D, 2007, GENET EPIDEMIOL, V31, P853, DOI 10.1002/gepi.20246; Himswort HP, 1940, BMJ-BRIT MED J, V1940, P719, DOI 10.1136/bmj.1.4139.719; Himsworth HP, 2011, DIABETIC MED, V28, P1440, DOI 10.1111/j.1464-5491.2011.3508.x; Ji F, 2005, STAT APPL GENET MOL, V4; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu HQ, 2010, HUM MOL GENET, V19, P2534, DOI 10.1093/hmg/ddq133; RISCH N, 1990, AM J HUM GENET, V46, P222; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith EN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002134; van der Sluis S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013929; Vassos E, 2012, BIOL PSYCHIAT, V72, P645, DOI 10.1016/j.biopsych.2012.02.040; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wray NR, 2012, EUR J HUM GENET, V20, P668, DOI 10.1038/ejhg.2011.257	40	128	129	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76295	10.1371/journal.pone.0076295	http://dx.doi.org/10.1371/journal.pone.0076295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146854	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400052
J	Noirclerc-Savoye, M; Lantez, V; Signor, L; Philippe, J; Vernet, T; Zapun, A				Noirclerc-Savoye, Marjolaine; Lantez, Violaine; Signor, Luca; Philippe, Jules; Vernet, Thierry; Zapun, Andre			Reconstitution of Membrane Protein Complexes Involved in Pneumococcal Septal Cell Wall Assembly	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN-3; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; DIVISION PROTEIN; BACILLUS-SUBTILIS; FTSI PBP3; TRIMERIC COMPLEX; PEPTIDOGLYCAN; TRANSPEPTIDASE; LOCALIZATION	The synthesis of peptidoglycan, the major component of the bacterial cell wall, is essential to cell survival, yet its mechanism remains poorly understood. In the present work, we have isolated several membrane protein complexes consisting of the late division proteins of Streptococcus pneumoniae: DivIB, DivIC, FtsL, PBP2x and FtsW, or subsets thereof. We have co-expressed membrane proteins from S. pneumoniae in Escherichia coli. By combining two successive affinity chromatography steps, we obtained membrane protein complexes with a very good purity. These complexes are functional, as indicated by the retained activity of PBP2x to bind a fluorescent derivative of penicillin and to hydrolyze the substrate analogue S2d. Moreover, we have evidenced the stabilizing role of protein-protein interactions within each complex. This work paves the way for a complete reconstitution of peptidoglycan synthesis in vitro, which will be critical to the elucidation of its intricate regulation mechanisms.	[Noirclerc-Savoye, Marjolaine; Lantez, Violaine; Signor, Luca; Philippe, Jules; Vernet, Thierry; Zapun, Andre] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Noirclerc-Savoye, Marjolaine; Lantez, Violaine; Signor, Luca; Philippe, Jules; Vernet, Thierry; Zapun, Andre] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Biol Struct, Grenoble, France; [Noirclerc-Savoye, Marjolaine; Lantez, Violaine; Signor, Luca; Philippe, Jules; Vernet, Thierry; Zapun, Andre] CNRS, Inst Biol Struct, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Noirclerc-Savoye, M (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France.	marjolaine.noirclerc@ibs.fr; thierry.vernet@ibs.fr	Signor, Luca/O-7489-2014	Signor, Luca/0000-0003-3880-2466; Noirclerc-Savoye, Marjolaine/0000-0002-5481-6561; Zapun, Andre/0000-0001-8953-4399	"Coopol innovation France-Chine" program; FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]	"Coopol innovation France-Chine" program; FRISBI; GRAL	This work was partly funded by the "Coopol innovation France-Chine" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. This work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI(ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB).	ADAM M, 1991, BIOCHEM J, V279, P601, DOI 10.1042/bj2790601; Arends SJR, 2004, J BACTERIOL, V186, P880, DOI 10.1128/JB.186.3.880-884.2004; Banzhaf M, 2012, MOL MICROBIOL, V85, P179, DOI 10.1111/j.1365-2958.2012.08103.x; Berg KH, 2013, J BACTERIOL, V195, P4342, DOI 10.1128/JB.00184-13; Berridge G, 2011, ANAL BIOCHEM, V410, P272, DOI 10.1016/j.ab.2010.11.008; Bertsche U, 2005, J BIOL CHEM, V280, P38096, DOI 10.1074/jbc.M508646200; Boncoeur E, 2012, BIOCHEMISTRY-US, V51, P7755, DOI 10.1021/bi300762p; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Cabeen MT, 2007, J CELL BIOL, V179, P381, DOI 10.1083/jcb.200708001; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; Di Guilmi AM, 1999, J BACTERIOL, V181, P2773, DOI 10.1128/JB.181.9.2773-2781.1999; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Gamba P, 2009, J BACTERIOL, V191, P4186, DOI 10.1128/JB.01758-08; Gerard P, 2002, J BACTERIOL, V184, P1925, DOI 10.1128/JB.184.7.1925-1931.2002; Ghigo JM, 2000, J BACTERIOL, V182, P116, DOI 10.1128/JB.182.1.116-129.2000; GHUYSEN JM, 1968, BACTERIOL REV, V32, P425, DOI 10.1128/MMBR.32.4_Pt_2.425-464.1968; Helassa N, 2012, FEBS J, V279, P2071, DOI 10.1111/j.1742-4658.2012.08592.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Korepanova A, 2012, CURR PROTOC PROTEIN, V29; Land AD, 2011, J BACTERIOL, V193, P4166, DOI 10.1128/JB.05245-11; LaPointe LM, 2013, BIOCHEMISTRY-US, V52, P2574, DOI 10.1021/bi400222r; Lebar MD, 2013, J AM CHEM SOC, V135, P4632, DOI 10.1021/ja312510m; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Martos A, 2012, TRENDS CELL BIOL, V22, P634, DOI 10.1016/j.tcb.2012.09.003; Massidda O, 1998, MICROBIOL-SGM, V144, P3069, DOI 10.1099/00221287-144-11-3069; Massidda O, 2013, ENVIRON MICROBIOL, DOI [10.1111/1462-2920.12189, DOI 10.1111/1462-2920.12189.PUBMED:23848140]; Masson S, 2009, J BIOL CHEM, V284, P27687, DOI 10.1074/jbc.M109.019471; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; Noirclerc-Savoye M, 2010, BIOTECHNOL J, V5, P978, DOI 10.1002/biot.201000132; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Perez-Nunez D, 2011, MOL MICROBIOL, V79, P759, DOI 10.1111/j.1365-2958.2010.07483.x; Piette A, 2004, J BACTERIOL, V186, P6110, DOI 10.1128/jb.186.18.6110-6117.2004; Robichon C, 2008, J BACTERIOL, V190, P6048, DOI 10.1128/JB.00462-08; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Rowland SL, 2010, J BACTERIOL, V192, P6116, DOI 10.1128/JB.00783-10; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sham LT, 2012, CURR OPIN MICROBIOL, V15, P194, DOI 10.1016/j.mib.2011.12.013; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Villanelo F, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-28; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wadsworth KD, 2008, MOL MICROBIOL, V67, P1143, DOI 10.1111/j.1365-2958.2008.06114.x; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Wissel MC, 2005, J BACTERIOL, V187, P320, DOI 10.1128/JB.187.1.320-328.2005; Wissel MC, 2004, J BACTERIOL, V186, P490, DOI 10.1128/JB.186.2.490-502.2004; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x; Zapun A, 2012, MICROB DRUG RESIST, V18, P256, DOI 10.1089/mdr.2011.0236; Zhao GS, 1997, J BACTERIOL, V179, P4901, DOI 10.1128/jb.179.15.4901-4908.1997	58	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2013	8	9							e75522	10.1371/journal.pone.0075522	http://dx.doi.org/10.1371/journal.pone.0075522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	246EK	24147156	Green Submitted, gold, Green Published			2022-12-27	WOS:000326520200108
J	Holechek, SA; Denzler, KL; Heck, MC; Schriewer, J; Buller, RM; Legrand, FA; Verardi, PH; Jones, LA; Yilma, T; Jacobs, BL				Holechek, Susan A.; Denzler, Karen L.; Heck, Michael C.; Schriewer, Jill; Buller, R. Mark; Legrand, Fatema A.; Verardi, Paulo H.; Jones, Leslie A.; Yilma, Tilahun; Jacobs, Bertram L.			Use of a Recombinant Vaccinia Virus Expressing Interferon Gamma for Post-Exposure Protection against Vaccinia and Ectromelia Viruses	PLOS ONE			English	Article							ANTIPOXVIRUS COMPOUND ST-246; HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE-RESPONSES; NITRIC-OXIDE; MICE; SMALLPOX; INHIBITION; EFFICACY; PROTEIN; MODEL	Post-exposure vaccination with vaccinia virus (VACV) has been suggested to be effective in minimizing death if administered within four days of smallpox exposure. While there is anecdotal evidence for efficacy of post-exposure vaccination this has not been definitively studied in humans. In this study, we analyzed post-exposure prophylaxis using several attenuated recombinant VACV in a mouse model. A recombinant VACV expressing murine interferon gamma (IFN-gamma) was most effective for post-exposure protection of mice infected with VACV and ectromelia virus (ECTV). Untreated animals infected with VACV exhibited severe weight loss and morbidity leading to 100% mortality by 8 to 10 days post-infection. Animals treated one day post-infection had milder symptoms, decreased weight loss and morbidity, and 100% survival. Treatment on days 2 or 3 post-infection resulted in 40% and 20% survival, respectively. Similar results were seen in ECTV-infected mice. Despite the differences in survival rates in the VACV model, the viral load was similar in both treated and untreated mice while treated mice displayed a high level of IFN-gamma in the serum. These results suggest that protection provided by IFN-gamma expressed by VACV may be mediated by its immunoregulatory activities rather than its antiviral effects. These results highlight the importance of IFN-gamma as a modulator of the immune response for post-exposure prophylaxis and could be used potentially as another post-exposure prophylaxis tool to prevent morbidity following infection with smallpox and other orthopoxviruses.	[Holechek, Susan A.; Denzler, Karen L.; Heck, Michael C.; Jacobs, Bertram L.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85069 USA; [Schriewer, Jill; Buller, R. Mark] St Louis Univ, Hlth Sci Ctr, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA; [Legrand, Fatema A.; Jones, Leslie A.; Yilma, Tilahun] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Int Lab Mol Biol Trop Dis Agents,Sch Vet Med, Davis, CA 95616 USA; [Verardi, Paulo H.] Univ Connecticut, Dept Pathobiol & Vet Sci, Storrs, CT USA	Arizona State University; Arizona State University-Tempe; Saint Louis University; University of California System; University of California Davis; University of Connecticut	Jacobs, BL (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85069 USA.	bjacobs@asu.edu			Biodefense Countermeasures Development: Project Bioshield; Department of Health and Human Services, Public Health Services [R01AI06650101]; Arizona State University Graduate Professional Student Association; Arizona State University Faculty Emeriti Association Fellowship; More Graduate Education at Mountain States Alliance MGE@MSA; National Institutes of Health [AI54951, AI53811, AI59185]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI059185, R01AI054951, R01AI095394, R21AI053811] Funding Source: NIH RePORTER	Biodefense Countermeasures Development: Project Bioshield; Department of Health and Human Services, Public Health Services; Arizona State University Graduate Professional Student Association; Arizona State University Faculty Emeriti Association Fellowship; More Graduate Education at Mountain States Alliance MGE@MSA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work received financial support from the Biodefense Countermeasures Development: Project Bioshield, Department of Health and Human Services, Public Health Services grant R01AI06650101 to B.L.J., Arizona State University Graduate Professional Student Association research grant to S. A. H., Arizona State University Faculty Emeriti Association Fellowship to S. A. H. and More Graduate Education at Mountain States Alliance MGE@MSA. National Institutes of Health Grants AI54951 and AI53811 to T.D.Y. and AI59185 to P. H. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaitua F, 2006, VIRUS RES, V116, P11, DOI 10.1016/j.virusres.2005.08.008; ALCAMI A, 1995, J VIROL, V69, P4633; Amorosa VK, 2003, CLIN INFECT DIS, V37, P426, DOI 10.1086/375823; ANDERSON KP, 1988, J IMMUNOL, V140, P3599; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P478; Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557; BLASCO R, 1993, J VIROL, V67, P3319, DOI 10.1128/JVI.67.6.3319-3325.1993; BLOOM DC, 1991, J VIROL, V65, P1530, DOI 10.1128/JVI.65.3.1530-1542.1991; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Buller RM, 2004, VIROLOGY, V318, P474, DOI 10.1016/j.virol.2003.11.015; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P532; Cheers C, 1999, IMMUNOL CELL BIOL, V77, P324, DOI 10.1046/j.1440-1711.1999.00829.x; CHEN W, 1992, VIROLOGY, V187, P433, DOI 10.1016/0042-6822(92)90445-U; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dato V., 2009, Morbidity and Mortality Weekly Report, V58, P1204; De Clercq E, 2004, REV MED VIROL, V14, P289, DOI 10.1002/rmv.439; Earl P, 1991, CURRENT PROTOCOLS MO; Esteban DJ, 2005, J GEN VIROL, V86, P2645, DOI 10.1099/vir.0.81090-0; FENNER F, 1949, J IMMUNOL, V63, P341; Fenner F., 1989, MONKEYPOX VIRUS ORTH, P227; FLEXNER C, 1987, NATURE, V330, P259, DOI 10.1038/330259a0; Gherardi MM, 2003, J GEN VIROL, V84, P1961, DOI 10.1099/vir.0.19120-0; Giavedoni L, 1997, J VIROL, V71, P866, DOI 10.1128/JVI.71.2.866-872.1997; GIAVEDONI LD, 1992, P NATL ACAD SCI USA, V89, P3409, DOI 10.1073/pnas.89.8.3409; Guerra S, 2005, J VIROL, V79, P2133, DOI 10.1128/JVI.79.4.2133-2140.2005; HARRIS N, 1995, J VIROL, V69, P910, DOI 10.1128/JVI.69.2.910-915.1995; Jentarra GM, 2008, VACCINE, V26, P2860, DOI 10.1016/j.vaccine.2008.03.044; KAPLAN C, 1989, ARCH VIROL, V106, P127, DOI 10.1007/BF01311044; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kibler KV, 1997, J VIROL, V71, P1992, DOI 10.1128/JVI.71.3.1992-2003.1997; KOHONENCORISH MRJ, 1990, EUR J IMMUNOL, V20, P157, DOI 10.1002/eji.1830200123; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Lanier R, 2010, VIRUSES-BASEL, V2, P2740, DOI 10.3390/v2122740; LeDuc JW, 2002, EMERG INFECT DIS, V8, P743, DOI 10.3201/eid0807.020032; Legrand FA, 2005, P NATL ACAD SCI USA, V102, P2940, DOI 10.1073/pnas.0409846102; Legrand FA, 2004, J VIROL, V78, P2770, DOI 10.1128/JVI.78.6.2770-2779.2004; Liu G, 2004, FEMS IMMUNOL MED MIC, V40, P201, DOI 10.1016/S0928-8244(03)00358-4; Mortimer PP, 2003, CLIN INFECT DIS, V36, P622, DOI 10.1086/374054; Moss B, 1991, CURRENT PROTOCOLS MO; Moss B, 2001, FIELDS VIROLOGY, P2849; MOSSMAN K, 1995, VIROLOGY, V208, P762, DOI 10.1006/viro.1995.1208; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Najarro P, 2001, J VIROL, V75, P3185, DOI 10.1128/JVI.75.7.3185-3196.2001; Nalca A, 2005, CLIN INFECT DIS, V41, P1765, DOI 10.1086/498155; Nalca A, 2008, ANTIVIR RES, V79, P121, DOI 10.1016/j.antiviral.2008.03.005; Nalca A, 2011, J GEN VIROL, V92, P31, DOI 10.1099/vir.0.026237-0; Paran N, 2009, J INFECT DIS, V199, P39, DOI 10.1086/595565; Parker S, 2009, VIROLOGY, V385, P11, DOI 10.1016/j.virol.2008.11.015; Parker S, 2007, FUTURE MICROBIOL, V2, P17, DOI 10.2217/17460913.2.1.17; Parker S, 2010, VIRUSES-BASEL, V2, P1918, DOI 10.3390/v2091918; Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P4118, DOI 10.1128/AAC.00762-07; Quenelle DC, 2007, ANTIMICROB AGENTS CH, V51, P689, DOI 10.1128/AAC.00879-06; Raggo C, 2000, J GEN VIROL, V81, P2665, DOI 10.1099/0022-1317-81-11-2665; RAMSHAW I, 1992, IMMUNOL REV, V127, P157, DOI 10.1111/j.1600-065X.1992.tb01413.x; RAMSHAW IA, 1987, NATURE, V329, P545, DOI 10.1038/329545a0; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Sbrana E, 2007, AM J TROP MED HYG, V76, P768, DOI 10.4269/ajtmh.2007.76.768; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sharma DP, 1996, J VIROL, V70, P7103, DOI 10.1128/JVI.70.10.7103-7107.1996; Shors T, 1997, VIROLOGY, V239, P269, DOI 10.1006/viro.1997.8881; Smith SK, 2009, ANTIMICROB AGENTS CH, V53, P1007, DOI 10.1128/AAC.01044-08; Smith VP, 2002, J VIROL, V76, P1124, DOI 10.1128/JVI.76.3.1124-1134.2002; Staib C, 2006, J GEN VIROL, V87, P2917, DOI 10.1099/vir.0.82068-0; Stittelaar KJ, 2006, NATURE, V439, P745, DOI 10.1038/nature04295; Symons JA, 2002, J GEN VIROL, V83, P2833, DOI 10.1099/0022-1317-83-11-2833; Thorne CD, 2003, ANN EMERG MED, V42, P665, DOI 10.1016/S0196-0644(03)00629-2; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; WALLACE GD, 1985, LAB ANIM SCI, V35, P41; Wittek R, 2006, INT J INFECT DIS, V10, P193, DOI 10.1016/j.ijid.2005.12.001; World Health Organization, 1980, GLOB ER SMALLP FIN R; Xiang Y, 1999, P NATL ACAD SCI USA, V96, P11537, DOI 10.1073/pnas.96.20.11537; Yang G, 2005, J VIROL, V79, P13139, DOI 10.1128/JVI.79.20.13139-13149.2005	73	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77879	10.1371/journal.pone.0077879	http://dx.doi.org/10.1371/journal.pone.0077879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147092	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200083
J	Whelan, J; Sonder, GJ; Bovee, L; Speksnijder, A; van den Hoek, A				Whelan, Jane; Sonder, Gerard J.; Bovee, Lian; Speksnijder, Arjen; van den Hoek, Anneke			Evaluation of Hepatitis A Vaccine in Post-Exposure Prophylaxis, The Netherlands, 2004-2012	PLOS ONE			English	Article							IMMUNE SERUM GLOBULIN; VIRUS-VACCINE; SINGLE; IMMUNOGENICITY; PREVENTION; AMSTERDAM; OUTBREAK; SAFETY; ADULTS	Background: The secondary attack rate of hepatitis A virus (HAV) among contacts of cases is up to 50%. Historically, contacts were offered immunoglobulin (IG, a human derived blood product) as post-exposure prophylaxis (PEP). Amid safety concerns about IG, HAV vaccine is increasingly recommended instead. Public health authorities' recommendations differ, particularly for healthy contacts >= 40 years old, where vaccine efficacy data is limited. We evaluated routine use of HAV vaccine as an alternative to immunoglobulin in PEP, in those considered at low risk of severe infection in the Netherlands. Methods: Household contacts of acute HAV cases notified in Amsterdam (2004-2012) were invited <= 14 days post-exposure, for baseline anti-HAV testing and PEP according to national guidelines: immunoglobulin if at risk of severe infection, or hepatitis A vaccine if healthy and at low risk (aged <30, or, 30-50 years and vaccinated <8 days post-exposure). Incidence of laboratory confirmed secondary infection in susceptible contacts was assessed 4-8 weeks post-exposure. In a vaccinated subgroup, relative risk (RR) of secondary infection with estimated using Poisson regression. Results: Of 547 contacts identified, 191 were susceptible to HAV. Per-protocol, 167 (87%) were vaccinated (mean: 6.7 days post-exposure, standard deviation(sd)=3.3) and 24 (13%) were given immunoglobulin (mean: 9.7 days postexposure, sd=2.8). At follow-up testing, 8/112 (7%) had a laboratory confirmed infection of whom 7 were symptomatic. All secondary infections occurred in vaccinated contacts, and half were >40 years of age. In healthy contacts vaccinated per-protocol <= 8 days post-exposure, RRref. <= 15 years of secondary infection in those >40 years was 12.0 (95%CI: 1.3-106.7). Conclusions: Timely administration of HAV vaccine in PEP was feasible and the secondary attack rate was low in those <40 years. Internationally, upper age-limits for post-exposure vaccination vary. Pending larger studies, immunoglobulin should be considered PEP of choice in people >40 years of age and those vulnerable to severe disease.	[Whelan, Jane; Sonder, Gerard J.; Bovee, Lian; van den Hoek, Anneke] Amsterdam Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands; [Sonder, Gerard J.; van den Hoek, Anneke] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Speksnijder, Arjen] Amsterdam Publ Hlth Serv GGD Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Whelan, J (corresponding author), Amsterdam Publ Hlth Serv GGD, Dept Infect Dis, Amsterdam, Netherlands.	jwhelan@ggd.amsterdam.nl	Speksnijder, Arjen/M-3406-2017	Speksnijder, Arjen/0000-0002-1966-7265; Whelan, Jane/0000-0003-3784-2749	Public Health Service of Amsterdam, the Netherlands	Public Health Service of Amsterdam, the Netherlands(Netherlands Government)	This research was funded by the Public Health Service of Amsterdam, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY A, 1954, NEW ENGL J MED, V250, P412, DOI 10.1056/NEJM195403112501003; BRIEM H, 1994, J MED VIROL, V44, P443, DOI 10.1002/jmv.1890440424; BROOKS BF, 1953, NEW ENGL J MED, V249, P58, DOI 10.1056/NEJM195307092490202; Crowcroft N S, 2001, Commun Dis Public Health, V4, P213; De Schrijver K, 2011, HEPATITIS A GUIDELIN; GINGRICH GA, 1983, AM J PUBLIC HEALTH, V73, P1190, DOI 10.2105/AJPH.73.10.1190; Health Council of the Netherlands, 2001, HLTH COUNC NETH PUBL, V2001; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Koff RS, 1998, LANCET, V351, P1643, DOI 10.1016/S0140-6736(98)01304-X; Lee PI, 2008, NEW ENGL J MED, V358, P32, DOI [10.1056/NEJMc073258, DOI 10.1056/NEJMC073258.PUBMED:1824042818234760]; MOSLEY JW, 1968, AM J EPIDEMIOL, V87, P539, DOI 10.1093/oxfordjournals.aje.a120845; National Advisory Committee for Infectious Disease Control (LOI), 2002, ADV LOI WORKGR SAF G; National Advisory Committee on Immunization and the Public Health Agency of Canada, 2012, HEP A VACC POST IM 4; National Advisory Committee on Immunization (NACI), 2000, CAN COMMUN DIS REP, V26, P12; National Center for the coordination of Infectious Disease Control (LCI), 2011, GUID HEP A; Novak R., 2007, Morbidity and Mortality Weekly Report, V56, P1080; Queensland Health, 2013, HEP A QUEENSL HLTH G; Sagliocca L, 1999, LANCET, V353, P1136, DOI 10.1016/S0140-6736(98)08139-2; SHOUVAL D, 1993, J HEPATOL, V18, pS32, DOI 10.1016/S0168-8278(05)80375-7; SHOUVAL D, 1993, VACCINE, V11, pS9, DOI 10.1016/0264-410X(93)90151-M; Sonder GJB, 2004, AM J PUBLIC HEALTH, V94, P1620, DOI 10.2105/AJPH.94.9.1620; STOKES J, 1945, JAMA-J AM MED ASSOC, V127, P144, DOI 10.1001/jama.1945.02860030016004; Taliani G, 2003, VACCINE, V21, P2234, DOI 10.1016/S0264-410X(03)00138-5; Thomas LM, 2009, GUIDANCE PREVENTION; Tjon GMS, 2005, J MED VIROL, V77, P360, DOI 10.1002/jmv.20464; Tjon GMS, 2006, J MED VIROL, V78, P1398, DOI 10.1002/jmv.20711; Van Herck K, 2011, J MED VIROL, V83, P1885, DOI 10.1002/jmv.22200; Victor JC, 2007, NEW ENGL J MED, V357, P1685, DOI 10.1056/NEJMoa070546; WERZBERGER A, 1992, NEW ENGL J MED, V327, P453, DOI 10.1056/NEJM199208133270702; Whelan J, 2013, VACCINE, V31, P1806, DOI 10.1016/j.vaccine.2013.01.053	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78914	10.1371/journal.pone.0078914	http://dx.doi.org/10.1371/journal.pone.0078914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147144	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200102
J	Braff, WA; Willner, D; Hugenholtz, P; Rabaey, K; Buie, CR				Braff, William A.; Willner, Dana; Hugenholtz, Philip; Rabaey, Korneel; Buie, Cullen R.			Dielectrophoresis-Based Discrimination of Bacteria at the Strain Level Based on Their Surface Properties	PLOS ONE			English	Article							INSULATOR-BASED DIELECTROPHORESIS; MUCOID PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-MITIS; ANTIBIOTIC-RESISTANCE; BINDING; ADHESION; PROTEINS; DEVICES	Insulator-based dielectrophoresis can be used to manipulate biological particles, but has thus far found limited practical applications due to low sensitivity. We present linear sweep three-dimensional insulator-based dielectrophoresis as a considerably more sensitive approach for strain-level discrimination bacteria. In this work, linear sweep three-dimensional insulator-based dielectrophoresis was performed on Pseudomonas aeruginosa PA14 along with six isogenic mutants as well as Streptococcus mitis SF100 and PS344. Strain-level discrimination was achieved between these clinically important pathogens with applied electric fields below 10 V/mm. This low voltage, high sensitivity technique has potential applications in clinical diagnostics as well as microbial physiology research.	[Braff, William A.; Buie, Cullen R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Willner, Dana; Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Rabaey, Korneel] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld, Australia; [Rabaey, Korneel] Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium	Massachusetts Institute of Technology (MIT); University of Queensland; University of Queensland; Ghent University	Buie, CR (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	crb@mit.edu	Hugenholtz, Philip/AAD-9138-2019	Hugenholtz, Philip/0000-0001-5386-7925; Rabaey, Korneel/0000-0001-8738-7778	National Science Foundation [1150615]; MIT International Science and Technology Initiatives; European Research Council	National Science Foundation(National Science Foundation (NSF)); MIT International Science and Technology Initiatives; European Research Council(European Research Council (ERC)European Commission)	This work was partially supported by the National Science Foundation (Award #1150615), the MIT International Science and Technology Initiatives Seed Fund, and a Starter Grant from the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Lail LI, 2007, ENVIRON SCI TECHNOL, V41, P8031, DOI 10.1021/es071047o; Alos JI, 2005, CLIN MICROBIOL INFEC, V11, P199, DOI 10.1111/j.1469-0691.2004.01057.x; Bensing BA, 2001, INFECT IMMUN, V69, P1373, DOI 10.1128/IAI.69.3.1373-1380.2001; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Braff WA, 2012, LAB CHIP, V12, P1327, DOI 10.1039/c2lc21212a; Brown L, 2006, LAB CHIP, V6, P66, DOI 10.1039/b512179e; Bruinsma GM, 2001, J MICROBIOL METH, V45, P95, DOI 10.1016/S0167-7012(01)00238-X; Chou CF, 2002, BIOPHYS J, V83, P2170, DOI 10.1016/S0006-3495(02)73977-5; Cummings EB, 2003, ANAL CHEM, V75, P4724, DOI 10.1021/ac0340612; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; HENRY RL, 1992, PEDIATR PULM, V12, P158, DOI 10.1002/ppul.1950120306; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; LAM J, 1980, INFECT IMMUN, V28, P546; Lapizco-Encinas BH, 2004, ELECTROPHORESIS, V25, P1695, DOI 10.1002/elps.200405899; Masuda T., 2011, 2011 IEEE 11th International Conference on Nanotechnology (IEEE-NANO), P241, DOI 10.1109/NANO.2011.6144622; Mitchell J, 2007, MOL MICROBIOL, V64, P844, DOI 10.1111/j.1365-2958.2007.05703.x; Mitchell J, 2009, INFECT IMMUN, V77, P3485, DOI 10.1128/IAI.01573-08; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Persat A, 2007, CHIPS TIPS LAB CHIP, P1; Rusconi R, 2010, J R SOC INTERFACE, V7, P1293, DOI 10.1098/rsif.2010.0096; Samuelson P, 2002, J BIOTECHNOL, V96, P129, DOI 10.1016/S0168-1656(02)00043-3; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Srivastava SK, 2011, ANAL BIOANAL CHEM, V399, P301, DOI 10.1007/s00216-010-4222-6; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893, DOI 10.1128/AEM.53.8.1893-1897.1987; Willner D, 2011, P NATL ACAD SCI USA, V108, P4547, DOI 10.1073/pnas.1000089107; Zellner P, 2012, ELECTROPHORESIS, V33, P2498, DOI 10.1002/elps.201100661; Zhu K, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3435336	29	41	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76751	10.1371/journal.pone.0076751	http://dx.doi.org/10.1371/journal.pone.0076751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146923	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400087
J	Kolb, AW; Ane, C; Brandt, CR				Kolb, Aaron W.; Ane, Cecile; Brandt, Curtis R.			Using HSV-1 Genome Phylogenetics to Track Past Human Migrations	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SEQUENCE VARIABILITY; NATURAL-RESISTANCE; APOLIPOPROTEIN-E; MIXED INFECTION; NERVOUS-SYSTEM; TYPE-1; RECOMBINATION; STRAINS; GENETICS	We compared 31 complete and nearly complete globally derived HSV-1 genomic sequences using HSV-2 HG52 as an outgroup to investigate their phylogenetic relationships and look for evidence of recombination. The sequences were retrieved from NCBI and were then aligned using Clustal W. The generation of a maximum likelihood tree resulted in a six clade structure that corresponded with the timing and routes of past human migration. The East African derived viruses contained the greatest amount of genetic diversity and formed four of the six clades. The East Asian and European/North American derived viruses formed separate clades. HSV-1 strains E07, E22 and E03 were highly divergent and may each represent an individual clade. Possible recombination was analyzed by partitioning the alignment into 5 kb segments, performing individual phylogenetic analysis on each partition and generating a. phylogenetic network from the results. However most evidence for recombination spread at the base of the tree suggesting that recombination did not significantly disrupt the clade structure. Examination of previous estimates of HSV-1 mutation rates in conjunction with the phylogenetic data presented here, suggests that the substitution rate for HSV-1 is approximately 1.38x10(-7) subs/site/year. In conclusion, this study expands the previously described HSV-1 three clade phylogenetic structures to a minimum of six and shows that the clade structure also mirrors global human migrations. Given that HSV-1 has co-evolved with its host, sequencing HSV-1 isolated from various populations could serve as a surrogate biomarker to study human population structure and migration patterns.	[Kolb, Aaron W.; Brandt, Curtis R.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA; [Ane, Cecile] Univ Wisconsin, Dept Bot, Madison, WI USA; [Ane, Cecile] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Brandt, Curtis R.] Univ Wisconsin, Dept Med Microbiol & Immunol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brandt, Curtis R.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Brandt, CR (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI USA.	crbrandt@wisc.edu		Ane, Cecile/0000-0002-4702-8217	NIH [R01EY07336, R01EY018597]; Core Grant for Vision Research [P30EY016665]; Research to Prevent Blindness, Inc. (RPB); RPB, Inc.; NATIONAL EYE INSTITUTE [R01EY018597, P30EY016665, R01EY023292, R01EY007336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Grant for Vision Research; Research to Prevent Blindness, Inc. (RPB)(Research to Prevent Blindness (RPB)); RPB, Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies were supported by grants from the NIH (R01EY07336 and R01EY018597) to CRB, a Core Grant for Vision Research (P30EY016665), a Research to Prevent Blindness Senior Scientist Award to CRB from Research to Prevent Blindness, Inc. (RPB), and an unrestricted grant to the Department of Ophthalmology and Visual Sciences from RPB, Inc.	Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Bhattacharjee PS, 2008, EXP EYE RES, V87, P122, DOI 10.1016/j.exer.2008.05.007; Bowden R, 2004, INFECT GENET EVOL, V4, P115, DOI 10.1016/j.meegid.2004.01.009; Brandt CR, 2005, EXP EYE RES, V80, P607, DOI 10.1016/j.exer.2004.09.007; Brandt CR, 2004, CURR EYE RES, V29, P103, DOI 10.1080/02713680490504533; BRANDT CR, 1991, J VIROL METHODS, V35, P127, DOI 10.1016/0166-0934(91)90128-M; BRANDT CR, 1990, INVEST OPHTH VIS SCI, V31, P2214; BROWN SM, 1992, J GEN VIROL, V73, P293, DOI 10.1099/0022-1317-73-2-293; Burgos JS, 2006, J VIROL, V80, P5383, DOI 10.1128/JVI.00006-06; CAMPADELLIFIUME G, 1990, J VIROL, V64, P6070, DOI 10.1128/JVI.64.12.6070-6079.1990; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; de Filippo C, 2012, P ROY SOC B-BIOL SCI, V279, P3256, DOI 10.1098/rspb.2012.0318; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998; DOYMAZ MZ, 1992, CURR TOP MICROBIOL, V179, P121; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Han X, 2001, J VIROL, V75, P3048, DOI 10.1128/JVI.75.6.3048-3052.2001; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JAVIER RT, 1986, SCIENCE, V234, P746, DOI 10.1126/science.3022376; KASTRUKOFF LF, 1986, J GEN VIROL, V67, P613, DOI 10.1099/0022-1317-67-4-613; KINTNER RL, 1995, ARCH VIROL, V140, P231, DOI 10.1007/BF01309859; KINTNER RL, 1995, CURR EYE RES, V14, P145, DOI 10.3109/02713689508999926; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Koelle DM, 2003, CLIN MICROBIOL REV, V16, P96, DOI 10.1128/CMR.16.1.96-113.2003; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P9061, DOI 10.1167/iovs.11-7812; Kolb AW, 2011, INVEST OPHTH VIS SCI, V52, P4630, DOI 10.1167/iovs.10-7032; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liesegang TJ, 2001, CORNEA, V20, P1, DOI 10.1097/00003226-200101000-00001; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; LOPEZ C, 1975, NATURE, V258, P152, DOI 10.1038/258152a0; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; Macdonald SJ, 2012, J VIROL, V86, P6371, DOI 10.1128/JVI.00646-12; Mador N, 2002, J NEUROVIROL, V8, P97, DOI 10.1080/13550280290167920; McGeoch DJ, 2000, J VIROL, V74, P10401, DOI 10.1128/JVI.74.22.10401-10406.2000; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; NISHIYAMA Y, 1991, J VIROL, V65, P4520, DOI 10.1128/JVI.65.8.4520-4524.1991; Norberg P, 2004, J VIROL, V78, P10755, DOI 10.1128/JVI.78.19.10755-10764.2004; Norberg P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022527; Pavesi A, 2005, J GEN VIROL, V86, P1315, DOI 10.1099/vir.0.80650-0; Pavesi A, 2004, J MOL EVOL, V58, P304, DOI 10.1007/s00239-003-2552-0; Pollara G, 2004, CURR OPIN INFECT DIS, V17, P199, DOI 10.1097/00001432-200406000-00005; SAKAOKA H, 1994, J GEN VIROL, V75, P513, DOI 10.1099/0022-1317-75-3-513; SEDARATI F, 1988, J VIROL, V62, P3037, DOI 10.1128/JVI.62.8.3037-3039.1988; Shackelton LA, 2006, J VIROL, V80, P9928, DOI 10.1128/JVI.00441-06; Sorensen LN, 2008, J IMMUNOL, V181, P8604, DOI 10.4049/jimmunol.181.12.8604; Streilein JW, 1997, IMMUNOL TODAY, V18, P443, DOI 10.1016/S0167-5699(97)01114-6; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; STULTING RD, 1985, INVEST OPHTH VIS SCI, V26, P1360; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Thomas J, 1997, IMMUNOL RES, V16, P375, DOI 10.1007/BF02786400; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; UMENE K, 1985, J GEN VIROL, V66, P2659, DOI 10.1099/0022-1317-66-12-2659; Whitley RJ, 1996, FIELDS VIROLOGY, P2297; YIRRELL DL, 1992, ARCH VIROL, V125, P227, DOI 10.1007/BF01309640; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	64	58	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76267	10.1371/journal.pone.0076267	http://dx.doi.org/10.1371/journal.pone.0076267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146849	Green Published, gold			2022-12-27	WOS:000326019400049
J	Lozano, M; Subira, ME; Aparicio, J; Lorenzo, C; Gomez-Merino, G				Lozano, Marina; Eulalia Subira, Maria; Aparicio, Jose; Lorenzo, Carlos; Gomez-Merino, Gala			Toothpicking and Periodontal Disease in a Neanderthal Specimen from Cova Forada Site (Valencia, Spain)	PLOS ONE			English	Article							DENTAL-CARIES; TASK ACTIVITY; TEETH; WEAR; GROOVES; POPULATIONS; DENTITIONS; ATAPUERCA; INDIANS; SAMPLE	We present a Neanderthal maxilla (CF-1) from Cova Forada site (Oliva, Valencia, Spain) with periodontal disease and evidence of attempts to alleviate pain with the use of a toothpick. Two interproximal grooves have been found on the distal surfaces of the upper left Pm-3 and M-1 of CF-1 maxilla. The location, morphology and size of the grooves coincide with other interproximal grooves found on the teeth of other fossil specimens. Heavy dental wear and periodontal disease would have caused the Cova Forada Neanderthal specimen pain and discomfort, which the individual attempted to mitigate using some kind of dental probe.	[Lozano, Marina; Lorenzo, Carlos; Gomez-Merino, Gala] Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain; [Lozano, Marina; Lorenzo, Carlos; Gomez-Merino, Gala] Univ Rovira & Virgili URV Tarragona, Area Prehist, Tarragona, Spain; [Eulalia Subira, Maria] Univ Autonoma Barcelona, Fac Biociencies, Unitat Antropol Biol GRAPAC, E-08193 Barcelona, Spain; [Eulalia Subira, Maria] MINOA Arqueol & Serv SL I D, Bellaterra, Spain; [Aparicio, Jose] Diputac Prov Valencia, Seccio Estudis Arqueol Valencians, Valencia, Spain	ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; Autonomous University of Barcelona	Lozano, M (corresponding author), Inst Catala Paleoecol Humana & Evolucio Social, IPHES, Tarragona, Spain.	mlozano@iphes.cat	Lozano, Marina/G-7293-2015; Lorenzo, Carlos/E-4290-2015; Gomez-Merino, Gala/AAB-3189-2019	Lozano, Marina/0000-0002-6304-7848; Lorenzo, Carlos/0000-0001-5706-293X; Gomez Merino, Gala/0000-0002-3906-3856	Direccion General de Investigacion of M.E.C. [CGL2012-38434-C03-01, CGL2012-38434-C03-03]; Generalitat of Catalunya [AGAUR 2009 SGR-324, SGR-566]	Direccion General de Investigacion of M.E.C.(German Research Foundation (DFG)); Generalitat of Catalunya(Generalitat de Catalunya)	This work is funded by the Direccion General de Investigacion of M.E.C., projects number CGL2012-38434-C03-01 and CGL2012-38434-C03-03. This research has been supported by AGAUR 2009 SGR-324 and SGR-566 projects of the Generalitat of Catalunya. Field work at the Cova Forada site is supported by Diputacion de Valencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger WA, 2004, CURR ANTHROPOL, V45, P403, DOI 10.1086/420905; BERRYMAN HE, 1979, AM J PHYS ANTHROPOL, V50, P209, DOI 10.1002/ajpa.1330500209; Bonfiglioli B, 2004, INT J OSTEOARCHAEOL, V14, P448, DOI 10.1002/oa.726; Brothwell D.R., 1981, DIGGING BONES EXCAVA; BROWN T, 1990, AM J PHYS ANTHROPOL, V81, P545, DOI 10.1002/ajpa.1330810410; Campillo D, 2002, CYPSELA, V14, P143; Chimenos E., 2002, ANTROPOLOGIA PALEONT, P293; de Castro J M, 1986, Paleopathol Newsl, P5; de Lumley M.A., 1973, ANTENEANDERTALIENS N; DECASTRO JMB, 1983, ANTHROPOLOGIE, V87, P521; DeCastro JMB, 1997, AM J PHYS ANTHROPOL, V102, P369, DOI 10.1002/(SICI)1096-8644(199703)102:3<369::AID-AJPA6>3.0.CO;2-Q; DeWitte SN, 2010, AM J PHYS ANTHROPOL, V142, P341, DOI 10.1002/ajpa.21228; Eckhardt R.B., 1988, CURR ANTHR, V29, P668; Finlayson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045927; FORMICOLA V, 1991, AM J PHYS ANTHROPOL, V86, P85, DOI 10.1002/ajpa.1330860108; FORMICOLA V, 1988, CURR ANTHROPOL, V29, P663, DOI 10.1086/203686; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; Frayer DW, 2010, J ANTHROPOL SCI, V88, P113; FRAYER DW, 1987, AM J PHYS ANTHROPOL, V74, P393, DOI 10.1002/ajpa.1330740311; Hardy K, 2012, NATURWISSENSCHAFTEN, V99, P617, DOI 10.1007/s00114-012-0942-0; Hillson S, 2001, INT J OSTEOARCHAEOL, V11, P249; Hlusko LJ, 2003, CURR ANTHROPOL, V44, P738, DOI 10.1086/379263; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Langley MC, 2008, CAMB ARCHAEOL J, V18, P289, DOI 10.1017/S0959774308000371; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; Molnar P, 2008, AM J PHYS ANTHROPOL, V136, P423, DOI 10.1002/ajpa.20824; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Perez P J, 1982, Paleopathol Newsl, V39, P11; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; ROSE JJ, 1983, AM J PHYS ANTHROPOL, V62, P255, DOI 10.1002/ajpa.1330620305; SCHULZ PD, 1977, AM J PHYS ANTHROPOL, V46, P87, DOI 10.1002/ajpa.1330460112; Siffre A, 1923, REV ANTHR, V33, P291; Skinner M, 1997, J ARCHAEOL SCI, V24, P677, DOI 10.1006/jasc.1996.0151; SMITH BH, 1984, AM J PHYS ANTHROPOL, V63, P39, DOI 10.1002/ajpa.1330630107; Subira ME, NEANDERTHAL RE UNPUB; UBELAKER DH, 1969, AM J PHYS ANTHROPOL, V30, P145, DOI 10.1002/ajpa.1330300118; Ungar PS, 2001, ARCH ORAL BIOL, V46, P285, DOI 10.1016/S0003-9969(00)00128-X; Urbanowski M, 2010, NATURWISSENSCHAFTEN, V97, P411, DOI 10.1007/s00114-010-0646-2; Zero DT, 2009, J AM DENT ASSOC, V140, p25S, DOI 10.14219/jada.archive.2009.0355	39	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76852	10.1371/journal.pone.0076852	http://dx.doi.org/10.1371/journal.pone.0076852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146934	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400089
J	Oulton, LJ; Haviland, V; Brown, C				Oulton, Lois Jane; Haviland, Vivian; Brown, Culum			Predator Recognition in Rainbowfish, Melanotaenia duboulayi, Embryos	PLOS ONE			English	Article							ANTIPREDATOR RESPONSES; SALAMANDER EGGS; AVOIDANCE; EXPOSURE; SALMON; NAIVE; CUES	Exposure to olfactory cues during embryonic development can have long term impacts on birds and amphibians behaviour. Despite the vast literature on predator recognition and responses in fishes, few researchers have determined how fish embryos respond to predator cues. Here we exposed four-day-old rainbowfish (Melanotaenia duboulayi) embryos to cues emanating from a novel predator, a native predator and injured conspecifics. Their response was assessed by monitoring heart rate and hatch time. Results showed that embryos have an innate capacity to differentiate between cues as illustrated by faster heart rates relative to controls. The greatest increase in heart rate occurred in response to native predator odour. While we found no significant change in the time taken for eggs to hatch, all treatments experienced slight delays as expected if embryos are attempting to reduce exposure to larval predators.	[Oulton, Lois Jane; Haviland, Vivian; Brown, Culum] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Brown, C (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	Culum.Brown@mq.edu.au	Brown, Culum/S-9826-2017	Brown, Culum/0000-0002-0210-1820	Environmental Trust Grant from The New South Wales Department of Environment and Heritage	Environmental Trust Grant from The New South Wales Department of Environment and Heritage	This project was funded by an Environmental Trust Grant from The New South Wales Department of Environment and Heritage www.environment.nsw.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto RE, 2003, BEHAV PROCESS, V60, P235, DOI 10.1016/S0376-6357(02)00127-4; BARRY MJ, 1995, AQUAT TOXICOL, V32, P115, DOI 10.1016/0166-445X(94)00084-4; Brown C, 1997, BEHAV ECOL SOCIOBIOL, V41, P61, DOI 10.1007/s002650050364; Brown C, 1999, ETHOLOGY, V105, P491, DOI 10.1046/j.1439-0310.1999.00442.x; Brown C, 2011, FISH COGNITION BEHAV, Vsecond, P240, DOI DOI 10.1002/9781444342536.CH11; Brown GE, 1997, BEHAVIOUR, V134, P1123, DOI 10.1163/156853997X00098; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Brown GE, 2009, BEHAV ECOL SOCIOBIOL, V63, P699, DOI 10.1007/s00265-008-0703-4; Chivers DP, 2001, CAN J ZOOL, V79, P867, DOI 10.1139/cjz-79-5-867; Dittman AH, 1996, J EXP BIOL, V199, P83; Dupuch A, 2004, CAN J ZOOL, V82, P407, DOI 10.1139/Z04-003; Eriksen MS, 2006, J FISH BIOL, V69, P114, DOI 10.1111/j.1095-8649.2006.01071.x; Gibson AK, 2006, J FISH BIOL, V69, P224, DOI 10.1111/j.1095-8649.2006.01102.x; GROOT EP, 1985, CAN J ZOOL, V63, P552, DOI 10.1139/z85-082; Hawkins LA, 2004, BEHAVIOUR, V141, P1249, DOI 10.1163/1568539042729694; Kelley Jennifer L., 2011, P174; Kydd E, 2009, J FISH BIOL, V74, P2187, DOI 10.1111/j.1095-8649.2009.02240.x; Marking LL, 1973, INVESTIGATIVE FISH C; Mathis A, 2008, P ROY SOC B-BIOL SCI, V275, P2603, DOI 10.1098/rspb.2008.0754; Moore RD, 1996, OIKOS, V77, P331, DOI 10.2307/3546073; Scheurer JA, 2007, J FISH BIOL, V70, P1057, DOI 10.1111/j.1095-8649.2007.01367.x; SIH A, 1993, AM NAT, V142, P947, DOI 10.1086/285583; Sneddon H, 1998, PHYSIOL BEHAV, V64, P133, DOI 10.1016/S0031-9384(98)00037-7; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8	24	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76061	10.1371/journal.pone.0076061	http://dx.doi.org/10.1371/journal.pone.0076061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146817	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400034
J	Schibille, N; Freestone, IC				Schibille, Nadine; Freestone, Ian C.			Composition, Production and Procurement of Glass at San Vincenzo al Volturno: An Early Medieval Monastic Complex in Southern Italy	PLOS ONE			English	Article							COLORLESS GLASS; CRYPTA BALBI; ROMAN; TECHNOLOGY; PROVENANCE; FRAGMENTS; ORIGINS; NATRON; WINDOW	136 glasses from the ninth-century monastery of San Vincenzo and its workshops have been analysed by electron microprobe in order to situate the assemblage within the first millennium CE glass making tradition. The majority of the glass compositions can be paralleled by Roman glass from the first to third centuries, with very few samples consistent with later compositional groups. Colours for trailed decoration on vessels, for vessel bodies and for sheet glass for windows were largely produced by melting the glass tesserae from old Roman mosaics. Some weakly-coloured transparent glass was obtained by re-melting Roman window glass, while some was produced by melting and mixing of tesserae, excluding the strongly coloured cobalt blues. Our data suggest that to feed the needs of the glass workshop, the bulk of the glass was removed as tesserae and windows from a large Roman building. This is consistent with a historical account according to which the granite columns of the monastic church were spolia from a Roman temple in the region. The purported shortage of natron from Egypt does not appear to explain the dependency of San Vincenzo on old Roman glass. Rather, the absence of contemporary primary glass may reflect the downturn in long-distance trade in the later first millennium C. E., and the role of patronage in the "ritual economy" founded upon donations and gift-giving of the time.	[Schibille, Nadine] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Freestone, Ian C.] UCL, Inst Archaeol, London, England	University of Oxford; University of London; University College London	Schibille, N (corresponding author), Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England.	nadine.schibille@uclmail.net		Schibille, Nadine/0000-0001-9242-0392; Freestone, Ian/0000-0002-8223-4649	Marie Curie Intra-European Fellowship for Career Development (FP7-PEOPLE-IEF) [236809]	Marie Curie Intra-European Fellowship for Career Development (FP7-PEOPLE-IEF)	This work was supported by a Marie Curie Intra-European Fellowship for Career Development (FP7-PEOPLE-IEF-2008; Grant Agreement No. 236809 to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, COMPOSITION PRODUCTI; Barber D.J., 2009, MINE MICROSCOPE ADV, P115; Bimson M, 2001, SAN VINCENZO VOLTURN, P285; Brill R.H., 1999, CHEM ANAL EARLY GLAS, V2; DeLaine J, 1997, BATHS CARACALLA STUD; Dell'Acqua F, 2001, STUDI RICERCHE ARCHE, P173; Fischer A, 1999, J ARCHAEOL SCI, V26, P893, DOI 10.1006/jasc.1999.0398; Foy D., 2003, CHANGES COMMERCE VER, P41; Foy Daniele, 2001, TOUT FEU TOUT SABLE, P100; Fredrickx P, 2004, X-RAY SPECTROM, V33, P326, DOI 10.1002/xrs.734; Freestone I., 2003, P ANN 16E C S ASS IN, P153; Freestone I., 2013, GLASS ROMAN EMPIRE; Freestone I.C., 2000, MOM D, P65; Freestone IC, 2006, GEOL SOC SPEC PUBL, V257, P201, DOI 10.1144/GSL.SP.2006.257.01.16; Freestone Ian C., 1992, MAT ISSUES ART ARCHA, V267, P739; Freestone IC, 2005, MATER RES SOC SYMP P, V852, P195; Freestone IC, 2002, ARCHAEOMETRY, V44, P257, DOI 10.1111/1475-4754.t01-1-00058; Freestone IC, ROMAN LIFE MARGINS E; GRATUZE B, 1990, ARCHAEOMETRY, V32, P155, DOI 10.1111/j.1475-4754.1990.tb00462.x; Henderson J, 2004, ARCHAEOMETRY, V46, P439, DOI 10.1111/j.1475-4754.2004.00167.x; Henderson J, 2002, ACCOUNTS CHEM RES, V35, P594, DOI 10.1021/ar0002020; HENDERSON J, 1991, MATER RES SOC SYMP P, V185, P601; Hodges R, 2011, SAN VINCENZO MAGGIOR, P157; Hodges R., 2011, SAN VINCENZO MAGGIOR; Hodges R, 2011, SAN VINCENZO MAGGIOR, P129; Hodges R, 2011, SAN VICENZO MAGGIORE, P433; Hodges R., 2012, DARK AGE EC NEW AUDI; Hodges R, 1991, ARCHAEOLOGIA STORIA, P67; Hodges Richard, 1997, LIGHT DARK AGES RISE; Hunter J.R., 1998, HAMWIC GLASS; Jackson CM, 2005, ARCHAEOMETRY, V47, P763, DOI 10.1111/j.1475-4754.2005.00231.x; Kunicki-Goldfinger JJ, J ARCHAEOLO IN PRESS; Lemke C, 1998, CERAM CIVIL, P269; Lilyquist C., 1993, STUDIES EARLY EGYPTI; Mass JL, 1998, CERAM CIVIL, P121; Mass JL, 1997, MATER RES SOC SYMP P, V462, P193; McCormick M., 2012, TRADE MARKETS BYZANT, P51; Mirti P, 2000, ARCHAEOMETRY, V42, P359, DOI 10.1111/j.1475-4754.2000.tb00887.x; Mirti P, 2001, ARCHAEOMETRY, V43, P491, DOI 10.1111/1475-4754.00032; Mitchell J, 2001, SAN VINCENZO VOLTURN, P279; Nenna M.-D., 2009, ANN 16 C ASS INT HIS, V17, P8; Paynter S, 2008, J GLASS STUD, V50, P271; Sanke M, 2002, Z ARCHAOLOGIE MITTEL, V30, P37; Sayre E.V., 1963, ADV GLASS TECHNOLOGY, P263; Sayre E.V., 1967, ARCHAEOLOGICAL CHEM, P279; Schibille N, 2008, ARCHAEOMETRY, V50, P627, DOI 10.1111/j.1475-4754.2007.00346.x; Schibille N, 2011, LATE BYZANTINE MINER; Schibille N, 2012, J ARCHAEOL SCI, V39, P1480, DOI 10.1016/j.jas.2012.01.020; Shortland A, 2006, J ARCHAEOL SCI, V33, P521, DOI 10.1016/j.jas.2005.09.011; Silvestri A, 2008, J ARCHAEOL SCI, V35, P1489, DOI 10.1016/j.jas.2007.10.014; Silvestri A, 2008, J ARCHAEOL SCI, V35, P331, DOI 10.1016/j.jas.2007.03.010; Silvestri A, 2005, ARCHAEOMETRY, V47, P797, DOI 10.1111/j.1475-4754.2005.00233.x; Silvestri A, 2011, J ARCHAEOL SCI, V38, P2509, DOI 10.1016/j.jas.2011.03.014; Stevenson J., 2001, SAN VINCENZO VOLTURN, VI, P203; Stevenson J, 1997, MAT CULTURE MEDIEVAL, P125; Tal O, 2008, J GLASS STUD, V50, P81; Theophilus C.R, 1961, DIVERSIS ARTIBUS; Tite M, 2008, ARCHAEOMETRY, V50, P67, DOI 10.1111/j.1475-4754.2007.00339.x; Wedepohl K H., 2003, GLAS ANTIKE MITTELAT; Wedepohl K.H., 1997, AUSGRABUNGEN FUNDE W, V9, P41; Whitehouse D, 2002, J GLASS STUD, V44, P193; Whitehouse D, 2003, EARLY MEDIEV EUR, V12, P301, DOI DOI 10.1111/J.0963-9462.2004; Wickham C., 1995, ARCHAEOLOGICAL MONOG, VII, P138; Willmott Hugh, GLASTONBURY ABBEY EX; Wypyski M. T., 2005, DUMBART OAKS PAP, P183, DOI DOI 10.2307/4128756; Wypyski MT, 2005, ARTS ANTIOCHART HIST, P115	66	41	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76479	10.1371/journal.pone.0076479	http://dx.doi.org/10.1371/journal.pone.0076479			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	239JR	24146876	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000326019400064
J	Tribelli, PM; Hay, AG; Lopez, NI				Tribelli, Paula M.; Hay, Anthony G.; Lopez, Nancy I.			The Global Anaerobic Regulator Anr, Is Involved in Cell Attachment and Aggregation Influencing the First Stages of Biofilm Development in Pseudomonas extremaustralis	PLOS ONE			English	Article							TWITCHING MOTILITY; GENE-EXPRESSION; AERUGINOSA; STRESS; POLY(3-HYDROXYBUTYRATE); RESPIRATION; INFECTIONS; SECRETION; FLAGELLAR; SYSTEM	Pseudomonas extremaustralis is a versatile Antarctic bacterium, able to grow under microaerobic and anaerobic conditions and is related to several non-pathogenic Pseudomonads. Here we report on the role of the global anaerobic regulator Anr, in the early steps of P. extremaustralis biofilm development. We found that the anr mutant was reduced in its ability to attach, to form aggregates and to display twitching motility but presented higher swimming motility than the wild type. In addition, microscopy revealed that the wild type biofilm contained more biomass and was thicker, but were less rough than that of the anr mutant. In silico analysis of the P. extremaustralis genome for Anr-like binding sites led to the identification of two biofilm-related genes as potential targets of this regulator. When measured using Quantitative Real Time PCR, we found that the anr mutant expressed lower levels of pilG, which encodes a component of Type IV pili and has been previously implicated in cellular adhesion. Levels of morA, involved in signal transduction and flagella development, were also lower in the mutant. Our data suggest that under low oxygen conditions, such as those encountered in biofilms, Anr differentially regulates aggregation and motility thus affecting the first stages of biofilm formation.	[Tribelli, Paula M.; Lopez, Nancy I.] Consejo Nacl Invest Cient & Tecn, IQUIBICEN, RA-1033 Buenos Aires, DF, Argentina; [Tribelli, Paula M.; Lopez, Nancy I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dpto Quim Biol, Buenos Aires, DF, Argentina; [Hay, Anthony G.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Cornell University	Lopez, NI (corresponding author), Consejo Nacl Invest Cient & Tecn, IQUIBICEN, RA-1033 Buenos Aires, DF, Argentina.	nan@qb.fcen.uba.ar		Lopez, Nancy/0000-0002-2966-3014; Tribelli, Paula Maria/0000-0001-9558-6275; Hay, Anthony/0000-0002-9427-148X	University of Buenos Aires-UBACyT [20020100100854]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)-PIP [0338]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT 0639]; CONICET; International Union of Biochemistry and Molecular Biology	University of Buenos Aires-UBACyT(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)-PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); International Union of Biochemistry and Molecular Biology	This work was supported by grants from University of Buenos Aires-UBACyT 2011-2014 Proyecto No 20020100100854, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)-PIP (2011) 0338, and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)-Programacion 2007, PICT 0639. N.I.L. is a career investigator from CONICET. P.M.T. received a post-graduate student fellowship from CONICET and a Wood-Wheland fellowship for short term research stays from the International Union of Biochemistry and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub ND, 2004, CURR MICROBIOL, V49, P170, DOI 10.1007/s00284-004-4254-2; Bertrand JJ, 2010, J BACTERIOL, V192, P994, DOI 10.1128/JB.01390-09; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cheng HP, 1998, J BACTERIOL, V180, P5183, DOI 10.1128/JB.180.19.5183-5191.1998; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; DARZINS A, 1993, J BACTERIOL, V175, P5934, DOI 10.1128/JB.175.18.5934-5944.1993; Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4; Folsom JP, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-294; GALIMAND M, 1991, J BACTERIOL, V173, P1598, DOI 10.1128/jb.173.5.1598-1606.1991; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Hong SH, 2010, MICROB BIOTECHNOL, V3, P344, DOI 10.1111/j.1751-7915.2010.00164.x; HUISMAN GW, 1991, J BIOL CHEM, V266, P2191; Jackson AA, 2013, J BACTERIOL, V195, P3093, DOI 10.1128/JB.02169-12; Junker LM, 2006, MICROBIOL-SGM, V152, P2233, DOI 10.1099/mic.0.28767-0; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Klebensberger J, 2009, ENVIRON MICROBIOL, V11, P3073, DOI 10.1111/j.1462-2920.2009.02012.x; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Newell PD, 2011, J BACTERIOL, V193, P4685, DOI 10.1128/JB.05483-11; O'Callaghan J, 2012, MICROBIOL-SGM, V158, P1057, DOI 10.1099/mic.0.056127-0; O'Callaghan J, 2011, MICROBIOL-SGM, V157, P3417, DOI 10.1099/mic.0.052050-0; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Romeo T, 2006, J BACTERIOL, V188, P7325, DOI 10.1128/JB.01317-06; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Shrout JD, 2011, MRS BULL, V36, P367, DOI 10.1557/mrs.2011.67; Sonnleitner E, 2011, MOL MICROBIOL, V80, P868, DOI 10.1111/j.1365-2958.2011.07620.x; Stanley NR, 2003, J BACTERIOL, V185, P1951, DOI 10.1128/JB.185.6.1951-1957.2003; Thompson LS, 2003, FEMS MICROBIOL LETT, V220, P187, DOI 10.1016/S0378-1097(03)00097-1; Tremblay J, 2008, J BASIC MICROB, V48, P509, DOI 10.1002/jobm.200800030; Tribelli PM, 2013, MICROBIOL-SGM, V159, P259, DOI 10.1099/mic.0.061085-0; Tribelli PM, 2012, BIODEGRADATION, V23, P645, DOI 10.1007/s10532-012-9540-2; Tribelli PM, 2012, J BACTERIOL, V194, P2381, DOI 10.1128/JB.00172-12; Tribelli PM, 2011, EXTREMOPHILES, V15, P541, DOI 10.1007/s00792-011-0384-1; Tribelli PM, 2010, J MOL MICROB BIOTECH, V19, P180, DOI 10.1159/000320261; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Ugidos A, 2008, ENVIRON MICROBIOL, V10, P1690, DOI 10.1111/j.1462-2920.2008.01586.x; Vallet-Gely I, 2007, J BACTERIOL, V189, P8667, DOI 10.1128/JB.01344-07; Waite RD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-162; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	49	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76685	10.1371/journal.pone.0076685	http://dx.doi.org/10.1371/journal.pone.0076685			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146909	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400081
J	Ulvskov, P; Paiva, DS; Domozych, D; Harholt, J				Ulvskov, Peter; Paiva, Dionisio Soares; Domozych, David; Harholt, Jesper			Classification, Naming and Evolutionary History of Glycosyltransferases from Sequenced Green and Red Algal Genomes	PLOS ONE			English	Article							SYNTHASE CESA GENES; CELL-WALL SYNTHESIS; HYDROXYPROLINE-ARABINOSIDES; CYANIDIOSCHYZON-MEROLAE; CARBOHYDRATE-METABOLISM; BIOINFORMATICS APPROACH; FLAGELLAR REGENERATION; GALDIERIA-SULPHURARIA; CELLULOSE SYNTHESIS; ANCHORED PROTEINS	The Archaeplastida consists of three lineages, Rhodophyta, Virideplantae and Glaucophyta. The extracellular matrix of most members of the Rhodophyta and Viridiplantae consists of carbohydrate-based or a highly glycosylated protein-based cell wall while the Glaucophyte covering is poorly resolved. In order to elucidate possible evolutionary links between the three advanced lineages in Archaeplastida, a genomic analysis was initiated. Fully sequenced genomes from the Rhodophyta and Virideplantae and the well-defined CAZy database on glycosyltransferases were included in the analysis. The number of glycosyltransferases found in the Rhodophyta and Chlorophyta are generally much lower then in land plants (Embryophyta). Three specific features exhibited by land plants increase the number of glycosyltransferases in their genomes: (1) cell wall biosynthesis, the more complex land plant cell walls require a larger number of glycosyltransferases for biosynthesis, (2) a richer set of protein glycosylation, and (3) glycosylation of secondary metabolites, demonstrated by a large proportion of family GT1 being involved in secondary metabolite biosynthesis. In a comparative analysis of polysaccharide biosynthesis amongst the taxa of this study, clear distinctions or similarities were observed in (1) N-linked protein glycosylation, i.e., Chlorophyta has different mannosylation and glucosylation patterns, (2) GPI anchor biosynthesis, which is apparently missing in the Rhodophyta and truncated in the Chlorophyta, (3) cell wall biosynthesis, where the land plants have unique cell wall related polymers not found in green and red algae, and (4) O-linked glycosylation where comprehensive orthology was observed in glycosylation between the Chlorophyta and land plants but not between the target proteins.	[Ulvskov, Peter; Paiva, Dionisio Soares; Harholt, Jesper] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Domozych, David] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Domozych, David] Skidmore Coll, Skidmore Microscopy Imaging Ctr, Saratoga Springs, NY 12866 USA	University of Copenhagen; Skidmore College; Skidmore College	Harholt, J (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark.	jesh@life.ku.dk	Harholt, Jesper/F-6865-2014; Ulvskov, Peter/I-1228-2014	Harholt, Jesper/0000-0002-7984-0066; Ulvskov, Peter/0000-0003-3776-818X	Villum-Kann Rasmussen grant; Danish Research Council [FTP-09-066624]; Villum Foundation; National Science Foundation (USA) [0919925]; Villum Fonden [00007173] Funding Source: researchfish	Villum-Kann Rasmussen grant; Danish Research Council(Det Frie Forskningsrad (DFF)); Villum Foundation(Villum Fonden); National Science Foundation (USA)(National Science Foundation (NSF)); Villum Fonden(Villum Fonden)	This work was supported by a Villum-Kann Rasmussen grant to the Pro-Active Plant Centre (www.proactiveplants.life.ku.dk), by the Danish Research Council (FTP-09-066624 to PU) and by the Villum Foundation's Young Investigator Programme to JH; National Science Foundation (USA) Molecular and Cell Biology Program grant 0919925 to DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Bai M. S., 2000, Journal of Phycology, V36, P3; BAILEY RW, 1968, J GEN MICROBIOL, V54, P269, DOI 10.1099/00221287-54-2-269; Bakker H, 2001, FEBS LETT, V507, P307, DOI 10.1016/S0014-5793(01)02999-4; BALSHUSEMANN D, 1990, EUR J BIOCHEM, V192, P231, DOI 10.1111/j.1432-1033.1990.tb19220.x; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Barbier G, 2005, PLANT PHYSIOL, V137, P460, DOI 10.1104/pp.104.051169; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Bollig K, 2007, CARBOHYD RES, V342, P2557, DOI 10.1016/j.carres.2007.08.008; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Campargue C, 1998, ANAL BIOCHEM, V257, P20, DOI 10.1006/abio.1997.2526; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chatterjee M, 2005, PLANT SCI, V168, P501, DOI 10.1016/j.plantsci.2004.09.015; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Delwiche CF, 2011, CURR BIOL, V21, pR417, DOI 10.1016/j.cub.2011.04.021; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Doblin MS, 2001, PLANT PHYSIOL, V125, P2040, DOI 10.1104/pp.125.4.2040; Domozych DS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00082; Domozych DS, 2009, ANN BOT-LONDON, V104, P1045, DOI 10.1093/aob/mcp193; Domozych DS, 2009, J EUKARYOT MICROBIOL, V56, P314, DOI 10.1111/j.1550-7408.2009.00392.x; Egelund J, 2004, PLANT PHYSIOL, V136, P2609, DOI 10.1104/pp.104.042978; Egelund J, 2010, ANN PLANT REV, P213; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; Estevez JM, 2009, GLYCOBIOLOGY, V19, P212, DOI 10.1093/glycob/cwn101; Fernandez PV, 2010, J PHYCOL, V46, P456, DOI 10.1111/j.1529-8817.2010.00821.x; Ferris PJ, 2001, BIOCHEMISTRY-US, V40, P2978, DOI 10.1021/bi0023605; FRY SC, 1982, BIOCHEM J, V204, P449, DOI 10.1042/bj2040449; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Gillmor CS, 2005, PLANT CELL, V17, P1128, DOI 10.1105/tpc.105.031815; Godel S, 2000, PROTIST, V151, P147, DOI 10.1078/1434-4610-00015; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Hansen SF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00059; Hansen SF, 2009, J PROTEOME RES, V8, P743, DOI 10.1021/pr800808m; Harholt J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035846; HELMCHEN TA, 1995, J MOL EVOL, V41, P203; Hicks GR, 2001, PLANT PHYSIOL, V127, P1334; HILLER RG, 1968, PLANTA, V78, P49; Hong ZL, 2001, PLANT CELL, V13, P769, DOI 10.1105/tpc.13.4.769; Izumi Y, 2003, PLANT CELL PHYSIOL, V44, P183, DOI 10.1093/pcp/pcg028; Keeling PJ, 2010, PHILOS T R SOC B, V365, P729, DOI 10.1098/rstb.2009.0103; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinoshita T, 2008, J BIOCHEM, V144, P287, DOI 10.1093/jb/mvn090; KLEIN U, 1987, PLANT PHYSIOL, V85, P892, DOI 10.1104/pp.85.4.892; Konishi T, 2007, GLYCOBIOLOGY, V17, P345, DOI 10.1093/glycob/cwl081; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1659, DOI 10.1093/pcp/pcm155; Lee PL, 2009, GLYCOBIOLOGY, V19, P655, DOI 10.1093/glycob/cwp035; Leliaert F, 2011, BIOESSAYS, V33, P683, DOI 10.1002/bies.201100035; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lunn JE, 2002, PLANT PHYSIOL, V128, P1490, DOI 10.1104/pp.010898; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Mackie W., 1974, ALGAL PHYSL BIOCH, V10, P40; Manfield IW, 2004, PLANT J, V40, P260, DOI 10.1111/j.1365-313X.2004.02208.x; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; MCCONVILLE MJ, 1993, J BIOL CHEM, V268, P15595; MCFADDEN GI, 1985, PROTOPLASMA, V128, P31, DOI 10.1007/BF01273232; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MILLER DH, 1972, PLANT PHYSIOL, V49, P3; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; MULLER T, 1984, EUR J BIOCHEM, V138, P153, DOI 10.1111/j.1432-1033.1984.tb07894.x; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Nosjean O, 1997, BBA-REV BIOMEMBRANES, V1331, P153, DOI 10.1016/S0304-4157(97)00005-1; Oesterhelt C, 2008, PLANTA, V227, P353, DOI 10.1007/s00425-007-0622-z; Oikawa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015481; Olszewski NE, 2010, BBA-GEN SUBJECTS, V1800, P49, DOI 10.1016/j.bbagen.2009.11.016; Orfila C, 2005, PLANTA, V222, P613, DOI 10.1007/s00425-005-0008-z; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Ostergaard L, 2002, PLANT MOL BIOL, V49, P559, DOI 10.1023/A:1015558231400; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Palmer JD, 2004, AM J BOT, V91, P1437, DOI 10.3732/ajb.91.10.1437; Panikulangara TJ, 2004, PLANT PHYSIOL, V136, P3148, DOI 10.1104/pp.104.042606; Pattison RJ, 2009, TRENDS PLANT SCI, V14, P92, DOI 10.1016/j.tplants.2008.11.008; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; Raven J. A., 1990, BIOL RED ALGAE, P171; REIZE IB, 1987, HELGOLANDER MEERESUN, V41, P149, DOI 10.1007/BF02364697; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roberts AW, 2004, ABSTR PAP AM CHEM S, V227, pU289; Roberts AW, 2002, EUKARYOT CELL, V1, P847, DOI 10.1128/EC.1.6.847-855.2002; Roberts E, 2009, J PHYCOL, V45, P203, DOI 10.1111/j.1529-8817.2008.00626.x; Rosenberg JN, 2008, CURR OPIN BIOTECH, V19, P430, DOI 10.1016/j.copbio.2008.07.008; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schnabelrauch LS, 1996, PLANT J, V9, P477, DOI 10.1046/j.1365-313X.1996.09040477.x; Schoberer J, 2011, MOL PLANT, V4, P220, DOI 10.1093/mp/ssq082; Seidler DG, 2006, J MOL MED, V84, P583, DOI 10.1007/s00109-006-0046-4; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; Sorensen I, 2010, PLANT PHYSIOL, V153, P366, DOI 10.1104/pp.110.154427; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Takano H, 2010, BBA-GEN SUBJECTS, V1800, P144, DOI 10.1016/j.bbagen.2009.07.020; Tounou Eiichirou, 2002, Cytologia (Tokyo), V67, P429, DOI 10.1508/cytologia.67.429; Tsekos I, 1999, J PHYCOL, V35, P635, DOI 10.1046/j.1529-8817.1999.3540635.x; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Verma DPS, 2001, PLANT MOL BIOL, V47, P693, DOI 10.1023/A:1013679111111; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wilson IBH, 2001, BBA-GEN SUBJECTS, V1527, P88, DOI 10.1016/S0304-4165(01)00151-9; Wodniok S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-104; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Yoon HS, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-78; Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x	121	25	25	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76511	10.1371/journal.pone.0076511	http://dx.doi.org/10.1371/journal.pone.0076511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146880	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400066
J	Felici, R; Lapucci, A; Ramazzotti, M; Chiarugi, A				Felici, Roberta; Lapucci, Andrea; Ramazzotti, Matteo; Chiarugi, Alberto			Insight into Molecular and Functional Properties of NMNAT3 Reveals New Hints of NAD Homeostasis within Human Mitochondria	PLOS ONE			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; OPEN READING FRAMES; POLY(ADP-RIBOSE) POLYMERASE-1; SUBCELLULAR COMPARTMENTATION; ADENINE-DINUCLEOTIDES; NONCODING RNAS; DNA-REPAIR; METABOLISM; CELLS; DISEASE	Among the enzymes involved in NAD homeostasis, nicotinamide mononucleotide adenylyltransferases (NMNAT1-3) are central to intracellular NAD formation. Although NMNAT3 is postulated to be a mitochondrial enzyme contributing to NAD-dependent organelle functioning, information on endogenous proteins is lacking. We report that in human cells a single gene nmnat3 localized on chromosome 3 codes for two mRNA splice variants NMNATv1 and FKSG76, whereas the previously reported NMNAT3v2 transcript is not present. However, NMNAT3v1 and FKSG76 proteins are not detectable, consistent with the finding that an upstream ORF in their mRNAs negatively regulates translation. NMNAT3v1 transfection demonstrates that the protein is cytosolic and inactive, whereas FKSG76 is mitochondrial but operates NAD cleavage rather than synthesis. In keeping with the lack of NMNAT3, we show that extracellular NAD, but not its metabolic precursors, sustains mitochondrial NAD pool in an ATP-independent manner. Data of the present study modify the scenario of the origin of mitochondrial NAD by showing that, in human cells, NMNAT3 is absent in mitochondria, and, akin to plants and yeast, cytosolic NAD maintains the mitochondrial NAD pool.	[Felici, Roberta; Lapucci, Andrea; Ramazzotti, Matteo; Chiarugi, Alberto] Univ Florence, Dept Hlth Sci, Florence, Italy	University of Florence	Felici, R (corresponding author), Univ Florence, Dept Hlth Sci, Florence, Italy.	roberta.felici@unifi.it	Ramazzotti, Matteo/J-4866-2012; Lapucci, Andrea/AAA-6645-2019	Ramazzotti, Matteo/0000-0002-6862-9409; LAPUCCI, Andrea/0000-0001-9613-7164	Regione Toscana Progetto Salute; Regione Toscana; Fondazione Giuseppe Tomasello ONLUS; Italian Federation for Research on Multiple Sclerosis (FISM)	Regione Toscana Progetto Salute(Regione Toscana); Regione Toscana(Regione Toscana); Fondazione Giuseppe Tomasello ONLUS; Italian Federation for Research on Multiple Sclerosis (FISM)	This work was supported by Regione Toscana Progetto Salute 2009 and Regione Toscana 2012, Fondazione Giuseppe Tomasello ONLUS, Italian Federation for Research on Multiple Sclerosis (FISM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali YO, 2011, J BIOL CHEM, V286, P19089, DOI 10.1074/jbc.M111.219295; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chiarugi A, 2002, MOL BRAIN RES, V109, P179, DOI 10.1016/S0169-328X(02)00558-2; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Cipriani G, 2005, J BIOL CHEM, V280, P17227, DOI 10.1074/jbc.M414526200; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; FORMENTINI L, 2008, BR J PHARM; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Lapucci A, 2011, MOL PHARMACOL, V79, P932, DOI 10.1124/mol.110.070110; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rustin P, 1997, MOL CELL BIOCHEM, V174, P115, DOI 10.1023/A:1006890525928; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhang XJ, 2003, J BIOL CHEM, V278, P13503, DOI 10.1074/jbc.M300073200	36	46	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76938	10.1371/journal.pone.0076938	http://dx.doi.org/10.1371/journal.pone.0076938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155910	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300044
J	Greco, A; Ragucci, M; Coda, ARD; Rosa, A; Gargiulo, S; Liuzzi, R; Gramanzini, M; Albanese, S; Pappata, S; Mancini, M; Brunetti, A; Salvatore, M				Greco, Adelaide; Ragucci, Monica; Coda, Anna Rita Daniela; Rosa, Alessandro; Gargiulo, Sara; Liuzzi, Raffaele; Gramanzini, Matteo; Albanese, Sandra; Pappata, Sabina; Mancini, Marcello; Brunetti, Arturo; Salvatore, Marco			High Frequency Ultrasound for In Vivo Pregnancy Diagnosis and Staging of Placental and Fetal Development in Mice	PLOS ONE			English	Article							GROWTH; TOOLS	Background: Ultrasound is a valuable non-invasive tool used in obstetrics and gynecology to monitor the growth and well being of the human fetus. The laboratory mouse has recently emerged as an appropriate model for fetal and perinatal studies because morphogenetic processes in mice exhibit adequate homology to those in humans, and genetic manipulations are relatively simple to perform in mice. High-frequency ultrasound (HFUS) has recently become available for small animal preclinical imaging and can be used to study pregnancy and development in the mouse. The objective of the current study was to assess the main applications of HFUS in the evaluation of fetal growth and placental function and to better understand human congenital diseases. Methodology/Principal Findings: On each gestational day, at least 5 dams were monitored with HFUS; a total of similar to 200 embryos were examined. Because it is not possible to measure each variable for the entire duration of the pregnancy, the parameters were divided into three groups as a function of the time at which they were measured. Univariate analysis of the relationship between each measurement and the embryonic day was performed using Spearman's rank correlation (Rs). Continuous linear regression was adopted for multivariate analysis of significant parameters. All statistical tests were two-sided, and a p value of 0.05 was considered statistically significant. Conclusions/Significance: The study describes the main applications of HFUS to assess changes in phenotypic parameters in the developing CD1 mouse embryo and fetus during pregnancy and to evaluating physiological fetal and placental growth and the development of principal organs such as the heart, kidney, liver, brain and eyes in the embryonic mouse. A database of normal structural and functional parameters of mouse development will provide a useful tool for the better understanding of morphogenetic and cardiovascular anomalies in transgenic and mutant mouse models.	[Greco, Adelaide; Rosa, Alessandro; Albanese, Sandra; Brunetti, Arturo; Salvatore, Marco] Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy; [Greco, Adelaide; Ragucci, Monica; Rosa, Alessandro; Albanese, Sandra; Brunetti, Arturo] SDN, IRCCS Fdn, Naples, Italy; [Coda, Anna Rita Daniela; Rosa, Alessandro; Gargiulo, Sara; Liuzzi, Raffaele; Gramanzini, Matteo; Albanese, Sandra; Pappata, Sabina; Mancini, Marcello; Brunetti, Arturo] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy; [Rosa, Alessandro; Albanese, Sandra; Brunetti, Arturo] Scarl, Naples, Italy	University of Naples Federico II; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Greco, A (corresponding author), Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy.	adegreco@unina.it	Liuzzi, Raffaele/AIC-0886-2022; Greco, Adelaide/C-7679-2018; Brunetti, Arturo/AAE-5261-2019; Salvatore, Marco/K-8083-2016; Albanese, Sandra/Q-3827-2018	Liuzzi, Raffaele/0000-0002-2350-6691; Greco, Adelaide/0000-0001-6841-1963; Brunetti, Arturo/0000-0001-7057-3494; Salvatore, Marco/0000-0001-9734-7702; Albanese, Sandra/0000-0002-7112-273X				Brown SD, 2006, COMPARATIVE MED, V56, P262; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Carter AM, 2006, PLACENTA, V21, P41; Dickinson H, 2008, REPROD BIOL, V8, P229, DOI 10.1016/S1642-431X(12)60014-X; Dickinson ME, 2006, DEV DYNAM, V235, P2386, DOI 10.1002/dvdy.20889; Foster FS, 2000, ULTRASOUND MED BIOL, V26, P1, DOI 10.1016/S0301-5629(99)00096-4; Foster FS, 2003, INVEST OPHTH VIS SCI, V44, P2361, DOI 10.1167/iovs.02-0911; Foster FS, 2002, ULTRASOUND MED BIOL, V28, P1165, DOI 10.1016/S0301-5629(02)00567-7; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Johnsen SL, 2006, EUR J OBSTET GYN R B, V127, P172, DOI 10.1016/j.ejogrb.2005.10.004; Kulandavelu S, 2006, ILAR J, V47, P103, DOI 10.1093/ilar.47.2.103; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; MAZZE RI, 1985, TERATOLOGY, V32, P339, DOI 10.1002/tera.1420320303; Mu JW, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-34; Mullis PE, 2008, BEST PRACT RES CL EN, V22, P173, DOI 10.1016/j.beem.2007.07.010; Pallares P, 2008, THERIOGENOLOGY, V70, P44, DOI 10.1016/j.theriogenology.2008.02.012; Phoon CKL, 2006, PEDIATR RES, V60, P14, DOI 10.1203/01.pdr.0000219441.28206.79; Russo M, 2007, VET REC, V160, P446, DOI 10.1136/vr.160.13.446; Slevin JC, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-10; Spurney CF, 2004, J AM SOC ECHOCARDIOG, V17, P893, DOI 10.1016/j.echo.2004.04.028; Srinivasan S, 1998, CIRCULATION, V98, P912, DOI 10.1161/01.CIR.98.9.912; Turnbull DH, 1999, COMPUT MED IMAG GRAP, V23, P25, DOI 10.1016/S0895-6111(98)00060-3; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Zhao H, 2008, BIOL REPROD, V78, P744, DOI 10.1095/biolreprod.107.064899	24	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77205	10.1371/journal.pone.0077205	http://dx.doi.org/10.1371/journal.pone.0077205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155928	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300062
J	Janusz, P; Kotwicki, T; Andrusiewicz, M; Kotwicka, M				Janusz, Piotr; Kotwicki, Tomasz; Andrusiewicz, Miroslaw; Kotwicka, Malgorzata			XbaI and PvuII Polymorphisms of Estrogen Receptor 1 Gene in Females with Idiopathic Scoliosis: No Association with Occurrence or Clinical Form	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ALPHA-GENE; LINKAGE DISEQUILIBRIUM; NATURAL-HISTORY; GROWTH; WOMEN; RISK; ESR1	Introduction: XbaI single nucleotide polymorphism (SNP) (A/G rs934099) in estrogen receptor 1 gene (ESR1) was described to be associated with curve severity in Japanese idiopathic scoliosis (IS) patients and in Chinese patients with both curve severity and predisposition to IS. PvuII SNP (C/T rs2234693) of ESR1 was described to be associated with the occurrence of IS in the Chinese population; however, two replication studies did not confirm the findings. The ESR1 SNPs have never been studied in Caucasian IS patients. Methods: Case-control study. 287 females with IS underwent clinical, radiological and genetic examinations. The patients were divided into three groups according to curve progression velocity: non-progressive IS, slowly progressive IS (progression <1 degrees per month), and rapidly progressive IS (progression >= 1 degrees per month). The radiological maximum Cobb angle was measured and surgery rate established. A control group consisted of 182 healthy females. Results: All results followed Hardy-Weinberg equilibrium. In the case-control study, genotype frequency in the patients did not differ for the XbaI (AA = 33.5%, AG = 49.1%, GG = 17.4%), nor for the PvuII (TT = 26.8%, TC = 50.2%, CC = 23.0%) comparing to controls (AA = 33.5%, AG = 50.5%, GG = 15.9%) and (TT = 23.1%, TC = 51.1%, CC = 25.8%), respectively, p = 0.3685, p = 0.6046. The haplotype frequency for the patients (AT = 47.1%, GC = 39.2%, AC = 8.9%, GT = 2.8%) did not differ from the controls (AT = 44.8%, GC = 37.4%, AC = 14.0%, GT = 3.8%), p = 0.0645. No difference was found either in XbaI (p = 0.8671) or PvuII (p = 0.3601) allele distribution between the patients and the controls. In the case study, there was no significant difference in genotype frequency for the non-progressive, slowly progressive, and rapidly progressive scoliosis. No difference was found in genotype or haplotype distribution for the mean maximum Cobb angle or the surgery rate. Conclusions: No association was found between ESR1 XbaI or ESR1 PvuII SNP and idiopathic scoliosis in Caucasian females. None of the previously reported associations could be confirmed, regarding curve severity, progression or operation rate.	[Janusz, Piotr; Kotwicki, Tomasz] Univ Med Sci, Dept Pediat Orthoped & Traumatol, Spine Disorders Unit, Poznan, Poland; [Andrusiewicz, Miroslaw; Kotwicka, Malgorzata] Univ Med Sci, Dept Cell Biol, Poznan, Poland		Janusz, P (corresponding author), Univ Med Sci, Dept Pediat Orthoped & Traumatol, Spine Disorders Unit, Poznan, Poland.	mdpjanusz@gmail.com	Andrusiewicz, Mirosław/N-3449-2017; Andrusiewicz, Mirosław/ABG-4949-2021	Andrusiewicz, Mirosław/0000-0002-8781-3447; Andrusiewicz, Mirosław/0000-0002-8781-3447; Janusz, Piotr/0000-0001-5702-4933	National Research Centre [N N403 584038]	National Research Centre(National Research Centre (NRC))	This study was supported by the National Research Centre grant N N403 584038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becherini L, 2000, HUM MOL GENET, V9, P2043, DOI 10.1093/hmg/9.13.2043; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; Dimeglio A, 2011, J PEDIATR ORTHOPED, V31, pS28, DOI 10.1097/BPO.0b013e318202c25d; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Gorman KF, 2012, EUR SPINE J, V21, P1905, DOI 10.1007/s00586-012-2389-6; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; HILL SM, 1989, CANCER RES, V49, P145; Ignaszak-Szczepaniak M, 2011, ACTA BIOCHIM POL, V58, P101; Inoue M, 2002, SPINE, V27, P2357, DOI 10.1097/00007632-200211010-00009; Ioannidis JPA, 2002, J BONE MINER RES, V17, P2048, DOI 10.1359/jbmr.2002.17.11.2048; Kobayashi S, 1996, J BONE MINER RES, V11, P306; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; Kotwicki T, 2013, ADOLESC HEALTH MED T, V4, P59, DOI 10.2147/AHMT.S32088; Leboeuf D, 2009, TRENDS ENDOCRIN MET, V20, P147, DOI 10.1016/j.tem.2008.12.004; Letellier K, 2008, J PINEAL RES, V45, P383, DOI 10.1111/j.1600-079X.2008.00603.x; Li XF, 2008, EUR SPINE J, V17, P1431, DOI 10.1007/s00586-008-0757-z; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; Lowe TG, 2000, J BONE JOINT SURG AM, V82A, P1157, DOI 10.2106/00004623-200008000-00014; Molvarec A, 2007, CLIN CHIM ACTA, V382, P100, DOI 10.1016/j.cca.2007.04.003; Negrini S, 2012, SCOLIOSIS SPINAL DIS, V7, DOI 10.1186/1748-7161-7-3; Patel MS, 2000, J BONE MINER RES, V15, P2231, DOI 10.1359/jbmr.2000.15.11.2231; PENSLER JM, 1990, J BONE MINER RES, V5, P797; RISEBOROUGH EJ, 1973, J BONE JOINT SURG AM, VA 55, P974, DOI 10.2106/00004623-197355050-00006; Roszkowska-Gancarz M, 2010, CLIN CHIM ACTA, V411, P1883, DOI 10.1016/j.cca.2010.06.028; Stavrou I, 2002, HUM REPROD, V17, P1101, DOI 10.1093/humrep/17.4.1101; STOKES IAF, 1994, SPINE, V19, P236, DOI 10.1097/00007632-199401001-00020; Takahashi Y, 2011, J ORTHOP RES, V29, P834, DOI 10.1002/jor.21322; Tang NLS, 2006, SPINE, V31, P2463, DOI 10.1097/01.brs.0000239179.81596.2b; Weinstein SL, 2003, JAMA-J AM MED ASSOC, V289, P559, DOI 10.1001/jama.289.5.559; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; Wu J, 2006, SPINE, V31, P1131, DOI 10.1097/01.brs.0000216603.91330.6f; WYNNE-DAVIES R, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P24; Xu LL, 2011, EUR SPINE J, V20, P1757, DOI 10.1007/s00586-011-1874-7; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043163; Yim APY, 2012, SPINE, V37, pE1148, DOI 10.1097/BRS.0b013e31825c036d; Zhao Dong, 2009, Orthop Surg, V1, P222, DOI 10.1111/j.1757-7861.2009.00038.x	36	26	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76806	10.1371/journal.pone.0076806	http://dx.doi.org/10.1371/journal.pone.0076806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155906	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300040
J	Montero-Melendez, T; Llor, X; Garcia-Planella, E; Perretti, M; Suarez, A				Montero-Melendez, Trinidad; Llor, Xavier; Garcia-Planella, Esther; Perretti, Mauro; Suarez, Antonio			Identification of Novel Predictor Classifiers for Inflammatory Bowel Disease by Gene Expression Profiling	PLOS ONE			English	Article							MICROARRAY DATA; CROHNS-DISEASE; SIGNATURE; CLASSIFICATION; MANAGEMENT; PROGNOSIS; SURVIVAL; CANCER	Background: Improvement of patient quality of life is the ultimate goal of biomedical research, particularly when dealing with complex, chronic and debilitating conditions such as inflammatory bowel disease (IBD). This is largely dependent on receiving an accurate and rapid diagnose, an effective treatment and in the prediction and prevention of side effects and complications. The low sensitivity and specificity of current markers burden their general use in the clinical practice. New biomarkers with accurate predictive ability are needed to achieve a personalized approach that take the inter-individual differences into consideration. Methods: We performed a high throughput approach using microarray gene expression profiling of colon pinch biopsies from IBD patients to identify predictive transcriptional signatures associated with intestinal inflammation, differential diagnosis (Crohn's disease or ulcerative colitis), response to glucocorticoids (resistance and dependence) or prognosis (need for surgery). Class prediction was performed with self-validating Prophet software package. Results: Transcriptional profiling divided patients in two subgroups that associated with degree of inflammation. Class predictors were identified with predictive accuracy ranging from 67 to 100%. The expression accuracy was confirmed by real time-PCR quantification. Functional analysis of the predictor genes showed that they play a role in immune responses to bacteria (PTN, OLFM4 and LILRA2), autophagy and endocytocis processes (ATG16L1, DNAJC6, VPS26B, RABGEF1, ITSN1 and TMEM127) and glucocorticoid receptor degradation (STS and MMD2). Conclusions: We conclude that using analytical algorithms for class prediction discovery can be useful to uncover gene expression profiles and identify classifier genes with potential stratification utility of IBD patients, a major step towards personalized therapy.	[Montero-Melendez, Trinidad; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England; [Llor, Xavier] Univ Illinois, Dept Med, Digest Dis & Nutr Sect, Chicago, IL USA; [Llor, Xavier] Univ Illinois, Ctr Canc, Chicago, IL USA; [Garcia-Planella, Esther] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Suarez, Antonio] Univ Granada, Ctr Invest Biomed, Armilla, Spain	University of London; Queen Mary University London; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; University of Granada	Suarez, A (corresponding author), Univ Granada, Ctr Invest Biomed, Armilla, Spain.	asuarez@ugr.es	Montero-Melendez, Trinidad/AAF-6345-2020; SUAREZ, ANTONIO/L-9221-2014	SUAREZ, ANTONIO/0000-0002-1006-7490; Montero-Melendez, Trinidad/0000-0002-3563-376X	Fundacio la Marato de TV3 [031531]; Spanish Health Ministry - Carlos III Institute [PI61550]	Fundacio la Marato de TV3; Spanish Health Ministry - Carlos III Institute	This study was funded by Fundacio la Marato de TV3 (031531) and Spanish Health Ministry - Carlos III Institute (PI61550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaugerie L, 2012, WORLD J GASTROENTERO, V18, P3806, DOI 10.3748/wjg.v18.i29.3806; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; D'Haens G, 2008, LANCET, V371, P660, DOI 10.1016/S0140-6736(08)60304-9; Ford LT, 2010, J CLIN PATHOL, V63, P288, DOI 10.1136/jcp.2009.069252; Gersemann M, 2012, J CROHNS COLITIS, V6, P425, DOI 10.1016/j.crohns.2011.09.013; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058; Lichtenstein GR, 2009, AM J GASTROENTEROL, V104, P465, DOI 10.1038/ajg.2008.168; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Lu HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033478; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McKinney EF, 2010, NAT MED, V16, P586, DOI 10.1038/nm.2130; Medina I, 2007, BIOINFORMATICS, V23, P390, DOI 10.1093/bioinformatics/btl602; Oz HS, 2009, DIGEST DIS SCI, V54, P2561, DOI 10.1007/s10620-008-0673-4; Sengupta S, 2001, GENE DEV, V15, P2367, DOI 10.1101/gad.202201; Srivastava Maya D, 2004, J Med, V35, P233; Svensson SL, 2010, J BIOL CHEM, V285, P16105, DOI 10.1074/jbc.M109.081232; Tedla N, 2011, TISSUE ANTIGENS, V77, P305, DOI 10.1111/j.1399-0039.2011.01633.x; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Limbergen J, 2011, GASTROENTEROLOGY, V141, P1566, DOI 10.1053/j.gastro.2011.09.018	24	46	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76235	10.1371/journal.pone.0076235	http://dx.doi.org/10.1371/journal.pone.0076235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155895	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300029
J	Ntsekhe, M; Matthews, K; Syed, FF; Deffur, A; Badri, M; Commerford, PJ; Gersh, BJ; Wilkinson, KA; Wilkinson, RJ; Mayosi, BM				Ntsekhe, Mpiko; Matthews, Kerryn; Syed, Faisal F.; Deffur, Armin; Badri, Motasim; Commerford, Patrick J.; Gersh, Bernard J.; Wilkinson, Katalin A.; Wilkinson, Robert J.; Mayosi, Bongani M.			Prevalence, Hemodynamics, and Cytokine Profile of Effusive-Constrictive Pericarditis in Patients with Tuberculous Pericardial Effusion	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INTERFERON-GAMMA; TNF-ALPHA; TGF-BETA; FIBROSIS; MANAGEMENT; INFECTION; IL-10	Background: Effusive constrictive pericarditis (ECP) is visceral constriction in conjunction with compressive pericardial effusion. The prevalence of proven tuberculous ECP is unknown. Whilst ECP is distinguished from effusive disease on hemodynamic grounds, it is unknown whether effusive-constrictive physiology has a distinct cytokine profile. We conducted a prospective study of prevalence and cytokine profile of effusive-constrictive disease in patients with tuberculous pericardial effusion. Methods: From July 2006 through July 2009, the prevalence of ECP and serum and pericardial levels of inflammatory cytokines were determined in adults with tuberculous pericardial effusion. The diagnosis of ECP was made by combined pericardiocentesis and cardiac catheterization. Results: Of 91 patients evaluated, 68 had tuberculous pericarditis. The 36/68 patients (52.9%; 95% confidence interval [CI]: 41.2-65.4) with ECP were younger (29 versus 37 years, P=0.02), had a higher pre-pericardiocentesis right atrial pressure (17.0 versus 10.0 mmHg, P<0.0001), serum concentration of interleukin-10 (IL-10) (38.5 versus 0.2 pg/ml, P<0.001) and transforming growth factor-beta (121.5 versus 29.1 pg/ml, P=0.02), pericardial concentration of IL-10 (84.7 versus 20.4 pg/ml, P=0.006) and interferon-gamma (2,568.0 versus 906.6 pg/ml, P=0.03) than effusive non-constrictive cases. In multivariable regression analysis, right atrial pressure > 15 mmHg (odds ratio [OR] = 48, 95% CI: 8.7-265; P<0.0001) and IL-10 > 200 pg/ml (OR=10, 95% CI: 1.1, 93; P=0.04) were independently associated with ECP. Conclusion: Effusive-constrictive disease occurs in half of cases of tuberculous pericardial effusion, and is characterized by greater elevation in the pre-pericardiocentesis right atrial pressure and pericardial and serum IL-10 levels compared to patients with effusive non-constrictive tuberculous pericarditis.	[Ntsekhe, Mpiko; Syed, Faisal F.; Badri, Motasim; Commerford, Patrick J.; Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa; [Ntsekhe, Mpiko; Syed, Faisal F.; Badri, Motasim; Commerford, Patrick J.; Mayosi, Bongani M.] Univ Cape Town, ZA-7925 Cape Town, Western Cape, South Africa; [Matthews, Kerryn; Deffur, Armin; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, Western Cape, South Africa; [Syed, Faisal F.; Gersh, Bernard J.] Mayo Clin, Div Cardiovasc Med, Rochester, MN USA; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Natl Inst Med Res, London NW7 1AA, England; [Wilkinson, Robert J.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	University of Cape Town; University of Cape Town; University of Cape Town; Mayo Clinic; MRC National Institute for Medical Research; Imperial College London	Mayosi, BM (corresponding author), Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa.	bongani.mayosi@uct.ac.za	Wilkinson, Katalin/AAF-6805-2020; ntsekhe, mpiko/AAI-8001-2021; Wilkinson, Katalin/AAQ-7713-2021; Badri, Motasim/E-1141-2013	ntsekhe, mpiko/0000-0002-0851-7675; Wilkinson, Katalin/0000-0002-9796-2040; Badri, Motasim/0000-0002-5268-6492; Matthews, Kerryn/0000-0003-2695-5895; Mayosi, Bongani/0000-0001-6641-8950; Wilkinson, Robert/0000-0002-2753-1800	Medical Research Council of South Africa; National Research Foundation of South Africa; Lily and Ernst Hausmann Trust; United Kingdom Wellcome Trust [083226, 084323, 088316]; United Kingdom Medical Research Council [U. 1175.02.002.00014.01]; Edith Sorrell Clinical Fellowship	Medical Research Council of South Africa(South African Medical Research Council); National Research Foundation of South Africa(National Research Foundation - South Africa); Lily and Ernst Hausmann Trust; United Kingdom Wellcome Trust(Wellcome Trust); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Edith Sorrell Clinical Fellowship	This work was supported by the Medical Research Council of South Africa; the National Research Foundation of South Africa; the Lily and Ernst Hausmann Trust; the United Kingdom Wellcome Trust (083226, 084323, 088316) and United Kingdom Medical Research Council (U. 1175.02.002.00014.01). MN was a recipient of the Edith Sorrell Clinical Fellowship from 2008 to 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarin V, 2005, AM J PHYSIOL-LUNG C, V288, pL841, DOI 10.1152/ajplung.00329.2004; Bergeron A, 2003, EUR RESPIR J, V22, P69, DOI 10.1183/09031936.03.00014703; Burgess LJ, 2002, INT J TUBERC LUNG D, V6, P439; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Fiorenza G, 2005, IMMUNOL LETT, V98, P45, DOI 10.1016/j.imlet.2004.09.008; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; HANCOCK EW, 1971, CIRCULATION, V43, P183, DOI 10.1161/01.CIR.43.2.183; Hancock EW, 2004, NEW ENGL J MED, V350, P435, DOI 10.1056/NEJMp038199; HERNANDEZPANDO R, 1994, IMMUNOLOGY, V82, P591; Jobsis PD, 2007, AM J PHYSIOL-HEART C, V293, pH3379, DOI 10.1152/ajpheart.00967.2007; Koksal D, 2006, TUBERK TORAK, V54, P17; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Matthews K, 2011, TUBERCULOSIS, V91, P587, DOI 10.1016/j.tube.2011.06.009; Mayosi BM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-2; Mayosi BM, 2008, SAMJ S AFR MED J, V98, P36; Mayosi BM, 2007, HEART, V93, P1176, DOI 10.1136/hrt.2007.127746; Ntsekhe M, 2012, CARDIOVASC J AFR, V23, P281, DOI 10.5830/CVJA-2011-072; Ntsekhe M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002253; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Reuter H, 2007, Cardiovasc J S Afr, V18, P20; Reuter H, 2005, TUBERCULOSIS EDINB, V86; Sagrista-Sauleda J, 2004, NEW ENGL J MED, V350, P469, DOI 10.1056/NEJMoa035630; Sagrista-Sauleda S, 2004, HEART, V90, P257, DOI 10.1136/hrt.2003.024828; Salami MA, 2012, CARDIOVASC J AFR, V23, DOI 10.5830/CVJA-2011-066; Sasse SA, 2003, AM J RESP CRIT CARE, V168, P700, DOI 10.1164/rccm.2202043; Seiscento M, 2007, RESPIROLOGY, V12, P660, DOI 10.1111/j.1440-1843.2007.01135.x; Shabetai R, 2004, HEART, V90, P255, DOI 10.1136/hrt.2003.024810; Syed FF, 2007, PROG CARDIOVASC DIS, V50, P218, DOI 10.1016/j.pcad.2007.03.002; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	29	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77532	10.1371/journal.pone.0077532	http://dx.doi.org/10.1371/journal.pone.0077532			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155965	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300099
J	Tamamura, Y; Tanaka, K; Akiba, M; Kanno, T; Hatama, S; Ishihara, R; Uchida, I				Tamamura, Yukino; Tanaka, Kiyoshi; Akiba, Masato; Kanno, Toru; Hatama, Shinichi; Ishihara, Ryoko; Uchida, Ikuo			Complete Nucleotide Sequences of Virulence-Resistance Plasmids Carried by Emerging Multidrug-Resistant Salmonella enterica Serovar Typhimurium Isolated from Cattle in Hokkaido, Japan	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; DT104 INFECTIONS; GENOMIC ISLAND; UNITED-STATES; DETERMINANTS; INTEGRONS; HUMANS; STRAIN	In the present study, we have shown that virulence-resistance plasmids from emerging multidrug-resistant isolates of Salmonella enterica serovar Typhimurium were derived from a virulence-associated plasmid, essential for systematic invasiveness of S. Typhimurium in mice (pSLT), through acquisition of a large insert containing a resistance island flanked by IS1294 elements. A bla(CMY-2)-carrying plasmid from a cefotaxime-resistant isolate comprised a segment of Escherichia coli plasmid pAR060302 and the replication region (IncFIB) of a virulence-resistance plasmid. These results provide insights into the evolution of drug resistance in emerging clones of S. Typhimurium.	[Tamamura, Yukino; Tanaka, Kiyoshi; Hatama, Shinichi; Ishihara, Ryoko; Uchida, Ikuo] Natl Inst Anim Hlth, Hokkaido Res Stn, Sapporo, Hokkaido, Japan; [Akiba, Masato] Natl Inst Anim Hlth, Tsukuba, Ibaraki 305, Japan; [Akiba, Masato] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Izumisano, Osaka, Japan; [Kanno, Toru] Natl Inst Anim Hlth, Exot Dis Res Div, Kodaira, Tokyo, Japan; [Kanno, Toru; Uchida, Ikuo] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Osaka Metropolitan University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University	Uchida, I (corresponding author), Natl Inst Anim Hlth, Hokkaido Res Stn, Sapporo, Hokkaido, Japan.	ikuouchi@affrc.go.jp						Ahmer BMM, 1999, J BACTERIOL, V181, P1364, DOI 10.1128/JB.181.4.1364-1368.1999; Besser TE, 2000, EPIDEMIOL INFECT, V124, P193, DOI 10.1017/S0950268899003283; Boyd D, 2001, J BACTERIOL, V183, P5725, DOI 10.1128/JB.183.19.5725-5732.2001; Brown HJ, 1996, J BACTERIOL, V178, P4429, DOI 10.1128/jb.178.15.4429-4437.1996; Chen CY, 2007, PLASMID, V57, P29, DOI 10.1016/j.plasmid.2006.05.005; Glynn MK, 1998, NEW ENGL J MED, V338, P1333, DOI 10.1056/NEJM199805073381901; Han J, 2012, FOOD RES INT, V45, P931, DOI 10.1016/j.foodres.2011.04.016; Herrero A, 2008, ANTIMICROB AGENTS CH, V52, P4514, DOI 10.1128/AAC.00563-08; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Mulvey MR, 2006, MICROBES INFECT, V8, P1915, DOI 10.1016/j.micinf.2005.12.028; Ng LK, 1999, ANTIMICROB AGENTS CH, V43, P3018, DOI 10.1128/AAC.43.12.3018; Rodicio MR, 2011, REV MED MICROBIOL, V22, P55, DOI 10.1097/MRM.0b013e328346d87d; Rotger R, 1999, Int Microbiol, V2, P177; Sandvang D, 1998, FEMS MICROBIOL LETT, V160, P37, DOI 10.1016/S0378-1097(98)00006-8; Shahada F, 2011, ANTIMICROB AGENTS CH, V55, P4114, DOI 10.1128/AAC.00560-11; Sugawara M, 2011, J VET MED SCI; Tamamura Y, 2011, APPL ENVIRON MICROB, V77, P1739, DOI 10.1128/AEM.01910-10; Tavakoli N, 2000, PLASMID, V44, P66, DOI 10.1006/plas.1999.1460; THRELFALL EJ, 1994, VET REC, V134, P577, DOI 10.1136/vr.134.22.577; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347	22	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77644	10.1371/journal.pone.0077644	http://dx.doi.org/10.1371/journal.pone.0077644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155970	gold, Green Submitted, Green Published			2022-12-27	WOS:000325887300104
J	Zhang, R; Rapin, N; Ying, ZX; Shklanka, E; Bodnarchuk, TW; Verge, VMK; Misra, V				Zhang, Rui; Rapin, Noreen; Ying, Zhengxin; Shklanka, Erika; Bodnarchuk, Timothy W.; Verge, Valerie M. K.; Misra, Vikram			Zhangfei/CREB-ZF - A Potential Regulator of the Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MEDULLOBLASTOMA CELLS; TRANSCRIPTION FACTORS; NEGATIVE REGULATOR; ACTIVATOR PXBP1(S); MESSENGER-RNA; ER STRESS; DEGRADATION; PROTEASOME; INTERACTS	Cells respond to perturbations in the microenvironment of the endoplasmic reticulum (ER), and to the overloading of its capacity to process secretory and membrane-associate proteins, by activating the Unfolded Protein Response (UPR). Genes that mediate the UPR are regulated by three basic leucine-zipper (bLZip) motif-containing transcription factors - Xbp1s, ATF4 and ATF6. A failure of the UPR to achieve homeostasis and its continued stimulation leads to apoptosis. Mechanisms must therefore exist to turn off the UPR if it successfully restores normalcy. The bLZip protein Zhangfei/CREBZF/SMILE is known to suppress the ability of several, seemingly structurally unrelated, transcription factors. These targets include Luman/CREB3 and CREBH, ER-resident bLZip proteins known to activate the UPR in some cell types. Here we show that Zhangfei had a suppressive effect on most UPR genes activated by the calcium ionophore thapsigargin. This effect was at least partially due to the interaction of Zhangfei with Xbp1s. The leucine zipper of Zhangfei was required for this interaction, which led to the subsequent proteasomal degradation of Xbp1s. Zhangfei suppressed the ability of Xbp1s to activate transcription from a promoter containing unfolded protein response elements and significantly reduced the ability to Xbp1s to activate the UPR as measured by RNA and protein levels of UPR-related genes. Finally, specific suppression of endogenous Zhangfei in thapsigargin-treated primary rat sensory neurons with siRNA directed to Zhangfei transcripts, led to a significant increase in transcripts and proteins of UPR genes, suggesting a potential role for Zhangfei in modulating the UPR.	[Zhang, Rui; Rapin, Noreen; Shklanka, Erika; Bodnarchuk, Timothy W.; Misra, Vikram] Univ Saskatchewan, Western Coll Vet Med, Dept Microbiol, Saskatoon, SK S7N 0W0, Canada; [Rapin, Noreen; Verge, Valerie M. K.] Univ Saskatchewan, Dept Anat & Cell Biol, Saskatoon, SK S7N 0W0, Canada; [Rapin, Noreen; Verge, Valerie M. K.] Univ Saskatchewan, Cameco Multiple Sclerosis Neurosci Res Ctr, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Misra, V (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Microbiol, Saskatoon, SK S7N 0W0, Canada.	Vikram.misra@usask.ca	Misra, Vikram/AAC-4266-2020; Ying, Zhengxin/A-8953-2011	Misra, Vikram/0000-0001-6818-7156; 	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canadian Institutes of Health Research [MOP74747]; Government of China (China Scholarship Council) [RZ-2010635007, ZY-20106030170]; University of Saskatchewan College of Graduate Studies	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of China (China Scholarship Council); University of Saskatchewan College of Graduate Studies	This study was supported by a Discovery grant to VM from the Natural Sciences and Engineering Research Council (NSERC, http://www.nserc-crsng.gc.ca) of Canada and a Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) grant to VMKV (MOP74747). RZ and ZY were supported by scholarships from the Government of China (China Scholarship Council, RZ-2010635007, ZY-20106030170) and the University of Saskatchewan College of Graduate Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bergeron T, 2012, VET COMP ONCOL; Bodnarchuk TW, 2012, J NEURO-ONCOL, V109, P485, DOI 10.1007/s11060-012-0927-z; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cardin E, 2007, FEBS J, V274, P5865, DOI 10.1111/j.1742-4658.2007.06110.x; Chan CP, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-6; Diehl JA, 2011, GASTROENTEROLOGY, V141, P38, DOI 10.1053/j.gastro.2011.05.018; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hogan MR, 2006, FEBS LETT, V580, P58, DOI 10.1016/j.febslet.2005.11.046; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Latreille M, 2006, J BIOL CHEM, V281, P26633, DOI 10.1074/jbc.M513556200; Lee JH, 2012, MOL CELL BIOCHEM, V368, P147, DOI 10.1007/s11010-012-1353-4; Liu XJ, 2012, J BIOL CHEM, V287, P19599, DOI 10.1074/jbc.M112.363622; Lopez-Mateo I, 2012, CELL CYCLE, V11, P3887, DOI 10.4161/cc.22133; Lu R, 2000, J VIROL, V74, P934, DOI 10.1128/JVI.74.2.934-943.2000; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Misra J, 2011, J BIOL CHEM, V286, P41972, DOI 10.1074/jbc.M111.274514; Misra V, 2005, J BIOL CHEM, V280, P15257, DOI 10.1074/jbc.M500728200; Mukai R, 2011, BIOCHEM BIOPH RES CO, V409, P328, DOI 10.1016/j.bbrc.2011.05.014; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Ohshima T, 2010, J CELL BIOCHEM, V111, P187, DOI 10.1002/jcb.22687; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; SADOWSKI I, 1992, GENE, V118, P137, DOI 10.1016/0378-1119(92)90261-M; St-Germain JR, 2008, EPIGENETICS-US, V3, P342, DOI 10.4161/epi.3.6.7203; TAMURA K, 1989, CANCER RES, V49, P5380; Valderrama X, 2009, J NEURO-ONCOL, V91, P7, DOI 10.1007/s11060-008-9682-6; Valderrama X, 2008, J NEUROVIROL, V14, P425, DOI 10.1080/13550280802275904; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wagner M, 2011, CURR OPIN CLIN NUTR, V14, P367, DOI 10.1097/MCO.0b013e32834778d4; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wardell SE, 2002, MOL CELL BIOL, V22, P5451, DOI 10.1128/MCB.22.15.5451-5466.2002; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yoshida H, 2009, CELL STRUCT FUNCT, V34, P1, DOI 10.1247/csf.06028; Zhou W, 2011, J BIOL CHEM, V286, P21687, DOI 10.1074/jbc.M110.212787	45	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77256	10.1371/journal.pone.0077256	http://dx.doi.org/10.1371/journal.pone.0077256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155933	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300067
J	Fieni, F; Stone, M; Ma, ZM; Dutra, J; Fritts, L; Miller, CJ				Fieni, Francis; Stone, Mars; Ma, Zhong-Min; Dutra, Joseph; Fritts, Linda; Miller, Christopher J.			Viral RNA Levels and env Variants in Semen and Tissues of Mature Male Rhesus Macaques Infected with SIV by Penile Inoculation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MALE GENITAL-TRACT; INTRAVAGINAL INOCULATION; SEXUAL TRANSMISSION; HIV-INFECTION; COMPARTMENTALIZATION; BLOOD; POPULATIONS; SEQUENCES; ALIGNMENT	HIV is shed in semen but the anatomic site of virus entry into the genital secretions is unknown. We determined viral RNA (vRNA) levels and the envelope gene sequence in the SIVmac 251 viral populations in the genital tract and semen of 5 adult male rhesus monkeys (Macaca mulatta) that were infected after experimental penile SIV infection. Paired blood and semen samples were collected from 1-9 weeks after infection and the monkeys were necropsied eleven weeks after infection. The axillary lymph nodes, testes, epididymis, prostate, and seminal vesicles were collected and vRNA levels and single-genome analysis of the SIVmac251 env variants was performed. At the time of semen collection, blood vRNA levels were between 3.09 and 7.85 log10 vRNA copies/ml plasma. SIV RNA was found in the axillary lymph nodes of all five monkeys and in 3 of 5 monkeys, all tissues examined were vRNA positive. In these 3 monkeys, vRNA levels (log10 SIVgag copies/ug of total tissue RNA) in the axillary lymph node (6.48 +/- 0.50) were significantly higher than in the genital tract tissues: testis (3.67 +/- 2.16; p<0.05), epididymis (3.08 +/- 1.19; p<0.0001), prostate (3.36 +/- 1.30; p<0.01), and seminal vesicle (2.67 +/- 1.50; p<0.0001). Comparison of the SIVmac251 env viral populations in blood plasma, systemic lymph node, and genital tract tissues was performed in two of the macaques. Visual inspection of the Neighbor-Joining phylograms revealed that in both animals, all the sequences were generally distributed evenly among all tissue compartments. Importantly, viral populations in the genital tissues were not distinct from those in the systemic tissues. Our findings demonstrate striking similarity in the viral populations in the blood and male genital tract tissues within 3 months of penile SIV transmission.	[Fieni, Francis; Stone, Mars; Ma, Zhong-Min; Dutra, Joseph; Fritts, Linda; Miller, Christopher J.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Fieni, Francis; Stone, Mars; Ma, Zhong-Min; Dutra, Joseph; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Miller, Christopher J.] Univ Calif Davis, Sch Med, Div Infect Dis, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Miller, CJ (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	cjmiller@ucdavis.edu			Public Health Service from grant National Center for Research Resources [P51RR00169]; Public Health Service from grant National Institute of Allergy and Infectious Disease [R01 AI066314]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI066314] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	Public Health Service from grant National Center for Research Resources; Public Health Service from grant National Institute of Allergy and Infectious Disease; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Public Health Service grants P51RR00169 from the National Center for Research Resources, R01 AI066314 (to CJM) from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001053; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Coombs RW, 2006, JAIDS-J ACQ IMM DEF, V41, P430, DOI 10.1097/01.qai.0000209895.82255.08; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; Curran R, 2002, J MED VIROL, V67, P9, DOI 10.1002/jmv.2186; Delwart EL, 1998, J VIROL, V72, P617, DOI 10.1128/JVI.72.1.617-623.1998; Diem K, 2008, AIDS RES HUM RETROV, V24, P561, DOI 10.1089/aid.2007.0115; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Genesca M, 2008, J VIROL, V82, P11181, DOI 10.1128/JVI.01433-08; Gupta P, 2000, J INFECT DIS, V182, P79, DOI 10.1086/315644; Haigwood NL, 2009, EUR J IMMUNOL, V39, P1994, DOI 10.1002/eji.200939576; Haigwood NL, 2004, AIDS REV, V6, P187; Kaizu M, 2006, J INFECT DIS, V194, P912, DOI 10.1086/507308; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Le Tortorec A, 2010, INT J ANDROL, V33, pE98, DOI 10.1111/j.1365-2605.2009.00973.x; Le Tortorec A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001792; Ma ZM, 2011, AIDS RES HUM RETROV, V27, P1259, DOI 10.1089/aid.2011.0090; Miller C J, 1994, Curr Top Microbiol Immunol, V188, P107; MILLER CJ, 1994, LAB INVEST, V70, P255; Paranjpe S, 2002, AIDS RES HUM RETROV, V18, P1271, DOI 10.1089/088922202320886316; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Qureshi H, 2011, J VIROL; Ritola K, 2004, J VIROL, V78, P11208, DOI 10.1128/JVI.78.20.11208-11218.2004; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SARASON RL, 1991, J MED PRIMATOL, V20, P122; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Stone M, 2009, VIROLOGY, V392, P260, DOI 10.1016/j.virol.2009.06.052; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Weiler AM, 2008, J VIROL, V82, P4154, DOI 10.1128/JVI.01947-07; Whitney JB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001293	33	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76367	10.1371/journal.pone.0076367	http://dx.doi.org/10.1371/journal.pone.0076367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146859	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400054
J	Glorioso, N; Herrera, VL; Didishvili, T; Ortu, MF; Zaninello, R; Fresu, G; Argiolas, G; Troffa, C; Ruiz-Opazo, N				Glorioso, Nicola; Herrera, Victoria L.; Didishvili, Tamara; Ortu, Maria F.; Zaninello, Roberta; Fresu, Giovanni; Argiolas, Guiseppe; Troffa, Chiara; Ruiz-Opazo, Nelson			Sex-Specific Effects of NLRP6/AVR and ADM Loci on Susceptibility to Essential Hypertension in a Sardinian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; SALT-SENSITIVE HYPERTENSION; BLOOD-PRESSURE; ADRENOMEDULLIN GENE; RAT MODEL; VARIANTS; DISEASE; MICE	Coronary artery disease, heart failure, fatal arrhythmias, stroke, and renal disease are the most common causes of mortality for humans, and essential hypertension remains a major risk factor. Elucidation of susceptibility loci for essential hypertension has been difficult because of its complex, multifactorial nature involving genetic, environmental, and sex-and age-dependent nature. We investigated whether the 11p15.5 region syntenic to rat chromosome 1 region containing multiple blood pressure quantitative trait loci (QTL) detected in Dahl rat intercrosses harbors polymorphisms that contribute to susceptibility/resistance to essential hypertension in a Sardinian population. Initial testing performed using microsatellite markers spanning 18 Mb of 11p15.5 detected a strong association between D11S1318 (at 2.1 Mb, P = 0.004) and D11S1346 (at 10.6 Mb, P = 0.00000004), suggesting that loci in close proximity to these markers may contribute to susceptibility in our Sardinian cohort. NLR family, pyrin domain containing 6/angiotensin-vasopressin receptor (NLRP6/AVR), and adrenomedullin (ADM) are in close proximity to D11S1318 and D11S1346, respectively; thus we tested single nucleotide polymorphisms (SNPs) within NLRP6/AVR and ADM for their association with hypertension in our Sardinian cohort. Upon sex stratification, we detected one NLRP6/AVR SNP associated with decreased susceptibility to hypertension in males (rs7948797G, P = 0.029; OR = 0.73 [0.57-0.94]). For ADM, sex-specific analysis showed a significant association between rs4444073C, with increased susceptibility to essential hypertension only in the male population (P = 0.006; OR = 1.44 [1.13-1.84]). Our results revealed an association between NLRP6/AVR and ADM loci with male essential hypertension, suggesting the existence of sex-specific NLRP6/AVR and ADM variants affecting male susceptibility to essential hypertension.	[Glorioso, Nicola; Ortu, Maria F.; Zaninello, Roberta; Fresu, Giovanni; Argiolas, Guiseppe; Troffa, Chiara] AUO Univ Sassari, Hypertens & Related Dis Ctr, Sassari, Sardinia, Italy; [Herrera, Victoria L.; Didishvili, Tamara; Ruiz-Opazo, Nelson] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	University of Sassari; Boston University	Ruiz-Opazo, N (corresponding author), AUO Univ Sassari, Hypertens & Related Dis Ctr, Sassari, Sardinia, Italy.	nruizo@bu.edu			NIH [HL098939]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grant HL098939 to NR-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cao YN, 2003, HYPERTENSION, V42, P369, DOI 10.1161/01.HYP.0000088560.10830.37; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Chao J, 2002, DRUG NEWS PERSPECT, V15, P511, DOI 10.1358/dnp.2002.15.8.840072; Charchar FJ, 2008, J HUM HYPERTENS, V22, P821, DOI 10.1038/jhh.2008.67; Chen GJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S4; Chen SF, 2013, HYPERTENS RES, V36, P74, DOI 10.1038/hr.2012.132; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ehret GB, 2008, EUR J HUM GENET, V16, P1507, DOI 10.1038/ejhg.2008.102; Glorioso N, 2001, HYPERTENSION, V38, P204, DOI 10.1161/01.HYP.38.2.204; Glorioso N, 2007, CIRC RES, V100, P1522, DOI 10.1161/01.RES.0000267716.96196.60; Glorioso N, 2011, PHYSIOL GENOMICS, V43, P1219, DOI 10.1152/physiolgenomics.00012.2011; Gong M, 2006, CLIN SCI, V110, P315, DOI 10.1042/CS20050208; Herrera VLM, 2008, PHYSIOL GENOMICS, V34, P65, DOI 10.1152/physiolgenomics.00199.2007; Herrera VLM, 2006, PHYSIOL GENOMICS, V26, P172, DOI 10.1152/physiolgenomics.00285.2005; Herrera VLM, 2011, PHYSIOL GENOMICS, V43, P32, DOI 10.1152/physiolgenomics.00154.2010; Herrera VLM, 1998, J CLIN INVEST, V102, P1102, DOI 10.1172/JCI3868; HERRERA VLM, 1990, SCIENCE, V249, P1023, DOI 10.1126/science.1975705; Kaneko Y, 2005, PHYSIOL GENOMICS, V20, P157, DOI 10.1152/physiolgenomics.00108.2004; Kauwe JSK, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S84; Kobayashi Y, 2005, HYPERTENS RES, V28, P229, DOI 10.1291/hypres.28.229; Levy D, 2007, CIRCULATION, V115, P3079, DOI 10.1161/CIRCULATIONAHA.106.652842; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nishikimi T, 2007, CURR MED CHEM, V14, P1689, DOI 10.2174/092986707780830943; Pedelty L, 2008, AM J MED, V121, pS23, DOI 10.1016/j.amjmed.2008.05.019; PIAZZA A, 1993, SCIENCE, V260, P9, DOI DOI 10.1126/SCIENCE.260.5104.9.PUBMED:17793514; Ruiz-Opazo N, 2002, MOL MED, V8, P24, DOI 10.1007/BF03402000; Shindo T, 2001, CIRCULATION, V104, P1964, DOI 10.1161/hc4101.097111; Wang ZG, 2008, CLIN EXP HYPERTENS, V30, P598, DOI 10.1080/10641960802443068	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77562	10.1371/journal.pone.0077562	http://dx.doi.org/10.1371/journal.pone.0077562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147025	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400125
J	Koshy, S; Wu, DL; Hu, XY; Tajhya, RB; Huq, R; Khan, FS; Pennington, MW; Wulff, H; Yotnda, P; Beeton, C				Koshy, Shyny; Wu, Danli; Hu, Xueyou; Tajhya, Rajeev B.; Huq, Redwan; Khan, Fatima S.; Pennington, Michael W.; Wulff, Heike; Yotnda, Patricia; Beeton, Christine			Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes	PLOS ONE			English	Article							MEMORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GATED K+ CHANNELS; POTASSIUM CHANNELS; KV1.3 CHANNEL; NK CELLS; ADAPTIVE IMMUNITY; PERIPHERAL-BLOOD; NOD/SCID MICE; ION CHANNELS	Natural killer (NK) cells are large granular lymphocytes that participate in both innate and adaptive immune responses against tumors and pathogens. They are also involved in other conditions, including organ rejection, graft-versus-host disease, recurrent spontaneous abortions, and autoimmune diseases such as multiple sclerosis. We demonstrate that human NK cells express the potassium channels Kv1.3 and KCa3.1. Expression of these channels does not vary with expression levels of maturation markers but varies between adherent and non-adherent NK cell subpopulations. Upon activation by mitogens or tumor cells, adherent NK (A-NK) cells preferentially up-regulate KCa3.1 and non-adherent (NA-NK) cells preferentially up-regulate Kv1.3. Consistent with this different phenotype, A-NK and NA-NK do not display the same sensitivity to the selective KCa3.1 blockers TRAM-34 and NS6180 and to the selective Kv1.3 blockers ShK-186 and PAP-1 in functional assays. Kv1.3 block inhibits the proliferation and degranulation of NA-NK cells with minimal effects on A-NK cells. In contrast, blocking KCa3.1 increases the degranulation and cytotoxicity of A-NK cells, but not of NA-NK cells. TRAM-34, however, does not affect their ability to form conjugates with target tumor cells, to migrate, or to express chemokine receptors. TRAM-34 and NS6180 also increase the proliferation of both A-NK and NA-NK cells. This results in a TRAM-34-induced increased ability of A-NK cells to reduce in vivo tumor growth. Taken together, our results suggest that targeting KCa3.1 on NK cells with selective blockers may be beneficial in cancer immunotherapy.	[Koshy, Shyny; Hu, Xueyou; Tajhya, Rajeev B.; Huq, Redwan; Khan, Fatima S.; Beeton, Christine] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Wu, Danli; Yotnda, Patricia] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Tajhya, Rajeev B.; Huq, Redwan] Baylor Coll Med, Grad Program Mol Physiol & Biophys, Houston, TX 77030 USA; [Pennington, Michael W.] Peptides Int, Louisville, KY USA; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California Davis	Beeton, C (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	beeton@bcm.edu	wulff, Heike/Z-2056-2019; Tajhya, Rajeev/C-7321-2016	Beeton, Christine/0000-0002-2500-5874; pennington, michael/0000-0001-5446-3447; Tajhya, Rajeev/0000-0002-5363-2293	Department of Defense Breast Cancer Research Program [BC096018]; American Heart Association [0665009Y]; NIH [GM076063, NS073712, RR024574, AI036211, CA125123]; American Lung Association [RT-197120-N]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073712] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Department of Defense Breast Cancer Research Program grant BC096018 (CB), American Heart Association grant 0665009Y (CB), NIH GM076063 (HW) and NS073712 (CB), and fellowship RT-197120-N from the American Lung Association (SK). The Cytometry and Cell Sorting Facility at Baylor College of Medicine is funded in part by the NIH (RR024574, AI036211, CA125123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C., 2007, JOVE-J VIS EXP, V8, pe326, DOI DOI 10.3791/3326; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Betts MR, 2004, METHOD CELL BIOL, V75, P497; Cahalan MD, 2001, J CLIN IMMUNOL, V21, P235, DOI 10.1023/A:1010958907271; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Castriconi R, 2007, CANCER IMMUNOL IMMUN, V56, P1733, DOI 10.1007/s00262-007-0317-0; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; Chang SC, 2012, TOXICON, V60, P840, DOI 10.1016/j.toxicon.2012.05.017; Chang YH, 2013, CANCER RES, V73, P1777, DOI 10.1158/0008-5472.CAN-12-3558; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Cho D, 2010, CLIN CANCER RES, V16, P3901, DOI 10.1158/1078-0432.CCR-10-0735; Chou CC, 2008, EXPERT REV MOL DIAGN, V8, P179, DOI 10.1586/14737159.8.2.179; Fujisaki H, 2009, CANCER RES, V69, P4010, DOI 10.1158/0008-5472.CAN-08-3712; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Grier JT, 2012, J CLIN INVEST, V122, P3769, DOI 10.1172/JCI64837; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Harada H, 2005, EUR J IMMUNOL, V35, P3599, DOI 10.1002/eji.200535125; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hu XY, 2012, J BIOL CHEM, V287, P4014, DOI 10.1074/jbc.M111.312264; Marcenaro E, 2011, ADV EXP MED BIOL, V780, P45, DOI 10.1007/978-1-4419-5632-3_5; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Matsushita N, 2007, IMMUNOPHARM IMMUNOT, V29, P31, DOI 10.1080/08923970701277791; MELDER RJ, 1990, J LEUKOCYTE BIOL, V48, P163, DOI 10.1002/jlb.48.2.163; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Quast SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039290; Rangaraju S, 2010, J BIOL CHEM, V285, P9124, DOI 10.1074/jbc.M109.071266; Ruggieri P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047825; SCHLICHTER L, 1986, P NATL ACAD SCI USA, V83, P451, DOI 10.1073/pnas.83.2.451; SCHLICHTER LC, 1989, EXP CELL RES, V184, P99, DOI 10.1016/0014-4827(89)90368-6; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; SIDELL N, 1986, J IMMUNOL, V137, P1650; Stabile H, 2010, BLOOD, V115, P2818, DOI 10.1182/blood-2009-07-235804; Strobaek D, 2012, BRIT J PHARMACOL, P1476; Sun R, 2003, J IMMUNOL METHODS, V279, P79, DOI 10.1016/S0022-1759(03)00245-X; Tarcha EJ, 2012, J PHARMACOL EXP THER, V342, P642, DOI 10.1124/jpet.112.191890; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Weisman Z, 1997, NAT IMMUN, V15, P269; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11	49	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76740	10.1371/journal.pone.0076740	http://dx.doi.org/10.1371/journal.pone.0076740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146918	Green Published, gold			2022-12-27	WOS:000325819400079
J	Pieperhoff, MS; Schmitt, M; Ferguson, DJP; Meissner, M				Pieperhoff, Manuela S.; Schmitt, Miriam; Ferguson, David J. P.; Meissner, Markus			The Role of Clathrin in Post-Golgi Trafficking in Toxoplasma gondii	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; MEMBRANE; PROTEIN; BIOGENESIS; IDENTIFICATION; RECRUITMENT; PLASMODIUM; EXPRESSION; APICOPLAST; TRANSPORT	Apicomplexan parasites are single eukaryotic cells with a highly polarised secretory system that contains unique secretory organelles (micronemes and rhoptries) that are required for host cell invasion. In contrast, the role of the endosomal system is poorly understood in these parasites. With many typical endocytic factors missing, we speculated that endocytosis depends exclusively on a clathrin-mediated mechanism. Intriguingly, in Toxoplasma gondii we were only able to observe the endogenous clathrin heavy chain 1 (CHC1) at the Golgi, but not at the parasite surface. For the functional characterisation of Toxoplasma gondii CHC1 we generated parasite mutants conditionally expressing the dominant negative clathrin Hub fragment and demonstrate that CHC1 is essential for vesicle formation at the trans-Golgi network. Consequently, the functional ablation of CHC1 results in Golgi aberrations, a block in the biogenesis of the unique secretory microneme and rhoptry organelles, and of the pellicle. However, we found no morphological evidence for clathrin mediating endocytosis in these parasites and speculate that they remodelled their vesicular trafficking system to adapt to an intracellular lifestyle.	[Pieperhoff, Manuela S.; Meissner, Markus] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Schmitt, Miriam] German Canc Res Ctr, Heidelberg, Germany; [Ferguson, David J. P.] Univ Oxford, Nuffield Dept Clin Lab Med, Oxford, England	University of Glasgow; Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford	Pieperhoff, MS (corresponding author), Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	manuela.pieperhoff@glasgow.ac.uk; markus.meissner@glasgow.ac.uk		Meissner, Markus/0000-0002-5341-5969; Ferguson, David/0000-0001-5045-819X	Wellcome Trust [087582/Z/08/Z, 085349]; EviMalAr (European Union, FP7)	Wellcome Trust(Wellcome TrustEuropean Commission); EviMalAr (European Union, FP7)	D.J.P. Ferguson is supported by an equipment grant from the Wellcome Trust. This work was funded by a Wellcome Trust Senior Fellowship (087582/Z/08/Z) and EviMalAr (European Union, FP7). The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHBAROU A, 1991, MOL BIOCHEM PARASIT, V47, P223, DOI 10.1016/0166-6851(91)90182-6; ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Agop-Nersesian C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001029; Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Allen ML, 1997, MOL BIOCHEM PARASIT, V88, P43, DOI 10.1016/S0166-6851(97)00069-8; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Bennett EM, 2001, TRAFFIC, V2, P851, DOI 10.1034/j.1600-0854.2001.21114.x; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Botero-Kleiven S, 2001, EXP PARASITOL, V98, P134, DOI 10.1006/expr.2001.4624; Breinich MS, 2009, CURR BIOL, V19, P277, DOI 10.1016/j.cub.2009.01.039; Burgess J, 2011, MOL BIOL CELL, V22, P2094, DOI 10.1091/mbc.E11-01-0054; Carruthers VB, 2000, INFECT IMMUN, V68, P4005, DOI 10.1128/IAI.68.7.4005-4011.2000; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Elde NC, 2005, PLOS GENET, V1, P514, DOI 10.1371/journal.pgen.0010052; Ferguson DJP, 2005, EUKARYOT CELL, V4, P814, DOI 10.1128/EC.4.4.814-826.2005; Ferguson DJP, 1998, METH MOL B, V80, P297; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gerald NJ, 2001, CELL MOTIL CYTOSKEL, V48, P213, DOI 10.1002/1097-0169(200103)48:3<213::AID-CM1010>3.0.CO;2-V; GROSS U, 1993, PARASITOL RES, V79, P191, DOI 10.1007/BF00931891; Harper JM, 2004, INT J PARASITOL, V34, P1047, DOI 10.1016/j.ijpara.2004.05.006; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Holzenspies JJ, 2010, REPRODUCTION, V140, P223, DOI 10.1530/REP-10-0045; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Karsten V, 1998, J CELL BIOL, V141, P1323, DOI 10.1083/jcb.141.6.1323; Kitakura S, 2011, PLANT CELL, V23, P1920, DOI 10.1105/tpc.111.083030; Kremer K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003213; Leung KF, 2008, TRAFFIC, V9, P1698, DOI 10.1111/j.1600-0854.2008.00797.x; Lige B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051773; Lingelbach K, 1998, J CELL SCI, V111, P1467; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; Liu SH, 1998, J CELL BIOL, V140, P1023, DOI 10.1083/jcb.140.5.1023; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 2006, SCIENCE, V313, P1591, DOI 10.1126/science.1118133; Nevin WD, 2009, PARASITOL INT, V58, P86, DOI 10.1016/j.parint.2008.12.002; Nichols BJ, 1998, BBA-MOL CELL RES, V1404, P9, DOI 10.1016/S0167-4889(98)00044-5; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Niswonger ML, 1997, P NATL ACAD SCI USA, V94, P8575, DOI 10.1073/pnas.94.16.8575; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pelletier L, 2002, NATURE, V418, P548, DOI 10.1038/nature00946; Pfluger SL, 2005, EUKARYOT CELL, V4, P432, DOI 10.1128/EC.4.2.432-442.2005; Radulescu AE, 2012, FASEB J, V26, P129, DOI 10.1096/fj.10-167684; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; SADAK A, 1988, MOL BIOCHEM PARASIT, V29, P203, DOI 10.1016/0166-6851(88)90075-8; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; SCHWARTZ AL, 1990, ANNU REV IMMUNOL, V8, P195, DOI 10.1146/annurev.immunol.8.1.195; Sloves PJ, 2012, CELL HOST MICROBE, V11, P515, DOI 10.1016/j.chom.2012.03.006; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Starnes GL, 2006, J BIOL CHEM, V281, P30745, DOI 10.1074/jbc.M606523200; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Van Damme D, 2011, P NATL ACAD SCI USA, V108, P615, DOI 10.1073/pnas.1017890108; van Dooren GG, 2009, CURR BIOL, V19, P267, DOI 10.1016/j.cub.2008.12.048; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X; Wang C, 2013, PLANT CELL, V25, P499, DOI 10.1105/tpc.112.108373	67	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77620	10.1371/journal.pone.0077620	http://dx.doi.org/10.1371/journal.pone.0077620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147036	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000325819400130
J	Shuvaev, VV; Han, JY; Tliba, S; Arguiri, E; Christofidou-Solomidou, M; Ramirez, SH; Dykstra, H; Persidsky, Y; Atochin, DN; Huang, PL; Muzykantov, VR				Shuvaev, Vladimir V.; Han, Jingyan; Tliba, Samira; Arguiri, Evguenia; Christofidou-Solomidou, Melpo; Ramirez, Servio H.; Dykstra, Holly; Persidsky, Yuri; Atochin, Dmitriy N.; Huang, Paul L.; Muzykantov, Vladimir R.			Anti-Inflammatory Effect of Targeted Delivery of SOD to Endothelium: Mechanism, Synergism with NO Donors and Protective Effects In Vitro and In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ALLEVIATES OXIDATIVE STRESS; CELL-ADHESION MOLECULE-1; OXIDASE-DERIVED ROS; SUPEROXIDE-DISMUTASE; NITRIC-OXIDE; INDUCED APOPTOSIS; CATALASE; ACTIVATION	Pro-inflammatory activation of vascular endothelium is implicated in pathogenesis of severe conditions including stroke, infarction and sepsis. We have recently reported that superoxide dismutase (SOD) conjugated with antibodies (Ab/SOD) that provide targeted delivery into endothelial endosomes mitigates inflammatory endothelial activation by cytokines and agonists of Toll-like receptors (TLR). The goal of this study was to appraise potential utility and define the mechanism of this effect. Ab/SOD, but not non-targeted SOD injected in mice alleviated endotoxin-induced leukocyte adhesion in the cerebral vasculature and protected brain from ischemia-reperfusion injury. Transfection of endothelial cells with SOD, but not catalase inhibited NF kappa B signaling and expression of Vascular Cell Adhesion Molecule-1 induced by both cytokines and TLR agonists. These results affirmed that Ab/SOD-quenched superoxide anion produced by endothelial cells in response to proinflammatory agents mediates NF kappa B activation. Furthermore, Ab/SOD potentiates anti-inflammatory effect of NO donors in endothelial cells in vitro, as well as in the endotoxin-challenged mice. These results demonstrate the central role of intracellular superoxide as a mediator of pro-inflammatory activation of endothelium and support the notion of utility of targeted interception of this signaling pathway for management of acute vascular inflammation.	[Shuvaev, Vladimir V.; Han, Jingyan; Tliba, Samira; Muzykantov, Vladimir R.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Shuvaev, Vladimir V.; Han, Jingyan; Tliba, Samira; Muzykantov, Vladimir R.] Univ Penn, Inst Translat Med & Therapeut, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA; [Arguiri, Evguenia; Christofidou-Solomidou, Melpo] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Ramirez, Servio H.; Dykstra, Holly; Persidsky, Yuri] Temple Univ, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19122 USA; [Atochin, Dmitriy N.; Huang, Paul L.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Atochin, Dmitriy N.; Huang, Paul L.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; [Atochin, Dmitriy N.; Huang, Paul L.] Harvard Univ, Sch Med, Boston, MA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Muzykantov, VR (corresponding author), Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu	Shuvaev, Vladimir/O-1719-2014; Atochin, Dmitriy/Q-3150-2016; Ramirez, Servio/F-8277-2014; Atochin, Dmitriy/AAH-8843-2020	Huang, Paul/0000-0002-5436-8658; Atochin, Dmitriy/0000-0002-2405-2070; ramirez, servio/0000-0002-4609-5653	National Institutes of Health [RO1 HL073940]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [Grant RO1 HL073940] (to V.R.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 1998, BIOCHEM J, V331, P853, DOI 10.1042/bj3310853; Atochin DN, 2004, STROKE, V35, P2177, DOI 10.1161/01.STR.0000137412.35700.0e; Atochin DN, 2000, UNDERSEA HYPERBAR M, V27, P185; Atochina EN, 1998, AM J PHYSIOL-LUNG C, V275, pL806, DOI 10.1152/ajplung.1998.275.4.L806; Bai JX, 2000, J BIOL CHEM, V275, P19241, DOI 10.1074/jbc.M000438200; Botos I, 2009, BBA-GENE REGUL MECH, V1789, P667, DOI 10.1016/j.bbagrm.2009.06.005; Cabrales P, 2010, FREE RADICAL BIO MED, V49, P530, DOI 10.1016/j.freeradbiomed.2010.04.034; Christofidou-Solomidou M, 2003, AM J PHYSIOL-LUNG C, V285, pL283, DOI 10.1152/ajplung.00021.2003; D'Alessio A, 2005, AM J PATHOL, V166, P1273, DOI 10.1016/S0002-9440(10)62346-2; D'Alessio A, 2010, J BIOL CHEM, V285, P23868, DOI 10.1074/jbc.M110.122853; DECATERINA R, 1995, J CLIN INVEST, V96, P60, DOI 10.1172/JCI118074; Dion C, 2005, INT IMMUNOL, V17, P1257, DOI 10.1093/intimm/dxh302; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Frazziano G, 2012, AM J PHYSIOL-HEART C, V302, pH2166, DOI 10.1152/ajpheart.00780.2011; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Giedt RJ, 2012, FREE RADICAL BIO MED, V52, P348, DOI [10.1016/j.freeradbiomed.2011.10.491, 10.1007/s10439-012-0568-6]; Han JY, 2012, THER DELIV, V3, P263, DOI 10.4155/TDE.11.151; Han JY, 2011, J PHARMACOL EXP THER, V338, P82, DOI 10.1124/jpet.111.180620; Haney MJ, 2012, NANOMEDICINE-UK, V7, P815, DOI [10.2217/NNM.11.156, 10.2217/nnm.11.156]; Hernandez-Saavedra D, 2005, BIOMED PHARMACOTHER, V59, P204, DOI 10.1016/j.biopha.2005.03.001; Huang J, 2007, J ETHNOPHARMACOL, V114, P180, DOI 10.1016/j.jep.2007.07.036; Kozower BD, 2003, NAT BIOTECHNOL, V21, P392, DOI 10.1038/nbt806; Laskin DL, 2010, ANN NY ACAD SCI, V1203, P60, DOI 10.1111/j.1749-6632.2010.05607.x; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Lin SJ, 2005, ARTERIOSCL THROM VAS, V25, P334, DOI 10.1161/01.ATV.0000152114.00114.d8; Looft-Wilson R, 2007, J CLIN INVEST, V117, P1961, DOI 10.1172/JCI29877; Manickam DS, 2012, J CONTROL RELEASE, V162, P636, DOI 10.1016/j.jconrel.2012.07.044; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Melendez JA, 1996, J BIOL CHEM, V271, P18898, DOI 10.1074/jbc.271.31.18898; Muro S, 2005, BLOOD, V105, P650, DOI 10.1182/blood-2004-05-1714; Muro S, 2003, J CELL SCI, V116, P1599, DOI 10.1242/jcs.00367; Muzykantov VR, 1999, P NATL ACAD SCI USA, V96, P2379, DOI 10.1073/pnas.96.5.2379; Nacharaju P, 2012, NITRIC OXIDE-BIOL CH, V27, P150, DOI 10.1016/j.niox.2012.06.003; Nowak K, 2007, AM J PHYSIOL-LUNG C, V293, pL162, DOI 10.1152/ajplung.00001.2007; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Oakley FD, 2009, J BIOL CHEM, V284, P33255, DOI 10.1074/jbc.M109.042127; Partridge J, 2007, FASEB J, V21, P3553, DOI 10.1096/fj.06-8059com; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Preissler G, 2011, TRANSPLANTATION, V92, P380, DOI 10.1097/TP.0b013e318226bc6b; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Ramirez SH, 2010, AM J PATHOL, V176, P881, DOI 10.2353/ajpath.2010.090671; Rosenbaugh EG, 2010, BIOMATERIALS, V31, P5218, DOI 10.1016/j.biomaterials.2010.03.026; Scherpereel A, 2002, J PHARMACOL EXP THER, V300, P777, DOI 10.1124/jpet.300.3.777; SCHMIDT KN, 1995, CHEM BIOL, V2, P13, DOI 10.1016/1074-5521(95)90076-4; Shuvaev VV, 2007, J PHARMACOL EXP THER, V323, P450, DOI 10.1124/jpet.107.127126; Shuvaev VV, 2011, ACS NANO, V5, P6991, DOI 10.1021/nn2015453; Shuvaev VV, 2011, J CONTROL RELEASE, V153, P56, DOI 10.1016/j.jconrel.2011.03.022; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; Shuvaev VV, 2009, J PHARMACOL EXP THER, V331, P404, DOI 10.1124/jpet.109.156877; SUZUKI YJ, 1995, BIOCHEM BIOPH RES CO, V210, P537, DOI 10.1006/bbrc.1995.1693; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P1289, DOI [10.1089/ars.2008.2333, 10.1089/ARS.2008.2333]; Waldow T, 2006, NITRIC OXIDE-BIOL CH, V15, P103, DOI 10.1016/j.niox.2005.12.005; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; Yeh LH, 2001, J VASC RES, V38, P551, DOI 10.1159/000051091; Zimmerman MC, 2011, CURR OPIN PHARMACOL, V11, P138, DOI 10.1016/j.coph.2011.01.001	58	42	44	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77002	10.1371/journal.pone.0077002	http://dx.doi.org/10.1371/journal.pone.0077002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146950	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400093
J	Collins, DW; Gudiseva, HV; Trachtman, BT; Jerrehian, M; Gorry, T; Merritt, WT; Rhodes, AL; Sankar, PS; Regina, M; Miller-Ellis, E; O'Brien, JM				Collins, David W.; Gudiseva, Harini V.; Trachtman, Benjamin T.; Jerrehian, Matthew; Gorry, Thomasine; Merritt, William T., III; Rhodes, Allison L.; Sankar, Prithvi S.; Regina, Meredith; Miller-Ellis, Eydie; O'Brien, Joan M.			Mitochondrial Sequence Variation in African-American Primary Open-Angle Glaucoma Patients	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; DNA SEQUENCES; EYE; DYSFUNCTION; PREVALENCE; MUTATIONS; LINEAGES; CELLS; BIAS; TREE	Primary open-angle glaucoma (POAG) is a major cause of blindness and results from irreversible retinal ganglion cell damage and optic nerve degeneration. In the United States, POAG is most prevalent in African-Americans. Mitochondrial genetics and dysfunction have been implicated in POAG, and potentially pathogenic sequence variations, in particular novel transversional base substitutions, are reportedly common in mitochondrial genomes (mtDNA) from POAG patient blood. The purpose of this study was to ascertain the spectrum of sequence variation in mtDNA from African-American POAG patients and determine whether novel nonsynonymous, transversional or other potentially pathogenic sequence variations are observed more commonly in POAG cases than controls. mtDNA from African-American POAG cases (n = 22) and age-matched controls (n = 22) was analyzed by deep sequencing of a single 16,487 base pair PCR amplicon by Ion Torrent, and candidate novel variants were validated by Sanger sequencing. Sequence variants were classified and interpreted using the MITOMAP compendium of polymorphisms. 99.8% of the observed variations had been previously reported. The ratio of novel variants to POAG cases was 7-fold lower than a prior estimate. Novel mtDNA variants were present in 3 of 22 cases, novel nonsynonymous changes in 1 of 22 cases and novel transversions in 0 of 22 cases; these proportions are significantly lower (p<.0005, p<.0004, p<.0001) than estimated previously for POAG, and did not differ significantly from controls. Although it is possible that mitochondrial genetics play a role in African-Americans' high susceptibility to POAG, it is unlikely that any mitochondrial respiratory dysfunction is due to an abnormally high incidence of novel mutations that can be detected in mtDNA from peripheral blood.	[Collins, David W.; Gudiseva, Harini V.; Trachtman, Benjamin T.; Jerrehian, Matthew; Gorry, Thomasine; Merritt, William T., III; Rhodes, Allison L.; Sankar, Prithvi S.; Regina, Meredith; Miller-Ellis, Eydie; O'Brien, Joan M.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Collins, DW (corresponding author), Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA.	davcol@mail.med.upenn.edu			Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; F.M. Kirby Foundation; Research to Prevent Blindness; Paul & Evanina Bell Mackall Foundation Trust; National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM [HHSN260220700001C, HHSN263201200001C]; NATIONAL EYE INSTITUTE [R01EY023557] Funding Source: NIH RePORTER	Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; F.M. Kirby Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Paul & Evanina Bell Mackall Foundation Trust; National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Department of Ophthalmology at the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA and with funds from the F.M. Kirby Foundation (http://foundationcenter.org/grantmaker/kirby/index.html), Research to Prevent Blindness (https://www.rpbusa.org/rpb/), The Paul & Evanina Bell Mackall Foundation Trust and the National Eye Institute, National Institutes of Health, Department of Health and Human Services, under eyeGENETM (http://www.nei.nih.gov/resources/eyegene.asp) contract Nos. HHSN260220700001C and HHSN263201200001C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Abu-Amero KK, 2012, MOL VIS, V18, P1955; Abu-Amero KK, 2011, MOL VIS, V17, P1468; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andrews R, 2006, BRIT J OPHTHALMOL, V90, P488, DOI 10.1136/bjo.2005.084335; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Calandrella N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.40; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; He Y, 2008, INVEST OPHTH VIS SCI, V49, P1447, DOI 10.1167/iovs.07-1361; Inagaki Y, 2006, JPN J OPHTHALMOL, V50, P128, DOI 10.1007/s10384-005-0290-0; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Ji FY, 2012, P NATL ACAD SCI USA, V109, P7391, DOI 10.1073/pnas.1202484109; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lascaratos G, 2012, MITOCHONDRION, V12, P202, DOI 10.1016/j.mito.2011.11.004; Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596; Mitchell P, 2002, OPHTHAL EPIDEMIOL, V9, P333, DOI 10.1076/opep.9.5.333.10335; Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rudnicka AR, 2006, INVEST OPHTH VIS SCI, V47, P4254, DOI 10.1167/iovs.06-0299; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; SINGH G, 1989, NEW ENGL J MED, V320, P1300, DOI 10.1056/NEJM198905183202002; Tengan CH, 1996, BIOCHEM MOL MED, V58, P130, DOI 10.1006/bmme.1996.0040; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varma R, 2004, OPHTHALMOLOGY, V111, P1121, DOI 10.1016/j.ophtha.2004.02.001; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yu-Wai-Man P, 2012, INVEST OPHTH VIS SCI, V53, P2438, DOI 10.1167/iovs.12-9815	34	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e76627	10.1371/journal.pone.0076627	http://dx.doi.org/10.1371/journal.pone.0076627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24146900	gold, Green Published, Green Submitted			2022-12-27	WOS:000325427100081
J	Kostyuk, SV; Konkova, MS; Ershova, ES; Alekseeva, AJ; Smirnova, TD; Stukalov, SV; Kozhina, EA; Shilova, NV; Zolotukhina, TV; Markova, ZG; Izhevskaya, VL; Baranova, A; Veiko, NN				Kostyuk, Svetlana V.; Konkova, Marina S.; Ershova, Elizaveta S.; Alekseeva, Anna J.; Smirnova, Tatiana D.; Stukalov, Sergey V.; Kozhina, Ekaterina A.; Shilova, Nadezda V.; Zolotukhina, Tatiana V.; Markova, Zhanna G.; Izhevskaya, Vera L.; Baranova, Ancha; Veiko, Natalia N.			An Exposure to the Oxidized DNA Enhances Both Instability of Genome and Survival in Cancer Cells	PLOS ONE			English	Article							CIRCULATING TUMOR DNA; NF-KAPPA-B; OXIDATIVE STRESS; ADAPTIVE RESPONSE; HUMAN-LYMPHOCYTES; NUCLEAR; EXPRESSION; TRANSCRIPTION; ACTIVATION; TISSUE	Background: Cell free DNA (cfDNA) circulates throughout the bloodstream of both healthy people and patients with various diseases and acts upon the cells. Response to cfDNA depends on concentrations and levels of the damage within cfDNA. Oxidized extracellular DNA acts as a stress signal and elicits an adaptive response. Principal Findings: Here we show that oxidized extracellular DNA stimulates the survival of MCF-7 tumor cells. Importantly, in cells exposed to oxidized DNA, the suppression of cell death is accompanied by an increase in the markers of genome instability. Short-term exposure to oxidized DNA results in both single-and double strand DNA breaks. Longer treatments evoke a compensatory response that leads to a decrease in the levels of chromatin fragmentations across cell populations. Exposure to oxidized DNA leads to a decrease in the activity of NRF2 and an increase in the activity of NF-kB and STAT3. A model that describes the role of oxidized DNA released from apoptotic cells in tumor biology is proposed. Conclusions/Significance: Survival of cells with an unstable genome may substantially augment progression of malignancy. Further studies of the effects of extracellular DNA on malignant and normal cells are warranted.	[Kostyuk, Svetlana V.; Konkova, Marina S.; Ershova, Elizaveta S.; Alekseeva, Anna J.; Smirnova, Tatiana D.; Stukalov, Sergey V.; Kozhina, Ekaterina A.; Shilova, Nadezda V.; Zolotukhina, Tatiana V.; Markova, Zhanna G.; Izhevskaya, Vera L.; Baranova, Ancha; Veiko, Natalia N.] Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia; [Ershova, Elizaveta S.] Russian Acad Med Sci, VA Negovsky Res Inst Gen Reanimatol, Moscow, Russia; [Baranova, Ancha] George Mason Univ, Sch Syst Biol, Ctr Study Chron Metab Dis, Fairfax, VA 22030 USA	Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Federal Research & Clinical Center of Intensive Care Medicine & Rehabilitology; Russian Academy of Medical Sciences; George Mason University	Kostyuk, SV (corresponding author), Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia.	svet.kostyuk@gmail.com; abaranov@gmu.edu	Konkova, Marina/F-3529-2017; Markova, Zhanna/B-1842-2016; , Ancha/B-4608-2012; Baranova, Anna/HGB-3721-2022; Izhevskaya, Vera/AAZ-6982-2020; Shilova, Nadezda/B-1822-2016; Ershova, Elizaveta/E-3220-2015	Markova, Zhanna/0000-0003-2941-2861; , Ancha/0000-0001-6810-5982; Izhevskaya, Vera/0000-0002-7246-5144; Shilova, Nadezda/0000-0002-0641-1084; Alekseeva, Anna/0000-0003-0164-0539; Ershova, Elizaveta/0000-0003-1206-5832	RFBR [12-04-32081, 12-04-32074]; Ministry of Education and Science of Russia [14.512.11.0090, 8273, 2012-1.1-12-000-2008-067]; Jeffress Foundation [J-1023]	RFBR(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science of Russia(Ministry of Education and Science, Russian Federation); Jeffress Foundation	This work was supported by the RFBR (12-04-32081; 12-04-32074), by the contracts No. 14.512.11.0090 and No. 8273 (under the call No. 2012-1.1-12-000-2008-067) of the Ministry of Education and Science of Russia and the Jeffress Foundation Grant No. J-1023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2011, ANN SURG ONCOL, V18, P2461, DOI 10.1245/s10434-011-1638-y; Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bulicheva N, 2008, ANN NY ACAD SCI, V1137, P273, DOI 10.1196/annals.1448.023; Crujeiras AB, 2013, FREE RADICAL RES, V47, P243, DOI 10.3109/10715762.2013.772604; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Dien J, 2006, AM J PATHOL, V169, P633, DOI 10.2353/ajpath.2006.051109; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Efremova LV, 2010, B EXP BIOL MED+, V149, P196, DOI 10.1007/s10517-010-0906-3; Ermakov A. V., 2010, Radiatsionnaya Biologiya Radioekologiya, V50, P42; Ermakov A. V., 2009, Radiatsionnaya Biologiya Radioekologiya, V49, P34; Ermakov AV, 2008, ANN NY ACAD SCI, V1137, P41, DOI 10.1196/annals.1448.024; Ermakov AV, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/649747; Ermakov AV, 2011, MUTAT RES-FUND MOL M, V712, P1, DOI 10.1016/j.mrfmmm.2011.03.002; Ermakov AV, 2009, MUTAT RES-FUND MOL M, V669, P155, DOI 10.1016/j.mrfmmm.2009.06.005; ERMAKOV AV, 2011, CIRCULATING NUCL ACI, pCH16; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; GLEBOVA KV, 2011, J NUCL ACIDS INVESTI, V2, P28; Gong B, 2012, ONCOL LETT, V3, P897, DOI 10.3892/ol.2012.576; Gorges TM, 2012, BIOMARKERS, V17, P498, DOI 10.3109/1354750X.2012.689133; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guillaud P, 1989, Anal Cell Pathol, V1, P25; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Hashad D, 2012, J CLIN LAB ANAL, V26, P467, DOI 10.1002/jcla.21548; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Henderson PT, 2010, MUTAT RES-GEN TOX EN, V703, P11, DOI 10.1016/j.mrgentox.2010.08.021; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Kamiya H, 2010, MUTAT RES-GEN TOX EN, V703, P32, DOI 10.1016/j.mrgentox.2010.06.003; Kohler C, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-105; Konkova Marina S., 2010, International Journal of Low Radiation, V7, P446, DOI 10.1504/IJLR.2010.037667; Kostjuk S, 2012, EXPERT OPIN BIOL TH, V12, pS99, DOI 10.1517/14712598.2012.690028; Kostyuk SV, 2010, B EXP BIOL MED+, V149, P191, DOI 10.1007/s10517-010-0905-4; KOSTYUK SV, 2013, MUTAT RES, V1, P44378; Kostyuk SV, 2012, MUTAT RES-FUND MOL M, V729, P52, DOI [10.1016/j.mrfmmm.2011.09.005, 10.16/j.mrfmmm.2011.09.005]; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Loseva P, 2012, EXPERT OPIN BIOL TH, V12, pS85, DOI 10.1517/14712598.2012.688948; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Pedruzzi LM, 2012, BIOCHIMIE, V94, P2461, DOI 10.1016/j.biochi.2012.07.015; Roth C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-4; Sandholm J, 2012, BREAST CANCER RES TR, V132, P411, DOI 10.1007/s10549-011-1590-3; Swystun LL, 2011, J THROMB HAEMOST, V9, P2313, DOI 10.1111/j.1538-7836.2011.04465.x; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Vera-Ramirez L, 2012, CANCER LETT, V327, P134, DOI 10.1016/j.canlet.2011.12.029; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Wang D, 1998, J BIOL CHEM, V273, P29411, DOI 10.1074/jbc.273.45.29411; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018618; Zhong Xiao Yan, 2007, Archives of Gynecology and Obstetrics, V276, P327, DOI 10.1007/s00404-007-0345-1	54	27	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77469	10.1371/journal.pone.0077469	http://dx.doi.org/10.1371/journal.pone.0077469			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147001	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200037
J	Liu, L; Yan, B; Huang, JL; Gu, QH; Wang, LN; Fang, M; Jiao, JP; Yue, XQ				Liu, Long; Yan, Bing; Huang, Junlong; Gu, Qunhao; Wang, Lina; Fang, Meng; Jiao, Jianpeng; Yue, Xiaoqiang			The Identification and Characterization of Novel N-glycan-based Biomarkers in Gastric Cancer	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; CARCINOEMBRYONIC ANTIGEN; CLINICAL-SIGNIFICANCE; PANCREATIC-CANCER; PROGNOSTIC VALUE; CA 72-4; SERUM; FUCOSYLATION; HAPTOGLOBIN	Background and Aims: To identify and validate N-glycan biomarkers in gastric cancer (GC) and to elucidate their underlying molecular mechanism of action. Methods: In total, 347 individuals, including patients with GC (gastric cancer) or atrophic gastritis and healthy controls, were randomly divided into a training group (n=287) and a retrospective validation group (n=60). Serum N-glycan profiling was achieved with DNA sequencer-assisted/fluorophore-assisted carbohydrate electrophoresis (DSA-FACE). Two diagnostic models were constructed based on the N-glycan profiles using logistic stepwise regression. The diagnostic performance of each model was assessed in retrospective, prospective (n=60), and follow-up (n=40) cohorts. Lectin blotting was performed to determine total core-fucosylation, and the expression of genes involved in core-fucosylation in GC was analyzed by reverse transcriptase-polymerase chain reaction. Results: We identified at least 9 N-glycan structures (peaks) and the levels of core fucose residues and fucosyltransferase were significantly decreased in GC. Two diagnostic models, designated GCglycoA and GCglycoB, were constructed to differentiate GC from control and atrophic gastritis. The areas under the receiver operating characteristic (ROC) curves (AUC) for both GCglycoA and GCglycoB were higher than those for CEA, CA19-9, CA125 and CA72-4. Compared with CEA, CA19-9, CA125 and CA72-4, the sensitivity of GCglycoA increased 29.66%, 37.28%, 56.78% and 61.86%, respectively, and the accuracy increased 10.62%, 16.82%, 25.67% and 28.76%, respectively. For GCglycoB, the sensitivity increased 27.97%, 35.59%, 55.09% and 60.17% and the accuracy increased 21.26%, 24.64%, 31.40% and 34.30% compared with CEA, CA19-9, CA125 and CA72-4, respectively. After curative surgery, the core fucosylated peak (peak 3) and the total core fucosylated N-glycans (sumfuc) were reversed. Conclusions: The results indicated that the diagnostic models based on N-glycan markers are valuable and noninvasive alternatives for identifying GC. We concluded that decreased core-fucosylation in both tissue and serum from GC patients may result from the decreased expression of fucosyltransferase.	[Liu, Long; Wang, Lina; Yue, Xiaoqiang] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Yan, Bing; Jiao, Jianpeng] Second Mil Med Univ, Changzheng Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China; [Huang, Junlong] Second Mil Med Univ, Fac Naval Med, Lab Stress Med, Dept Naut Med, Shanghai, Peoples R China; [Gu, Qunhao] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Fang, Meng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Lab Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Shanghai University of Traditional Chinese Medicine; Naval Medical University	Yue, XQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China.	yuexiaoqiang@163.com		Yue, Xiaoqiang/0000-0001-6872-9664	National Natural Science Foundation of China [81102693, 81102565]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grants 81102693 and 81102565). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Carpelan-Holmstrom M, 2002, ANTICANCER RES, V22, P2311; de Leoz MLA, 2008, DIS MARKERS, V25, P243, DOI 10.1155/2008/515318; Fang M, 2010, INT J CANCER, V127, P148, DOI 10.1002/ijc.25030; Gaspar MJ, 2001, TUMOR BIOL, V22, P318, DOI 10.1159/000050633; HAGA Y, 1986, AM J MED SCI, V292, P30, DOI 10.1097/00000441-198607000-00006; Ishizuka A, 2008, BIOCHEM J, V413, P227, DOI 10.1042/BJ20071562; Kim YG, 2009, ANAL BIOCHEM, V391, P151, DOI 10.1016/j.ab.2009.05.015; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Lattova E, 2009, RAPID COMMUN MASS SP, V23, P2983, DOI 10.1002/rcm.4202; Li D, 2001, CLIN CHIM ACTA, V313, P15, DOI 10.1016/S0009-8981(01)00644-1; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Miyamoto S, 2006, CURR OPIN MOL THER, V8, P507; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Nakano M, 2008, INT J CANCER, V122, P2301, DOI 10.1002/ijc.23364; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; Saldova R, 2011, ANN ONCOL, V22, P1113, DOI 10.1093/annonc/mdq570; Tocchi A, 1998, J CANCER RES CLIN, V124, P450, DOI 10.1007/s004320050198; Turnbull JE, 2007, NAT CHEM BIOL, V3, P74, DOI 10.1038/nchembio0207-74; Ychou M, 2000, DIS MARKERS, V16, P105, DOI 10.1155/2000/595492; Zhao YP, 2012, CANCER, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0043383.PUBMED:22912865	23	13	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77821	10.1371/journal.pone.0077821	http://dx.doi.org/10.1371/journal.pone.0077821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147084	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200079
J	Branco, S; Bruns, TD; Singleton, I				Branco, Sara; Bruns, Thomas D.; Singleton, Ian			Fungi at a Small Scale: Spatial Zonation of Fungal Assemblages around Single Trees	PLOS ONE			English	Article							ECTOMYCORRHIZAL FUNGI; PRIMARY SUCCESSION; FOREST SOILS; MICROBIAL COMMUNITY; SPECIES RICHNESS; DIVERSITY; MYCELIUM; DIFFERENTIATION; IDENTIFICATION; PATTERNS	Biological communities are often structured by environmental factors even at small spatial scales. Fungi are no exception, though the patterns and mechanisms underlying their community structure are usually unknown. Previous work documented zonation in fungi under tree canopies primarily through their fruiting patterns. Here we investigate the existence of zonation patterns in fungal communities around isolated Pinus muricata trees of different ages in northern coastal California. Using a combination of ingrowth bags and pyrosequencing to target underground mycelium we found highly diverse soil fungal communities associated with single trees. Both ectomycorrhizal and non-ectomycorrhizal fungi were present in all samples, but the latter were more species rich, dominated the samples by sequence read abundance, and showed partitioning by canopy-defined zones and tree age. Soil chemistry was correlated with fungal zonation, but host root density was not. Our results indicate different guilds of fungi partition space differently and are driven by distinct environmental parameters.	[Branco, Sara; Bruns, Thomas D.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Singleton, Ian] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Singleton, Ian] Newcastle Univ, Newcastle Inst Res Sustainabil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of California System; University of California Berkeley; Newcastle University - UK; Newcastle University - UK	Branco, S (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	sara.mayer.branco@gmail.com		Singleton, Ian/0000-0002-3866-668X	National Science Foundation [DEB 0742868, DBI 1046115]; EC FP7 Marie Curie International Outgoing Fellowship award	National Science Foundation(National Science Foundation (NSF)); EC FP7 Marie Curie International Outgoing Fellowship award	Financial support was provided by National Science Foundation grants DEB 0742868 and DBI 1046115. IS acknowledges funding from an EC FP7 Marie Curie International Outgoing Fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Agerer R, 2001, MYCORRHIZA, V11, P107, DOI 10.1007/s005720100108; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Ashkannejhad S, 2006, NEW PHYTOL, V169, P345, DOI 10.1111/j.1469-8137.2005.01593.x; Bruns TD, 2009, NEW PHYTOL, V181, P463, DOI 10.1111/j.1469-8137.2008.02652.x; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burke DJ, 2009, APPL ENVIRON MICROB, V75, P7639, DOI 10.1128/AEM.01648-09; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cox F, 2010, ECOL LETT, V13, P1103, DOI 10.1111/j.1461-0248.2010.01494.x; Deacon J. W., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P249; Dickie IA, 2002, NEW PHYTOL, V156, P527, DOI 10.1046/j.1469-8137.2002.00535.x; Feinstein LM, 2013, MOL ECOL, V22, P1171, DOI 10.1111/mec.12160; Frankland JC, 1998, MYCOL RES, V102, P1, DOI 10.1017/S0953756297005364; Frey SD, 2004, FOREST ECOL MANAG, V196, P159, DOI 10.1016/j.foreco.2004.03.018; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hornung M., 1985, Soil Use and Management, V1, P24, DOI 10.1111/j.1475-2743.1985.tb00648.x; Horton TR, 2001, MOL ECOL, V10, P1855, DOI 10.1046/j.0962-1083.2001.01333.x; Ishida TA, 2008, NEW PHYTOL, V180, P491, DOI 10.1111/j.1469-8137.2008.02572.x; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Kerekes J, 2013, MOL ECOL, V22, P2827, DOI 10.1111/mec.12259; MASON PA, 1987, FUNGAL INFECTION PLA, P253; McGuire KL, 2010, ECOLOGY, V91, P2324, DOI 10.1890/09-0654.1; Murata M, 2013, MYCORRHIZA, V23, P641, DOI 10.1007/s00572-013-0504-0; Nara K, 2003, NEW PHYTOL, V159, P743, DOI 10.1046/j.1469-8137.2003.00844.x; Nara K, 2003, NEW PHYTOL, V158, P193, DOI 10.1046/j.1469-8137.2003.00724.x; Newton A. C., 1992, Mycorrhiza, V2, P75, DOI 10.1007/BF00203253; Nilsson LO, 2007, OECOLOGIA, V153, P375, DOI 10.1007/s00442-007-0735-x; Nilsson RH, 2010, FUNGAL ECOL, V3, P284, DOI 10.1016/j.funeco.2010.05.002; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x; Peay KG, 2012, MOL ECOL, V21, P4122, DOI 10.1111/j.1365-294X.2012.05666.x; Peay KG, 2011, FUNGAL ECOL, V4, P233, DOI 10.1016/j.funeco.2010.09.010; Peay KG, 2010, ECOLOGY, V91, P3631, DOI 10.1890/09-2237.1; Peay KG, 2009, J ECOL, V97, P537, DOI 10.1111/j.1365-2745.2009.01489.x; Robinson CH, 2009, SOIL BIOL BIOCHEM, V41, P414, DOI 10.1016/j.soilbio.2008.10.021; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Talbot JM, 2013, SOIL BIOL BIOCHEM, V57, P282, DOI 10.1016/j.soilbio.2012.10.004; Talbot JM, 2012, ECOLOGY, V93, P345, DOI 10.1890/11-0843.1; Taylor AFS, 2002, PLANT SOIL, V244, P19, DOI 10.1023/A:1020279815472; Taylor DL, 2010, CAN J FOREST RES, V40, P1288, DOI 10.1139/X10-081; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Terwilliger J, 1999, OIKOS, V85, P83, DOI 10.2307/3546794; Trowbridge J, 2004, MYCORRHIZA, V14, P283, DOI 10.1007/s00572-003-0264-3; Wallander H, 2013, SOIL BIOL BIOCHEM, V57, P1034, DOI 10.1016/j.soilbio.2012.08.027; Wallander H, 2001, NEW PHYTOL, V151, P753, DOI 10.1046/j.0028-646x.2001.00199.x; Wallander H, 2010, NEW PHYTOL, V187, P1124, DOI 10.1111/j.1469-8137.2010.03324.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; ZINKE PJ, 1962, ECOLOGY, V43, P130, DOI 10.2307/1932049	54	38	38	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78295	10.1371/journal.pone.0078295	http://dx.doi.org/10.1371/journal.pone.0078295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147130	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400155
J	Ding, XB; Guo, L; Zhang, Y; Fan, SJ; Gu, M; Lu, Y; Jiang, D; Li, YM; Huang, C; Zhou, ZQ				Ding, Xiaobo; Guo, Lu; Zhang, Yu; Fan, Shengjie; Gu, Ming; Lu, Yan; Jiang, Dong; Li, Yiming; Huang, Cheng; Zhou, Zhiqin			Extracts of Pomelo Peels Prevent High-Fat Diet-Induced Metabolic Disorders in C57BL/6 Mice through Activating the PPAR alpha and GLUT4 Pathway	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; CITRUS FLAVONOIDS; INSULIN-RESISTANCE; SERUM-CHOLESTEROL; ENERGY-METABOLISM; OXIDATIVE STRESS; NARINGIN; OBESITY; ANTIOBESITY; ANTIOXIDANT	Objective: Metabolic syndrome is a serious health problem in both developed and developing countries. The present study investigated the anti-metabolic disorder effects of different pomelo varieties on obese C57BL/6 mice induced by high-fat (HF) diet. Design: The peels of four pomelo varieties were extracted with ethanol and the total phenols and flavonoids content of these extracts were measured. For the animal experiment, the female C57BL/6 mice were fed with a Chow diet or a HF diet alone or supplemented with 1% (w/w) different pomelo peel extracts for 8 weeks. Body weight and food intake were measured every other day. At the end of the treatment, the fasting blood glucose, glucose tolerance and insulin (INS) tolerance test, serum lipid profile and insulin levels, and liver lipid contents were analyzed. The gene expression analysis was performed with a quantitative real-time PCR assay. Result: The present study showed that the Citrus grandis liangpinyou (LP) and beibeiyou (BB) extracts were more potent in anti-metabolic disorder effects than the duanshiyou (DS) and wubuyou (WB) extracts. Both LP and BB extracts blocked the body weight gain, lowered fasting blood glucose, serum TC, liver lipid levels, and improved glucose tolerance and insulin resistance, and lowered serum insulin levels in HF diet-fed mice. Compared with the HF group, LP and BB peel extracts increased the mRNA expression of PPAR alpha and its target genes, such as FAS, PGC-1 alpha and PGC-1 beta, and GLUT4 in the liver and white adipocyte tissue (WAT). Conclusion: We found that that pomelo peel extracts could prevent high-fat diet-induced metabolic disorders in C57BL/6 mice through the activation of the PPAR alpha and GLUT4 signaling. Our results indicate that pomelo peels could be used as a dietary therapy and the potential source of drug for metabolic disorders.	[Ding, Xiaobo; Guo, Lu; Zhang, Yu; Fan, Shengjie; Gu, Ming; Lu, Yan; Li, Yiming; Huang, Cheng] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China; [Ding, Xiaobo; Lu, Yan; Zhou, Zhiqin] Southwest Univ, Coll Hort & Landscape Architecture, Chongqing, Peoples R China; [Ding, Xiaobo; Lu, Yan; Zhou, Zhiqin] Minist Educ, Key Lab Hort Sci Southern Mountainous Reg, Chongqing, Peoples R China; [Jiang, Dong] Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China	Shanghai University of Traditional Chinese Medicine; Southwest University - China; Chinese Academy of Agricultural Sciences	Li, YM (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China.	ymlius@163.com; chuang.shutcm@gmail.com; zzqswu@yahoo.com	Guo, Lu/AAZ-7783-2020	Guo, Lu/0000-0003-2121-6401	National Natural Science Foundation of China [31171930]; Fundamental Research Funds for the Central Universities [XDJK2013A014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the the National Natural Science Foundation of China (31171930) and the Fundamental Research Funds for the Central Universities (XDJK2013A014). All surgery was performed under ethyl urethane anesthesia, and all efforts were made to minimize suffering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, OVERVIEW CITRUS AURA, DOI DOI 10.5897/AJPS; Bok SH, 1999, J NUTR, V129, P1182, DOI 10.1093/jn/129.6.1182; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Committee CP, 2005, CHINESE PHARMACOPOEI, P1; Demonty I, 2010, J NUTR, V140, P1615, DOI 10.3945/jn.110.124735; Ding XB, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/678592; FOLCH J, 1957, J BIOL CHEM, V226, P497; Galleano M, 2012, ANN NY ACAD SCI, V1259, P87, DOI 10.1111/j.1749-6632.2012.06511.x; Goto T, 2013, MOL NUTR FOOD RES, V57, P20, DOI 10.1002/mnfr.201200522; Goto T, 2011, AM J PHYSIOL-ENDOC M, V301, pE1022, DOI 10.1152/ajpendo.00061.2011; Hong HJ, 2010, DANGYUJA CITRUS GRAN, P361; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Hung JY, 2010, LUNG CANCER, V68, P366, DOI 10.1016/j.lungcan.2009.08.013; Huong DTT, 2006, NUTRITION, V22, P546, DOI 10.1016/j.nut.2005.11.006; Jang HD, 2010, FOOD CHEM, V118, P554, DOI 10.1016/j.foodchem.2009.05.020; Jung UJ, 2003, CLIN NUTR, V22, P561, DOI 10.1016/S0261-5614(03)00059-1; Jung UJ, 2006, INT J BIOCHEM CELL B, V38, P1134, DOI 10.1016/j.biocel.2005.12.002; Kang SI, 2012, BIOL PHARM BULL, V35, P223, DOI 10.1248/bpb.35.223; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lee YS, 2013, J NUTR BIOCHEM, V24, P156, DOI 10.1016/j.jnutbio.2012.03.014; Lee YS, 2011, PHYTOMEDICINE, V18, P648, DOI 10.1016/j.phymed.2010.11.005; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lien DN, 2010, VNU J SCI NAT SCI TE, V26, P224; Mahmoud AM, 2012, J DIABETES COMPLICAT, V26, P483, DOI 10.1016/j.jdiacomp.2012.06.001; Mulvihill EE, 2012, PPAR RES, V2012, DOI 10.1155/2012/857142; Ono E, 2011, BIOCHEM BIOPH RES CO, V410, P677, DOI 10.1016/j.bbrc.2011.06.055; Park HJ, 2013, J NUTR BIOCHEM, V24, P419, DOI 10.1016/j.jnutbio.2011.12.009; Pu P, 2012, ARCH BIOCHEM BIOPHYS, V518, P61, DOI 10.1016/j.abb.2011.11.026; Raasmaja A, 2013, FOOD CHEM, V138, P1392, DOI 10.1016/j.foodchem.2012.09.140; Ramful D, 2010, J AGR FOOD CHEM, V58, P11119, DOI 10.1021/jf102762s; Roza JM, 2007, ALTERN THER HEALTH M, V13, P44; Sharma AK, 2011, BRIT J NUTR, V106, P1713, DOI 10.1017/S000711451100225X; Shin HS, 2011, FOOD SCI BIOTECHNOL, V20, P1235, DOI 10.1007/s10068-011-0170-y; Singhal J, 2012, CANCER PREV RES, V5, P473, DOI 10.1158/1940-6207.CAPR-11-0318; Steiner G, 2001, LANCET, V357, P905; Tanaka T, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/516981; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Wang YC, 2008, FOOD CHEM, V106, P277, DOI 10.1016/j.foodchem.2007.05.086; Wu SJ, 2011, AFR J BIOTECHNOL, V10, P7668; Yamada T, 2011, J EPIDEMIOL, V21, P169, DOI 10.2188/jea.JE20100084; Zarina Z., 2013, International Food Research Journal, V20, P313; Zhang Y, 2012, PPAR RES, V2012, DOI 10.1155/2012/374936; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	43	47	50	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77915	10.1371/journal.pone.0077915	http://dx.doi.org/10.1371/journal.pone.0077915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147098	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400142
J	Qu, Q; Qu, J; Zhan, M; Wu, LX; Zhang, YW; Lou, XY; Fu, LJ; Zhou, HH				Qu, Qiang; Qu, Jian; Zhan, Min; Wu, Lan-Xiang; Zhang, Yi-Wen; Lou, Xiao-Ya; Fu, Li-Juan; Zhou, Hong-Hao			Different Involvement of Promoter Methylation in the Expression of Organic Cation/Carnitine Transporter 2 (OCTN2) in Cancer Cell Lines	PLOS ONE			English	Article							DNA METHYLATION; CATION TRANSPORTER-2; CARNITINE DEFICIENCY; GENE-EXPRESSION; DOWN-REGULATION; CROHN-DISEASE; UP-REGULATION; SLC22A5; ASSOCIATION; IDENTIFICATION	Organic cation/carnitine transporter 2 (OCTN2) is responsible for the cellular uptake of the antineoplastic agent, oxaliplatin. Epigenetic modification is a possible mechanism of altered drug-transporter expression in cancers, leading to altered efficacy of chemotherapeutic drugs. However, the mechanisms governing OCTN2 regulation are not completely understood. In this study, the low levels of OCTN2 in HepG2 and LS174T cells were elevated by the demethylating reagent, decitabine (DCA). To further reveal the epigenetic mechanism of down-regulation of OCTN2, we found that Region-1 within the OCTN2 promoter (spanning -354 to +85) was a determinant of OCTN2 expression in a luciferase reporter assay. Moreover, methylation-specific PCR (MSP) and bisulfite genomic sequencing showed that the degree of individual methylated CpG sites within this region was inversely correlated with the levels of OCTN2 in different cancer cells. Application of DCA to HepG2 and LS174T cells reversed the hypermethylation status of the OCTN2 promoter and increased OCTN2 expression, enhancing cellular uptake of oxaliplatin. Thus, we identified that promoter methylation is responsible for epigenetic down-regulation of OCTN2 in HepG2 and LS174T cells. Given the essential role of OCTN2 in cancer cell uptake of chemotherapeutics, and thus treatment efficacy, pretreatment with a demethylating reagent is a possible strategy for optimizing pharmacotherapies against cancers.	[Qu, Qiang; Qu, Jian; Zhan, Min; Zhang, Yi-Wen; Lou, Xiao-Ya; Zhou, Hong-Hao] Cent S Univ, Xiangya Sch Med, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha 410083, Hunan, Peoples R China; [Wu, Lan-Xiang; Fu, Li-Juan] Chongqing Med Univ, Inst Life Sci, Chongqing, Peoples R China	Central South University; Chongqing Medical University	Zhou, HH (corresponding author), Cent S Univ, Xiangya Sch Med, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Changsha 410083, Hunan, Peoples R China.	hhzhou2003@163.com			China Scholarship Council [201206370103]; National Scientific Foundation of China [81273595, 81072706]; Scientific Foundation of Hunan [11K073, 10JJ4020]; "863" Project [2012AA02A518]; Research Innovation Foundation of Graduate Student in Hunan province, P.R.C [CX2011B056];  [NCET-10-0843]	China Scholarship Council(China Scholarship Council); National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Foundation of Hunan; "863" Project(National High Technology Research and Development Program of China); Research Innovation Foundation of Graduate Student in Hunan province, P.R.C; 	This work was supported by the State Scholarship Fund from China Scholarship Council (File No. 201206370103), the National Scientific Foundation of China (No. 81273595, 81072706), the Scientific Foundation of Hunan (No. 11K073, 10JJ4020), the "863" Project (No. 2012AA02A518), NCET-10-0843 and Research Innovation Foundation of Graduate Student in Hunan province, P.R.C (CX2011B056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini S, 2012, PHARM RES, V68, P1; Aoki M, 2008, AM J PHYSIOL-RENAL, V295, pF165, DOI 10.1152/ajprenal.90257.2008; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216; Chu SH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-156; D'Argenio G, 2010, J BIOL CHEM, V285, P27078, DOI 10.1074/jbc.M110.109678; Fisher SA, 2006, HUM MUTAT, V27, P778, DOI 10.1002/humu.20358; Grigat S, 2009, DRUG METAB DISPOS, V37, P330, DOI 10.1124/dmd.108.023929; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Imai S, 2009, MOL PHARMACOL, V75, P568, DOI 10.1124/mol.108.052589; Jong NN, 2011, J PHARMACOL EXP THER, V338, P537, DOI 10.1124/jpet.111.181297; Kano T, 2009, DRUG METAB DISPOS, V37, P1009, DOI 10.1124/dmd.108.025015; Kato S, 2009, BIOPHARM DRUG DISPOS, V30, P495, DOI 10.1002/bdd.681; Koch A, 2008, EXP BIOL MED, V233, P356, DOI 10.3181/0706-RM-168; Kurimoto M, 2013, LEUKEMIA, V27, P233, DOI 10.1038/leu.2012.178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040475; Martin V, 2013, BRIT J CANCER, V108, P2005, DOI 10.1038/bjc.2013.188; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Ringseis R, 2007, PHARMACOL RES, V56, P175, DOI 10.1016/j.phrs.2007.06.001; Scalise M, 2012, CELL BIOCHEM FUNCT, V30, P419, DOI 10.1002/cbf.2816; Schaeffeler E, 2011, GENOME MED, V3, DOI 10.1186/gm298; Sheikhnejad G, 1999, J MOL BIOL, V285, P2021, DOI 10.1006/jmbi.1998.2426; Shoji Y, 1998, AM J HUM GENET, V63, P101, DOI 10.1086/301911; Siedlecki P, 2006, J MED CHEM, V49, P678, DOI 10.1021/jm050844z; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tang NLS, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9053; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Yamazaki K, 2004, J HUM GENET, V49, P664, DOI 10.1007/s10038-004-0204-x; Yoon YA, 2012, ANN CLIN LAB SCI, V42, P424	32	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76474	10.1371/journal.pone.0076474	http://dx.doi.org/10.1371/journal.pone.0076474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146874	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400062
J	Shen, H; Gelberman, RH; Silva, MJ; Sakiyama-Elbert, SE; Thomopoulos, S				Shen, Hua; Gelberman, Richard H.; Silva, Matthew J.; Sakiyama-Elbert, Shelly E.; Thomopoulos, Stavros			BMP12 induces tenogenic differentiation of adipose-derived stromal cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE MORPHOGENETIC PROTEIN-2; CHONDROGENIC DIFFERENTIATION; TENDON; MARROW; REPAIR; EXPRESSION; CARTILAGE; SCLERAXIS; GROWTH	Adipose-derived stromal cells (ASCs) are pluripotent cells that have the capacity to differentiate into tendon fibroblasts (TFs). They are abundant in adults, easy to access, and are therefore an ideal cell source for tendon tissue engineering. Despite this potential, the molecular cues necessary for tenogenic differentiation of ASCs are unknown. Unlike other bone morphogenetic proteins (BMPs), BMP12, BMP13, and BMP14 have been reported to be less osteo-chondrogenic and to induce tendon rather than bone formation in vivo. This study investigated the effects of BMP12 and BMP14 on ASC differentiation in vitro. In canine ASCs, BMP12 effectively increased the expression of the tendon markers scleraxis and tenomodulin at both mRNA and protein levels. Consistent with these results, BMP12 induced scleraxis promoter driven-GFP and tenomodulin protein expression in mouse ASCs. Although BMP12 also enhanced the expression of the cartilage matrix gene aggrecan in ASCs, the resulting levels remained considerably lower than those detected in tendon fibroblasts. In addition, BMP12 reduced expression of the bone marker osteocalcin, but not the osteogenic transcription factor runx-2. BMP14 exhibited similar, but marginally less potent and selective effects, compared to BMP12. BMPs are known to signal through the canonical Smad pathway and the non-canonical mitogen-activated protein kinase (MAPK) pathway. BMP12 triggered robust phosphorylation of Smad1/5/8 but not Smad2/3 or p38 MAPK in ASCs. The effect was likely conveyed by type I receptors ALK2/3/6, as phosphorylation of Smad1/5/8 was blocked by the ALK2/3/6 inhibitor LDN-193189 but not by the ALK4/5/7 inhibitor SB-505124. Moreover, ALK6 was found to be the most abundant type I receptor in ASCs, with mRNA expression 100 to 10,000 times that of any other type I receptor. Collectively, results support the conclusion that BMP12 induces tenogenic differentiation of ASCs via the Smad1/5/8 pathway.	[Shen, Hua; Gelberman, Richard H.; Silva, Matthew J.; Thomopoulos, Stavros] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Sakiyama-Elbert, Shelly E.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Thomopoulos, S (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA.	thomopouloss@wudosis.wustl.edu	Sakiyama-Elbert, Shelly/A-6753-2008	Sakiyama-Elbert, Shelly/0000-0003-4832-5851; Silva, Matthew/0000-0001-7375-4522	NIH [AR062947]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062947] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was funded by the NIH (AR062947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Gelberman RH, 1999, J BONE JOINT SURG AM, V81A, P975, DOI 10.2106/00004623-199907000-00010; GELBERMAN RH, 1982, J HAND SURG-AM, V7, P170, DOI 10.1016/S0363-5023(82)80083-X; Gimble Jeffrey M, 2011, Front Biosci (Schol Ed), V3, P69, DOI 10.2741/s133; Gruber R, 2000, CYTOKINE, V12, P1630, DOI 10.1006/cyto.2000.0760; Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019; Hoffmann A, 2006, J CLIN INVEST, V116, P940, DOI 10.1172/JCI22689; HORIBE S, 1990, J ORTHOPAED RES, V8, P167, DOI 10.1002/jor.1100080203; Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567; Ju WJ, 2000, J BONE MINER RES, V15, P1889, DOI 10.1359/jbmr.2000.15.10.1889; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Lee J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016806, 10.1371/journal.pone.0020933]; Lou JR, 1999, CLIN ORTHOP RELAT R, P333; Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Nishimura R, 1998, J BIOL CHEM, V273, P1872, DOI 10.1074/jbc.273.4.1872; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; P Mafi, 2011, Open Orthop J, V5, P253, DOI 10.2174/1874325001105010253; Panetta NJ, 2010, PLAST RECONSTR SURG, V125, P483, DOI 10.1097/PRS.0b013e3181c82d75; Park A, 2010, TISSUE ENG PT A, V16, P2941, DOI 10.1089/ten.tea.2009.0710; Phinney DG, 2012, J CELL BIOCHEM, V113, P2806, DOI 10.1002/jcb.24166; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Rozemuller H, 2010, STEM CELLS DEV, V19, P1911, DOI 10.1089/scd.2009.0510; SCHELLENBERG A, 2013, STEM CELLS AGING MET, V976, P143; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Shahab-Osterloh S, 2010, STEM CELLS, V28, P1590, DOI 10.1002/stem.487; Sharma P, 2008, DISABIL REHABIL, V30, P1733, DOI 10.1080/09638280701788274; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Silva Matthew J, 2002, J Orthop Sci, V7, P508, DOI 10.1007/s007760200090; Steurer Michael, 2008, BMC Res Notes, V1, P71, DOI 10.1186/1756-0500-1-71; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Valcourt U, 1999, EXP CELL RES, V251, P264, DOI 10.1006/excr.1999.4584; Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xu L, 2006, BBA-GENE STRUCT EXPR, V1759, P503, DOI 10.1016/j.bbaexp.2006.11.001; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Zuk P, 2011, CONNECT TISSUE RES, V52, P119, DOI 10.3109/03008207.2010.484515	57	62	67	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77613	10.1371/journal.pone.0077613	http://dx.doi.org/10.1371/journal.pone.0077613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155967	gold, Green Published			2022-12-27	WOS:000325887300101
J	Welch, KC; Allalou, A; Sehgal, P; Cheng, J; Ashok, A				Welch, Kenneth C., Jr.; Allalou, Amina; Sehgal, Prateek; Cheng, Jason; Ashok, Aarthi			Glucose Transporter Expression in an Avian Nectarivore: The Ruby-Throated Hummingbird (Archilochus colubris)	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; IN-VIVO; DIFFERENTIAL EXPRESSION; CARBOHYDRATE-METABOLISM; TISSUE DISTRIBUTION; PASSER-DOMESTICUS; BROILER-CHICKENS; FUEL SELECTION; INGESTED SUGAR; INSULIN	Glucose transporter (GLUT) proteins play a key role in the transport of monosaccharides across cellular membranes, and thus, blood sugar regulation and tissue metabolism. Patterns of GLUT expression, including the insulin-responsive GLUT4, have been well characterized in mammals. However, relatively little is known about patterns of GLUT expression in birds with existing data limited to the granivorous or herbivorous chicken, duck and sparrow. The smallest avian taxa, hummingbirds, exhibit some of the highest fasted and fed blood glucose levels and display an unusual ability to switch rapidly and completely between endogenous fat and exogenous sugar to fuel energetically expensive hovering flight. Despite this, nothing is known about the GLUT transporters that enable observed rapid rates of carbohydrate flux. We examined GLUT (GLUT1, 2, 3, & 4) expression in pectoralis, leg muscle, heart, liver, kidney, intestine and brain from both zebra finches (Taeniopygia guttata) and ruby-throated hummingbirds (Archilochus colubris). mRNA expression of all four transporters was probed using reverse-transcription PCR (RT-PCR). In addition, GLUT1 and 4 protein expression were assayed by western blot and immunostaining. Patterns of RNA and protein expression of GLUT1-3 in both species agree closely with published reports from other birds and mammals. As in other birds, and unlike in mammals, we did not detect GLUT4. A lack of GLUT4 correlates with hyperglycemia and an uncoupling of exercise intensity and relative oxidation of carbohydrates in hummingbirds. The function of GLUTs present in hummingbird muscle tissue (e. g. GLUT1 and 3) remain undescribed. Thus, further work is necessary to determine if high capillary density, and thus surface area across which cellular-mediated transport of sugars into active tissues (e. g. muscle) occurs, rather than taxon-specific differences in GLUT density or kinetics, can account for observed rapid rates of sugar flux into these tissues.	[Welch, Kenneth C., Jr.; Allalou, Amina; Sehgal, Prateek; Cheng, Jason; Ashok, Aarthi] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough	Welch, KC (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada.	kwelch@utsc.utoronto.ca	Welch, Kenneth C./F-1276-2011	Welch, Kenneth C./0000-0002-3283-6510; Allalou, Amina/0000-0002-2414-0206	Natural Sciences and Engineering Research Council (NSERC) of Canada [386466]; Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF) [25326]; Ontario Research Fund - Research Infrastructure Program (ORF-RIP) [25326]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF)(Canada Foundation for Innovation); Ontario Research Fund - Research Infrastructure Program (ORF-RIP)	This study was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant #386466 (http://www.nserc-crsng.gc.ca/index_eng.asp), Canada Foundation for Innovation - Leaders Opportunity Fund (CFI-LOF) grant #25326 (http://www.innovation.ca/), and Ontario Research Fund - Research Infrastructure Program (ORF-RIP) grant #25326 (http://www.ontario.ca/business-and-economy/ontario-research-fund) to KCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN P, 1975, ACTA PHYSIOL SCAND, V95, P203, DOI 10.1111/j.1748-1716.1975.tb10043.x; BAKER H G, 1975, Biotropica, V7, P37, DOI 10.2307/2989798; Baker HG, 1998, BIOTROPICA, V30, P559, DOI 10.1111/j.1744-7429.1998.tb00097.x; Bertoldo A, 2006, DIABETES, V55, P3028, DOI 10.2337/db06-0762; Beuchat CA, 1998, COMP BIOCHEM PHYS A, V120, P409, DOI 10.1016/S1095-6433(98)10039-9; BONADONNA RC, 1993, DIABETES, V42, P191, DOI 10.2337/diabetes.42.1.191; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Brozinick JT, 1997, BIOCHEM J, V321, P75, DOI 10.1042/bj3210075; Carver FM, 2001, CELL MOL LIFE SCI, V58, P645, DOI 10.1007/PL00000887; Caviedes-Vidal E, 2007, P NATL ACAD SCI USA, V104, P19132, DOI 10.1073/pnas.0703159104; Chen CCW, FUNCT ECOL IN PRESS; CHEN KK, 1945, J PHARMACOL EXP THER, V84, P74; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; Chida Y, 2000, COMP BIOCHEM PHYS C, V126, P187, DOI 10.1016/S0742-8413(00)00111-0; CODERRE L, 1995, J BIOL CHEM, V270, P27584, DOI 10.1074/jbc.270.46.27584; Croissant JD, 2000, J BIOL CHEM, V275, P1944, DOI 10.1074/jbc.275.3.1944; DIAMOND JM, 1986, NATURE, V320, P62, DOI 10.1038/320062a0; DOUEN AG, 1990, J BIOL CHEM, V265, P13427; Fueger PT, 2007, J PHYSIOL-LONDON, V582, P801, DOI 10.1113/jphysiol.2007.132902; Fueger PT, 2004, ENDOCRINOLOGY, V145, P4912, DOI 10.1210/en.2004-0465; FURLER SM, 1991, AM J PHYSIOL, V261, pE337, DOI 10.1152/ajpendo.1991.261.3.E337; Gaudreault N, 2004, DIABETOLOGIA, V47, P2081, DOI 10.1007/s00125-004-1583-4; Grinyer I, 1969, CAN J ZOOL; HABER RS, 1993, ENDOCRINOLOGY, V132, P2538, DOI 10.1210/en.132.6.2538; Hall JR, 2006, J EXP BIOL, V209, P4490, DOI 10.1242/jeb.02532; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KARASOV WH, 1986, AUK, V103, P453, DOI 10.1093/auk/103.3.453; Khan AH, 2001, J BIOL CHEM, V276, P4063, DOI 10.1074/jbc.M007419200; Kono T, 2005, BRIT POULTRY SCI, V46, P510, DOI 10.1080/00071660500181289; Kristiansen S, 1997, AM J PHYSL ENDOC M; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauritzen HPMM, 2008, DIABETES, V57, P315, DOI 10.2337/db06-1578; MATHIEUCOSTELLO O, 1992, RESP PHYSIOL, V89, P113, DOI 10.1016/0034-5687(92)90075-8; McClelland GB, 2004, COMP BIOCHEM PHYS B, V139, P443, DOI 10.1016/j.cbpc.2004.07.003; McWhorter TJ, 2000, PHYSIOL BIOCHEM ZOOL, V73, P313, DOI 10.1086/316753; McWhorter TJ, 2006, BIOL LETT-UK, V2, P131, DOI 10.1098/rsbl.2005.0388; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Planas JV, 2000, FEBS LETT, V481, P266, DOI 10.1016/S0014-5793(00)02020-2; Polakof S, 2011, COMP BIOCHEM PHYS B, V160, P123, DOI 10.1016/j.cbpb.2011.07.006; POST RL, 1961, J BIOL CHEM, V236, P269; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Seki Y, 2003, GEN COMP ENDOCR, V133, P80, DOI 10.1016/S0016-6480(03)00145-X; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Stuart CA, 2000, AM J PHYSIOL-ENDOC M, V279, pE855, DOI 10.1152/ajpendo.2000.279.4.E855; Suarez RK, 2011, J EXP BIOL, V214, P172, DOI 10.1242/jeb.047936; SUAREZ RK, 1992, EXPERIENTIA, V48, P565, DOI 10.1007/BF01920240; SUAREZ RK, 1990, P NATL ACAD SCI USA, V87, P9207, DOI 10.1073/pnas.87.23.9207; SUAREZ RK, 1991, P NATL ACAD SCI USA, V88, P4870, DOI 10.1073/pnas.88.11.4870; Sweazea KL, 2006, COMP BIOCHEM PHYS B, V144, P387, DOI 10.1016/j.cbpb.2006.04.009; Sweazea KL, 2006, COMP BIOCHEM PHYS B, V144, P263, DOI 10.1016/j.cbpb.2005.12.027; Sweazea KL, 2005, J EXP ZOOL PART A, V303A, P143, DOI 10.1002/jez.a.131; Teerijoki H, 2000, BBA-GENE STRUCT EXPR, V1494, P290, DOI 10.1016/S0167-4781(00)00216-5; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Tokushima Y, 2005, COMP BIOCHEM PHYS B, V141, P43, DOI 10.1016/j.cbpc.2005.01.008; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Weber JM, 2004, INT CONGR SER, V1275, P22, DOI 10.1016/j.ics.2004.09.043; Welch KC, 2007, J EXP BIOL, V210, P2154, DOI 10.1242/jeb.005363; Welch KC, 2006, PHYSIOL BIOCHEM ZOOL, V79, P1082, DOI 10.1086/507665; Welch KC, 2009, COMP BIOCHEM PHYS B, V152, P324, DOI 10.1016/j.cbpb.2008.12.013; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; ZIERATH JR, 1995, BIOCHEM J, V311, P517, DOI 10.1042/bj3110517	64	18	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77003	10.1371/journal.pone.0077003	http://dx.doi.org/10.1371/journal.pone.0077003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155916	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300050
J	Bibault, JE; Dewas, S; Vautravers-Dewas, C; Hollebecque, A; Jarraya, H; Lacornerie, T; Lartigau, E; Mirabel, X				Bibault, Jean-Emmanuel; Dewas, Sylvain; Vautravers-Dewas, Claire; Hollebecque, Antoine; Jarraya, Hajer; Lacornerie, Thomas; Lartigau, Eric; Mirabel, Xavier			Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity	PLOS ONE			English	Article							PHASE-I; RADIOTHERAPY; TUMORS; REIRRADIATION; CANCER	Purpose: Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC) has been evaluated in several recent studies. The CyberKnife (R) is an SBRT system that allows for real-time tracking of the tumor. The purpose of this study was to evaluate the prognostic factors for local control and overall survival following this treatment. Patients and Methods: 75 patients with 96 liver-confined HCC were treated with SBRT at the Oscar Lambret Comprehensive Cancer Center. Fiducials were implanted in the liver before treatment and were used as markers to track the lesion's movement. Treatment response was scored according to RECIST v1.1. Local control and overall survival were calculated using the Kaplan and Meier method. A stepwise multivariate analysis (Cox regression) of prognostic factors was performed for local control and overall survival. Results: There were 67 patients with Child-Turcotte-Pugh (CTP) Class A and eight patients with CTP Class B. Treatment was administered in three sessions. A total dose of 40-45 Gy to the 80% isodose line was delivered. The median follow-up was 10 months (range, 3-49 months). The local control rate was 89.8% at 1 and 2 years. Overall survival was 78.5% and 50.4% at 1 and 2 years, respectively. Toxicity mainly consisted of grade 1 and grade 2 events. Higher alpha-fetoprotein (aFP) levels were associated with less favorable local control (HR= 1.001; 95% CI [1.000, 1.002]; p=0.0063). A higher dose was associated with better local control (HR= 0.866; 95% CI [0.753, 0.996]; p= 0.0441). A Child-Pugh score higher than 5 was associated with worse overall survival (HR= 3.413; 95% CI [1.235, 9.435]; p= 0.018). Conclusion: SBRT affords good local tumor control and higher overall survival rates than other historical controls (best supportive care or sorafenib). High aFP levels were associated with lesser local control, but a higher treatment dose improved local control.	[Bibault, Jean-Emmanuel; Dewas, Sylvain; Vautravers-Dewas, Claire; Lacornerie, Thomas; Lartigau, Eric; Mirabel, Xavier] Acad Radiat Oncol Dept, Lille, France; [Bibault, Jean-Emmanuel; Dewas, Sylvain; Vautravers-Dewas, Claire; Lacornerie, Thomas; Lartigau, Eric; Mirabel, Xavier] Univ Lille 2, CLCC Oscar Lambret, Lille, France; [Hollebecque, Antoine] Univ Paris, Inst Gustave Roussy, Dept Med, Villejuif, France; [Jarraya, Hajer] CLCC Oscar Lambret, Dept Radiol, Lille, France	UNICANCER; Centre Oscar Lambret; Universite de Lille - ISITE; Universite de Lille; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; Centre Oscar Lambret	Mirabel, X (corresponding author), Acad Radiat Oncol Dept, Lille, France.	x-mirabel@o-lambret.fr	Hollebecque, Antoine/M-2695-2013; lartigau, eric/GSI-5327-2022	Hollebecque, Antoine/0000-0003-2869-7551; Lacornerie, Thomas/0000-0001-8994-5999; Bibault, Jean-Emmanuel/0000-0002-1728-6776	Accuray	Accuray	The radiation therapy department at the Oscar Lambret Comprehensive Cancer Center has a clinical research program partially funded by Accuray. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolino DL, 2011, INT J RADIAT ONCOL, V81, pE447, DOI 10.1016/j.ijrobp.2011.04.011; BLOMGREN H, 1995, ACTA ONCOL, V34, P861, DOI 10.3109/02841869509127197; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Bujold A, 2013, J CLIN ONCOL, V31, P1631, DOI 10.1200/JCO.2012.44.1659; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Comet B, 2012, INT J RADIAT ONCOL, V84, P203, DOI 10.1016/j.ijrobp.2011.11.054; Dewas S, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-166; Dewas S, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-77; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Feng M, 2011, SEMIN RADIAT ONCOL, V21, P271, DOI 10.1016/j.semradonc.2011.05.002; Huang WY, 2012, INT J RADIAT ONCOL, V84, P355, DOI 10.1016/j.ijrobp.2011.11.058; Kang J-K, 2012, CANCER; Klein J, 2013, INT J RADIAT ONCOL, V87, P22, DOI 10.1016/j.ijrobp.2012.08.043; Kwon JH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-475; Lencioni R, 2012, SEMIN ONCOL, V39, P503, DOI 10.1053/j.seminoncol.2012.05.004; Lencioni R, 2012, RADIOLOGY, V262, P43, DOI 10.1148/radiol.11110144; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; McGinn CJ, 1998, J CLIN ONCOL, V16, P2246, DOI 10.1200/JCO.1998.16.6.2246; Romero AM, 2006, ACTA ONCOL, V45, P831, DOI 10.1080/02841860600897934; O'Connor JK, 2012, LIVER TRANSPLANT, V18, P949, DOI 10.1002/lt.23439; Qian J, 2003, WORLD J GASTROENTERO, V9, P1885, DOI 10.3748/wjg.v9.i9.1885; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Seo YS, 2010, J SURG ONCOL, V102, P209, DOI 10.1002/jso.21593; Tse RV, 2008, J CLIN ONCOL, V26, P657, DOI 10.1200/JCO.2007.14.3529; Vautravers-Dewas C, 2011, INT J RADIAT ONCOL, V81, pE39, DOI 10.1016/j.ijrobp.2010.12.047; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; Xie BR, 2012, DIGEST DIS SCI, V57, P1122, DOI 10.1007/s10620-012-2136-1	29	83	90	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77472	10.1371/journal.pone.0077472	http://dx.doi.org/10.1371/journal.pone.0077472			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147002	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400120
J	Rakus, D; Gizak, A; Kasprzak, AA; Zarzycki, M; Maciaszczyk-Dziubinska, E; Dzugaj, A				Rakus, Dariusz; Gizak, Agnieszka; Kasprzak, Andrzej A.; Zarzycki, Marek; Maciaszczyk-Dziubinska, Ewa; Dzugaj, Andrzej			The Mechanism of Calcium-Induced Inhibition of Muscle Fructose 1,6-bisphosphatase and Destabilization of Glyconeogenic Complex	PLOS ONE			English	Article							GLYCEROL-PHOSPHATE-DEHYDROGENASE; GLYCOLYTIC-ENZYMES; LIVER FRUCTOSE-1,6-BISPHOSPHATASE; SKELETAL-MUSCLE; TERMINAL REGION; AMP INHIBITION; DYNAMIC LOOP; ALDOLASE; FBPASE; LOCALIZATION	The mechanism by which calcium inhibits the activity of muscle fructose 1,6-bisphosphatase (FBPase) and destabilizes its interaction with aldolase, regulating glycogen synthesis from non-carbohydrates in skeletal muscle is poorly understood. In the current paper, we demonstrate evidence that Ca2+ affects conformation of the catalytic loop 52-72 of muscle FBPase and inhibits its activity by competing with activatory divalent cations, e.g. Mg2+ and Zn2+. We also propose the molecular mechanism of Ca2+-induced destabilization of the aldolase-FBPase interaction, showing that aldolase associates with FBPase in its active form, i.e. with loop 52-72 in the engaged conformation, while Ca2+ stabilizes the disengaged-like form of the loop.	[Rakus, Dariusz; Gizak, Agnieszka] Univ Wroclaw, Dept Anim Mol Physiol, PL-50138 Wroclaw, Poland; [Kasprzak, Andrzej A.] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland; [Zarzycki, Marek; Dzugaj, Andrzej] Univ Wroclaw, Depatment Genet, PL-50138 Wroclaw, Poland; [Maciaszczyk-Dziubinska, Ewa] Univ Wroclaw, Dept Genet & Cell Physiol, PL-50138 Wroclaw, Poland	University of Wroclaw; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Wroclaw; University of Wroclaw	Rakus, D (corresponding author), Univ Wroclaw, Dept Anim Mol Physiol, PL-50138 Wroclaw, Poland.	drakus@biol.uni.wroc.pl	Kasprzak, Andrzej A. A/R-4476-2016; Rakus, Dariusz/AAU-8496-2021	Kasprzak, Andrzej A. A/0000-0002-3602-5379; Rakus, Dariusz/0000-0002-3823-3163; Gizak, Agnieszka/0000-0001-9367-0270; Maciaszczyk-Dziubinska, Ewa/0000-0003-4681-7190; Rakus, Dariusz/0000-0002-3511-0459	Polish Ministry of Science and Higher Education Grant [N N301 069139]; Experimental Biology Institute of Wroclaw University Research Grant	Polish Ministry of Science and Higher Education Grant(Ministry of Science and Higher Education, Poland); Experimental Biology Institute of Wroclaw University Research Grant	This work was partially supported by Polish Ministry of Science and Higher Education Grant [no N N301 069139] and by Experimental Biology Institute of Wroclaw University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Robaiy S, 1999, BIOL CHEM, V380, P1079, DOI 10.1515/BC.1999.134; CASAZZA JP, 1979, J BIOL CHEM, V254, P4661; CHENZION M, 1993, BIOCHEM MED METAB B, V49, P173, DOI 10.1006/bmmb.1993.1020; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Choe JY, 1998, BIOCHEMISTRY-US, V37, P11441, DOI 10.1021/bi981112u; Cornish-Bowden A, 2002, FUNDAMENTALS ENZYME, P95; Dzugaj A, 2006, ADV ENZYME REGUL, V46, P51, DOI 10.1016/j.advenzreg.2006.01.021; Fournier PA, 2002, COMP BIOCHEM PHYS A, V133, P755, DOI 10.1016/S1095-6433(02)00254-4; Gizak A, 2004, FEBS LETT, V576, P445, DOI 10.1016/j.febslet.2004.09.050; Gizak A, 2008, PROTEINS, V72, P209, DOI 10.1002/prot.21909; Gizak A, 2013, BBA-MOL CELL RES, V1833, P622, DOI 10.1016/j.bbamcr.2012.11.028; GODING JW, 1976, J IMMUNOL METHODS, V13, P215, DOI 10.1016/0022-1759(76)90068-5; Iancu CV, 2005, J BIOL CHEM, V280, P19737, DOI 10.1074/jbc.M501011200; KE HM, 1991, P NATL ACAD SCI USA, V88, P2989, DOI 10.1073/pnas.88.8.2989; Kowalski W, 2012, J CELL PHYSIOL, V227, P2613, DOI 10.1002/jcp.22998; Kowalski W, 2009, FEBS LETT, V583, P1841, DOI 10.1016/j.febslet.2009.05.004; Kraft T, 2000, J MUSCLE RES CELL M, V21, P691, DOI 10.1023/A:1005623002979; Mamczur P, 2005, FEBS LETT, V579, P1607, DOI 10.1016/j.febslet.2005.01.071; Nelson SW, 2000, J BIOL CHEM, V275, P29986, DOI 10.1074/jbc.M000473200; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Ovadi J, 2000, INT REV CYTOL, V192, P255; Rakus D, 2000, BIOCHEM BIOPH RES CO, V275, P611, DOI 10.1006/bbrc.2000.3308; Rakus D, 2004, BIOCHEMISTRY-US, V43, P14948, DOI 10.1021/bi048886x; Rakus D, 2003, FEBS LETT, V547, P11, DOI 10.1016/S0014-5793(03)00661-6; Rakus D, 2003, BIOL CHEM, V384, P51, DOI 10.1515/BC.2003.006; Rakus D, 2000, COMP BIOCHEM PHYS B, V127, P123, DOI 10.1016/S0305-0491(00)00245-5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Singh P, 2004, J BIOL CHEM, V279, P35176, DOI 10.1074/jbc.M402282200; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; VERTESSY B, 1987, EUR J BIOCHEM, V164, P655, DOI 10.1111/j.1432-1033.1987.tb11176.x; VERTESSY BG, 1991, BIOCHIM BIOPHYS ACTA, V1078, P236, DOI 10.1016/0167-4838(91)90564-G; Vertessy BG, 1997, J BIOL CHEM, V272, P25542, DOI 10.1074/jbc.272.41.25542; Zarzycki M, 2007, FEBS LETT, V581, P1347, DOI 10.1016/j.febslet.2007.02.051; Zhang RL, 1996, BIOCHEMISTRY-US, V35, P3038, DOI 10.1021/bi952188i; ZHANG YP, 1994, J MOL BIOL, V244, P609, DOI 10.1006/jmbi.1994.1755	35	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76669	10.1371/journal.pone.0076669	http://dx.doi.org/10.1371/journal.pone.0076669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146906	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400072
J	Yousuf, MA; Zhou, XH; Mukherjee, S; Chintakuntlawar, AV; Lee, JY; Ramke, M; Chodosh, J; Rajaiya, J				Yousuf, Mohammad A.; Zhou, Xiaohong; Mukherjee, Santanu; Chintakuntlawar, Ashish V.; Lee, Jeong Yoon; Ramke, Mirja; Chodosh, James; Rajaiya, Jaya			Caveolin-1 Associated Adenovirus Entry into Human Corneal Cells	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; ALPHA(V) INTEGRINS; TYPE-19 INFECTION; EARLY STEPS; HOST-CELLS; CLATHRIN; ENDOCYTOSIS; EXPRESSION; RECEPTOR; SIMIAN-VIRUS-40	The cellular entry of viruses represents a critical area of study, not only for viral tropism, but also because viral entry dictates the nature of the immune response elicited upon infection. Epidemic keratoconjunctivitis (EKC), caused by viruses within human adenovirus species D (HAdV-D), is a severe, ocular surface infection associated with corneal inflammation. Clathrin-mediated endocytosis has previously been shown to play a critical role in entry of other HAdV species into many host cell types. However, HAdV-D endocytosis into corneal cells has not been extensively studied. Herein, we show an essential role for cholesterol rich, lipid raft microdomains and caveolin-1, in the entry of HAdV-D37 into primary human corneal fibroblasts. Cholesterol depletion using methyl-beta-cyclodextrin (M beta CD) profoundly reduced viral infection. When replenished with soluble cholesterol, the effect of M beta CD was reversed, allowing productive viral infection. HAdV-D37 DNA was identified in caveolin-1 rich endosomal fractions after infection. Src kinase activity was also increased in caveolin-1 rich endosomal fractions after infection, and Src phosphorylation and CXCL1 induction were both decreased in caveolin-1-/-mice corneas compared to wild type mice. siRNA knock down of caveolin-1 in corneal cells reduced chemokine induction upon viral infection, and caveolin-1-/-mouse corneas showed reduced cellular entry of HAdV-D37. As a control, HAdV-C2, a non-corneal pathogen, appeared to utilize the caveolar pathway for entry into A549 cells, but failed to infect corneal cells entirely, indicating virus and cell specific tropism. Immuno-electron microscopy confirmed the presence of caveolin-1 in HAdV-D37-containing vesicles during the earliest stages of viral entry. Collectively, these experiments indicate for the first time that HAdV-D37 uses a lipid raft mediated caveolin-1 associated pathway for entry into corneal cells, and connects the processes of viral entry with downstream proinflammatory cell signaling.	[Yousuf, Mohammad A.; Zhou, Xiaohong; Mukherjee, Santanu; Chintakuntlawar, Ashish V.; Lee, Jeong Yoon; Ramke, Mirja; Chodosh, James; Rajaiya, Jaya] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Rajaiya, J (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA.	jaya_rajaiya@meei.harvard.edu	Mukherjee, Santanu/AAF-1684-2020	Mukherjee, Santanu/0000-0001-8344-7200; Rajaiya, Jaya/0000-0002-4559-5613; Mittermaier, Mirja/0000-0003-0678-6676; Chintakuntlawar, Ashish/0000-0002-2907-6522	national Institutes of Health (NIH) [EY013124, EY021558, EY014104]; Research to Prevent Blindness Senior Scientific Investigator Award; Falk Foundation; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R01EY013124, R01EY021558, P30EY014104] Funding Source: NIH RePORTER	national Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Senior Scientific Investigator Award(Research to Prevent Blindness (RPB)); Falk Foundation; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by national Institutes of Health (NIH) grants EY013124, EY021558, and EY014104, a Research to Prevent Blindness Senior Scientific Investigator Award (JC), the Falk Foundation, and the Massachusetts Lions Eye Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Cheshenko N, 2005, J BIOL CHEM, V280, P31116, DOI 10.1074/jbc.M503518200; Chintakuntlawar AV, 2007, INVEST OPHTH VIS SCI, V48, P781, DOI 10.1167/iovs.06-1036; Chintakuntlawar AV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000841; Chintakuntlawar AV, 2009, J INTERF CYTOK RES, V29, P657, DOI 10.1089/jir.2009.0006; Chodosh J, 2000, INVEST OPHTH VIS SCI, V41, P783; Colin M, 2005, MOL THER, V11, P224, DOI 10.1016/j.ymthe.2004.10.007; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Deng GM, 2008, J IMMUNOL, V181, P4019, DOI 10.4049/jimmunol.181.6.4019; Descamps D, 2009, CURR GENE THER, V9, P115, DOI 10.2174/156652309787909544; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dunn EF, 2012, PROG MOL BIOL TRANSL, V106, P223, DOI 10.1016/B978-0-12-396456-4.00002-X; Eash S, 2004, J VIROL, V78, P11583, DOI 10.1128/JVI.78.21.11583-11590.2004; Empig CJ, 2002, J VIROL, V76, P5266, DOI 10.1128/JVI.76.10.5266-5270.2002; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; FAG JA, 2003, SUBCELLULAR FRACTION; Gilbert JM, 2000, J VIROL, V74, P8582, DOI 10.1128/JVI.74.18.8582-8588.2000; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gruenberg J, 2009, CURR OPIN CELL BIOL, V21, P582, DOI 10.1016/j.ceb.2009.03.008; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Guo CJ, 2011, J VIROL, V85, P6416, DOI 10.1128/JVI.01500-10; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Harmon B, 2012, J VIROL, V86, P12954, DOI 10.1128/JVI.02242-12; HORWITZ M, 1996, FIELDS VIROLOGY; Iacobelli-Martinez M, 2005, J VIROL, V79, P11259, DOI 10.1128/JVI.79.17.11259-11268.2005; Iacobelli-Martinez M, 2007, J VIROL, V81, P1305, DOI 10.1128/JVI.01926-06; Kalin S, 2010, J VIROL, V84, P5336, DOI 10.1128/JVI.02494-09; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Lauer KP, 2004, J GEN VIROL, V85, P2615, DOI 10.1099/vir.0.80118-0; Leopold PL, 1998, HUM GENE THER, V9, P367, DOI 10.1089/hum.1998.9.3-367; Li E, 2001, J VIROL, V75, P5405, DOI 10.1128/JVI.75.11.5405-5409.2001; Li E, 1998, J VIROL, V72, P8806, DOI 10.1128/JVI.72.11.8806-8812.1998; Li EG, 2000, J BIOL CHEM, V275, P14729, DOI 10.1074/jbc.275.19.14729; Li EG, 1998, J VIROL, V72, P2055, DOI 10.1128/JVI.72.3.2055-2061.1998; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002; Martin-Acebes MA, 2007, VIROLOGY, V369, P105, DOI 10.1016/j.virol.2007.07.021; MATHIAS P, 1994, J VIROL, V68, P6811, DOI 10.1128/JVI.68.10.6811-6814.1994; Meier O, 2005, J VIROL, V79, P2604, DOI 10.1128/JVI.79.4.2604-2613.2005; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Natarajan K, 2003, J IMMUNOL, V170, P6234, DOI 10.4049/jimmunol.170.12.6234; Nemerow GR, 2009, MOL THER, V17, P1490, DOI 10.1038/mt.2009.177; Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725, DOI 10.1128/MMBR.63.3.725-734.1999; Nilsson EC, 2011, NAT MED, V17, P105, DOI 10.1038/nm.2267; Nomura R, 2004, J VIROL, V78, P8701, DOI 10.1128/JVI.78.16.8701-8708.2004; O'Donnell V, 2008, J VIROL, V82, P9075, DOI 10.1128/JVI.00732-08; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Parton RG, 2013, NAT REV MOL CELL BIO, V14, P98, DOI 10.1038/nrm3512; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pho MT, 2000, J VIROL, V74, P2288, DOI 10.1128/JVI.74.5.2288-2292.2000; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; Querbes W, 2006, J VIROL, V80, P9402, DOI 10.1128/JVI.01086-06; RABINOWITZ S, 1992, J CELL BIOL, V116, P95, DOI 10.1083/jcb.116.1.95; Rajaiya J, 2009, MOL VIS, V15, P2879; Rajaiya J, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-17; Rajala MS, 2005, J VIROL, V79, P12332, DOI 10.1128/JVI.79.19.12332-12341.2005; Rauma T, 1999, J VIROL, V73, P9664, DOI 10.1128/JVI.73.11.9664-9668.1999; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x; Robinson CM, 2013, MBIO, V4, DOI 10.1128/mBio.00595-12; Robinson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-213; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rogee S, 2007, MOL THER, V15, P1963, DOI 10.1038/sj.mt.6300283; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sakurai F, 2006, GENE THER, V13, P1118, DOI 10.1038/sj.gt.3302749; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Schlormann W, 2010, HISTOCHEM CELL BIOL, V133, P223, DOI 10.1007/s00418-009-0651-8; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Sirena D, 2004, J VIROL, V78, P4454, DOI 10.1128/JVI.78.9.4454-4462.2004; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Stuart AD, 2002, J VIROL, V76, P9307, DOI 10.1128/JVI.76.18.9307-9322.2002; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Thomas KW, 2002, J BIOL CHEM, V277, P492, DOI 10.1074/jbc.M108107200; Thorley JA, 2010, PROTOPLASMA, V244, P15, DOI 10.1007/s00709-010-0152-6; Wang KN, 1998, J VIROL, V72, P3455, DOI 10.1128/JVI.72.4.3455-3458.1998; Wang YH, 2009, J CLIN INVEST, V119, P1604, DOI 10.1172/JCI37905; Wang ZJ, 2009, ACS NANO, V3, P4110, DOI 10.1021/nn9012274; Westermann M, 1999, HISTOCHEM CELL BIOL, V111, P71, DOI 10.1007/s004180050335; WICKHAM TJ, 1994, J CELL BIOL, V127, P257, DOI 10.1083/jcb.127.1.257; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Xiao JN, 2005, INVEST OPHTH VIS SCI, V46, P3777, DOI 10.1167/iovs.05-0724; Xie JS, 2006, J VIROL, V80, P11833, DOI 10.1128/JVI.00857-06; Zaiss AK, 2009, J CELL BIOCHEM, V108, P778, DOI 10.1002/jcb.22328	99	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77462	10.1371/journal.pone.0077462	http://dx.doi.org/10.1371/journal.pone.0077462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147000	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400119
J	Carroll, IM; Ringel-Kulka, T; Ferrier, L; Wu, MC; Siddle, JP; Bueno, L; Ringel, Y				Carroll, Ian M.; Ringel-Kulka, Tamar; Ferrier, Laurent; Wu, Michael C.; Siddle, Jennica P.; Bueno, Lionel; Ringel, Yehuda			Fecal Protease Activity Is Associated with Compositional Alterations in the Intestinal Microbiota	PLOS ONE			English	Article							PROTEINASE-ACTIVATED RECEPTOR-2; STREPTOCOCCUS-PNEUMONIAE; BOWEL; PERMEABILITY; PAIN; PROTEOLYSIS; MICROFLORA; SIGNATURES; BACTERIA; COLITIS	Objective: Intestinal proteases carry out a variety of functions in the gastrointestinal (GI) tract. Studies have reported that elevated enteric proteases in patients with GI disease can alter intestinal physiology, however the origin (human vs. microbial) of elevated proteases in patients with GI disease is unclear. Aim: The aim of this study was to investigate the association between protease activity and the microbiota in human fecal samples. Design: In order to capture a wide range of fecal protease (FP) activity stool samples were collected from 30 IBS patients and 24 healthy controls. The intestinal microbiota was characterized using 454 high throughput pyro-sequencing of the 16S rRNA gene. The composition and diversity of microbial communities were determined and compared using the Quantitative Insights Into Microbial Ecology (QIIME) pipeline. FP activity levels were determined using an ELISA-based method. FP activity was ranked and top and bottom quartiles (n=13 per quartile) were identified as having high and low FP activity, respectively. Results: The overall diversity of the intestinal microbiota displayed significant clustering separation (p = 0.001) between samples with high vs. low FP activity. The Lactobacillales, Lachnospiraceae, and Streptococcaceae groups were positively associated with FP activity across the entire study population, whilst the Ruminococcaceae family and an unclassified Coriobacteriales family were negatively associated with FP activity. Conclusions: These data demonstrate significant associations between specific intestinal bacterial groups and fecal protease activity and provide a basis for further causative studies investigating the role of enteric microbes and GI diseases.	[Carroll, Ian M.; Siddle, Jennica P.; Ringel, Yehuda] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA; [Ringel-Kulka, Tamar] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Wu, Michael C.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC USA; [Ferrier, Laurent; Bueno, Lionel] INRA, Toxalim UMR1331, Neurogastroenterol & Nutr Grp, F-31931 Toulouse, France	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; INRAE	Ringel, Y (corresponding author), Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27599 USA.	ringel@med.unc.edu	Wu, Michael/X-5084-2019; Core, UNC Microbiome/AAB-3304-2022	Wu, Michael/0000-0002-3357-6570; Ferrier, Laurent/0000-0003-2981-7375	young investigator grant for probiotics research; global probiotics committee; National Institutes of Health [DK084294, DK075621];  [DK092330]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, R03DK084294, K01DK092330, K23DK075621] Funding Source: NIH RePORTER	young investigator grant for probiotics research; global probiotics committee; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the young investigator grant for probiotics research, supported by the global probiotics committee, and by DK092330 awarded to IC. This study was also funded by DK084294 and DK075621 grants from the National Institutes of Health awarded to YR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annahazi A, 2009, PAIN, V144, P209, DOI 10.1016/j.pain.2009.04.017; Antalis TM, 2007, NAT CLIN PRACT GASTR, V4, P393, DOI 10.1038/ncpgasthep0846; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bonifait L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-47; Bustos D, 1998, MEDICINA-BUENOS AIRE, V58, P262; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carroll IM, 2012, NEUROGASTROENT MOTIL, V24, P521, DOI 10.1111/j.1365-2982.2012.01891.x; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; Connolly KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018984; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Eeckhaut V, 2008, INT J SYST EVOL MICR, V58, P2799, DOI 10.1099/ijs.0.65730-0; Einsfeldt K, 2011, VACCINE, V29, P7136, DOI 10.1016/j.vaccine.2011.05.073; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gecse K, 2008, GUT, V57, P591, DOI 10.1136/gut.2007.140210; GIBSON SAW, 1989, APPL ENVIRON MICROB, V55, P679, DOI 10.1128/AEM.55.3.679-683.1989; Hague A, 1997, GASTROENTEROLOGY, V112, P1036, DOI 10.1053/gast.1997.v112.agast971036; Kanazawa M, 2008, AM J GASTROENTEROL, V103, P2550, DOI 10.1111/j.1572-0241.2008.02066.x; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; MACFARLANE GT, 1988, J APPL BACTERIOL, V64, P37, DOI 10.1111/j.1365-2672.1988.tb02427.x; MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Midtvedt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066074; Mirza S, 2011, INFECT IMMUN, V79, P2440, DOI 10.1128/IAI.00489-10; MUNKHOLM P, 1994, GUT, V35, P68, DOI 10.1136/gut.35.1.68; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Pruteanu M, 2011, INFLAMM BOWEL DIS, V17, P1189, DOI 10.1002/ibd.21475; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Roka R, 2007, NEUROGASTROENT MOTIL, V19, P57, DOI 10.1111/j.1365-2982.2006.00851.x; Roka R, 2007, CLIN GASTROENTEROL H, V5, P550, DOI 10.1016/j.cgh.2006.12.004; Saifeddine M, 1996, BRIT J PHARMACOL, V118, P521, DOI 10.1111/j.1476-5381.1996.tb15433.x; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Shulman RJ, 2008, J PEDIATR-US, V153, P646, DOI 10.1016/j.jpeds.2008.04.062; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Wani JH, 1996, INFECT IMMUN, V64, P3967, DOI 10.1128/IAI.64.10.3967-3974.1996; Williams David A., 1990, Vet Clin Pathol, V19, P20, DOI 10.1111/j.1939-165X.1990.tb00536.x; Woodmansey EJ, 2004, APPL ENVIRON MICROB, V70, P6113, DOI 10.1128/AEM.70.10.6113-6122.2004	44	37	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78017	10.1371/journal.pone.0078017	http://dx.doi.org/10.1371/journal.pone.0078017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147109	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200094
J	Daima, HK; Selvakannan, PR; Shukla, R; Bhargava, SK; Bansal, V				Daima, Hemant K.; Selvakannan, P. R.; Shukla, Ravi; Bhargava, Suresh K.; Bansal, Vipul			Fine-Tuning the Antimicrobial Profile of Biocompatible Gold Nanoparticles by Sequential Surface Functionalization Using Polyoxometalates and Lysine	PLOS ONE			English	Article							AG SHELL NANOPARTICLES; SILVER NANOPARTICLES; ANTIBACTERIAL ACTIVITY; AMINO-ACIDS; ESCHERICHIA-COLI; ANTIBIOTICS; TIO2; MECHANISMS; PARTICLES; CELLS	Antimicrobial action of nanomaterials is typically assigned to the nanomaterial composition, size and/or shape, whereas influence of complex corona stabilizing the nanoparticle surface is often neglected. We demonstrate sequential surface functionalization of tyrosine-reduced gold nanoparticles (AuNPs(Tyr)) with polyoxometalates (POMs) and lysine to explore controlled chemical functionality-driven antimicrobial activity. Our investigations reveal that highly biocompatible gold nanoparticles can be tuned to be a strong antibacterial agent by fine-tuning their surface properties in a controllable manner. The observation from the antimicrobial studies on a gram negative bacterium Escherichia coli were further validated by investigating the anticancer properties of these step-wise surface-controlled materials against A549 human lung carcinoma cells, which showed a similar toxicity pattern. These studies highlight that the nanomaterial toxicity and biological applicability are strongly governed by their surface corona.	[Daima, Hemant K.; Selvakannan, P. R.; Shukla, Ravi; Bhargava, Suresh K.; Bansal, Vipul] RMIT Univ, Sch Appl Sci, NanoBiotechnol Res Lab, Melbourne, Vic 3001, Australia	Royal Melbourne Institute of Technology (RMIT)	Bansal, V (corresponding author), RMIT Univ, Sch Appl Sci, NanoBiotechnol Res Lab, Melbourne, Vic 3001, Australia.	vipul.bansal@rmit.edu.au	Bansal, Vipul/B-2485-2008; Bhargava, Suresh K./C-5783-2011; Daima, Hemant Kumar/D-3586-2013; Bhargava, Suresh K./AAQ-2675-2020; PERIASAMY, SELVAKANNAN/H-2418-2013	Bansal, Vipul/0000-0002-3354-4317; Bhargava, Suresh K./0000-0002-3127-8166; Daima, Hemant Kumar/0000-0002-9109-430X; Bhargava, Suresh K./0000-0002-3127-8166; Shukla, Ravi/0000-0002-1537-9637; PERIASAMY, SELVAKANNAN/0000-0001-5859-8226	Ian Potter Foundation	Ian Potter Foundation	Authors acknowledge the support of the Ian Potter Foundation for establishing a multimode spectroscopy facility at RMIT University that was used in this study. Authors also acknowledge the support of RMIT Microscopy and Microanalysis Facility (RMMF) for providing technical assistance and access to their characterization facilities. The technical assistance of Mr. Paul Morrison for acquiring ICP-MS data and Ms Zahra Homan for acquiring AAS data is also duly acknowledged.	Amin RM, 2009, NANOMEDICINE-UK, V4, P637, DOI 10.2217/NNM.09.50; Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Daima H.K., 2011, INT C NAN TECHN SOC, P1; Daima HK, 2014, NANOSCALE, V6, P758, DOI 10.1039/c3nr03806h; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; FLYNN KJ, 1986, MAR BIOL, V90, P159, DOI 10.1007/BF00569122; Goodman CM, 2004, BIOCONJUGATE CHEM, V15, P897, DOI 10.1021/bc049951i; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Hasenknopf B, 2005, FRONT BIOSCI-LANDMRK, V10, P275, DOI 10.2741/1527; HILL CL, 1995, COORDIN CHEM REV, V143, P407, DOI 10.1016/0010-8545(95)01141-B; Hung A, 2013, CHEM SCI, V4, P928, DOI 10.1039/c2sc21639f; Iliev V, 2007, J MOL CATAL A-CHEM, V263, P32, DOI 10.1016/j.molcata.2006.08.019; Joshi H, 2004, J PHYS CHEM B, V108, P11535, DOI 10.1021/jp048766z; Kong YM, 2007, MATER LETT, V61, P2393, DOI 10.1016/j.matlet.2006.09.023; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Mandal S, 2003, J AM CHEM SOC, V125, P8440, DOI 10.1021/ja034972t; Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Nederberg F, 2011, NAT CHEM, V3, P409, DOI [10.1038/nchem.1012, 10.1038/NCHEM.1012]; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Pearson A, 2011, LANGMUIR, V27, P9245, DOI 10.1021/la201655n; Pearson A, 2011, LANGMUIR, V27, P6661, DOI 10.1021/la2007765; POPE MT, 1991, ANGEW CHEM INT EDIT, V30, P34, DOI 10.1002/anie.199100341; Radovic-Moreno AF, 2012, ACS NANO, V6, P4279, DOI 10.1021/nn3008383; Ramanathan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017707; Rhule JT, 1998, CHEM REV, V98, P327, DOI 10.1021/cr960396q; ROSEN BP, 1971, J BIOL CHEM, V246, P3653; Sanyal A, 2005, ADV FUNCT MATER, V15, P273, DOI 10.1002/adfm.200400107; Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v; Selvakannan PR, 2004, LANGMUIR, V20, P7825, DOI 10.1021/la049258j; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Silverstein RB, 1967, SPECTROMETRIC IDENTI; Wiesner MR, 2006, ENVIRON SCI TECHNOL, V40, P4336, DOI 10.1021/es062726m; Yamase T, 2005, J MATER CHEM, V15, P4773, DOI 10.1039/b504585a	42	88	88	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e79676	10.1371/journal.pone.0079676	http://dx.doi.org/10.1371/journal.pone.0079676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147146	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200104
J	Gallopin, M; Rau, A; Jaffrezic, F				Gallopin, Melina; Rau, Andrea; Jaffrezic, Florence			A Hierarchical Poisson Log-Normal Model for Network Inference from RNA Sequencing Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SEQ; MICRORNAS	Gene network inference from transcriptomic data is an important methodological challenge and a key aspect of systems biology. Although several methods have been proposed to infer networks from microarray data, there is a need for inference methods able to model RNA-seq data, which are count-based and highly variable. In this work we propose a hierarchical Poisson log-normal model with a Lasso penalty to infer gene networks from RNA-seq data; this model has the advantage of directly modelling discrete data and accounting for inter-sample variance larger than the sample mean. Using real microRNA-seq data from breast cancer tumors and simulations, we compare this method to a regularized Gaussian graphical model on log-transformed data, and a Poisson log-linear graphical model with a Lasso penalty on power-transformed data. For data simulated with large inter-sample dispersion, the proposed model performs better than the other methods in terms of sensitivity, specificity and area under the ROC curve. These results show the necessity of methods specifically designed for gene network inference from RNA-seq data.	[Gallopin, Melina; Rau, Andrea; Jaffrezic, Florence] INRA, Dept Genet Anim, Jouy En Josas, France; [Gallopin, Melina; Rau, Andrea; Jaffrezic, Florence] AgroParis Tech, Dept Genet Anim, Paris, France; [Gallopin, Melina] Univ Paris 11, Dept Math, F-91405 Orsay, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Gallopin, M (corresponding author), INRA, Dept Genet Anim, Jouy En Josas, France.	melina.gallopin@jouy.inra.fr	Gallopin, Mélina/L-2937-2017	Gallopin, Mélina/0000-0002-2431-7825				Allen GI, 2012, IEEE INT C BIOINF BI; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Auer PL, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1627; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cai Y, 2012, IEEE INT WORK GENOM, P46, DOI 10.1109/GENSIPS.2012.6507723; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; Erdos P, 1959, PUBLICATIONES MATH, V6, P419; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Giorgi FM, 2013, BIOINFORMATICS, V29, P717, DOI 10.1093/bioinformatics/btt053; Giraud C, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1625; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo JA, 2011, BIOMETRIKA, V98, P1, DOI 10.1093/biomet/asq060; Hong SJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt145; Iancu OD, 2012, BIOINFORMATICS, V28, P1592, DOI 10.1093/bioinformatics/bts245; Karlis D, 2005, STAT COMPUT, V15, P255, DOI 10.1007/s11222-005-4069-4; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROBINSON MD, 2010, GENOME BIOL, V11; Schelldorfer N, 2012, J COMPUTATI IN PRESS, P1; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Srivastava N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2861; Stahlhut Espinosa Carlos E, 2006, Yale J Biol Med, V79, P131; Verzelen N, 2012, ELECTRON J STAT, V6, P38, DOI 10.1214/12-EJS666; Whittaker J., 1990, GRAPHICAL MODELS APP; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Zou C, 2012, CELL CYCLE, V11, P2137, DOI 10.4161/cc.20598	32	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77503	10.1371/journal.pone.0077503	http://dx.doi.org/10.1371/journal.pone.0077503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147011	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200039
J	Hermey, G; Mahlke, C; Gutzmann, JJ; Schreiber, J; Bluthgen, N; Kuhl, D				Hermey, Guido; Mahlke, Claudia; Gutzmann, Jakob J.; Schreiber, Joerg; Bluethgen, Nils; Kuhl, Dietmar			Genome-Wide Profiling of the Activity-Dependent Hippocampal Transcriptome	PLOS ONE			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; SYNAPTIC PLASTICITY; NERVOUS-SYSTEM; KAINIC ACID; NEURONAL-ACTIVITY; TARGET GENES; EXPRESSION; PROTEIN; SEIZURE	Activity-dependent gene expression is central for sculpting neuronal connectivity in the brain. Despite the importance for synaptic plasticity, a comprehensive analysis of the temporal changes in the transcriptomic response to neuronal activity is lacking. In a genome wide survey we identified genes that were induced at 1, 4, 8, or 24 hours following neuronal activity in the hippocampus. According to their distinct expression kinetics we assigned these genes to five clusters, each containing approximately 200 genes. Using in situ hybridizations the regulated expression of 24 genes was validated. Apart from known activity-dependent genes our study reveals a large number of unknown induced genes with distinct expression kinetics. Among these we identified several genes with complex temporal expression patterns. Furthermore, our study provides examples for activity-induced exon switching in the coding region of genes and activity-induced alternative splicing of the 3'-UTR. One example is Zwint. In contrast to the constitutively expressed variant, the induced Zwint transcript harbors multiple regulatory elements in the 3'-UTR. Taken together, our study provides a comprehensive analysis of the transcriptomic response to neuronal activity and sheds new light on expression kinetics and alternative splicing events.	[Hermey, Guido; Mahlke, Claudia; Gutzmann, Jakob J.; Kuhl, Dietmar] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg, Inst Mol & Cellular Cognit, Hamburg, Germany; [Schreiber, Joerg] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Bluethgen, Nils] Charite, Inst Theoret Biol, D-13353 Berlin, Germany; [Bluethgen, Nils] Charite, Inst Pathol, D-13353 Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hermey, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol Hamburg, Inst Mol & Cellular Cognit, Hamburg, Germany.	hermey@zmnh.uni-hamburg.de; kuhl@zmnh.uni-hamburg.de	Kuhl, Dietmar/A-4689-2009; Bluthgen, Nils/A-1711-2011; Hermey, Guido/AAC-5565-2020	Kuhl, Dietmar/0000-0002-4772-6701; Bluthgen, Nils/0000-0002-0171-7447; Hermey, Guido/0000-0003-4762-5262	German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase I; German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase II; FORSYS-Partner program	German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase I; German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase II; FORSYS-Partner program	This work was supported by the German Federal Ministry for Education and Research (BMBF) from the Bernstein Centre Berlin phase I (DK) and phase II (NB) and by the FORSYS-Partner program (NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1998, SCIENCE, V279, P338, DOI 10.1126/science.279.5349.338; Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Altar CA, 2004, J NEUROSCI, V24, P2667, DOI 10.1523/JNEUROSCI.5377-03.2004; Barnes G, 2003, HIPPOCAMPUS, V13, P1, DOI 10.1002/hipo.10041; Bottai D, 2002, J NEUROSCI, V22, P167, DOI 10.1523/JNEUROSCI.22-01-00167.2002; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Chen CY, 1995, TRENDS BIOCHEM SCI, V11, P465, DOI DOI 10.1016/S0968-0004(00)89102-1.PUBMED:8578590; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Duman RS, 2002, MOL PSYCHIATR, V7, pS29, DOI 10.1038/sj.mp.4001016; Elam C, 2005, CANCER RES, V65, P3117, DOI 10.1158/0008-5472.CAN-04-0749; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; French PJ, 2001, EUR J NEUROSCI, V14, P2037, DOI 10.1046/j.0953-816x.2001.01818.x; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hermey G, 2004, J NEUROCHEM, V88, P1470, DOI 10.1046/j.1471-4159.2004.02286.x; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Jacobs GH, 2006, NUCLEIC ACIDS RES, V34, pD37, DOI 10.1093/nar/gkj159; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kielbasa SM, 2010, NUCLEIC ACIDS RES, V38, pW275, DOI 10.1093/nar/gkq438; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lee HK, 2002, J NEUROCHEM, V81, P1338, DOI 10.1046/j.1471-4159.2002.00937.x; Leslie JH, 2011, PROG NEUROBIOL, V94, P223, DOI 10.1016/j.pneurobio.2011.05.002; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Park CS, 2006, J BIOL CHEM, V281, P30195, DOI 10.1074/jbc.M605876200; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Sala C, 2003, J NEUROSCI, V23, P6327; Schoch S, 2006, CELL TISSUE RES, V326, P379, DOI 10.1007/s00441-006-0244-y; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; van Vlijmen T, 2008, FEBS LETT, V582, P2838, DOI 10.1016/j.febslet.2008.07.012; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Zucman-Rossi J, 1996, GENOMICS, V38, P247, DOI 10.1006/geno.1996.0625	47	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76903	10.1371/journal.pone.0076903	http://dx.doi.org/10.1371/journal.pone.0076903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146943	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200026
J	Collier, N; Tran, MV; Le, HQ; Ha, QT; Oellrich, A; Rebholz-Schuhmann, D				Collier, Nigel; Mai-vu Tran; Hoang-quynh Le; Quang-Thuy Ha; Oellrich, Anika; Rebholz-Schuhmann, Dietrich			Learning to Recognize Phenotype Candidates in the Auto-Immune Literature Using SVM Re-Ranking	PLOS ONE			English	Article							ONTOLOGY; INFORMATION; GENE; TOOL; PROTEIN; CORPUS; NAMES	The identification of phenotype descriptions in the scientific literature, case reports and patient records is a rewarding task for bio-medical text mining. Any progress will support knowledge discovery and linkage to other resources. However because of their wide variation a number of challenges still remain in terms of their identification and semantic normalisation before they can be fully exploited for research purposes. This paper presents novel techniques for identifying potential complex phenotype mentions by exploiting a hybrid model based on machine learning, rules and dictionary matching. A systematic study is made of how to combine sequence labels from these modules as well as the merits of various ontological resources. We evaluated our approach on a subset of Medline abstracts cited by the Online Mendelian Inheritance of Man database related to auto-immune diseases. Using partial matching the best micro-averaged F-score for phenotypes and five other entity classes was 79.9%. A best performance of 75.3% was achieved for phenotype candidates using all semantics resources. We observed the advantage of using SVM-based learn-to-rank for sequence label combination over maximum entropy and a priority list approach. The results indicate that the identification of simple entity types such as chemicals and genes are robustly supported by single semantic resources, whereas phenotypes require combinations. Altogether we conclude that our approach coped well with the compositional structure of phenotypes in the auto-immune domain.	[Collier, Nigel; Rebholz-Schuhmann, Dietrich] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Collier, Nigel; Mai-vu Tran; Hoang-quynh Le] Natl Inst Informat, Tokyo, Japan; [Mai-vu Tran; Hoang-quynh Le; Quang-Thuy Ha] Univ Engn & Technol VNU, Knowledge Technol Lab, Hanoi, Vietnam; [Oellrich, Anika] Wellcome Trust Sanger Inst, Mouse Informat Grp, Cambridge, England; [Rebholz-Schuhmann, Dietrich] Univ Zurich, Dept Computat Linguist, Zurich, Switzerland	European Molecular Biology Laboratory (EMBL); Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Vietnam National University Hanoi; Wellcome Trust Sanger Institute; University of Zurich	Collier, N (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Wellcome Trust Genome Campus, Cambridge, England.	collier@ebi.ac.uk	Ha, Quang-Thuy/AAB-9678-2022	Ha, Quang-Thuy/0000-0002-3901-3357; Collier, Nigel/0000-0002-7230-4164; Rebholz-Schuhmann, Dietrich/0000-0002-1018-0370	EC Marie Curie International Incoming Fellowship grant [301806]; National Institute of Informatics internship grant	EC Marie Curie International Incoming Fellowship grant; National Institute of Informatics internship grant	NC is supported by an EC Marie Curie International Incoming Fellowship grant (http://ec.europa.eu/research/mariecurieactions/index_en.htm) for project Phenominer (project number 301806). MT and HL are supported by a National Institute of Informatics internship grant (www.nii.ac.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisswanger E, 2008, APPL ONTOL, V3, P205, DOI 10.3233/AO-2008-0057; Blake A., 2003, Tourism Economics, V9, P449; Campos D., 2013, BMC BIOINFORMATICS, V14; Carpenter Bob, 2007, P 2 BIOCR CHALL EV W, V23, P307; Chen LF, 2004, STUD HEALTH TECHNOL, V107, P758; Collier N, 2012, P 24 INT C COMP LING; Corbett P, 2007, P WORKSH BIONLP 2007, P57; Cui Licong, 2012, AMIA Annu Symp Proc, V2012, P1191; de Bruijn B, 2011, J AM MED INFORM ASSN, V18, P557, DOI 10.1136/amiajnl-2011-000150; Di Eugenio B, 2004, COMPUT LINGUIST, V30, P95, DOI 10.1162/089120104773633402; Doan S, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-36; Dowell KG, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap019; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Fukuda K, 1998, Pac Symp Biocomput, P707; Gerner M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-85; GKOUTOS G, 2004, BUILDING MOUSE PHENO, P178; Gremse M, 2011, NUCLEIC ACIDS RES, V39, pD507, DOI 10.1093/nar/gkq968; Grishman R, 1998, P 6 WORKSH VER LARG, P152; Groza Tudor, 2012, The Semantic Web. 11th International Semantic Web Conference (ISWC 2012). Proceedings, P82, DOI 10.1007/978-3-642-35173-0_6; Groza T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-265; Hanisch D, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S14; Hirschman L., 2012, DATABASE, V2012; Hoehndorf R, 2012, BIOINFORMATICS, V28, P1783, DOI 10.1093/bioinformatics/bts250; Hoehndorf R, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr538; Hoehndorf R, 2010, BIOINFORMATICS, V26, P3112, DOI 10.1093/bioinformatics/btq578; Kabiljo R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-233; Kawazoe A, 2006, P INT WORKSH BIOM ON, P77; Kazama J., 2002, P WORKSHOP NATURAL L, P1, DOI DOI 10.3115/1118149.1118150; Khordad M, 2011, LECT NOTES ARTIF INT, V6657, P246, DOI 10.1007/978-3-642-21043-3_30; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Kim JD, 2006, TRNLPUT20061 U TOK S; Krallinger M, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s1, 10.1186/gb-2008-9-S2-S4, 10.1186/gb-2008-9-s2-s4, 10.1186/gb-2008-9-S2-S1]; Krauthammer M, 2000, GENE, V259, P245, DOI 10.1016/S0378-1119(00)00431-5; Leaman Robert, 2008, Pac Symp Biocomput, P652; Lyle R, 2000, NAT GENET, V25, P19, DOI 10.1038/75546; Mabee PM, 2007, TRENDS ECOL EVOL, V22, P345, DOI 10.1016/j.tree.2007.03.013; Magnini B., 2006, P 2 WORKSH ONT LEARN, P26; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Nigel C, 2000, P 18 C COMP LING COL, P201, DOI [DOI 10.3115/990820.990850, DOI 10.3115/990820]; Ohta Tomoko, 2012, P WORKSH DET STRUCT, P27; Okazaki N, 2007, CFRSUITE FAST IMPLEM; Ratnaparkhi Adwait, 1996, C EMP METH NAT LANG; Rebholz-Schuhmann Dietrich, 2011, J Biomed Semantics, V2 Suppl 5, pS11, DOI 10.1186/2041-1480-2-S5-S11; Rebholz-Schuhmann Dietrich, 2010, Journal of Bioinformatics and Computational Biology, V8, P163, DOI 10.1142/S0219720010004562; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Robinson PN, 2008, AM J HUM GENET, V83, P610, DOI 10.1016/j.ajhg.2008.09.017; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Scheuermann Richard H, 2009, Summit Transl Bioinform, V2009, P116; Schwartz Ariel S, 2003, Pac Symp Biocomput, P451; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Shen D., 2004, ACL, P589, DOI [10.3115/1218955.1219030, DOI 10.3115/1218955.1219030]; Smedley D, 2013, NUCLEIC ACIDS RES, V2013; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Smith CL, 2009, WIRES SYST BIOL MED, V1, P390, DOI 10.1002/wsbm.44; Suakkaphong N, 2011, J AM SOC INF SCI TEC, V62, P727, DOI 10.1002/asi.21488; Tanabe L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S3; Tateisi Y, 2000, P COLING 2000 WORKSH, P28; Tsuruoka, 2004, P INT JOINT WORKSH N, P70, DOI DOI 10.3115/1567594.1567610; Tsuruoka Y, 2005, LECT NOTES COMPUT SC, V3746, P382; Tsuruoka Y., 2003, P ACL 2003 WORKSH NA, P41; Tuason O, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P238; Uzuner O, 2010, J AM MED INFORM ASSN, V17, P514, DOI 10.1136/jamia.2010.003947; Verspoor K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-207; Vlachos A., 2006, P HLT NAACL BIONLP W; Zhou G, 2004, P JOINT WORKSH NAT L, P96, DOI DOI 10.3115/1567594.1567616	65	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e72965	10.1371/journal.pone.0072965	http://dx.doi.org/10.1371/journal.pone.0072965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155869	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300003
J	Mittinty, MN; Golley, RK; Smithers, LG; Brazionis, L; Lynch, JW				Mittinty, Murthy N.; Golley, Rebecca K.; Smithers, Lisa G.; Brazionis, Laima; Lynch, John W.			A Preference Based Measure of Complementary Feeding Quality: Application to the Avon Longitudinal Study of Parents and Children	PLOS ONE			English	Article							DECISION-MAKING; UTILITY-THEORY; DIET QUALITY; HEALTH; BIOMARKERS; INDEXES	This paper presents the development of the Complementary Feeding Utility Index (CFUI), a composite index aimed to measure adherence to infant feeding guidelines. Through an axiomatic characterization this paper shows the advantages in using the CFUI are the following: it avoids the use of arbitrary cut-offs, and by converting observed diet preferences into utilities, summing the score is meaningful. In addition, as the CFUI is designed to be scored continuously, it allows the transition from intake of beneficial foods (in low quantities) and intake of detrimental foods (in high quantities) to be more subtle. The paper first describes the rationale being the development of the CFUI and then elaborates on the methodology used to develop the CFUI, including the process of selecting the components. The methodology is applied to data collected from the Avon Longitudinal Study of Parents and Children to show the advantages of the CFUI over traditional diet index approaches. Unlike traditional approaches, the distribution of the CFUI does not peak towards mean value but distributes evenly towards the tails of the distribution.	[Mittinty, Murthy N.; Smithers, Lisa G.; Brazionis, Laima; Lynch, John W.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Golley, Rebecca K.] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Lynch, John W.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Adelaide; University of South Australia; University of Bristol	Mittinty, MN (corresponding author), Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia.	murthy.mittinty@adelaide.edu.au	Lynch, John W/A-4797-2008; Golley, Rebecca K/D-1606-2009; Smithers, Lisa/D-1605-2009	Lynch, John W/0000-0003-2781-7902; Smithers, Lisa/0000-0002-6585-7836; Golley, Rebecca/0000-0001-5197-7987	UK Medical Research Council [74882]; Wellcome Trust [076467]; National Medical Health Research Council Australian Research Fellow; John Lynch NHMRC Australian Fellow Program; Medical Research Council [G9815508] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Medical Health Research Council Australian Research Fellow; John Lynch NHMRC Australian Fellow Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The UK Medical Research Council (Grant ref: 74882) the Wellcome Trust (Grant ref: 076467) and the University of Bristol provide core support for ALSPAC. John Lynch was supported with the National Medical Health Research Council Australian Research Fellow. MNM, LGS and LB were supported by John Lynch NHMRC Australian Fellow Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Arvaniti F, 2008, CRIT REV FOOD SCI, V48, P317, DOI 10.1080/10408390701326268; DYER JS, 1992, MANAGE SCI, V38, P645, DOI 10.1287/mnsc.38.5.645; Emmett P, 2009, EUR J CLIN NUTR, V63, pS38, DOI 10.1038/ejcn.2008.63; Golley RK, 2012, J NUTR, V142, P901, DOI 10.3945/jn.111.154971; Hann CS, 2001, AM J CLIN NUTR, V74, P479; HARVEY CM, 1981, MANAGE SCI, V27, P190, DOI 10.1287/mnsc.27.2.190; Kant AK, 2005, J AM COLL NUTR, V24, P294, DOI 10.1080/07315724.2005.10719477; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Keeney R.L., 1976, DECISIONS MULTIPLE O; Kourlaba G, 2009, ANN EPIDEMIOL, V19, P692, DOI 10.1016/j.annepidem.2009.03.019; Moeller S. M., 2007, Journal of the American Dietetic Association, V107, P1233, DOI 10.1016/j.jada.2007.03.014; NATHAN HSK, 2008, WP2008001 IGIDR; Pohekar SD, 2004, RENEW SUST ENERG REV, V8, P365, DOI 10.1016/j.rser.2003.12.007; Salukvadze NI., 2007, MODEL ASSISTED STAT, V2, P239, DOI [10.3233/MAS-2007-2406., DOI 10.3233/MAS-2007-2406]; Smithers LG, 2011, NUTR REV, V69, P449, DOI 10.1111/j.1753-4887.2011.00407.x; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; von Neumann J., 1947, THEORY GAMES EC BEHA, V2; Waijers P, 2005, INDEXES OVERALL DIET; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Wirt A, 2009, PUBLIC HEALTH NUTR, V12, P2473, DOI 10.1017/S136898000900531X; World Health Organization, 2008, DEF CONCL CONS M H 1; Zeleny M., 1974, Computers & Operations Research, V1, P479, DOI 10.1016/0305-0548(74)90064-1; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76111	10.1371/journal.pone.0076111	http://dx.doi.org/10.1371/journal.pone.0076111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155886	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300020
J	Xu, XH; Qu, WM; Bian, MJ; Huang, F; Fei, J; Urade, Y; Huang, ZL				Xu, Xin-Hong; Qu, Wei-Min; Bian, Min-Juan; Huang, Fang; Fei, Jian; Urade, Yoshihiro; Huang, Zhi-Li			Essential Roles of GABA Transporter-1 in Controlling Rapid Eye Movement Sleep and in Increased Slow Wave Activity after Sleep Deprivation	PLOS ONE			English	Article							UPTAKE INHIBITOR TIAGABINE; STEM GABAERGIC NEURONS; PARADOXICAL REM SLEEP; HOMEOSTATIC REGULATION; CEREBRAL-CORTEX; MICE; MECHANISMS; RECEPTOR; ACTIVATION; RAT	GABA is the major inhibitory neurotransmitter in the mammalian central nervous system that has been strongly implicated in the regulation of sleep. GABA transporter subtype 1 (GAT1) constructs high affinity reuptake sites for GABA and regulates GABAergic transmission in the brain. However, the role of GAT1 in sleep-wake regulation remains elusive. In the current study, we characterized the spontaneous sleep-wake cycle and responses to sleep deprivation in GAT1 knock-out (KO) mice. GAT1 KO mice exhibited dominant theta-activity and a remarkable reduction of EEG power in low frequencies across all vigilance stages. Under baseline conditions, spontaneous rapid eye movement (REM) sleep of KO mice was elevated both during the light and dark periods, and non-REM (NREM) sleep was reduced during the light period only. KO mice also showed more state transitions from NREM to REM sleep and from REM sleep to wakefulness, as well as more number of REM and NREM sleep bouts than WT mice. During the dark period, KO mice exhibited more REM sleep bouts only. Six hours of sleep deprivation induced rebound increases in NREM and REM sleep in both genotypes. However, slow wave activity, the intensity component of NREM sleep was briefly elevated in WT mice but remained completely unchanged in KO mice, compared with their respective baselines. These results indicate that GAT1 plays a critical role in the regulation of REM sleep and homeostasis of NREM sleep.	[Xu, Xin-Hong; Qu, Wei-Min; Huang, Zhi-Li] Fudan Univ, Shanghai Med Coll, Dept Pharmacol, Shanghai 200433, Peoples R China; [Qu, Wei-Min; Huang, Fang; Huang, Zhi-Li] Fudan Univ, Inst Brain Sci, Shanghai 200433, Peoples R China; [Bian, Min-Juan; Huang, Fang; Huang, Zhi-Li] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Fei, Jian] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan	Fudan University; Fudan University; Fudan University; Tongji University	Qu, WM (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Pharmacol, Shanghai 200433, Peoples R China.	quweimin@fudan.edu.cn; huangzl@fudan.edu.cn		Huang, Zhi-Li/0000-0001-9359-1150	National Natural Science Foundation of China [30901797, 30970955, 31070957, 31171010, 31121061, 31271164]; Shanghai Committee of Science and Technology [10441901600, 11ZR1402000, 13140903100]; National Basic Research Program of China [2009CB5220004, 2011CB711000]; Shanghai Leading Academic Discipline Project [B119]; Ph.D. Programs Foundation of Ministry of Education of China [20110071110033]; China National Science and Technology Major Project for Drug Discovery [2009ZX09303-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Basic Research Program of China(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); China National Science and Technology Major Project for Drug Discovery	This study was supported in part by grants-in-aid for scientific research from National Natural Science Foundation of China (30901797, 30970955, 31070957, 31171010, 31121061, 31271164), Shanghai Committee of Science and Technology (10441901600, 11ZR1402000, 13140903100), National Basic Research Program of China (2009CB5220004, 2011CB711000), Shanghai Leading Academic Discipline Project (B119), Ph.D. Programs Foundation of Ministry of Education of China (20110071110033) and China National Science and Technology Major Project for Drug Discovery (2009ZX09303-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borhegyi Z, 2004, J NEUROSCI, V24, P8470, DOI 10.1523/JNEUROSCI.1413-04.2004; Bragina L, 2008, J NEUROCHEM, V105, P1781, DOI 10.1111/j.1471-4159.2008.05273.x; Brodie MJ, 1995, EPILEPSIA, V36, pS7, DOI 10.1111/j.1528-1157.1995.tb06015.x; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cai YQ, 2006, J NEUROSCI RES, V84, P255, DOI 10.1002/jnr.20884; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Chiu CS, 2002, J NEUROSCI, V22, P10251; Clement O, 2012, J NEUROSCI, V32, P16763, DOI 10.1523/JNEUROSCI.1885-12.2012; Conti F, 2004, BRAIN RES REV, V45, P196, DOI 10.1016/j.brainresrev.2004.03.003; Datta S, 2007, NEUROSCI BIOBEHAV R, V31, P775, DOI 10.1016/j.neubiorev.2007.02.004; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gong N, 2009, J NEUROSCI, V29, P15836, DOI 10.1523/JNEUROSCI.4643-09.2009; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; GUASTELLA J, 1990, SCIENCE, V249, P1303, DOI 10.1126/science.1975955; Gvilia I, 2006, J NEUROSCI, V26, P9426, DOI 10.1523/JNEUROSCI.2012-06.2006; Huang ZL, 2006, P NATL ACAD SCI USA, V103, P4687, DOI 10.1073/pnas.0600451103; Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; JUHASZ G, 1994, NEUROSCI LETT, V172, P155, DOI 10.1016/0304-3940(94)90685-8; Lancel M, 1998, BRIT J PHARMACOL, V123, P1471, DOI 10.1038/sj.bjp.0701769; Leach JP, 1998, LANCET, V351, P203, DOI 10.1016/S0140-6736(97)05035-6; Liu GX, 2007, NEUROPSYCHOPHARMACOL, V32, P1531, DOI 10.1038/sj.npp.1301281; Liu Z, 2012, CNS NEUROSCI THER, V18, P623, DOI 10.1111/j.1755-5949.2012.00334.x; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Mathias S, 2001, NEUROBIOL AGING, V22, P247, DOI 10.1016/S0197-4580(00)00232-3; McGinty D, 2001, SLEEP MED REV, V5, P323, DOI 10.1053/smrv.2001.0170; Nitz D, 1996, AM J PHYSIOL-REG I, V271, pR1707, DOI 10.1152/ajpregu.1996.271.6.R1707; Qiu MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045471; Qu WM, 2008, J NEUROSCI, V28, P8462, DOI 10.1523/JNEUROSCI.1819-08.2008; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Qu WM, 2010, J NEUROSCI, V30, P4382, DOI 10.1523/JNEUROSCI.4936-09.2010; Sanford LD, 2003, J NEUROPHYSIOL, V90, P938, DOI 10.1152/jn.00993.2002; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Schachter SC, 1999, CLIN NEUROPHARMACOL, V22, P312; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Simon AP, 2006, J NEUROSCI, V26, P9038, DOI 10.1523/JNEUROSCI.1401-06.2006; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; Vienne J, 2010, J NEUROSCI, V30, P14194, DOI 10.1523/JNEUROSCI.3145-10.2010; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Xi MC, 1999, J NEUROPHYSIOL, V82, P2015, DOI 10.1152/jn.1999.82.4.2015	45	3	3	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75823	10.1371/journal.pone.0075823	http://dx.doi.org/10.1371/journal.pone.0075823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155871	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300005
J	Dakshinamoorthy, G; Munirathinam, G; Stoicescu, K; Reddy, MV; Kalyanasundaram, R				Dakshinamoorthy, Gajalakshmi; Munirathinam, Gnanasekar; Stoicescu, Kristen; Reddy, Maryada Venkatarami; Kalyanasundaram, Ramaswamy			Large Extracellular Loop of Tetraspanin as a Potential Vaccine Candidate for Filariasis	PLOS ONE			English	Article							BRUGIA-MALAYI; PROTECTIVE IMMUNITY; LYMPHATIC FILARIASIS; ONCHOCERCA-VOLVULUS; BANCROFTIAN FILARIASIS; SCHISTOSOMA-MANSONI; ANTIBODY-RESPONSES; HIGH-LEVEL; INFECTION; ANTIGEN	Lymphatic filariasis affects nearly 120 million people worldwide and mass preventive chemotherapy is currently used as a strategy to control this infection. This has substantially reduced the incidence of the infection in several parts of the world. However, a prophylactic vaccine would be more effective in preventing future infections and will supplement the mass chemotherapy efforts. Unfortunately, there is no licensed vaccine available currently to prevent this infection. Molecules expressed on the surface of the parasite are potential candidates for vaccine development as they are exposed to the host immune system. In this study we show that the large extracellular loop of tetraspanin (TSP LEL), a protein expressed on the cuticle of Brugia malayi and Wuchereria bancrofti is a potential vaccine candidate. Our results showed that BmTSP LEL is expressed on the surface of B. malayi infective third stage larvae (L3) and sera from human subjects who are putatively immune to lymphatic filariasis carry high titer of IgG1 and IgG3 antibodies against BmTSP LEL and WbTSP LEL. We also showed that these antibodies in the sera of human subjects can participate in the killing of B. malayi L3 in an antibody dependent cell-mediated cytotoxicity mechanism. Vaccination trials in mice showed that close to 64% protection were achieved against challenge infections with B. malayi L3. Immunized animals showed high titer of anti-WbTSP LEL IgG1, IgG2a and IgG2b antibodies in the sera and IFN-gamma secreting cells in the spleen. Onchocerca volvulus another filarial parasite also expresses TSP LEL. Cross-reactivity studies showed that IgG1 antibody in the sera of endemic normal subjects, recognize OvTSP LEL. Similarly, anti-OvTSP LEL antibodies in the sera of subjects who are immune to O. volvulus were also shown to cross-react with rWbTSP LEL and rBmTSP LEL. These findings thus suggested that rTSP LEL can be developed as a potential vaccine candidate against multiple filarial infections.	[Dakshinamoorthy, Gajalakshmi; Munirathinam, Gnanasekar; Stoicescu, Kristen; Kalyanasundaram, Ramaswamy] Univ Illinois, Coll Med Rockford, Dept Biomed Sci, Rockford, IL USA; [Reddy, Maryada Venkatarami] Mahatma Gandhi Inst Med Sci, Dept Biochem, Sevagram, Maharashtra, India	University of Illinois System; University of Illinois Chicago; University of Illinois Rockford; Mahatma Gandhi Institute of Medical Sciences, Sevagram	Kalyanasundaram, R (corresponding author), Univ Illinois, Coll Med Rockford, Dept Biomed Sci, Rockford, IL USA.	ramswamy@uic.edu			National Institutes of Health [RO1 AI064745]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funding from National Institutes of Health through grant RO1 AI064745. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM D, 1989, AM J TROP MED HYG, V40, P598, DOI 10.4269/ajtmh.1989.40.598; Anand SB, 2007, PARASITOL RES, V101, P981, DOI 10.1007/s00436-007-0571-2; Anand SB, 2012, APPL BIOCHEM BIOTECH, V167, P1351, DOI 10.1007/s12010-012-9643-6; Babayan SA, 2012, PARASITE IMMUNOL, V34, P243, DOI 10.1111/j.1365-3024.2011.01350.x; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; CASSONE A, 2010, MBIO, V1, DOI DOI 10.1128/MBI0.00042-10.PUBMED:20689748.RETRIEVED; Cho-Ngwa F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000800; Cupit PM, 2011, INT J PARASITOL, V41, P1249, DOI 10.1016/j.ijpara.2011.07.007; Da'dara AA, 2001, VACCINE, V20, P359, DOI 10.1016/S0264-410X(01)00374-7; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Dakshinamoorthy G, 2013, VACCINE, V31, P1616, DOI 10.1016/j.vaccine.2012.09.055; Dakshinamoorthy G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034077; Dang ZS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001570; Dang ZS, 2009, VACCINE, V27, P7339, DOI 10.1016/j.vaccine.2009.09.045; Dash Y, 2011, INFECT IMMUN, V79, P838, DOI 10.1128/IAI.00128-10; FAN S, 1991, CELL IMMUNOL, V135, P78, DOI 10.1016/0008-8749(91)90255-A; FREEDMAN DO, 1989, J CLIN INVEST, V83, P14, DOI 10.1172/JCI113850; Gnanasekar M, 2008, DNA SEQUENCE, V19, P151, DOI 10.1080/10425170701517614; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hoerauf A, 2011, CLIN MICROBIOL INFEC, V17, P977, DOI 10.1111/j.1469-0691.2011.03586.x; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Jones EL, 2011, BIOCHEM SOC T, V39, P506, DOI 10.1042/BST0390506; Jones MK, 2004, BIOESSAYS, V26, P752, DOI 10.1002/bies.20058; KIPPS TJ, 1985, J EXP MED, V161, P1, DOI 10.1084/jem.161.1.1; Kurniawan-Atmadja A, 1998, PARASITE IMMUNOL, V20, P9, DOI 10.1046/j.1365-3024.1998.t01-1-00118.x; Lahariya C, 2011, J VECTOR DIS, V48, P1; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Liu XS, 2009, J IMMUNOL, V183, P51, DOI 10.4049/jimmunol.0802047; MacDonald AJ, 2002, INFECT IMMUN, V70, P2796, DOI 10.1128/IAI.70.6.2796-2804.2002; Madhumathi J, 2010, VACCINE, V28, P5038, DOI 10.1016/j.vaccine.2010.05.012; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Makepeace BL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000544; Michael E, 2000, TROP MED SCI PRACT, V1, P41; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Murray J, 2001, MOL BIOCHEM PARASIT, V118, P89, DOI 10.1016/S0166-6851(01)00374-7; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Pearson MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001564; Perez-Sanchez R, 2006, PROTEOMICS, V6, pS226, DOI 10.1002/pmic.200500420; Pokharel DR, 2006, VACCINE, V24, P6208, DOI 10.1016/j.vaccine.2006.05.103; Rao KVN, 2000, MOL BIOCHEM PARASIT, V107, P71, DOI 10.1016/S0166-6851(99)00231-5; Ravindran B, 2003, MED MICROBIOL IMMUN, V192, P41, DOI 10.1007/s00430-002-0157-7; ROZSNYAY Z, 1989, IMMUNOLOGY, V66, P491; Sahoo MK, 2009, VACCINE, V27, P4263, DOI 10.1016/j.vaccine.2009.05.015; Samykutty A, 2010, PROCEDIA VACCINOL, V3, P12, DOI 10.1016/j.provac.2010.11.003; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Steel C, 1996, J INFECT DIS, V174, P598, DOI 10.1093/infdis/174.3.598; Stewart GR, 1997, INFECT IMMUN, V65, P164, DOI 10.1128/IAI.65.1.164-170.1997; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Teillaud J. L., 2012, ELS, DOI [10.1002/ 9780470015902.a0000498.pub2, DOI 10.1002/9780470015902.A0000498.PUB2]; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Tran MH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000840; Vedi S, 2008, VACCINE, V26, P5997, DOI 10.1016/j.vaccine.2008.08.073; Veerapathran A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000457; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037019; Zeldenryk LM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001366	56	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77394	10.1371/journal.pone.0077394	http://dx.doi.org/10.1371/journal.pone.0077394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146990	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400116
J	Franken, J; Brandt, BA; Tai, SL; Bauer, FF				Franken, Jaco; Brandt, Bianca A.; Tai, Siew L.; Bauer, Florian F.			Biosynthesis of Levan, a Bacterial Extracellular Polysaccharide, in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							WINE YEAST; LEVANSUCRASE; FERMENTATION; EXPRESSION; FRUCTANS; CLONING; MUTANT; DOMAIN; CDNA	Levans are fructose polymers synthesized by a broad range of micro-organisms and a limited number of plant species as non-structural storage carbohydrates. In microbes, these polymers contribute to the formation of the extracellular polysaccharide (EPS) matrix and play a role in microbial biofilm formation. Levans belong to a larger group of commercially important polymers, referred to as fructans, which are used as a source of prebiotic fibre. For levan, specifically, this market remains untapped, since no viable production strategy has been established. Synthesis of levan is catalysed by a group of enzymes, referred to as levansucrases, using sucrose as substrate. Heterologous expression of levansucrases has been notoriously difficult to achieve in Saccharomyces cerevisiae. As a strategy, this study used an invertase (Delta suc2) null mutant and two separate, engineered, sucrose accumulating yeast strains as hosts for the expression of the levansucrase M1FT, previously cloned from Leuconostoc mesenteroides. Intracellular sucrose accumulation was achieved either by expression of a sucrose synthase (Susy) from potato or the spinach sucrose transporter (SUT). The data indicate that in both.suc2 and the sucrose accumulating strains, the M1FT was able to catalyse fructose polymerisation. In the absence of the predicted M1FT secretion signal, intracellular levan accumulation was significantly enhanced for both sucrose accumulation strains, when grown on minimal media. Interestingly, co-expression of M1FT and SUT resulted in hyper-production and extracellular build-up of levan when grown in rich medium containing sucrose. This study presents the first report of levan production in S. cerevisiae and opens potential avenues for the production of levan using this well established industrial microbe. Furthermore, the work provides interesting perspectives when considering the heterologous expression of sugar polymerizing enzymes in yeast.	[Franken, Jaco; Brandt, Bianca A.; Tai, Siew L.; Bauer, Florian F.] Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, Western Cape, South Africa	Stellenbosch University	Bauer, FF (corresponding author), Univ Stellenbosch, Inst Wine Biotechnol, ZA-7600 Stellenbosch, Western Cape, South Africa.	fb2@sun.ac.za	Bauer, Florian/A-1078-2013; Tai, Siew L/E-6476-2016	Bauer, Florian/0000-0001-5764-4542; Tai, Siew L/0000-0002-2148-3115; Brandt, Bianca Anina/0000-0001-9197-8095	NRF NPPD postdoctoral fellowship; National Research Foundation of SA [78691]; Winetech	NRF NPPD postdoctoral fellowship; National Research Foundation of SA; Winetech	JF was supported by an NRF NPPD postdoctoral fellowship. National Research Foundation of SA, grant number 78691 (http://www.nrf.ac.za/). The research was financially supported by Winetech, the research funding body of the SA wine industry (IWBT-Y08/01; http://www.winetech.co.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banguela A, 2011, J BIOTECHNOL, V154, P93, DOI 10.1016/j.jbiotec.2011.04.007; Batista AS, 2004, J MOL MICROB BIOTECH, V8, P26, DOI 10.1159/000082078; BELY M, 1990, AM J ENOL VITICULT, V41, P319; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Berthels NJ, 2004, FEMS YEAST RES, V4, P683, DOI 10.1016/j.femsyr.2004.02.005; Cairns AJ, 2003, J EXP BOT, V54, P549, DOI 10.1093/jxb/erg056; Chiang CJ, 2009, APPL MICROBIOL BIOT, V82, P445, DOI 10.1007/s00253-008-1772-z; Demel RA, 1998, BBA-BIOMEMBRANES, V1375, P36, DOI 10.1016/S0005-2736(98)00138-2; Dogsa I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062044; Eyeghe-Bickong HA, 2012, J CHROMATOGR B, V885, P43, DOI 10.1016/j.jchromb.2011.12.011; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Kang FK, 2005, BBA-GENE STRUCT EXPR, V1727, P5, DOI 10.1016/j.bbaexp.2004.10.012; Kang HK, 2011, FOOD SCI BIOTECHNOL, V20, P277, DOI 10.1007/s10068-011-0039-0; Krugel U, 2008, PLANT CELL, V20, P2497, DOI 10.1105/tpc.108.058271; Lafraya A, 2011, APPL ENVIRON MICROB, V77, P6148, DOI 10.1128/AEM.05032-11; Liesche J, 2010, MOL PLANT, V3, P1064, DOI 10.1093/mp/ssq059; Olvera C, 2012, APPL ENVIRON MICROB, V78, P1820, DOI 10.1128/AEM.07222-11; Pretorius IS, 2005, AUST J GRAPE WINE R, V11, P83, DOI 10.1111/j.1755-0238.2005.tb00281.x; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Rehm J, 1998, J BACTERIOL, V180, P1305, DOI 10.1128/JB.180.5.1305-1310.1998; RIESMEIER JW, 1992, EMBO J, V11, P4705, DOI 10.1002/j.1460-2075.1992.tb05575.x; SALANOUBAT M, 1987, GENE, V60, P47, DOI 10.1016/0378-1119(87)90212-5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCOTTI PA, 1994, YEAST, V10, P29, DOI 10.1002/yea.320100104; Scotti PA, 1996, YEAST, V12, P953, DOI 10.1002/(SICI)1097-0061(199608)12:10<953::AID-YEA998>3.0.CO;2-#; Shida T, 2002, BIOSCI BIOTECH BIOCH, V66, P1555, DOI 10.1271/bbb.66.1555; SHIH IL, 2010, BIORESOURCE TECHNOL, V120, P3966; SHIMAMURA A, 1987, CARBOHYD RES, V165, P150, DOI 10.1016/0008-6215(87)80091-5; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; TOLEDO LET, 2001, ELECTRON J BIOTECHN, V7, P115; Turk SCHJ, 1997, NEW PHYTOL, V136, P29, DOI 10.1046/j.1469-8137.1997.00727.x; Velazquez-Hernandez ML, 2009, J APPL MICROBIOL, V106, P1763, DOI 10.1111/j.1365-2672.2008.04120.x; Volschenk H, 1997, NAT BIOTECHNOL, V15, P253, DOI 10.1038/nbt0397-253; WISE CS, 1955, ANAL CHEM, V27, P33, DOI 10.1021/ac60097a011	38	29	29	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77499	10.1371/journal.pone.0077499	http://dx.doi.org/10.1371/journal.pone.0077499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147008	gold, Green Published			2022-12-27	WOS:000325819400123
J	Hattab, T; Lasram, FB; Albouy, C; Sammari, C; Romdhane, MS; Cury, P; Leprieur, F; Le Loc'h, F				Hattab, Tarek; Lasram, Frida Ben Rais; Albouy, Camille; Sammari, Cherif; Romdhane, Mohamed Salah; Cury, Philippe; Leprieur, Fabien; Le Loc'h, Francois			The Use of a Predictive Habitat Model and a Fuzzy Logic Approach for Marine Management and Planning	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; FISH ASSEMBLAGES; SPATIAL-DISTRIBUTION; PSEUDO-ABSENCES; CLIMATE-CHANGE; DISTRIBUTIONS; SUITABILITY; PERFORMANCE; CLASSIFICATION; COMMUNITY	Bottom trawl survey data are commonly used as a sampling technique to assess the spatial distribution of commercial species. However, this sampling technique does not always correctly detect a species even when it is present, and this can create significant limitations when fitting species distribution models. In this study, we aim to test the relevance of a mixed methodological approach that combines presence-only and presence-absence distribution models. We illustrate this approach using bottom trawl survey data to model the spatial distributions of 27 commercially targeted marine species. We use an environmentally-and geographically-weighted method to simulate pseudo-absence data. The species distributions are modelled using regression kriging, a technique that explicitly incorporates spatial dependence into predictions. Model outputs are then used to identify areas that met the conservation targets for the deployment of artificial anti-trawling reefs. To achieve this, we propose the use of a fuzzy logic framework that accounts for the uncertainty associated with different model predictions. For each species, the predictive accuracy of the model is classified as 'high'. A better result is observed when a large number of occurrences are used to develop the model. The map resulting from the fuzzy overlay shows that three main areas have a high level of agreement with the conservation criteria. These results align with expert opinion, confirming the relevance of the proposed methodology in this study.	[Hattab, Tarek; Lasram, Frida Ben Rais; Romdhane, Mohamed Salah] INAT, UR Ecosyst & Ressources Aquat 03AGRO1, Tunis, Tunisia; [Hattab, Tarek; Cury, Philippe; Le Loc'h, Francois] IRD, UMR Ecosyst Marins Exploites 212, Sete, France; [Albouy, Camille] UQAR, Dept Biol Chim & Geog, Quebec City, PQ, Canada; [Sammari, Cherif] INSTM, Lab Milieu Marin, Salammbo, Tunisia; [Leprieur, Fabien] UM2, UMR 5119, Lab Ecol Syst Marins Cotiers, Montpellier, France	Universite de Carthage; Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Quebec; Universite du Quebec a Rimouski; Institut National des Sciences et Technologies de la Mer; Universite de Montpellier	Hattab, T (corresponding author), INAT, UR Ecosyst & Ressources Aquat 03AGRO1, Tunis, Tunisia.	hattab.tarek@gmail.com	Leprieur, Fabien/C-4430-2008; Hattab, Tarek/K-2992-2014; Le Loc'h, François/A-5038-2008; albouy, camille/ABD-2206-2021; albouy, camille/H-9317-2012; Leprieur, Fabien/ABA-4433-2020; Romdhane, Mohamed Salah/GTB-5864-2022	Hattab, Tarek/0000-0002-1420-5758; Le Loc'h, François/0000-0002-3372-6997; albouy, camille/0000-0003-1629-2389; albouy, camille/0000-0003-1629-2389; Romdhane, Mohamed Salah/0000-0002-3343-7554; Ben Rais Lasram, Frida/0000-0003-3327-908X; Cury, philippe/0000-0002-4622-4208	Institut de Recherche pour le Developpement; Fondation pour la Recherche sur la Biodiversite	Institut de Recherche pour le Developpement; Fondation pour la Recherche sur la Biodiversite	This work was partly funded by the Institut de Recherche pour le Developpement (http://www.ird.fr/) and by the 'Fondation pour la Recherche sur la Biodiversite' (http://www.fondationbiodiversite.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy C, 2012, GLOBAL CHANGE BIOL, V18, P2995, DOI 10.1111/j.1365-2486.2012.02772.x; Anderson RP, 2003, J BIOGEOGR, V30, P591, DOI 10.1046/j.1365-2699.2003.00867.x; [Anonymous], 1999, B I NAT SCI TECH MER; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Batisse M., 1995, GLOBAL REPRESENTATIV, VI, P77; Ben Mustapha K., 2007, MEDSUDMED TECHNICAL, P32; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chambers J. M., 1991, STAT MODELS S; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Degraer S, 2008, CONT SHELF RES, V28, P369, DOI 10.1016/j.csr.2007.09.001; Direction Generale de la Peche et de l'Aquaculture (DGPA), 2010, ANN STAT PECH TUN; Dixon PM, 2005, ECOLOGY, V86, P1114, DOI 10.1890/04-0601; El Lakhrach H, 2012, MEDITERR MAR SCI, V13, P12, DOI 10.12681/mms.19; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Ferrier S, 2006, J APPL ECOL, V43, P393, DOI 10.1111/j.1365-2664.2006.01149.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanberry BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044486; Harris PT, 2009, OCEAN COAST MANAGE, V52, P22, DOI 10.1016/j.ocecoaman.2008.09.009; Hattour A., 1991, CHALUTAGE EAUX TUNIS; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Hengl T, 2009, ECOL MODEL, V220, P3499, DOI 10.1016/j.ecolmodel.2009.06.038; HILL MO, 1976, TAXON, V25, P249, DOI 10.2307/1219449; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hoffman JC, 2009, MAR COAST FISH, V1, P255, DOI 10.1577/C08-048.1; Jensen AC, 2000, ARTIFICIAL REEFS EUR; Jimenez-Valverde A, 2008, ANN ZOOL FENN, V45, P200, DOI 10.5735/086.045.0305; Johnson AF, 2013, FISH FISH, V14, P256, DOI 10.1111/j.1467-2979.2012.00466.x; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Katsanevakis S, 2009, FISHERIES SCI, V75, P13, DOI 10.1007/s12562-008-0033-5; KING G, 2001, POLITICAL ANAL, V0009; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loiselle BA, 2003, CONSERV BIOL, V17, P1591, DOI 10.1111/j.1523-1739.2003.00233.x; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacLeod CD, 2008, HYDROBIOLOGIA, V612, P21, DOI 10.1007/s10750-008-9491-0; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Maxwell DL, 2009, J SEA RES, V61, P258, DOI 10.1016/j.seares.2008.11.008; McCullagh P, 1989, GEN LINEAR MODELS; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Monk J, 2011, CONT SHELF RES, V31, pS17, DOI 10.1016/j.csr.2010.02.012; Monk J, 2014, FISH FISH, V15, P352, DOI 10.1111/faf.12039; Monk J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034558; Monk J, 2010, MAR ECOL PROG SER, V420, P157, DOI 10.3354/meps08858; Montero J, 2009, STUD FUZZ SOFT COMP, V243, P67; Montgomery DC., 2007, DESIGN ANAL EXPT; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; Munoz-Perez JJ, 2000, B MAR SCI, V67, P761; Najar B, 2010, EVOLUTION PROFILS DE, V39; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Palialexis A, 2011, HYDROBIOLOGIA, V670, P241, DOI 10.1007/s10750-011-0673-9; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinson LM, 2011, GLOBAL ECOL BIOGEOGR, V20, P789, DOI 10.1111/j.1466-8238.2010.00636.x; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Teh LCL, 2011, ENVIRON MANAGE, V47, P536, DOI 10.1007/s00267-011-9645-0; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Valavanis VD, 2008, HYDROBIOLOGIA, V612, P5, DOI 10.1007/s10750-008-9493-y; Watson J.E.M., 2011, CONSERVATION BIOGEOG, P136; WILLIAMS AK, 2003, THESIS VIRGINIA POLY; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Yackulic CB, 2012, METHODS ECOLOGY EVOL, P236, DOI [10.1111/2041-210x12004, DOI 10.1111/2041-210X12004]; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zarnetske PL, 2007, ECOL APPL, V17, P1714, DOI 10.1890/06-1312.1; Zheng BY, 2000, STAT MED, V19, P1771, DOI 10.1002/1097-0258(20000715)19:13<1771::AID-SIM485>3.3.CO;2-G	76	40	40	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76430	10.1371/journal.pone.0076430	http://dx.doi.org/10.1371/journal.pone.0076430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146867	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400057
J	Stronen, AV; Jedrzejewska, B; Pertoldi, C; Demontis, D; Randi, E; Niedzialkowska, M; Pilot, M; Sidorovich, VE; Dykyy, I; Kusak, J; Tsingarska, E; Kojola, I; Karamanlidis, AA; Ornicans, A; Lobkov, VA; Dumenko, V; Czarnomska, SD				Stronen, Astrid V.; Jedrzejewska, Bogumila; Pertoldi, Cino; Demontis, Ditte; Randi, Ettore; Niedzialkowska, Magdalena; Pilot, Malgorzata; Sidorovich, Vadim E.; Dykyy, Ihor; Kusak, Josip; Tsingarska, Elena; Kojola, Ilpo; Karamanlidis, Alexandros A.; Ornicans, Aivars; Lobkov, Vladimir A.; Dumenko, Vitalii; Czarnomska, Sylwia D.			North-South Differentiation and a Region of High Diversity in European Wolves (Canis lupus)	PLOS ONE			English	Article							GENETIC-STRUCTURE; POPULATION-STRUCTURE; WOLF POPULATIONS; MITOCHONDRIAL; DIET; VARIABILITY; DISPERSAL; HISTORY; SIZE; CONSEQUENCES	European wolves (Canis lupus) show population genetic structure in the absence of geographic barriers, and across relatively short distances for this highly mobile species. Additional information on the location of and divergence between population clusters is required, particularly because wolves are currently recolonizing parts of Europe. We evaluated genetic structure in 177 wolves from 11 countries using over 67K single nucleotide polymorphism (SNP) loci. The results supported previous findings of an isolated Italian population with lower genetic diversity than that observed across other areas of Europe. Wolves from the remaining countries were primarily structured in a north-south axis, with Croatia, Bulgaria, and Greece (Dinaric-Balkan) differentiated from northcentral wolves that included individuals from Finland, Latvia, Belarus, Poland and Russia. Carpathian Mountain wolves in central Europe had genotypes intermediate between those identified in northcentral Europe and the Dinaric-Balkan cluster. Overall, individual genotypes from northcentral Europe suggested high levels of admixture. We observed high diversity within Belarus, with wolves from western and northern Belarus representing the two most differentiated groups within northcentral Europe. Our results support the presence of at least three major clusters (Italy, Carpathians, Dinaric-Balkan) in southern and central Europe. Individuals from Croatia also appeared differentiated from wolves in Greece and Bulgaria. Expansion from glacial refugia, adaptation to local environments, and human-related factors such as landscape fragmentation and frequent killing of wolves in some areas may have contributed to the observed patterns. Our findings can help inform conservation management of these apex predators and the ecosystems of which they are part.	[Stronen, Astrid V.; Jedrzejewska, Bogumila; Niedzialkowska, Magdalena; Czarnomska, Sylwia D.] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Pertoldi, Cino] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Pertoldi, Cino; Randi, Ettore] Aalborg Univ, Sect Environm Engn, Dept 18, Aalborg, Denmark; [Pertoldi, Cino] Aalborg Zoo, Aalborg, Denmark; [Demontis, Ditte] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Randi, Ettore] Ist Super Protez & Ric Ambientale, Genet Lab, Ozzano Dell Emilia, BO, Italy; [Pilot, Malgorzata] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Sidorovich, Vadim E.] Natl Acad Sci, Inst Zool, Minsk, BELARUS; [Dykyy, Ihor] Ivan Franko Natl Univ Lviv, Dept Zool, Fac Biol, Lvov, Ukraine; [Kusak, Josip] Univ Zagreb, Fac Vet Med, Dept Biol, Zagreb 41000, Croatia; [Tsingarska, Elena] BALKANI Wildlife Soc, Sofia, Bulgaria; [Kojola, Ilpo] Finnish Game & Fisheries Res Inst, Oulu, Finland; [Karamanlidis, Alexandros A.] Civil Soc Protect & Management Wildlife & Nat Env, ARCTUROS, Thessaloniki, Greece; [Karamanlidis, Alexandros A.] Norwegian Univ Life Sci, Dept Ecol & Nat Resources Management, As, Norway; [Ornicans, Aivars] Latvian State Forest Res Inst Silava, Salaspils, Latvia; [Lobkov, Vladimir A.] Natl II Mechnikov Univ, Zool Museum Odessa, Odessa, Ukraine; [Dumenko, Vitalii] Biosphere Reserve Askania Nova, Chaplynka Dist, Kherson Region, Ukraine	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Aarhus University; Aalborg University; Aarhus University; Italian Institute for Environmental Protection & Research (ISPRA); Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; Ministry of Education & Science of Ukraine; Ivan Franko National University Lviv; University of Zagreb; Natural Resources Institute Finland (Luke); Norwegian University of Life Sciences; Latvian State Forest Research Institute "Silava"; Ministry of Education & Science of Ukraine; Odesa I. I. Mechnikov National University	Stronen, AV (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	astrid.stronen@gmail.com	Kusak, Josip/T-8344-2019; Demontis, Ditte/M-4515-2013; Karamanlidis, Alexandros/S-8239-2017; Stronen, Astrid Vik/AFJ-8208-2022; Pertoldi, Cino/I-1746-2012; Dietz, Rune/F-9154-2015	Karamanlidis, Alexandros/0000-0003-0943-1619; Stronen, Astrid Vik/0000-0002-5169-6736; Pertoldi, Cino/0000-0002-4644-8981; Dietz, Rune/0000-0001-9652-317X; Dykyy, Ihor/0000-0003-3625-8567; Demontis, Ditte/0000-0001-9124-2766; Niedzialkowska, Magdalena/0000-0002-7746-4116; Pilot, Malgorzata/0000-0002-6057-5768; Kusak, Josip/0000-0002-5544-6486; Czarnomska, Sylwia/0000-0002-8081-0956	BIOCONSUS [245737]; BIOGEAST [247652]; Mammal Research Institute at the Polish Academy of Sciences; Polish Ministry of Science and Higher Education [6P04F 09421, NN 303 418437]; EURONATUR (Germany); Marie Curie Transfer of Knowledge Fellowships [MTKD-CT-2005-029957]; Danish Natural Science Research Council [11-103926, 09-065999, 95095995]; Carlsberg Foundation [2011-01-0059]; ISPRA (Instituto Superiore per la Protezione e la Ricerca Ambientale); Italian Ministry of Environment	BIOCONSUS; BIOGEAST; Mammal Research Institute at the Polish Academy of Sciences; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EURONATUR (Germany); Marie Curie Transfer of Knowledge Fellowships; Danish Natural Science Research Council(Danish Natural Science Research Council); Carlsberg Foundation(Carlsberg Foundation); ISPRA (Instituto Superiore per la Protezione e la Ricerca Ambientale); Italian Ministry of Environment	This study was funded by BIOCONSUS (Research Potential in Conservation and Sustainable Management of Biodiversity, 7th Framework Programme contract no. 245737), BIOGEAST (Biodiversity of East-European and Siberian large mammals on the level of genetic variation of populations, 7th Framework Programme contract no. 247652), The Mammal Research Institute at the Polish Academy of Sciences, the Polish Ministry of Science and Higher Education (grants no. 6P04F 09421 and NN 303 418437), EURONATUR (Germany), Marie Curie Transfer of Knowledge Fellowships to CP and JK (project BIORESC in the 6th Framework Programme, contract no. MTKD-CT-2005-029957), grants to CP from the Danish Natural Science Research Council (grant number: #11-103926, #09-065999 and 95095995) and the Carlsberg Foundation (grant number 2011-01-0059), ISPRA (Instituto Superiore per la Protezione e la Ricerca Ambientale) and the Italian Ministry of Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J, 2012, MAMMAL REV, V42, P1, DOI 10.1111/j.1365-2907.2011.00185.x; Aspi J, 2009, CONSERV GENET, V10, P815, DOI 10.1007/s10592-008-9642-x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Brandstrom M, 2008, GENOME RES, V18, P881, DOI 10.1101/gr.075242.107; Carmichael LE, 2007, MOL ECOL, V16, P3466, DOI 10.1111/j.1365-294X.2007.03381.x; Ciucci P, 2009, J WILDLIFE MANAGE, V73, P1300, DOI 10.2193/2008-510; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; DUMENKO VP, 2001, T ZOOLOGICAL MUSEUM, V4, P170; DUMENKO VP, 2005, NEWS BIOSPHERE RESER, V7, P102; DUMENKO VP, 2004, NEWS BIOSPHERE RESER, V6, P83; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Geffen E, 2004, MOL ECOL, V13, P2481, DOI 10.1111/j.1365-294X.2004.02244.x; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Gomercic T, 2010, ZOOL STUD, V49, P816; GURSKII I G, 1975, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V80, P131; Gursky I.G., 1985, P487; Haasl RJ, 2011, HEREDITY, V106, P158, DOI 10.1038/hdy.2010.21; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; Hofreiter M, 2007, CURR BIOL, V17, pR609, DOI 10.1016/j.cub.2007.06.031; Huck M, 2011, ACTA THERIOL, V56, P91, DOI 10.1007/s13364-010-0006-9; *ILL INC, 2010, GENOMESTUDIO GEN MOD, P18815; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jansson E, 2012, MOL ECOL, V21, P5178, DOI 10.1111/mec.12010; Jedrzejewska B, 1996, MAMMAL REV, V26, P103; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Jedrzejewski Wlodzimierz, 2010, P207; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kahlke R-D., 1999, HIST ORIGIN EVOLUTIO; Knowles JC, 2010, THESIS U ALBERTA EDM; Kojola I, 2004, J ZOOL, V263, P229, DOI 10.1017/S0952836904005084; Kusak J, 2005, EUR J WILDLIFE RES, V51, P254, DOI 10.1007/s10344-005-0111-2; KUSAK J, 2009, 2009 NOVEMBER 20 22, P51; Liberg O, 2012, P ROY SOC B-BIOL SCI, V279, P910, DOI 10.1098/rspb.2011.1275; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; LINNELL J, 2008, GUIDELINES POPULATIO, P70501; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; Milenkovic M, 2010, J MAMMAL, V91, P376, DOI 10.1644/09-MAMM-A-265.1; Munoz-Fuentes V, 2009, J BIOGEOGR, V36, P1516, DOI 10.1111/j.1365-2699.2008.02067.x; Nosil P, 2005, EVOLUTION, V59, P705; Nowak S, 2011, MAMM BIOL, V76, P709, DOI 10.1016/j.mambio.2011.06.007; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; PAPAGEORGIOU N, 1994, ACTA THERIOL, V39, P411, DOI 10.4098/AT.arch.94-48; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039341; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2012, R LANG ENV STAT COMP; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Rice AM, 2011, ECOL LETT, V14, P9, DOI 10.1111/j.1461-0248.2010.01546.x; Riley SPD, 2006, MOL ECOL, V15, P1733, DOI 10.1111/j.1365-294X.2006.02907.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rueness EK, 2003, NATURE, V425, P69, DOI 10.1038/nature01942; Sacks BN, 2005, MOL ECOL, V14, P1241, DOI 10.1111/j.1365-294X.2005.02473.x; Sacks BN, 2004, MOL ECOL, V13, P1265, DOI 10.1111/j.1365-294X.2004.02110.x; Schede J.-U., 2010, WOLFE BRANDENBURG SP; Sidorovich VE, 2007, CAN J ZOOL, V85, P295, DOI 10.1139/Z07-001; Sidorovich VE, 2003, WILDLIFE BIOL, V9, P103, DOI 10.2981/wlb.2003.032; Straka M, 2012, CONSERV GENET, V13, P153, DOI 10.1007/s10592-011-0271-4; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; Wabakken P, 2007, J WILDLIFE MANAGE, V71, P1631, DOI 10.2193/2006-222; Weckworth BV, 2005, MOL ECOL, V14, P917, DOI 10.1111/j.1365-294X.2005.02461.x	70	49	50	0	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76454	10.1371/journal.pone.0076454	http://dx.doi.org/10.1371/journal.pone.0076454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146871	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400059
J	Vernon, LT; Demko, CA; Babineau, DC; Wang, XL; Toossi, Z; Weinberg, A; Rodriguez, B				Vernon, Lance T.; Demko, Catherine A.; Babineau, Denise C.; Wang, Xuelei; Toossi, Zahra; Weinberg, Aaron; Rodriguez, Benigno			Effect of Nadir CD4+T Cell Count on Clinical Measures of Periodontal Disease in HIV plus Adults before and during Immune Reconstitution on HAART	PLOS ONE			English	Article							ORAL-HEALTH-CARE; PEOPLE; IMMUNODEFICIENCY; INDIVIDUALS; PREVALENCE	Background: The contribution of HIV-infection to periodontal disease (PD) is poorly understood. We proposed that immunological markers would be associated with improved clinical measures of PD. Methods: We performed a longitudinal cohort study of HIV-infected adults who had started highly active antiretroviral therapy (HAART) <2 years. PD was characterized clinically as the percent of teeth with >= 1 site with periodontal probing depth (PPD) >= 5.0mm, recession (REC) >0mm, clinical attachment level (CAL) >= 4.0mm, and bleeding on probing (BOP) at >= 4 sites/tooth and microbiologically as specific periodontopathogen concentration. Linear mixed-effects models were used to assess the associations between immune function and PD. Results: Forty (40) subjects with median 2.7 months on HAART and median nadir CD4+ T-cell count of 212 cells/mu l completed a median 3 visits. Over 24 months, CD4+ T-cell count increased by a mean 173 cells/mu l (p<0.001) and HIV RNA decreased by 0.5 log(10) copies/ml (p<0.001); concurrently, PPD, CAL and BOP decreased by a mean 11.7%, 12.1%, and 14.7% respectively (all p<0.001). Lower nadir CD4+ T-cell count was associated with worse baseline REC (-6.72%; p=0.04) and CAL (9.06%; p<0.001). Further, lower nadir CD4+ T-cell count was associated with a greater relative longitudinal improvement in PPD in subjects with higher baseline levels of Porphyromonas gingivalis (p=0.027), and BOP in subjects with higher baseline levels of Porphyromonas gingivalis or Treponema denticola (p=0.001 and p=0.006 respectively). Longitudinal changes from baseline in CD4+ T-cell count and level of HIV RNA were not independently associated with longitudinal changes in any clinical markers of PD. Conclusion: Degree of immunosuppression was associated with baseline gingival recession. After HAART initiation, measures of active PD improved most in those with lower nadir CD4+ T-cell counts and higher baseline levels of specific periodontopathogens. Nadir CD4+ T-cell count differentially influences periodontal disease both before and after HAART in HIV-infected adults.	[Vernon, Lance T.; Weinberg, Aaron] Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA; [Demko, Catherine A.] Case Western Reserve Univ, Sch Dent Med, Dept Community Dent, Cleveland, OH 44106 USA; [Babineau, Denise C.; Wang, Xuelei] Case Western Reserve Univ, Ctr Clin Invest, Cleveland, OH 44106 USA; [Toossi, Zahra] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [Rodriguez, Benigno] Case Western Reserve Univ, Univ Hosp Cleveland, Ctr AIDS Res, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Vernon, LT (corresponding author), Case Western Reserve Univ, Sch Dent Med, Dept Biol Sci, Cleveland, OH 44106 USA.	ltv1@case.edu	Rodriguez, Benigno/C-3365-2009	Rodriguez, Benigno/0000-0001-9736-7957; Weinberg, Aaron/0000-0002-9960-7181	National Institute of Dental and Craniofacial Research [K23 DE15746-01A1, R21 DE21376-01]; Center for AIDS Research (CFAR) [AI36219]; William T. Dahms, M.D. Clinical Research Unit (Dahms CRU) of the Clinical and Translational Science Center [UL1 RR024989]; NIH [M01 RR000080]; CWRU Department of Biological Sciences [OPR892515]; Case Western Reserve University/Cleveland Clinic CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health [UL1 RR024989]; NIH roadmap for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080, UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K23DE015746, R21DE021376] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Center for AIDS Research (CFAR); William T. Dahms, M.D. Clinical Research Unit (Dahms CRU) of the Clinical and Translational Science Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CWRU Department of Biological Sciences; Case Western Reserve University/Cleveland Clinic CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was from National Institute of Dental and Craniofacial Research, Grants K23 DE15746-01A1 and R21 DE21376-01, The Center for AIDS Research (CFAR), AI36219, the William T. Dahms, M.D. Clinical Research Unit (Dahms CRU) of the Clinical and Translational Science Center, UL1 RR024989, NIH, M01 RR000080, the CWRU Department of Biological Sciences, OPR892515, and the Case Western Reserve University/Cleveland Clinic CTSA Grant, UL1 RR024989 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health and NIH roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2006, J PERIODONTOL, V77, P773, DOI 10.1902/jop.2006.P04039; Beck James D, 2002, Ann Periodontol, V7, P79, DOI 10.1902/annals.2002.7.1.79; Beck JD, 2005, CIRCULATION, V112, P19, DOI 10.1161/CIRCULATIONAHA.104.511998; Benjamin RM, 2012, PUBLIC HEALTH REP, V127, P1; Currier JS, 2007, AIDS, V21, P1137, DOI 10.1097/QAD.0b013e32811ebf79; DRINKARD CR, 1991, COMMUNITY DENT ORAL, V19, P281, DOI 10.1111/j.1600-0528.1991.tb00168.x; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Eke PI, 2010, J DENT RES, V89, P1208, DOI 10.1177/0022034510377793; FLEISS JL, 1987, COMMUNITY DENT ORAL, V15, P221, DOI 10.1111/j.1600-0528.1987.tb00525.x; FRIEDMAN RB, 1991, J PERIODONTOL, V62, P623, DOI 10.1902/jop.1991.62.10.623; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hsue P, 2003, INCREASED ATHEROSCLE; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Jeanty Y, 2012, PUBLIC HEALTH REP, V127, P17, DOI 10.1177/00333549121270S204; Kinane DF, 2006, PERIODONTOL 2000, V40, P107, DOI 10.1111/j.1600-0757.2005.00136.x; Lekakis J, 2008, CLIN SCI, V115, P189, DOI 10.1042/CS20070353; Mangili A, 2007, CLIN INFECT DIS, V44, P1368, DOI 10.1086/516616; McKaig RG, 1998, J PUBLIC HEALTH DENT, V58, P294, DOI 10.1111/j.1752-7325.1998.tb03012.x; Morillo JM, 2004, J CLIN PERIODONTOL, V31, P1054, DOI [10.1111/j.1600-051x.2004.00608.x, 10.1111/j.1600-051X.2004.00608.x]; Mulligan R, 2004, COMMUNITY DENT ORAL, V32, P86, DOI 10.1111/j.0301-5661.2004.00128.x; Ndiaye CF, 1997, J PERIODONTOL, V68, P827, DOI 10.1902/jop.1997.68.9.827; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Rajabiun S, 2012, PUBLIC HEALTH REP, V127, P73, DOI 10.1177/00333549121270S210; Robinson P G, 1996, Oral Dis, V2, P45; Robinson PC, 2002, ORAL DIS, V8, P144, DOI 10.1034/j.1601-0825.8.s2.5.x; RYDER MI, 1988, J ACQ IMMUN DEF SYND, V1, P346; Scheutz F, 1997, J CLIN PERIODONTOL, V24, P580, DOI 10.1111/j.1600-051X.1997.tb00232.x; Seymour RA, 2003, BRIT DENT J, V194, P649, DOI 10.1038/sj.bdj.4810352; Singer R, 2012, PUBLIC HEALTH REP, V127, P36, DOI 10.1177/00333549121270S206; Tobias CR, 2012, PUBLIC HEALTH REP, V127, P45, DOI 10.1177/00333549121270S207; Toossi Z, 2005, CLIN EXP IMMUNOL, V142, P327, DOI 10.1111/j.1365-2249.2005.02913.x; Vernon LT, 2011, AIDS RES HUM RETROV, V27, P1157, DOI [10.1089/aid.2010.0320, 10.1089/AID.2010.0320]; Vernon LT, 2009, COMMUNITY DENT ORAL, V37, P427, DOI 10.1111/j.1600-0528.2009.00485.x; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Winkler J R, 1987, CDA J, V15, P20; WINKLER JR, 1989, J AM DENT ASSOC, pS25	37	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76986	10.1371/journal.pone.0076986	http://dx.doi.org/10.1371/journal.pone.0076986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146949	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400092
J	Wang, HJ; Zhang, GQ; Qi, HN				Wang, Hang-jun; Zhang, Guang-qun; Qi, Heng-nian			Wood Recognition Using Image Texture Features	PLOS ONE			English	Article							AUTOCORRELATIONS	Inspired by theories of higher local order autocorrelation (HLAC), this paper presents a simple, novel, yet very powerful approach for wood recognition. The method is suitable for wood database applications, which are of great importance in wood related industries and administrations. At the feature extraction stage, a set of features is extracted from Mask Matching Image (MMI). The MMI features preserve the mask matching information gathered from the HLAC methods. The texture information in the image can then be accurately extracted from the statistical and geometrical features. In particular, richer information and enhanced discriminative power is achieved through the length histogram, a new histogram that embodies the width and height histograms. The performance of the proposed approach is compared to the state-of-the-art HLAC approaches using the wood stereogram dataset ZAFU WS 24. By conducting extensive experiments on ZAFU WS 24, we show that our approach significantly improves the classification accuracy.	[Wang, Hang-jun] Zhejiang A&F Univ, Coll Tianmu, Linan, Peoples R China; [Wang, Hang-jun] Chinese Acad Sci, Hefei Inst Intelligent Machines, Hefei, Peoples R China; [Wang, Hang-jun] Univ Sci & Technol China, Dept Automat, Hefei 230026, Peoples R China; [Zhang, Guang-qun; Qi, Heng-nian] Zhejiang A&F Univ, Sch Informat & Technol, Linan, Peoples R China	Zhejiang A&F University; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Zhejiang A&F University	Wang, HJ (corresponding author), Zhejiang A&F Univ, Coll Tianmu, Linan, Peoples R China.	hangjunw@mail.ustc.edu.cn			National Science Foundation of China [60970082]; Talent Start-up Foundation of Zhejiang AF University [2013FR051]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talent Start-up Foundation of Zhejiang AF University	This work is supported by the grants of the National Science Foundation of China, No. 60970082, and the Talent Start-up Foundation of Zhejiang A&F University under grant No. 2013FR051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaho S, 1993, B ELECTROTECHNICAL L, V57, P973; [Anonymous], 1989, IAWA BULL, V10, P219; Baas P, 2004, IAWA J, V25, P1, DOI 10.1163/22941932-90000349; Bremananth R, 2009, INT J INTELL SYST TE, V4, P54; Canadian Wood Council, 2012, DES WOOD SUST; CHEN YQ, 1995, PATTERN RECOGN, V28, P537, DOI 10.1016/0031-3203(94)00116-4; Csurka G., 2004, WORKSHOP STAT LEARNI, P1, DOI DOI 10.1234/12345678; Dalal N, 2005, P IEEE COMPUTER SOC, P20; Douglas JG, 2004, WOOD SCI; Francisco-Fernandez M, 2012, CHEMOMETR INTELL LAB, V118, P159, DOI 10.1016/j.chemolab.2012.07.003; Galasso Fabio, 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2342, DOI 10.1109/CVPRW.2009.5206591; Goudail F, 1996, IEEE T PATTERN ANAL, V18, P1024, DOI 10.1109/34.541411; Hang-jun Wang, 2010, 2010 International Conference on Computer Application and System Modeling (ICCASM 2010), P477, DOI 10.1109/ICCASM.2010.5620573; Kobayashi T, 2008, LECT NOTES COMPUT SC, V5302, P346, DOI 10.1007/978-3-540-88682-2_27; Kreutz M, 1996, PATTERN RECOGN, V29, P19, DOI 10.1016/0031-3203(95)00078-X; Kurita T., 1998, P AS C COMP VIS, P89; Lajevardi S, 2010, SIGNAL IMAGE VIDEO P, V4, P113; Lazebnik S., 2006, 2006 IEEE COMP SOC C, P2169; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mallik A, 2011, CHEMOMETR INTELL LAB, V107, P351, DOI 10.1016/j.chemolab.2011.05.005; Matsukawa T, 2010, VISAPP 2010: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 2, P325; Matsukawa T, 2010, LECT NOTES COMPUT SC, V5996, P384; McGraw-Hill Editors, 2002, MCGRAW HILL ENC SCI, P600; MCLAUGHLIN JA, 1968, INFORM CONTROL, V12, P121, DOI 10.1016/S0019-9958(68)90241-6; Nadaraj M, 2008, INT J SIMULATION SYS, V9, P9; Nomotoy N, 2005, P IAPR C MACH VIS AP, P265; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Otsu N., 1988, Proceedings of IAPR Workshop on Computer Vision: Special Hardware and Industrial Applications, P431; Pan S., 2012, TRANS MACH LEARN DAT, V5, P45; Pan S, 2011, COMPUT ELECTRON AGR, V75, P250, DOI 10.1016/j.compag.2010.11.010; Piuri V, 2010, IEEE T SYST MAN CY C, V40, P358, DOI 10.1109/TSMCC.2009.2039479; Rojas JAM, 2011, APPL ACOUST, V72, P934, DOI 10.1016/j.apacoust.2011.05.016; Schoch W, PREPARATION WOOD MIC; Tanaka Y, 2010, IEEE T IMAGE PROCESS, V19, P934, DOI 10.1109/TIP.2009.2038820; Tarrio-Saavedra J, 2011, J THERM ANAL CALORIM, V104, P87, DOI 10.1007/s10973-010-1157-2; Toyoda T., 2005, 4 INT WORKSH TEXT AN, V12, P131; Toyoda T, 2007, PATTERN RECOGN, V40, P1466, DOI 10.1016/j.patcog.2006.10.006; Wang XF, 2010, PATTERN RECOGN, V43, P603, DOI 10.1016/j.patcog.2009.08.002; WWF, 2011, LIV PLAN REP 2010; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yusof R, 2010, 2010 12TH INTERNATIONAL CONFERENCE ON COMPUTER MODELLING AND SIMULATION (UKSIM), P289, DOI 10.1109/UKSIM.2010.61	41	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76101	10.1371/journal.pone.0076101	http://dx.doi.org/10.1371/journal.pone.0076101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146821	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400038
J	Zhao, XJ; Yun, KM; Seese, RR; Wang, ZY				Zhao, Xiaojie; Yun, Keming; Seese, Ronald R.; Wang, Zhenyuan			Galnon Facilitates Extinction of Morphine-Conditioned Place Preference but Also Potentiates the Consolidation Process	PLOS ONE			English	Article							RECOGNITION MEMORY; NEUROPEPTIDE GALANIN; DRUG MEMORIES; RECONSOLIDATION; REINFORCEMENT; MECHANISMS; ADDICTION; RECEPTORS; NICOTINE; CONTEXT	Learning and memory systems are intimately involved in drug addiction. Previous studies suggest that galanin, a neuropeptide that binds G-protein coupled receptors, plays essential roles in the encoding of memory. In the present study, we tested the function of galnon, a galanin receptor 1 and 2 agonist, in reward-associated memory, using conditioned place preference (CPP), a widely used paradigm in drug-associated memory. Either before or following CPP-inducing morphine administration, galnon was injected at four different time points to test the effects of galanin activation on different reward-associated memory processes: 15 min before CPP training (acquisition), immediately after CPP training (consolidation), 15 min before the post-conditioning test (retrieval), and multiple injection after post-tests (reconsolidation and extinction). Galnon enhanced consolidation and extinction processes of morphine-induced CPP memory, but the compound had no effect on acquisition, retrieval, or reconsolidation processes. Our findings demonstrate that a galanin receptor 1 and 2 agonist, galnon, may be used as a viable compound to treat drug addiction by facilitating memory extinction process.	[Zhao, Xiaojie; Wang, Zhenyuan] Xi An Jiao Tong Univ, Coll Med, Dept Forens Sci, Xian 710049, Shaanxi, Peoples R China; [Zhao, Xiaojie] Nanjing Med Univ, Dept Forens Med, Nanjing, Jiangsu, Peoples R China; [Yun, Keming] Shanxi Med Univ, Sch Forens Med, Taiyuan, Shanxi, Peoples R China; [Seese, Ronald R.] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92717 USA	Xi'an Jiaotong University; Nanjing Medical University; Shanxi Medical University; University of California System; University of California Irvine	Wang, ZY (corresponding author), Xi An Jiao Tong Univ, Coll Med, Dept Forens Sci, Xian 710049, Shaanxi, Peoples R China.	wzy218@mail.xjtu.edu.cn	wang, zhenyuan/AAB-4874-2021		National Sciences Foundation of China (NSFC) [81072509, 81273335]	National Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Sciences Foundation of China (NSFC, No. 81072509 & 81273335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Abramov U, 2004, NEUROPEPTIDES, V38, P55, DOI 10.1016/j.npep.2004.01.001; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Crawley JN, 1996, LIFE SCI, V58, P2185, DOI 10.1016/0024-3205(96)00093-8; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; Diergaarde L, 2008, EUR J PHARMACOL, V585, P453, DOI 10.1016/j.ejphar.2008.03.010; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Farahmandfar M, 2010, BEHAV BRAIN RES, V211, P156, DOI 10.1016/j.bbr.2010.03.013; Fricks-Gleason AN, 2008, LEARN MEMORY, V15, P643, DOI 10.1101/lm.1054608; Hawes JJ, 2008, NEUROPSYCHOPHARMACOL, V33, P1864, DOI 10.1038/sj.npp.1301579; Heinrichs SC, 2010, BEHAV BRAIN RES, V207, P353, DOI 10.1016/j.bbr.2009.10.013; Hyman SE, 2007, FOCUS, V5, P220; Jackson KJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2339, DOI 10.1038/npp.2011.123; Kuteeva E, 2008, NEUROPSYCHOPHARMACOL, V33, P2573, DOI 10.1038/sj.npp.1301660; LAND T, 1991, INT J PEPT PROT RES, V38, P267; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Lu XY, 2005, NEUROPEPTIDES, V39, P143, DOI 10.1016/j.npep.2004.12.012; Lu XY, 2005, P NATL ACAD SCI USA, V102, P874, DOI 10.1073/pnas.0408891102; Ma MX, 2007, NEUROSCIENCE, V147, P1059, DOI 10.1016/j.neuroscience.2007.05.020; Mariani RK, 2011, PSYCHOPHARMACOLOGY, V215, P483, DOI 10.1007/s00213-011-2215-6; Massey PV, 2003, NEUROPHARMACOLOGY, V44, P40, DOI 10.1016/S0028-3908(02)00297-6; Mazarati A, 2001, NEUROSCIENTIST, V7, P506, DOI 10.1177/107385840100700607; Milekic MH, 2006, J NEUROSCI, V26, P3010, DOI 10.1523/JNEUROSCI.4818-05.2006; Milton AL, 2012, NEUROSCI BIOBEHAV R, V36, P1119, DOI 10.1016/j.neubiorev.2012.01.002; Mitrovic SM, 2011, EUR REV MED PHARMACO, V15, P524; Mitrovic SM, 2011, PSYCHIAT DANUB, V23, P53; Narasimhaiah R, 2009, PSYCHOPHARMACOLOGY, V204, P95, DOI 10.1007/s00213-008-1438-7; Neugebauer NM, 2011, PHARMACOL BIOCHEM BE, V98, P87, DOI 10.1016/j.pbb.2010.12.015; Ogren SO, 1999, BRAIN RES, V848, P174, DOI 10.1016/S0006-8993(99)01973-3; Palmatier MI, 2007, PSYCHOPHARMACOLOGY, V195, P235, DOI 10.1007/s00213-007-0897-6; Pedreira ME, 2002, J NEUROSCI, V22, P8305; Picciotto MR, 2010, EXPERIENTIA SUPPL, V102, P195, DOI 10.1007/978-3-0346-0228-0_14; Picciotto MR, 2010, BRAIN RES, V1314, P206, DOI 10.1016/j.brainres.2009.08.033; Picciotto MR, 2005, NEUROPEPTIDES, V39, P313, DOI 10.1016/j.npep.2004.12.001; Rajarao SJR, 2007, NEUROPEPTIDES, V41, P307, DOI 10.1016/j.npep.2007.05.001; Robinson MJF, 2007, BEHAV BRAIN RES, V178, P146, DOI 10.1016/j.bbr.2006.12.013; Robinson MJF, 2010, BEHAV BRAIN RES, V216, P281; Saar K, 2002, P NATL ACAD SCI USA, V99, P7136, DOI 10.1073/pnas.102163499; Sadler R, 2007, BEHAV PHARMACOL, V18, P699, DOI 10.1097/FBP.0b013e3282effb81; Sorg BA, 2012, NEUROSCI BIOBEHAV R, V36, P1400, DOI 10.1016/j.neubiorev.2012.02.004; Steiner RA, 2001, P NATL ACAD SCI USA, V98, P4184, DOI 10.1073/pnas.061445598; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Wang XY, 2008, J NEUROSCI, V28, P5602, DOI 10.1523/JNEUROSCI.0750-08.2008; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P9028, DOI 10.1073/pnas.1533224100; Zhai HF, 2008, BEHAV PHARMACOL, V19, P211, DOI 10.1097/FBP.0b013e3282fe88a0; Zhao XJ, 2011, NEUROSCI LETT, V501, P50, DOI 10.1016/j.neulet.2011.06.050	48	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76395	10.1371/journal.pone.0076395	http://dx.doi.org/10.1371/journal.pone.0076395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146862	gold, Green Published			2022-12-27	WOS:000325819400055
J	Bassett, E; Moore, S				Bassett, Emma; Moore, Spencer			Gender Differences in the Social Pathways Linking Neighborhood Disadvantage to Depressive Symptoms in Adults	PLOS ONE			English	Article							SOCIOECONOMIC DISADVANTAGE; MAJOR DEPRESSION; PHYSICAL HEALTH; DISORDER; OLDER; ASSOCIATIONS	Depression debilitates the lives of millions and is projected to be the second leading disease burden worldwide by 2020. At the population level, the causes of depression are found in the everyday social and physical environments in which people live. Research has shown that men and women often experience neighbourhood environments differently and that these variations are often reflected in health outcomes. The current study examines whether social and environmental correlates of depression are similar in men and women. This study examines whether (i) there are gender differences in the association between neighbourhood disadvantage and depressive symptoms, and (ii) dimensions of social capital and cohesion mediate these associations. Data come from the Montreal Neighbourhood Networks and Healthy Aging Study, which consists of a cluster stratified sample of Montreal census tracts (n(ct) = 300) and individuals within those tracts (n(i) = 2707). Depressive symptoms and social capital were measured with a questionnaire. Neighbourhood disadvantage was measured at the census tract level using data from the 2006 Canada Census. Multilevel logistic regression stratified by gender and a three-step mediation analysis procedure were used. Final sample size for these analyses was 2574 adults. Depressive symptoms had a prevalence of 17.3% in the overall sample. Disadvantage was associated with depressive symptoms in women only (OR = 1.25, 95% CI = 1.01-1.55). Perceived neighbourhood cohesion was shown to mediate the association of disadvantage and depressive symptoms in women (ab = 0.02; 95% CI = 0.003-0.04, p<0.05). Other socio-relational variables, specifically generalized trust and trust in neighbours were associated with depression in women but did not act as mediating variables. Health promotion initiatives meant to combat depression may wish to consider gender differences in the design and implementation of neighbourhood or peer-based programs.	[Bassett, Emma; Moore, Spencer] Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada; [Moore, Spencer] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Moore, S (corresponding author), Queens Univ, Sch Kinesiol & Hlth Studies, Kingston, ON, Canada.	mooresp@queensu.ca	Moore, Spencer/AAJ-5022-2020	Moore, Spencer/0000-0002-1229-9578	Canadian Institutes of Health Research - Institute of Aging (MOP) [84584]	Canadian Institutes of Health Research - Institute of Aging (MOP)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research - Institute of Aging (MOP #84584) (www.cihr.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott S, 2008, J HEALTH PSYCHOL, V13, P874, DOI 10.1177/1359105308095060; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Browning CR, 2002, J HEALTH SOC BEHAV, V43, P383, DOI 10.2307/3090233; BRUCE ML, 1994, SOC PSYCH PSYCH EPID, V29, P165; Carpiano RM, 2006, SOC SCI MED, V62, P165, DOI 10.1016/j.socscimed.2005.05.020; Caughy MO, 2003, SOC SCI MED, V57, P227, DOI 10.1016/S0277-9536(02)00342-8; Echeverria S, 2008, HEALTH PLACE, V14, P853, DOI 10.1016/j.healthplace.2008.01.004; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Haines VA, 2011, J HEALTH SOC BEHAV, V52, P58, DOI 10.1177/0022146510394951; Hybels CF, 2006, AM J GERIAT PSYCHIAT, V14, P498, DOI 10.1097/01.JGP.0000194649.49784.29; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Karriker-Jaffe KJ, 2009, AM J COMMUN PSYCHOL, V43, P189, DOI 10.1007/s10464-009-9236-x; Kenny DA, 2008, ORGAN RES METHODS, V11, P353, DOI 10.1177/1094428107308978; Kruger DJ, 2007, AM J COMMUN PSYCHOL, V40, P261, DOI 10.1007/s10464-007-9139-7; Krull JL, 1999, EVALUATION REV, V23, P418, DOI 10.1177/0193841X9902300404; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Matheson FI, 2006, SOC SCI MED, V63, P2604, DOI 10.1016/j.socscimed.2006.07.001; Moore S, 2011, HEALTH PLACE, V17, P536, DOI 10.1016/j.healthplace.2010.12.010; Mulvaney C, 2005, SOC PSYCH PSYCH EPID, V40, P202, DOI 10.1007/s00127-005-0859-4; Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037/0022-3514.77.5.1061; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Patten SB, 2006, CAN J PSYCHIAT, V51, P84, DOI 10.1177/070674370605100204; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rajaratnam JK, 2008, INT J MENT HEALTH AD, V6, P464, DOI DOI 10.1007/S11469-007-9115-3; Rosenquist JN, 2011, MOL PSYCHIATR, V16, P273, DOI 10.1038/mp.2010.13; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Ross CE, 2000, J HEALTH SOC BEHAV, V41, P177, DOI 10.2307/2676304; Schneiders J, 2003, J EPIDEMIOL COMMUN H, V57, P699, DOI 10.1136/jech.57.9.699; Silver E, 2002, SOC SCI MED, V55, P1457, DOI 10.1016/S0277-9536(01)00266-0; Stafford M, 2005, SOC SCI MED, V60, P1681, DOI 10.1016/j.socscimed.2004.08.028; Uddin M, 2010, DEPRESS ANXIETY, V27, P658, DOI 10.1002/da.20692; Walters K, 2004, AM J PUBLIC HEALTH, V94, P1768, DOI 10.2105/AJPH.94.10.1768; Webber M, 2011, J AFFECT DISORDERS, V129, P149, DOI 10.1016/j.jad.2010.08.005	35	37	37	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76554	10.1371/journal.pone.0076554	http://dx.doi.org/10.1371/journal.pone.0076554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239KL	24146888	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200017
J	Hoover-Plow, J; Sa, QL; Huang, MG; Grondolsky, J				Hoover-Plow, Jane; Sa, Qila; Huang, Menggui; Grondolsky, Jessica			Genetic Dissection of Quantitative Trait Loci for Hemostasis and Thrombosis on Mouse Chromosomes 11 and 5 Using Congenic and Subcongenic Strains	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; VON-WILLEBRAND-FACTOR; NITRIC-OXIDE SYNTHASE; E-DEFICIENT MICE; ATHEROSCLEROSIS SUSCEPTIBILITY; LIPOPROTEIN METABOLISM; SUBSTITUTION STRAINS; ARTERIAL THROMBOSIS; INSULIN-RESISTANCE; HUMAN PLATELETS	Susceptibility to thrombosis varies in human populations as well as many inbred mouse strains. Only a small portion of this variation has been identified, suggesting that there are unknown modifier genes. The objective of this study was to narrow the quantitative trait locus (QTL) intervals previously identified for hemostasis and thrombosis on mouse distal chromosome 11 (Hmtb6) and on chromosome 5 (Hmtb4 and Hmtb5). In a tail bleeding/rebleeding assay, a reporter assay for hemostasis and thrombosis, subcongenic strain (6A-2) had longer clot stability time than did C57BL/6J (B6) mice but a similar time to the B6-Chr11(A/J) consomic mice, confirming the Hmtb6 phenotype. Six congenic and subcongenic strains were constructed for chromosome 5, and the congenic strain, 2A-1, containing the shortest A/J interval (16.6 cM, 26.6 Mbp) in the Hmtb4 region, had prolonged clot stability time compared to B6 mice. In the 3A-2 and CSS-5 mice bleeding time was shorter than for B6, mice confirming the Hmtb5 QTL. An increase in bleeding time was identified in another congenic strain (3A-1) with A/J interval (24.8 cM, 32.9 Mbp) in the proximal region of chromosome 5, confirming a QTL for bleeding previously mapped to that region and designated as Hmtb10. The subcongenic strain 4A-2 with the A/J fragment in the proximal region had a long occlusion time of the carotid artery after ferric chloride injury and reduced dilation after injury to the abdominal aorta compared to B6 mice, suggesting an additional locus in the proximal region, which was designated Hmtb11 (5 cM, 21.4 Mbp). CSS-17 mice crossed with congenic strains, 3A-1 and 3A-2, modified tail bleeding. Using congenic and subcongenic analysis, candidate genes previously identified and novel genes were identified as modifiers of hemostasis and thrombosis in each of the loci Hmtb6, Hmtb4, Hmtb10, and Hmtb11.	[Hoover-Plow, Jane] Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Cardiovasc Med, Cleveland, OH USA; Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Mol Cardiol, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hoover-Plow, J (corresponding author), Lerner Res Inst, Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Cardiovasc Med, Cleveland, OH USA.	hooverj@ccf.org		, Menggui/0000-0002-4942-5558	National Institutes of Health (NIH) [HL065204, HL078701]; American Heart Association [0825602D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065204, R01HL078701] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (NIH) HL065204, NIH HL078701, and the American Heart Association 0825602D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allayee H, 2003, ARTERIOSCL THROM VAS, V23, P1501, DOI 10.1161/01.ATV.0000090886.40027.DC; Almind K, 2003, DIABETES, V52, P1535, DOI 10.2337/diabetes.52.6.1535; Anderson PD, 2003, HUM GENET, V113, P10, DOI 10.1007/s00439-003-0933-5; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Baker AB, 2012, J AM COLL CARDIOL, V59, P1551, DOI 10.1016/j.jacc.2011.11.057; Baker AB, 2009, CIRC RES, V104, P380, DOI 10.1161/CIRCRESAHA.108.180695; BORCHMAN D, 1995, CLIN EXP IMMUNOL, V102, P373; Braun A, 2011, FRONT BIOSCI-LANDMRK, V16, P2144, DOI 10.2741/3844; Buchner DA, 2011, OBESITY, V19, P917, DOI 10.1038/oby.2010.214; Buchner DA, 2008, PHYSIOL GENOMICS, V35, P116, DOI 10.1152/physiolgenomics.00033.2008; Caprini JA, 2004, CIRCULATION, V109, pI4, DOI 10.1161/01.CIR.0000122869.59485.36; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; Chiu S, 2007, PHYSIOL GENOMICS, V31, P75, DOI 10.1152/physiolgenomics.00267.2006; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Cleator JH, 2006, BLOOD, V107, P2736, DOI 10.1182/blood-2004-07-2698; Dorsam RT, 2002, J BIOL CHEM, V277, P47588, DOI 10.1074/jbc.M208778200; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Eren M, 2002, CIRCULATION, V106, P491, DOI 10.1161/01.CIR.0000023186.60090.FB; Falati S, 2006, BLOOD, V107, P535, DOI 10.1182/blood-2005-04-1512; Furie B, 1996, HAEMOSTASIS, V26, P60; Ghosh A, 2011, BLOOD, V117, P6355, DOI 10.1182/blood-2011-02-338582; Ginsburg D, 2005, J THROMB HAEMOST, V3, P1561, DOI 10.1111/j.1538-7836.2005.01461.x; Godecke A, 1998, CIRC RES, V82, P186; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; Gwynn B, 2000, BLOOD, V96, P4227; Hollon TR, 2002, J NEUROSCI, V22, P10801, DOI 10.1523/jneurosci.22-24-10801.2002; Hoover-Plow J, 2001, BRAIN RES, V898, P256, DOI 10.1016/S0006-8993(01)02191-6; Hoover-Plow JL, 2008, INFLAMM RES, V57, P457, DOI 10.1007/s00011-008-7062-5; Hoover-Plow Jane, 2006, BMC Blood Disord, V6, P6, DOI 10.1186/1471-2326-6-6; HOOVERPLOW J, 1980, P SOC EXP BIOL MED, V165, P409; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hughes SD, 1997, ARTERIOSCL THROM VAS, V17, P1725, DOI 10.1161/01.ATV.17.9.1725; Humphries S E, 1992, Ann Epidemiol, V2, P371; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kim E, 2003, BIOCHEM BIOPH RES CO, V304, P313, DOI 10.1016/S0006-291X(03)00588-6; Kubo Y, 2005, MOL CELL BIOL, V25, P4138, DOI 10.1128/MCB.25.10.4138-4149.2005; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lembertas AV, 1997, J CLIN INVEST, V100, P1240, DOI 10.1172/JCI119637; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Marsden PA, 2003, J CLIN INVEST, V112, P58, DOI 10.1172/JCI200318114; Mehrabian M, 2001, CIRC RES, V89, P125, DOI 10.1161/hh1401.093458; Mehrabian M, 1998, J CLIN INVEST, V101, P2485, DOI 10.1172/JCI1748; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; Mohlke KL, 1996, P NATL ACAD SCI USA, V93, P15352, DOI 10.1073/pnas.93.26.15352; Moore KJ, 2000, ANNU REV GENET, V34, P653, DOI 10.1146/annurev.genet.34.1.653; Mori T, 1996, THROMB HAEMOSTASIS, V75, P49; Mouzeyan A, 2000, J LIPID RES, V41, P573; Mu JL, 1999, J LIPID RES, V40, P1328; NADEAU JH, 1995, J INFLAMM, V45, P27; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; NAGGERT JK, 1995, MAMM GENOME, V6, P131, DOI 10.1007/BF00303258; Nesheim M, 2003, CHEST, V124, p33S, DOI 10.1378/chest.124.3_suppl.33S; NIMPF J, 1985, THROMB HAEMOSTASIS, V54, P397; NOVAK EK, 1984, BLOOD, V63, P536; Nurden AT, 2012, EXPERT REV HEMATOL, V5, P487, DOI [10.1586/EHM.12.46, 10.1586/ehm.12.46]; PURCELLHUYNH DA, 1995, J CLIN INVEST, V96, P1845, DOI 10.1172/JCI118230; Quinton TM, 2004, J THROMB HAEMOST, V2, P978, DOI 10.1111/j.1538-7836.2004.00741.x; RHEA KE, 1991, J ULTRAS MED, V10, P316; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Ruppel KM, 2005, P NATL ACAD SCI USA, V102, P8281, DOI 10.1073/pnas.0503326102; Sa Q, 2008, MAMM GENOME, V19, P406, DOI 10.1007/s00335-008-9122-0; Sa Q, 2011, THROMB J, V9, DOI 10.1186/1477-9560-9-9; Sa Q, 2010, MAMM GENOME, V21, P337, DOI 10.1007/s00335-010-9274-6; SCHLAGER G, 1967, GENETICS, V57, P319; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Smith J, 2003, CURR OPIN LIPIDOL, V14, P499, DOI 10.1097/00041433-200310000-00011; Smith JD, 2006, ARTERIOSCL THROM VAS, V26, P597, DOI 10.1161/01.ATV.0000201044.33220.5c; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Voetsch B, 2004, ARTERIOSCL THROM VAS, V24, P216, DOI 10.1161/01.ATV.0000107402.79771.fc; WARDEN CH, 1995, J CLIN INVEST, V95, P1545, DOI 10.1172/JCI117827; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Yazbek SN, 2011, GENOME RES, V21, P1065, DOI 10.1101/gr.120741.111	74	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77539	10.1371/journal.pone.0077539	http://dx.doi.org/10.1371/journal.pone.0077539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147020	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200044
J	Langford-Smith, KJ; Sandiford, Z; Langford-Smith, A; Wilkinson, FL; Jones, SA; Wraith, JE; Wynn, RF; Bigger, BW				Langford-Smith, Kia J.; Sandiford, Zara; Langford-Smith, Alex; Wilkinson, Fiona L.; Jones, Simon A.; Wraith, J. Ed; Wynn, Robert F.; Bigger, Brian W.			Signal One and Two Blockade Are Both Critical for Non-Myeloablative Murine HSCT across a Major Histocompatibility Complex Barrier	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW-TRANSPLANTATION; LOW-DOSE IRRADIATION; MIXED CHIMERISM; T-CELLS; COSTIMULATION BLOCKADE; MONOCLONAL-ANTIBODY; MEDIATED ALLORESISTANCE; ALLOGENEIC CHIMERISM; CENTRAL TOLERANCE	Non-myeloablative allogeneic haematopoietic stem cell transplantation (HSCT) is rarely achievable clinically, except where donor cells have selective advantages. Murine non-myeloablative conditioning regimens have limited clinical success, partly through use of clinically unachievable cell doses or strain combinations permitting allograft acceptance using immunosuppression alone. We found that reducing busulfan conditioning in murine syngeneic HSCT, increases bone marrow (BM): blood SDF-1 ratio and total donor cells homing to BM, but reduces the proportion of donor cells engrafting. Despite this, syngeneic engraftment is achievable with non-myeloablative busulfan (25 mg/kg) and higher cell doses induce increased chimerism. Therefore we investigated regimens promoting initial donor cell engraftment in the major histocompatibility complex barrier mismatched CBA to C57BL/6 allo-transplant model. This requires full myeloablation and immunosuppression with non-depleting anti-CD4/CD8 blocking antibodies to achieve engraftment of low cell doses, and rejects with reduced intensity conditioning (<= 75 mg/kg busulfan). We compared increased antibody treatment, G-CSF, niche disruption and high cell dose, using reduced intensity busulfan and CD4/8 blockade in this model. Most treatments increased initial donor engraftment, but only addition of co-stimulatory blockade permitted long-term engraftment with reduced intensity or non-myeloablative conditioning, suggesting that signal 1 and 2 T-cell blockade is more important than early BM niche engraftment for transplant success.	[Langford-Smith, Kia J.; Sandiford, Zara; Langford-Smith, Alex; Wilkinson, Fiona L.; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Manchester, Lancs, England; [Jones, Simon A.; Wraith, J. Ed] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Wynn, Robert F.] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 1HA, Lancs, England	University of Manchester; University of Manchester; Royal Manchester Children's Hospital	Bigger, BW (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Human Dev, Manchester, Lancs, England.	Brian.Bigger@manchester.ac.uk	Langford-Smith, Alex/K-7624-2017; Langford-Smith, Alex/H-5249-2011; Bigger, Brian/I-3553-2012	Langford-Smith, Alex/0000-0001-7006-0592; Langford-Smith, Alex/0000-0001-7006-0592; Wynn, robert/0000-0002-6046-8428; Bigger, Brian/0000-0002-9708-1112; Wilkinson, Fiona/0000-0002-0358-3489	UK MPS Society; Canadian MPS Society	UK MPS Society; Canadian MPS Society	This study was funded by the UK MPS Society and the Canadian MPS Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2001, J IMMUNOL, V167, P1103, DOI 10.4049/jimmunol.167.2.1103; Anam K, 2006, TRANSPL IMMUNOL, V15, P199, DOI 10.1016/j.trim.2005.09.009; Ashizuka S, 2006, EXP HEMATOL, V34, P359, DOI 10.1016/j.exphem.2005.11.011; Baskiewicz-Masiuk M, 2009, FOLIA HISTOCHEMICA C, P395; Bigenzahn S, 2005, AM J TRANSPLANT, V5, P1237, DOI 10.1111/j.1600-6143.2005.00862.x; Bigger BW, 2006, GENE THER, V13, P117, DOI 10.1038/sj.gt.3302638; Blaha P, 2005, TRANSPLANTATION, V80, P237, DOI 10.1097/01.TP.0000164510.25625.70; Chinen J, 2010, J ALLERGY CLIN IMMUN, V125, pS324, DOI 10.1016/j.jaci.2009.11.014; Cui JS, 1999, BRIT J HAEMATOL, V107, P895, DOI 10.1046/j.1365-2141.1999.01779.x; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Daley SR, 2008, AM J TRANSPLANT, V8, P2265, DOI 10.1111/j.1600-6143.2008.02382.x; Davies JD, 1997, TRANSPLANTATION, V63, P1570, DOI 10.1097/00007890-199706150-00005; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Dumont FJ, 1995, LIFE SCI, V58, P373, DOI 10.1016/0024-3205(95)02233-3; Fehr T, 2005, EUR J IMMUNOL, V35, P2679, DOI 10.1002/eji.200526190; Ferrer IR, 2011, AM J TRANSPLANT, V11, P654, DOI 10.1111/j.1600-6143.2011.03473.x; Gilson CR, 2009, J IMMUNOL, V183, P1625, DOI 10.4049/jimmunol.0900339; Graca L, 2004, P NATL ACAD SCI USA, V101, P10122, DOI 10.1073/pnas.0400084101; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; Graca L, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-9; Honey K, 1999, J IMMUNOL, V163, P4805; Hsieh MM, 2007, EXP HEMATOL, V35, P1415, DOI 10.1016/j.exphem.2007.05.009; Ito H, 2001, J IMMUNOL, V166, P2970, DOI 10.4049/jimmunol.166.5.2970; Jopling C, 2001, BRIT J HAEMATOL, V113, P970, DOI 10.1046/j.1365-2141.2001.02825.x; Langford-Smith A, 2012, MOL THER, V20, P1610, DOI 10.1038/mt.2012.82; Lucas CL, 2011, BLOOD, V117, P5532, DOI 10.1182/blood-2010-11-318675; Luo B, 2007, EUR J IMMUNOL, V37, P1233, DOI 10.1002/eji.200636938; Mardiney M, 1996, BLOOD, V87, P4049; Meng A, 2003, EXP HEMATOL, V31, P1348, DOI 10.1016/j.exphem.2003.08.014; Metzler B, 2008, TRANSPL IMMUNOL, V20, P106, DOI 10.1016/j.trim.2008.07.002; Moreland LW, 2002, ARTHRITIS RHEUM, V46, P1470, DOI 10.1002/art.10294; Nierlich PN, 2010, TRANSPL INT, V23, P1179, DOI 10.1111/j.1432-2277.2010.01120.x; PREE I, 2006, DRUG DISCOV TODAY TH, V3, P41, DOI DOI 10.1016/J.DDSTR.2006.02.002; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; Quesenberry PJ, 2001, BLOOD, V97, P557, DOI 10.1182/blood.V97.2.557; Sergijenko A, MOL THERAPY IN PRESS; Seung E, 2003, J CLIN INVEST, V112, P795, DOI 10.1172/JC1200318599; Singhal S, 2000, BONE MARROW TRANSPL, V26, P489, DOI 10.1038/sj.bmt.1702542; Takeuchi Y, 2004, AM J TRANSPLANT, V4, P31, DOI 10.1046/j.1600-6135.2003.00272.x; Taylor PA, 2001, BLOOD, V98, P467, DOI 10.1182/blood.V98.2.467; Wekerle T, 2002, TRANSPL INT, V15, P248, DOI 10.1007/s00147-002-0411-3; Werkele T, 2000, NAT MED, V6, P464, DOI 10.1038/74731; Westerhof GR, 2000, CANCER RES, V60, P5470; Westerhuis G, 2005, BLOOD, V106, P2215, DOI 10.1182/blood-2005-04-1391; Wilkinson FL, 2013, MOL THER, V21, P868, DOI 10.1038/mt.2013.29; Wilkinson FL, 2013, MOL THERAPY IN PRESS; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wynn R, 2011, HEMATOL-AM SOC HEMAT, P285, DOI 10.1182/asheducation-2011.1.285; Wynn RF, 2009, J PEDIATR-US, V154, P609, DOI 10.1016/j.jpeds.2008.11.005; Yamazaki M, 2007, AM J TRANSPLANT, V7, P1710, DOI 10.1111/j.1600-6143.2007.01839.x; YEAGER AM, 1991, BLOOD, V78, P3312	52	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77632	10.1371/journal.pone.0077632	http://dx.doi.org/10.1371/journal.pone.0077632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147041	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200054
J	Philp, A; MacKenzie, MG; Belew, MY; Towler, MC; Corstorphine, A; Papalamprou, A; Hardie, DG; Baar, K				Philp, Andrew; MacKenzie, Matthew G.; Belew, Micah Y.; Towler, Mhairi C.; Corstorphine, Alan; Papalamprou, Angela; Hardie, D. Grahame; Baar, Keith			Glycogen Content Regulates Peroxisome Proliferator Activated Receptor-partial derivative (PPAR-partial derivative) Activity in Rat Skeletal Muscle	PLOS ONE			English	Article							PGC-1-ALPHA PROTEIN EXPRESSION; MESSENGER-RNA EXPRESSION; ENDURANCE EXERCISE; MITOCHONDRIAL BIOGENESIS; NUCLEAR ABUNDANCE; FATTY-ACIDS; DELTA; INCREASES; GAMMA; METABOLISM	Performing exercise in a glycogen depleted state increases skeletal muscle lipid utilization and the transcription of genes regulating mitochondrial beta-oxidation. Potential candidates for glycogen-mediated metabolic adaptation are the peroxisome proliferator activated receptor (PPAR) coactivator-1 alpha (PGC-1 alpha) and the transcription factor/nuclear receptor PPAR-partial derivative. It was therefore the aim of the present study to examine whether acute exercise with or without glycogen manipulation affects PGC-1 alpha and PPAR-partial derivative function in rodent skeletal muscle. Twenty female Wistar rats were randomly assigned to 5 experimental groups (n = 4): control [CON]; normal glycogen control [NG-C]; normal glycogen exercise [NG-E]; low glycogen control [LG-C]; and low glycogen exercise [LG-E]). Gastrocnemius (GTN) muscles were collected immediately following exercise and analyzed for glycogen content, PPAR-partial derivative activity via chromatin immunoprecipitation (ChIP) assays, AMPK alpha 1/alpha 2 kinase activity, and the localization of AMPK and PGC-1 alpha. Exercise reduced muscle glycogen by 47 and 75% relative to CON in the NG-E and LG-E groups, respectively. Exercise that started with low glycogen (LG-E) finished with higher AMPK-alpha 2 activity (147%, p<0.05), nuclear AMPK-alpha 2 and PGC-1 alpha, but no difference in AMPK-alpha 1 activity compared to CON. In addition, PPAR-partial derivative binding to the CPT1 promoter was significantly increased only in the LG-E group. Finally, cell reporter studies in contracting C2C12 myotubes indicated that PPAR-partial derivative activity following contraction is sensitive to glucose availability, providing mechanistic insight into the association between PPAR-partial derivative and glycogen content/substrate availability. The present study is the first to examine PPAR-partial derivative activity in skeletal muscle in response to an acute bout of endurance exercise. Our data would suggest that a factor associated with muscle contraction and/or glycogen depletion activates PPAR-partial derivative and initiates AMPK translocation in skeletal muscle in response to exercise.	[Philp, Andrew] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Philp, Andrew; Belew, Micah Y.; Papalamprou, Angela; Baar, Keith] Univ Calif Davis, Davis, CA 95616 USA; [Philp, Andrew; MacKenzie, Matthew G.; Towler, Mhairi C.; Corstorphine, Alan; Hardie, D. Grahame; Baar, Keith] Univ Dundee, Div Cell Signalling & Immunol, Dundee, Scotland; [MacKenzie, Matthew G.] Univ Dundee, Jacqui Wood Canc Ctr, Dundee, Scotland; [Towler, Mhairi C.] Vivomotion, Dundee, Scotland	University of Birmingham; University of California System; University of California Davis; University of Dundee; University of Dundee	Baar, K (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	kbaar@ucdavis.edu	Hardie, David/Z-1979-2019	Philp, Andrew/0000-0003-3860-4136; Baar, Keith/0000-0001-9337-6186; Hardie, Grahame/0000-0002-8373-7379	E. Baar Memorial Research Trust	E. Baar Memorial Research Trust	The work was supported by the E. Baar Memorial Research Trust (KB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Freyssenet D, 2007, J APPL PHYSIOL, V102, P529, DOI 10.1152/japplphysiol.01126.2005; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Hansen AK, 2005, J APPL PHYSIOL, V98, P93, DOI 10.1152/japplphysiol.00163.2004; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Holst D, 2003, BBA-MOL CELL BIOL L, V1633, P43, DOI 10.1016/S1388-1981(03)00071-4; Hulston CJ, 2010, MED SCI SPORT EXER, V42, P2046, DOI 10.1249/MSS.0b013e3181dd5070; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Philp A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1343, DOI 10.1152/ajpendo.00004.2012; Philp A, 2011, AM J PHYSIOL-REG I, V301, pR864, DOI 10.1152/ajpregu.00232.2011; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Pilegaard H, 2002, J PHYSIOL-LONDON, V541, P261, DOI 10.1113/jphysiol.2002.016832; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Steinberg GR, 2006, APPL PHYSIOL NUTR ME, V31, P302, DOI 10.1139/H06-003; Stellingwerff T, 2012, INT J SPORT NUTR EXE, V22, P392, DOI 10.1123/ijsnem.22.5.392; Terada S, 2005, ACTA PHYSIOL SCAND, V184, P59, DOI 10.1111/j.1365-201X.2005.01423.x; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watt MJ, 2004, J MOL ENDOCRINOL, V33, P533, DOI 10.1677/jme.1.01499; Watt MJ, 2002, J PHYSIOL-LONDON, V541, P969, DOI 10.1113/jphysiol.2002.018820; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284; Wojtaszewski JFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE813, DOI 10.1152/ajpendo.00436.2002; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Yeo WK, 2008, J APPL PHYSIOL, V105, P1462, DOI 10.1152/japplphysiol.90882.2008	44	35	35	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77200	10.1371/journal.pone.0077200	http://dx.doi.org/10.1371/journal.pone.0077200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146969	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200032
J	Shin, J; Xie, DL; Zhong, XP				Shin, Jinwook; Xie, Danli; Zhong, Xiao-Ping			MicroRNA-34a Enhances T Cell Activation by Targeting Diacylglycerol Kinase zeta	PLOS ONE			English	Article							IMMUNE-SYSTEM; DIFFERENTIATION; RECOGNITION; ALPHA; RESPONSES; MIR-34A; IMPAIRS; ABSENCE; ANERGY; RAS	The engagement of the T cell receptor (TCR) induces the generation of diacylglycerol (DAG), an important second messenger activating both the Ras/Erk and PKC theta/NF kappa B pathways. DAG kinases (DGKs) participate in the metabolism of DAG by converting it to phosphatidic acid. DGK zeta has been demonstrated to be able to inhibit DAG signaling following TCR engagement. Deficiency of DGK zeta increases the sensitivity of T cells to TCR stimulation, resulting in enhanced T cell activation ex vivo and in vivo. However, the mechanisms that control DGK zeta expression are poorly understood. Here we demonstrate that DGK zeta mRNA is a direct target of a cellular microRNA miR-34a. The DGK zeta transcript is decreased, whereas the primary miR-34a is upregulated upon TCR stimulation. Ectopic miR-34a expression suppresses DGK zeta protein expression through the seed match binding to both the 3' untranslated region and coding region of DGK zeta mRNA, leading to increased ERK1/2 phosphorylation and surface expression of the T cell activation marker CD69 following TCR cross-linking. In contrast, overexpression of a miR-34a competitive inhibitor increases DGK zeta expression and suppresses TCR-mediated T cell activation. Together, our data demonstrate that miR-34a is a negative regulator for DGK zeta and may play an important role in regulating T cell activation.	[Shin, Jinwook; Xie, Danli; Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA; [Xie, Danli] Wenzhou Med Univ, Sch Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zhong, Xiao-Ping] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA	Duke University; Wenzhou Medical University; Duke University	Zhong, XP (corresponding author), Duke Univ, Med Ctr, Dept Pediat, Div Allergy & Immunol, Durham, NC 27710 USA.	zhong001@mc.duke.edu	Shin, Jinwook/AAG-6004-2019	Shin, Jinwook/0000-0003-3476-7595	National Institutes of Health [AI076357, AI079088, AI101206]; American Cancer Society [RSG-08-186-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079088, R01AI076357, R01AI101206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study is supported by the National Institutes of Health (AI076357, AI079088, and AI101206) and the American Cancer Society (RSG-08-186-01-LIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Guo R, 2008, P NATL ACAD SCI USA, V105, P11909, DOI 10.1073/pnas.0711856105; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jiang P, 2012, EXP CELL RES, V318, P1175, DOI 10.1016/j.yexcr.2012.03.018; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Krishna S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00178; Krishna S, 2012, J IMMUNOL, V189, P1209, DOI 10.4049/jimmunol.1102429; Kulis M, 2011, J ALLERGY CLIN IMMUN, V128, P212, DOI 10.1016/j.jaci.2011.02.035; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liu CH, 2007, J EXP MED, V204, P781, DOI 10.1084/jem.20061856; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Martinez-Moreno M, 2012, MOL CELL BIOL, V32, P4168, DOI 10.1128/MCB.00654-12; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Olenchock BA, 2006, J EXP MED, V203, P1471, DOI 10.1084/jem.20052424; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sanjuan MA, 2001, J CELL BIOL, V153, P207, DOI 10.1083/jcb.153.1.207; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Shin J, 2012, BLOOD, V119, P3306, DOI 10.1182/blood-2011-05-353342; Shin J, 2012, J IMMUNOL, V188, P2111, DOI 10.4049/jimmunol.1102265; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Topham MK, 2006, J CELL BIOCHEM, V97, P474, DOI 10.1002/jcb.20704; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zheng Y, 2012, J EXP MED, V209, P2157, DOI 10.1084/jem.20120342; Zhong XP, 2008, IMMUNOL REV, V224, P249, DOI 10.1111/j.1600-065X.2008.00647.x; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958; Zhong XP, 2002, J BIOL CHEM, V277, P31089, DOI 10.1074/jbc.M203818200	41	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77983	10.1371/journal.pone.0077983	http://dx.doi.org/10.1371/journal.pone.0077983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147106	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200091
J	Anderwald, CH; Tura, A; Gessl, A; Luger, A; Pacini, G; Krebs, M				Anderwald, Christian-Heinz; Tura, Andrea; Gessl, Alois; Luger, Anton; Pacini, Giovanni; Krebs, Michael			Adequately Adapted Insulin Secretion and Decreased Hepatic Insulin Extraction Cause Elevated Insulin Concentrations in Insulin Resistant Non-Diabetic Adrenal Incidentaloma Patients	PLOS ONE			English	Article							ORAL GLUCOSE-TOLERANCE; BETA-CELL FUNCTION; C-PEPTIDE; SUBCLINICAL CUSHINGS; DIABETES-MELLITUS; SENSITIVITY; DEXAMETHASONE; METABOLISM; ENDOCRINE; 1ST-PHASE	Background: Insulin-resistance is commonly found in adrenal incidentaloma (AI) patients. However, little is known about beta-cell secretion in AI, because comparisons are difficult, since beta-cell-function varies with altered insulin-sensitivity. Objectives: To retrospectively analyze beta-cell function in non-diabetic AI, compared to healthy controls (CON). Methods: AI (n=217, 34% males, 57 +/- 1years, body-mass-index: 27.7 +/- 0.3kg/m(2)) and CON [n=25, 32% males, 56 +/- 1years, 26.7 +/- 0.8kg/m(2)] with comparable anthropometry (p >= 0.31) underwent oral-glucose-tolerance-tests (OGTTs) with glucose, insulin, and C-peptide measurements. 1mg-dexamethasone-suppression-tests were performed in AI. AI were divided according to post-dexamethasone-suppression-test cortisol-thresholds of 1.8 and 5 mu g/dL into 3subgroups: pDexa<1.8 mu g/dL, pDexa1.8-5 mu g/dL and pDexa>5 mu g/dL. Using mathematical modeling, whole-body insulin-sensitivity [Clamp-like-Index (CLIX)], insulinogenic Index, Disposition Index, Adaptation Index, and hepatic insulin extraction were calculated. Results: CLIX was lower in AI combined (4.9 +/- 0.2mg . kg(-1) . min(-1)), pDexa<1.8 mu g/dL (4.9 +/- 0.3) and pDexa1.8-5 mu g/dL (4.7 +/- 0.3, p<0.04 vs. CON:6.7 +/- 0.4). Insulinogenic and Disposition Indexes were 35%-97% higher in AI and each subgroup (p<0.008 vs. CON), whereas C-peptide-derived Adaptation Index, compensating for insulin-resistance, was comparable between AI, subgroups, and CON. Mathematical estimation of insulin-derived (insulinogenic and Disposition) Indexes from associations to insulin-sensitivity in CON revealed that AI-subgroups had similar to 19%-32% higher insulin-secretion than expectable. These insulin-secretion-index differences negatively (r=-0.45, p<0.001) correlated with hepatic insulin extraction, which was 13-16% lower in AI and subgroups (p<0.003 vs.CON). Conclusions: AI-patients show insulin-resistance, but adequately adapted insulin secretion with higher insulin concentrations during an OGTT, because of decreased hepatic insulin extraction; this finding affects all AI-patients, regardless of dexamethasone-suppression-test outcome.	[Anderwald, Christian-Heinz; Gessl, Alois; Luger, Anton; Krebs, Michael] Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria; [Anderwald, Christian-Heinz; Tura, Andrea; Pacini, Giovanni] Natl Res Council ISIB CNR, Metab Unit, Inst Biomed Engn, Padua, Italy; [Anderwald, Christian-Heinz] Mariahilf Community Pharm, Arnoldstein, Austria; [Anderwald, Christian-Heinz] Specialized Hosp Complex Agathenhof, Med Direct, Micheldorf, Austria	Medical University of Vienna	Anderwald, CH (corresponding author), Med Univ Vienna, Div Endocrinol & Metab, Dept Internal Med 3, Vienna, Austria.	christian-heinz.anderwald@meduniwien.ac.at	Anderwald, Christian Heinz/AAG-2271-2021	Anderwald, Christian Heinz/0000-0001-7485-0815; Krebs, Michael/0000-0002-9265-7274				Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Anderwald C, 2007, EUR J CLIN INVEST, V37, P774, DOI 10.1111/j.1365-2362.2007.01858.x; Anderwald C, 2002, DIABETES, V51, P3025, DOI 10.2337/diabetes.51.10.3025; Anderwald C, 2007, DIABETES CARE, V30, P2374, DOI 10.2337/dc07-0422; Anderwald C, 2011, DIABETES CARE, V34, P1475, DOI 10.2337/dc10-2266; Anderwald C, 2011, DIABETES CARE, V34, P437, DOI 10.2337/dc10-1137; Anderwald C, 2011, J CLIN ENDOCR METAB, V96, P515, DOI 10.1210/jc.2010-1398; Anderwald C, 2009, ENDOCRINOLOGIST, V19, P302, DOI 10.1097/TEN.0b013e3181c0479d; Anderwald CH, 2012, DIABETES CARE, V35, P2580, DOI 10.2337/dc12-0197; Beaudry JL, 2012, DIABETES-METAB RES, V28, P560, DOI 10.1002/dmrr.2310; Bonadonna RC, 2003, DIABETES, V52, P470, DOI 10.2337/diabetes.52.2.470; Cerutti F, 1998, ACTA PAEDIATR, V87, P1045, DOI 10.1080/080352598750031356; CHAP Z, 1986, J CLIN INVEST, V78, P1355, DOI 10.1172/JCI112722; Chiodini I, 2011, J CLIN ENDOCR METAB, V96, P1223, DOI 10.1210/jc.2010-2722; Chiodini I, 2010, J CLIN ENDOCR METAB, V95, P2736, DOI 10.1210/jc.2009-2387; Chiodini L, 2005, EUR J ENDOCRINOL, V153, P837, DOI 10.1530/eje.1.02045; Elbein SC, 2000, DIABETES CARE, V23, P221, DOI 10.2337/diacare.23.2.221; Faerch K, 2010, J PHYSIOL-LONDON, V588, P759, DOI 10.1113/jphysiol.2009.184028; Fernandez-Real JM, 1998, CLIN ENDOCRINOL, V49, P53, DOI 10.1046/j.1365-2265.1998.00437.x; Garrapa GGM, 2001, J CLIN ENDOCR METAB, V86, P5301, DOI 10.1210/jc.86.11.5301; Goran MI, 2002, DIABETES CARE, V25, P2184, DOI 10.2337/diacare.25.12.2184; ISLES CG, 1983, CLIN ENDOCRINOL, V18, P37, DOI 10.1111/j.1365-2265.1983.tb03184.x; Ivovic M, 2013, METABOLISM, V62, P786, DOI 10.1016/j.metabol.2012.12.006; KautzkyWiller A, 1996, METABOLISM, V45, P486, DOI 10.1016/S0026-0495(96)90224-3; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Muscogiuri G, 2011, CLIN ENDOCRINOL, V74, P300, DOI 10.1111/j.1365-2265.2010.03928.x; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Stadler M, 2006, DIABETES CARE, V29, P1031, DOI 10.2337/dc05-1247; Stadler M, 2009, DIABETOLOGIA, V52, P2435, DOI 10.1007/s00125-009-1520-7; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P4872, DOI 10.1210/jc.2001-011766; Terzolo M, 2002, J CLIN ENDOCR METAB, V87, P998, DOI 10.1210/jc.87.3.998; Tura A, 2001, AM J PHYSIOL-ENDOC M, V281, pE966, DOI 10.1152/ajpendo.2001.281.5.E966; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005; Tura A, 2011, AM J PHYSIOL-REG I, V300, pR941, DOI 10.1152/ajpregu.00650.2010; Vila G, 2010, EUR J ENDOCRINOL, V163, P225, DOI 10.1530/EJE-10-0282; Wiesner TD, 2003, J CLIN ENDOCR METAB, V88, P3632, DOI 10.1210/jc.2003-030000; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470	38	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77326	10.1371/journal.pone.0077326	http://dx.doi.org/10.1371/journal.pone.0077326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146977	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400101
J	Balanda, KP; Buckley, CM; Barron, SJ; Fahy, LE; Madden, JM; Harrington, JM; Perry, IJ; Kearney, PM				Balanda, Kevin P.; Buckley, Claire M.; Barron, Steve J.; Fahy, Lorraine E.; Madden, Jamie M.; Harrington, Janas M.; Perry, Ivan J.; Kearney, Patricia M.			Prevalence of Diabetes in the Republic of Ireland: Results from the National Health Survey (SLAN) 2007	PLOS ONE			English	Article							DIAGNOSIS; MELLITUS	Background: Current estimates of diabetes prevalence in the Republic of Ireland (RoI) are based on UK epidemiological studies. This study uses Irish data to describe the prevalence of doctor-diagnosed diabetes amongst all adults aged 18+ years and undiagnosed diabetes amongst those aged 45+ years. Methods: The survey of lifestyle attitudes and nutrition (SLAN) 2007 is based on a nationally representative sample of Irish adults aged 18+ years (n = 10,364). Self-reported doctor-diagnosed diabetes was recorded for respondents in the full sample. Diabetes medication use, measured height and weight, and non-fasting blood samples were variously recorded in sub-samples of younger (n = 967) and older (n = 1,207) respondents. Results: The prevalence of doctor-diagnosed diabetes amongst adults aged 18+ years was 3.5% (95% CI 3.1% 3.9%). After adjustment for other explanatory variables; the risk of self-reported doctor-diagnosed diabetes was significantly related to age (p < 0.0001), employment status (p = 0.0003) and obesity (p = 0.0003). Amongst adults aged 45+ years, the prevalence of doctor-diagnosed diabetes was 8.9% (95% CI 7.3% - 10.5%) and undiagnosed diabetes was 2.8% (95% CI 1.4% - 4.1%). This represented 31.2% of diabetes cases in this age group. Conclusion: Notwithstanding methodological differences, these prevalence estimates are consistent with those in the UK and France. However, the percentage of undiagnosed cases amongst adults aged 45+ years appears to be higher in the RoI. Increased efforts to improve early detection and population level interventions to address adverse diet and lifestyle factors are urgently needed.	[Balanda, Kevin P.; Barron, Steve J.; Fahy, Lorraine E.] Inst Publ Hlth Ireland, Dublin, Ireland; [Buckley, Claire M.] Natl Univ Ireland Univ Coll Cork, Dept Gen Practice, Cork, Ireland; [Buckley, Claire M.; Madden, Jamie M.; Harrington, Janas M.; Perry, Ivan J.; Kearney, Patricia M.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland	University College Cork; University College Cork	Balanda, KP (corresponding author), Inst Publ Hlth Ireland, Dublin, Ireland.	kevin.balanda@publichealth.ie	Harrington, Janas/AAV-8123-2021	Harrington, Janas/0000-0002-6238-7031; Kearney, Patricia/0000-0001-9599-3540; Madden, Jamie/0000-0003-2383-5150; Balanda, Kevin/0000-0002-6780-8536; Perry, Ivan/0000-0002-4965-9792	Health Research Board; Department of Health in the Republic of Ireland	Health Research Board; Department of Health in the Republic of Ireland	This work has been part-funded by the Health Research Board (www.hrb.ie) and the Department of Health (www.dohc.ie) in the Republic of Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Association of Public Health Observatories, 2010, APHO DIAB PREV MOD K; Balanda K., 2010, MAKING CHRONIC CONDI; Bishop YM., 2007, DISCRETE MULTIVARIAT; Bonaldi C, 2011, DIABETIC MED, V28, P583, DOI 10.1111/j.1464-5491.2011.03250.x; Central Statistics Office, 2006, CENS POP; Central Statistics Office, 2006, Q NAT HOUS SURV; Creagh D, 2002, Ir Med J, V95, P298; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Department of Health and Children, 2005, REP NATL TASKFORCE O, P1; Department of Health and Children, 2010, CHANG CARD HLTH NAT, P2010; Fonseca V, 2009, DIABETES CARE, V32, P1344, DOI 10.2337/dc09-9034; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hayes L, 2012, DIABETIC MED, V29, P115, DOI 10.1111/j.1464-5491.2011.03389.x; Health Service Executive, 2008, 1 HLTH SERV EX; Mc Hugh S, 2009, PRIM CARE DIABETES, V3, P225, DOI 10.1016/j.pcd.2009.09.002; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Morgan K, 2008, SLAN 2007 SURVEY LIF; Peters AL, 1996, JAMA-J AM MED ASSOC, V276, P1246, DOI 10.1001/jama.276.15.1246; Pierce MB, 2009, DIABETIC MED, V26, P679, DOI 10.1111/j.1464-5491.2009.02755.x; Smith SM, 2003, DIABETIC MED, V20, P717, DOI 10.1046/j.1464-5491.2003.00998.x; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; WAUGH N, 2007, HEALTH TECHNOL ASSES, V11, pR9; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78406	10.1371/journal.pone.0078406	http://dx.doi.org/10.1371/journal.pone.0078406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147134	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400157
J	Ben-Zvi, M; Amariglio, N; Paret, G; Nevo-Caspi, Y				Ben-Zvi, Michal; Amariglio, Ninette; Paret, Gideon; Nevo-Caspi, Yael			F11R Expression upon Hypoxia Is Regulated by RNA Editing	PLOS ONE			English	Article							GENE-EXPRESSION; DEAMINASE; ADENOSINE; ADAR1	F11R is a cell adhesion molecule found on the surface of human platelets. It plays a role in platelet aggregation, cell migration and cell proliferation. F11R is subjected to RNA editing, a post-transcriptional modification which affects RNA structure, stability, localization, translation and splicing. RNA editing in the 3'UTR of F11R and RNA levels are increased upon hypoxia. We therefore set to examine if RNA editing plays a role in the increase of F11R RNA seen upon hypoxic conditions. We show that ADAR1, but not ADAR2, takes part in the editing of F11R however editing alone is not sufficient for obtaining an elevation in RNA levels. In addition we show that hyper-edited mature mRNAs are retained in the nucleus and are associated with p54(nrb). We therefore conclude that hypoxia-induced edited RNAs of F11R are preferentially stabilized and accumulate in the nucleus preventing their export to the cytoplasm for translation. This mechanism may be used by additional proteins in the cell as part of the cell's effort to reduce metabolism upon hypoxic stress.	[Ben-Zvi, Michal; Paret, Gideon; Nevo-Caspi, Yael] Safra Childrens Hosp, Chaim Sheba Med Ctr, Dept Pediat Crit Care Med, Tel Hashomer, Israel; [Ben-Zvi, Michal; Paret, Gideon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Amariglio, Ninette] Chaim Sheba Med Ctr, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Amariglio, Ninette] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Bar Ilan University	Nevo-Caspi, Y (corresponding author), Safra Childrens Hosp, Chaim Sheba Med Ctr, Dept Pediat Crit Care Med, Tel Hashomer, Israel.	yael.caspi@sheba.health.gov.il			Amisragaz; general internal departmental resources	Amisragaz; general internal departmental resources	Amisragaz is a non-medical and non-pharmaceutical Israeli company that philanthropically supports our Pediatric Intensive Care Department. The current work was funded by general internal departmental resources. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Chen LL, 2008, CELL CYCLE, V7, P3294, DOI 10.4161/cc.7.21.6927; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Desterro JMP, 2003, J CELL SCI, V116, P1805, DOI 10.1242/jcs.00371; Englander MT, 2005, J NEUROSCI, V25, P648, DOI 10.1523/JNEUROSCI.3895-04.2005; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hundley HA, 2008, RNA, V14, P2050, DOI 10.1261/rna.1165008; Kaplan C, 2008, NATION, V286, P30; Lev-Maor G, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r29; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; McSherry EA, 2009, INT J CANCER, V125, P1343, DOI 10.1002/ijc.24498; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Nevo-Caspi Y, 2011, SHOCK, V35, P585, DOI 10.1097/SHK.0b013e31820fe4b7; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; PATTERSON JB, 1995, VIROLOGY, V210, P508, DOI 10.1006/viro.1995.1370; Pichiule P, 2002, J APPL PHYSIOL, V93, P1131, DOI 10.1152/japplphysiol.00318.2002; Poulsen H, 2001, MOL CELL BIOL, V21, P7862, DOI 10.1128/MCB.21.22.7862-7871.2001; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Pullirsch D, 2010, RNA BIOL, V7, P205, DOI 10.4161/rna.7.2.11286; Severson EA, 2009, CURR OPIN CELL BIOL, V21, P701, DOI 10.1016/j.ceb.2009.06.005; Severson EA, 2009, ANN NY ACAD SCI, V1165, P10, DOI 10.1111/j.1749-6632.2009.04034.x; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4	27	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77702	10.1371/journal.pone.0077702	http://dx.doi.org/10.1371/journal.pone.0077702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147060	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400126
J	Donfrancesco, C; Palleschi, S; Palmieri, L; Rossi, B; Lo Noce, C; Pannozzo, F; Spoto, B; Tripepi, G; Zoccali, C; Giampaoli, S				Donfrancesco, Chiara; Palleschi, Simonetta; Palmieri, Luigi; Rossi, Barbara; Lo Noce, Cinzia; Pannozzo, Fabio; Spoto, Belinda; Tripepi, Giovanni; Zoccali, Carmine; Giampaoli, Simona			Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CREATININE MEASUREMENT; RENAL-FUNCTION; ASSOCIATION; ALBUMINURIA; PREDICTION; EQUATION; SMOKING; PROFILE; WOMEN	Background: Chronic kidney disease (CKD) independently increases the risk of death and cardiovascular disease (CVD) in the general population. However, the relationship between estimated glomerular filtration rate (eGFR) and CVD/death risk in a general population at low risk of CVD has not been explored so far. Design: Baseline and longitudinal data of 1465 men and 1459 women aged 35-74 years participating to the MATISS study, an Italian general population cohort, were used to evaluate the role of eGFR in the prediction of all-cause mortality and incident CVD. Methods: Bio-bank stored sera were used to evaluate eGFR at baseline. Serum creatinine was measured on thawed samples by means of an IDMS-calibrated enzymatic method. eGFR was calculated by the CKD-EPI formula. Results: At baseline, less than 2% of enrolled persons had eGFR < 60 mL/min/1.73m(2) and more than 70% had a 10-year cardiovascular risk score < 10%. In people 60 or more years old, the first and the last eGFR quintiles (< 90 and >= 109 mL/min/1.73m(2), respectively) were associated to an increased risk for both all-cause mortality (hazard ratio 1.6, 95% confidence interval 1.2-2.1 and 4.3, 1.6-11.7, respectively) and incident CVD (1.6, 1.0-2.4 and 7.0, 2.2-22.9, respectively), even if adjusted for classical risk factors. Conclusions: These findings strongly suggest that in an elderly, general population at low risk of CVD and low prevalence of reduced renal filtration, even a modest eGFR reduction is related to all-cause mortality and CVD incidence, underlying the potential benefit to this population of considering eGFR for their risk prediction.	[Donfrancesco, Chiara; Palmieri, Luigi; Lo Noce, Cinzia; Giampaoli, Simona] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy; [Palleschi, Simonetta; Rossi, Barbara] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Pannozzo, Fabio; Zoccali, Carmine] AUSL, Latina, Italy; [Spoto, Belinda; Tripepi, Giovanni] IBIM, CNT, Reggio Di Calabria, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR)	Donfrancesco, C (corresponding author), Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy.	chiara.donfrancesco@iss.it	Palleschi, Simonetta/G-8563-2011; Rossi, Barbara/AAB-6997-2021; PALMIERI, LUIGI/O-1845-2017; Rossi, Barbara/AAB-6108-2021; donfrancesco, chiara/K-1460-2016	Palleschi, Simonetta/0000-0002-2180-0168; Rossi, Barbara/0000-0002-4358-5243; PALMIERI, LUIGI/0000-0002-4298-2642; Zoccali, Carmine/0000-0002-6616-1996; donfrancesco, chiara/0000-0002-8040-5571	Italian Ministry of Health; SYSKID	Italian Ministry of Health(Ministry of Health, Italy); SYSKID	The MATISS Study is part of the CUORE Project - Epidemiology and Prevention of Cardiovascular Disease, funded by the Italian Ministry of Health and coordinated by the National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanita, Rome, Italy. This study was also partially funded by a grant by SYSKID (System Biology towards novel understanding of CKD diagnosis and treatment). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang A, 2011, NEPHRON CLIN PRACT, V119, pC171, DOI 10.1159/000325669; Cirillo M, 2012, J NEPHROL, V25, P7, DOI 10.5301/jn.5000045; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Di Angelantonio E, 2007, PLOS MED, V4, P1497, DOI 10.1371/journal.pmed.0040270; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Donfrancesco C, 2010, G ITAL CARDIOL, V11, p20S, DOI 10.1714/576.6810; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Ferrario M, 2005, INT J EPIDEMIOL, V34, P413, DOI 10.1093/ije/dyh405; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Germano G, 2012, EUR HEART J, V33, P137; Giampaoli S, 2006, AM J EPIDEMIOL, V163, P893, DOI 10.1093/aje/kwj110; Giampaoli S, 1997, ACTA CARDIOL, V52, P411; GIAMPAOLI S, 2007, ITAL J PUBLIC HLTH, V5, P102; Gislefoss RE, 2008, SCAND J CLIN LAB INV, V68, P402, DOI 10.1080/00365510701809235; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Greenberg N, 2012, CLIN CHEM, V58, P391, DOI 10.1373/clinchem.2011.172288; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Ishizaka N, 2008, HYPERTENS RES, V31, P485, DOI 10.1291/hypres.31.485; Ito H, 2011, AM J EPIDEMIOL, V174, P949, DOI 10.1093/aje/kwr185; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MAHMOODI BK, 2012, LANCET, V380, P1, DOI DOI 10.1016/S0140-6736(11)61925-9.PUBMED:22770441; Mathisen UD, 2011, J AM SOC NEPHROL, V22, P927, DOI 10.1681/ASN.2010050479; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Menotti A, 2000, HEART, V84, P238, DOI 10.1136/heart.84.3.238; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Nitsch D, 2006, NEPHROL DIAL TRANSPL, V21, P935, DOI 10.1093/ndt/gfk021; Palmieri L, 2006, EUR J CARDIOV PREV R, V13, P562, DOI 10.1097/01.hjr.0000221866.27039.4b; Palmieri Luigi, 2004, Ann Ist Super Sanita, V40, P393; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; van der Velde M, 2010, CLIN J AM SOC NEPHRO, V5, P2053, DOI 10.2215/CJN.08851209; *WHO, 1999, MONICA MAN, P81146; World Health Organization, 1977, INT CLASS DIS MAN IN; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	38	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78475	10.1371/journal.pone.0078475	http://dx.doi.org/10.1371/journal.pone.0078475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147135	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400158
J	Kinderman, P; Schwannauer, M; Pontin, E; Tai, S				Kinderman, Peter; Schwannauer, Matthias; Pontin, Eleanor; Tai, Sara			Psychological Processes Mediate the Impact of Familial Risk, Social Circumstances and Life Events on Mental Health	PLOS ONE			English	Article							RELIABILITY; PSYCHIATRY; VALIDITY; MODEL	Background: Despite widespread acceptance of the 'biopsychosocial model', the aetiology of mental health problems has provoked debate amongst researchers and practitioners for decades. The role of psychological factors in the development of mental health problems remains particularly contentious, and to date there has not been a large enough dataset to conduct the necessary multivariate analysis of whether psychological factors influence, or are influenced by, mental health. This study reports on the first empirical, multivariate, test of the relationships between the key elements of the biospychosocial model of mental ill-health. Methods and Findings: Participants were 32,827 (age 18-85 years) self-selected respondents from the general population who completed an open-access online battery of questionnaires hosted by the BBC. An initial confirmatory factor analysis was performed to assess the adequacy of the proposed factor structure and the relationships between latent and measured variables. The predictive path model was then tested whereby the latent variables of psychological processes were positioned as mediating between the causal latent variables (biological, social and circumstantial) and the outcome latent variables of mental health problems and well-being. This revealed an excellent fit to the data, S-B chi(2) (3199, N = 23,397) = 126654.8, p<.001; RCFI = .97; RMSEA = .04 (.038-.039). As hypothesised, a family history of mental health difficulties, social deprivation, and traumatic or abusive life-experiences all strongly predicted higher levels of anxiety and depression. However, these relationships were strongly mediated by psychological processes; specifically lack of adaptive coping, rumination and self-blame. Conclusion: These results support a significant revision of the biopsychosocial model, as psychological processes determine the causal impact of biological, social, and circumstantial risk factors on mental health. This has clear implications for policy, education and clinical practice as psychological processes such as rumination and self-blame are amenable to evidence-based psychological therapies.	[Kinderman, Peter; Pontin, Eleanor] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Schwannauer, Matthias] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland; [Tai, Sara] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	University of Liverpool; University of Edinburgh; University of Manchester	Kinderman, P (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	p.kinderman@liverpool.ac.uk		Tai, Sara/0000-0002-8316-5796				Beck A.T., 1967, DEPRESSION CLIN EXPT; Bentall R.P., 2003, MADNESS EXPLAINED PS; Bentler P.M., 2006, MULTIVARIATE SOFTWAR; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bloom DE, 2011, GLOBAL EC BURDEN NON; Bracken P, 2012, BRIT J PSYCHIAT, V201, P430, DOI 10.1192/bjp.bp.112.109447; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Buchanan G.M., 1995, EXPLANATORY STYLE, V1st; Chamberlain Samuel R, 2006, Curr Psychiatry Rep, V8, P458, DOI 10.1007/s11920-006-0051-x; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Elliott R, 1997, J NEUROL NEUROSUR PS, V63, P74, DOI 10.1136/jnnp.63.1.74; ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Grace JB., 2015, STRUCTURAL EQUATION; GUZE SB, 1989, PSYCHOL MED, V19, P315, DOI 10.1017/S0033291700012356; Health Survey for England, 2011, HLTH SOC CAR LIF; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Kinderman P, 1996, PERS INDIV DIFFER, V20, P261, DOI 10.1016/0191-8869(95)00186-7; Kinderman P, 2005, HARVARD REV PSYCHIAT, V13, P206, DOI 10.1080/10673220500243349; Kinderman P, 2011, QUAL LIFE RES, V20, P1035, DOI 10.1007/s11136-010-9841-z; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Marmot MG., 2006, SOCIAL DETERMINANTS; Milne BJ, 2009, AM J MED GENET B, V150B, P41, DOI 10.1002/ajmg.b.30764; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; National Development Team for Social Inclusion, REV MEAS SOC EXCL; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; Office for National Statistics, 2003, LAB FORC SURV HOUS D; Organization WH, 2016, GLOBAL STATUS REPORT; Pilgrim D., 2002, J MENTAL HLTH, V11, P585, DOI DOI 10.1080/09638230020023930; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Ullman JB, 2006, USING MULTIVARIATE S, P653; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563	36	53	53	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76564	10.1371/journal.pone.0076564	http://dx.doi.org/10.1371/journal.pone.0076564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24146890	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400071
J	Liu, H; Li, Y; Wei, Q; Liu, CX; Bolund, L; Vajta, G; Dou, HW; Yang, WX; Xu, Y; Luan, J; Wang, J; Yang, HM; Staunstrup, NH; Du, YT				Liu, Huan; Li, Yong; Wei, Qiang; Liu, Chunxin; Bolund, Lars; Vajta, Gabor; Dou, Hongwei; Yang, Wenxian; Xu, Ying; Luan, Jing; Wang, Jun; Yang, Huanming; Staunstrup, Nicklas Heine; Du, Yutao			Development of Transgenic Minipigs with Expression of Antimorphic Human Cryptochrome 1	PLOS ONE			English	Article							PERIPHERAL CIRCADIAN CLOCKS; GENE-EXPRESSION; BODY-TEMPERATURE; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; METABOLIC SYNDROME; HANDMADE CLONING; SOMATIC-CELLS; CLONED PIGS; MICE	Minipigs have become important biomedical models for human ailments due to similarities in organ anatomy, physiology, and circadian rhythms relative to humans. The homeostasis of circadian rhythms in both central and peripheral tissues is pivotal for numerous biological processes. Hence, biological rhythm disorders may contribute to the onset of cancers and metabolic disorders including obesity and type II diabetes, amongst others. A tight regulation of circadian clock effectors ensures a rhythmic expression profile of output genes which, depending on cell type, constitute about 3-20% of the transcribed mammalian genome. Central to this system is the negative regulator protein Cryptochrome 1 (CRY1) of which the dysfunction or absence has been linked to the pathogenesis of rhythm disorders. In this study, we generated transgenic Bama-minipigs featuring expression of the Cys414-Ala antimorphic human Cryptochrome 1 mutant (hCRY1(AP)). Using transgenic donor fibroblasts as nuclear donors, the method of handmade cloning (HMC) was used to produce reconstructed embryos, subsequently transferred to surrogate sows. A total of 23 viable piglets were delivered. All were transgenic and seemingly healthy. However, two pigs with high transgene expression succumbed during the first two months. Molecular analyzes in epidermal fibroblasts demonstrated disturbances to the expression profile of core circadian clock genes and elevated expression of the proinflammatory cytokines IL-6 and TNF-alpha, known to be risk factors in cancer and metabolic disorders.	[Liu, Huan; Li, Yong; Wei, Qiang; Liu, Chunxin; Bolund, Lars; Vajta, Gabor; Wang, Jun; Yang, Huanming; Du, Yutao] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Dou, Hongwei; Yang, Wenxian; Xu, Ying; Luan, Jing; Staunstrup, Nicklas Heine; Du, Yutao] BGI Shenzhen, BGI Ark Biotechnol, Shenzhen, Guangdong, Peoples R China; [Liu, Huan; Li, Yong; Wei, Qiang; Liu, Chunxin; Dou, Hongwei; Yang, Wenxian; Xu, Ying; Luan, Jing; Du, Yutao] BGI Shenzhen, ShenZhen Engn Lab Genom Assisted Anim Breeding, Shenzhen, Guangdong, Peoples R China; [Bolund, Lars; Staunstrup, Nicklas Heine] Univ Aarhus, Dept Biomed, Aarhus C, Denmark; [Vajta, Gabor] Cent Queensland Univ, Rockhampton, Qld 4702, Australia; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Aarhus University; Central Queensland University; University of Copenhagen; King Abdulaziz University	Staunstrup, NH (corresponding author), BGI Shenzhen, BGI Ark Biotechnol, Shenzhen, Guangdong, Peoples R China.	nhs@hum-gen.au.dk; duyt@genomics.cn	Wang, Jun/A-7261-2013; Vajta, Gabor/I-3672-2016; Staunstrup, Nicklas Heine/D-4870-2017; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Staunstrup, Nicklas Heine/0000-0002-5989-9298; Liu, Huan/0000-0003-3909-0931; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	ShenZhen Engineering Laboratory for Genomics-Assisted Animal Breeding in Shenzhen, China; National Basic Research Program of China (973 Program) [2011CB944201]	ShenZhen Engineering Laboratory for Genomics-Assisted Animal Breeding in Shenzhen, China; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by research grants from ShenZhen Engineering Laboratory for Genomics-Assisted Animal Breeding in Shenzhen, China and the National Basic Research Program of China (973 Program 2011CB944201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mashhadi RH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004853; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bollinger T, 2010, GERONTOLOGY, V56, P574, DOI 10.1159/000281827; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brown S, 2005, AM POETRY REV, V34, P3; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Du Y, 2007, THERIOGENOLOGY, V68, P1104, DOI 10.1016/j.theriogenology.2007.07.021; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Fan YZ, 2007, CURR BIOL, V17, P1091, DOI 10.1016/j.cub.2007.05.048; Forster R, 2010, J PHARMACOL TOX MET, V62, P227, DOI 10.1016/j.vascn.2010.05.007; Glossop NRJ, 2002, J CELL SCI, V115, P3369; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Hasan S, 2012, FASEB J, V26, P2414, DOI 10.1096/fj.11-201699; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kragh PM, 2009, TRANSGENIC RES, V18, P545, DOI 10.1007/s11248-009-9245-4; Kragh PM, 2004, REPROD FERT DEVELOP, V16, P315, DOI 10.1071/RD04007; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Nagashima K, 2005, AM J PHYSIOL-REG I, V288, pR329, DOI 10.1152/ajpregu.00395.2004; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Okano S, 2010, EUR J CLIN INVEST, V40, P1011, DOI 10.1111/j.1365-2362.2010.02359.x; Okano S, 2009, NEUROSCI LETT, V451, P246, DOI 10.1016/j.neulet.2009.01.014; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; OXENHANDLER RW, 1979, AM J PATHOL, V96, P707; Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Schmidt M, 2010, THERIOGENOLOGY, V74, P1233, DOI 10.1016/j.theriogenology.2010.05.026; Schonig K, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-77; Sei H, 2001, NEUROREPORT, V12, P1461, DOI 10.1097/00001756-200105250-00033; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Staunstrup NH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036658; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Vandermeulen G, 2009, VACCINE, V27, P4272, DOI 10.1016/j.vaccine.2009.05.022; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woo KC, 2010, MOL CELL BIOL, V30, P197, DOI 10.1128/MCB.01154-09; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Xi SM, 2004, INT J EXP PATHOL, V85, P223, DOI 10.1111/j.0959-9673.2004.00394.x; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112; Zhang P, 2012, CELL REPROGRAM, V14, P258, DOI 10.1089/cell.2011.0073; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	61	4	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76098	10.1371/journal.pone.0076098	http://dx.doi.org/10.1371/journal.pone.0076098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146819	gold, Green Published, Green Submitted			2022-12-27	WOS:000326019400035
J	Pellegrino, P; Carnovale, C; Perrone, V; Pozzi, M; Antoniazzi, S; Clementi, E; Radice, S				Pellegrino, Paolo; Carnovale, Carla; Perrone, Valentina; Pozzi, Marco; Antoniazzi, Stefania; Clementi, Emilio; Radice, Sonia			Acute Disseminated Encephalomyelitis Onset: Evaluation Based on Vaccine Adverse Events Reporting Systems	PLOS ONE			English	Article								Objective: To evaluate epidemiological features of post vaccine acute disseminated encephalomyelitis (ADEM) by considering data from different pharmacovigilance surveillance systems. Methods: The Vaccine Adverse Event Reporting System (VAERS) database and the EudraVigilance post-authorisation module (EVPM) were searched to identify post vaccine ADEM cases. Epidemiological features including sex and related vaccines were analysed. Results: We retrieved 205 and 236 ADEM cases from the EVPM and VAERS databases, respectively, of which 404 were considered for epidemiological analysis following verification and causality assessment. Half of the patients had less than 18 years and with a slight male predominance. The time interval from vaccination to ADEM onset was 2-30 days in 61% of the cases. Vaccine against seasonal flu and human papilloma virus vaccine were those most frequently associated with ADEM, accounting for almost 30% of the total cases. Mean number of reports per year between 2005 and 2012 in VAERS database was 40 +/- 21.7, decreasing after 2010 mainly because of a reduction of reports associated with human papilloma virus and Diphtheria, Pertussis, Tetanus, Polio and Haemophilus Influentiae type B vaccines. Conclusions: This study has a high epidemiological power as it is based on information on adverse events having occurred in over one billion people. It suffers from lack of rigorous case verification due to the weakness intrinsic to the surveillance databases used. At variance with previous reports on a prevalence of ADEM in childhood we demonstrate that it may occur at any age when post vaccination. This study also shows that the diminishing trend in post vaccine ADEM reporting related to Diphtheria, Pertussis, Tetanus, Polio and Haemophilus Influentiae type B and human papilloma virus vaccine groups is most likely due to a decline in vaccine coverage indicative of a reduced attention to this adverse drug reaction.	[Pellegrino, Paolo; Carnovale, Carla; Perrone, Valentina; Clementi, Emilio; Radice, Sonia] Univ Milan, Clin Pharmacol Unit, Univ Hosp Luigi Sacco, Milan, Italy; [Pozzi, Marco; Clementi, Emilio] Sci Inst IRCCS E Medea, I-23842 Bosisio Parini, Lecco, Italy; [Antoniazzi, Stefania] IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy	University of Milan; Luigi Sacco Hospital; IRCCS Eugenio Medea; IRCCS Ca Granda Ospedale Maggiore Policlinico	Clementi, E (corresponding author), Univ Milan, Clin Pharmacol Unit, Univ Hosp Luigi Sacco, Milan, Italy.	emilio.clementi@unimi.it; sonia.radice@unimi.it	Pozzi, Marco/Z-2684-2019; Pozzi, Marco/J-7915-2016; Carnovale, Carla/Z-3073-2019	Pozzi, Marco/0000-0002-3800-5697; Pozzi, Marco/0000-0002-3800-5697; Carnovale, Carla/0000-0002-4107-196X	Italian Medicines Agency, AIFA; Centre of Pharmacovigilance of Regione Lombardia (Monitoraggio degli Eventi Avversi in Pediatria project); Italian Ministry of Health	Italian Medicines Agency, AIFA; Centre of Pharmacovigilance of Regione Lombardia (Monitoraggio degli Eventi Avversi in Pediatria project); Italian Ministry of Health(Ministry of Health, Italy)	The financial support by the Italian Medicines Agency, AIFA, and the Centre of Pharmacovigilance of Regione Lombardia (Monitoraggio degli Eventi Avversi in Pediatria project, to EC) and the Italian Ministry of Health (RC 2013 to EC) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennetto L, 2004, J NEUROL NEUROSUR PS, V75, pI22, DOI 10.1136/jnnp.2003.034256; Burwen DR, 2012, AM J PUBLIC HEALTH, V102, P1921, DOI 10.2105/AJPH.2011.300510; Collet JP, 2007, MONITORING SIGNALS V, V78, P178; Huynh W, 2008, J CLIN NEUROSCI, V15, P1315, DOI 10.1016/j.jocn.2008.05.002; Lievano F, 2012, VACCINE, V30, P6918, DOI 10.1016/j.vaccine.2012.08.057; Loughlin AM, 2012, VACCINE, V30, P7253, DOI 10.1016/j.vaccine.2012.09.074; Mayet A, 2011, VACCINE, V29, P2576, DOI 10.1016/j.vaccine.2011.01.056; McNeil MM, 2013, VACCINE, V31, P2673, DOI 10.1016/j.vaccine.2013.04.009; Murthy SNK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e21; Shoamanesh A, 2011, VACCINE, V29, P8182, DOI 10.1016/j.vaccine.2011.08.103; Singleton JA, 1999, VACCINE, V17, P2908, DOI 10.1016/S0264-410X(99)00132-2; Tenembaum S, 2002, NEUROLOGY, V59, P1224, DOI 10.1212/WNL.59.8.1224; Tenembaum S, 2007, NEUROLOGY, V68, pS23, DOI 10.1212/01.wnl.0000259404.51352.7f	13	44	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77766	10.1371/journal.pone.0077766	http://dx.doi.org/10.1371/journal.pone.0077766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147076	Green Published, Green Submitted, gold			2022-12-27	WOS:000326019400133
J	Bent, ZW; Brazel, DM; Tran-Gyamfi, MB; Hamblin, RY; VanderNoot, VA; Branda, SS				Bent, Zachary W.; Brazel, David M.; Tran-Gyamfi, Mary B.; Hamblin, Rachelle Y.; VanderNoot, Victoria A.; Branda, Steven S.			Use of a Capture-Based Pathogen Transcript Enrichment Strategy for RNA-Seq Analysis of the Francisella Tularensis LVS Transcriptome during Infection of Murine Macrophages	PLOS ONE			English	Article							LIVE VACCINE STRAIN; VIRULENCE GENE-EXPRESSION; RESPIRATORY BURST; ESCHERICHIA-COLI; OXIDATIVE STRESS; PURINE AUXOTROPH; SUF OPERON; IDENTIFICATION; NOVICIDA; REGULATOR	Francisella tularensis is a zoonotic intracellular pathogen that is capable of causing potentially fatal human infections. Like all successful bacterial pathogens, F. tularensis rapidly responds to changes in its environment during infection of host cells, and upon encountering different microenvironments within those cells. This ability to appropriately respond to the challenges of infection requires rapid and global shifts in gene expression patterns. In this study, we use a novel pathogen transcript enrichment strategy and whole transcriptome sequencing (RNA-Seq) to perform a detailed characterization of the rapid and global shifts in F. tularensis LVS gene expression during infection of murine macrophages. We performed differential gene expression analysis on all bacterial genes at two key stages of infection: phagosomal escape, and cytosolic replication. By comparing the F. tularensis transcriptome at these two stages of infection to that of the bacteria grown in culture, we were able to identify sets of genes that are differentially expressed over the course of infection. This analysis revealed the temporally dynamic expression of a number of known and putative transcriptional regulators and virulence factors, providing insight into their role during infection. In addition, we identified several F. tularensis genes that are significantly up-regulated during infection but had not been previously identified as virulence factors. These unknown genes may make attractive therapeutic or vaccine targets.	[Bent, Zachary W.; Brazel, David M.; Tran-Gyamfi, Mary B.; Hamblin, Rachelle Y.; VanderNoot, Victoria A.; Branda, Steven S.] Sandia Natl Labs, Livermore, CA USA	United States Department of Energy (DOE); Sandia National Laboratories	Bent, ZW (corresponding author), Sandia Natl Labs, Livermore, CA USA.	zbent@sandia.gov		Branda, Steven/0000-0001-8763-1013; Brazel, David/0000-0001-5361-2498	U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bell BL, 2010, INFECT IMMUN, V78, P2189, DOI 10.1128/IAI.00021-10; Bent ZW, 2013, ANAL BIOCHEM, V438, P90, DOI 10.1016/j.ab.2013.03.008; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Crane DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033349; Dai S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00144; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Edwards JA, 2011, INFECT IMMUN, V79, P3348, DOI 10.1128/IAI.05124-11; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; FARON M, 2013, INFECT IMMUN, P1465; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Fuller JR, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-216; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grall N, 2009, MICROBIOL-SGM, V155, P2560, DOI 10.1099/mic.0.029058-0; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Ireland PM, 2011, MICROBIOL-SGM, V157, P3172, DOI 10.1099/mic.0.052902-0; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Langevin SA, 2013, RNA BIOL, V10, P502, DOI 10.4161/rna.24284; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; MACK K, 1994, LETT APPL MICROBIOL, V19, P158, DOI 10.1111/j.1472-765X.1994.tb00931.x; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Morner T., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P1123; Mortensen BL, 2010, INFECT IMMUN, V78, P5022, DOI 10.1128/IAI.00544-10; Moule MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001065; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Pechous RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002487; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Sammons-Jackson WL, 2008, DNA CELL BIOL, V27, P387, DOI 10.1089/dna.2007.0687; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VanderNoot VA, 2012, BIOTECHNIQUES, V53, P373, DOI 10.2144/000113937; Walters KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062412; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Zogaj X, 2012, INFECT IMMUN, V80, P4239, DOI 10.1128/IAI.00702-12	69	13	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77834	10.1371/journal.pone.0077834	http://dx.doi.org/10.1371/journal.pone.0077834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155975	gold, Green Submitted, Green Published			2022-12-27	WOS:000325887300109
J	Cereda, C; Leoni, E; Milani, P; Pansarasa, O; Mazzini, G; Guareschi, S; Alvisi, E; Ghiroldi, A; Diamanti, L; Bernuzzi, S; Ceroni, M; Cova, E				Cereda, Cristina; Leoni, Emanuela; Milani, Pamela; Pansarasa, Orietta; Mazzini, Giuliano; Guareschi, Stefania; Alvisi, Elena; Ghiroldi, Andrea; Diamanti, Luca; Bernuzzi, Stefano; Ceroni, Mauro; Cova, Emanuela			Altered Intracellular Localization of SOD1 in Leukocytes from Patients with Sporadic Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; HEXANUCLEOTIDE REPEAT; OXIDATIVE STRESS; GENE-MUTATIONS; WILD-TYPE; ALS; LYMPHOCYTES; PROTEINS; C9ORF72; FORM	Several lines of evidence support the hypothesis of a toxic role played by wild type SOD1 (WT-SOD1) in the pathogenesis of sporadic amyotrophic lateral sclerosis (SALS). In this study we investigated both distribution and expression profile of WT-SOD1 in leukocytes from 19 SALS patients and 17 healthy individuals. Immunofluorescence experiments by confocal microscopy showed that SOD1 accumulates in the nuclear compartment in a group of SALS subjects. These results were also confirmed by western blot carried out on soluble nuclear and cytoplasmic fractions, with increased nuclear SOD1 level (p<0.05). In addition, we observed the presence of cytoplasmic SOD1 aggregates in agreement with an increased amount of the protein recovered by the insoluble fraction. A further confirmation of the overall increased level of SOD1 has been obtained from single cells analysis using flow cytometry as cells from SALS patients showed an higher SOD1 protein content (p<0.05). These findings add further evidence to the hypothesis of an altered WT-SOD1 expression profile in peripheral blood mononuclear cells (PBMCs) from patients with ALS suggesting that WT-SOD1 species with different degrees of solubility could be involved in the pathogenesis of the disease.	[Cereda, Cristina; Leoni, Emanuela; Milani, Pamela; Pansarasa, Orietta; Guareschi, Stefania; Ghiroldi, Andrea; Cova, Emanuela] C Mondino Natl Neurol Inst, Lab Expt Neurobiol, Pavia, Italy; [Leoni, Emanuela; Milani, Pamela; Alvisi, Elena; Ghiroldi, Andrea; Diamanti, Luca; Ceroni, Mauro] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy; [Mazzini, Giuliano] Univ Pavia, Dept Anim Biol, IGM CNR, I-27100 Pavia, Italy; [Alvisi, Elena; Diamanti, Luca; Ceroni, Mauro] C Mondino Natl Neurol Inst, Div Gen Neurol, Pavia, Italy; [Bernuzzi, Stefano] IRCCS Fdn San Matteo, Immunohematol & Transfus Serv, Pavia, Italy; [Bernuzzi, Stefano] IRCCS Fdn San Matteo, Ctr Transplantat Immunol, Pavia, Italy	IRCCS Fondazione Casimiro Mondino; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Pavia; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Leoni, E (corresponding author), C Mondino Natl Neurol Inst, Lab Expt Neurobiol, Pavia, Italy.	emanuelaleoni@gmail.com	CEREDA, CRISTINA/G-8208-2011; Ghiroldi, Andrea/AAO-4409-2020; Diamanti, Luca/AAB-8860-2019; ceroni, mauro/G-7080-2011; Pansarasa, Orietta/A-2012-2019	CEREDA, CRISTINA/0000-0001-9571-0862; Ghiroldi, Andrea/0000-0002-2896-7390; ceroni, mauro/0000-0002-8947-5007; putchakatla, venkateswarlu/0000-0002-5045-9819; Diamanti, Luca/0000-0002-4540-6886				Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Armentero MT, 2011, NEUROBIOL AGING, V32, P2142, DOI 10.1016/j.neurobiolaging.2010.01.004; Borroni B, 2009, HUM MUTAT, V30, pE974, DOI 10.1002/humu.21100; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Byrne S, 2012, LANCET NEUROL, V11, P232, DOI 10.1016/S1474-4422(12)70014-5; Cereda C, 2006, NEUROL SCI, V27, P312, DOI 10.1007/s10072-006-0702-z; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Cova E, 2006, NEUROSCI LETT, V399, P186, DOI 10.1016/j.neulet.2006.01.057; Cova E, 2010, NEUROCHEM INT, V56, P687, DOI 10.1016/j.neuint.2010.02.004; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Forsberg K, 2011, ACTA NEUROPATHOL, V121, P623, DOI 10.1007/s00401-011-0805-3; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Gagliardi S, 2010, NEUROBIOL DIS, V39, P198, DOI 10.1016/j.nbd.2010.04.008; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Inoue E, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/795946; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Leuner K, 2007, J NEURAL TRANSM-SUPP, P207; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mougeot JLC, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-74; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Nardo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025545; Nardo G, 2009, ANTIOXID REDOX SIGN, V11, P1559, DOI [10.1089/ars.2009.2548, 10.1089/ARS.2009.2548]; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Orlacchio A, 2010, BRAIN, V133, P591, DOI 10.1093/brain/awp325; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Pokrishevsky E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035050; Prudencio M, 2009, J NEUROCHEM, V108, P1009, DOI 10.1111/j.1471-4159.2008.05839.x; Radunovic A, 1999, AMYOTROPH LATERAL SC, V1, P45; Rao AK, 2008, MOL ENDOCRINOL, V22, P1113, DOI 10.1210/me.2007-0381; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Vigilanza P, 2008, CELL MOL LIFE SCI, V65, P991, DOI 10.1007/s00018-008-7526-3; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zuo Z, 2011, BLOOD, V118, P413, DOI 10.1182/blood-2011-01-330704	45	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75916	10.1371/journal.pone.0075916	http://dx.doi.org/10.1371/journal.pone.0075916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155874	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300008
J	Chiang, TC; Liang, KC; Chen, JH; Hsieh, CH; Huang, YA				Chiang, Tzu-Ching; Liang, Keng-Chen; Chen, Jyh-Horng; Hsieh, Chao-Hsien; Huang, Yun-An			Brain Deactivation in the Outperformance in Bimodal Tasks: An fMRI Study	PLOS ONE			English	Article							SELECTIVE ATTENTION; DIVIDED ATTENTION; WORKING-MEMORY; VISUAL-MOTION; DEFAULT-MODE; INTEGRATION; PERCEPTION; MECHANISMS; RESOURCES; ANATOMY	While it is known that some individuals can effectively perform two tasks simultaneously, other individuals cannot. How the brain deals with performing simultaneous tasks remains unclear. In the present study, we aimed to assess which brain areas corresponded to various phenomena in task performance. Nineteen subjects were requested to sequentially perform three blocks of tasks, including two unimodal tasks and one bimodal task. The unimodal tasks measured either visual feature binding or auditory pitch comparison, while the bimodal task required performance of the two tasks simultaneously. The functional magnetic resonance imaging (fMRI) results are compatible with previous studies showing that distinct brain areas, such as the visual cortices, frontal eye field (FEF), lateral parietal lobe (BA7), and medial and inferior frontal lobe, are involved in processing of visual unimodal tasks. In addition, the temporal lobes and Brodmann area 43 (BA43) were involved in processing of auditory unimodal tasks. These results lend support to concepts of modality-specific attention. Compared to the unimodal tasks, bimodal tasks required activation of additional brain areas. Furthermore, while deactivated brain areas were related to good performance in the bimodal task, these areas were not deactivated where the subject performed well in only one of the two simultaneous tasks. These results indicate that efficient information processing does not require some brain areas to be overly active; rather, the specific brain areas need to be relatively deactivated to remain alert and perform well on two tasks simultaneously. Meanwhile, it can also offer a neural basis for biofeedback in training courses, such as courses in how to perform multiple tasks simultaneously.	[Chiang, Tzu-Ching] Natl Chung Cheng Univ, Dept Psychol, Min Hsiung Township, Chia Yi County, Taiwan; [Chiang, Tzu-Ching] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Liang, Keng-Chen] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Jyh-Horng; Hsieh, Chao-Hsien; Huang, Yun-An] Natl Taiwan Univ, Interdisciplinary MRI Lab, Taipei 10764, Taiwan	National Chung Cheng University; University System of Ohio; Ohio State University; National Taiwan University; National Taiwan University	Chiang, TC (corresponding author), Natl Chung Cheng Univ, Dept Psychol, Min Hsiung Township, Chia Yi County, Taiwan.	tcchiang@ccms.ntu.edu.tw	Hsieh, Chao-Hsien/AAM-3978-2021	Hsieh, Chao-Hsien/0000-0002-2249-1301; Liang, Keng-Chen/0000-0002-3292-6882; Huang, Yun-An/0000-0002-2401-6686	National Science Council of Taiwan [NSC-98-2410-H-194-025]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the National Science Council of Taiwan (grant code: NSC-98-2410-H-194-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; ALLPORT DA, 1972, Q J EXP PSYCHOL, V24, P225, DOI 10.1080/00335557243000102; Berman RA, 2002, COGNITIVE BRAIN RES, V14, P64, DOI 10.1016/S0926-6410(02)00061-7; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen LH, 2010, BRAIN RES, V1354, P152, DOI 10.1016/j.brainres.2010.07.064; CHIANG TC, 2013, J BEHAV BRAIN SCI, V3, P1465; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Curtis CE, 2003, J COGNITIVE NEUROSCI, V15, P409, DOI 10.1162/089892903321593126; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Dufour A, 1999, EXP BRAIN RES, V126, P215, DOI 10.1007/s002210050731; Emberson LL, 2011, Q J EXP PSYCHOL, V64, P1021, DOI 10.1080/17470218.2010.538972; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Foxe JJ, 2005, EXP BRAIN RES, V166, P393, DOI 10.1007/s00221-005-2379-6; Gherri E, 2011, J COGNITIVE NEUROSCI, V23, P832, DOI 10.1162/jocn.2010.21468; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Houghton RJ, 2003, J EXP PSYCHOL HUMAN, V29, P731, DOI 10.1037/0096-1523.29.4.731; JOHNSTON WA, 1978, J EXP PSYCHOL GEN, V107, P420, DOI 10.1037/0096-3445.107.4.420; Kaiser P., 1991, LIMITS VISION, P171; Koene A, 2007, J VISION, V7, DOI 10.1167/7.11.14; Leo F, 2008, EXP BRAIN RES, V186, P67, DOI 10.1007/s00221-007-1204-9; Loose R, 2003, HUM BRAIN MAPP, V18, P249, DOI 10.1002/hbm.10082; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; MCLEOD P, 1977, Q J EXP PSYCHOL, V29, P651, DOI 10.1080/14640747708400639; Milner AD, 2012, P ROY SOC B-BIOL SCI, V279, P2289, DOI 10.1098/rspb.2011.2663; Mozolic JL, 2008, EXP BRAIN RES, V184, P39, DOI 10.1007/s00221-007-1080-3; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; Patching GR, 2004, PERCEPT PSYCHOPHYS, V66, P131, DOI 10.3758/BF03194867; Patching GR, 2002, J EXP PSYCHOL HUMAN, V28, P755, DOI 10.1037//0096-1523.28.4.755; Poremba A, 2003, SCIENCE, V299, P568, DOI 10.1126/science.1078900; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rees G, 1998, PHILOS T R SOC B, V353, P1283, DOI 10.1098/rstb.1998.0283; Rees G, 2001, NEUROPSYCHOLOGIA, V39, P937, DOI 10.1016/S0028-3932(01)00016-1; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Schneider KA, 2003, COGNITIVE PSYCHOL, V47, P333, DOI 10.1016/S0010-0285(03)00035-5; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SHIFFRIN RM, 1974, PERCEPT PSYCHOPHYS, V15, P460, DOI 10.3758/BF03199286; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P624, DOI 10.1162/jocn.1997.9.5.624; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Soto-Faraco S, 2002, Q J EXP PSYCHOL-A, V55, P23, DOI 10.1080/02724980143000136; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P389, DOI 10.3758/BF03211906; SUMMERFIELD C, 2009, COGNITIVE NEUROSCIEN, P1019; Talsma D, 2002, PSYCHOPHYSIOLOGY, V39, P689, DOI 10.1017/S004857720200152X; Talsma D, 2001, PSYCHOPHYSIOLOGY, V38, P736, DOI 10.1017/S0048577201000798; Tomasi D, 2006, HUM BRAIN MAPP, V27, P694, DOI 10.1002/hbm.20211; Vohn R, 2007, HUM BRAIN MAPP, V28, P1267, DOI 10.1002/hbm.20350; Wickens Christopher D., 1984, PROCESSING RESOURCES, P63	49	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77408	10.1371/journal.pone.0077408	http://dx.doi.org/10.1371/journal.pone.0077408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155952	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300086
J	Nakahira, K; Morita, A; Kim, NS; Yanagihara, I				Nakahira, Kumiko; Morita, Akihiro; Kim, Nam-Soon; Yanagihara, Itaru			Phosphorylation of FOXP3 by LCK Downregulates MMP9 Expression and Represses Cell Invasion	PLOS ONE			English	Article							TYROSINE KINASE P56(LCK); NUCLEAR FACTOR; CANCER-CELLS; T-CELLS; KAPPA-B; TRANSCRIPTION; ENTEROPATHY; PROGRESSION; ACTIVATION; ONCOGENE	Forkhead Box P3 (FOXP3) is a member of the forkhead/winged helix family of the transcription factors and plays an important role not only as a master gene in T-regulatory cells, but also as a tumor suppressor. In this study, we identified lymphocyte-specific protein tyrosine kinase (LCK), which correlates with cancer malignancy, as a binding partner of FOXP3. FOXP3 downregulated LCK-induced MMP9, SKP2, and VEGF-A expression. We observed that LCK phosphorylated Tyr-342 of FOXP3 by immunoprecipitation and in vitro kinase assay, and the replacement of Tyr-342 with phenylalanine (Y342F) abolished the ability to suppress MMP9 expression. Although FOXP3 decreased the invasive ability induced by LCK in MCF-7 cells, Y342F mutation in FOXP3 diminished this suppressive effect. Thus we demonstrate for the first time that LCK upregulates FOXP3 by tyrosine phosphorylation, resulting in decreased MMP9, SKP2, and VEGF-A expression, and suppressed cellular invasion. We consider that further clarification of transcriptional mechanism of FOXP3 may facilitate the development of novel therapeutic approaches to suppress cancer malignancy.	[Nakahira, Kumiko; Morita, Akihiro; Yanagihara, Itaru] Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Dev Med, Izumi Ku, Osaka, Japan; [Kim, Nam-Soon] Korea Res Inst Biosci & Biotechnol, Biomed Genom Res Ctr, Taejon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Yanagihara, I (corresponding author), Osaka Med Ctr Maternal & Child Hlth, Res Inst, Dept Dev Med, Izumi Ku, Osaka, Japan.	itaruy@mch.pref.osaka.jp			Ministry of Health, Labor and Welfare, Japan; Seiiku Cohort Study for Children and Mothers, Health and Labour Sciences Research Grants, Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [23591609]; Foundation for Mother and Child Well-being, Osaka, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Seiiku Cohort Study for Children and Mothers, Health and Labour Sciences Research Grants, Japan; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Mother and Child Well-being, Osaka, Japan	This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare, JapanH22-Kagaku-Ippann-006 (IY); Seiiku Cohort Study for Children and Mothers, Health and Labour Sciences Research Grants, Japan H22-Jisedai-Ippann008 (IY); Ministry of Education, Culture, Sports, Science and Technology (MEXT) 23591609 (IY), Japan, The Foundation for Mother and Child Well-being, Osaka, Japan (KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2005, P NATL ACAD SCI USA, V102, P5138, DOI 10.1073/pnas.0501675102; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Chakraborty G, 2006, J BIOL CHEM, V281, P11322, DOI 10.1074/jbc.M512546200; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iwata M, 2007, BLOOD, V109, P85, DOI 10.1182/blood-2006-05-020289; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; KOSTER A, 1991, ANTICANCER RES, V11, P193; Lalmansingh AS, 2012, BBA-GENE REGUL MECH, V1819, P707, DOI 10.1016/j.bbagrm.2012.02.018; Mahabeleshwar GH, 2003, J BIOL CHEM, V278, P52598, DOI 10.1074/jbc.M308941200; McInnes N, 2012, ONCOGENE, V31, P1045, DOI 10.1038/onc.2011.293; Morawski PA, 2013, J BIOL CHEM; NAKAMURA K, 1993, ONCOGENE, V8, P3133; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; Seavitt JR, 1999, MOL CELL BIOL, V19, P4200; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yurchak LK, 1996, J BIOL CHEM, V271, P12549, DOI 10.1074/jbc.271.21.12549; Zhang HY, 2010, CANCER LETT, V287, P91, DOI 10.1016/j.canlet.2009.06.001; Zuo T, 2007, J CLIN INVEST, V117, P3765, DOI 10.1172/JCI32538; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	29	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77099	10.1371/journal.pone.0077099	http://dx.doi.org/10.1371/journal.pone.0077099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155921	gold, Green Submitted, Green Published			2022-12-27	WOS:000325887300055
J	Norris, SL; Holmer, HK; Ogden, LA; Burda, BU; Fu, RW				Norris, Susan L.; Holmer, Haley K.; Ogden, Lauren A.; Burda, Brittany U.; Fu, Rongwei			Conflicts of Interest among Authors of Clinical Practice Guidelines for Glycemic Control in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							INTEREST DISCLOSURES; ASSOCIATION; PREVALENCE; TRIALS	Background: Conflict of interest (COI) is an important potential source of bias in the development of clinical practice guidelines (CPGs). Objectives: To examine rates of disclosure of COI, including financial interests in companies that manufacture drugs that are recommended in CPGs on glycemic control in type 2 diabetes mellitus, and to explore the relationship between recommendations for specific drugs in a guideline and author COI. Methods: We identified a cohort of relevant guidelines from the National Guideline Clearinghouse (NGC) and abstracted COI disclosures from all guideline authors for this observational, cross-sectional study. We determined which hypoglycemic drugs were recommended in each guideline, and explored the relationship between specific disclosures and whether a drug was recommended. Results: Among 13 included guidelines, the percentage of authors with one or more financial disclosures varied from 0 to 94% (mean 44.2%), and was particularly high for two US-based guidelines (91% and 94%). Three guidelines disclosed no author financial COI. The percentage of authors with disclosures of financial interests in manufacturers of recommended drugs was also high (mean 30%). On average, 56% of manufacturers of patented drugs recommended in each guideline had one or more authors with a financial interest in their company. We did not find a significant relationship between financial interests and whether a drug was recommended in our sample; US-based guidelines were more likely to make recommendations for a specific drug compared to non-US based guidelines. Discussion: Authors of this cohort of guidelines have financial interests directly related to the drugs that they are recommending. Although we did not find an association between author COI and drugs recommended in these guidelines and we cannot draw conclusions about the validity of the recommendations, the credibility of many of these guidelines is in doubt.	[Norris, Susan L.; Holmer, Haley K.; Ogden, Lauren A.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Burda, Brittany U.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA; [Fu, Rongwei] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	Oregon Health & Science University; Kaiser Permanente; Oregon Health & Science University	Norris, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.	norriss@ohsu.edu		Holmer, Haley/0000-0003-4198-8708	Agency for Healthcare Research and Quality [HS018500-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018500] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This manuscript was the result of work performed for the Agency for Healthcare Research and Quality under grant HS018500-01 (S. Norris) (http://www.ahrq.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; American Diabetes Association (ADA), 2012, DIABETES CARE S1, V35, pS16, DOI DOI 10.2337/DC11-2080; [Anonymous], 2017, NATION; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhattacharyya N, 2009, OTOLARYNG HEAD NECK, V141, P311, DOI 10.1016/j.otohns.2009.06.010; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; *CADTH, 2009, OPT THER REC PRESCR, P1465; *CADTH, 2010, OPT THER REC PRESCR, P1465; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Chimonas S, 2011, ARCH INTERN MED, V171, P81, DOI 10.1001/archinternmed.2010.341; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Fretheim Atle, 2006, Health Res Policy Syst, V4, P27, DOI 10.1186/1478-4505-4-27; FUGHBERMAN A, 2011, PLOS MED, P8; Germano G, 2012, EUR HEART J, V33, P137; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Handelsman Y, 2011, ENDOCR PRACT, V17, P1, DOI 10.4158/EP.17.S2.1; Holloway RG, 2008, NEUROLOGY, V71, P57, DOI 10.1212/01.wnl.0000316319.19159.c3; Holmer HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058625; Hutchings Andrew, 2006, J Health Serv Res Policy, V11, P172, DOI 10.1258/135581906777641659; *ICSI, 2012, DIAGN MAN TYP 2 DIAB, P1465; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Mendelson TB, 2011, ARCH INTERN MED, V171, P577, DOI 10.1001/archinternmed.2011.96; Neuman J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5621; NICE, 2010, LIR TREATM TYP 2 DIA; *NICE, 2008, MAN DIAB ITS COMPL P; Norris SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047343; Norris SL, 2012, J CLIN EPIDEMIOL, V65, P725, DOI 10.1016/j.jclinepi.2011.12.011; Norris SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025153; Okike K, 2009, NEW ENGL J MED, V361, P1466, DOI 10.1056/NEJMsa0807160; Papanikolaou G N, 2001, BMC Med Res Methodol, V1, P3, DOI 10.1186/1471-2288-1-3; *PHARM RES MAN AM, 2011, IND PHARM PUBL HOUS, P1465; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Ransohoff DF, 2013, JAMA-J AM MED ASSOC, V309, P139, DOI 10.1001/jama.2012.156703; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Scottish Intercollegiate Guidelines Network Management of Diabetes, 2010, MAN DIAB NAT CLIN GU; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; *U MICH HLTH SYST, 2009, MAN TYP 2 DIAB MELL, P1465; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; Weinfurt KP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002128; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; 2011, WISC DIAB PREV CONTR, P1465; 2011, J PRIM HLTH CARE, P1465	50	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75284	10.1371/journal.pone.0075284	http://dx.doi.org/10.1371/journal.pone.0075284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155870	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300004
J	Verwer, PEB; ten Kate, MT; Falcone, FH; Morroll, S; Verbrugh, HA; Bakker-Woudenberg, IAJM; van de Sande, WWJ				Verwer, Patricia E. B.; ten Kate, Marian T.; Falcone, Franco H.; Morroll, Shaun; Verbrugh, Henri A.; Bakker-Woudenberg, Irma A. J. M.; van de Sande, Wendy W. J.			Evidence Supporting a Role for Mammalian Chitinases in Efficacy of Caspofungin against Experimental Aspergillosis in Immunocompromised Rats	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; INVASIVE PULMONARY ASPERGILLOSIS; ANTIFUNGAL ACTIVITY; SYSTEMIC INFECTION; NEUTROPENIC RATS; IN-VITRO; CHITOTRIOSIDASE; FUMIGATUS; ENDOCHITINASE; INFLAMMATION	Objectives: Caspofungin, currently used as salvage therapy for invasive pulmonary aspergillosis ( IPA), strangely only causes morphological changes in fungal growth in vitro but does not inhibit the growth. In vivo it has good efficacy. Therefore the question arises how this in vivo activity is reached. Caspofungin is known to increase the amount of chitin in the fungal cell wall. Mammals produce two chitinases, chitotriosidase and AMCase, which can hydrolyse chitin. We hypothesized that the mammalian chitinases play a role in the in vivo efficacy of caspofungin. Methods: In order to determine the role of chitotriosidase and AMCase in IPA, both chitinases were measured in rats which did or did not receive caspofungin treatment. In order to understand the role of each chitinase in the breakdown of the caspofungin-exposed cells, we also exposed caspofungin treated fungi to recombinant enzymes in vitro. Results: IPA in immunocompromised rats caused a dramatic increase in chitinase activity. This increase in chitinase activity was still noted when rats were treated with caspofungin. In vitro, it was demonstrated that the action of both chitinases were needed to lyse the fungal cell wall upon caspofungin exposure. Conclusion: Caspofungin seemed to alter the cell wall in such a way that the two chitinases, when combined, could lyse the fungal cell wall and assisted in clearing the fungal pathogen. We also found that both chitinases combined had a direct effect on the fungus in vitro.	[Verwer, Patricia E. B.; ten Kate, Marian T.; Verbrugh, Henri A.; Bakker-Woudenberg, Irma A. J. M.; van de Sande, Wendy W. J.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Falcone, Franco H.; Morroll, Shaun] Univ Nottingham, Sch Pharm, Div Mol & Cellular Sci, Nottingham NG7 2RD, England	Erasmus University Rotterdam; Erasmus MC; University of Nottingham	Verwer, PEB (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	p.verwer@erasmusmc.nl	van de Sande, Wendy/AAS-4545-2021; Falcone, Franco/AAE-8026-2021; Falcone, Franco H/F-9210-2013	van de Sande, Wendy/0000-0002-8652-8783; Falcone, Franco/0000-0002-1732-9932; Falcone, Franco H/0000-0002-1732-9932	Wellcome Trust [GR065978MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (GR065978MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Bolar JP, 2001, TRANSGENIC RES, V10, P533, DOI 10.1023/A:1013036732691; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Chen L, 2009, CLIN EXP DERMATOL, V34, P55, DOI 10.1111/j.1365-2230.2008.03092.x; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; Felse PA, 2000, BIOPROCESS ENG, V23, P127, DOI 10.1007/s004499900133; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; Hall AJ, 2008, MICROBES INFECT, V10, P69, DOI 10.1016/j.micinf.2007.10.007; Hartl D, 2009, J IMMUNOL, V182, P5098, DOI 10.4049/jimmunol.0803446; Hohl TM, 2008, J INFECT DIS, V198, P176, DOI 10.1086/589304; Homer RJ, 2006, AM J PHYSIOL-LUNG C, V291, pL502, DOI 10.1152/ajplung.00364.2005; Moss RB, 2005, MED MYCOL, V43, pS203, DOI 10.1080/13693780500052255; Moss RB, 2010, CURR OPIN PULM MED, V16, P598, DOI 10.1097/MCP.0b013e32833e24a6; Overdijk B, 1996, GLYCOBIOLOGY, V6, P627, DOI 10.1093/glycob/6.6.627; Overdijk B, 1999, MICROBIOL-UK, V145, P259, DOI 10.1099/13500872-145-1-259; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Seibold MA, 2008, J ALLERGY CLIN IMMUN, V122, P944, DOI 10.1016/j.jaci.2008.08.023; TRONSMO A, 1993, ANAL BIOCHEM, V208, P74, DOI 10.1006/abio.1993.1010; van de Sande WWJ, 2008, ANTIMICROB AGENTS CH, V52, P1345, DOI 10.1128/AAC.00536-07; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; van Vianen W, 2006, J ANTIMICROB CHEMOTH, V57, P732, DOI 10.1093/jac/dkl015; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	25	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75848	10.1371/journal.pone.0075848	http://dx.doi.org/10.1371/journal.pone.0075848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155872	Green Published, gold, Green Submitted			2022-12-27	WOS:000325887300006
J	Zhang, XL; Li, XC; Xiao, X; Sun, R; Tian, ZG; Wei, HM				Zhang, Xiaolong; Li, Xian Chang; Xiao, Xiang; Sun, Rui; Tian, Zhigang; Wei, Haiming			CD4(+)CD62L(+) Central Memory T Cells Can Be Converted to Foxp3(+) T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; B-VIRUS INFECTION; TGF-BETA; IN-VIVO; IMMUNE PATHOLOGY; REGULATORY CELLS; RETINOIC ACID; EXPRESSION; SUPPRESSION; INDUCTION	The peripheral Foxp3(+) Treg pool consists of naturally arising Treg (nTreg) and adaptive Treg cells (iTreg). It is well known that naive CD4(+) T cells can be readily converted to Foxp3(+) iTreg in vitro, and memory CD4(+) T cells are resistant to conversion. In this study, we investigated the induction of Foxp3(+) T cells from various CD4(+) T-cell subsets in human peripheral blood. Though naive CD4(+) T cells were readily converted to Foxp3(+) T cells with TGF-beta and IL-2 treatment in vitro, such Foxp3(+) T cells did not express the memory marker CD45RO as do Foxp3(+) T cells induced in the peripheral blood of Hepatitis B Virus (HBV) patients. Interestingly, a subset of human memory CD4(+) T cells, defined as CD62L(+) central memory T cells, could be induced by TGF-beta to differentiate into Foxp3(+) T cells. It is well known that Foxp3(+) T cells derived from human CD4(+)CD25(-) T cells in vitro are lack suppressive functions. Our data about the suppressive functions of CD4(+)CD62L(+) central memory T cell-derived Foxp3(+) T cells support this conception, and an epigenetic analysis of these cells showed a similar methylation pattern in the FOXP3 Treg-specific demethylated region as the naive CD4(+) T cell-derived Foxp3(+) T cells. But further research showed that mouse CD4(+) central memory T cells also could be induced to differentiate into Foxp3(+) T cells, such Foxp3(+) T cells could suppress the proliferation of effector T cells. Thus, our study identified CD4(+)CD62L(+) central memory T cells as a novel potential source of iTreg.	[Zhang, Xiaolong; Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Li, Xian Chang; Xiao, Xiang] Brigham & Womens Hosp, Transplant Res Ctr, Boston, MA 02115 USA; [Li, Xian Chang; Xiao, Xiang] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA; [Sun, Rui; Tian, Zhigang; Wei, Haiming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Tian, ZG (corresponding author), Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	tzg@ustc.edu.cn; ustcwhm@ustc.edu.cn	Tian, Zhigang/J-3512-2013	Li, Xian Chang/0000-0002-5981-2762; xiao, xiang/0000-0001-6644-6118	Ministry of Science & Technology of China [2009CB522403, 2012CB519004]; Natural Science Foundation of China [31021061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070315] Funding Source: NIH RePORTER	Ministry of Science & Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Ministry of Science & Technology of China (973 Basic Science Project 2009CB522403, 2012CB519004) and Natural Science Foundation of China (#31021061). This work was supported by Ministry of Science & Technology of China (973 Basic Science Project 2009CB522403, 2012CB519004) and Natural Science Foundation of China (#31021061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Antunes I, 2008, IMMUNITY, V29, P782, DOI 10.1016/j.immuni.2008.09.016; Antunes I, 2010, J VIROL, V84, P12564, DOI 10.1128/JVI.01559-10; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clarke SL, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000129; Daniel V, 2008, TRANSPL INT, V21, P646, DOI 10.1111/j.1432-2277.2008.00662.x; Daniel V, 2011, HUM IMMUNOL, V72, P699, DOI 10.1016/j.humimm.2011.05.020; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dejaco C, 2006, EUR J IMMUNOL, V36, P245, DOI [10.1002/eji.200535193, 10.1002/eji.200535651]; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Kim BS, 2010, P NATL ACAD SCI USA, V107, P8742, DOI 10.1073/pnas.0911756107; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Liu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013267; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; Nagar M, 2008, INT IMMUNOL, V20, P1041, DOI 10.1093/intimm/dxn062; Peng GP, 2008, IMMUNOLOGY, V123, P57, DOI 10.1111/j.1365-2567.2007.02691.x; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Presicce P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028118; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Stockinger B, 2004, SEMIN IMMUNOL, V16, P295, DOI 10.1016/j.smim.2004.08.010; Stockinger B, 2006, IMMUNOL REV, V211, P39, DOI 10.1111/j.0105-2896.2006.00381.x; Stoop JN, 2005, HEPATOLOGY, V41, P771, DOI 10.1002/hep.20649; Sun C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002594; Szajnik M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011469; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang J, 2009, J IMMUNOL, V183, P4119, DOI 10.4049/jimmunol.0901065; Wang WS, 2009, INT IMMUNOL, V21, P1065, DOI 10.1093/intimm/dxp072; Wing K, 2002, IMMUNOLOGY, V106, P190, DOI 10.1046/j.1365-2567.2002.01412.x; Wing K, 2006, INT IMMUNOL, V18, P991, DOI 10.1093/intimm/dxl044; Xiao X, 2008, J IMMUNOL, V181, P3193, DOI 10.4049/jimmunol.181.5.3193; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	51	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77322	10.1371/journal.pone.0077322	http://dx.doi.org/10.1371/journal.pone.0077322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155942	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300076
J	Gsell, M; Mascher, G; Schuiki, I; Ploier, B; Hrastnik, C; Daum, G				Gsell, Martina; Mascher, Gerald; Schuiki, Irmgard; Ploier, Birgit; Hrastnik, Claudia; Daum, Guenther			Transcriptional Response to Deletion of the Phosphatidylserine Decarboxylase Psd1p in the Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							SYNTHETIC LETHAL INTERACTION; PLASMA-MEMBRANE; MITOCHONDRIAL PHOSPHATIDYLETHANOLAMINE; BIOSYNTHETIC PATHWAYS; GENE; IDENTIFICATION; PROTEINS; PHOSPHATIDYLCHOLINE; LOCALIZATION; CASSETTE	In the yeast, Saccharomyces cerevisiae, the synthesis of the essential phospholipid phosphatidylethanolamine (PE) is accomplished by a network of reactions which comprises four different pathways. The enzyme contributing most to PE formation is the mitochondrial phosphatidylserine decarboxylase 1 (Psd1p) which catalyzes conversion of phosphatidylserine (PS) to PE. To study the genome wide effect of an unbalanced cellular and mitochondrial PE level and in particular the contribution of Psd1p to this depletion we performed a DNA microarray analysis with Delta psd1 deletion mutant. This approach revealed that 54 yeast genes were significantly up-regulated in the absence of PSD1 compared to wild type. Surprisingly, marked down-regulation of genes was not observed. A number of different cellular processes in different subcellular compartments were affected in Delta psd1 mutant. Deletion mutants bearing defects in all 54 candidate genes, respectively, were analyzed for their growth phenotype and their phospholipid profile. Only three mutants, namely Delta pm2, Delta gph1 and Delta rsb1, were affected in one of these parameters. The possible link of these mutations to PE deficiency and PSD1 deletion is discussed.	[Gsell, Martina; Mascher, Gerald; Schuiki, Irmgard; Ploier, Birgit; Hrastnik, Claudia; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria.	guenther.daum@tugraz.at			Austrian Science Fund FWF [21429]; DK Molecular Enzymology [W901-B05]; Austrian Science Fund (FWF) [W 901, P 21429] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); DK Molecular Enzymology(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund FWF (http://www.fwf.ac.at/)(project 21429 and DK Molecular Enzymology W901-B05 to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Birner R, 2003, INT REV CYTOL, V225, P273, DOI 10.1016/S0074-7696(05)25007-6; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; CARSON MA, 1984, J BIOL CHEM, V259, P6267; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; DAUM G, 1982, J BIOL CHEM, V257, P3028; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Donzeau M, 1996, MOL MICROBIOL, V20, P449, DOI 10.1111/j.1365-2958.1996.tb02631.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; HAID A, 1983, METHOD ENZYMOL, V96, P192; Heinisch JJ, 1998, YEAST, V14, P203, DOI 10.1002/(SICI)1097-0061(199802)14:3<203::AID-YEA205>3.3.CO;2-#; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HUI SW, 1981, ARCH BIOCHEM BIOPHYS, V207, P227, DOI 10.1016/0003-9861(81)90029-1; HWANG PK, 1989, MOL CELL BIOL, V9, P1659, DOI 10.1128/MCB.9.4.1659; Johnson SS, 2010, J BIOL CHEM, V285, P35792, DOI 10.1074/jbc.M110.162883; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo ZL, 2009, MICROBIOL-SGM, V155, P4036, DOI 10.1099/mic.0.030726-0; Manente M, 2009, FEMS YEAST RES, V9, P673, DOI 10.1111/j.1567-1364.2009.00513.x; Nebauer R, 2007, FEBS J, V274, P6180, DOI 10.1111/j.1742-4658.2007.06138.x; Pichler H, 2001, EUR J BIOCHEM, V268, P2351, DOI 10.1046/j.1432-1327.2001.02116.x; Rachidi N, 2000, MOL MICROBIOL, V35, P1421, DOI 10.1046/j.1365-2958.2000.01807.x; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Schuiki I, 2010, BBA-MOL CELL BIOL L, V1801, P480, DOI 10.1016/j.bbalip.2009.12.008; SERRANO R, 1988, METHOD ENZYMOL, V157, P533; Sertil O, 1997, GENE, V192, P199, DOI 10.1016/S0378-1119(97)00028-0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van den Hazel HB, 1999, J BIOL CHEM, V274, P1934, DOI 10.1074/jbc.274.4.1934; Wilson WA, 2010, CAN J MICROBIOL, V56, P408, DOI [10.1139/W10-027, 10.1139/w10-027]; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77380	10.1371/journal.pone.0077380	http://dx.doi.org/10.1371/journal.pone.0077380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146988	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400114
J	Itoh, M; Umegaki-Arao, N; Guo, ZY; Liu, L; Higgins, CA; Christiano, AM				Itoh, Munenari; Umegaki-Arao, Noriko; Guo, Zongyou; Liu, Liang; Higgins, Claire A.; Christiano, Angela M.			Generation of 3D Skin Equivalents Fully Reconstituted from Human Induced Pluripotent Stem Cells (iPSCs)	PLOS ONE			English	Article							FIBROBLAST-LIKE CELLS; EPIDERMOLYSIS-BULLOSA; VII COLLAGEN; ASCORBIC-ACID; GENE CORRECTION; DIFFERENTIATION; INDUCTION; EXPRESSION; CARCINOMA; SUPPORT	Recent generation of patient-specific induced pluripotent stem cells (PS-iPSCs) provides significant advantages for cell-and gene-based therapy. Establishment of iPSC-based therapy for skin diseases requires efficient methodology for differentiating iPSCs into both keratinocytes and fibroblasts, the major cellular components of the skin, as well as the reconstruction of skin structures using these iPSC-derived skin components. We previously reported generation of keratinocytes from human iPSCs for use in the treatment of recessive dystrophic epidermolysis bullosa (RDEB) caused by mutations in the COL7A1 gene. Here, we developed a protocol for differentiating iPSCs into dermal fibroblasts, which also produce type VII collagen and therefore also have the potential to treat RDEB. Moreover, we generated in vitro 3D skin equivalents composed exclusively human iPSC-derived keratinocytes and fibroblasts for disease models and regenerative therapies for skin diseases, first demonstrating that iPSCs can provide the basis for modeling a human organ derived entirely from two different types of iPSC-derived cells.	[Itoh, Munenari; Umegaki-Arao, Noriko; Guo, Zongyou; Liu, Liang; Higgins, Claire A.; Christiano, Angela M.] Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10027 USA; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, Coll Phys & Surg, New York, NY USA	Columbia University; Columbia University	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10027 USA.	amc65@columbia.edu		Higgins, Claire/0000-0002-9742-5149; Itoh, Munenari/0000-0003-3640-6355	Dr. Ines Mandl Research Fellowship (Columbia University); NYSTAR (The New York State Foundation for Science, Technology and Innovation); National Institutes of Health/National Center for Advancing Translational Sciences) [SDH C024321, U18TR000561-01]; Helmsley Stem Cell Starter Grants (Columbia University); Core facilities of the Skin Disease Research Center at Columbia University (from NIH/NIAMS) [P30AR044535]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U18TR000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR044535] Funding Source: NIH RePORTER	Dr. Ines Mandl Research Fellowship (Columbia University); NYSTAR (The New York State Foundation for Science, Technology and Innovation); National Institutes of Health/National Center for Advancing Translational Sciences); Helmsley Stem Cell Starter Grants (Columbia University); Core facilities of the Skin Disease Research Center at Columbia University (from NIH/NIAMS); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the Dr. Ines Mandl Research Fellowship (Columbia University), and grants from NYSTAR (The New York State Foundation for Science, Technology and Innovation), SDH C024321 (New York State Stem Cell Science), U18TR000561-01 (As part of Tissue Chip Awards from National Institutes of Health/National Center for Advancing Translational Sciences) and Helmsley Stem Cell Starter Grants (Columbia University). This work was supported by the Core facilities of the Skin Disease Research Center at Columbia University (P30AR044535 from NIH/NIAMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar M, 2009, DEV DYNAM, V238, P431, DOI 10.1002/dvdy.21854; Carlson Mark W, 2008, Curr Protoc Cell Biol, VChapter 19, DOI 10.1002/0471143030.cb1909s41; Chen HF, 2009, HUM REPROD, V24, P1114, DOI 10.1093/humrep/dep003; Do TV, 2008, MOL CANCER RES, V6, P695, DOI 10.1158/1541-7786.MCR-07-0294; Fine JD, 2009, J AM ACAD DERMATOL, V60, P203, DOI 10.1016/j.jaad.2008.09.035; FRANCESCHI RT, 1992, NUTR REV, V50, P65; Fritsch A, 2008, J CLIN INVEST, V118, P1669, DOI 10.1172/JCI34292; Hewitt KJ, 2009, TISSUE ENG PT A, V15, P3417, DOI [10.1089/ten.tea.2009.0060, 10.1089/ten.TEA.2009.0060]; Hewitt KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017128; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Howden SE, 2011, P NATL ACAD SCI USA, V108, P6537, DOI 10.1073/pnas.1103388108; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; Jonkman MF, 1999, AM J MED GENET, V85, P361, DOI 10.1002/(SICI)1096-8628(19990806)85:4<361::AID-AJMG11>3.0.CO;2-E; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kumar D, 2005, BIOCHEM BIOPH RES CO, V332, P135, DOI 10.1016/j.bbrc.2005.04.098; Lorda-Diez CI, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-69; Martins VL, 2009, J CELL SCI, V122, P1788, DOI 10.1242/jcs.042895; MAUVIEL A, 1994, J BIOL CHEM, V269, P25; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005; Ortiz-Urda S, 2003, J CLIN INVEST, V111, P251, DOI 10.1172/JCI200317193; PINNELL SR, 1987, ARCH DERMATOL, V123, P1684, DOI 10.1001/archderm.123.12.1684; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Shamis Y, 2012, IN VITRO CELL DEV-AN, V48, P112, DOI 10.1007/s11626-011-9478-4; SHARON N, 2007, MESODERMAL DIFFERENT, P129; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Togo S, 2011, IN VITRO CELL DEV-AN, V47, P114, DOI 10.1007/s11626-010-9367-2; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; Uitto J, 2011, J INVEST DERMATOL, V132, P820; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Watt SA, 2011, ONCOGENE, V30, P4666, DOI 10.1038/onc.2011.180; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Woodley DT, 2007, MOL THER, V15, P628, DOI 10.1038/sj.mt.6300041; Woodley DT, 2003, J INVEST DERMATOL, V121, P1021, DOI 10.1046/j.1523-1747.2003.12571.x; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996; Yusa K, 2011, NATURE, V478, P391, DOI 10.1038/nature10424; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	42	130	141	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77673	10.1371/journal.pone.0077673	http://dx.doi.org/10.1371/journal.pone.0077673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147053	Green Submitted, Green Published, gold			2022-12-27	WOS:000325819400134
J	Luo, HJ; Yang, T; Jin, XJ; Pang, XH; Li, JP; Chai, YC; Li, L; Zhang, Y; Zhang, LP; Zhang, ZH; Wu, WJ; Zhang, Q; Hu, XT; Sun, JW; Jiang, XM; Fan, ZP; Huang, ZW; Wu, H				Luo, Huajie; Yang, Tao; Jin, Xiaojie; Pang, Xiuhong; Li, Jiping; Chai, Yongchuan; Li, Lei; Zhang, Yi; Zhang, Luping; Zhang, Zhihua; Wu, Wenjing; Zhang, Qin; Hu, Xianting; Sun, Jingwen; Jiang, Xuemei; Fan, Zhuping; Huang, Zhiwu; Wu, Hao			Association of GRM7 Variants with Different Phenotype Patterns of Age-Related Hearing Impairment in an Elderly Male Han Chinese Population	PLOS ONE			English	Article							GENE POLYMORPHISM; PRESBYCUSIS; SUSCEPTIBILITY; THRESHOLDS; PREVALENCE; PATHOLOGY; ENZYMES; GRHL2	Several single nucleotide polymorphisms (SNPs) of the Glutamate metabotrophic receptor 7 gene (GRM7) have recently been identified by the genome-wide association study (GWAS) as potentially playing a role in susceptibility to age-related hearing impairment (ARHI), however this has not been validated in the Han Chinese population. The aim of this study was to determine if these SNPs are also associated with ARHI in an elderly male Han Chinese population. In this case-control candidate genes association study, a total of 982 men with ARHI and 324 normal-hearing controls subjects were studied. Using K-means cluster analysis, four audiogram shape subtypes of ARHI were identified in the case group: "flat shape (FL)'', "sloping shape (SL)", "2-4 kHz abrupt loss (AL) shape" and "8 kHz dip (8D) shape''. Results suggested that the SNP rs11928865 (A> T) of GRM7 was significantly associated with ARHI after adjusting for non-genetic factors (p= 0.000472, OR= 1.599, 95% CI= 1.229 similar to 2.081). Furthermore, frequency of TT genotype (rs11928865) were significant higher in the SL subgroup and AL subgroup with compared to controls group (p= 9.41E-05, OR= 1.945, 95% CI= 1.393 similar to 2.715; p= 0.000109, OR= 1.915, 95% CI= 1.378-2.661 adjusted, respectively) after Bonferroni correction. However, there wasn't significant difference in the frequency of the TT genotype between cases in the FL subgroup or the 8D subgroup with when compared with controls. Results of the current study suggest that, in an elderly male Han Chinese population, GRM7 SNP rs11928865 (TT) occurs more frequently in ARHI patients with SL and AL phenotype patterns.	[Luo, Huajie; Yang, Tao; Pang, Xiuhong; Chai, Yongchuan; Li, Lei; Zhang, Luping; Zhang, Zhihua; Wu, Wenjing; Zhang, Qin; Hu, Xianting; Sun, Jingwen; Huang, Zhiwu; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Luo, Huajie; Yang, Tao; Pang, Xiuhong; Chai, Yongchuan; Li, Lei; Zhang, Luping; Zhang, Zhihua; Wu, Wenjing; Zhang, Qin; Hu, Xianting; Sun, Jingwen; Huang, Zhiwu; Wu, Hao] Shanghai Jiao Tong Univ, Sch Med, Ear Inst, Shanghai 200030, Peoples R China; [Jiang, Xuemei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Hlth Check Up Ctr, Shanghai 200030, Peoples R China; [Luo, Huajie; Jin, Xiaojie; Li, Jiping; Zhang, Yi] Shanghai Jiao Tong Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, RenJi Hosp, Shanghai 200030, Peoples R China; [Fan, Zhuping] Shanghai Jiao Tong Univ, Sch Med, RenJi Hosp, Hlth Check Up Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Huang, ZW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China.	huangzw086@hotmail.com; wuhao7622@sina.com	zhang, luping/AAQ-2069-2020; Pang, Xiuhong/ABE-2751-2021; zhang, zh/GWV-4677-2022	Yang, Tao/0000-0001-6011-987X	National Basic Research Program of China [2011CB504501]; Research Special Fund for Public Welfare Industry of Health, Ministry of Health of China [201202005]; 12th Five-Year National Key Technologies Research & Development program [2012BAI12B01]; National Science Foundation of China [81222010]; Shanghai Municipal Science and Technology Commission [11PJ1407000]	National Basic Research Program of China(National Basic Research Program of China); Research Special Fund for Public Welfare Industry of Health, Ministry of Health of China; 12th Five-Year National Key Technologies Research & Development program; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by a grant from National Basic Research Program of China 2011CB504501 (HW); grant from the Research Special Fund for Public Welfare Industry of Health, Ministry of Health of China No. 201202005 (HW); grant from the 12th Five-Year National Key Technologies Research & Development program No. 2012BAI12B01 (ZH); grants from National Science Foundation of China 81222010 (TY) and grants from Shanghai Municipal Science and Technology Commission 11PJ1407000 (TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bared A, 2010, OTOLARYNG HEAD NECK, V143, P263, DOI 10.1016/j.otohns.2010.03.024; Christensen K, 2001, J AM GERIATR SOC, V49, P1512, DOI 10.1046/j.1532-5415.2001.4911245.x; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; DeStefano AL, 2003, ARCH OTOLARYNGOL, V129, P285, DOI 10.1001/archotol.129.3.285; Dubno JR, 1997, J SPEECH LANG HEAR R, V40, P444, DOI 10.1044/jslhr.4002.444; Dupret JM, 2005, CURR MED CHEM, V12, P311, DOI 10.2174/0929867053363289; *EN ISO, 2000, BS70292000 EN ISO; Fay R.R, 2010, AGING AUDITORY SYSTE, p[18, 31]; Fitzgibbons P J, 1996, J Am Acad Audiol, V7, P183; Fransen E, 2004, EAR HEARING, V25, P133, DOI 10.1097/01.AUD.0000120362.69077.0B; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Garringer HJ, 2006, ARCH OTOLARYNGOL, V132, P506, DOI 10.1001/archotol.132.5.506; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Gates GA, 1999, ARCH OTOLARYNGOL, V125, P654, DOI 10.1001/archotol.125.6.654; Helfer KS, 2009, J AM ACAD AUDIOL, V20, P264, DOI 10.3766/jaaa.20.4.6; Huang Q, 2010, EUR ARCH OTO-RHINO-L, V267, P1179, DOI 10.1007/s00405-010-1270-7; Huyghe JR, 2008, AM J HUM GENET, V83, P401, DOI 10.1016/j.ajhg.2008.08.002; Karlsson KK, 1997, EAR HEARING, V18, P114, DOI 10.1097/00003446-199704000-00003; Lee CY, 2010, INT J AUDIOL, V49, P628, DOI 10.3109/14992021003796887; Lin YH, 2011, LARYNGOSCOPE, V121, P1303, DOI 10.1002/lary.21771; Margolis RH, 2007, INT J AUDIOL, V46, P746, DOI 10.1080/14992020701572652; Markaryan A, 2009, LARYNGOSCOPE, V119, P1184, DOI 10.1002/lary.20218; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Newman DL, 2012, HEARING RES, V294, P125, DOI 10.1016/j.heares.2012.08.016; O'Grady G, 2007, INT J AUDIOL, V46, P183, DOI 10.1080/14992020601145294; Ohlemiller Kevin K, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P439, DOI 10.1097/01.moo.0000134450.99615.22; Pacala JT, 2012, JAMA-J AM MED ASSOC, V307, P1185, DOI 10.1001/jama.2012.305; PARMET S, 2007, JAMA PATIENT, P298; Price K, 2009, HEARING RES, V252, P29, DOI 10.1016/j.heares.2009.02.010; Pujol R, 1990, Acta Otolaryngol Suppl, V476, P32; SCHERER EQ, 2005, BMC EAR NOSE THROAT, V29, P5; SCHUKNECHT HF, 1964, ARCHIV OTOLARYNGOL, V80, P369; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; Seidman MD, 2000, AM J OTOL, V21, P161, DOI 10.1016/S0196-0709(00)80003-4; Stenklev NC, 2004, INT J AUDIOL, V43, P295, DOI 10.1080/14992020400050039; Sugiura S, 2010, ACTA OTO-LARYNGOL, V130, P487, DOI 10.3109/00016480903283758; Uchida Y, 2009, LARYNGOSCOPE, V119, P938, DOI 10.1002/lary.20181; Unal M, 2005, LARYNGOSCOPE, V115, P2238, DOI 10.1097/01.mlg.0000183694.10583.12; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Van Eyken E, 2006, HUM MUTAT, V27, P1007, DOI 10.1002/humu.20375; Van Laer L, 2008, HUM MOL GENET, V17, P159, DOI 10.1093/hmg/ddm292; Van Laer L, 2010, EUR J HUM GENET, V18, P685, DOI 10.1038/ejhg.2009.234; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; VANLAER L, 2007, GENES HEARING DEAFNE, P79; Wiley TL, 2008, J AM ACAD AUDIOL, V19, P281, DOI 10.3766/jaaa.19.4.2; Wingfield A, 2007, J GERONTOL A-BIOL, V62, P1294, DOI 10.1093/gerona/62.11.1294; World Health Organization, 2012, WORLD HLTH STAT; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976	48	16	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77153	10.1371/journal.pone.0077153	http://dx.doi.org/10.1371/journal.pone.0077153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146964	gold, Green Published, Green Submitted			2022-12-27	WOS:000325819400101
J	Shan, M; Zhang, XY; Liu, XL; Qin, Y; Liu, T; Liu, Y; Wang, J; Zhong, ZB; Zhang, YX; Geng, JS; Pang, D				Shan, Ming; Zhang, Xianyu; Liu, Xiaolong; Qin, Yu; Liu, Tong; Liu, Yang; Wang, Ji; Zhong, Zhenbin; Zhang, Youxue; Geng, Jingshu; Pang, Da			P16 and P53 Play Distinct Roles in Different Subtypes of Breast Cancer	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; GENE-EXPRESSION; BASAL-LIKE; TUMOR-SUPPRESSOR; TP53 MUTATION; IN-SITU; OVEREXPRESSION; CARCINOMAS; INACTIVATION; PATHWAYS	Breast cancers are heterogeneous and complex diseases, and subtypes of breast cancers may involve unique molecular mechanisms. The p16(INK4a) and p53 pathways are two of the major pathways involved in control of the cell cycle. They also play key roles in tumorigenesis. However, whether the roles of these pathways differ in the subtypes of breast cancer is unclear. Therefore, p16 and p53 expression were investigated in different breast cancer subtypes to ascertain their contributions to these cancers. A total of 400 cases of non-invasive ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC), including the major molecular subtypes luminal-A, luminal-B, Her-2, and triple-negative subtypes, and 50 cases of normal controls were compared. Luminal-A cancers expressed the lowest level of p16 among the subtypes in DCIS, and the level of p16 expression was up-regulated in the luminal-A of IDC (P<0.008). Triple-negative breast cancers were characterized by a correlation of p53 overexpression with a high level of p16 expression. Luminal lesion types with high p16 expression in DCIS were found to be more likely to develop into aggressive breast cancers, possibly promoted by p53 dysfunction. Taken together, the present study suggest that p16 expression in luminal-A breast cancers is associated with their progression from DCIS to IDC, and both p53 and p16 expressions are important for the development of triple-negative breast cancers in DCIS and IDC.	[Shan, Ming; Zhang, Xianyu; Liu, Tong; Liu, Yang; Wang, Ji; Zhong, Zhenbin; Zhang, Youxue; Pang, Da] Harbin Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, Harbin, Peoples R China; [Liu, Xiaolong; Qin, Yu; Geng, Jingshu] Harbin Med Univ, Dept Pathol, Affiliated Tumor Hosp, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Pang, D (corresponding author), Harbin Med Univ, Affiliated Tumor Hosp, Dept Breast Surg, Harbin, Peoples R China.	pangdasir@163.com		LIU, TONG/0000-0001-9234-1328	Affiliated Tumour Hospital of Harbin Medical University [JJZ2010-04]; Harbin Medical University [WLD-QN1118]; National Natural Science Fund [81172498]; Technological innovation talent research special funds of Harbin [2011RFXYS056]	Affiliated Tumour Hospital of Harbin Medical University; Harbin Medical University; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Technological innovation talent research special funds of Harbin	This study was supported by the funding of The Affiliated Tumour Hospital of Harbin Medical University (JJZ2010-04), the "Wu Liande" funding of Harbin Medical University (WLD-QN1118), The National Natural Science Fund (81172498) and the Technological innovation talent research special funds of Harbin (2011RFXYS056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartley AN, 2002, ARCH PATHOL LAB MED, V126, P456; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Crawford YG, 2004, CANCER CELL, V5, P263, DOI 10.1016/S1535-6108(04)00023-6; Derenzini M, 2009, J PATHOL, V219, P373, DOI 10.1002/path.2612; Dublin EA, 1998, INT J CANCER, V79, P71, DOI 10.1002/(SICI)1097-0215(19980220)79:1<71::AID-IJC14>3.0.CO;2-K; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Geradts J, 2000, MODERN PATHOL, V13, P945, DOI 10.1038/modpathol.3880172; Goldstein I, 2011, CANCER GENE THER, V18, P2, DOI 10.1038/cgt.2010.63; Hainaut P, 2000, ADV CANCER RES, V77, P81; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Hui R, 2000, CLIN CANCER RES, V6, P2777; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Levine Arnold J., 2004, Cell, VS116, pS67, DOI 10.1016/S0092-8674(04)00036-4; Livasy CA, 2007, HUM PATHOL, V38, P197, DOI 10.1016/j.humpath.2006.08.017; Milde-Langosch K, 2001, BREAST CANCER RES TR, V67, P61, DOI 10.1023/A:1010623308275; Montanari M, 2005, J CELL PHYSIOL, V202, P215, DOI 10.1002/jcp.20120; Nuovo GJ, 1999, P NATL ACAD SCI USA, V96, P12754, DOI 10.1073/pnas.96.22.12754; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Radpour R, 2010, MODERN PATHOL, V23, P763, DOI 10.1038/modpathol.2009.195; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Silva J, 2003, J PATHOL, V199, P289, DOI 10.1002/path.1297; Soong R, 1996, HUM PATHOL, V27, P1050, DOI 10.1016/S0046-8177(96)90282-8; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stewart CL, 2001, J NEURO-ONCOL, V51, P183, DOI 10.1023/A:1010615822317; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Zhang D, 2008, ONCOGENE, V27, P4305, DOI 10.1038/onc.2008.76; Zhang JM, 2006, CANCER RES, V66, P10325, DOI 10.1158/0008-5472.CAN-06-1594	41	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76408	10.1371/journal.pone.0076408	http://dx.doi.org/10.1371/journal.pone.0076408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146864	gold, Green Submitted, Green Published			2022-12-27	WOS:000325819400056
J	Taavela, J; Koskinen, O; Huhtala, H; Lahdeaho, ML; Popp, A; Laurila, K; Collin, P; Kaukinen, K; Kurppa, K; Maki, M				Taavela, Juha; Koskinen, Outi; Huhtala, Heini; Lahdeaho, Marja-Leena; Popp, Alina; Laurila, Kaija; Collin, Pekka; Kaukinen, Katri; Kurppa, Kalle; Maki, Markku			Validation of Morphometric Analyses of Small-Intestinal Biopsy Readouts in Celiac Disease	PLOS ONE			English	Article							SMALL-BOWEL; VILLOUS ATROPHY; GLUTEN; DIAGNOSIS; REPRODUCIBILITY; SYMPTOMS; PITFALLS; SPRUE	Background: Assessment of the gluten-induced small-intestinal mucosal injury remains the cornerstone of celiac disease diagnosis. Usually the injury is evaluated using grouped classifications (e. g. Marsh groups), but this is often too imprecise and ignores minor but significant changes in the mucosa. Consequently, there is a need for validated continuous variables in everyday practice and in academic and pharmacological research. Methods: We studied the performance of our standard operating procedure (SOP) on 93 selected biopsy specimens from adult celiac disease patients and non-celiac disease controls. The specimens, which comprised different grades of gluten-induced mucosal injury, were evaluated by morphometric measurements. Specimens with tangential cutting resulting from poorly oriented biopsies were included. Two accredited evaluators performed the measurements in blinded fashion. The intraobserver and interobserver variations for villus height and crypt depth ratio (VH: CrD) and densities of intraepithelial lymphocytes (IELs) were analyzed by the Bland-Altman method and intraclass correlation. Results: Unevaluable biopsies according to our SOP were correctly identified. The intraobserver analysis of VH: CrD showed a mean difference of 0.087 with limits of agreement from -0.398 to 0.224; the standard deviation (SD) was 0.159. The mean difference in interobserver analysis was 0.070, limits of agreement -0.516 to 0.375, and SD 0.227. The intraclass correlation coefficient in intraobserver variation was 0.983 and that in interobserver variation 0.978. CD3(+) IEL density countings in the paraffin-embedded and frozen biopsies showed SDs of 17.1% and 16.5%; the intraclass correlation coefficients were 0.961 and 0.956, respectively. Conclusions: Using our SOP, quantitative, reliable and reproducible morphometric results can be obtained on duodenal biopsy specimens with different grades of gluten-induced injury. Clinically significant changes were defined according to the error margins (2SD) of the analyses in VH: CrD as 0.4 and in CD3(+)-stained IELs as 30%.	[Taavela, Juha; Koskinen, Outi; Lahdeaho, Marja-Leena; Popp, Alina; Laurila, Kaija; Kurppa, Kalle; Maki, Markku] Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Taavela, Juha; Koskinen, Outi; Lahdeaho, Marja-Leena; Popp, Alina; Laurila, Kaija; Kurppa, Kalle; Maki, Markku] Tampere Univ Hosp, Tampere, Finland; [Huhtala, Heini] Univ Tampere, Tampere Sch Hlth Sci, FIN-33101 Tampere, Finland; [Popp, Alina] Inst Mother & Child Care Alfred Rusescu, Bucharest, Romania; [Popp, Alina] Univ Med & Pharm Carol Davila, Bucharest, Romania; [Collin, Pekka; Kaukinen, Katri] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, Tampere, Finland; [Kaukinen, Katri] Seinajoki Cent Hosp, Dept Med, Seinajoki, Finland; [Kaukinen, Katri] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland	Tampere University; Tampere University; Tampere University Hospital; Tampere University; Carol Davila University of Medicine & Pharmacy; Tampere University; Tampere University Hospital; Seinajoki Central Hospital; Tampere University	Maki, M (corresponding author), Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland.	markku.maki@uta.fi	Taavela, Juha/AAI-4415-2021	Taavela, Juha/0000-0003-3948-9555; Kurppa, Kalle/0000-0003-4757-2164	Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Foundation for Pediatric Research; Finnish Medical Foundation; Finnish Celiac Society; Academy of Finland; Sigrid Juselius Foundation; Elna Kaarina Savolainen's fund	Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital; Foundation for Pediatric Research; Finnish Medical Foundation; Finnish Celiac Society; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Elna Kaarina Savolainen's fund	This study is supported by the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital, the Foundation for Pediatric Research, The Finnish Medical Foundation, the Finnish Celiac Society, the Academy of Finland, the Sigrid Juselius Foundation and Elna Kaarina Savolainen's fund allocated for the development of cancer treatment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguelles-Grande C, 2012, J CLIN PATHOL, V65, P242, DOI 10.1136/jclinpath-2011-200372; Bardella MT, 2007, HISTOPATHOLOGY, V50, P465, DOI 10.1111/j.1365-2559.2007.02621.x; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Collin P, 2005, EUR J GASTROEN HEPAT, V17, P85, DOI 10.1097/00042737-200501000-00017; Corazza GR, 2007, CLIN GASTROENTEROL H, V5, P838, DOI 10.1016/j.cgh.2007.03.019; Corazza GR, 2005, J CLIN PATHOL, V58, P573, DOI 10.1136/jcp.2004.023978; de Serre NPM, 2000, HISTOPATHOLOGY, V37, P70, DOI 10.1046/j.1365-2559.2000.00926.x; Jarvinen TT, 2003, AM J GASTROENTEROL, V98, P1332, DOI 10.1016/S0002-9270(03)00230-2; Kaukinen K, 2007, ALIMENT PHARM THER, V25, P1237, DOI 10.1111/j.1365-2036.2007.03311.x; Kaukinen K, 2005, SCAND J GASTROENTERO, V40, P564, DOI 10.1080/00365520510023422; KUITUNEN P, 1982, J PEDIATR GASTR NUTR, V1, P525, DOI 10.1097/00005176-198212000-00012; Kurppa K, 2009, GASTROENTEROLOGY, V136, P816, DOI 10.1053/j.gastro.2008.11.040; Lahdeaho ML, 2012, EXPERT OPIN BIOL TH, V12, P1589, DOI 10.1517/14712598.2012.721766; Lahdeaho ML, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-129; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Midhagen G, 2003, AM J GASTROENTEROL, V98, P2023, DOI 10.1111/j.1572-0241.2003.07632.x; Mubarak A, 2011, SCAND J GASTROENTERO, V46, P1065, DOI 10.3109/00365521.2011.589471; Oberhuber G, 2000, BIOMED PHARMACOTHER, V54, P368, DOI 10.1016/S0753-3322(01)80003-2; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Ravelli A, 2012, PATHOL RES PRACT, V208, P197, DOI 10.1016/j.prp.2012.01.008; RISDON RA, 1974, GUT, V15, P9, DOI 10.1136/gut.15.1.9; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; SHIDRAWI RG, 1994, J CLIN PATHOL, V47, P693, DOI 10.1136/jcp.47.8.693; SHINER M, 1964, JAMA-J AM MED ASSOC, V188, P45; Sollid LM, 2011, J INTERN MED, V269, P604, DOI 10.1111/j.1365-2796.2011.02376.x; Taavela J, 2013, CLIN GASTROENTEROL H, V11, P166, DOI 10.1016/j.cgh.2012.09.030; THURLBECK WM, 1960, AM J CLIN PATHOL, V34, P108, DOI 10.1093/ajcp/34.2.108; Veress B, 2004, SCAND J GASTROENTERO, V39, P138, DOI 10.1080/00365520310007675	31	119	119	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76163	10.1371/journal.pone.0076163	http://dx.doi.org/10.1371/journal.pone.0076163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146832	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400044
J	Vleut, I; Levy-Tacher, SI; de Boer, WF; Galindo-Gonzalez, J; Vazquez, LB				Vleut, Ivar; Israel Levy-Tacher, Samuel; de Boer, Willem Frederik; Galindo-Gonzalez, Jorge; Vazquez, Luis-Bernardo			Tropical Secondary Forest Management Influences Frugivorous Bat Composition, Abundance and Fruit Consumption in Chiapas, Mexico	PLOS ONE			English	Article							RAIN-FOREST; COMMUNITY STRUCTURE; NEOTROPICAL FOREST; FORAGING HABITAT; SCATTERED TREES; SEED DISPERSAL; EATING BATS; SUCCESSION; VEGETATION; DIVERSITY	Most studies on frugivorous bat assemblages in secondary forests have concentrated on differences among successional stages, and have disregarded the effect of forest management. Secondary forest management practices alter the vegetation structure and fruit availability, important factors associated with differences in frugivorous bat assemblage structure, and fruit consumption and can therefore modify forest succession. Our objective was to elucidate factors (forest structural variables and fruit availability) determining bat diversity, abundance, composition and species-specific abundance of bats in (i) secondary forests managed by Lacandon farmers dominated by Ochroma pyramidale, in (ii) secondary forests without management, and in (iii) mature rain forests in Chiapas, Southern Mexico. Frugivorous bat species diversity (Shannon H') was similar between forest types. However, bat abundance was highest in rain forest and O. pyramidale forests. Bat species composition was different among forest types with more Carollia sowelli and Sturnira lilium captures in O. pyramidale forests. Overall, bat fruit consumption was dominated by early-successional shrubs, highest late-successional fruit consumption was found in rain forests and more bats consumed early-successional shrub fruits in O. pyramidale forests. Ochroma pyramidale forests presented a higher canopy openness, tree height, lower tree density and diversity of fruit than secondary forests. Tree density and canopy openness were negatively correlated with bat species diversity and bat abundance, but bat abundance increased with fruit abundance and tree height. Hence, secondary forest management alters forests' structural characteristics and resource availability, and shapes the frugivorous bat community structure, and thereby the fruit consumption by bats.	[Vleut, Ivar; Israel Levy-Tacher, Samuel; Vazquez, Luis-Bernardo] El Colegio De La Frontera Sur ECOSUR, San Cristobal Las Casas, Chiapas, Mexico; [de Boer, Willem Frederik] Wageningen Univ, Resource Ecol Grp, NL-6700 AP Wageningen, Netherlands; [Galindo-Gonzalez, Jorge] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa 91000, Veracruz, Mexico	El Colegio de la Frontera Sur (ECOSUR); Wageningen University & Research; Universidad Veracruzana	Vleut, I (corresponding author), El Colegio De La Frontera Sur ECOSUR, San Cristobal Las Casas, Chiapas, Mexico.	ivar82@yahoo.com	Galindo-González, Jorge/M-2585-2014; Levy-Tacher, Samuel/T-4454-2018; Vazquez, Luis-Bernardo/A-8358-2013	Galindo-González, Jorge/0000-0003-2583-2754; Levy-Tacher, Samuel/0000-0002-8853-4810; Vazquez, Luis-Bernardo/0000-0002-1673-2455	Etnobiologia para la Conservacion A.C.; CONACyT-Mexico [239503]	Etnobiologia para la Conservacion A.C.; CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was funded by Etnobiologia para la Conservacion A.C. and by a doctoral scholarship awarded to the first author by CONACyT-Mexico (Reg. 239503). Idea Wild and Fondo Institucional de Fomento Regional para el Desarrollo Cientifico, Tecnologico y de Innovacion (FORDECYT) (Agreement 116306) provided mist nets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, WATCHING LACANDON MA; [Anonymous], 2005, ARBOLES TROPICALES M; Castro-Luna AA, 2012, MAMM BIOL, V77, P32, DOI 10.1016/j.mambio.2011.06.009; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Castro-Luna AA, 2007, ANIM CONSERV, V10, P219, DOI 10.1111/j.1469-1795.2007.00097.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Crampton LH, 1998, CONSERV BIOL, V12, P1347, DOI 10.1046/j.1523-1739.1998.97209.x; CROME FHJ, 1988, ECOLOGY, V69, P1960, DOI 10.2307/1941173; Dalling JW, 1999, J TROP ECOL, V15, P827, DOI 10.1017/S0266467499001200; Diemont SAW, 2006, ECOL ENG, V28, P205, DOI 10.1016/j.ecoleng.2005.10.012; Douterlungne D, 2010, RESTOR ECOL, V18, P322, DOI 10.1111/j.1526-100X.2008.00459.x; Dumont ER, 2003, BAT ECOLOGY, P398; Estrada A, 2001, ECOGRAPHY, V24, P94, DOI 10.1034/j.1600-0587.2001.240111.x; FAO, 2010, 163 FAO; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Fleming, 1986, FRUGIVORES SEED DISP, P105, DOI DOI 10.1007/978-94-009-4812-9_11; Fleming T.H., 1986, FRUGIVORES SEED DISP, P1105; FLEMING TH, 1991, J MAMMAL, V72, P493, DOI 10.2307/1382132; FLEMING TH, 1981, BIOTROPICA, V13, P45, DOI 10.2307/2388069; Ford WM, 2005, BIOL CONSERV, V126, P528, DOI 10.1016/j.biocon.2005.07.003; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Galindo-Gonzalez J, 2009, J TROP ECOL, V25, P205, DOI 10.1017/S0266467409005859; GENTRY AH, 1974, ANN MO BOT GARD, V61, P728, DOI 10.2307/2395026; da Silva AG, 2008, J MAMMAL, V89, P43, DOI 10.1644/06-MAMM-A-300.1; Gorresen PM, 2004, J MAMMAL, V85, P688, DOI 10.1644/BWG-125; GREIG N, 1993, ECOLOGY, V74, P2125, DOI 10.2307/1940857; GUEVARA S, 1997, HIST NATURAL TUXTLAS, P43; Herrera LG, 2002, OECOLOGIA, V133, P280, DOI 10.1007/s00442-002-1036-z; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HUTCHESON K, 1970, J THEOR BIOL, V29, P151, DOI 10.1016/0022-5193(70)90124-4; JANSON CH, 1983, SCIENCE, V219, P187, DOI 10.1126/science.219.4581.187; JONES G, 1991, J ZOOL, V225, P393, DOI 10.1111/j.1469-7998.1991.tb03824.x; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Krebs C.J., 2014, ECOLOGICAL METHODOLO; KUNZ TH, 1994, FUNCT ECOL, V8, P665; Kunz TH, 2003, BAT ECOLOGY, P3; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lacki MJ, 2003, ACTA CHIROPTEROL, V5, P199, DOI 10.3161/001.005.0211; LEVY-TACHER S. I., 2000, THESIS COLEGIO POSGR; Levy-Tacher SI, 2005, J SUSTAIN AGR, V26, P49, DOI 10.1300/J064v26n01_06; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; MacSwiney MC, 2008, J APPL ECOL, V45, P1364, DOI 10.1111/j.1365-2664.2008.01531.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MARINHOFILHO JS, 1991, J TROP ECOL, V7, P59, DOI 10.1017/S0266467400005083; McCune B, 2002, ANAL ECOLOGICAL COMM; Medellin R, 2008, IDENTIFICACION MURCI; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Medellin RA, 1999, BIOTROPICA, V31, P478, DOI 10.1111/j.1744-7429.1999.tb00390.x; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nations J. D., 1980, Journal of Anthropological Research, V36, P1; PALMEIRIM J, 1985, BIOTROPICA, V17, P82, DOI 10.2307/2388385; Pearson TRH, 2003, OECOLOGIA, V137, P456, DOI 10.1007/s00442-003-1361-x; R. D. C. Team, 2005, R LANG ENV STAT COMP; Reid F. A., 2009, FIELD GUIDE MAMMALS; Russo D, 2007, ACTA OECOL, V31, P119, DOI 10.1016/j.actao.2006.11.001; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schulze MD, 2000, BIOTROPICA, V32, P174, DOI 10.1646/0006-3606(2000)032[0174:ACOTPB]2.0.CO;2; Straube FC, 2002, CHIRO NEOTR, V8, P150, DOI DOI 10.1017/CB09781107415324.004; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Vleut I, 2013, J TROP ECOL, V29, P173, DOI 10.1017/S0266467413000126; Vleut I, 2012, J MAMMAL, V93, P1469, DOI 10.1644/12-MAMM-A-005.1; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; WILLIAMSLINERA G, 1990, J ECOL, V78, P356, DOI 10.2307/2261117; Willig MR, 2007, BIOTROPICA, V39, P737, DOI 10.1111/j.1744-7429.2007.00322.x; Wulms M, 2009, THESIS U APPL SCI VE; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]	71	16	17	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77584	10.1371/journal.pone.0077584	http://dx.doi.org/10.1371/journal.pone.0077584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147029	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400127
J	Cho, T; Ryu, JK; Taghibiglou, C; Ge, Y; Chan, AW; Liu, LD; Lu, J; McLarnon, JG; Wang, YT				Cho, Taesup; Ryu, Jae K.; Taghibiglou, Changiz; Ge, Yuan; Chan, Allen W.; Liu, Lidong; Lu, Jie; McLarnon, James G.; Wang, Yu Tian			Long-Term Potentiation Promotes Proliferation/Survival and Neuronal Differentiation of Neural Stem/Progenitor Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ADULT DENTATE GYRUS; CULTURED HIPPOCAMPAL-NEURONS; NEWLY GENERATED NEURONS; MICROTUBULE-ASSOCIATED PROTEIN; INTERMEDIATE-FILAMENT PROTEIN; NMDA RECEPTOR ACTIVATION; DEEP BRAIN-STIMULATION; STEM-CELLS; PROGENITOR CELLS	Neural stem cell (NSC) replacement therapy is considered a promising cell replacement therapy for various neurodegenerative diseases. However, the low rate of NSC survival and neurogenesis currently limits its clinical potential. Here, we examined if hippocampal long-term potentiation (LTP), one of the most well characterized forms of synaptic plasticity, promotes neurogenesis by facilitating proliferation/survival and neuronal differentiation of NSCs. We found that the induction of hippocampal LTP significantly facilitates proliferation/survival and neuronal differentiation of both endogenous neural progenitor cells (NPCs) and exogenously transplanted NSCs in the hippocampus in rats. These effects were eliminated by preventing LTP induction by pharmacological blockade of the N-methyl-D-aspartate glutamate receptor (NMDAR) via systemic application of the receptor antagonist, 3-[(R)-2-carboxypiperazin-4-yl]-propyl-1-phosphonic acid (CPP). Moreover, using a NPC-neuron co-culture system, we were able to demonstrate that the LTP-promoted NPC neurogenesis is at least in part mediated by a LTP-increased neuronal release of brain-derived neurotrophic factor (BDNF) and its consequent activation of tropomysosin receptor kinase B (TrkB) receptors on NSCs. Our results indicate that LTP promotes the neurogenesis of both endogenous and exogenously transplanted NSCs in the brain. The study suggests that pre-conditioning of the host brain receiving area with a LTP-inducing deep brain stimulation protocol prior to NSC transplantation may increase the likelihood of success of using NSC transplantation as an effective cell therapy for various neurodegenerative diseases.	[Cho, Taesup; Taghibiglou, Changiz; Ge, Yuan; Chan, Allen W.; Liu, Lidong; Lu, Jie; Wang, Yu Tian] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Cho, Taesup; Taghibiglou, Changiz; Ge, Yuan; Chan, Allen W.; Liu, Lidong; Lu, Jie; Wang, Yu Tian] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Ryu, Jae K.; McLarnon, James G.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Wang, Yu Tian] China Med Univ Hosp, Translat Med Res Ctr, Taichung, Taiwan; [Wang, Yu Tian] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	University of British Columbia; University of British Columbia; University of British Columbia; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wang, YT (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada.	ytwang@brain.ubc.ca	Chan, Allen/AAF-4718-2020; Wang, Yu Tian/J-8255-2015; Taghibiglou, Changiz/H-4590-2019	Liu, Lidong/0000-0002-7026-690X	Canadian Institutes of Health Research (CIHR); Howard Hughes Medical Institute; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; HSFBC	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Taiwan Department of Health Clinical Trial and Research Center of Excellence; HSFBC	This work was supported in part by the Canadian Institutes of Health Research (CIHR), Howard Hughes Medical Institute and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004). YTW is the holder of the Heart and Stroke Foundation of British Columbia and the Yukon (HSFBC & Y) Chair in Stroke Research. T. C was supported by a Doctoral Award from the HSFBC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; AHMED S, 1995, J NEUROSCI, V15, P5765; Arevalo JC, 2006, CELL MOL LIFE SCI, V63, P1523, DOI 10.1007/s00018-006-6010-1; Arias-Carrion O, 2007, REV NEUROLOGIA, V44, P541, DOI 10.33588/rn.4409.2006426; Babu H, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.001.2009; Bading JR, 2002, J DRUG TARGET, V10, P359, DOI 10.1080/10611860290031831; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bekkers JM, 1996, J NEUROPHYSIOL, V75, P1250, DOI 10.1152/jn.1996.75.3.1250; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Brustle O, 1996, CURR OPIN NEUROBIOL, V6, P688, DOI 10.1016/S0959-4388(96)80104-8; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Chawla S, 1998, Indian J Pathol Microbiol, V41, P355; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Chun SK, 2006, NEUROBIOL LEARN MEM, V86, P322, DOI 10.1016/j.nlm.2006.05.005; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Farmer J, 2004, NEUROSCIENCE, V124, P71, DOI 10.1016/j.neuroscience.2003.09.029; Filali M, 2004, EXP BRAIN RES, V156, P274, DOI 10.1007/s00221-003-1784-y; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Goldman SA, 1997, J NEUROBIOL, V32, P554, DOI 10.1002/(SICI)1097-4695(19970605)32:6<554::AID-NEU2>3.0.CO;2-Z; Gould E, 1997, J NEUROSCI, V17, P2492; Haniu M, 1997, J BIOL CHEM, V272, P25296, DOI 10.1074/jbc.272.40.25296; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Joo JY, 2007, J CELL SCI, V120, P1358, DOI 10.1242/jcs.002154; Kameda M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.70; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; Kinoshita M, 2005, J COMP NEUROL, V484, P249, DOI 10.1002/cne.20473; Kitamura T, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-13; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Kuhn HG, 2007, CURR PHARM BIOTECHNO, V8, P127; KURKI P, 1986, EXP CELL RES, V166, P209, DOI 10.1016/0014-4827(86)90520-3; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Li Guo Hua, 2009, Int J Physiol Pathophysiol Pharmacol, V2, P47; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Liem RKH, 1993, CURR OPIN CELL BIOL, V5, P12, DOI 10.1016/S0955-0674(05)80003-1; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lledo PM, 2006, B ACAD NAT MED PARIS, V190, P385, DOI 10.1016/S0001-4079(19)33325-4; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muthusamy KA, 2007, J NEUROSURG, V107, P814, DOI 10.3171/JNS-07/10/0814; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryu JK, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-39; Ryu JK, 2009, J NEUROSCI, V29, P3, DOI 10.1523/JNEUROSCI.2888-08.2009; Ryu JK, 2004, NEUROBIOL DIS, V16, P68, DOI 10.1016/j.nbd.2004.01.016; Skarsgard ED, 2005, J PEDIATR SURG, V40, P1817, DOI 10.1016/j.jpedsurg.2005.08.047; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Taghibiglou C, 2009, NAT MED, V15, P1399, DOI 10.1038/nm.2064; TAPLEY P, 1992, ONCOGENE, V7, P371; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Taupin P, 2006, CURR OPIN MOL THER, V8, P225; THOMSON AM, 1989, NATURE, V338, P422, DOI 10.1038/338422a0; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Tronnier VM, 1997, STEREOT FUNCT NEUROS, V69, P62, DOI 10.1159/000099853; Tronnier VM, 1997, J NEUROSURG, V87, P700, DOI 10.3171/jns.1997.87.5.0700; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang YS, 2004, J BIOL CHEM, V279, P41267, DOI 10.1074/jbc.C400199200; Wei LC, 2002, DEV BRAIN RES, V139, P9, DOI 10.1016/S0165-3806(02)00509-6; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	106	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76860	10.1371/journal.pone.0076860	http://dx.doi.org/10.1371/journal.pone.0076860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146937	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200022
J	Fu, JQ; Akhmedov, D; Berdeaux, R				Fu, Jingqi; Akhmedov, Dmitry; Berdeaux, Rebecca			The Short Isoform of the Ubiquitin Ligase NEDD4L Is a CREB Target Gene in Hepatocytes	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; REGULATES HEPATIC GLUCONEOGENESIS; INSULIN SENSITIVITY; GLUCOSE-METABOLISM; COACTIVATOR TORC2; C2 DOMAIN; PHOSPHORYLATION; EXPRESSION; KINASE; HYPERTENSION	During cycles of fasting and feeding, liver function is regulated by both transcriptional and post-translational events. Regulated protein degradation has recently emerged as a key mechanism to control abundance of specific hepatic proteins under different nutritional conditions. As glucagon signaling through cAMP and PKA is central to glucose output during fasting, we hypothesized that this signaling pathway may also regulate ubiquitin ligases in the fasted state. Here we show that fasting stimuli promote expression of the short isoform of the E3 ubiquitin ligase Nedd4l in primary mouse hepatocytes. Nedd4l-short mRNA and NEDD4L (short isoform) protein accumulate in glucagon-treated primary mouse hepatocytes and in liver tissues during fasting. We identified a functional cAMP response element in the alternate Nedd4l-short promoter; mutation of this element blunts cAMP-induced expression of a Nedd4l reporter construct. CREB occupies the endogenous Nedd4l locus near this element. CREB and its coactivator CRTC2, both activated by fasting stimuli, contribute to glucagon-stimulated Nedd4l-short expression in primary hepatocytes. siRNA-mediated Nedd4l depletion in primary hepatocytes did not affect gluconeogenic gene expression, glucose output or glycogen synthesis. Our findings reveal a new mechanism of Nedd4l transcriptional regulation in liver cells.	[Fu, Jingqi; Akhmedov, Dmitry] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Berdeaux, Rebecca] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Berdeaux, R (corresponding author), Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA.	Rebecca.berdeaux@uth.tmc.edu		Berdeaux, Rebecca/0000-0002-9929-1711; Fu, Jingqi/0000-0003-3871-428X	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK092590, P30DK056338]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059847]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, R01DK092590] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Institutes of Diabetes and Digestive and Kidney Diseases (R01DK092590, P30DK056338) and Arthritis and Musculoskeletal and Skin Diseases (R01AR059847). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Boase NA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1284; Canettieri G, 2005, CELL METAB, V2, P331, DOI 10.1016/j.cmet.2005.09.008; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; FLEIG WE, 1987, J BIOL CHEM, V262, P1155; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Hasstedt SJ, 2013, J HUM GENET, V58, P378, DOI 10.1038/jhg.2013.21; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McDonough CW, 2009, HUM GENET, V126, P805, DOI 10.1007/s00439-009-0732-8; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Molusky MM, 2012, DIABETES, V61, P1025, DOI 10.2337/db11-0970; Osawa Y, 2011, FASEB J, V25, P1133, DOI 10.1096/fj.10-168351; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Qi H, 2003, MOL CELL ENDOCRINOL, V210, P51, DOI 10.1016/j.mce.2003.08.009; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Salway JG., 2004, METABOLISM GLANCE, V3rd, P125; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Stewart R, 2013, P NATL ACAD SCI USA, V110, P117, DOI 10.1073/pnas.1212676110; Stewart R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024714; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Uno M, 2013, CELL REP, V3, P79, DOI 10.1016/j.celrep.2012.12.018; Van Huysse JW, 2012, HYPERTENSION, V60, P691, DOI 10.1161/HYPERTENSIONAHA.112.193045; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Wang YL, 2013, INT J MOL SCI, V14, P7433, DOI 10.3390/ijms14047433; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yu JX, 2013, J BIOL CHEM, V288, P3823, DOI 10.1074/jbc.M112.397885; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	43	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78522	10.1371/journal.pone.0078522	http://dx.doi.org/10.1371/journal.pone.0078522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147136	Green Submitted, gold, Green Published			2022-12-27	WOS:000326022200098
J	Hedhli, D; Denis, O; Barkan, D; Daffe, M; Glickman, MS; Huygen, K				Hedhli, Dorsaf; Denis, Olivier; Barkan, Daniel; Daffe, Mamadou; Glickman, Michael S.; Huygen, Kris			M.tuberculosis Mutants Lacking Oxygenated Mycolates Show Increased Immunogenicity and Protective Efficacy as Compared to M. bovis BCG Vaccine in an Experimental Mouse Model	PLOS ONE			English	Article							CD8 T-CELLS; MYCOBACTERIUM-TUBERCULOSIS; MYCOLIC ACIDS; IMMUNITY; CYCLOPROPANATION; INFECTION; PROTEINS; EPITOPES; AG85A	The existing vaccine against tuberculosis (M. bovis BCG) exerts some protection against the extrapulmonary forms of the disease, particularly in young children, but is not very effective against the pulmonary form of TB, which often results from the reactivation of a latent M. tuberculosis (M.tb) infection. Among the new approaches in TB vaccine development, live attenuated M.tb mutants are a promising new avenue. Here we report on the vaccine potential of two highly attenuated M.tb mutants, MGM1991 and M.tbhma::hyg (HMA), lacking all oxygenated mycolates in their cell wall. In C57BL/6 mice, stronger Th1 (IFN-gamma, IL-2 and TNF-alpha) and IL-17 responses could be induced following subcutaneous vaccination with either of the two mutants, than following vaccination with M. bovis BCG. Significantly more mycobacteria specific IFN-gamma producing CD4(+) and particularly CD8(+) T cells could be detected by intracellular cytokine staining in mice vaccinated with the M.tb mutants. Finally, vaccination with either of the two mutants conferred stronger protection against intratracheal M.tb challenge than vaccination with BCG, as indicated by reduced bacterial replication in lungs at 4 to 12 weeks after challenge. Protection against M.tb dissemination, as indicated by reduced bacterial numbers in spleen, was comparable for both mutants to protection conferred by BCG.	[Hedhli, Dorsaf; Denis, Olivier; Huygen, Kris] Sci Inst Publ Hlth, WIV ISP, Serv Immunol, Brussels, Belgium; [Barkan, Daniel; Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Barkan, Daniel; Glickman, Michael S.] Mem Sloan Kettering Canc Ctr, Div Infect Dis, New York, NY 10021 USA; [Daffe, Mamadou] CNRS, Dept Mecanismes Mol Infect Mycobacteriennes, Inst Pharmacol & Biol Struct, Toulouse, France; [Daffe, Mamadou] Univ Toulouse 3, UMR 5089, F-31062 Toulouse, France	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Huygen, K (corresponding author), Sci Inst Publ Hlth, WIV ISP, Serv Immunol, Site Ukkel, Brussels, Belgium.	kris.huygen@wiv-isp.be		Huygen, Kris/0000-0001-7808-0512; Glickman, Michael S/0000-0001-7918-5164	Flemish Scientific Research Foundation (FWO-Vlaanderen) [G.0063-09N]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053417] Funding Source: NIH RePORTER	Flemish Scientific Research Foundation (FWO-Vlaanderen); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by a grant from the Flemish Scientific Research Foundation (FWO-Vlaanderen G.0063-09N) (to D. H. and K. H.). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aguilo JI, 2013, CELL MICROBIOL, DOI 10.1111/cmi12169; Aporta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045213; Arlehamn CSL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003130; Asensio JAG, 2008, EXPERT OPIN BIOL TH, V8, P201, DOI 10.1517/14712598.8.2.201 ; Barkan D, 2012, INFECT IMMUN, V80, P1958, DOI 10.1128/IAI.00021-12; Brandt L, 1996, J IMMUNOL, V157, P3527; Brennan MJ, 2012, VACCINE, V30, P2811, DOI 10.1016/j.vaccine.2012.02.036; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Korf H, 2009, J CLIN INVEST, V119, P1626, DOI 10.1172/JCI35288; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; MINNIKIN DE, 1984, J GEN MICROBIOL, V130, P2733; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Romano M, 2012, MICROBES INFECT, V14, P86, DOI 10.1016/j.micinf.2011.08.011; Romano M, 2006, IMMUNOLOGY, V118, P321, DOI 10.1111/j.1365-2567.2006.02373.x; Romano M, 2012, EXPERT OPIN BIOL TH, V12, P1601, DOI 10.1517/14712598.2012.721768; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Ryan AA, 2009, J IMMUNOL, V182, P7172, DOI 10.4049/jimmunol.0801694; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Vander Beken S, 2011, EUR J IMMUNOL, V41, P450, DOI 10.1002/eji.201040719; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001	34	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e76442	10.1371/journal.pone.0076442	http://dx.doi.org/10.1371/journal.pone.0076442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146869	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200014
J	Jin, JO; Shinohara, Y; Yu, Q				Jin, Jun-O; Shinohara, Yoshinori; Yu, Qing			Innate Immune Signaling Induces Interleukin-7 Production from Salivary Gland Cells and Accelerates the Development of Primary Sjogren's Syndrome in a Mouse Model	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; AUTOIMMUNE EXOCRINOPATHY; EPITHELIAL-CELLS; T-CELLS; EXPRESSION; MICE; PATHOGENESIS; ACTIVATION; IL-7; INDUCTION	Elevated IL-7 in the target tissues is closely associated with multiple autoimmune disorders, including Sjogren's syndrome (SS). We recently found that IL-7 plays an essential role in the development and onset of primary SS (pSS) in C57BL/6.NOD-Aec1Aec2 mice, a well-defined mouse model of primary SS. However, environmental signals that cause excessive IL-7 production are not well-characterized. Innate immune signaling plays a critical role in shaping the adaptive immune responses including autoimmune responses. We and others have previously shown that innate immune signaling can induce IL-7 expression in lungs and intestines of C57BL/6 mice. In this study, we characterized the effects of poly I:C, a double-stranded RNA analog and toll-like receptor 3 agonist, on the induction of IL-7 expression in salivary glands and on pSS development. We showed that poly I:C administration to C57BL/6 mice rapidly induced IL-7 expression in the salivary glands in a type 1 IFN- and IFN-gamma-dependent manner. Moreover, poly I:C-induced IL-7 contributed to the optimal up-regulation of CXCL9 in the salivary glands, which may subsequently promote recruitment of more IFN-gamma-producing T cells. Repeated administration of poly I:C to C57BL/6.NOD-Aec1Aec2 mice accelerated the development of SS-like exocrinopathy, and this effect was abolished by the blockade of IL-7 receptor signaling with a neutralizing antibody. Finally, poly I:C or a combination of IFN-alpha and IFN-gamma induced IL-7 gene expression and protein production in a human salivary gland epithelial cell line. Hence, we demonstrate that IL-7 expression in the salivary gland cells can be induced by poly I:C and delineate a crucial mechanism by which innate immune signals facilitate the development of pSS, which is through induction of IL-7 in the target tissues.	[Jin, Jun-O; Yu, Qing] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Shinohara, Yoshinori] Kyushu Univ, Div Oral Rehabil, Fukuoka 812, Japan	Harvard University; Forsyth Institute; Kyushu University	Yu, Q (corresponding author), Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA.	qyu@forsyth.org	yu, qing/HGC-4611-2022; Jin, Jun-O/G-2998-2014	Jin, Jun-O/0000-0003-4216-8111	National Institutes of Health [P30DE020751]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P30DE020751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grants from the National Institutes of Health (P30DE020751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Bikker A, 2010, ARTHRITIS RHEUM-US, V62, P969, DOI 10.1002/art.27318; Calzascia T, 2008, P NATL ACAD SCI USA, V105, P2999, DOI 10.1073/pnas.0712135105; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; Cha S, 2004, SCAND J IMMUNOL, V60, P552, DOI 10.1111/j.0300-9475.2004.01508.x; Cha S, 2002, ADV EXP MED BIOL, V506, P1035; Deshmukh US, 2009, J ORAL PATHOL MED, V38, P42, DOI 10.1111/j.1600-0714.2008.00700.x; Gonzalez-Quintial R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027528; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hartgring SAY, 2006, ANN RHEUM DIS, V65, P69, DOI 10.1136/ard.2006.058479; Hartgring SAY, 2010, ARTHRITIS RHEUM-US, V62, P2716, DOI 10.1002/art.27578; Hayakawa I, 2007, IMMUNOLOGY, V122, P73, DOI 10.1111/j.1365-2567.2007.02614.x; Ittah M, 2008, EUR J IMMUNOL, V38, P1058, DOI 10.1002/eji.200738013; Ittah M, 2009, EUR J IMMUNOL, V39, P1271, DOI 10.1002/eji.200839086; Jin J-O, 2013, ARTHRITIS RHEUM; Jin JO, 2013, J LEUKOCYTE BIOL, V93, P413, DOI 10.1189/jlb.0712360; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Katsifis GE, 2007, CLIN REV ALLERG IMMU, V32, P252, DOI 10.1007/s12016-007-8011-8; Kawakami A, 2007, J RHEUMATOL, V34, P1019; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Lee BH, 2009, ARCH IMMUNOL THER EX, V57, P57, DOI 10.1007/s00005-009-0002-4; Lee LF, 2012, P NATL ACAD SCI USA, V109, P12674, DOI 10.1073/pnas.1203795109; Lee LF, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002400; Li J, 2010, KOREAN J PHYSIOL PHA, V14, P235, DOI 10.4196/kjpp.2010.14.4.235; Mariette X, 2010, CURR OPIN RHEUMATOL, V22, P471, DOI 10.1097/BOR.0b013e32833c36c5; Matsumoto M, 2011, REV MED VIROL; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Nandula SR, 2011, ORAL DIS, V17, P801, DOI 10.1111/j.1601-0825.2011.01839.x; Nguyen CQ, 2008, ARTHRITIS RHEUM-US, V58, P734, DOI 10.1002/art.23214; Nguyen CQ, 2007, J IMMUNOL, V179, P2318, DOI 10.4049/jimmunol.179.4.2318; Nguyen CQ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2676; Nikolov NP, 2009, CURR OPIN RHEUMATOL, V21, P465, DOI 10.1097/BOR.0b013e32832eba21; Park JH, 2010, NAT IMMUNOL, V11, P257, DOI 10.1038/ni.1840; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Roescher N, 2010, ANN RHEUM DIS, V69, P945, DOI 10.1136/ard.2009.115378; Sawa Y, 2009, IMMUNITY, V30, P447, DOI 10.1016/j.immuni.2009.01.007; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Segal B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-46; Sharma R, 2009, J IMMUNOL, V183, P3212, DOI 10.4049/jimmunol.0804355; Shinohara T, 2011, J IMMUNOL, V186, P2623, DOI 10.4049/jimmunol.1000057; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Theander E, 2004, ARTHRITIS RHEUM-US, V50, P1262, DOI 10.1002/art.20176; Totsuka T, 2007, J IMMUNOL, V178, P4737, DOI 10.4049/jimmunol.178.8.4737; Vosters JL, 2009, ARTHRITIS RHEUM-US, V60, P3633, DOI 10.1002/art.24980; Voulgarelis M, 2010, NAT REV RHEUMATOL, V6, P529, DOI 10.1038/nrrheum.2010.118; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Yamazaki M, 2003, J IMMUNOL, V171, P1556, DOI 10.4049/jimmunol.171.3.1556; Yin HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018003	51	43	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77605	10.1371/journal.pone.0077605	http://dx.doi.org/10.1371/journal.pone.0077605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147035	Green Published, gold, Green Submitted			2022-12-27	WOS:000326022200051
J	Kidoaki, S; Sakashita, H				Kidoaki, Satoru; Sakashita, Hiroyuki			Rectified Cell Migration on Saw-Like Micro-Elastically Patterned Hydrogels with Asymmetric Gradient Ratchet Teeth	PLOS ONE			English	Article							FORCE MICROSCOPY; STEM-CELLS; MOTILITY; HAPTOTAXIS; SUBSTRATE; MOVEMENT; MORPHOGENESIS; RIGIDITY; GELATIN	To control cell motility is one of the essential technologies for biomedical engineering. To establish a methodology of the surface design of elastic substrate to control the long-range cell movements, here we report a sophisticated cell culture hydrogel with a micro-elastically patterned surface that allows long-range durotaxis. This hydrogel has a sawlike pattern with asymmetric gradient ratchet teeth, and rectifies random cell movements. Durotaxis only occurs at boundaries in which the gradient strength of elasticity is above a threshold level. Consequently, in gels with unit teeth patterns, durotaxis should only occur at the sides of the teeth in which the gradient strength of elasticity is above this threshold level. Therefore, such gels are expected to support the long-range biased movement of cells via a mechanism similar to the Feynman-Smoluchowski ratchet, i.e., rectified cell migration. The present study verifies this working hypothesis by using photolithographic microelasticity patterning of photocurable gelatin gels. Gels in which each teeth unit was 100-120 mu m wide with a ratio of ascending: descending elasticity gradient of 1: 2 and a peak elasticity of ca. 100 kPa supported the efficient rectified migration of 3T3 fibroblast cells. In addition, long-range cell migration was most efficient when soft lanes were introduced perpendicular to the saw-like patterns. This study demonstrates that asymmetric elasticity gradient patterning of cell culture gels is a versatile means of manipulating cell motility.	[Kidoaki, Satoru] Kyushu Univ, Inst Mat Chem & Engn, Res Field Biomed & Biophys Chem, Fukuoka 812, Japan; [Sakashita, Hiroyuki] Kyushu Univ, Grad Sch Engn, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kidoaki, S (corresponding author), Kyushu Univ, Inst Mat Chem & Engn, Res Field Biomed & Biophys Chem, Fukuoka 812, Japan.	kidoaki@ms.ifoc.kyushu-u.ac.jp	Kidoaki, Satoru/AAR-2704-2020	Kidoaki, Satoru/0000-0001-9138-0018	Management Expenses Grants for National Universities Corporations "Nano-Macro Materials, Devices and System Research Alliance" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; PRESTO program "Nanosystems and Emergent Functions" from the Japan Science Technology (JST) Agency; Cabinet Office, Government of Japan	Management Expenses Grants for National Universities Corporations "Nano-Macro Materials, Devices and System Research Alliance" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; PRESTO program "Nanosystems and Emergent Functions" from the Japan Science Technology (JST) Agency; Cabinet Office, Government of Japan	This work was supported by the Management Expenses Grants for National Universities Corporations "Nano-Macro Materials, Devices and System Research Alliance" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, the PRESTO program "Nanosystems and Emergent Functions" from the Japan Science Technology (JST) Agency, and the Funding Program for World-Leading Innovative R&D on Science and Technology "Innovative NanoBiodevice based on Single Molecule Analysis" from the Cabinet Office, Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Beningo KA, 2002, TRENDS CELL BIOL, V12, P79, DOI 10.1016/S0962-8924(01)02205-X; Bernstein Lori R., 1994, Current Opinion in Oncology, V6, P106, DOI 10.1097/00001622-199401000-00015; Braiman-Wiksman L, 2007, TOXICOL PATHOL, V35, P767, DOI 10.1080/01926230701584189; BRANDLEY BK, 1989, DEV BIOL, V135, P74, DOI 10.1016/0012-1606(89)90159-0; CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0; CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Feynman RP., 1963, FEYNMAN LECT PHYS, V1, P46; Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Hess DA, 2011, METHODS MOL BIOL, V750, P25, DOI 10.1007/978-1-61779-145-1_2; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Kawano T, 2011, BIOMATERIALS, V32, P2725, DOI 10.1016/j.biomaterials.2011.01.009; Keller R, 2005, CURR OPIN CELL BIOL, V17, P533, DOI 10.1016/j.ceb.2005.08.006; Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015; Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174; Ko YG, 2013, BIOMATERIALS, V34, P353, DOI 10.1016/j.biomaterials.2012.09.071; Kumar G, 2007, ADV MATER, V19, P1084, DOI 10.1002/adma.200601629; LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lowe B, 1997, J EXP BIOL, V200, P1593; Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772; McLennan R, 2012, DEVELOPMENT, V139, P2935, DOI 10.1242/dev.081471; Munevar S, 2001, BIOPHYS J, V80, P1744, DOI 10.1016/S0006-3495(01)76145-0; Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237; PARENTE L, 1979, AGENTS ACTIONS, V9, P190, DOI 10.1007/BF02024733; RADMACHER M, 1995, BIOPHYS J, V69, P264, DOI 10.1016/S0006-3495(95)79897-6; Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Saranak J, 1997, NATURE, V387, P465, DOI 10.1038/387465a0; TRINKAUS JP, 1985, J NEUROSCI RES, V13, P1, DOI 10.1002/jnr.490130102; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Wu HW, 1998, SCANNING, V20, P389; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	42	17	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e78067	10.1371/journal.pone.0078067	http://dx.doi.org/10.1371/journal.pone.0078067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147112	Green Published, Green Submitted, gold			2022-12-27	WOS:000326022200095
J	Meng, JR; Majidi, M; Fang, BL; Ji, L; Bekele, BN; Minna, JD; Roth, JA				Meng, Jieru; Majidi, Mourad; Fang, Bingliang; Ji, Lin; Bekele, B. Nebiyou; Minna, John D.; Roth, Jack A.			The Tumor Suppressor Gene TUSC2 (FUS1) Sensitizes NSCLC to the AKT Inhibitor MK2206 in LKB1-dependent Manner	PLOS ONE			English	Article							CELL LUNG-CANCER; HOMOZYGOUS DELETION REGION; TYROSINE KINASE INHIBITOR; POTENT ANTITUMOR-ACTIVITY; HUMAN-CHROMOSOME 3P21.3; PROTEIN EXPRESSION; SIGNALING PATHWAY; IN-VIVO; PHASE-I; GEFITINIB	TUSC2-defective gene expression is detected in the majority of lung cancers and is associated with worse overall survival. We analyzed the effects of TUSC2 re-expression on tumor cell sensitivity to the AKT inhibitor, MK2206, and explored their mutual signaling connections, in vitro and in vivo. TUSC2 transient expression in three LKB1-defective non-small cell lung cancer (NSCLC) cell lines combined with MK2206 treatment resulted in increased repression of cell viability and colony formation, and increased apoptotic activity. In contrast, TUSC2 did not affect the response to MK2206 treatment for two LKB1-wild type NSCLC cell lines. In vivo, TUSC2 systemic delivery, by nanoparticle gene transfer, combined with MK2206 treatment markedly inhibited growth of tumors in a human LKB1-defective H322 lung cancer xenograft mouse model. Biochemical analysis showed that TUSC2 transient expression in LKB1-defective NSCLC cells significantly stimulated AMP-activated protein kinase (AMPK) phosphorylation and enzymatic activity. More importantly, AMPK gene knockdown abrogated TUSC2-MK2206 cooperation, as evidenced by reduced sensitivity to the combined treatment. Together, TUSC2 re-expression and MK2206 treatment was more effective in inhibiting the phosphorylation and kinase activities of AKT and mTOR proteins than either single agent alone. In conclusion, these findings support the hypothesis that TUSC2 expression status is a biological variable that potentiates MK2206 sensitivity in LKB1-defective NSCLC cells, and identifies the AMPK/AKT/mTOR signaling axis as an important regulator of this activity.	[Meng, Jieru; Majidi, Mourad; Fang, Bingliang; Ji, Lin; Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Sect Thorac Mol Oncol, Houston, TX 77030 USA; [Bekele, B. Nebiyou] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Meng, JR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Sect Thorac Mol Oncol, Houston, TX 77030 USA.	jennymeng@hotmail.com			National Cancer Institute Specialized Program of Research Excellence (SPORE) Grant [CA-70907]; Cancer Center [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA070907] Funding Source: NIH RePORTER	National Cancer Institute Specialized Program of Research Excellence (SPORE) Grant; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute Specialized Program of Research Excellence (SPORE) Grant CA-70907 (J. Minna and J. Roth) and Cancer Center Support Grant CA16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bortul R, 2003, LEUKEMIA, V17, P379, DOI 10.1038/sj.leu.2402793; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; Ciardiello F, 2001, CLIN CANCER RES, V7, P1459; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; Goff LW, 2012, INVEST NEW DRUG, V30, P290, DOI 10.1007/s10637-010-9528-x; Gopalan B, 2004, TECHNOL CANCER RES T, V3, P647, DOI 10.1177/153303460400300615; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267, DOI 10.1200/JCO.2001.19.13.3267; Ito I, 2004, CANCER GENE THER, V11, P733, DOI 10.1038/sj.cgt.7700756; Ivanova AV, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-91; Ji L, 2002, CANCER RES, V62, P2715; Ji L, 2008, J THORAC ONCOL, V3, P327, DOI 10.1097/JTO.0b013e31816bce65; King TD, 2006, BIOCHEM PHARMACOL, V71, P1637, DOI 10.1016/j.bcp.2006.03.005; Lerman MI, 2000, CANCER RES, V60, P6116; Li GD, 2011, ANTICANCER RES, V31, P11; Liang XY, 2010, CANCER BIOL THER, V9, P156, DOI 10.4161/cbt.9.2.10452; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Meng JR, 2009, CANCER BIOL THER, V8, P2073, DOI 10.4161/cbt.8.21.9844; Ono M, 2004, MOL CANCER THER, V3, P465; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Seufferlein T, 1996, CANCER RES, V56, P3895; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	30	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77067	10.1371/journal.pone.0077067	http://dx.doi.org/10.1371/journal.pone.0077067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146957	Green Submitted, Green Published, gold			2022-12-27	WOS:000326022200031
J	Madsen, EA; Persson, T; Sayehli, S; Lenninger, S; Sonesson, G				Madsen, Elainie Alenkr; Persson, Tomas; Sayehli, Susan; Lenninger, Sara; Sonesson, Goran			Chimpanzees Show a Developmental Increase in Susceptibility to Contagious Yawning: A Test of the Effect of Ontogeny and Emotional Closeness on Yawn Contagion	PLOS ONE			English	Article							ASPERGER-SYNDROME; FACIAL EXPRESSIONS; NEONATAL IMITATION; SOCIAL MODULATION; PAN-TROGLODYTES; EMPATHY; SELF; DISSOCIATION; RECOGNITION; AFFILIATION	Contagious yawning has been reported for humans, dogs and several non-human primate species, and associated with empathy in humans and other primates. Still, the function, development and underlying mechanisms of contagious yawning remain unclear. Humans and dogs show a developmental increase in susceptibility to yawn contagion, with children showing an increase around the age of four, when also empathy-related behaviours and accurate identification of others' emotions begin to clearly evince. Explicit tests of yawn contagion in non-human apes have only involved adult individuals and examined the existence of conspecific yawn contagion. Here we report the first study of heterospecific contagious yawning in primates, and the ontogeny of susceptibility thereto in chimpanzees, Pan troglodytes verus. We examined whether emotional closeness, defined as attachment history with the yawning model, affected the strength of contagion, and compared the contagiousness of yawning to nose-wiping. Thirty-three orphaned chimpanzees observed an unfamiliar and familiar human (their surrogate human mother) yawn, gape and nose-wipe. Yawning, but not nose-wiping, was contagious for juvenile chimpanzees, while infants were immune to contagion. Like humans and dogs, chimpanzees are subject to a developmental trend in susceptibility to contagious yawning, and respond to heterospecific yawn stimuli. Emotional closeness with the model did not affect contagion. The familiarity-biased social modulatory effect on yawn contagion previously found among some adult primates, seem to only emerge later in development, or be limited to interactions with conspecifics. The influence of the 'chameleon effect', targeted vs. generalised empathy, perspective-taking and visual attention on contagious yawning is discussed.	[Madsen, Elainie Alenkr; Persson, Tomas] Lund Univ, Dept Cognit Sci, Lund, Sweden; [Madsen, Elainie Alenkr; Lenninger, Sara; Sonesson, Goran] Lund Univ, Dept Semiot, Ctr Languages & Literature, Lund, Sweden; [Sayehli, Susan] Lund Univ, Dept Linguist, Ctr Languages & Literature, Lund, Sweden; [Sayehli, Susan] Lund Univ, Humanities Lab, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Madsen, EA (corresponding author), Lund Univ, Dept Cognit Sci, Lund, Sweden.	Elainie.Madsen@gmail.com	Sonesson, Göran/L-8470-2013	Sonesson, Göran/0000-0003-2517-2397	Swedish Research Council [2008-28315-58867-29]; Centre for Cognitive Semiotics, Lund University; Riksbankens Jubileumsfond [M2008-0408:1-E]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Cognitive Semiotics, Lund University; Riksbankens Jubileumsfond	The research was part of the project 'Precursors of Sign Use in Intersubjectivity and Imitation', (2008-28315-58867-29), funded by Swedish Research Council (http://www.vr.se/inenglish). Financial support was also given by the Centre for Cognitive Semiotics, Lund University (http://project.sol.lu.se/en/ccs/), funded by Riksbankens Jubileumsfond (M2008-0408:1-E; http://www.rj.se/english). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELMANN PK, 1989, ANNU REV PSYCHOL, V40, P249, DOI 10.1146/annurev.ps.40.020189.001341; Anderson JR, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P233, DOI 10.1007/4-431-30248-4_15; Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Arnott SR, 2009, COGN AFFECT BEHAV NE, V9, P335, DOI 10.3758/CABN.9.3.335; Bard KA, 2007, ANIM COGN, V10, P233, DOI 10.1007/s10071-006-0062-3; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; BLOOMSMITH M, 2005, NURSERY REARING NONH, P289; BORKE H, 1973, DEV PSYCHOL, V9, P102, DOI 10.1037/h0035080; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Campbell MW, 2010, FRONT NEUROL NEUROSC, V28, P120, DOI 10.1159/000307090; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; Carpenter M, CHILD DEV IN PRESS; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cook R, BBS IN PRESS; Cooper NR, 2012, COGN AFFECT BEHAV NE, V12, P393, DOI 10.3758/s13415-011-0081-7; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; de Waal F., 2001, APE SUSHI MASTER CUL; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Demuru E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049613; DEPUTTE BL, 1994, ETHOLOGY, V98, P221; Dziobek I, 2008, J AUTISM DEV DISORD, V38, P464, DOI 10.1007/s10803-007-0486-x; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Gallup AC, 2008, PHYSIOL BEHAV, V95, P10, DOI 10.1016/j.physbeh.2008.05.003; Giganti F, 2009, CURR PSYCHOL LETT, V25, P2; Giganti F, 2012, J DEV PSYCH, V101, P111; Guggisberg AG, 2011, NEUROSCI BIOBEHAV R, V35, P1302, DOI 10.1016/j.neubiorev.2010.12.004; Haker H, 2012, BRAIN IMAGING BEHAV; Harr AL, 2009, ANIM COGN, V12, P833, DOI 10.1007/s10071-009-0233-0; HARRIGAN JA, 1984, MOTIV EMOTION, V8, P157, DOI 10.1007/BF00993071; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Hatfield E, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P19; Helt MS, 2010, CHILD DEV, V81, P1620, DOI 10.1111/j.1467-8624.2010.01495.x; Holle H, 2012, P NATL ACAD SCI; Jefferis VE, 2003, FUNCTIONAL PUR UNPUB; Joly-Mascheroni RM, 2008, BIOL LETTERS, V4, P446, DOI 10.1098/rsbl.2008.0333; Jones SS, 2009, PHILOS T R SOC B, V364, P2325, DOI 10.1098/rstb.2009.0045; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; LEHMANN HE, 1979, B MENNINGER CLIN, V43, P123; Lewis M, 2002, BEHAV BRAIN SCI, V25, P42, DOI 10.1017/S0140525X02450017; Madsen EA, 2013, ANIM COGN, V16, P233, DOI 10.1007/s10071-012-0568-9; Maginnity M., 2007, THESIS U CANTERBURY; Massen JJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040697; McGrew WC, 2001, BEHAVIOUR, V138, P329, DOI 10.1163/15685390152032497; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meno P, 2003, CURR PSYCHOL LETT, V11, P1; Millen A, 2011, BIOL LETTERS, V7, P440, DOI 10.1098/rsbl.2010.0966; Miller ML, 2012, BEHAV PROCESS, V89, P264, DOI 10.1016/j.beproc.2011.12.012; Nahab FB, 2009, HUM BRAIN MAPP, V30, P1744, DOI 10.1002/hbm.20638; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; O'Hara SJ, 2011, ANIM BEHAV, V81, P335, DOI 10.1016/j.anbehav.2010.11.005; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Papoiu A D P, 2011, Br J Dermatol, V164, P1299, DOI 10.1111/j.1365-2133.2011.10318.x; Paukner A, 2006, BIOL LETTERS, V2, P36, DOI 10.1098/rsbl.2005.0411; Paukner A, 2009, SCIENCE, V325, P880, DOI 10.1126/science.1176269; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; POVINELLI DJ, 1994, J COMP PSYCHOL, V108, P74, DOI 10.1037/0735-7036.108.1.74; Preston SD, 2002, BBS, V25, P279; Preston SD, 2007, EMPATHY IN MENTAL ILLNESS, P428, DOI 10.1017/CBO9780511543753.024; PROVINE RR, 1986, ETHOLOGY, V72, P109, DOI 10.1111/j.1439-0310.1986.tb00611.x; PROVINE RR, 1992, B PSYCHONOMIC SOC, V30, P1; Rogers K, 2007, J AUTISM DEV DISORD, V37, P709, DOI 10.1007/s10803-006-0197-8; Romero T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071365; Schurmann M, 2005, NEUROIMAGE, V24, P1260, DOI 10.1016/j.neuroimage.2004.10.022; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Senju A, 2009, J AUTISM DEV DISORD, V39, P1598, DOI 10.1007/s10803-009-0785-5; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Silva K, 2012, ANIM COGN, V15, P721, DOI 10.1007/s10071-012-0473-2; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; Tinbergen, 1951, STUDY INSTINCT; Usui S, 2013, AUTISM RES TREAT, V2013, P1; van Baaren RB, 2004, PSYCHOL SCI, V15, P71, DOI 10.1111/j.0963-7214.2004.01501012.x; Walusinski O, 2013, CLIN ANAT, V26; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Widen SC, 2003, DEV PSYCHOL, V39, P114, DOI 10.1037//0012-1649.39.1.114; WIGGERS M, 1985, DEV PSYCHOL, V21, P338, DOI 10.1037/0012-1649.21.2.338; Wilkinson A, 2011, CURR ZOOL, V57, P477, DOI 10.1093/czoolo/57.4.477; Wobber V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017147; Yoon JMD, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2010.02.011; Zlatev J, 2008, J PHYSIOL-PARIS, V102, P137, DOI 10.1016/j.jphysparis.2008.03.016	86	29	29	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76266	10.1371/journal.pone.0076266	http://dx.doi.org/10.1371/journal.pone.0076266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24146848	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400048
J	Fregnani, CMS; Fregnani, JHTG; Latorre, MDDD; de Almeida, AM				Sirna Fregnani, Cristiane Menezes; Tavares Guerreiro Fregnani, Jose Humberto; Dias de Oliveira Latorre, Maria do Rosario; de Almeida, Ana Maria			Evaluation of the Psychometric Properties of the Functional Assessment of Cancer Therapy-Cervix Questionnaire in Brazil	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH SURVEY SF-36; CHINESE VERSION; RELIABILITY; VALIDATION; VALIDITY; ONCOLOGY	Background: Although cervical cancer is the second most common tumor among Brazilian women, studies that evaluate the quality of life of these women are still scarce. This situation is explained by the lack of specific and validated tools for this purpose in Portuguese (Brazil). The aim of this study was to evaluate the psychometric properties of the Portuguese version of the FACT-CX (Functional Assessment of Cancer Therapy-Cervix) questionnaire in a population of Brazilian women with cervical cancer. Methods: The psychometric properties of the FACT-CX questionnaire were tested in a sample of 100 women diagnosed with cervical cancer who were previously treated in the Barretos Cancer Hospital. We analyzed the internal consistency (Cronbach's alpha), reproducibility (intraclass correlation coefficient - ICC), confirmatory factor analysis, convergent validity (correlation with the SF-36 questionnaire), and discriminant validity by disease stage and two questions related to self-perception of health was also performed. Results: The scales had Cronbach's alpha coefficients ranging from 0.61 to 0.80. However, three scales did not have a statistically significant coefficient greater than 0.70. The ICC ranged from 0.68 to 0.82 and all considered satisfactory. Factor analysis did not generate consistent components. The FACT-G and FACT-CX total scores had good internal consistency and reproducibility, and also correlated well with the General Health and Vitality scales of the SF-36. However, only two FACT-CX scales had a significant correlation with SF-36. Discriminant analysis showed that FACT-CX failed to discriminate groups according to clinical stage but was able to divide the women according to the self-perception of health. Conclusion: FATC-CX total score had good internal consistency, reproducibility and discriminant validity. In addition, it correlated well with General Health and Vitality scales of SF-36. However, three scales had questionable internal consistency and only two had significant correlation with SF-36.	[Sirna Fregnani, Cristiane Menezes] Univ Sao Paulo, Coll Nursing, Grad Program Publ Hlth Nursing, BR-14049 Ribeirao Preto, Brazil; [Sirna Fregnani, Cristiane Menezes; Tavares Guerreiro Fregnani, Jose Humberto] Barretos Canc Hosp IEP HCB, Res & Teaching Inst, Barretos, Brazil; [Dias de Oliveira Latorre, Maria do Rosario] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil; [de Almeida, Ana Maria] Univ Sao Paulo, Dept Maternal Infant & Publ Hlth Nursing, Coll Nursing, BR-14049 Ribeirao Preto, Brazil	Universidade de Sao Paulo; Hospital de Cancer de Barretos; Universidade de Sao Paulo; Universidade de Sao Paulo	Fregnani, CMS (corresponding author), Univ Sao Paulo, Coll Nursing, Grad Program Publ Hlth Nursing, BR-14049 Ribeirao Preto, Brazil.	cfregnani@usp.br	Fregnani, José H/H-4238-2012; Latorre, Maria RDO/J-5780-2014; Almeida, Ana Maria/I-2247-2012	Fregnani, José H/0000-0002-5235-6469; Latorre, Maria RDO/0000-0002-5189-3457; 				Abayomi J, 2005, J HUM NUTR DIET, V18, P353, DOI 10.1111/j.1365-277X.2005.00633.x; Basen-Engquist K, 2001, J CLIN ONCOL, V19, P1809, DOI 10.1200/JCO.2001.19.6.1809; Bensoussan A, 2001, AUST NZ J PUBL HEAL, V25, P71, DOI 10.1111/j.1467-842X.2001.tb00554.x; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Boling W, 2003, INT J GYNECOL CANCER, V13, P5, DOI 10.1046/j.1525-1438.2003.13051.x; Brasil, 2011, EST 2012 INC CANC BR; Cella D, 2010, GYNECOL ONCOL, V119, P531, DOI 10.1016/j.ygyno.2010.08.020; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Ciconelli RM, 1999, REV BRAS REUMATOL, V39, P143, DOI DOI 10.1590/S0482-50042010000300005; Colwell HH, 2010, ONCOLOGIST, V15, P308, DOI 10.1634/theoncologist.2009-0034; Debb SM, 2011, PSYCHO-ONCOLOGY, V20, P19, DOI 10.1002/pon.1698; Ding Y, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-124; Fayers P. M., 2000, QUALITY LIFE ASSESSM; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fernandes WC, 2010, REV LAT-AM ENFERM, V18, P360, DOI 10.1590/S0104-11692010000300010; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Garland SN, 2011, CANCER-AM CANCER SOC, V117, P1302, DOI 10.1002/cncr.25556; Hu J, 2010, DIABETES RES CLIN PR, V88, P273, DOI 10.1016/j.diabres.2010.03.005; Ishikawa NM, 2010, SUPPORT CARE CANCER, V18, P481, DOI 10.1007/s00520-009-0697-0; Janda M, 2005, GYNECOL ONCOL, V97, P568, DOI 10.1016/j.ygyno.2005.01.047; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Mastropietro Ana Paula, 2007, Rev. Saúde Pública, V41, P260, DOI 10.1590/S0034-89102007000200013; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Park SY, 2007, CANCER-AM CANCER SOC, V110, P2716, DOI 10.1002/cncr.23094; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Penson RT, 2006, INT J GYNECOL OBSTET, V95, pS247, DOI 10.1016/S0020-7292(06)60040-4; Pignata S, 2001, ANN ONCOL, V12, pS37, DOI 10.1093/annonc/12.suppl_3.S37; Sanchez R, 2011, QUAL LIFE RES, V20, P19, DOI 10.1007/s11136-010-9727-0; Sapnas Kathryn G, 2002, J Nurs Meas, V10, P135; Shin DW, 2009, ONCOLOGY-BASEL, V76, P190, DOI 10.1159/000201571; Tong MCF, 2009, HEAD NECK-J SCI SPEC, V31, P738, DOI 10.1002/hed.21023; Victorson D, 2008, QUAL LIFE RES, V17, P1137, DOI 10.1007/s11136-008-9398-2; Wan CH, 2007, LUNG CANCER, V56, P415, DOI 10.1016/j.lungcan.2007.01.004; Ward WL, 1999, QUAL LIFE RES, V8, P181, DOI 10.1023/A:1008821826499; Ware J.E., 1994, SF 36 PHYS MENTAL HL; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79	38	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77947	10.1371/journal.pone.0077947	http://dx.doi.org/10.1371/journal.pone.0077947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	239JR	24147102	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400144
J	Wang, ZM; Zhang, P; Lin, MJ; Tan, B; Qiu, HB; Yu, WF				Wang, Zhen-Meng; Zhang, Peng; Lin, Mi-Jia; Tan, Bo; Qiu, Hai-Bo; Yu, Wei-Feng			Influence of Obstructive Jaundice on Pharmacodynamics of Rocuronium	PLOS ONE			English	Article							NEUROMUSCULAR BLOCKING-AGENTS; PHARMACOKINETICS; SENSITIVITY; SAFETY; RATS	Background: Anesthetics are variable in patients with obstructive jaundice. The minimum alveolar concentration awake of desflurane is reduced in patients with obstructive jaundice, while it has no effect on pharmacodynamics and pharmacokinetics of propofol. In this study, we investigated the influence of obstructive jaundice on the pharmacodynamics and blood concentration of rocuronium. Methods: Included in this study were 26 control patients and 27 patients with obstructive jaundice. Neuromuscular block of rocuronium was monitored by acceleromyography. Onset time, spontaneous recovery of the height of twitch first (T1) to 25% of the final T1 value (Duration 25%, Dur 25%), recovery index (RI), and spontaneous recovery of train-of-four (TOF) ratios to 70% were measured. The plasma rocuronium concentrations were determined by high performance liquid chromatography using berberine as an internal standard. Results: There was no significant difference in onset time between the two groups. The Dur 25%, the recovery index and the time of recovery of the TOF ratios to 70% were all prolonged in the obstructive jaundice group compared with the control group. The plasma concentration of rocuronium at 60, 90 and 120 min after bolus administration was significantly higher in the obstructive jaundice group. Conclusions: The neuromuscular blockade by rocuronium is prolonged in obstructive jaundice patients, and therefore precautions should be taken in case of postoperative residual neuromuscular block. The possible reason is impedance of rocuronium excretion due to biliary obstruction and increased plasma unbound rocuronium because of free bilirubin competing with it for albumin binding.	[Wang, Zhen-Meng; Qiu, Hai-Bo; Yu, Wei-Feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Anesthesia & Intens Care, Shanghai, Peoples R China; [Zhang, Peng] Second Mil Med Univ, Changhai Hosp, Dept Clin Diag, Shanghai, Peoples R China; [Lin, Mi-Jia] Fujian Med Univ, Dept Anesthesia, Affiliated Hosp 1, Fuzhou, Fujian Province, Peoples R China; [Tan, Bo] Fudan Univ, Analyt Ctr, Sch Pharm, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Fujian Medical University; Fudan University	Yu, WF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Anesthesia & Intens Care, Shanghai, Peoples R China.	ywf808@sohu.com	Yu, Wei/GZL-3831-2022		National Natural Science Foundation of China [81100312]; Innovation Program of Shanghai Municipal Education Committee [12ZZ081]; Science Program of Fujian Provincal Education Office [JB11053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Committee; Science Program of Fujian Provincal Education Office	This work was supported by the National Natural Science Foundation of China (81100312); the Innovation Program of Shanghai Municipal Education Committee (12ZZ081); and the Science Program of Fujian Provincal Education Office (JB11053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillard C, 2005, BRIT J ANAESTH, V95, P622, DOI 10.1093/bja/aei240; Brandoni A, 2006, HEPATOLOGY, V43, P1092, DOI 10.1002/hep.21142; BRODERSEN R, 1974, J CLIN INVEST, V54, P1353, DOI 10.1172/JCI107882; Fuchs-Buder T, 2007, ACTA ANAESTH SCAND, V51, P789, DOI 10.1111/j.1399-6576.2007.01352.x; KHUENIBRADY K, 1990, ANESTHESIOLOGY, V72, P669, DOI 10.1097/00000542-199004000-00016; KIMURA T, 1988, J PHARMACOBIO-DYNAM, V11, P839, DOI 10.1248/bpb1978.11.839; Kocabas S, 2008, EUR J ANAESTH, V25, P940, DOI 10.1017/S0265021508004717; [刘维 LIU Wei], 2008, [中国新药杂志, Chinese Journal New Drugs], V17, P1047; MAGORIAN T, 1995, ANESTH ANALG, V80, P754, DOI 10.1097/00000539-199504000-00018; McCourt KC, 1998, ANAESTHESIA, V53, P867, DOI 10.1046/j.1365-2044.1998.00342.x; Puhringer FK, 2008, ANESTHESIOLOGY, V109, P188, DOI 10.1097/ALN.0b013e31817f5bc7; Robertson EN, 2005, EUR J ANAESTH, V22, P4, DOI 10.1017/S0265021505000025; Song JC, 2009, ACTA ANAESTH SCAND, V53, P1329, DOI 10.1111/j.1399-6576.2009.02079.x; Song J. C., 2009, Current Drug Delivery, V6, P317; Song JG, 2009, ANESTHESIOLOGY, V111, P561, DOI 10.1097/ALN.0b013e3181adf49f; Sparr HJ, 2001, DRUGS, V61, P919, DOI 10.2165/00003495-200161070-00003; Suzuki T, 2007, BRIT J ANAESTH, V99, P721, DOI 10.1093/bja/aem253; vanMiert MM, 1997, BRIT J CLIN PHARMACO, V44, P139, DOI 10.1046/j.1365-2125.1997.00653.x; Wang ZM, 2011, MED HYPOTHESES, V76, P100, DOI 10.1016/j.mehy.2010.08.041; Whalley DG, 1998, CAN J ANAESTH, V45, P954, DOI 10.1007/BF03012303; WIERDA JMKH, 1995, EUR J ANAESTH, V12, P45; YAMAO T, 1994, BIOL PHARM BULL, V17, P691	22	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e78052	10.1371/journal.pone.0078052	http://dx.doi.org/10.1371/journal.pone.0078052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147111	Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400147
J	Forwood, SE; Walker, AD; Hollands, GJ; Marteau, TM				Forwood, Suzanna E.; Walker, Alexander D.; Hollands, Gareth J.; Marteau, Theresa M.			Choosing between an Apple and a Chocolate Bar: the Impact of Health and Taste Labels	PLOS ONE			English	Article							VEGETABLE INTAKE; FOOD; CHOICE; FRUIT; EAT	Increasing the consumption of fruit and vegetables is a central component of improving population health. Reasons people give for choosing one food over another suggest health is of lower importance than taste. This study assesses the impact of using a simple descriptive label to highlight the taste as opposed to the health value of fruit on the likelihood of its selection. Participants (N=439) were randomly allocated to one of five groups that varied in the label added to an apple: apple; healthy apple; succulent apple; healthy and succulent apple; succulent and healthy apple. The primary outcome measure was selection of either an apple or a chocolate bar as a dessert. Measures of the perceived qualities of the apple (taste, health, value, quality, satiety) and of participant characteristics (restraint, belief that tasty foods are unhealthy, BMI) were also taken. When compared with apple selection without any descriptor (50%), the labels combining both health and taste descriptors significantly increased selection of the apple ('healthy & succulent' 65.9% and 'succulent & healthy' 62.4%), while the use of a single descriptor had no impact on the rate of apple selection ('healthy' 50.5% and 'succulent' 52%). The strongest predictors of individual dessert choice were the taste score given to the apple, and the lack of belief that healthy foods are not tasty. Interventions that emphasize the taste attributes of healthier foods are likely to be more effective at achieving healthier diets than those emphasizing health alone.	[Forwood, Suzanna E.; Walker, Alexander D.; Hollands, Gareth J.; Marteau, Theresa M.] Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England	University of Cambridge	Forwood, SE (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Cambridge, England.	Sef26@cam.ac.uk	Forwood, Suzanna/A-5376-2008	Forwood, Suzanna/0000-0002-8406-5121; Hollands, Gareth/0000-0002-0492-3924; Marteau, Theresa/0000-0003-3025-1129	Department of Health, UK	Department of Health, UK	This research was funded by the Department of Health, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chernev A, 2011, J CONSUM PSYCHOL, V21, P178, DOI 10.1016/j.jcps.2010.08.002; Cooper AJ, 2012, DIABETES CARE, V35, P1293, DOI 10.2337/dc11-2388; Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467; Glanz K, 1998, J AM DIET ASSOC, V98, P1118, DOI 10.1016/S0002-8223(98)00260-0; Hollands GJ, 2011, HEALTH PSYCHOL, V30, P195, DOI 10.1037/a0022261; Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442; Ledoux TA, 2011, OBES REV, V12, pe143, DOI 10.1111/j.1467-789X.2010.00786.x; Papies EK, 2012, CURR OBES REP, V1, P99, DOI 10.1007/s13679-012-0009-8; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Renner B, 2012, APPETITE, V59, P117, DOI 10.1016/j.appet.2012.04.004; STEPTOE A, 1995, APPETITE, V25, P267, DOI 10.1006/appe.1995.0061; Wardle J, 2000, HEALTH EDUC RES, V15, P39, DOI 10.1093/her/15.1.39; Yeomans MR, 2001, PHYSIOL BEHAV, V73, P533, DOI 10.1016/S0031-9384(01)00502-9	13	10	10	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77500	10.1371/journal.pone.0077500	http://dx.doi.org/10.1371/journal.pone.0077500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	237RD	24155964	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300098
J	Inai, K; Burnside, JL; Hoffman, S; Toole, BP; Sugi, Y				Inai, Kei; Burnside, Jessica L.; Hoffman, Stanley; Toole, Bryan P.; Sugi, Yukiko			BMP-2 Induces Versican and Hyaluronan That Contribute to Post-EMT AV Cushion Cell Migration	PLOS ONE			English	Article							HEART-VALVE DEVELOPMENT; EXPRESSION; GROWTH; ACTIVATION; RECEPTOR; PROTEIN; KINASE; MATRIX; TRANSFORMATION; PROLIFERATION	Distal outgrowth and maturation of mesenchymalized endocardial cushions are critical morphogenetic events during post-EMT atrioventricular (AV) valvuloseptal morphogenesis. We explored the role of BMP-2 in the regulation of valvulogenic extracellular matrix (ECM) components, versican and hyaluronan (HA), and cell migration during post-EMT AV cushion distal outgrowth/expansion. We observed intense staining of versican and HA in AV cushion mesenchyme from the early cushion expansion stage, Hamburger and Hamilton (HH) stage-17 to the cushion maturation stage, HH stage-29 in the chick. Based on this expression pattern we examined the role of BMP-2 in regulating versican and HA using 3D AV cushion mesenchymal cell (CMC) aggregate cultures on hydrated collagen gels. BMP-2 induced versican expression and HA deposition as well as mRNA expression of versican and Has2 by CMCs in a dose dependent manner. Noggin, an antagonist of BMP, abolished BMP-2-induced versican and HA as well as mRNA expression of versican and Has2. We further examined whether BMP-2-promoted cell migration was associated with expression of versican and HA. BMP-2-promoted cell migration was significantly impaired by treatments with versican siRNA and HA oligomer. In conclusion, we provide evidence that BMP-2 induces expression of versican and HA by AV CMCs and that these ECM components contribute to BMP-2-induced CMC migration, indicating critical roles for BMP-2 in distal outgrowth/expansion of mesenchymalized AV cushions.	[Sugi, Yukiko] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; Med Univ S Carolina, Cardiovasc Dev Biol Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Sugi, Y (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	sugiy@musc.edu			AHA [10GRANT3900044]; Lawrence J. and Florence A. DeGeorge Charitable Trust; GEAR TO [0056]; NIH [HL33756, P20 GM103444];  [NSF-EPS-0903795]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL033756, R01HL033756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103444] Funding Source: NIH RePORTER	AHA(American Heart Association); Lawrence J. and Florence A. DeGeorge Charitable Trust; GEAR TO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The following sources supported this work: AHA 10GRANT3900044 and Lawrence J. and Florence A. DeGeorge Charitable Trust (YS); NSF-EPS-0903795, GEAR TO #0056 (YS), NIH HL33756 (RRM), NIH P20 GM103444 (N. Vyavahare, YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; BALDWIN HS, 1994, CIRC RES, V74, P244, DOI 10.1161/01.RES.74.2.244; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Casini P, 2012, DEV DYNAM, V241, P294, DOI 10.1002/dvdy.23715; Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566; Craig EA, 2009, GLYCOBIOLOGY, V19, P890, DOI 10.1093/glycob/cwp064; DE LA CRUZ M V, 1998, LIVING MORPHOGENESIS; Du WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013828; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Dutt S, 2006, J BIOL CHEM, V281, P12123, DOI 10.1074/jbc.M510834200; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Inai K, 2008, DEV BIOL, V315, P383, DOI 10.1016/j.ydbio.2007.12.028; Kern CB, 2007, DEV DYNAM, V236, P671, DOI 10.1002/dvdy.21059; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kim Y, 2008, J BIOL CHEM, V283, P22513, DOI 10.1074/jbc.M708319200; Klewer SE, 2006, GENE EXPR PATTERNS, V6, P462, DOI 10.1016/j.modgep.2005.11.005; Lebaron RG, 1996, PERSPECT DEV NEUROBI, V3, P261; Lincoln J, 2006, DEV BIOL, V292, P290, DOI 10.1016/j.ydbio.2005.12.042; Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Matsumoto K, 2006, J BIOL CHEM, V281, P18257, DOI 10.1074/jbc.M510330200; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Okagawa H, 2007, DEV BIOL, V306, P179, DOI 10.1016/j.ydbio.2007.03.015; Oosthoek PW, 1998, ANAT EMBRYOL, V198, P317, DOI 10.1007/s004290050187; Ori M, 2006, DEVELOPMENT, V133, P631, DOI 10.1242/dev.02225; Park C, 2006, DEVELOPMENT, V133, P3473, DOI 10.1242/dev.02499; Park YS, 2012, ONCOL REP, V27, P339, DOI 10.3892/or.2011.1532; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Rivera-Feliciano J, 2006, DEV BIOL, V295, P580, DOI 10.1016/j.ydbio.2006.03.043; Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5; Shi SL, 2004, J BIOL CHEM, V279, P12060, DOI 10.1074/jbc.M310091200; Shimabukuro Y, 2011, J CELL PHYSIOL, V226, P809, DOI 10.1002/jcp.22406; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Singh R, 2012, CELL MOL LIFE SCI, V69, P1377, DOI 10.1007/s00018-011-0884-2; Slomiany MG, 2009, CANCER RES, V69, P1293, DOI 10.1158/0008-5472.CAN-08-2491; Song LY, 2007, DEV BIOL, V301, P276, DOI 10.1016/j.ydbio.2006.08.004; Sugi Y, 2004, DEV BIOL, V269, P505, DOI 10.1016/j.ydbio.2004.01.045; Sugi Y, 2003, DEV BIOL, V258, P252, DOI 10.1016/S0012-1606(03)00099-X; SUGI Y, 2012, J NEONATAL BIOL, V1, P101; Toole B P, 2001, Methods Mol Biol, V171, P479; Wang JK, 2005, DEV BIOL, V286, P299, DOI 10.1016/j.ydbio.2005.07.035; Wang J, 2011, BIRTH DEFECTS RES A, V91, P441, DOI 10.1002/bdra.20785; Ward JA, 2003, AM J PATHOL, V162, P1403, DOI 10.1016/S0002-9440(10)64273-3; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Zanin MKB, 1999, ANAT RECORD, V256, P366; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	57	17	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e77593	10.1371/journal.pone.0077593	http://dx.doi.org/10.1371/journal.pone.0077593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24147033	Green Published, gold, Green Submitted			2022-12-27	WOS:000325819400129
J	Schlegel, W; Raimann, A; Halbauer, D; Scharmer, D; Sagmeister, S; Wessner, B; Helmreich, M; Haeusler, G; Egerbacher, M				Schlegel, Werner; Raimann, Adalbert; Halbauer, Daniel; Scharmer, Daniela; Sagmeister, Susanne; Wessner, Barbara; Helmreich, Magdalena; Haeusler, Gabriele; Egerbacher, Monika			Insulin-Like Growth Factor I (IGF-1) Ec/Mechano Growth Factor - A Splice Variant of IGF-1 within the Growth Plate	PLOS ONE			English	Article							E-PEPTIDE ACTIONS; ARTICULAR CHONDROCYTES; MONOCLONAL-ANTIBODIES; MECHANICAL OVERLOAD; MUSCLE FUNCTION; MGF EXPRESSION; BONE-GROWTH; HORMONE; GENE; CELLS	Human insulin-like growth factor 1 Ec (IGF-1Ec), also called mechano growth factor (MGF), is a splice variant of insulin-like growth factor 1 (IGF-1), which has been shown in vitro as well as in vivo to induce growth and hypertrophy in mechanically stimulated or damaged muscle. Growth, hypertrophy and responses to mechanical stimulation are important reactions of cartilaginous tissues, especially those in growth plates. Therefore, we wanted to ascertain if MGF is expressed in growth plate cartilage and if it influences proliferation of chondrocytes, as it does in musculoskeletal tissues. MGF expression was analyzed in growth plate and control tissue samples from piglets aged 3 to 6 weeks. Furthermore, growth plate chondrocyte cell culture was used to evaluate the effects of the MGF peptide on proliferation. We showed that MGF is expressed in considerable amounts in the tissues evaluated. We found the MGF peptide to be primarily located in the cytoplasm, and in some instances, it was also found in the nucleus of the cells. Addition of MGF peptides was not associated with growth plate chondrocyte proliferation.	[Schlegel, Werner; Raimann, Adalbert; Halbauer, Daniel; Sagmeister, Susanne] Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria; [Scharmer, Daniela; Helmreich, Magdalena; Haeusler, Gabriele; Egerbacher, Monika] Vet Univ Vienna, Inst Anat Histol & Embryol, A-1030 Vienna, Austria; [Wessner, Barbara] Univ Vienna, Ctr Sports Sci & Univ Sports, Dept Sports & Exercise Physiol, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Raimann, A (corresponding author), Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria.	adalbert.raimann@meduniwien.ac.at	Raimann, Adalbert/N-7215-2017; Wessner, Barbara/J-8244-2012	Raimann, Adalbert/0000-0002-3551-594X; Wessner, Barbara/0000-0002-9061-7914; Haeusler, Gabriele/0000-0001-7919-3447				ADAMO ML, 1991, MOL ENDOCRINOL, V5, P1677, DOI 10.1210/mend-5-11-1677; Albrecht C, 2010, INT J MOL MED, V26, P317, DOI 10.3892/ijmm_00000468; Albrecht C, 2009, INT J MOL MED, V23, P347, DOI 10.3892/ijmm_00000138; Annunziata M, 2011, ACTA DIABETOL, V48, P1, DOI 10.1007/s00592-010-0227-z; Ates K, 2007, FEBS LETT, V581, P2727, DOI 10.1016/j.febslet.2007.05.030; BENYA PD, 1993, EXP CELL RES, V204, P268, DOI 10.1006/excr.1993.1033; Brisson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045588; Burniston JG, 2005, MUSCLE NERVE, V32, P767, DOI 10.1002/mus.20407; Chan SJ, 2000, AM ZOOL, V40, P213; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2010, AGING CELL, V9, P126, DOI 10.1111/j.1474-9726.2009.00541.x; Connolly SA, 2004, RADIOLOGY, V233, P505, DOI 10.1148/radiol.2332030131; CONOVER CA, 1993, REGUL PEPTIDES, V48, P1, DOI 10.1016/0167-0115(93)90330-B; CONOVER CA, 1989, J CLIN ENDOCR METAB, V69, P25, DOI 10.1210/jcem-69-1-25; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Dai ZQ, 2010, GROWTH HORM IGF RES, V20, P275, DOI 10.1016/j.ghir.2010.03.005; Deng MY, 2011, INT ORTHOP, V35, P1099, DOI 10.1007/s00264-010-1141-2; DICKSON MC, 1991, J MOL ENDOCRINOL, V6, P17, DOI 10.1677/jme.0.0060017; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Gohring AR, 2010, BIOTECHNOL PROGR, V26, P1116, DOI 10.1002/btpr.402; Goldspink G, 1996, RES VET SCI, V60, P193, DOI 10.1016/S0034-5288(96)90038-7; Goldspink G, 2005, PHYSIOLOGY, V20, P232, DOI 10.1152/physiol.00004.2005; Gotterbarm T, 2008, LAB ANIM-UK, V42, P71, DOI 10.1258/la.2007.06029e; Govoni KE, 2007, PHYSIOL GENOMICS, V30, P354, DOI 10.1152/physiolgenomics.00022.2007; GREEN H, 1985, DIFFERENTIATION, V29, P195, DOI 10.1111/j.1432-0436.1985.tb00316.x; Heinemeier KM, 2007, J APPL PHYSIOL, V102, P573, DOI 10.1152/japplphysiol.00866.2006; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; HUNZIKER EB, 1994, J CLIN INVEST, V93, P1078, DOI 10.1172/JCI117058; ISAKSSON OGP, 1987, ENDOCR REV, V8, P426, DOI 10.1210/edrv-8-4-426; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Langenskiold A, 1998, J PEDIATR ORTHOPED, V18, P173, DOI 10.1097/00004694-199803000-00008; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Lewis DA, 2009, J INVEST DERMATOL, V129, P787, DOI 10.1038/jid.2008.293; Loeser RF, 2000, ARTHRITIS RHEUM, V43, P2110, DOI 10.1002/1529-0131(200009)43:9<2110::AID-ANR23>3.0.CO;2-U; LOWE WL, 1988, MOL ENDOCRINOL, V2, P528, DOI 10.1210/mend-2-6-528; Manes S, 1997, ENDOCRINOLOGY, V138, P905, DOI 10.1210/en.138.3.905; Marlovits S, 2004, INT J MOL MED, V13, P281; McKoy G, 1999, J PHYSIOL-LONDON, V516, P583, DOI 10.1111/j.1469-7793.1999.0583v.x; Milingos D, 2006, ANN NY ACAD SCI, V1092, P434, DOI 10.1196/annals.1365.042; Milingos DS, 2011, MOL MED, V17, P21, DOI 10.2119/molmed.2010.00043; Mills P, 2007, AM J TRANSPLANT, V7, P2247, DOI 10.1111/j.1600-6143.2007.01927.x; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; Moschos MM, 2011, IN VIVO, V25, P179; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Owino V, 2001, FEBS LETT, V505, P259, DOI 10.1016/S0014-5793(01)02825-3; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Perry RJ, 2008, CLIN ENDOCRINOL, V68, P4; Philippou A, 2008, IN VIVO, V22, P27; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; SAUNDERS JC, 1991, J MOL ENDOCRINOL, V7, P233, DOI 10.1677/jme.0.0070233; Savendahl L, 2005, HORM RES, V64, P94, DOI 10.1159/000087764; Schlegel W, 2010, MOL CELL ENDOCRINOL, V327, P65, DOI 10.1016/j.mce.2010.06.005; SIEGFRIED JM, 1992, P NATL ACAD SCI USA, V89, P8107, DOI 10.1073/pnas.89.17.8107; Stavropoulou A, 2009, MOL MED, V15, P127, DOI 10.2119/molmed.2009.00012; Tan DSW, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-17; Tang LL, 2006, ARCH ORAL BIOL, V51, P1080, DOI 10.1016/j.archoralbio.2006.06.009; THURSTON MN, 1985, CELL TISSUE KINET, V18, P575, DOI 10.1111/j.1365-2184.1985.tb00700.x; van der Eerden B C, 2001, J Pediatr Endocrinol Metab, V14 Suppl 6, P1527; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; Wilson HE, 2001, GROWTH HORM IGF RES, V11, P10, DOI 10.1054/ghir.2000.0182; Xin C, 2012, ARCH ORAL BIOL, V57, P720, DOI 10.1016/j.archoralbio.2011.11.016; Yang SY, 1996, J MUSCLE RES CELL M, V17, P487, DOI 10.1007/BF00123364; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6	68	19	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76133	10.1371/journal.pone.0076133	http://dx.doi.org/10.1371/journal.pone.0076133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146828	Green Published, Green Submitted, gold			2022-12-27	WOS:000325819400041
J	Rundle, CH; Mohan, S; Edderkaoui, B				Rundle, Charles H.; Mohan, Subburaman; Edderkaoui, Bouchra			Duffy Antigen Receptor for Chemokines Regulates Post-Fracture Inflammation	PLOS ONE			English	Article							C-C CHEMOKINES; ENDOTHELIAL-CELLS; MESSENGER-RNA; GROWTH-FACTOR; MICE LACKING; LUNG INJURY; EXPRESSION; BONE; GENE; DARC	There is now considerable experimental data to suggest that inflammatory cells collaborate in the healing of skeletal fractures. In terms of mechanisms that contribute to the recruitment of inflammatory cells to the fracture site, chemokines and their receptors have received considerable attention. Our previous findings have shown that Duffy antigen receptor for chemokines (Darc), the non-classical chemokine receptor that does not signal, but rather acts as a scavenger of chemokines that regulate cell migration, is a negative regulator of peak bone density in mice. Furthermore, because Darc is expressed by inflammatory and endothelial cells, we hypothesized that disruption of Darc action will affect post-fracture inflammation and consequently will affect fracture healing. To test this hypothesis, we evaluated fracture healing in mice with targeted disruption of Darc and corresponding wild type (WT) control mice. We found that fracture callus cartilage formation was significantly greater (33%) at 7 days post-surgery in Darc-KO compared to WT mice. The increased cartilage was associated with greater Collagen (Col) II expression at 3 days post-fracture and Col-X at 7 days post-fracture compared to WT mice, suggesting that Darc deficiency led to early fracture cartilage formation and differentiation. We then compared the expression of cytokine and chemokine genes known to be induced during inflammation. Interleukin (Il)-1 beta, Il-6, and monocyte chemotactic protein 1 were all down regulated in the fractures derived from Darc-KO mice at one day post-fracture, consistent with an altered inflammatory response. Furthermore, the number of macrophages was significantly reduced around the fractures in Darc-KO compared to WT mice. Based on these data, we concluded that Darc plays a role in modulating the early inflammatory response to bone fracture and subsequent cartilage formation. However, the early cartilage formation was not translated with an early bone formation at the fracture site in Darc-KO compared to WT mice.	[Rundle, Charles H.; Mohan, Subburaman; Edderkaoui, Bouchra] Jerry L Pettis Mem Vet Adm Med Ctr, Res Serv, Musculoskeletal Dis Ctr, Loma Linda, CA 92354 USA; [Rundle, Charles H.; Mohan, Subburaman; Edderkaoui, Bouchra] Loma Linda Univ, Dept Med, Loma Linda, CA 92350 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Biochem, Loma Linda, CA 92350 USA; [Mohan, Subburaman] Loma Linda Univ, Dept Physiol, Loma Linda, CA 92350 USA	Loma Linda University; Loma Linda University; Loma Linda University	Edderkaoui, B (corresponding author), Jerry L Pettis Mem Vet Adm Med Ctr, Res Serv, Musculoskeletal Dis Ctr, Loma Linda, CA 92354 USA.	Bouchra.Edderkaoui@va.gov			USAMRMC ORTHOPAEDIC RESEARCH PROGRAM [W81XWH-10-1-0952]	USAMRMC ORTHOPAEDIC RESEARCH PROGRAM	The project described was supported by USAMRMC ORTHOPAEDIC RESEARCH PROGRAM (http://mrmc-rad6.army.mil/). Grant/Contract/MIPR No.: W81XWH-10-1-0952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auron PE, 1998, CYTOKINE GROWTH F R, V9, P221, DOI 10.1016/S1359-6101(98)00018-5; Bancroft JD, 2002, ENZYME HISTOCHEMISTR; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Borzi RM, 2000, ARTHRITIS RHEUM, V43, P1734, DOI 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B; CHAUDHURI A, 1989, J BIOL CHEM, V264, P13770; Chaudhuri A, 2003, CYTOKINE, V21, P137, DOI 10.1016/S1043-4666(03)00033-4; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Chung R, 2006, J LEUKOCYTE BIOL, V80, P1272, DOI 10.1189/jlb.0606365; CRUESS RL, 1975, CAN J SURG, V18, P403; Dawson TC, 2000, BLOOD, V96, P1681, DOI 10.1182/blood.V96.5.1681.h8001681a_1681_1684; Edderkaoui B, 2007, GENOME RES, V17, P577, DOI 10.1101/gr.6009507; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Frost A, 1997, ACTA ORTHOP SCAND, V68, P91, DOI 10.3109/17453679709003987; Fukuma N, 2003, BIOCHEM BIOPH RES CO, V303, P137, DOI 10.1016/S0006-291X(03)00293-6; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Goldring MB, 1992, DEGRADATION ARTICULA; Harrison SL, 2011, J ORTHOP RES, V29, P1361, DOI 10.1002/jor.21321; Hierl T, 1998, EXP CLIN ENDOCR DIAB, V106, P324, DOI 10.1055/s-0029-1211993; Horne K, 2009, INFLAMM RES, V58, P431, DOI 10.1007/s00011-009-0023-9; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Iwamoto S, 1996, BLOOD, V87, P378; Johnson CS, 2000, BONE, V26, P461, DOI 10.1016/S8756-3282(00)00244-1; Jung YS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.48; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Kon T, 2001, J BONE MINER RES, V16, P1004, DOI 10.1359/jbmr.2001.16.6.1004; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Lee JS, 2006, J IMMUNOL, V177, P8086, DOI 10.4049/jimmunol.177.11.8086; LINKHART TA, 1991, J BONE MINER RES, V6, P1285; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo H, 2000, MOL CELL BIOL, V20, P3097, DOI 10.1128/MCB.20.9.3097-3101.2000; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; MCGRATH MH, 1985, ANN PLAS SURG, V15, P105, DOI 10.1097/00000637-198508000-00004; Morioka M, 2000, BIOCHEM BIOPH RES CO, V268, P60, DOI 10.1006/bbrc.1999.2063; Mumme M, 2012, EUR CELLS MATER, V24, P224, DOI 10.22203/eCM.v024a16; Olmedo ML, 1999, J ORTHOP TRAUMA, V13, P356, DOI 10.1097/00005131-199906000-00006; Olmedo ML, 2000, CELL MOL BIOL, V46, P89; PEIPER SC, 1995, J EXP MED, V181, P1311, DOI 10.1084/jem.181.4.1311; Recknagel S, 2013, J TRAUMA ACUTE CARE, V74, P531, DOI 10.1097/TA.0b013e318278956d; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Reutershan J, 2009, EUR J IMMUNOL, V39, P1597, DOI 10.1002/eji.200839089; RICKARD DJ, 1993, CALCIFIED TISSUE INT, V52, P227, DOI 10.1007/BF00298724; Rundle CH, 2008, CALCIFIED TISSUE INT, V83, P276, DOI 10.1007/s00223-008-9169-7; SIMMONS DJ, 1985, CLIN ORTHOP RELAT R, P100; Studer RK, 2004, ARTHRITIS RES THER, V6, pR56, DOI 10.1186/ar1022; van den Berg WB, 1999, ANN RHEUM DIS, V58, P40; Vielhauer V, 2009, AM J PATHOL, V175, P119, DOI 10.2353/ajpath.2009.080590; Walsh M, 2010, J BONE JOINT SURG AM, V92A, P1082, DOI 10.2106/JBJS.H.01329; Westacott CI, 1996, SEMIN ARTHRITIS RHEU, V25, P254, DOI 10.1016/S0049-0172(96)80036-9; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Yuan GH, 2001, DRUG NEWS PERSPECT, V14, P591; Yuan GH, 2001, ARTHRITIS RHEUM-US, V44, P1056, DOI 10.1002/1529-0131(200105)44:5<1056::AID-ANR186>3.3.CO;2-L; Zarbock A, 2010, AM J PHYSIOL-LUNG C, V298, pL462, DOI 10.1152/ajplung.00224.2009	53	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77362	10.1371/journal.pone.0077362	http://dx.doi.org/10.1371/journal.pone.0077362			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24146983	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200034
J	Shrivastava, P; Bagchi, T				Shrivastava, Parul; Bagchi, Tamishraha			IL-10 Modulates In Vitro Multinucleate Giant Cell Formation in Human Tuberculosis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; PULMONARY TUBERCULOSIS; GRANULOMA-FORMATION; INTERFERON-GAMMA; IFN-GAMMA; INFECTION; LUNG; BETA	Background: Multinucleated giant cells (MGC) are the histologic hallmark of granuloma which is known to limit tuberculosis infection. Both Th1 and Th2 type of cytokines regulate the immune response occurring within the granulomas. The objective of the study was to determine whether tuberculosis patient monocytes differed in their MGC forming ability as compared to healthy controls. Methods: In vitro MGC formation was carried out by treatment of monocytes with cytokine containing culture supernatant of ConA or PPD stimulated peripheral mononuclear cells. IL-2, TNF-alpha, IL-4, IL-10 and TGF-beta cytokine levels were analysed in culture supernatants using ELISA. IL-4 and IL-10 were added to culture supernatant separately and simultaneously along with their respective neutralizing antibodies and their consequent effect on MGC formation was evaluated. Results : MGC formation was significantly low in patient monocytes incubated with autologous culture supernatant as compared to control culture supernatant. Cytokine analysis of the culture supernatants revealed that while IL-4 levels were similar in patients and controls, increased IL-10 levels were found in patients. Exogenous addition of IL-10 resulted in reduced MGC formation. Contrastingly, when IL-4 was added exogenously, it led to increased MGC formation. The effects of both IL-10 and IL-4 were reversed upon addition of their respective antibodies. Conclusion: The findings suggest that one of the factors contributing to the disease could be the effect of cytokines on the functionality of monocytes, which are crucial in the fight against the organism. Significantly reduced MGC formation was observed on addition of IL-10. The findings imply an overriding role of IL-10 in MGC formation. The suppressive effect of IL-10 on MGC formation was further confirmed by addition of IL-10 neutralizing antibody.	[Bagchi, Tamishraha] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Microbiol, Vadodara, India; Maharaja Sayajirao Univ Baroda, Fac Sci, Ctr Biotechnol, Vadodara, India	Maharaja Sayajirao University Baroda; Maharaja Sayajirao University Baroda	Bagchi, T (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Microbiol, Vadodara, India.	mailforbagchi@yahoo.com			University Grants Commission (Government of India); UGC-DRS programme	University Grants Commission (Government of India)(University Grants Commission, India); UGC-DRS programme	The authors would like to thank the University Grants Commission (Government of India) for the award of Research Fellowships in Sciences for Meritorious Students to P. S. and for research funds under the UGC-DRS programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SS, 2004, INFECT IMMUN, V72, P1358, DOI 10.1128/IAI.72.3.1358-1363.2004; Almeida AS, 2009, J IMMUNOL, V183, P718, DOI 10.4049/jimmunol.0801212; Aung H, 2000, TUBERCLE LUNG DIS, V80, P61, DOI 10.1054/tuld.2000.0235; Binder F, 2013, MOL IMMUNOL, V54, P157, DOI 10.1016/j.molimm.2012.12.004; Birkness KA, 2007, IMMUNOL CELL BIOL, V85, P160, DOI 10.1038/sj.icb.7100019; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Cyktor JC, 2013, J IMMUNOL, V190, P2778, DOI 10.4049/jimmunol.1202722; de Waal Malefyt R, 2013, J IMMUNOL, V190, P2778, DOI [10.4049/jimmunol.1202722, DOI 10.4049/JIMMUN0L.1202722.PUBMED:23396944]; Ehlers S, 2005, CLIN INFECT DIS, V41, pS199, DOI 10.1086/429998; Ehlers S, 2010, CELL HOST MICROBE, V7, P6, DOI 10.1016/j.chom.2009.12.010; Gasser A, 1999, INFECT IMMUN, V67, P395, DOI 10.1128/IAI.67.1.395-402.1999; Hernandez-Pando R, 2004, EUR J IMMUNOL, V34, P174, DOI 10.1002/eji.200324253; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; McNally AK, 2011, EXP MOL PATHOL, V91, P673, DOI 10.1016/j.yexmp.2011.06.012; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; MOST J, 1990, EUR J IMMUNOL, V20, P1661, DOI 10.1002/eji.1830200807; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Ohtsuka K, 1998, J IMMUNOL, V160, P2539; Pereira CB, 2004, MICROBES INFECT, V6, P25, DOI 10.1016/j.micinf.2003.10.007; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Sasindran SJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00002; Shaler CR, 2011, AM J PATHOL, V178, P1622, DOI 10.1016/j.ajpath.2010.12.022; TAKASHIMA T, 1993, J IMMUNOL, V150, P3002; TOOSSI Z, 1995, INFECT IMMUN, V63, P224, DOI 10.1128/IAI.63.1.224-228.1995; Vernal Rolando, 2008, Infectious Disorders - Drug Targets, V8, P207; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	28	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2013	8	10							e77680	10.1371/journal.pone.0077680	http://dx.doi.org/10.1371/journal.pone.0077680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239KL	24147054	gold, Green Published, Green Submitted			2022-12-27	WOS:000326022200064
J	Goyal, RK; Hancock, REW; Mattoo, AK; Misra, S				Goyal, Ravinder K.; Hancock, Robert E. W.; Mattoo, Autar K.; Misra, Santosh			Expression of an Engineered Heterologous Antimicrobial Peptide in Potato Alters Plant Development and Mitigates Normal Abiotic and Biotic Responses	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; DISEASE RESISTANCE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; SIGNALING PATHWAYS; PRIMARY METABOLISM; DEFENSE RESPONSES; CATIONIC PEPTIDE; GENE-EXPRESSION; BROAD-SPECTRUM	Antimicrobial cationic peptides (AMPs) are ubiquitous small proteins used by living cells to defend against a wide spectrum of pathogens. Their amphipathic property helps their interaction with negatively charged cellular membrane of the pathogen causing cell lysis and death. AMPs also modulate signaling pathway(s) and cellular processes in animal models; however, little is known of cellular processes other than the pathogen-lysis phenomenon modulated by AMPs in plants. An engineered heterologous AMP, msrA3, expressed in potato was previously shown to cause resistance of the transgenic plants against selected fungal and bacterial pathogens. These lines together with the wild type were studied for growth habits, and for inducible defense responses during challenge with biotic (necrotroph Fusarium solani) and abiotic stressors (dark-induced senescence, wounding and temperature stress). msrA3-expression not only conferred protection against F. solani but also delayed development of floral buds and prolonged vegetative phase. Analysis of select gene transcript profiles showed that the transgenic potato plants were suppressed in the hypersensitive (HR) and reactive oxygen species (ROS) responses to both biotic and abiotic stressors. Also, the transgenic leaves accumulated lesser amounts of the defense hormone jasmonic acid upon wounding with only a slight change in salicylic acid as compared to the wild type. Thus, normal host defense responses to the pathogen and abiotic stressors were mitigated by msrA3 expression suggesting MSRA3 regulates a common step(s) of these response pathways. The stemming of the pathogen growth and mitigating stress response pathways likely contributes to resource reallocation for higher tuber yield.	[Goyal, Ravinder K.; Misra, Santosh] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Mattoo, Autar K.] ARS, Henry A Wallace Beltsville Agr Res Ctr, USDA, Sustainable Agr Syst Lab, Beltsville, MD USA	University of Victoria; University of British Columbia; United States Department of Agriculture (USDA)	Mattoo, AK (corresponding author), ARS, Henry A Wallace Beltsville Agr Res Ctr, USDA, Sustainable Agr Syst Lab, Beltsville, MD USA.	autar.mattoo@ars.usda.gov	Hancock, Robert E. W./E-1145-2013; Mattoo, Autar/U-9751-2019	Hancock, Robert E. W./0000-0001-5989-8503; Mattoo, Autar/0000-0001-9226-7164	NCE-AFMNet, Canada	NCE-AFMNet, Canada	This study was funded by the NCE-AFMNet, Canada grant (to S.M.). Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Rahman T, 2012, MOL PLANT MICROBE IN, V25, P1584, DOI 10.1094/MPMI-07-12-0187-R; AbuQamar S, 2009, PLANT J, V58, P347, DOI 10.1111/j.1365-313X.2008.03783.x; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Alkan N, 2012, MOL PLANT MICROBE IN, V25, P85, DOI 10.1094/MPMI-01-11-0020; Almasia NI, 2008, MOL PLANT PATHOL, V9, P329, DOI 10.1111/J.1364-3703.2008.00469.X; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arimura GI, 2011, INT J MOL SCI, V12, P3723, DOI 10.3390/ijms12063723; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Baldwin IT, 2001, PLANT PHYSIOL, V127, P1449, DOI 10.1104/pp.010762; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Bellincampi D, 2000, PLANT PHYSIOL, V122, P1379, DOI 10.1104/pp.122.4.1379; Bernards MA, 1999, PLANT PHYSIOL, V121, P135, DOI 10.1104/pp.121.1.135; Berrocal-Lobo M, 2002, PLANT PHYSIOL, V128, P951, DOI 10.1104/pp.010685; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Bowler C, 2000, TRENDS PLANT SCI, V5, P241, DOI 10.1016/S1360-1385(00)01628-9; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Bruessow F, 2010, PLANT J, V62, P876, DOI 10.1111/j.1365-313X.2010.04200.x; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Choi HW, 2007, PLANT PHYSIOL, V145, P890, DOI 10.1104/pp.107.103325; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Collinge M, 2001, PLANT MOL BIOL, V46, P521, DOI 10.1023/A:1010639225091; D'Ippolito S, 2010, PHYSIOL MOL PLANT P, V75, P3, DOI 10.1016/j.pmpp.2010.09.002; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Fatima T, 2012, FUNCT PLANT BIOL, V39, P246, DOI 10.1071/FP11240; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gadjev I, 2008, INT REV CEL MOL BIO, V270, P87, DOI 10.1016/S1937-6448(08)01403-2; Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; Garcia-Olmedo F, 2001, FEBS LETT, V498, P219, DOI 10.1016/S0014-5793(01)02456-5; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Godoy LC, 2012, P NATL ACAD SCI USA, V109, P20373, DOI 10.1073/pnas.1218938109; GRAHAM TL, 1977, APPL ENVIRON MICROB, V34, P424, DOI 10.1128/AEM.34.4.424-432.1977; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Horvath DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042036; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Hyodo H., 1991, PLANT HORMONE ETHYLE; Jansky S., 2000, Plant Breeding Reviews, V19, P69; Jones RW, 2005, GEN IMPROV SOLAN CRO, V1, P397; Kausch KD, 2012, AMINO ACIDS, V42, P843, DOI 10.1007/s00726-011-1000-5; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Klingler J, 2005, PLANT PHYSIOL, V137, P1445, DOI 10.1104/pp.104.051243; Knorzer OC, 1996, PHYSIOL PLANTARUM, V97, P388, DOI 10.1034/j.1399-3054.1996.970225.x; Kumar V, 2004, P NATL ACAD SCI USA, V101, P10535, DOI 10.1073/pnas.0403496101; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Maekawa T, 2012, P NATL ACAD SCI USA, V109, P20119, DOI 10.1073/pnas.1218059109; Martinez C, 1998, MOL PLANT MICROBE IN, V11, P1038, DOI 10.1094/MPMI.1998.11.11.1038; MEHTA RA, 1992, J BIOL CHEM, V267, P2810; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Murphy AS, 1999, PLANT PHYSIOL, V121, P1375, DOI 10.1104/pp.121.4.1375; Nahirnak V, 2012, PLANT PHYSIOL, V158, P252, DOI 10.1104/pp.111.186544; Nambeesan S, 2012, PLANT PHYSIOL, V158, P1034, DOI 10.1104/pp.111.188698; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Osusky M, 2005, THEOR APPL GENET, V111, P711, DOI 10.1007/s00122-005-2056-y; Osusky M, 2004, TRANSGENIC RES, V13, P181, DOI 10.1023/B:TRAG.0000026076.72779.60; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Pelegrini PB, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/250349; Ponti D, 2003, BIOCHEM J, V370, P121, DOI 10.1042/BJ20021444; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Prusky D, 2013, ANNU REV PHYTOPATHOL, V51, P155, DOI 10.1146/annurev-phyto-082712-102349; Razdan M.K., 2005, GENETIC IMPROVEMENT, V1; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Robinson MW, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00325; Rojo E, 1999, PLANT J, V20, P135, DOI 10.1046/j.1365-313x.1999.00570.x; ROSS AF, 1961, VIROLOGY, V14, P340, DOI 10.1016/0042-6822(61)90319-1; ROSS H, 1986, ADV PLANT BREED S13; Royo J, 1996, J BIOL CHEM, V271, P21012, DOI 10.1074/jbc.271.35.21012; Scalschi L, 2013, MOL PLANT PATHOL, V14, P342, DOI 10.1111/mpp.12010; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Segura A, 1999, MOL PLANT MICROBE IN, V12, P16, DOI 10.1094/MPMI.1999.12.1.16; Sklensky DE, 2011, J EXP BOT, V62, P4323, DOI 10.1093/jxb/err148; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Suzuki Y, 2013, J EXP BOT, V64, P1145, DOI 10.1093/jxb/ers398; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; TENG PS, 1984, CRC CR REV PLANT SCI, V2, P21, DOI 10.1080/07352688409382187; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Ton J, 2002, MOL PLANT MICROBE IN, V15, P27, DOI 10.1094/MPMI.2002.15.1.27; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Vicente R., 2011, Agronomy Research, V9, P501; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Weaver LM, 2001, PLANT PHYSIOL, V127, P876, DOI 10.1104/pp.010312; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Wong JH, 2007, CURR PROTEIN PEPT SC, V8, P446, DOI 10.2174/138920307782411446; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003699; Zimnoch-Guzowska E, 2005, GEN IMPROV SOLAN CRO, V1, P339; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	113	26	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77505	10.1371/journal.pone.0077505	http://dx.doi.org/10.1371/journal.pone.0077505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147012	Green Submitted, gold, Green Published			2022-12-27	WOS:000326019400116
J	Picin, A; Peresani, M; Falgueres, C; Gruppioni, G; Bahain, JJ				Picin, Andrea; Peresani, Marco; Falgueres, Christophe; Gruppioni, Giulia; Bahain, Jean-Jacques			San Bernardino Cave (Italy) and the Appearance of Levallois Technology in Europe: Results of a Radiometric and Technological Reassessment	PLOS ONE			English	Article							SCARIO SALERNO; WESTERN EUROPE.; DENTAL REMAINS; SITE; NEANDERTHAL; ATAPUERCA; EMERGENCE; SPAIN; STRATIGRAPHY; ASSEMBLAGES	The introduction of Levallois technology in Europe marked the transition from the Lower to the early Middle Paleolithic. This new method of flake production was accompanied by significant behavioral changes in hominin populations. The emergence of this technological advance is considered homogeneous in the European archaeological record at the Marine isotopic stage (MIS) 9/MIS 8 boundary. In this paper we report a series of combined electron spin resonance/U-series dates on mammal bones and teeth recovered from the lower units of San Bernardino Cave (Italy) and the technological analyses of the lithic assemblages. The San Bernardino Cave has yielded the earliest evidence of Levallois production on the Italian Peninsula recovered to date. In addition to our results and the review of the archaeological record, we describe the chronological and geographical differences between European territories and diversities in terms of technological developments. The belated emergence of Levallois technology in Italy compared to western Europe corresponds to the late Italian Neanderthal speciation event. The new radiometric dates and the technological analyses of San Bernardino Cave raise the issue of the different roles of glacial refugia in the peopling and the spread of innovative flaking strategies in Europe during the late Middle Pleistocene.	[Picin, Andrea] Neanderthal Museum, Mettmann, Germany; [Picin, Andrea] Inst Catala Paleoecol Humana & Evolucio Social IP, Tarragona, Spain; [Picin, Andrea] Univ Rovira & Virgili, Area Prehist, E-43007 Tarragona, Spain; [Peresani, Marco; Gruppioni, Giulia] Univ Ferrara, Dipartimento Studi Umanist, Sez Sci Preistor & Antropol, I-44100 Ferrara, Italy; [Falgueres, Christophe; Gruppioni, Giulia; Bahain, Jean-Jacques] Museum Natl Hist Nat, Dept Prehist, UMR7194, F-75231 Paris, France	Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili; University of Ferrara; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Bahain, JJ (corresponding author), Museum Natl Hist Nat, Dept Prehist, UMR7194, F-75231 Paris, France.	bahain@mnhn.fr	Picin, Andrea/R-1288-2016; Peresani, Marco/X-1343-2019; Bahain, Jean-Jacques/AAB-8910-2019	Picin, Andrea/0000-0002-8831-8325; Bahain, Jean-Jacques/0000-0002-1446-5568; FALGUERES, christophe/0000-0003-0644-4852; Peresani, Marco/0000-0001-6562-6336	Italian Ministry of Culture - Veneto Archaeological Superintendence; Province of Vicenza; Veneto Region - Department for Cultural Heritage; Neanderthal Museum Foundation	Italian Ministry of Culture - Veneto Archaeological Superintendence; Province of Vicenza; Veneto Region - Department for Cultural Heritage; Neanderthal Museum Foundation	Research at Grotta di San Bernardino was directed by Prof. Alberto Broglio and one of the authors (M. P.) in the framework of a project supported by the Italian Ministry of Culture - Veneto Archaeological Superintendence, the Province of Vicenza and the Veneto Region - Department for Cultural Heritage. Andrea Picin is beneficiary of the Fuhlrott-Research Fellowship of the Neanderthal Museum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2002, ANTHROPOLOGIE, V106, P695; Amorosi A, 1996, SEDIMENT GEOL, V102, P275, DOI 10.1016/0037-0738(95)00074-7; [Anonymous], 2006, EURASIAN PREHISTORY; [Anonymous], 2010, SETTLEMENT DYNAMICS; Arobba D., 2008, TOIR GROTT BAS ATT C, P69; Auguste P, 1995, CADRES BIOSTRATIGRAP; Bahain JJ, 2007, METHODE DATATION RES, V3; Baissas P, 1986, B MUS ANTHR PREHIST, V29, P5; Benazzi S, 2002, ANAL MORFOMETRICA AL; Benini A, 2009, FAENZA FOGLIO 239; Berger GW, 2008, J HUM EVOL, V55, P300, DOI 10.1016/j.jhevol.2008.02.012; Bietti A, 1992, QUATERNARIA NOVA, VII, P41; Boeda E., 1994, CONCEPT LEVALLOIS VA; Bordes F, 1951, ANTHROPOLOGIE, V55, P1; Bordes F, 1953, BULL SOC PREHIST FR, V50, P457, DOI 10.3406/bspf.1953.5156; Bordes F, 1950, ANTHROPOLOGIE, V54, P393; Boscato P., 2009, RIV SCI PREISTORICHE, VLIX, P5; Breuil H., 1959, HOMMES PIERRE ANCIEN; Bruner E, 2007, VERTEBR PALEOBIOL PA, P23; Caloi L, 1998, QUATERN INT, V47-8, P77, DOI 10.1016/S1040-6182(97)00073-6; Carobene L., 1990, QUATERNARIO, V3, P75; Coltorti M, 2006, QUATERN INT, V156, P118, DOI 10.1016/j.quaint.2006.05.025; Cremaschi M., 1990, Quaternary International, V5, P23, DOI 10.1016/1040-6182(90)90022-V; DECASTRO JMB, 1988, J HUM EVOL, V17, P279; DELUMLEY H, 1960, CR HEBD ACAD SCI, V250, P1887; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; di Cesnola A.P., 1996, PALEOLITHIQUE INFERI; Dibble Harold L., 2006, Paleoanthropology, V2006, P1; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Eppes MC, 2008, GEODERMA, V147, P97, DOI 10.1016/j.geoderma.2008.07.011; Fabre V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005151; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; Falgueres C, 2006, J ARCHAEOL SCI, V33, P149, DOI 10.1016/j.jas.2005.07.006; Farabegoli E., 1997, AGIP GEODINAMICA AMB, P1; Fernandez Peris J., 2007, COVA BOLOMOR TAVERNE; Ferraro F, 2009, QUATERN INT, V204, P54, DOI 10.1016/j.quaint.2008.12.002; Fitte P, 1948, B SOC HIST NATURELLE, V1, P3; Fontana F, 2010, QUATERN INT, V223, P465, DOI 10.1016/j.quaint.2010.02.013; Gaudzinski S, 2006, INTERD CONTRIB ARCH, P137, DOI 10.1007/0-387-24661-4_8; Grimaldi S, 1998, ANAL TECHNOLOGIQUE C, P109; GRUN R, 1988, NUCL TRACKS RAD MEAS, V14, P237; Hearty P.J., 1986, Z GEOMORPHOL, V62, P131; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hopkinson T, 2011, INVESTIGATING ARCHAEOLOGICAL CULTURES: MATERIAL CULTURE, VARIABILITY, AND TRANSMISSION, P229, DOI 10.1007/978-1-4419-6970-5_12; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Hublin JJ, 2009, CR PALEVOL, V8, P503, DOI 10.1016/j.crpv.2009.04.001; Locht J.-L., 2010, GALLIA PREHISTOIRE, V52, P1; MALATESTA A, 1988, PALAEOGEOGR PALAEOCL, V68, P311, DOI 10.1016/0031-0182(88)90048-X; Malatesta A, 1978, QUATERNARIA, V20, P203; MALLEGNI F, 1987, ANTHROPOLOGIE, V91, P163; Mallegni F, 2001, HOMO, V52, P233; MALLEGNI F, 1989, AM J PHYS ANTHROPOL, V79, P475, DOI 10.1002/ajpa.1330790404; Manzi G, 2011, QUATERNARY SCI REV, V30, P1420, DOI 10.1016/j.quascirev.2010.05.034; Martini M, 2001, J CULT HERIT, V2, P179, DOI 10.1016/S1296-2074(01)01126-8; Martinon-Torres M, 2006, EVOLUCION APARATO DE; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; McNabb J, 1992, LITHICS, V13; McNabb J, 1992, CLACTONIAN BRIT LOWE; Menendez Granda DL, 2009, TRANSICION MODO 2 MO; Milli S, 2005, QUATERN INT, V126, P251, DOI 10.1016/j.quaint.2004.04.025; Moncel MH, 2011, CURR ANTHROPOL, V52, P37, DOI 10.1086/658179; Monnier GF, 2006, CURR ANTHROPOL, V47, P709, DOI 10.1086/506280; Mussi M., 2002, EARLIEST ITALY OVERV; Mussi M., 1995, EARLIEST OCCUPATION, P27; Feliner GN, 2011, TAXON, V60, P365, DOI 10.1002/tax.602007; Nomade S, 2011, QUAT GEOCHRONOL, V6, P453, DOI 10.1016/j.quageo.2011.03.008; Onoratini G, 2012, QUATERN INT, V255, P141, DOI 10.1016/j.quaint.2011.05.015; Ordonez S., 1990, GEOGACETA, V8, P53; Peresani M, 2001, SETTLEMENT DYNAMICS, P485; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Picotti V, 2008, J GEOPHYS RES SOLID, V113, P4; Premo LS, 2009, P NATL ACAD SCI USA, V106, P33, DOI 10.1073/pnas.0809194105; Rink WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054608; Rodriguez J, 2006, PALAEOGEOGR PALAEOCL, V239, P355, DOI 10.1016/j.palaeo.2006.02.001; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Ronchitelli A, 2011, QUATERN INT, V231, P95, DOI 10.1016/j.quaint.2010.07.006; Rosas A, 2007, VERTEBR PALEOBIOL PA, P37; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Rots V, 2013, J ARCHAEOL SCI, V40, P497, DOI 10.1016/j.jas.2012.06.042; Rougier H, 2003, ETUDE DESCRIPTIVE CO; SANTONJA M, 1990, J WORLD PREHIST, V4, P45, DOI 10.1007/BF00974819; Santonja M., 1995, EARLIEST OCCUPATION, P7; Santonja M., 2006, AXE AGE ACHEULIAN TO, P429; Santonja M, 2010, QUATERN INT, V223, P154, DOI 10.1016/j.quaint.2010.02.010; Scott B, 2011, DEV QUATER SCI, V14, P91; Segre AG, 1982, ATT 23 RIUN SCI IIPP, P177; Shao QF, 2012, QUAT GEOCHRONOL, V10, P406, DOI 10.1016/j.quageo.2012.02.009; Shennan S, 2001, CAMB ARCHAEOL J, V11, P5, DOI 10.1017/S0959774301000014; Soriano S, 2000, OUTILLAGE BIFACIAL O; Tozzi C, 1965, RIV STUDI LIGUIRI, VXX, P5; Tuffreau A, 1995, DEFINITION INTERPRET, P413; VALOCH K, 1968, ANTHROPOLOGIE, V72, P453; Wagner GA, 2010, P NATL ACAD SCI USA, V107, P19726, DOI 10.1073/pnas.1012722107; Walker MJ, 2011, P NATL ACAD SCI USA, V108, P10087, DOI 10.1073/pnas.1107318108; Warren SH, 1951, P GEOLOGISTS ASS, P62; White M, 2011, DEV QUATER SCI, V14, P53; White MJ, 2000, J WORLD PREHIST, V14, P1, DOI 10.1023/A:1007874901792; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	99	48	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e76182	10.1371/journal.pone.0076182	http://dx.doi.org/10.1371/journal.pone.0076182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	239JR	24146836	Green Published, gold, Green Submitted			2022-12-27	WOS:000326019400043
J	Wei, JS; Johansson, P; Chen, L; Song, YK; Tolman, C; Li, S; Hurd, L; Patidar, R; Wen, XY; Badgett, TC; Cheuk, ATC; Marshall, JC; Steeg, PS; Diez, JPV; Yu, YL; Gutkind, JS; Khan, J				Wei, Jun S.; Johansson, Peter; Chen, Li; Song, Young K.; Tolman, Catherine; Li, Samuel; Hurd, Laura; Patidar, Rajesh; Wen, Xinyu; Badgett, Thomas C.; Cheuk, Adam T. C.; Marshall, Jean-Claude; Steeg, Patricia S.; Diez, Jose P. Vaque; Yu, Yanlin; Gutkind, J. Silvio; Khan, Javed			Massively Parallel Sequencing Reveals an Accumulation of De Novo Mutations and an Activating Mutation of LPAR1 in a Patient with Metastatic Neuroblastoma	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID LPA; CELL MOTILITY; ALK KINASE; N-MYC; CANCER; EXPRESSION; TUMORS; GENE; DNA; TRANSCRIPTION	Neuroblastoma is one of the most genomically heterogeneous childhood malignances studied to date, and the molecular events that occur during the course of the disease are not fully understood. Genomic studies in neuroblastoma have showed only a few recurrent mutations and a low somatic mutation burden. However, none of these studies has examined the mutations arising during the course of disease, nor have they systemically examined the expression of mutant genes. Here we performed genomic analyses on tumors taken during a 3.5 years disease course from a neuroblastoma patient (bone marrow biopsy at diagnosis, adrenal primary tumor taken at surgical resection, and a liver metastasis at autopsy). Whole genome sequencing of the index liver metastasis identified 44 non-synonymous somatic mutations in 42 genes (0.85 mutation/MB) and a large hemizygous deletion in the ATRX gene which has been recently reported in neuroblastoma. Of these 45 somatic alterations, 15 were also detected in the primary tumor and bone marrow biopsy, while the other 30 were unique to the index tumor, indicating accumulation of de novo mutations during therapy. Furthermore, transcriptome sequencing on the 3 tumors demonstrated only 3 out of the 15 commonly mutated genes (LPAR1, GATA2, and NUFIP1) had high level of expression of the mutant alleles, suggesting potential oncogenic driver roles of these mutated genes. Among them, the druggable G-protein coupled receptor LPAR1 was highly expressed in all tumors. Cells expressing the LPAR1 R163W mutant demonstrated a significantly increased motility through elevated Rho signaling, but had no effect on growth. Therefore, this study highlights the need for multiple biopsies and sequencing during progression of a cancer and combinatorial DNA and RNA sequencing approach for systematic identification of expressed driver mutations.	[Wei, Jun S.; Johansson, Peter; Chen, Li; Song, Young K.; Tolman, Catherine; Li, Samuel; Hurd, Laura; Patidar, Rajesh; Wen, Xinyu; Badgett, Thomas C.; Cheuk, Adam T. C.; Khan, Javed] NCI, Oncogen Sect, Pediat Oncol Branch, Adv Technol Ctr, Bethesda, MD 20892 USA; [Wen, Xinyu] NCI, Adv Biomed Comp Ctr, SAIC Frederick Inc, Frederick, MD 21701 USA; [Marshall, Jean-Claude; Steeg, Patricia S.] NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Diez, Jose P. Vaque; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Cell Growth Regulat Sect, Bethesda, MD USA; [Yu, Yanlin] NCI, Canc Modeling Sect, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wei, JS (corresponding author), NCI, Oncogen Sect, Pediat Oncol Branch, Adv Technol Ctr, Bethesda, MD 20892 USA.	weij@mail.nih.gov; khanjav@mail.nih.gov	Leon, Javier/K-4615-2014; Gutkind, J. Silvio/J-1201-2016; Khan, Javed/P-9157-2014; Patidar, Rajesh/G-9389-2019; Johansson, Peter A/K-1053-2014; Patidar, Rajesh/M-5520-2019; Vaqué, José P/H-8413-2015	Gutkind, J. Silvio/0000-0002-5150-4482; Patidar, Rajesh/0000-0003-3578-8208; Johansson, Peter A/0000-0001-7015-5452; Patidar, Rajesh/0000-0003-3578-8208; Vaqué, José P/0000-0002-3913-2495	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011002, ZIABC010806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Berenjeno IM, 2007, ONCOGENE, V26, P4295, DOI 10.1038/sj.onc.1210194; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cabart P, 2004, ONCOGENE, V23, P5316, DOI 10.1038/sj.onc.1207684; Caselli R, 2007, J HUM GENET, V52, P535, DOI 10.1007/s10038-007-0151-4; Castel V, 2010, CLIN TRANSL ONCOL, V12, P49, DOI 10.1007/s12094-010-0466-z; Chen M, 2007, AM J PHYSIOL-CELL PH, V292, pC1927, DOI 10.1152/ajpcell.00400.2006; Chen QR, 2007, J MOL DIAGN, V9, P80, DOI 10.2353/jmoldx.2007.060111; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Deshpande GP, 2009, DNA REPAIR, V8, P672, DOI 10.1016/j.dnarep.2009.01.016; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Esiashvili N, 2007, PEDIATR BLOOD CANCER, V49, P41, DOI 10.1002/pbc.20859; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; George RE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000255; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GOODMAN M, 1999, CANC INCIDENCE SURVI, P1975; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Horak CE, 2007, CANCER RES, V67, P7238, DOI 10.1158/0008-5472.CAN-07-0962; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mitter D, 2011, EUR J HUM GENET, V19, P947, DOI 10.1038/ejhg.2011.58; Mladenov E, 2006, GENES CELLS, V11, P513, DOI 10.1111/j.1365-2443.2006.00958.x; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Obo Y, 2009, MUTAT RES-FUND MOL M, V660, P47, DOI 10.1016/j.mrfmmm.2008.10.005; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Park SY, 2011, ONCOGENE, V30, P1351, DOI 10.1038/onc.2010.517; Podda MG, 2010, TUMORI, V96, P684, DOI 10.1177/030089161009600507; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Shida D, 2003, CANCER RES, V63, P1706; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Willett RT, 2011, J NEUROSCI, V31, P4444, DOI 10.1523/JNEUROSCI.4616-10.2011; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yamada T, 2004, J BIOL CHEM, V279, P6595, DOI 10.1074/jbc.M308133200; Yamada T, 2009, BIOCHEM BIOPH RES CO, V378, P424, DOI 10.1016/j.bbrc.2008.11.044; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123	67	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2013	8	10							e77731	10.1371/journal.pone.0077731	http://dx.doi.org/10.1371/journal.pone.0077731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239JR	24147068	Green Submitted, Green Published, gold			2022-12-27	WOS:000326019400129
J	Galletti, MFBM; Fujita, A; Nishiyama, MY; Malossi, CD; Pinter, A; Soares, JF; Daffre, S; Labruna, MB; Fogaca, AC				Galletti, Maria Fernanda B. M.; Fujita, Andre; Nishiyama, Milton Y., Jr.; Malossi, Camila D.; Pinter, Adriano; Soares, Joao F.; Daffre, Sirlei; Labruna, Marcelo B.; Fogaca, Andrea C.			Natural Blood Feeding and Temperature Shift Modulate the Global Transcriptional Profile of Rickettsia rickettsii Infecting Its Tick Vector	PLOS ONE			English	Article							BRAZILIAN SPOTTED-FEVER; AMBLYOMMA-AUREOLATUM; GENE-EXPRESSION; ANKYRIN REPEAT; PROTEIN; AMPLIFICATION; CAJENNENSE; EVOLUTION; BACTERIUM; INVASION	Rickettsia rickettsii is an obligate intracellular tick-borne bacterium that causes Rocky Mountain Spotted Fever (RMSF), the most lethal spotted fever rickettsiosis. When an infected starving tick begins blood feeding from a vertebrate host, R. rickettsii is exposed to a temperature elevation and to components in the blood meal. These two environmental stimuli have been previously associated with the reactivation of rickettsial virulence in ticks, but the factors responsible for this phenotype conversion have not been completely elucidated. Using customized oligonucleotide microarrays and high-throughput microfluidic qRT-PCR, we analyzed the effects of a 10 degrees C temperature elevation and of a blood meal on the transcriptional profile of R. rickettsii infecting the tick Amblyomma aureolatum. This is the first study of the transcriptome of a bacterium in the genus Rickettsia infecting a natural tick vector. Although both stimuli significantly increased bacterial load, blood feeding had a greater effect, modulating five-fold more genes than the temperature upshift. Certain components of the Type IV Secretion System (T4SS) were up-regulated by blood feeding. This suggests that this important bacterial transport system may be utilized to secrete effectors during the tick vector's blood meal. Blood feeding also up-regulated the expression of antioxidant enzymes, which might correspond to an attempt by R. rickettsii to protect itself against the deleterious effects of free radicals produced by fed ticks. The modulated genes identified in this study, including those encoding hypothetical proteins, require further functional analysis and may have potential as future targets for vaccine development.	[Galletti, Maria Fernanda B. M.; Malossi, Camila D.; Daffre, Sirlei; Fogaca, Andrea C.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Fujita, Andre] Univ Sao Paulo, Dept Ciencias Comp, Inst Matemat & Estatist, Sao Paulo, Brazil; [Nishiyama, Milton Y., Jr.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Pinter, Adriano] Superintendencia Controle Endemias SUCEN, Sao Paulo, Brazil; [Soares, Joao F.; Labruna, Marcelo B.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Fogaca, AC (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	deafog@usp.br	Daffre, Sirlei/M-4233-2013; Fogaca, Andrea/C-1322-2012; Nishiyama, Milton Y/H-4002-2013; Nishiyama, Milton/AAE-5736-2021; Labruna, Marcelo B/B-6241-2013; Galletti, Maria Fernanda BM/M-4738-2013; Pinter, Adriano/AAG-6459-2019; Fujita, Andre/Q-1271-2019; Fogaca, Andrea C/M-4267-2013; Pinter, Adriano/B-9827-2012	Daffre, Sirlei/0000-0002-9966-0433; Nishiyama, Milton Y/0000-0002-2410-0562; Nishiyama, Milton/0000-0002-2410-0562; Labruna, Marcelo B/0000-0002-9675-3132; Pinter, Adriano/0000-0003-4596-3268; Fujita, Andre/0000-0002-7756-7051; Pinter, Adriano/0000-0003-4596-3268; Dantas Malossi, Camila/0000-0002-3841-2479; Fogaca, Andrea/0000-0002-0890-6136	Sao Paulo Research Foundation (FAPESP) [2008/053570-0]; Coordination for the Improvement of Higher Education Personnel (CAPES); National Council for Scientific and Technological Development [CNPq; the National Institutes of Science and Technology Program in Molecular Entomology (INCT-EM)]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development [CNPq; the National Institutes of Science and Technology Program in Molecular Entomology (INCT-EM)]	This work was supported by funds from the Sao Paulo Research Foundation (FAPESP; Grant 2008/053570-0), the Coordination for the Improvement of Higher Education Personnel (CAPES), and the National Council for Scientific and Technological Development [CNPq; the National Institutes of Science and Technology Program in Molecular Entomology (INCT-EM)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; Ballman KV, 2004, BIOINFORMATICS, V20, P2778, DOI 10.1093/bioinformatics/bth327; Beckwith J, 2013, RES MICROBIOL, V164, P497, DOI 10.1016/j.resmic.2013.03.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Conway T, 2003, MOL MICROBIOL, V47, P879, DOI 10.1046/j.1365-2958.2003.03338.x; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Dzik JM, 2010, ACTA BIOCHIM POL, V57, P443; Ellison DW, 2008, INFECT IMMUN, V76, P542, DOI 10.1128/IAI.00952-07; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; GILFORD JH, 1955, P NATL ACAD SCI USA, V41, P870, DOI 10.1073/pnas.41.11.870; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Guedes E, 2005, MEM I OSWALDO CRUZ, V100, P841, DOI 10.1590/S0074-02762005000800004; HAYES SF, 1982, INFECT IMMUN, V37, P779, DOI 10.1128/IAI.37.2.779-785.1982; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Kang Y, 2011, GENOME RES, V21, P925, DOI 10.1101/gr.116103.110; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; Labruna MB, 2008, J MED ENTOMOL, V45, P1156, DOI 10.1603/0022-2585(2008)45[1156:CSOLSO]2.0.CO;2; Labruna MB, 2011, EMERG INFECT DIS, V17, P829, DOI 10.3201/eid1705.101524; Labruna MB, 2009, ANN NY ACAD SCI, V1166, P156, DOI 10.1111/j.1749-6632.2009.04516.x; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Lawson JN, 2006, DNA CELL BIOL, V25, P627, DOI 10.1089/dna.2006.25.627; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; Pinter A, 2006, ANN NY ACAD SCI, V1078, P523, DOI 10.1196/annals.1374.103; Policastro PF, 1997, J MED MICROBIOL, V46, P839, DOI 10.1099/00222615-46-10-839; Rahman MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003399; Rahman MS, 2005, MICROBIOL-SGM, V151, P589, DOI 10.1099/mic.0.27556-0; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Rovery C, 2005, ANN NY ACAD SCI, V1063, P79, DOI 10.1196/annals.1355.011; Spencer RR, 1923, PUBLIC HEALTH REP, V38, P333, DOI 10.2307/4576667; Stroher E, 2012, BIOCHEM J, V446, P333, DOI 10.1042/BJ20112131; Tokarz R, 2004, INFECT IMMUN, V72, P5419, DOI 10.1128/IAI.72.9.5419-5432.2004; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Uchiyama T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00230; Voth Daniel E, 2011, Cell Logist, V1, P128; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Walker DH, 2001, AM J TROP MED HYG, V65, P936, DOI 10.4269/ajtmh.2001.65.936; WINKLER HH, 1976, J BIOL CHEM, V251, P389	50	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77388	10.1371/journal.pone.0077388	http://dx.doi.org/10.1371/journal.pone.0077388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155949	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300083
J	Hibert, P; Prunier-Mirebeau, D; Beseme, O; Chwastyniak, M; Tamareille, S; Lamon, D; Furber, A; Pinet, F; Prunier, F				Hibert, Pierre; Prunier-Mirebeau, Delphine; Beseme, Olivia; Chwastyniak, Maggy; Tamareille, Sophie; Lamon, Delphine; Furber, Alain; Pinet, Florence; Prunier, Fabrice			Apolipoprotein A-I Is a Potential Mediator of Remote Ischemic Preconditioning	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; 1ST MYOCARDIAL-INFARCTION; HIGH-DENSITY-LIPOPROTEINS; ISCHEMIA/REPERFUSION INJURY; REPERFUSION INJURY; ADENOSINE RECEPTORS; RENAL ISCHEMIA; RAT-HEART; PROTECTS; OCCLUSION	Background: Remote ischemic preconditioning (RIPC) has emerged as an attractive strategy in clinical settings. Despite convincing evidence of the critical role played by circulating humoral mediators, their actual identities remain unknown. In this study, we aimed to identify RIPC-induced humoral mediators using a proteomic approach. Methods: and Results Rats were exposed to 10-min limb ischemia followed by 5-(RIPC 5') or 10-min (RIPC 10') reperfusion prior to blood sampling. The control group only underwent blood sampling. Plasma samples were analyzed using surface-enhanced laser desorption and ionization - time of flight - mass spectrometry (SELDI-TOF-MS). Three protein peaks were selected for their significant increase in RIPC 10'. They were identified and confirmed as apolipoprotein A-I (ApoA-I). Additional rats were exposed to myocardial ischemia-reperfusion (I/R) and assigned to one of the following groups RIPC+myocardial infarction (MI) (10-min limb ischemia followed by 10-min reperfusion initiated 20 minutes prior to myocardial I/R), ApoA-I+MI (10 mg/kg ApoA-I injection 10 minutes before myocardial I/R), and MI (no further intervention). In comparison with untreated MI rats, RIPC reduced infarct size (52.2 +/- 3.7% in RIPC+MI vs. 64.9 +/- 2.6% in MI; p<0.05). Similarly, ApoA-I injection decreased infarct size (50.9 +/- 3.8%; p<0.05 vs. MI). Conclusions: RIPC was associated with a plasmatic increase in ApoA-I. Furthermore, ApoA-I injection before myocardial I/R recapitulated the cardioprotection offered by RIPC in rats. This data suggests that ApoA-I may be a protective blood-borne factor involved in the RIPC mechanism.	[Hibert, Pierre; Prunier-Mirebeau, Delphine; Tamareille, Sophie; Furber, Alain; Prunier, Fabrice] LUNAM Univ, Angers, France; [Hibert, Pierre; Tamareille, Sophie; Lamon, Delphine; Furber, Alain; Prunier, Fabrice] Univ Angers, Lab Cardioprotect Remodelage & Thrombose, Angers, France; [Prunier-Mirebeau, Delphine] Univ Angers, CHU Angers, Dept Biochim & Genet, CNRS,INSERM,U771,UMR 6214, Angers, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] INSERM, U744, F-59045 Lille, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] Inst Pasteur, F-59019 Lille, France; [Beseme, Olivia; Chwastyniak, Maggy; Pinet, Florence] Univ Lille Nord France, IFR142, Lille, France; [Furber, Alain; Prunier, Fabrice] CHU Angers, Serv Cardiol, Angers, France; [Pinet, Florence] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France	Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Lille - ISITE; CHU Lille	Prunier, F (corresponding author), LUNAM Univ, Angers, France.	faprunier@chu-angers.fr	Prunier, Fabrice/A-5210-2011; Prunier, Delphine/K-3301-2015; Tamareille, Sophie/K-1770-2015; Pinet, Florence/F-2892-2013	Tamareille, Sophie/0000-0001-8563-6558; Pinet, Florence/0000-0002-5471-1487	Servier and Conseil General du Maine et Loire; ANR [ANR-11-EMMA-029-01]; Fondation Coeur Recherche	Servier and Conseil General du Maine et Loire(Region Pays de la Loire); ANR(French National Research Agency (ANR)); Fondation Coeur Recherche	Delphine Lamon and Pierre Hibert were supported by fellowships from Servier and Conseil General du Maine et Loire, respectively. This work was supported in part by grants from ANR (ANR-11-EMMA-029-01) and the Fondation Coeur & Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ZA, 2007, CIRCULATION, V116, pI98, DOI 10.1161/circulationaha.106.679167; Beseme O, 2010, ELECTROPHORESIS, V31, P2697, DOI 10.1002/elps.201000188; Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Breivik L, 2011, BASIC RES CARDIOL, V106, P135, DOI 10.1007/s00395-010-0133-0; Brevoord D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042179; Cheung MMH, 2006, J AM COLL CARDIOL, V47, P2277, DOI 10.1016/j.jacc.2006.01.066; Dickson EW, 1999, J THROMB THROMBOLYS, V8, P123, DOI 10.1023/A:1008911101951; Dickson EW, 1999, AM J PHYSIOL-HEART C, V277, pH2451, DOI 10.1152/ajpheart.1999.277.6.H2451; Diwan V, 2008, J CARDIOVASC PHARM, V51, P126, DOI 10.1097/FJC.0b013e31815d88c9; Dubois E, 2011, PROTEOM CLIN APPL, V5, P57, DOI 10.1002/prca.201000056; Fertin M, 2011, J PROTEOMICS, V74, P420, DOI 10.1016/j.jprot.2010.12.005; Fertin M, 2010, PROTEOM CLIN APPL, V4, P654, DOI 10.1002/prca.200900178; Ghanbari-Niaki A, 2007, BIOCHEM BIOPH RES CO, V361, P841, DOI 10.1016/j.bbrc.2007.07.100; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Gu SS, 2007, LIFE SCI, V81, P702, DOI 10.1016/j.lfs.2007.06.021; Hajrasouliha AR, 2008, EUR J PHARMACOL, V579, P246, DOI 10.1016/j.ejphar.2007.09.034; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Hausenloy DJ, 2011, NAT REV CARDIOL, V8, P619, DOI 10.1038/nrcardio.2011.85; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hepponstall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048284; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Imaizumi S, 2008, J AM COLL CARDIOL, V51, P1604, DOI 10.1016/j.jacc.2007.12.040; Kerendi F, 2005, BASIC RES CARDIOL, V100, P404, DOI 10.1007/s00395-005-0539-2; Khabazian BM, 2009, EUR J APPL PHYSIOL, V107, P351, DOI 10.1007/s00421-009-1133-3; Kharbanda RK, 2002, CIRCULATION, V106, P2881, DOI 10.1161/01.CIR.0000043806.51912.9B; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Lang SC, 2006, BASIC RES CARDIOL, V101, P149, DOI 10.1007/s00395-005-0565-0; Lim SY, 2010, BASIC RES CARDIOL, V105, P651, DOI 10.1007/s00395-010-0099-y; Lim SY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00027; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Lyssenko NN, 2012, BBA-MOL CELL BIOL L, V1821, P456, DOI 10.1016/j.bbalip.2011.07.020; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OXMAN T, 1997, AM J PHYSIOL-HEART C, V273, pH1707; Pell TJ, 1998, AM J PHYSIOL-HEART C, V275, pH1542, DOI 10.1152/ajpheart.1998.275.5.H1542; Peralta C, 2001, HEPATOLOGY, V33, P100, DOI 10.1053/jhep.2001.20529; Pinet F, 2008, PROTEOMICS, V8, P1798, DOI 10.1002/pmic.200700781; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Puppione DL, 2009, COMP BIOCHEM PHYS D, V4, P305, DOI 10.1016/j.cbd.2009.09.001; Rossoni G, 2004, J PHARMACOL EXP THER, V308, P79, DOI 10.1124/jpet.103.057141; Shi N, 2008, J BIOMED SCI, V15, P577, DOI 10.1007/s11373-008-9258-7; Shimizu M, 2010, J SURG RES, V158, P155, DOI 10.1016/j.jss.2008.08.010; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z; Tapuria N, 2008, J SURG RES, V150, P304, DOI 10.1016/j.jss.2007.12.747; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Weinbrenner C, 2004, CARDIOVASC RES, V61, P591, DOI 10.1016/j.cardiores.2003.10.008; Weinbrenner C, 2002, CARDIOVASC RES, V55, P590, DOI 10.1016/S0008-6363(02)00446-7; Wolfrum S, 2002, CARDIOVASC RES, V55, P583, DOI 10.1016/S0008-6363(02)00408-X; Xiao L, 2001, EUR J PHARMACOL, V427, P131, DOI 10.1016/S0014-2999(01)01231-6	50	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77211	10.1371/journal.pone.0077211	http://dx.doi.org/10.1371/journal.pone.0077211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155931	Green Published, gold			2022-12-27	WOS:000325887300065
J	Lin, SF; Lin, JD; Chou, TC; Huang, YY; Wong, RJ				Lin, Shu-Fu; Lin, Jen-Der; Chou, Ting-Chao; Huang, Yu-Yao; Wong, Richard J.			Utility of a Histone Deacetylase Inhibitor (PXD101) for Thyroid Cancer Treatment	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CELL-LINES; INCREASING INCIDENCE; VALPROIC ACID; IN-VITRO; PACLITAXEL; CARCINOMA; APOPTOSIS; REPAIR; SENSITIVITY	Background: We evaluated the therapeutic effects of the histone deacetylase inhibitor PXD101 alone and in combination with conventional chemotherapy in treating thyroid cancer. Methodology/Principal Findings: We studied eight cell lines from four types of thyroid cancer (papillary, follicular, anaplastic and medullary). The cytotoxicity of PXD101 alone and in combination with three conventional chemotherapeutic agents (doxorubicin, paclitaxel and docetaxel) was measured using LDH assay. Western blot assessed expression of acetylation of histone H3, histone H4 and tubulin, proteins associated with apoptosis, RAS/RAF/ERK and PI3K/AKT/mTOR signaling pathways, DNA damage and repair. Apoptosis and intracellular reactive oxygen species (ROS) were measured by flow cytometry. Mice bearing flank anaplastic thyroid cancers (ATC) were daily treated with intraperitoneal injection of PXD101 for 5 days per week. PXD101 effectively inhibited thyroid cancer cell proliferation in a dose-dependent manner. PXD101 induced ROS accumulation and inhibited RAS/RAF/ERK and PI3K/mTOR pathways in sensitive cells. Double-stranded DNA damage and apoptosis were induced by PXD101 in both sensitive and resistant cell lines. PXD101 retarded growth of 8505C ATC xenograft tumors with promising safety. Combination therapy of PXD101with doxorubicin and paclitaxel demonstrated synergistic effects against four ATC lines in vitro. Conclusions: PXD101 represses thyroid cancer proliferation and has synergistic effects in combination with doxorubicin and paclitaxel in treating ATC. These findings support clinical trials using PXD101 for patients with this dismal disease.	[Lin, Shu-Fu; Lin, Jen-Der; Huang, Yu-Yao] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Taoyuan, Taiwan; [Chou, Ting-Chao] Mem Sloan Kettering Canc Ctr, Lab Preclin Pharmacol Core, New York, NY 10021 USA; [Wong, Richard J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Chang Gung Memorial Hospital; Chang Gung University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Huang, YY (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Taoyuan, Taiwan.	yyh@cgmh.org.tw; wongr@mskcc.org	Chou, Ting-Chao/B-4111-2009; Chou, Ting-Chao/AAA-7881-2020	Chou, Ting-Chao/0000-0002-3340-1594; Chou, Ting-Chao/0000-0002-3340-1594; Huang, Yu-Yao/0000-0002-4501-6140; Lin, Shu-Fu/0000-0001-8877-9685	Chang Gung Memorial Hospital; Chang Gung University [CMRPG3A0161, CMRPG3A0162, CMRPG3A0163, CMRPG370581, CMRPG370582, CMRPG370583]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung University	This work was supported by Chang Gung Memorial Hospital and Chang Gung University (CMRPG3A0161, CMRPG3A0162, CMRPG3A0163, CMRPG370581, CMRPG370582 and CMRPG370583)(http://www.cgmh.org.tw/. http://www.cgu.edu.tw/bin/home.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Ain KB, 2000, THYROID, V10, P587, DOI 10.1089/thy.2000.10.587; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Borbone E, 2010, ONCOGENE, V29, P105, DOI 10.1038/onc.2009.306; Catalano MG, 2007, ENDOCR-RELAT CANCER, V14, P839, DOI 10.1677/ERC-07-0096; Catalano MG, 2006, J ENDOCRINOL, V191, P465, DOI 10.1677/joe.1.06970; CHAN D, 2013, J CANCER RES CLIN, P24064; Chou TC, 2005, COMPUSYN DRUG COMBIN; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Furuya F, 2004, ENDOCRINOLOGY, V145, P2865, DOI 10.1210/en.2003-1258; Greenberg VL, 2001, THYROID, V11, P315, DOI 10.1089/10507250152039046; Guerra A, 2012, J CLIN ENDOCR METAB, V97, P517, DOI 10.1210/jc.2011-0618; Huang YY, 2007, J CLIN ENDOCR METAB, V92, P1965, DOI 10.1210/jc.2007-0040; Hwang JJ, 2010, J UROLOGY, V184, P2557, DOI 10.1016/j.juro.2010.07.035; Ito Y, 2013, NAT REV ENDOCRINOL, V9, P178, DOI 10.1038/nrendo.2012.257; Jin N, 2011, CLIN CANCER RES, V17, P6482, DOI 10.1158/1078-0432.CCR-11-0933; Kachhap SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011208; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kotian S, 2011, J BIOL CHEM, V286, P7722, DOI 10.1074/jbc.C110.194233; Lassen U, 2010, BRIT J CANCER, V103, P12, DOI 10.1038/sj.bjc.6605726; Lin SF, 2007, SURGERY, V142, P976, DOI 10.1016/j.surg.2007.09.017; Lin SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046726; Luong QT, 2006, CLIN CANCER RES, V12, P5570, DOI 10.1158/1078-0432.CCR-06-0367; Maggio SC, 2004, CANCER RES, V64, P2590, DOI 10.1158/0008-5472.CAN-03-2631; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mitsiades CS, 2005, CLIN CANCER RES, V11, P3958, DOI 10.1158/1078-0432.CCR-03-0776; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; Ohta K, 1997, J CLIN ENDOCR METAB, V82, P2633, DOI 10.1210/jc.82.8.2633; Plumb JA, 2003, MOL CANCER THER, V2, P721; Qian XZ, 2006, MOL CANCER THER, V5, P2086, DOI 10.1158/1535-7163.MCT-06-0111; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Smallridge RC, 2012, THYROID, V22, P1104, DOI 10.1089/thy.2012.0302; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; Wirth LJ, 2013, NEW ENGL J MED, V368, P664, DOI 10.1056/NEJMcpc1210080; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Zarnegar R, 2002, SURGERY, V132, P984, DOI 10.1067/msy.2002.128690	52	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77684	10.1371/journal.pone.0077684	http://dx.doi.org/10.1371/journal.pone.0077684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155971	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300105
J	Ruan, ZY; Zhai, Y; Song, JL; Shi, YH; Li, K; Zhao, B; Yan, YC				Ruan, Zhiyong; Zhai, Yi; Song, Jinlong; Shi, Yanhua; Li, Kang; Zhao, Bin; Yan, Yanchun			Molecular Cloning and Characterization of a Newly Isolated Pyrethroid-Degrading Esterase Gene from a Genomic Library of Ochrobactrum anthropi YZ-1	PLOS ONE			English	Article							HYDROLYZING CARBOXYLESTERASE GENE; LAMBDA-CYHALOTHRIN; BIOCHEMICAL-CHARACTERIZATION; PURIFICATION; INSECTICIDES; STRAIN; BIODEGRADATION; LIVER; FATE	A novel pyrethroid-degrading esterase gene pytY was isolated from the genomic library of Ochrobactrum anthropi YZ-1. It possesses an open reading frame (ORF) of 897 bp. Blast search showed that its deduced amino acid sequence shares moderate identities (30% to 46%) with most homologous esterases. Phylogenetic analysis revealed that PytY is a member of the esterase VI family. pytY showed very low sequence similarity compared with reported pyrethroid-degrading genes. PytY was expressed, purified, and characterized. Enzyme assay revealed that PytY is a broad-spectrum degrading enzyme that can degrade various pyrethroids. It is a new pyrethroid-degrading gene and enriches genetic resource. Kinetic constants of Km and Vmax were 2.34 mmol.L-1 21 and 56.33 nmol min(-1), respectively, with lambda-cyhalothrin as substrate. PytY displayed good degrading ability and stability over a broad range of temperature and pH. The optimal temperature and pH were of 35 degrees C and 7.5. No cofactors were required for enzyme activity. The results highlighted the potential use of PytY in the elimination of pyrethroid residuals from contaminated environments.	[Ruan, Zhiyong; Zhao, Bin] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Song, Jinlong; Shi, Yanhua; Yan, Yanchun] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China; [Zhai, Yi] Chongqing Acad Agr Sci, Inst Agr Engn, Chongqing, Peoples R China; [Ruan, Zhiyong] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China; [Li, Kang] Natl Inst Food & Drug Control, Inst Biol Prod Control, Beijing, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; National Institute of Food & Drug Control - China	Zhao, B (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China.	binzhao@mail.hzau.edu.cn; yanyanchun@caas.cn			Hi-Tech Research and Development Program of China [2008AA10Z402]; National Natural Science Foundation of China [31170119]; Basic Research Fund of CAAS [0042012003, 0042011006]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Fund of CAAS	This work was supported by the Hi-Tech Research and Development Program of China (2008AA10Z402), the National Natural Science Foundation of China (31170119), and the Basic Research Fund of CAAS (Nos. 0042012003 and 0042011006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER M, 1981, SCIENCE, V211, P132, DOI 10.1126/science.7444456; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiang SW, 1996, PESTIC BIOCHEM PHYS, V54, P181, DOI 10.1006/pest.1996.0022; Choi YJ, 2004, APPL ENVIRON MICROB, V70, P3213, DOI 10.1128/AEM.70.6.3213-3221.2004; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; DEMOUTE JP, 1989, PESTIC SCI, V27, P375, DOI 10.1002/ps.2780270406; Fetoui H, 2010, EXP TOXICOL PATHOL, V62, P593, DOI 10.1016/j.etp.2009.08.004; Giri S, 2002, MUTAT RES-GEN TOX EN, V520, P125, DOI 10.1016/S1383-5718(02)00197-3; Glogauer A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-54; Guo P, 2009, INT BIODETER BIODEGR, V63, P1107, DOI 10.1016/j.ibiod.2009.09.008; Housset P., 2009, Bayer CropScience Journal, V62, P135; Kasai S., 2004, Journal of Pesticide Science, V29, P220, DOI 10.1584/jpestics.29.220; Katsuda Y, 1999, PESTIC SCI, V55, P775, DOI 10.1002/(SICI)1096-9063(199908)55:8&lt;775::AID-PS27&gt;3.0.CO;2-N; Kolaczinski JH, 2004, FOOD CHEM TOXICOL, V42, P697, DOI 10.1016/j.fct.2003.12.008; Lee MH, 2006, APPL ENVIRON MICROB, V72, P7406, DOI 10.1128/AEM.01157-06; Li G, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-38; Liang WQ, 2005, J AGR FOOD CHEM, V53, P7415, DOI 10.1021/jf051460k; Lutnicka H, 1999, WATER RES, V33, P3441, DOI 10.1016/S0043-1354(99)00054-8; MALONEY SE, 1993, APPL ENVIRON MICROB, V59, P2007, DOI 10.1128/AEM.59.7.2007-2013.1993; MIYAMOTO J, 1968, AGR BIOL CHEM TOKYO, V32, P628, DOI 10.1080/00021369.1968.10859116; Sambrook J., 2001, MOL CLONING LAB MANU; Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254; SMITH TM, 1986, RESIDUE REV, V97, P93; Sogorb MA, 2002, TOXICOL LETT, V128, P215, DOI 10.1016/S0378-4274(01)00543-4; Stok JE, 2004, J BIOL CHEM, V279, P29863, DOI 10.1074/jbc.M403673200; SUZUKI T, 1978, PESTIC BIOCHEM PHYS, V8, P186, DOI 10.1016/0048-3575(78)90038-X; Tallur PN, 2008, BIODEGRADATION, V19, P77, DOI 10.1007/s10532-007-9116-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Velmurugan B, 2007, ENVIRON TOXICOL PHAR, V24, P286, DOI 10.1016/j.etap.2007.07.001; Wang BZ, 2009, APPL ENVIRON MICROB, V75, P5496, DOI 10.1128/AEM.01298-09; Wu PC, 2006, J AGR FOOD CHEM, V54, P836, DOI 10.1021/jf052691u; Yang C. R., 2010, PROCESS BIOCHEM, V45, P1937; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P1152, DOI 10.1016/j.fct.2010.02.002; Zhai Y, 2012, J HAZARD MATER, V221, P206, DOI 10.1016/j.jhazmat.2012.04.031; Zhang C, 2010, BIORESOURCE TECHNOL, V101, P3423, DOI 10.1016/j.biortech.2009.12.083; Zhang Q, 2010, J ENVIRON SCI, V22, P428, DOI 10.1016/S1001-0742(09)60125-X	37	28	35	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77329	10.1371/journal.pone.0077329	http://dx.doi.org/10.1371/journal.pone.0077329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155944	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300078
J	Ruffinatti, FA; Gilardino, A; Lovisolo, D; Ferraro, M				Ruffinatti, Federico Alessandro; Gilardino, Alessandra; Lovisolo, Davide; Ferraro, Mario			Spatial Wavelet Analysis of Calcium Oscillations in Developing Neurons	PLOS ONE			English	Article							GROWTH CONE; TRANSIENTS; SIGNALS; DIFFERENTIATION; BIOLOGY; CELLS	Calcium signals play a major role in the control of all key stages of neuronal development, and in particular in the growth and orientation of neuritic processes. These signals are characterized by high spatial compartmentalization, a property which has a strong relevance in the different roles of specific neuronal regions in information coding. In this context it is therefore important to understand the structural and functional basis of this spatial compartmentalization, and in particular whether the behavior at each compartment is merely a consequence of its specific geometry or the result of the spatial segregation of specific calcium influx/efflux mechanisms. Here we have developed a novel approach to separate geometrical from functional differences, regardless on the assumptions on the actual mechanisms involved in the generation of calcium signals. First, spatial indices are derived with a wavelet-theoretic approach which define a measure of the oscillations of cytosolic calcium concentration in specific regions of interests (ROIs) along a cell, in our case developing chick ciliary ganglion neurons. The resulting spatial profile demonstrates clearly that different ROIs along the neuron are characterized by specific patterns of calcium oscillations. Next we have investigated whether this inhomogeneity is due just to geometrical factors, namely the surface to volume ratio in the different subcompartments (e.g. soma vs. growth cone) or it depends on their specific biophysical properties. To this aim correlation functions are computed between the activity indices and the surface/volume ratio along the cell: the data thus obtained are validated by a statistical analysis on a dataset of 15 different cells. This analysis shows that whereas in the soma calcium dynamics is highly correlated to the surface/volume ratio, correlations drop in the growth cone-neurite region, suggesting that in this latter case the key factor is the expression of specific mechanisms controlling calcium influx/efflux.	[Ruffinatti, Federico Alessandro; Gilardino, Alessandra; Lovisolo, Davide] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Ferraro, Mario] Univ Turin, Dept Phys, Turin, Italy; [Ruffinatti, Federico Alessandro; Gilardino, Alessandra; Lovisolo, Davide] Univ Turin, NIS Interdept Ctr, Turin, Italy; [Lovisolo, Davide; Ferraro, Mario] Univ Turin, Neurosci Inst Turin, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Turin	Ferraro, M (corresponding author), Univ Turin, Dept Phys, Turin, Italy.	ferraro@ph.unito.it	RUFFINATTI, FEDERICO ALESSANDRO/ABA-8065-2020	RUFFINATTI, FEDERICO ALESSANDRO/0000-0002-3084-0380	University of Turin	University of Turin	This research has been performed exclusively thanks to institutional funds of University of Turin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1914, DIALOGUES 2 NEW SCI; Bussow R, 2007, MECH SYST SIGNAL PR, V21, P2970, DOI 10.1016/j.ymssp.2007.06.001; Berrill NJ, 1935, J MORPHOL, V56, P353, DOI 10.1002/jmor.1050570204; Bottenstein JE, 1983, CURRENT METHODS CELL, V4, P107; Daubechies I., 1992, 10 LECT WAVELETS, DOI [10.1137/1.9781611970104.ch1, DOI 10.1137/1.9781611970104.CH1]; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Debnath L, 1998, INT J MATH EDUC SCI, V29, P677; Distasi C, 1998, EUR J NEUROSCI, V10, P2276, DOI 10.1046/j.1460-9568.1998.00239.x; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; GOUPILLAUD P, 1984, GEOEXPLORATION, V23, P85, DOI 10.1016/0016-7142(84)90025-5; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hutchins BI, 2008, J NEUROSCI, V28, P143, DOI 10.1523/JNEUROSCI.4548-07.2008; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Munck S, 2002, CELL CALCIUM, V31, P27, DOI 10.1054/ceca.2001.0253; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Robles E, 2003, NEURON, V38, P597, DOI 10.1016/S0896-6273(03)00260-5; Ruffinatti FA, 2011, J NEUROSCI METH, V199, P310, DOI 10.1016/j.jneumeth.2011.05.009; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573, DOI 10.1113/jphysiol.1993.sp019963; Spitzer NC, 2000, BIOESSAYS, V22, P811; Tang FJ, 2003, J NEUROSCI, V23, P927; Thompson D.W, 1917, GROWTH FORM; Thul R, 2008, ADV EXP MED BIOL, V641, P1; Van Acker K, 2000, J NEUROPHYSIOL, V83, P1052, DOI 10.1152/jn.2000.83.2.1052; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Yamada RX, 2008, J NEUROSCI, V28, P4613, DOI 10.1523/JNEUROSCI.0019-08.2008; ZADOR A, 1994, J NEUROSCI, V14, P4705; Zamburlin P, 2009, J NEUROSCI METH, V185, P178, DOI 10.1016/j.jneumeth.2009.09.013; Zamburlin P, 2013, PFLUGERS AR IN PRESS; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	34	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e75986	10.1371/journal.pone.0075986	http://dx.doi.org/10.1371/journal.pone.0075986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155880	Green Submitted, Green Published, gold			2022-12-27	WOS:000325887300014
J	Oster, AM; Russell, K; Wiegand, RE; Valverde, E; Forrest, DW; Cribbin, M; Le, BC; Paz-Bailey, G				Oster, Alexandra M.; Russell, Kate; Wiegand, Ryan E.; Valverde, Eduardo; Forrest, David W.; Cribbin, Melissa; Le, Binh C.; Paz-Bailey, Gabriela		NHBS Study Grp	HIV Infection and Testing among Latino Men Who Have Sex with Men in the United States: The Role of Location of Birth and Other Social Determinants	PLOS ONE			English	Article							VIRAL-HEPATITIS; HEALTH-CARE; BLACK-MEN; YOUNG MEN; SURVEILLANCE; PREVENTION; PREVALENCE; IMPACT; GAY; DISPARITIES	Background: In the United States, Latino men who have sex with men (MSM) are disproportionately affected by HIV. Latino MSM are a diverse group who differ culturally based on their countries or regions of birth and their time in the United States. We assessed differences in HIV prevalence and testing among Latino MSM by location of birth, time since arrival, and other social determinants of health. Methods: For the 2008 National HIV Behavioral Surveillance System, a cross-sectional survey conducted in large US cities, MSM were interviewed and tested for HIV infection. We used generalized estimating equations to test associations between various factors and 1) prevalent HIV infection and 2) being tested for HIV infection in the past 12 months. Results: Among 1734 Latino MSM, HIV prevalence was 19%. In multivariable analysis, increasing age, low income, and gay identity were associated with HIV infection. Moreover, men who were U.S.-born or who arrived >= 5 years ago had significantly higher HIV prevalence than recent immigrants. Among men not reporting a previous positive HIV test, 63% had been tested for HIV infection in the past 12 months; recent testing was most strongly associated with having seen a health care provider and disclosing male-male attraction/sexual behavior to a health care provider. Conclusions: We identified several social determinants of health associated with HIV infection and testing among Latino MSM. Lower HIV prevalence among recent immigrants contrasts with higher prevalence among established immigrants and suggests a critical window of opportunity for HIV prevention, which should prioritize those with low income, who are at particular risk for HIV infection. Expanding health care utilization and encouraging communication with health care providers about sexual orientation may increase testing.	[Oster, Alexandra M.; Russell, Kate; Wiegand, Ryan E.; Valverde, Eduardo; Cribbin, Melissa; Le, Binh C.; Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; [Forrest, David W.] Univ Miami, Miami, FL USA	Centers for Disease Control & Prevention - USA; University of Miami	Oster, AM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	AOster@cdc.gov		Woodworth, Kate/0000-0001-9343-3355; Wiegand, Ryan/0000-0002-9486-1850	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The National HIV Behavioral Surveillance System is funded by the Centers for Disease Control and Prevention (CDC). Study design and data collection are conducted by funded sites in accordance with a standardized protocol developed by CDC. Data analysis and preparation of the manuscript were conducted by CDC staff.	Allen DR, 2009, PUBLIC HEALTH REP, V124, P26, DOI 10.1177/003335490912400106; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 2001, SOCIAL DISCRIMINATIO; Ayala G, 2012, AM J PUBLIC HEALTH, V102, pS242, DOI 10.2105/AJPH.2011.300641; Behel SK, 2008, J URBAN HEALTH, V85, P727, DOI 10.1007/s11524-008-9303-x; Beltran VM, 2011, PUBLIC HEALTH REP, V126, P41, DOI 10.1177/00333549111260S309; Bianchi FT, 2007, CULT HEALTH SEX, V9, P505, DOI 10.1080/13691050701243547; Darrow WW, 2009, AIDS BEHAV, V13, P1178, DOI 10.1007/s10461-009-9601-7; Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401; Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927; Egan JE, 2011, AIDS BEHAV, V15, pS35, DOI 10.1007/s10461-011-9902-5; Espinoza L, 2008, JAIDS-J ACQ IMM DEF, V49, P94, DOI 10.1097/QAI.0b013e3181820129; Frieden TR, 2010, AM J PUBLIC HEALTH, V100, P590, DOI 10.2105/AJPH.2009.185652; Hall HI, 2007, AM J PUBLIC HEALTH, V97, P1060, DOI 10.2105/AJPH.2006.087551; Harawa NT, 2004, JAIDS-J ACQ IMM DEF, V35, P526, DOI 10.1097/00126334-200404150-00011; Herek GM, 1999, AM BEHAV SCI, V42, P1126; Lieb S, 2011, AIDS BEHAV, V15, P596, DOI 10.1007/s10461-010-9820-y; London A S, 1999, J Immigr Health, V1, P195, DOI 10.1023/A:1021811917532; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Malebranche DJ, 2004, J NATL MED ASSOC, V96, P97; Mancl LA, 2001, BIOMETRICS, V57, P126, DOI 10.1111/j.0006-341X.2001.00126.x; Pew Hispanic Center, 2012, STAT PORTR HISP US 2; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Satcher D, 2010, PUBLIC HEALTH REP, V125, P6, DOI 10.1177/00333549101250S402; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; World Health Organization, 2010, HLTH MIGR WAY FORW R	26	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2013	8	9							e73779	10.1371/journal.pone.0073779	http://dx.doi.org/10.1371/journal.pone.0073779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217DY	24147151	Green Published, gold			2022-12-27	WOS:000324338200079
J	Cao, HL; Auguet, JC; Gu, JD				Cao, Huiluo; Auguet, Jean-Christophe; Gu, Ji-Dong			Global Ecological Pattern of Ammonia-Oxidizing Archaea	PLOS ONE			English	Article							AUSTRIAN CENTRAL ALPS; NITROSOPUMILUS-MARITIMUS; COMMUNITY STRUCTURE; RELATIVE ABUNDANCE; HOT-SPRINGS; AMOA GENES; SOIL-PH; DIVERSITY; BACTERIA; CRENARCHAEOTA	Background: The global distribution of ammonia-oxidizing archaea (AOA), which play a pivotal role in the nitrification process, has been confirmed through numerous ecological studies. Though newly available amoA (ammonia monooxygenase subunit A) gene sequences from new environments are accumulating rapidly in public repositories, a lack of information on the ecological and evolutionary factors shaping community assembly of AOA on the global scale is apparent. Methodology and Results: We conducted a meta-analysis on uncultured AOA using over ca. 6,200 archaeal amoA gene sequences, so as to reveal their community distribution patterns along a wide spectrum of physicochemical conditions and habitat types. The sequences were dereplicated at 95% identity level resulting in a dataset containing 1,476 archaeal amoA gene sequences from eight habitat types: namely soil, freshwater, freshwater sediment, estuarine sediment, marine water, marine sediment, geothermal system, and symbiosis. The updated comprehensive amoA phylogeny was composed of three major monophyletic clusters (i.e. Nitrosopumilus, Nitrosotalea, Nitrosocaldus) and a non-monophyletic cluster constituted mostly by soil and sediment sequences that we named Nitrososphaera. Diversity measurements indicated that marine and estuarine sediments as well as symbionts might be the largest reservoirs of AOA diversity. Phylogenetic analyses were further carried out using macroevolutionary analyses to explore the diversification pattern and rates of nitrifying archaea. In contrast to other habitats that displayed constant diversification rates, marine planktonic AOA interestingly exhibit a very recent and accelerating diversification rate congruent with the lowest phylogenetic diversity observed in their habitats. This result suggested the existence of AOA communities with different evolutionary history in the different habitats. Conclusion and Significance: Based on an up-to-date amoA phylogeny, this analysis provided insights into the possible evolutionary mechanisms and environmental parameters that shape AOA community assembly at global scale.	[Cao, Huiluo; Gu, Ji-Dong] Univ Hong Kong, Sch Biol Sci, Lab Environm Microbiol & Toxicol, Hong Kong, Hong Kong, Peoples R China; [Auguet, Jean-Christophe] Univ Pau & Pays Adour, UMR CNRS IPREM 5254, Equipe Environm Microbiol, Pau, France; [Gu, Ji-Dong] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Universite de Pau et des Pays de l'Adour; University of Hong Kong	Gu, JD (corresponding author), Univ Hong Kong, Sch Biol Sci, Lab Environm Microbiol & Toxicol, Hong Kong, Hong Kong, Peoples R China.	jdgu@hkucc.hku.hk	Auguet, Jean-Christophe/H-5697-2015; Gu, Ji-Dong/AAF-2291-2019; Gu, Ji-Dong/AAO-7851-2020; Cao, Heping/AAC-1666-2021	Auguet, Jean-Christophe/0000-0003-4340-7161; Klasson, K. Thomas/0000-0003-3358-3081; Cao, Heping/0000-0002-0958-1468; Scheffler, Brian/0000-0003-1968-8952; Shockey, Jay/0000-0002-5057-5457	University of Hong Kong	University of Hong Kong(University of Hong Kong)	PhD studentship (HC) from The University of Hong Kong supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; Auguet JC, 2011, APPL ENVIRON MICROB, V77, P1937, DOI 10.1128/AEM.01213-10; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Barberan A, 2011, MOL ECOL, V20, P1988, DOI 10.1111/j.1365-294X.2011.05057.x; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Bernhard AE, 2010, APPL ENVIRON MICROB, V76, P1285, DOI 10.1128/AEM.02018-09; Biller SJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00252; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Cao HL, 2011, METHOD ENZYMOL, V496, P35, DOI 10.1016/B978-0-12-386489-5.00002-6; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cuhel J, 2010, APPL ENVIRON MICROB, V76, P1870, DOI 10.1128/AEM.02484-09; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Enwall K, 2005, APPL ENVIRON MICROB, V71, P8335, DOI 10.1128/AEM.71.12.8335-8343.2005; Erguder TH, 2009, FEMS MICROBIOL REV, V33, P855, DOI 10.1111/j.1574-6976.2009.00179.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fernandez-Guerra A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047330; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; Jiang HC, 2010, APPL ENVIRON MICROB, V76, P4538, DOI 10.1128/AEM.00143-10; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Junier P, 2010, APPL MICROBIOL BIOT, V85, P425, DOI 10.1007/s00253-009-2228-9; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kim JG, 2012, ENV MICROBIOL; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Labrenz M, 2010, ISME J, V4, P1496, DOI 10.1038/ismej.2010.78; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu ZH, 2011, MICROBIOL RES, V166, P337, DOI 10.1016/j.micres.2010.08.002; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Lliros M, 2010, APPL ENVIRON MICROB, V76, P6853, DOI 10.1128/AEM.02864-09; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Martin AP, 2004, EVOLUTION, V58, P946; Molina V, 2010, ENVIRON MICROBIOL, V12, P2450, DOI 10.1111/j.1462-2920.2010.02218.x; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rogers DR, 2010, APPL ENVIRON MICROB, V76, P7938, DOI 10.1128/AEM.02056-09; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; van der Wielen PWJJ, 2009, APPL ENVIRON MICROB, V75, P4687, DOI 10.1128/AEM.00387-09; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027597; Weidler GW, 2008, APPL ENVIRON MICROB, V74, P5934, DOI 10.1128/AEM.02602-07; Weidler GW, 2007, APPL ENVIRON MICROB, V73, P259, DOI 10.1128/AEM.01570-06; Wessen E, 2011, ISME J, V5, P1213, DOI 10.1038/ismej.2010.206; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08	69	184	195	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e52853	10.1371/journal.pone.0052853	http://dx.doi.org/10.1371/journal.pone.0052853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	24146944	gold, Green Published, Green Submitted			2022-12-27	WOS:000315524900006
J	Zhang, Q; Sun, J; Liu, SZ; Wei, QP				Zhang, Qiang; Sun, Jian; Liu, Songzhong; Wei, Qinping			Manure Refinement Affects Apple Rhizosphere Bacterial Community Structure: A Study in Sandy Soil	PLOS ONE			English	Article							MICROBIAL COMMUNITY; PYROSEQUENCING REVEALS; LOESS PLATEAU; LAND-USE; DIVERSITY; LANDSCAPE; ROOTS; CHINA; SCALE	We used DNA-based pyrosequencing to characterize the bacterial community structure of the sandy soil of an apple orchard with different manure ratios. Five manure percentages (5%, 10%, 15%, 20% and 25%) were examined. More than 10,000 valid reads were obtained for each replicate. The communities were composed of five dominant groups (Proteobacteria, Actinobacteria, Chloroflexi, Acidobacteria and Bacteroidetes), of which Proteobacteria content gradually decreased from 41.38% to 37.29% as manure ratio increased from 0% to 25%, respectively. Redundancy analysis showed that 37 classes were highly correlated with manure ratio, 18 of which were positively correlated. Clustering revealed that the rhizosphere samples were grouped into three components: low manure (control, 5%) treatment, medium manure (10%, 15%) treatment and high manure (20%, 25%) treatment. Venn analysis of species types of these three groups revealed that the bacteria community difference was primarily reflected by quantity ratio rather than species variety. Although greater manure content led to higher soil organic matter content, the medium manure improved soil showed the highest urease activity and saccharase activity, while 5% to 20% manure ratio improvement also resulted in higher bacteria diversity than control and 25% manure ratio treatment. Our experimental results suggest that the use of a proper manure ratio results in significantly higher soil enzyme activity and different bacteria community patterns, whereas the use of excessive manure amounts has negative effect on soil quality.	[Zhang, Qiang; Sun, Jian; Liu, Songzhong; Wei, Qinping] Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Wei, QP (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Forestry & Pomol, Beijing, Peoples R China.	qinpingwei@gmail.com			China Agriculture Research System [CARS-28]	China Agriculture Research System	China Agriculture Research System, CARS-28, Minister of Agriculture (PRC), http://english.agri.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Alkorta Itziar, 2003, Rev Environ Health, V18, P65; Bell TH, 2011, APPL ENVIRON MICROB, V77, P4163, DOI 10.1128/AEM.00172-11; Bougnom B. P., 2012, Organic Agriculture, V2, P1, DOI 10.1007/s13165-012-0020-0; Bougnom B.P., 2009, BODENKULT, V60, P5; Chenu C, 2000, SOIL SCI SOC AM J, V64, P1479, DOI 10.2136/sssaj2000.6441479x; DeBruyn JM, 2009, ENVIRON SCI TECHNOL, V43, P3467, DOI 10.1021/es803348g; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Feris K, 2003, APPL ENVIRON MICROB, V69, P5563, DOI 10.1128/AEM.69.9.5563-5573.2003; Ge GF, 2010, PLANT SOIL, V326, P31, DOI 10.1007/s11104-009-0186-8; Guckland A, 2009, J PLANT NUTR SOIL SC, V172, P500, DOI 10.1002/jpln.200800072; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Jackson SA, 2012, MICROB ECOL, V64, P105, DOI 10.1007/s00248-011-0002-x; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kindler R, 2006, SOIL BIOL BIOCHEM, V38, P2860, DOI 10.1016/j.soilbio.2006.04.047; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kwon S, 2010, J MICROBIOL BIOTECHN, V20, P1717, DOI 10.4014/jmb.1007.07012; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lin XG, 2012, ENVIRON SCI TECHNOL, V46, P5764, DOI 10.1021/es3001695; Makhalanyane TP, 2012, ENV MICROBIOLOGY REP; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marx MC, 2005, SOIL BIOL BIOCHEM, V37, P35, DOI 10.1016/j.soilbio.2004.05.024; Mazzola M, 1999, PHYTOPATHOLOGY, V89, P920, DOI 10.1094/PHYTO.1999.89.10.920; Militon C, 2010, FEMS MICROBIOL ECOL, V74, P669, DOI 10.1111/j.1574-6941.2010.00982.x; MILLER S.S., 2002, J TREE FRUIT PRODUCT, V31, P11, DOI DOI 10.1300/J072V03N01_; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nocker A, 2010, INT MICROBIOL, V13, P59, DOI 10.2436/20.1501.01.111; Plassart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044279; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Raymond J, 2004, MOL BIOL EVOL, V21, P541, DOI 10.1093/molbev/msh047; Francisco SS, 2011, J SCI FOOD AGR, V91, P1569, DOI 10.1002/jsfa.4349; Sherry A, 2013, INT BIODETER BIODEGR, V81, P105, DOI 10.1016/j.ibiod.2012.04.009; Sugiyama A, 2010, PLANT DIS, V94, P1329, DOI 10.1094/PDIS-02-10-0090; Tekere M, 2012, AFR J MICROBIOL RES, V6, P4993, DOI 10.5897/AJMR12.250; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Uroz S, 2010, ENV MICROBIOL REP, V2, P281, DOI 10.1111/j.1758-2229.2009.00117.x; WAKABAYASHI H, 1986, INT J SYST BACTERIOL, V36, P396, DOI 10.1099/00207713-36-3-396; Wang B, 2011, ENVIRON EARTH SCI, V62, P915, DOI 10.1007/s12665-010-0577-4; Wang J, 2001, J ARID ENVIRON, V48, P537, DOI 10.1006/jare.2000.0763; WU QT, 1994, CAN J MICROBIOL, V40, P916, DOI 10.1139/m94-147	43	38	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e76937	10.1371/journal.pone.0076937	http://dx.doi.org/10.1371/journal.pone.0076937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155909	gold, Green Published, Green Submitted			2022-12-27	WOS:000325887300043
J	Chapman, R; Stutz, H; Jacobs, W; Shephard, E; Williamson, AL				Chapman, Rosamund; Stutz, Helen; Jacobs, William, Jr.; Shephard, Enid; Williamson, Anna-Lise			Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; TYPE-1 SUBTYPE-C; IMMUNODEFICIENCY-VIRUS TYPE-1; BACILLUS-CALMETTE-GUERIN; DNA VACCINE; LISTERIA-MONOCYTOGENES; ELITE CONTROLLERS; IMMUNE-RESPONSES; TUBERCULOSIS; INFECTION	In previous studies we have shown that a pantothenate auxotroph of Myocbacterium bovis BCG (BCG Delta panCD) expressing HIV-1 subtype C Gag induced Gag-specific immune responses in mice and Chacma baboons after prime-boost immunization in combination with matched rMVA and VLP vaccines respectively. In this study recombinant BCG (rBCG) expressing HIV-1 subtype C reverse transcriptase and a truncated envelope were constructed using both the wild type BCG Pasteur strain as a vector and the pantothenate auxotroph. Mice were primed with rBCG expressing Gag and RT and boosted with a recombinant MVA, expressing a polyprotein of Gag, RT, Tat and Nef (SAAVI MVA-C). Priming with rBCG Delta panCD expressing Gag or RT rather than the wild type rBCG expressing Gag or RT resulted in higher frequencies of total HIV-specific CD8(+) T cells and increased numbers of T cells specific to the subdominant Gag and RT epitopes. Increasing the dose of rBCG from 10(5) cfu to 10(7) cfu also led to an increase in the frequency of responses to subdominant HIV epitopes. A mix of the individual rBCG Delta panCD vaccines expressing either Gag, RT or the truncated Env primed the immune system for a boost with SAAVI MVA-C and generated five-fold higher numbers of HIV-specific IFN-gamma-spot forming cells than mice primed with rBCG Delta panCD containing an empty vector control. Priming with the individual rBCG Delta panCD vaccines or the mix and boosting with SAAVI MVA-C also resulted in the generation of HIV-specific CD4(+) and CD8(+) T cells producing IFN-gamma and TNF-alpha and CD4(+) cells producing IL-2. The rBCG vaccines tested in this study were able to prime the immune system for a boost with rMVA expressing matching antigens, inducing robust, HIV-specific T cell responses to both dominant and subdominant epitopes in the individual proteins when used as individual vaccines or in a mix.	[Chapman, Rosamund; Stutz, Helen; Shephard, Enid; Williamson, Anna-Lise] Albert Einstein Coll Med, Inst Infect Dis & Mol Med, Bronx, NY 10467 USA; [Chapman, Rosamund; Stutz, Helen; Williamson, Anna-Lise] Albert Einstein Coll Med, Dept Clin Lab Sci, Div Med Virol, Bronx, NY 10467 USA; [Jacobs, William, Jr.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Shephard, Enid] Univ Cape Town, Fac Hlth Sci, Dept Med, ZA-7925 Cape Town, South Africa; [Shephard, Enid] MRC, Cape Town, South Africa; [Williamson, Anna-Lise] Natl Hlth Lab Serv, Cape Town, South Africa	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Cape Town	Chapman, R (corresponding author), Albert Einstein Coll Med, Inst Infect Dis & Mol Med, Bronx, NY 10467 USA.	Ros.Chapman@uct.ac.za	Chapman, Rosamund/AAJ-6490-2020	Chapman, Rosamund/0000-0001-9162-2099; Waller, Karen/0000-0002-0530-3292; Williamson, Anna-Lise/0000-0002-5467-1200	South African AIDS Vaccine Initiative (SAAVI) [PIA R21/R33, 5R33AI73182-4]; National Institutes of Health (NIH USA) [PIA R21/R33, 5R33AI73182-4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI073182, R01AI026170, R37AI026170] Funding Source: NIH RePORTER	South African AIDS Vaccine Initiative (SAAVI); National Institutes of Health (NIH USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the South African AIDS Vaccine Initiative (SAAVI) and National Institutes of Health (NIH USA) for funding from the Phased Innovation Awards (PIA R21/R33) in AIDS Vaccine Research; grant number 5R33AI73182-4. This work is also based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami Y, 2006, J VIROL, V80, P10288, DOI 10.1128/JVI.01681-06; Burgers WA, 2006, J GEN VIROL, V87, P399, DOI 10.1099/vir.0.81379-0; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08; Chapman R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032769; Chege GK, 2013, J VIROL, V87, P5151, DOI 10.1128/JVI.03178-12; Eisenhut M, 2009, VACCINE, V27, P6116, DOI 10.1016/j.vaccine.2009.08.031; Ferrando-Martinez S, 2012, J VIROL, V86, P3667, DOI 10.1128/JVI.07034-11; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hopkins R, 2011, EUR J IMMUNOL, V41, P3542, DOI 10.1002/eji.201141962; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Joseph J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/357370; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Mata M, 1998, J IMMUNOL, V161, P2985; Mata M, 1999, J IMMUNOL, V163, P1449; Mattapallil JJ, 2006, J MED PRIMATOL, V35, P217, DOI 10.1111/j.1600-0684.2006.00170.x; Mederle I, 2003, VACCINE, V21, P4153, DOI 10.1016/S0264-410X(03)00537-1; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Neyrolles O, 2001, J IMMUNOL, V166, P447, DOI 10.4049/jimmunol.166.1.447; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002; Rosario M, 2010, J VIROL, V84, P5898, DOI 10.1128/JVI.02607-09; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Russell MS, 2007, J IMMUNOL, V179, P211, DOI 10.4049/jimmunol.179.1.211; Russell MS, 2009, J IMMUNOL, V183, P7710, DOI 10.4049/jimmunol.0901274; Sad S, 2008, J IMMUNOL, V180, P5853, DOI 10.4049/jimmunol.180.9.5853; Shephard E, 2008, AIDS RES HUM RETROV, V24, P207, DOI 10.1089/aid.2007.0206; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; van Harmelen JH, 2003, VACCINE, V21, P4380, DOI 10.1016/S0264-410X(03)00406-7; Williamson AL, 2012, SAMJ S AFR MED J, V102, P452, DOI 10.7196/SAMJ.5668; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000	38	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2013	8	8							e71601	10.1371/journal.pone.0071601	http://dx.doi.org/10.1371/journal.pone.0071601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219RU	23977084	gold, Green Submitted, Green Published			2022-12-27	WOS:000324527300024
J	Montanari, S; Saeed, M; Knabel, M; Kim, Y; Troggio, M; Malnoy, M; Velasco, R; Fontana, P; Won, K; Durel, CE; Perchepied, L; Schaffer, R; Wiedow, C; Bus, V; Brewer, L; Gardiner, SE; Crowhurst, RN; Chagne, D				Montanari, Sara; Saeed, Munazza; Knaebel, Mareike; Kim, YoonKyeong; Troggio, Michela; Malnoy, Mickael; Velasco, Riccardo; Fontana, Paolo; Won, KyungHo; Durel, Charles-Eric; Perchepied, Laure; Schaffer, Robert; Wiedow, Claudia; Bus, Vincent; Brewer, Lester; Gardiner, Susan E.; Crowhurst, Ross N.; Chagne, David			Identification of Pyrus Single Nucleotide Polymorphisms (SNPs) and Evaluation for Genetic Mapping in European Pear and Interspecific Pyrus Hybrids	PLOS ONE			English	Article							LINKAGE MAPS; GENOME SEQUENCE; VENTURIA-PIRINA; DIVERSITY; JAPANESE; FRUIT; RESISTANCE	We have used new generation sequencing (NGS) technologies to identify single nucleotide polymorphism (SNP) markers from three European pear (Pyrus communis L.) cultivars and subsequently developed a subset of 1096 pear SNPs into high throughput markers by combining them with the set of 7692 apple SNPs on the IRSC apple Infinium (R) II 8K array. We then evaluated this apple and pear Infinium (R) II 9K SNP array for large-scale genotyping in pear across several species, using both pear and apple SNPs. The segregating populations employed for array validation included a segregating population of European pear ('Old Home' x 'Louise Bon Jersey') and four interspecific breeding families derived from Asian (P. pyrifolia Nakai and P. bretschneideri Rehd.) and European pear pedigrees. In total, we mapped 857 polymorphic pear markers to construct the first SNP-based genetic maps for pear, comprising 78% of the total pear SNPs included in the array. In addition, 1031 SNP markers derived from apple (13% of the total apple SNPs included in the array) were polymorphic and were mapped in one or more of the pear populations. These results are the first to demonstrate SNP transferability across the genera Malus and Pyrus. Our construction of high density SNP-based and gene-based genetic maps in pear represents an important step towards the identification of chromosomal regions associated with a range of horticultural characters, such as pest and disease resistance, orchard yield and fruit quality.	[Montanari, Sara; Troggio, Michela; Malnoy, Mickael; Velasco, Riccardo; Fontana, Paolo] Fdn Edmund Mach, Ist Agr San Michele Adige, Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Montanari, Sara; Saeed, Munazza; Knaebel, Mareike; Wiedow, Claudia; Gardiner, Susan E.; Chagne, David] New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand; [Montanari, Sara; Durel, Charles-Eric; Perchepied, Laure] INRA, Inst Rech Hort & Semences, UMR1345, F-49071 Beaucouze, France; [Montanari, Sara; Durel, Charles-Eric; Perchepied, Laure] Univ Angers, UMR1345, Inst Rech Hort & Semences, F-49045 Angers, France; [Montanari, Sara; Durel, Charles-Eric; Perchepied, Laure] AgroCampus Ouest, UMR1345, Inst Rech Hort & Semences, F-49045 Angers, France; [Saeed, Munazza] Massey Univ, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Knaebel, Mareike; Schaffer, Robert] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Kim, YoonKyeong; Won, KyungHo] Pear Res Stn, Natl Inst Hort & Herbal Sci, Naju, South Korea; [Schaffer, Robert; Crowhurst, Ross N.] DSIR, Mt Albert Res Ctr, Auckland, New Zealand; [Bus, Vincent] Hawkes Bay Res Ctr, Havelock North, New Zealand; [Brewer, Lester] Motueka Res Ctr, Motueka, New Zealand	Fondazione Edmund Mach; New Zealand Institute for Plant & Food Research Ltd; INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; Universite d'Angers; Massey University; University of Auckland; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; New Zealand Institute for Plant & Food Research Ltd	Chagne, D (corresponding author), New Zealand Inst Plant & Food Res Ltd Plant & Foo, Palmerston North Res Ctr, Palmerston North, New Zealand.	David.Chagne@plantandfood.co.nz	Crowhurst, Ross N/N-8892-2017; Bus, Vincent/B-1318-2011; Chagne, David/A-2596-2010; Gardiner, Susan Elizabeth/A-2477-2010; Louys, Julien/GLN-6714-2022; Malnoy, Mickael/AAO-5431-2021; Price, Gilbert J/N-3282-2013; Knaebel, Mareike/O-5631-2016; malnoy, mickael/C-5007-2012; Wiedow, Claudia/O-9291-2016	Crowhurst, Ross N/0000-0003-0608-2134; Bus, Vincent/0000-0003-4071-4457; Chagne, David/0000-0003-4018-0694; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Malnoy, Mickael/0000-0002-5158-534X; Price, Gilbert J/0000-0001-8406-4594; Knaebel, Mareike/0000-0002-0293-1250; malnoy, mickael/0000-0002-5158-534X; Wiedow, Claudia/0000-0003-3402-5460; Schaffer, Robert/0000-0003-1272-667X; Louys, Julien/0000-0001-7539-0689; Velasco, Riccardo/0000-0002-8760-5031; Montanari, Sara/0000-0001-9224-056X	FEM PhD school; Massey University Doctoral Scholarship; New Zealand Ministry of Science and Innovation grant "Pipfruit: a juicy future" [27744]; National Institute of Horticultural and Herbal Science grant	FEM PhD school; Massey University Doctoral Scholarship; New Zealand Ministry of Science and Innovation grant "Pipfruit: a juicy future"; National Institute of Horticultural and Herbal Science grant	SM is funded by the FEM PhD school. MS is funded by a Massey University Doctoral Scholarship. MK is funded by the New Zealand Ministry of Science and Innovation grant "Pipfruit: a juicy future" (Contract number: 27744). The visiting scientist fellowship of YKK to PFR was funded by a National Institute of Horticultural and Herbal Science grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brewer L, 2005, ACTA HORTIC, P595, DOI 10.17660/ActaHortic.2005.671.83; Brewer L. R., 2002, Acta Horticulturae, P571; Brewer LR, 2009, NEW ZEAL J CROP HORT, V37, P211, DOI 10.1080/01140670909510266; Bus V, 2013, ACTA HORTIC, V976, P493, DOI 10.17660/ActaHortic.2013.976.69; Carlson CS, 2006, HUM MOL GENET, V15, P1931, DOI 10.1093/hmg/ddl115; Celton Jean-Marc, 2009, BMC Res Notes, V2, P182, DOI 10.1186/1756-0500-2-182; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Costa F, 2008, TREE GENET GENOMES, V4, P575, DOI 10.1007/s11295-008-0133-5; Dondini L, 2004, MOL BREEDING, V14, P407, DOI 10.1007/s11032-004-0505-y; Doyle J. J., 1987, PHYTOCHEM B, P11; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Hand ML, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-219; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Iketani H, 2001, BREEDING SCI, V51, P179, DOI 10.1270/jsbbs.51.179; Jacob HB, 1998, ACTA HORTIC, P169, DOI 10.17660/ActaHortic.1998.475.20; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lu Min, 2010, American-Eurasian Journal of Agricultural and Environmental Science, V9, P303; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Peace C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048305; Pierantoni L, 2004, THEOR APPL GENET, V109, P1519, DOI 10.1007/s00122-004-1775-9; Rice KM, 2003, ANN HUM GENET, V67, P165, DOI 10.1046/j.1469-1809.2003.00020.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sawcer SJ, 2004, HUM MOL GENET, V13, P1943, DOI 10.1093/hmg/ddh202; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Terakami S, 2013, ACTA HORTIC, V976, P463; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamamoto T, 2004, ACTA HORTIC, P51, DOI 10.17660/ActaHortic.2004.663.2; Yamamoto T, 2002, THEOR APPL GENET, V106, P9, DOI 10.1007/s00122-002-0966-5; Yamamoto T, 2007, BREEDING SCI, V57, P321, DOI 10.1270/jsbbs.57.321; Yamamoto Toshiya, 2009, V6, P163, DOI 10.1007/978-0-387-77491-6_8	47	59	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2013	8	10							e77022	10.1371/journal.pone.0077022	http://dx.doi.org/10.1371/journal.pone.0077022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	237RD	24155917	Green Published, Green Submitted, gold			2022-12-27	WOS:000325887300051
J	Cao, HP; Shockey, JM; Klasson, KT; Chapital, DC; Mason, CB; Scheffler, BE				Cao, Heping; Shockey, Jay M.; Klasson, K. Thomas; Chapital, Dorselyn C.; Mason, Catherine B.; Scheffler, Brian E.			Developmental Regulation of Diacylglycerol Acyltransferase Family Gene Expression in Tung Tree Tissues	PLOS ONE			English	Article							TRIACYLGLYCEROL BIOSYNTHESIS; TRIGLYCERIDE SYNTHESIS; ARABIDOPSIS-THALIANA; QUANTITATIVE PCR; SKELETAL-MUSCLE; MESSENGER-RNA; CLUSTAL-W; RT-PCR; OIL; CLONING	Diacylglycerol acyltransferases (DGAT) catalyze the final and rate-limiting step of triacylglycerol (TAG) biosynthesis in eukaryotic organisms. DGAT genes have been identified in numerous organisms. Multiple isoforms of DGAT are present in eukaryotes. We previously cloned DGAT1 and DGAT2 genes of tung tree (Vernicia fordii), whose novel seed TAGs are useful in a wide range of industrial applications. The objective of this study was to understand the developmental regulation of DGAT family gene expression in tung tree. To this end, we first cloned a tung tree gene encoding DGAT3, a putatively soluble form of DGAT that possesses 11 completely conserved amino acid residues shared among 27 DGAT3s from 19 plant species. Unlike DGAT1 and DGAT2 subfamilies, DGAT3 is absent from animals. We then used TaqMan and SYBR Green quantitative real-time PCR, along with northern and western blotting, to study the expression patterns of the three DGAT genes in tung tree tissues. Expression results demonstrate that 1) all three isoforms of DGAT genes are expressed in developing seeds, leaves and flowers; 2) DGAT2 is the major DGAT mRNA in tung seeds, whose expression profile is well-coordinated with the oil profile in developing tung seeds; and 3) DGAT3 is the major form of DGAT mRNA in tung leaves, flowers and immature seeds prior to active tung oil biosynthesis. These results suggest that DGAT2 is probably the major TAG biosynthetic isoform in tung seeds and that DGAT3 gene likely plays a significant role in TAG metabolism in other tissues. Therefore, DGAT2 should be a primary target for tung oil engineering in transgenic organisms.	[Cao, Heping; Shockey, Jay M.; Klasson, K. Thomas; Chapital, Dorselyn C.; Mason, Catherine B.] ARS, USDA, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA; [Scheffler, Brian E.] ARS, USDA, Genom & Bioinformat Res Unit, Stoneville, MS USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Cao, HP (corresponding author), ARS, USDA, So Reg Res Ctr, Commod Utilizat Res Unit, New Orleans, LA USA.	Heping.Cao@ars.usda.gov	Auguet, Jean-Christophe/H-5697-2015; Gu, Ji-Dong/AAF-2291-2019; Gu, Ji-Dong/AAO-7851-2020; Cao, Heping/AAC-1666-2021	Auguet, Jean-Christophe/0000-0003-4340-7161; Klasson, K. Thomas/0000-0003-3358-3081; Cao, Heping/0000-0002-0958-1468; Scheffler, Brian/0000-0003-1968-8952; Shockey, Jay/0000-0002-5057-5457	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS [6435-41000-106-00D]	USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS	This work was supported by the USDA-Agricultural Research Service Quality and Utilization of Agricultural Products Research Program 306 through CRIS 6435-41000-106-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CE, 1929, J AGRIC RES, V38, P0679; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x; Aranguren MI, 2012, POLYM TEST, V31, P7, DOI 10.1016/j.polymertesting.2011.09.001; Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034; Cao HP, 2013, IN VITRO CELL DEV-AN, V49, P759, DOI 10.1007/s11626-013-9671-8; Cao HP, 2013, IND CROP PROD, V50, P248, DOI 10.1016/j.indcrop.2013.07.030; Cao HP, 2012, J AGR FOOD CHEM, V60, P12296, DOI 10.1021/jf304690e; Cao HP, 2012, APPL MICROBIOL BIOT, V96, P711, DOI 10.1007/s00253-012-3869-7; Cao Heping, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-249; Cao HP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-73; Cao HP, 2004, J BIOL CHEM, V279, P21489, DOI 10.1074/jbc.M400900200; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Cao HP, 1999, PLANT PHYSIOL, V120, P205, DOI 10.1104/pp.120.1.205; CAO HP, 1995, PHYSIOL PLANTARUM, V95, P176, DOI 10.1111/j.1399-3054.1995.tb00825.x; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chen HC, 2004, DIABETES, V53, P1445, DOI 10.2337/diabetes.53.6.1445; Chen YH, 2012, RENEW ENERG, V44, P305, DOI 10.1016/j.renene.2012.01.098; Chen YH, 2010, BIORESOURCE TECHNOL, V101, P9521, DOI 10.1016/j.biortech.2010.06.117; Chen YC, 2010, IND CROP PROD, V32, P684, DOI 10.1016/j.indcrop.2010.06.009; Manh DV, 2012, ENERGY, V48, P519, DOI 10.1016/j.energy.2012.09.065; Durrett TP, 2010, P NATL ACAD SCI USA, V107, P9464, DOI 10.1073/pnas.1001707107; Dyer JM, 2004, J AM OIL CHEM SOC, V81, P647, DOI 10.1007/s11746-004-956-x; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; Gidda SK, 2009, PLANT PHYSIOL BIOCH, V47, P867, DOI 10.1016/j.plaphy.2009.05.008; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Hwang YT, 2004, PLANT CELL, V16, P3002, DOI 10.1105/tpc.104.026039; ICHIHARA K, 1988, BIOCHIM BIOPHYS ACTA, V958, P125, DOI 10.1016/0005-2760(88)90253-6; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; Kamisaka Y, 2007, BIOCHEM J, V408, P61, DOI 10.1042/BJ20070449; Kamisaka Y, 2010, APPL MICROBIOL BIOT, V88, P105, DOI 10.1007/s00253-010-2725-x; KOPACZ BM, 1968, J AM OIL CHEM SOC, V45, P285, DOI 10.1007/BF02652428; Kwiatkowska M, 2012, FOLIA HISTOCHEM CYTO, V50, P427, DOI [10.5603/19752, 10.5603/FHC.2012.0058]; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin JT, 1998, LIPIDS, V33, P59, DOI 10.1007/s11745-998-0180-3; Liu CG, 2013, IND CROP PROD, V43, P677, DOI 10.1016/j.indcrop.2012.07.072; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Park JY, 2008, APPL BIOCHEM BIOTECH, V148, P109, DOI 10.1007/s12010-007-8082-2; Pastor S, 2013, PLANT SCI, V203, P79, DOI 10.1016/j.plantsci.2012.12.009; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Peng ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061363; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POTTER GF, 1968, J AM OIL CHEM SOC, V45, P281, DOI 10.1007/BF02652427; PRYDE EH, 1979, J AM OIL CHEM SOC, V56, pA719, DOI 10.1007/BF02667427; Rani SH, 2013, MICROBIOL-SGM, V159, P155, DOI 10.1099/mic.0.063156-0; Rani SH, 2010, J BIOL CHEM, V285, P38337, DOI 10.1074/jbc.M110.133116; Roorda BD, 2005, J LIPID RES, V46, P230, DOI 10.1194/jlr.M400416-JLR200; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samadzadeh M, 2011, PROG ORG COAT, V70, P383, DOI 10.1016/j.porgcoat.2010.08.017; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHNEEBERGER C, 1995, PCR METH APPL, V4, P234; Schneider UV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038451; Shang Q, 2012, APPL BIOCHEM BIOTECH, V168, P106, DOI 10.1007/s12010-011-9364-2; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Shockey JM, 2005, PLANT SCI, V169, P375, DOI 10.1016/j.plantsci.2005.03.023; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Sonntag N.O.V., 1979, BAILEYS IND OIL FAT, V1, P289; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Tang F, 1998, PLANT PHYSIOL, V117, P717; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Weselake Randall J., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-24; Xu JY, 2008, PLANT BIOTECHNOL J, V6, P799, DOI 10.1111/j.1467-7652.2008.00358.x; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; ZIMMERMAN JM, 1968, J THEOR BIOL, V21, P170, DOI 10.1016/0022-5193(68)90069-6; Zou JT, 1999, PLANT J, V19, P645, DOI 10.1046/j.1365-313x.1999.00555.x	88	184	195	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2013	8	10							e76946	10.1371/journal.pone.0076946	http://dx.doi.org/10.1371/journal.pone.0076946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	236SL	24146944	Green Submitted, gold, Green Published			2022-12-27	WOS:000325819400090
J	Montanari, S; Louys, J; Price, GJ				Montanari, Shaena; Louys, Julien; Price, Gilbert J.			Pliocene Paleoenvironments of Southeastern Queensland, Australia Inferred from Stable Isotopes of Marsupial Tooth Enamel	PLOS ONE			English	Article							CHINCHILLA LOCAL FAUNA; EASTERN AUSTRALIA; LATE PLEISTOCENE; OXYGEN ISOTOPES; ATMOSPHERIC CO2; CARBON ISOTOPES; BONE PHOSPHATE; ICE CORE; ECOLOGY; BIOGEOCHEMISTRY	The Chinchilla Local Fauna is a diverse assemblage of both terrestrial and aquatic Pliocene vertebrates from the fluviatile Chinchilla Sand deposits of southeastern Queensland, Australia. It represents one of Australia's few but exceptionally rich Pliocene vertebrate localities, and as such is an important source of paleoecological data concerning Pliocene environmental changes and its effects on ecosystems. Prior inferences about the paleoenvironment of this locality made on the basis of qualitative observations have ranged from grassland to open woodland to wetland. Examination of the carbon and oxygen isotopes in the tooth enamel of marsupials from this site represents a quantitative method for inferring the paleoenvironments and paleoecology of the fossil fauna. Results from Chinchilla show that Protemnodon sp. indet. consumed both C3 and C4 photosynthesis plant types (mean delta C-13= -14.5 +/- 2.0%), and therefore probably occupied a mixed vegetation environment. Macropus sp. indet. from Chinchilla also consumed a mixed diet of both C3 and C4 plants, with more of a tendency for C4 plant consumption (mean delta C-13= -10.3 +/- 2.3%). Interestingly, their isotopic dietary signature is more consistent with tropical and temperate kangaroo communities than the sub-tropical communities found around Chinchilla today. Other genera sampled in this study include the extinct kangaroo Troposodon sp. indet. and the fossil diprotodontid Euryzygoma dunense each of which appear to have occupied distinct dietary niches. This study suggests that southeastern Queensland hosted a mosaic of tropical forests, wetlands and grasslands during the Pliocene and was much less arid than previously thought.	[Montanari, Shaena] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Louys, Julien; Price, Gilbert J.] Univ Queensland, Sch Earth Sci, St Lucia, Qld, Australia	American Museum of Natural History (AMNH); University of Queensland	Montanari, S (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	smontanari@amnh.org	Crowhurst, Ross N/N-8892-2017; Bus, Vincent/B-1318-2011; Chagne, David/A-2596-2010; Gardiner, Susan Elizabeth/A-2477-2010; Louys, Julien/GLN-6714-2022; Malnoy, Mickael/AAO-5431-2021; Price, Gilbert J/N-3282-2013; Knaebel, Mareike/O-5631-2016; malnoy, mickael/C-5007-2012; Wiedow, Claudia/O-9291-2016	Crowhurst, Ross N/0000-0003-0608-2134; Bus, Vincent/0000-0003-4071-4457; Chagne, David/0000-0003-4018-0694; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Malnoy, Mickael/0000-0002-5158-534X; Price, Gilbert J/0000-0001-8406-4594; Knaebel, Mareike/0000-0002-0293-1250; malnoy, mickael/0000-0002-5158-534X; Wiedow, Claudia/0000-0003-3402-5460; Schaffer, Robert/0000-0003-1272-667X; Louys, Julien/0000-0001-7539-0689; Velasco, Riccardo/0000-0002-8760-5031; Montanari, Sara/0000-0001-9224-056X	National Science Foundation; Richard Gilder Graduate School; University of Queensland; University of Queensland [2012003222]; Australian Research Council [DE120101533]; Australian Research Council (ARC) [DP0881279]	National Science Foundation(National Science Foundation (NSF)); Richard Gilder Graduate School; University of Queensland(University of Queensland); University of Queensland(University of Queensland); Australian Research Council(Australian Research Council); Australian Research Council (ARC)(Australian Research Council)	SM was supported by the National Science Foundation Graduate Research Fellowship and the Richard Gilder Graduate School. JL is supported by University of Queensland Postdoctoral Fellowship and University of Queensland Early Career Research Grant 2012003222. GJP is supported by Australian Research Council grant DE120101533 and Australian Research Council (ARC) Discovery Grant DP0881279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer M, 1994, HIST AUSTR VEGETATIO, P80; AYLIFFE LK, 1990, GEOCHIM COSMOCHIM AC, V54, P2603, DOI 10.1016/0016-7037(90)90246-H; BARTHOLOMAI A, 1975, Memoirs of the Queensland Museum, V17, P195; Bartholomai A., 1976, BUREAU MINERAL RESOU, V166, P151; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; Bocherens H, 1996, PALAIOS, V11, P306, DOI 10.2307/3515241; Cerling TE, 1999, OECOLOGIA, V120, P364, DOI 10.1007/s004420050869; COPLEN TB, 1994, PURE APPL CHEM, V66, P273, DOI 10.1351/pac199466020273; DANSGAARD W, 1964, TELLUS, V16, P436; Dawson L, 2004, ALCHERINGA, V28, P275, DOI 10.1080/03115510408619285; Dawson L, 2004, ALCHERINGA, V28, P267, DOI 10.1080/03115510408619284; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; EPSTEIN S, 1977, SCIENCE, V198, P1209, DOI 10.1126/science.198.4323.1209; Forbes MS, 2010, PALAEOGEOGR PALAEOCL, V291, P319, DOI 10.1016/j.palaeo.2010.03.003; Fraser RA, 2008, PALAEOGEOGR PALAEOCL, V269, P66, DOI 10.1016/j.palaeo.2008.08.004; FRIEDLI H, 1986, NATURE, V324, P237, DOI 10.1038/324237a0; GAFFNEY E S, 1981, American Museum Novitates, P1; GAFFNEY ES, 1979, J PALEONTOL, V53, P1354; Greenwood D. R., 2005, Tropical rainforests: past, present and future, P336; Grocke DR, 1997, AUST J BOT, V45, P607, DOI 10.1071/BT96040; HATTERSLEY PW, 1983, OECOLOGIA, V57, P113, DOI 10.1007/BF00379569; Hill Robert S., 1992, Beagle, V9, P1; Hill RS, 1994, HIST AUSTR VEGETATIO; HILLSON S, 1996, DENT ANTHR; Johnson BJ, 1997, PALAEOGEOGR PALAEOCL, V136, P121, DOI 10.1016/S0031-0182(97)00043-6; Koch PL, 1998, CHEM GEOL, V152, P119, DOI 10.1016/S0009-2541(98)00101-6; Kohn MJ, 1999, SCIENCE, V283, P335, DOI 10.1126/science.283.5400.335; LEETHORP JA, 1989, J HUM EVOL, V18, P183, DOI 10.1016/0047-2484(89)90048-1; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; LOCKER S, 1986, INITIAL REP DEEP SEA, V90, P1079; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; MacFadden BJ, 2004, OECOLOGIA, V140, P169, DOI 10.1007/s00442-004-1571-x; Mackness BS, 2000, AUST J EARTH SCI, V47, P807, DOI 10.1046/j.1440-0952.2000.00812.x; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; McGowran B., 2000, Memoir of the Association of Australasian Palaeontologists, V23, P405; Murphy BP, 2007, GEOCHIM COSMOCHIM AC, V71, P3847, DOI 10.1016/j.gca.2007.05.012; Murphy BP, 2007, FUNCT ECOL, V21, P757, DOI 10.1111/j.1365-2435.2007.01284.x; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; OLSON S L, 1975, Emu, V75, P49; OLSON S L, 1977, Emu, V77, P127; Price GJ, 2012, EPISODES, V35, P160, DOI 10.18814/epiiugs/2012/v35i1/015; Price GJ, 2008, QUATERNARY SCI REV, V27, P2516, DOI 10.1016/j.quascirev.2008.08.026; Price GJ, 2009, REC AUST MUS, V61, P39, DOI 10.3853/j.0067-1975.61.2009.1518; Prideaux GJ, 2007, NATURE, V445, P422, DOI 10.1038/nature05471; Sponheimer M, 1999, J ARCHAEOL SCI, V26, P723, DOI 10.1006/jasc.1998.0388; Tedford R. H., 1992, Beagle, V9, P173; Tedford R. H., 2006, ALCHERINGA AUSTRALAS, V30, P313, DOI [10.1080/03115510609506870, DOI 10.1080/03115510609506870]; TIESZEN LL, 1991, J ARCHAEOL SCI, V18, P227, DOI 10.1016/0305-4403(91)90063-U; Travouillon KJ, 2009, PALAEOGEOGR PALAEOCL, V276, P24, DOI 10.1016/j.palaeo.2009.02.025; Woods J.T., 1960, J GEOL SOC AUST, V7, P393; Wroe S, 2000, ALCHERINGA, V24, P319, DOI 10.1080/03115510008619535; Yeakel JD, 2007, P ROY SOC B-BIOL SCI, V274, P1723, DOI 10.1098/rspb.2007.0330	52	59	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66221	10.1371/journal.pone.0066221	http://dx.doi.org/10.1371/journal.pone.0066221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	24155917	gold, Green Published, Green Submitted			2022-12-27	WOS:000320322400088
J	Dahal, N; Abdelhamed, H; Lu, JJ; Karsi, A; Lawrence, ML				Dahal, Neeti; Abdelhamed, Hossam; Lu, Jingjun; Karsi, Attila; Lawrence, Mark L.			Tricarboxylic Acid Cycle and One-Carbon Metabolism Pathways Are Important in Edwardsiella ictaluri Virulence	PLOS ONE			English	Article							ESCHERICHIA-COLI; FUMARATE REDUCTASE; CHANNEL CATFISH; SUCCINATE-DEHYDROGENASE; MUTANT; REPLACEMENT; EXPRESSION; VACCINE; GENES; LIVE	Edwardsiella ictaluri is a Gram-negative facultative intracellular pathogen causing enteric septicemia of channel catfish (ESC). The disease causes considerable economic losses in the commercial catfish industry in the United States. Although antibiotics are used as feed additive, vaccination is a better alternative for prevention of the disease. Here we report the development and characterization of novel live attenuated E. ictaluri mutants. To accomplish this, several tricarboxylic acid cycle (sdhC, mdh, and frdA) and one-carbon metabolism genes (gcvP and glyA) were deleted in wild type E. ictaluri strain 93146 by allelic exchange. Following bioluminescence tagging of the E. ictaluri Delta sdhC, Delta mdh, Delta frdA, Delta gcvP, and Delta glyA mutants, their dissemination, attenuation, and vaccine efficacy were determined in catfish fingerlings by in vivo imaging technology. Immunogenicity of each mutant was also determined in catfish fingerlings. Results indicated that all of the E. ictaluri mutants were attenuated significantly in catfish compared to the parent strain as evidenced by 2,265-fold average reduction in bioluminescence signal from all the mutants at 144 h post-infection. Catfish immunized with the E. ictaluri Delta sdhC, Delta mdh, Delta frdA, and Delta glyA mutants had 100% relative percent survival (RPS), while E. ictaluri Delta gcvP vaccinated catfish had 31.23% RPS after re-challenge with the wild type E. ictaluri.	[Dahal, Neeti; Lu, Jingjun; Karsi, Attila; Lawrence, Mark L.] Mississippi State Univ, Coll Vet Med Sci, Dept Basic Sci, Mississippi State, MS 39762 USA; [Abdelhamed, Hossam] Benha Univ, Fac Vet Med, Dept Fish Dis & Management, Moshtohor Toukh, Egypt	Mississippi State University; Egyptian Knowledge Bank (EKB); Benha University	Karsi, A (corresponding author), Mississippi State Univ, Coll Vet Med Sci, Dept Basic Sci, Mississippi State, MS 39762 USA.	karsi@cvm.msstate.edu; lawrence@cvm.msstate.edu	Karsi, Attila/AAG-5046-2019; Dahanukar, Neelesh/B-2816-2012	Karsi, Attila/0000-0001-6845-3346; Dahanukar, Neelesh/0000-0001-7162-9023; Padhye, Anand/0000-0002-5971-4759; Molur, Sanjay/0000-0001-8230-518X; Modak, Nikhil/0000-0003-3303-7056	United States Department of Agriculture [2009-65119-05671]	United States Department of Agriculture(United States Department of Agriculture (USDA))	The research reported herein was supported by United States Department of Agriculture grant #2009-65119-05671 to MLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamed H, 2013, VET MICROBIOL, V162, P858, DOI 10.1016/j.vetmic.2012.11.006; AINSWORTH AJ, 1990, DEV COMP IMMUNOL, V14, P201, DOI 10.1016/0145-305X(90)90091-R; Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; [Anonymous], 2006, CASE SUMMARY REPORT; Arias CR, 2003, J FISH DIS, V26, P415, DOI 10.1046/j.1365-2761.2003.00475.x; Barker HC, 2000, MOL MICROBIOL, V35, P1518, DOI 10.1046/j.1365-2958.2000.01820.x; Booth NJ, 2006, J AQUAT ANIM HEALTH, V18, P101, DOI 10.1577/H05-025.1; Cooper Richard K. Ii, 1996, Journal of Aquatic Animal Health, V8, P319, DOI 10.1577/1548-8667(1996)008&lt;0319:UOAMTT&gt;2.3.CO;2; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Dung TT, 2008, MICROB DRUG RESIST, V14, P311, DOI 10.1089/mdr.2008.0848; Ge ZM, 2000, MICROB PATHOGENESIS, V29, P279, DOI 10.1006/mpat.2000.0391; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Karsi A, 2007, PLASMID, V57, P286, DOI 10.1016/j.plasmid.2006.11.002; Karsi A, 2006, FEMS MICROBIOL LETT, V260, P216, DOI 10.1111/j.1574-6968.2006.00310.x; Karsi A, 2009, APPL ENVIRON MICROB, V75, P2166, DOI 10.1128/AEM.02449-08; Klesius PH, 1997, AQUACULTURE, V157, P147, DOI 10.1016/S0044-8486(97)00076-8; Klesius PH, 1999, ADV VETER MED AP, V41, P523; Lan MZ, 2007, FISH SHELLFISH IMMUN, V23, P521, DOI 10.1016/j.fsi.2006.11.002; Lawrence ML, 1997, INFECT IMMUN, V65, P4642, DOI 10.1128/IAI.65.11.4642-4651.1997; Lawrence ML, 1997, VET MICROBIOLOGY PAR; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; MEEDEL TH, 1974, J BACTERIOL, V118, P905, DOI 10.1128/JB.118.3.905-910.1974; Mercado-Lubo R, 2008, INFECT IMMUN, V76, P1128, DOI 10.1128/IAI.01226-07; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; PLAMANN MD, 1983, MOL GEN GENET, V192, P15, DOI 10.1007/BF00327641; Santander J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015944; STAUFFER LT, 1994, GENE, V142, P17, DOI 10.1016/0378-1119(94)90349-2; Thune RL, 1999, J AQUAT ANIM HEALTH, V11, P358, DOI 10.1577/1548-8667(1999)011&lt;0358:AAMOEI&gt;2.0.CO;2; USDA, 2003, HIGHL NAHMS CATF 2 2; Waterstrat PR, 1988, J FISH DIS, V289-294; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	35	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65973	10.1371/journal.pone.0065973	http://dx.doi.org/10.1371/journal.pone.0065973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762452	gold, Green Published, Green Submitted			2022-12-27	WOS:000321094800082
J	Guo, FD; Liu, CL; Xia, H; Bi, YP; Zhao, CZ; Zhao, SZ; Hou, L; Li, FG; Wang, XJ				Guo, Fengdan; Liu, Chuanliang; Xia, Han; Bi, Yuping; Zhao, Chuanzhi; Zhao, Shuzhen; Hou, Lei; Li, Fuguang; Wang, Xingjun			Induced Expression of AtLEC1 and AtLEC2 Differentially Promotes Somatic Embryogenesis in Transgenic Tobacco Plants	PLOS ONE			English	Article							AUXIN RESPONSE FACTORS; TRANSCRIPTION FACTOR; LEAFY COTYLEDON1; MERISTEM GENE; ARABIDOPSIS; ETHYLENE; ENCODES; LEAFY-COTYLEDON1; BIOSYNTHESIS; MAINTENANCE	Arabidopsis LEAFY COTYLEDON (LEC) genes, AtLEC1 and AtLEC2, are important embryonic regulators that play key roles in morphogenesis and maturation phases during embryo development. Ectopic expression of AtLEC1 and AtLEC2 in tobacco caused abnormality in transgenic seedling. When transgenic seeds germinated on medium containing 30 mM DEX, LEC1 transgenic seedlings were ivory and fleshy, with unexpanded cotyledons, stubby hypocotyls, short roots and no obvious callus formation at the shoot meristem position. While LEC2 transgenic seedlings formed embryonic callus on the shoot apical meristem and somatic embryo-like structures emerged from the surface of the callus. When callus were transferred to hormone free MS0 medium more shoots were regenerated from each callus. However, shoot formation was not observed in LEC1 overexpressors. To investigate the mechanisms of LEC2 in somatic embryogenesis, we studied global gene expression by digital gene expression profiling analysis. The results indicated that ectopic expression of LEC2 genes induced accumulation of embryo-specific proteins such as seed storage proteins, late embryogenesis abundant (LEA) proteins, fatty acid biosynthetic enzymes, products of steroid biosynthesis related genes and key regulatory genes of the embryo development. Genes of plant-specific transcription factors such as NAC domain protein, AP2 and GRAS family, resistance-related as well as salicylic acid signaling related genes were up-regulated in LEC2 transgenic seedlings. Ectopi c expression of LEC2 induced large number of somatic embryo formation and shoot regeneration but 20 d DEX induction of LEC1 is not sufficient to induce somatic embryogenesis and shoot formation. Our data provide new information to understand the mechanisms on LEC2 gene's induction of somatic embryogenesis.	[Guo, Fengdan; Xia, Han; Bi, Yuping; Zhao, Chuanzhi; Zhao, Shuzhen; Hou, Lei; Wang, Xingjun] Shandong Acad Agr Sci, High Tech Res Ctr, Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan, Peoples R China; [Liu, Chuanliang; Li, Fuguang] Cotton Res Inst CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China; [Guo, Fengdan; Bi, Yuping; Wang, Xingjun] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shandong Normal University	Li, FG (corresponding author), Cotton Res Inst CAAS, State Key Lab Cotton Biol, Anyang, Peoples R China.	aylifug@163.com; xingjunw@hotmail.com	Zhao, Chuanzhi/AAC-9232-2022	Zhang, Tong/0000-0003-1148-4322; Ju, Feng/0000-0003-4137-5928	genetically modified organisms breeding major projects [2011ZX08010-004]; National Natural Science Foundation of China [30871324, 31000720, 31101427]; Shandong Province Natural Science Foundation [ZR2010CZ002, ZR2011CZ002, ZR2010CQ008]; Shandong Province "Taishan Scholar'' foundation [tshw20100416]	genetically modified organisms breeding major projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Province "Taishan Scholar'' foundation	This study was supported by genetically modified organisms breeding major projects (2011ZX08010-004); National Natural Science Foundation of China (30871324, 31000720, 31101427); Shandong Province Natural Science Foundation (ZR2010CZ002, ZR2011CZ002, ZR2010CQ008); and Shandong Province "Taishan Scholar'' foundation (tshw20100416). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Casson SA, 2006, PLANT PHYSIOL, V142, P526, DOI 10.1104/pp.106.080895; Chen Q, 2011, PLANT CELL, V23, P3335, DOI 10.1105/tpc.111.089870; Curaba J, 2004, PLANT PHYSIOL, V136, P3660, DOI 10.1104/pp.104.047266; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Harding EW, 2003, PLANT PHYSIOL, V133, P653, DOI 10.1104/pp.103.023499; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; HECK GR, 1995, PLANT CELL, V7, P1271, DOI 10.1105/tpc.7.8.1271; HORSCH RB, 1986, P NATL ACAD SCI USA, V83, P2571, DOI 10.1073/pnas.83.8.2571; Imin N, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-110; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; Karami Omid, 2009, J Chem Biol, V2, P177, DOI 10.1007/s12154-009-0028-4; Kumar V, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue2-fulltext-1; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; MEINKE DW, 1994, PLANT CELL, V6, P1049, DOI 10.1105/tpc.6.8.1049; Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; ROUSTAN JP, 1990, BIOL PLANTARUM, V32, P273, DOI 10.1007/BF02886947; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shkolnik-Inbar D, 2011, PLANT SIGNAL BEHAV, V6, P694, DOI 10.4161/psb.6.5.14978; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; To A, 2006, PLANT CELL, V18, P1642, DOI 10.1105/tpc.105.039925; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Wang H, 2004, PLANT CELL, V16, P1206, DOI 10.1105/tpc.021261; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; WEST MAL, 1994, PLANT CELL, V6, P1731, DOI 10.1105/tpc.6.12.1731; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Zheng QL, 2013, PLANT PHYSIOL, V161, P2113, DOI 10.1104/pp.113.216275; Zheng YM, 2009, PLANT CELL, V21, P2563, DOI 10.1105/tpc.109.068890	44	109	117	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2013	8	8							e71714	10.1371/journal.pone.0071714	http://dx.doi.org/10.1371/journal.pone.0071714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	200UV	24146837	Green Published, Green Submitted, gold			2022-12-27	WOS:000323097300146
